<SEC-DOCUMENT>0000883984-22-000041.txt : 20220809
<SEC-HEADER>0000883984-22-000041.hdr.sgml : 20220809
<ACCEPTANCE-DATETIME>20220808193400
ACCESSION NUMBER:		0000883984-22-000041
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		113
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220809
DATE AS OF CHANGE:		20220808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICU MEDICAL INC/DE
		CENTRAL INDEX KEY:			0000883984
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330022692
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34634
		FILM NUMBER:		221145997

	BUSINESS ADDRESS:	
		STREET 1:		951 CALLE AMANECER
		CITY:			SAN CLEMENTE
		STATE:			CA
		ZIP:			92763-6212
		BUSINESS PHONE:		949-366-2183

	MAIL ADDRESS:	
		STREET 1:		951 CALLE AMANECER
		CITY:			SAN CLEMENTE
		STATE:			CA
		ZIP:			92763-6212
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>icui-20220630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:b855b77c-6988-4216-8748-36632a973ac3,g:ab2a959a-be44-44c8-8165-c7a4fa090087,d:10abb94289aa46ab94dfc506ddec4961--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:icui="http://www.icumed.com/20220630" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>icui-20220630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80L2ZyYWc6NjA1Mzg3MTEyZjY0NDk5ZThkNWVkZTJhNzEyMTI2ZTQvdGFibGU6YWRkYjRjODNiYTY4NDU3M2E4ZWI0ZGI1MjQwMWYyYzYvdGFibGVyYW5nZTphZGRiNGM4M2JhNjg0NTczYThlYjRkYjUyNDAxZjJjNl8yLTEtMS0xLTg1NDI3_a9ce8c61-8d5a-44b6-a3c1-c1e5af60049e">0000883984</ix:nonNumeric><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80L2ZyYWc6NjA1Mzg3MTEyZjY0NDk5ZThkNWVkZTJhNzEyMTI2ZTQvdGFibGU6YWRkYjRjODNiYTY4NDU3M2E4ZWI0ZGI1MjQwMWYyYzYvdGFibGVyYW5nZTphZGRiNGM4M2JhNjg0NTczYThlYjRkYjUyNDAxZjJjNl8zLTEtMS0xLTg1NDI3_25f1cd81-f1cd-4db6-bed5-692dac619088">ICU MEDICAL INC/DE</ix:nonNumeric><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80L2ZyYWc6NjA1Mzg3MTEyZjY0NDk5ZThkNWVkZTJhNzEyMTI2ZTQvdGFibGU6YWRkYjRjODNiYTY4NDU3M2E4ZWI0ZGI1MjQwMWYyYzYvdGFibGVyYW5nZTphZGRiNGM4M2JhNjg0NTczYThlYjRkYjUyNDAxZjJjNl80LTEtMS0xLTg1NDI3_c6f28d5f-2f58-46c0-b56d-889ce0968e7f">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80L2ZyYWc6NjA1Mzg3MTEyZjY0NDk5ZThkNWVkZTJhNzEyMTI2ZTQvdGFibGU6YWRkYjRjODNiYTY4NDU3M2E4ZWI0ZGI1MjQwMWYyYzYvdGFibGVyYW5nZTphZGRiNGM4M2JhNjg0NTczYThlYjRkYjUyNDAxZjJjNl81LTEtMS0xLTg1NDI3_3a4adc2b-d4b3-41b3-bfd5-e8220fb59d63">December 31</ix:nonNumeric><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80L2ZyYWc6NjA1Mzg3MTEyZjY0NDk5ZThkNWVkZTJhNzEyMTI2ZTQvdGFibGU6YWRkYjRjODNiYTY4NDU3M2E4ZWI0ZGI1MjQwMWYyYzYvdGFibGVyYW5nZTphZGRiNGM4M2JhNjg0NTczYThlYjRkYjUyNDAxZjJjNl82LTEtMS0xLTg1NDI3_584032b8-2b25-4fda-961d-940de8f7a48e">2022</ix:nonNumeric><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80L2ZyYWc6NjA1Mzg3MTEyZjY0NDk5ZThkNWVkZTJhNzEyMTI2ZTQvdGFibGU6YWRkYjRjODNiYTY4NDU3M2E4ZWI0ZGI1MjQwMWYyYzYvdGFibGVyYW5nZTphZGRiNGM4M2JhNjg0NTczYThlYjRkYjUyNDAxZjJjNl83LTEtMS0xLTg1NDI3_30a58d44-dee6-40c5-a6c3-7f2e49af24d5">Q2</ix:nonNumeric><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU2_ddab537f-8bc6-4122-8738-75e9f83ccca8">P9Y</ix:nonNumeric><ix:nonNumeric contextRef="idd93fce1951b4c91b5dfa5a11db9552d_D20220101-20220630" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU3_94ff8303-bbea-4e2c-80a0-75c79ec80ddf">P8Y</ix:nonNumeric><ix:nonNumeric contextRef="i4ddbcba35a73453a9962ad5faf060cf7_D20220101-20220630" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU4_39b70a39-6a8c-49b7-a62c-b1011d2a541c">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="i497114901c8d417699b72d49f9b47c6f_D20220101-20220630" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU5_9bab9dac-782a-4c71-afdc-921a87d1c7b7">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i85f9f9c7345841549043760a5ef3a629_D20220101-20220630" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDYw_9c9b33b6-6b8e-4b28-8e2a-6c3cc63df867">P6Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="icui-20220630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad30622d1b0f462ca40c8e5a1116afb3_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c62d5316ba94e7c8299c081bae93fc3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1020977b89154456bc4bc43c30abde86_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f541893d2604b1cb5bdb8cdba0b8805_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c3e5c01706a44a59cb0634c607efb09_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f27b113c4d4421a8448db7016572b2f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc6f5985837b4f60a2b0978f880b946b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ba7f4943fe34dcd87c78019ba0eaec5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ca88d5a959149c5ab0f5a844b420ce3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ee94c9079b94b2d8fa66b18e8121025_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94d55d90e0334acf8952a54ea3eb127b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i588327c08f70456fada2d66c38b51e64_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b031e42e24b410b9c3e6366a1a16a57_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1f9683afb0c4a3ea5a33c6e397e1533_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41bb039617594a87acecb9723e17821e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie62f7b97e63d401a8fa9db1823871df6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f837794d02a4a309041880510914516_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i751dca1c7f254c71bec4904c65af1d0b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b2480b622124e56a1087548cb6e0cf0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i396ef2387b3b4cfe950c3f23ad00b3cd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f22c3698eff4a70b949d07786441335_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic71346e40fe54d37ba3383c1be84de74_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i204a869a54cc47739b6dbf488053eeb3_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia068519b02ab427c9665a8614ee0735b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea288493ae2f462290ba011ea37b3d86_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id920d44e14eb45dd938699e476719d0a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e061c30f5d84e94bc70f17124d6757b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb1f82e7e0dc42abae0fc933d35a46e1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e4fef5bff944c76884d175d38d5163b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica66dd658337400da4427ae2a417bec7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b64a06bc2aa421788ade8257344c7c6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb7bc6143f0a46a8905e6b6f840e73b8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec8771f969b149858b2fe843e8e5ca57_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d268c33a3374123930ac2daf085b23a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1b618394b8c4a9fbd7ef856984c3846_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87a9b654e9114b85a43f7707ccf4a716_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i270393932a514786a51aea891f82a426_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf3bdc1709be44ab8f7e21eff6b6f947_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d78058125d8497e8caf757d8e36e07b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21594db97b18415da81085ad86be9dbe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i370da095060646f9b9a5b42d2b8a471c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3710964cba21471c9be4ef3805401052_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic44bcf27ee524bb48481e9f36804453e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8313f8bcbe94858a403e65a717841bf_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic01f9f53437648c6a182b99958017af1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c7325fe79e2481bb7929b1555e5d560_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i341cb29b86794db193ec2722d6ed4c0b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33f91750301e465f851bd681c449d83b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87b490ee070e48afb48c060408137232_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i677d5b1f2bf24e7e814304d237496841_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieddaa7ac708c434c8a3193b3e07498ba_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02543008f10f4f5e88a7d69f73b7216b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide0cac148c1a4f83bdc265c0ca6c1a88_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5a196eec7194c459ffcb870a785ba8d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic868ed7581a2477f82cf3b4625c2c5ae_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09c6e851dc8544dc80903b26922759ba_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibff8b68601c04517ba11d27b118b9b3b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8235a1a7b2144b4484a52b863d830ae2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dcbcc32613744fd9211f209efad177d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7094f1ba4fdb4923823c90a6d6847969_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib67e39c6b55d4121bfac0b087eaee089_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7b9ceb789614f918f4e10ee376eb65a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e358c7559e544b4bb8922a2a7bde625_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59f12359cc364997814de3aec371b48f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i072d1cca614444628db770eff0b59d62_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3e56704a1f44738b385e2b4569e21d0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55063029c0d44ea78a93faf80c101754_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic338096c01ce4426a46e77906113c1b8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i92956d7d960f45f3bea45f7aa025342c_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5289794172a4cb198e8aa0169b4c3b2_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9639169305914239b5bd07cfd412c105_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd1869288e4244bfa1eeb70afaf8d8b1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">icui:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69cd3733592345e3b3f6a2fba4b5f08d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic884346985a24c95b00b5aacf1b3975a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd93fce1951b4c91b5dfa5a11db9552d_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ddbcba35a73453a9962ad5faf060cf7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i497114901c8d417699b72d49f9b47c6f_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85f9f9c7345841549043760a5ef3a629_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida3d6c67a93c4582b8cb475e3d531c8c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c90af4126704fd9b931fd425c90445a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3f122ddd9b745f8952af44b2b23b0cb_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe03e5366a5944d9a0a9a40abcb641dc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30121bdcbe2c464c8ed3b44ec7055f4b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebdd9a3a6a1149b18e00453de01f406d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77a00ec4d4be4edfb0626ca6dc4a51d8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f5dcf4e8d7c447c96f6a1391e551243_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a9ce85809f343a4aa82fc58533ef7f7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia97a17795307447680a6d14b0a583adb_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6ddb824958a4849b40442c9bad27a5a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dd4e597d17447488d221348105e1bdd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i512b8be12e094d459307488f3940c386_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i349a5bf778244242883e275326abbbc6_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3c50f5fe7bb40ffacbf183985941a02_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4c07ed0518e42d8a531402774100df5_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefd60bb319394d118b895166607b7b8d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee3b1a6579e747d2a23f2be0ea003d7c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10978132bc5f4022a4c6518a79988c69_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2aeab60d1fcb4a7584c05d0319a0b156_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i961a96cb425c440eada93964a19186b9_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbee468195c04505b91056e9f3302922_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i920322efa6a64088a2f6d5a382fc36ce_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae1bb5bb3d0f4ae98eaf40951a717632_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i491a4bfbfd2746e19e9d49c2c5681cee_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8821ac00c20b4afc99c120d017a83ecb_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i712c9670278049fc823b141f1937afa2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id35f7bc641e64653a45020c7540094a9_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22c729de11504d73a6a77ce1d5ccc78f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bf1efd2f7fc49028373bab90caa5c99_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesSmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ee76c84d43746a9b29b9dbe3e3cbab5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesSmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c55a4b3cfe845d386e5ac7d196b83a1_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesSmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58eace8558db4d639d849abeb781cfeb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesSmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77b4bc25012a43c1af56c984cacd3be8_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VascularAccessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if311b897ac014b9587d953a2b2922e0b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VascularAccessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3ea2c1e27c94bdaa8b13528fbdb0dcb_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VascularAccessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7c8ec6c32704111ac8f0d54f2437ec5_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VascularAccessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i700cf99eae6a4036bea762420b65262e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VitalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c0e18fb79fa41c49a1d8e3564ebaf32_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VitalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bedb9e9ac7948fc9e52661e267a3094_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VitalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3587782975144bb967dd1df75ddee2f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VitalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b87c8dac7974a8782e310a9135de722_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7260b43edc5c4f09b88e2c68f47f0400_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib727cbf7f11a4c139194b7e121bfd07c_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e56919e5c00481180fbdf59082fd04d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbc9ee3ce53e43b9a4de6b99351dbc6c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd47aba974954e0781a2414535bc312d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2457c39ef148408db901026663d3bfb7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id767533fe49f44c4a9d6dfa028a7691f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c248127119d40b5845f0892855f08ae_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b13c4aa80b74968a828e6ba37616e44_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8435bfea45414116839eacf40cc750c4_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fba10f79d7446689094ad47012f06b7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3de7eb8fd7af48e39044549859b11d7a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4627a160fec94c4fb9bc050310d7da34_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2150dcd378042cdb345d5d0d362d0ed_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8494e9281e3c4b64a4ce4f950c59f2db_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad535f7eeb684a27aeb1b18c36ba3197_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50a1c52d23e24394a0575ed9cb391bf5_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if490f6070f954ef6a7b2580ba7b91d5a_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b423f9055fe4080a992d69631ef9969_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i288a4309c79045fab93c86aeac495b54_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id013675bfeeb448290d2bae1c0721424_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib78f819fc4074defb921bd3f7e151c87_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2160e64516a449cbb6842e6568cca20_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd0f6486a9914867b3cbed5c46e761c4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96315c122c9e477f909fef66929bc3ef_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20a968e1b0184b1bb3eccc6e2daa86f6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1deebfa912054645813b6d49cf6b7ae2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i053cf9509eae4840907fad5c27160755_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36cddf068b6e4a8597c963ee835bdc8e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d633f7881b646788b8fc5ddcda35b2b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6801313ae892411d80498d2ae6f075f6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c13faab0ca94890afab0dfa9adc50c3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i097d704989b14390b8eebff2668fa80d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dc422a484844921bbf2f8fbbb10898d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i553b9c6ad3c74f348590e3901e6e1b17_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf36e1c35c0a471f9a34f9aed4cbef39_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i028128b1abf446339af1e589f519b8d9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CZK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5248e92406ce4b4b8dd1c3ea4e3ec5e0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b6271edab564d0d9a598187c3a83a1b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife89df7388b14e7cb238bfad25c03b9f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64b799c44978482fb2ff58859d2765f8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:Srt_MultipleCurrencyAxisAxis">icui:OtherCurrenciesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice7c1260b0af4402ab4a9770171b528b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="mxn"><xbrli:measure>iso4217:MXN</xbrli:measure></xbrli:unit><xbrli:context id="i2c64e77d7d424ea9a38c6d4686e8b917_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8409b01efbb64d52a8e1b1ba086f135b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge3MemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55561adaa418415b8dbb5d994e03b04a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19fbaecc04d148dd8a7958cc6db4d311_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib22458f807284867a571b93988d38746_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f054f416194468e9358fe16a192fca7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if944aaea429e473cb610016ebaa83d93_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e2c0ba582504cc48fcbbe00aa935289_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie49637e4065640909d80091d4f51b5e2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6c822cbb6204a8fbc869b98546fc0a9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia88b203034af462ba59ce8d2a771f6a4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30640c390ffe4ca3bbe943506380dba9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3055adfcb5fa4b46a0af772247ae8ab3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5ed44f463b34b44bccf081e0e44d41f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac7fe1e5d9204ae3b38fd2c49a0a6e89_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6f8316a6a9c4c7b91a059642a5d585a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i835758b56b034a758a8a1945eb8fc86a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea1b1e213c5e4dee964f3d2dcaa7b6c7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1440f9c7c021440dbd8518b33fc69b16_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia03482d0fb2b4cb88ba9ce3d231c7823_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcc8fe10383a4514ae5fb955ea53cee7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic437309b851c4a58af26fe68c63fb604_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9410778f607e40788f828c216003f59c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36babf8d7dfd41d181155b5c382f90ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b64e553997e42bfa00e761e1f1423e1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa0f2e530a594d488d3ff7ff069e9259_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a827026c8f345f481b0f331dcd5ab32_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie10e3fd3b1274966991829e8a47fb1c2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0057918c4754ed39cdcb09ec091a595_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1083c069125426aaf5b7d941291660b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33a3cf5799fb4e7697ec6da3105f357e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7eba8aa425b64fd29a1360ccd19218c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ef45ebfcb134a09b0559c70de16d1c2_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie350394256c849be935f6f7e19ce7ae1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25a9e2b857e94469b5a51e1bd32d2292_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ca9c6f83f3d4ea38a171209da718f73_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6be297d6f8ec4c55a99cf8bffc94a709_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id416d1da99e846e3aaa8a4ffd93c3dc0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie64ccbe5cd244a88a92378e31ed3beea_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ad63d7dee5443088e6be3aff832a962_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f932f4ad8184e0b96bb58e33032ad67_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:TradingRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51abb32c548d4ae5992b6128d78ae406_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:TradingRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f713455967a47018e27c47844e6c2c8_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:TradingRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5e0141476f94fe0bfee40a9c342136d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:TradingRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e3b921cd5684eac8e40c2c8881181c2_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4621aecc6f943bcb50bb51cdee5e129_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa5feb023289462185a42fb720643359_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1beaa72fcf4443b087df773c477cfd11_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae30f57ba95c4fc1ab17958acaab1941_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0da6f417faba4021a4bd87936cc94e7a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fc915cd5e904c928ed953fcd58e88e7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24fdd3c882204e068d38aca3948a28fb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia62f1bfa4e614fbc90c0973fbb269e1b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie258ecbde2a94022ab481b913bd25b59_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib35fc47993e9429b8c5b9c8b0c6f2875_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8ab8c183e0c4d38ac3476ef91b085a0_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5fdd88104094d56a78a0e9fabdc14a4_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bead07f8fe6479b8b72129168423936_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24098b59b80b4522b8391e7bf6c24095_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62dc3d65ef234ddea6fa46fa39a08264_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ac4af49606d42a88d64c2bf0f4d2ffd_I20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f9761d9634c46b781358f8378ab19ae_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b0af7a88e20446b955b939f110edf80_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i145f9f310696405282fedab047eef187_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5deeb60e9c8249d1b8f46228ce05178b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e7b46f30d624154ab030a8d61d3e985_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3c25d168c744771bf633b071b06a295_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2461c3123264a1587619f55ed019061_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4371c9b4e2d342968b4e3151c7d4db30_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9c2724891314520aa738b30070bc9b7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7572d325e38d473d9ae705b76dddaf85_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26d53d1856c64aba9b247414ff1cbf72_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i271412c8b7d54c31bbe00f90c08636d9_I20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20fb2b51d6784bdcb7bd9ea46521840f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2293f058fbe474d887a278af1dc364d_I20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i629f0cf89dde42a49602d16e5cfd879b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">icui:MeasurementinputadjustedEBITDAvolatilityDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fa400eb022d4774bc0cd29d07a48121_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i880eec97a0864f7f95ece75713ea01a9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5e38a3a78e2405384dff3169dad04c7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">icui:MeasurementInputMarketPriceofRiskDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i904e390537e1451b9a0b56b3895e0ad9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63cb18161ad04f4abb209fda84a747fe_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib00f088272f9420d8932ea1b42312e11_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88960ec8f42c4c90b987ccc14648a60b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie327d35dcba8456fb9278a53ad44949a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i335c02bca87342c3af0d55271dc60da8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5c4a92b0ce541338d7536509042ea7b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaea350bdc70b431c9a82fd66e420fa04_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc18153c27d94cd6a2c7151fb5dc9bd0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i517040ce9ec34b609db5b705439f553a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ffcb622eea74c2297c2e694f6d00439_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1de545bcfec4a5888eea70f8e7b8036_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82e5e28cacc74c919e50d739b06edf75_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i688065cd861c47e7bd70568dc32ce595_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc30cc767c204190b9d227e826c7af7a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i957a2bdf19bb4e459e210f02fdc311af_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia097420328df4d0ba8aad76512275995_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3f7f6920e264be38b38e91385534cf4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnOutLiabilityST</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb8b9ef489414d54902e74776b3ad3ca_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:STEarnoutLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3db367bb1a0046df994e640235391d11_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:STEarnoutLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf917acde63245d09eb8fa04aa6cb67b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:STEarnoutLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bdd238b3bd44e3aa0a5ddeb8d8233cf_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bf4e764536e4ffa9c77a176f003216e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9baebbfe2a8c434b87c84f5e0ad8cb0a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i632c944bb938432aa0eedc42d20802a7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic60a257dc9bd4e0eb4f59ade43d2cb14_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic149dfd8f6d1483d9ded55c35ef93307_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44e3a6c8a6664cad9862b4281ded5217_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8db92612840f4756b2e77eb032bb8d41_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i094fd5abbce944aa910cc40d499b5d9f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfa1710f03974c6d9d1ae45570f5c02d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3e79b2e14f043c09c7080259bcdd720_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfeedac3a27d4227a69f70be2d89e06a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife12602b15f94cd9890c4082d74581b3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3695974f62448dab66775d219f590d3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a4009ff512d42959a09607b0d1d2dd5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i377767425d0240109a95844ff08b1b34_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8df718d5aa84441b74a7a6e2b03f17e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56f3580c0d3d47f48f3a427759653368_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib739ab062f854a70996bee0b00130a93_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8cdb41c17a14a2695ba262420cf3df1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e5fa69d927941dfb31719735e9e8088_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a78e7cf24d64503b2511a1cdc74b41f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7507e0229527439dafdb4203eddf647e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i711e70f031664741a45a58f17b0b937b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide25da1d24d146b2b6367f763603416f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib56ba1e346ee4357b863011abaca4f3b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3ad6f6fa60f49b0995c5869f3d2d033_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i130e8f7da5ee4027903cf2856abf00a3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bd14230b4e94aff9f2dc05493cfc1b1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie611c9fc1bb545cc8ad94fbe19af222c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8debaac8649c406fbca98e4b486e4b1d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78603e4cb0ca4c0f99214a90dd735480_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac454971b49349949220dae2173838e4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c88697ab66446b8a82b091623fd4777_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81e0ca54acfd4d24a778f4024742013b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib37a7d73ddd44f5598941e2ca4cc04d4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:LongtermInvestmentsDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9c9a9e9ea2345208d64fa0d5a8fffda_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:AvailableforsaleDebtSecurityCurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bde06c37d8c4dda852f5deb015fa18f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:LongtermInvestmentsDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a3de3a660434987a7100fcd8c1caebb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9d9c289f8a048eb84ce2a838b84d175_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a7c45ae71c244ff8f548dfdd2b6fb8c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56979378a15940b694ad44f79ca40db8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb10aa868d234581b425b2f11483e45f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:MoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id13943d7016047a08b86a41eba983610_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:MoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35c21123a9bc47cd9c241397fb0086b8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i243cc12eefac42478d6f254dfb50666d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4159aa37c1ba4a859994bf41400f8ba2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9372198522d4b5e97f8e9e8a9b15104_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7bed48ab3274a438be9d461548445dd_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d507359794c441296c07ef57b1f0b4b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89f8e80bcf3e4d15871f08d9315a0795_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4a59c6b81a24315a01e330cedd0027d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife9514c78ddc4a699ba11b09beca198e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief2e729c06b343f28aba776743c330ef_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i513ee50364c14e7d859a7bb7ef23a477_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbc7d651107948d2916b913aaa7d668f_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i912dc15e8c1a41bc9d8224503705d967_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib169ababb8144e438fd240b38a3232b3_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic03a916b576f45269b9d7cee1deb9752_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07478469fd9c4f93a9c4a903a48bc4f4_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id253a421eb2943f5b837dd25a641e2ca_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e4951321f444b24b28bde3fdc96ef0e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1cd92e8416b47e985b5956012374d3d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d3d1938206b417f890a9c160ac8e76a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief440a8c15424f91aa2bf9703a08d2c8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ef4386b3aad40caa1451437ce839832_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i821291babde14cd093a6b4ddeccede07_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie00a9e8c2c894c7ca4b21d05ef790de9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4b19c227969431ca7e4a6627d90949e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3927812c539f471a9f7e842582263841_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66a5adf9d5824096bc840c2ea8b7fbe9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19657ff16caa42fc8b51e10fb536a6f4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1713967f58146769aa8e6ad535a9f9c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cf2d32391d5446c87fb358fa5d38e52_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4895000d5a7b4fe3b49e4d144fa4308c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91c9f9c254834c91bccad9081f3bec3e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2172b4c33734723af96689c9f9c83cf_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i820c1b83d10b4a7caf83661d1ff3d33f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia65456c188d34d4daf133f0f0dbc3e2c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie48f38dcedd64e93a8ecf7ac063f60b0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia442a59e504b4b4cbe247d028ddb1705_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b85afc4ff3d4a5092568e3fb7e051d8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:Greaterthan400to100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a39638d60794625b2a97bb8ccf76e08_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:Greaterthan400to100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4fa2d7effb948959c4419141b81fa27_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo400To100ButGreaterThan300To100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01fc89ab55b9471e88acff5bc284c6d9_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo400To100ButGreaterThan300To100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdfa16b6f741491d8b6775ba1b22da74_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqual300To100ButGreaterThan250to100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29510191d44e477fa81d72fe9d21c1ec_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqual300To100ButGreaterThan250to100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c9d6aabc294426da5585018b63ccb2f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo250To100ButGreaterThan200To100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e79efd88abe4a75b2c34f56667180b3_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo250To100ButGreaterThan200To100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e5ce3e367bf4ebf8d8b4d98965dedbc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo200To100Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62429302fe0f4afea07772eb2f1866ae_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo200To100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide283ac530ac4b1781126c399a2552b9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:GreaterThan275To100Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb1d7ec7e4a44aabae7ac85788f5014f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThan275To100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48afd3427c1e42f6ad2d86e852ef64dd_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94b17ce1db9045be81548ad59c39078e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic864df7a10e243439b16f94f4d8947a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i978540de7dd847ba96e233480ca7d760_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia45c28b3f1cc4a4d9f0add866a4154b7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i326812ecd5b9421880949758af6f0760_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if99dcd7880d44918a4d5f088ad265d59_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58bf8064282948fe8016498a02b9e92e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29830fec1151487f84613c8fe2e23f62_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f62f6e8b1f049a2bfc7cd1ba2c8c6b7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8b148239611411ab103bf9e35a00370_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9a33f79f91d4f94880ad5f50170dd8b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02b67f1e6ebf44f4920d2e1c7a980457_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idffc4822f1e84243b7a821f4b832cdb0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bb27df1c81b4fe5815f7411937625c3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b7c25e7ac474113b90c767b63e9973b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26135335385b4c188e9fa42192dd9586_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3003d8cd4355481fbc735d083ddbdec1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i327a4bd08003426f90e1ed91e3bc0365_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6236b35e282a499d9e7335ded3b1511a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i381b31d9849d4793b208bb77bd5696f5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id987a884b9304292b23dd52b1a4a527a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88f2c0cc386c4a87970c9caa95befd39_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d062c01630e4345ab1b152378e6a45f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i368b376abe90453ca246cd3e38e97a22_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49c58f1374874b18a884724db405192e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b7fcd5651cc4fba8ada251f0eae1319_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00701bb034dc42d893efa54ca1dd9b8e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i106e9ee178e6436f90b29d6557dfb488_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71a8aaadf61b4f2d8e906baa19a20857_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c3789fe01ab44e98e7b6e29e62a089e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86d81cabd26944f7aa9415595f6e5c33_I20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b3ce23df5e4479c839dc97cc6e1b807_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68ee0370a4e34ec2b3cd2a4b34eed398_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDgtMy0xLTEtODU0Mjc_7ecf9fe4-2d46-462b-9cf4-25760587797c id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNy0zLTEtMS04NTQyNw_7c780213-5204-477b-b6b3-ae2adcd49fc1 id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDctMy0xLTEtODU0Mjc_7df968fa-74a0-4035-acd1-eeb6318c14ec id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTktMy0xLTEtODU0Mjc_1a768a17-8ec1-4d51-80ce-724b75333158 id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMy0xLTEtODU0Mjc_8e53ce40-ac43-42cc-a11c-3226d211576c id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDYtMS0xLTEtODU0Mjc_c7816a3a-1526-470e-a0a1-e9473483f3d0 id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTYtMy0xLTEtODU0Mjc_20a86bd3-d267-4832-a6f6-a0a9852dc66d id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjAtMy0xLTEtODU0Mjc_98804e62-7dcb-45a0-ada1-b1376c0f6a5c id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDYtMy0xLTEtODU0Mjc_a84bb210-1803-4baa-ac5d-57f746b7383b id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNC0zLTEtMS04NTQyNw_c7816a3a-1526-470e-a0a1-e9473483f3d0 id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTMtMy0xLTEtODU0Mjc_a200078c-32a4-4024-a320-77430ba61723 id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfOC0zLTEtMS04NTQyNw_f9216bd5-da46-48b1-a355-82bc8bd6fed3 id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzktMy0xLTEtODU0Mjc_2871088d-bd3c-4197-a27a-5f41e2e83bf3 id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDUtMy0xLTEtODU0Mjc_9c051bf9-d922-4ab2-a1db-ef3cb50205da id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNi0zLTEtMS04NTQyNw_8f5791fa-67d3-4c79-9c18-33fd2dc8da71 id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTUtMy0xLTEtODU0Mjc_982c10b6-6cc1-42a0-baea-8cfceabaac7b id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjctMy0xLTEtODU0Mjc_0b66ff3d-bacc-4678-9b15-ad53ab26038d id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDQtMy0xLTEtODU0Mjc_a2adcdf4-12bb-4dbf-87f9-67e10866727a id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjgtMy0xLTEtODU0Mjc_8afdd3aa-5a0b-425b-b184-3ffcbe32cf0b id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfOS0zLTEtMS04NTQyNw_b868de97-3495-4f39-b1bd-267a25b30699 id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzItMy0xLTEtODU0Mjc_bd6f07d7-06ca-4c37-9865-d066a96bbee2 id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjItMy0xLTEtODU0Mjc_ab78ba20-06e6-4bf3-9f75-ba44192aa452 id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjMtMy0xLTEtODU0Mjc_795ca416-85d4-4924-bccc-6c25a58dc1ff id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNS0zLTEtMS04NTQyNw_84e883a6-02b5-4319-8d81-06bce0c327f7 id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzQtMy0xLTEtODU0Mjc_d7802ddb-c456-4e56-9062-abf9b7f1b622 id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzgtMy0xLTEtODU0Mjc_17312d52-ce0a-4631-84dd-a18eb2bde954 id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzctMy0xLTEtODU0Mjc_36d5f6c7-aaaa-4da0-9b8c-4dfd3b733fce id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTAtMy0xLTEtODU0Mjc_f6a76a36-acfc-48aa-82f4-e8c6fa59895b id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzAtMy0xLTEtODU0Mjc_d52e19a4-0c54-48ba-809b-99370fedffe8 id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDMtMy0xLTEtODU0Mjc_8f550f7b-10c4-44a3-b4d6-264c9356e795 id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMy0xLTEtODU0Mjc_d8f3800b-263d-4855-b3f8-572c0e60c1b3" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i10abb94289aa46ab94dfc506ddec4961_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGV4dHJlZ2lvbjpmYjJiN2QxODI5M2I0ZWU2OTI1NzNhODZhNjhkOTZlNl8xOTgz_9d379cc3-89ae-4985-9ffb-3583157aac63">10-Q</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.465%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6ODI2OGRjMGJiNTI1NDgzZTkxZjEyYTQ1NGQyODQyM2UvdGFibGVyYW5nZTo4MjY4ZGMwYmI1MjU0ODNlOTFmMTJhNDU0ZDI4NDIzZV8wLTAtMS0xLTg1NDI3_b92ed6a9-bdc0-402c-9046-3d040f5e846c">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the quarterly period ended: <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGV4dHJlZ2lvbjpmYjJiN2QxODI5M2I0ZWU2OTI1NzNhODZhNjhkOTZlNl8xMjQ_17f83e4b-dc42-4715-bb57-67b572c19e41">June&#160;30, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.465%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6YWI2ZDBmOGI5ZDNiNDkwNGFlOWJjMmZkODYxZWJkNTMvdGFibGVyYW5nZTphYjZkMGY4YjlkM2I0OTA0YWU5YmMyZmQ4NjFlYmQ1M18wLTAtMS0xLTg1NDI3_3f7fe168-36dc-484c-8f57-fa8efb08887d">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File No.:&#160;<ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGV4dHJlZ2lvbjpmYjJiN2QxODI5M2I0ZWU2OTI1NzNhODZhNjhkOTZlNl8xOTg0_5e306587-fda5-4669-b76f-02cd127349b3">001-34634</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICU MEDICAL,&#160;INC. </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.908%"><tr><td style="width:1.0%"></td><td style="width:47.027%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.029%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6Mjg3NDNhNGI1NTA1NDQ1Mzg3YTZjYjU5MTcxNWUwZGYvdGFibGVyYW5nZToyODc0M2E0YjU1MDU0NDUzODdhNmNiNTkxNzE1ZTBkZl8wLTAtMS0xLTg1NDI3_ef807712-9bbb-45ac-9d72-98b978043040">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6Mjg3NDNhNGI1NTA1NDQ1Mzg3YTZjYjU5MTcxNWUwZGYvdGFibGVyYW5nZToyODc0M2E0YjU1MDU0NDUzODdhNmNiNTkxNzE1ZTBkZl8wLTItMS0xLTg1NDI3_215c985d-42fd-45c2-8852-1e14a9adf529">33-0022692</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.043%"><tr><td style="width:1.0%"></td><td style="width:16.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.639%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6MTgzZDlhZjJiZDg5NGRiMzhjYWEzYmRhMjFhYjAyZDQvdGFibGVyYW5nZToxODNkOWFmMmJkODk0ZGIzOGNhYTNiZGEyMWFiMDJkNF8wLTAtMS0xLTg1NDI3_c424a0e7-c450-4f22-ad63-5b1b78f85a32">951 Calle Amanecer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6MTgzZDlhZjJiZDg5NGRiMzhjYWEzYmRhMjFhYjAyZDQvdGFibGVyYW5nZToxODNkOWFmMmJkODk0ZGIzOGNhYTNiZGEyMWFiMDJkNF8wLTItMS0xLTg1NDI3_bb48c1d0-68da-4a4c-a9d0-ff993eb931e3">San Clemente</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6MTgzZDlhZjJiZDg5NGRiMzhjYWEzYmRhMjFhYjAyZDQvdGFibGVyYW5nZToxODNkOWFmMmJkODk0ZGIzOGNhYTNiZGEyMWFiMDJkNF8wLTQtMS0xLTg1NDI3_145ce4f2-6cc9-4b9a-b7ad-1140ccc98644">California</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6MTgzZDlhZjJiZDg5NGRiMzhjYWEzYmRhMjFhYjAyZDQvdGFibGVyYW5nZToxODNkOWFmMmJkODk0ZGIzOGNhYTNiZGEyMWFiMDJkNF8wLTYtMS0xLTg1NDI3_3d04331c-136e-49c7-83cb-fa96f603de1e">92673</ix:nonNumeric></span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGV4dHJlZ2lvbjpmYjJiN2QxODI5M2I0ZWU2OTI1NzNhODZhNjhkOTZlNl8xOTg1_8e1c60bf-2c19-4dd0-886b-92804551a189">949</ix:nonNumeric>) <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGV4dHJlZ2lvbjpmYjJiN2QxODI5M2I0ZWU2OTI1NzNhODZhNjhkOTZlNl8xOTg2_aa5629cf-e9e9-437e-898f-a28d194a9265">366-2183</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160; <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGV4dHJlZ2lvbjpmYjJiN2QxODI5M2I0ZWU2OTI1NzNhODZhNjhkOTZlNl8xOTg3_1e640920-2106-49c5-bbc7-88386647c6b1">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160; <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGV4dHJlZ2lvbjpmYjJiN2QxODI5M2I0ZWU2OTI1NzNhODZhNjhkOTZlNl8xOTgx_b5831886-f1c8-4c3e-90f8-48ad00ed406d">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.059%"><tr><td style="width:1.0%"></td><td style="width:26.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.148%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6ZmExZmE2OWFiOWNhNDA4ZDljZWY4ZjBhOWZlMTg3ZTMvdGFibGVyYW5nZTpmYTFmYTY5YWI5Y2E0MDhkOWNlZjhmMGE5ZmUxODdlM18wLTAtMS0xLTg1NDI3_24c3bb12-9b14-4438-a1ce-24cd2ee2a275">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6ZmExZmE2OWFiOWNhNDA4ZDljZWY4ZjBhOWZlMTg3ZTMvdGFibGVyYW5nZTpmYTFmYTY5YWI5Y2E0MDhkOWNlZjhmMGE5ZmUxODdlM18yLTQtMS0xLTg1NDI3_f98b3802-4c1c-4f74-a722-20070a554ab0">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6ZmExZmE2OWFiOWNhNDA4ZDljZWY4ZjBhOWZlMTg3ZTMvdGFibGVyYW5nZTpmYTFmYTY5YWI5Y2E0MDhkOWNlZjhmMGE5ZmUxODdlM180LTQtMS0xLTg1NDI3_2a4136c5-9b15-4400-b676-946dad5baf7a">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act):&#160; Yes&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGV4dHJlZ2lvbjpmYjJiN2QxODI5M2I0ZWU2OTI1NzNhODZhNjhkOTZlNl8xOTgy_443a2c1e-2011-4ec5-994c-f12961e61207">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.908%"><tr><td style="width:1.0%"></td><td style="width:42.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6Y2M2N2E4MmEzZGU4NGY4ZjlkYzI4NmY4M2M1ODdjNDIvdGFibGVyYW5nZTpjYzY3YTgyYTNkZTg0ZjhmOWRjMjg2ZjgzYzU4N2M0Ml8xLTAtMS0xLTg1NDI3_c3f53d99-ce0f-471e-a60a-61c04860cf6e">Common stock, par value $0.10 per share</ix:nonNumeric></span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6Y2M2N2E4MmEzZGU4NGY4ZjlkYzI4NmY4M2M1ODdjNDIvdGFibGVyYW5nZTpjYzY3YTgyYTNkZTg0ZjhmOWRjMjg2ZjgzYzU4N2M0Ml8xLTEtMS0xLTg1NDI3_c318619e-c39a-4e83-826d-79f1d9e5f262">ICUI</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6Y2M2N2E4MmEzZGU4NGY4ZjlkYzI4NmY4M2M1ODdjNDIvdGFibGVyYW5nZTpjYzY3YTgyYTNkZTg0ZjhmOWRjMjg2ZjgzYzU4N2M0Ml8xLTItMS0xLTg1NDI3_f2b695fc-b6e6-4783-8346-546e642a1044">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Global Select Market)</span></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date:</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.908%"><tr><td style="width:1.0%"></td><td style="width:42.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Outstanding&#160;at July 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iad30622d1b0f462ca40c8e5a1116afb3_I20220731" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6ZTBjMDg4ODQ5MjFjNGU0ZTgyZjc5ZWVlZmYwZTY1OGIvdGFibGVyYW5nZTplMGMwODg4NDkyMWM0ZTRlODJmNzllZWVmZjBlNjU4Yl8xLTItMS0xLTg1NDI3_705bdd4a-7264-442c-91d0-15b828c39a0f">23,899,381</ix:nonFraction></span></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i10abb94289aa46ab94dfc506ddec4961_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June&#160;30, 2022</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page&#160;Number</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">PART I.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_10">Financial Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_13">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_16">Condensed Consolidated Balance Sheets at </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_16">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_16">, 2022 and December&#160;31,&#160;2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_19">Condensed Consolidated Statements of Operations for the Three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_19">and S</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_19">ix </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_19">Months</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_19"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_19">Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_19">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_19">, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_22">Condensed Consolidated Statements of Comprehensive (Loss) Income for the Three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_22">and Si</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_22">x </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_22">Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_22">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_22">, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_22">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_25">Condensed Consolidated Statements of Stockholders' Equity for the Three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_25">and Six </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_25">Months</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_25"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_25">Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_25">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_25">, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_25">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_28">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_28">Six </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_28">Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_28">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_28">, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_94">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_94">37</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_109">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_109">55</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_112">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_112">55</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">PART II.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_115">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_118">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_118">56</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_121">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_121">56</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_124">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_124">57</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_127">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_127">58</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_130">Signature</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_130">59</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i10abb94289aa46ab94dfc506ddec4961_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="i10abb94289aa46ab94dfc506ddec4961_13"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.52pt;text-decoration:underline">Financial Statements (Unaudited)</span></div><div><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(In thousands, except par value data)&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CURRENT ASSETS:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNC0xLTEtMS04NTQyNw_4fa68340-aa02-4c4e-ac60-f63f23e33810">255,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNC0zLTEtMS04NTQyNw_c7816a3a-1526-470e-a0a1-e9473483f3d0">552,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNS0xLTEtMS04NTQyNw_a423844e-874f-4bd9-900c-9c0c2eb0b015">13,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNS0zLTEtMS04NTQyNw_84e883a6-02b5-4319-8d81-06bce0c327f7">14,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENT SECURITIES</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNi0xLTEtMS04NTQyNw_8a62a2ee-9111-40d9-a0ca-8fcc176b3f8a">268,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNi0zLTEtMS04NTQyNw_8f5791fa-67d3-4c79-9c18-33fd2dc8da71">567,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNy0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOmIyMWUxNDE4Y2EyYTQ4MDViMDdlNjc5YmNhZTczZjg4XzY3_3384f385-257e-48ba-8895-ec7fd9572282">7,557</ix:nonFraction> at June&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNy0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOmIyMWUxNDE4Y2EyYTQ4MDViMDdlNjc5YmNhZTczZjg4Xzgw_0d1abd55-ff43-4954-89d5-03d83c32fcc7">7,038</ix:nonFraction> at December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNy0xLTEtMS04NTQyNw_2eab2d00-5af4-4fd8-a61d-f20c48990821">216,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNy0zLTEtMS04NTQyNw_7c780213-5204-477b-b6b3-ae2adcd49fc1">105,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfOC0xLTEtMS04NTQyNw_7ffc5f50-6a4d-441d-8348-7fa70abe137e">583,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfOC0zLTEtMS04NTQyNw_f9216bd5-da46-48b1-a355-82bc8bd6fed3">290,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfOS0xLTEtMS04NTQyNw_9652d15a-8e3c-4021-b7ef-53e6ddc9b4a4">27,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfOS0zLTEtMS04NTQyNw_b868de97-3495-4f39-b1bd-267a25b30699">19,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTAtMS0xLTEtODU0Mjc_952a149a-b863-42f4-a8af-74813481cd02">94,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTAtMy0xLTEtODU0Mjc_f6a76a36-acfc-48aa-82f4-e8c6fa59895b">46,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL CURRENT ASSETS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTMtMS0xLTEtODU0Mjc_16374070-b404-4eee-982f-4e786ac0860e">1,189,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTMtMy0xLTEtODU0Mjc_a200078c-32a4-4024-a320-77430ba61723">1,029,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PROPERTY, PLANT AND EQUIPMENT, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTUtMS0xLTEtODU0Mjc_0a4d4978-bbc2-4212-9b86-e950fc74af67">667,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTUtMy0xLTEtODU0Mjc_982c10b6-6cc1-42a0-baea-8cfceabaac7b">468,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OPERATING LEASE RIGHT-OF-USE ASSETS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTYtMS0xLTEtODU0Mjc_f5c8f1f0-3f4e-4d94-8df8-b33a7b0ea9df">83,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTYtMy0xLTEtODU0Mjc_20a86bd3-d267-4832-a6f6-a0a9852dc66d">39,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LONG-TERM INVESTMENT SECURITIES</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTgtMS0xLTEtODU0Mjc_10a412ec-1ecf-44f7-935f-014cb3a8be6c">1,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTgtMy0xLTEtODU0Mjc_1a86d6ef-f59e-4310-851a-e13ddbfa98e9">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GOODWILL</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTktMS0xLTEtODU0Mjc_bfda98b9-97b2-4ede-ba9e-6df8da4bf299">1,421,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTktMy0xLTEtODU0Mjc_1a768a17-8ec1-4d51-80ce-724b75333158">43,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">INTANGIBLE ASSETS, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjAtMS0xLTEtODU0Mjc_69837df0-9897-405f-88bb-bfed64c9593f">1,080,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjAtMy0xLTEtODU0Mjc_98804e62-7dcb-45a0-ada1-b1376c0f6a5c">188,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DEFERRED INCOME TAXES</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjEtMS0xLTEtODU0Mjc_83c9e78d-6d6f-4ce1-91f0-7a2ee002955e">43,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjEtMy0xLTEtODU0Mjc_9803d10d-07df-4df2-993b-02223d06956a">42,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OTHER ASSETS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjItMS0xLTEtODU0Mjc_3073f79a-92ca-4e1e-9ac6-7bd3d204dd1d">101,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjItMy0xLTEtODU0Mjc_ab78ba20-06e6-4bf3-9f75-ba44192aa452">63,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL ASSETS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjMtMS0xLTEtODU0Mjc_fec7af3c-097d-4c0c-883d-2b9c0e50850b">4,589,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjMtMy0xLTEtODU0Mjc_795ca416-85d4-4924-bccc-6c25a58dc1ff">1,880,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CURRENT LIABILITIES:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjctMS0xLTEtODU0Mjc_76e894b1-f405-4b0f-8d09-037d1c90f66d">201,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjctMy0xLTEtODU0Mjc_0b66ff3d-bacc-4678-9b15-ad53ab26038d">81,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjgtMS0xLTEtODU0Mjc_141b9bba-62eb-435e-881c-5d90b66c2687">247,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjgtMy0xLTEtODU0Mjc_8afdd3aa-5a0b-425b-b184-3ffcbe32cf0b">118,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjktMS0xLTEtODU0Mjc_8c946fc1-fc5e-4b0f-bd33-64909c52e4ca">19,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjktMy0xLTEtODU0Mjc_b2b95ba6-d096-44ae-bc61-ed506e9069df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzAtMS0xLTEtODU0Mjc_3a164ca1-4d5d-441a-8d54-75e097f6bd40">17,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzAtMy0xLTEtODU0Mjc_d52e19a4-0c54-48ba-809b-99370fedffe8">1,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent earn-out liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzEtMS0xLTEtODU0Mjc_f3e29878-e144-43fc-b119-df4501652277">290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzEtMy0xLTEtODU0Mjc_3f41152b-41d0-4340-ae5b-aac764a9b902">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL CURRENT LIABILITIES</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzItMS0xLTEtODU0Mjc_8080a350-826a-41a8-8dc8-1bd56088a3d1">485,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzItMy0xLTEtODU0Mjc_bd6f07d7-06ca-4c37-9865-d066a96bbee2">200,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CONTINGENT EARN-OUT LIABILITY</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzQtMS0xLTEtODU0Mjc_3e65fcad-21d2-4984-9e36-1af803575742">30,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzQtMy0xLTEtODU0Mjc_d7802ddb-c456-4e56-9062-abf9b7f1b622">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LONG-TERM DEBT</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzUtMS0xLTEtODU0Mjc_32661f70-c2ec-4eb3-a9fd-4ca83d56fe28">1,636,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzUtMy0xLTEtODU0Mjc_449c7fd2-8a38-4e55-b490-80f37c922e1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OTHER LONG-TERM LIABILITIES</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzYtMS0xLTEtODU0Mjc_711490af-2640-4710-b423-d26afc11d5c4">128,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzYtMy0xLTEtODU0Mjc_56404a65-c819-4a16-8dc1-c9dbef278f91">41,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DEFERRED INCOME TAXES</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzctMS0xLTEtODU0Mjc_8f164938-7420-47bf-9d9c-d91e9adcd46a">204,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzctMy0xLTEtODU0Mjc_36d5f6c7-aaaa-4da0-9b8c-4dfd3b733fce">1,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">INCOME TAX LIABILITY</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzgtMS0xLTEtODU0Mjc_d13d73c4-3ad0-4067-84ed-6b0de57635df">18,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzgtMy0xLTEtODU0Mjc_17312d52-ce0a-4631-84dd-a18eb2bde954">18,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COMMITMENTS AND CONTINGENCIES (Note 19)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzktMS0xLTEtODU0Mjc_f34703ab-7e8e-4ea6-81b3-38fc8ac00756">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzktMy0xLTEtODU0Mjc_2871088d-bd3c-4197-a27a-5f41e2e83bf3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">STOCKHOLDERS&#8217; EQUITY:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Convertible preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjo5OGE1MzMyNTdmNjY0MjMxYjk0NjE3MTJmMDg0MGI4Yl8zMw_74035a30-b6dc-4262-896d-5cdc139e0378">1.00</ix:nonFraction> par value; Authorized &#8212; <ix:nonFraction unitRef="shares" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjo5OGE1MzMyNTdmNjY0MjMxYjk0NjE3MTJmMDg0MGI4Yl82MA_927b724a-ff27-40d9-bd4f-4cd35c5433d5">500</ix:nonFraction> shares; Issued and outstanding &#8212; <ix:nonFraction unitRef="shares" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjo5OGE1MzMyNTdmNjY0MjMxYjk0NjE3MTJmMDg0MGI4Yl85Ng_316e6b71-e146-49c5-80b6-3ef782e2adf4"><ix:nonFraction unitRef="shares" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjo5OGE1MzMyNTdmNjY0MjMxYjk0NjE3MTJmMDg0MGI4Yl85Ng_3c2e5024-3c66-49e3-bb58-3aa959f5276c"><ix:nonFraction unitRef="shares" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjo5OGE1MzMyNTdmNjY0MjMxYjk0NjE3MTJmMDg0MGI4Yl85Ng_e83c1ae3-8c57-42ef-98fa-e78c445f3ada"><ix:nonFraction unitRef="shares" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjo5OGE1MzMyNTdmNjY0MjMxYjk0NjE3MTJmMDg0MGI4Yl85Ng_f6cb30a4-bc6d-40e3-8a0a-1b8d7019edd4">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMS0xLTEtODU0Mjc_3c3c7471-1194-44c9-82f6-25bd2463953c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMy0xLTEtODU0Mjc_8e53ce40-ac43-42cc-a11c-3226d211576c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjplYzdiMzA4NGNhMTc0NDMyYjhlYTJjYzFmODc0MzZiY18xOQ_3bab818f-34b9-4218-bf9a-d4c3f9562f5b">0.10</ix:nonFraction> par value; Authorized &#8212; <ix:nonFraction unitRef="shares" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjplYzdiMzA4NGNhMTc0NDMyYjhlYTJjYzFmODc0MzZiY180Ng_9f74d9e9-430b-4ae0-88b1-4f09468f32c0">80,000</ix:nonFraction> shares; Issued &#8212; <ix:nonFraction unitRef="shares" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjplYzdiMzA4NGNhMTc0NDMyYjhlYTJjYzFmODc0MzZiY182Ng_1f8962a2-fc5f-4f47-a6e5-cac454f90cfb">23,899</ix:nonFraction> shares at June&#160;30, 2022 and <ix:nonFraction unitRef="shares" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjplYzdiMzA4NGNhMTc0NDMyYjhlYTJjYzFmODc0MzZiY184Ng_04ae5949-a01b-4404-9eee-21a76abeb24a">21,280</ix:nonFraction> shares at December&#160;31, 2021; and outstanding &#8212; <ix:nonFraction unitRef="shares" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjplYzdiMzA4NGNhMTc0NDMyYjhlYTJjYzFmODc0MzZiY18xMjE_338a098e-e0db-463a-9db4-8f9ff77f4e2a">23,898</ix:nonFraction> shares at June&#160;30, 2022 and <ix:nonFraction unitRef="shares" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjplYzdiMzA4NGNhMTc0NDMyYjhlYTJjYzFmODc0MzZiY18xNDE_1633790a-7122-4a62-b0bd-c1f9cf6a48ff">21,280</ix:nonFraction> shares at December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMS0xLTEtODU0Mjc_dccc1f9c-d69c-47d9-a9fe-2e236a47a472">2,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMy0xLTEtODU0Mjc_d8f3800b-263d-4855-b3f8-572c0e60c1b3">2,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDMtMS0xLTEtODU0Mjc_e2025a18-cbc9-4a7c-bd5e-6112b3563a66">1,309,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDMtMy0xLTEtODU0Mjc_8f550f7b-10c4-44a3-b4d6-264c9356e795">721,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock, at cost (<ix:nonFraction unitRef="shares" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="0" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDQtMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjowY2Q0MzgzMWE0ZmU0Yjc1OTFlNDc4MDRhM2Q4ODE4MV8yOQ_bb2cb424-f902-4510-b5d2-52a65710f4a7">406</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="0" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDQtMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjowY2Q0MzgzMWE0ZmU0Yjc1OTFlNDc4MDRhM2Q4ODE4MV8zNg_4cdac348-18a5-407a-b0ab-02409e012f81">119</ix:nonFraction> shares, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDQtMS0xLTEtODU0Mjc_1d7d6836-9cda-4f29-bdea-7ba49355d05c">92</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDQtMy0xLTEtODU0Mjc_a2adcdf4-12bb-4dbf-87f9-67e10866727a">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDUtMS0xLTEtODU0Mjc_58f53d7d-a235-4de2-8902-f87f96ceb36e">866,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDUtMy0xLTEtODU0Mjc_9c051bf9-d922-4ab2-a1db-ef3cb50205da">911,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDYtMS0xLTEtODU0Mjc_8a7446d6-78a4-49cd-81ff-55738dbb04b5">92,275</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDYtMy0xLTEtODU0Mjc_a84bb210-1803-4baa-ac5d-57f746b7383b">19,269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL STOCKHOLDERS' EQUITY</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDctMS0xLTEtODU0Mjc_645d5e3d-7d16-4e4c-be94-45d75c81a207">2,085,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDctMy0xLTEtODU0Mjc_7df968fa-74a0-4035-acd1-eeb6318c14ec">1,616,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDgtMS0xLTEtODU0Mjc_07d51782-7658-4192-906f-9d4eb09cc067">4,589,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDgtMy0xLTEtODU0Mjc_7ecf9fe4-2d46-462b-9cf4-25760587797c">1,880,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;<ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2" footnoteRole="http://www.xbrl.org/2003/role/footnote">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</ix:footnote></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i10abb94289aa46ab94dfc506ddec4961_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL REVENUES</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMi0xLTEtMS04NTQyNw_9d92a596-c230-47ed-ba16-163ae57a0d91">561,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMi0zLTEtMS04NTQyNw_ec993baf-1bd8-4709-806a-224128593678">321,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMi01LTEtMS04NTQyNw_22fdce6e-67ea-44e6-a4e8-d05c3f83a58c">1,104,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMi03LTEtMS04NTQyNw_6304aa03-fc65-4853-a42b-389267c65cfd">639,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COST OF GOODS SOLD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMy0xLTEtMS04NTQyNw_8bba90f8-c284-4077-a3bf-7c23e07d4b8e">393,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMy0zLTEtMS04NTQyNw_1177eee8-dafa-4a17-8b4f-0e90378ee59b">198,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMy01LTEtMS04NTQyNw_d15b451a-99f0-42a4-a733-5e1811eb53f2">767,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMy03LTEtMS04NTQyNw_0e097e06-9da8-4629-895c-0e1fafd71158">403,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GROSS PROFIT</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNC0xLTEtMS04NTQyNw_699d7c9f-6a9a-4e0d-a8e3-dd133c4732fd">167,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNC0zLTEtMS04NTQyNw_9b703a6d-5d69-4f0a-bb53-b8ed9b557a60">123,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNC01LTEtMS04NTQyNw_f52d97e6-3da7-43d2-a0af-4ea6468da1ad">336,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNC03LTEtMS04NTQyNw_dc39afa8-ecd7-4832-836d-4cc83eedf7af">236,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OPERATING EXPENSES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNi0xLTEtMS04NTQyNw_d693781a-dd83-4b94-9b5b-a5da3afae64d">158,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNi0zLTEtMS04NTQyNw_13279944-d529-40dc-92ec-44240c0f0193">73,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNi01LTEtMS04NTQyNw_1e8a9fb9-c224-408d-984e-d6e6d719f702">311,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNi03LTEtMS04NTQyNw_6472e04e-e4c3-4073-bee9-b814d5964cf0">146,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNy0xLTEtMS04NTQyNw_002ad1cf-a83e-4535-b638-8639df2db6c6">22,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNy0zLTEtMS04NTQyNw_063a3fe0-7afb-4978-a525-33fa74bc4c8c">11,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNy01LTEtMS04NTQyNw_f58862f0-5ef8-46d7-a303-fcddb17eb37a">46,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNy03LTEtMS04NTQyNw_fd3643c1-9bb8-469c-a922-3e1c097c8ef6">22,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, strategic transaction and integration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="icui:Restructuringandstrategictransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfOC0xLTEtMS04NTQyNw_fdcbd047-fb19-4846-ae24-36ce87301509">13,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="icui:Restructuringandstrategictransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfOC0zLTEtMS04NTQyNw_3557c683-9eb5-4beb-8b8f-4cd16c0027f1">3,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="icui:Restructuringandstrategictransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfOC01LTEtMS04NTQyNw_0846fb90-c783-4790-9bee-646198af17ff">47,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="icui:Restructuringandstrategictransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfOC03LTEtMS04NTQyNw_c33420a8-86fc-4ed3-8c03-6e04e49966ad">6,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent earn-out</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfOS0xLTEtMS04NTQyNw_672efb5d-922c-4ef4-b4c1-a1fe63af3a60">27,194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfOS0zLTEtMS04NTQyNw_fd75fd3f-8d8a-4eec-bc0e-7270d9352041">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfOS01LTEtMS04NTQyNw_c050510e-b889-45da-9adb-3934e16fe7ae">27,194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfOS03LTEtMS04NTQyNw_a4b85351-f828-41ff-b388-35216febd268">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="icui:Contractsettlement" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTAtMS0xLTEtODU0Mjc_8bdac89f-1ed4-464a-b090-8d57290d5582">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="icui:Contractsettlement" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTAtMy0xLTEtODU0Mjc_2ebb6c23-5e64-4c9a-83e0-dba1f55fe685">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="icui:Contractsettlement" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTAtNS0xLTEtODU0Mjc_7adb4f12-abd2-473d-9295-e4f2c510e408">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="icui:Contractsettlement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTAtNy0xLTEtODU0Mjc_b1f40a5c-062f-4bc5-849d-d5d6cea317dc">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL OPERATING EXPENSES</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTEtMS0xLTEtODU0Mjc_8af48f4a-a80a-4b01-8ffa-076673260acc">167,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTEtMy0xLTEtODU0Mjc_4eff3a10-0a6e-45e0-994c-ae333814ec65">89,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTEtNS0xLTEtODU0Mjc_ba1d3863-787b-419c-bdd0-4741d9fbcd62">378,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTEtNy0xLTEtODU0Mjc_0efb0847-71aa-4e0f-af70-c8749bb62adc">175,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(LOSS) INCOME FROM OPERATIONS</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTItMS0xLTEtODU0Mjc_03e7f2af-97da-4f9a-9e79-84add5f9e377">48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTItMy0xLTEtODU0Mjc_3debc007-53d1-45ea-bc6d-a6391dc3437d">34,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTItNS0xLTEtODU0Mjc_35726923-d2a3-49a4-a9ca-e6042a9b9712">42,209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTItNy0xLTEtODU0Mjc_dca32c89-17eb-4cd9-a543-e588800d6025">61,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INTEREST EXPENSE</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTQtMS0xLTEtODU0Mjc_657b3bfd-9ed6-45e5-9f19-6c9db1377290">16,273</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTQtMy0xLTEtODU0Mjc_cade71d0-38ce-464d-b928-c397c2ee5d46">163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTQtNS0xLTEtODU0Mjc_806e6073-a537-4cf4-ad09-416362b7f23b">29,917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTQtNy0xLTEtODU0Mjc_1d28df4c-120f-43a7-87f9-d50871ba6e00">324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTHER (EXPENSE) INCOME, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTUtMS0xLTEtODU0Mjc_e8ad5a13-3321-4b7e-b931-53aca70c9974">533</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTUtMy0xLTEtODU0Mjc_6a1007e9-6742-4b08-8849-be04f01545c9">525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTUtNS0xLTEtODU0Mjc_d84ea6be-1a69-4ac8-b2ec-8334a0da3fe5">471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTUtNy0xLTEtODU0Mjc_867a6f4a-5004-4d3b-94c3-e3e79d21500a">1,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(LOSS) INCOME BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTYtMS0xLTEtODU0Mjc_f8a07140-cc8d-4576-b767-f6f776830176">16,854</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTYtMy0xLTEtODU0Mjc_b9797233-ba10-4b0d-9e97-977e47c6bdba">34,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTYtNS0xLTEtODU0Mjc_7b5cec61-ae77-45f8-b3de-cb1beb23b2bc">71,655</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTYtNy0xLTEtODU0Mjc_dc517544-017d-4479-ba91-e87da52db0ec">61,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BENEFIT (PROVISION) FOR INCOME TAXES</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTctMS0xLTEtODU0Mjc_03818b8f-25ea-4908-8e81-f1719a45ec5a">9,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTctMy0xLTEtODU0Mjc_fd431091-cbb0-4db4-af49-e3f21ae8d465">6,434</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTctNS0xLTEtODU0Mjc_fa38eb8f-f44e-497e-9ea3-8069fa1ff522">26,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTctNy0xLTEtODU0Mjc_46095bf2-cdad-4699-898f-efe4d6d11658">9,795</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NET (LOSS) INCOME</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTgtMS0xLTEtODU0Mjc_694bca44-5066-43f8-9bac-f2b98991cbce">7,474</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTgtMy0xLTEtODU0Mjc_b36dbc33-626b-42ba-b91d-3f1dc83e6848">28,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTgtNS0xLTEtODU0Mjc_6c777e2a-1ef8-4921-8c5b-39d3d19495c0">45,542</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTgtNy0xLTEtODU0Mjc_599a94c8-c215-4a49-a49d-028e60b79c1c">52,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NET (LOSS) INCOME PER SHARE</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjAtMS0xLTEtODU0Mjc_3ace7090-f853-4c36-8d00-9049bdb1c4d3">0.31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjAtMy0xLTEtODU0Mjc_1c664d29-e032-4693-b97d-7c427d0411b9">1.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjAtNS0xLTEtODU0Mjc_77f3e0b7-4d89-4cf5-9f27-244897cae761">1.91</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjAtNy0xLTEtODU0Mjc_5c287b1a-1dba-45a8-bd9f-ef7ff9e6207a">2.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjEtMS0xLTEtODU0Mjc_365d164f-dc78-4ff5-b7a0-d3803f49298f">0.31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjEtMy0xLTEtODU0Mjc_b21260af-a8f4-4e5b-be2f-e699be8a2997">1.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjEtNS0xLTEtODU0Mjc_fbe60e37-3a26-4186-87f4-dba39273db7a">1.91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjEtNy0xLTEtODU0Mjc_215b8b58-cb37-4332-befa-987b26939378">2.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WEIGHTED AVERAGE NUMBER OF SHARES</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjMtMS0xLTEtODU0Mjc_63f4b6ae-4a4e-4442-aa23-46c76c1d2d81">23,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjMtMy0xLTEtODU0Mjc_7dc67316-042c-4395-acf2-f2bbd2ea49e4">21,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjMtNS0xLTEtODU0Mjc_4726efc8-02c1-4fad-9e8c-8f36a8f9fe10">23,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjMtNy0xLTEtODU0Mjc_9dec3e7d-9a88-4f25-9611-6c294d0a54d0">21,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjQtMS0xLTEtODU0Mjc_05555fbd-0927-46da-95ca-1d673f569e3e">23,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjQtMy0xLTEtODU0Mjc_e5f81b59-f402-41c5-a91a-86766c24f40f">21,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjQtNS0xLTEtODU0Mjc_423b2934-6806-468a-b595-f1282e08632b">23,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjQtNy0xLTEtODU0Mjc_8514220d-387d-40dc-9b1e-f76803c62058">21,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i10abb94289aa46ab94dfc506ddec4961_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NET (LOSS) INCOME</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfMi0xLTEtMS04NTQyNw_256965ba-9715-42a6-bb7c-f6e33bf4a9d8">7,474</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfMi0zLTEtMS04NTQyNw_57fe10a4-fbab-40e5-a0ca-ea10e49d8498">28,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfMi01LTEtMS04NTQyNw_b1817e2d-c3df-4c75-9e35-c71577c303f9">45,542</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfMi03LTEtMS04NTQyNw_31371ac2-6cd6-4ec2-9eb5-219ec19cabe1">52,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge adjustments, net of tax of $<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNC0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOjRmN2MyZmIwOTIyNzQyY2Q4MzE4YzYxYThiNTc4NGM1XzQ4_00677c72-c65b-4e3a-8b7e-23ab829c6359">4,370</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNC0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOjRmN2MyZmIwOTIyNzQyY2Q4MzE4YzYxYThiNTc4NGM1XzU2_bb027a36-0359-439a-b4c7-eb965113a103">111</ix:nonFraction>) for the three months ended June 30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNC0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOjRmN2MyZmIwOTIyNzQyY2Q4MzE4YzYxYThiNTc4NGM1XzU0OTc1NTgxNDEwNg_1c4aa0ed-0416-4630-82ea-fc6c22877ce4">11,681</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNC0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOjRmN2MyZmIwOTIyNzQyY2Q4MzE4YzYxYThiNTc4NGM1XzU0OTc1NTgxNDExNQ_420cf454-4352-48db-9e5c-987dd5113c90">409</ix:nonFraction>) for the six months ended June 30, 2022 and 2021, respectively.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNC0xLTEtMS04NTQyNw_d71df4c7-53f6-404c-bbf2-233969e705b6">8,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNC0zLTEtMS04NTQyNw_04578eef-1cf9-4efe-b955-28d527ca458e">352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNC01LTEtMS04NTQyNw_b50a612a-8662-4f58-90c4-2261fff1807e">31,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNC03LTEtMS04NTQyNw_88b4d435-0b7c-49d6-b7a0-329dfe60a031">1,296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment, net of tax of $<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNS0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOmI3ODIxZjk5ZjBiYzRkYTNhNDFiZWNmNDFhN2IxNTk1XzU5_043ac23e-827d-43d7-bf91-526072eddcf7"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNS0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOmI3ODIxZjk5ZjBiYzRkYTNhNDFiZWNmNDFhN2IxNTk1XzU5_aea17f1e-4e0d-47fa-a7bc-dcadb6deb2e7"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNS0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOmI3ODIxZjk5ZjBiYzRkYTNhNDFiZWNmNDFhN2IxNTk1XzU5_b032cd2f-19bb-40f8-8010-5919d2b5d165"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNS0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOmI3ODIxZjk5ZjBiYzRkYTNhNDFiZWNmNDFhN2IxNTk1XzU5_edea30a3-bf49-4eb0-8212-50f6a397261c">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> for all periods</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNS0xLTEtMS04NTQyNw_07596cc4-eaf0-418d-9aae-b7affae6a537">99,805</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNS0zLTEtMS04NTQyNw_738dbfac-62a4-454a-87c7-402d1fb10354">1,302</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNS01LTEtMS04NTQyNw_a77e918a-ae52-4f5d-84d4-620860ad87b9">104,751</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNS03LTEtMS04NTQyNw_ead3e02a-6c55-496e-b6ae-c6b3bd11a0bf">6,156</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments, net of tax of $<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNi0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOjE4ZDdkMmU2YjYxNDRiMWQ5YjFiN2ZkMTU4M2YzMWYzXzM3_2e8f43ae-f3b6-4df8-9e9d-48025832f651"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNi0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOjE4ZDdkMmU2YjYxNDRiMWQ5YjFiN2ZkMTU4M2YzMWYzXzM3_3271c95f-27be-4454-8874-1bcfceea725b"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNi0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOjE4ZDdkMmU2YjYxNDRiMWQ5YjFiN2ZkMTU4M2YzMWYzXzM3_63b2b573-8bec-4a87-a53a-5855cd1778b5"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNi0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOjE4ZDdkMmU2YjYxNDRiMWQ5YjFiN2ZkMTU4M2YzMWYzXzM3_6bcea9a9-db29-4902-9668-61471d6ac734">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> for all periods</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNi0xLTEtMS04NTQyNw_4fdf5a28-1362-4201-af43-9b6df5785f19">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNi0zLTEtMS04NTQyNw_9eb74e42-f5ab-4f0d-bbfb-b03613ca6a00">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNi01LTEtMS04NTQyNw_6988703a-ecbb-4c42-99a3-48f5a860dff3">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNi03LTEtMS04NTQyNw_4518b2e8-10f0-4091-9895-152fca3528d8">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNy0xLTEtMS04NTQyNw_e674835b-4bef-48b3-be9b-688eaaa4ca06">91,647</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNy0zLTEtMS04NTQyNw_32cf2cb8-c58f-4197-8a2a-aba3fd4f65ce">962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNy01LTEtMS04NTQyNw_7f1d897f-f900-4965-8687-71388cda0078">73,006</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNy03LTEtMS04NTQyNw_5edfa8b0-91c7-48a5-9c8a-99690db3f4fc">7,429</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COMPREHENSIVE (LOSS) INCOME</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfOC0xLTEtMS04NTQyNw_efcc5cb2-07b4-4981-a974-36a5b86b767f">99,121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfOC0zLTEtMS04NTQyNw_6eb567f3-03ee-4ca4-94d5-1f3291f0b185">29,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfOC01LTEtMS04NTQyNw_7d5da0a6-4551-4a9b-a5d0-17c01a5be071">118,548</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfOC03LTEtMS04NTQyNw_a1a2bb33-9d71-4764-87f2-5c25d6bfc444">44,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i10abb94289aa46ab94dfc506ddec4961_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICU MEDICAL,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.783%"><tr><td style="width:1.0%"></td><td style="width:38.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.431%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.902%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.878%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.280%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>(Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c62d5316ba94e7c8299c081bae93fc3_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMi0yLTEtMS04NTQyNw_b91e5882-f018-4f5b-b02b-96f17493c61b">21,280</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1020977b89154456bc4bc43c30abde86_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMi00LTEtMS04NTQyNw_ca774ec3-4f71-418a-850c-bca5b4eb1490">2,128</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f541893d2604b1cb5bdb8cdba0b8805_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMi02LTEtMS04NTQyNw_6c79bb58-1cc5-410e-a6e5-53648484cb54">721,412</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c3e5c01706a44a59cb0634c607efb09_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMi04LTEtMS04NTQyNw_a74cc025-05a9-4081-8122-fa7a5f33b95a">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f27b113c4d4421a8448db7016572b2f_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMi0xMC0xLTEtODU0Mjc_d7d48fb4-1df7-457b-9879-e557489d6cad">911,787</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc6f5985837b4f60a2b0978f880b946b_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMi0xMi0xLTEtODU0Mjc_d755d490-7038-4dab-8ee1-455821b702ab">19,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMi0xNC0xLTEtODU0Mjc_6e2de77d-0d1d-40f6-af66-0d4b853a6821">1,616,031</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock and exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ba7f4943fe34dcd87c78019ba0eaec5_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMy0yLTEtMS04NTQyNw_531eb91b-8789-4a6f-80a7-34e0c162d657">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca88d5a959149c5ab0f5a844b420ce3_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMy00LTEtMS04NTQyNw_f150a57b-31dc-40e0-8a30-6f00a590b0d5">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ee94c9079b94b2d8fa66b18e8121025_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMy02LTEtMS04NTQyNw_2289fefa-1568-4cab-b7f9-93d12bc3b8cc">2,965</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d55d90e0334acf8952a54ea3eb127b_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMy04LTEtMS04NTQyNw_fc6b71fe-b41a-465b-9c2c-4f4fc566dd17">5,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMy0xNC0xLTEtODU0Mjc_0bf39131-0e6e-4f6e-9814-245b3ceed59b">2,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3ba7f4943fe34dcd87c78019ba0eaec5_D20220101-20220331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNC0yLTEtMS04NTQyNw_79c66fbc-fbf3-4b74-bcd5-c2fce984ea1a">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94d55d90e0334acf8952a54ea3eb127b_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNC04LTEtMS04NTQyNw_0297ae06-c0f4-4cca-ae96-06529e4ca14a">8,743</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNC0xNC0xLTEtODU0Mjc_b8c67f27-8ce3-4dfb-97ce-99c86e1690e0">8,743</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNS0yLTEtMS04NTQyNw_23ecb287-1b31-4cd7-9b99-065d8ddf8e48">2,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca88d5a959149c5ab0f5a844b420ce3_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNS00LTEtMS04NTQyNw_96d2dcfc-9084-45cb-90fb-8377f5353032">250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ee94c9079b94b2d8fa66b18e8121025_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNS02LTEtMS04NTQyNw_9394b151-a42e-4aec-b720-b99641ff061d">575,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNS0xNC0xLTEtODU0Mjc_8f40112a-570d-44f5-b604-482cacb48456">575,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ee94c9079b94b2d8fa66b18e8121025_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNi02LTEtMS04NTQyNw_e8187b29-158b-4c6c-b20c-af27a1c8e61e">12,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNi0xNC0xLTEtODU0Mjc_8ef38533-a514-416b-820e-cc6c27f84954">12,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b031e42e24b410b9c3e6366a1a16a57_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNy0xMi0xLTEtODU0Mjc_ab0a5cb1-8b66-4439-b224-c8f7963029d6">18,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNy0xNC0xLTEtODU0Mjc_76e58e8f-1ee9-455e-ab6b-9a297f091e29">18,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1f9683afb0c4a3ea5a33c6e397e1533_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOC0xMC0xLTEtODU0Mjc_c7b398f4-23f5-4f5d-ba11-0095b39ef229">38,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOC0xNC0xLTEtODU0Mjc_ccd656a4-12a4-4bc2-b33f-e136fb7c9393">38,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41bb039617594a87acecb9723e17821e_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOS0yLTEtMS04NTQyNw_80b7e948-fb42-4607-b2fb-a3fbdf728ced">23,897</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie62f7b97e63d401a8fa9db1823871df6_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOS00LTEtMS04NTQyNw_6652133c-3006-453d-b715-efc436203343">2,390</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f837794d02a4a309041880510914516_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOS02LTEtMS04NTQyNw_d29251d8-d018-4403-9e6f-b03294b974e1">1,306,264</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i751dca1c7f254c71bec4904c65af1d0b_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOS04LTEtMS04NTQyNw_5e9ca1d5-50e9-40ca-93ef-923e2f45ed56">2,843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b2480b622124e56a1087548cb6e0cf0_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOS0xMC0xLTEtODU0Mjc_2a4a8f5c-99bc-4db8-87d0-19d88c48f498">873,719</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i396ef2387b3b4cfe950c3f23ad00b3cd_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOS0xMi0xLTEtODU0Mjc_41e7a48d-94f2-43d8-85ef-675952f51f05">628</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f22c3698eff4a70b949d07786441335_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOS0xNC0xLTEtODU0Mjc_e954fa7d-2ed8-4e42-93c7-98fdeb53149e">2,178,902</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock and exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic71346e40fe54d37ba3383c1be84de74_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTAtMi0xLTEtODU0Mjc_d31bba0b-7119-426a-babd-a1df956dd7f3">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204a869a54cc47739b6dbf488053eeb3_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTAtNC0xLTEtODU0Mjc_c82e53c8-f0de-44e5-b470-c6d884935880">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia068519b02ab427c9665a8614ee0735b_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTAtNi0xLTEtODU0Mjc_135f09c9-cc90-4672-ae6c-ae385048f591">4,428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea288493ae2f462290ba011ea37b3d86_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTAtOC0xLTEtODU0Mjc_ce0cc9a5-40dd-4f64-919b-e9c507adb2b9">4,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTAtMTQtMS0xLTg1NDI3_7102f181-e890-41e5-82ec-fd37b9f865d0">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic71346e40fe54d37ba3383c1be84de74_D20220401-20220630" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTEtMi0xLTEtODU0Mjc_10a1f372-5b08-4f1d-b054-093a7e57f07a">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea288493ae2f462290ba011ea37b3d86_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTEtOC0xLTEtODU0Mjc_365ac4da-d733-4c8f-8a53-cbdfc8f75ba4">1,695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTEtMTQtMS0xLTg1NDI3_8bf46baa-42cb-4158-978c-efb3879aa6d9">1,695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia068519b02ab427c9665a8614ee0735b_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTItNi0xLTEtODU0Mjc_96ed0bbc-3a2d-49ca-b7da-0198708e3811">7,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTItMTQtMS0xLTg1NDI3_4b59fda3-8736-4ce6-8c3e-47db31863137">7,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id920d44e14eb45dd938699e476719d0a_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTMtMTItMS0xLTg1NDI3_cb85b272-b8ce-46ed-b5b8-77ad17c4be45">91,647</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTMtMTQtMS0xLTg1NDI3_6a5b1bc6-b6f3-4015-ac61-de7b89d51baa">91,647</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e061c30f5d84e94bc70f17124d6757b_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTQtMTAtMS0xLTg1NDI3_bcd39850-6289-4181-8830-3be477b6f06c">7,474</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTQtMTQtMS0xLTg1NDI3_a92a8419-6460-43b6-bc4d-ef49f5bfe7c1">7,474</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb1f82e7e0dc42abae0fc933d35a46e1_I20220630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTUtMi0xLTEtODU0Mjc_c985159c-1c78-41b8-921d-1f11200fe671">23,899</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e4fef5bff944c76884d175d38d5163b_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTUtNC0xLTEtODU0Mjc_45c06e33-ba78-4d74-924d-cb9dae0d4e66">2,390</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica66dd658337400da4427ae2a417bec7_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTUtNi0xLTEtODU0Mjc_615069e6-ee73-4f31-a0f2-1c5f55b07e7f">1,309,598</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b64a06bc2aa421788ade8257344c7c6_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTUtOC0xLTEtODU0Mjc_6513d8eb-c7b3-4a9a-bfb7-5c494e179d6e">92</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb7bc6143f0a46a8905e6b6f840e73b8_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTUtMTAtMS0xLTg1NDI3_641a8436-725c-4199-9db5-35e2e5716f54">866,245</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec8771f969b149858b2fe843e8e5ca57_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTUtMTItMS0xLTg1NDI3_db2c5a10-6099-4952-916c-86dd48f30ac4">92,275</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTUtMTQtMS0xLTg1NDI3_1329beb5-d790-4709-9804-eb810c1aa91c">2,085,866</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.783%"><tr><td style="width:1.0%"></td><td style="width:38.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.431%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.902%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.878%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.280%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>(Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d268c33a3374123930ac2daf085b23a_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMi0yLTEtMS04NTQyNw_59947b70-de90-4c87-95a2-201db208ceba">21,058</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b618394b8c4a9fbd7ef856984c3846_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMi00LTEtMS04NTQyNw_4f470cf7-b96e-4a51-b47b-a27cd60728c6">2,106</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87a9b654e9114b85a43f7707ccf4a716_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMi02LTEtMS04NTQyNw_25f1b065-e350-4390-8d15-a7f62e865315">693,068</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i270393932a514786a51aea891f82a426_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMi04LTEtMS04NTQyNw_0e02b7a0-1895-41ed-8722-8d906dddfbb9">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf3bdc1709be44ab8f7e21eff6b6f947_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMi0xMC0xLTEtODU0Mjc_51b8ea73-af56-4169-8952-e524cd33a497">808,652</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d78058125d8497e8caf757d8e36e07b_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMi0xMi0xLTEtODU0Mjc_6446b380-d908-4e5e-9ebf-48459d5ce45a">1,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21594db97b18415da81085ad86be9dbe_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMi0xNC0xLTEtODU0Mjc_618e7801-db06-4417-b9bf-4d7f4c0213ef">1,502,265</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock and exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i370da095060646f9b9a5b42d2b8a471c_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMy0yLTEtMS04NTQyNw_b8cf68cd-a077-49d9-996d-81c560b7bdb8">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3710964cba21471c9be4ef3805401052_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMy00LTEtMS04NTQyNw_390ac132-3f54-4a41-9c39-55786b737bdf">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44bcf27ee524bb48481e9f36804453e_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMy02LTEtMS04NTQyNw_f7b92832-82af-49a4-b80d-9b60266264d0">2,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8313f8bcbe94858a403e65a717841bf_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMy04LTEtMS04NTQyNw_aabd3450-9377-43af-a819-321ddb2e5eea">2,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic01f9f53437648c6a182b99958017af1_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMy0xNC0xLTEtODU0Mjc_5b08a46d-26fe-47d0-b1e3-3cb70da32843">4,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i370da095060646f9b9a5b42d2b8a471c_D20210101-20210331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNC0yLTEtMS04NTQyNw_ea78378d-7aea-4006-8915-3036685e2dbe">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8313f8bcbe94858a403e65a717841bf_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNC04LTEtMS04NTQyNw_48492232-e35c-4f89-9b8d-5276f7f2d86f">7,723</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic01f9f53437648c6a182b99958017af1_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNC0xNC0xLTEtODU0Mjc_e4807da4-d41f-4179-828a-3c13256d92db">7,723</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44bcf27ee524bb48481e9f36804453e_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNS02LTEtMS04NTQyNw_eb9dc013-8e93-4584-b2a2-51e36e8c8f0a">6,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic01f9f53437648c6a182b99958017af1_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNS0xNC0xLTEtODU0Mjc_f3ce0ad4-3242-4ed9-85bd-2439f2438920">6,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c7325fe79e2481bb7929b1555e5d560_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNi0xMi0xLTEtODU0Mjc_3ef7192f-841a-47c7-b199-d2c218735f32">8,391</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic01f9f53437648c6a182b99958017af1_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNi0xNC0xLTEtODU0Mjc_2907ca90-c1a0-4368-bc6d-c188fc381f73">8,391</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341cb29b86794db193ec2722d6ed4c0b_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNy0xMC0xLTEtODU0Mjc_f4f5c34a-6e8f-4984-96a0-ddff5509c019">23,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic01f9f53437648c6a182b99958017af1_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNy0xNC0xLTEtODU0Mjc_75db5dda-afb2-4498-b086-8c81c3d8591a">23,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i33f91750301e465f851bd681c449d83b_I20210331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOC0yLTEtMS04NTQyNw_7a82b5d5-035e-4d79-bf70-1f7976981f15">21,219</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87b490ee070e48afb48c060408137232_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOC00LTEtMS04NTQyNw_11512afa-dcbd-48af-a9c6-48646b7d4213">2,122</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i677d5b1f2bf24e7e814304d237496841_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOC02LTEtMS04NTQyNw_c8183cfc-86d6-439a-9679-22b96c324fef">701,586</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieddaa7ac708c434c8a3193b3e07498ba_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOC04LTEtMS04NTQyNw_24bea448-196f-456a-8e91-bec11e72eb03">5,410</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02543008f10f4f5e88a7d69f73b7216b_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOC0xMC0xLTEtODU0Mjc_cce09bc1-98bf-494c-8af5-800c8ee7ce30">832,383</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide0cac148c1a4f83bdc265c0ca6c1a88_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOC0xMi0xLTEtODU0Mjc_bf37efe9-ac95-4356-a9d7-55c5958745be">9,913</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5a196eec7194c459ffcb870a785ba8d_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOC0xNC0xLTEtODU0Mjc_f1695954-69fc-4924-8b78-7a053ad46ad8">1,520,768</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock and exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic868ed7581a2477f82cf3b4625c2c5ae_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOS0yLTEtMS04NTQyNw_3f55f2ba-8c31-4329-bb36-dbada0aa1c41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09c6e851dc8544dc80903b26922759ba_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOS00LTEtMS04NTQyNw_e04653b9-1f59-4ae9-9cbc-59323e98fa9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibff8b68601c04517ba11d27b118b9b3b_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOS02LTEtMS04NTQyNw_ee2a0b74-8c74-4b42-9f19-7cca4a9049f0">2,685</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8235a1a7b2144b4484a52b863d830ae2_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOS04LTEtMS04NTQyNw_e93ac723-6953-4ba5-a416-c9fd309a5abe">3,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOS0xNC0xLTEtODU0Mjc_e2780fa4-4de6-4dc1-9fae-bf21ae277d70">552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic868ed7581a2477f82cf3b4625c2c5ae_D20210401-20210630" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTAtMi0xLTEtODU0Mjc_10422ed2-ee40-41aa-b6b5-616c8fda3a3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8235a1a7b2144b4484a52b863d830ae2_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTAtOC0xLTEtODU0Mjc_ab713f28-4e64-46e2-a5b4-601004211249">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTAtMTQtMS0xLTg1NDI3_3da982ab-935f-479c-96c0-5b30fc829d6c">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibff8b68601c04517ba11d27b118b9b3b_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTEtNi0xLTEtODU0Mjc_d0d412b0-2811-4a2b-a710-ecd3d8e100f6">6,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTEtMTQtMS0xLTg1NDI3_e80b7f94-cd71-4290-b20b-8496df5397bb">6,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dcbcc32613744fd9211f209efad177d_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTItMTItMS0xLTg1NDI3_81d1b95e-354f-4d2f-8153-bbdefe88a07e">962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTItMTQtMS0xLTg1NDI3_1e37fe52-da21-4050-a1e2-f7dc4224c4fd">962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7094f1ba4fdb4923823c90a6d6847969_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTMtMTAtMS0xLTg1NDI3_14969954-0a9a-4e2d-a4ba-7e600f22970f">28,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTMtMTQtMS0xLTg1NDI3_d4deb5e5-076d-415d-89ed-362289376397">28,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib67e39c6b55d4121bfac0b087eaee089_I20210630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTQtMi0xLTEtODU0Mjc_bac4bafc-0a4a-4857-9364-6ee8790e0e86">21,219</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7b9ceb789614f918f4e10ee376eb65a_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTQtNC0xLTEtODU0Mjc_ddfec3a9-6b28-42c5-9293-5daad453b44f">2,122</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e358c7559e544b4bb8922a2a7bde625_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTQtNi0xLTEtODU0Mjc_d3e3e11d-d31f-447a-9b03-3d8a3d450291">705,582</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59f12359cc364997814de3aec371b48f_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTQtOC0xLTEtODU0Mjc_5039ce6c-d6a1-4945-aeb0-f564b774416a">2,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i072d1cca614444628db770eff0b59d62_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTQtMTAtMS0xLTg1NDI3_4ec92277-c69b-44ce-afdf-b48533ac211f">860,781</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3e56704a1f44738b385e2b4569e21d0_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTQtMTItMS0xLTg1NDI3_756e9a43-912a-40d3-833a-51517fd2f0cf">8,951</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55063029c0d44ea78a93faf80c101754_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTQtMTQtMS0xLTg1NDI3_559edb00-010c-4459-bd41-9f6d151fb065">1,557,265</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i10abb94289aa46ab94dfc506ddec4961_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(In thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMy0xLTEtMS04NTQyNw_b1817e2d-c3df-4c75-9e35-c71577c303f9">45,542</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMy0zLTEtMS04NTQyNw_31371ac2-6cd6-4ec2-9eb5-219ec19cabe1">52,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNS0xLTEtMS04NTQyNw_41853c54-250c-448d-a74c-2e7af7e2da88">119,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNS0zLTEtMS04NTQyNw_0ad647fa-fd68-4cb3-a507-1f79c9489a75">44,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of inventory step-up</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="icui:AmortizationOfInventoryStepUp" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNi0xLTEtMS04NTQyNw_2c38c8a4-c58d-4f60-aed6-48e480c8078d">22,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="icui:AmortizationOfInventoryStepUp" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNi0zLTEtMS04NTQyNw_399f954c-55c8-419c-a307-7f227ed17493">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNy0xLTEtMS04NTQyNw_ec6082fd-3ab7-4610-a18a-e5f9612a4192">10,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNy0zLTEtMS04NTQyNw_bad274a0-f81b-475d-86d5-ffc1e8dc4fc4">4,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfOC0xLTEtMS04NTQyNw_982bb859-b3b1-4e8f-9289-6f245fd42910">99</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfOC0zLTEtMS04NTQyNw_6eada802-f180-4216-896f-740cb14fd862">342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for warranty and returns</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="icui:ProvisionForWarrantyAndReturns" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfOS0xLTEtMS04NTQyNw_2fefeda5-32bf-46b8-b07d-e14523427e92">1,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" sign="-" name="icui:ProvisionForWarrantyAndReturns" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfOS0zLTEtMS04NTQyNw_c3b55ec5-1100-4301-9842-df88550b672c">345</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTAtMS0xLTEtODU0Mjc_1215286d-f8b9-4c9e-beaa-dac2d6f009d2">19,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTAtMy0xLTEtODU0Mjc_37399e35-ab73-4214-ac6f-1bb6aa55e40f">12,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on disposal of property, plant and equipment and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTEtMS0xLTEtODU0Mjc_b63048e3-65a5-48f4-a8c3-086c762f6608">267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTEtMy0xLTEtODU0Mjc_5819f5f6-332e-477c-9323-51097404a8bb">829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bond premium amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:InvestmentIncomeAmortizationOfPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTItMS0xLTEtODU0Mjc_dd943bae-19e2-4136-a94f-a89039c5c885">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:InvestmentIncomeAmortizationOfPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTItMy0xLTEtODU0Mjc_cb839902-8d1b-45c6-81b8-6e4eeaa5897f">364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt issuance costs amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTMtMS0xLTEtODU0Mjc_bec71de0-6648-4dac-9820-694c1b5cf206">3,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTMtMy0xLTEtODU0Mjc_2fa264c4-ab84-403b-a96c-2c40251d4b2c">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of contingent earn-out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTQtMS0xLTEtODU0Mjc_90e7664e-15b4-4b3b-aeb8-b1f12c2a3b7a">27,194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTQtMy0xLTEtODU0Mjc_5ae230f5-5a7d-4fef-80da-2147fb6e7d3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Usage of spare parts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="icui:Sparepartsusage" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTYtMS0xLTEtODU0Mjc_64ffbb3d-6c13-47c9-9eb7-8f0db07ee80b">5,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="icui:Sparepartsusage" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTYtMy0xLTEtODU0Mjc_a5360e4d-7044-429b-85ef-fe586bfddd28">5,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTctMS0xLTEtODU0Mjc_f1568d44-8a91-4f60-a4a0-903dc172e28d">2,807</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTctMy0xLTEtODU0Mjc_42719e2e-52e6-4021-a78a-2df53a037206">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of amounts acquired:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTktMS0xLTEtODU0Mjc_a2e3e575-fea7-4af6-870f-cfc3e49d6125">1,090</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTktMy0xLTEtODU0Mjc_fe86b235-bdf7-4e94-876d-ae38b31d080e">2,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjAtMS0xLTEtODU0Mjc_fadff606-1fa5-4c7d-8df8-3468e0868664">100,024</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjAtMy0xLTEtODU0Mjc_a68ef366-98c5-42e4-a7a2-df4986f13b9d">13,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjEtMS0xLTEtODU0Mjc_5dd2ba57-e531-4566-9925-95ff34415152">4,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjEtMy0xLTEtODU0Mjc_743e49ca-b182-49b9-9047-38983e00d63f">759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjItMS0xLTEtODU0Mjc_d824122a-1581-4ee4-b4eb-7a736d43e3b2">17,323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjItMy0xLTEtODU0Mjc_ae8eaba4-f217-4d60-8b0a-c41a9d0ec246">7,632</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjMtMS0xLTEtODU0Mjc_62116b00-9826-4c7b-af1a-d8d0e4621950">22,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjMtMy0xLTEtODU0Mjc_193e6706-3dc5-45d3-afc6-608d4f285ccb">1,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjQtMS0xLTEtODU0Mjc_e6f0f8c4-74ef-4292-8ae1-14299ba9542e">33,509</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjQtMy0xLTEtODU0Mjc_9146b8c2-29f2-4b3a-bb9d-f39d5e99134a">17,068</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes, including excess tax benefits and deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjUtMS0xLTEtODU0Mjc_ecfb0830-8776-4840-9166-a296d6ed986a">45,798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" sign="-" name="icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjUtMy0xLTEtODU0Mjc_daac4a9e-0061-48a3-a08d-3953659a00af">5,970</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash (used in) provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjYtMS0xLTEtODU0Mjc_6559a07d-7cea-491b-8293-c3e0dff9a642">62,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjYtMy0xLTEtODU0Mjc_d67a6686-eba5-4aa1-a24a-39e8385cfcbc">106,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjgtMS0xLTEtODU0Mjc_ba4942ac-5a37-42cb-b646-ae13c6a11315">48,039</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjgtMy0xLTEtODU0Mjc_ccc59ca3-8ddb-4dd9-a7c5-e3a2364441f5">29,693</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjktMS0xLTEtODU0Mjc_a6aebb63-6aa7-45a3-bef3-dc7915108edb">900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjktMy0xLTEtODU0Mjc_57c82258-39ef-4a6d-a91b-dbac8d5a604e">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzAtMS0xLTEtODU0Mjc_cb174e7b-7007-4a78-bb49-429bc9fbe0f1">1,844,164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzAtMy0xLTEtODU0Mjc_3b845a7b-b383-4233-bcee-de4de0e41b1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible asset additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzEtMS0xLTEtODU0Mjc_276fa507-32a7-477f-ba7d-f22b2de9a4bc">4,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzEtMy0xLTEtODU0Mjc_aaef188d-8d13-4f12-b139-442cb0f1225b">4,136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzMtMS0xLTEtODU0Mjc_838cc18c-4776-4306-b092-6f1f7cb2699f">3,397</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzMtMy0xLTEtODU0Mjc_9f99b304-8fce-4a2f-becb-34a97da4aafc">10,034</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale and maturities of investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzQtMS0xLTEtODU0Mjc_abdb1e9f-cca5-489c-b80f-ecb81e7054c8">26,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzQtMy0xLTEtODU0Mjc_250d3237-5191-49ea-9f26-4114eb33d59b">7,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzUtMS0xLTEtODU0Mjc_09051ae2-5688-41b9-a853-8e121d858f7d">1,872,942</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzUtMy0xLTEtODU0Mjc_e0b92eb3-0cdf-4202-9005-fb27c1eabdd6">36,660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt, net of lender debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzctMS0xLTEtODU0Mjc_44716822-87d7-4ba4-9b6f-304d68fa8cf1">1,672,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzctMy0xLTEtODU0Mjc_5a78c956-355d-440c-9dcf-c88e0768b5af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Principal repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzgtMS0xLTEtODU0Mjc_fd521466-91ff-476a-8202-fd3ffb932924">18,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzgtMy0xLTEtODU0Mjc_baca9f33-17d8-47f7-86af-320288015c2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of third-party debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzktMS0xLTEtODU0Mjc_6bc3cba2-1ded-425d-b641-7ed975184b19">1,852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzktMy0xLTEtODU0Mjc_08657fcb-386f-4e46-94af-6535760d1a41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDAtMS0xLTEtODU0Mjc_99db17a5-d85a-4d62-9348-ec35d67d8886">2,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDAtMy0xLTEtODU0Mjc_140b1e9e-8d6e-4158-bb57-92307e9e5b96">5,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDEtMS0xLTEtODU0Mjc_8950f142-b180-410d-a448-6e4a3db13d65">321</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDEtMy0xLTEtODU0Mjc_93f5102a-1cf4-4fcd-ad07-ebc69e7f5baa">296</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDItMS0xLTEtODU0Mjc_2c5ef343-d9bc-44b0-b68c-31d7416e0431">10,438</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDItMy0xLTEtODU0Mjc_c7f3512a-1ae9-4033-9ea9-3e5a0507565a">7,819</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDMtMS0xLTEtODU0Mjc_272528c5-4a33-4ac1-b48c-6cb46c983fb4">1,644,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDMtMy0xLTEtODU0Mjc_f5e5bca3-0d0f-4205-8664-4b4e771ad23c">2,699</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDQtMS0xLTEtODU0Mjc_5734c425-af85-410b-89b2-8e82486e1d6f">6,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDQtMy0xLTEtODU0Mjc_492ce1d0-9db1-4a47-8ebc-504f39c8f940">783</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDUtMS0xLTEtODU0Mjc_400ac14b-5d8e-4901-9c77-dd830a414916">297,129</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDUtMy0xLTEtODU0Mjc_d9d2d6ec-cb98-4aff-aa81-26f2b7174fb3">65,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH AND CASH EQUIVALENTS, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDYtMS0xLTEtODU0Mjc_c7816a3a-1526-470e-a0a1-e9473483f3d0">552,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21594db97b18415da81085ad86be9dbe_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDYtMy0xLTEtODU0Mjc_5dfaa4dc-14e7-4163-9111-2ba25febceb1">396,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH AND CASH EQUIVALENTS, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDctMS0xLTEtODU0Mjc_5f037dfc-6ae9-44de-8345-facc456af367">255,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55063029c0d44ea78a93faf80c101754_I20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDctMy0xLTEtODU0Mjc_10595029-c248-4d77-a2fc-16e0a804277a">462,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICU MEDICAL,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:73.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Accounts payable for property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOmIyZGVkNTM3Y2U2ZjQ1NjZhM2U2ZjMxMjU3OTM3NTQ4L3RhYmxlcmFuZ2U6YjJkZWQ1MzdjZTZmNDU2NmEzZTZmMzEyNTc5Mzc1NDhfNy0xLTEtMS04NTQyNw_68afaf95-6cda-4fa0-becf-917d7dd91e11">5,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOmIyZGVkNTM3Y2U2ZjQ1NjZhM2U2ZjMxMjU3OTM3NTQ4L3RhYmxlcmFuZ2U6YjJkZWQ1MzdjZTZmNDU2NmEzZTZmMzEyNTc5Mzc1NDhfNy0zLTEtMS04NTQyNw_48b6fb80-63a5-4f78-85d7-938615ef64dc">1,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Detail of assets acquired and liabilities assumed in acquisitions*:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:FairValueOfAssetsAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOmIyZGVkNTM3Y2U2ZjQ1NjZhM2U2ZjMxMjU3OTM3NTQ4L3RhYmxlcmFuZ2U6YjJkZWQ1MzdjZTZmNDU2NmEzZTZmMzEyNTc5Mzc1NDhfMTEtMS0xLTEtODU0Mjc_71bfb15a-da24-49b5-bd08-cce4fb2bc2f0">1,658,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOmIyZGVkNTM3Y2U2ZjQ1NjZhM2U2ZjMxMjU3OTM3NTQ4L3RhYmxlcmFuZ2U6YjJkZWQ1MzdjZTZmNDU2NmEzZTZmMzEyNTc5Mzc1NDhfMTItMS0xLTEtODU0Mjc_e0e80e0b-5fbe-4de7-9801-2e40f0bccef9">1,844,164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOmIyZGVkNTM3Y2U2ZjQ1NjZhM2U2ZjMxMjU3OTM3NTQ4L3RhYmxlcmFuZ2U6YjJkZWQ1MzdjZTZmNDU2NmEzZTZmMzEyNTc5Mzc1NDhfMTMtMS0xLTEtODU0Mjc_066ffb0b-cb27-43ed-921c-d559fbc8819a">575,975</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="icui:ContingentConsiderationAllAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOmIyZGVkNTM3Y2U2ZjQ1NjZhM2U2ZjMxMjU3OTM3NTQ4L3RhYmxlcmFuZ2U6YjJkZWQ1MzdjZTZmNDU2NmEzZTZmMzEyNTc5Mzc1NDhfMTQtMS0xLTEtODU0Mjc_d9b56323-c3a9-4767-9138-99907df9981c">55,158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill, acquired during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="icui:GoodwillAcquiredDuringPeriodAllAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOmIyZGVkNTM3Y2U2ZjQ1NjZhM2U2ZjMxMjU3OTM3NTQ4L3RhYmxlcmFuZ2U6YjJkZWQ1MzdjZTZmNDU2NmEzZTZmMzEyNTc5Mzc1NDhfMTUtMS0xLTEtODU0Mjc_2c587f3e-b772-4b04-9466-ff332064701f">1,437,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities assumed/Adjustments to liabilities assumed</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:LiabilitiesAssumed1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOmIyZGVkNTM3Y2U2ZjQ1NjZhM2U2ZjMxMjU3OTM3NTQ4L3RhYmxlcmFuZ2U6YjJkZWQ1MzdjZTZmNDU2NmEzZTZmMzEyNTc5Mzc1NDhfMTYtMS0xLTEtODU0Mjc_38277516-99cb-453a-b6d4-0e3749d190bd">621,206</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*Includes amounts related to the acquisition of Smiths Medical 2020 Limited and measurement period adjustments related to a 2021 acquisition of a small foreign infusion systems supplier.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i10abb94289aa46ab94dfc506ddec4961_31"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)</span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_34"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.19pt"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8zNC9mcmFnOjZiZmVmMWNmYWZlYTRmN2E5Y2I1YWJhMzdlMTMwNzMwL3RleHRyZWdpb246NmJmZWYxY2ZhZmVhNGY3YTljYjVhYmEzN2UxMzA3MzBfMjA0NQ_c0720f89-f72d-4fcf-b34c-6f0d46d4c748" continuedAt="i3a75f81717bb4b45ab53923e2e20975e" escape="true">Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="i3a75f81717bb4b45ab53923e2e20975e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S.") and pursuant to the rules&#160;and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and reflect all adjustments, consisting of only normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of the consolidated results for the interim periods presented. Results for the interim period are not necessarily indicative of results for the full year. Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules&#160;and regulations. The condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report on Form&#160;10-K of ICU Medical,&#160;Inc., ("ICU") a Delaware corporation, filed with the SEC for the year ended December&#160;31, 2021.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are engaged in the development, manufacturing and sale of innovative medical products used in infusion therapy and critical care applications.&#160;We sell the majority of our products through our direct sales force and through independent distributors throughout the U.S. and internationally.&#160;We also sell certain products on an original equipment manufacturer basis to other medical device manufacturers. All subsidiaries are wholly owned and are included in the condensed consolidated financial statements.&#160;All intercompany balances and transactions have been eliminated.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired Smiths Medical 2020 Limited ("Smiths Medical"), see Note 3: Acquisitions. Our condensed consolidated statement of operations includes the results of operations for Smiths Medical from January 7, 2022 through June 25, 2022, which is the current end of their 4-4-5 accounting period.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8zNy9mcmFnOjYzOTU3Y2JjYTNmYTQzZGZhMTI5ZDk1YjVmNzBiYzUyL3RleHRyZWdpb246NjM5NTdjYmNhM2ZhNDNkZmExMjlkOTViNWY3MGJjNTJfMjU3MQ_4f005a69-8de5-43fc-a1f6-4c05603a939a" continuedAt="i9340e5ceb8ae4b8bb334ac13ec4bec4e" escape="true">New Accounting Pronouncements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9340e5ceb8ae4b8bb334ac13ec4bec4e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional guidance for a limited period of time to ease the potential burden for reference rate reform on financial reporting. Due to concerns about structural risks of interbank offered rates and, particularly, the risk of cessation of the London Interbank Offered Rate ("LIBOR"), regulators around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction-based and less susceptible to manipulation. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued as a result of reference rate reform. Optional expedients may be applied to contracts that are modified as a result of the reference rate reform. Modifications of contracts within the scope of Topic 470, Debt, should be accounted for by prospectively adjusting the effective interest rate. Modifications of contracts within the scope of ASC 842, Leases, should be accounted for as a continuation of the existing contracts with no reassessments of the lease classification and the discount rate (incremental borrowing rate). Exceptions to Topic 815, Derivatives and Hedging, results in not having a dedesignation of a hedging relationship if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. In November 2021, we entered into two forward-starting swaps whereby the variable leg of the swap referenced LIBOR. These swaps were amended in early 2022 to transition to an alternative reference rate (see Note 8: Derivatives and Hedging Activities). The amendments in this ASU allow for certain expedients that will allow us to assume that our hedged interest payments are probable of occurring regardless of any expected modification in their terms related to reference rate reform and will allow us to continue hedge accounting for a cash flow hedge for which the hedged interest rate risk changes if the hedge is highly effective under ASC 815, Derivatives and Hedging, or the optional expedient under this ASU is elected. The impact of this ASU on our contracts has not been and is not expected to be material.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i10abb94289aa46ab94dfc506ddec4961_40"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzQ1Mw_d8a231e7-3b88-4483-b041-cd3e8ec698b4" continuedAt="iaf7b036482f34b38b5aec54bf68bdd0a" escape="true">Acquisitions</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iaf7b036482f34b38b5aec54bf68bdd0a" continuedAt="i0677f995c5cf4e04bc625f53e291d2ec"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Acquisition</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired <ix:nonFraction unitRef="number" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="0" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzc_934184ec-ec30-4aa4-97e7-61140bb3c45c">100.0</ix:nonFraction>% of the equity interests in Smiths Medical, the holding company of Smiths Group plc's global medical device business, from Smiths Group International Holdings Limited (&#8220;Smiths&#8221;). The acquisition of Smiths Medical aligns with our strategic growth plans, enabling us to broaden our product offerings to include syringe and ambulatory infusion devices, vascular access, and vital care products and to strengthen and expand our global market reach.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash consideration for the acquisition was $<ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="icui:BusinessCombinationConsiderationTransferredCash" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTc0_db733cff-35f1-4de7-84f7-2e7bca1335ad">1.9</ix:nonFraction>&#160;billion, which was financed with existing cash balances and proceeds from the credit agreement entered into on January 6, 2022 (see Note 17: Long-Term Debt). We also issued share consideration to Smiths of <ix:nonFraction unitRef="shares" contextRef="i92956d7d960f45f3bea45f7aa025342c_D20220101-20220630" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzc1_8d71f4a1-d4cf-4d10-afb1-22745d9bcc8b">2.5</ix:nonFraction>&#160;million shares of our common stock. The fair value of the common shares issued to Smiths was determined based on the opening market price of our common stock on the acquisition date. Smiths may be entitled to an additional $<ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfOTkz_f57f8a4c-49e2-4287-97b2-46056af04838">100.0</ix:nonFraction>&#160;million in cash consideration contingent on our common stock achieving certain price targets for certain periods after closing in accordance with the terms of the Share Sale and Purchase Agreement (the "Purchase Agreement"). In the event that (a) on or prior to the third anniversary of closing the 30-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="INF" name="icui:MinimumStockPriceTargetForEarnOutPayment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfMTQwMg_3661aa80-6586-4ec7-9b3a-3422591a9a57">300.00</ix:nonFraction> per share or (b) on or prior to the fourth anniversary of closing the 45-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="INF" name="icui:MinimumStockPriceTargetForEarnOutPayment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfMTU5MA_c64bc7af-7f91-4850-b979-28097b88d743">300.00</ix:nonFraction> per share (each a "Price Target"), and provided Smiths beneficially owns at least <ix:nonFraction unitRef="number" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="1" name="icui:RequiredShareHoldingOfStockIssuedAtAcquisition" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfMTY3NQ_14b630b8-99b2-4368-9372-27d94227f83d">50.0</ix:nonFraction>% of the shares of common stock issued at closing at the time the Price Target is achieved, then Smiths will be entitled to receive the additional $<ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfMTgyMw_f57f8a4c-49e2-4287-97b2-46056af04838">100.0</ix:nonFraction>&#160;million in cash consideration. The fair value of the contingent consideration was determined using an option pricing model, specifically the Monte Carlo Simulation. In the analysis, the determinants of payout are simulated in a risk neutral framework over a large number of simulation paths. The fair value of the contingent consideration is then calculated as the average present value across all simulated paths. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preliminary Purchase Price Allocation</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzQ1NQ_b8bfaf5a-1dcf-4b41-8fcd-99109b9f034c" continuedAt="i79ea49f95bd446e09345e96f727cfc42" escape="true">The following table summarizes the estimated purchase price and the preliminary allocation of the purchase price related to the assets acquired and liabilities assumed (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="i0677f995c5cf4e04bc625f53e291d2ec" continuedAt="ibea7bdf249bd4286a98ccc32a37c6ee5"><ix:continuation id="i79ea49f95bd446e09345e96f727cfc42"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated cash consideration for acquired assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMC0yLTEtMS05MDQ0Mw_c5fe6cf5-7e5b-4e24-981c-db8f77837f31">1,922,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preliminary fair value of contingent consideration payable to Smiths</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92956d7d960f45f3bea45f7aa025342c_D20220101-20220630" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMS0yLTEtMS04NTQyNw_012f50e6-b562-4b02-a84f-d34c02bc8ee3">53,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of ICU Medical, Inc. common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92956d7d960f45f3bea45f7aa025342c_D20220101-20220630" decimals="-3" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfNC0yLTEtMS04NTQyNw_ddaa7b87-07d9-41a5-859c-65587e926004">2,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Price per share (ICU's opening market price on the acquisition date)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfNS0yLTEtMS04NTQyNw_cfeef921-0c0d-44f0-91bf-962fd80acad4">230.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of ICU shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfNi0yLTEtMS04NTQyNw_fddc8a44-ef1b-4381-8f74-fcd722a898c1">575,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated consideration to be paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92956d7d960f45f3bea45f7aa025342c_D20220101-20220630" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfNy0yLTEtMS04NTQyNw_455ec063-9067-4a5e-be67-39e60cdab5e0">2,552,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Preliminary Purchase Price Allocation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTAtMi0xLTEtODU0Mjc_36874652-4dce-4134-97a1-e08c6669ea12">78,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTEtMi0xLTEtODU0Mjc_4a68b5fa-7b04-4d88-8a0f-a0e0a7d298dd">118,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTItMi0xLTEtODU0Mjc_3ee275ed-6395-4dd1-8b50-732151a6cb54">226,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTMtMi0xLTEtODU0Mjc_a9a79fff-ae61-48ac-9d00-d0b62ee9446a">53,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTQtMi0xLTEtODU0Mjc_8d6ab59e-2a80-426f-8a77-ea320bdfa5e5">210,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="icui:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTUtMi0xLTEtODU0Mjc_a171f4a4-60cc-4a34-9520-a8109d5fab57">55,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTYtMi0xLTEtODU0Mjc_9671343b-79f2-4bd1-90f2-dea5d9cb52c5">975,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTctMi0xLTEtODU0Mjc_e749a3ce-594f-45ec-92c0-05430a677d8c">9,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTgtMi0xLTEtODU0Mjc_facfacc2-8f18-4619-a127-21163c931f08">379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTktMi0xLTEtODU0Mjc_eb5edba7-c002-4e89-8ce9-c772e5216b9f">105,291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMjAtMi0xLTEtODU0Mjc_59132e6c-d100-4ae8-8131-ecd62f228741">175,099</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="icui:BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMjEtMi0xLTEtODU0Mjc_a402571d-b8c8-402a-8fe8-0ec2ecb1200a">24,332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMjItMi0xLTEtODU0Mjc_10f5743d-10dc-4198-ba8f-ec36c8640e3e">85,739</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMjMtMi0xLTEtODU0Mjc_f7a92814-a6db-4617-a24c-733f07220344">228,689</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMjQtMi0xLTEtODU0Mjc_dc950235-8c7e-4d18-b621-bf25e595e75e">1,107,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - not tax deductible</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-3" name="icui:BusinessCombinationGoodwillNonDeductible" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMjUtMi0xLTEtODU0Mjc_14ee4b98-1a7a-43d1-8bbe-9c545df71023">1,444,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated Purchase Consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5289794172a4cb198e8aa0169b4c3b2_D20220401-20220630" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMjYtMi0xLTEtODU0Mjc_29426d06-f383-40c2-831f-0c986468e30d">2,552,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimated identifiable intangible assets include $<ix:nonFraction unitRef="usd" contextRef="i9639169305914239b5bd07cfd412c105_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfMjU1MA_138b1839-60d8-4ede-86a7-fc8a9e86e4fb">540.0</ix:nonFraction>&#160;million of customer relationships, $<ix:nonFraction unitRef="usd" contextRef="ifd1869288e4244bfa1eeb70afaf8d8b1_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfMjU4MA_dc3a3149-98bb-4e3d-87c2-1342523d734f">400.0</ix:nonFraction>&#160;million of developed technology, $<ix:nonFraction unitRef="usd" contextRef="i69cd3733592345e3b3f6a2fba4b5f08d_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDQy_13277da9-4d43-45c4-8277-f157a55cdcb5">30.0</ix:nonFraction>&#160;million of internally developed software, and $<ix:nonFraction unitRef="usd" contextRef="ic884346985a24c95b00b5aacf1b3975a_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfMjYxMg_b21aac88-eadc-4298-8fe2-0aaf88cce524">5.0</ix:nonFraction>&#160;million of trade mark. The estimated weighted-average amortization period for the total identifiable intangible assets is approximately <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU2_ddab537f-8bc6-4122-8738-75e9f83ccca8">nine</span> years, and, for each identifiable intangible asset is estimated as follows: <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU3_94ff8303-bbea-4e2c-80a0-75c79ec80ddf">eight</span> years for customer relationships, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU4_39b70a39-6a8c-49b7-a62c-b1011d2a541c">ten</span> years for developed technology, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU5_9bab9dac-782a-4c71-afdc-921a87d1c7b7">five</span> years for internally developed software, and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDYw_9c9b33b6-6b8e-4b28-8e2a-6c3cc63df867">six</span> months for the trade mark. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimated accrued liabilities includes, among other things, accrued warranty reserves, accrued restructuring initiatives, accrued salaries and related benefits, deferred revenue and accrued sales and use taxes.</span></div></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above purchase price and purchase price allocation are preliminary and subject to future revision as the acquired assets and liabilities assumed are dependent upon the finalization of the related valuations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The identifiable intangible assets and other long-lived assets acquired have been valued as Level 3 assets at fair value. The estimated fair value of identifiable intangible assets were developed using the income approach and are based on critical estimates, judgments and assumptions derived from: analysis of market conditions; discount rate; discounted cash flows; royalty rates; customer retention rates; and/or estimated useful lives. Certain other intangible assets were valued using a cost to replace method, estimating the labor and non-labor costs required to replace the asset under the premise that it was not part of the transaction. Property, plant and equipment was valued with the consideration of remaining economic lives. The raw materials inventory was valued at historical cost and adjusted for any obsolescence which we estimate to approximate replacement cost, the work in process was valued at estimated sales proceeds less costs to complete and costs to sell, and finished goods inventory was valued at estimated sales proceeds less costs to sell. The prepaid expenses and other current assets and assumed liabilities were recorded at their carrying values as of the date of the acquisition, as their carrying values approximated their fair values due to their short-term nature.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="ibea7bdf249bd4286a98ccc32a37c6ee5" continuedAt="i929abde352174035a00f4b436f56f744"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Information</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smiths Medical is included in our consolidated results beginning on January 7, 2022. Total revenues and net loss attributable to Smiths Medical for the period from January 7, 2022 to June 30, 2022 were $<ix:nonFraction unitRef="usd" contextRef="i92956d7d960f45f3bea45f7aa025342c_D20220101-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNDkwOA_43443ed2-0954-4c71-aa82-6a491ff13782">437.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i92956d7d960f45f3bea45f7aa025342c_D20220101-20220630" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNDkxNQ_685de504-79e1-482f-88c0-ed60c7675594">65.5</ix:nonFraction>&#160;million, respectively, and for the three months ended June 30, 2022 were $<ix:nonFraction unitRef="usd" contextRef="id5289794172a4cb198e8aa0169b4c3b2_D20220401-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NTE0_477e21f3-2ffa-420b-8df1-eaffe68834f4">222.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="id5289794172a4cb198e8aa0169b4c3b2_D20220401-20220630" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NTMw_2657ec58-1c1d-4225-8f62-8278966191c8">26.0</ix:nonFraction>&#160;million. The following unaudited pro forma financial information presents the combined results of operations of ICU and Smiths Medical as if the acquisition had occurred on January 1, 2021. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place on the date indicated or of results that may occur in the future. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><ix:nonNumeric contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzQ1Ng_3476f781-0109-494f-bf08-0df7aff5f24e" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.425%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjIxNGNmMWM5NzczMDRiZjM5ZGUwYmIzNjQwMTIxMDljL3RhYmxlcmFuZ2U6MjE0Y2YxYzk3NzMwNGJmMzlkZTBiYjM2NDAxMjEwOWNfMi0xLTEtMS04NTQyNw_e2de4f66-60d6-450b-af1d-c016d4aed633">561,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjIxNGNmMWM5NzczMDRiZjM5ZGUwYmIzNjQwMTIxMDljL3RhYmxlcmFuZ2U6MjE0Y2YxYzk3NzMwNGJmMzlkZTBiYjM2NDAxMjEwOWNfMi0zLTEtMS04NTQyNw_236fc798-6fda-45c6-b3f5-f2fc416af965">625,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjIxNGNmMWM5NzczMDRiZjM5ZGUwYmIzNjQwMTIxMDljL3RhYmxlcmFuZ2U6MjE0Y2YxYzk3NzMwNGJmMzlkZTBiYjM2NDAxMjEwOWNfMi01LTEtMS05MDU0NA_b15c8ec7-26cc-4d67-991b-820a6069c9f6">1,124,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjIxNGNmMWM5NzczMDRiZjM5ZGUwYmIzNjQwMTIxMDljL3RhYmxlcmFuZ2U6MjE0Y2YxYzk3NzMwNGJmMzlkZTBiYjM2NDAxMjEwOWNfMi03LTEtMS05MDU0Ng_ad46895c-a99b-4f90-9970-c15e38535c31">1,227,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjIxNGNmMWM5NzczMDRiZjM5ZGUwYmIzNjQwMTIxMDljL3RhYmxlcmFuZ2U6MjE0Y2YxYzk3NzMwNGJmMzlkZTBiYjM2NDAxMjEwOWNfMy0xLTEtMS04NTQyNw_2bccce42-c4c4-43b3-8c2e-225798ba95d6">7,474</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjIxNGNmMWM5NzczMDRiZjM5ZGUwYmIzNjQwMTIxMDljL3RhYmxlcmFuZ2U6MjE0Y2YxYzk3NzMwNGJmMzlkZTBiYjM2NDAxMjEwOWNfMy0zLTEtMS04NTQyNw_3bd6c63e-09e1-433c-9b81-822fac70db8a">34,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjIxNGNmMWM5NzczMDRiZjM5ZGUwYmIzNjQwMTIxMDljL3RhYmxlcmFuZ2U6MjE0Y2YxYzk3NzMwNGJmMzlkZTBiYjM2NDAxMjEwOWNfMy01LTEtMS05MDU0OA_8731cfa9-154c-4b1a-9d6a-5a8488db923f">59,425</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjIxNGNmMWM5NzczMDRiZjM5ZGUwYmIzNjQwMTIxMDljL3RhYmxlcmFuZ2U6MjE0Y2YxYzk3NzMwNGJmMzlkZTBiYjM2NDAxMjEwOWNfMy03LTEtMS05MDU1MA_26c8a63d-0cda-45d9-8a60-8505f8dabd9b">31,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results presented above include the impact of the following adjustments: incremental amortization expense on intangible assets acquired of $<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="icui:ProFormaAdjustmentAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTU0NQ_f64ab53a-539c-4f30-a52f-73d4e7392ced">1.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="icui:ProFormaAdjustmentAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTU1Mg_bdf62c6d-abf2-4dd5-b38f-86fbef3c8bcf">55.5</ix:nonFraction>&#160;million for the six months ended June 30, 2022 and 2021, respectively, incremental interest expense, including amortization of debt discount and debt issuance costs, on the Credit Facilities of $<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="icui:ProFormaAdjustmentFinanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTc0NA_a99c6f67-e95d-4ab7-bf44-898268e17b22">0.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="icui:ProFormaAdjustmentFinanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTc1MQ_b34d1747-cd9b-4e27-96cc-c641ad7c59e3">25.4</ix:nonFraction>&#160;million for the six months ended June 30, 2022 and 2021, respectively; and a $<ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="icui:ProFormaAdjustmentInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTgyNg_75ab3608-7bc1-4f95-ab26-de89d9d6a4af">27.4</ix:nonFraction>&#160;million expense related to the increase in fair value of inventory for the six months ended June 30, 2021. In addition, there were non-recurring adjustments directly attributable to the business combination, including acquisition-related cost of $<ix:nonFraction unitRef="usd" contextRef="ida3d6c67a93c4582b8cb475e3d531c8c_I20220630" decimals="-3" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNjA3MA_21959d69-dea2-4d90-81d0-865de9c412e8">13.5</ix:nonFraction>&#160;million for the six months ended June 30, 2021 and adjustments related to the extinguishment of related party loans receivable and payable equal to $<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="icui:ProFormaAdjustmentRelatedPartyLoans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNjIxNg_94c62293-a3b6-4a5a-9ba0-a5e8710320d6">80.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="icui:ProFormaAdjustmentRelatedPartyLoans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNjIyMw_890627a5-5ab2-4f01-8233-24cbaae66daf">45.0</ix:nonFraction>&#160;million for the six months ended June 30, 2022 and 2021, respectively. The unaudited pro forma results include IFRS to U.S. GAAP adjustments for Smiths Medical historical results and adjustments for accounting policy alignment, which were materially similar to the Company. Any differences in accounting policies were adjusted to reflect the accounting policies of the Company in the unaudited pro forma results presented. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Acquisition</span></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i929abde352174035a00f4b436f56f744">During November 2021, we acquired a small foreign infusion systems supplier and paid an initial gross cash payment of approximately $<ix:nonFraction unitRef="usd" contextRef="i0c90af4126704fd9b931fd425c90445a_D20220401-20220630" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNjc5Ng_0ce2d870-a597-4a8d-982b-2dccdf5fda04">15.4</ix:nonFraction>&#160;million. In addition to the initial cash consideration, total consideration for the acquisition includes an additional holdback of $<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="icui:BusinessCombinationConsiderationHoldbackLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNjkyMg_cb9021f9-4889-40d5-9b06-8d6f9759ff98">0.5</ix:nonFraction>&#160;million, to be paid two years from the completion date of the acquisition, and also a potential earn-out payment of up to $<ix:nonFraction unitRef="usd" contextRef="i0c90af4126704fd9b931fd425c90445a_D20220401-20220630" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzAzOQ_3a0ab32a-b455-4197-ba5b-5f3d05891529">2.5</ix:nonFraction>&#160;million, consisting of (i) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="i0c90af4126704fd9b931fd425c90445a_D20220401-20220630" decimals="-6" name="icui:ContingentConsiderationGrossST" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzA3OQ_a21666b2-407f-4c5f-a0eb-e333580d28ee">1.0</ix:nonFraction>&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="i0c90af4126704fd9b931fd425c90445a_D20220401-20220630" decimals="-5" name="icui:ContingentConsiderationGrossLT" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzIyNg_1be40ef8-a912-418d-b046-fee7976ea1dc">1.5</ix:nonFraction>&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of June 30, 2022, the total consideration which includes the acquisition date fair value of the contingent consideration was $<ix:nonFraction unitRef="usd" contextRef="ie3f122ddd9b745f8952af44b2b23b0cb_D20220101-20220630" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzQ0OA_b99b7fc9-7fa7-45d0-b2f4-129032362e60">17.1</ix:nonFraction>&#160;million.</ix:continuation> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div style="text-indent:36pt"><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4:  <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfMTUzNg_b88c822f-04cf-4748-b494-2d001244b2f7" continuedAt="i0e6a8ff2dc9b43b599eac5fce03532b0" escape="true">Restructuring, Strategic Transaction and Integration</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0e6a8ff2dc9b43b599eac5fce03532b0" continuedAt="if229927b7e354d419ef7fc6bbeaf6389"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Restructuring, strategic transaction and integration expenses were $<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="icui:Restructuringstrategictransactionandintegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfMTM2_90c2af6d-dd2d-4b3a-9f26-6a779e00aebe">13.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="icui:Restructuringstrategictransactionandintegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfMTQz_6bbd13e7-0be9-4bd1-8656-2a2743ece28e">3.8</ix:nonFraction> million for the three months ended June 30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="icui:Restructuringstrategictransactionandintegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfNTQ5NzU1ODE1NDQy_b866eed3-dadc-4c6f-9553-09b48bbb2f94">47.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="icui:Restructuringstrategictransactionandintegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfNTQ5NzU1ODE1NDU0_eb4501c4-b83f-4c2f-b7a6-59763156b265">6.6</ix:nonFraction> million for six months ended June 30, 2022 and 2021, respectively.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three and six months ended June 30, 2022, restructuring charges were $<ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfMjc5_b890bcb9-751a-405f-98c0-5850f166719f">1.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfNTQ5NzU1ODE2MjQ0_74697366-c6f3-4d83-8105-f620256e2ccf">4.9</ix:nonFraction>&#160;million, respectively,  and were related to severance costs. Restructuring charges during the three and six months ended June 30, 2021 were not material.&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfMTUyOA_8349118c-6628-4983-89f8-422b919d2126" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity in our restructuring-related accrual by major type of cost for the period ended June&#160;30, 2022 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.840%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Severance Pay and Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retention and Facility Closure Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe03e5366a5944d9a0a9a40abcb641dc_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMS0yLTEtMS04NzkzNA_192c628b-f89e-4591-b53f-0f16fd1a36f2">499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30121bdcbe2c464c8ed3b44ec7055f4b_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMS02LTEtMS04NzkzNA_222edc1a-14b2-4194-9c3a-e2404c2dbdc1">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMS04LTEtMS04Nzk4Nw_10e04f63-2490-4286-91c8-ca28b0d5d859">664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired restructuring liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebdd9a3a6a1149b18e00453de01f406d_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMi0yLTEtMS04Nzk4OQ_c0803a31-f15d-4272-9d5e-99c1f9f390c0">5,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a00ec4d4be4edfb0626ca6dc4a51d8_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMi02LTEtMS04Nzk5OQ_3c613df2-542f-43ae-9988-7522573a7aed">1,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f22c3698eff4a70b949d07786441335_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMi04LTEtMS04ODAwOQ_12004515-fab6-479b-9b11-b97ccae819c1">7,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5dcf4e8d7c447c96f6a1391e551243_D20220101-20220331" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMi0yLTEtMS04NzkzNA_eb7bb672-bea3-46e6-bcfa-6513a8fd468d">3,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9ce85809f343a4aa82fc58533ef7f7_D20220101-20220331" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMi02LTEtMS04NzkzNA_06f96c12-42c9-4f2e-bd39-a94d006013e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMy04LTEtMS04ODAxMQ_6299827a-5f38-48ab-a1d0-07a99dd2cdcb">3,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5dcf4e8d7c447c96f6a1391e551243_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMy0yLTEtMS04NzkzNA_a235a4dc-ba90-4121-9c6a-738d741f1bb6">2,030</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9ce85809f343a4aa82fc58533ef7f7_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMy02LTEtMS04NzkzNA_aa815724-55e5-4444-abde-c05a73509b88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNC04LTEtMS04ODAxMw_fd21dedf-5d0f-4fce-9036-312c5535df78">2,030</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5dcf4e8d7c447c96f6a1391e551243_D20220101-20220331" decimals="-3" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNC0yLTEtMS04NzkzNA_44cd60d0-5be5-44d8-8e17-df9f980821bd">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a9ce85809f343a4aa82fc58533ef7f7_D20220101-20220331" decimals="-3" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNC02LTEtMS04NzkzNA_ab26bf68-4672-4e19-90f6-858eb9545a31">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331" decimals="-3" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNS04LTEtMS04ODAxNQ_ef099a22-354e-49ac-b57f-99fcae35d1e7">187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebdd9a3a6a1149b18e00453de01f406d_I20220331" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNi0yLTEtMS04Nzk5Nw_56296464-dcc3-4bdf-b137-054b0cbe8bb8">7,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a00ec4d4be4edfb0626ca6dc4a51d8_I20220331" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNi02LTEtMS04ODAwNw_d58a83b1-146a-4e8e-8a71-f406332ee54e">1,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f22c3698eff4a70b949d07786441335_I20220331" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNi04LTEtMS04ODAxNw_6bf5111e-4702-43b5-8575-c72e6f581c88">9,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97a17795307447680a6d14b0a583adb_D20220401-20220630" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNi0yLTEtMS04NzkzNA_dd68f9f0-3b4b-4ac9-9ae9-5e3b8517436f">1,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6ddb824958a4849b40442c9bad27a5a_D20220401-20220630" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNi02LTEtMS04NzkzNA_2fe11888-b75a-4256-bab6-591f9d1cdbc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNy04LTEtMS04ODAxOQ_b52cd5f6-9057-4072-8f54-4c97a70021bc">1,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia97a17795307447680a6d14b0a583adb_D20220401-20220630" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNy0yLTEtMS04NzkzNA_66feeafc-f0a6-4c02-8a51-4c0821f87d70">3,352</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6ddb824958a4849b40442c9bad27a5a_D20220401-20220630" decimals="-3" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNy02LTEtMS04NzkzNA_339dcf41-3dbe-46de-8be0-18157f48a24c">212</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfOC04LTEtMS04ODAxOQ_9fa782a0-40be-4cc3-b8dc-85a3c3b2df70">3,564</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia97a17795307447680a6d14b0a583adb_D20220401-20220630" decimals="-3" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfOC0yLTEtMS04NzkzNA_dad4037a-3ca1-45c6-81ce-6072a73593f4">256</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6ddb824958a4849b40442c9bad27a5a_D20220401-20220630" decimals="-3" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfOC02LTEtMS04NzkzNA_47585e28-74af-4468-8c39-99dc67f43364">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfOS04LTEtMS04ODAxOQ_9bcad69e-62fe-4a37-bfa2-44f9101f402d">350</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia97a17795307447680a6d14b0a583adb_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfOS0yLTEtMS04NzkzNA_999f24ae-8567-421e-99ea-14fce8a6e59e">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6ddb824958a4849b40442c9bad27a5a_D20220401-20220630" decimals="-3" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfOS02LTEtMS04NzkzNA_842872cd-5051-4f88-bdcb-795393a7ce4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMTAtOC0xLTEtODgwMTk_d4a8f6a5-0294-4b9c-b10a-079c65a9e939">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dd4e597d17447488d221348105e1bdd_I20220630" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMTEtMi0xLTEtODgwMTk_4f1880c9-5f6e-43ea-ad9a-07e146cfb007">5,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i512b8be12e094d459307488f3940c386_I20220630" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMTEtNi0xLTEtODgwMTk_c6a66335-3d08-4d45-867f-8421ece4a8ff">1,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMTEtOC0xLTEtODgwMTk_2d30147f-a43b-4fb4-b6a1-6141f15c64f7">6,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strategic Transaction and Integration Expenses</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if229927b7e354d419ef7fc6bbeaf6389">&#160;&#160;&#160;&#160;We incurred and expensed $<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-5" name="icui:StrategicTransactionandIntegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfNjI4_560b3241-5732-4418-89ea-dd59fa5adbd8">11.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-5" name="icui:StrategicTransactionandIntegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfNjM1_7a025fc3-049a-4c85-89e5-6e140cf02f31">3.7</ix:nonFraction> million in strategic transaction and integration expenses during the three months ended June 30, 2022 and 2021, respectively, and we incurred and expensed $<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-5" name="icui:StrategicTransactionandIntegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfNTQ5NzU1ODE1NjAw_8678ce6d-dc38-4c04-a166-92a0b897d5ab">42.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-5" name="icui:StrategicTransactionandIntegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfNTQ5NzU1ODE1NjEw_fbb0f1e2-312a-4754-8b25-1ad3250b6bd1">6.5</ix:nonFraction> million in strategic transaction and integration expenses during the six months ended June 30, 2022 and 2021, respectively, which are included in restructuring, strategic transaction and integration expenses in our condensed consolidated statements of operations. The strategic transaction and integration expenses during the three and six months ended June 30, 2022 were primarily related to transaction and integration expenses associated with our acquisition of Smiths Medical on January 6, 2022 (see Note 3: Acquisitions) which primarily included legal expenses, bank fees and employee costs. The six months ended June 30, 2022 also included a United Kingdom stamp tax. The strategic transaction and integration expenses for the three and six months ended June 30, 2021 were primarily related to integration costs associated with acquisitions, the Hospira Infusion Systems ("HIS") earn-out dispute with Pfizer and one-time costs incurred to comply with regulatory initiatives.</ix:continuation>  </span></div><div><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5:  <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RleHRyZWdpb246NzRmOWI5YjEwNTkzNDdjN2JjNzJiNzE5YmViNmYzY2VfMzQxMA_f1c8dabd-856a-467c-ab6a-c03321dab7ba" continuedAt="idd8f026664f04f30bb4ec26718904bb0" escape="true">Revenue</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="idd8f026664f04f30bb4ec26718904bb0" continuedAt="i8d9bbed7cd8b4c3ca2778c7ed286a3b1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Following our acquisition of Smiths Medical, our primary product lines are Infusion Consumables, Infusion Systems, IV Solutions, Critical Care, Infusion Systems-Smiths Medical, Vascular Access-Smiths Medical and Vital Care-Smiths Medical. The vast majority of our sales of these products are made on a stand-alone basis to hospitals and distributors. Revenue is typically recognized upon transfer of control of the products, which we deem to be at point of shipment. However, for purposes of revenue recognition for our software licenses and renewals, we consider the control of these products to be transferred to a customer at a certain point in time; therefore, we recognize revenue at the start of the applicable license term.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i8d9bbed7cd8b4c3ca2778c7ed286a3b1" continuedAt="i7a27fba889d9446eb4ab342361f13df8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Payment is typically due in full within 30 days of delivery or the start of the contract term.  Revenue is recorded in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We offer certain volume-based rebates to our distribution customers, which we record as variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between the prices we charge our distribution customers and the contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts in order to determine the transaction price, we use information available at the time, including our historical experience.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We also warranty products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available at that time and our historical experience. We also provide for extended service-type warranties, which we consider to be separate performance obligations. We allocate a portion of the transaction price to the extended service-type warranty based on its estimated relative selling price, and recognize revenue over the period the warranty service is provided. Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue disaggregated</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents our revenues disaggregated by product line (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.841%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product line</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Consumables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i349a5bf778244242883e275326abbbc6_D20220401-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfMi0xLTEtMS04NTQyNw_b5341d7e-2c3c-4edd-b84f-4ecfdc8e6e8c">144,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3c50f5fe7bb40ffacbf183985941a02_D20210401-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfMi0zLTEtMS04NTQyNw_51e60317-8f53-4b38-b73b-92cdf7a03ad1">136,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c07ed0518e42d8a531402774100df5_D20220101-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfMi01LTEtMS05MDU2MA_76efeb1c-65e5-4cde-a2e8-6356c7459a3d">284,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefd60bb319394d118b895166607b7b8d_D20210101-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfMi03LTEtMS05MDU2NA_14bd50e9-f6ec-4bd9-9671-d25760919604">262,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee3b1a6579e747d2a23f2be0ea003d7c_D20220401-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfMy0xLTEtMS04NTQyNw_bb49e264-f410-4a15-b3fd-43251db7e756">87,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10978132bc5f4022a4c6518a79988c69_D20210401-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfMy0zLTEtMS04NTQyNw_7c74f916-3cb8-4413-ae12-9fbbe54f8a56">84,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aeab60d1fcb4a7584c05d0319a0b156_D20220101-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfMy01LTEtMS05MDU2MA_e71a0938-7bf6-4b89-8924-6c2159a0b36e">174,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961a96cb425c440eada93964a19186b9_D20210101-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfMy03LTEtMS05MDU2NA_1e0738c0-ec18-4a6e-bc10-6841e0518573">168,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbee468195c04505b91056e9f3302922_D20220401-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNC0xLTEtMS04NTQyNw_61da8917-1251-40ef-bc1f-f4df6f0fe851">94,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i920322efa6a64088a2f6d5a382fc36ce_D20210401-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNC0zLTEtMS04NTQyNw_5c5474b7-a860-40e8-8a3e-4e64c1711daa">88,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae1bb5bb3d0f4ae98eaf40951a717632_D20220101-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNC01LTEtMS05MDU2MA_7ad67ca7-41cd-4fdd-8f81-c0d5d056ae25">182,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491a4bfbfd2746e19e9d49c2c5681cee_D20210101-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNC03LTEtMS05MDU2NA_9a6b90eb-d4ec-49b3-8581-811d0bf19879">182,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8821ac00c20b4afc99c120d017a83ecb_D20220401-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNS0xLTEtMS04NTQyNw_bedf6f74-be58-483f-8a82-13b034d6fa1d">12,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i712c9670278049fc823b141f1937afa2_D20210401-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNS0zLTEtMS04NTQyNw_586da575-204a-4000-8e06-dcb109f30c5a">12,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id35f7bc641e64653a45020c7540094a9_D20220101-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNS01LTEtMS05MDU2MA_d614ce14-89a9-4e8a-9576-adf932382368">24,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22c729de11504d73a6a77ce1d5ccc78f_D20210101-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNS03LTEtMS05MDU2NA_a907726b-d152-4dc0-9969-f2a640e50425">25,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Systems-Smiths Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bf1efd2f7fc49028373bab90caa5c99_D20220401-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNi0xLTEtMS04NTQyNw_abc9e1b7-2978-4258-b813-0f8157f3d5f9">77,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee76c84d43746a9b29b9dbe3e3cbab5_D20210401-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNi0zLTEtMS04NTQyNw_19a0aa0a-b3fd-4ed6-9705-db319c561241">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c55a4b3cfe845d386e5ac7d196b83a1_D20220101-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNi01LTEtMS05MDU2MA_f957e4b9-28a4-4d7a-82d2-4b1887970e3e">144,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58eace8558db4d639d849abeb781cfeb_D20210101-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNi03LTEtMS05MDU2NA_b403da4c-3f06-455e-a840-be3d575cfd4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vascular Access-Smiths Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77b4bc25012a43c1af56c984cacd3be8_D20220401-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNy0xLTEtMS04NTQyNw_ca2746f7-5f92-4c00-9a48-b9831ca1865b">77,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if311b897ac014b9587d953a2b2922e0b_D20210401-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNy0zLTEtMS04NTQyNw_9c2c50a2-7853-4879-b3bd-82e2264d1f70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3ea2c1e27c94bdaa8b13528fbdb0dcb_D20220101-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNy01LTEtMS05MDU2MA_a82bcea0-c210-4bd6-8155-b1f60b32fec6">156,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c8ec6c32704111ac8f0d54f2437ec5_D20210101-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNy03LTEtMS05MDU2NA_19f2fec9-e743-4e48-b60a-e0d3fd665969">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vital Care-Smiths Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i700cf99eae6a4036bea762420b65262e_D20220401-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfOC0xLTEtMS04NTQyNw_82cec0f5-efd0-47cc-bf6f-309584ae1fa1">67,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c0e18fb79fa41c49a1d8e3564ebaf32_D20210401-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfOC0zLTEtMS04NTQyNw_8f793144-6879-4d74-89de-25572d87159b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bedb9e9ac7948fc9e52661e267a3094_D20220101-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfOC01LTEtMS05MDU2MA_d3138bd6-2844-442c-908c-ee445d3c4157">137,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3587782975144bb967dd1df75ddee2f_D20210101-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfOC03LTEtMS05MDU2NA_cd7ec1ea-084d-42a6-8038-9ce7d07d7e62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfOS0xLTEtMS04NTQyNw_b5d23ed9-fda5-4c54-a7b1-181e4b49b261">561,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfOS0zLTEtMS04NTQyNw_eb78bb66-83d2-4af7-90bb-54c976138192">321,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfOS01LTEtMS05MDU2MA_87001daf-08ae-4a15-a19f-1ec6122e3ae3">1,104,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfOS03LTEtMS05MDU2NA_52df927d-8691-4fce-8f72-7cdfd0c6e058">639,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Infusion Systems-Smiths Medical, Vascular Access-Smiths Medical and Vital Care-Smiths Medical represent our newly integrated product lines following our acquisition of Smiths Medical on January 6, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RleHRyZWdpb246NzRmOWI5YjEwNTkzNDdjN2JjNzJiNzE5YmViNmYzY2VfMzQxMg_09a636fc-9b57-4dc6-97ec-6d43dca10202" continuedAt="idd3b73633a0f44919b4f786243821237" escape="true">The following table represents our revenues disaggregated by geography (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="idd3b73633a0f44919b4f786243821237"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.841%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geography</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b87c8dac7974a8782e310a9135de722_D20220401-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfMi0xLTEtMS04NTQyNw_03725e4e-cc74-4882-be88-a8c383ccb720">87,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7260b43edc5c4f09b88e2c68f47f0400_D20210401-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfMi0zLTEtMS04NTQyNw_2e6c2548-384f-4cef-94c4-0d092c3e8f79">37,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib727cbf7f11a4c139194b7e121bfd07c_D20220101-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfMi01LTEtMS04NTQyNw_19df7b14-4ec6-4c2c-8567-fe989b3432d2">173,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e56919e5c00481180fbdf59082fd04d_D20210101-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfMi03LTEtMS04NTQyNw_c9ae281f-42a1-493d-acfc-1c21cf670ae2">72,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc9ee3ce53e43b9a4de6b99351dbc6c_D20220401-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfNi0xLTEtMS04NTQyNw_29c41541-6ec4-4deb-b8d8-7a661fc4afbe">109,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd47aba974954e0781a2414535bc312d_D20210401-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfNi0zLTEtMS04NTQyNw_44e37ac9-22c0-4ff1-a2f4-628455d29512">59,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2457c39ef148408db901026663d3bfb7_D20220101-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfNi01LTEtMS04NTQyNw_3f866ae7-0deb-42cf-ab40-dbd12d34aea1">218,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id767533fe49f44c4a9d6dfa028a7691f_D20210101-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfNi03LTEtMS04NTQyNw_84d19eca-a945-4d99-abae-495c0008aa53">115,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Foreign</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c248127119d40b5845f0892855f08ae_D20220401-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfNy0xLTEtMS04NTQyNw_c5e417a1-cbca-4739-92de-5fa67b63f50f">197,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b13c4aa80b74968a828e6ba37616e44_D20210401-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfNy0zLTEtMS04NTQyNw_43a30ba2-b39c-4a9d-aa5d-62f53aa18875">97,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8435bfea45414116839eacf40cc750c4_D20220101-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfNy01LTEtMS04NTQyNw_49914a0d-203e-49ec-b14d-d901205d9893">392,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fba10f79d7446689094ad47012f06b7_D20210101-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfNy03LTEtMS04NTQyNw_80c338bd-44ff-46cb-8c4a-3edd080005cc">187,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de7eb8fd7af48e39044549859b11d7a_D20220401-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfOC0xLTEtMS04NTQyNw_79ca8b4c-81c7-4e21-afa0-02760985223b">363,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4627a160fec94c4fb9bc050310d7da34_D20210401-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfOC0zLTEtMS04NTQyNw_5f7eeeb1-8a49-4e73-9cb1-19fd3822dbce">224,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2150dcd378042cdb345d5d0d362d0ed_D20220101-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfOC01LTEtMS04NTQyNw_663a7f92-b395-484f-8c14-e15cbc03f37d">711,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8494e9281e3c4b64a4ce4f950c59f2db_D20210101-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfOC03LTEtMS04NTQyNw_22866126-598f-41ce-8bbf-3e654ad97426">452,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfOS0xLTEtMS04NTQyNw_3f57d069-f1e9-497e-8d7e-2f58f0320477">561,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfOS0zLTEtMS04NTQyNw_494b400a-e851-4d50-b17b-15a1ea7c648f">321,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfOS01LTEtMS04NTQyNw_3600bad2-5f9d-4dd1-8bb6-d439c0ff8c35">1,104,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfOS03LTEtMS04NTQyNw_75f27dd9-ff16-4b47-bd0f-f513fe66e4a0">639,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i7a27fba889d9446eb4ab342361f13df8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract balances</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RleHRyZWdpb246NzRmOWI5YjEwNTkzNDdjN2JjNzJiNzE5YmViNmYzY2VfMzQwNg_cabcb6e1-8ab5-4914-8aea-89e7fd8b2443" continuedAt="i9ebcb0c5aafe4e2594ff940129196792" escape="true">The following table presents the changes in our contract balances for the six months ended June 30, 2022 and 2021 (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i9ebcb0c5aafe4e2594ff940129196792"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMS0xLTEtMS04NTQyNw_0cbc9d4f-4caa-4d7c-8a70-2315103a6431">7,461</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of acquired deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad535f7eeb684a27aeb1b18c36ba3197_I20210630" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMi0xLTEtMS04NTQyNw_6db06add-5395-4088-8a62-3995f7ca0124">51,245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50a1c52d23e24394a0575ed9cb391bf5_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMy0xLTEtMS04NTQyNw_82505e18-15fb-4bef-9ff8-e013e97faaac">14,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50a1c52d23e24394a0575ed9cb391bf5_D20220101-20220630" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfNC0xLTEtMS04NTQyNw_4e371b13-eb45-4767-bdba-13ed59ba9b7f">7,349</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if490f6070f954ef6a7b2580ba7b91d5a_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfNS0xLTEtMS04NTQyNw_54da918e-2de4-4055-933c-8d35975e0ebd">8,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if490f6070f954ef6a7b2580ba7b91d5a_D20220101-20220630" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfNi0xLTEtMS04NTQyNw_c5f1e648-0c08-4f5d-aee3-d1c6c226cceb">9,067</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b423f9055fe4080a992d69631ef9969_D20220101-20220630" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfNy0xLTEtMS04NTQyNw_9da301f8-3db1-4779-8aa5-ef7ecdec9fe2">2,972</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b423f9055fe4080a992d69631ef9969_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfOC0xLTEtMS04NTQyNw_3f3cc33f-107b-4197-9fe9-f87ebc29bfff">232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i288a4309c79045fab93c86aeac495b54_D20220101-20220630" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfOS0xLTEtMS04NTQyNw_c9ce5628-f1b5-4ce6-bf63-b8b82005e834">1,005</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i288a4309c79045fab93c86aeac495b54_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMTAtMS0xLTEtODU0Mjc_ac2fa007-56f6-40b1-bc08-dc65324054be">2,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMTEtMS0xLTEtODU0Mjc_1936579b-24fe-4e5b-ad41-a10732235ddd">53,066</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21594db97b18415da81085ad86be9dbe_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMTMtMS0xLTEtODU0Mjc_73ed80ac-b3a6-4441-b769-8199804501dd">6,430</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id013675bfeeb448290d2bae1c0721424_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMTQtMS0xLTEtODU0Mjc_2aa1abcb-0d0c-4168-b08e-0176c1bb76a5">4,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id013675bfeeb448290d2bae1c0721424_D20210101-20210630" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMTUtMS0xLTEtODU0Mjc_ad096ea8-de2f-442c-87b1-7061dbf1a1b6">5,435</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib78f819fc4074defb921bd3f7e151c87_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMTYtMS0xLTEtODU0Mjc_9783ceea-f17b-4ece-8913-fd34b66c8a62">4,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib78f819fc4074defb921bd3f7e151c87_D20210101-20210630" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMTctMS0xLTEtODU0Mjc_142833f0-47e7-4df6-b08b-38e24ffa2215">2,212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55063029c0d44ea78a93faf80c101754_I20210630" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMTgtMS0xLTEtODU0Mjc_de3de220-ec37-40f6-b658-0851f6225cb4">4,968</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of June 30, 2022, revenue from remaining performance obligations is as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.516%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recognition Timing</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&lt; 12 Months</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&gt; 12 Months</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2160e64516a449cbb6842e6568cca20_I20220630" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfMi0xLTEtMS04NTQyNw_f750643a-72c1-4ea9-aa42-cdab82f16233">19,744</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0f6486a9914867b3cbed5c46e761c4_I20220630" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfMi0zLTEtMS04NTQyNw_7f30f241-e48f-4204-a1f3-8ee3d3e20e04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96315c122c9e477f909fef66929bc3ef_I20220630" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfMy0xLTEtMS04NTQyNw_e8e1da84-068a-4453-9852-1c099413d7c5">7,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20a968e1b0184b1bb3eccc6e2daa86f6_I20220630" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfMy0zLTEtMS04NTQyNw_6c5b45db-c5d7-4361-8e3c-f20083edc7b6">1,647</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1deebfa912054645813b6d49cf6b7ae2_I20220630" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfNC0xLTEtMS04NTQyNw_c1273107-f120-4c25-afe0-9b5ccc36b6d8">1,175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i053cf9509eae4840907fad5c27160755_I20220630" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfNC0zLTEtMS04NTQyNw_0a717d84-5da1-44e9-adfa-f8fd8f4ac90c">13,569</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36cddf068b6e4a8597c963ee835bdc8e_I20220630" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfNS0xLTEtMS04NTQyNw_215862bc-95ff-4a64-bac1-b3b28efaea9a">1,903</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d633f7881b646788b8fc5ddcda35b2b_I20220630" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfNS0zLTEtMS04NTQyNw_34c32e8a-3506-449a-b686-d16ac82e0d4c">7,278</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6801313ae892411d80498d2ae6f075f6_I20220630" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfNi0xLTEtMS04NTQyNw_179acb98-7871-4e9c-b8ad-9d3b99e876de">30,572</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c13faab0ca94890afab0dfa9adc50c3_I20220630" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfNi0zLTEtMS04NTQyNw_a6954749-0ac5-479d-a80e-4ec2c8ef023f">22,494</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Other deferred revenue includes pump development programs, purchased training and extended warranty.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="i10abb94289aa46ab94dfc506ddec4961_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6:  <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RleHRyZWdpb246MGZiYmVkZjQ3NDg2NDIyMGFjMDk5NWZjYzI5NWQ4M2JfMjc3OA_74d263c8-129f-48f9-9bc4-421feeeb6231" continuedAt="i8ecf4dd2c26247199fd776ce505dedae" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="i8ecf4dd2c26247199fd776ce505dedae" continuedAt="i5f44c24f76134e0683e2ea0d6a517b2a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception. Our operating lease assets are separately stated in operating lease right-of-use ("ROU") assets and our financing lease assets are included in other assets on our condensed consolidated balance sheets. Our lease liabilities are included in accrued liabilities and other long-term liabilities on our condensed consolidated balance sheets. We have elected not to recognize an ROU asset and lease liability for leases with terms of twelve months or less.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Lease ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Most of our leases do not provide an implicit rate, therefore we use our incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term based on the information available at commencement date. Our lease ROU assets exclude lease incentives and initial direct costs incurred. Our lease terms include options to extend when it is reasonably certain that we will exercise that option. All of our leases have </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i5f44c24f76134e0683e2ea0d6a517b2a" continuedAt="ia0bea269ebc4486d8a4e457cbc6d1f62"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stated lease payments, which may include fixed rental increases. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our leases are for corporate, research and development and sales and support offices, distribution facilities, device service centers and certain equipment. Our leases have original lease terms of <ix:nonNumeric contextRef="i097d704989b14390b8eebff2668fa80d_I20220630" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RleHRyZWdpb246MGZiYmVkZjQ3NDg2NDIyMGFjMDk5NWZjYzI5NWQ4M2JfMTUxNQ_ba85247c-a071-4b60-9579-4527bcc5077b">one year</ix:nonNumeric> to <ix:nonNumeric contextRef="i8dc422a484844921bbf2f8fbbb10898d_I20220630" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RleHRyZWdpb246MGZiYmVkZjQ3NDg2NDIyMGFjMDk5NWZjYzI5NWQ4M2JfMTUyMQ_e27ffa74-91c6-4a79-b0e0-4b0e5667e40b">fifteen years</ix:nonNumeric>, some of which include options to extend the leases for up to an additional <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="icui:Optiontoextendinyears" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RleHRyZWdpb246MGZiYmVkZjQ3NDg2NDIyMGFjMDk5NWZjYzI5NWQ4M2JfMTYwMA_9ce66b75-ef82-4bd4-8e29-0d8360cf998f">five years</ix:nonNumeric>. For all of our leases, we do not include optional periods of extension in our current lease terms for the exercise of options to extend is not reasonably certain.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RleHRyZWdpb246MGZiYmVkZjQ3NDg2NDIyMGFjMDk5NWZjYzI5NWQ4M2JfMjc4Ng_25e77204-cf47-4d57-a2c1-e88ae1379512" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of our lease cost (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:36.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.266%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.266%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.713%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfMi0xLTEtMS04NTQyNw_ea82e914-8ad9-4c19-91d0-ee42224be911">5,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfMi0zLTEtMS04NTQyNw_8b6ad47b-ce59-46c4-89d2-0c3cd1191110">2,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfMi01LTEtMS04NTQyNw_040e0059-c428-4b3f-a545-60801951a95c">10,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfMi03LTEtMS04NTQyNw_eea0fd3a-2d5b-43f9-89cd-0b6ce7784889">5,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfMy0xLTEtMS04NTQyNw_87d28744-65d7-4d3a-bb99-2f644111687b">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfMy0zLTEtMS04NTQyNw_9da48dc9-2234-4de8-bbac-cc8250b113fe">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfMy01LTEtMS04NTQyNw_190292b5-c81d-4f1d-a3c3-a88ef961b394">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfMy03LTEtMS04NTQyNw_49f07759-9244-448a-be58-e705864a3814">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; reduction of ROU asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfNC0xLTEtMS04NTQyNw_ac05b617-2ab5-4324-9388-a5ee199b9ce2">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfNC0zLTEtMS04NTQyNw_1471f3a0-9934-4a06-8e1e-04ff48922411">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfNC01LTEtMS04NTQyNw_aab7793d-f4a7-405d-90a3-40ba932e69ab">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfNC03LTEtMS04NTQyNw_f7f4b32e-ee40-4dc3-827c-aa357def078f">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfNS0xLTEtMS04NTQyNw_e66ed0a5-ad1a-4758-8ccb-da11f76b780d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfNS0zLTEtMS04NTQyNw_ea608d7a-68aa-425e-8d85-4793fd45a66d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfNS01LTEtMS04NTQyNw_97080f39-4736-44bd-b033-7ca27794d8f1">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfNS03LTEtMS04NTQyNw_76ebfff6-2330-4bfe-b8fb-a6fb177e42f7">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfOC0xLTEtMS04NTQyNw_ec36d727-8617-428a-b9db-2dd1bb4048bd">5,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfOC0zLTEtMS04NTQyNw_f364b914-2eac-4c2d-97b5-9fcc447a5512">3,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfOC01LTEtMS04NTQyNw_322fd17d-0c27-47c7-9995-de2a0e6fe916">11,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfOC03LTEtMS04NTQyNw_c8f10fd8-b4b4-40ee-98e5-cad13c18c7a1">6,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense on our finance leases is included in other income (expense), net in our condensed consolidated statements of operations. The reduction of the operating and finance ROU assets is included as noncash lease expense in selling, general and administrative expenses in our condensed consolidated statements of operations.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RleHRyZWdpb246MGZiYmVkZjQ3NDg2NDIyMGFjMDk5NWZjYzI5NWQ4M2JfMjc4MA_762bf5c4-e581-48cd-beb1-f0c7637cea04" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental cash flow information related to our leases (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjFiYTA0ZjE2ZTYzNzQwNTRhODg3NzZiNWU5YjYwMGIwL3RhYmxlcmFuZ2U6MWJhMDRmMTZlNjM3NDA1NGE4ODc3NmI1ZTliNjAwYjBfMy0xLTEtMS04NTQyNw_15df0805-05a9-463e-ae86-6d12160e00ad">12,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjFiYTA0ZjE2ZTYzNzQwNTRhODg3NzZiNWU5YjYwMGIwL3RhYmxlcmFuZ2U6MWJhMDRmMTZlNjM3NDA1NGE4ODc3NmI1ZTliNjAwYjBfMy0zLTEtMS04NTQyNw_43b73c79-a80c-4225-94ad-2dbf294f52e6">5,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjFiYTA0ZjE2ZTYzNzQwNTRhODg3NzZiNWU5YjYwMGIwL3RhYmxlcmFuZ2U6MWJhMDRmMTZlNjM3NDA1NGE4ODc3NmI1ZTliNjAwYjBfNC0xLTEtMS04NTQyNw_47c78679-ae27-4a83-b313-98d8fe4bea29">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjFiYTA0ZjE2ZTYzNzQwNTRhODg3NzZiNWU5YjYwMGIwL3RhYmxlcmFuZ2U6MWJhMDRmMTZlNjM3NDA1NGE4ODc3NmI1ZTliNjAwYjBfNC0zLTEtMS04NTQyNw_857ec3d8-5c41-430c-a029-6d1638eab3ba">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjFiYTA0ZjE2ZTYzNzQwNTRhODg3NzZiNWU5YjYwMGIwL3RhYmxlcmFuZ2U6MWJhMDRmMTZlNjM3NDA1NGE4ODc3NmI1ZTliNjAwYjBfNy0xLTEtMS04NTQyNw_5d54c48f-d7f5-4c37-a603-8d1dd0925af9">3,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjFiYTA0ZjE2ZTYzNzQwNTRhODg3NzZiNWU5YjYwMGIwL3RhYmxlcmFuZ2U6MWJhMDRmMTZlNjM3NDA1NGE4ODc3NmI1ZTliNjAwYjBfNy0zLTEtMS04NTQyNw_d36014e8-01e9-4e3d-ba69-903ee8a1cf3e">1,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjFiYTA0ZjE2ZTYzNzQwNTRhODg3NzZiNWU5YjYwMGIwL3RhYmxlcmFuZ2U6MWJhMDRmMTZlNjM3NDA1NGE4ODc3NmI1ZTliNjAwYjBfOC0xLTEtMS04NTQyNw_8251b613-7140-4dbc-976f-a50c2f37ab9d">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjFiYTA0ZjE2ZTYzNzQwNTRhODg3NzZiNWU5YjYwMGIwL3RhYmxlcmFuZ2U6MWJhMDRmMTZlNjM3NDA1NGE4ODc3NmI1ZTliNjAwYjBfOC0zLTEtMS04NTQyNw_660d0504-c740-4fd9-acbc-d5a86fb74d94">332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="ia0bea269ebc4486d8a4e457cbc6d1f62" continuedAt="ica722ca263d84572965e10b28b04fa5c"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="icui:AssetsandLiabilitiesLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RleHRyZWdpb246MGZiYmVkZjQ3NDg2NDIyMGFjMDk5NWZjYzI5NWQ4M2JfMjc3Ng_46d627f1-27d3-47f9-a970-2d7e573b8105" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfMy0xLTEtMS04NTQyNw_48877f3f-8254-4bbc-af89-4ea3d7b587d5">83,323</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfMy0zLTEtMS04NTQyNw_4cb1fd0f-216a-405e-8cc8-c90d143a5e7d">39,847</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfNS0xLTEtMS04NTQyNw_f22e9ce9-46dc-4dbf-b725-1c5d01ee7b84">19,929</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfNS0zLTEtMS04NTQyNw_2838fdc6-b29f-4b1f-8c28-0684a5c516aa">9,009</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfNi0xLTEtMS04NTQyNw_a2fe1444-0c3a-4af7-8259-6b99aae61c1a">68,491</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfNi0zLTEtMS04NTQyNw_e4e7765a-2d9c-4a47-a6d5-baa220364143">33,971</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfNy0xLTEtMS04NTQyNw_6d27c046-c264-4395-b4e4-c3e66a78e5e0">88,420</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfNy0zLTEtMS04NTQyNw_10095220-0c91-4f44-b0fe-1df6ece3d10e">42,980</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfMTAtMS0xLTEtODU0Mjc_bbc27a88-b55c-4bb1-976d-9b37839ee0ae">6.3</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfMTAtMy0xLTEtODU0Mjc_b34813dd-3a48-484b-8302-823a53022682">5.9</ix:nonNumeric> years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfMTMtMS0xLTEtODU0Mjc_3fedb92b-0708-4fcb-85fb-4e4452719bf2">4.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfMTMtMy0xLTEtODU0Mjc_42d7d1f0-e390-425d-95d3-93cc53a5f7bc">4.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfMy0xLTEtMS04NTQyNw_5c8f88fd-c853-4927-88fb-a0b779133eb2">2,335</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfMy0zLTEtMS04NTQyNw_1135b702-da22-4b5f-9c6f-ec7781fdfcc2">2,673</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfNS0xLTEtMS04NTQyNw_0f1a3807-e8d2-479b-87f3-648b24a34d47">650</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfNS0zLTEtMS04NTQyNw_e616dc3e-168c-4ba2-9901-fb61734fc9e5">643</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfNi0xLTEtMS04NTQyNw_39d6a6cd-44ae-4afd-beab-caf472fdd40f">1,741</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfNi0zLTEtMS04NTQyNw_2206edc1-7e6f-47b0-a43a-cdaa6d31e8d3">2,067</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfNy0xLTEtMS04NTQyNw_70c41b7a-3c9c-4e3b-b248-f9569e7c2ac3">2,391</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfNy0zLTEtMS04NTQyNw_d7051fa7-67df-4ddc-a822-f99539a412e8">2,710</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfMTAtMS0xLTEtODU0Mjc_e8a39cdb-2bff-4d9f-b501-88d74384352a">5.3</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfMTAtMy0xLTEtODU0Mjc_16ddbc9a-6378-4cf3-8ba8-b7ea86933230">5.6</ix:nonNumeric> years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfMTMtMS0xLTEtODU0Mjc_13f373a4-fea3-4ee9-a8a2-8acde8525704">4.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfMTMtMy0xLTEtODU0Mjc_6a1338da-d1bf-45e2-a2fe-a815daf7ff18">4.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="ica722ca263d84572965e10b28b04fa5c"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RleHRyZWdpb246MGZiYmVkZjQ3NDg2NDIyMGFjMDk5NWZjYzI5NWQ4M2JfMjc3Mg_63c4dcdf-cd7d-4f23-9be7-375d7e1f373a" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfMS0xLTEtMS04NTQyNw_6cd9045b-c561-4853-8edb-224121e6f42e">12,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfMS0zLTEtMS04NTQyNw_4a935ad6-153f-4402-9466-c081fca7c46e">371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfMi0xLTEtMS04NTQyNw_93976c0d-cc2e-497d-b085-3441dfe52bda">21,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfMi0zLTEtMS04NTQyNw_53f65113-6928-4480-ba44-e6866c2dfab6">742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfMy0xLTEtMS04NTQyNw_2a97fc8a-24ed-4dc4-920c-66effcfdf1cd">17,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfMy0zLTEtMS04NTQyNw_648f127c-2969-436f-be08-80deda0ce203">459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfNC0xLTEtMS04NTQyNw_b11aee87-32f5-4916-bfa3-d9b483169ea6">12,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfNC0zLTEtMS04NTQyNw_cfbd12a5-7d7b-43d7-bcea-e8e0ff55cf1e">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfNS0xLTEtMS04NTQyNw_dc163015-f667-4a22-a134-a440a14de9b8">10,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfNS0zLTEtMS04NTQyNw_ec632348-a6b9-4597-8c1e-9f4bfee297bc">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfNi0xLTEtMS04NTQyNw_66e46c0d-78e5-454d-befe-31dc92824a93">8,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfNi0zLTEtMS04NTQyNw_49c71eac-7853-482f-9861-9d594c05db63">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfNy0xLTEtMS04NTQyNw_a2dfd849-b9a7-496b-91a6-ffd96699d463">17,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfNy0zLTEtMS04NTQyNw_022a8514-1e82-445b-b447-ba80fdb0d7c6">426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfOC0xLTEtMS04NTQyNw_5f312b2d-aff1-474b-8559-b4db2adb1e2b">99,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfOC0zLTEtMS04NTQyNw_a20a233d-3c86-4c8b-91a2-520c30e0faec">2,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfOS0xLTEtMS04NTQyNw_d0ec20f8-6e12-465d-951a-31b72e3bef3b">11,232</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfOS0zLTEtMS04NTQyNw_a97d360b-5bdc-4990-858a-3ca1ef219152">285</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfMTAtMS0xLTEtODU0Mjc_57ae2c9e-d609-48e9-8e5d-520b4d64e2d0">88,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfMTAtMy0xLTEtODU0Mjc_2ee64cc3-f125-47e3-aa97-f4268245e8b6">2,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RleHRyZWdpb246OTVkNjkyYTM1ZDA0NDIxYTkwZWJlNzkzYTI5NzViNDlfMTQwOQ_1a066a52-50a4-4d74-a5e2-78411d8ea218" continuedAt="i50e63b7f7cc1477aae0b823d00ab133e" escape="true">Net Income Per Share</ix:nonNumeric></span></div><ix:continuation id="i50e63b7f7cc1477aae0b823d00ab133e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period plus dilutive securities. Dilutive securities include outstanding common stock options and unvested restricted stock units, less the number of shares that could have been purchased with the proceeds from the exercise of the options, using the treasury stock method. Options and restricted stock units that are anti-dilutive are not included in the treasury stock method calculation. Due to the net loss for the three and six months ended June 30 2022, any potentially common shares were not included in the computation of diluted earnings per share as they would have had an anti-dilutive effect, therefore basic and diluted net loss per share are equal for the period. There were <ix:nonFraction unitRef="shares" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RleHRyZWdpb246OTVkNjkyYTM1ZDA0NDIxYTkwZWJlNzkzYTI5NzViNDlfOTkw_98497284-c5ed-49bf-927f-607ef3d660d9">12,107</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RleHRyZWdpb246OTVkNjkyYTM1ZDA0NDIxYTkwZWJlNzkzYTI5NzViNDlfOTk3_4bfe432f-7a3c-428c-9bce-ff04d3162a83">12,080</ix:nonFraction> anti-dilutive securities for the three and six months ended June 30, 2021, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RleHRyZWdpb246OTVkNjkyYTM1ZDA0NDIxYTkwZWJlNzkzYTI5NzViNDlfMTQwMg_33abbb8f-6155-4a2a-a8e8-a56768877aa6" continuedAt="iebb99a2f10314133b4bb97a9d7e2a6e3" escape="true">The following table presents the calculation of net earnings per common share (&#8220;EPS&#8221;) &#8212; basic and diluted (in thousands, except per share data):&#160; </ix:nonNumeric></span></div><ix:continuation id="iebb99a2f10314133b4bb97a9d7e2a6e3"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfMi0xLTEtMS04NTQyNw_256965ba-9715-42a6-bb7c-f6e33bf4a9d8">7,474</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfMi0zLTEtMS04NTQyNw_57fe10a4-fbab-40e5-a0ca-ea10e49d8498">28,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfMi01LTEtMS04NTQyNw_b1817e2d-c3df-4c75-9e35-c71577c303f9">45,542</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfMi03LTEtMS04NTQyNw_31371ac2-6cd6-4ec2-9eb5-219ec19cabe1">52,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding (basic)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfMy0xLTEtMS04NTQyNw_63f4b6ae-4a4e-4442-aa23-46c76c1d2d81">23,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfMy0zLTEtMS04NTQyNw_7dc67316-042c-4395-acf2-f2bbd2ea49e4">21,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfMy01LTEtMS04NTQyNw_4726efc8-02c1-4fad-9e8c-8f36a8f9fe10">23,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfMy03LTEtMS04NTQyNw_9dec3e7d-9a88-4f25-9611-6c294d0a54d0">21,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNC0xLTEtMS04NTQyNw_930c83af-e89e-438f-92ad-1b82f8b63f31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNC0zLTEtMS04NTQyNw_cd9a6fb1-4de4-4c20-b3de-2e610b3c0a2f">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNC01LTEtMS04NTQyNw_b7d842c9-67bc-4257-988f-63d11182f43e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNC03LTEtMS04NTQyNw_d7b5b2d8-0732-4d09-a788-d5cce1498c52">542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common and common equivalent shares outstanding (diluted)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNS0xLTEtMS04NTQyNw_9dac36d3-6e97-4c6a-81ba-0f45c4602294">23,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNS0zLTEtMS04NTQyNw_41381648-f09c-4241-a5dd-84f93556c66a">21,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNS01LTEtMS04NTQyNw_cd305ef7-c73e-462d-a3a8-c8d575a3ab1d">23,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNS03LTEtMS04NTQyNw_75ce3419-d5d2-4cb4-83ef-bcfbe31ac138">21,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNi0xLTEtMS04NTQyNw_61d955e9-61a4-4ab0-80a8-d63129757838">0.31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNi0zLTEtMS04NTQyNw_c51ba753-f611-4921-96b0-084768785567">1.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNi01LTEtMS04NTQyNw_4117a0bf-fb48-4336-974c-a13222568f08">1.91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNi03LTEtMS04NTQyNw_bcbafbfc-bf5d-4867-a2b5-433d68795084">2.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNy0xLTEtMS04NTQyNw_75a26f61-842b-4541-91bd-48bca22ce41f">0.31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNy0zLTEtMS04NTQyNw_3f3304c0-dc4a-4881-b79e-a4665b631f1f">1.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNy01LTEtMS04NTQyNw_92950e01-8ac7-46ac-ab13-95ff2beb032e">1.91</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNy03LTEtMS04NTQyNw_11579d77-4212-4022-a7de-e285e2228a09">2.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No dilutive effect for the three and six months ended June 30, 2022;  therefore, zero incremental shares included for the period.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNTk2Nw_4d959adb-89f6-4d8a-b928-ea553f5d5f88" continuedAt="i661c16c55e3243c09895aed882f08b20" escape="true">Derivatives and Hedging Activities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i661c16c55e3243c09895aed882f08b20" continuedAt="i06e6cb6ceeb54e4b8c399a47a7e6ece8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Accounting and Hedging Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The purposes of our cash flow hedging programs are to manage the foreign currency exchange rate risk on forecasted revenues and expenses denominated in currencies other than the functional currency of the operating unit, and to manage floating interest rate risk associated with future interest payments on the variable-rate term loans issued in January 2022. We do not issue derivatives for trading or speculative purposes.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i06e6cb6ceeb54e4b8c399a47a7e6ece8" continuedAt="i75bc2b7066234cacbd72ca67f64de40d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions. The derivative instruments we utilize, including various foreign exchange contracts and interest rate swaps, are designated and qualify as cash flow hedges. Our derivative instruments are recorded at fair value on the condensed consolidated balance sheets and are classified based on the instrument's maturity date. We record gains or losses from changes in the fair values of the derivative instruments as a component of other comprehensive income (loss) and we reclassify those gains or losses into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. If the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, we reclassify the gain or loss on the related derivative instrument from accumulated other comprehensive loss into earnings immediately.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Rate Risk</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange Forward Contracts</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign exchange forward contracts to hedge a portion of our forecasted foreign currency-denominated revenues and expenses to minimize the effect of foreign exchange rate movements on the related cash flows. These contracts are agreements to buy or sell a quantity of a currency at a predetermined future date and at a predetermined exchange rate. Our foreign exchange forward contracts hedge exposures principally denominated in Mexican Pesos ("MXN"), Euros, Czech Koruna ("CZK"), Japanese Yen ("JPY"), U.S. Dollar ("USD") and Chinese Renminbi ("CNH") and have varying maturities with an average term of approximately twelve months. The total notional amount of these outstanding derivative contracts as of June&#160;30, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMjM3MA_f4ce09dc-b731-4a1a-bb86-5b6abdef84f9">209.2</ix:nonFraction>&#160;million, which included the notional equivalent of $<ix:nonFraction unitRef="usd" contextRef="i553b9c6ad3c74f348590e3901e6e1b17_I20220630" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMjQxNg_659c3996-98be-4bd4-88e0-f58edfcb2edd">43.1</ix:nonFraction>&#160;million in MXN, $<ix:nonFraction unitRef="usd" contextRef="idf36e1c35c0a471f9a34f9aed4cbef39_I20220630" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMjQzNw_1a0333fd-ddfa-41e2-82e6-f3cfa1f7ebfa">39.7</ix:nonFraction>&#160;million in Euros, $<ix:nonFraction unitRef="usd" contextRef="i028128b1abf446339af1e589f519b8d9_I20220630" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMjQ1MA_7f01ba0f-3578-4d54-ac77-0d3e47bcf501">18.3</ix:nonFraction>&#160;million in CZK, $<ix:nonFraction unitRef="usd" contextRef="i5248e92406ce4b4b8dd1c3ea4e3ec5e0_I20220630" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMjQ3MA_fa873337-0a26-4175-9150-91ead0d6ffd1">18.8</ix:nonFraction>&#160;million in JPY, $<ix:nonFraction unitRef="usd" contextRef="i6b6271edab564d0d9a598187c3a83a1b_I20220630" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNTQ5NzU1ODIwMjA5_8bd0103d-bf02-4c3d-8049-18fadc96d052">19.3</ix:nonFraction>&#160;million in CNH, $<ix:nonFraction unitRef="usd" contextRef="ife89df7388b14e7cb238bfad25c03b9f_I20220630" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNTQ5NzU1ODIwMjI0_22428ba4-d744-4c49-b4e2-cd4122f86d6f">36.3</ix:nonFraction>&#160;million in USD and $<ix:nonFraction unitRef="usd" contextRef="i64b799c44978482fb2ff58859d2765f8_I20220630" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMjQ5Mw_70230e9d-0685-49b8-ab47-dcee5f296c0f">33.9</ix:nonFraction>&#160;million in other foreign currencies, with terms currently through July 2023. We did not have such derivative contracts as of December 31, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cross-currency Par Forward Contracts</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into cross-currency par forward contracts to hedge a portion of our Mexico forecasted expenses denominated in MXN. These contracts are agreements to exchange cash flows from one currency to another at specified intervals over the contract term with all exchanges occurring at the same predetermined rate. In November 2021, we entered into a one-year cross-currency par forward contract with a term from December 1, 2021 to December 1, 2022. The total notional amount of this outstanding derivative as of June&#160;30, 2022 and December 31, 2021 was approximately <ix:nonFraction unitRef="mxn" contextRef="ice7c1260b0af4402ab4a9770171b528b_I20220630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMzI0NQ_31297fdb-b44c-4a43-ba1a-81f564191232">208.2</ix:nonFraction> million MXN and <ix:nonFraction unitRef="mxn" contextRef="i2c64e77d7d424ea9a38c6d4686e8b917_I20211231" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMzI1Ng_e3e596c1-13ed-44ec-bb32-55c06bd3a94b">413.1</ix:nonFraction>&#160;million MXN, respectively. The derivative instrument matures in equal monthly amounts at a fixed forward rate of <ix:nonFraction unitRef="number" contextRef="ice7c1260b0af4402ab4a9770171b528b_I20220630" decimals="2" name="us-gaap:DerivativeForwardExchangeRate1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMzM2NA_50e4c052-c92b-4f1e-a38d-642ea7478be2">21.60</ix:nonFraction> MXN/USD. Preceding this contract we had a one-year cross-currency par forward contract with a term from November 3, 2020 to December 1, 2021 that matured in equal monthly amounts at a fixed forward rate of <ix:nonFraction unitRef="number" contextRef="i8409b01efbb64d52a8e1b1ba086f135b_I20211231" decimals="2" name="us-gaap:DerivativeForwardExchangeRate1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMzU3Mw_eece240f-cfc8-4d49-9d3b-16aa21326e74">24.26</ix:nonFraction> MXN/USD.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Floating Interest Rate Risk</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, in anticipation of entering into the new senior secured credit facilities in January 2022, which includes a variable-rate term loan A and a variable-rate term loan B (see Note 17: Long-Term Debt), we entered into two forward-starting interest rate swaps. In February 2022, certain terms under the agreements were amended to reflect the transition from LIBOR to the Secured Overnight Financing Rate ("SOFR"), an alternative reference rate. Under the interest rate swap agreements we exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount. Effective March 30, 2022, the term loan A swap, as amended, has an initial notional amount of $<ix:nonFraction unitRef="usd" contextRef="i55561adaa418415b8dbb5d994e03b04a_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNDM2MQ_81673b57-03cb-4785-97ab-397aaf63fb5d">300.0</ix:nonFraction>&#160;million, reducing to $<ix:nonFraction unitRef="usd" contextRef="i55561adaa418415b8dbb5d994e03b04a_I20220630" decimals="-6" name="icui:InterestRateSwapEndingNotionalValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNDM3Nw_8391bb66-57a1-4873-83f8-b0c0793ce482">150.0</ix:nonFraction>&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2027. We will pay a fixed rate of <ix:nonFraction unitRef="number" contextRef="i55561adaa418415b8dbb5d994e03b04a_I20220630" decimals="6" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNDQ4NA_bed24950-dee4-4f99-b890-8bd667ab8c6c">1.32</ix:nonFraction>% and will receive the greater of 3-month USD SOFR or (<ix:nonFraction unitRef="number" contextRef="i55561adaa418415b8dbb5d994e03b04a_I20220630" decimals="4" sign="-" name="icui:DerivativeVariableRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNDUzOQ_d1d8730b-30fe-4281-add8-285da5c052a3">0.15</ix:nonFraction>)%. Effective March 30, 2022, the term loan B swap, as amended, has an initial notional amount of $<ix:nonFraction unitRef="usd" contextRef="i19fbaecc04d148dd8a7958cc6db4d311_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNDYzNw_864e9765-cf63-413d-bfe3-314559e4a732">750.0</ix:nonFraction>&#160;million, reducing to $<ix:nonFraction unitRef="usd" contextRef="i19fbaecc04d148dd8a7958cc6db4d311_I20220630" decimals="-3" name="icui:InterestRateSwapEndingNotionalValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNDY1Mw_9b268b46-a76d-4118-b2c2-224b6a50110c">46.9</ix:nonFraction>&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2026. We will pay a fixed rate of <ix:nonFraction unitRef="number" contextRef="i19fbaecc04d148dd8a7958cc6db4d311_I20220630" decimals="6" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNDc2MA_fff0aa17-d80d-444a-bfa0-9280c0c6662d">1.17</ix:nonFraction>% and will receive the greater of 3-month USD SOFR or <ix:nonFraction unitRef="number" contextRef="i19fbaecc04d148dd8a7958cc6db4d311_I20220630" decimals="4" name="icui:DerivativeVariableRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNDgxNQ_d04f882b-738f-4d19-9ead-8f706c116821">0.35</ix:nonFraction>%. These swaps effectively convert the relevant portion of the floating-rate term loans to fixed rates.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNTk1Mw_7fde67f7-a6d7-4a18-8e68-dd110c8b0edc" continuedAt="i287e49bc1a504a359ebef4fd1a7939d3" escape="true">The following table presents the fair values of our derivative instruments included within the Condensed Consolidated Balance Sheets (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i75bc2b7066234cacbd72ca67f64de40d" continuedAt="i42e90bc275a3427ba86257e222f35624"><ix:continuation id="i287e49bc1a504a359ebef4fd1a7939d3" continuedAt="i54d09dfa33c64f99a461a278a0b527b5"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Condensed Consolidated Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Derivatives</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib22458f807284867a571b93988d38746_I20220630" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNC0yLTEtMS04NTQyNw_f5acea91-536b-4d75-b16a-7ef5aa610271">9,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f054f416194468e9358fe16a192fca7_I20220630" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNC00LTEtMS04NTQyNw_e68f4496-be82-4a00-8871-706f4f579788">15,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if944aaea429e473cb610016ebaa83d93_I20220630" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNC02LTEtMS04NTQyNw_83474f5c-5f24-4b06-a5dc-f551880f4f4e">24,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2c0ba582504cc48fcbbe00aa935289_I20220630" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNS0yLTEtMS04NTQyNw_363eec8c-0cd9-480f-aad1-c1a327bf586b">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie49637e4065640909d80091d4f51b5e2_I20220630" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNS00LTEtMS04NTQyNw_844c77cb-f5d1-4b3b-bc00-2288e617a5e8">23,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6c822cbb6204a8fbc869b98546fc0a9_I20220630" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNS02LTEtMS04NTQyNw_acd3c730-9dbd-48c3-b97e-c656b9f3a75f">23,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88b203034af462ba59ce8d2a771f6a4_I20220630" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNi0yLTEtMS04NTQyNw_6c12d581-8bde-44de-9ef4-6f6fb21b3ab5">9,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30640c390ffe4ca3bbe943506380dba9_I20220630" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNi00LTEtMS04NTQyNw_93af4ac5-7114-4b48-b0f2-ed0f21a5ae6e">39,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNi02LTEtMS04NTQyNw_0909cba1-1580-44b7-81f0-ff4b282d65c3">48,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055adfcb5fa4b46a0af772247ae8ab3_I20220630" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfOC0yLTEtMS04NTQyNw_17086cfe-b5be-47a9-bdd4-4b4ee7ca9601">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5ed44f463b34b44bccf081e0e44d41f_I20220630" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfOC00LTEtMS04NTQyNw_3eefb8f7-7cec-4ef7-bde3-a791bcd6d74e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac7fe1e5d9204ae3b38fd2c49a0a6e89_I20220630" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfOC02LTEtMS04NTQyNw_2909b4af-b465-470c-ba12-0e649ad11a7e">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6f8316a6a9c4c7b91a059642a5d585a_I20220630" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfOS0yLTEtMS04NTQyNw_ba060b5b-677a-4dc4-9f63-701b572a15e2">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i835758b56b034a758a8a1945eb8fc86a_I20220630" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfOS00LTEtMS04NTQyNw_a158ff7e-d919-4e86-a234-c5ef095d340a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea1b1e213c5e4dee964f3d2dcaa7b6c7_I20220630" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfOS02LTEtMS04NTQyNw_10d56fa2-42cd-4855-b428-befca239f131">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88b203034af462ba59ce8d2a771f6a4_I20220630" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTAtMi0xLTEtODU0Mjc_53cf136f-8a6c-4773-95e6-0424323a0ae5">627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30640c390ffe4ca3bbe943506380dba9_I20220630" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTAtNC0xLTEtODU0Mjc_f75cae5e-d314-4aaf-b34f-36f9032a6c49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTAtNi0xLTEtODU0Mjc_2db4f454-629f-4403-94f7-bf491f8bfaf8">627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1440f9c7c021440dbd8518b33fc69b16_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTMtMi0xLTEtODU0Mjc_0d9d1599-4b9e-4a2d-9f2d-e1644bf80438">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia03482d0fb2b4cb88ba9ce3d231c7823_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTMtNC0xLTEtODU0Mjc_1a21f524-ed72-446e-b428-1f44a4c46511">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcc8fe10383a4514ae5fb955ea53cee7_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTMtNi0xLTEtODU0Mjc_5046c209-8498-4dc5-9b58-2c377330dd58">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic437309b851c4a58af26fe68c63fb604_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTQtMi0xLTEtODU0Mjc_a96d4d60-4ce8-4e24-bc0b-c0feb757801d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9410778f607e40788f828c216003f59c_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTQtNC0xLTEtODU0Mjc_c0d87923-06a3-4752-b46f-6473c6fc1555">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36babf8d7dfd41d181155b5c382f90ce_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTQtNi0xLTEtODU0Mjc_78d353e6-58a7-4a6f-9860-e5388725a250">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b64e553997e42bfa00e761e1f1423e1_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTUtMi0xLTEtODU0Mjc_67576db6-7b3b-46f9-89ea-aaa0af219188">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa0f2e530a594d488d3ff7ff069e9259_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTUtNC0xLTEtODU0Mjc_a9d3e67c-f7d5-49a1-92c2-995e1f5f7b05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTUtNi0xLTEtODU0Mjc_bd62533d-7ee8-4b8b-87f0-662fe05b2537">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a827026c8f345f481b0f331dcd5ab32_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTctMi0xLTEtODU0Mjc_47ee5466-4ae5-4392-8fb4-cd823a94f476">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie10e3fd3b1274966991829e8a47fb1c2_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTctNC0xLTEtODU0Mjc_628835fc-2da1-4bb9-bf58-53fcc1043ebb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0057918c4754ed39cdcb09ec091a595_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTctNi0xLTEtODU0Mjc_268d8bb1-d16b-4c60-acda-8793c931206c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1083c069125426aaf5b7d941291660b_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTgtMi0xLTEtODU0Mjc_27a2494e-5709-45e4-baf1-b05d8d997577">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a3cf5799fb4e7697ec6da3105f357e_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTgtNC0xLTEtODU0Mjc_6561d436-d993-4a03-90b0-3a61fbefbea8">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7eba8aa425b64fd29a1360ccd19218c4_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTgtNi0xLTEtODU0Mjc_ca0c8fc1-6335-4113-920e-45ad6a136c59">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b64e553997e42bfa00e761e1f1423e1_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTktMi0xLTEtODU0Mjc_a5d10a39-b063-476c-afc8-07f3bb9816b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa0f2e530a594d488d3ff7ff069e9259_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTktNC0xLTEtODU0Mjc_9ecfc897-84c4-4633-b645-edd929c1dc24">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTktNi0xLTEtODU0Mjc_3083dd82-a99b-40cc-a615-e2470ba46b7d">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized the following gains on our derivative instruments designated as cash flow hedges (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain Recognized in Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ef45ebfcb134a09b0559c70de16d1c2_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNS0yLTEtMS04NTQyNw_3499c9af-307c-4ac8-8e0d-4a3adb6f02fe">5,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie350394256c849be935f6f7e19ce7ae1_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNS00LTEtMS04NTQyNw_e523c9b2-8349-4c5d-a3b7-11fa2d7d6488">441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a9e2b857e94469b5a51e1bd32d2292_D20220101-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNC02LTEtMS05MDU3OA_e240bd99-cb7a-4499-a726-9c1b709a6298">8,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ca9c6f83f3d4ea38a171209da718f73_D20210101-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNC04LTEtMS05MDU4MA_35c665da-1b8c-4a66-8d4d-04d369e34c42">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6be297d6f8ec4c55a99cf8bffc94a709_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNi0yLTEtMS04NTQyNw_11e3be45-c070-4f17-bbe2-169061b08900">9,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id416d1da99e846e3aaa8a4ffd93c3dc0_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNi00LTEtMS04NTQyNw_5c5368f1-181a-4b38-baa0-d2e7b9c6f3ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie64ccbe5cd244a88a92378e31ed3beea_D20220101-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNS02LTEtMS05MDU3OA_c36f25ca-3564-4c7e-a8c2-0e7ef0b64508">39,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ad63d7dee5443088e6be3aff832a962_D20210101-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNS04LTEtMS05MDU4MA_5cbc35d8-f1ef-42a9-a387-e3d385b4af98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNy0yLTEtMS04NTQyNw_f0c887f6-b8b4-452a-bdba-93e9c3bef24c">14,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNy00LTEtMS04NTQyNw_905bfaf5-9674-4a4c-8be3-c777e7e0d0eb">441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNi02LTEtMS05MDU3OA_04255198-b1ed-4e54-ad5c-acc930db6ae0">47,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNi04LTEtMS05MDU4MA_6fa80a32-0375-4b3e-a67d-fa782dbfea1e">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i42e90bc275a3427ba86257e222f35624" continuedAt="ib48f31c096724a5bad91de7dd6c36ebf"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i54d09dfa33c64f99a461a278a0b527b5">The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):</ix:continuation></span></div><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNTk2Ng_2dbf82ef-c685-49b2-ad28-c23176bc5f49" continuedAt="ib79af73b122f4e3c88f12c6b3dcb67fa" escape="true"><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Reclassified From Accumulated Other Comprehensive (Loss) Income into Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f932f4ad8184e0b96bb58e33032ad67_D20220401-20220630" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNS00LTEtMS04NTQyNw_568ef0e3-0e0c-4766-b4ff-9bcffe05d793">1,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51abb32c548d4ae5992b6128d78ae406_D20210401-20210630" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNS02LTEtMS04NTQyNw_1a1ca0af-cb95-4b20-a2b6-fb455ea0882b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f713455967a47018e27c47844e6c2c8_D20220101-20220630" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNC04LTEtMS05MDU4Mg_3d30cd76-7844-47f4-a119-5a0c43c66ae1">4,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e0141476f94fe0bfee40a9c342136d_D20210101-20210630" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNC0xMC0xLTEtOTA1ODQ_661b1381-39d6-4f9c-8193-2a75e73905c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e3b921cd5684eac8e40c2c8881181c2_D20220401-20220630" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNi00LTEtMS04NTQyNw_ebce3773-d5cf-4eb0-ae5e-fa51eb22dae8">1,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4621aecc6f943bcb50bb51cdee5e129_D20210401-20210630" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNi02LTEtMS04NTQyNw_3bd3db1a-f017-4fe4-a77e-397563914512">903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa5feb023289462185a42fb720643359_D20220101-20220630" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNS04LTEtMS05MDU4Mg_372dc948-c395-4b85-a57b-6affe3f25bae">1,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1beaa72fcf4443b087df773c477cfd11_D20210101-20210630" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNS0xMC0xLTEtOTA1ODQ_3a5e2911-57ec-40ef-9340-beb90da4844e">1,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae30f57ba95c4fc1ab17958acaab1941_D20220401-20220630" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNy00LTEtMS04NTQyNw_d1a4125e-352b-4674-8d4f-d6da5e7edf16">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0da6f417faba4021a4bd87936cc94e7a_D20210401-20210630" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNy02LTEtMS04NTQyNw_394eed89-a054-4eef-ab55-a64252460ce2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc915cd5e904c928ed953fcd58e88e7_D20220101-20220630" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNi04LTEtMS05MDU4Mg_6dfa835c-29eb-4cbb-ae8a-a716e2fd8dce">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24fdd3c882204e068d38aca3948a28fb_D20210101-20210630" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNi0xMC0xLTEtOTA1ODQ_37ee2587-02ab-46a3-92fa-0c175caea78c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia62f1bfa4e614fbc90c0973fbb269e1b_D20220401-20220630" decimals="-3" name="us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNy00LTEtMS05MDU4Ng_def1a483-296b-444e-b36f-a992712d05ad">1,524</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie258ecbde2a94022ab481b913bd25b59_D20210401-20210630" decimals="-3" name="us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNy02LTEtMS05MDU4OA_0f4861f7-d8bc-4cc8-ba39-94b223af6bef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib35fc47993e9429b8c5b9c8b0c6f2875_D20220101-20220630" decimals="-3" name="us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNy04LTEtMS05MDU5MA_770b211e-b99d-4a18-b381-f03bf19611e3">1,524</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8ab8c183e0c4d38ac3476ef91b085a0_D20210101-20210630" decimals="-3" name="us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNy0xMC0xLTEtOTA1OTI_4be7a216-7e32-47c9-8ab9-545df71cd955">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5fdd88104094d56a78a0e9fabdc14a4_D20220401-20220630" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfOS00LTEtMS04NTQyNw_69cce413-7971-49ac-8292-aed8e1908073">1,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bead07f8fe6479b8b72129168423936_D20210401-20210630" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfOS02LTEtMS04NTQyNw_afe5646c-795c-4b53-9275-ac463aa13f21">903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24098b59b80b4522b8391e7bf6c24095_D20220101-20220630" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfOC04LTEtMS05MDU4Mg_126de7a3-f6da-401f-8f12-87c542626d88">4,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62dc3d65ef234ddea6fa46fa39a08264_D20210101-20210630" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfOC0xMC0xLTEtOTA1ODQ_478dfd4f-c42e-4654-ae53-c45bb4336444">1,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents location of gain reclassified from accumulated other comprehensive income into income as a result that a forecasted transaction is no longer probable of occurring.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib48f31c096724a5bad91de7dd6c36ebf"><ix:continuation id="ib79af73b122f4e3c88f12c6b3dcb67fa">As of June&#160;30, 2022, we expect an estimated $<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNTYyOA_78351d08-510a-4303-9279-9dfd8686114e">8.5</ix:nonFraction>&#160;million in deferred gains on the outstanding foreign exchange contracts and an estimated $<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNTcxMg_f7a0cf22-4215-4809-8d02-da3b9d42116e">15.7</ix:nonFraction>&#160;million in deferred gains on the interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.</ix:continuation></ix:continuation>&#160;&#160;&#160;&#160;</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:19.736%"><div><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_58"></div></div><div style="display:inline-block;max-width:7.017%;min-width:6.684%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:19.736%"></div><div style="display:inline-block;max-width:7.017%;min-width:6.684%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:19.736%"></div><div style="display:inline-block;max-width:7.017%;min-width:6.684%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:19.741%"></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNzQ3NQ_177e5fc9-e725-40cd-852a-5f7bf136cf2d" continuedAt="ifee85e05dfd94a84bc8ac6e9478d498f" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="ifee85e05dfd94a84bc8ac6e9478d498f" continuedAt="i103217de8fd44521a651496a07a952e6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. There are three levels of inputs that may be used to measure fair value:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1:  quoted prices in active markets for identical assets or liabilities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2:  inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3:  unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Earn-out Liabilities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired Smiths Medical with a combination of cash consideration and share consideration issued at closing. Total consideration for the acquisition includes a potential earn-out payment of $<ix:nonFraction unitRef="usd" contextRef="id5289794172a4cb198e8aa0169b4c3b2_D20220401-20220630" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMTE4MQ_91ab19a1-9ff5-443d-9ad7-06948c11454f">100.0</ix:nonFraction>&#160;million in cash contingent on our common stock achieving certain Price Targets from the closing date to either the third or fourth anniversary of closing (see Note 3: Acquisitions for additional information) and provided Smiths beneficially owns at least <ix:nonFraction unitRef="number" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="8" name="icui:OwnershipRequirementForEarnoutPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMTQzMQ_2c10e94b-9546-43f8-8d72-dcf93ba2bc1d">50.0</ix:nonFraction>% of the shares of common stock issued at closing at the time the Price Target is achieved. The initial estimated fair value of the earn-out was determined to be $<ix:nonFraction unitRef="usd" contextRef="i4ac4af49606d42a88d64c2bf0f4d2ffd_I20220106" decimals="-4" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMTU5NA_1330b56b-2521-4b73-8575-c6b905d97a58">53.5</ix:nonFraction>&#160;million. The initial fair value of the earn-out was determined using a Monte Carlo simulation model. The model utilized several assumptions including volatility and the risk-free interest rate. The assumed volatility is based on the average of the historical volatility of our common stock price and the implied volatility of certain at-the-money traded options. The risk-free interest rate is equal to the yield on U.S. Treasury securities at constant maturity for the period commensurate with the term of the earn-out. At each reporting date subsequent to the acquisition, we will remeasure the earn-out liability and recognize any changes in its fair value in our consolidated statements of operations. If the probability of achieving the Price Targets during their respective measurement periods is significantly greater than initially anticipated, the realization of an additional liability and related expense will have a significant impact on our consolidated financial statements in the period recognized. As of June 30, 2022, the estimated fair value of the contingent earn-out is $<ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-4" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNTQ5NzU1ODIxOTIy_f59d24ec-ad59-465c-93e0-1388e5d882c4">26.1</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="i103217de8fd44521a651496a07a952e6" continuedAt="i454e9010f3804878b24b28daa2647d1f"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $<ix:nonFraction unitRef="usd" contextRef="i0c90af4126704fd9b931fd425c90445a_D20220401-20220630" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMjc2OA_64038993-b9c1-4409-b815-b5c71f4c97de">2.5</ix:nonFraction>&#160;million, consisting of (i) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-6" name="icui:ContingentConsiderationGrossST" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMjgwOA_9c22209f-eeb2-4e49-9efb-953d242d9250">1.0</ix:nonFraction>&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-5" name="icui:ContingentConsiderationGrossLT" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMjk1NQ_1a06907f-d7b7-44e1-998c-91186c8e6fbb">1.5</ix:nonFraction>&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of June 30, 2022, the estimated fair value of the total contingent earn-out is $<ix:nonFraction unitRef="usd" contextRef="i2f9761d9634c46b781358f8378ab19ae_I20220630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMzEzMQ_e31d472a-8c4f-47bc-a50e-89fc769b6b32">1.7</ix:nonFraction>&#160;million. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out payment shall not exceed $<ix:nonFraction unitRef="usd" contextRef="i2b0af7a88e20446b955b939f110edf80_D20220101-20220630" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMzQ3Ng_c210bcb3-1869-407a-a970-7c605c4a4114">6.0</ix:nonFraction>&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of both June 30, 2022 and December 31, 2021, the estimated fair value of the contingent earn-out is $<ix:nonFraction unitRef="usd" contextRef="i145f9f310696405282fedab047eef187_I20220630" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMzkwMg_bcd64318-012a-43df-b20e-0d4faea8abe4">2.6</ix:nonFraction>&#160;million. The estimated fair value of the contingent earn-out is calculated using a probability-weighted cash flow model based on historical revenue streams and the likelihood that the revenue targets will be met.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the fourth quarter of 2019, we recognized an earn-out liability related to the acquisition of Pursuit Vascular, Inc. ("Pursuit"). Pursuit's former equity holders were entitled up to $<ix:nonFraction unitRef="usd" contextRef="i5deeb60e9c8249d1b8f46228ce05178b_D20220101-20220630" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNDMwMQ_33f35956-a609-469f-ba96-6d1f41ba7150">50.0</ix:nonFraction> million in additional cash consideration contingent upon the achievement of certain sales and gross profit targets for specific customers. The earn-out was calculated as a percentage of gross profit achieved during the earn-out period against a pre-determined target gross profit, not to exceed $<ix:nonFraction unitRef="usd" contextRef="i5deeb60e9c8249d1b8f46228ce05178b_D20220101-20220630" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNDU5MQ_3c62b2a1-77c8-4b69-abf3-035d8c4a0fe7">50.0</ix:nonFraction> million. During the earn-out period, we used a Monte Carlo simulation model to determine the fair value of the earn-out liability. The Monte Carlo simulation model utilized multiple input variables to determine the value of the earn-out liability including historical volatility, a risk-free interest rate, counter party credit risk and projected future gross profit (see the simulation input table below related to Pursuit). The historical volatility was based on the median of ICU and a certain peer group. The risk-free interest rate was equal to the yield, as of the valuation date, of the zero-coupon U.S. Treasury bill that was commensurate with the term of the earn-out. The counter party credit risk was based on a synthetic credit rating of B1. As of June 30, 2021, the earn-out measurement period ended. Based on the actual sales and gross profit achieved during the measurement period, we calculated the actual earn-out amount to be $<ix:nonFraction unitRef="usd" contextRef="i2e7b46f30d624154ab030a8d61d3e985_I20220630" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNTUzMA_4d5a4def-b930-4b54-9ce0-454ae140202c">26.3</ix:nonFraction>&#160;million. The $<ix:nonFraction unitRef="usd" contextRef="i2e7b46f30d624154ab030a8d61d3e985_I20220630" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNTUzOA_8265f006-3126-4aeb-a644-9f66431d4896">26.3</ix:nonFraction>&#160;million earn-out calculation was finalized and accepted by Pursuit's former equity holders and was paid out in the fourth quarter of 2021. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contingent earn-out liabilities are separately stated on our condensed consolidated balance sheets.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNzQ1NA_b2fc117c-8621-4a8e-93a4-6efb8f94f544" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a reconciliation of the Level 3 earn-out liabilities measured at estimated fair value (in thousands):  </span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmEwNmNmZTBiZWI0YTRjMTQ5NjU3ZmIwYjhlOTAxNWM0L3RhYmxlcmFuZ2U6YTA2Y2ZlMGJlYjRhNGMxNDk2NTdmYjBiOGU5MDE1YzRfMS0yLTEtMS04NTQyNw_96e54acd-0072-4aad-857e-96140723a3d4">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition date fair value estimate of earn-out</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmEwNmNmZTBiZWI0YTRjMTQ5NjU3ZmIwYjhlOTAxNWM0L3RhYmxlcmFuZ2U6YTA2Y2ZlMGJlYjRhNGMxNDk2NTdmYjBiOGU5MDE1YzRfMi0yLTEtMS04NTQyNw_686eda1c-171e-4934-95a1-3353ff8badb8">55,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331" decimals="-3" name="icui:CurrencyTranslationOnEarnOut" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmEwNmNmZTBiZWI0YTRjMTQ5NjU3ZmIwYjhlOTAxNWM0L3RhYmxlcmFuZ2U6YTA2Y2ZlMGJlYjRhNGMxNDk2NTdmYjBiOGU5MDE1YzRfNC0yLTEtMS04NTQyNw_9c894aed-7464-4ca8-add3-fa38c99fe8c6">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f22c3698eff4a70b949d07786441335_I20220331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmEwNmNmZTBiZWI0YTRjMTQ5NjU3ZmIwYjhlOTAxNWM0L3RhYmxlcmFuZ2U6YTA2Y2ZlMGJlYjRhNGMxNDk2NTdmYjBiOGU5MDE1YzRfNS0yLTEtMS04NTQyNw_977ea1e4-a65e-411d-a8c3-d56467ce072b">57,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of earn-out (included in income from operations as a separate line item)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmEwNmNmZTBiZWI0YTRjMTQ5NjU3ZmIwYjhlOTAxNWM0L3RhYmxlcmFuZ2U6YTA2Y2ZlMGJlYjRhNGMxNDk2NTdmYjBiOGU5MDE1YzRfNi0yLTEtMS04NTQyNw_ec64671b-b901-4913-87e8-079739c1ee6a">27,194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" name="icui:CurrencyTranslationOnEarnOut" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmEwNmNmZTBiZWI0YTRjMTQ5NjU3ZmIwYjhlOTAxNWM0L3RhYmxlcmFuZ2U6YTA2Y2ZlMGJlYjRhNGMxNDk2NTdmYjBiOGU5MDE1YzRfNy0yLTEtMS05MDE5MA_1897228a-bf8a-436c-9fe9-052f45d30530">98</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmEwNmNmZTBiZWI0YTRjMTQ5NjU3ZmIwYjhlOTAxNWM0L3RhYmxlcmFuZ2U6YTA2Y2ZlMGJlYjRhNGMxNDk2NTdmYjBiOGU5MDE1YzRfNy0yLTEtMS04NTQyNw_1e1dc4af-7fc2-4a98-9102-c953e7d033ca">30,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;$53.5 million relates to our acquisition of Smiths Medical and $1.6 million relates to our acquisition of a small foreign infusions systems supplier in the fourth quarter of 2021 (see Note 3: Acquisitions).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; Primarily relates to the change in fair value of the Smiths Medical earn-out.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3c25d168c744771bf633b071b06a295_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRjMzgxYTBmOWVlNDRhZTFhNTFkNjBjNzM4MjE1MWZiL3RhYmxlcmFuZ2U6NGMzODFhMGY5ZWU0NGFlMWE1MWQ2MGM3MzgyMTUxZmJfMS0yLTEtMS04NTQyNw_eed03b4e-b277-4b7f-9bdc-37da10f2d1e7">26,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of earn-out (included in income from operations as a separate line item)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2461c3123264a1587619f55ed019061_D20210101-20210331" decimals="-3" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRjMzgxYTBmOWVlNDRhZTFhNTFkNjBjNzM4MjE1MWZiL3RhYmxlcmFuZ2U6NGMzODFhMGY5ZWU0NGFlMWE1MWQ2MGM3MzgyMTUxZmJfMy0yLTEtMS04NTQyNw_c093a20f-b0a5-41e4-9fbb-e2b50a13d166">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4371c9b4e2d342968b4e3151c7d4db30_I20210331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRjMzgxYTBmOWVlNDRhZTFhNTFkNjBjNzM4MjE1MWZiL3RhYmxlcmFuZ2U6NGMzODFhMGY5ZWU0NGFlMWE1MWQ2MGM3MzgyMTUxZmJfNC0yLTEtMS04NTQyNw_f0cb61d4-a334-43b4-8ae0-9403658cc422">26,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of earn-out (included in income from operations as a separate line item)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9c2724891314520aa738b30070bc9b7_D20210401-20210630" decimals="-3" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRjMzgxYTBmOWVlNDRhZTFhNTFkNjBjNzM4MjE1MWZiL3RhYmxlcmFuZ2U6NGMzODFhMGY5ZWU0NGFlMWE1MWQ2MGM3MzgyMTUxZmJfNS0yLTEtMS04NTQyNw_ee382de8-821b-4137-b2e4-b53f4f6b2b15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7572d325e38d473d9ae705b76dddaf85_I20210630" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRjMzgxYTBmOWVlNDRhZTFhNTFkNjBjNzM4MjE1MWZiL3RhYmxlcmFuZ2U6NGMzODFhMGY5ZWU0NGFlMWE1MWQ2MGM3MzgyMTUxZmJfNi0yLTEtMS04NTQyNw_f4978435-c28d-4dff-b79a-71d8334f249b">26,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i454e9010f3804878b24b28daa2647d1f" continuedAt="ifc5ef5b732b9486294caf579cc7e5c9b"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNzQ3OQ_6f7a7a63-56be-4376-aafb-217c0a61b436" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide quantitative information about Level 3 inputs for fair value measurement of our earn-out liabilities related to Smiths Medical and Pursuit:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smiths Medical Earn-out</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.961%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At Acquisition<br/>January 6, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26d53d1856c64aba9b247414ff1cbf72_I20220630" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjM0OGVjZDdhZGI0MzQwMjJiZDY1Mjk3Njc5OTJjNzM1L3RhYmxlcmFuZ2U6MzQ4ZWNkN2FkYjQzNDAyMmJkNjUyOTc2Nzk5MmM3MzVfMS0yLTEtMS05MDIwMw_333a05ad-11aa-4319-9ae5-186e13833e42">40.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i271412c8b7d54c31bbe00f90c08636d9_I20220106" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjM0OGVjZDdhZGI0MzQwMjJiZDY1Mjk3Njc5OTJjNzM1L3RhYmxlcmFuZ2U6MzQ4ZWNkN2FkYjQzNDAyMmJkNjUyOTc2Nzk5MmM3MzVfMS0yLTEtMS04NTQyNw_318768d0-62e5-4842-94ca-5359337fe501">37.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-Free Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i20fb2b51d6784bdcb7bd9ea46521840f_I20220630" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjM0OGVjZDdhZGI0MzQwMjJiZDY1Mjk3Njc5OTJjNzM1L3RhYmxlcmFuZ2U6MzQ4ZWNkN2FkYjQzNDAyMmJkNjUyOTc2Nzk5MmM3MzVfMi0yLTEtMS05MDIwMw_a4d6d9a6-1732-460f-ae2b-68cfcc3e7d59">2.97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id2293f058fbe474d887a278af1dc364d_I20220106" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjM0OGVjZDdhZGI0MzQwMjJiZDY1Mjk3Njc5OTJjNzM1L3RhYmxlcmFuZ2U6MzQ4ZWNkN2FkYjQzNDAyMmJkNjUyOTc2Nzk5MmM3MzVfMi0yLTEtMS04NTQyNw_709bbabb-669c-4285-b1f7-ddc405448303">1.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pursuit Earn-out</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue/Gross Profit Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i629f0cf89dde42a49602d16e5cfd879b_I20210630" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRkMTRjNDhmNDc1NTRjZTk4NjU0NzUwZTUyNjMxYWRmL3RhYmxlcmFuZ2U6NGQxNGM0OGY0NzU1NGNlOTg2NTQ3NTBlNTI2MzFhZGZfMS0yLTEtMS04NTQyNw_ce1c6c3a-3808-43f9-8651-82efe5192447">25.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6fa400eb022d4774bc0cd29d07a48121_I20210630" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRkMTRjNDhmNDc1NTRjZTk4NjU0NzUwZTUyNjMxYWRmL3RhYmxlcmFuZ2U6NGQxNGM0OGY0NzU1NGNlOTg2NTQ3NTBlNTI2MzFhZGZfMi0yLTEtMS04NTQyNw_e925a7ed-027c-4c35-8ef8-c21fb35b4918">12.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-Free Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i880eec97a0864f7f95ece75713ea01a9_I20210630" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRkMTRjNDhmNDc1NTRjZTk4NjU0NzUwZTUyNjMxYWRmL3RhYmxlcmFuZ2U6NGQxNGM0OGY0NzU1NGNlOTg2NTQ3NTBlNTI2MzFhZGZfMy0yLTEtMS04NTQyNw_2b230b4f-ce3f-4c7b-a03b-5ddf6523ad9a">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Counter Party Risk</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5e38a3a78e2405384dff3169dad04c7_I20210630" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRkMTRjNDhmNDc1NTRjZTk4NjU0NzUwZTUyNjMxYWRmL3RhYmxlcmFuZ2U6NGQxNGM0OGY0NzU1NGNlOTg2NTQ3NTBlNTI2MzFhZGZfNC0yLTEtMS04NTQyNw_af6ece08-dfb2-4b60-b42c-01d07787e8da">3.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments, Foreign Exchange Contracts and Interest Rate Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our investments consist of corporate bonds and U.S treasury securities. The fair value of our corporate bonds is estimated using observable market-based inputs such as quoted prices, interest rates and yield curves or Level 2 inputs. The fair value of our U.S. treasury securities are based on quoted market prices in active markets and are included in the Level 1 fair value hierarchy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair value of our Level 2 foreign exchange contracts, including forward contracts and cross-currency par forward contracts, is estimated using observable market inputs such as known notional value amounts, spot and forward exchange rates. These inputs relate to liquid, heavily traded currencies with active markets which are available for the full term of the derivative.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our Level 2 interest rate swaps is estimated using a pricing model that reflects the terms of the contracts, including the period to maturity, and relies on observable market inputs such as known notional value amounts and USD interest rate curves.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNzQ3MQ_bcca3952-13a9-4e36-a6d7-7560246bf5d4" continuedAt="i40c830c192ea484099a9e71a5c2594c6" escape="true">Our assets and liabilities measured at fair value on a recurring basis consisted of the following Level 1, 2 and 3 inputs as defined above (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="ifc5ef5b732b9486294caf579cc7e5c9b"><ix:continuation id="i40c830c192ea484099a9e71a5c2594c6"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.793%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i904e390537e1451b9a0b56b3895e0ad9_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNC0xLTEtMS04NTQyNw_744e591c-2adc-44ad-9b8d-f1aba67b1518">11,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63cb18161ad04f4abb209fda84a747fe_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNC0zLTEtMS04NTQyNw_b140022d-771d-4512-b7b2-73efa1e8a73c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib00f088272f9420d8932ea1b42312e11_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNC01LTEtMS04NTQyNw_1983cd88-ed22-4e68-be37-dd39ff02da6d">11,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88960ec8f42c4c90b987ccc14648a60b_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNC03LTEtMS04NTQyNw_a40b7014-2ab9-4a01-8976-26a096968a6a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie327d35dcba8456fb9278a53ad44949a_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNS0xLTEtMS05MDE5Mg_5211791e-aa33-45c8-9dc0-73237ab36a73">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i335c02bca87342c3af0d55271dc60da8_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNS0zLTEtMS05MDE5Mg_10282ede-19b8-4ecb-b13a-26612eca6544">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c4a92b0ce541338d7536509042ea7b_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNS01LTEtMS05MDE5Mg_085cf875-05ea-493e-a9f7-e956ea79f7ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea350bdc70b431c9a82fd66e420fa04_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNS03LTEtMS05MDE5Mg_5d5199b1-555a-47c5-bb82-9e1a9ef76ba6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNS0xLTEtMS04NTQyNw_33537a28-c4b8-493b-b89b-bdf403d77d15">1,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc18153c27d94cd6a2c7151fb5dc9bd0_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNS0zLTEtMS04NTQyNw_3487c9fc-f812-42a2-8b19-e6291ad28414">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i517040ce9ec34b609db5b705439f553a_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNS01LTEtMS04NTQyNw_8a3efa81-3b9e-4c64-bee9-f41a1c96b09a">1,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ffcb622eea74c2297c2e694f6d00439_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNS03LTEtMS04NTQyNw_a11e008d-e2b7-4775-a436-7aac1057ab82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if944aaea429e473cb610016ebaa83d93_I20220630" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNy0xLTEtMS04NTQyNw_32c88e1f-2a0e-4736-828d-344b88ecff6f">9,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1de545bcfec4a5888eea70f8e7b8036_I20220630" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNy0zLTEtMS04NTQyNw_5401c00b-a070-42b3-8717-3294094f1f79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82e5e28cacc74c919e50d739b06edf75_I20220630" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNy01LTEtMS04NTQyNw_2c9dc7f7-253b-4340-82cb-146b24059866">9,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i688065cd861c47e7bd70568dc32ce595_I20220630" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNy03LTEtMS04NTQyNw_f4f22b2e-046d-4bca-8d93-060233d19b1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6c822cbb6204a8fbc869b98546fc0a9_I20220630" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfOC0xLTEtMS04NTQyNw_0b1846fa-9637-45d6-97ca-5b90ae680d3a">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc30cc767c204190b9d227e826c7af7a_I20220630" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfOC0zLTEtMS04NTQyNw_d1eddfa2-6e23-4c0e-a89f-5763a862527e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957a2bdf19bb4e459e210f02fdc311af_I20220630" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfOC01LTEtMS04NTQyNw_2ef4bd1d-5fd2-4909-9dcd-5d1dda1653b9">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia097420328df4d0ba8aad76512275995_I20220630" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfOC03LTEtMS04NTQyNw_90cdb0a5-ebc2-4ac1-b6b6-724e20f29371">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if944aaea429e473cb610016ebaa83d93_I20220630" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTQtMS0xLTEtOTAxOTQ_ea3108a9-bdfa-4281-a50a-bcfd924513fb">15,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1de545bcfec4a5888eea70f8e7b8036_I20220630" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTQtMy0xLTEtOTAxOTQ_634f701e-15b4-46da-b2d5-25d30277fda0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82e5e28cacc74c919e50d739b06edf75_I20220630" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTQtNS0xLTEtOTAxOTQ_149ed541-2ca7-4f12-9703-d24122d59f32">15,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i688065cd861c47e7bd70568dc32ce595_I20220630" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTQtNy0xLTEtOTAxOTQ_dcf0ad4a-e33d-4fa1-9deb-1ffae0889af5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6c822cbb6204a8fbc869b98546fc0a9_I20220630" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTMtMS0xLTEtODU0Mjc_45c99b22-9b8f-45bd-b7a4-6b1d96dfc621">23,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc30cc767c204190b9d227e826c7af7a_I20220630" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTMtMy0xLTEtODU0Mjc_5d02172c-a941-4502-b462-17a5790b9e19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957a2bdf19bb4e459e210f02fdc311af_I20220630" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTMtNS0xLTEtODU0Mjc_37b9ee94-6203-46aa-be4e-36f53c3321cc">23,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia097420328df4d0ba8aad76512275995_I20220630" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTMtNy0xLTEtODU0Mjc_76b409f3-d559-4c06-ad8f-6b655a07d8d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTQtMS0xLTEtODU0Mjc_af96e303-24dd-4b9e-b8c0-b951ee0c7479">63,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc18153c27d94cd6a2c7151fb5dc9bd0_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTQtMy0xLTEtODU0Mjc_ab86cda5-ca93-4586-89d6-2f690c85bede">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i517040ce9ec34b609db5b705439f553a_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTQtNS0xLTEtODU0Mjc_3d829396-6116-4d3d-b86b-77ab883890be">62,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ffcb622eea74c2297c2e694f6d00439_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTQtNy0xLTEtODU0Mjc_721451b4-8c06-4383-9c40-b77e4212cbd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - ST</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3f7f6920e264be38b38e91385534cf4_I20220630" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTktMS0xLTEtOTA2NzA_84fca8f7-a715-4be5-8fac-384958712c93">290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8b9ef489414d54902e74776b3ad3ca_I20220630" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTktMy0xLTEtOTA2NzI_5cbf0aff-8fc8-4bdc-aa91-4e6849b8ae98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db367bb1a0046df994e640235391d11_I20220630" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTktNS0xLTEtOTA2NzY_6054b18b-e784-4e5e-acde-f89bf740628c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf917acde63245d09eb8fa04aa6cb67b_I20220630" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTktNy0xLTEtOTA2NzQ_cfd4f268-15e9-450a-99a9-1aefb5a003bb">290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bdd238b3bd44e3aa0a5ddeb8d8233cf_I20220630" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTgtMS0xLTEtODU0Mjc_6f6bbfbe-20cf-4fc6-b44d-2c5364129bed">30,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bf4e764536e4ffa9c77a176f003216e_I20220630" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTgtMy0xLTEtODU0Mjc_df19c65b-986a-4755-894e-922e6ddbc60c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9baebbfe2a8c434b87c84f5e0ad8cb0a_I20220630" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTgtNS0xLTEtODU0Mjc_1cc11fc4-f238-4b5b-9ac7-7ceaa337a65d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632c944bb938432aa0eedc42d20802a7_I20220630" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTgtNy0xLTEtODU0Mjc_b09c7a45-5a5b-4cfb-810a-1bc74c080878">30,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac7fe1e5d9204ae3b38fd2c49a0a6e89_I20220630" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjAtMS0xLTEtODU0Mjc_5fa5ff3e-6da2-42ea-9674-ae9689ebf657">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic60a257dc9bd4e0eb4f59ade43d2cb14_I20220630" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjAtMy0xLTEtODU0Mjc_cad1cd17-619d-44c1-992a-fa2ea69cc7fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic149dfd8f6d1483d9ded55c35ef93307_I20220630" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjAtNS0xLTEtODU0Mjc_54072b99-9746-4caf-9a02-4503e0340bef">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44e3a6c8a6664cad9862b4281ded5217_I20220630" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjAtNy0xLTEtODU0Mjc_526f8b44-e52e-4fbc-ab4c-6431e2f44b9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8db92612840f4756b2e77eb032bb8d41_I20220630" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjEtMS0xLTEtODU0Mjc_1a54d917-4402-4236-bbd8-a4dbb5638226">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094fd5abbce944aa910cc40d499b5d9f_I20220630" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjEtMy0xLTEtODU0Mjc_9183ff7e-f572-4d23-9aad-83540a80a377">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfa1710f03974c6d9d1ae45570f5c02d_I20220630" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjEtNS0xLTEtODU0Mjc_eddda053-1e4a-4e76-95c1-d3bb4f028caa">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3e79b2e14f043c09c7080259bcdd720_I20220630" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjEtNy0xLTEtODU0Mjc_37839e69-a999-4bbd-926b-81d31e8a77ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfeedac3a27d4227a69f70be2d89e06a_I20220630" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjQtMS0xLTEtODU0Mjc_9ee03151-0996-491e-853f-dcabf347aaf8">31,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife12602b15f94cd9890c4082d74581b3_I20220630" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjQtMy0xLTEtODU0Mjc_c9d7f2e4-e9c8-487c-82ae-8fc4762853e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3695974f62448dab66775d219f590d3_I20220630" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjQtNS0xLTEtODU0Mjc_97122d15-d0cb-4344-9069-94c4df328a29">627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4009ff512d42959a09607b0d1d2dd5_I20220630" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjQtNy0xLTEtODU0Mjc_039aa2e6-1950-4623-8ed3-83f0507db77c">30,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNC0xLTEtMS04NTQyNw_4476e069-124f-4253-bb6f-d8b08f6514f3">14,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i377767425d0240109a95844ff08b1b34_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNC0zLTEtMS04NTQyNw_43f1a3bb-f679-42ff-838d-adaed8d41810">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8df718d5aa84441b74a7a6e2b03f17e_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNC01LTEtMS04NTQyNw_4a610cc2-e7a4-426c-afc6-cbafa41f8f7e">14,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56f3580c0d3d47f48f3a427759653368_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNC03LTEtMS04NTQyNw_39783a37-dcef-4f35-a63f-9b6558147dc3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNS0xLTEtMS04NTQyNw_2e7ae138-c0b9-431d-9008-a3ff90270971">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i377767425d0240109a95844ff08b1b34_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNS0zLTEtMS04NTQyNw_09782be2-2862-4a9c-bc11-aa69ced9d565">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8df718d5aa84441b74a7a6e2b03f17e_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNS01LTEtMS04NTQyNw_4168df5e-6215-495b-a80b-4b90b261ab70">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56f3580c0d3d47f48f3a427759653368_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNS03LTEtMS04NTQyNw_7088fe5b-c827-43a2-9c9f-36d5c7365d54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency par forward contract:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcc8fe10383a4514ae5fb955ea53cee7_I20211231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNy0xLTEtMS04NTQyNw_9c9feaf4-fe1c-421f-98ab-cf31c09f369e">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib739ab062f854a70996bee0b00130a93_I20211231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNy0zLTEtMS04NTQyNw_a388018b-c345-42f3-be2a-d2feb6b456fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8cdb41c17a14a2695ba262420cf3df1_I20211231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNy01LTEtMS04NTQyNw_14cf4abb-b755-4f38-abdb-3efe1d887d57">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e5fa69d927941dfb31719735e9e8088_I20211231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNy03LTEtMS04NTQyNw_32609add-d3d8-4617-80d2-895366391d55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTAtMS0xLTEtODU0Mjc_fc6f17e5-bbf7-4a0e-8b11-41bf370ff777">20,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i377767425d0240109a95844ff08b1b34_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTAtMy0xLTEtODU0Mjc_43f6f094-457c-498c-9eb0-557109864a07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8df718d5aa84441b74a7a6e2b03f17e_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTAtNS0xLTEtODU0Mjc_b3291514-c60e-4156-a12e-1dec00367c25">20,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56f3580c0d3d47f48f3a427759653368_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTAtNy0xLTEtODU0Mjc_c17ce107-6b1a-47af-9fa7-2dbdfe0f1e57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a78e7cf24d64503b2511a1cdc74b41f_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTMtMS0xLTEtODU0Mjc_76d5ff0a-505b-4d3e-894b-45425562c61c">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7507e0229527439dafdb4203eddf647e_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTMtMy0xLTEtODU0Mjc_61d9f067-08e7-4c55-bb7a-dfb6fc132d81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i711e70f031664741a45a58f17b0b937b_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTMtNS0xLTEtODU0Mjc_51a5f8c5-8054-4567-9bfe-c60903d7dade">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide25da1d24d146b2b6367f763603416f_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTMtNy0xLTEtODU0Mjc_d4bef741-3c31-41fe-bc31-e5fd3259be4e">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib56ba1e346ee4357b863011abaca4f3b_I20211231" decimals="-3" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTgtMS0xLTEtOTA2NjE_e7a6f3c0-17a3-4f4c-8c1b-92d6886988c4">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3ad6f6fa60f49b0995c5869f3d2d033_I20211231" decimals="-3" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTgtMy0xLTEtOTA2NjM_545040c2-db34-4860-89c9-28ef12e3f794">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i130e8f7da5ee4027903cf2856abf00a3_I20211231" decimals="-3" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTgtNS0xLTEtOTA2NjU_7de8c069-c59f-41c6-8140-2c194408f31e">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd14230b4e94aff9f2dc05493cfc1b1_I20211231" decimals="-3" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTgtNy0xLTEtOTA2Njg_72b2cb93-dcb0-4374-ab66-3123d6b377ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie611c9fc1bb545cc8ad94fbe19af222c_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTktMS0xLTEtODU0Mjc_30b1494a-ec4c-4eb9-b788-c15e6cde0b78">4,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8debaac8649c406fbca98e4b486e4b1d_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTktMy0xLTEtODU0Mjc_38db2cde-34a6-43a8-92a3-6401411ed136">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78603e4cb0ca4c0f99214a90dd735480_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTktNS0xLTEtODU0Mjc_83eea3b8-85b7-4a15-bb62-1b24f33cb228">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac454971b49349949220dae2173838e4_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTktNy0xLTEtODU0Mjc_4252bb8c-5c26-410f-bd4f-82975fe7023d">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i10abb94289aa46ab94dfc506ddec4961_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10:  <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="icui:InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RleHRyZWdpb246N2I5MDczMDc5YzM0NGQ5ZWJlOTU1Zjk5ZTRjZjhiMGRfNDE1Mw_92300b2b-7477-4cb9-a382-0037a649dc82" continuedAt="iceac1dd636c9488aab0f7fd115b0bad7" escape="true">Investment Securities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iceac1dd636c9488aab0f7fd115b0bad7" continuedAt="i3c40db6244ad429a92daa98663515522"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Available-for-sale Securities</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our available-for-sale investment securities currently consist of short-term and long-term corporate bonds and short-term U.S. treasury securities and are considered &#8220;investment grade&#8221; and are carried at fair value. We assess our investment in available-for-sale debt securities for impairment each reporting period. If an unrealized loss exists, we determine whether any portion of the decline in fair value below the amortized cost basis is credit-related by reviewing several factors, including, but not limited to, the extent of the fair value decline and changes in the financial condition of the issuer. We record an impairment for credit-related losses through an allowance, limited to the amount of the unrealized loss. If we either intend to sell or it is more likely than not we will be required to sell the debt security before its anticipated recovery, any allowance is written off and the amortized cost basis is written down to fair value through a charge against net earnings. Unrealized gains and non-credit-related unrealized losses are recorded, net of tax, in other comprehensive income (loss). We did not have any investments in available-for-sale debt securities in unrealized loss positions as of June 30, 2022 or December 31, 2021.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost of the debt securities are adjusted for the amortization of premiums computed under the effective interest method. Such amortization is included in other income, net in our condensed consolidated statements of operations. Realized gains and losses are accounted for on the specific identification method. There have been <ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-6" name="us-gaap:GainLossOnSaleOfInvestments" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RleHRyZWdpb246N2I5MDczMDc5YzM0NGQ5ZWJlOTU1Zjk5ZTRjZjhiMGRfNDE1NQ_d61e5282-1b42-45c2-ade2-b38816f9a51f">no</ix:nonFraction> realized gains or losses on the disposal of these investments. The scheduled maturities of the debt securities are between 2022 and 2024. All short-term investment securities are callable within one year.  </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RleHRyZWdpb246N2I5MDczMDc5YzM0NGQ5ZWJlOTU1Zjk5ZTRjZjhiMGRfNDE1Nw_84eafbd8-316c-4210-9e40-4e02d8d114cc" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.301%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding <br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i904e390537e1451b9a0b56b3895e0ad9_I20220630" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMi0xLTEtMS04NTQyNw_ee79471c-d2a3-41a9-9ac1-2b6794bfab73">11,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c88697ab66446b8a82b091623fd4777_D20220101-20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMi0zLTEtMS04NTQyNw_fa698af7-ea08-462e-9f09-8d0c7429ef04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i904e390537e1451b9a0b56b3895e0ad9_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMi01LTEtMS04NTQyNw_a35b9b61-ee5f-4fd9-a078-62ea2efdadf0">11,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie327d35dcba8456fb9278a53ad44949a_I20220630" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMy0xLTEtMS04NjkzMA_3d46e442-f0ee-4eed-9c49-753da35f512a">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81e0ca54acfd4d24a778f4024742013b_D20220101-20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMy0zLTEtMS05MDIwNg_f07fd99b-4391-40bf-8f9f-828a459c7cdd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie327d35dcba8456fb9278a53ad44949a_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMy01LTEtMS05MDIwNg_7aa8ceda-9b0f-4c26-813f-4039890c58b4">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib37a7d73ddd44f5598941e2ca4cc04d4_I20220630" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMy0xLTEtMS04NTQyNw_b80d2dfb-4360-4cc4-ab6f-7e4284024109">1,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib37a7d73ddd44f5598941e2ca4cc04d4_I20220630" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMy0zLTEtMS04NTQyNw_583ca19d-7e27-4044-b2c1-474fc8b2b80c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib37a7d73ddd44f5598941e2ca4cc04d4_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMy01LTEtMS04NTQyNw_b719a151-9e5e-47f8-8e79-3be771d87b32">1,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfNC0xLTEtMS04NTQyNw_cd7ce93f-7413-45f6-9064-a96d1e75de7e">15,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib37a7d73ddd44f5598941e2ca4cc04d4_I20220630" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfNC0zLTEtMS04NTQyNw_c8b80f4b-5c78-4278-a67f-0032362165b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfNC01LTEtMS04NTQyNw_37da64e5-8de1-4656-bd6b-a3af39fd80a9">15,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding<br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfOC0xLTEtMS04NTQyNw_ed40eaad-4ea3-4eb0-a512-8987fc652692">14,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c9a9e9ea2345208d64fa0d5a8fffda_D20210101-20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfOC0zLTEtMS04NTQyNw_80dee62c-2a4b-4a4f-9275-6132bb5e5a5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfOC01LTEtMS04NTQyNw_6cecdb9c-7799-41e1-b1f5-b2b4ac547a40">14,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bde06c37d8c4dda852f5deb015fa18f_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfOS0xLTEtMS04NTQyNw_74d97761-3101-46d8-9152-52aaa9fe0e31">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bde06c37d8c4dda852f5deb015fa18f_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfOS0zLTEtMS04NTQyNw_f1e4200e-3f5e-4cfc-90a5-d3ebd91c8e77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bde06c37d8c4dda852f5deb015fa18f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfOS01LTEtMS04NTQyNw_4738fe59-4055-47bb-b919-5f28e0d4ef3a">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMTAtMS0xLTEtODU0Mjc_8f809c8e-4dc9-49d9-9764-16234f5c17cb">19,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bde06c37d8c4dda852f5deb015fa18f_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMTAtMy0xLTEtODU0Mjc_027751a8-de30-4ec6-ac5c-8245bdc2a539">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMTAtNS0xLTEtODU0Mjc_d96e68e2-d038-4c06-a7af-a5973bb871ae">19,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Non-Marketable Equity Securities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, we acquired approximately a <ix:nonFraction unitRef="number" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="1" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RleHRyZWdpb246N2I5MDczMDc5YzM0NGQ5ZWJlOTU1Zjk5ZTRjZjhiMGRfMjA4Mg_cedef215-f3c0-4e21-b547-a8f0dc233b78">20.0</ix:nonFraction>% non-marketable equity interest in a nonpublic company and entered into a three-year distribution agreement where we have the exclusive rights to market, sell and distribute the company's products in exchange for a cash payment of $<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RleHRyZWdpb246N2I5MDczMDc5YzM0NGQ5ZWJlOTU1Zjk5ZTRjZjhiMGRfMjMxNQ_d82b94dc-63e2-418c-bb23-c8b683d386f0">3.3</ix:nonFraction>&#160;million. In addition, we were granted an exclusive license for all of the seller's intellectual property. At the expiration of the distribution agreement we have the right but not the obligation to acquire the remaining interest in the business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the equity method of accounting for investments when we determine we have a significant influence, but not a controlling interest in the investee. We determine whether we have significant influence by considering key factors such as ownership interest, representation on the board of directors, participation in policy making decisions, business relationship and material intra-entity transactions, among other factors. Our equity method investment is reported at cost and adjusted each period for our share of the investee's income or (loss) and dividend paid, if any. We eliminate any intra-entity profits to the extent of our beneficial interest. We record our share of the investee's income or (loss) on a one quarter lag. We report our proportionate share of the investee's income or (loss) resulting from this investment in other income, net in our condensed consolidated statements of operations. The carrying value of our equity method investment is reported in other assets on our </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i3c40db6244ad429a92daa98663515522"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condensed consolidated balance sheets (see Note 11: Prepaid Expenses and Other Current Assets and Other Assets). We assess our equity method investments for impairment on an annual basis or whenever events or circumstances indicate that the carrying value of the investment may not be recoverable. Our recorded share of the investee's loss was not material for the three and six months ended June 30, 2022. We did not receive any dividend distributions from this investment during the three and six months ended June 30, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RleHRyZWdpb246N2I5MDczMDc5YzM0NGQ5ZWJlOTU1Zjk5ZTRjZjhiMGRfNDE1MA_433c4e52-7116-429e-98da-6a9659337fa6" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-marketable equity method investment consists of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.839%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOmQyMDNkY2IwNDY1YzQ0Mjg5YTcwNzAxOTA1NTZmYjQyL3RhYmxlcmFuZ2U6ZDIwM2RjYjA0NjVjNDQyODlhNzA3MDE5MDU1NmZiNDJfMi0yLTEtMS04NTQyNw_34071615-abd2-4533-bbcb-f60f0e1465dc">3,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOmQyMDNkY2IwNDY1YzQ0Mjg5YTcwNzAxOTA1NTZmYjQyL3RhYmxlcmFuZ2U6ZDIwM2RjYjA0NjVjNDQyODlhNzA3MDE5MDU1NmZiNDJfMi00LTEtMS04NTQyNw_60072c1b-0de3-4cdd-98c2-552f7cbb568c">3,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in non-marketable debt securities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter 2022, we received $<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RleHRyZWdpb246N2I5MDczMDc5YzM0NGQ5ZWJlOTU1Zjk5ZTRjZjhiMGRfNTQ5NzU1ODIwMTE1_13dbfef4-6d46-4853-86d0-cea47ac47c88">19.0</ix:nonFraction>&#160;million in proceeds from a promissory note related to an acquired investment as part of the Smiths Medical acquisition.</span></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i10abb94289aa46ab94dfc506ddec4961_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="icui:PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RleHRyZWdpb246MDA4MjIxYjMwZjQ2NDlkNTgzZDcwZTliMmZhYzIwYzlfMjI2_1d677a44-c489-4003-b26a-f8c26a9b46d6" continuedAt="ifdf516bbba2541b6a79b69a2c7313c7b" escape="true">Prepaid Expenses and Other Current Assets and Other Assets</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ifdf516bbba2541b6a79b69a2c7313c7b"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RleHRyZWdpb246MDA4MjIxYjMwZjQ2NDlkNTgzZDcwZTliMmZhYzIwYzlfMjIx_d8c69ef4-0250-4e17-a1c7-16b79acf66fb" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.839%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses and receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:OtherPrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfMi0yLTEtMS04NTQyNw_c28a4d30-0c00-4e82-a9aa-f30c1e5ff354">27,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:OtherPrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfMi00LTEtMS04NTQyNw_ef76e607-6a80-46da-b0e8-a8cf3732079d">14,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid vendor expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="icui:PrepaidVendorExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfMy0yLTEtMS04ODIyMg_27c08220-6386-4a82-b8e0-a8249bb253c7">5,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="icui:PrepaidVendorExpenses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfMy00LTEtMS04ODIxNQ_f0a348e9-a871-4349-8ca1-c1d61058095a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:DeferredCostsAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfMy0yLTEtMS04NTQyNw_02579ceb-6650-4817-a7a3-9b4179eb3c18">7,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:DeferredCostsAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfMy00LTEtMS04NTQyNw_f978f9b4-cc87-4696-9ed5-e74be38693bb">12,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance and property taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="icui:Prepaidinsuranceandpropertytaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfNC0yLTEtMS04NTQyNw_4218a4d2-10e7-462e-bae7-7bbb89f294fd">16,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="icui:Prepaidinsuranceandpropertytaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfNC00LTEtMS04NTQyNw_0f3698d0-a97c-499a-8889-124386d189b3">6,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT/GST receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="icui:Prepaidothertaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfNS0yLTEtMS04NTQyNw_90e25280-2479-4f22-ba4d-9af47f1ece15">3,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="icui:Prepaidothertaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfNS00LTEtMS04NTQyNw_909ff03d-7d6a-4345-9cfb-3eccdb42ef12">4,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax charge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="icui:Deferredtaxcharge" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfNi0yLTEtMS04NTQyNw_1eb1e72e-b9e2-4e68-acf8-70ed5b0678b1">4,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="icui:Deferredtaxcharge" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfNi00LTEtMS04NTQyNw_cd97c9e3-41ae-4315-8dad-be5ce550fe05">4,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfNy0yLTEtMS04NTQyNw_c6442f95-a70a-4adf-ac4e-b65508d76e85">9,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfNy00LTEtMS04NTQyNw_79a11aa2-cd48-47b1-97b2-b9bbe0e56612">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if944aaea429e473cb610016ebaa83d93_I20220630" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfOC0yLTEtMS04NzY2MQ_41853bf8-8e5f-4fd0-98cb-a6b01cdb6629">15,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcc8fe10383a4514ae5fb955ea53cee7_I20211231" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfOC00LTEtMS04NzY2OA_567d34b6-93a8-46c3-bec8-38095a9c5b4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:DepositAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfOC0yLTEtMS04NTQyNw_7718df43-25a5-4b82-905c-6fe84b1957de">1,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:DepositAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfOC00LTEtMS04NTQyNw_d0575381-5836-4c60-a1f1-5237357d10ae">1,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfOS0yLTEtMS04NTQyNw_6602fbb7-dd00-460f-bb72-ecbc8532c233">3,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfOS00LTEtMS04NTQyNw_e45a4c5e-ae86-441e-aea4-fc962cc8ad68">2,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfMTAtMi0xLTEtODU0Mjc_fdd74777-1918-4aaa-97cc-dca70631f118">94,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfMTAtNC0xLTEtODU0Mjc_999b050f-f576-4133-80b7-11aa90817021">46,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RleHRyZWdpb246MDA4MjIxYjMwZjQ2NDlkNTgzZDcwZTliMmZhYzIwYzlfMjI0_1ec0a082-6129-4ccc-9523-0114c147389d" escape="true"><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.839%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pump lease receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfMi0yLTEtMS04NTQyNw_ce06f05f-220f-4154-be5b-743317f18413">28,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfMi00LTEtMS04NTQyNw_e8a949cf-1b9c-4e93-82b5-cb80693e5cdf">25,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spare parts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="icui:SpareParts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfMy0yLTEtMS04NTQyNw_9807f877-e93a-4fc1-8c66-f9d89bd942ae">34,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="icui:SpareParts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfMy00LTEtMS04NTQyNw_96044906-1f9b-4b7b-b7de-9145665e60c6">28,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfNC0yLTEtMS04NTQyNw_33115010-405c-4bab-8c6a-d6a112735718">3,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfNC00LTEtMS04NTQyNw_f3e6868d-fcff-49aa-8a52-7f7f4728ad2d">3,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfNS0yLTEtMS04NTQyNw_b47cb9ea-b308-4ee2-8ddf-0a66a4b349ad">6,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfNS00LTEtMS04NTQyNw_aaee600a-27bb-4e17-abf2-3a854443dfef">2,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfNi0yLTEtMS04NTQyNw_2b18ce4c-953c-4f24-ba35-f5bb80f40191">2,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfNi00LTEtMS04NTQyNw_a946921f-b9f1-4136-aca6-46c26d9d7ec4">2,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30640c390ffe4ca3bbe943506380dba9_I20220630" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfNy0yLTEtMS04NTQyNw_e966a309-3da8-4f4d-8c93-6d6fa4138ab0">23,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa0f2e530a594d488d3ff7ff069e9259_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfNy00LTEtMS04NTQyNw_5d6814fa-34f8-4356-a3a6-97267394f05e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a3de3a660434987a7100fcd8c1caebb_I20220630" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfOC0yLTEtMS04NTQyNw_e7c7a020-d7b8-4c2a-b08f-c90292234390">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9d9c289f8a048eb84ce2a838b84d175_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfOC00LTEtMS04NTQyNw_96d85fca-7719-4fcc-8ba0-b50c1fd061ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfOS0yLTEtMS04NTQyNw_d8078314-1d68-41f1-af94-53b8e9d3dc30">3,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfOS00LTEtMS04NTQyNw_c89f19c2-3baa-4716-a369-fa348706dd78">526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfMTAtMi0xLTEtODU0Mjc_c36bf5a7-638f-4fed-a99a-63a640700268">101,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfMTAtNC0xLTEtODU0Mjc_b3de94e8-ecdb-488a-b629-5d45f0ce9282">63,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i10abb94289aa46ab94dfc506ddec4961_67"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12:  <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RleHRyZWdpb246Njc4YTIyYWIzMWI2NDM2MWIyMWMzMjE0NTU4MWEyOWRfNTg0_a2943c19-1e53-4e81-aafc-340cca4db0bc" continuedAt="ib7d4836c714044d1a7c51cf8e856d30b" escape="true">Inventories</ix:nonNumeric></span></div><ix:continuation id="ib7d4836c714044d1a7c51cf8e856d30b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Inventories are stated at the lower of cost or net realizable value with cost determined using the first-in, first-out method. Inventory costs include material, labor and overhead related to the manufacturing of our products. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RleHRyZWdpb246Njc4YTIyYWIzMWI2NDM2MWIyMWMzMjE0NTU4MWEyOWRfNTk3_5784b8ee-f36a-4cd2-a274-d2b6ee3b3199" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RhYmxlOmU3N2M4MTcwMzRiZTQzMTc4NGI2M2Y0NjJiYzY0MWZjL3RhYmxlcmFuZ2U6ZTc3YzgxNzAzNGJlNDMxNzg0YjYzZjQ2MmJjNjQxZmNfMi0xLTEtMS04NTQyNw_5f4b027a-6e3c-4a1b-8441-76b852fae2d3">240,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RhYmxlOmU3N2M4MTcwMzRiZTQzMTc4NGI2M2Y0NjJiYzY0MWZjL3RhYmxlcmFuZ2U6ZTc3YzgxNzAzNGJlNDMxNzg0YjYzZjQ2MmJjNjQxZmNfMi0zLTEtMS04NTQyNw_abdaee76-1a5f-4818-b556-47d48fb78a06">135,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RhYmxlOmU3N2M4MTcwMzRiZTQzMTc4NGI2M2Y0NjJiYzY0MWZjL3RhYmxlcmFuZ2U6ZTc3YzgxNzAzNGJlNDMxNzg0YjYzZjQ2MmJjNjQxZmNfMy0xLTEtMS04NTQyNw_63ac3a49-62f2-4427-9659-da755ef0aa7f">71,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RhYmxlOmU3N2M4MTcwMzRiZTQzMTc4NGI2M2Y0NjJiYzY0MWZjL3RhYmxlcmFuZ2U6ZTc3YzgxNzAzNGJlNDMxNzg0YjYzZjQ2MmJjNjQxZmNfMy0zLTEtMS04NTQyNw_136efaaf-b8a4-4f4c-9970-57115aba4784">36,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RhYmxlOmU3N2M4MTcwMzRiZTQzMTc4NGI2M2Y0NjJiYzY0MWZjL3RhYmxlcmFuZ2U6ZTc3YzgxNzAzNGJlNDMxNzg0YjYzZjQ2MmJjNjQxZmNfNC0xLTEtMS04NTQyNw_0b6a6fe6-565d-4ca4-aca7-ac048e21d3f1">271,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RhYmxlOmU3N2M4MTcwMzRiZTQzMTc4NGI2M2Y0NjJiYzY0MWZjL3RhYmxlcmFuZ2U6ZTc3YzgxNzAzNGJlNDMxNzg0YjYzZjQ2MmJjNjQxZmNfNC0zLTEtMS04NTQyNw_44797281-e350-4e2c-9094-c91dd1f0368c">118,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RhYmxlOmU3N2M4MTcwMzRiZTQzMTc4NGI2M2Y0NjJiYzY0MWZjL3RhYmxlcmFuZ2U6ZTc3YzgxNzAzNGJlNDMxNzg0YjYzZjQ2MmJjNjQxZmNfNS0xLTEtMS04NTQyNw_1da3ce35-c7d6-4ba8-832e-fe475b266971">583,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RhYmxlOmU3N2M4MTcwMzRiZTQzMTc4NGI2M2Y0NjJiYzY0MWZjL3RhYmxlcmFuZ2U6ZTc3YzgxNzAzNGJlNDMxNzg0YjYzZjQ2MmJjNjQxZmNfNS0zLTEtMS04NTQyNw_8b651dff-3c7b-40da-a603-18057fc18b5f">290,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, inventories increased significantly due to the acquisition of Smiths Medical. All acquired inventory was recorded at fair value on January 6, 2022 in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (see Note 3: Acquisitions).</span></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</span></div><div id="i10abb94289aa46ab94dfc506ddec4961_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RleHRyZWdpb246ODg1YWIyNjUxMzQ2NDBlNGE4N2RmY2MyMGYzNDllNmFfNjAy_21fdf4ca-1256-4e55-bb63-65b26f219d59" continuedAt="ibbea2dcc3a784cd69820a397a862ea8e" escape="true">Property, Plant and Equipment</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibbea2dcc3a784cd69820a397a862ea8e"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RleHRyZWdpb246ODg1YWIyNjUxMzQ2NDBlNGE4N2RmY2MyMGYzNDllNmFfNjAw_bb9c0f91-6149-42d7-9800-b4c060c28eb2" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consists of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfMi0xLTEtMS04NTQyNw_839ef5d4-c8fd-4170-81de-b32f3c21d8fd">407,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfMi0zLTEtMS04NTQyNw_d99e0642-d703-40b9-a35e-b747d40f1f2e">321,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, building and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a7c45ae71c244ff8f548dfdd2b6fb8c_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfMy0xLTEtMS04NTQyNw_359dcd6b-abd2-45cf-8471-ffa15f0f1662">271,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56979378a15940b694ad44f79ca40db8_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfMy0zLTEtMS04NTQyNw_7e930b89-c9e9-489e-89ea-5a45a981c04c">243,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb10aa868d234581b425b2f11483e45f_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfNC0xLTEtMS04NTQyNw_f7198016-384e-4054-9973-a49129b1bba3">75,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id13943d7016047a08b86a41eba983610_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfNC0zLTEtMS04NTQyNw_d7080e19-c4d7-44ad-8021-89169438a151">60,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35c21123a9bc47cd9c241397fb0086b8_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfNS0xLTEtMS04NTQyNw_5faf0136-70cb-421a-8f48-1618b4af0129">115,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243cc12eefac42478d6f254dfb50666d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfNS0zLTEtMS04NTQyNw_f232499b-ca7d-418c-8854-f1410d547183">102,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfNi0xLTEtMS04NTQyNw_c84df23a-230f-41f8-adf0-719a70045495">29,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfNi0zLTEtMS04NTQyNw_221766c5-68b5-4ceb-b3f3-aa51484cdc08">7,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments placed with customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4159aa37c1ba4a859994bf41400f8ba2_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfNy0xLTEtMS04NTQyNw_4ec1b1a7-a898-4efc-80b6-bf6227d5487b">110,592</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9372198522d4b5e97f8e9e8a9b15104_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfNy0zLTEtMS04NTQyNw_3226e13b-6db5-4a96-bcfc-119a0f5fbcb8">97,384</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfOC0xLTEtMS04NTQyNw_b8342d8b-4f41-420a-8ad1-e4c3a6222c12">136,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfOC0zLTEtMS04NTQyNw_86c22402-5820-4fcf-8f71-e4dfa22f7821">72,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfOS0xLTEtMS04NTQyNw_740f191f-8833-42f8-a55a-3688b6a7186d">1,147,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfOS0zLTEtMS04NTQyNw_04999323-431b-40fd-9d43-c181cc5f20b1">905,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfMTAtMS0xLTEtODU0Mjc_a32b88a8-e6a9-4194-b269-10bd429fb8ff">479,509</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfMTAtMy0xLTEtODU0Mjc_1a205fad-0344-47e6-9973-d75a7f2d76e8">436,739</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfMTEtMS0xLTEtODU0Mjc_d43e9d3f-d200-4874-9f65-cc78469058da">667,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfMTEtMy0xLTEtODU0Mjc_4d10df42-1c3f-4925-a7b6-b266cd3cd2c6">468,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Instruments placed with customers consist of drug-delivery and monitoring systems placed with customers under operating leases.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RleHRyZWdpb246ODg1YWIyNjUxMzQ2NDBlNGE4N2RmY2MyMGYzNDllNmFfMzEz_34f0a4ae-b9de-416b-b185-723b55a0dbba">24.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RleHRyZWdpb246ODg1YWIyNjUxMzQ2NDBlNGE4N2RmY2MyMGYzNDllNmFfMzIw_67d3c059-dec1-4313-8428-34f93effdbb3">46.4</ix:nonFraction>&#160;million for the three and six months ended June 30, 2022, respectively. Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RleHRyZWdpb246ODg1YWIyNjUxMzQ2NDBlNGE4N2RmY2MyMGYzNDllNmFfNTQ5NzU1ODE0NzQ5_62574526-9c90-4691-97a3-49cf71f7f679">16.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="INF" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RleHRyZWdpb246ODg1YWIyNjUxMzQ2NDBlNGE4N2RmY2MyMGYzNDllNmFfNTQ5NzU1ODE0NzY0_cc98764d-92ba-4fd9-976d-96549c3a2da2">32.7</ix:nonFraction>&#160;million for the three and six months ended June 30, 2021 and 2021, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June 30, 2022, property, plant and equipment and related depreciation expense increased significantly due to the acquisition of Smiths Medical (see Note 3: Acquisitions).</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i10abb94289aa46ab94dfc506ddec4961_73"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14:  <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RleHRyZWdpb246NWY3MDM3NzRmZDJkNGEwNWIzYmJmMDZiYWU0ZGVmM2RfMTQyNQ_e2f9eadd-eb0e-4c0c-95a7-6724eb8a1ee7" continuedAt="if718ead345054b1a8ff83b658ef16b5a" escape="true">Goodwill and Intangible Assets, Net</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if718ead345054b1a8ff83b658ef16b5a" continuedAt="ie57b658c101344d4b44fa2f23553cdfd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RleHRyZWdpb246NWY3MDM3NzRmZDJkNGEwNWIzYmJmMDZiYWU0ZGVmM2RfMTQyMA_42a796c6-3e9f-47a8-ba55-64f351cfd36f" continuedAt="i6f85ab500d204b339662fd57481e32db" escape="true">The following table presents the changes in the carrying amount of our goodwill (in thousands):</ix:nonNumeric></span></div><ix:continuation id="i6f85ab500d204b339662fd57481e32db"><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjRmMjBiNDc1ZjY5YzRmMjBhYmMwNzg4ZDQ2YTU2ZDIyL3RhYmxlcmFuZ2U6NGYyMGI0NzVmNjljNGYyMGFiYzA3ODhkNDZhNTZkMjJfMS0yLTEtMS04NTQyNw_e99293ce-e88e-45e0-bdf1-9f5016caafb5">43,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjRmMjBiNDc1ZjY5YzRmMjBhYmMwNzg4ZDQ2YTU2ZDIyL3RhYmxlcmFuZ2U6NGYyMGI0NzVmNjljNGYyMGFiYzA3ODhkNDZhNTZkMjJfMi0yLTEtMS04NTQyNw_d7b7c7ae-3fbd-4410-b797-7e9db31ce39c">1,444,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjRmMjBiNDc1ZjY5YzRmMjBhYmMwNzg4ZDQ2YTU2ZDIyL3RhYmxlcmFuZ2U6NGYyMGI0NzVmNjljNGYyMGFiYzA3ODhkNDZhNTZkMjJfMy0yLTEtMS04NTQyNw_fdb8bcd3-6c46-47de-84cb-86884de35919">7,128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjRmMjBiNDc1ZjY5YzRmMjBhYmMwNzg4ZDQ2YTU2ZDIyL3RhYmxlcmFuZ2U6NGYyMGI0NzVmNjljNGYyMGFiYzA3ODhkNDZhNTZkMjJfNC0yLTEtMS04NTQyNw_0b90a3bb-df8d-48d6-b9f7-665fc0a7ab7a">60,034</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjRmMjBiNDc1ZjY5YzRmMjBhYmMwNzg4ZDQ2YTU2ZDIyL3RhYmxlcmFuZ2U6NGYyMGI0NzVmNjljNGYyMGFiYzA3ODhkNDZhNTZkMjJfNS0yLTEtMS04NTQyNw_3e449487-73ab-4c1c-b3e4-8ae9fd9a8313">1,421,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to Smiths Medical acquired on January 6, 2022.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other reflects measurement period adjustments related to a 2021 acquisition of a small foreign infusion systems supplier.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RleHRyZWdpb246NWY3MDM3NzRmZDJkNGEwNWIzYmJmMDZiYWU0ZGVmM2RfMTQyNw_e772a81a-146d-44f6-8df3-6ae0ad80e3fa" continuedAt="i81337cb80033478c9b3e92cd5d2c0dd6" escape="true">Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):</ix:nonNumeric></span></div><ix:continuation id="i81337cb80033478c9b3e92cd5d2c0dd6" continuedAt="i21e161fff4484845b7e896b06dfe1a85"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.362%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life&#160;in&#160;Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if7bed48ab3274a438be9d461548445dd_D20220101-20220630" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMi0yLTEtMS04NTQyNw_05544c65-bbff-4a62-806f-7aad21f42e22">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d507359794c441296c07ef57b1f0b4b_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMi00LTEtMS04NTQyNw_f01befdf-1491-46c7-85b5-a1ac431715c2">28,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d507359794c441296c07ef57b1f0b4b_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMi02LTEtMS04NTQyNw_5e8d5bb8-ea7c-4319-afa1-c59336b41782">17,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d507359794c441296c07ef57b1f0b4b_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMi04LTEtMS04NTQyNw_16a1e601-98ae-4d01-8d92-87c57064902e">10,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i89f8e80bcf3e4d15871f08d9315a0795_D20220101-20220630" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMy0yLTEtMS04NTQyNw_0d8b3e1f-6efb-4137-90fe-2a807ce81dc6">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4a59c6b81a24315a01e330cedd0027d_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMy00LTEtMS04NTQyNw_ab8f3f1e-9305-4e16-b1c2-a406e039fcbb">10,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4a59c6b81a24315a01e330cedd0027d_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMy02LTEtMS04NTQyNw_0d5d8a3e-5a6e-4b26-b8bc-dcac7796c41f">6,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4a59c6b81a24315a01e330cedd0027d_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMy04LTEtMS04NTQyNw_3bb0e89d-2e85-43c7-bde2-ec2ccde717db">3,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ife9514c78ddc4a699ba11b09beca198e_D20220101-20220630" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNC0yLTEtMS04NTQyNw_f894183f-0f9c-4c6b-a2d5-1048b341cc9c">8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief2e729c06b343f28aba776743c330ef_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNC00LTEtMS04NTQyNw_30a8d1ce-5687-4b62-8068-b0db874facc9">581,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief2e729c06b343f28aba776743c330ef_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNC02LTEtMS04NTQyNw_6377408f-5249-480e-a2eb-05efdbf3834c">68,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief2e729c06b343f28aba776743c330ef_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNC04LTEtMS04NTQyNw_d8789d53-f22f-47a3-add4-bd748dd9d6b1">513,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i85f9f9c7345841549043760a5ef3a629_D20220101-20220630" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNS0yLTEtMS04NTQyNw_a1877f3f-b8a3-478e-aec9-39cafe6241d8">1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513ee50364c14e7d859a7bb7ef23a477_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNS00LTEtMS04NTQyNw_e5520563-7283-428a-959f-288f88d364cd">5,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513ee50364c14e7d859a7bb7ef23a477_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNS02LTEtMS04NTQyNw_0d8f42f6-39d9-4e8b-937b-90fc1f45c07e">5,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513ee50364c14e7d859a7bb7ef23a477_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNS04LTEtMS04NTQyNw_a58ef612-9f1a-4ac0-b19b-a0301dba74f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibbc7d651107948d2916b913aaa7d668f_D20220101-20220630" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNi0yLTEtMS04NTQyNw_81117b2a-5eca-4463-916c-7dd5c1af724c">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912dc15e8c1a41bc9d8224503705d967_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNi00LTEtMS04NTQyNw_df59b934-565a-4047-a229-a9da09b8353f">18,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912dc15e8c1a41bc9d8224503705d967_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNi02LTEtMS04NTQyNw_b09b82e6-09d6-4965-90dc-cd38435bedd5">5,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912dc15e8c1a41bc9d8224503705d967_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNi04LTEtMS04NTQyNw_8ab0dcb4-f4d8-495b-ac56-da6ee7c96eb7">12,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib169ababb8144e438fd240b38a3232b3_D20220101-20220630" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNy0yLTEtMS04NTQyNw_ecfa6fb7-d2a3-4b5a-8b45-7bf109a8edd1">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03a916b576f45269b9d7cee1deb9752_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNy00LTEtMS04NTQyNw_6d0de33a-e6fe-43e3-b083-bbfd48942195">584,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03a916b576f45269b9d7cee1deb9752_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNy02LTEtMS04NTQyNw_56fcd544-b22e-4073-87e6-9107189d1a72">78,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03a916b576f45269b9d7cee1deb9752_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNy04LTEtMS04NTQyNw_f66fa124-4625-43a7-aa32-59e5036fcf49">505,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i07478469fd9c4f93a9c4a903a48bc4f4_D20220101-20220630" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfOC0yLTEtMS04NTQyNw_af0347e8-2cb4-47c5-aa43-548da1e22fed">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id253a421eb2943f5b837dd25a641e2ca_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfOC00LTEtMS04NTQyNw_563be082-9e37-48c1-997e-ab0f5b9c8505">9,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id253a421eb2943f5b837dd25a641e2ca_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfOC02LTEtMS04NTQyNw_b07fc09f-00e3-4326-86d7-104f9dd5fa82">3,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id253a421eb2943f5b837dd25a641e2ca_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfOC04LTEtMS04NTQyNw_2414bb25-f440-404e-845e-b82b19210430">5,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfOS00LTEtMS04NTQyNw_e3b21718-0988-4974-bc9c-ed870f94c3e3">1,237,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfOS02LTEtMS04NTQyNw_32318599-3e56-4687-86ed-f55b741c8d5a">185,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfOS04LTEtMS04NTQyNw_cde56a6a-e5ba-4bb1-81bb-4ecdfd99e7a5">1,051,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMTEtNC0xLTEtODU0Mjc_65104b85-f00c-44d7-8b0e-9b94aa883151">28,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMTEtOC0xLTEtODU0Mjc_f352d8fa-b3b5-4ede-aa51-0ff21a18d2d7">28,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMTMtNC0xLTEtODU0Mjc_e7ae662c-157d-491c-8663-f348ae074f31">1,265,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMTMtNi0xLTEtODU0Mjc_f150df22-41da-46f3-afc3-15511db0e3be">185,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMTMtOC0xLTEtODU0Mjc_b2e7da31-1b79-4117-9fb4-16545cb8c204">1,080,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="ie57b658c101344d4b44fa2f23553cdfd"><div><ix:continuation id="i21e161fff4484845b7e896b06dfe1a85"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.362%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life in Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8e4951321f444b24b28bde3fdc96ef0e_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMi0yLTEtMS04NTQyNw_b53f72b6-9535-4bc3-9d4c-aa921185c921">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1cd92e8416b47e985b5956012374d3d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMi00LTEtMS04NTQyNw_2dd49742-93d6-4ee6-9f5e-9cad356da4c7">27,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1cd92e8416b47e985b5956012374d3d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMi02LTEtMS04NTQyNw_55e6035c-5f6e-46ee-88c7-b7de217a2531">16,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1cd92e8416b47e985b5956012374d3d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMi04LTEtMS04NTQyNw_7c9399a1-52ad-4172-9ea0-57be8aa9ba20">10,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1d3d1938206b417f890a9c160ac8e76a_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMy0yLTEtMS04NTQyNw_55aa7c04-bdb5-43e2-b752-33c42856f82c">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief440a8c15424f91aa2bf9703a08d2c8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMy00LTEtMS04NTQyNw_4a61a7a1-ce2c-4842-8fb3-f7df60566b4c">10,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief440a8c15424f91aa2bf9703a08d2c8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMy02LTEtMS04NTQyNw_2a50e096-ff46-4de9-b6cb-77c152804552">6,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief440a8c15424f91aa2bf9703a08d2c8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMy04LTEtMS04NTQyNw_25a96122-6af5-4eca-a4a7-7c0f5e7fd9f4">4,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4ef4386b3aad40caa1451437ce839832_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNC0yLTEtMS04NTQyNw_f1d0ce9b-85a2-4cf4-91cb-41d700d45403">9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i821291babde14cd093a6b4ddeccede07_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNC00LTEtMS04NTQyNw_c74ec8a6-26ae-48c5-a157-3b6a26ae92fb">57,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i821291babde14cd093a6b4ddeccede07_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNC02LTEtMS04NTQyNw_c7640979-72cb-440b-aa44-15e39839da9a">33,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i821291babde14cd093a6b4ddeccede07_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNC04LTEtMS04NTQyNw_d4688a56-92ed-4e81-bbc0-9bcfc0f3e04c">24,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie00a9e8c2c894c7ca4b21d05ef790de9_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNS0yLTEtMS04NTQyNw_64c687be-3b46-441e-9c62-6120c8da0ea1">4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4b19c227969431ca7e4a6627d90949e_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNS00LTEtMS04NTQyNw_e6fe2201-341d-416b-be82-3f3e87923dc9">425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4b19c227969431ca7e4a6627d90949e_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNS02LTEtMS04NTQyNw_6e2c01d8-cf89-49d4-b170-21835182d796">425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4b19c227969431ca7e4a6627d90949e_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNS04LTEtMS04NTQyNw_f9fa2787-6277-433c-9c58-e33821027f11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3927812c539f471a9f7e842582263841_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNi0yLTEtMS04NTQyNw_cf8d93bc-e107-40dd-8f22-4b9fa619a805">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66a5adf9d5824096bc840c2ea8b7fbe9_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNi00LTEtMS04NTQyNw_fae9a19e-ac0d-4085-8e91-62dac61b117a">18,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66a5adf9d5824096bc840c2ea8b7fbe9_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNi02LTEtMS04NTQyNw_d01befda-73b1-4211-81f4-a92bd8995ff6">4,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66a5adf9d5824096bc840c2ea8b7fbe9_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNi04LTEtMS04NTQyNw_4b464d92-a76d-4ebc-908a-74aa607a4d8d">13,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i19657ff16caa42fc8b51e10fb536a6f4_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNy0yLTEtMS04NTQyNw_49d271e2-853c-4127-9c1a-51b641c84924">13</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1713967f58146769aa8e6ad535a9f9c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNy00LTEtMS04NTQyNw_2d463305-fbb9-4eee-a665-20900ff9c0cb">152,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1713967f58146769aa8e6ad535a9f9c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNy02LTEtMS04NTQyNw_a8ff554a-26f6-4517-b6cf-57d8c20b3802">49,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1713967f58146769aa8e6ad535a9f9c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNy04LTEtMS04NTQyNw_d6bc4d0d-2a69-443a-8cee-c503c1aa1d98">103,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9cf2d32391d5446c87fb358fa5d38e52_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfOC0yLTEtMS04NTQyNw_d5e2ff6e-ac41-438b-a092-43a02ec847c6">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4895000d5a7b4fe3b49e4d144fa4308c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfOC00LTEtMS04NTQyNw_15b40cfa-1d4b-47e7-bf19-c02084fc42ce">9,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4895000d5a7b4fe3b49e4d144fa4308c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfOC02LTEtMS04NTQyNw_e6837eab-b53f-4ca8-804f-283918ab09be">2,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4895000d5a7b4fe3b49e4d144fa4308c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfOC04LTEtMS04NTQyNw_48542630-14f7-4b87-8ccd-1ebf4e19a351">6,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfOS00LTEtMS04NTQyNw_d87df289-2fba-424b-ba2f-0736adfdab0f">275,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfOS02LTEtMS04NTQyNw_246a9b47-f312-488b-adf7-8a2455d2beee">112,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfOS04LTEtMS04NTQyNw_1454989d-e718-44ae-859e-ddd4e66f0fdf">162,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMTEtNC0xLTEtODU0Mjc_3227f07a-87b1-468b-88e8-f4794d244864">25,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMTEtOC0xLTEtODU0Mjc_9850df89-b972-4c8d-b61f-8c35c7bccf5b">25,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMTMtNC0xLTEtODU0Mjc_8bd2cedb-1ab5-470e-9b2b-7906a8349584">301,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMTMtNi0xLTEtODU0Mjc_fa3c3492-e409-4522-bf34-d95276d1bc7d">112,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMTMtOC0xLTEtODU0Mjc_d9589791-c56c-4c6f-a53a-e7f9cca69210">188,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with definite lives are amortized on a straight-line basis over their estimated useful lives. During the three months ended June&#160;30, 2022 and 2021, intangible asset amortization expense was $<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="INF" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RleHRyZWdpb246NWY3MDM3NzRmZDJkNGEwNWIzYmJmMDZiYWU0ZGVmM2RfMTA3MA_1e70af2d-e633-4c78-98b2-4ad9a8c337cb">41.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="INF" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RleHRyZWdpb246NWY3MDM3NzRmZDJkNGEwNWIzYmJmMDZiYWU0ZGVmM2RfMTA3Nw_dbb42cc2-0b62-44e3-8a3e-1533ba8d4ac8">5.8</ix:nonFraction> million, respectively.  During the six months ended June&#160;30, 2022 and 2021, intangible asset amortization expense was $<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RleHRyZWdpb246NWY3MDM3NzRmZDJkNGEwNWIzYmJmMDZiYWU0ZGVmM2RfNTQ5NzU1ODE1Nzcx_13ae3a95-b59a-4ada-bd39-c4efeb020754">73.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RleHRyZWdpb246NWY3MDM3NzRmZDJkNGEwNWIzYmJmMDZiYWU0ZGVmM2RfNTQ5NzU1ODE1Nzg2_a1ffdc33-c1c3-4397-866b-a720cb1e0b5b">11.6</ix:nonFraction>&#160;million, respectively. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June 30, 2022, intangible assets and related amortization expense increased significantly due to the acquisition of Smiths Medical (see Note 3: Acquisitions).</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RleHRyZWdpb246NWY3MDM3NzRmZDJkNGEwNWIzYmJmMDZiYWU0ZGVmM2RfMTQzMw_2fb1a773-bdf2-4ae0-b848-8d4f9b715a66" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022 estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOmI5MWMzMGYwYjcwYzQyNDFhOTNkMTY5YmQxMDdlYzE4L3RhYmxlcmFuZ2U6YjkxYzMwZjBiNzBjNDI0MWE5M2QxNjliZDEwN2VjMThfMC0yLTEtMS04NTQyNw_0b96bcab-e71d-4526-9d48-3f10ece8a942">65,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOmI5MWMzMGYwYjcwYzQyNDFhOTNkMTY5YmQxMDdlYzE4L3RhYmxlcmFuZ2U6YjkxYzMwZjBiNzBjNDI0MWE5M2QxNjliZDEwN2VjMThfMS0yLTEtMS04NTQyNw_0d21ca9d-813d-404b-9d41-aa35f874b369">136,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOmI5MWMzMGYwYjcwYzQyNDFhOTNkMTY5YmQxMDdlYzE4L3RhYmxlcmFuZ2U6YjkxYzMwZjBiNzBjNDI0MWE5M2QxNjliZDEwN2VjMThfMi0yLTEtMS04NTQyNw_b427463c-23c8-400d-8e31-6497ed12d116">135,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOmI5MWMzMGYwYjcwYzQyNDFhOTNkMTY5YmQxMDdlYzE4L3RhYmxlcmFuZ2U6YjkxYzMwZjBiNzBjNDI0MWE5M2QxNjliZDEwN2VjMThfMy0yLTEtMS04NTQyNw_d59589bf-ea6c-4fa1-95ac-b37948c33519">127,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOmI5MWMzMGYwYjcwYzQyNDFhOTNkMTY5YmQxMDdlYzE4L3RhYmxlcmFuZ2U6YjkxYzMwZjBiNzBjNDI0MWE5M2QxNjliZDEwN2VjMThfNC0yLTEtMS04NTQyNw_3c676f16-bff6-4b4d-9943-a03441cc35af">127,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOmI5MWMzMGYwYjcwYzQyNDFhOTNkMTY5YmQxMDdlYzE4L3RhYmxlcmFuZ2U6YjkxYzMwZjBiNzBjNDI0MWE5M2QxNjliZDEwN2VjMThfNS0yLTEtMS04NTQyNw_ce5ade77-40db-48ac-bf10-07307706bc16">119,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOmI5MWMzMGYwYjcwYzQyNDFhOTNkMTY5YmQxMDdlYzE4L3RhYmxlcmFuZ2U6YjkxYzMwZjBiNzBjNDI0MWE5M2QxNjliZDEwN2VjMThfNi0yLTEtMS04NTQyNw_ce11b10a-2b56-4346-ac9e-b999aac57ba9">339,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOmI5MWMzMGYwYjcwYzQyNDFhOTNkMTY5YmQxMDdlYzE4L3RhYmxlcmFuZ2U6YjkxYzMwZjBiNzBjNDI0MWE5M2QxNjliZDEwN2VjMThfNy0yLTEtMS04NTQyNw_8eebaf67-514a-498e-aa55-ae4a72a48f90">1,051,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 15:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RleHRyZWdpb246NmNiNjY5Y2U1MDJlNDJkNzgyYWE1YjU1M2Y0NmQ4Y2VfOTM5_08d04297-7c0d-42c5-89ce-06b1fe7cf3f2" continuedAt="i32bcc6d8380649d5b98ad8817439996a" escape="true">Accrued Liabilities and Other Long-Term Liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i32bcc6d8380649d5b98ad8817439996a" continuedAt="i0840750e97b949fb9e1fcf87f3eddcaa">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RleHRyZWdpb246NmNiNjY5Y2U1MDJlNDJkNzgyYWE1YjU1M2Y0NmQ4Y2VfOTM2_03dcc703-6f2f-4279-bbe1-32d528760278" continuedAt="i8bd7a78835eb49778e4a1d228f03abdf" escape="true">Accrued liabilities consist of the following (in thousands):&#160;</ix:nonNumeric></ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i0840750e97b949fb9e1fcf87f3eddcaa" continuedAt="ifac79d28f8c84a80940942684a22b4f8"><ix:continuation id="i8bd7a78835eb49778e4a1d228f03abdf" continuedAt="ib08cf3f3f34d45c0adbbcb061cda4661"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="icui:AccruedSalariesAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMi0xLTEtMS04NTQyNw_d94b3f4c-056e-43e9-8701-4143bf6cf1b2">56,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="icui:AccruedSalariesAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMi0zLTEtMS04NTQyNw_4c92fa18-5c06-4608-90d6-393e968d1e3a">27,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incentive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AccruedBonusesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMy0xLTEtMS04NTQyNw_868c5d4b-1e9f-4674-8467-733a96dbe535">16,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AccruedBonusesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMy0zLTEtMS04NTQyNw_52be2d26-c96d-4d9a-a4c9-605f5aba617c">33,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-ST</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfNS0xLTEtMS04NTQyNw_f545631f-b9aa-4356-be64-ffa7f46a28b8">19,929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfNS0zLTEtMS04NTQyNw_a6ecfa6e-a0a6-4307-ba15-68f19c313465">9,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfOS0xLTEtMS04NTQyNw_ba53d63b-668b-496b-8eaf-9c710d39507e">7,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfOS0zLTEtMS04NTQyNw_92e32b47-5ffc-4342-bead-6e8c67d93cee">1,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:RestructuringReserveCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTAtMS0xLTEtODU0Mjc_8bd2af25-02e5-4089-8f45-d26f9b618178">6,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:RestructuringReserveCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTAtMy0xLTEtODU0Mjc_53825f10-d99f-4c5f-9fa4-634417b64ed3">664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="icui:UnfavorablecontractliabilityST" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTItMS0xLTEtODU0Mjc_75289167-c1a9-4c9e-9734-4da69fc21e7d">35,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="icui:UnfavorablecontractliabilityST" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTItMy0xLTEtODU0Mjc_ac124ed1-915a-480e-9b3d-8a0f11dcdf32">12,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="icui:Accruedothertaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTMtMS0xLTEtODU0Mjc_dc054986-acf2-482d-b615-c19fe63f9c11">2,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="icui:Accruedothertaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTMtMy0xLTEtODU0Mjc_7fc309cb-1b61-4ad5-8987-ccd36de56277">4,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTQtMS0xLTEtODU0Mjc_d0ebf7a3-8953-40b2-81cf-12096e306f61">10,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTQtMy0xLTEtODU0Mjc_b9ea10f3-8b78-46d2-8e7d-55d2a64c8797">773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="icui:Accruedlegalfees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTUtMS0xLTEtODU0Mjc_9648d2d7-be76-489a-a65e-3883087de61c">3,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="icui:Accruedlegalfees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTUtMy0xLTEtODU0Mjc_10f01306-8381-44dd-9009-6905302ffe02">3,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="icui:Outsidesalescommissions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTctMS0xLTEtODU0Mjc_a207d9cf-6a97-4cf1-89c1-29051227e7b3">24,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="icui:Outsidesalescommissions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTctMy0xLTEtODU0Mjc_d9ef8980-dfd2-4ccb-aa57-e759253a2acb">5,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties and returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTgtMS0xLTEtODU0Mjc_04d03e67-af05-4f42-872c-e24462c1634e">546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTgtMy0xLTEtODU0Mjc_878619fd-e527-4de6-9128-cac05b3abd4f">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Field service corrective action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="icui:FieldServiceCorrectiveAction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTktMS0xLTEtODkzMzQ_8f652722-92d9-4a0c-967c-0b50bf9c1cb7">30,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="icui:FieldServiceCorrectiveAction" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTktMy0xLTEtODkzNDE_f088af30-f578-46cb-b61d-802d4ddd11a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued freight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="icui:Accruedfreight" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTktMS0xLTEtODU0Mjc_46bb5272-38eb-4107-bdbb-a907ff9b0cf6">10,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="icui:Accruedfreight" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTktMy0xLTEtODU0Mjc_72da726c-6a70-45d5-a62d-164901cae0d5">9,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a3de3a660434987a7100fcd8c1caebb_I20220630" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjAtMS0xLTEtODU0Mjc_f4f95ea3-2943-4ad8-8d77-87fb23f97708">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9d9c289f8a048eb84ce2a838b84d175_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjAtMy0xLTEtODU0Mjc_6c2991f5-eceb-454c-8ca1-365f8c7c8a8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued audit fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="icui:AccruedAuditFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjUtMS0xLTEtODU0Mjc_2c9913a5-49d4-4196-a56a-2f02d5394020">4,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="icui:AccruedAuditFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjUtMy0xLTEtODU0Mjc_dcdc3c7c-ec8a-4aaf-beb7-0bd411491ed3">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjYtMS0xLTEtODU0Mjc_e1e2992d-931c-4642-ba36-386cca5100ff">3,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjYtMy0xLTEtODU0Mjc_5f04ac5f-0228-467e-b3a1-8fef2a2025d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjgtMS0xLTEtODU0Mjc_089a8133-7eba-4824-a973-49f99a3d940c">13,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjgtMy0xLTEtODU0Mjc_231b9f19-7290-43fe-85c2-81b44add115e">8,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjktMS0xLTEtODU0Mjc_f2ce828b-f124-4902-8c4c-fc0cff3596e1">247,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjktMy0xLTEtODU0Mjc_5dd80f2b-124e-426c-bd75-38abf93be11b">118,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to field corrective actions associated with certain products in connection with a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities consist of the following (in thousands):&#160;</span></div></ix:continuation></ix:continuation><div style="margin-bottom:3pt;margin-top:5pt"><ix:continuation id="ifac79d28f8c84a80940942684a22b4f8"><ix:continuation id="ib08cf3f3f34d45c0adbbcb061cda4661"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-LT</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMy0xLTEtMS04NTQyNw_ca971f34-7214-420d-9acf-71afec674763">68,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMy0zLTEtMS04NTQyNw_baa0e60f-b3b1-4457-8fa9-c7c52dd586b4">33,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfNC0xLTEtMS04NTQyNw_d2079ab1-ede6-4af3-aab2-1b99be1d0b0b">6,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfNC0zLTEtMS04NTQyNw_cd2bbb70-0b03-42cf-84e5-7d01a6c91a53">1,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:AccruedRentCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfNS0xLTEtMS04NTQyNw_07d73171-dc97-4582-b883-a981da04bbee">1,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:AccruedRentCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfNS0zLTEtMS04NTQyNw_f245c805-6624-4ead-ac50-ff789d46c604">1,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="icui:Liabilitiesforcontracts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfNi0xLTEtMS04NTQyNw_9c603903-b23e-4aaa-a33f-b62c3814594b">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="icui:Liabilitiesforcontracts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfNi0zLTEtMS04NTQyNw_c1a78960-2d43-4990-a609-4944eecf1a4c">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfNy0xLTEtMS04NTQyNw_9bde889c-c6e8-4204-b9b6-199e602ebc6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfNy0zLTEtMS04NTQyNw_7a2d7342-eaa1-4a62-94bd-0aa91e2f44af">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a3de3a660434987a7100fcd8c1caebb_I20220630" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfOC0xLTEtMS04NTQyNw_9d6f5745-6eb1-4b47-9d66-04ca620e6410">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9d9c289f8a048eb84ce2a838b84d175_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfOC0zLTEtMS04NTQyNw_e4fc7f6b-96bf-46a7-a1c1-b5f9f2139519">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liability-LT</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTAtMS0xLTEtODU0Mjc_a664205b-1956-403e-a406-ebc3021ad337">1,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTAtMy0xLTEtODU0Mjc_9989cbd6-9475-4d65-874a-537adc857142">2,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTEtMS0xLTEtODU0Mjc_529825f5-15db-4010-924e-a7a4a9316193">23,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTEtMy0xLTEtODU0Mjc_e73b865c-c9a1-42de-b21c-a42ff67281e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Field service corrective action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c13faab0ca94890afab0dfa9adc50c3_I20220630" decimals="-3" name="us-gaap:ProductLiabilityAccrualComponentAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTItMS0xLTEtODU0Mjc_031e48c6-60c6-41db-ac74-bbc4e0ddd707">23,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c9f9c254834c91bccad9081f3bec3e_I20211231" decimals="-3" name="us-gaap:ProductLiabilityAccrualComponentAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTItMy0xLTEtODU0Mjc_25fbae9f-465d-41d0-996c-3e47bb0dc160">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTMtMS0xLTEtODU0Mjc_abe4ed5b-8596-4ca7-af28-e9ed681de079">3,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTMtMy0xLTEtODU0Mjc_55b63ad2-ac9d-47e5-9c15-2aee913487ff">1,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTQtMS0xLTEtODU0Mjc_a4482248-d083-4556-ba3c-355e939b64c7">128,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTQtMy0xLTEtODU0Mjc_95bfdade-0b69-4b71-abba-44821dd85fb0">41,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consists of contracts with customers and suppliers that were valued at below market at the time of the Hospira Infusion Systems acquisition.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to field corrective actions associated with certain products in connection with a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i10abb94289aa46ab94dfc506ddec4961_79"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 16:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfMTE1OA_1d228ae2-2366-409e-bdb1-49c1a776ab6e" continuedAt="i2fd610d507c94c69be9d3c7f4458264a" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i2fd610d507c94c69be9d3c7f4458264a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes were accrued at an estimated effective tax rate of <ix:nonFraction unitRef="number" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfOTU_4c3a1811-0c1b-45ae-b0b9-7dde86daa98b">56</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNTQ5NzU1ODE1MjEx_a2e65db0-ed70-4822-a338-529d5f3401cb">36</ix:nonFraction>% for the three and six months ended June 30, 2022, respectively, as compared to <ix:nonFraction unitRef="number" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNTQ5NzU1ODE1MjAy_6695ef59-32dc-4517-ad1a-0d3cdea18ff4">18</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNTQ5NzU1ODE1MjA3_425e6787-4273-4b8f-86fd-87a9c496f624">16</ix:nonFraction>% for the three and six months ended June 30, 2021, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective tax rate for the three and six months ended June 30, 2022 differs from the federal statutory rate of <ix:nonFraction unitRef="number" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="2" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfMjU1_bfaba7a5-8155-4ffe-846b-4c02d0f3d78c">21</ix:nonFraction>% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, section 162(m) excess compensation, foreign-derived intangible income ("FDII") and tax credits and the following discrete items recognized during the interim period:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the three and six months ended June 30, 2022 of $<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNjY2_2baef5d1-57c0-4fa1-a017-28e8fef29075">0.0&#160;million</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNTQ5NzU1ODE1NTky_7b56b771-21f1-4369-8f3f-a1d140d17c70">2.6</ix:nonFraction>&#160;million, respectively. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The revaluation of the contingent consideration during the three and six months ended June 30, 2022 resulted in a tax expense of $<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-6" name="icui:ContingentConsiderationTaxExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNTQ5NzU1ODE1NjA2_c2ca3e46-53ce-4577-a413-93656158aa92">0.0&#160;million</ix:nonFraction>  and $<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-6" name="icui:ContingentConsiderationTaxExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNTQ5NzU1ODE1NjIw_219b32ca-d504-4da0-884b-34d7731108fd">0.0&#160;million</ix:nonFraction>, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective tax rate for the three and six months ended June 30, 2021 differs from the federal statutory rate of <ix:nonFraction unitRef="number" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="2" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNzU4_b848f603-32bb-442f-b277-f547181fd798">21</ix:nonFraction>% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, global intangible low taxed income ("GILTI"), FDII and tax credits. The effective tax rate during the three and six months ended June 30, 2021 included a discrete tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfMTAyNg_34a30ed3-fb41-4bc6-bae9-6044cccfefca">0.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="INF" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNTQ5NzU1ODE1NjMz_7428be21-3964-4cd1-85da-64dc2caebf8c">2.2</ix:nonFraction> million, respectively, related to excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the period.</span></div></ix:continuation><div><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 17:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTEyMTg_c1aeb66d-7be0-4bc1-b0e6-f46a2be82c8e" continuedAt="i85c8103143d0485f94c114a818fa122e" escape="true">Long-Term Debt</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i85c8103143d0485f94c114a818fa122e" continuedAt="iaace82384fa445deaa1a257e18091894"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Credit Agreement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, in connection with the acquisition of Smiths Medical, we entered into a Credit Agreement (the "Credit Agreement") with Wells Fargo Bank, National Association, Wells Fargo Securities, LLC, Barclays Bank PLC and certain other financial institutions (the &#8220;Lenders&#8221;) for $<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-6" name="icui:TotalSeniorSecuredCreditFacility" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMzQy_8150f52e-8608-45d5-9437-4a6a60641d90">2.2</ix:nonFraction>&#160;billion of senior secured credit facilities. The senior secured credit facilities include (i) a five-year Tranche A term loan of $<ix:nonFraction unitRef="usd" contextRef="if2172b4c33734723af96689c9f9c83cf_D20220401-20220630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNDY2_15b73261-c8b3-4f70-8447-88fe6407e0b0">850.0</ix:nonFraction>&#160;million (the "Term Loan A"), (ii) a seven-year Tranche B term loan of $<ix:nonFraction unitRef="usd" contextRef="i820c1b83d10b4a7caf83661d1ff3d33f_D20220401-20220630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNTMx_9c6b579c-9f57-4828-8d1e-5449a419ab9f">850.0</ix:nonFraction>&#160;million (the "Term Loan B") and (iii) a five-year revolving credit facility of $<ix:nonFraction unitRef="usd" contextRef="ia65456c188d34d4daf133f0f0dbc3e2c_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNjA1_7b10cca1-0b24-44a4-a951-c25062128b5b">500.0</ix:nonFraction>&#160;million (the "Revolving Credit Facility"), with separate sub-limits of $<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-6" name="icui:RevolverSubLimits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNjcx_49f4bf64-0cf5-469d-9aff-b2d056c008a4">50.0</ix:nonFraction>&#160;million for letters of credit and swingline loans (collectively, the "Senior Secured Credit Facilities"). We used the proceeds from borrowings under the Term Loan A and the Term Loan B (collectively, the "Term Loans") to fund a portion of the cash consideration for the purchase of Smiths Medical and the related fees and expenses incurred in connection with the acquisition. We did not incur borrowings under the Revolving Credit Facility on the closing date of the acquisition. The proceeds from any future borrowings under the Revolving Credit Facility may be used for working capital and other general corporate purposes.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with entering into the Credit Agreement, during the period ended March 31, 2022, we incurred $<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTQwMA_c54ab961-a40f-4547-ac0e-0f4fed82d4d2">37.8</ix:nonFraction> million in debt discount and issuance costs, which were allocated to the Term Loan A, the Term Loan B and the Revolving Credit Facility based on lender commitment amounts relative to each type of fees paid. The lender and third-party discount and issuance costs allocated to the Term Loan A and the Term Loan B were $<ix:nonFraction unitRef="usd" contextRef="ie48f38dcedd64e93a8ecf7ac063f60b0_I20220630" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTcxMQ_25b4c3c8-2cf1-4862-8733-48114ab073e0">15.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia442a59e504b4b4cbe247d028ddb1705_I20220630" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTcxOA_0df23a68-a475-4d34-9c41-3e77faf8d78f">13.4</ix:nonFraction> million, respectively, and are reflected as a direct deduction from the face amount of the corresponding term loans on the condensed consolidated balance sheet. These costs are being amortized to interest expense over the respective terms of the loans using the effective interest method. The issuance costs allocated to the Revolving Credit Facility were $<ix:nonFraction unitRef="usd" contextRef="ia65456c188d34d4daf133f0f0dbc3e2c_I20220630" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMjA2OQ_2bfa6b2e-a403-4417-a184-2421796b440a">8.7</ix:nonFraction> million, which are capitalized and included in prepaid expenses and other current assets and other assets on our condensed consolidated balance sheets. These costs are being amortized to interest expense over the term of the Revolving Credit Facility using the straight-line method. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net funds received from the Term Loan A and the Term Loan B, after deducting debt issuance costs, were $<ix:nonFraction unitRef="usd" contextRef="ie48f38dcedd64e93a8ecf7ac063f60b0_I20220630" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMjQ1Ng_89845ddc-8036-4f7a-b359-366ce67174c3">834.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia442a59e504b4b4cbe247d028ddb1705_I20220630" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMjQ2Mw_52d18140-fd01-4edd-b088-afa47c5f1858">836.6</ix:nonFraction> million, respectively.   </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity Dates</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity date for the Term Loan A and the Revolving Credit Facility is <ix:nonNumeric contextRef="if2172b4c33734723af96689c9f9c83cf_D20220401-20220630" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMjU3Ng_70b6091b-384f-4b06-88c3-59f9b8d87c57">January 6, 2027</ix:nonNumeric>, and the maturity date for the Term Loan B is <ix:nonNumeric contextRef="i820c1b83d10b4a7caf83661d1ff3d33f_D20220401-20220630" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMjYyNQ_be6194e0-cb2f-463a-b424-07e46c38532c">January 6, 2029</ix:nonNumeric>. Pursuant to the terms and conditions of the Credit Agreement, the maturity dates of the Term Loans and the Revolving Credit Facility may be extended upon our request, subject to the consent of the Lenders.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Terms</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="iaace82384fa445deaa1a257e18091894" continuedAt="iaa297b28d0084233ba9891db2236f79d"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, the Term Loans and borrowings under the Revolving Credit Facility denominated in U.S. dollars bear interest, at our option, on either: (1) the Base Rate, as defined below, plus the applicable margin, as indicated below ("Base Rate Loans") or (2) the Adjusted Term Secured Overnight Financing Rate ("Adjusted Term SOFR"), as defined below, plus the applicable margin, as indicated below ("Term SOFR Loans"). </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Base Rate is defined as the highest of (a) the Prime Rate, (b) the Federal Funds Rate plus <ix:nonFraction unitRef="number" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="3" name="icui:InterestPercentageAddedToFederalFundsRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMzM3Mw_a2733144-32b1-43f6-9b9a-670f946745a5">0.50</ix:nonFraction>% and (c) Adjusted Term SOFR (as defined below) for a one-month period plus, in each case, plus <ix:nonFraction unitRef="number" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="2" name="icui:InterestPercentageAddedToBaseRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMzQ3MA_76ce62dd-614a-4b43-ae29-acbb21e90b50">1.00</ix:nonFraction>%.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted Term SOFR is the rate per annum equal to (a) Term SOFR plus (b) the Term SOFR Adjustment. Term SOFR is the forward-looking term rate based on SOFR and is calculated separately for Term SOFR Loans and Base Rate Loans, as specified in the Credit Agreement. The Term SOFR Adjustment is a percentage per annum of <ix:nonFraction unitRef="number" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="3" name="icui:TerSOFRInterestRateAdjustmentForBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMzc5Mw_3d1f16ce-1a3e-43fa-95f9-aeea13c6e0a0">0.10</ix:nonFraction>% for Base Rate Loans and between <ix:nonFraction unitRef="number" contextRef="i097d704989b14390b8eebff2668fa80d_I20220630" decimals="3" name="icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMzgyOA_bbd19091-f886-4120-b64f-cec97041a52e">0.10</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i8dc422a484844921bbf2f8fbbb10898d_I20220630" decimals="8" name="icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMzgzNA_3e2df748-d959-4f9e-b1cc-426b4de948e3">0.25</ix:nonFraction>% for Term SOFR Loans based on the applicable interest period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility Commitment Fee</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility has a per annum commitment fee at an initial rate of <ix:nonFraction unitRef="number" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNDAyNA_94549f73-ce87-41b3-939b-08f4ad834ed5">0.25</ix:nonFraction>% which is applied to the available amount of the Revolving Credit Facility. Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the commitment fee will be determined by reference to the leverage ratio in effect from time to time as set forth in the table below.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Applicable Interest Margins</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan A and borrowings under the Revolving Credit Facility have an initial applicable margin of <ix:nonFraction unitRef="number" contextRef="ie48f38dcedd64e93a8ecf7ac063f60b0_I20220630" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNDUwNA_d14a41c4-d608-4c5f-b5c6-b8842cfa891e">0.75</ix:nonFraction>% per annum for Base Rate Loans and <ix:nonFraction unitRef="number" contextRef="ie48f38dcedd64e93a8ecf7ac063f60b0_I20220630" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNDU0MQ_760dbe1f-b2a7-4253-bf65-b7c33fb318b7">1.75</ix:nonFraction>% per annum for Term SOFR Loans.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" name="icui:ApplicableMarginBasedOnLeverageRatioTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTEyMTY_fec935eb-c540-40f2-99cf-051ab3a051cc" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan A and borrowings under the Revolving Credit Facility will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitment Fee Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 4.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7b85afc4ff3d4a5092568e3fb7e051d8_I20220630" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMS0xLTEtMS04NTQyNw_ba6fc87e-960b-498c-9cbb-d8e89be846ec">2.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7b85afc4ff3d4a5092568e3fb7e051d8_I20220630" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMS0yLTEtMS04NTQyNw_eb616616-a237-4f22-b7af-7fc3051347c3">1.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0a39638d60794625b2a97bb8ccf76e08_D20220401-20220630" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMS0zLTEtMS04NTQyNw_bd66293a-e9c6-45a7-96d0-bfb6ad61c2e6">0.35</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 4.00 to 1.0 but greater than 3.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if4fa2d7effb948959c4419141b81fa27_I20220630" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMi0xLTEtMS04NTQyNw_818ec3a1-de54-4448-948a-699381786476">2.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if4fa2d7effb948959c4419141b81fa27_I20220630" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMi0yLTEtMS04NTQyNw_9fe011d0-7e97-4e31-acc4-5b1c328166ee">1.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i01fc89ab55b9471e88acff5bc284c6d9_D20220401-20220630" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMi0zLTEtMS04NTQyNw_3648758b-049c-4e06-9d30-904ca71a2f01">0.30</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 3.00 to 1.0 but greater than 2.50 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibdfa16b6f741491d8b6775ba1b22da74_I20220630" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMy0xLTEtMS04NTQyNw_294a234b-8abf-4112-af52-699e564f9551">1.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibdfa16b6f741491d8b6775ba1b22da74_I20220630" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMy0yLTEtMS04NTQyNw_94530512-8286-4378-8272-ce52ae671cc6">0.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i29510191d44e477fa81d72fe9d21c1ec_D20220401-20220630" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMy0zLTEtMS04NTQyNw_17b03dd3-6d91-46a6-9db1-7752d1ef19d9">0.25</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.50 to 1.0 but greater than 2.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c9d6aabc294426da5585018b63ccb2f_I20220630" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfNC0xLTEtMS04NTQyNw_e94d2214-4780-48cb-88cb-671418e198e8">1.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c9d6aabc294426da5585018b63ccb2f_I20220630" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfNC0yLTEtMS04NTQyNw_a2c96333-eb6e-4c3a-a2a6-0c010c710bbc">0.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6e79efd88abe4a75b2c34f56667180b3_D20220401-20220630" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfNC0zLTEtMS04NTQyNw_5969109d-f9e2-4160-b5f9-f7461edcbe98">0.20</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e5ce3e367bf4ebf8d8b4d98965dedbc_I20220630" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfNS0xLTEtMS04NTQyNw_716e3912-004b-4a73-85c0-a66bd1a4a108">1.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e5ce3e367bf4ebf8d8b4d98965dedbc_I20220630" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfNS0yLTEtMS04NTQyNw_146af6bc-9740-4799-840f-2c3904eab6f3">0.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i62429302fe0f4afea07772eb2f1866ae_D20220401-20220630" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfNS0zLTEtMS04NTQyNw_115e65e5-fe66-4e7d-9a61-0b66087849e0">0.15</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan B has an initial applicable margin of <ix:nonFraction unitRef="number" contextRef="ia442a59e504b4b4cbe247d028ddb1705_I20220630" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNDk3OQ_09e7349c-cb20-4f5d-9bf3-d014319c0c96">1.5</ix:nonFraction>% per annum for Base Rate Loans and <ix:nonFraction unitRef="number" contextRef="ia442a59e504b4b4cbe247d028ddb1705_I20220630" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNTAxNg_22111f49-cc4d-4c11-94f1-97d18c39d4cd">2.5</ix:nonFraction>% per annum for Term SOFR Loans.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan B will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: </span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.368%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.667%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 2.75 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide283ac530ac4b1781126c399a2552b9_I20220630" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmZhODU1MTM0NTZkNDRkYjNiNjYzZWU5ZmUzZTA3NTM4L3RhYmxlcmFuZ2U6ZmE4NTUxMzQ1NmQ0NGRiM2I2NjNlZTlmZTNlMDc1MzhfMS0xLTEtMS04NTQyNw_32c670bb-b6ff-4fcb-8a53-174fc02dbbdd">2.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide283ac530ac4b1781126c399a2552b9_I20220630" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmZhODU1MTM0NTZkNDRkYjNiNjYzZWU5ZmUzZTA3NTM4L3RhYmxlcmFuZ2U6ZmE4NTUxMzQ1NmQ0NGRiM2I2NjNlZTlmZTNlMDc1MzhfMS0yLTEtMS04NTQyNw_fd3cabed-08eb-4ab6-9a1c-f557615e8698">1.50</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.75 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibb1d7ec7e4a44aabae7ac85788f5014f_I20220630" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmZhODU1MTM0NTZkNDRkYjNiNjYzZWU5ZmUzZTA3NTM4L3RhYmxlcmFuZ2U6ZmE4NTUxMzQ1NmQ0NGRiM2I2NjNlZTlmZTNlMDc1MzhfMi0xLTEtMS04NTQyNw_c4add4ba-f822-4d17-b84e-5cc7659f9680">2.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibb1d7ec7e4a44aabae7ac85788f5014f_I20220630" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmZhODU1MTM0NTZkNDRkYjNiNjYzZWU5ZmUzZTA3NTM4L3RhYmxlcmFuZ2U6ZmE4NTUxMzQ1NmQ0NGRiM2I2NjNlZTlmZTNlMDc1MzhfMi0yLTEtMS04NTQyNw_ba11b3ad-8291-4f36-ac63-ae0d23b21770">1.25</ix:nonFraction>%</span></td></tr></table></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="iaa297b28d0084233ba9891db2236f79d" continuedAt="idac376d4631444938527276576fb535e"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principal Payments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on the Term Loans are due on the last day of each calendar quarter commencing on June 30, 2022. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan A will amortize in nineteen consecutive quarterly installments in an amount equal to <ix:nonFraction unitRef="number" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="3" name="icui:TermAPrincipalPaymentFirst2Years" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNTU4Nw_69b20dcf-18c5-4b50-8503-4a4d2c770dc8">2.50</ix:nonFraction>% of the original principal amount in each of the first two years, <ix:nonFraction unitRef="number" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="8" name="icui:TermAPrincipalPaymentYear3And4" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNTY1NQ_f272e64a-187d-466c-aa7f-1d8e28ac8e82">5.00</ix:nonFraction>% in each of the third and fourth years and <ix:nonFraction unitRef="number" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="3" name="icui:TermAPrincipalPaymentInYear5" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNTcwMA_c5bafebc-4ae0-4191-a9c6-2ccd0d35e466">7.50</ix:nonFraction>% in the fifth year, with a final payment of the remaining outstanding principal balance due on the maturity date.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan B matures in twenty-seven consecutive quarterly installments in an amount equal to <ix:nonFraction unitRef="number" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="4" name="icui:TermLoanBPrincipalPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNTkxNg_477bc12a-7130-440a-af2f-40a20754418b">0.25</ix:nonFraction>% of the original principal amount, with a final payment of the remaining outstanding principal balance due on the maturity date.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may borrow, prepay and re-borrow amounts under the Revolving Credit Facility, in accordance with the terms and conditions of the Credit Agreement, with all outstanding amounts due at maturity. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2022, we prepaid $<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="INF" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNjI3Ng_b4902df5-2911-42f0-96bc-cdde93acc154">16.0</ix:nonFraction> million in principal payments on the Term Loan A principal balance. During 2022, we paid $<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="INF" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNTQ5NzU1ODI1MTky_bb0fad0b-4aac-4eda-8442-3dd7d5f25bfc">18.1</ix:nonFraction>&#160;million in principal payments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Payments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest payments on Base Rate Loans are payable quarterly in arrears on the last business day of each calendar quarter and the applicable maturity date. Interest periods on Term SOFR Loans will be determined, at our option, as either one, three or six months and will be payable on the last day of each interest period and the applicable maturity date. In the case of any interest periods of more than three months' duration, the interest payment will be payable on each day prior to the last day of such interest period that occurs at three-month intervals.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commitment fee on the Revolving Credit Facility is payable quarterly in arrears on the third business day following the last day of each calendar quarter and at the maturity date. The commitment fee is included in interest expense in our condensed consolidated statements of operations.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantors and Collateral</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Credit Agreement are unconditionally guaranteed, on a joint and several basis, by ICU Medical, Inc. and certain of our existing subsidiaries. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Covenants</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains affirmative and negative covenants, including certain financial covenants. The negative covenants include restrictions regarding the incurrence of liens and indebtedness, certain merger and acquisition transactions, asset sales and other dispositions, other investments, dividends, share purchases and payments affecting subsidiaries, changes in nature of business, fiscal year or organizational documents, prepayments and redemptions of subordinated and other junior debt, transactions with affiliates, and other matters.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenants include the Senior Secured Leverage Ratio and the Interest Coverage Ratio, both defined below, and pertain to the Term Loan A and the Revolving Credit Facility.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Secured Leverage Ratio is defined, at any such date, as the ratio of: (a) all Funded Debt, as defined in the Credit Agreement, that is secured by a lien on any asset or property minus the lesser of (i) all unrestricted cash and cash equivalents and (ii) $<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-6" name="icui:LeverageRatioCalculationCeilingSubtractedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfODQzMQ_3ba9313c-c3f3-4f76-b6d4-62c61378cb6a">500.0</ix:nonFraction>&#160;million, to (b) Consolidated EBITDA, as defined in the Credit Agreement, for the most recently completed four fiscal quarters, calculated on a pro forma basis. The maximum Senior Secured Leverage Ratio is 4.50 to 1.00 until June 30, 2024. Thereafter, the maximum Senior Secured Leverage Ratio is 4.00 to 1.00, with limited permitted exception.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Interest Coverage ratio is defined, at any such date, as the ratio of Consolidated EBITDA, as defined in the Credit Agreement, to Consolidated Interest Expense, as defined in the Credit Agreement, paid or payable in cash, for the most recently completed four fiscal quarters. The minimum Interest Coverage ratio is 3.00 to 1.00.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were in compliance with all financial covenants as of June 30, 2022.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="idac376d4631444938527276576fb535e" continuedAt="i89a6e7bbd29b4179993353a920e37f79"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary events of default, including, among others: non-payments of principal and interest; breach of representations and warranties; covenant defaults; cross-defaults and cross-acceleration to certain other material indebtedness; the existence of bankruptcy or insolvency proceedings; certain events under ERISA; material judgments; and a change of control. If an event of default occurs and is not cured within any applicable grace period or is not waived, the administrative agent and the Lenders are entitled to take various actions, including, without limitation, the acceleration of all amounts due and the termination of commitments under the Senior Secured Credit Facilities.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2017 Credit Facility</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On November 8, 2017, we entered into a five-year senior secured revolving credit facility with various lenders for $<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTAwMjM_24a5ce42-ecce-44d0-b826-4263dea430b1">150.0</ix:nonFraction> million, with Wells Fargo Bank, National Association as the administrative agent, swingline lender and issuing lender (the "Prior Credit Facility"). The Prior Credit Facility, which was set to mature on <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:LineOfCreditFacilityExpirationDate1" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTAyMjE_f3d25aba-e3ae-45b1-aafe-f2a3e2e7b786">November 8, 2022</ix:nonNumeric>, was terminated in connection with entering into the Credit Agreement on January 6, 2022. There were <ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-5" name="us-gaap:LinesOfCreditCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTAzMjU_9ffe22f3-1f03-4bfb-92ac-b672002b0df5">no</ix:nonFraction> borrowings outstanding under the Prior Credit Facility at that date or at December 31, 2021. The remaining unamortized deferred debt issuance costs related to the Prior Credit Facility were not material and were expensed in connection with its termination. See further details of the terms of the Prior Credit Facility in Note 11 in Part II, Item 8, of our 2021 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTEyMTk_b3d28366-a286-4a77-96e2-55c670c21abb" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of our long-term debt consist of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2172b4c33734723af96689c9f9c83cf_D20220401-20220630" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfMy0xLTEtMS04NTQyNw_0ff6f663-085a-4a30-aae6-64fcef8b333b">4.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie48f38dcedd64e93a8ecf7ac063f60b0_I20220630" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfMy0zLTEtMS04NTQyNw_a43afa48-0df7-4865-9137-2d2db1236e58">834,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B &#8212; principal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i820c1b83d10b4a7caf83661d1ff3d33f_D20220401-20220630" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfNC0xLTEtMS04NTQyNw_ff261258-2a79-49e9-9810-829ffc5ffb6c">5.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia442a59e504b4b4cbe247d028ddb1705_I20220630" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfNC0zLTEtMS04NTQyNw_c1ef7f4c-3258-41f0-b08d-7ef7c3f68532">847,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48afd3427c1e42f6ad2d86e852ef64dd_D20220401-20220630" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfNS0xLTEtMS04NTQyNw_248e22c6-ce2d-4b6d-8306-ed779ad53a56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfNS0zLTEtMS04NTQyNw_a87e90ff-ac56-4d91-9adf-521da5b114af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less unamortized debt issuance costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="INF" sign="-" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfNi0zLTEtMS04NTQyNw_c616994c-ff47-4490-9d2d-af11f614ba40">26,783</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying value of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfNy0zLTEtMS04NTQyNw_940e9ab0-a0e3-40f1-882e-39e383241dc2">1,655,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfOC0zLTEtMS04NTQyNw_6cf8bf78-a1dd-46c2-a044-116ff1271564">19,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfOS0zLTEtMS04NTQyNw_3ec42bb6-8661-4b8b-a6a5-55bea01e8161">1,636,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprised of $<ix:nonFraction unitRef="usd" contextRef="ie48f38dcedd64e93a8ecf7ac063f60b0_I20220630" decimals="INF" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTA4NTQ_7844b893-e96b-40e4-8d92-c25ef0ab919a">14.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia442a59e504b4b4cbe247d028ddb1705_I20220630" decimals="INF" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTA4NjE_387bcf2b-8a63-4ffc-afb3-2d805541834d">12.6</ix:nonFraction> million relating to the Term Loan A and the Term Loan B, respectively.</span></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTEyMjA_10e87473-6b16-4517-b3e9-4d02b9aeb552" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years is approximately (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjcxZWU1Y2Q1OGQ3OTRhMjhhMWU3OTA0Y2I1NjBjZDdmL3RhYmxlcmFuZ2U6NzFlZTVjZDU4ZDc5NGEyOGExZTc5MDRjYjU2MGNkN2ZfMC0yLTEtMS04NTQyNw_27e6766d-caab-483e-a98f-8ca2d0c0db59">4,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjcxZWU1Y2Q1OGQ3OTRhMjhhMWU3OTA0Y2I1NjBjZDdmL3RhYmxlcmFuZ2U6NzFlZTVjZDU4ZDc5NGEyOGExZTc5MDRjYjU2MGNkN2ZfMS0yLTEtMS04NTQyNw_14124301-0dbe-418d-b5b0-fec236558c62">29,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjcxZWU1Y2Q1OGQ3OTRhMjhhMWU3OTA0Y2I1NjBjZDdmL3RhYmxlcmFuZ2U6NzFlZTVjZDU4ZDc5NGEyOGExZTc5MDRjYjU2MGNkN2ZfMi0yLTEtMS04NTQyNw_34bcba54-38c2-4f69-bd38-02bcb208dbbe">51,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjcxZWU1Y2Q1OGQ3OTRhMjhhMWU3OTA0Y2I1NjBjZDdmL3RhYmxlcmFuZ2U6NzFlZTVjZDU4ZDc5NGEyOGExZTc5MDRjYjU2MGNkN2ZfMy0yLTEtMS04NTQyNw_d39b71ac-f44e-4582-a9f1-284bc79cb4f2">51,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjcxZWU1Y2Q1OGQ3OTRhMjhhMWU3OTA0Y2I1NjBjZDdmL3RhYmxlcmFuZ2U6NzFlZTVjZDU4ZDc5NGEyOGExZTc5MDRjYjU2MGNkN2ZfNC0yLTEtMS04NTQyNw_7554ab8f-f074-4a5e-9b1e-596d0d772568">72,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjcxZWU1Y2Q1OGQ3OTRhMjhhMWU3OTA0Y2I1NjBjZDdmL3RhYmxlcmFuZ2U6NzFlZTVjZDU4ZDc5NGEyOGExZTc5MDRjYjU2MGNkN2ZfNS0yLTEtMS04NTQyNw_3938cff8-c1f7-4b5e-a6d5-9c5d6ea14419">672,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjcxZWU1Y2Q1OGQ3OTRhMjhhMWU3OTA0Y2I1NjBjZDdmL3RhYmxlcmFuZ2U6NzFlZTVjZDU4ZDc5NGEyOGExZTc5MDRjYjU2MGNkN2ZfNi0yLTEtMS04NTQyNw_8baaa94d-7f90-4c09-88e3-e342b515d333">801,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjcxZWU1Y2Q1OGQ3OTRhMjhhMWU3OTA0Y2I1NjBjZDdmL3RhYmxlcmFuZ2U6NzFlZTVjZDU4ZDc5NGEyOGExZTc5MDRjYjU2MGNkN2ZfNy0yLTEtMS04NTQyNw_4a7e149f-c026-4a8b-841e-cf2ff5505bb1">1,681,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" name="icui:InterestExpenseOnLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTEyMjE_c1b669e9-7c3a-42a1-8877-f6a44c32d9af" continuedAt="i708b710a58dc485483479d15992677c2" escape="true">The following table presents the total interest expense related to our long-term debt (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div style="text-align:center;text-indent:36pt"><ix:continuation id="i89a6e7bbd29b4179993353a920e37f79"><ix:continuation id="i708b710a58dc485483479d15992677c2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.841%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="INF" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfMi0xLTEtMS04NTQyNw_20a6b7be-fe96-4c1c-b205-f82aabccba04">12,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="INF" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfMi0zLTEtMS04NTQyNw_c2712dbf-8178-45e1-801e-10df7ef2be5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="INF" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfMi01LTEtMS05MDY5OQ_cb015bd2-0424-46c0-b9bf-6310d521c279">22,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="INF" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfMi03LTEtMS05MDcwMQ_36a0823c-ef0e-4db2-9c5a-ebee40e4a323">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="INF" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfMy0xLTEtMS04NTQyNw_5f3f03ec-0d59-4090-8da9-8772cbf0f64a">1,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="INF" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfMy0zLTEtMS04NTQyNw_4a993c5a-5547-45e0-8737-87a2d2d04fdf">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="INF" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfMy01LTEtMS05MDY5OQ_75ce2444-d929-4e0d-a3bd-df1ae9eec38d">3,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="INF" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfMy03LTEtMS05MDcwMQ_bc516713-db13-4dd5-9b12-346c4e11c391">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment fee &#8212; Revolving Credit Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfNC0xLTEtMS04NTQyNw_28d0c906-4a54-4bae-9908-f770a28f2c5e">309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfNC0zLTEtMS04NTQyNw_0fe95e2c-ef1e-4adc-8aa2-849142005236">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfNC01LTEtMS05MDY5OQ_52db7c3d-5a22-4321-b290-9697d1f96697">661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfNC03LTEtMS05MDcwMQ_19bc84c0-8206-45ae-ada2-7c72c71ab167">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="INF" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfNS0xLTEtMS04NTQyNw_b9749117-cd01-465f-8d0c-3a0c52440613">14,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="INF" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfNS0zLTEtMS04NTQyNw_6835b97e-ef73-4c50-bed6-e43355f5fff5">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="INF" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfNS01LTEtMS05MDY5OQ_6a261ab4-fa4f-4698-b52e-31bba9b93431">26,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="INF" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfNS03LTEtMS05MDcwMQ_d4dbac2d-2380-43e9-a6a2-212376d73228">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i10abb94289aa46ab94dfc506ddec4961_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 18:  <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMjU3MQ_064e5992-7fd8-407a-9c73-7ebe0829ab87" continuedAt="i5af61844770a4bfbaa814a321d043df5" escape="true">Stockholders' Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5af61844770a4bfbaa814a321d043df5" continuedAt="i0745bbdb39c54c01b1926a00f7397d49"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shareholders Agreement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the completion of the Smiths Medical acquisition on January 6, 2022, Smiths owns approximately <ix:nonFraction unitRef="number" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="3" name="icui:SmithsGroupOwnershipAcquisitionSharesIssued" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMTU5_3ba3451a-9f3f-404b-b5af-83c7cca80753">10.5</ix:nonFraction>% of the total outstanding shares of our common stock (see Note 3: Acquisitions). At closing, in connection with the issuance of the share consideration, we entered into a Shareholders Agreement (the &#8220;Shareholders Agreement&#8221;) with Smiths. The Shareholders Agreement imposes certain restrictions on Smiths including prohibiting certain transfers of the shares of our common stock issued (i) for 6 months following the closing of the acquisition transaction and (ii) to certain of our competitors and certain other parties, as well as customary standstill limitations. The Shareholders Agreement also permits Smiths to designate one individual for election to our Board of Directors (the "Board") so long as Smiths beneficially owns at least <ix:nonFraction unitRef="number" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="2" name="icui:SmithsGroupOwnershipRequiredForBoardRepresentation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfOTAw_7551cc34-5171-4c69-9711-2e1b0c8a98eb">5.0</ix:nonFraction>% of the total outstanding shares of our common stock. On February 1, 2022, our Board appointed a new director designated by Smiths pursuant to the Shareholders Agreement who was elected to the Board at the 2022 Annual Meeting of Stockholders held in May 2022. This appointment expands the size of our Board from eight to nine members. See our Current Report on Form 8-K filed on February 1, 2022 for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In August 2019, our Board approved a share purchase plan to purchase up to $<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-5" name="icui:TreasuryStockPurchasePlan" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMTQzNw_ce51ef44-eb62-4ffd-87d1-e80ab9412700">100.0</ix:nonFraction> million of our common stock. This plan has no expiration date. During the three months ended June&#160;30, 2022, we did not purchase any shares of our common stock under our share purchase plan. As of June&#160;30, 2022, all of the $<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMTYzMg_aa18a873-382b-42ae-b071-4349dbf815a2">100.0</ix:nonFraction> million available for purchase was remaining under the plan. We are currently limited on share purchases in accordance with the terms and conditions of our Credit Agreement (see Note 17: Long-Term Debt).  </span></div><div><span><br/></span></div><div><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2022, we withheld <ix:nonFraction unitRef="shares" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="0" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMTg3OA_16a4b4a3-d9de-4147-b2f8-7e464fe2da4c">44,759</ix:nonFraction> shares of our common stock from employee vested restricted stock units in consideration for $<ix:nonFraction unitRef="usd" contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMTk3Mw_5185850d-62e2-41cb-a415-8b78cc9af5c3">10.4</ix:nonFraction> million in payments made on the employees' behalf for their minimum statutory income tax withholding obligations. For the three months ended June 30, 2021, we withheld&#160;<ix:nonFraction unitRef="shares" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="0" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMjEzNw_35115d75-393d-41cf-8f4c-13962d970831">37,882</ix:nonFraction>&#160;shares of our common stock from employee vested restricted stock units in consideration for&#160;$<ix:nonFraction unitRef="usd" contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMjIzMg_b37749a9-8a3f-4648-80b3-f9a5b8e1a939">7.8</ix:nonFraction> million&#160;in payments made on the employees' behalf for their minimum statutory income tax withholding obligations. Treasury stock is used to issue shares for stock option exercises and restricted stock grants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive (Loss) Income ("AOCI")</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMjU3Mw_f9f5dfcf-242b-46d0-b9bd-58d1dfdb92d5" continuedAt="ic4128caed6ea4393ac2482eed918eed0" escape="true">The components of AOCI, net of tax, were as follows (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i0745bbdb39c54c01b1926a00f7397d49"><ix:continuation id="ic4128caed6ea4393ac2482eed918eed0"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:39.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Losses) Gains on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94b17ce1db9045be81548ad59c39078e_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMS0yLTEtMS04NTQyNw_33e194d9-50aa-4a70-8e82-eeeafdcabaf5">19,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic864df7a10e243439b16f94f4d8947a7_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMS00LTEtMS04NTQyNw_040443a9-dbdf-489e-ae83-b03f6b932f64">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i978540de7dd847ba96e233480ca7d760_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMS02LTEtMS04NTQyNw_25662bbe-9f1d-4a85-8b3b-0665f29add15">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMS04LTEtMS04NTQyNw_5cf4edbc-65fd-4e2d-9c02-cdf30b6e0158">19,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia45c28b3f1cc4a4d9f0add866a4154b7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMi0yLTEtMS04NTQyNw_652ccae8-2e28-459c-ad7f-87e060a67e96">4,946</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i326812ecd5b9421880949758af6f0760_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMi00LTEtMS04NTQyNw_c4e69c81-489f-4f7a-86dd-4b22b8aacde7">25,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99dcd7880d44918a4d5f088ad265d59_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMi02LTEtMS04NTQyNw_5a767ad2-399e-4139-a97b-528ffad4a7b2">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMi04LTEtMS04NTQyNw_dc5da14a-687e-4f6b-b1a3-7185a383fb2b">20,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia45c28b3f1cc4a4d9f0add866a4154b7_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMy0yLTEtMS04NTQyNw_2a3e57c5-50a4-4665-badc-93aa3624b64c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i326812ecd5b9421880949758af6f0760_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMy00LTEtMS04NTQyNw_7612f292-fbbb-4959-8222-8f0b519ee0aa">2,210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99dcd7880d44918a4d5f088ad265d59_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMy02LTEtMS04NTQyNw_9dec038b-7074-4de9-8fbb-7541f823fcd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMy04LTEtMS04NTQyNw_37508c63-fbed-4e0f-bb85-dbcef6a7b817">2,210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia45c28b3f1cc4a4d9f0add866a4154b7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNC0yLTEtMS04NTQyNw_5d28e9d0-8969-498a-bec3-db6cca47a5e8">4,946</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i326812ecd5b9421880949758af6f0760_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNC00LTEtMS04NTQyNw_85fd53bb-8a47-4236-91a1-ee4d242f9a27">23,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99dcd7880d44918a4d5f088ad265d59_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNC02LTEtMS04NTQyNw_9ee47c82-40f1-42e8-ad4f-5afb6073e569">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNC04LTEtMS04NTQyNw_ae75081d-75ce-465e-92e7-30c37c0183b1">18,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58bf8064282948fe8016498a02b9e92e_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNS0yLTEtMS04NTQyNw_d17a7ba6-97b9-464b-9554-6a415a9a99c4">23,991</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29830fec1151487f84613c8fe2e23f62_I20220331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNS00LTEtMS04NTQyNw_1a5f33d2-4fca-4f1a-8ede-57667ce6b14e">23,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f62f6e8b1f049a2bfc7cd1ba2c8c6b7_I20220331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNS02LTEtMS04NTQyNw_622ebef8-abc9-4921-b425-77a730c25f2f">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f22c3698eff4a70b949d07786441335_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNS04LTEtMS04NTQyNw_52698cb0-e0bc-4b2f-afd9-49ae38504887">628</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8b148239611411ab103bf9e35a00370_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNi0yLTEtMS04NTQyNw_6dd00515-5051-4187-886e-aced9276ce8b">99,805</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9a33f79f91d4f94880ad5f50170dd8b_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNi00LTEtMS04NTQyNw_71ff4f33-f6ce-4753-9a85-7358e52581ff">10,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b67f1e6ebf44f4920d2e1c7a980457_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNi02LTEtMS04NTQyNw_ffc34b5d-9a3a-4417-90b7-64c8707c6531">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNi04LTEtMS04NTQyNw_03783155-7927-4fff-9be7-8099b5d33940">89,546</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8b148239611411ab103bf9e35a00370_D20220401-20220630" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNy0yLTEtMS04NTQyNw_19a6ebe7-b6e3-4132-b55d-b80b80337db7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9a33f79f91d4f94880ad5f50170dd8b_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNy00LTEtMS04NTQyNw_5fbe8457-9955-48fa-b763-5ff7ce3018f1">2,101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b67f1e6ebf44f4920d2e1c7a980457_D20220401-20220630" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNy02LTEtMS04NTQyNw_fed5a645-44c3-4b76-8e97-51f5864eb355">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNy04LTEtMS04NTQyNw_d9a4b104-fa3d-4645-bc6a-6dd5c5c8ddaf">2,101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8b148239611411ab103bf9e35a00370_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfOC0yLTEtMS04NTQyNw_afd36e96-791c-47a9-8ae8-2705f14be4f3">99,805</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9a33f79f91d4f94880ad5f50170dd8b_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfOC00LTEtMS04NTQyNw_4e8b4374-77eb-4a58-99b7-c60f1ca49158">8,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b67f1e6ebf44f4920d2e1c7a980457_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfOC02LTEtMS04NTQyNw_a4a7540c-3ed0-4d4c-af49-83e79b4d92b7">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfOC04LTEtMS04NTQyNw_c037c06b-dac1-4813-8377-c405d11e0889">91,647</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idffc4822f1e84243b7a821f4b832cdb0_I20220630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfOS0yLTEtMS04NTQyNw_2e62bc29-abc2-428b-a660-d503b237f673">123,796</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb27df1c81b4fe5815f7411937625c3_I20220630" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfOS00LTEtMS04NTQyNw_00538b09-228f-441d-926a-119061e6b1e0">31,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7c25e7ac474113b90c767b63e9973b_I20220630" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfOS02LTEtMS04NTQyNw_bce7e787-2960-480e-be66-1dacdbacb2c3">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfOS04LTEtMS04NTQyNw_2a46420e-708b-44d1-adc2-8c442e14b7e0">92,275</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:39.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26135335385b4c188e9fa42192dd9586_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMS0yLTEtMS04NTQyNw_a643e7c6-1623-4c02-b6bf-dbce41c3964e">4,381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3003d8cd4355481fbc735d083ddbdec1_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMS00LTEtMS04NTQyNw_9a19cf57-ed96-4d24-b0b9-4f386ad64a48">2,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i327a4bd08003426f90e1ed91e3bc0365_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMS02LTEtMS04NTQyNw_1964efce-5412-424a-8637-fd4c5a733716">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21594db97b18415da81085ad86be9dbe_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMS04LTEtMS04NTQyNw_33b2aa97-6698-46d0-b222-ae64f48c802e">1,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6236b35e282a499d9e7335ded3b1511a_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMi0yLTEtMS04NTQyNw_d5fc80d1-c38f-4fbb-b6cb-bda515a8ec1a">7,458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i381b31d9849d4793b208bb77bd5696f5_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMi00LTEtMS04NTQyNw_a04f04bc-485c-4285-ac16-79879854d4bb">306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id987a884b9304292b23dd52b1a4a527a_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMi02LTEtMS04NTQyNw_35c35f42-1cb4-4775-ab9c-aedbf09f6065">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic01f9f53437648c6a182b99958017af1_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMi04LTEtMS04NTQyNw_8f323550-b815-4378-b8fc-59c32a8a7044">7,752</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6236b35e282a499d9e7335ded3b1511a_D20210101-20210331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMy0yLTEtMS04NTQyNw_bac55f08-cfb1-4d27-9ebe-29cf208c47b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i381b31d9849d4793b208bb77bd5696f5_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMy00LTEtMS04NTQyNw_679c8393-310c-40d9-9b54-a9de7de7ab35">639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id987a884b9304292b23dd52b1a4a527a_D20210101-20210331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMy02LTEtMS04NTQyNw_6542be94-0c3c-41b8-8e6a-87d63edbee03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic01f9f53437648c6a182b99958017af1_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMy04LTEtMS04NTQyNw_dba280c1-f8bf-4848-8df0-b24df5aec882">639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6236b35e282a499d9e7335ded3b1511a_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNC0yLTEtMS04NTQyNw_177ac799-5e49-4f54-b75b-e250e326b654">7,458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i381b31d9849d4793b208bb77bd5696f5_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNC00LTEtMS04NTQyNw_ed1297b8-5324-4cf4-a4b1-0ce8a10ac1e7">945</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id987a884b9304292b23dd52b1a4a527a_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNC02LTEtMS04NTQyNw_777dd57f-7104-4e41-85ce-33040f3ba4bd">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic01f9f53437648c6a182b99958017af1_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNC04LTEtMS04NTQyNw_5e25ea97-71d8-4ff7-a2e9-2b79fe716ec6">8,391</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88f2c0cc386c4a87970c9caa95befd39_I20210331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNS0yLTEtMS04NTQyNw_e5f5da85-2356-467c-904c-04ebe0a614ca">11,839</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d062c01630e4345ab1b152378e6a45f_I20210331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNS00LTEtMS04NTQyNw_83e4d816-15ed-43d7-b958-209a291fe4f9">1,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i368b376abe90453ca246cd3e38e97a22_I20210331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNS02LTEtMS04NTQyNw_4e27ae33-72c3-4336-a14b-38055d5a2f46">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5a196eec7194c459ffcb870a785ba8d_I20210331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNS04LTEtMS04NTQyNw_fb60afbc-c612-4326-b687-d715c2e97460">9,913</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c58f1374874b18a884724db405192e_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNi0yLTEtMS04NTQyNw_24033b1c-f34b-4c51-b311-89750c38e2d6">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b7fcd5651cc4fba8ada251f0eae1319_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNi00LTEtMS04NTQyNw_9898fb1b-dd5c-413d-9dd5-d8c2e0ce6c6d">335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00701bb034dc42d893efa54ca1dd9b8e_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNi02LTEtMS04NTQyNw_5a7a4111-ecaf-4f4e-b4ce-e37b945d38ce">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNi04LTEtMS04NTQyNw_e7413cf8-cc21-4750-a939-a7be35ef2b59">1,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c58f1374874b18a884724db405192e_D20210401-20210630" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNy0yLTEtMS04NTQyNw_47fc4246-dbdb-41a8-8295-ef2a24534ffe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b7fcd5651cc4fba8ada251f0eae1319_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNy00LTEtMS04NTQyNw_b7452041-1147-4f0a-bbb0-761f3fbc370e">687</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00701bb034dc42d893efa54ca1dd9b8e_D20210401-20210630" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNy02LTEtMS04NTQyNw_41018484-3d31-4a60-a728-583c90ad553a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNy04LTEtMS04NTQyNw_1c680565-45b1-47ca-b05f-3660cdcb32e7">687</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c58f1374874b18a884724db405192e_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfOC0yLTEtMS04NTQyNw_ecd03846-863f-40f2-9a24-4ffa5a895a60">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b7fcd5651cc4fba8ada251f0eae1319_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfOC00LTEtMS04NTQyNw_8d61207d-ed9a-4270-a759-f7f4153bb3fe">352</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00701bb034dc42d893efa54ca1dd9b8e_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfOC02LTEtMS04NTQyNw_8b5d106f-b95f-4454-b345-888544a8fa57">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfOC04LTEtMS04NTQyNw_d7abf986-a38d-4bef-9d58-727619bfe49d">962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i106e9ee178e6436f90b29d6557dfb488_I20210630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfOS0yLTEtMS04NTQyNw_4cc79863-9c17-455f-a4d6-b9eb3fbc17e2">10,537</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71a8aaadf61b4f2d8e906baa19a20857_I20210630" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfOS00LTEtMS04NTQyNw_a1806930-d7a0-4281-87b8-89baa5ae0768">1,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3789fe01ab44e98e7b6e29e62a089e_I20210630" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfOS02LTEtMS04NTQyNw_f6c0ea5c-fb6b-44a4-8892-ae3af8c2e866">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55063029c0d44ea78a93faf80c101754_I20210630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfOS04LTEtMS04NTQyNw_31a989fc-ca9d-46c1-89fa-53dd63768659">8,951</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i10abb94289aa46ab94dfc506ddec4961_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 19:  <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMzcyMg_8b890ff8-cf42-4f04-9c42-a160e79cb394" continuedAt="ia872725a815448d49c76127426a2003c" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia872725a815448d49c76127426a2003c" continuedAt="i6af24e0e0a4e43d9a0372f45eed4782f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are involved in various legal proceedings, most of which are routine litigation, in the normal course of business.&#160;Our management does not believe that the resolution of the unsettled legal proceedings that we are involved with will have a material adverse impact on our financial position or results of operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, we have agreed to indemnify our officers and directors to the maximum extent permitted under Delaware law and to indemnify customers as to certain intellectual property matters or other matters related to sales of our products.&#160;There is no maximum limit on the indemnification that may be required under these agreements.&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we can provide no assurances, we have never incurred, nor do we expect to incur, any material liability for indemnification.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired Smiths Medical. Total consideration for the acquisition includes a potential earn-out payment of $<ix:nonFraction unitRef="usd" contextRef="id5289794172a4cb198e8aa0169b4c3b2_D20220401-20220630" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMTA3NA_5d874618-c177-409f-b3a7-9e7c511c5ee6">100.0</ix:nonFraction>&#160;million in cash contingent on our common stock achieving a certain volume-weighted average price from </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i6af24e0e0a4e43d9a0372f45eed4782f" continuedAt="i090184c921e64afda18b4233832e7be9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the closing date to either the third or fourth anniversary of closing. As of June&#160;30, 2022, the estimated fair value of the contingent earn-out is $<ix:nonFraction unitRef="usd" contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630" decimals="-4" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMTMwNw_af084cc9-4db6-4961-8165-906776438284">26.1</ix:nonFraction>&#160;million (see Note 9: Fair Value Measurements).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to being acquired, during 2021, Smiths Medical received a Warning Letter from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility. The Warning Letter cited, among other things, failures to comply with FDA's medical device reporting requirements and failures to comply with applicable portions of the Quality System Regulation. A provision for the estimated costs related to the field service corrective action was recorded on the opening acquired balance sheet of Smiths Medical in the amount of $<ix:nonFraction unitRef="usd" contextRef="i86d81cabd26944f7aa9415595f6e5c33_I20220106" decimals="-5" name="us-gaap:ProductLiabilityAccrualComponentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMTg4MA_0d523905-8425-4b34-8479-46b12e24a534">55.1</ix:nonFraction>&#160;million. The initial estimate recorded was based on a probability-weighted estimate of the costs required to settle the obligation. The actual costs to be incurred are dependent upon the scope of the work necessary to achieve regulatory clearance and could differ from the original estimate. The estimated field service corrective action recorded at June 30, 2022 is $<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-5" name="us-gaap:ProductLiabilityAccrualComponentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMjI0Mw_ed1af346-a09f-4783-8f1e-4de9280aceea">53.9</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $<ix:nonFraction unitRef="usd" contextRef="i0c90af4126704fd9b931fd425c90445a_D20220401-20220630" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMjQxMg_5a79a3f8-13cb-4654-85e5-c8f2e6855e1a">2.5</ix:nonFraction>&#160;million, consisting of (i) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-6" name="icui:ContingentConsiderationGrossST" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMjQ1Mg_e11c2465-591e-4be3-ba41-0d286e2ad80b">1.0</ix:nonFraction>&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630" decimals="-5" name="icui:ContingentConsiderationGrossLT" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMjU5OQ_2ad7215c-461e-4a00-afc2-fbb04adb836f">1.5</ix:nonFraction>&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of June&#160;30, 2022, the estimated fair value of the contingent earn-out is $<ix:nonFraction unitRef="usd" contextRef="i2f9761d9634c46b781358f8378ab19ae_I20220630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMjc1Nw_0dc0dd9d-ff86-4803-a543-19ada674413d">1.7</ix:nonFraction>&#160;million (see Note 9: Fair Value Measurements).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out shall not exceed $<ix:nonFraction unitRef="usd" contextRef="i4b3ce23df5e4479c839dc97cc6e1b807_D20220101-20220630" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMzEzMQ_31d58ff8-ebbc-438d-a2e0-ef0a7b55ad53">6.0</ix:nonFraction>&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of June&#160;30, 2022, the estimated fair value of the contingent earn-out is $<ix:nonFraction unitRef="usd" contextRef="i68ee0370a4e34ec2b3cd2a4b34eed398_I20220630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMzUxOA_34ffa419-d8cc-4d5f-b2f8-179bbcc3cbcf">2.6</ix:nonFraction>&#160;million (see Note 9: Fair Value Measurements).</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="i090184c921e64afda18b4233832e7be9" continuedAt="i2e1034ed56774ce2aa2684eef886cfae">&#160;&#160;&#160;&#160;</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2e1034ed56774ce2aa2684eef886cfae">We have non-cancelable operating lease agreements where we are contractually obligated to pay certain lease payment amounts (see Note 6: Leases).</ix:continuation> </span></div><div><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 20:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV85MS9mcmFnOmVkMjBiYTUyOGYwYjQ4NjVhZWEzMGM4Y2ZiYzBhODQ1L3RleHRyZWdpb246ZWQyMGJhNTI4ZjBiNDg2NWFlYTMwYzhjZmJjMGE4NDVfMTk1MA_49cace45-ff53-4a79-bc0d-f08ec014bb98" continuedAt="i7b3fe98de04b4538804379e5b964c9ff" escape="true">Collaborative and Other Arrangements</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7b3fe98de04b4538804379e5b964c9ff">&#160;&#160;&#160;&#160;On February 3, 2017, we entered into two Manufacturing and Supply Agreements ("MSAs") whereby (i) Pfizer will manufacture and supply us with certain agreed upon products for an initial five-year term with a one-time two-year option to extend and (ii) we will manufacture and supply Pfizer certain agreed upon products for a term of five or ten years depending on the product, also with a one-time two-year option to extend. The MSAs provide each party with mutually beneficial interests and both of the MSAs are to be jointly managed by both Pfizer and ICU. The initial supply price, which will be annually updated, is in full consideration for all costs associated with the manufacture, documentation, packaging and certification of the products. On January 1, 2021, we amended our MSA with Pfizer, whereby we manufacture and supply certain agreed upon products to Pfizer. The amendments included a change to the term of the agreement to end on December 31, 2024 with Pfizer's unilateral election to extend through December 31, 2025. Other changes to the terms of the MSA included (i) amendments to our level of supply of products to Pfizer, (ii) certain changes to our manufacturing lines, (iii) updates to our supply price with added volume price tiers for annual periods and (iv) certain minimum purchase requirements for certain products. On February 1, 2022, effective as of January 1, 2022, upon our request, Pfizer executed a Product Addendum (the "Product Addendum") to our MSA, whereby Pfizer manufactures and supplies to us certain agreed upon products. The Product Addendum includes the supply of additional product to us subject to certain time and pricing terms and conditions. The Product Addendum includes a minimum purchase obligation of $<ix:nonFraction unitRef="usd" contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630" decimals="-5" name="us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV85MS9mcmFnOmVkMjBiYTUyOGYwYjQ4NjVhZWEzMGM4Y2ZiYzBhODQ1L3RleHRyZWdpb246ZWQyMGJhNTI4ZjBiNDg2NWFlYTMwYzhjZmJjMGE4NDVfMTgxMA_17adff83-5a9b-47a4-99b2-a8145a52859e">29.6</ix:nonFraction>&#160;million and expires on November 30, 2022. As of March 31, 2022, we had satisfied the minimum purchase obligations under the Product Addendum.</ix:continuation> </span></div><div><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_94"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 2.  Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following information should be read in conjunction with the condensed consolidated financial statements and accompanying notes in this Form 10-Q, as well as the audited consolidated financial statements and related notes for the fiscal year ended December 31, 2021 included in our Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;When used in this report, the terms &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to ICU Medical, Inc. ("ICU") and its subsidiaries included in our condensed consolidated financial statements unless context requires otherwise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Developments</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022 we completed the acquisition of Smiths Medical 2020 Limited ("Smiths Medical"), the holding company of Smiths Group plc's global medical device business. See "Acquisitions" below for additional detail regarding the acquisition transaction. Smiths Medical is engaged in the development, manufacture and sale of syringe and ambulatory infusion devices, vascular access, and vital care products used in hospital, emergency, home and alternative care settings. Our acquisition of Smiths Medical was strategic and increases our focus and scale in infusion therapy globally which we believe will enhance our competitive position as a leader within the industry.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combination of ICU and Smiths Medical brings together two highly complementary product portfolios to create a comprehensive range of offerings utilized in the infusion therapy care continuum. Our existing product portfolio includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needlefree connectors designed to help meet clinical, safety and workflow goals. In addition, we manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for preparing and administering hazardous IV drugs, and cardiac monitoring systems for critically ill patients. The acquisition of Smiths Medical broadened our product portfolio to include syringe and ambulatory pumps, peripheral IV catheters, fluid warming and respiratory devices, silicone and PVC tracheotomy tubes, among other products. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Smiths Medical acquisition, we are initially presenting the following product lines in addition to our legacy product lines: Infusion Systems-Smiths Medical, Vascular Access-Smiths Medical and Vital Care-Smiths Medical. See "Products" in the remainder of this item for a list of our primary products included in each line. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary customers are acute care hospitals, wholesalers, ambulatory clinics and alternate site facilities, such as clinics, home health care providers and long-term care facilities. With the addition of Smiths Medical we sell our products in more than 90 countries throughout the world.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information is additional to and not a substitute for the Business section under Part I, Item 1 of our Annual Report on Form 10-K for the year ended December 31, 2021 and should be read in conjunction with that filing:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Manufacturing Changes</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the acquisition of the Smiths Medical business, we now operate additional manufacturing facilities including five facilities in the United States ("U.S."), two facilities in Mexico and two in the UK, and one facility in the Czech Republic, Italy and China.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Service Centers</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the acquisition of the Smiths Medical business, we now operate additional service and repair facilities in the U.S., Canada, two locations in Europe and four locations in Asia. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distribution Changes</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Smiths Medical acquisition, we operate two additional main distribution centers, one in the U.S. supporting the Americas and International and one in the Netherlands mainly supporting EMEA. We have a further eleven smaller distribution centers globally three of which are in the U.S., two centers in EMEA and China, and one center in Canada, the U.K., Japan and India.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Competition Changes</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Infusion Systems product line of Smiths Medical competes with many of the same competitors as those referenced in Part I, Item 1. "Business" of our 2021 Annual Report on Form 10-K as well as additional competitors such as Moog Medical and Fresenius.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Vascular Access product line of Smiths Medical competes with many of the same competitors as those referenced in Part I, Item 1. "Business" of our 2021 Annual Report on Form 10-K as well as additional competitors such Angio Dynamics, Greiner Bio-One, and Teleflex Incorporated. Our ability to remain competitive in this market will depend on our ability to focus on demonstrable patient outcomes by differentiating our products by improving device functionality and by providing successful customer training programs on the use and maintenance of our products. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Vital Care product line of Smiths Medical competes with numerous competitors due to its wide range of business. Those include multinational competitors such as Medtronic and Philips Healthcare as well as smaller more focused competitors such as Belmont and Intersurgical plc. Our ability to compete in this market will depend on our ability to continue to make technological advances to our products, thereby increasing customer efficiency and by providing product support that improves clinical decision-making that ultimately enhances patient safety.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, our primary product offerings by product line are listed below. We have presented our financial results in accordance with these product lines: </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Consumables</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Infusion therapy sets, used in hospitals and ambulatory clinics, consist of a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient&#8217;s vein, that may or may not be used with an IV pump.&#160; Our primary Infusion Consumable products are:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Clave&#8482; needlefree products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including the MicroClave, MicroClave Clear, and NanoClave&#8482; brand of connectors, accessories, extension and administration sets used for the administration of IV fluids and medications and the Neutron catheter patency device, used to help maintain patency of central venous catheters;</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">SwabCap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and SwabTip disinfecting caps, used to protect and disinfect any needlefree connector, including competitive brands of connectors, and male luers; </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">ClearGuard HD </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">antimicrobial barrier caps for hemodialysis catheters; and</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Tego</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hemodialysis connector used to cap and protect hemodialysis central venous catheter hubs.</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Closed System Transfer Devices ("CSTD") and hazardous drug compounding systems</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are used to prepare and deliver hazardous IV medications such as those used in chemotherapy, which, if released, can have harmful effects on the healthcare worker and environment.&#160;Our products are:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">ChemoLock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CSTD, which utilizes a proprietary needlefree connection method, is used for the preparation and administration of hazardous drugs. ChemoLock is used to limit the escape of hazardous drug or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury;</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">ChemoClave</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an ISO Connection standard and universally compatible CSTD used for the preparation and administration of hazardous drugs. ChemoClave utilizes standard ISO luer locking connections, making it compatible with all brands of needlefree connectors and pump delivery systems. ChemoClave also is used to limit the escape of hazardous drug or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminate the risk of needlestick injury; and</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Diana</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hazardous drug compounding system, an automated sterile compounding system that incorporates ChemoClave and ChemoLock CSTD consumables and IV workflow technology for the accurate, safe, and efficient preparation of hazardous drugs. It is a user-controlled automated system that provides repeatable accuracy of drug mixes and minimizes clinician exposure to hazardous drugs while helping to maintain the sterility of the drugs being mixed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of hazardous drugs typically takes place in a pharmacy where drugs are removed from vials and prepared for delivery to a patient. Those prepared drugs are then transferred to a nursing unit where the chemotherapy is administered via an infusion pump set to a patient. Components of the ChemoClave and ChemoLock product lines are used both in pharmacies and on the nursing floors for the preparation and administration of hazardous drugs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Systems</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We offer a wide range of infusion pumps, dedicated IV sets, software and professional services. Our primary Infusion System products are dedicated IV sets and the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Infusion Pump Hardware:</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Plum 360&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plum 360&#8482; infusion pump is an ICU Medical MedNet&#8482; ready large volume infusion pump with an extensive drug library and wireless capability. Plum 360 was named the 2018, 2019 and 2020 Best in KLAS winner as top-performing IV smart pump and was the first medical device to be awarded UL Cybersecurity Assurance Program Certification. Also, in 2021 and 2022, the Plum 360 won the award as the top-performing Smart Pump EMR-Integrated; and</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">LifeCare PCA&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The LifeCare PCA infusion pump is an ICU Medical MedNet&#8482; ready patient-controlled analgesia pump ("PCA"), providing complete IV Electronic Health Record ("IV-EHR") interoperability since 2016.</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV Medication Safety Software:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">ICU Medical MedNet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482;: ICU Medical MedNet is an enterprise-class medication management platform for any sized healthcare system that can help reduce medication errors, improve quality of care, streamline workflows and maximize revenue capture. ICU Medical MedNet connects our industry-leading smart pumps to a hospital&#8217;s EHR, asset tracking systems, and alarm notification platforms with the largest array of integration partners. </span></div><div style="padding-left:72pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Professional Services: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In addition to the products above, our teams of clinical, information technology, and professional services experts work with customers to develop and deliver safe and efficient infusion systems, providing customized and personalized configuration, implementation, and data analytics services to complement our infusion hardware and software.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IV Solutions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We provide a broad portfolio of IV solutions to meet our customers&#8217; clinical needs, providing a consistent supply of IV solutions, irrigation, and nutritionals to help provide safe and effective patient care. Our primary IV Solutions products are:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;IV Therapy and Diluents:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Including Sodium Chloride, Dextrose, Balanced Electrolyte Solutions, Lactated Ringer's, Ringer's, Mannitol, Sodium Chloride/Dextrose and Sterile Water.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Irrigation:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Including Sodium Chloride Irrigation, Sterile Water Irrigation, Physiologic Solutions, Ringer's Irrigation, Acetic Acid Irrigation, Glycine Irrigation, Sorbitol-Mannitol Irrigation, Flexible Containers and Pour Bottle Options.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Care</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our Critical Care products help clinicians get accurate real-time access to patients&#8217; hemodynamic and cardiac status with an extensive portfolio of monitoring systems and advanced sensors &amp; catheters.&#160;Measurements provided by our systems help clinicians determine how well the heart is pumping blood and how efficiently oxygen from the blood is being used by the tissues. Our primary Critical Care products are:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cogent&#8482; 2-in-1 hemodynamic monitoring system;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">CardioFlo&#8482; hemodynamic monitoring system;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">TDQ&#8482; and OptiQ&#8482; cardiac output monitoring catheters;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">TriOx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">venous oximetry catheters;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Transpac&#8482; blood pressure transducers; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SafeSet&#8482; closed blood sampling and conservation system.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Systems-Smiths Medical </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer a wide range of infusion pumps, disposables and safety software for use in both hospital and home settings. These products participate in adjacent categories to the legacy ICU Medical Infusion Systems segment. The primary Infusion Systems-Smith Medical products are:</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ambulatory Infusion Hardware:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">CADD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ambulatory infusion pumps and disposables, including administration sets and medication cassette reservoirs, support a variety of IV pain management therapies across clinical care areas from hospital to outpatient treatment. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Syringe Infusion Hardware:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Medfusion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> syringe infusion pumps are designed for the administration of fluids and medication requiring precisely controlled infusion rates from a variety of syringe sizes in acute care settings. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Infusion Software:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:14.5pt">PharmGuard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> Medication Safety Software</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Medfusion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4000 syringe and CADD&#8482; Solis pumps allows for customized drug libraries to support the standardization of protocols for medication administration throughout the facility. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vascular Access-Smiths Medical</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Vascular Access-Smiths Medical products allow clinicians to safely access the patients' bloodstream to deliver fluids and medication or to obtain blood samples. Vascular Access products are often used in conjunction with Consumables and Infusion Systems devices. Our primary Vascular Access products are:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Jelco</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> safety and conventional peripheral IV catheters, sharps safety devices for hypodermic injection, and venipuncture blood collection and peripheral IV catheters designed to help prevent needlestick injury and to reduce the risks associated with blood exposure and contamination while reducing patients' risk of infection;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">DELTEC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">implantable ports and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GRIPPER</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> non-coring needles for portal access; </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Portex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> arterial blood sampling syringes, anesthesia trays and kits for pain management;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13.8pt">Powerwand</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> midline catheters; and</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13.8pt">MEDEX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> LogiCal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pressure Monitoring System and components.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vital Care-Smiths Medical</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer a range of devices and systems to maintain patients' airways and maintain body temperature before, during and after surgery. Our primary Vital Care products are:  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> temperature management systems used in perioperative and critical care settings to help monitor and regulate patient temperature through rapid infusion, routine blood and fluid warming, irrigation warming and convective warming.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Portex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">acapella</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> bronchial hygiene products used to mobilize pulmonary secretions to facilitate the opening of airways in patients with chronic respiratory diseases such as chronic obstructive pulmonary disease, or COPD, asthma and cystic fibrosis.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Portex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bivona</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tracheostomy tubes in PVC and silicone construction that provide a secure airway for both surgical and percutaneous procedures. Our silicone tracheostomy tubes are customizable to accommodate unique patient requirements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S. a substantial amount of our products are sold to group purchasing organization member hospitals. We believe that as healthcare providers continue to either consolidate or join major buying organizations, the success of our products will depend, in part, on our ability, either independently or through strategic relationships to secure long-term contracts with large healthcare providers and major buying organizations.&#160;Although we believe that we are not dependent on any single distributor, large healthcare provider or major buying organization for distribution of our products, the loss of a strategic relationship with any one of these organizations or a decline in the demand for our products could have a material adverse effect on our operating results.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that achievement of our growth objectives worldwide will require increased efforts by us in sales and marketing and product acquisition and development; however, there is no assurance that we will be successful in implementing our growth strategy. Product development or acquisition efforts may not succeed, and even if we do develop or acquire additional products, there is no assurance that we will achieve profitable sales of such products.&#160;Increased expenditures for sales and marketing and product acquisition and development may not yield desired results when expected, or at all.&#160;While we have taken steps to control these risks, there are certain risks that may be outside of our control, and there is no assurance that steps we have taken will succeed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality/Quarterly Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There are no significant seasonal aspects to our business. We can experience fluctuations in net sales as a result of variations in the ordering patterns of our largest customers, which may be driven more by the novel coronavirus and its variants (&#8220;COVID-19&#8221;) pandemic surges and its impact on hospital admissions and procedure volumes along with production scheduling and customer inventory levels, and less by seasonality.&#160;Our expenses often do not fluctuate in the same manner as net sales, which may cause fluctuations in operating income that are disproportionate to fluctuations in our revenue.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired 100% of the equity interests in Smiths Medical from Smiths Group International Holdings Limited (&#8220;Smiths&#8221;) for cash consideration of $1.9 billion and the issuance of 2.5 million shares of our common stock valued at $576.0 million. We funded the cash portion of the consideration paid with a combination of proceeds from a Credit Agreement dated January 6, 2022 (the "Credit Agreement") and our cash and cash equivalents. The fair value of the common shares issued to Smiths was determined based on the opening market price of our common stock on the acquisition date. Smiths may be entitled to a potential contingent earn-out payment of $100.0 million based on our common stock achieving certain price targets on or prior to the third or fourth anniversary of closing. See Note 3, Acquisitions in our accompanying condensed consolidated financial statements for further details on the acquisition. See "Liquidity and Capital Resources" in the remainder of this item and Note 17 in our accompanying condensed consolidated financial statements for additional information regarding the Credit Agreement.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">COVID-19</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;COVID-19 continues to have an impact on our business operations. Our manufacturing, distribution and pump service facilities continue to operate under our business continuity plan and our precautionary safety measures implemented to maximize the safety of our employees and mitigate disruption to our business remain in effect. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we continually monitor the ongoing and evolving impact of the effect of the COVID-19 pandemic on our operations the overall impact will not be fully reflected in our results of operations until future periods.&#160;The duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be fully predicted at this time, as such, the impact of the pandemic on our overall financial performance remain uncertain and cannot as yet be quantified. For discussion of the risks and uncertainties we face associated with the COVID-19 pandemic, see Part I, Item 1A. "Risk Factors" of our 2021 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We present income statement data in Part I, Item 1. "Financial Statements." The following table shows, for the three and six months ended June&#160;30, 2022 and 2021, the percentages of each income statement caption in relation to total revenue:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, strategic transaction and integration expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent earn-out</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit (provision) for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to comparing changes in revenue on a U.S. GAAP basis, we also compare the changes in revenue from one period to another using constant currency. We provide constant currency information to enhance the visibility of underlying business trends, excluding the effects of changes in foreign currency translation rates. To calculate our constant currency results, we apply the average exchange rate for revenues from the prior year to the current year results. These results should be considered in addition to, not as a substitute for, results reported in accordance with GAAP. Results on a constant currency basis, as we present them, may not be comparable to similarly titled measures used by other companies and are not measures of performance presented in accordance with GAAP.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Consumables</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes our total Infusion Consumables revenue (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Infusion Consumables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Infusion Consumables revenue increased for the three and six months ended June&#160;30, 2022, as compared to the same periods in the prior year, due to increased customer demand in our global core infusion, global oncology and renal products.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On a constant currency basis, Infusion Consumables revenue would have been $148.6 million, an increase of $12.4 million or 9.1% and $291.1 million, an increase of $28.5 million or 10.9%, for the three and six months ended June 30, 2022, respectively, as compared to the same periods in the prior year. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Systems</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes our total Infusion Systems revenue (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Infusion Systems</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Infusion Systems revenue increased for the three and six months ended June&#160;30, 2022, as compared to the same periods in the prior year, due to higher large volume pump ("LVP") dedicated set sales driven by larger install base of LVPs, offset partially by lower sales related to our non-LVP products. On a constant currency basis, Infusion Systems revenue would have been $90.0 million, an increase of $5.3 million or 6.3%, and $178.7 million, an increase of $9.7 million or 5.7%, for the three and six months ended June 30, 2022, respectively, as compared to the same periods in the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IV Solutions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total IV Solutions revenue (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IV Solutions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IV Solutions revenue increased for the three months ended June&#160;30, 2022, as compared to the same period in the prior year, primarily due to an increase in contract manufacturing sales to Pfizer. For the six months ended June 30, 2022, IV Solutions revenue was flat as compared to the same period in the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Care</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes our total Critical Care revenue (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Critical Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical Care revenue decreased slightly for the three and six months ended June&#160;30, 2022, as compared to the same periods in the prior year. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Systems-Smiths Medical</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes our total Infusion Systems-Smiths Medical revenue (in millions):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Infusion Systems-Smiths Medical</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">nm</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Infusion Systems-Smiths Medical revenue is a result of the acquisition of Smiths Medical. The year-to-date amount in the table above represents approximately six months of revenue from the closing date of the transaction to the end of the current quarter ended June 30, 2022. Revenues in the current periods are lower than historical results due to operational challenges caused by supply chain and fulfillment constraints.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vascular Access-Smiths Medical</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes our total Vascular Access revenue (in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vascular Access-Smiths Medical</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">nm</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Vascular Access-Smiths Medical revenue is a result of the acquisition of Smiths Medical. The year-to-date amount in the table above represents approximately six months of revenue from the closing date of the transaction to the end of the current quarter. Revenues in the current periods are lower than historical results due to operational challenges caused by supply chain and fulfillment constraints.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vital Care-Smiths Medical</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vital Care-Smiths Medical</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">nm</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Vital Care-Smiths Medical revenue is a result of the acquisition of Smiths Medical. The year-to-date amount in the table above represents approximately six months of revenue from the closing date of the transaction to the end of the current quarter. Revenues in the current periods are lower than historical results due to operational challenges caused by supply chain and fulfillment constraints.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Margins</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;For the three months ended June&#160;30, 2022 and 2021, gross margins were 29.9% and 38.4%, respectively. For the six months ended June&#160;30, 2022 and 2021, gross margins were 30.5% and 36.9%, respectively. The decrease in gross margins for the three and six months ended June 30, 2022, as compared to the same period in the prior year, was driven by the acquisition of Smiths Medical, inflationary cost increases in our supply chain, and lower manufacturing absorption due to supply chain disruptions. Smiths Medical gross margins are lower than historical ICU margins for the current quarter and year-to-date period due primarily to spending on quality systems and product-related remediation, the cost recognition of the purchase accounting write-up of inventory and freight costs. The inflationary cost increases during 2022 notably impacted our freight rates as well as, labor and materials costs. Partially offsetting the decreases to gross margins in the current periods was the impact from increased sales of higher margin consumables.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative (&#8220;SG&amp;A&#8221;) Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total SG&amp;A Expenses (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">312.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expenses increased for the three and six months&#160;ended June&#160;30, 2022, as compared to the same periods in the prior year. For the three and six months ended June 30, 2022, increases of $83.5 million and $156.3 million, respectively, was due to the impact of the Smiths Medical acquisition.  Expense increases related to Smiths Medical included, $28.1 million of salaries and benefits and $33.6 million of depreciation and amortization expense for the three months ended June 30, 2022 and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$56.2 million of salaries and benefits and $58.8 million of depreciation and amortization expense for the six months ended June 30, 2022. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development (&#8220;R&amp;D&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total R&amp;D Expenses (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&amp;D</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses increased for the three and six months ended June&#160;30, 2022, as compared to the same periods in the prior year primarily due to the acquisition of Smiths Medical. For the three and six months ended June 30, 2022, the increase included $9.3 million and $21.1 million, respectively, related to Smiths Medical R&amp;D expenses. R&amp;D expenses during both periods primarily relate to compensation and related benefit expenses on current R&amp;D projects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring, Strategic Transaction and Integration Expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, strategic transaction and integration expenses were $13.5 million and $47.4 million for the three and six months ended June 30, 2022, respectively, as compared to $3.8 million and $6.6 million for the three and six months ended June 30, 2021, respectively.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring charges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Restructuring charges were $1.7 million and $4.9 million for the three and six months ended June 30 2022, respectively,  and were related to severance costs. We expect to pay unpaid restructuring charges as of June 30, 2022 by the end of 2022. Restructuring charges were $0.1 million for both the three and six months ended June 30, 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strategic transaction and integration expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Strategic transaction and integration expenses were $11.8 million and $42.5 million for the three and six months ended June 30, 2022, respectively, as compared to $3.7 million and $6.5 million for the three and six months ended June 30, 2021, respectively. The strategic transaction and integration expenses during the three and six months ended June 30, 2022 were primarily related to our acquisition of Smiths Medical which primarily included legal expenses, bank fees and employee costs.The strategic transaction and integration expenses during the six months ended June 30, 2022 also included a United Kingdom stamp tax. The strategic transaction and integration expenses during the three and six months ended June 30, 2021 were primarily related to integration costs associated with acquisitions, the Hospira Infusion Systems ("HIS") earn-out dispute with Pfizer and one-time costs incurred to comply with regulatory initiatives.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Settlement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not incur contract settlement expense for the three and six months ended June 30, 2022. For the three and six months ended June 30, 2021, we recorded $0.1 million in contract settlement expense.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was $16.3 million and $0.2 million for the three months ended June 30, 2022 and 2021, respectively. Interest expense was $29.9 million and $0.3 million for the six months ended June 30, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the three and six months ended June 30, 2022 includes the contractual interest incurred on borrowings under the Credit Agreement, the per annum commitment fee charged on the available amount of the revolving credit facility contained in the Credit Agreement and the amortization of debt issuance costs incurred in connection with entering into the Credit Agreement (see Note 17: Long-Term Debt in our accompanying condensed consolidated financial statements for additional information). </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the three and six months ended June 30, 2021 includes the per annum commitment fee charged on the unused portion of the revolver under our 2017 Credit Facility (the "Prior Credit Facility") and the amortization of financing costs that were incurred in 2017 in connection with entering into the Prior Credit Facility. The Prior Credit Facility was terminated in connection with entering into the Credit Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other (expense) income netted to $(0.5) million and $0.5 million for the three and six months ended June 30, 2022, respectively, as compared to $0.5 million and $1.2 million for the three and six months ended June 30, 2021, respectively. For the three months ended June 30, 2022, other expense, net was related to $2.7 million in foreign exchange losses and $0.6 million of loss from disposed assets, mostly offset by $2.0 million of miscellaneous income and $0.8 million of interest income. For the six months ended June 30, 2022, other income, net was related to $2.6 million of miscellaneous income and $1.4 million of interest income, partially offset by $2.5 million in foreign exchange losses and $1.0 million of loss from disposed assets.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June 30, 2021, the other income, net was related to $0.7 million of interest income and $0.2 million of miscellaneous income, partially offset by $0.2 million in foreign exchange losses and $0.2 million of loss from disposed assets. For the six months ended June 30, 2021, the other income, net was related to $1.4 million of interest income, $0.4 million of miscellaneous income and $0.3 million in foreign exchange gains, partially offset by $0.8 million of loss from disposed assets. For the three months ended June 30, 2020, the other income, net was primarily related to $1.5 million in foreign exchange gains. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended June 30, 2022 and 2021, income taxes were accrued at an estimated effective tax rate of 56% and 18%, respectively. For the six months ended June 30, 2022 and 2021, income taxes were accrued at an estimated effective tax rate of 36% and 16%, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">                </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The effective tax rate for the three and six months ended June 30, 2022 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, section 162(m) excess compensation, foreign-derived intangible income ("FDII") and tax credits. The effective tax rate during the three and six months ended June 30, 2022 included a tax benefit of $0.0 million and $2.6 million, respectively, related to the excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the period.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The effective tax rate for the three and six months ended June 30, 2022 also included a nil tax impact of the revaluation of contingent consideration.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective tax rate for the three and six months ended June 30, 2021 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, GILTI, FDII and tax credits. The effective tax rate during the three and six months ended June 30, 2021, respectively, included a tax benefit of $0.4 million and $2.2 million related to the excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the periods.</span></div><div style="margin-bottom:5pt"><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Liquidity and Capital Resources</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly evaluate our liquidity and capital resources, including our access to external capital, to ensure we can adequately meet our principal cash requirements, which include working capital requirements, planned capital investments in our business, commitments, acquisition restructuring and integration expenses, investments in quality systems and quality compliance objectives, payment of interest expense, repayment of outstanding borrowings, income tax obligations and acquisition opportunities in accordance with our growth strategy.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Liquidity</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary sources of liquidity are cash and cash equivalents, our short-term investment portfolio, cash flows from our operations and access to borrowing arrangements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Funds generated from operations are held in cash and cash equivalents and investment securities. During the six months ended June 30, 2022, our cash and cash equivalents and short-term investment securities decreased by $298.4 million from $567.2 million at December&#160;31, 2021 to $268.9 million at June&#160;30, 2022, which was primarily due to our use of existing </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cash balances to partially fund the Smiths Medical acquisition in January 2022 and due to building inventory safety stock levels to respond to supply chain constraints. Our short-term investment portfolio consists of investment-grade corporate bonds and U.S. treasury securities and is primarily intended to facilitate capital preservation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Credit Agreement and Access to Capital</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into the Credit Agreement with various lenders on January 6, 2022 in connection with the closing of the Smiths Medical acquisition. The Credit Agreement provides for a five-year term loan A facility of $850.0 million (the "Term Loan A"), a seven-year term loan B facility of $850.0 million (the "Term Loan B") and a five-year revolving credit facility of $500.0 million (the "Revolving Credit Facility") (collectively, the "Senior Secured Credit Facilities"). The proceeds from the term loans were used to finance a portion of the cash consideration for the Smiths Medical acquisition. The outstanding aggregate principal amount of the term loans is $1.7 billion as of June 30, 2022, which includes the Term Loan A that will mature in January 2027 and the Term Loan B that will mature in January 2029. The proceeds of future borrowings under the Revolving Credit Facility, which expires in January 2027, may be used as a source of liquidity to support our ongoing working capital requirements and other general corporate purposes. There are no outstanding borrowings under the Revolving Credit Facility as of June 30, 2022. As part of entering into the Senior Secured Credit Facilities, we were assigned issuer and Term Loan B credit ratings. At the date of issuance of this report, our issuer and Term Loan B credit ratings assigned and outlook were as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuer/Term Loan B <br/>Credit Ratings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outlook</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Moody's</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ba3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fitch</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BB/BBB-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Standard &amp; Poor's</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BB/BB</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains financial covenants that pertain to the Term Loan A and the Revolving Credit Facility. Specifically, we are required to maintain a Senior Secured Leverage Ratio of no more than 4.50 to 1.00 until June 30, 2024, with stepdowns to 4.00 to 1.00 thereafter, and an Interest Coverage Ratio of no less than 3.00 to 1.00 (defined and discussed in greater detail in Note 17: Long-Term Debt to our accompanying condensed consolidated financial statements). We were in compliance with these financial covenants as of June 30, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2017 Credit Facility</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 8, 2017, we entered into a five-year revolving credit facility with various lenders for $150.0 million (the "Prior Credit Facility"). The Prior Credit Facility, which was set to expire in November 2022, was terminated upon entering into the new Senior Secured Credit Facilities. There were no outstanding borrowings under the Prior Credit Facility at the time of its termination.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash and cash equivalents along with cash flows expected to be generated from future operations and the funds received and accessible under the Senior Secured Credit Facilities will provide us with sufficient liquidity to finance our cash requirements for the next twelve months. In the event that we experience downturns, cyclical fluctuations in our business that are more severe or longer than anticipated, fail to achieve anticipated revenue and expense levels, or have significant unplanned cash expenditures, we may need to obtain or seek alternative sources of capital or financing, and we can provide no assurances that the terms of such capital or financing will be available to us on favorable terms, if at all. Our ability to generate cash flows from operations, issue debt or enter into other financing arrangements on acceptable terms could be adversely affected if there is a material decline in the demand for our products or in the solvency of our customers or suppliers, deterioration in our key financial ratios or credit ratings or other significantly unfavorable changes in conditions. See Part I. Item 1A. "Risk Factors&#8221; in our 2021 Annual Report on Form 10-K for discussion of the risks and uncertainties associated with our debt financing.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uses of Liquidity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capital Expenditures</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022, there have been no material changes to our estimate for 2022 planned capital expenditures, as previously disclosed in our 2021 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Obligations</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal commitments at June 30, 2022 include both short and long-term future obligations. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have non-cancelable operating lease agreements where we are contractually obligated for certain lease payment amounts. We assumed additional operating leases as a result of our acquisition of Smiths Medical. For more information regarding our operating lease obligations, (see Note 6: Leases to our accompanying condensed consolidated financial statements). </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above, in January 2022, we incurred borrowings under Senior Secured Credit Facilities. The principal repayment obligations and estimated interest payments on the term loans and estimated commitment fee payments on the revolver are estimated in the table below. Interest payments on the term loans were estimated using an Adjusted Term SOFR rate and an initial applicable margin of 1.75% for Term Loan A and 2.50% for Term Loan B and the revolver commitment fees were estimated using the initial rate of 0.25%. The applicable margin rate and commitment fee rate will change from time to time in accordance with a preset pricing grid based on the leverage ratio (see Note 17: Long-Term Debt to our accompanying condensed consolidated financial statements for pricing grids related to the Senior Secured Credit Facilities). We expect to fund these obligations with our existing cash and cash equivalents and cash generated from our future operations. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:26.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.298%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remainder of 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A Principal Payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A Interest Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B Principal Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B Interest Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver Commitment Fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Minimum Purchase Obligations</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2022, effective as of January 1, 2022, upon our request, Pfizer executed a Product Addendum (the "Product Addendum") to our Manufacturing and Supply Agreements to supply us with additional product subject to certain time and pricing terms and conditions (see Note 20: Collaborative and Other Arrangements to our accompanying condensed consolidated financial statements for additional information). As of June 30, 2022, we had satisfied the minimum purchase obligations under the Product Addendum. The Product Addendum expires on November 30, 2022. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Future Capital Investments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022, there have been no material changes to our estimate for restructuring and integration expenses along with spending to support quality systems and quality compliance objectives, as previously disclosed in our 2021 Annual Report on Form 10-K. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnifications </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we have agreed to indemnify our officers and directors to the maximum extent permitted under Delaware law and to indemnify customers as to certain intellectual property matters related to sales of our products. There is no maximum limit on the indemnification that may be required under these agreements.&#160;Although we can provide no assurances, we have never incurred, nor do we expect to incur, any liability for indemnification.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Historical Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net cash used in operations for the six months ended June&#160;30, 2022 was $62.7 million. Net income plus adjustments for non-cash net expenses contributed $108.2 million. Net cash used in operations as a result of changes in operating assets and liabilities was $170.9 million.&#160;The changes in operating assets and liabilities included a $100.0 million increase in inventories, a $17.3 million increase in other assets, a $33.5 million decrease in accrued liabilities and $45.8 million in net changes in income taxes, including excess tax benefits and deferred income taxes and a $1.1 million increase in accounts receivable. Offsetting these amounts was a $4.7 million decrease in prepaid expenses and other current assets and a $22.1 million increase in accounts payable. The increase in inventory was primarily due to the increase in safety stock. The increase in other assets was due to the purchase of spare parts and the capitalization of debt issuance costs allocated to the revolving credit facility. The decrease in accrued liabilities was primarily due to the payout of annual bonuses. The net changes in income taxes was a result of recording the current deferred provision and the timing of payments. The increase in accounts receivable is primarily due to collection efforts and the timing of revenue. The net decrease in prepaid expenses and other current assets was primarily due to a decrease in deferred costs mostly offset by capitalized debt issuance costs allocated to the revolving credit facility. The increase in accounts payable was due to the timing of payments.       </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net cash provided by operations for the six months ended June&#160;30, 2021 was $106.1 million. Net income plus adjustments for non-cash net expenses contributed $122.2 million. Net cash used in operations as a result of changes in operating assets and liabilities was $16.1 million. The changes in operating assets and liabilities included a $17.1 million decrease in accrued liabilities, a $7.6 million increase in other assets, $6.0 million in net changes in income taxes, including excess tax benefits and deferred income taxes and a $1.6 million decrease in accounts payable. Offsetting these amounts was a $13.4 million decrease in inventories, a $2.1 million decrease in accounts receivables, and a $0.8 million decrease in prepaid expenses and other assets. The decrease in accrued liabilities was primarily due to the payment of annual bonuses. The net changes in income taxes was a result of the timing of payments. The increase in other assets was due to the purchase of spare parts. The decrease in accounts payable was due to the timing of payments. The decrease in inventory was primarily due to the timing of production and customer purchases combined with the reduction in capitalized manufacturing variances. The decrease in accounts receivable is primarily due to collection efforts. The net decrease in prepaid expenses and other current assets was primarily due to a decrease in prepaid insurance, property taxes and deferred costs, offset by an increase in annual software renewals.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes the changes in our investing cash flows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Cash Flows:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,039)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,693)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,346)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,844,164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,844,164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,136)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,397)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,034)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,872,942)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,660)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,836,282)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Our purchases of property, plant and equipment increased during the quarter due to the acquisition of Smiths Medical and will also vary from period to period based on additional investments needed to support new and existing products and expansion of our manufacturing facilities.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Our business acquisitions will vary from period to period based upon our current growth strategy and our ability to execute on desirable target companies. On January 6, 2022, we completed the acquisition of Smiths Medical. The cash consideration for the transaction was $1.9 billion, which was financed with existing cash balances and borrowings under the Credit Agreement. Acquired cash was $78.8 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchases of investment securities will vary from period to period based on current cash needs, planning for known future transactions and changes in our investment strategy. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Proceeds from the sale of our investment securities will vary from period to period based on the maturity dates of the investments. Includes $19.0 million in proceeds received during the second quarter of 2022 from a promissory note related to an acquired investment as part of the Smiths Medical acquisition.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in our financing cash flows (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Cash Flows:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt, net of lender debt issuance costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,672,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,672,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments on long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of third-party debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(296)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,819)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,619)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,644,887&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,699)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,647,586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we borrowed an aggregate of $1.7 billion under Senior Secured Credit Facilities contained in the Credit Agreement to partially finance our acquisition of Smiths Medical (see Note 17: Long-Term Debt to our accompanying condensed consolidated financial statements for additional information). The proceeds are net of $27.3 million in payments of lender debt issuance costs.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Payment of $18.1 million of principal payments on the Senior Secured Credit Facilities and $1.9 million in third-party debt issuance costs.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Proceeds from the exercise of stock options will vary from period to period based on the volume of options exercised and the exercise price of the specific options exercised.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)      </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2022, our employees surrendered 44,759 shares of our common stock from vested restricted stock awards as consideration for approximately $10.4 million in minimum statutory withholding obligations paid on their behalf. During the six months ended June 30, 2021, our employees surrendered 37,882 shares of our common stock from vested restricted stock awards as consideration for approximately $7.8 million in minimum statutory withholding obligations paid on their behalf.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock purchase plan, which authorized the repurchase of up to $100.0 million of our common stock, was approved by our Board of Directors in August 2019. This plan has no expiration date.&#160;As of June&#160;30, 2022, all of the $100.0 million available for purchase was remaining under the plan. </span></div><div style="margin-bottom:5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i10abb94289aa46ab94dfc506ddec4961_103"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i10abb94289aa46ab94dfc506ddec4961_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our 2021 Annual Report on Form 10-K, we identified the critical accounting policies which affect our more significant estimates and assumptions used in preparing our consolidated financial statements. There have been no material changes to our critical accounting policies from those previously disclosed in our 2021 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2: New Accounting Pronouncements in Part&#160;I,&#160;Item 1. "Financial Statements."</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i10abb94289aa46ab94dfc506ddec4961_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various portions of this Quarterly Report on Form&#160;10-Q, including this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, and documents referenced herein, describe trends in our business and finances that we perceive and state some of our expectations and beliefs about our future. These statements about the future are &#8220;forward-looking statements,&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended, and we may identify them by using words such as "anticipate," "believe," "expect," "estimate," "intend," "plan," "will," "continue," "could," "may," and by similar expressions and statements about aims, goals and plans. The forward-looking statements are based on the best information currently available to us and assumptions that we believe are reasonable, but we do not intend the statements to be representations as to future results. They include, without limitation, statements about:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future growth; future operating results and various elements of operating results, including future expenditures and effects with respect to sales and marketing and product development and acquisition efforts; future sales and unit volumes of products; expected increases and decreases in sales; deferred revenue; accruals for restructuring charges, future license, royalty and revenue share income; production costs; gross margins; litigation expense; future SG&amp;A and R&amp;D expenses; manufacturing expenses; future costs of expanding our business; income; losses; cash flow; amortization; source of funds for capital purchases and operations; future tax rates; alternative sources of capital or financing; changes in working capital items such as receivables and inventory; selling prices; and income taxes;</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">factors affecting operating results, such as shipments to specific customers; reduced dependence on current proprietary products; loss of a strategic relationship; change in demand; domestic and international sales; expansion in international markets, selling prices; future increases or decreases in sales of certain products and in certain markets and distribution channels; maintaining strategic relationships and securing long-term and multi-product contracts with large healthcare providers and major buying organizations; increases in systems capabilities; introduction, development and sales of new products, acquisition and integration of businesses and product lines (including Smiths Medical); benefits of our products over competing systems; qualification of our new products for the expedited Section 510(k) clearance procedure; possibility of lengthier clearance process for new products; planned increases in marketing; warranty claims; rebates; product returns; bad debt expense; amortization expense; inventory requirements; lives of property and equipment; manufacturing efficiencies and cost savings; unit manufacturing costs; establishment or expansion of production facilities inside or outside of the United States; planned new orders for semi-automated or fully automated assembly machines for new products; adequacy of production capacity; results of R&amp;D; our plans to repurchase shares of our common stock; asset impairment losses; relocation of manufacturing facilities and personnel; effect of expansion of manufacturing facilities on production efficiencies and resolution of production inefficiencies; the effect of costs to customers and delivery times; business seasonality and fluctuations in quarterly results; customer ordering patterns and the effects of new accounting pronouncements; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new or extended contracts with manufacturers and buying organizations; dependence on a small number of customers; loss of larger distributors and the ability to locate other distributors; impact of our recently completed acquisition of the Smiths Medical business; the outcome of our strategic initiatives; regulatory approvals and compliance; including the work necessary to achieve regulatory clearance with respect to the Smiths Medical Warning Letter; outcome of litigation; patent protection and intellectual property landscape; patent infringement claims and the impact of newly issued patents on other medical devices; competitive and market factors, including continuing development of competing products by other manufacturers; improved production processes and higher volume production; innovation requirements; consolidation of the healthcare provider market and downward pressure on selling prices; distribution or financial capabilities of competitors; healthcare reform legislation; use of treasury stock; working capital requirements; liquidity and realizable value of our investment securities; future investment alternatives; foreign currency denominated financial instruments; foreign exchange risk; commodity price risk; our expectations regarding liquidity and capital resources over the next twelve months; capital expenditures; plans to convert existing space; acquisitions of other businesses or product lines, indemnification liabilities and contractual liabilities. </span></div><div style="padding-left:72pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Forward-looking statements involve certain risks and uncertainties, which may cause actual results to differ materially from those discussed in each such statement.&#160; First, one should consider the factors and risks described in the statements themselves or otherwise discussed herein. Those factors are uncertain, and if one or more of them turn out differently than we currently expect, our operating results may differ materially from our current expectations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Second, investors should read the forward-looking statements in conjunction with the Risk Factors discussed in Part&#160;I,&#160;Item 1A of our Annual Report on Form&#160;10-K for the year ended December 31, 2021, Part II, Item 1A of this Quarterly Report on Form 10-Q and our other reports filed with the Securities and Exchange Commission ("SEC").&#160; Also, actual future operating results are subject to other important factors and risks that we cannot predict or control, including without limitation, the following:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impacts of the COVID-19 pandemic on us, our business and on domestic and global economies generally;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the integration of Smiths Medical being more difficult, time-consuming or costly than expected;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic and business conditions, both in the U.S. and internationally;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unexpected changes in our arrangements with Pfizer or our other large customers;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">outcome of litigation;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations in foreign exchange rates and other risks of doing business internationally;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased competition for skilled workers;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreases in availability of the raw materials needed to manufacture our products;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of price and safety considerations on the healthcare industry;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competitive factors, such as product innovation, new technologies, marketing and distribution strength and price erosion;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the successful development and marketing of new products;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unanticipated market shifts and trends;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of legislation affecting government reimbursement of healthcare costs;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes by our major customers and independent distributors in their strategies that might affect their efforts to market  our products;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effects of additional governmental regulations;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unanticipated production problems;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquisition and integration expenses (including as it relates to the Smiths Medical acquisition);</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability of patent protection and the cost of enforcing and of defending patent claims;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">natural disasters and outbreak of disease or illness;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">supply chain constraints or disruptions;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impact of inflation on raw materials, freight charges and labor, especially in the U.S.; and</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interest rate increases.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements in this report are subject to additional risks and uncertainties, including those detailed from time to time in our other filings with the SEC. These forward-looking statements are made only as of the date hereof and, except as required by law, we undertake no obligation to update or revise any of them, whether as a result of new information, future events or otherwise.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i10abb94289aa46ab94dfc506ddec4961_109"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt;text-decoration:underline">Quantitative and Qualitative Disclosures about Market Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the Smiths Medical acquisition on January 6, 2022 we entered into the Senior Secured Credit Facilities totaling approximately $2.2 billion consisting of a variable-rate term loan A facility of $850.0 million, a variable-rate term loan B facility of $850.0 million and a revolving credit facility of $500.0 million. We are exposed to changes in interest rates on all of these variable-rate debt instruments. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term loan A facility currently bears interest based on Adjusted Term SOFR plus an initial applicable margin of 1.75% per year. The term loan B facility currently bears interest based on Adjusted Term SOFR subject to a 0.50% floor plus an initial applicable margin of 2.5%. We used a sensitivity analyses to measure our interest rate risk exposure. If the SOFR rate increases or decreases 1% from June 30, 2022, the additional annual interest expense or savings related to the term loans would amount to approximately $16.8 million. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to mitigate and offset a portion of this interest rate risk exposure associated with these debt instruments we entered into interest rate swaps to achieve a targeted mix of fixed and variable-rate debt. The term loan A swap has an initial notional amount of $300.0&#160;million, reducing to $150.0&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2027 and we will pay a fixed rate of 1.32% and will receive the greater of 3-month USD SOFR or (0.15)%. The term loan B swap has an initial notional amount of $750.0&#160;million, reducing to $46.9&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2026 and we will pay a fixed rate of 1.17% and will receive the greater of 3-month USD SOFR or 0.35%. See Note 8: Derivatives and Hedging Activities to the condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We transact business globally in multiple currencies, some of which are considered volatile. Our international revenues and expenses and working capital positions denominated in these foreign currencies expose us to the risk of fluctuations in foreign currency exchange rates against the U.S. dollar. As the receiver of foreign currencies we are adversely affected by the strengthening of the U.S. dollar and other currencies relative to the operating unit functional currency. Our hedging policy attempts to manage these risks to an acceptable level. We manage our foreign currency exposures on a consolidated basis to take advantage of net exposures and natural offsets, which are then further reduced by the gains and losses of our hedging instruments. Gains and losses on the hedging instruments offset gains and losses on the hedged forecasted transactions and reduce the earnings volatility related to foreign exchange, however we do not hedge our entire foreign exchange exposure and are still subject to earnings volatility due to foreign exchange risk.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign exchange forward contracts hedge a portion of our forecasted foreign currency-denominated revenues and expenses (principally Mexican Pesos, Euros, Czech Koruna, Japanese Yen, U.S. Dollar and Chinese Renminbi) that differ from the functional currency of the operating unit. These derivative contracts are designated and qualify as cash flow hedges (see Note 8: Derivatives and Hedging Activities to the condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q). We performed a sensitivity analysis to estimate changes in the fair value of our foreign exchange derivatives due to potential changes in near-term foreign exchange rates. At June 30, 2022, the effect of a hypothetical 10% weakening in the actual foreign exchange rates used for the applicable currencies did not result in a material impact of these outstanding derivatives contracts.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_112"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt;text-decoration:underline">Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Limitations on Effectiveness of Controls and Procedures</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In designing and evaluating our disclosure controls and procedures, management recognizes that any controls</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are resource constraints, and that management is required to apply judgment in evaluating the benefits of possible</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">controls and procedures relative to their costs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive officer and principal financial officer have concluded, based on their evaluation of our disclosure controls and procedures (as defined in Rules&#160;13a-15(e)&#160;and 15d-15(e)&#160;under the Securities Exchange Act of 1934, as amended (the "Exchange Act")), as of the end of the period covered by this Report, that our disclosure controls and procedures are effective at a reasonable assurance level. As permitted by related SEC staff interpretive guidance for newly acquired</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">businesses, the internal control over financial reporting of Smiths Medical was excluded from the evaluation of the</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effectiveness of our disclosure controls and procedures as of June 30, 2022. Smiths Medical, which we acquired in</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 2022, represented approximately 41% of our consolidated total assets as of June 30, 2022, and 40% and 40%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our consolidated total revenue for the three and six months ended June 30, 2022, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in our internal control over financial reporting during the quarter ended June&#160;30, 2022 that has materially affected or is reasonably likely to materially affect our internal control over financial reporting, except as mentioned above. </span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_115"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II - OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_118"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt;text-decoration:underline">Legal Proceedings</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain legal proceedings in which we are involved are discussed in Part I, Item 1. "Financial Statements" of this Form 10-Q in Note 19. Commitments and Contingencies to the Condensed Consolidated Financial Statements, and is incorporated herein by reference. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i10abb94289aa46ab94dfc506ddec4961_121"></div><div style="padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.8pt;text-decoration:underline">Risk Factors</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In evaluating an investment in our common stock, investors should consider carefully, among other things, the risk factors previously disclosed in Part&#160;I,&#160;Item 1A of our Annual Report on Form&#160;10-K filed with the SEC for the year ended December&#160;31, 2021, as well as the information contained in this Quarterly Report and our other reports and registration statements filed with the SEC.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Smiths Medical acquisition completed in the period has resulted in organizational changes and significant growth to our business. If we fail to effectively manage this growth and change to our business in a manner that preserves our reputation with customers and the key aspects of our corporate culture, our business, financial condition and results of operations could be harmed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Smiths Medical acquisition has resulted in significant growth in our personnel and operations, adding approximately 6,700 employees to our headcount, bringing our total headcount as of June 30, 2022 to approximately 15,300 employees. We will continue to incur significant expenditures and the allocation of management time to assimilate the Smiths Medical employees in a manner that preserves the key aspects of our corporate culture, including a focus on strong customer satisfaction, but there can be no assurance that we will be successful in our efforts. If we do not effectively integrate, train and manage our combined employee base and maintain strong customer relationships, our corporate culture could be undermined, the quality of our products and customer service could suffer, and our reputation could be harmed, each of which could adversely impact our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Smiths Medical acquisition is a significant acquisition for us and the product offerings within Smiths Medical are not product offerings that we previously offered. The success of our business will depend, in part, on our ability to realize our anticipated benefits, opportunities and synergies from combining our legacy businesses and Smiths Medical. We can provide no assurance that the anticipated benefits of the Smiths Medical acquisition will be fully realized in the time frame anticipated or at all. Integrating the operations of Smiths Medical with that of our legacy business will be a complex, costly and time-consuming process. The integration process may disrupt the businesses and, if implemented ineffectively, would restrict the realization of the full expected benefits. The failure to meet the challenges involved in integrating the two businesses could cause an interruption of, or a loss of momentum in, the activities of the combined businesses and could adversely affect the results of operations of the combined businesses. Potential difficulties that may be encountered in the integration process include the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">challenges in preserving important strategic customer and other third-party relationships of both businesses;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the diversion of management&#8217;s attention to integration matters;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">challenges in maintaining employee morale and retaining or attracting key employees;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">potential incompatibility of corporate cultures;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">changes in the combined business due to potential divestitures or requirements imposed by antitrust regulators;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">costs, delays and other difficulties consolidating corporate and administrative infrastructures and information systems and in implementing common systems and procedures including, in particular, our internal controls over financial reporting; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">coordinating and integrating a geographically dispersed organization, including operations in jurisdictions we currently do not operate in.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any one or all of these factors may increase operating costs or lower anticipated financial performance. Achieving the anticipated benefits and the potential benefits underlying our reasons for the Smiths Medical business acquisition will depend on successful integration of the businesses. Because of the significance of the Smiths Medical business acquisition to us, our failure to successfully integrate the Smiths Medical business with that of our own could have a material adverse impact on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no other material changes in the risk factors other than those mentioned above from those previously disclosed under &#8220;Risk Factors&#8221; in Part I, Item 1A of our Annual Report on Form 10-K with the SEC for the year ended December 31, 2021.</span></div><div id="i10abb94289aa46ab94dfc506ddec4961_124"></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt;text-decoration:underline">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Sales of Unregistered Securities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, as part of the consideration for the acquisition of Smiths Medical, we issued 2.5 million unregistered shares of our common stock to Smiths Group International Holdings Limited.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance of these shares to Smiths Medical in accordance with the terms and subject to the conditions set forth in a shareholders agreement was made in reliance on the private offering exemption of Section 4(a)(2) of the Securities Act and/or the private offering safe harbor provision of Rule 506 of Regulation D promulgated thereunder, as transactions not involving a public offering.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase of Equity Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following is a summary of our stock repurchasing activity during the second quarter of 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total number of shares<br/>purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>price&#160;paid<br/>per&#160;share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total number of shares<br/>purchased&#160;as<br/>part&#160;of&#160;a<br/>publicly<br/>announced<br/>program</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">dollar&#160;value&#160;that</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">may&#160;yet&#160;be</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">purchased&#160;under</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">the&#160;program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">04/01/2022 &#8212; 04/30/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">05/01/2022 &#8212; 05/31/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">06/01/2022 &#8212; 06/30/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter of 2022 total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">____________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock purchase plan, which authorized the repurchase of up to $100.0 million of our common stock, was authorized by our Board of Directors and publicly announced in August, 2019.&#160;This plan has no expiration date.  We are not obligated to make any purchases under our stock purchase program. Subject to applicable state and federal corporate and securities laws, purchases under a stock purchase program may be made at such times and in such amounts as we deem appropriate. Purchases made under our stock purchase program can be discontinued at any time we feel additional purchases are not warranted.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i10abb94289aa46ab94dfc506ddec4961_127"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 6.  Exhibits</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit&#160;Index</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.490%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/883984/000088398422000026/exhibit101_41522.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Executive Employment Agreement, dated as of April 15, 2022, by and between ICU Medical, Inc. and Vivek Jain. Filed as an Exhibit to Registrant's Current Report on Form 8-K filed April 20, 2022, and incorporated herein by reference.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="icui-ex31163022.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Executive Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="icui-ex31263022.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Financial Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="icui-ex32163022.htm">32.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - this instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i10abb94289aa46ab94dfc506ddec4961_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signature</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICU Medical,&#160;Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.146%"><tr><td style="width:1.0%"></td><td style="width:64.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.165%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Brian M. Bonnell</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 8, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian M. Bonnell</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Authorized Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>icui-ex31163022.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i7939d0684a0648bf996ea24cd7edc04c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Vivek Jain, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this quarterly report on Form&#160;10-Q of ICU Medical,&#160;Inc.&#59;</font></div><div style="padding-left:36pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:108pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.728%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 8, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Vivek Jain</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>icui-ex31263022.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i26454f3a7452498aa93a0d126fa63b3f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian M. Bonnell, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%;padding-left:24pt">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I have reviewed this quarterly report on Form&#160;10-Q of ICU Medical,&#160;Inc.&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt"> Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt"> The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:4.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.547%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 8, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brian M. Bonnell</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="text-align:right;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:right;text-indent:36pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>icui-ex32163022.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i66438b8418d0473aa9259fd5292389a9_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of ICU Medical,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-Q for the period ended June&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Vivek Jain, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167;&#160;1350, as adopted pursuant to &#167;&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 8, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Vivek Jain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vivek Jain</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of ICU Medical,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-Q for the period ended June&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Brian M. Bonnell, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167;&#160;1350, as adopted pursuant to &#167;&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 8, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brian M. Bonnell</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian M. Bonnell</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>icui-20220630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b855b77c-6988-4216-8748-36632a973ac3,g:ab2a959a-be44-44c8-8165-c7a4fa090087-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:icui="http://www.icumed.com/20220630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.icumed.com/20220630">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DEIDocument" roleURI="http://www.icumed.com/role/DEIDocument">
        <link:definition>0001001 - Document - DEI Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofIncome" roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical" roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Comprehensive Income (Paranthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityStatement" roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Stockholders' Equity Statement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.icumed.com/role/BasisofPresentation">
        <link:definition>2101101 - Disclosure - Basis of Presentation:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.icumed.com/role/NewAccountingPronouncements">
        <link:definition>2102102 - Disclosure - New Accounting Pronouncements:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncementsNewAccountingPronouncementsAdoptedPolicies" roleURI="http://www.icumed.com/role/NewAccountingPronouncementsNewAccountingPronouncementsAdoptedPolicies">
        <link:definition>2203201 - Disclosure - New Accounting Pronouncements New Accounting Pronouncements Adopted (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitions" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions">
        <link:definition>2104103 - Disclosure - Business Combinations and Asset Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitionsTables" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables">
        <link:definition>2305301 - Disclosure - Business Combinations and Asset Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails">
        <link:definition>2406401 - Disclosure - Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitionsDetails" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails">
        <link:definition>2407402 - Disclosure - Business Combinations and Asset Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails">
        <link:definition>2408403 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails">
        <link:definition>2409404 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringStrategicTransactionandIntegrationNotes" roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes">
        <link:definition>2110104 - Disclosure - Restructuring, Strategic Transaction and Integration (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringStrategicTransactionandIntegrationTables" roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables">
        <link:definition>2311302 - Disclosure - Restructuring, Strategic Transaction and Integration (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringStrategicTransactionandIntegrationRestructuringDetails" roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails">
        <link:definition>2412405 - Disclosure - Restructuring, Strategic Transaction and Integration Restructuring (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringStrategicTransactionandIntegrationLiabilityDetails" roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails">
        <link:definition>2413406 - Disclosure - Restructuring, Strategic Transaction and Integration Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StrategicTransactionandIntegrationDetails" roleURI="http://www.icumed.com/role/StrategicTransactionandIntegrationDetails">
        <link:definition>2414407 - Disclosure - Strategic Transaction and Integration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNotes" roleURI="http://www.icumed.com/role/RevenueNotes">
        <link:definition>2115105 - Disclosure - Revenue (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.icumed.com/role/RevenueTables">
        <link:definition>2316303 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDetails" roleURI="http://www.icumed.com/role/RevenueDetails">
        <link:definition>2417408 - Disclosure - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregatedRevenuebyGeographyDetails" roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails">
        <link:definition>2418409 - Disclosure - Revenue Disaggregated Revenue by Geography (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregatedRevenuebyProductLineDetails" roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails">
        <link:definition>2419410 - Disclosure - Revenue Disaggregated Revenue by Product Line (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueContractLiabilitiesDetails" roleURI="http://www.icumed.com/role/RevenueContractLiabilitiesDetails">
        <link:definition>2420411 - Disclosure - Revenue Contract Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNotes" roleURI="http://www.icumed.com/role/LeasesNotes">
        <link:definition>2121106 - Disclosure - Leases (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.icumed.com/role/LeasesTables">
        <link:definition>2322304 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTextDetails" roleURI="http://www.icumed.com/role/LeasesTextDetails">
        <link:definition>2423412 - Disclosure - Leases Text (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetails" roleURI="http://www.icumed.com/role/LeasesDetails">
        <link:definition>2424413 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCashFlowOperatingActivitiesLesseeDetails" roleURI="http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails">
        <link:definition>2425414 - Disclosure - Leases Cash Flow, Operating Activities, Lessee (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAssetsandLiabilitiesLesseeDetails" roleURI="http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails">
        <link:definition>2426415 - Disclosure - Leases Assets and Liabilities, Lessee (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturityDetails" roleURI="http://www.icumed.com/role/LeasesMaturityDetails">
        <link:definition>2427416 - Disclosure - Leases Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShare" roleURI="http://www.icumed.com/role/NetIncomePerShare">
        <link:definition>2128107 - Disclosure - Net Income Per Share:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareTables" roleURI="http://www.icumed.com/role/NetIncomePerShareTables">
        <link:definition>2329305 - Disclosure - Net Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareDetails" roleURI="http://www.icumed.com/role/NetIncomePerShareDetails">
        <link:definition>2430417 - Disclosure - Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareDetails1" roleURI="http://www.icumed.com/role/NetIncomePerShareDetails1">
        <link:definition>2431418 - Disclosure - Net Income Per Share (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsNotes" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes">
        <link:definition>2132108 - Disclosure - Derivative Financial Instruments (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsTables" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsTables">
        <link:definition>2333306 - Disclosure - Derivative Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails">
        <link:definition>2434419 - Disclosure - Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails">
        <link:definition>2435420 - Disclosure - Derivative Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsInterestRateSwapsDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails">
        <link:definition>2436421 - Disclosure - Derivative Financial Instruments Interest Rate Swaps (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails">
        <link:definition>2437422 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2438423 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails">
        <link:definition>2439424 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresNotes" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes">
        <link:definition>2140109 - Disclosure - Fair Value Measures and Disclosures (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresTables" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables">
        <link:definition>2341307 - Disclosure - Fair Value Measures and Disclosures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresDetails" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails">
        <link:definition>2442425 - Disclosure - Fair Value Measures and Disclosures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails">
        <link:definition>2443426 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails">
        <link:definition>2444427 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails">
        <link:definition>2445428 - Disclosure - Fair Value Measures and Disclosures Liability Measurement Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails">
        <link:definition>2446429 - Disclosure - Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesNotes" roleURI="http://www.icumed.com/role/InvestmentSecuritiesNotes">
        <link:definition>2147110 - Disclosure - Investment Securities (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesTables" roleURI="http://www.icumed.com/role/InvestmentSecuritiesTables">
        <link:definition>2348308 - Disclosure - Investment Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesDetails" roleURI="http://www.icumed.com/role/InvestmentSecuritiesDetails">
        <link:definition>2449430 - Disclosure - Investment Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesTableDetails" roleURI="http://www.icumed.com/role/InvestmentSecuritiesTableDetails">
        <link:definition>2450431 - Disclosure - Investment Securities Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestmentsDetails" roleURI="http://www.icumed.com/role/EquityMethodInvestmentsDetails">
        <link:definition>2451432 - Disclosure - Equity Method Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidsandOtherCurrentAssetsNotes" roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes">
        <link:definition>2152111 - Disclosure - Prepaids and Other Current Assets (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidsandOtherCurrentAssetsTables" roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables">
        <link:definition>2353309 - Disclosure - Prepaids and Other Current Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails" roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails">
        <link:definition>2454433 - Disclosure - Prepaids and Other Current Assets Prepaids and Other Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsNoncurrentDetails" roleURI="http://www.icumed.com/role/OtherAssetsNoncurrentDetails">
        <link:definition>2455434 - Disclosure - Other Assets Noncurrent(Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.icumed.com/role/Inventories">
        <link:definition>2156112 - Disclosure - Inventories:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.icumed.com/role/InventoriesTables">
        <link:definition>2357310 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://www.icumed.com/role/InventoriesDetails">
        <link:definition>2458435 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipment" roleURI="http://www.icumed.com/role/PropertyandEquipment">
        <link:definition>2159113 - Disclosure - Property and Equipment:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://www.icumed.com/role/PropertyandEquipmentTables">
        <link:definition>2360311 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentDetails" roleURI="http://www.icumed.com/role/PropertyandEquipmentDetails">
        <link:definition>2461436 - Disclosure - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTextDetails" roleURI="http://www.icumed.com/role/PropertyandEquipmentTextDetails">
        <link:definition>2462437 - Disclosure - Property and Equipment Text (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNotes" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes">
        <link:definition>2163114 - Disclosure - Goodwill and Intangible Assets (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>2364312 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsGoodwillTableDetails" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails">
        <link:definition>2465438 - Disclosure - Goodwill and Intangible Assets Goodwill Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsIntangiblesTableDetails" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails">
        <link:definition>2466439 - Disclosure - Goodwill and Intangible Assets Intangibles Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTextDetails" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails">
        <link:definition>2467440 - Disclosure - Goodwill and Intangible Assets Text (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets5YearAmortizationDetails" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails">
        <link:definition>2468441 - Disclosure - Goodwill and Intangible Assets 5-Year Amortization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesNotes" roleURI="http://www.icumed.com/role/AccruedLiabilitiesNotes">
        <link:definition>2169115 - Disclosure - Accrued Liabilities (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesTables" roleURI="http://www.icumed.com/role/AccruedLiabilitiesTables">
        <link:definition>2370313 - Disclosure - Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesDetails" roleURI="http://www.icumed.com/role/AccruedLiabilitiesDetails">
        <link:definition>2471442 - Disclosure - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesLongtermliabilitiesDetails" roleURI="http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails">
        <link:definition>2472443 - Disclosure - Accrued Liabilities Long-term liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.icumed.com/role/IncomeTaxes">
        <link:definition>2173116 - Disclosure - Income Taxes:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectivetaxrateDetails" roleURI="http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails">
        <link:definition>2474444 - Disclosure - Income Taxes Effective tax rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsNotes" roleURI="http://www.icumed.com/role/LongTermObligationsNotes">
        <link:definition>2175117 - Disclosure - Long-Term Obligations (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsTables" roleURI="http://www.icumed.com/role/LongTermObligationsTables">
        <link:definition>2376314 - Disclosure - Long-Term Obligations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsDetails" roleURI="http://www.icumed.com/role/LongTermObligationsDetails">
        <link:definition>2477445 - Disclosure - Long-Term Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsInterestRateTermsDetails" roleURI="http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails">
        <link:definition>2478446 - Disclosure - Long-Term Obligations Interest Rate Terms (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsTerminatedCreditAgreementDetails" roleURI="http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails">
        <link:definition>2479447 - Disclosure - Long-Term Obligations Terminated Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsTableDetails" roleURI="http://www.icumed.com/role/LongTermObligationsTableDetails">
        <link:definition>2480448 - Disclosure - Long-Term Obligations Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsScheduleofMaturitiesDetails" roleURI="http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails">
        <link:definition>2481449 - Disclosure - Long-Term Obligations Schedule of Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsInterestExpenseDetails" roleURI="http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails">
        <link:definition>2482450 - Disclosure - Long-Term Obligations Interest Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsPrincipalPaymentDetails" roleURI="http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails">
        <link:definition>2483451 - Disclosure - Long-Term Obligations Principal Payment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.icumed.com/role/CommitmentsandContingencies">
        <link:definition>2184118 - Disclosure - Commitments and Contingencies:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesContingencyDetails" roleURI="http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails">
        <link:definition>2485452 - Disclosure - Commitments and Contingencies Contingency (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeandOtherArrangementsNotes" roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes">
        <link:definition>2186119 - Disclosure - Collaborative and Other Arrangements (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeandOtherArrangementsTables" roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsTables">
        <link:definition>2387315 - Disclosure - Collaborative and Other Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeandOtherArrangementsDetails" roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails">
        <link:definition>2488453 - Disclosure - Collaborative and Other Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Equity" roleURI="http://www.icumed.com/role/Equity">
        <link:definition>2189120 - Disclosure - Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityTables" roleURI="http://www.icumed.com/role/EquityTables">
        <link:definition>2390316 - Disclosure - Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityDetails" roleURI="http://www.icumed.com/role/EquityDetails">
        <link:definition>2491454 - Disclosure - Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2492455 - Disclosure - Equity Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="icui_FieldServiceCorrectiveAction" abstract="false" name="FieldServiceCorrectiveAction" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ProFormaAdjustmentRelatedPartyLoans" abstract="false" name="ProFormaAdjustmentRelatedPartyLoans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_MinimumStockPriceTargetForEarnOutPayment" abstract="false" name="MinimumStockPriceTargetForEarnOutPayment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ShortTermMember" abstract="true" name="ShortTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ProFormaAdjustmentFinanceCosts" abstract="false" name="ProFormaAdjustmentFinanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ProvisionForWarrantyAndReturns" abstract="false" name="ProvisionForWarrantyAndReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_LessThanOrEqual300To100ButGreaterThan250to100Member" abstract="true" name="LessThanOrEqual300To100ButGreaterThan250to100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_AmortizationOfInventoryStepUp" abstract="false" name="AmortizationOfInventoryStepUp" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Outsidesalescommissions" abstract="false" name="Outsidesalescommissions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TermAPrincipalPaymentInYear5" abstract="false" name="TermAPrincipalPaymentInYear5" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_AvailableforsaleDebtSecurityCurrentMember" abstract="true" name="AvailableforsaleDebtSecurityCurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Liabilitiesforcontracts" abstract="false" name="Liabilitiesforcontracts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_IVSolutionsMember" abstract="true" name="IVSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ContractassetandliabilitybalancesLineItems" abstract="true" name="ContractassetandliabilitybalancesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" abstract="true" name="LessThanOrEqualTo400To100ButGreaterThan300To100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_SpareParts" abstract="false" name="SpareParts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TreasuryStockPurchasePlan" abstract="false" name="TreasuryStockPurchasePlan" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TermLoanAMember" abstract="true" name="TermLoanAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_RevolverSubLimits" abstract="false" name="RevolverSubLimits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_OtherCurrenciesMember" abstract="true" name="OtherCurrenciesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Accruedlegalfees" abstract="false" name="Accruedlegalfees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_AssetsandLiabilitiesLeasesTableTextBlock" abstract="false" name="AssetsandLiabilitiesLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_ApplicableMarginBaseRateLoans" abstract="false" name="ApplicableMarginBaseRateLoans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_EquipmentrevenueMember" abstract="true" name="EquipmentrevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ContingentConsiderationGrossLT" abstract="false" name="ContingentConsiderationGrossLT" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" abstract="true" name="LessThanOrEqualTo250To100ButGreaterThan200To100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ForeignInfusionSystemSupplierMember" abstract="true" name="ForeignInfusionSystemSupplierMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_BusinessCombinationConsiderationHoldbackLiability" abstract="false" name="BusinessCombinationConsiderationHoldbackLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Accruedothertaxes" abstract="false" name="Accruedothertaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_CommonStockSharesMember" abstract="true" name="CommonStockSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_MeasurementinputadjustedEBITDAvolatilityDomain" abstract="true" name="MeasurementinputadjustedEBITDAvolatilityDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Sparepartsusage" abstract="false" name="Sparepartsusage" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_InterestRateSwapEndingNotionalValue" abstract="false" name="InterestRateSwapEndingNotionalValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_LongTermMember" abstract="true" name="LongTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" abstract="false" name="TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_AccruedSalariesAndBenefits" abstract="false" name="AccruedSalariesAndBenefits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_LeverageRatioLevelDomain" abstract="true" name="LeverageRatioLevelDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_OwnershipRequirementForEarnoutPayment" abstract="false" name="OwnershipRequirementForEarnoutPayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_ApplicableMarginBasedOnLeverageRatioTable" abstract="true" name="ApplicableMarginBasedOnLeverageRatioTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_TermAPrincipalPaymentFirst2Years" abstract="false" name="TermAPrincipalPaymentFirst2Years" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_BusinessCombinationConsiderationTransferredCash" abstract="false" name="BusinessCombinationConsiderationTransferredCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TermLoanDomain" abstract="true" name="TermLoanDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_AccruedAuditFees" abstract="false" name="AccruedAuditFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_CriticalCareMember" abstract="true" name="CriticalCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Hedge3MemberMember" abstract="true" name="Hedge3MemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Optiontoextendinyears" abstract="false" name="Optiontoextendinyears" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="icui_ComputerEquipmentAndSoftwareMember" abstract="true" name="ComputerEquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ProFormaAdjustmentInventory" abstract="false" name="ProFormaAdjustmentInventory" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_LeverageRatioCalculationCeilingSubtractedAmount" abstract="false" name="LeverageRatioCalculationCeilingSubtractedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Hedge2Member" abstract="true" name="Hedge2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_PursuitVascularInc.Member" abstract="true" name="PursuitVascularInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_SmithsGroupOwnershipAcquisitionSharesIssued" abstract="false" name="SmithsGroupOwnershipAcquisitionSharesIssued" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_SoftwarerevenueMember" abstract="true" name="SoftwarerevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TotalSeniorSecuredCreditFacility" abstract="false" name="TotalSeniorSecuredCreditFacility" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ContingentConsiderationAllAcquisitions" abstract="false" name="ContingentConsiderationAllAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TermLoanAxis" abstract="true" name="TermLoanAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_InfusionConsumablesSmithsMedicalMember" abstract="true" name="InfusionConsumablesSmithsMedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ContingentConsiderationGrossST" abstract="false" name="ContingentConsiderationGrossST" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Srt_MultipleCurrencyAxisDomain" abstract="true" name="Srt_MultipleCurrencyAxisDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_RequiredShareHoldingOfStockIssuedAtAcquisition" abstract="false" name="RequiredShareHoldingOfStockIssuedAtAcquisition" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_UnfavorablecontractliabilityST" abstract="false" name="UnfavorablecontractliabilityST" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_EarnoutliabilityMember" abstract="true" name="EarnoutliabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_LongtermInvestmentsDomain" abstract="true" name="LongtermInvestmentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Contractsettlement" abstract="false" name="Contractsettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_VitalCareMember" abstract="true" name="VitalCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_OtherDeferredRevenueMember" abstract="true" name="OtherDeferredRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Prepaidinsuranceandpropertytaxes" abstract="false" name="Prepaidinsuranceandpropertytaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_SmithsGroupOwnershipRequiredForBoardRepresentation" abstract="false" name="SmithsGroupOwnershipRequiredForBoardRepresentation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_Restructuringandstrategictransaction" abstract="false" name="Restructuringandstrategictransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_EarnOutLiabilityST" abstract="false" name="EarnOutLiabilityST" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_MoldsMember" abstract="true" name="MoldsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Restructuringstrategictransactionandintegration" abstract="false" name="Restructuringstrategictransactionandintegration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_DocumentAndEntityInformationAbstract" abstract="true" name="DocumentAndEntityInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" abstract="false" name="ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ContingentConsiderationTaxExpense" abstract="false" name="ContingentConsiderationTaxExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Greaterthan400to100Member" abstract="true" name="Greaterthan400to100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_SmithsMedicalMember" abstract="true" name="SmithsMedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TermLoanBMember" abstract="true" name="TermLoanBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" abstract="false" name="PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_InternationalDistributorMember" abstract="true" name="InternationalDistributorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_GoodwillAcquiredDuringPeriodAllAcquisitions" abstract="false" name="GoodwillAcquiredDuringPeriodAllAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_BusinessCombinationGoodwillNonDeductible" abstract="false" name="BusinessCombinationGoodwillNonDeductible" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ContractassetandliabilitybalancesTable" abstract="true" name="ContractassetandliabilitybalancesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_InterestExpenseOnLongTermDebtTableTextBlock" abstract="false" name="InterestExpenseOnLongTermDebtTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_Deferredtaxcharge" abstract="false" name="Deferredtaxcharge" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ApplicableMarginTermSOFRLoans" abstract="false" name="ApplicableMarginTermSOFRLoans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_InstrumentsPlacedwithCustomersMember" abstract="true" name="InstrumentsPlacedwithCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_PrepaidVendorExpenses" abstract="false" name="PrepaidVendorExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TermLoanBPrincipalPayment" abstract="false" name="TermLoanBPrincipalPayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_LOngTermObligationsDisclosureAbstract" abstract="true" name="LOngTermObligationsDisclosureAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" abstract="false" name="IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_GovernmentGrantRevenueMember" abstract="true" name="GovernmentGrantRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TimingAxis" abstract="true" name="TimingAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_DevelopedTechnologyMember" abstract="true" name="DevelopedTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_DerivativeVariableRateFloor" abstract="false" name="DerivativeVariableRateFloor" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_InfusionConsumablesMember" abstract="true" name="InfusionConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Srt_MultipleCurrencyAxisAxis" abstract="true" name="Srt_MultipleCurrencyAxisAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_ProFormaAdjustmentAmortization" abstract="false" name="ProFormaAdjustmentAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_StrategicTransactionandIntegration" abstract="false" name="StrategicTransactionandIntegration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" abstract="false" name="TerSOFRInterestRateAdjustmentForBaseRateLoans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_Accruedfreight" abstract="false" name="Accruedfreight" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_MeasurementInputMarketPriceofRiskDomain" abstract="true" name="MeasurementInputMarketPriceofRiskDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TermAPrincipalPaymentYear3And4" abstract="false" name="TermAPrincipalPaymentYear3And4" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_InterestPercentageAddedToFederalFundsRate" abstract="false" name="InterestPercentageAddedToFederalFundsRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_TimingDomain" abstract="true" name="TimingDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_LessThan275To100Member" abstract="true" name="LessThan275To100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_LeverageRatioLevelAxis" abstract="true" name="LeverageRatioLevelAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_InfusionSystemsMember" abstract="true" name="InfusionSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_OtherforeigncountriesMember" abstract="true" name="OtherforeigncountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ApplicableMarginBasedOnLeverageRatioLineItems" abstract="true" name="ApplicableMarginBasedOnLeverageRatioLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_GreaterThan275To100Member" abstract="true" name="GreaterThan275To100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_VascularAccessMember" abstract="true" name="VascularAccessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Prepaidothertaxes" abstract="false" name="Prepaidothertaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_CurrencyTranslationOnEarnOut" abstract="false" name="CurrencyTranslationOnEarnOut" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_LessThanOrEqualTo200To100Member" abstract="true" name="LessThanOrEqualTo200To100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" abstract="false" name="BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" abstract="false" name="ApplicableMarginBasedOnLeverageRatioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_InterestPercentageAddedToBaseRate" abstract="false" name="InterestPercentageAddedToBaseRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_Contingentconsiderationgross" abstract="false" name="Contingentconsiderationgross" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" abstract="false" name="InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_ForeignMember" abstract="true" name="ForeignMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_STEarnoutLiabilityMember" abstract="true" name="STEarnoutLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>icui-20220630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b855b77c-6988-4216-8748-36632a973ac3,g:ab2a959a-be44-44c8-8165-c7a4fa090087-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="icui-20220630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f80c3f45-2f1a-4dc1-9272-357cc15c2cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e523f09f-de50-4b31-a06f-d8eeb26e8f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f80c3f45-2f1a-4dc1-9272-357cc15c2cbe" xlink:to="loc_us-gaap_LiabilitiesCurrent_e523f09f-de50-4b31-a06f-d8eeb26e8f44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_958d95dd-1b1e-48c0-a2aa-b4e22cd11c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f80c3f45-2f1a-4dc1-9272-357cc15c2cbe" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_958d95dd-1b1e-48c0-a2aa-b4e22cd11c6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_748f6ff1-7d20-4c56-80e6-f3672d73bffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f80c3f45-2f1a-4dc1-9272-357cc15c2cbe" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_748f6ff1-7d20-4c56-80e6-f3672d73bffb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b81a85f1-a608-4f99-89cf-19f7402230ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f80c3f45-2f1a-4dc1-9272-357cc15c2cbe" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b81a85f1-a608-4f99-89cf-19f7402230ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_afb3afdc-c903-422f-9ea6-6af416eb7612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f80c3f45-2f1a-4dc1-9272-357cc15c2cbe" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_afb3afdc-c903-422f-9ea6-6af416eb7612" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_20d31a91-bbf2-4d7d-b53b-e522cfe8d7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f80c3f45-2f1a-4dc1-9272-357cc15c2cbe" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_20d31a91-bbf2-4d7d-b53b-e522cfe8d7f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_64ee04a6-44b4-4c07-8801-788b3edd1d04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f80c3f45-2f1a-4dc1-9272-357cc15c2cbe" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_64ee04a6-44b4-4c07-8801-788b3edd1d04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f70d2713-194d-4d01-a957-4c1e68a45f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_bb53f6bb-ad3f-48b8-8a6d-8d73483278fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f70d2713-194d-4d01-a957-4c1e68a45f9d" xlink:to="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_bb53f6bb-ad3f-48b8-8a6d-8d73483278fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b9598d66-03da-40d6-9a33-04bc1a40c17d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f70d2713-194d-4d01-a957-4c1e68a45f9d" xlink:to="loc_us-gaap_CommonStockValue_b9598d66-03da-40d6-9a33-04bc1a40c17d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_60c5e277-978a-4dcd-b83e-f3aebdc176ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f70d2713-194d-4d01-a957-4c1e68a45f9d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_60c5e277-978a-4dcd-b83e-f3aebdc176ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_e6b0cf95-664c-4fba-a41e-bf9942f301f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f70d2713-194d-4d01-a957-4c1e68a45f9d" xlink:to="loc_us-gaap_TreasuryStockValue_e6b0cf95-664c-4fba-a41e-bf9942f301f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0edbfaa5-d88d-4672-85d9-f4fd71a823f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f70d2713-194d-4d01-a957-4c1e68a45f9d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0edbfaa5-d88d-4672-85d9-f4fd71a823f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_225e6271-102a-4399-bfb9-be391b2d7f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f70d2713-194d-4d01-a957-4c1e68a45f9d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_225e6271-102a-4399-bfb9-be391b2d7f06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_125fce82-b628-4b04-908b-32a530cb44bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_39e0ccdf-8cad-4a2d-bcd0-47f160b9bbfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_125fce82-b628-4b04-908b-32a530cb44bd" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_39e0ccdf-8cad-4a2d-bcd0-47f160b9bbfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_fced2b09-25d4-43e1-bff1-64f0a2a06cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_125fce82-b628-4b04-908b-32a530cb44bd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_fced2b09-25d4-43e1-bff1-64f0a2a06cef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a2fcb92e-dadc-407d-8ac0-9ded0ed58fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_62eb3b30-c5a6-408b-ac70-0eefedc15d03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a2fcb92e-dadc-407d-8ac0-9ded0ed58fa4" xlink:to="loc_us-gaap_AssetsCurrent_62eb3b30-c5a6-408b-ac70-0eefedc15d03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_af4abffb-5f19-42e5-ad9c-584ce2e4e1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a2fcb92e-dadc-407d-8ac0-9ded0ed58fa4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_af4abffb-5f19-42e5-ad9c-584ce2e4e1a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c33dcdef-7d29-4504-bd02-abc6bda4333f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a2fcb92e-dadc-407d-8ac0-9ded0ed58fa4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c33dcdef-7d29-4504-bd02-abc6bda4333f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_ff8676d0-254f-45d9-812c-d1554ebdcc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a2fcb92e-dadc-407d-8ac0-9ded0ed58fa4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_ff8676d0-254f-45d9-812c-d1554ebdcc6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f0e8112f-9116-452d-8fb4-b49c1b2f0182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a2fcb92e-dadc-407d-8ac0-9ded0ed58fa4" xlink:to="loc_us-gaap_Goodwill_f0e8112f-9116-452d-8fb4-b49c1b2f0182" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4b1a3123-5640-402d-b720-ffb944d6ad82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a2fcb92e-dadc-407d-8ac0-9ded0ed58fa4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4b1a3123-5640-402d-b720-ffb944d6ad82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_438754d5-93ea-4781-8f8f-366e740cbb06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a2fcb92e-dadc-407d-8ac0-9ded0ed58fa4" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_438754d5-93ea-4781-8f8f-366e740cbb06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_a43b0893-d6e4-4885-982d-6aec6307791c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a2fcb92e-dadc-407d-8ac0-9ded0ed58fa4" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_a43b0893-d6e4-4885-982d-6aec6307791c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cedc0e99-bb1a-45c6-8859-646a4f43b74f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_a372da29-caaf-4ee2-b624-306255406962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_cedc0e99-bb1a-45c6-8859-646a4f43b74f" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_a372da29-caaf-4ee2-b624-306255406962" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_fd1102a6-ceb8-4f50-88aa-cc32cc270132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_cedc0e99-bb1a-45c6-8859-646a4f43b74f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_fd1102a6-ceb8-4f50-88aa-cc32cc270132" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b82c4d89-5e99-4dab-b375-bd5e05aad214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_cedc0e99-bb1a-45c6-8859-646a4f43b74f" xlink:to="loc_us-gaap_InventoryNet_b82c4d89-5e99-4dab-b375-bd5e05aad214" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_3420f90c-751a-4ae0-a9c5-29b868dc7226" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_cedc0e99-bb1a-45c6-8859-646a4f43b74f" xlink:to="loc_us-gaap_PrepaidTaxes_3420f90c-751a-4ae0-a9c5-29b868dc7226" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e2d1cef4-61f6-4c08-8742-533b47380581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_cedc0e99-bb1a-45c6-8859-646a4f43b74f" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e2d1cef4-61f6-4c08-8742-533b47380581" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_53dcb060-9d29-4a8d-8a64-454a654d5e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_3434e9d4-4728-4b23-b39d-fa4863b4b478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_53dcb060-9d29-4a8d-8a64-454a654d5e5c" xlink:to="loc_us-gaap_AccountsPayableCurrent_3434e9d4-4728-4b23-b39d-fa4863b4b478" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a192a91f-da01-461e-aa10-04230aabff07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_53dcb060-9d29-4a8d-8a64-454a654d5e5c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a192a91f-da01-461e-aa10-04230aabff07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_1b43d1fc-6626-47f4-9e9f-18322219a5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_53dcb060-9d29-4a8d-8a64-454a654d5e5c" xlink:to="loc_us-gaap_LongTermDebtCurrent_1b43d1fc-6626-47f4-9e9f-18322219a5a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_4525b54d-c985-41ba-a49a-0448b50ac291" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_53dcb060-9d29-4a8d-8a64-454a654d5e5c" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_4525b54d-c985-41ba-a49a-0448b50ac291" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_b8bea6e7-8c7a-431b-9def-ae6adcf59dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_53dcb060-9d29-4a8d-8a64-454a654d5e5c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_b8bea6e7-8c7a-431b-9def-ae6adcf59dc3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="icui-20220630.xsd#CondensedConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3545f210-dc29-4368-bd9a-0c1b0c0665c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_57d16bd5-57e0-4280-a16c-ec7b28fccf89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_3545f210-dc29-4368-bd9a-0c1b0c0665c5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_57d16bd5-57e0-4280-a16c-ec7b28fccf89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_bb05cde6-2339-4722-955c-ad8b2f536739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_3545f210-dc29-4368-bd9a-0c1b0c0665c5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_bb05cde6-2339-4722-955c-ad8b2f536739" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2d91a371-3963-40d5-82c5-40f050f07081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_8092820f-6189-4e97-af2b-43a16a338db2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2d91a371-3963-40d5-82c5-40f050f07081" xlink:to="loc_us-gaap_GrossProfit_8092820f-6189-4e97-af2b-43a16a338db2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_5505928c-8e45-4b08-a9a1-63b068a82a17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2d91a371-3963-40d5-82c5-40f050f07081" xlink:to="loc_us-gaap_OperatingExpenses_5505928c-8e45-4b08-a9a1-63b068a82a17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_693b19ec-792a-4e53-b94b-0e94c1d77dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_49fcbb3a-cb0c-4845-b4df-ad38930d7e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_693b19ec-792a-4e53-b94b-0e94c1d77dba" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_49fcbb3a-cb0c-4845-b4df-ad38930d7e50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_24d78f2b-ace2-4dd5-8552-f486c538ae39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_693b19ec-792a-4e53-b94b-0e94c1d77dba" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_24d78f2b-ace2-4dd5-8552-f486c538ae39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringandstrategictransaction_753d2037-d589-4ab4-ba07-58100915f651" xlink:href="icui-20220630.xsd#icui_Restructuringandstrategictransaction"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_693b19ec-792a-4e53-b94b-0e94c1d77dba" xlink:to="loc_icui_Restructuringandstrategictransaction_753d2037-d589-4ab4-ba07-58100915f651" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contractsettlement_bc661305-00e0-4843-806c-1eda0ba9fbfe" xlink:href="icui-20220630.xsd#icui_Contractsettlement"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_693b19ec-792a-4e53-b94b-0e94c1d77dba" xlink:to="loc_icui_Contractsettlement_bc661305-00e0-4843-806c-1eda0ba9fbfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2f48edc7-f696-4b18-bb4a-25705eec946d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_693b19ec-792a-4e53-b94b-0e94c1d77dba" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2f48edc7-f696-4b18-bb4a-25705eec946d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_dea314bb-ecab-4862-a268-9dc440924150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6d60e7ca-ce45-444d-b4da-b908cfd68b90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_dea314bb-ecab-4862-a268-9dc440924150" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6d60e7ca-ce45-444d-b4da-b908cfd68b90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_f04aea84-951b-45a2-b8cc-ee6412917f75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_dea314bb-ecab-4862-a268-9dc440924150" xlink:to="loc_us-gaap_CostOfRevenue_f04aea84-951b-45a2-b8cc-ee6412917f75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3de6605d-f846-43f0-9386-99c2eafcd377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_edcd200f-ecd3-426b-beae-491b50cfa561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3de6605d-f846-43f0-9386-99c2eafcd377" xlink:to="loc_us-gaap_OperatingIncomeLoss_edcd200f-ecd3-426b-beae-491b50cfa561" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_32de4921-9b53-4d23-b5d1-6d645399ddde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3de6605d-f846-43f0-9386-99c2eafcd377" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_32de4921-9b53-4d23-b5d1-6d645399ddde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_822e92f0-077c-4e2a-8ee0-7fbd0eb0f1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3de6605d-f846-43f0-9386-99c2eafcd377" xlink:to="loc_us-gaap_InterestExpense_822e92f0-077c-4e2a-8ee0-7fbd0eb0f1ef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="icui-20220630.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_10b71fcb-214e-418b-a118-ccaf3bd36856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5473d2f5-8747-4a4d-8bb5-ed312cea3ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_10b71fcb-214e-418b-a118-ccaf3bd36856" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5473d2f5-8747-4a4d-8bb5-ed312cea3ad9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_47aaeaa7-a2cf-4d39-8934-3624fbf502f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_10b71fcb-214e-418b-a118-ccaf3bd36856" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_47aaeaa7-a2cf-4d39-8934-3624fbf502f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9a8eb721-591f-4fde-a895-6b7416e90699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_10b71fcb-214e-418b-a118-ccaf3bd36856" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9a8eb721-591f-4fde-a895-6b7416e90699" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7f02a619-0fdf-4cc0-9a95-6aa6d49a40a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_aa37159a-9150-4841-89f0-a811cba7d9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_7f02a619-0fdf-4cc0-9a95-6aa6d49a40a0" xlink:to="loc_us-gaap_ProfitLoss_aa37159a-9150-4841-89f0-a811cba7d9a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_99e20332-a112-413f-8656-c2b9a92976e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_7f02a619-0fdf-4cc0-9a95-6aa6d49a40a0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_99e20332-a112-413f-8656-c2b9a92976e1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="icui-20220630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c0c43653-d65a-471f-a348-9489394c4670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_us-gaap_ProfitLoss_c0c43653-d65a-471f-a348-9489394c4670" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_733ba7ba-740b-45c9-b869-07adba987979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_733ba7ba-740b-45c9-b869-07adba987979" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AmortizationOfInventoryStepUp_68b2b8f6-f1ce-46e1-88b3-0b29caa8cc80" xlink:href="icui-20220630.xsd#icui_AmortizationOfInventoryStepUp"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_icui_AmortizationOfInventoryStepUp_68b2b8f6-f1ce-46e1-88b3-0b29caa8cc80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_a248861a-2a72-4f16-a506-951e4d037137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_a248861a-2a72-4f16-a506-951e4d037137" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_da99d928-9bf5-4757-8a33-887e54c5bbda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_da99d928-9bf5-4757-8a33-887e54c5bbda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProvisionForWarrantyAndReturns_eed3d635-2f81-4733-86e4-d6c157f537b6" xlink:href="icui-20220630.xsd#icui_ProvisionForWarrantyAndReturns"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_icui_ProvisionForWarrantyAndReturns_eed3d635-2f81-4733-86e4-d6c157f537b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_bf18af77-0cd0-4f98-98dc-9f6b9167174e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_us-gaap_ShareBasedCompensation_bf18af77-0cd0-4f98-98dc-9f6b9167174e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_c00f48b1-b3dc-4f42-a61d-e921fd9bb3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_c00f48b1-b3dc-4f42-a61d-e921fd9bb3f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_f710e700-1581-4fc5-8088-54b5792a8bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_f710e700-1581-4fc5-8088-54b5792a8bf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_43ff954a-98c1-43ba-9a3e-75619bbc2a29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_43ff954a-98c1-43ba-9a3e-75619bbc2a29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sparepartsusage_0e2d1ad1-e3d6-4185-a691-96ec72e6fd48" xlink:href="icui-20220630.xsd#icui_Sparepartsusage"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_icui_Sparepartsusage_0e2d1ad1-e3d6-4185-a691-96ec72e6fd48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_86e4642c-e0cb-4017-abd1-ea7af01621e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_86e4642c-e0cb-4017-abd1-ea7af01621e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ec9b8b66-0d3b-45a0-9a28-5daba6c47fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ec9b8b66-0d3b-45a0-9a28-5daba6c47fc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_794aa099-1397-498e-90a7-3896b63c7785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_794aa099-1397-498e-90a7-3896b63c7785" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5b9409be-f39c-4613-b847-535e58aef8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5b9409be-f39c-4613-b847-535e58aef8f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_0d88f0e2-cbeb-407d-8083-e34ec818d3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_0d88f0e2-cbeb-407d-8083-e34ec818d3a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_529e6a0f-2161-4731-b0e4-414450b81624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_529e6a0f-2161-4731-b0e4-414450b81624" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_17044192-906a-44b6-accb-d2aaa0dcedb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_17044192-906a-44b6-accb-d2aaa0dcedb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_bb9bab61-de6d-4911-a4f0-c6edddd37b75" xlink:href="icui-20220630.xsd#icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_bb9bab61-de6d-4911-a4f0-c6edddd37b75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8489fe1f-514f-4be1-8b65-01df33d3d69d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19e62d23-6fd8-463d-962a-123428ffa8a7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8489fe1f-514f-4be1-8b65-01df33d3d69d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ef98208-64c1-43c0-b3e6-888665f3b108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_efc4a93f-1256-49c7-b485-bfa6206e6afb" xlink:href="icui-20220630.xsd#icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ef98208-64c1-43c0-b3e6-888665f3b108" xlink:to="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_efc4a93f-1256-49c7-b485-bfa6206e6afb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_227d6682-844b-46c7-abeb-f3d1dab6122c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ef98208-64c1-43c0-b3e6-888665f3b108" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_227d6682-844b-46c7-abeb-f3d1dab6122c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_0f632e89-4fb8-4daa-ac50-bdf7fb52e366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ef98208-64c1-43c0-b3e6-888665f3b108" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_0f632e89-4fb8-4daa-ac50-bdf7fb52e366" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_6487c7dc-6dfe-4ea3-9f00-63c4d8bbecc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ef98208-64c1-43c0-b3e6-888665f3b108" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_6487c7dc-6dfe-4ea3-9f00-63c4d8bbecc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_dc175500-b723-42a2-a6f2-aaa2117ba640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ef98208-64c1-43c0-b3e6-888665f3b108" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_dc175500-b723-42a2-a6f2-aaa2117ba640" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7ea07b4c-b668-4be8-b1f0-dbe3c09c96c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ef98208-64c1-43c0-b3e6-888665f3b108" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7ea07b4c-b668-4be8-b1f0-dbe3c09c96c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6b9ce61b-d988-4928-a5b1-f61f9dddc11c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6554f887-420d-459a-b62c-6595d3eed607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6b9ce61b-d988-4928-a5b1-f61f9dddc11c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6554f887-420d-459a-b62c-6595d3eed607" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_6815e0e2-1eff-4d8c-8b82-cc92460458d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6b9ce61b-d988-4928-a5b1-f61f9dddc11c" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_6815e0e2-1eff-4d8c-8b82-cc92460458d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ca24c5e9-6b04-4728-aa6b-d77cb517d25b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6b9ce61b-d988-4928-a5b1-f61f9dddc11c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ca24c5e9-6b04-4728-aa6b-d77cb517d25b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_1facc533-a4e9-4a17-8194-cb8f43b451d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6b9ce61b-d988-4928-a5b1-f61f9dddc11c" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_1facc533-a4e9-4a17-8194-cb8f43b451d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_b312f52e-77a6-4354-acd6-f35f5dbc35e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6b9ce61b-d988-4928-a5b1-f61f9dddc11c" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_b312f52e-77a6-4354-acd6-f35f5dbc35e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_21b49cbb-ac33-473c-a215-7d8bdad94514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6b9ce61b-d988-4928-a5b1-f61f9dddc11c" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_21b49cbb-ac33-473c-a215-7d8bdad94514" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_92af29d0-12be-4d99-9c23-5e2078f7e414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ed5ad5f0-b55b-4030-9a8b-b75edf4fe4de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_92af29d0-12be-4d99-9c23-5e2078f7e414" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ed5ad5f0-b55b-4030-9a8b-b75edf4fe4de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d3d3161f-423f-4a69-ac98-ebdb50d8f033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_92af29d0-12be-4d99-9c23-5e2078f7e414" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d3d3161f-423f-4a69-ac98-ebdb50d8f033" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_31d9986b-81a5-4e6d-8e8e-09a67fa95872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_92af29d0-12be-4d99-9c23-5e2078f7e414" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_31d9986b-81a5-4e6d-8e8e-09a67fa95872" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_e84bb064-2a1c-41d7-8606-75d875137b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_92af29d0-12be-4d99-9c23-5e2078f7e414" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_e84bb064-2a1c-41d7-8606-75d875137b8e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InventoriesDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e9c83e85-7d41-4c6a-8617-865ece100eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_fc927a72-f9f5-449f-bbbc-da4c8d5f0d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e9c83e85-7d41-4c6a-8617-865ece100eeb" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_fc927a72-f9f5-449f-bbbc-da4c8d5f0d4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_5dbbf2e9-56d7-4d11-855e-4484764a9b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e9c83e85-7d41-4c6a-8617-865ece100eeb" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_5dbbf2e9-56d7-4d11-855e-4484764a9b49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_ba2505b8-528a-4c75-a363-08b2330ee36d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e9c83e85-7d41-4c6a-8617-865ece100eeb" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_ba2505b8-528a-4c75-a363-08b2330ee36d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#PropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a22d6001-cf31-489e-be19-f62d1cc7ba31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_f85961aa-8770-4d69-ba96-3aadb9f92e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_a22d6001-cf31-489e-be19-f62d1cc7ba31" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_f85961aa-8770-4d69-ba96-3aadb9f92e36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0397a9d4-078d-4f42-aba5-97a30bba61ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_a22d6001-cf31-489e-be19-f62d1cc7ba31" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0397a9d4-078d-4f42-aba5-97a30bba61ec" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>icui-20220630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b855b77c-6988-4216-8748-36632a973ac3,g:ab2a959a-be44-44c8-8165-c7a4fa090087-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="icui-20220630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" id="i86f5cb385c5a4ac38b4fe613b0ab985a_CondensedConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b47d6a4d-667b-4938-afe9-1b946fc50d36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b47d6a4d-667b-4938-afe9-1b946fc50d36" xlink:to="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dbe229dc-f1e0-4dc9-a9f8-36f60845ce66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dbe229dc-f1e0-4dc9-a9f8-36f60845ce66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_7ff64042-b935-4bd1-b063-23ad895ae038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_7ff64042-b935-4bd1-b063-23ad895ae038" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_505767a9-adf0-42d8-941f-28941ed68cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_505767a9-adf0-42d8-941f-28941ed68cbd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_c9a465a7-f6e8-4573-a647-746ba5e81017" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_c9a465a7-f6e8-4573-a647-746ba5e81017" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8ac34480-0ef1-450b-9f63-bce2087e852a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:to="loc_us-gaap_InventoryNet_8ac34480-0ef1-450b-9f63-bce2087e852a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_a127bf93-e190-4e05-9ca4-1433d09fac43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:to="loc_us-gaap_PrepaidTaxes_a127bf93-e190-4e05-9ca4-1433d09fac43" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_dc01b927-4fa0-4d1a-b132-f2520f7f8d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_dc01b927-4fa0-4d1a-b132-f2520f7f8d7d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_109fd4a8-4f7d-4819-b7dd-590c9dbbd973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:to="loc_us-gaap_AssetsCurrent_109fd4a8-4f7d-4819-b7dd-590c9dbbd973" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_017ea2c3-e03a-4eab-a7b2-34fcc5011c59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_017ea2c3-e03a-4eab-a7b2-34fcc5011c59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3a14c95e-af1e-449a-ad3e-8176adf5a91d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3a14c95e-af1e-449a-ad3e-8176adf5a91d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_2f851da1-bcae-4e54-b74b-11f88514b9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_2f851da1-bcae-4e54-b74b-11f88514b9c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c39e9af7-6045-4f7d-b64f-11f297116d78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_Goodwill_c39e9af7-6045-4f7d-b64f-11f297116d78" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b529e28e-bf8c-4001-b8b2-a4d24fee699f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b529e28e-bf8c-4001-b8b2-a4d24fee699f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_940b6fc0-6770-40c0-a476-0194e5bdf472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_940b6fc0-6770-40c0-a476-0194e5bdf472" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c9d18569-1830-4caf-9ff0-e31aae3024e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c9d18569-1830-4caf-9ff0-e31aae3024e3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3cd56acf-ed94-4d1a-bb8b-8ac681c155d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_Assets_3cd56acf-ed94-4d1a-bb8b-8ac681c155d9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b47d6a4d-667b-4938-afe9-1b946fc50d36" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_d45bc681-da80-480b-81d2-012d6c5aedc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_d45bc681-da80-480b-81d2-012d6c5aedc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_39a113cd-cf53-4b4d-a808-dcb74dc65e42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d45bc681-da80-480b-81d2-012d6c5aedc5" xlink:to="loc_us-gaap_AccountsPayableCurrent_39a113cd-cf53-4b4d-a808-dcb74dc65e42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_d24af433-0db4-4aea-88f0-9415b4278cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d45bc681-da80-480b-81d2-012d6c5aedc5" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_d24af433-0db4-4aea-88f0-9415b4278cb4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_e38100f5-eb40-4a94-b5b6-719d4e8c3e95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d45bc681-da80-480b-81d2-012d6c5aedc5" xlink:to="loc_us-gaap_LongTermDebtCurrent_e38100f5-eb40-4a94-b5b6-719d4e8c3e95" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_0972bf76-22f7-4d6e-938e-633dab5cd66d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d45bc681-da80-480b-81d2-012d6c5aedc5" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_0972bf76-22f7-4d6e-938e-633dab5cd66d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_aa1fd095-8ef3-4e5f-8b44-628a46cf955c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d45bc681-da80-480b-81d2-012d6c5aedc5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_aa1fd095-8ef3-4e5f-8b44-628a46cf955c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_423f19c9-4f15-41f3-bf63-83a09607615a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d45bc681-da80-480b-81d2-012d6c5aedc5" xlink:to="loc_us-gaap_LiabilitiesCurrent_423f19c9-4f15-41f3-bf63-83a09607615a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_6176f05f-c035-4c02-a2ba-b78d59d30673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_6176f05f-c035-4c02-a2ba-b78d59d30673" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_17723f70-513b-470f-833a-f645236a36b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_17723f70-513b-470f-833a-f645236a36b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a45a8b5a-090b-4304-a188-e751099c6a23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a45a8b5a-090b-4304-a188-e751099c6a23" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_91e37836-7d6c-41c2-9d76-e7392d02295a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_91e37836-7d6c-41c2-9d76-e7392d02295a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_ecd3bbbb-b418-46a4-b329-f95b914a507c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_ecd3bbbb-b418-46a4-b329-f95b914a507c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_eac3a6e3-b66a-439b-8922-1d90e7776233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_CommitmentsAndContingencies_eac3a6e3-b66a-439b-8922-1d90e7776233" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_5b112b06-12bc-4726-8d65-5a1e99c0c1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:to="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_5b112b06-12bc-4726-8d65-5a1e99c0c1a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_14def67c-c973-4b3c-ba2d-a260014f33d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:to="loc_us-gaap_CommonStockValue_14def67c-c973-4b3c-ba2d-a260014f33d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_05dbfa36-0147-481a-984b-ecec707450a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_05dbfa36-0147-481a-984b-ecec707450a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_dfeaacf2-32a6-4ca8-90db-f46f4d56e526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:to="loc_us-gaap_TreasuryStockValue_dfeaacf2-32a6-4ca8-90db-f46f4d56e526" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_993e5183-8b4c-4eeb-b799-7c6118fec20c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_993e5183-8b4c-4eeb-b799-7c6118fec20c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a2c661aa-bed2-485f-b09e-4f9b526b39c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a2c661aa-bed2-485f-b09e-4f9b526b39c5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1dff8dec-2084-4966-b41b-2d6c0eb0040f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1dff8dec-2084-4966-b41b-2d6c0eb0040f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d571f69d-e03a-476c-b9a3-b6a09d9e5e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_d571f69d-e03a-476c-b9a3-b6a09d9e5e24" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_fcb892ae-6d72-42bd-990e-4a74e8943fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b47d6a4d-667b-4938-afe9-1b946fc50d36" xlink:to="loc_us-gaap_StatementTable_fcb892ae-6d72-42bd-990e-4a74e8943fd5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_248599b4-550f-48f2-bdbe-575b67ad60a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_fcb892ae-6d72-42bd-990e-4a74e8943fd5" xlink:to="loc_srt_StatementScenarioAxis_248599b4-550f-48f2-bdbe-575b67ad60a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_248599b4-550f-48f2-bdbe-575b67ad60a4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_248599b4-550f-48f2-bdbe-575b67ad60a4" xlink:to="loc_srt_ScenarioUnspecifiedDomain_248599b4-550f-48f2-bdbe-575b67ad60a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b104f8c5-9095-4ec3-b235-b70e46901f9e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_248599b4-550f-48f2-bdbe-575b67ad60a4" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b104f8c5-9095-4ec3-b235-b70e46901f9e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="icui-20220630.xsd#CondensedConsolidatedStatementsofIncome"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="extended" id="i5ef5fa9577d4493baddabf7fcd84adeb_CondensedConsolidatedStatementsofIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_ad12ed62-5b36-43ca-a147-b6c10810a7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_RevenuesAbstract_ad12ed62-5b36-43ca-a147-b6c10810a7a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b726a3be-8274-405b-970b-b45df44875ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_ad12ed62-5b36-43ca-a147-b6c10810a7a6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b726a3be-8274-405b-970b-b45df44875ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_0228241d-d212-4796-b54e-7cb5b4a177ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_ad12ed62-5b36-43ca-a147-b6c10810a7a6" xlink:to="loc_us-gaap_CostOfRevenue_0228241d-d212-4796-b54e-7cb5b4a177ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c0db6e5a-8cca-48cc-aadd-4bef699d1dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_ad12ed62-5b36-43ca-a147-b6c10810a7a6" xlink:to="loc_us-gaap_GrossProfit_c0db6e5a-8cca-48cc-aadd-4bef699d1dd1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_f9eca9d7-e0fc-4c0c-83af-416ade2d6e49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_OperatingExpensesAbstract_f9eca9d7-e0fc-4c0c-83af-416ade2d6e49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_255f406e-7a2f-43ba-b2d4-2ff6deb52528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f9eca9d7-e0fc-4c0c-83af-416ade2d6e49" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_255f406e-7a2f-43ba-b2d4-2ff6deb52528" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_7e629245-9174-4978-9437-dd3ddc52c015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f9eca9d7-e0fc-4c0c-83af-416ade2d6e49" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_7e629245-9174-4978-9437-dd3ddc52c015" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringandstrategictransaction_7a85c9e0-e314-43af-95c1-1c0fc3cced66" xlink:href="icui-20220630.xsd#icui_Restructuringandstrategictransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f9eca9d7-e0fc-4c0c-83af-416ade2d6e49" xlink:to="loc_icui_Restructuringandstrategictransaction_7a85c9e0-e314-43af-95c1-1c0fc3cced66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_727299d3-2970-4a76-9e1c-8762f6de7810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f9eca9d7-e0fc-4c0c-83af-416ade2d6e49" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_727299d3-2970-4a76-9e1c-8762f6de7810" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contractsettlement_34e5af69-13a9-457a-aa87-fafe84752ec6" xlink:href="icui-20220630.xsd#icui_Contractsettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f9eca9d7-e0fc-4c0c-83af-416ade2d6e49" xlink:to="loc_icui_Contractsettlement_34e5af69-13a9-457a-aa87-fafe84752ec6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_942c6756-903a-42e9-b888-381d54b777ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f9eca9d7-e0fc-4c0c-83af-416ade2d6e49" xlink:to="loc_us-gaap_OperatingExpenses_942c6756-903a-42e9-b888-381d54b777ae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1b316604-26c9-4afa-baa7-71023e54bb06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_OperatingIncomeLoss_1b316604-26c9-4afa-baa7-71023e54bb06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_1fb62884-1b7b-491a-a9c9-bc9e69fd1443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_InterestExpense_1fb62884-1b7b-491a-a9c9-bc9e69fd1443" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_129aa3e3-49df-4d5f-8055-a482f2c95650" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_129aa3e3-49df-4d5f-8055-a482f2c95650" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bdd7445c-5d82-47b6-9fab-af4af1c4b9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bdd7445c-5d82-47b6-9fab-af4af1c4b9f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_594b278a-9e8f-49ac-974e-951fb74cf715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_594b278a-9e8f-49ac-974e-951fb74cf715" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_56690e9d-a266-41ae-9254-ffca3aa7b0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_ProfitLoss_56690e9d-a266-41ae-9254-ffca3aa7b0aa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8cd99568-f1b9-4601-a9cd-fc9e7cc8346f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_EarningsPerShareAbstract_8cd99568-f1b9-4601-a9cd-fc9e7cc8346f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_cf7cac77-43d2-4995-b598-7d3b8c4bf542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8cd99568-f1b9-4601-a9cd-fc9e7cc8346f" xlink:to="loc_us-gaap_EarningsPerShareBasic_cf7cac77-43d2-4995-b598-7d3b8c4bf542" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_27318880-c35b-44a6-9221-c97741df3359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8cd99568-f1b9-4601-a9cd-fc9e7cc8346f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_27318880-c35b-44a6-9221-c97741df3359" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bf5f4999-0fbe-4464-b434-2b4fe081ef52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bf5f4999-0fbe-4464-b434-2b4fe081ef52" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e80f349c-c8a0-4c92-ad46-8ba06ce83098" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bf5f4999-0fbe-4464-b434-2b4fe081ef52" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e80f349c-c8a0-4c92-ad46-8ba06ce83098" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6a70263f-c753-48e4-bf76-b2254459609c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bf5f4999-0fbe-4464-b434-2b4fe081ef52" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6a70263f-c753-48e4-bf76-b2254459609c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e7fa286e-8eb0-4add-8f65-2e0cb5d0ff5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_StatementTable_e7fa286e-8eb0-4add-8f65-2e0cb5d0ff5a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ffb8e771-ded6-489e-ad15-a53e512a9fa0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e7fa286e-8eb0-4add-8f65-2e0cb5d0ff5a" xlink:to="loc_srt_ProductOrServiceAxis_ffb8e771-ded6-489e-ad15-a53e512a9fa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ffb8e771-ded6-489e-ad15-a53e512a9fa0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ffb8e771-ded6-489e-ad15-a53e512a9fa0" xlink:to="loc_srt_ProductsAndServicesDomain_ffb8e771-ded6-489e-ad15-a53e512a9fa0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cbba0a0d-d93a-4236-ae92-aa7547de0ea5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ffb8e771-ded6-489e-ad15-a53e512a9fa0" xlink:to="loc_srt_ProductsAndServicesDomain_cbba0a0d-d93a-4236-ae92-aa7547de0ea5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="icui-20220630.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended" id="i1d67d2580ca54127925d6e1b384b25ca_CondensedConsolidatedStatementsofComprehensiveIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e24af8b1-fc00-4891-81a1-6653ee46471e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_df0063d8-4988-4ca4-a43b-7578dd5e1e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e24af8b1-fc00-4891-81a1-6653ee46471e" xlink:to="loc_us-gaap_ProfitLoss_df0063d8-4988-4ca4-a43b-7578dd5e1e33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e2cdffbd-73b7-4a48-8bed-8029b3217809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e24af8b1-fc00-4891-81a1-6653ee46471e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e2cdffbd-73b7-4a48-8bed-8029b3217809" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5e505edb-8695-4516-9d65-39f2ef2c0c15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e2cdffbd-73b7-4a48-8bed-8029b3217809" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5e505edb-8695-4516-9d65-39f2ef2c0c15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a8038e84-f611-4347-821d-cdbd3f94d95e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e2cdffbd-73b7-4a48-8bed-8029b3217809" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a8038e84-f611-4347-821d-cdbd3f94d95e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4978692d-d14d-4702-a70d-2f3982ea79fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e2cdffbd-73b7-4a48-8bed-8029b3217809" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4978692d-d14d-4702-a70d-2f3982ea79fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8792d343-836d-4d2e-bb08-9de78d15b3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e2cdffbd-73b7-4a48-8bed-8029b3217809" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8792d343-836d-4d2e-bb08-9de78d15b3fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e217b3e7-1395-413b-a4d5-35a25c8217b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e24af8b1-fc00-4891-81a1-6653ee46471e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e217b3e7-1395-413b-a4d5-35a25c8217b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_941dc6e7-a8f9-4718-a3b9-7bdf58698478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e24af8b1-fc00-4891-81a1-6653ee46471e" xlink:to="loc_us-gaap_StatementTable_941dc6e7-a8f9-4718-a3b9-7bdf58698478" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_0f1eeaaf-dd4f-4a1d-a91b-266288c3877b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_941dc6e7-a8f9-4718-a3b9-7bdf58698478" xlink:to="loc_srt_StatementScenarioAxis_0f1eeaaf-dd4f-4a1d-a91b-266288c3877b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0f1eeaaf-dd4f-4a1d-a91b-266288c3877b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_0f1eeaaf-dd4f-4a1d-a91b-266288c3877b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0f1eeaaf-dd4f-4a1d-a91b-266288c3877b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_117d62f2-64c6-4a16-b966-7cfa62235a9b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_0f1eeaaf-dd4f-4a1d-a91b-266288c3877b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_117d62f2-64c6-4a16-b966-7cfa62235a9b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement" xlink:type="simple" xlink:href="icui-20220630.xsd#CondensedConsolidatedStatementsofStockholdersEquityStatement"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement" xlink:type="extended" id="i2a31928ee9aa4b3aa70817c9aa88000f_CondensedConsolidatedStatementsofStockholdersEquityStatement">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9380ff01-7015-4ba2-ab2c-5238e1287fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9380ff01-7015-4ba2-ab2c-5238e1287fd1" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4e7ee1f4-eabb-42a4-b7fc-05630b2a5635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4e7ee1f4-eabb-42a4-b7fc-05630b2a5635" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_97f8edaf-7e7c-4b19-88e1-cf8f8bbdddb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_StockholdersEquity_97f8edaf-7e7c-4b19-88e1-cf8f8bbdddb9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e17ab5f4-3e86-475e-9585-d7aaa6ae9b23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e17ab5f4-3e86-475e-9585-d7aaa6ae9b23" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_778512ea-1c5c-42aa-ae4b-184fb8d4ec0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_778512ea-1c5c-42aa-ae4b-184fb8d4ec0d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_2b36e847-6a9b-4740-8600-745c46a9defc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_2b36e847-6a9b-4740-8600-745c46a9defc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_7285c145-f0f1-4c65-92cb-ec2ae0b08e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_7285c145-f0f1-4c65-92cb-ec2ae0b08e3f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_59792255-898e-429c-adf7-e7e780a40e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_59792255-898e-429c-adf7-e7e780a40e71" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_89e3ef3b-f002-4a67-a18e-81855c03d1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_89e3ef3b-f002-4a67-a18e-81855c03d1e6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_031f591d-3e7c-410e-a1d7-a52120ba6c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_031f591d-3e7c-410e-a1d7-a52120ba6c0f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e61ca260-8bc9-4aeb-8382-94a194046e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e61ca260-8bc9-4aeb-8382-94a194046e24" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_88d21e57-0230-4a89-8036-66add0212cce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_88d21e57-0230-4a89-8036-66add0212cce" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_396321ee-b439-441a-b758-54c4060d078d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_NetIncomeLoss_396321ee-b439-441a-b758-54c4060d078d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5c01d486-d119-4a1a-863c-839280220f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7089df9f-c281-41cc-910e-fc7f00ecd58f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_aa494eb1-0d0e-461b-86c1-f15fec4886b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_aa494eb1-0d0e-461b-86c1-f15fec4886b2" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7a4f49a1-8a9a-4aa0-8fcc-82a31e0b19fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9380ff01-7015-4ba2-ab2c-5238e1287fd1" xlink:to="loc_us-gaap_StatementTable_7a4f49a1-8a9a-4aa0-8fcc-82a31e0b19fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_937cb51b-581e-4c48-bdb1-cfb3323e3906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7a4f49a1-8a9a-4aa0-8fcc-82a31e0b19fd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_937cb51b-581e-4c48-bdb1-cfb3323e3906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_937cb51b-581e-4c48-bdb1-cfb3323e3906_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_937cb51b-581e-4c48-bdb1-cfb3323e3906" xlink:to="loc_us-gaap_EquityComponentDomain_937cb51b-581e-4c48-bdb1-cfb3323e3906_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_130bdc9f-0020-4fe7-90a7-3b26102b92c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_937cb51b-581e-4c48-bdb1-cfb3323e3906" xlink:to="loc_us-gaap_EquityComponentDomain_130bdc9f-0020-4fe7-90a7-3b26102b92c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CommonStockSharesMember_b9f1d928-f080-4b58-b855-4c024c13fddc" xlink:href="icui-20220630.xsd#icui_CommonStockSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_130bdc9f-0020-4fe7-90a7-3b26102b92c9" xlink:to="loc_icui_CommonStockSharesMember_b9f1d928-f080-4b58-b855-4c024c13fddc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f0637149-1f75-4ec1-aaef-bc103c6065c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_130bdc9f-0020-4fe7-90a7-3b26102b92c9" xlink:to="loc_us-gaap_CommonStockMember_f0637149-1f75-4ec1-aaef-bc103c6065c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d3fbc4e0-ee25-465b-9cee-249e1d2cd7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_130bdc9f-0020-4fe7-90a7-3b26102b92c9" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d3fbc4e0-ee25-465b-9cee-249e1d2cd7ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_375e4e6b-070f-4e94-93af-df6dd430d81d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_130bdc9f-0020-4fe7-90a7-3b26102b92c9" xlink:to="loc_us-gaap_TreasuryStockMember_375e4e6b-070f-4e94-93af-df6dd430d81d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_42b2a62e-d02c-4f29-8a6c-1c83371f91d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_130bdc9f-0020-4fe7-90a7-3b26102b92c9" xlink:to="loc_us-gaap_RetainedEarningsMember_42b2a62e-d02c-4f29-8a6c-1c83371f91d7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c2c430cd-7d32-42e9-b43b-e169c7f34744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_130bdc9f-0020-4fe7-90a7-3b26102b92c9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c2c430cd-7d32-42e9-b43b-e169c7f34744" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="icui-20220630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended" id="ie04b20be52eb4a528f60823f32d7f1de_CondensedConsolidatedStatementsofCashFlows">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_45fd7634-5e29-4a42-954f-1faa078bd875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_1a6a4fb7-ce78-431c-a29d-3b136a6ff77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_45fd7634-5e29-4a42-954f-1faa078bd875" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_1a6a4fb7-ce78-431c-a29d-3b136a6ff77f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_a8c409c1-c114-4848-9949-e30bb5048220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_1a6a4fb7-ce78-431c-a29d-3b136a6ff77f" xlink:to="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_a8c409c1-c114-4848-9949-e30bb5048220" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_a8c409c1-c114-4848-9949-e30bb5048220" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_41783692-9060-439a-89a6-8f150b91bb18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_ProfitLoss_41783692-9060-439a-89a6-8f150b91bb18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_520e46bf-fcc9-4b4e-a2d3-698ec362764f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_520e46bf-fcc9-4b4e-a2d3-698ec362764f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AmortizationOfInventoryStepUp_885052bd-be2a-425e-8aa8-1dee111df9b0" xlink:href="icui-20220630.xsd#icui_AmortizationOfInventoryStepUp"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_icui_AmortizationOfInventoryStepUp_885052bd-be2a-425e-8aa8-1dee111df9b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_e4e6ddd6-3a6c-444d-8d2c-e6d82187ca1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_e4e6ddd6-3a6c-444d-8d2c-e6d82187ca1c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_5b655420-2d10-4475-801f-4a72ab009a00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_5b655420-2d10-4475-801f-4a72ab009a00" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProvisionForWarrantyAndReturns_697e5cf0-23fd-4500-b9c9-08d79c2c3d58" xlink:href="icui-20220630.xsd#icui_ProvisionForWarrantyAndReturns"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_icui_ProvisionForWarrantyAndReturns_697e5cf0-23fd-4500-b9c9-08d79c2c3d58" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c34f2493-901a-4ae3-ade6-f2d2915d422c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_ShareBasedCompensation_c34f2493-901a-4ae3-ade6-f2d2915d422c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_3c973b67-21d6-4f5b-86bb-f9d3224c0e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_3c973b67-21d6-4f5b-86bb-f9d3224c0e7e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_a44bab24-c18e-4e00-a2c6-4e92c55e476e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_a44bab24-c18e-4e00-a2c6-4e92c55e476e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_ebc96f8b-15f2-471e-9bfe-01dd8830a7a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_ebc96f8b-15f2-471e-9bfe-01dd8830a7a2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5807f66c-bcb1-4387-a7bb-ee66bbfa5517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5807f66c-bcb1-4387-a7bb-ee66bbfa5517" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sparepartsusage_bc40b1a5-8b3f-40e9-940e-767a6652eef4" xlink:href="icui-20220630.xsd#icui_Sparepartsusage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_icui_Sparepartsusage_bc40b1a5-8b3f-40e9-940e-767a6652eef4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_521a3e3c-893c-4eea-ad98-875cfa78aae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_521a3e3c-893c-4eea-ad98-875cfa78aae9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_417252f5-306a-456d-9b22-f1068756fa55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_417252f5-306a-456d-9b22-f1068756fa55" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1e88bd71-6525-411a-bbdf-98d75602a160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1e88bd71-6525-411a-bbdf-98d75602a160" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2cf61349-debf-4b4c-9276-dbe62e24dd5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2cf61349-debf-4b4c-9276-dbe62e24dd5f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9ccb93aa-9b9f-42a0-adf8-8864f2f2f98e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9ccb93aa-9b9f-42a0-adf8-8864f2f2f98e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f016c56f-1297-49cf-97c4-a15283dd1125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f016c56f-1297-49cf-97c4-a15283dd1125" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7c222259-5621-4b10-a885-1d33f84ba28f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7c222259-5621-4b10-a885-1d33f84ba28f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_0b281f78-c42e-4fa9-b1c9-1e5893ae65d7" xlink:href="icui-20220630.xsd#icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_0b281f78-c42e-4fa9-b1c9-1e5893ae65d7" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c3aeafa-fa46-45ff-8a5f-91940a9df3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c3aeafa-fa46-45ff-8a5f-91940a9df3cb" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df72a101-9ea9-41b0-849f-713656b85a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_a8c409c1-c114-4848-9949-e30bb5048220" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df72a101-9ea9-41b0-849f-713656b85a0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a7a79476-0bdd-4772-aeac-04d2ce1f9465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df72a101-9ea9-41b0-849f-713656b85a0f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a7a79476-0bdd-4772-aeac-04d2ce1f9465" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_66e2144f-1a52-4c2b-b589-6dc6aff69ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df72a101-9ea9-41b0-849f-713656b85a0f" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_66e2144f-1a52-4c2b-b589-6dc6aff69ed8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_44c8d1dd-09b3-4555-b39f-fec08d5d48ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df72a101-9ea9-41b0-849f-713656b85a0f" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_44c8d1dd-09b3-4555-b39f-fec08d5d48ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_a82aa1cc-d5fd-47e5-99af-f72162368e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df72a101-9ea9-41b0-849f-713656b85a0f" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_a82aa1cc-d5fd-47e5-99af-f72162368e3e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_6884046e-6ecf-4172-9aa0-742e4c3948fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df72a101-9ea9-41b0-849f-713656b85a0f" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_6884046e-6ecf-4172-9aa0-742e4c3948fc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_021c46e8-35c1-4e55-9c89-9dd97d1e5a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df72a101-9ea9-41b0-849f-713656b85a0f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_021c46e8-35c1-4e55-9c89-9dd97d1e5a8d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_a8c409c1-c114-4848-9949-e30bb5048220" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_7a898c82-2f97-48cd-8c54-c9660829394f" xlink:href="icui-20220630.xsd#icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:to="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_7a898c82-2f97-48cd-8c54-c9660829394f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_f9648fc9-4ba0-4001-87b7-4b7d7befb638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_f9648fc9-4ba0-4001-87b7-4b7d7befb638" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_75636ddc-73e0-41ac-a5a3-744cee8746ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_75636ddc-73e0-41ac-a5a3-744cee8746ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_a28b5d61-43fd-402f-a7ab-bafe182bb539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_a28b5d61-43fd-402f-a7ab-bafe182bb539" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_c00e223a-03c9-447a-82f4-cef1739caf47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_c00e223a-03c9-447a-82f4-cef1739caf47" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0e3d1722-0ad2-47e9-8c98-f5aa100159da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0e3d1722-0ad2-47e9-8c98-f5aa100159da" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a6cd387d-ccfa-4425-b2e8-9c040fb5f787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a6cd387d-ccfa-4425-b2e8-9c040fb5f787" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_14a96eb7-ca75-4b4a-9e1a-fa4e859597c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_1a6a4fb7-ce78-431c-a29d-3b136a6ff77f" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_14a96eb7-ca75-4b4a-9e1a-fa4e859597c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_bf2254d8-0032-4c0d-933a-34cb310eb3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_14a96eb7-ca75-4b4a-9e1a-fa4e859597c1" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_bf2254d8-0032-4c0d-933a-34cb310eb3b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fd7a0bac-f7f4-4caa-8135-a4aa0d8e2f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_45fd7634-5e29-4a42-954f-1faa078bd875" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fd7a0bac-f7f4-4caa-8135-a4aa0d8e2f7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_964fab85-22ca-4d5d-b847-498f9d7b44c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_45fd7634-5e29-4a42-954f-1faa078bd875" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_964fab85-22ca-4d5d-b847-498f9d7b44c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_7cf151ab-1e86-453a-b217-9db05bea8956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_45fd7634-5e29-4a42-954f-1faa078bd875" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_7cf151ab-1e86-453a-b217-9db05bea8956" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_13260465-c803-4c3b-8d95-f07875dde7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7cf151ab-1e86-453a-b217-9db05bea8956" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_13260465-c803-4c3b-8d95-f07875dde7da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fff0fc93-228f-483a-9b70-9de2f77b260e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_45fd7634-5e29-4a42-954f-1faa078bd875" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fff0fc93-228f-483a-9b70-9de2f77b260e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_1705a17b-8d65-4e53-9ebe-6148e16db0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fff0fc93-228f-483a-9b70-9de2f77b260e" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_1705a17b-8d65-4e53-9ebe-6148e16db0ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bb648516-de30-4ac2-8b67-944dd9a1e442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fff0fc93-228f-483a-9b70-9de2f77b260e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bb648516-de30-4ac2-8b67-944dd9a1e442" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_334ec3fb-35ca-478a-8ec5-a99dba2f69fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fff0fc93-228f-483a-9b70-9de2f77b260e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_334ec3fb-35ca-478a-8ec5-a99dba2f69fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationAllAcquisitions_45b6ae54-01ba-4e4a-a34f-3007bafad9f8" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationAllAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fff0fc93-228f-483a-9b70-9de2f77b260e" xlink:to="loc_icui_ContingentConsiderationAllAcquisitions_45b6ae54-01ba-4e4a-a34f-3007bafad9f8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GoodwillAcquiredDuringPeriodAllAcquisitions_d891d4ff-5702-4671-9f2b-f6d993ee6d75" xlink:href="icui-20220630.xsd#icui_GoodwillAcquiredDuringPeriodAllAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fff0fc93-228f-483a-9b70-9de2f77b260e" xlink:to="loc_icui_GoodwillAcquiredDuringPeriodAllAcquisitions_d891d4ff-5702-4671-9f2b-f6d993ee6d75" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_ac175cba-38a4-46e9-a44f-6a4c1bb94aec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fff0fc93-228f-483a-9b70-9de2f77b260e" xlink:to="loc_us-gaap_LiabilitiesAssumed1_ac175cba-38a4-46e9-a44f-6a4c1bb94aec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_89554f07-9282-439e-ba0a-f7b1f5d1d8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_45fd7634-5e29-4a42-954f-1faa078bd875" xlink:to="loc_us-gaap_StatementTable_89554f07-9282-439e-ba0a-f7b1f5d1d8d9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_35fddf0b-5dd1-404a-a419-8072f42abbff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_89554f07-9282-439e-ba0a-f7b1f5d1d8d9" xlink:to="loc_srt_StatementScenarioAxis_35fddf0b-5dd1-404a-a419-8072f42abbff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_35fddf0b-5dd1-404a-a419-8072f42abbff_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_35fddf0b-5dd1-404a-a419-8072f42abbff" xlink:to="loc_srt_ScenarioUnspecifiedDomain_35fddf0b-5dd1-404a-a419-8072f42abbff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b25b66b6-8c11-4cb4-9191-65e745472c34" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_35fddf0b-5dd1-404a-a419-8072f42abbff" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b25b66b6-8c11-4cb4-9191-65e745472c34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_705bbee2-1e9f-42aa-b812-275248b0eb20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_89554f07-9282-439e-ba0a-f7b1f5d1d8d9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_705bbee2-1e9f-42aa-b812-275248b0eb20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_705bbee2-1e9f-42aa-b812-275248b0eb20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_705bbee2-1e9f-42aa-b812-275248b0eb20" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_705bbee2-1e9f-42aa-b812-275248b0eb20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_258008f4-e75e-4904-a52c-0007ef4a7e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_705bbee2-1e9f-42aa-b812-275248b0eb20" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_258008f4-e75e-4904-a52c-0007ef4a7e89" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails" xlink:type="extended" id="i7d697e6696ce4856a554490dd1d62337_BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2a1f681b-7017-4791-bdb1-516112e80390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_8f14e07d-14e5-4472-a757-398cd0bf9a37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a1f681b-7017-4791-bdb1-516112e80390" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_8f14e07d-14e5-4472-a757-398cd0bf9a37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_a0abca0a-a9b0-4fc0-aa07-5af8a07c25e6" xlink:href="icui-20220630.xsd#icui_Contingentconsiderationgross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a1f681b-7017-4791-bdb1-516112e80390" xlink:to="loc_icui_Contingentconsiderationgross_a0abca0a-a9b0-4fc0-aa07-5af8a07c25e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_f47e346c-36cc-4092-b3f4-b4d70148166d" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationGrossST"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a1f681b-7017-4791-bdb1-516112e80390" xlink:to="loc_icui_ContingentConsiderationGrossST_f47e346c-36cc-4092-b3f4-b4d70148166d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_83eb5e0e-dd6e-4012-aa11-04fe66f24076" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a1f681b-7017-4791-bdb1-516112e80390" xlink:to="loc_icui_ContingentConsiderationGrossLT_83eb5e0e-dd6e-4012-aa11-04fe66f24076" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationHoldbackLiability_fa0328c7-40e1-4ab4-8086-c49c977f6920" xlink:href="icui-20220630.xsd#icui_BusinessCombinationConsiderationHoldbackLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a1f681b-7017-4791-bdb1-516112e80390" xlink:to="loc_icui_BusinessCombinationConsiderationHoldbackLiability_fa0328c7-40e1-4ab4-8086-c49c977f6920" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d6c0e35f-e274-4bca-871a-d99056fde187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a1f681b-7017-4791-bdb1-516112e80390" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d6c0e35f-e274-4bca-871a-d99056fde187" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_189b68d7-6cd5-40f4-94af-a3dc3011a492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a1f681b-7017-4791-bdb1-516112e80390" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_189b68d7-6cd5-40f4-94af-a3dc3011a492" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_93689f38-b202-4265-bc40-a4dd9505aeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_189b68d7-6cd5-40f4-94af-a3dc3011a492" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_93689f38-b202-4265-bc40-a4dd9505aeb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_93689f38-b202-4265-bc40-a4dd9505aeb9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_93689f38-b202-4265-bc40-a4dd9505aeb9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_93689f38-b202-4265-bc40-a4dd9505aeb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c7d27d74-7f92-44f8-a701-8e907d0c49a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_93689f38-b202-4265-bc40-a4dd9505aeb9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c7d27d74-7f92-44f8-a701-8e907d0c49a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_2724a2c1-1134-4408-8a2a-0b2b72654267" xlink:href="icui-20220630.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c7d27d74-7f92-44f8-a701-8e907d0c49a7" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_2724a2c1-1134-4408-8a2a-0b2b72654267" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#BusinessCombinationsandAssetAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails" xlink:type="extended" id="ib52aea07f82944149a5093189b1ab499_BusinessCombinationsandAssetAcquisitionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c813084d-cb83-4f03-9ec2-4d712421815d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_fd4113db-b1cd-4b2a-81a0-8e217d2f1ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c813084d-cb83-4f03-9ec2-4d712421815d" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_fd4113db-b1cd-4b2a-81a0-8e217d2f1ac6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationTransferredCash_21576ea0-d49a-4372-bc94-a6352c4fb2fa" xlink:href="icui-20220630.xsd#icui_BusinessCombinationConsiderationTransferredCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c813084d-cb83-4f03-9ec2-4d712421815d" xlink:to="loc_icui_BusinessCombinationConsiderationTransferredCash_21576ea0-d49a-4372-bc94-a6352c4fb2fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_51025daa-cdf3-4329-b3c9-4c572e4a672b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c813084d-cb83-4f03-9ec2-4d712421815d" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_51025daa-cdf3-4329-b3c9-4c572e4a672b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_016243e3-9533-4f76-a2b6-476882828cde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c813084d-cb83-4f03-9ec2-4d712421815d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_016243e3-9533-4f76-a2b6-476882828cde" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MinimumStockPriceTargetForEarnOutPayment_0981f38f-3e5c-4823-80b3-9075e444a4bd" xlink:href="icui-20220630.xsd#icui_MinimumStockPriceTargetForEarnOutPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c813084d-cb83-4f03-9ec2-4d712421815d" xlink:to="loc_icui_MinimumStockPriceTargetForEarnOutPayment_0981f38f-3e5c-4823-80b3-9075e444a4bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_b927e3b4-9d21-4fa7-85c0-aee73561565f" xlink:href="icui-20220630.xsd#icui_RequiredShareHoldingOfStockIssuedAtAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c813084d-cb83-4f03-9ec2-4d712421815d" xlink:to="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_b927e3b4-9d21-4fa7-85c0-aee73561565f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae921024-d9f1-4cb7-b85b-ead083624aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c813084d-cb83-4f03-9ec2-4d712421815d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae921024-d9f1-4cb7-b85b-ead083624aa9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_639142bb-47fc-4b01-ab2e-c91ef22853bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae921024-d9f1-4cb7-b85b-ead083624aa9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_639142bb-47fc-4b01-ab2e-c91ef22853bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_639142bb-47fc-4b01-ab2e-c91ef22853bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_639142bb-47fc-4b01-ab2e-c91ef22853bd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_639142bb-47fc-4b01-ab2e-c91ef22853bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cbd60a2b-9787-49f9-818a-19e094f3555a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_639142bb-47fc-4b01-ab2e-c91ef22853bd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cbd60a2b-9787-49f9-818a-19e094f3555a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_1dc12d88-1aae-4e94-8c57-520d4589fd7c" xlink:href="icui-20220630.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cbd60a2b-9787-49f9-818a-19e094f3555a" xlink:to="loc_icui_SmithsMedicalMember_1dc12d88-1aae-4e94-8c57-520d4589fd7c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails" xlink:type="extended" id="iee9f5d62af8e427ca2cadea24bd8ff87_BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_3544d5cb-8d7c-47f8-9f98-ceaa0a524b55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_3544d5cb-8d7c-47f8-9f98-ceaa0a524b55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_67e68a2e-45d8-444c-8086-4cae87049edf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_67e68a2e-45d8-444c-8086-4cae87049edf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_eb976a85-3c08-40a4-9cd9-d64f330bbdee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_eb976a85-3c08-40a4-9cd9-d64f330bbdee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_b0cc08f3-4fc2-4138-862b-1fa82261db8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_b0cc08f3-4fc2-4138-862b-1fa82261db8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_8518f7d2-5feb-4f79-8d0a-0f29b4a0dcbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_8518f7d2-5feb-4f79-8d0a-0f29b4a0dcbf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2dcdeca1-89b5-4196-b9ea-da03008d37c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2dcdeca1-89b5-4196-b9ea-da03008d37c8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a5d9176a-baa1-4e68-becf-caf37cb22e18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a5d9176a-baa1-4e68-becf-caf37cb22e18" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_e515d6ed-5301-47a6-bab6-6c25b9e02889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_e515d6ed-5301-47a6-bab6-6c25b9e02889" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_96ae9486-f708-46bd-a166-3b6661478698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_96ae9486-f708-46bd-a166-3b6661478698" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_3b630478-df1c-4d10-bebc-1c5ff3378bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_3b630478-df1c-4d10-bebc-1c5ff3378bcf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_973c11a6-ebf1-4bda-bf4a-4ef5658251ab" xlink:href="icui-20220630.xsd#icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_973c11a6-ebf1-4bda-bf4a-4ef5658251ab" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_afe28f6a-ec99-47e5-b93f-a6dfd9f17373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_afe28f6a-ec99-47e5-b93f-a6dfd9f17373" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_7d3b95ec-57a4-4355-a7ff-f83ef0affdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_7d3b95ec-57a4-4355-a7ff-f83ef0affdf2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_4c60ea2c-75d1-4e5a-bcd8-b9d7137d3f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_4c60ea2c-75d1-4e5a-bcd8-b9d7137d3f0d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_74bb003b-b4c8-4b93-869d-a136c90f1b14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_74bb003b-b4c8-4b93-869d-a136c90f1b14" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_63e24df1-8840-4920-84d7-4aa8656af46e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_63e24df1-8840-4920-84d7-4aa8656af46e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_a5b8679b-3ba0-4293-a844-6f0a02024f8a" xlink:href="icui-20220630.xsd#icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_a5b8679b-3ba0-4293-a844-6f0a02024f8a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_ece63125-a3cb-4f09-88a0-fdbab6a8e700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_ece63125-a3cb-4f09-88a0-fdbab6a8e700" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_c5543bd1-8e9b-4fcb-b45c-59a48a97d315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_c5543bd1-8e9b-4fcb-b45c-59a48a97d315" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ed0b0ea0-3950-4034-a3c3-4f38cdfbece5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ed0b0ea0-3950-4034-a3c3-4f38cdfbece5" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationGoodwillNonDeductible_ece1c70c-2fc8-46d9-9b56-32e8fa0610fd" xlink:href="icui-20220630.xsd#icui_BusinessCombinationGoodwillNonDeductible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_icui_BusinessCombinationGoodwillNonDeductible_ece1c70c-2fc8-46d9-9b56-32e8fa0610fd" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5ed73875-ed63-4e12-8355-21de1c7f0024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5ed73875-ed63-4e12-8355-21de1c7f0024" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e1067a87-8c3f-48f8-95d8-07cd384b48a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e1067a87-8c3f-48f8-95d8-07cd384b48a3" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_652c3d13-f460-4ae6-bfd5-b080c1391262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_652c3d13-f460-4ae6-bfd5-b080c1391262" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9d272a00-3778-4a4f-b56d-7638bb5a52bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_652c3d13-f460-4ae6-bfd5-b080c1391262" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9d272a00-3778-4a4f-b56d-7638bb5a52bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9d272a00-3778-4a4f-b56d-7638bb5a52bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9d272a00-3778-4a4f-b56d-7638bb5a52bb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9d272a00-3778-4a4f-b56d-7638bb5a52bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a810f65-9a91-460e-a932-95ea01db00fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9d272a00-3778-4a4f-b56d-7638bb5a52bb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a810f65-9a91-460e-a932-95ea01db00fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_2e13f578-1f86-4f53-aa14-b771cf6f96bb" xlink:href="icui-20220630.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a810f65-9a91-460e-a932-95ea01db00fd" xlink:to="loc_icui_SmithsMedicalMember_2e13f578-1f86-4f53-aa14-b771cf6f96bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_35404ca2-dfaa-4fc8-9462-39334bc9b81e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_652c3d13-f460-4ae6-bfd5-b080c1391262" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_35404ca2-dfaa-4fc8-9462-39334bc9b81e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_35404ca2-dfaa-4fc8-9462-39334bc9b81e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_35404ca2-dfaa-4fc8-9462-39334bc9b81e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_35404ca2-dfaa-4fc8-9462-39334bc9b81e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_35404ca2-dfaa-4fc8-9462-39334bc9b81e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_0a4c3397-c654-4ad8-aaa9-42ed97cce626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:to="loc_us-gaap_CustomerRelationshipsMember_0a4c3397-c654-4ad8-aaa9-42ed97cce626" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DevelopedTechnologyMember_159dff12-4423-40d1-919e-73e3cb283db0" xlink:href="icui-20220630.xsd#icui_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:to="loc_icui_DevelopedTechnologyMember_159dff12-4423-40d1-919e-73e3cb283db0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_51239555-d53f-4e90-b889-72275af4a925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_51239555-d53f-4e90-b889-72275af4a925" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_fc2eb94b-2003-4ec3-9c5b-d9b7b74d6001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_fc2eb94b-2003-4ec3-9c5b-d9b7b74d6001" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_eca4e4ad-746e-4730-b0f1-d30ffc50ae31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_eca4e4ad-746e-4730-b0f1-d30ffc50ae31" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_4e909076-8117-4eda-89fb-13e3275eefe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_4e909076-8117-4eda-89fb-13e3275eefe0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_0d02bc01-44ed-4a71-b182-930da175fb0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:to="loc_us-gaap_TrademarksMember_0d02bc01-44ed-4a71-b182-930da175fb0d" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails" xlink:type="extended" id="i17acee6f544c4c6da92d0871c5970e8a_BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_26ef5fb1-132b-43a8-97ed-d8ce90ea0205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_300e5e5b-2055-4f55-82ef-2748cff84dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_26ef5fb1-132b-43a8-97ed-d8ce90ea0205" xlink:to="loc_us-gaap_Revenues_300e5e5b-2055-4f55-82ef-2748cff84dfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_52e7db38-a021-4201-8e73-b22353845a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_26ef5fb1-132b-43a8-97ed-d8ce90ea0205" xlink:to="loc_us-gaap_ProfitLoss_52e7db38-a021-4201-8e73-b22353845a04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_628c4841-76f9-40de-b8e5-14942d0ef356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_26ef5fb1-132b-43a8-97ed-d8ce90ea0205" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_628c4841-76f9-40de-b8e5-14942d0ef356" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6aa80f80-c79f-496c-b59d-3540da78b013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_26ef5fb1-132b-43a8-97ed-d8ce90ea0205" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6aa80f80-c79f-496c-b59d-3540da78b013" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1a6fbcef-e297-445f-94a1-ced977f73499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6aa80f80-c79f-496c-b59d-3540da78b013" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1a6fbcef-e297-445f-94a1-ced977f73499" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a6fbcef-e297-445f-94a1-ced977f73499_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1a6fbcef-e297-445f-94a1-ced977f73499" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a6fbcef-e297-445f-94a1-ced977f73499_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5eda333b-3328-4f62-81cf-97cd0dcac838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1a6fbcef-e297-445f-94a1-ced977f73499" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5eda333b-3328-4f62-81cf-97cd0dcac838" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_908437ec-a481-4293-b7e5-208859ef093d" xlink:href="icui-20220630.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5eda333b-3328-4f62-81cf-97cd0dcac838" xlink:to="loc_icui_SmithsMedicalMember_908437ec-a481-4293-b7e5-208859ef093d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis_d3bf10e3-01e9-49c4-afc5-e19f6b2356c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6aa80f80-c79f-496c-b59d-3540da78b013" xlink:to="loc_us-gaap_NonrecurringAdjustmentAxis_d3bf10e3-01e9-49c4-afc5-e19f6b2356c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_d3bf10e3-01e9-49c4-afc5-e19f6b2356c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_d3bf10e3-01e9-49c4-afc5-e19f6b2356c1" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_d3bf10e3-01e9-49c4-afc5-e19f6b2356c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_ef7381c5-bc05-47d4-a277-28dba0cd44a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_d3bf10e3-01e9-49c4-afc5-e19f6b2356c1" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_ef7381c5-bc05-47d4-a277-28dba0cd44a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_01783c5c-7764-4d64-8e5e-a10b5dc426a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_ef7381c5-bc05-47d4-a277-28dba0cd44a0" xlink:to="loc_us-gaap_AcquisitionRelatedCostsMember_01783c5c-7764-4d64-8e5e-a10b5dc426a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2134a37c-5025-4aaf-bd39-331f309cd9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_cb4f6edb-97c0-4b83-a862-d3daea363349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_157d8cb0-6388-42af-bf74-699b577bb77d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_28d5521d-7d98-4f3a-b5fd-d03ddc4bd2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7000ed9e-d229-4010-826f-16ded94108dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7000ed9e-d229-4010-826f-16ded94108dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1e983772-9fb0-4074-bac2-5883fb02a244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_530f2a30-9ef7-489f-b949-284360119eb4" xlink:href="icui-20220630.xsd#icui_SmithsMedicalMember"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#RestructuringStrategicTransactionandIntegrationLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails" xlink:type="extended" id="ie0ea1957895149fea885a6cdee89b7e2_RestructuringStrategicTransactionandIntegrationLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_8c1a84e3-f2df-421d-aa9d-b994d9273a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_9a02cbd6-0a74-4ca2-b76c-07901053e4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c1a84e3-f2df-421d-aa9d-b994d9273a45" xlink:to="loc_us-gaap_RestructuringReserve_9a02cbd6-0a74-4ca2-b76c-07901053e4fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_25f62d78-8fad-41a5-9a6d-14cdb4f20692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c1a84e3-f2df-421d-aa9d-b994d9273a45" xlink:to="loc_us-gaap_RestructuringCharges_25f62d78-8fad-41a5-9a6d-14cdb4f20692" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_911113b6-82a3-48be-92db-f12a654f9f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c1a84e3-f2df-421d-aa9d-b994d9273a45" xlink:to="loc_us-gaap_PaymentsForRestructuring_911113b6-82a3-48be-92db-f12a654f9f2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_a0291b0d-16e2-4832-bdd3-e9db8d6f2238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c1a84e3-f2df-421d-aa9d-b994d9273a45" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_a0291b0d-16e2-4832-bdd3-e9db8d6f2238" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_1ad903c4-7931-4865-8a6e-981453d0868a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c1a84e3-f2df-421d-aa9d-b994d9273a45" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_1ad903c4-7931-4865-8a6e-981453d0868a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_414f8c54-2fb9-400a-b4fe-5d1d96118498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities_2f8dd12e-8800-45f0-a7d1-66142e912a18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c1a84e3-f2df-421d-aa9d-b994d9273a45" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities_2f8dd12e-8800-45f0-a7d1-66142e912a18" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2c4b9714-904e-491d-a11d-21ce4c78a06b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c1a84e3-f2df-421d-aa9d-b994d9273a45" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2c4b9714-904e-491d-a11d-21ce4c78a06b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_1accaec5-193a-4a4c-b4da-7506d46675b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2c4b9714-904e-491d-a11d-21ce4c78a06b" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_1accaec5-193a-4a4c-b4da-7506d46675b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_1accaec5-193a-4a4c-b4da-7506d46675b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1accaec5-193a-4a4c-b4da-7506d46675b5" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_1accaec5-193a-4a4c-b4da-7506d46675b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_d2d59ae3-3ec1-48cd-a617-e329d966d069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1accaec5-193a-4a4c-b4da-7506d46675b5" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_d2d59ae3-3ec1-48cd-a617-e329d966d069" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_b0f61a4d-536e-4170-aa1f-a9b220e58385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_d2d59ae3-3ec1-48cd-a617-e329d966d069" xlink:to="loc_us-gaap_EmployeeSeveranceMember_b0f61a4d-536e-4170-aa1f-a9b220e58385" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_d10b571e-4adf-4904-a779-bdff03af53d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_d2d59ae3-3ec1-48cd-a617-e329d966d069" xlink:to="loc_us-gaap_FacilityClosingMember_d10b571e-4adf-4904-a779-bdff03af53d3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#RevenueDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RevenueDetails" xlink:type="extended" id="i4c119a288f994daead4efbe4456fe53d_RevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_b3d755c4-1f7b-4bed-b03a-1c5a165fc5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_14ac58b8-b04a-4e1b-81ca-766f4af2ca89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b3d755c4-1f7b-4bed-b03a-1c5a165fc5cb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_14ac58b8-b04a-4e1b-81ca-766f4af2ca89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_12080865-c48c-434a-810c-b94aa39b7f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b3d755c4-1f7b-4bed-b03a-1c5a165fc5cb" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_12080865-c48c-434a-810c-b94aa39b7f0a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8c8bb3e5-10d0-46ff-abb7-5c3e6a1f01b1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_12080865-c48c-434a-810c-b94aa39b7f0a" xlink:to="loc_srt_ProductOrServiceAxis_8c8bb3e5-10d0-46ff-abb7-5c3e6a1f01b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8c8bb3e5-10d0-46ff-abb7-5c3e6a1f01b1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8c8bb3e5-10d0-46ff-abb7-5c3e6a1f01b1" xlink:to="loc_srt_ProductsAndServicesDomain_8c8bb3e5-10d0-46ff-abb7-5c3e6a1f01b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_923fa40c-298d-4ce3-a1db-505eca2fa78b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8c8bb3e5-10d0-46ff-abb7-5c3e6a1f01b1" xlink:to="loc_srt_ProductsAndServicesDomain_923fa40c-298d-4ce3-a1db-505eca2fa78b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember_982702b4-b9fd-4e7d-9a14-d22a44b6ed4f" xlink:href="icui-20220630.xsd#icui_InfusionSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_923fa40c-298d-4ce3-a1db-505eca2fa78b" xlink:to="loc_icui_InfusionSystemsMember_982702b4-b9fd-4e7d-9a14-d22a44b6ed4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember_5f2dbc1c-d08b-4639-b8c1-1429a2b10945" xlink:href="icui-20220630.xsd#icui_EquipmentrevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_923fa40c-298d-4ce3-a1db-505eca2fa78b" xlink:to="loc_icui_EquipmentrevenueMember_5f2dbc1c-d08b-4639-b8c1-1429a2b10945" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember_aeec051b-3c29-4eb8-b217-ccce8c791508" xlink:href="icui-20220630.xsd#icui_SoftwarerevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_923fa40c-298d-4ce3-a1db-505eca2fa78b" xlink:to="loc_icui_SoftwarerevenueMember_aeec051b-3c29-4eb8-b217-ccce8c791508" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#RevenueDisaggregatedRevenuebyGeographyDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails" xlink:type="extended" id="ia319f3f4b985417e9b27f48860a96c1b_RevenueDisaggregatedRevenuebyGeographyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_00f6c491-212c-4b55-8f73-a603056c5c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_74cfd13e-6b56-4a92-9bfa-f4128d4e763c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_00f6c491-212c-4b55-8f73-a603056c5c7e" xlink:to="loc_us-gaap_Revenues_74cfd13e-6b56-4a92-9bfa-f4128d4e763c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f23d1282-a180-423c-b4e0-3b22f6094837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_00f6c491-212c-4b55-8f73-a603056c5c7e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f23d1282-a180-423c-b4e0-3b22f6094837" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b7564e77-0de4-4fb6-af02-92268fe90e75" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f23d1282-a180-423c-b4e0-3b22f6094837" xlink:to="loc_srt_StatementGeographicalAxis_b7564e77-0de4-4fb6-af02-92268fe90e75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b7564e77-0de4-4fb6-af02-92268fe90e75_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_b7564e77-0de4-4fb6-af02-92268fe90e75" xlink:to="loc_srt_SegmentGeographicalDomain_b7564e77-0de4-4fb6-af02-92268fe90e75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ccbe9a36-fbd3-418c-8c46-909427f61ff6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_b7564e77-0de4-4fb6-af02-92268fe90e75" xlink:to="loc_srt_SegmentGeographicalDomain_ccbe9a36-fbd3-418c-8c46-909427f61ff6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_ef0b8a67-c827-4e67-b665-f2189e77317f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ccbe9a36-fbd3-418c-8c46-909427f61ff6" xlink:to="loc_us-gaap_EMEAMember_ef0b8a67-c827-4e67-b665-f2189e77317f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherforeigncountriesMember_b2777b78-fc86-4982-9cf0-e8cb73c0524e" xlink:href="icui-20220630.xsd#icui_OtherforeigncountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ccbe9a36-fbd3-418c-8c46-909427f61ff6" xlink:to="loc_icui_OtherforeigncountriesMember_b2777b78-fc86-4982-9cf0-e8cb73c0524e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignMember_7d8e3433-288d-487e-aec8-64f48d26beb4" xlink:href="icui-20220630.xsd#icui_ForeignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ccbe9a36-fbd3-418c-8c46-909427f61ff6" xlink:to="loc_icui_ForeignMember_7d8e3433-288d-487e-aec8-64f48d26beb4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_52cc0fe6-ea29-4399-ae61-51f5d9c82f18" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ccbe9a36-fbd3-418c-8c46-909427f61ff6" xlink:to="loc_country_US_52cc0fe6-ea29-4399-ae61-51f5d9c82f18" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#RevenueDisaggregatedRevenuebyProductLineDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails" xlink:type="extended" id="i3072cb3c243e4ba88313d18e83f03b81_RevenueDisaggregatedRevenuebyProductLineDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_bb9c241f-21d8-4e75-abcb-cb5f36541d25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_eb40572d-3ebc-4d34-806c-cb790ce942ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bb9c241f-21d8-4e75-abcb-cb5f36541d25" xlink:to="loc_us-gaap_Revenues_eb40572d-3ebc-4d34-806c-cb790ce942ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_55b5c72f-eed2-4f20-90eb-5e8213ff1048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bb9c241f-21d8-4e75-abcb-cb5f36541d25" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_55b5c72f-eed2-4f20-90eb-5e8213ff1048" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e8446bc5-cb53-4960-a1e3-347fb03caa9b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_55b5c72f-eed2-4f20-90eb-5e8213ff1048" xlink:to="loc_srt_ProductOrServiceAxis_e8446bc5-cb53-4960-a1e3-347fb03caa9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e8446bc5-cb53-4960-a1e3-347fb03caa9b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e8446bc5-cb53-4960-a1e3-347fb03caa9b" xlink:to="loc_srt_ProductsAndServicesDomain_e8446bc5-cb53-4960-a1e3-347fb03caa9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e8446bc5-cb53-4960-a1e3-347fb03caa9b" xlink:to="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesMember_cfd440a3-98f2-4f0a-8b9a-aed639f2f013" xlink:href="icui-20220630.xsd#icui_InfusionConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:to="loc_icui_InfusionConsumablesMember_cfd440a3-98f2-4f0a-8b9a-aed639f2f013" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember_c0d4b13a-04d0-429e-b2fe-32d8c69f7392" xlink:href="icui-20220630.xsd#icui_InfusionSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:to="loc_icui_InfusionSystemsMember_c0d4b13a-04d0-429e-b2fe-32d8c69f7392" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IVSolutionsMember_3f1c1c4b-84cc-49bb-8ea8-193210b88b3f" xlink:href="icui-20220630.xsd#icui_IVSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:to="loc_icui_IVSolutionsMember_3f1c1c4b-84cc-49bb-8ea8-193210b88b3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CriticalCareMember_013877ed-4284-4986-bc67-e7bc4001d2e9" xlink:href="icui-20220630.xsd#icui_CriticalCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:to="loc_icui_CriticalCareMember_013877ed-4284-4986-bc67-e7bc4001d2e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesSmithsMedicalMember_b25a03eb-4ee6-4947-9462-dce8f5561ff5" xlink:href="icui-20220630.xsd#icui_InfusionConsumablesSmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:to="loc_icui_InfusionConsumablesSmithsMedicalMember_b25a03eb-4ee6-4947-9462-dce8f5561ff5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_VascularAccessMember_aa524075-1f8d-4327-9269-3563ccc272c3" xlink:href="icui-20220630.xsd#icui_VascularAccessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:to="loc_icui_VascularAccessMember_aa524075-1f8d-4327-9269-3563ccc272c3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_VitalCareMember_fad90faf-45bd-45e8-8258-5cab3b7fd569" xlink:href="icui-20220630.xsd#icui_VitalCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:to="loc_icui_VitalCareMember_fad90faf-45bd-45e8-8258-5cab3b7fd569" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueContractLiabilitiesDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#RevenueContractLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RevenueContractLiabilitiesDetails" xlink:type="extended" id="ia311728dc6b449c9bcbfce0a8a4ece76_RevenueContractLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesLineItems_f9137b00-2541-4636-a4c2-4c10ba1091a1" xlink:href="icui-20220630.xsd#icui_ContractassetandliabilitybalancesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInDeferredRevenueRollForward_e3be2bf7-ab0a-4bf8-ae5b-3139366ef1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInDeferredRevenueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_f9137b00-2541-4636-a4c2-4c10ba1091a1" xlink:to="loc_us-gaap_MovementInDeferredRevenueRollForward_e3be2bf7-ab0a-4bf8-ae5b-3139366ef1f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_7dc18ce7-2f54-4241-978a-f10c3c674d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_f9137b00-2541-4636-a4c2-4c10ba1091a1" xlink:to="loc_us-gaap_ContractWithCustomerLiability_7dc18ce7-2f54-4241-978a-f10c3c674d2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_2dc04c48-c5f3-4be2-82c3-2e9203fbc92a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_f9137b00-2541-4636-a4c2-4c10ba1091a1" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_2dc04c48-c5f3-4be2-82c3-2e9203fbc92a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueAdditions_38edb890-978f-4792-b98f-82cad2b87a81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_f9137b00-2541-4636-a4c2-4c10ba1091a1" xlink:to="loc_us-gaap_DeferredRevenueAdditions_38edb890-978f-4792-b98f-82cad2b87a81" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_31283669-c0c5-443d-b1b1-5505b31da2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_98213d09-9ef5-4b16-b8a7-94a03d8b57e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_f9137b00-2541-4636-a4c2-4c10ba1091a1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_98213d09-9ef5-4b16-b8a7-94a03d8b57e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesTable_ce0c05a2-b94a-413f-90a4-f8380ca24873" xlink:href="icui-20220630.xsd#icui_ContractassetandliabilitybalancesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_f9137b00-2541-4636-a4c2-4c10ba1091a1" xlink:to="loc_icui_ContractassetandliabilitybalancesTable_ce0c05a2-b94a-413f-90a4-f8380ca24873" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7255e9c1-0d3c-40ee-a815-cf74c7cec691" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_ce0c05a2-b94a-413f-90a4-f8380ca24873" xlink:to="loc_srt_ProductOrServiceAxis_7255e9c1-0d3c-40ee-a815-cf74c7cec691" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7255e9c1-0d3c-40ee-a815-cf74c7cec691_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_7255e9c1-0d3c-40ee-a815-cf74c7cec691" xlink:to="loc_srt_ProductsAndServicesDomain_7255e9c1-0d3c-40ee-a815-cf74c7cec691_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e0cadbe8-88bb-4b06-90d6-3dfd101e2015" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_7255e9c1-0d3c-40ee-a815-cf74c7cec691" xlink:to="loc_srt_ProductsAndServicesDomain_e0cadbe8-88bb-4b06-90d6-3dfd101e2015" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember_18b887fc-b075-40a5-8aa9-9161393e4da5" xlink:href="icui-20220630.xsd#icui_EquipmentrevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e0cadbe8-88bb-4b06-90d6-3dfd101e2015" xlink:to="loc_icui_EquipmentrevenueMember_18b887fc-b075-40a5-8aa9-9161393e4da5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember_298a97a4-2b91-45fd-b73f-db1c4bc5607c" xlink:href="icui-20220630.xsd#icui_SoftwarerevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e0cadbe8-88bb-4b06-90d6-3dfd101e2015" xlink:to="loc_icui_SoftwarerevenueMember_298a97a4-2b91-45fd-b73f-db1c4bc5607c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GovernmentGrantRevenueMember_4d4ebd12-9ff5-4cba-a61d-ea41db8942c8" xlink:href="icui-20220630.xsd#icui_GovernmentGrantRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e0cadbe8-88bb-4b06-90d6-3dfd101e2015" xlink:to="loc_icui_GovernmentGrantRevenueMember_4d4ebd12-9ff5-4cba-a61d-ea41db8942c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherDeferredRevenueMember_14221855-7951-48fd-a950-93c1a97f72dd" xlink:href="icui-20220630.xsd#icui_OtherDeferredRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e0cadbe8-88bb-4b06-90d6-3dfd101e2015" xlink:to="loc_icui_OtherDeferredRevenueMember_14221855-7951-48fd-a950-93c1a97f72dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_98a66f02-0063-437b-a695-6fc9f6480530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_ce0c05a2-b94a-413f-90a4-f8380ca24873" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_98a66f02-0063-437b-a695-6fc9f6480530" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98a66f02-0063-437b-a695-6fc9f6480530_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_98a66f02-0063-437b-a695-6fc9f6480530" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98a66f02-0063-437b-a695-6fc9f6480530_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81ab58ee-434d-41cb-b399-5cc518e6ebf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_98a66f02-0063-437b-a695-6fc9f6480530" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81ab58ee-434d-41cb-b399-5cc518e6ebf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_2ebfd83e-b314-445b-b329-a0dfd41e0d95" xlink:href="icui-20220630.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81ab58ee-434d-41cb-b399-5cc518e6ebf9" xlink:to="loc_icui_SmithsMedicalMember_2ebfd83e-b314-445b-b329-a0dfd41e0d95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_1b35f211-ef58-460b-9c5b-c07271e1430a" xlink:href="icui-20220630.xsd#icui_TimingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_ce0c05a2-b94a-413f-90a4-f8380ca24873" xlink:to="loc_icui_TimingAxis_1b35f211-ef58-460b-9c5b-c07271e1430a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_1b35f211-ef58-460b-9c5b-c07271e1430a_default" xlink:href="icui-20220630.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TimingAxis_1b35f211-ef58-460b-9c5b-c07271e1430a" xlink:to="loc_icui_TimingDomain_1b35f211-ef58-460b-9c5b-c07271e1430a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_f4117485-5e2f-4afa-aa3a-c38f44138c28" xlink:href="icui-20220630.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TimingAxis_1b35f211-ef58-460b-9c5b-c07271e1430a" xlink:to="loc_icui_TimingDomain_f4117485-5e2f-4afa-aa3a-c38f44138c28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermMember_de069813-1018-4899-a504-fd34ee0ae8b3" xlink:href="icui-20220630.xsd#icui_ShortTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TimingDomain_f4117485-5e2f-4afa-aa3a-c38f44138c28" xlink:to="loc_icui_ShortTermMember_de069813-1018-4899-a504-fd34ee0ae8b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermMember_3fe2decf-85af-47f7-8f8c-4194109dea6f" xlink:href="icui-20220630.xsd#icui_LongTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TimingDomain_f4117485-5e2f-4afa-aa3a-c38f44138c28" xlink:to="loc_icui_LongTermMember_3fe2decf-85af-47f7-8f8c-4194109dea6f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesTextDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#LeasesTextDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/LeasesTextDetails" xlink:type="extended" id="ic56de892f8a24792a35f414950421de6_LeasesTextDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_7d8dfa0b-e437-41f9-8961-7cbb9dc1b0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Optiontoextendinyears_35e9d0d9-e778-402a-9879-625cd0f5477d" xlink:href="icui-20220630.xsd#icui_Optiontoextendinyears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7d8dfa0b-e437-41f9-8961-7cbb9dc1b0cf" xlink:to="loc_icui_Optiontoextendinyears_35e9d0d9-e778-402a-9879-625cd0f5477d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ed96ca93-9327-4eaa-a7d0-ed60bf520923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7d8dfa0b-e437-41f9-8961-7cbb9dc1b0cf" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ed96ca93-9327-4eaa-a7d0-ed60bf520923" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_c00b6d49-90d5-481a-a34c-66a935629937" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7d8dfa0b-e437-41f9-8961-7cbb9dc1b0cf" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_c00b6d49-90d5-481a-a34c-66a935629937" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e0db06e9-6193-4b5c-8c59-2150cb7cd3b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c00b6d49-90d5-481a-a34c-66a935629937" xlink:to="loc_srt_RangeAxis_e0db06e9-6193-4b5c-8c59-2150cb7cd3b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e0db06e9-6193-4b5c-8c59-2150cb7cd3b2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e0db06e9-6193-4b5c-8c59-2150cb7cd3b2" xlink:to="loc_srt_RangeMember_e0db06e9-6193-4b5c-8c59-2150cb7cd3b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fd72ff22-545c-46dc-9ffe-fde59355351b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e0db06e9-6193-4b5c-8c59-2150cb7cd3b2" xlink:to="loc_srt_RangeMember_fd72ff22-545c-46dc-9ffe-fde59355351b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9fff9dde-5ceb-4fae-8b2b-fd4cc7c15571" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fd72ff22-545c-46dc-9ffe-fde59355351b" xlink:to="loc_srt_MaximumMember_9fff9dde-5ceb-4fae-8b2b-fd4cc7c15571" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_74864462-cd7c-4862-ad27-de118e21f863" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fd72ff22-545c-46dc-9ffe-fde59355351b" xlink:to="loc_srt_MinimumMember_74864462-cd7c-4862-ad27-de118e21f863" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#NetIncomePerShareDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/NetIncomePerShareDetails" xlink:type="extended" id="i9ecba423e3424adca3cd77819e0098ef_NetIncomePerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_18a4ebfc-bf4c-44b7-b9e8-87ec117ac1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_18a4ebfc-bf4c-44b7-b9e8-87ec117ac1cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_16180e04-e080-40b3-9785-9baf0ece21ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:to="loc_us-gaap_ProfitLoss_16180e04-e080-40b3-9785-9baf0ece21ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_667b57fe-9ba6-4f95-9a77-4e64770269cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_667b57fe-9ba6-4f95-9a77-4e64770269cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_493284af-ef4c-4f3a-9308-66e7b453d803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_493284af-ef4c-4f3a-9308-66e7b453d803" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f8084b28-407b-485d-9681-34112694d4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f8084b28-407b-485d-9681-34112694d4d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_74271e03-16fe-4df6-ae72-67668af04074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:to="loc_us-gaap_EarningsPerShareBasic_74271e03-16fe-4df6-ae72-67668af04074" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6da81129-cd4d-487d-862f-5512cc4277a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6da81129-cd4d-487d-862f-5512cc4277a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2b72e5f7-9f4c-4a3b-a49f-2e2e3279016b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2b72e5f7-9f4c-4a3b-a49f-2e2e3279016b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ca8b790b-3a4f-4fe9-afe6-2e740b7e71e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2b72e5f7-9f4c-4a3b-a49f-2e2e3279016b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ca8b790b-3a4f-4fe9-afe6-2e740b7e71e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ca8b790b-3a4f-4fe9-afe6-2e740b7e71e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ca8b790b-3a4f-4fe9-afe6-2e740b7e71e2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ca8b790b-3a4f-4fe9-afe6-2e740b7e71e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ef38bb0-92e2-4866-8572-fa8969d36982" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ca8b790b-3a4f-4fe9-afe6-2e740b7e71e2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ef38bb0-92e2-4866-8572-fa8969d36982" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails" xlink:type="extended" id="i7c221aeaf03f4c909887c36ecc9e24ee_DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e533d961-c90f-4b60-a992-87faaa4a4ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_560190e2-8d47-4736-81dd-5daa92aa28f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e533d961-c90f-4b60-a992-87faaa4a4ab4" xlink:to="loc_us-gaap_DerivativeNotionalAmount_560190e2-8d47-4736-81dd-5daa92aa28f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_fa0519dc-e4d3-4679-af9e-3a3558cf077e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_e533d961-c90f-4b60-a992-87faaa4a4ab4" xlink:to="loc_us-gaap_DerivativeTable_fa0519dc-e4d3-4679-af9e-3a3558cf077e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_61b78cf2-fda4-402c-8eb5-6bfb5f365a77" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fa0519dc-e4d3-4679-af9e-3a3558cf077e" xlink:to="loc_srt_CurrencyAxis_61b78cf2-fda4-402c-8eb5-6bfb5f365a77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_61b78cf2-fda4-402c-8eb5-6bfb5f365a77_default" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_61b78cf2-fda4-402c-8eb5-6bfb5f365a77" xlink:to="loc_currency_AllCurrenciesDomain_61b78cf2-fda4-402c-8eb5-6bfb5f365a77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_98c5ebb1-1d72-49bd-8942-51a829d2a5ae" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_61b78cf2-fda4-402c-8eb5-6bfb5f365a77" xlink:to="loc_currency_AllCurrenciesDomain_98c5ebb1-1d72-49bd-8942-51a829d2a5ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN_e447d763-c700-4698-adf9-faf63952a8b7" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_MXN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_98c5ebb1-1d72-49bd-8942-51a829d2a5ae" xlink:to="loc_currency_MXN_e447d763-c700-4698-adf9-faf63952a8b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_e69417a1-cf33-4e3b-a01b-89f61279b665" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_98c5ebb1-1d72-49bd-8942-51a829d2a5ae" xlink:to="loc_currency_EUR_e69417a1-cf33-4e3b-a01b-89f61279b665" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CZK_32c4a0eb-e51b-4678-8f14-6c0b37755df7" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CZK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_98c5ebb1-1d72-49bd-8942-51a829d2a5ae" xlink:to="loc_currency_CZK_32c4a0eb-e51b-4678-8f14-6c0b37755df7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_b51ac00d-e956-4a9a-a2cf-cf4c4a4cc945" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_98c5ebb1-1d72-49bd-8942-51a829d2a5ae" xlink:to="loc_currency_JPY_b51ac00d-e956-4a9a-a2cf-cf4c4a4cc945" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisAxis_2502d45f-a2a7-426c-8b77-ce72493700fe" xlink:href="icui-20220630.xsd#icui_Srt_MultipleCurrencyAxisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fa0519dc-e4d3-4679-af9e-3a3558cf077e" xlink:to="loc_icui_Srt_MultipleCurrencyAxisAxis_2502d45f-a2a7-426c-8b77-ce72493700fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisDomain_2502d45f-a2a7-426c-8b77-ce72493700fe_default" xlink:href="icui-20220630.xsd#icui_Srt_MultipleCurrencyAxisDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_Srt_MultipleCurrencyAxisAxis_2502d45f-a2a7-426c-8b77-ce72493700fe" xlink:to="loc_icui_Srt_MultipleCurrencyAxisDomain_2502d45f-a2a7-426c-8b77-ce72493700fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisDomain_19e742c0-e427-45a7-9288-8d350788f4ba" xlink:href="icui-20220630.xsd#icui_Srt_MultipleCurrencyAxisDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_Srt_MultipleCurrencyAxisAxis_2502d45f-a2a7-426c-8b77-ce72493700fe" xlink:to="loc_icui_Srt_MultipleCurrencyAxisDomain_19e742c0-e427-45a7-9288-8d350788f4ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherCurrenciesMember_5fd08226-5d80-458c-b1aa-2e30ead34f59" xlink:href="icui-20220630.xsd#icui_OtherCurrenciesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_Srt_MultipleCurrencyAxisDomain_19e742c0-e427-45a7-9288-8d350788f4ba" xlink:to="loc_icui_OtherCurrenciesMember_5fd08226-5d80-458c-b1aa-2e30ead34f59" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#DerivativeFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails" xlink:type="extended" id="i668ee67c0a9f451da23ff4fe85bab75c_DerivativeFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_98ffcb48-57df-433f-89ed-ec8401967427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeForwardExchangeRate1_90d88060-e7cd-48cd-a0c9-af0292c34d98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeForwardExchangeRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_98ffcb48-57df-433f-89ed-ec8401967427" xlink:to="loc_us-gaap_DerivativeForwardExchangeRate1_90d88060-e7cd-48cd-a0c9-af0292c34d98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_0f296163-af2d-4caf-ae55-d9086fff35e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_98ffcb48-57df-433f-89ed-ec8401967427" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_0f296163-af2d-4caf-ae55-d9086fff35e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_04d9eff6-2414-405d-80a9-a4328300b39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_98ffcb48-57df-433f-89ed-ec8401967427" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_04d9eff6-2414-405d-80a9-a4328300b39d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a1eb5234-67b4-4dfe-a29a-b446ddd0a41c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_98ffcb48-57df-433f-89ed-ec8401967427" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a1eb5234-67b4-4dfe-a29a-b446ddd0a41c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_11cab3eb-b77c-402d-a1d9-e74f8e0ff427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_98ffcb48-57df-433f-89ed-ec8401967427" xlink:to="loc_us-gaap_DerivativeTable_11cab3eb-b77c-402d-a1d9-e74f8e0ff427" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3bcfa680-b32d-40bc-b19b-5013bcfc3ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_11cab3eb-b77c-402d-a1d9-e74f8e0ff427" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3bcfa680-b32d-40bc-b19b-5013bcfc3ed5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3bcfa680-b32d-40bc-b19b-5013bcfc3ed5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3bcfa680-b32d-40bc-b19b-5013bcfc3ed5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3bcfa680-b32d-40bc-b19b-5013bcfc3ed5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_156f45c5-7203-4be9-a861-8f1f3d4f3c30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3bcfa680-b32d-40bc-b19b-5013bcfc3ed5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_156f45c5-7203-4be9-a861-8f1f3d4f3c30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge2Member_b091dd57-0c99-4dcd-8825-575e1307bddf" xlink:href="icui-20220630.xsd#icui_Hedge2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_156f45c5-7203-4be9-a861-8f1f3d4f3c30" xlink:to="loc_icui_Hedge2Member_b091dd57-0c99-4dcd-8825-575e1307bddf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge3MemberMember_2607b3d1-49e1-45f7-9674-abe4a00ef79d" xlink:href="icui-20220630.xsd#icui_Hedge3MemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_156f45c5-7203-4be9-a861-8f1f3d4f3c30" xlink:to="loc_icui_Hedge3MemberMember_2607b3d1-49e1-45f7-9674-abe4a00ef79d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_937e2ba4-9650-4e31-a17f-5997500ee231" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_11cab3eb-b77c-402d-a1d9-e74f8e0ff427" xlink:to="loc_srt_CurrencyAxis_937e2ba4-9650-4e31-a17f-5997500ee231" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_937e2ba4-9650-4e31-a17f-5997500ee231_default" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_937e2ba4-9650-4e31-a17f-5997500ee231" xlink:to="loc_currency_AllCurrenciesDomain_937e2ba4-9650-4e31-a17f-5997500ee231_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_e4787339-1995-4c28-9d79-c2eb7fbcc94e" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_937e2ba4-9650-4e31-a17f-5997500ee231" xlink:to="loc_currency_AllCurrenciesDomain_e4787339-1995-4c28-9d79-c2eb7fbcc94e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN_b0dbc487-d872-416a-9940-c248ee01b56d" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_MXN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_e4787339-1995-4c28-9d79-c2eb7fbcc94e" xlink:to="loc_currency_MXN_b0dbc487-d872-416a-9940-c248ee01b56d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY_a09439c1-9dd1-46f5-adc6-09aeed2b4f31" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CNY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_e4787339-1995-4c28-9d79-c2eb7fbcc94e" xlink:to="loc_currency_CNY_a09439c1-9dd1-46f5-adc6-09aeed2b4f31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_64a2d4b2-ad32-45f9-a7f0-fda9db5542b7" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_e4787339-1995-4c28-9d79-c2eb7fbcc94e" xlink:to="loc_currency_USD_64a2d4b2-ad32-45f9-a7f0-fda9db5542b7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#DerivativeFinancialInstrumentsInterestRateSwapsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails" xlink:type="extended" id="i7459e99c71984a19ae243777d4ec7266_DerivativeFinancialInstrumentsInterestRateSwapsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_7abffde0-fc3b-425d-b29c-2793b26c3e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_9fd2fa9b-fc86-4ae7-84ad-1623ad949acf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_7abffde0-fc3b-425d-b29c-2793b26c3e16" xlink:to="loc_us-gaap_DerivativeNotionalAmount_9fd2fa9b-fc86-4ae7-84ad-1623ad949acf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestRateSwapEndingNotionalValue_53fdcdda-7f04-409b-a5fb-231b0aaa8e53" xlink:href="icui-20220630.xsd#icui_InterestRateSwapEndingNotionalValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_7abffde0-fc3b-425d-b29c-2793b26c3e16" xlink:to="loc_icui_InterestRateSwapEndingNotionalValue_53fdcdda-7f04-409b-a5fb-231b0aaa8e53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_dc7f4366-7756-4ee5-9497-0d8a1f017271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_7abffde0-fc3b-425d-b29c-2793b26c3e16" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_dc7f4366-7756-4ee5-9497-0d8a1f017271" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DerivativeVariableRateFloor_8fa65635-62ce-449e-838c-01ac0f806051" xlink:href="icui-20220630.xsd#icui_DerivativeVariableRateFloor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_7abffde0-fc3b-425d-b29c-2793b26c3e16" xlink:to="loc_icui_DerivativeVariableRateFloor_8fa65635-62ce-449e-838c-01ac0f806051" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_a3cde0e2-6162-42a1-8124-c3de23707eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_7abffde0-fc3b-425d-b29c-2793b26c3e16" xlink:to="loc_us-gaap_DerivativeTable_a3cde0e2-6162-42a1-8124-c3de23707eaa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f93212f4-7984-4eb5-826b-0447995e8d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_a3cde0e2-6162-42a1-8124-c3de23707eaa" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f93212f4-7984-4eb5-826b-0447995e8d2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f93212f4-7984-4eb5-826b-0447995e8d2b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f93212f4-7984-4eb5-826b-0447995e8d2b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f93212f4-7984-4eb5-826b-0447995e8d2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c25ec7b5-aad8-49f2-ab29-c0ff41f337dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f93212f4-7984-4eb5-826b-0447995e8d2b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c25ec7b5-aad8-49f2-ab29-c0ff41f337dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_77e616f7-f7fb-4d66-8892-c3fb7c39fdfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c25ec7b5-aad8-49f2-ab29-c0ff41f337dd" xlink:to="loc_us-gaap_InterestRateSwapMember_77e616f7-f7fb-4d66-8892-c3fb7c39fdfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_5db057a1-978c-4f01-a9ac-c56fac906135" xlink:href="icui-20220630.xsd#icui_TermLoanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_a3cde0e2-6162-42a1-8124-c3de23707eaa" xlink:to="loc_icui_TermLoanAxis_5db057a1-978c-4f01-a9ac-c56fac906135" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_5db057a1-978c-4f01-a9ac-c56fac906135_default" xlink:href="icui-20220630.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TermLoanAxis_5db057a1-978c-4f01-a9ac-c56fac906135" xlink:to="loc_icui_TermLoanDomain_5db057a1-978c-4f01-a9ac-c56fac906135_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_5f408903-6617-46d2-924a-24155bcbc651" xlink:href="icui-20220630.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TermLoanAxis_5db057a1-978c-4f01-a9ac-c56fac906135" xlink:to="loc_icui_TermLoanDomain_5f408903-6617-46d2-924a-24155bcbc651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_d4b19d3b-b85a-438d-b66b-02a25c459866" xlink:href="icui-20220630.xsd#icui_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_5f408903-6617-46d2-924a-24155bcbc651" xlink:to="loc_icui_TermLoanAMember_d4b19d3b-b85a-438d-b66b-02a25c459866" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_352f0e6f-1155-470d-a8c0-93767bcca759" xlink:href="icui-20220630.xsd#icui_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_5f408903-6617-46d2-924a-24155bcbc651" xlink:to="loc_icui_TermLoanBMember_352f0e6f-1155-470d-a8c0-93767bcca759" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails" xlink:type="extended" id="i78d9b315e0544133b88254e0c1d88599_DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_ef5126b5-d188-4800-a745-ede7b518abe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_82303b03-5319-4fe7-b4dc-c92f8fb0e38d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ef5126b5-d188-4800-a745-ede7b518abe4" xlink:to="loc_us-gaap_DerivativeAssets_82303b03-5319-4fe7-b4dc-c92f8fb0e38d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_d8cce746-5501-42f7-9783-b2300122e226" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ef5126b5-d188-4800-a745-ede7b518abe4" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_d8cce746-5501-42f7-9783-b2300122e226" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_fe13be09-fd3a-42ac-8d81-d70e6c9acaee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ef5126b5-d188-4800-a745-ede7b518abe4" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_fe13be09-fd3a-42ac-8d81-d70e6c9acaee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_de89a182-31af-4732-9ce5-16287208ef02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ef5126b5-d188-4800-a745-ede7b518abe4" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_de89a182-31af-4732-9ce5-16287208ef02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_d9b0d769-d70c-4294-b46b-bd3b3c4b6673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ef5126b5-d188-4800-a745-ede7b518abe4" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_d9b0d769-d70c-4294-b46b-bd3b3c4b6673" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_4a5bc46c-2645-4051-b6d4-d73700aba068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ef5126b5-d188-4800-a745-ede7b518abe4" xlink:to="loc_us-gaap_DerivativeLiabilities_4a5bc46c-2645-4051-b6d4-d73700aba068" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d60c7623-0be0-48bd-a514-6d0b32455af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ef5126b5-d188-4800-a745-ede7b518abe4" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d60c7623-0be0-48bd-a514-6d0b32455af5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b4faad45-3d5f-43ab-b4c4-c62c70e81123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d60c7623-0be0-48bd-a514-6d0b32455af5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b4faad45-3d5f-43ab-b4c4-c62c70e81123" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b4faad45-3d5f-43ab-b4c4-c62c70e81123_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b4faad45-3d5f-43ab-b4c4-c62c70e81123" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b4faad45-3d5f-43ab-b4c4-c62c70e81123_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7b7eb75e-3497-4cb4-b523-75d98c00d1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b4faad45-3d5f-43ab-b4c4-c62c70e81123" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7b7eb75e-3497-4cb4-b523-75d98c00d1b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_5ae62477-2163-4e06-bb96-54234d111934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7b7eb75e-3497-4cb4-b523-75d98c00d1b9" xlink:to="loc_us-gaap_ForeignExchangeContractMember_5ae62477-2163-4e06-bb96-54234d111934" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ab785f80-a106-473a-9dc2-75f5f479a0da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7b7eb75e-3497-4cb4-b523-75d98c00d1b9" xlink:to="loc_us-gaap_InterestRateSwapMember_ab785f80-a106-473a-9dc2-75f5f479a0da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7260fdc8-4f97-44cf-bde8-efc45997c05e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d60c7623-0be0-48bd-a514-6d0b32455af5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7260fdc8-4f97-44cf-bde8-efc45997c05e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7260fdc8-4f97-44cf-bde8-efc45997c05e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7260fdc8-4f97-44cf-bde8-efc45997c05e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7260fdc8-4f97-44cf-bde8-efc45997c05e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_19f47772-f426-42b8-802b-4c80df340757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7260fdc8-4f97-44cf-bde8-efc45997c05e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_19f47772-f426-42b8-802b-4c80df340757" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_27c7b656-bbcc-4f73-9c3d-3de107ea630f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_19f47772-f426-42b8-802b-4c80df340757" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_27c7b656-bbcc-4f73-9c3d-3de107ea630f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_569386a5-88f3-4258-8017-c5caa560853a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_19f47772-f426-42b8-802b-4c80df340757" xlink:to="loc_us-gaap_OtherAssetsMember_569386a5-88f3-4258-8017-c5caa560853a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_c952109e-369a-4c87-b49a-bec314bb4eef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_19f47772-f426-42b8-802b-4c80df340757" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_c952109e-369a-4c87-b49a-bec314bb4eef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_ce740da3-bb38-4d47-b657-3d5a0ca4ac3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_19f47772-f426-42b8-802b-4c80df340757" xlink:to="loc_us-gaap_OtherLiabilitiesMember_ce740da3-bb38-4d47-b657-3d5a0ca4ac3c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b7226c09-3305-45e7-b0c5-039dcc027557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d60c7623-0be0-48bd-a514-6d0b32455af5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b7226c09-3305-45e7-b0c5-039dcc027557" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b7226c09-3305-45e7-b0c5-039dcc027557_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b7226c09-3305-45e7-b0c5-039dcc027557" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b7226c09-3305-45e7-b0c5-039dcc027557_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2e69f9e1-9aa3-4b69-bd5c-7d2088ec564b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b7226c09-3305-45e7-b0c5-039dcc027557" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2e69f9e1-9aa3-4b69-bd5c-7d2088ec564b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="ie37809ec1a1b43b49db5211811e16fa9_DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_189caa7b-d50d-4a54-bc79-edebbc550d94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_a42e4e31-cc4b-465d-8073-82cc65dcec63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_189caa7b-d50d-4a54-bc79-edebbc550d94" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_a42e4e31-cc4b-465d-8073-82cc65dcec63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a0c86202-560d-4069-a341-8474932056d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_189caa7b-d50d-4a54-bc79-edebbc550d94" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a0c86202-560d-4069-a341-8474932056d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9a069e93-14ba-4268-8270-a757b874db23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a0c86202-560d-4069-a341-8474932056d8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9a069e93-14ba-4268-8270-a757b874db23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9a069e93-14ba-4268-8270-a757b874db23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9a069e93-14ba-4268-8270-a757b874db23" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9a069e93-14ba-4268-8270-a757b874db23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a9e90dfc-994d-487f-9829-50db5a59a104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9a069e93-14ba-4268-8270-a757b874db23" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a9e90dfc-994d-487f-9829-50db5a59a104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_205e240b-efa3-42ee-8404-ea1e433cdbc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a9e90dfc-994d-487f-9829-50db5a59a104" xlink:to="loc_us-gaap_ForeignExchangeContractMember_205e240b-efa3-42ee-8404-ea1e433cdbc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_17ebc37b-54d9-4b94-a64e-32f477a2c17b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a9e90dfc-994d-487f-9829-50db5a59a104" xlink:to="loc_us-gaap_InterestRateSwapMember_17ebc37b-54d9-4b94-a64e-32f477a2c17b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" xlink:type="extended" id="i7c7200c0d3c146049d2592fe7a0c5eea_DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a332ffd8-577d-4c4e-a736-5f819e1ce981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_f6e7a621-72a6-475f-ae5b-946696ad6592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a332ffd8-577d-4c4e-a736-5f819e1ce981" xlink:to="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_f6e7a621-72a6-475f-ae5b-946696ad6592" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_0467de5b-92e6-4edf-9216-b83488bda726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a332ffd8-577d-4c4e-a736-5f819e1ce981" xlink:to="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_0467de5b-92e6-4edf-9216-b83488bda726" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_5def0355-2acc-4aa5-bb7d-f9d21addc882" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a332ffd8-577d-4c4e-a736-5f819e1ce981" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_5def0355-2acc-4aa5-bb7d-f9d21addc882" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_48886faa-5fda-47aa-8b11-f9870f1f8b78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a332ffd8-577d-4c4e-a736-5f819e1ce981" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_48886faa-5fda-47aa-8b11-f9870f1f8b78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_d4901ad2-fae5-4b6c-873c-9f11be89a3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a332ffd8-577d-4c4e-a736-5f819e1ce981" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_d4901ad2-fae5-4b6c-873c-9f11be89a3ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ef690c86-1a0f-4bdd-aba3-49e6d19e335d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a332ffd8-577d-4c4e-a736-5f819e1ce981" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ef690c86-1a0f-4bdd-aba3-49e6d19e335d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f8283c17-71bc-49ff-a993-5c010fd2b53f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ef690c86-1a0f-4bdd-aba3-49e6d19e335d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f8283c17-71bc-49ff-a993-5c010fd2b53f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f8283c17-71bc-49ff-a993-5c010fd2b53f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f8283c17-71bc-49ff-a993-5c010fd2b53f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f8283c17-71bc-49ff-a993-5c010fd2b53f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4a6fe299-c6f9-453b-a4fb-076035f88570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f8283c17-71bc-49ff-a993-5c010fd2b53f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4a6fe299-c6f9-453b-a4fb-076035f88570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_75b1fe8d-b2b4-4548-a739-b955ef3269ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a6fe299-c6f9-453b-a4fb-076035f88570" xlink:to="loc_us-gaap_ForeignExchangeContractMember_75b1fe8d-b2b4-4548-a739-b955ef3269ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8dea3de1-e74a-4efa-aec6-cd46e05250a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a6fe299-c6f9-453b-a4fb-076035f88570" xlink:to="loc_us-gaap_InterestRateSwapMember_8dea3de1-e74a-4efa-aec6-cd46e05250a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_489a8ad6-b6e9-48ca-b5ab-c563a0b9d35a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ef690c86-1a0f-4bdd-aba3-49e6d19e335d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_489a8ad6-b6e9-48ca-b5ab-c563a0b9d35a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_489a8ad6-b6e9-48ca-b5ab-c563a0b9d35a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_489a8ad6-b6e9-48ca-b5ab-c563a0b9d35a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_489a8ad6-b6e9-48ca-b5ab-c563a0b9d35a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f274fc2b-30c6-432b-a052-e74259f69218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_489a8ad6-b6e9-48ca-b5ab-c563a0b9d35a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f274fc2b-30c6-432b-a052-e74259f69218" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingRevenueMember_1df77f23-cc05-4988-8f68-4abad68d55b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f274fc2b-30c6-432b-a052-e74259f69218" xlink:to="loc_us-gaap_TradingRevenueMember_1df77f23-cc05-4988-8f68-4abad68d55b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_7867af4d-3099-405c-935a-e4d275895edc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f274fc2b-30c6-432b-a052-e74259f69218" xlink:to="loc_us-gaap_CostOfSalesMember_7867af4d-3099-405c-935a-e4d275895edc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_ea400e55-a7ba-49fc-be6c-b149dc9f2975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f274fc2b-30c6-432b-a052-e74259f69218" xlink:to="loc_us-gaap_InterestExpenseMember_ea400e55-a7ba-49fc-be6c-b149dc9f2975" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f9618053-0115-4a16-bc65-3551ac42843b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ef690c86-1a0f-4bdd-aba3-49e6d19e335d" xlink:to="loc_us-gaap_HedgingDesignationAxis_f9618053-0115-4a16-bc65-3551ac42843b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f9618053-0115-4a16-bc65-3551ac42843b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_f9618053-0115-4a16-bc65-3551ac42843b" xlink:to="loc_us-gaap_HedgingDesignationDomain_f9618053-0115-4a16-bc65-3551ac42843b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_eca8273d-6005-4ed8-a065-b0debcb0f850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_f9618053-0115-4a16-bc65-3551ac42843b" xlink:to="loc_us-gaap_HedgingDesignationDomain_eca8273d-6005-4ed8-a065-b0debcb0f850" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3e01483f-6464-417a-bf06-0cc837e67fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ef690c86-1a0f-4bdd-aba3-49e6d19e335d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3e01483f-6464-417a-bf06-0cc837e67fd6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3e01483f-6464-417a-bf06-0cc837e67fd6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3e01483f-6464-417a-bf06-0cc837e67fd6" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3e01483f-6464-417a-bf06-0cc837e67fd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f346b1bf-4efb-4914-abea-976db1d55415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3e01483f-6464-417a-bf06-0cc837e67fd6" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f346b1bf-4efb-4914-abea-976db1d55415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_9a5af5f9-d124-4188-a761-680a588a5204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f346b1bf-4efb-4914-abea-976db1d55415" xlink:to="loc_us-gaap_CashFlowHedgingMember_9a5af5f9-d124-4188-a761-680a588a5204" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#FairValueMeasuresandDisclosuresDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails" xlink:type="extended" id="i527b35b5ff064a0783d38c234c92e16b_FairValueMeasuresandDisclosuresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1748e0e5-788c-4e97-9025-92124a1e52ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_217f8b9f-2739-4362-94ce-65c064fce2a4" xlink:href="icui-20220630.xsd#icui_Contingentconsiderationgross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1748e0e5-788c-4e97-9025-92124a1e52ae" xlink:to="loc_icui_Contingentconsiderationgross_217f8b9f-2739-4362-94ce-65c064fce2a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f6d54a11-6ccf-42b1-b6b8-0d454657c810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1748e0e5-788c-4e97-9025-92124a1e52ae" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f6d54a11-6ccf-42b1-b6b8-0d454657c810" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_c27ceb4d-c302-4082-8644-1d9693ef3896" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationGrossST"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1748e0e5-788c-4e97-9025-92124a1e52ae" xlink:to="loc_icui_ContingentConsiderationGrossST_c27ceb4d-c302-4082-8644-1d9693ef3896" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_bc2a4a75-0e12-430b-bc90-f6ef4f66766c" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1748e0e5-788c-4e97-9025-92124a1e52ae" xlink:to="loc_icui_ContingentConsiderationGrossLT_bc2a4a75-0e12-430b-bc90-f6ef4f66766c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_074f98b3-454d-40a4-8983-c20628b6e946" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1748e0e5-788c-4e97-9025-92124a1e52ae" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_074f98b3-454d-40a4-8983-c20628b6e946" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OwnershipRequirementForEarnoutPayment_069c030e-f0b3-4acd-970e-dd21515d3a08" xlink:href="icui-20220630.xsd#icui_OwnershipRequirementForEarnoutPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1748e0e5-788c-4e97-9025-92124a1e52ae" xlink:to="loc_icui_OwnershipRequirementForEarnoutPayment_069c030e-f0b3-4acd-970e-dd21515d3a08" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_96565c84-62da-4d57-9c78-c8e2b1eb56a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1748e0e5-788c-4e97-9025-92124a1e52ae" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_96565c84-62da-4d57-9c78-c8e2b1eb56a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5cd976f5-cdbd-4575-a6c8-30296b1e4bae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_96565c84-62da-4d57-9c78-c8e2b1eb56a3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5cd976f5-cdbd-4575-a6c8-30296b1e4bae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5cd976f5-cdbd-4575-a6c8-30296b1e4bae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5cd976f5-cdbd-4575-a6c8-30296b1e4bae" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5cd976f5-cdbd-4575-a6c8-30296b1e4bae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_545bd036-e70e-4cf7-9549-07e8f5168b64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5cd976f5-cdbd-4575-a6c8-30296b1e4bae" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_545bd036-e70e-4cf7-9549-07e8f5168b64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_a309dbb2-9009-4ed5-b94e-2d6c8bead724" xlink:href="icui-20220630.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_545bd036-e70e-4cf7-9549-07e8f5168b64" xlink:to="loc_icui_PursuitVascularInc.Member_a309dbb2-9009-4ed5-b94e-2d6c8bead724" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_75859d0f-540a-4bf6-8a65-a12282a8d1fb" xlink:href="icui-20220630.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_545bd036-e70e-4cf7-9549-07e8f5168b64" xlink:to="loc_icui_SmithsMedicalMember_75859d0f-540a-4bf6-8a65-a12282a8d1fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_6cc6774d-fb97-4653-aec5-dbe675c9ba3c" xlink:href="icui-20220630.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_545bd036-e70e-4cf7-9549-07e8f5168b64" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_6cc6774d-fb97-4653-aec5-dbe675c9ba3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_77734049-f52d-4e5c-b6e5-557f00db9af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_96565c84-62da-4d57-9c78-c8e2b1eb56a3" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_77734049-f52d-4e5c-b6e5-557f00db9af3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_77734049-f52d-4e5c-b6e5-557f00db9af3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_77734049-f52d-4e5c-b6e5-557f00db9af3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_77734049-f52d-4e5c-b6e5-557f00db9af3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_7e95b338-7961-45a4-af17-678e9d15ef09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_77734049-f52d-4e5c-b6e5-557f00db9af3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_7e95b338-7961-45a4-af17-678e9d15ef09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_41d5063d-7603-4433-bdc9-0159f168148b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_7e95b338-7961-45a4-af17-678e9d15ef09" xlink:to="loc_us-gaap_LiabilityMember_41d5063d-7603-4433-bdc9-0159f168148b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails" xlink:type="extended" id="ic44f546530fa4711b46badacea18de84_FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3ccf157a-293b-416f-aff0-6ddbb8ccc527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ce9b3ca6-e0b6-4584-9784-0e78b003b2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3ccf157a-293b-416f-aff0-6ddbb8ccc527" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ce9b3ca6-e0b6-4584-9784-0e78b003b2e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_3ebe37bd-1300-44c1-b71e-bbffeb10b064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3ccf157a-293b-416f-aff0-6ddbb8ccc527" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_3ebe37bd-1300-44c1-b71e-bbffeb10b064" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_eb82d2c9-2bd4-4a36-975e-8d37e331c03d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3ccf157a-293b-416f-aff0-6ddbb8ccc527" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_eb82d2c9-2bd4-4a36-975e-8d37e331c03d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CurrencyTranslationOnEarnOut_a87b72b9-1a10-46c0-9aab-1c9d630e4f54" xlink:href="icui-20220630.xsd#icui_CurrencyTranslationOnEarnOut"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3ccf157a-293b-416f-aff0-6ddbb8ccc527" xlink:to="loc_icui_CurrencyTranslationOnEarnOut_a87b72b9-1a10-46c0-9aab-1c9d630e4f54" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_83c2baa4-f7b9-448b-aae1-11e2a3cbfa1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3ccf157a-293b-416f-aff0-6ddbb8ccc527" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_83c2baa4-f7b9-448b-aae1-11e2a3cbfa1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2e0ff1c1-e292-4816-b84d-9b54d9fbf1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_83c2baa4-f7b9-448b-aae1-11e2a3cbfa1b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2e0ff1c1-e292-4816-b84d-9b54d9fbf1cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e0ff1c1-e292-4816-b84d-9b54d9fbf1cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2e0ff1c1-e292-4816-b84d-9b54d9fbf1cc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e0ff1c1-e292-4816-b84d-9b54d9fbf1cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_811ab4c2-3354-44e2-9d19-332b078cc69a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2e0ff1c1-e292-4816-b84d-9b54d9fbf1cc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_811ab4c2-3354-44e2-9d19-332b078cc69a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_24ae3160-f154-4800-887b-e543f08acdb6" xlink:href="icui-20220630.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_811ab4c2-3354-44e2-9d19-332b078cc69a" xlink:to="loc_icui_PursuitVascularInc.Member_24ae3160-f154-4800-887b-e543f08acdb6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails" xlink:type="extended" id="ib2b3f3c009de4caf89a2d94153c219d1_FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_65a8a356-ecbc-43ce-b6f6-f5c14c32115d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1ed1c0c2-97f1-4a64-b19e-af1a91c04120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_65a8a356-ecbc-43ce-b6f6-f5c14c32115d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1ed1c0c2-97f1-4a64-b19e-af1a91c04120" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_bf74a33f-87c8-408f-b372-987757c3ed05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_65a8a356-ecbc-43ce-b6f6-f5c14c32115d" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_bf74a33f-87c8-408f-b372-987757c3ed05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_955f9991-3f2a-4a88-97a1-14c32f66a11c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_65a8a356-ecbc-43ce-b6f6-f5c14c32115d" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_955f9991-3f2a-4a88-97a1-14c32f66a11c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_619d583e-c44c-4806-b837-c50440facd58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_955f9991-3f2a-4a88-97a1-14c32f66a11c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_619d583e-c44c-4806-b837-c50440facd58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_619d583e-c44c-4806-b837-c50440facd58_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_619d583e-c44c-4806-b837-c50440facd58" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_619d583e-c44c-4806-b837-c50440facd58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_56bed086-3b90-40d2-a4f2-edd0ec3db41b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_619d583e-c44c-4806-b837-c50440facd58" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_56bed086-3b90-40d2-a4f2-edd0ec3db41b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_305fad12-c6fb-4dc1-8eef-688544869864" xlink:href="icui-20220630.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_56bed086-3b90-40d2-a4f2-edd0ec3db41b" xlink:to="loc_icui_PursuitVascularInc.Member_305fad12-c6fb-4dc1-8eef-688544869864" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9345f063-ed22-471c-9648-97b78c3598e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_955f9991-3f2a-4a88-97a1-14c32f66a11c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9345f063-ed22-471c-9648-97b78c3598e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9345f063-ed22-471c-9648-97b78c3598e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9345f063-ed22-471c-9648-97b78c3598e4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9345f063-ed22-471c-9648-97b78c3598e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4761cbf0-d414-4e4f-8b5e-f9516a6eaa21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9345f063-ed22-471c-9648-97b78c3598e4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4761cbf0-d414-4e4f-8b5e-f9516a6eaa21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_33d64a90-2112-429d-9914-087ce1021205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_955f9991-3f2a-4a88-97a1-14c32f66a11c" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_33d64a90-2112-429d-9914-087ce1021205" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_33d64a90-2112-429d-9914-087ce1021205_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_33d64a90-2112-429d-9914-087ce1021205" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_33d64a90-2112-429d-9914-087ce1021205_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7b545858-b516-4da1-80d8-f17bab667bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_33d64a90-2112-429d-9914-087ce1021205" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7b545858-b516-4da1-80d8-f17bab667bb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_bb316df4-39dd-420f-918b-59a8c371716f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_955f9991-3f2a-4a88-97a1-14c32f66a11c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_bb316df4-39dd-420f-918b-59a8c371716f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_bb316df4-39dd-420f-918b-59a8c371716f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_bb316df4-39dd-420f-918b-59a8c371716f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_bb316df4-39dd-420f-918b-59a8c371716f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_c086a43e-6601-441e-9721-5983bca46cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_bb316df4-39dd-420f-918b-59a8c371716f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_c086a43e-6601-441e-9721-5983bca46cb8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails" xlink:type="extended" id="if849c6f7264b45639af3eed129a64b6b_FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_9f527e33-3d92-4bc0-af11-d1a4fcac660a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_a199fc69-a73f-41e2-8caf-abb1d62e2aef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_9f527e33-3d92-4bc0-af11-d1a4fcac660a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_a199fc69-a73f-41e2-8caf-abb1d62e2aef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_551c84b8-59f7-4880-a516-db60419fc37c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_9f527e33-3d92-4bc0-af11-d1a4fcac660a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_551c84b8-59f7-4880-a516-db60419fc37c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bcda04b8-3e59-4345-8688-4fd1c12bc8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_551c84b8-59f7-4880-a516-db60419fc37c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bcda04b8-3e59-4345-8688-4fd1c12bc8dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bcda04b8-3e59-4345-8688-4fd1c12bc8dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bcda04b8-3e59-4345-8688-4fd1c12bc8dc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bcda04b8-3e59-4345-8688-4fd1c12bc8dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35e35f5c-3064-4c04-9aee-f4758f5717c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bcda04b8-3e59-4345-8688-4fd1c12bc8dc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35e35f5c-3064-4c04-9aee-f4758f5717c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_c3de3150-bcc7-4413-9abc-a2e2c2dadc4f" xlink:href="icui-20220630.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35e35f5c-3064-4c04-9aee-f4758f5717c3" xlink:to="loc_icui_PursuitVascularInc.Member_c3de3150-bcc7-4413-9abc-a2e2c2dadc4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_7c073c6e-fa7b-4a70-9a92-3de5db3a6e51" xlink:href="icui-20220630.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35e35f5c-3064-4c04-9aee-f4758f5717c3" xlink:to="loc_icui_SmithsMedicalMember_7c073c6e-fa7b-4a70-9a92-3de5db3a6e51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_b8526eea-bc88-48bc-bdbf-0d33c0cdfa05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_551c84b8-59f7-4880-a516-db60419fc37c" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_b8526eea-bc88-48bc-bdbf-0d33c0cdfa05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_b8526eea-bc88-48bc-bdbf-0d33c0cdfa05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_b8526eea-bc88-48bc-bdbf-0d33c0cdfa05" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_b8526eea-bc88-48bc-bdbf-0d33c0cdfa05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_de7bd330-dfc7-4138-8bd1-15222c607cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_b8526eea-bc88-48bc-bdbf-0d33c0cdfa05" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_de7bd330-dfc7-4138-8bd1-15222c607cfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MeasurementinputadjustedEBITDAvolatilityDomain_ff5cf105-eb58-4b18-b4a1-37fdce7994c8" xlink:href="icui-20220630.xsd#icui_MeasurementinputadjustedEBITDAvolatilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_de7bd330-dfc7-4138-8bd1-15222c607cfe" xlink:to="loc_icui_MeasurementinputadjustedEBITDAvolatilityDomain_ff5cf105-eb58-4b18-b4a1-37fdce7994c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_d36669e9-1688-48a9-b775-8edda7aed74c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_de7bd330-dfc7-4138-8bd1-15222c607cfe" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_d36669e9-1688-48a9-b775-8edda7aed74c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_bc812f0f-527d-42d0-b5f6-39903aa5f9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_de7bd330-dfc7-4138-8bd1-15222c607cfe" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_bc812f0f-527d-42d0-b5f6-39903aa5f9d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MeasurementInputMarketPriceofRiskDomain_3d1cb7ca-5b43-4e4f-b94d-42239c39ac49" xlink:href="icui-20220630.xsd#icui_MeasurementInputMarketPriceofRiskDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_de7bd330-dfc7-4138-8bd1-15222c607cfe" xlink:to="loc_icui_MeasurementInputMarketPriceofRiskDomain_3d1cb7ca-5b43-4e4f-b94d-42239c39ac49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_e361e570-f17d-4ac2-8fc1-fa504075676b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_de7bd330-dfc7-4138-8bd1-15222c607cfe" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_e361e570-f17d-4ac2-8fc1-fa504075676b" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails" xlink:type="extended" id="i77737e4b043a49a5993fda3ab7034d34_FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_11c5c56e-4f86-42ae-a441-2a26dec356bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_11c5c56e-4f86-42ae-a441-2a26dec356bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_83fc3ccb-f1aa-45d8-a1a4-8aa6977e70db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_83fc3ccb-f1aa-45d8-a1a4-8aa6977e70db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_3a1d908b-f320-43d1-a0e0-d4eedba06d30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_3a1d908b-f320-43d1-a0e0-d4eedba06d30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_47780d7d-4d89-4842-a50a-ef98d8ae4c84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonfinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_47780d7d-4d89-4842-a50a-ef98d8ae4c84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_ff0f4bf6-ded9-46fa-bac9-f00a0116c758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_ff0f4bf6-ded9-46fa-bac9-f00a0116c758" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_feb9be3d-ee92-416d-bca6-10f47bd1b16a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_feb9be3d-ee92-416d-bca6-10f47bd1b16a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_3168ad4a-1459-4429-97df-74220e09afdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_3168ad4a-1459-4429-97df-74220e09afdf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_e1146bd4-5732-4229-8756-17c22b7b17ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_e1146bd4-5732-4229-8756-17c22b7b17ee" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_a99eb408-81cc-43c4-bb4f-c1ccec85448e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_a99eb408-81cc-43c4-bb4f-c1ccec85448e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c25ad4bc-35c3-410b-8dc9-6ec52915a70b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c25ad4bc-35c3-410b-8dc9-6ec52915a70b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a48bb895-1601-45c7-88a7-bc6c7e64edf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c25ad4bc-35c3-410b-8dc9-6ec52915a70b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a48bb895-1601-45c7-88a7-bc6c7e64edf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a48bb895-1601-45c7-88a7-bc6c7e64edf1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a48bb895-1601-45c7-88a7-bc6c7e64edf1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a48bb895-1601-45c7-88a7-bc6c7e64edf1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b0125f42-90f6-4e40-b77b-9067b0ab689a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a48bb895-1601-45c7-88a7-bc6c7e64edf1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b0125f42-90f6-4e40-b77b-9067b0ab689a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_ac1ced5d-afe0-44de-abfb-e97eec555393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b0125f42-90f6-4e40-b77b-9067b0ab689a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_ac1ced5d-afe0-44de-abfb-e97eec555393" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1e0daf64-9b3c-466d-a373-3f06cb0a0c79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b0125f42-90f6-4e40-b77b-9067b0ab689a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1e0daf64-9b3c-466d-a373-3f06cb0a0c79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_39614a19-8810-45f4-b46d-55dad6559a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b0125f42-90f6-4e40-b77b-9067b0ab689a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_39614a19-8810-45f4-b46d-55dad6559a01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_93a2fa6c-481e-4999-8cf7-999a625ccd14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c25ad4bc-35c3-410b-8dc9-6ec52915a70b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_93a2fa6c-481e-4999-8cf7-999a625ccd14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_93a2fa6c-481e-4999-8cf7-999a625ccd14_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_93a2fa6c-481e-4999-8cf7-999a625ccd14" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_93a2fa6c-481e-4999-8cf7-999a625ccd14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_987b1bf2-738d-447d-aae5-52a3bab55819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_93a2fa6c-481e-4999-8cf7-999a625ccd14" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_987b1bf2-738d-447d-aae5-52a3bab55819" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_d1460688-c830-4652-b749-9d8e551c2cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_987b1bf2-738d-447d-aae5-52a3bab55819" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_d1460688-c830-4652-b749-9d8e551c2cdc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_76c87889-c3f0-4a88-a356-f7bf04f88282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_987b1bf2-738d-447d-aae5-52a3bab55819" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_76c87889-c3f0-4a88-a356-f7bf04f88282" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_fc932ef1-2346-428a-bed1-2d77c2c96012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_987b1bf2-738d-447d-aae5-52a3bab55819" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_fc932ef1-2346-428a-bed1-2d77c2c96012" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_435ee4ba-e559-4b08-a552-670ff4738c17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_987b1bf2-738d-447d-aae5-52a3bab55819" xlink:to="loc_us-gaap_OtherAssetsMember_435ee4ba-e559-4b08-a552-670ff4738c17" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_5d4e5a08-fc44-40ec-b3cc-eb515a8f48c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_987b1bf2-738d-447d-aae5-52a3bab55819" xlink:to="loc_us-gaap_OtherLiabilitiesMember_5d4e5a08-fc44-40ec-b3cc-eb515a8f48c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_e2cb9a1e-083b-444b-a2ef-1f3083680248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c25ad4bc-35c3-410b-8dc9-6ec52915a70b" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_e2cb9a1e-083b-444b-a2ef-1f3083680248" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e2cb9a1e-083b-444b-a2ef-1f3083680248_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_e2cb9a1e-083b-444b-a2ef-1f3083680248" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e2cb9a1e-083b-444b-a2ef-1f3083680248_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8650ac03-06b8-4dfc-99a0-d4b648c2a73e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_e2cb9a1e-083b-444b-a2ef-1f3083680248" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8650ac03-06b8-4dfc-99a0-d4b648c2a73e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EarnoutliabilityMember_db0fd098-cc0e-4444-aa27-40a26968d5d4" xlink:href="icui-20220630.xsd#icui_EarnoutliabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8650ac03-06b8-4dfc-99a0-d4b648c2a73e" xlink:to="loc_icui_EarnoutliabilityMember_db0fd098-cc0e-4444-aa27-40a26968d5d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesTotalMember_7c87ce10-8782-4ef0-835a-ede8a79980cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesTotalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8650ac03-06b8-4dfc-99a0-d4b648c2a73e" xlink:to="loc_us-gaap_LiabilitiesTotalMember_7c87ce10-8782-4ef0-835a-ede8a79980cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EarnOutLiabilityST_f3db2264-17c6-482f-8627-ad7abc1085c8" xlink:href="icui-20220630.xsd#icui_EarnOutLiabilityST"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8650ac03-06b8-4dfc-99a0-d4b648c2a73e" xlink:to="loc_icui_EarnOutLiabilityST_f3db2264-17c6-482f-8627-ad7abc1085c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_STEarnoutLiabilityMember_b19c17bd-52ef-451d-bd19-3bbf438c6ac0" xlink:href="icui-20220630.xsd#icui_STEarnoutLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8650ac03-06b8-4dfc-99a0-d4b648c2a73e" xlink:to="loc_icui_STEarnoutLiabilityMember_b19c17bd-52ef-451d-bd19-3bbf438c6ac0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_c01e6a97-17f6-4a3c-ad08-5291aafe78a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c25ad4bc-35c3-410b-8dc9-6ec52915a70b" xlink:to="loc_us-gaap_InvestmentTypeAxis_c01e6a97-17f6-4a3c-ad08-5291aafe78a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_c01e6a97-17f6-4a3c-ad08-5291aafe78a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_c01e6a97-17f6-4a3c-ad08-5291aafe78a7" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_c01e6a97-17f6-4a3c-ad08-5291aafe78a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_10e668e5-9d7d-44df-b3be-627004f0b331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_c01e6a97-17f6-4a3c-ad08-5291aafe78a7" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_10e668e5-9d7d-44df-b3be-627004f0b331" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_68ee3c38-9c3f-4eb5-830a-9538386c32b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_10e668e5-9d7d-44df-b3be-627004f0b331" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_68ee3c38-9c3f-4eb5-830a-9538386c32b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_39eb5b45-7dd0-4fdd-b23d-6a4137a89809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_10e668e5-9d7d-44df-b3be-627004f0b331" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_39eb5b45-7dd0-4fdd-b23d-6a4137a89809" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InvestmentSecuritiesTableDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#InvestmentSecuritiesTableDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/InvestmentSecuritiesTableDetails" xlink:type="extended" id="i9e88c50964d14d3ba738603ac15af9f1_InvestmentSecuritiesTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3b793d8d-972d-4b42-8627-29fc195faa7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3b793d8d-972d-4b42-8627-29fc195faa7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_2e40ff2c-18fd-4207-84ec-b17da5eb8b39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_2e40ff2c-18fd-4207-84ec-b17da5eb8b39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_6839ada3-2da9-4b11-aab4-5e54af163805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_6839ada3-2da9-4b11-aab4-5e54af163805" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_35a1345e-bfd4-4df7-af50-caa9cfd9d143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_35a1345e-bfd4-4df7-af50-caa9cfd9d143" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_652073ad-a24e-4563-88d6-c2a2746f4866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_652073ad-a24e-4563-88d6-c2a2746f4866" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_14caf6ea-9698-4fea-b313-a4bb888a21d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_14caf6ea-9698-4fea-b313-a4bb888a21d8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_128daf0f-0bf6-4bc9-8d8d-74d366c44314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_128daf0f-0bf6-4bc9-8d8d-74d366c44314" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_7fea62c1-f628-47b5-9ea5-281844cbd4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_7fea62c1-f628-47b5-9ea5-281844cbd4e2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_89773a6e-f8c2-4580-9dcd-ce351cf7c22a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_89773a6e-f8c2-4580-9dcd-ce351cf7c22a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_22830ea2-698c-458e-874a-597aa752e435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_89773a6e-f8c2-4580-9dcd-ce351cf7c22a" xlink:to="loc_us-gaap_InvestmentTypeAxis_22830ea2-698c-458e-874a-597aa752e435" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_22830ea2-698c-458e-874a-597aa752e435_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_22830ea2-698c-458e-874a-597aa752e435" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_22830ea2-698c-458e-874a-597aa752e435_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_3be230b6-b72c-4bdb-973f-38fa429149f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_22830ea2-698c-458e-874a-597aa752e435" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_3be230b6-b72c-4bdb-973f-38fa429149f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AvailableforsaleDebtSecurityCurrentMember_1c50d12e-5794-4bc6-af19-ff22602b2813" xlink:href="icui-20220630.xsd#icui_AvailableforsaleDebtSecurityCurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3be230b6-b72c-4bdb-973f-38fa429149f6" xlink:to="loc_icui_AvailableforsaleDebtSecurityCurrentMember_1c50d12e-5794-4bc6-af19-ff22602b2813" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongtermInvestmentsDomain_94668a46-58eb-4ab5-a0a8-cafda21c73a8" xlink:href="icui-20220630.xsd#icui_LongtermInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3be230b6-b72c-4bdb-973f-38fa429149f6" xlink:to="loc_icui_LongtermInvestmentsDomain_94668a46-58eb-4ab5-a0a8-cafda21c73a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_b552b426-da0d-47fd-ab89-76673ee1f657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3be230b6-b72c-4bdb-973f-38fa429149f6" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_b552b426-da0d-47fd-ab89-76673ee1f657" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_5911cfe5-fdbb-4458-83b8-b22007f40ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3be230b6-b72c-4bdb-973f-38fa429149f6" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_5911cfe5-fdbb-4458-83b8-b22007f40ddd" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/OtherAssetsNoncurrentDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#OtherAssetsNoncurrentDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/OtherAssetsNoncurrentDetails" xlink:type="extended" id="i567df78dd57545408576fc63684701e6_OtherAssetsNoncurrentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_d3b809dc-b6df-42a7-b35b-5869c6d1df31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_45c0d15f-04f8-4486-bf91-1bf0799d0780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d3b809dc-b6df-42a7-b35b-5869c6d1df31" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_45c0d15f-04f8-4486-bf91-1bf0799d0780" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_f04d67cf-5944-4f01-840e-9d54f965bcbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_d3b809dc-b6df-42a7-b35b-5869c6d1df31" xlink:to="loc_us-gaap_DerivativeTable_f04d67cf-5944-4f01-840e-9d54f965bcbf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_542b6183-0a83-4571-aab2-e0bc0cea6f50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f04d67cf-5944-4f01-840e-9d54f965bcbf" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_542b6183-0a83-4571-aab2-e0bc0cea6f50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_542b6183-0a83-4571-aab2-e0bc0cea6f50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_542b6183-0a83-4571-aab2-e0bc0cea6f50" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_542b6183-0a83-4571-aab2-e0bc0cea6f50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ca6b0e85-1bd8-4ef1-8c79-2dafbf549aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_542b6183-0a83-4571-aab2-e0bc0cea6f50" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ca6b0e85-1bd8-4ef1-8c79-2dafbf549aad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3e49188c-3ee7-4a4a-93f8-78e4c27ad870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ca6b0e85-1bd8-4ef1-8c79-2dafbf549aad" xlink:to="loc_us-gaap_InterestRateSwapMember_3e49188c-3ee7-4a4a-93f8-78e4c27ad870" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_c868cac0-4bd8-46bf-aa48-d4accbc5e153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ca6b0e85-1bd8-4ef1-8c79-2dafbf549aad" xlink:to="loc_us-gaap_ForeignExchangeMember_c868cac0-4bd8-46bf-aa48-d4accbc5e153" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#PropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="extended" id="i84b3c310c68a4e9ea063343bd99192a1_PropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f5fa7841-1227-49b3-b1b6-5c8752f21f46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_427aa31f-c9cf-4010-9d51-e07cecdec5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f5fa7841-1227-49b3-b1b6-5c8752f21f46" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_427aa31f-c9cf-4010-9d51-e07cecdec5ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5e687461-b5b6-4c3f-b46a-0ba2a9467633" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f5fa7841-1227-49b3-b1b6-5c8752f21f46" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5e687461-b5b6-4c3f-b46a-0ba2a9467633" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a0d2474c-d027-4c0d-b23b-2ba9b2e142ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f5fa7841-1227-49b3-b1b6-5c8752f21f46" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a0d2474c-d027-4c0d-b23b-2ba9b2e142ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_b2a2d5a4-c4a0-4485-8b5a-4ec93e2202d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f5fa7841-1227-49b3-b1b6-5c8752f21f46" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_b2a2d5a4-c4a0-4485-8b5a-4ec93e2202d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_59018c90-aa11-4203-96ae-7d2c44072617" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f5fa7841-1227-49b3-b1b6-5c8752f21f46" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_59018c90-aa11-4203-96ae-7d2c44072617" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_dd62c57d-f64b-49c6-9541-8ced2f6f700e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f5fa7841-1227-49b3-b1b6-5c8752f21f46" xlink:to="loc_us-gaap_ConstructionInProgressGross_dd62c57d-f64b-49c6-9541-8ced2f6f700e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3eb37b61-9161-4dcc-93be-fa16091ddddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f5fa7841-1227-49b3-b1b6-5c8752f21f46" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3eb37b61-9161-4dcc-93be-fa16091ddddc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1887b503-9a82-4017-a1f1-8bccabf2170d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3eb37b61-9161-4dcc-93be-fa16091ddddc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1887b503-9a82-4017-a1f1-8bccabf2170d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1887b503-9a82-4017-a1f1-8bccabf2170d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1887b503-9a82-4017-a1f1-8bccabf2170d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1887b503-9a82-4017-a1f1-8bccabf2170d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_174e3166-23f8-4033-838b-716e8746e0e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1887b503-9a82-4017-a1f1-8bccabf2170d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_174e3166-23f8-4033-838b-716e8746e0e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember_e1b80315-c02d-46f3-a81b-62dad08a72e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_174e3166-23f8-4033-838b-716e8746e0e6" xlink:to="loc_us-gaap_LandBuildingsAndImprovementsMember_e1b80315-c02d-46f3-a81b-62dad08a72e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MoldsMember_3de78c2d-1651-4171-a8ed-563154f3c33d" xlink:href="icui-20220630.xsd#icui_MoldsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_174e3166-23f8-4033-838b-716e8746e0e6" xlink:to="loc_icui_MoldsMember_3de78c2d-1651-4171-a8ed-563154f3c33d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ComputerEquipmentAndSoftwareMember_4583ee06-03e8-4945-8e3b-14c7626e02b1" xlink:href="icui-20220630.xsd#icui_ComputerEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_174e3166-23f8-4033-838b-716e8746e0e6" xlink:to="loc_icui_ComputerEquipmentAndSoftwareMember_4583ee06-03e8-4945-8e3b-14c7626e02b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InstrumentsPlacedwithCustomersMember_6406db55-56d2-494b-bbed-db9ff3acc6be" xlink:href="icui-20220630.xsd#icui_InstrumentsPlacedwithCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_174e3166-23f8-4033-838b-716e8746e0e6" xlink:to="loc_icui_InstrumentsPlacedwithCustomersMember_6406db55-56d2-494b-bbed-db9ff3acc6be" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#GoodwillandIntangibleAssetsIntangiblesTableDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails" xlink:type="extended" id="ia96db5644a454880a8ff427f98b68893_GoodwillandIntangibleAssetsIntangiblesTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_570013a9-8ead-4f6a-9a78-901ef661543b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_570013a9-8ead-4f6a-9a78-901ef661543b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_15ff01a2-8716-47b7-b61e-9eee9acf14e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_15ff01a2-8716-47b7-b61e-9eee9acf14e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ea074800-2c4a-4567-81c4-22b15c2146aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ea074800-2c4a-4567-81c4-22b15c2146aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7038a2ab-4de7-4d65-acb0-61eca9693679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7038a2ab-4de7-4d65-acb0-61eca9693679" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9eec40c4-84ff-4d5f-b7d1-f3168e9887af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9eec40c4-84ff-4d5f-b7d1-f3168e9887af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_da741338-e516-402c-9839-da6f5ace68df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_da741338-e516-402c-9839-da6f5ace68df" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_437dde1e-3967-4209-8180-6a3a5acfc74c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_437dde1e-3967-4209-8180-6a3a5acfc74c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7b8a4b3a-e6ab-4fda-a37e-90006829ab7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7b8a4b3a-e6ab-4fda-a37e-90006829ab7a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_542bd84a-cc3b-4f2f-9bc3-cee43779add3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7b8a4b3a-e6ab-4fda-a37e-90006829ab7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_542bd84a-cc3b-4f2f-9bc3-cee43779add3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_542bd84a-cc3b-4f2f-9bc3-cee43779add3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_542bd84a-cc3b-4f2f-9bc3-cee43779add3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_542bd84a-cc3b-4f2f-9bc3-cee43779add3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_542bd84a-cc3b-4f2f-9bc3-cee43779add3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_17df1e57-0ebe-4523-85e0-06eaa1704356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:to="loc_us-gaap_PatentsMember_17df1e57-0ebe-4523-85e0-06eaa1704356" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_1791e962-1b52-4fb1-a344-cf6a67a6b76e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:to="loc_us-gaap_CustomerContractsMember_1791e962-1b52-4fb1-a344-cf6a67a6b76e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_2b695667-88bb-4f66-8bdd-7f47afd23fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_2b695667-88bb-4f66-8bdd-7f47afd23fe9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_afba8cc3-98f8-4f9c-858d-9f5f00984c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:to="loc_us-gaap_TrademarksMember_afba8cc3-98f8-4f9c-858d-9f5f00984c86" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_35a55a2f-8797-4f07-9327-272914131676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:to="loc_us-gaap_TradeNamesMember_35a55a2f-8797-4f07-9327-272914131676" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_f7ba6899-0f66-4fff-b2a9-30fdb7044a22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_f7ba6899-0f66-4fff-b2a9-30fdb7044a22" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_e87d9900-d9e8-4e73-a07b-ba1d2c9ed920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_e87d9900-d9e8-4e73-a07b-ba1d2c9ed920" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_63a0b1c0-075a-4f01-be3c-eed20db54492" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7b8a4b3a-e6ab-4fda-a37e-90006829ab7a" xlink:to="loc_srt_ConsolidationItemsAxis_63a0b1c0-075a-4f01-be3c-eed20db54492" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_63a0b1c0-075a-4f01-be3c-eed20db54492_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_63a0b1c0-075a-4f01-be3c-eed20db54492" xlink:to="loc_srt_ConsolidationItemsDomain_63a0b1c0-075a-4f01-be3c-eed20db54492_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a5e51864-fa22-4456-a1f7-e4605d1fa0aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_63a0b1c0-075a-4f01-be3c-eed20db54492" xlink:to="loc_srt_ConsolidationItemsDomain_a5e51864-fa22-4456-a1f7-e4605d1fa0aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4f02525e-95d1-45b3-a4af-25cf5f9813f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7b8a4b3a-e6ab-4fda-a37e-90006829ab7a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4f02525e-95d1-45b3-a4af-25cf5f9813f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4f02525e-95d1-45b3-a4af-25cf5f9813f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4f02525e-95d1-45b3-a4af-25cf5f9813f8" xlink:to="loc_us-gaap_SegmentDomain_4f02525e-95d1-45b3-a4af-25cf5f9813f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0fde0e82-e6a5-4dab-a787-a1eb52c1e5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4f02525e-95d1-45b3-a4af-25cf5f9813f8" xlink:to="loc_us-gaap_SegmentDomain_0fde0e82-e6a5-4dab-a787-a1eb52c1e5d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ab11aebd-9e5f-434e-98bd-35c41f017103" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7b8a4b3a-e6ab-4fda-a37e-90006829ab7a" xlink:to="loc_srt_RangeAxis_ab11aebd-9e5f-434e-98bd-35c41f017103" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ab11aebd-9e5f-434e-98bd-35c41f017103_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ab11aebd-9e5f-434e-98bd-35c41f017103" xlink:to="loc_srt_RangeMember_ab11aebd-9e5f-434e-98bd-35c41f017103_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7f2f7490-3b8a-4ddd-860e-b69b452ea97e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ab11aebd-9e5f-434e-98bd-35c41f017103" xlink:to="loc_srt_RangeMember_7f2f7490-3b8a-4ddd-860e-b69b452ea97e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#AccruedLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesDetails" xlink:type="extended" id="i0d80ff532c2d43eda69d429b1bd93170_AccruedLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6adc765c-e8bd-4ede-9c52-66b666aa8ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_2a01d604-66dd-480f-a681-e3e1fc2eab88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6adc765c-e8bd-4ede-9c52-66b666aa8ef7" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_2a01d604-66dd-480f-a681-e3e1fc2eab88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_dfd1f491-2f67-4460-a22d-cd067d768428" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_6adc765c-e8bd-4ede-9c52-66b666aa8ef7" xlink:to="loc_us-gaap_DerivativeTable_dfd1f491-2f67-4460-a22d-cd067d768428" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b58f128a-6083-482a-b640-77f9b9fbff4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_dfd1f491-2f67-4460-a22d-cd067d768428" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b58f128a-6083-482a-b640-77f9b9fbff4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b58f128a-6083-482a-b640-77f9b9fbff4e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b58f128a-6083-482a-b640-77f9b9fbff4e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b58f128a-6083-482a-b640-77f9b9fbff4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_09b479e3-a0d1-4d44-b6c0-b2dc7ec4058d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b58f128a-6083-482a-b640-77f9b9fbff4e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_09b479e3-a0d1-4d44-b6c0-b2dc7ec4058d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_6d7992bc-fbf5-47ff-aa2d-5055eea0e193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_09b479e3-a0d1-4d44-b6c0-b2dc7ec4058d" xlink:to="loc_us-gaap_ForeignExchangeMember_6d7992bc-fbf5-47ff-aa2d-5055eea0e193" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems_72b87451-f04d-42e4-b31b-c5ef1ff6f6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_1a1b0a5b-d6f6-4d90-9ce2-c548aa928022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_72b87451-f04d-42e4-b31b-c5ef1ff6f6d3" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_1a1b0a5b-d6f6-4d90-9ce2-c548aa928022" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable_f8a39fc1-ba46-4709-8d27-fd4129221803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_72b87451-f04d-42e4-b31b-c5ef1ff6f6d3" xlink:to="loc_us-gaap_ProductLiabilityContingencyTable_f8a39fc1-ba46-4709-8d27-fd4129221803" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_0b09f8c4-c89b-4a9f-91b0-7e87a3fbbd16" xlink:href="icui-20220630.xsd#icui_TimingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_f8a39fc1-ba46-4709-8d27-fd4129221803" xlink:to="loc_icui_TimingAxis_0b09f8c4-c89b-4a9f-91b0-7e87a3fbbd16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_0b09f8c4-c89b-4a9f-91b0-7e87a3fbbd16_default" xlink:href="icui-20220630.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TimingAxis_0b09f8c4-c89b-4a9f-91b0-7e87a3fbbd16" xlink:to="loc_icui_TimingDomain_0b09f8c4-c89b-4a9f-91b0-7e87a3fbbd16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_5ba33fb1-07d4-461f-b3b8-2023ef2c09dc" xlink:href="icui-20220630.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TimingAxis_0b09f8c4-c89b-4a9f-91b0-7e87a3fbbd16" xlink:to="loc_icui_TimingDomain_5ba33fb1-07d4-461f-b3b8-2023ef2c09dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermMember_0da79ce5-010f-48cb-867d-1503d0e59037" xlink:href="icui-20220630.xsd#icui_ShortTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TimingDomain_5ba33fb1-07d4-461f-b3b8-2023ef2c09dc" xlink:to="loc_icui_ShortTermMember_0da79ce5-010f-48cb-867d-1503d0e59037" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#AccruedLiabilitiesLongtermliabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails" xlink:type="extended" id="ibeaa40eeef114644b0dfffffdf8899a4_AccruedLiabilitiesLongtermliabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems_63368949-4749-4287-841a-8814ae750144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_43008444-cc60-4af1-91f5-69b232cad90d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_63368949-4749-4287-841a-8814ae750144" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_43008444-cc60-4af1-91f5-69b232cad90d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_64544f59-a59b-4afe-951f-ea7d676a4495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_63368949-4749-4287-841a-8814ae750144" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_64544f59-a59b-4afe-951f-ea7d676a4495" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable_81861f7b-b91f-4eba-9f3b-8004239ad2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_63368949-4749-4287-841a-8814ae750144" xlink:to="loc_us-gaap_ProductLiabilityContingencyTable_81861f7b-b91f-4eba-9f3b-8004239ad2d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_c65e4f26-a575-4887-88a6-fc7d42e1a884" xlink:href="icui-20220630.xsd#icui_TimingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_81861f7b-b91f-4eba-9f3b-8004239ad2d2" xlink:to="loc_icui_TimingAxis_c65e4f26-a575-4887-88a6-fc7d42e1a884" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_c65e4f26-a575-4887-88a6-fc7d42e1a884_default" xlink:href="icui-20220630.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TimingAxis_c65e4f26-a575-4887-88a6-fc7d42e1a884" xlink:to="loc_icui_TimingDomain_c65e4f26-a575-4887-88a6-fc7d42e1a884_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_4bba79a3-1d96-4e4e-85ae-e7e9b5aa6f10" xlink:href="icui-20220630.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TimingAxis_c65e4f26-a575-4887-88a6-fc7d42e1a884" xlink:to="loc_icui_TimingDomain_4bba79a3-1d96-4e4e-85ae-e7e9b5aa6f10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermMember_c14e0774-adf7-4df0-8141-4666b04130db" xlink:href="icui-20220630.xsd#icui_LongTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TimingDomain_4bba79a3-1d96-4e4e-85ae-e7e9b5aa6f10" xlink:to="loc_icui_LongTermMember_c14e0774-adf7-4df0-8141-4666b04130db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_396a9b35-5f53-486e-a940-bab872335ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_92394bcf-555a-4a89-9ed4-94f0058a3202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_396a9b35-5f53-486e-a940-bab872335ae6" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_92394bcf-555a-4a89-9ed4-94f0058a3202" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_61d2451e-4d84-4f11-9c86-ec3a9b55563a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_396a9b35-5f53-486e-a940-bab872335ae6" xlink:to="loc_us-gaap_DerivativeTable_61d2451e-4d84-4f11-9c86-ec3a9b55563a" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5707178a-0365-4db6-942b-dd32b87ca58c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_61d2451e-4d84-4f11-9c86-ec3a9b55563a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5707178a-0365-4db6-942b-dd32b87ca58c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5707178a-0365-4db6-942b-dd32b87ca58c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5707178a-0365-4db6-942b-dd32b87ca58c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5707178a-0365-4db6-942b-dd32b87ca58c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ae932aba-8770-4eaa-bee9-07ccb7fa2a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5707178a-0365-4db6-942b-dd32b87ca58c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ae932aba-8770-4eaa-bee9-07ccb7fa2a3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_a4529882-a86f-4985-917a-592ac49344dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ae932aba-8770-4eaa-bee9-07ccb7fa2a3d" xlink:to="loc_us-gaap_ForeignExchangeMember_a4529882-a86f-4985-917a-592ac49344dc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#LongTermObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/LongTermObligationsDetails" xlink:type="extended" id="i891f713578984d58849fcb89a732d739_LongTermObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TotalSeniorSecuredCreditFacility_bc483222-d0bd-4985-b21c-5ba2bf944d2b" xlink:href="icui-20220630.xsd#icui_TotalSeniorSecuredCreditFacility"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:to="loc_icui_TotalSeniorSecuredCreditFacility_bc483222-d0bd-4985-b21c-5ba2bf944d2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_7288e4b5-ea43-4fa7-99c7-0aeb330050e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_7288e4b5-ea43-4fa7-99c7-0aeb330050e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_28e44ffc-8f4d-4ee2-ba94-697d1f157052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_28e44ffc-8f4d-4ee2-ba94-697d1f157052" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RevolverSubLimits_b721067f-6b79-4804-b13c-2edf9d4a45fb" xlink:href="icui-20220630.xsd#icui_RevolverSubLimits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:to="loc_icui_RevolverSubLimits_b721067f-6b79-4804-b13c-2edf9d4a45fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_66a06f56-1a95-4218-8079-2c9ec71e3780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_66a06f56-1a95-4218-8079-2c9ec71e3780" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e80269e9-a6db-418c-a88c-e255d2bbbf3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:to="loc_us-gaap_LongTermDebt_e80269e9-a6db-418c-a88c-e255d2bbbf3c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_19634170-da21-466e-8b7d-1cd016e4d79c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_19634170-da21-466e-8b7d-1cd016e4d79c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount_efbd7af8-727c-40e6-aa9a-1fc00da6dcf7" xlink:href="icui-20220630.xsd#icui_LeverageRatioCalculationCeilingSubtractedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:to="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount_efbd7af8-727c-40e6-aa9a-1fc00da6dcf7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ec7acefc-a391-49fc-8e11-3d7b78276326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:to="loc_us-gaap_DebtInstrumentTable_ec7acefc-a391-49fc-8e11-3d7b78276326" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5d9b7129-6f6b-45e2-b1f9-35320f0aa36e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ec7acefc-a391-49fc-8e11-3d7b78276326" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5d9b7129-6f6b-45e2-b1f9-35320f0aa36e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5d9b7129-6f6b-45e2-b1f9-35320f0aa36e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5d9b7129-6f6b-45e2-b1f9-35320f0aa36e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5d9b7129-6f6b-45e2-b1f9-35320f0aa36e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3b933f46-a2e7-4803-99f2-9d67345dedc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5d9b7129-6f6b-45e2-b1f9-35320f0aa36e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3b933f46-a2e7-4803-99f2-9d67345dedc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e2593a4d-1c00-4dce-af95-5391dd4b9d98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3b933f46-a2e7-4803-99f2-9d67345dedc5" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e2593a4d-1c00-4dce-af95-5391dd4b9d98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_ef043979-7abc-4cb4-abc5-28daaf77ea55" xlink:href="icui-20220630.xsd#icui_TermLoanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ec7acefc-a391-49fc-8e11-3d7b78276326" xlink:to="loc_icui_TermLoanAxis_ef043979-7abc-4cb4-abc5-28daaf77ea55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_ef043979-7abc-4cb4-abc5-28daaf77ea55_default" xlink:href="icui-20220630.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TermLoanAxis_ef043979-7abc-4cb4-abc5-28daaf77ea55" xlink:to="loc_icui_TermLoanDomain_ef043979-7abc-4cb4-abc5-28daaf77ea55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_fa133a2e-2694-4ad3-84f4-57dbdc706132" xlink:href="icui-20220630.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TermLoanAxis_ef043979-7abc-4cb4-abc5-28daaf77ea55" xlink:to="loc_icui_TermLoanDomain_fa133a2e-2694-4ad3-84f4-57dbdc706132" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_a378b002-8dc3-4f42-9178-62d8bc8712b8" xlink:href="icui-20220630.xsd#icui_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_fa133a2e-2694-4ad3-84f4-57dbdc706132" xlink:to="loc_icui_TermLoanAMember_a378b002-8dc3-4f42-9178-62d8bc8712b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_4ff2b76d-0aaa-4abe-8121-83ceb6e027a1" xlink:href="icui-20220630.xsd#icui_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_fa133a2e-2694-4ad3-84f4-57dbdc706132" xlink:to="loc_icui_TermLoanBMember_4ff2b76d-0aaa-4abe-8121-83ceb6e027a1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#LongTermObligationsInterestRateTermsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails" xlink:type="extended" id="idd73d09222a74414a3a55dfaacfa4205_LongTermObligationsInterestRateTermsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_089b5a89-3e90-4a14-b95f-b656ed8621a2" xlink:href="icui-20220630.xsd#icui_ApplicableMarginBasedOnLeverageRatioLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBaseRateLoans_21d69751-3fee-4021-916d-7055e654e817" xlink:href="icui-20220630.xsd#icui_ApplicableMarginBaseRateLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_089b5a89-3e90-4a14-b95f-b656ed8621a2" xlink:to="loc_icui_ApplicableMarginBaseRateLoans_21d69751-3fee-4021-916d-7055e654e817" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginTermSOFRLoans_a532f38b-098a-4739-9d21-6f40104bef5d" xlink:href="icui-20220630.xsd#icui_ApplicableMarginTermSOFRLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_089b5a89-3e90-4a14-b95f-b656ed8621a2" xlink:to="loc_icui_ApplicableMarginTermSOFRLoans_a532f38b-098a-4739-9d21-6f40104bef5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_f014bbbf-6cad-44d4-858a-16881b3d3cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_089b5a89-3e90-4a14-b95f-b656ed8621a2" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_f014bbbf-6cad-44d4-858a-16881b3d3cd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_4dd40f14-4cab-4511-829c-3b7ad9b7609a" xlink:href="icui-20220630.xsd#icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_089b5a89-3e90-4a14-b95f-b656ed8621a2" xlink:to="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_4dd40f14-4cab-4511-829c-3b7ad9b7609a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_3a511c99-afbc-492e-84b3-e0dacfcfff72" xlink:href="icui-20220630.xsd#icui_ApplicableMarginBasedOnLeverageRatioTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_089b5a89-3e90-4a14-b95f-b656ed8621a2" xlink:to="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_3a511c99-afbc-492e-84b3-e0dacfcfff72" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_c7b317b7-c198-4a5f-8f64-3f5cf37c076e" xlink:href="icui-20220630.xsd#icui_TermLoanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_3a511c99-afbc-492e-84b3-e0dacfcfff72" xlink:to="loc_icui_TermLoanAxis_c7b317b7-c198-4a5f-8f64-3f5cf37c076e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_c7b317b7-c198-4a5f-8f64-3f5cf37c076e_default" xlink:href="icui-20220630.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TermLoanAxis_c7b317b7-c198-4a5f-8f64-3f5cf37c076e" xlink:to="loc_icui_TermLoanDomain_c7b317b7-c198-4a5f-8f64-3f5cf37c076e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_06ff857c-6fcd-4324-82e4-baa9d4377762" xlink:href="icui-20220630.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TermLoanAxis_c7b317b7-c198-4a5f-8f64-3f5cf37c076e" xlink:to="loc_icui_TermLoanDomain_06ff857c-6fcd-4324-82e4-baa9d4377762" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_c35f511d-93a8-4d8e-a27c-14fb80801eb0" xlink:href="icui-20220630.xsd#icui_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_06ff857c-6fcd-4324-82e4-baa9d4377762" xlink:to="loc_icui_TermLoanAMember_c35f511d-93a8-4d8e-a27c-14fb80801eb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_554a1a15-7c81-4495-ba64-0addc3f41ca4" xlink:href="icui-20220630.xsd#icui_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_06ff857c-6fcd-4324-82e4-baa9d4377762" xlink:to="loc_icui_TermLoanBMember_554a1a15-7c81-4495-ba64-0addc3f41ca4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelAxis_b3468c16-11be-4efa-96a9-83c1f43e9ced" xlink:href="icui-20220630.xsd#icui_LeverageRatioLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_3a511c99-afbc-492e-84b3-e0dacfcfff72" xlink:to="loc_icui_LeverageRatioLevelAxis_b3468c16-11be-4efa-96a9-83c1f43e9ced" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelDomain_b3468c16-11be-4efa-96a9-83c1f43e9ced_default" xlink:href="icui-20220630.xsd#icui_LeverageRatioLevelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_LeverageRatioLevelAxis_b3468c16-11be-4efa-96a9-83c1f43e9ced" xlink:to="loc_icui_LeverageRatioLevelDomain_b3468c16-11be-4efa-96a9-83c1f43e9ced_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:href="icui-20220630.xsd#icui_LeverageRatioLevelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_LeverageRatioLevelAxis_b3468c16-11be-4efa-96a9-83c1f43e9ced" xlink:to="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Greaterthan400to100Member_6b878b94-b934-41ae-a118-1f82dae9bf3e" xlink:href="icui-20220630.xsd#icui_Greaterthan400to100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:to="loc_icui_Greaterthan400to100Member_6b878b94-b934-41ae-a118-1f82dae9bf3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_abebcae5-6712-4838-abca-b80f8fed8e32" xlink:href="icui-20220630.xsd#icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:to="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_abebcae5-6712-4838-abca-b80f8fed8e32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_8d612a7f-2936-4afa-b6c0-ef526460c75b" xlink:href="icui-20220630.xsd#icui_LessThanOrEqual300To100ButGreaterThan250to100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:to="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_8d612a7f-2936-4afa-b6c0-ef526460c75b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_cf7bcab2-fc39-49db-8b69-4e8d08adefae" xlink:href="icui-20220630.xsd#icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:to="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_cf7bcab2-fc39-49db-8b69-4e8d08adefae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo200To100Member_30ee325c-3f92-4bcc-91af-35a9d0034f1e" xlink:href="icui-20220630.xsd#icui_LessThanOrEqualTo200To100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:to="loc_icui_LessThanOrEqualTo200To100Member_30ee325c-3f92-4bcc-91af-35a9d0034f1e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GreaterThan275To100Member_87810cd0-adca-4292-b71b-d63e67caad44" xlink:href="icui-20220630.xsd#icui_GreaterThan275To100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:to="loc_icui_GreaterThan275To100Member_87810cd0-adca-4292-b71b-d63e67caad44" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThan275To100Member_1e3031b5-dd5b-4ebb-9414-eb8d900959b4" xlink:href="icui-20220630.xsd#icui_LessThan275To100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:to="loc_icui_LessThan275To100Member_1e3031b5-dd5b-4ebb-9414-eb8d900959b4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a312379d-f308-40e3-a9c2-4b7b027edc28" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_3a511c99-afbc-492e-84b3-e0dacfcfff72" xlink:to="loc_srt_RangeAxis_a312379d-f308-40e3-a9c2-4b7b027edc28" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a312379d-f308-40e3-a9c2-4b7b027edc28_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a312379d-f308-40e3-a9c2-4b7b027edc28" xlink:to="loc_srt_RangeMember_a312379d-f308-40e3-a9c2-4b7b027edc28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2459fd56-8312-4a53-9835-fa8a011a3e68" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a312379d-f308-40e3-a9c2-4b7b027edc28" xlink:to="loc_srt_RangeMember_2459fd56-8312-4a53-9835-fa8a011a3e68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2a45be1d-4caa-4eaf-9a35-e25c388a7708" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2459fd56-8312-4a53-9835-fa8a011a3e68" xlink:to="loc_srt_MaximumMember_2a45be1d-4caa-4eaf-9a35-e25c388a7708" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_10fcb048-b97a-45ba-8e2f-14265c33f47f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2459fd56-8312-4a53-9835-fa8a011a3e68" xlink:to="loc_srt_MinimumMember_10fcb048-b97a-45ba-8e2f-14265c33f47f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsTableDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#LongTermObligationsTableDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/LongTermObligationsTableDetails" xlink:type="extended" id="iab819057e30744089913430edd0f2fa4_LongTermObligationsTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_68e52ab5-1582-4c77-b094-733320e3def4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_68e52ab5-1582-4c77-b094-733320e3def4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_03600ef4-b225-43aa-9585-65dd3623a458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_03600ef4-b225-43aa-9585-65dd3623a458" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_5f030f65-6a08-4f56-9326-bb32a9109c14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_5f030f65-6a08-4f56-9326-bb32a9109c14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_6a332f19-db54-4798-bb68-879f5f137038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_6a332f19-db54-4798-bb68-879f5f137038" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_3a87b529-8683-44e6-bc20-a1f2278414ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:to="loc_us-gaap_DebtCurrent_3a87b529-8683-44e6-bc20-a1f2278414ae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e5181fc4-abe0-44e0-869c-a5505c2e3786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e5181fc4-abe0-44e0-869c-a5505c2e3786" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_0f7fa3e9-cdea-4304-8073-852e42634435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_0f7fa3e9-cdea-4304-8073-852e42634435" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_09f48637-839a-463b-9efc-099b4f3ae756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:to="loc_us-gaap_DebtInstrumentTable_09f48637-839a-463b-9efc-099b4f3ae756" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_c2ef0db2-d700-41da-b365-9cfa87c4088c" xlink:href="icui-20220630.xsd#icui_TermLoanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_09f48637-839a-463b-9efc-099b4f3ae756" xlink:to="loc_icui_TermLoanAxis_c2ef0db2-d700-41da-b365-9cfa87c4088c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_c2ef0db2-d700-41da-b365-9cfa87c4088c_default" xlink:href="icui-20220630.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TermLoanAxis_c2ef0db2-d700-41da-b365-9cfa87c4088c" xlink:to="loc_icui_TermLoanDomain_c2ef0db2-d700-41da-b365-9cfa87c4088c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_1a60919a-7a2b-48e8-b83f-fba9f2f852e0" xlink:href="icui-20220630.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TermLoanAxis_c2ef0db2-d700-41da-b365-9cfa87c4088c" xlink:to="loc_icui_TermLoanDomain_1a60919a-7a2b-48e8-b83f-fba9f2f852e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_0609ccda-4e53-4c0b-a009-e4085ad95ed7" xlink:href="icui-20220630.xsd#icui_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_1a60919a-7a2b-48e8-b83f-fba9f2f852e0" xlink:to="loc_icui_TermLoanAMember_0609ccda-4e53-4c0b-a009-e4085ad95ed7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_ffefffa2-19c8-4dd2-9b82-62de36cc9ad2" xlink:href="icui-20220630.xsd#icui_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_1a60919a-7a2b-48e8-b83f-fba9f2f852e0" xlink:to="loc_icui_TermLoanBMember_ffefffa2-19c8-4dd2-9b82-62de36cc9ad2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c3e1dd4b-ed6d-4c9a-9d54-08d91572d6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_09f48637-839a-463b-9efc-099b4f3ae756" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c3e1dd4b-ed6d-4c9a-9d54-08d91572d6b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c3e1dd4b-ed6d-4c9a-9d54-08d91572d6b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c3e1dd4b-ed6d-4c9a-9d54-08d91572d6b1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c3e1dd4b-ed6d-4c9a-9d54-08d91572d6b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ecea38ed-1813-4963-8495-c7f30bcb8ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c3e1dd4b-ed6d-4c9a-9d54-08d91572d6b1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ecea38ed-1813-4963-8495-c7f30bcb8ec0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ea68c47b-d8c8-4a19-9c96-860b613d993b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ecea38ed-1813-4963-8495-c7f30bcb8ec0" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ea68c47b-d8c8-4a19-9c96-860b613d993b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#CommitmentsandContingenciesContingencyDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails" xlink:type="extended" id="i18134945866c458e9ed268d6d44f624f_CommitmentsandContingenciesContingencyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_fe0e420b-0308-41d5-a5d0-afe61bd55de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_a0db8b1a-74ce-483f-82a3-c4b3f9baee48" xlink:href="icui-20220630.xsd#icui_Contingentconsiderationgross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_fe0e420b-0308-41d5-a5d0-afe61bd55de1" xlink:to="loc_icui_Contingentconsiderationgross_a0db8b1a-74ce-483f-82a3-c4b3f9baee48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_efd21afa-bcb1-4855-8397-130124a0e765" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationGrossST"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_fe0e420b-0308-41d5-a5d0-afe61bd55de1" xlink:to="loc_icui_ContingentConsiderationGrossST_efd21afa-bcb1-4855-8397-130124a0e765" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_5db7530b-0aa4-4dbb-a50a-202994bbfb88" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_fe0e420b-0308-41d5-a5d0-afe61bd55de1" xlink:to="loc_icui_ContingentConsiderationGrossLT_5db7530b-0aa4-4dbb-a50a-202994bbfb88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3c1edfd2-3982-4f7b-bc05-ef7ae658a397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_fe0e420b-0308-41d5-a5d0-afe61bd55de1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3c1edfd2-3982-4f7b-bc05-ef7ae658a397" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_3a72e079-f4a3-4937-98f5-be26b270bf30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_fe0e420b-0308-41d5-a5d0-afe61bd55de1" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_3a72e079-f4a3-4937-98f5-be26b270bf30" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5c683317-b429-4877-a978-6c820dae2862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_fe0e420b-0308-41d5-a5d0-afe61bd55de1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5c683317-b429-4877-a978-6c820dae2862" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1767f18a-1fce-404f-b39b-f50a8e77547a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5c683317-b429-4877-a978-6c820dae2862" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1767f18a-1fce-404f-b39b-f50a8e77547a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1767f18a-1fce-404f-b39b-f50a8e77547a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1767f18a-1fce-404f-b39b-f50a8e77547a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1767f18a-1fce-404f-b39b-f50a8e77547a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e846880-2058-47aa-9ace-cd003bdd6f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1767f18a-1fce-404f-b39b-f50a8e77547a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e846880-2058-47aa-9ace-cd003bdd6f4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_d513d125-78b0-496f-a781-e36885e28029" xlink:href="icui-20220630.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e846880-2058-47aa-9ace-cd003bdd6f4a" xlink:to="loc_icui_SmithsMedicalMember_d513d125-78b0-496f-a781-e36885e28029" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_412a0fd9-c0f9-4085-b1f7-01257d59d8a2" xlink:href="icui-20220630.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e846880-2058-47aa-9ace-cd003bdd6f4a" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_412a0fd9-c0f9-4085-b1f7-01257d59d8a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InternationalDistributorMember_8a4327c1-f80e-4db7-b4d0-9fe865f0cee6" xlink:href="icui-20220630.xsd#icui_InternationalDistributorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e846880-2058-47aa-9ace-cd003bdd6f4a" xlink:to="loc_icui_InternationalDistributorMember_8a4327c1-f80e-4db7-b4d0-9fe865f0cee6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#EquityAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i61d98d6eaadf4e6f8559661c85967ce0_EquityAccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3d0a043-9696-4b7c-9f52-5911c7c0d9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2bc2c8e6-a480-4073-a5bf-24a0f328d627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3d0a043-9696-4b7c-9f52-5911c7c0d9d4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2bc2c8e6-a480-4073-a5bf-24a0f328d627" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_bab0e1d5-690a-4c26-a980-7e4a7f1eac70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3d0a043-9696-4b7c-9f52-5911c7c0d9d4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_bab0e1d5-690a-4c26-a980-7e4a7f1eac70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2768a117-8b5e-40dd-9c34-58b20fb7718a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3d0a043-9696-4b7c-9f52-5911c7c0d9d4" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2768a117-8b5e-40dd-9c34-58b20fb7718a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f377260f-12d9-4d3c-aaea-2ed55bdc4411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3d0a043-9696-4b7c-9f52-5911c7c0d9d4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f377260f-12d9-4d3c-aaea-2ed55bdc4411" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_623b0306-8a0a-4a70-b5eb-8137b3de49f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3d0a043-9696-4b7c-9f52-5911c7c0d9d4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_623b0306-8a0a-4a70-b5eb-8137b3de49f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_eba07e69-aee8-4c26-9239-520a0f75e1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3d0a043-9696-4b7c-9f52-5911c7c0d9d4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_eba07e69-aee8-4c26-9239-520a0f75e1ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_20b0a092-0a41-4f61-84ca-14cf91c98062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_eba07e69-aee8-4c26-9239-520a0f75e1ea" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_20b0a092-0a41-4f61-84ca-14cf91c98062" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_20b0a092-0a41-4f61-84ca-14cf91c98062_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_20b0a092-0a41-4f61-84ca-14cf91c98062" xlink:to="loc_us-gaap_EquityComponentDomain_20b0a092-0a41-4f61-84ca-14cf91c98062_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_34143f7c-6cc1-4c39-b549-5e9c3a306a36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_20b0a092-0a41-4f61-84ca-14cf91c98062" xlink:to="loc_us-gaap_EquityComponentDomain_34143f7c-6cc1-4c39-b549-5e9c3a306a36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_a2955aaa-5b94-415a-97fa-4a67ed67fbbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_34143f7c-6cc1-4c39-b549-5e9c3a306a36" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_a2955aaa-5b94-415a-97fa-4a67ed67fbbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_67a840e2-22e8-428c-8119-84684d5a22da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_34143f7c-6cc1-4c39-b549-5e9c3a306a36" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_67a840e2-22e8-428c-8119-84684d5a22da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0eed7480-3d8f-43ee-a0d5-13e546d5cda5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_34143f7c-6cc1-4c39-b549-5e9c3a306a36" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0eed7480-3d8f-43ee-a0d5-13e546d5cda5" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>icui-20220630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b855b77c-6988-4216-8748-36632a973ac3,g:ab2a959a-be44-44c8-8165-c7a4fa090087-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_1c6d68b8-72bc-4921-94a2-40d7ba35af98_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_fba914e4-5c97-44d5-bf5e-4a2d1260b4eb_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_cc7ede4b-bb12-41a3-91a5-ffc7d7e979ca_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LessThan275To100Member_ee9f237e-c590-470f-9a93-a6fa22df07aa_terseLabel_en-US" xlink:label="lab_icui_LessThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessthan2point75to1</link:label>
    <link:label id="lab_icui_LessThan275To100Member_label_en-US" xlink:label="lab_icui_LessThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than 2.75 to1.00 [Member]</link:label>
    <link:label id="lab_icui_LessThan275To100Member_documentation_en-US" xlink:label="lab_icui_LessThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than 2.75:1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThan275To100Member" xlink:href="icui-20220630.xsd#icui_LessThan275To100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LessThan275To100Member" xlink:to="lab_icui_LessThan275To100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_57414ba7-a6d1-4466-aa3e-be6798811dff_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Accruedfreight_fa38c9ca-6913-413a-ba08-11f0fe748a8c_terseLabel_en-US" xlink:label="lab_icui_Accruedfreight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued freight</link:label>
    <link:label id="lab_icui_Accruedfreight_label_en-US" xlink:label="lab_icui_Accruedfreight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued freight</link:label>
    <link:label id="lab_icui_Accruedfreight_documentation_en-US" xlink:label="lab_icui_Accruedfreight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued freight</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedfreight" xlink:href="icui-20220630.xsd#icui_Accruedfreight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Accruedfreight" xlink:to="lab_icui_Accruedfreight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_b611ec09-be23-4006-b633-65ff7fd513dd_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5c35606d-9302-4b71-b70e-0e10cf70046a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_59747d2b-afdb-4b38-9269-5ad59509d7fb_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanBPrincipalPayment_5be51543-5481-4f67-b91f-102f2f5a7b84_terseLabel_en-US" xlink:label="lab_icui_TermLoanBPrincipalPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Principal Payment %</link:label>
    <link:label id="lab_icui_TermLoanBPrincipalPayment_label_en-US" xlink:label="lab_icui_TermLoanBPrincipalPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Principal Payment %</link:label>
    <link:label id="lab_icui_TermLoanBPrincipalPayment_documentation_en-US" xlink:label="lab_icui_TermLoanBPrincipalPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Principal Payment %</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBPrincipalPayment" xlink:href="icui-20220630.xsd#icui_TermLoanBPrincipalPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanBPrincipalPayment" xlink:to="lab_icui_TermLoanBPrincipalPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_85d27c38-54c2-4d6d-88ae-8ec2c40c28e3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_b2b2cdbb-79d3-4db0-897f-70793a7afa85_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investment securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_4c36e031-5a17-4c98-a5e7-f0187a42de31_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, outstanding shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InternationalDistributorMember_2d679119-daa8-4edc-bb5b-d3c18809361b_terseLabel_en-US" xlink:label="lab_icui_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Distributor</link:label>
    <link:label id="lab_icui_InternationalDistributorMember_label_en-US" xlink:label="lab_icui_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Distributor [Member]</link:label>
    <link:label id="lab_icui_InternationalDistributorMember_documentation_en-US" xlink:label="lab_icui_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Distributor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InternationalDistributorMember" xlink:href="icui-20220630.xsd#icui_InternationalDistributorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InternationalDistributorMember" xlink:to="lab_icui_InternationalDistributorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock_a8c64d26-4499-420c-9d02-2a79a42a0c57_terseLabel_en-US" xlink:label="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">investments in Debt and Marketable Equity Securities and Equity Method Investments [Text Block]</link:label>
    <link:label id="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">investments in Debt and Marketable Equity Securities and Equity Method Investments [Text Block]</link:label>
    <link:label id="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock_documentation_en-US" xlink:label="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">investments in Debt and Marketable Equity Securities and Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:href="icui-20220630.xsd#icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:to="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_f1fdb231-a89b-4ad6-853a-d8964073d645_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_be00c582-94c2-444a-aaf5-ed59f5b539b0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_070bfbe0-e9a3-495a-b331-d1a4f1d59448_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_01704782-e464-488f-af79-c91353e6aa97_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_0fef1caf-66b3-4f54-8028-102ab3c280ae_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_1af8b0fd-0c41-4b30-aa10-edc45f7d1aca_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_6467ec7c-ff0d-4f35-bcc9-a2b46480b338_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_6bc48220-388b-4758-a299-9214718d5f6b_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_4aaf4565-e72c-4341-bb0b-43b0cb56c7e1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of asset</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_b2b927a1-1dea-4e67-94f5-cfae1c5b80b6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans_679e71bc-83fa-4dfe-be9d-8064e2b54832_terseLabel_en-US" xlink:label="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ter SOFR Interest Rate % Adjustment for Base Rate Loans</link:label>
    <link:label id="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans_label_en-US" xlink:label="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ter SOFR Interest Rate % Adjustment for Base Rate Loans</link:label>
    <link:label id="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans_documentation_en-US" xlink:label="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ter SOFR Interest Rate % Adjustment for Base Rate Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:href="icui-20220630.xsd#icui_TerSOFRInterestRateAdjustmentForBaseRateLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:to="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_725f2301-a955-46df-b98e-e0be29e261c8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_28a2978c-895f-4cfb-b194-bb176e708663_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_0f713b89-d52e-4032-99ea-2c4569f4b4a3_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset and Liability [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_10b9aaaa-ca4f-4cda-aeda-0d1800dbce21_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_254edc77-958f-4d98-b372-179c64e19e64_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f6abad94-9f5f-4222-a3a7-c42f49042e10_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_OtherCurrenciesMember_71b5218a-3253-4196-bff8-8c87d72fcdf0_terseLabel_en-US" xlink:label="lab_icui_OtherCurrenciesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">other currencies</link:label>
    <link:label id="lab_icui_OtherCurrenciesMember_label_en-US" xlink:label="lab_icui_OtherCurrenciesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">other currencies [Member]</link:label>
    <link:label id="lab_icui_OtherCurrenciesMember_documentation_en-US" xlink:label="lab_icui_OtherCurrenciesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">other currencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherCurrenciesMember" xlink:href="icui-20220630.xsd#icui_OtherCurrenciesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_OtherCurrenciesMember" xlink:to="lab_icui_OtherCurrenciesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_6a68a84a-3d5c-4dda-9b5b-d0eb1a706f42_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_e5c6e3ee-9f60-434d-ba27-f691e99ee790_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER ASSETS</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AccruedAuditFees_9d5df006-2943-4aa9-9c20-907c022d6cf3_terseLabel_en-US" xlink:label="lab_icui_AccruedAuditFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued audit fees</link:label>
    <link:label id="lab_icui_AccruedAuditFees_label_en-US" xlink:label="lab_icui_AccruedAuditFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued audit fees</link:label>
    <link:label id="lab_icui_AccruedAuditFees_documentation_en-US" xlink:label="lab_icui_AccruedAuditFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued audit fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedAuditFees" xlink:href="icui-20220630.xsd#icui_AccruedAuditFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AccruedAuditFees" xlink:to="lab_icui_AccruedAuditFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_a2a8adbe-1b03-4950-8df3-e5b92f5bcf81_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0e51c6d9-4d2f-4553-9823-0c390cc49ba5_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InterestRateSwapEndingNotionalValue_34b0c094-a197-4476-be19-07d649da7edf_terseLabel_en-US" xlink:label="lab_icui_InterestRateSwapEndingNotionalValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Ending Notional Value</link:label>
    <link:label id="lab_icui_InterestRateSwapEndingNotionalValue_label_en-US" xlink:label="lab_icui_InterestRateSwapEndingNotionalValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Ending Notional Value</link:label>
    <link:label id="lab_icui_InterestRateSwapEndingNotionalValue_documentation_en-US" xlink:label="lab_icui_InterestRateSwapEndingNotionalValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Ending Notional Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestRateSwapEndingNotionalValue" xlink:href="icui-20220630.xsd#icui_InterestRateSwapEndingNotionalValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InterestRateSwapEndingNotionalValue" xlink:to="lab_icui_InterestRateSwapEndingNotionalValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_9d4688fc-4a67-4f2f-9a7e-2e1f06ded930_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d21b2f07-e195-4b88-a085-e9963c2fd8d9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_837b29b4-7c8c-4f74-b9e3-0bf755c90767_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_36dc40e6-9f47-4755-8356-bb0aa3740910_negatedTerseLabel_en-US" xlink:label="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable</link:label>
    <link:label id="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_label_en-US" xlink:label="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable</link:label>
    <link:label id="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_documentation_en-US" xlink:label="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:href="icui-20220630.xsd#icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:to="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_5398b813-ead2-4849-9b44-f45e303eca0c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_604615ea-33f8-4d5d-a5de-eb459334e6bc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Other Investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_43018153-94f7-46f3-a85d-15fa265f26d1_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SoftwarerevenueMember_b7e77a36-ee8e-4e79-82b0-d6f3ff193b3a_terseLabel_en-US" xlink:label="lab_icui_SoftwarerevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software revenue [Member]</link:label>
    <link:label id="lab_icui_SoftwarerevenueMember_label_en-US" xlink:label="lab_icui_SoftwarerevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software revenue [Member]</link:label>
    <link:label id="lab_icui_SoftwarerevenueMember_documentation_en-US" xlink:label="lab_icui_SoftwarerevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember" xlink:href="icui-20220630.xsd#icui_SoftwarerevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SoftwarerevenueMember" xlink:to="lab_icui_SoftwarerevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_d9713fb6-6a0b-42ea-9bc1-da922201ea5b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedBonusesCurrent_187020bd-9995-4775-a141-04ed059c6284_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive compensation</link:label>
    <link:label id="lab_us-gaap_AccruedBonusesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Bonuses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedBonusesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedBonusesCurrent" xlink:to="lab_us-gaap_AccruedBonusesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_c88abf40-bf37-4ee0-b644-cd8d7a9d5b78_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_967a9562-32cd-46cb-84d4-987e9fd1f68d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8b9d939a-1827-46e4-a2e8-199c689f4a33_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_efc2f5e5-c8aa-44f9-9212-e379e387820e_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_801d3b96-fd0f-40f9-a529-223a0f9727af_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_48ee43e6-3010-4f77-90d6-95496bbeb1c6_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_dc05a6c7-4576-4de7-849c-07d8d5c02fd4_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b6b53ec0-7334-433f-963c-bd0e722e5d79_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f71d1185-30e5-4ef4-97d6-515c30065f3f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_79e73305-3dce-4f4b-9c19-1b999bf2813c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_e3069b35-71b6-4d02-8295-562c8b048241_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_a093e4c6-8e22-47e0-82d2-070e9c72e828_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_c285921a-2fca-4310-bf8c-bd80c13469da_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_83b043ea-7364-44f0-919d-3dbc490d9ddc_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_7c6ad1c0-e39e-467e-a8bd-147fbd1173cf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5e11b5f4-0e28-4b56-900b-a7f9a1814d3a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_6cc08ab8-d35c-431e-b5b9-1e2b939a2f65_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_257d3bb2-f38a-44fe-8f8c-26f495fed72a_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems_abf818a1-e7a8-47ff-a8b8-97877f332452_terseLabel_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Line Items]</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems_label_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Line Items]</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems_documentation_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:href="icui-20220630.xsd#icui_ApplicableMarginBasedOnLeverageRatioLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:to="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_fdae0fc2-1364-45e2-a145-c6e73ebbaf6d_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_f9044c1e-ac26-4daa-96cb-319f780d591a_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_2e56a63f-32c2-4d30-bcf9-618b6ad72bbc_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_3d39d73b-a931-4a9e-90c4-eb941d49d088_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_69e507d2-5a57-468b-ae13-aef4f4fecec3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Deferredtaxcharge_82ec8e1e-9d79-489b-8afa-91fab13e5138_terseLabel_en-US" xlink:label="lab_icui_Deferredtaxcharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax charge</link:label>
    <link:label id="lab_icui_Deferredtaxcharge_label_en-US" xlink:label="lab_icui_Deferredtaxcharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax charge</link:label>
    <link:label id="lab_icui_Deferredtaxcharge_documentation_en-US" xlink:label="lab_icui_Deferredtaxcharge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Deferredtaxcharge" xlink:href="icui-20220630.xsd#icui_Deferredtaxcharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Deferredtaxcharge" xlink:to="lab_icui_Deferredtaxcharge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_4a757f27-3cb7-4683-b17b-aa11cf05c25a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_4f804b5c-1915-4508-a2bb-7e601580bdec_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_442add64-bbfa-442f-84fc-2c5533ef3070_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_0c62dee8-1b59-411c-8cd1-3feacc1cda25_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InterestPercentageAddedToBaseRate_54e3ff5c-99b6-4b5a-9535-3c131224660f_terseLabel_en-US" xlink:label="lab_icui_InterestPercentageAddedToBaseRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Base Rate</link:label>
    <link:label id="lab_icui_InterestPercentageAddedToBaseRate_label_en-US" xlink:label="lab_icui_InterestPercentageAddedToBaseRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Base Rate</link:label>
    <link:label id="lab_icui_InterestPercentageAddedToBaseRate_documentation_en-US" xlink:label="lab_icui_InterestPercentageAddedToBaseRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Base Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestPercentageAddedToBaseRate" xlink:href="icui-20220630.xsd#icui_InterestPercentageAddedToBaseRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InterestPercentageAddedToBaseRate" xlink:to="lab_icui_InterestPercentageAddedToBaseRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_2d4ee558-0b00-4566-8869-04caae3d3343_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_91f553bb-cb3a-49a2-af4a-753a1a322675_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_4db3e983-8072-4666-b5cb-5a70ac5a82de_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_183e6426-7363-473a-80f7-21e7156537fe_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TreasuryStockPurchasePlan_b062ab2d-9529-4420-ac5c-c97aa5cd4dc3_terseLabel_en-US" xlink:label="lab_icui_TreasuryStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Purchase Plan</link:label>
    <link:label id="lab_icui_TreasuryStockPurchasePlan_label_en-US" xlink:label="lab_icui_TreasuryStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Purchase Plan</link:label>
    <link:label id="lab_icui_TreasuryStockPurchasePlan_documentation_en-US" xlink:label="lab_icui_TreasuryStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TreasuryStockPurchasePlan" xlink:href="icui-20220630.xsd#icui_TreasuryStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TreasuryStockPurchasePlan" xlink:to="lab_icui_TreasuryStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c7e84cd7-2f3a-4242-821f-9aeeb1505856_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_604185cd-285d-43dc-b651-8a567b6fef6d_terseLabel_en-US" xlink:label="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessthanorequal3to1butgreaterthan2point5to1</link:label>
    <link:label id="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_label_en-US" xlink:label="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal 3.00 to 1.00 but greater than 2.50to1.00 [Member]</link:label>
    <link:label id="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_documentation_en-US" xlink:label="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal 3.00 to 1.00 but greater than 2.50to1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:href="icui-20220630.xsd#icui_LessThanOrEqual300To100ButGreaterThan250to100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:to="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Restructuringandstrategictransaction_2c1e9c84-7976-49bc-a3a7-355f7d5d56d7_terseLabel_en-US" xlink:label="lab_icui_Restructuringandstrategictransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, strategic transaction and integration</link:label>
    <link:label id="lab_icui_Restructuringandstrategictransaction_label_en-US" xlink:label="lab_icui_Restructuringandstrategictransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and strategic transaction</link:label>
    <link:label id="lab_icui_Restructuringandstrategictransaction_documentation_en-US" xlink:label="lab_icui_Restructuringandstrategictransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and strategic transaction expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringandstrategictransaction" xlink:href="icui-20220630.xsd#icui_Restructuringandstrategictransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Restructuringandstrategictransaction" xlink:to="lab_icui_Restructuringandstrategictransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_484763c9-696b-4620-b016-332aa0832f76_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies [Text Block]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_58c88430-2553-445a-be48-c0b557fdceb0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_2c167c57-1385-46c5-968e-a2289c76bfe1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_EarnoutliabilityMember_26b3a7ef-5d92-42e2-bd48-e80e9ff1336f_terseLabel_en-US" xlink:label="lab_icui_EarnoutliabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out liability [Member]</link:label>
    <link:label id="lab_icui_EarnoutliabilityMember_label_en-US" xlink:label="lab_icui_EarnoutliabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out liability [Member]</link:label>
    <link:label id="lab_icui_EarnoutliabilityMember_documentation_en-US" xlink:label="lab_icui_EarnoutliabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EarnoutliabilityMember" xlink:href="icui-20220630.xsd#icui_EarnoutliabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_EarnoutliabilityMember" xlink:to="lab_icui_EarnoutliabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_3ac49b73-305a-4797-ba16-e6823e52042b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_49e7fcfb-81e3-4c5a-992e-f0d2c0d6a4f7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_9556636e-ec4f-463b-96eb-86f285e1ee03_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_66fc0473-9dc7-466f-bf2e-6646ee415708_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0fe512e9-7c20-45d0-a134-640bf13dd663_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_a6d036e0-3468-4a8b-a334-4ceef9a72165_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ca2661e3-035f-44b1-b937-42d1f1e1e877_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_a11ece86-56d0-4e05-a46e-2d1fe07fdea2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_f158287c-3e1b-4dc9-ad87-d50c7d82a644_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CZK_67649c3e-e212-4f78-bbf7-a090b2921a96_terseLabel_en-US" xlink:label="lab_currency_CZK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Czech Republic, Koruny</link:label>
    <link:label id="lab_currency_CZK_label_en-US" xlink:label="lab_currency_CZK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Czech Republic, Koruny</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CZK" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CZK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CZK" xlink:to="lab_currency_CZK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_e791f5e4-0d9e-49bd-a1db-a4bd8956c370_negatedLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_e99f1d42-0cb5-4b93-95df-4ecbf76a649b_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_664cd6d5-916a-4b35-94d5-ec3ecf0a269b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b8ee7320-0ef4-4a4c-80ef-91f447b0a5a2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_1394d1ac-ab11-4968-a690-b30678cf8c2c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_4f3f03fb-3e7a-43ff-8b3d-5d0b53db4285_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_1ccccff0-5464-443a-a57c-8f1dab308da2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e2145d17-3f62-4f7c-98ff-645e66549061_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_5addeb2c-548a-4fd3-83bf-c43e7bfdc181_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_30e25c43-dc80-464e-90a7-c5e0d42533f4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_be1d0672-5b74-4dca-9898-0fc3cfd5d77e_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EPS - basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_448a6e97-86fd-4ff3-a61a-d05881eab8d7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_190c7a73-4130-4b6a-be78-ed38d7af3771_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Other Adjustments, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2c99ac80-b4da-4377-894f-37bf1061903c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_e7147ba7-4a81-4016-a010-4777a2fe1ffa_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Outsidesalescommissions_91ca7624-488b-429b-94e9-75299a344bac_terseLabel_en-US" xlink:label="lab_icui_Outsidesalescommissions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Fees</link:label>
    <link:label id="lab_icui_Outsidesalescommissions_label_en-US" xlink:label="lab_icui_Outsidesalescommissions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside sales commissions</link:label>
    <link:label id="lab_icui_Outsidesalescommissions_documentation_en-US" xlink:label="lab_icui_Outsidesalescommissions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside sales commissions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Outsidesalescommissions" xlink:href="icui-20220630.xsd#icui_Outsidesalescommissions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Outsidesalescommissions" xlink:to="lab_icui_Outsidesalescommissions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_1ef11ea3-2315-4b31-9aef-6cd4a47cd746_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, after Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued_fe9e2cb9-8f8a-460a-8e42-29b8d8e59580_terseLabel_en-US" xlink:label="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Acquisition Shares Issued</link:label>
    <link:label id="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued_label_en-US" xlink:label="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Acquisition Shares Issued</link:label>
    <link:label id="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued_documentation_en-US" xlink:label="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Acquisition Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:href="icui-20220630.xsd#icui_SmithsGroupOwnershipAcquisitionSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:to="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6878a6fc-ab2c-4154-b8f7-e84eb5fea470_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTINGENT EARN-OUT LIABILITY</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_e2660ab9-b2ab-4154-acd6-64966ecf7928_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_3c47a613-660f-408a-bb45-6d1945209674_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1bf2799c-7dc4-4a67-b4b1-6c42692e93ad_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_5c270e80-03eb-4ac7-9e44-061f2f1b64aa_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_f1ed4864-72a2-4bd1-9062-6256d76076f7_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_7f99de0b-487b-4a76-a6ae-87663749b734_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_15c1fe0c-2561-405f-a518-ff80fb1b15cd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_debaa5a0-194c-4453-9018-830bf34072e5_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_ec4e3028-74a5-4cca-b64f-609e6cd360d5_terseLabel_en-US" xlink:label="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonfinancial Liabilities Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonfinancial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonfinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanBMember_940868e8-99d3-41dd-9d55-db9bd6d7a5b4_terseLabel_en-US" xlink:label="lab_icui_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B</link:label>
    <link:label id="lab_icui_TermLoanBMember_label_en-US" xlink:label="lab_icui_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B [Member]</link:label>
    <link:label id="lab_icui_TermLoanBMember_documentation_en-US" xlink:label="lab_icui_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember" xlink:href="icui-20220630.xsd#icui_TermLoanBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanBMember" xlink:to="lab_icui_TermLoanBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_124bdb94-0fac-407c-a523-36ece531f3d2_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_a73d53cb-bb4a-4104-b93f-43b6cd26856d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_a8d99a0e-883f-4fe4-b6b8-5197d77abd7f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InfusionConsumablesMember_950e423f-577d-408a-bb2b-f4a0b8748280_terseLabel_en-US" xlink:label="lab_icui_InfusionConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables [Member]</link:label>
    <link:label id="lab_icui_InfusionConsumablesMember_label_en-US" xlink:label="lab_icui_InfusionConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables [Member]</link:label>
    <link:label id="lab_icui_InfusionConsumablesMember_documentation_en-US" xlink:label="lab_icui_InfusionConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesMember" xlink:href="icui-20220630.xsd#icui_InfusionConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InfusionConsumablesMember" xlink:to="lab_icui_InfusionConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_7da2e0c0-0200-4c9c-8301-5358f774ab78_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_4ec82f22-b1e6-4c63-acb4-2a1b8a74ecc5_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_6cf77de8-5b06-48da-ac3e-ccf83e49c0f7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_40107555-514e-4178-b47a-aec146ab2771_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:to="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_2f96c008-5ae9-468e-9fd0-fb107d082227_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_2725ba44-c09e-41fc-b0a6-c34b72a62e26_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_86eb7976-aac5-4cb8-b8f4-d369ef907487_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER LONG-TERM LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Other than Long-term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:to="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_b68271b2-c854-4e03-bf50-5c9a3046e87e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_c885b914-13b8-40d7-810a-a16dd224575a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0a843993-b5cb-4692-ab73-45540cb3a8e6_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b3ead0d9-a831-446c-a025-9fd2296d7717_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_OtherDeferredRevenueMember_1e8a645a-6b4a-4513-9d96-0f3c2617d0b5_terseLabel_en-US" xlink:label="lab_icui_OtherDeferredRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other deferred revenue</link:label>
    <link:label id="lab_icui_OtherDeferredRevenueMember_label_en-US" xlink:label="lab_icui_OtherDeferredRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other deferred revenue [Member]</link:label>
    <link:label id="lab_icui_OtherDeferredRevenueMember_documentation_en-US" xlink:label="lab_icui_OtherDeferredRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other deferred revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherDeferredRevenueMember" xlink:href="icui-20220630.xsd#icui_OtherDeferredRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_OtherDeferredRevenueMember" xlink:to="lab_icui_OtherDeferredRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_39e12953-2364-482d-b107-2df8541aae64_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_585a0707-4348-4a61-b11c-9dc38b441150_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_86c75899-9b18-476d-92d5-059fbf3daa7a_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_8349c66a-ea81-4367-a61e-f1dd98e180de_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_b31a72b7-330d-4a28-9b2d-57dd71b52fc4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAbstract_89316822-40d9-4b89-9e01-96074fffd500_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash [Abstract]</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAbstract_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAbstract" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_697f6f93-8274-406f-a2bf-c48feeecbed1_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_73aeab27-61b0-43e9-b5f5-1a977e862bda_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_bc82341c-fc50-4f1e-aeec-8322f0c9e7f4_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8c32450d-8549-46f8-8e99-6bf7a4fa25cc_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_e6b041f0-c4cd-4dee-bc05-8788e1570571_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_96435da8-8890-4264-9a82-3128ff008e1a_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payments to be Received</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_658e021a-bea2-42b5-a5d1-b8040bdb0197_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_41cf0187-bacb-45f0-860e-2b1929e048d7_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_f73592a3-fd0f-4dd3-86a2-86f0e82982ab_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_BusinessCombinationGoodwillNonDeductible_4c92c9b2-d7cb-4e67-a3e2-5557fe5b8698_terseLabel_en-US" xlink:label="lab_icui_BusinessCombinationGoodwillNonDeductible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, goodwill- non deductible</link:label>
    <link:label id="lab_icui_BusinessCombinationGoodwillNonDeductible_label_en-US" xlink:label="lab_icui_BusinessCombinationGoodwillNonDeductible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, goodwill- non deductible</link:label>
    <link:label id="lab_icui_BusinessCombinationGoodwillNonDeductible_documentation_en-US" xlink:label="lab_icui_BusinessCombinationGoodwillNonDeductible" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, goodwill- non deductible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationGoodwillNonDeductible" xlink:href="icui-20220630.xsd#icui_BusinessCombinationGoodwillNonDeductible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_BusinessCombinationGoodwillNonDeductible" xlink:to="lab_icui_BusinessCombinationGoodwillNonDeductible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_6a9f195e-2b3e-4d71-af4a-755d5b96ce37_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_c4bc73bd-88d7-41e6-9195-956a0429caba_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_91fe4898-eb1f-4fe1-af0d-4a1413d1a6b4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_StrategicTransactionandIntegration_c44390a8-cc56-42d7-bdc8-e5481972b48d_terseLabel_en-US" xlink:label="lab_icui_StrategicTransactionandIntegration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Transaction and Integration</link:label>
    <link:label id="lab_icui_StrategicTransactionandIntegration_label_en-US" xlink:label="lab_icui_StrategicTransactionandIntegration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Transaction and Integration</link:label>
    <link:label id="lab_icui_StrategicTransactionandIntegration_documentation_en-US" xlink:label="lab_icui_StrategicTransactionandIntegration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Transaction and Integration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_StrategicTransactionandIntegration" xlink:href="icui-20220630.xsd#icui_StrategicTransactionandIntegration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_StrategicTransactionandIntegration" xlink:to="lab_icui_StrategicTransactionandIntegration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_54a44b5c-4b24-4b60-8c4d-e45314def110_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_cc1d0427-302c-4ad7-a95d-f47be4777a17_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_596fa389-644a-4b84-9fbb-9990de3660f0_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_0cacc8bc-d348-4b93-93fc-1403b6a6d088_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_62e77c3d-efa8-4279-ad49-4e34fd38eb87_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_279ca68a-f2ad-46d7-9ce0-006d95f8360e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_84c2ae03-ecb1-4cc5-8bc5-9a027296cedd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share [Text Block]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_114f0652-b9b6-4afe-8f00-c0962aab1050_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING EXPENSES:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_9476a081-60db-47cc-a071-5f6a28773085_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_79883f31-107a-4cdf-9742-3821cf27f431_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_d10646ae-b7fe-4821-9994-e34db46e95c5_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_1482075b-a0e2-4815-8b39-f971781746c0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7342b0b1-f5b9-477b-918d-2cee7e777adf_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_68119fc5-5d57-44f7-a615-49fefe623b89_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentDomain_b1d76ed8-ba28-49e8-8e8c-15815b9a230a_terseLabel_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Domain]</link:label>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentDomain_label_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain" xlink:to="lab_us-gaap_NonrecurringAdjustmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_2b8e1647-3144-4caf-8355-24d029034270_terseLabel_en-US" xlink:label="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids, other current assets and other noncurrent assets [Text Block]</link:label>
    <link:label id="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_label_en-US" xlink:label="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids, other current assets and other noncurrent assets [Text Block]</link:label>
    <link:label id="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_documentation_en-US" xlink:label="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids, other current assets and other noncurrent assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:href="icui-20220630.xsd#icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:to="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_a5af7b54-3cd0-4060-8bc4-c65e0c357ab2_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Text Block]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ProFormaAdjustmentRelatedPartyLoans_738338f4-84b3-4245-bb71-7e1df4f24038_terseLabel_en-US" xlink:label="lab_icui_ProFormaAdjustmentRelatedPartyLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Related Party Loans</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentRelatedPartyLoans_label_en-US" xlink:label="lab_icui_ProFormaAdjustmentRelatedPartyLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Related Party Loans</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentRelatedPartyLoans_documentation_en-US" xlink:label="lab_icui_ProFormaAdjustmentRelatedPartyLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Related Party Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentRelatedPartyLoans" xlink:href="icui-20220630.xsd#icui_ProFormaAdjustmentRelatedPartyLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ProFormaAdjustmentRelatedPartyLoans" xlink:to="lab_icui_ProFormaAdjustmentRelatedPartyLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_355cdc2d-f9bf-4f4d-958f-1d910ac66e55_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent earn-out</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LongtermInvestmentsDomain_22692c8c-62ca-4d14-9f83-851a939dfc79_terseLabel_en-US" xlink:label="lab_icui_LongtermInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments [Domain]</link:label>
    <link:label id="lab_icui_LongtermInvestmentsDomain_label_en-US" xlink:label="lab_icui_LongtermInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments [Domain]</link:label>
    <link:label id="lab_icui_LongtermInvestmentsDomain_documentation_en-US" xlink:label="lab_icui_LongtermInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongtermInvestmentsDomain" xlink:href="icui-20220630.xsd#icui_LongtermInvestmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LongtermInvestmentsDomain" xlink:to="lab_icui_LongtermInvestmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ShortTermMember_1b17e683-587c-4434-bf42-75c82da86469_terseLabel_en-US" xlink:label="lab_icui_ShortTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term</link:label>
    <link:label id="lab_icui_ShortTermMember_label_en-US" xlink:label="lab_icui_ShortTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term [Member]</link:label>
    <link:label id="lab_icui_ShortTermMember_documentation_en-US" xlink:label="lab_icui_ShortTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermMember" xlink:href="icui-20220630.xsd#icui_ShortTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ShortTermMember" xlink:to="lab_icui_ShortTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_f35791b0-b580-4d26-8e15-a5bfb50dac9b_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_888192e0-be91-497e-bbd1-77da6d7287df_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_0bb64473-59f6-402e-856c-ed1e19b84a91_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_66fc4f21-66be-491b-881b-e41f4d4aa04a_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_39acdceb-e79d-4de7-a3d3-8f055a7d4d0b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, authorized shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount_2394f353-0ca5-4914-9bb6-6c9698995d7a_terseLabel_en-US" xlink:label="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Calculation Ceiling Subtracted Amount</link:label>
    <link:label id="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount_label_en-US" xlink:label="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Calculation Ceiling Subtracted Amount</link:label>
    <link:label id="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount_documentation_en-US" xlink:label="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Calculation Ceiling Subtracted Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:href="icui-20220630.xsd#icui_LeverageRatioCalculationCeilingSubtractedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:to="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_01b6439b-42e0-49d8-baf1-5ad228155601_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_b7428192-e997-4b89-8f3b-b0e35b2fffda_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_6695b79b-3b5f-4466-ae7c-2ce88cc696fc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsCurrent" xlink:to="lab_us-gaap_DerivativeAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_0fa9babd-71cf-4b10-bde5-dcefbae53fa4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_OtherforeigncountriesMember_84463464-5004-41de-ac04-3c9d94a5320a_terseLabel_en-US" xlink:label="lab_icui_OtherforeigncountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:label id="lab_icui_OtherforeigncountriesMember_label_en-US" xlink:label="lab_icui_OtherforeigncountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:label id="lab_icui_OtherforeigncountriesMember_documentation_en-US" xlink:label="lab_icui_OtherforeigncountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherforeigncountriesMember" xlink:href="icui-20220630.xsd#icui_OtherforeigncountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_OtherforeigncountriesMember" xlink:to="lab_icui_OtherforeigncountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_bdad0293-f352-4fd8-a514-15d464b45952_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_fde6bf96-92c7-4cb9-a3c2-8be544c1943b_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ProFormaAdjustmentAmortization_efce9751-8238-4e08-87c1-34ea948fdc5a_terseLabel_en-US" xlink:label="lab_icui_ProFormaAdjustmentAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Amortization</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentAmortization_label_en-US" xlink:label="lab_icui_ProFormaAdjustmentAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Amortization</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentAmortization_documentation_en-US" xlink:label="lab_icui_ProFormaAdjustmentAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentAmortization" xlink:href="icui-20220630.xsd#icui_ProFormaAdjustmentAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ProFormaAdjustmentAmortization" xlink:to="lab_icui_ProFormaAdjustmentAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_edff5625-3b43-402c-b4f5-5cd978bed611_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AvailableforsaleDebtSecurityCurrentMember_c4dc12d6-34df-4aeb-97ed-d77cfe04a14d_terseLabel_en-US" xlink:label="lab_icui_AvailableforsaleDebtSecurityCurrentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Debt Security Current [Member]</link:label>
    <link:label id="lab_icui_AvailableforsaleDebtSecurityCurrentMember_label_en-US" xlink:label="lab_icui_AvailableforsaleDebtSecurityCurrentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Debt Security Current [Member]</link:label>
    <link:label id="lab_icui_AvailableforsaleDebtSecurityCurrentMember_documentation_en-US" xlink:label="lab_icui_AvailableforsaleDebtSecurityCurrentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Debt Security Current [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AvailableforsaleDebtSecurityCurrentMember" xlink:href="icui-20220630.xsd#icui_AvailableforsaleDebtSecurityCurrentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AvailableforsaleDebtSecurityCurrentMember" xlink:to="lab_icui_AvailableforsaleDebtSecurityCurrentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_37de31c0-708e-4ef6-bc1a-3609a8a19337_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_eedc351d-eecd-4425-a3be-f07f29463ce1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_GreaterThan275To100Member_d3af5598-2336-4acb-8590-d07ef34c5d66_terseLabel_en-US" xlink:label="lab_icui_GreaterThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greaterthan2point75to1</link:label>
    <link:label id="lab_icui_GreaterThan275To100Member_label_en-US" xlink:label="lab_icui_GreaterThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greater than 2.75 to1.00 [Member]</link:label>
    <link:label id="lab_icui_GreaterThan275To100Member_documentation_en-US" xlink:label="lab_icui_GreaterThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greater than 2.75 to1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GreaterThan275To100Member" xlink:href="icui-20220630.xsd#icui_GreaterThan275To100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_GreaterThan275To100Member" xlink:to="lab_icui_GreaterThan275To100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue_c8f28ae6-59d3-4f73-9e85-5bf0604d2f14_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivative Assets, at Fair Value</link:label>
    <link:label id="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivative Assets, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:to="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_c83f3b9d-595d-4d48-9414-0aeed1ec65c4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_ff32004d-d156-47c0-b385-7573dfd3bf05_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT LIABILITIES:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities_4df6866f-7ced-49f9-a5e0-177d5d8fd32f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restructuring Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restructuring Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7ec87253-4a87-4d7c-ab6d-8adc79a8a799_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_bc5e5ca1-88de-4589-a281-d0e171266a28_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_CriticalCareMember_902a8052-9285-4a73-b1d6-96440dc45b53_terseLabel_en-US" xlink:label="lab_icui_CriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Critical Care [Member]</link:label>
    <link:label id="lab_icui_CriticalCareMember_label_en-US" xlink:label="lab_icui_CriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Critical Care [Member]</link:label>
    <link:label id="lab_icui_CriticalCareMember_documentation_en-US" xlink:label="lab_icui_CriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Critical Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CriticalCareMember" xlink:href="icui-20220630.xsd#icui_CriticalCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_CriticalCareMember" xlink:to="lab_icui_CriticalCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_24325831-accd-490b-a3e7-115ce71663e1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_9fc1beaf-33b8-4484-886c-e4b508db69ee_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3808bb01-2c14-4826-a32b-33f52f709e23_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_80db40b4-be72-460a-8f37-399676fec520_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentAxis_60e39c1a-1962-40d0-a486-debd01885028_terseLabel_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Axis]</link:label>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentAxis_label_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis" xlink:to="lab_us-gaap_NonrecurringAdjustmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_7814209a-f4d1-42df-a865-a6fab6ac87b2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_c18a35f4-7d3f-4ba7-bbcd-e23c61529256_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_MeasurementInputMarketPriceofRiskDomain_506413a2-6f0f-4a56-b251-2a086c604f67_terseLabel_en-US" xlink:label="lab_icui_MeasurementInputMarketPriceofRiskDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Market Price of Risk [Domain]</link:label>
    <link:label id="lab_icui_MeasurementInputMarketPriceofRiskDomain_label_en-US" xlink:label="lab_icui_MeasurementInputMarketPriceofRiskDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Market Price of Risk [Domain]</link:label>
    <link:label id="lab_icui_MeasurementInputMarketPriceofRiskDomain_documentation_en-US" xlink:label="lab_icui_MeasurementInputMarketPriceofRiskDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Market Price of Risk [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MeasurementInputMarketPriceofRiskDomain" xlink:href="icui-20220630.xsd#icui_MeasurementInputMarketPriceofRiskDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_MeasurementInputMarketPriceofRiskDomain" xlink:to="lab_icui_MeasurementInputMarketPriceofRiskDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_6e2354d3-62b8-4346-a110-18d8df4ae037_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories [Text Block]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_8a197c07-9e76-4b5e-ac1e-c0c84f86b737_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermAPrincipalPaymentFirst2Years_68d320e3-a2a3-4964-bc63-54ce02f232b7_terseLabel_en-US" xlink:label="lab_icui_TermAPrincipalPaymentFirst2Years" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A principal payment % First 2 Years</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentFirst2Years_label_en-US" xlink:label="lab_icui_TermAPrincipalPaymentFirst2Years" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A principal payment % First 2 Years</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentFirst2Years_documentation_en-US" xlink:label="lab_icui_TermAPrincipalPaymentFirst2Years" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A principal payment % First 2 Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentFirst2Years" xlink:href="icui-20220630.xsd#icui_TermAPrincipalPaymentFirst2Years"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermAPrincipalPaymentFirst2Years" xlink:to="lab_icui_TermAPrincipalPaymentFirst2Years" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_787af0f6-666e-4db6-95b3-2be1aedbc71c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a3fee125-4746-4066-8f16-e5fb3290fae2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LeverageRatioLevelDomain_441d5c04-6348-482e-97f6-82b54ec0f9bf_terseLabel_en-US" xlink:label="lab_icui_LeverageRatioLevelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level [Domain]</link:label>
    <link:label id="lab_icui_LeverageRatioLevelDomain_label_en-US" xlink:label="lab_icui_LeverageRatioLevelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level [Domain]</link:label>
    <link:label id="lab_icui_LeverageRatioLevelDomain_documentation_en-US" xlink:label="lab_icui_LeverageRatioLevelDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelDomain" xlink:href="icui-20220630.xsd#icui_LeverageRatioLevelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LeverageRatioLevelDomain" xlink:to="lab_icui_LeverageRatioLevelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0dace71b-0506-4684-93eb-ace8cd5e6ce0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_a2df878c-0d1d-4ff7-a023-daa87da7964b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_1f405b87-3fc2-410a-8a10-08e3a346e648_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_48a0cd71-b41e-4972-a472-64a7e895e427_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.10 par value - Authorized-80,000 shares; Issued 23,899 shares at June 30,2022 and 21,280 shares at December 31, 2021 and outstanding 23,898 shares at June 30, 2022 and 21,280 shares at December 31, 2021</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_38f18567-61bb-4388-9766-4b34d3a4def1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_04b5596b-f339-43b2-a699-e54b2f3613f8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_25704f15-0aa7-4086-82f5-550565b3cd2f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeAmortizationOfPremium_2eef1327-3f0b-42b0-9fbe-30b5e5b6c19d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bond premium amortization</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeAmortizationOfPremium_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Amortization of Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:to="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_fa80dbae-4e02-44d3-a202-7077a027c995_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER (EXPENSE) INCOME, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_a97232fa-e0e3-4d48-ae2c-bf04a077cc39_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_64783153-721e-4e8a-8b86-5986b8025bcb_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_c2aade17-5c03-4161-a003-b8a01e38602d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6bf4294b-4e89-4d15-b11a-f617f82f4ee1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_29ad1e03-bff0-4fa5-8029-991cd0662c82_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_b50126d6-5596-4eee-9af2-c002ce8d59e5_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6f065e7a-a2ac-43d7-8228-c2d2ee9d7f39_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositAssets_af618fd6-4e16-492e-a8b6-966ca51f41b0_terseLabel_en-US" xlink:label="lab_us-gaap_DepositAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit Assets</link:label>
    <link:label id="lab_us-gaap_DepositAssets_label_en-US" xlink:label="lab_us-gaap_DepositAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositAssets" xlink:to="lab_us-gaap_DepositAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_3090e055-19c0-4bb5-bba6-66fdc3f9dcb4_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAX LIABILITY</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_3f74c464-884b-4cee-8390-176829ca9f32_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_VitalCareMember_7a430e4d-9655-445b-9c39-bbd992c3de88_terseLabel_en-US" xlink:label="lab_icui_VitalCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vital Care</link:label>
    <link:label id="lab_icui_VitalCareMember_label_en-US" xlink:label="lab_icui_VitalCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vital Care [Member]</link:label>
    <link:label id="lab_icui_VitalCareMember_documentation_en-US" xlink:label="lab_icui_VitalCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vital Care</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_VitalCareMember" xlink:href="icui-20220630.xsd#icui_VitalCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_VitalCareMember" xlink:to="lab_icui_VitalCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_f250a37e-dda1-462c-a8bf-7b5df563358f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_3cdf629d-ca0b-4684-a260-9f48297c4291_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_3b6a686d-7028-4c31-a239-37cfb57f657e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDate" xlink:to="lab_us-gaap_DebtInstrumentMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTable_035eb9eb-141a-44d0-8dcc-0efab980b480_terseLabel_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Table]</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTable_label_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Table]</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTable_documentation_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:href="icui-20220630.xsd#icui_ApplicableMarginBasedOnLeverageRatioTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:to="lab_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_941eca83-8a0d-484d-a21a-a27d58ee633e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Hedge3MemberMember_4bb36401-3249-44ed-a4ae-0672ab880c8a_terseLabel_en-US" xlink:label="lab_icui_Hedge3MemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 3 [Member] [Member]</link:label>
    <link:label id="lab_icui_Hedge3MemberMember_label_en-US" xlink:label="lab_icui_Hedge3MemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 3 [Member] [Member]</link:label>
    <link:label id="lab_icui_Hedge3MemberMember_documentation_en-US" xlink:label="lab_icui_Hedge3MemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge3MemberMember" xlink:href="icui-20220630.xsd#icui_Hedge3MemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Hedge3MemberMember" xlink:to="lab_icui_Hedge3MemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_77655757-4f75-45ad-a039-7dd689dadf8b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent[TableTextBlock]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_3d542cda-6aa5-4c03-9b83-ceccaa290bec_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_8845d6eb-93bc-4b05-8da1-30ac9367fcb8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_383fbd69-cf90-4ce2-a725-a717f8fba705_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_eb412c8d-ce81-41bd-adf3-c5f966ca928a_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive securities</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_35b785c0-a089-4c48-954b-2b63ba44496b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_dca25550-f210-41d4-9d12-e281659ae29a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_563cbe81-d07c-4c48-ba5d-f846c1af387e_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_3e16241b-9825-40bc-9efd-bd7c97f956a4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-term and Short-term, Combined Amount</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-term and Short-term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquisitionRelatedCostsMember_ba255126-42f1-42b8-a425-da6e627a8bdf_terseLabel_en-US" xlink:label="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Costs</link:label>
    <link:label id="lab_us-gaap_AcquisitionRelatedCostsMember_label_en-US" xlink:label="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquisitionRelatedCostsMember" xlink:to="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_GoodwillAcquiredDuringPeriodAllAcquisitions_b3656a1c-9e37-4e63-a4b5-0727788947ee_terseLabel_en-US" xlink:label="lab_icui_GoodwillAcquiredDuringPeriodAllAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, acquired during period</link:label>
    <link:label id="lab_icui_GoodwillAcquiredDuringPeriodAllAcquisitions_label_en-US" xlink:label="lab_icui_GoodwillAcquiredDuringPeriodAllAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, acquired during period - All acquisitions</link:label>
    <link:label id="lab_icui_GoodwillAcquiredDuringPeriodAllAcquisitions_documentation_en-US" xlink:label="lab_icui_GoodwillAcquiredDuringPeriodAllAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, acquired during period - All acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GoodwillAcquiredDuringPeriodAllAcquisitions" xlink:href="icui-20220630.xsd#icui_GoodwillAcquiredDuringPeriodAllAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_GoodwillAcquiredDuringPeriodAllAcquisitions" xlink:to="lab_icui_GoodwillAcquiredDuringPeriodAllAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandBuildingsAndImprovementsMember_4ed4e900-e9cb-4bb8-94ea-0533e7f3af6e_terseLabel_en-US" xlink:label="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, Buildings and Improvements [Member]</link:label>
    <link:label id="lab_us-gaap_LandBuildingsAndImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, Buildings and Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandBuildingsAndImprovementsMember" xlink:to="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_88c9b988-9648-49af-86a2-979d7d0ebf50_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_c74d4fdb-5e9e-4eb2-9f32-8e41d01067a6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SmithsMedicalMember_4a3ae940-9477-4d37-b387-dc83231ba3dd_terseLabel_en-US" xlink:label="lab_icui_SmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmithsMedical</link:label>
    <link:label id="lab_icui_SmithsMedicalMember_label_en-US" xlink:label="lab_icui_SmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmithsMedical [Member]</link:label>
    <link:label id="lab_icui_SmithsMedicalMember_documentation_en-US" xlink:label="lab_icui_SmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmithsMedical</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember" xlink:href="icui-20220630.xsd#icui_SmithsMedicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SmithsMedicalMember" xlink:to="lab_icui_SmithsMedicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_6b44bf00-e7d5-4296-ab2c-425e20b22762_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due after Year Five</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2ca12433-7603-4118-b8bb-4ad0ba06cb2f_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Contingentconsiderationgross_3d4a339c-5d22-43ee-bd33-ad7e11183b88_terseLabel_en-US" xlink:label="lab_icui_Contingentconsiderationgross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration gross</link:label>
    <link:label id="lab_icui_Contingentconsiderationgross_label_en-US" xlink:label="lab_icui_Contingentconsiderationgross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration gross</link:label>
    <link:label id="lab_icui_Contingentconsiderationgross_documentation_en-US" xlink:label="lab_icui_Contingentconsiderationgross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross" xlink:href="icui-20220630.xsd#icui_Contingentconsiderationgross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Contingentconsiderationgross" xlink:to="lab_icui_Contingentconsiderationgross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_a3a2ab59-21cd-49f7-8776-7d3ce085b13b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_589729c9-266f-43b3-af47-15f02f06ad1d_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f1e23329-d53e-4e11-b465-c8c43f550106_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1861e5c8-2f0c-4901-a47d-f2a75302a715_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_e569666c-f4d7-4807-8087-253a71bb3377_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2dfba3fc-337e-4c22-b570-6471c48da8ad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ApplicableMarginTermSOFRLoans_3e376785-95eb-4746-a36a-3c9182f3fc74_terseLabel_en-US" xlink:label="lab_icui_ApplicableMarginTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Term SOFR Loans</link:label>
    <link:label id="lab_icui_ApplicableMarginTermSOFRLoans_label_en-US" xlink:label="lab_icui_ApplicableMarginTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Term SOFR Loans</link:label>
    <link:label id="lab_icui_ApplicableMarginTermSOFRLoans_documentation_en-US" xlink:label="lab_icui_ApplicableMarginTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Term SOFR Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginTermSOFRLoans" xlink:href="icui-20220630.xsd#icui_ApplicableMarginTermSOFRLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ApplicableMarginTermSOFRLoans" xlink:to="lab_icui_ApplicableMarginTermSOFRLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_d97026d0-3c99-46cb-bde0-e87b69ab506f_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_4b8edff3-e0cd-4a51-841d-bf4e5f1b9d65_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_9c789b9c-8dd8-4665-b4a2-7bc396ac542e_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_621c0d69-a3b8-4a58-89a6-d22b5a78c793_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_1c3d0ff5-0288-45c5-8e8b-bab5c77299f3_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_a439f707-dc3e-44cc-b767-6e6397556c89_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_8e60d96d-d7a5-466a-b291-e55a53c963b8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_df5203d6-88ae-4a6e-bd21-29ffdb847f30_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_db9efcb4-bc2c-43da-888e-6845e0d4cfe2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_9b856c82-84c4-4397-8bee-8eda1039127a_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(LOSS) INCOME FROM OPERATIONS</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_ad5c8c7b-b812-44aa-afcd-eb4e1eecd01d_terseLabel_en-US" xlink:label="lab_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_label_en-US" xlink:label="lab_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:to="lab_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRentCurrentAndNoncurrent_09e8b0f0-5c57-40c8-8b52-62c383f8f7b7_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rent</link:label>
    <link:label id="lab_us-gaap_AccruedRentCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRentCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_19806a0c-e447-447c-8a6c-9c48c91931b7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_61081e94-d032-495c-9771-29917e47c620_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_68d206b2-ec64-4eb1-8458-46d21172fd20_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_2c2b663c-cc68-405c-88c2-37ac355a88bb_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_473f655a-fa11-44f7-bbf2-531b9c444777_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_01cd6882-6f75-472c-bd04-b1eacc3de0e3_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_d3dcd07e-e3c3-4a53-ae4e-b4d54307de36_terseLabel_en-US" xlink:label="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes, including excess tax benefits and deferred income taxes</link:label>
    <link:label id="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_label_en-US" xlink:label="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease in income taxes, including excess tax benefits and deferred income taxes</link:label>
    <link:label id="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_documentation_en-US" xlink:label="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net change during the reporting period in the carrying amount as of the balance sheet date of payments made for taxes. Also includes the net change during the reporting period in the account that represents the temporary difference that results from income (loss) that is recognized for accounting purposes but not for tax purposes and vice versa.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:href="icui-20220630.xsd#icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:to="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6a86e7a6-450a-4fb2-aa4c-f0d3fffca7c4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_e02627d2-f581-4d1a-8ef3-9f6647ad49cd_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerContractsMember_a1f9409f-3394-47f0-b8f9-9dd4c2dc8cd7_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerContractsMember_label_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerContractsMember" xlink:to="lab_us-gaap_CustomerContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_94b030f8-a587-4235-a81f-9287538d0429_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_8986b31c-e9ee-4430-8346-f9ade54d6e5b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_9f577dc3-fd12-44fe-b0f7-6a4b49575cc7_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_6384ab0e-399a-49cb-924e-2629aabdaf31_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_41879454-855a-43d6-a068-a28c89209c3a_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_825e75ea-d170-4123-8aa8-25f966fef3f0_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_1975da48-66ce-4c40-acd9-4cc7e5de495f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_9f9a1055-a80a-4fb7-96bc-f3520d90f5a1_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InterestPercentageAddedToFederalFundsRate_f9126047-dbc8-4a49-8ffd-dcbfd468e992_terseLabel_en-US" xlink:label="lab_icui_InterestPercentageAddedToFederalFundsRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Federal Funds Rate</link:label>
    <link:label id="lab_icui_InterestPercentageAddedToFederalFundsRate_label_en-US" xlink:label="lab_icui_InterestPercentageAddedToFederalFundsRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Federal Funds Rate</link:label>
    <link:label id="lab_icui_InterestPercentageAddedToFederalFundsRate_documentation_en-US" xlink:label="lab_icui_InterestPercentageAddedToFederalFundsRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Federal Funds Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestPercentageAddedToFederalFundsRate" xlink:href="icui-20220630.xsd#icui_InterestPercentageAddedToFederalFundsRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InterestPercentageAddedToFederalFundsRate" xlink:to="lab_icui_InterestPercentageAddedToFederalFundsRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_4b883172-a523-435b-8200-824daeac61e1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_b78e2c3b-950a-4af3-8399-0c9ace626cdf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_45c7dd15-77bd-4b85-9ed7-f477a3acf176_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Restructuringstrategictransactionandintegration_70d518b2-ea72-411c-8621-02c0ced24652_terseLabel_en-US" xlink:label="lab_icui_Restructuringstrategictransactionandintegration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, strategic transaction and integration</link:label>
    <link:label id="lab_icui_Restructuringstrategictransactionandintegration_label_en-US" xlink:label="lab_icui_Restructuringstrategictransactionandintegration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, strategic transaction and integration</link:label>
    <link:label id="lab_icui_Restructuringstrategictransactionandintegration_documentation_en-US" xlink:label="lab_icui_Restructuringstrategictransactionandintegration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, strategic transaction and integration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringstrategictransactionandintegration" xlink:href="icui-20220630.xsd#icui_Restructuringstrategictransactionandintegration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Restructuringstrategictransactionandintegration" xlink:to="lab_icui_Restructuringstrategictransactionandintegration" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisAxis_a75359f2-d36f-41a1-b5f1-18f50389a982_terseLabel_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis [Axis]</link:label>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisAxis_label_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis [Axis]</link:label>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisAxis_documentation_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisAxis" xlink:href="icui-20220630.xsd#icui_Srt_MultipleCurrencyAxisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Srt_MultipleCurrencyAxisAxis" xlink:to="lab_icui_Srt_MultipleCurrencyAxisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TotalSeniorSecuredCreditFacility_56d40c8f-c4b6-4ef8-9006-c5a138d4f585_terseLabel_en-US" xlink:label="lab_icui_TotalSeniorSecuredCreditFacility" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TotalSeniorSecuredCreditFacility</link:label>
    <link:label id="lab_icui_TotalSeniorSecuredCreditFacility_label_en-US" xlink:label="lab_icui_TotalSeniorSecuredCreditFacility" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TotalSeniorSecuredCreditFacility</link:label>
    <link:label id="lab_icui_TotalSeniorSecuredCreditFacility_documentation_en-US" xlink:label="lab_icui_TotalSeniorSecuredCreditFacility" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TotalSeniorSecuredCreditFacility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TotalSeniorSecuredCreditFacility" xlink:href="icui-20220630.xsd#icui_TotalSeniorSecuredCreditFacility"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TotalSeniorSecuredCreditFacility" xlink:to="lab_icui_TotalSeniorSecuredCreditFacility" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b855ccc1-0234-447b-8b10-3e0bd7c0004a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_fb0890ca-b5fd-46f0-9909-c28a2b3ebbc2_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_EarnOutLiabilityST_7841a115-a41b-45ee-b60c-6c4c08a1dfa8_terseLabel_en-US" xlink:label="lab_icui_EarnOutLiabilityST" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out liability ST</link:label>
    <link:label id="lab_icui_EarnOutLiabilityST_label_en-US" xlink:label="lab_icui_EarnOutLiabilityST" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out liability ST</link:label>
    <link:label id="lab_icui_EarnOutLiabilityST_documentation_en-US" xlink:label="lab_icui_EarnOutLiabilityST" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out liability ST</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EarnOutLiabilityST" xlink:href="icui-20220630.xsd#icui_EarnOutLiabilityST"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_EarnOutLiabilityST" xlink:to="lab_icui_EarnOutLiabilityST" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FacilityClosingMember_7e2fa9ac-0126-4a38-9618-d22076f7ed1a_terseLabel_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:label id="lab_us-gaap_FacilityClosingMember_label_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FacilityClosingMember" xlink:to="lab_us-gaap_FacilityClosingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_831631f7-0bd4-4790-b72c-7d4bcf9dfda6_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_IVSolutionsMember_7daf1260-b600-4a96-9bd3-f9e94d110a24_terseLabel_en-US" xlink:label="lab_icui_IVSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IV Solutions [Member]</link:label>
    <link:label id="lab_icui_IVSolutionsMember_label_en-US" xlink:label="lab_icui_IVSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IV Solutions [Member]</link:label>
    <link:label id="lab_icui_IVSolutionsMember_documentation_en-US" xlink:label="lab_icui_IVSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IV Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IVSolutionsMember" xlink:href="icui-20220630.xsd#icui_IVSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_IVSolutionsMember" xlink:to="lab_icui_IVSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_b894b9ba-870e-4f90-8e8b-0b0393ee392e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_PursuitVascularInc.Member_98fe6c30-1471-44a6-8edc-af7af4eaa4e9_terseLabel_en-US" xlink:label="lab_icui_PursuitVascularInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pursuit Vascular, Inc. [Member]</link:label>
    <link:label id="lab_icui_PursuitVascularInc.Member_label_en-US" xlink:label="lab_icui_PursuitVascularInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pursuit Vascular, Inc. [Member]</link:label>
    <link:label id="lab_icui_PursuitVascularInc.Member_documentation_en-US" xlink:label="lab_icui_PursuitVascularInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pursuit Vascular, Inc. [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member" xlink:href="icui-20220630.xsd#icui_PursuitVascularInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_PursuitVascularInc.Member" xlink:to="lab_icui_PursuitVascularInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_115ae945-6fa4-45c8-86e2-ca9b0bd63461_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContingentConsiderationTaxExpense_3345634e-a592-46b6-a413-b994705b87e7_terseLabel_en-US" xlink:label="lab_icui_ContingentConsiderationTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration, tax expense</link:label>
    <link:label id="lab_icui_ContingentConsiderationTaxExpense_label_en-US" xlink:label="lab_icui_ContingentConsiderationTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration, tax expense</link:label>
    <link:label id="lab_icui_ContingentConsiderationTaxExpense_documentation_en-US" xlink:label="lab_icui_ContingentConsiderationTaxExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration, tax expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationTaxExpense" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContingentConsiderationTaxExpense" xlink:to="lab_icui_ContingentConsiderationTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_e97e0b8b-8a23-43ac-a706-541dd8bef701_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_452a7864-6ddc-433e-be35-5556e8ddc502_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_3ee8a979-bda6-41e1-9c8f-c94fb6d39c8a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_8fe6b32f-4847-404a-b78e-2f1d57c91a93_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_51a26013-21ff-42ad-8288-756118bd599c_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_44a2e567-f05a-4d75-9b8d-028845069fd9_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_2dac3a73-3ef6-4ace-ba9b-13fd9ed3b0a8_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_6d971a00-b552-416a-989a-b41b166abeb3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AmortizationOfInventoryStepUp_b0ac936e-02e5-41cf-add0-8d30ac874816_terseLabel_en-US" xlink:label="lab_icui_AmortizationOfInventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Inventory Step-up</link:label>
    <link:label id="lab_icui_AmortizationOfInventoryStepUp_label_en-US" xlink:label="lab_icui_AmortizationOfInventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Inventory Step-up</link:label>
    <link:label id="lab_icui_AmortizationOfInventoryStepUp_documentation_en-US" xlink:label="lab_icui_AmortizationOfInventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Inventory Step-up</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AmortizationOfInventoryStepUp" xlink:href="icui-20220630.xsd#icui_AmortizationOfInventoryStepUp"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AmortizationOfInventoryStepUp" xlink:to="lab_icui_AmortizationOfInventoryStepUp" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_4d0db0af-43d1-4fb2-bd7f-950292764a09_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, issued shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_2a6947c1-1d0f-43c4-8ca5-5866f8f754f1_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductLiabilityAccrualComponentAmount_44628d72-2353-47d0-b7bc-da79ddcc3e66_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityAccrualComponentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Accrual, Component Amount</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityAccrualComponentAmount_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityAccrualComponentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Accrual, Component Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityAccrualComponentAmount" xlink:to="lab_us-gaap_ProductLiabilityAccrualComponentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_4c761ee5-98f4-4d61-ac86-f6d378a85795_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d5fe47f9-03f1-48a9-a1ee-b7947f3d84da_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3dea0cef-e10d-4efb-b0f1-578742725dc6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LessThanOrEqualTo200To100Member_8e5e94a2-9575-44b1-953a-79231c663e12_terseLabel_en-US" xlink:label="lab_icui_LessThanOrEqualTo200To100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessthanorequalto2to1</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo200To100Member_label_en-US" xlink:label="lab_icui_LessThanOrEqualTo200To100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 2.00 to 1.00 [Member]</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo200To100Member_documentation_en-US" xlink:label="lab_icui_LessThanOrEqualTo200To100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 2.00 to 1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo200To100Member" xlink:href="icui-20220630.xsd#icui_LessThanOrEqualTo200To100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LessThanOrEqualTo200To100Member" xlink:to="lab_icui_LessThanOrEqualTo200To100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_1cd9b4e0-ae05-4bb6-8067-65ac5f6eae30_terseLabel_en-US" xlink:label="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</link:label>
    <link:label id="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_label_en-US" xlink:label="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</link:label>
    <link:label id="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_documentation_en-US" xlink:label="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:href="icui-20220630.xsd#icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:to="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_bd5a4850-9cea-4fb1-95af-a418a3747a64_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TimingAxis_608f3758-eb3f-4e7b-93f5-0b2adb0c928d_terseLabel_en-US" xlink:label="lab_icui_TimingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing [Axis]</link:label>
    <link:label id="lab_icui_TimingAxis_label_en-US" xlink:label="lab_icui_TimingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing [Axis]</link:label>
    <link:label id="lab_icui_TimingAxis_documentation_en-US" xlink:label="lab_icui_TimingAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis" xlink:href="icui-20220630.xsd#icui_TimingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TimingAxis" xlink:to="lab_icui_TimingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_9f86ab4f-276b-416d-8c2c-ba9c645afb6f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Optiontoextendinyears_fb6b5f1f-c5c3-463f-a58b-42b1c9c1ff01_terseLabel_en-US" xlink:label="lab_icui_Optiontoextendinyears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Option to Extend</link:label>
    <link:label id="lab_icui_Optiontoextendinyears_label_en-US" xlink:label="lab_icui_Optiontoextendinyears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optiontoextendinyears</link:label>
    <link:label id="lab_icui_Optiontoextendinyears_documentation_en-US" xlink:label="lab_icui_Optiontoextendinyears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optiontoextendinyears</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Optiontoextendinyears" xlink:href="icui-20220630.xsd#icui_Optiontoextendinyears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Optiontoextendinyears" xlink:to="lab_icui_Optiontoextendinyears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_88d08cc4-632c-4ac4-ab3d-6319940aacb0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_a20d3e7d-468c-458e-a30c-e9f6bf284dee_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NON-CASH INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeMember_c4dc8c14-fe45-45de-8ecd-c0a1a786deee_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeMember" xlink:to="lab_us-gaap_ForeignExchangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_d2aadc5f-902c-426c-9cde-8465d4ac5923_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_CommonStockSharesMember_24c90520-9922-4cf8-b252-a340b9968cd6_terseLabel_en-US" xlink:label="lab_icui_CommonStockSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Shares [Member]</link:label>
    <link:label id="lab_icui_CommonStockSharesMember_label_en-US" xlink:label="lab_icui_CommonStockSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Shares [Member]</link:label>
    <link:label id="lab_icui_CommonStockSharesMember_documentation_en-US" xlink:label="lab_icui_CommonStockSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CommonStockSharesMember" xlink:href="icui-20220630.xsd#icui_CommonStockSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_CommonStockSharesMember" xlink:to="lab_icui_CommonStockSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_ff3f8f13-1107-4f8e-8490-1b02bbe2824d_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9af00062-467d-4c2c-9a39-029cb40694a1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_f79cea81-4fc7-4872-929f-4d96158849bf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsNoncurrent" xlink:to="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_86653c56-8e1e-4027-9f25-d3054f4e27b2_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_41735faa-4d2d-4300-b350-9dec77b80b47_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ApplicableMarginBaseRateLoans_34722f33-84d0-42b0-82c8-e98aeaa78720_terseLabel_en-US" xlink:label="lab_icui_ApplicableMarginBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Base Rate Loans</link:label>
    <link:label id="lab_icui_ApplicableMarginBaseRateLoans_label_en-US" xlink:label="lab_icui_ApplicableMarginBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Base Rate Loans</link:label>
    <link:label id="lab_icui_ApplicableMarginBaseRateLoans_documentation_en-US" xlink:label="lab_icui_ApplicableMarginBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Base Rate Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBaseRateLoans" xlink:href="icui-20220630.xsd#icui_ApplicableMarginBaseRateLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ApplicableMarginBaseRateLoans" xlink:to="lab_icui_ApplicableMarginBaseRateLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Accruedothertaxes_f052a5bf-4a80-41a0-9dfb-92fe04dd62ae_terseLabel_en-US" xlink:label="lab_icui_Accruedothertaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued other taxes</link:label>
    <link:label id="lab_icui_Accruedothertaxes_label_en-US" xlink:label="lab_icui_Accruedothertaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued other taxes</link:label>
    <link:label id="lab_icui_Accruedothertaxes_documentation_en-US" xlink:label="lab_icui_Accruedothertaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued other taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedothertaxes" xlink:href="icui-20220630.xsd#icui_Accruedothertaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Accruedothertaxes" xlink:to="lab_icui_Accruedothertaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_b3eb1161-70f0-405d-955b-dad3a47ed9e1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_9b8c7928-066d-49d8-8425-c4ccde33971d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_413bab3f-f7bb-4ea4-a12a-962838f53db3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_MoldsMember_372c0a12-ecb3-48e0-be89-c865df942d1a_terseLabel_en-US" xlink:label="lab_icui_MoldsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molds [Member]</link:label>
    <link:label id="lab_icui_MoldsMember_label_en-US" xlink:label="lab_icui_MoldsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molds [Member]</link:label>
    <link:label id="lab_icui_MoldsMember_documentation_en-US" xlink:label="lab_icui_MoldsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MoldsMember" xlink:href="icui-20220630.xsd#icui_MoldsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_MoldsMember" xlink:to="lab_icui_MoldsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_84b3b356-3e86-4f06-959e-6dddd6589e84_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_ab54ae0a-0209-480c-bb78-d4aa5f740249_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_24667698-72cf-4c34-8d06-02b2fed1d088_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_8697b62c-2bcc-4ca6-aae9-28f53ec6e440_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_1ca489e0-c1f8-4039-b447-098aa0c4ae55_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_7ac9a30f-019c-4dce-8515-eceed470fdaa_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_481d958f-b306-4ddc-84a3-34a9e93cf8c2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_0ec396c1-4019-4fe7-84e7-6bba63242f9f_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_56e510fa-da9c-4c12-8c5f-77d171c6c304_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_b5c2d7dd-8967-4ff5-8b2d-fd22da116520_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_a6a318f1-35a2-4b69-8723-fef0b6c9240b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_21b93302-469e-434b-b2c2-d1affabd1df9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_e3092239-460a-4ba3-ae61-d26aa059d712_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_28883ab8-8a49-4557-b21a-ebf3b89869fb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_26e9c95a-33cd-44a5-a037-72ea3f47cea8_verboseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_DocumentAndEntityInformationAbstract_5363cc27-fbab-4f4e-a78c-de2af1b2b850_terseLabel_en-US" xlink:label="lab_icui_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
    <link:label id="lab_icui_DocumentAndEntityInformationAbstract_label_en-US" xlink:label="lab_icui_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
    <link:label id="lab_icui_DocumentAndEntityInformationAbstract_documentation_en-US" xlink:label="lab_icui_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DocumentAndEntityInformationAbstract" xlink:href="icui-20220630.xsd#icui_DocumentAndEntityInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_DocumentAndEntityInformationAbstract" xlink:to="lab_icui_DocumentAndEntityInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_2813bcec-9516-494f-b94f-7adf90985238_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_4bc6ed7e-5a5f-4426-8945-aeede79af476_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_5ad0e39b-7884-4927-90bb-41ffe6268eaa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_3a32b4e4-3963-4843-99f8-552ec1bf802a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_efac7349-358f-49f3-9cef-05463185d266_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_9fe52b26-1541-4cae-9a87-df49492bcd3a_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Text Block]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TimingDomain_7a99af5b-49d7-424c-85e7-0c48e5d56c11_terseLabel_en-US" xlink:label="lab_icui_TimingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing [Domain]</link:label>
    <link:label id="lab_icui_TimingDomain_label_en-US" xlink:label="lab_icui_TimingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing [Domain]</link:label>
    <link:label id="lab_icui_TimingDomain_documentation_en-US" xlink:label="lab_icui_TimingDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain" xlink:href="icui-20220630.xsd#icui_TimingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TimingDomain" xlink:to="lab_icui_TimingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_32dbf4ee-c178-40a0-ae8d-cb5de0e9a8e2_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_1b9e374e-d7ee-474c-a092-aadc9a49defd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2d128eb9-f8fe-460b-b7be-37e09b710791_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dda0aaaf-ec15-483c-902c-fddc4a126fe9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_f8dc01e0-c823-4b89-91f9-67b842351b5e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BENEFIT (PROVISION) FOR INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bf6ce8f-d957-407a-8e46-392b8254b1f4_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_25d05371-653a-40f0-baef-f0bcccd4b4bf_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_cffedcdb-f46b-4a52-a664-c5dd32d0f1e3_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_FieldServiceCorrectiveAction_f6430197-9831-45f4-933a-c0e5ec78d233_terseLabel_en-US" xlink:label="lab_icui_FieldServiceCorrectiveAction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Field service corrective action</link:label>
    <link:label id="lab_icui_FieldServiceCorrectiveAction_label_en-US" xlink:label="lab_icui_FieldServiceCorrectiveAction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Field service corrective action</link:label>
    <link:label id="lab_icui_FieldServiceCorrectiveAction_documentation_en-US" xlink:label="lab_icui_FieldServiceCorrectiveAction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Field service corrective action</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_FieldServiceCorrectiveAction" xlink:href="icui-20220630.xsd#icui_FieldServiceCorrectiveAction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_FieldServiceCorrectiveAction" xlink:to="lab_icui_FieldServiceCorrectiveAction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_fdb610bd-2614-47ad-a60c-691186014dff_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9009aa6c-050d-4b64-bb12-1b9a5e37d35b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_4cff58de-618c-4d9d-8f10-e057f443b766_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_6fcc2f53-120a-40ec-917b-2680d1fdb461_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_232ba53f-0723-4014-8cdb-20d2dec9d4f8_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_817a6a0c-96bb-44a0-af36-4b3745adf369_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_9984d6ee-093b-46d7-bf08-480c9661f42a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_60d853ae-5d19-4e76-b74a-bd870540ee50_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL CURRENT ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_4ba0ee66-fb1f-41c9-b619-6f04ac52ebbc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dc0c0bc6-134b-4808-9ebf-21ac54129860_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_455b8658-1a4d-4d3c-880e-c2f4e8905cb4_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_119a6f42-0f3a-48ea-b965-1690e63adbec_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_2c36614e-96a5-4cf5-9404-dd26fe7838c3_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_c3dedcf2-7769-48ab-abf2-d37047c02d00_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_584c657e-e7ee-4755-8b36-e2676724f8a1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Loss) Income, Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1f254e1b-d581-4351-99bc-1e1a16e5b51c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_dada5057-1098-42ce-bd26-a9f222e1020f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_MXN_5cb711de-dd01-467e-869e-c30ba3128fde_terseLabel_en-US" xlink:label="lab_currency_MXN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mexico, Pesos</link:label>
    <link:label id="lab_currency_MXN_label_en-US" xlink:label="lab_currency_MXN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mexico, Pesos</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_MXN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_MXN" xlink:to="lab_currency_MXN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_308e6d8b-9f65-4931-a696-60014ec09326_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Earn-Out Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_9e30f19a-8559-4bb7-b7be-03117dcfc663_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_49ce80dc-4e93-45ce-a4f8-66794ba16691_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_9030e0c6-3bd5-4644-bdf4-e842f6891369_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_61118b3f-9a4d-436a-ba3f-9aecd48731ab_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_8131f7c6-5f9d-4e2b-89c9-75c936c04bf4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_75848c04-c918-4f3a-8bb5-2d240c03505d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, par value</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_8694a6a2-70d7-4c92-a6c1-66457e902cc4_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_00a7a02a-b31a-4ed0-9bfc-b1035a7e80bf_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_3ef2b696-1da0-4aa0-8898-a8a24b1ce374_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d370f0b6-c93a-4f64-a1c6-5ea07ca0171f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e710e79b-10a4-4a81-93b2-6caeed5a6313_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment, net of taxes of $0 for all periods</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_BusinessCombinationConsiderationHoldbackLiability_b31f74cc-18f9-4002-bd62-42779414f61f_terseLabel_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationHoldbackLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration, Holdback liability</link:label>
    <link:label id="lab_icui_BusinessCombinationConsiderationHoldbackLiability_label_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationHoldbackLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration, Holdback liability</link:label>
    <link:label id="lab_icui_BusinessCombinationConsiderationHoldbackLiability_documentation_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationHoldbackLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration, Holdback liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationHoldbackLiability" xlink:href="icui-20220630.xsd#icui_BusinessCombinationConsiderationHoldbackLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_BusinessCombinationConsiderationHoldbackLiability" xlink:to="lab_icui_BusinessCombinationConsiderationHoldbackLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_cfb48e5a-d083-4dea-a4ef-413b44e6d1d5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_edeed860-581a-4f4f-9eeb-efa312a7bb02_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_93ea60ec-77a5-49a8-8a21-4e504fb9ec4a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContingentConsiderationGrossST_1ede2c7e-2853-4255-aa3e-3dfd319732d7_terseLabel_en-US" xlink:label="lab_icui_ContingentConsiderationGrossST" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross ST</link:label>
    <link:label id="lab_icui_ContingentConsiderationGrossST_label_en-US" xlink:label="lab_icui_ContingentConsiderationGrossST" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross ST</link:label>
    <link:label id="lab_icui_ContingentConsiderationGrossST_documentation_en-US" xlink:label="lab_icui_ContingentConsiderationGrossST" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross ST</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationGrossST"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContingentConsiderationGrossST" xlink:to="lab_icui_ContingentConsiderationGrossST" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a82f71e4-c8e5-4fdd-b339-6d0b7d62f972_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_CurrencyTranslationOnEarnOut_8155382b-a48e-4868-b102-f8da7c9a9fd2_negatedTerseLabel_en-US" xlink:label="lab_icui_CurrencyTranslationOnEarnOut" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation on earn-out</link:label>
    <link:label id="lab_icui_CurrencyTranslationOnEarnOut_label_en-US" xlink:label="lab_icui_CurrencyTranslationOnEarnOut" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation on earn-out</link:label>
    <link:label id="lab_icui_CurrencyTranslationOnEarnOut_documentation_en-US" xlink:label="lab_icui_CurrencyTranslationOnEarnOut" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation on earn-out</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CurrencyTranslationOnEarnOut" xlink:href="icui-20220630.xsd#icui_CurrencyTranslationOnEarnOut"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_CurrencyTranslationOnEarnOut" xlink:to="lab_icui_CurrencyTranslationOnEarnOut" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_73ab40e7-f757-423f-b13b-550ba27f548b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_b2392b2e-81c2-4e83-90fb-12c1eaf1876a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_d5fe5b5a-d9bc-4e36-91fe-883dab4a6aae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_268502b9-6017-46c2-af2f-4df7ea69b02b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investment securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_19a37118-1e04-4a4a-b0f5-381798c2b53c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyTable_d43f448b-d4b5-49e6-9e2e-bdde6a08601d_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyTable_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable" xlink:to="lab_us-gaap_ProductLiabilityContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_bef6643d-5e82-476b-91de-19639741cdcd_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_JPY_ee8af17c-b947-407e-80e0-0ef6cb98e2f0_terseLabel_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:label id="lab_currency_JPY_label_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_JPY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY" xlink:to="lab_currency_JPY" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContractassetandliabilitybalancesTable_626c8ec3-f275-4927-9f89-18632d6356ef_terseLabel_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Table]</link:label>
    <link:label id="lab_icui_ContractassetandliabilitybalancesTable_label_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Table]</link:label>
    <link:label id="lab_icui_ContractassetandliabilitybalancesTable_documentation_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesTable" xlink:href="icui-20220630.xsd#icui_ContractassetandliabilitybalancesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContractassetandliabilitybalancesTable" xlink:to="lab_icui_ContractassetandliabilitybalancesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ed0eff4d-afc5-421c-b217-8e21d4938d19_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_29253fd1-3826-49a5-833f-9f7e05a59139_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_1bd793ca-038f-46b7-aff5-71d5ec57ac17_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_7718a8f5-df87-4d6e-be2c-3cd3730c378c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investment securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_df06a186-f192-4329-aed1-69c50062e6ea_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) Income from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_e3048421-52d2-4d43-a98c-7ebb2613032b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_412637f0-8ee3-47b3-b660-b7848f54b65b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_541b8e07-378b-4800-94a9-3c0a24037bb4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_e7e85a17-157f-4862-ab6e-c3e53de0502b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_f4b3a565-3688-48f2-b5fb-da9918972848_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_965b5a0c-6226-417d-9d4b-aa1a7c179a5f_terseLabel_en-US" xlink:label="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt, net of lender debt issuance costs</link:label>
    <link:label id="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_label_en-US" xlink:label="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt, net of lender debt issuance costs</link:label>
    <link:label id="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_documentation_en-US" xlink:label="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt, net of lender debt issuance costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:href="icui-20220630.xsd#icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:to="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_22a13cd7-33c1-4a80-aaa2-3df2b64be8bd_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_GovernmentGrantRevenueMember_1a7b250c-84ac-4297-83e1-b060dab57398_terseLabel_en-US" xlink:label="lab_icui_GovernmentGrantRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Revenue</link:label>
    <link:label id="lab_icui_GovernmentGrantRevenueMember_label_en-US" xlink:label="lab_icui_GovernmentGrantRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Revenue [Member]</link:label>
    <link:label id="lab_icui_GovernmentGrantRevenueMember_documentation_en-US" xlink:label="lab_icui_GovernmentGrantRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GovernmentGrantRevenueMember" xlink:href="icui-20220630.xsd#icui_GovernmentGrantRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_GovernmentGrantRevenueMember" xlink:to="lab_icui_GovernmentGrantRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Greaterthan400to100Member_4953a1a0-3be9-40c7-90aa-977f8a6b5b13_terseLabel_en-US" xlink:label="lab_icui_Greaterthan400to100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greaterthan 4to1</link:label>
    <link:label id="lab_icui_Greaterthan400to100Member_label_en-US" xlink:label="lab_icui_Greaterthan400to100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greaterthan4.00to1.00 [Member]</link:label>
    <link:label id="lab_icui_Greaterthan400to100Member_documentation_en-US" xlink:label="lab_icui_Greaterthan400to100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greaterthan4.00to1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Greaterthan400to100Member" xlink:href="icui-20220630.xsd#icui_Greaterthan400to100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Greaterthan400to100Member" xlink:to="lab_icui_Greaterthan400to100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b8ef0773-c240-438b-8f63-135fc4e71800_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_2c4a7ea2-2804-4689-92e0-ef3949b286fe_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_531916de-c86d-4b90-977c-f306f1cc3f96_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_5adccbae-571c-42f5-acb4-e0ed7e746385_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_20da3b7b-9a2e-47b8-8d14-801ee9663f50_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_1c69493b-db41-488d-bec1-7dcc615be61c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_731e9ab7-bfcf-4fb5-9b27-4194060a498b_terseLabel_en-US" xlink:label="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required Share Holding Of Stock Issued At Acquisition</link:label>
    <link:label id="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_label_en-US" xlink:label="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required Share Holding Of Stock Issued At Acquisition</link:label>
    <link:label id="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_documentation_en-US" xlink:label="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required Share Holding Of Stock Issued At Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:href="icui-20220630.xsd#icui_RequiredShareHoldingOfStockIssuedAtAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:to="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_96149205-4c8b-445e-a9d2-e4b256d44907_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec6338be-97e1-442c-9c2a-4441c135421b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_4d75e9de-5108-4af1-9be8-b55fd03b4bae_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LOngTermObligationsDisclosureAbstract_7941bd72-d4bc-4c85-8b10-90b6f5749878_terseLabel_en-US" xlink:label="lab_icui_LOngTermObligationsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOng-Term Obligations Disclosure [Abstract]</link:label>
    <link:label id="lab_icui_LOngTermObligationsDisclosureAbstract_label_en-US" xlink:label="lab_icui_LOngTermObligationsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOng-Term Obligations Disclosure [Abstract]</link:label>
    <link:label id="lab_icui_LOngTermObligationsDisclosureAbstract_documentation_en-US" xlink:label="lab_icui_LOngTermObligationsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOng-Term Obligations Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LOngTermObligationsDisclosureAbstract" xlink:href="icui-20220630.xsd#icui_LOngTermObligationsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract" xlink:to="lab_icui_LOngTermObligationsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_fc8d3980-ca28-45f4-9967-532e6ff2c2c4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_b45a4d28-d315-4880-bfe8-1951c42947bf_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_89a30457-d200-4754-ac72-8d8b8c86b3ba_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InfusionConsumablesSmithsMedicalMember_2a1df34d-0662-40cc-98d6-a3865af9627b_terseLabel_en-US" xlink:label="lab_icui_InfusionConsumablesSmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables-Smiths Medical</link:label>
    <link:label id="lab_icui_InfusionConsumablesSmithsMedicalMember_label_en-US" xlink:label="lab_icui_InfusionConsumablesSmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables-Smiths Medical [Member]</link:label>
    <link:label id="lab_icui_InfusionConsumablesSmithsMedicalMember_documentation_en-US" xlink:label="lab_icui_InfusionConsumablesSmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables-Smiths Medical</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesSmithsMedicalMember" xlink:href="icui-20220630.xsd#icui_InfusionConsumablesSmithsMedicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InfusionConsumablesSmithsMedicalMember" xlink:to="lab_icui_InfusionConsumablesSmithsMedicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_eb748159-99e9-4cf1-9057-7cff3a4b6385_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_39c2f0c2-a94f-4665-bab5-a39503e0c3fa_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_b77fbb9d-bfd8-485e-8df3-e173293cdb72_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisDomain_3273a87d-acf0-40ed-99ad-13fdc9bbb633_terseLabel_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis [Domain]</link:label>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisDomain_label_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis [Domain]</link:label>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisDomain_documentation_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisDomain" xlink:href="icui-20220630.xsd#icui_Srt_MultipleCurrencyAxisDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Srt_MultipleCurrencyAxisDomain" xlink:to="lab_icui_Srt_MultipleCurrencyAxisDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_1bdee4d0-1bab-4257-abdf-0161ef189308_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_c02c493b-19e3-41f0-8ad8-11b6bd7f7da4_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Liabilitiesforcontracts_4a4d8e21-3010-4946-88f7-ef5469e57d66_terseLabel_en-US" xlink:label="lab_icui_Liabilitiesforcontracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities for contracts</link:label>
    <link:label id="lab_icui_Liabilitiesforcontracts_label_en-US" xlink:label="lab_icui_Liabilitiesforcontracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities for contracts</link:label>
    <link:label id="lab_icui_Liabilitiesforcontracts_documentation_en-US" xlink:label="lab_icui_Liabilitiesforcontracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities for contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Liabilitiesforcontracts" xlink:href="icui-20220630.xsd#icui_Liabilitiesforcontracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Liabilitiesforcontracts" xlink:to="lab_icui_Liabilitiesforcontracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_44f975bc-73c9-4bad-ba6a-a3ac2462cbea_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_MeasurementinputadjustedEBITDAvolatilityDomain_f2b02612-ae18-48cf-80fb-4e3b2704153a_terseLabel_en-US" xlink:label="lab_icui_MeasurementinputadjustedEBITDAvolatilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MeasurementinputadjustedEBITDAvolatility [Domain]</link:label>
    <link:label id="lab_icui_MeasurementinputadjustedEBITDAvolatilityDomain_label_en-US" xlink:label="lab_icui_MeasurementinputadjustedEBITDAvolatilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MeasurementinputadjustedEBITDAvolatility [Domain]</link:label>
    <link:label id="lab_icui_MeasurementinputadjustedEBITDAvolatilityDomain_documentation_en-US" xlink:label="lab_icui_MeasurementinputadjustedEBITDAvolatilityDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MeasurementinputadjustedEBITDAvolatility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MeasurementinputadjustedEBITDAvolatilityDomain" xlink:href="icui-20220630.xsd#icui_MeasurementinputadjustedEBITDAvolatilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_MeasurementinputadjustedEBITDAvolatilityDomain" xlink:to="lab_icui_MeasurementinputadjustedEBITDAvolatilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_STEarnoutLiabilityMember_0c1785bb-abd8-4889-8d33-f9dd0835e077_terseLabel_en-US" xlink:label="lab_icui_STEarnoutLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ST Earnout Liability</link:label>
    <link:label id="lab_icui_STEarnoutLiabilityMember_label_en-US" xlink:label="lab_icui_STEarnoutLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ST Earnout Liability [Member]</link:label>
    <link:label id="lab_icui_STEarnoutLiabilityMember_documentation_en-US" xlink:label="lab_icui_STEarnoutLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ST Earnout Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_STEarnoutLiabilityMember" xlink:href="icui-20220630.xsd#icui_STEarnoutLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_STEarnoutLiabilityMember" xlink:to="lab_icui_STEarnoutLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_ab4b7b1e-f038-48e3-9785-7a5466b20983_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ForeignMember_cddfd9c7-b8dd-4a3d-b948-ff14e16dae96_terseLabel_en-US" xlink:label="lab_icui_ForeignMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign [Member]</link:label>
    <link:label id="lab_icui_ForeignMember_label_en-US" xlink:label="lab_icui_ForeignMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign [Member]</link:label>
    <link:label id="lab_icui_ForeignMember_documentation_en-US" xlink:label="lab_icui_ForeignMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignMember" xlink:href="icui-20220630.xsd#icui_ForeignMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ForeignMember" xlink:to="lab_icui_ForeignMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_8c41c009-63fb-4116-af64-25f3b30d7bce_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanAMember_35dae787-a761-46a4-ad0c-bd7b81991ea7_terseLabel_en-US" xlink:label="lab_icui_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A</link:label>
    <link:label id="lab_icui_TermLoanAMember_label_en-US" xlink:label="lab_icui_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A [Member]</link:label>
    <link:label id="lab_icui_TermLoanAMember_documentation_en-US" xlink:label="lab_icui_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember" xlink:href="icui-20220630.xsd#icui_TermLoanAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanAMember" xlink:to="lab_icui_TermLoanAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock_8ee3c230-4590-473d-a095-5f414e7fc1ff_terseLabel_en-US" xlink:label="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on long term debt</link:label>
    <link:label id="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on long term debt [Table Text Block]</link:label>
    <link:label id="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock_documentation_en-US" xlink:label="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on long term debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:href="icui-20220630.xsd#icui_InterestExpenseOnLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:to="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_0fb77135-099e-4058-b588-7a8f47037252_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1b46845a-8b80-45d3-9f1f-dbdf75b23a83_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_361de7bf-94be-497f-9dbe-1d882809a3b8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_a4377f91-7165-443e-a32f-2f778b5eabb8_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_8a5dbb9e-2bb7-45ea-8251-8e1c6bc37080_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_d3c67e33-efc1-4287-bc32-2df1abcbcfd2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:to="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ProFormaAdjustmentFinanceCosts_ea727f62-970a-4279-8883-6dd217e693b0_terseLabel_en-US" xlink:label="lab_icui_ProFormaAdjustmentFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Finance Costs</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentFinanceCosts_label_en-US" xlink:label="lab_icui_ProFormaAdjustmentFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Finance Costs</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentFinanceCosts_documentation_en-US" xlink:label="lab_icui_ProFormaAdjustmentFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Finance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentFinanceCosts" xlink:href="icui-20220630.xsd#icui_ProFormaAdjustmentFinanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ProFormaAdjustmentFinanceCosts" xlink:to="lab_icui_ProFormaAdjustmentFinanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsAndOtherAssets_6b43f3bd-a307-4a08-b3cf-2d3e4b094d37_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs and Other Assets</link:label>
    <link:label id="lab_us-gaap_DeferredCostsAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCostsAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsAndOtherAssets" xlink:to="lab_us-gaap_DeferredCostsAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_898af0d2-cb3d-49bd-bd75-6a6d2a6bd847_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_ca1c0ed7-3003-4d44-afc9-f8fa369d6948_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0e8e210d-4597-4f90-97e1-ae820a4799d8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b0579d45-f541-41f9-8155-1e41621ebd70_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding (for basic calculation)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_e612ae0e-cd64-483a-bc2b-8dbc95237c09_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_10b89cad-bf25-490c-af4c-5eb77caa36a9_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (In dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationDate1_d83749f5-22dd-4a3a-b35d-643aca90d565_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Expiration Date</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationDate1_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_2daef1e4-c14f-4625-a500-c963c64a2389_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_22c1cc3f-a4df-45d3-88d0-d8da97fd5314_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_0a9632b1-85ac-47b6-82dc-6229953b5125_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_25375247-071e-4e89-8ef5-3e7ecc8b4776_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_3b905dc8-0d07-4fde-93b2-ffade3a59624_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5007c4d9-3a25-4825-9025-d39bbad55c60_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_2eb4776c-bbea-4159-90d7-2b33e33ecf4f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_MinimumStockPriceTargetForEarnOutPayment_318495e7-82d9-4a45-babd-7332aff55c79_terseLabel_en-US" xlink:label="lab_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Stock Price Target for Earn-out Payment</link:label>
    <link:label id="lab_icui_MinimumStockPriceTargetForEarnOutPayment_label_en-US" xlink:label="lab_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Stock Price Target for Earn-out Payment</link:label>
    <link:label id="lab_icui_MinimumStockPriceTargetForEarnOutPayment_documentation_en-US" xlink:label="lab_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Stock Price Target for Earn-out Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:href="icui-20220630.xsd#icui_MinimumStockPriceTargetForEarnOutPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:to="lab_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_5634c98d-0d5b-4950-ad2c-cc9d3f119754_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2a510373-0f09-4118-b3e1-d2a6082586d0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_f968bd22-8189-4735-85da-5b7f1560a821_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_c69324ec-0d80-46fe-8362-dd0b273be4a1_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INTANGIBLE ASSETS, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_e9cbcb26-4f72-415c-89cc-f153b15099f7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_666fa04c-8948-444e-954e-a2090264bd25_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_6274d52f-e746-412d-b54c-c20da032be1a_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_90cb171b-a4d6-4ea1-b6b1-a6eb7cb9832f_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation_d75f33ee-e050-4530-8138-33fc377c04fb_terseLabel_en-US" xlink:label="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Required for Board Representation</link:label>
    <link:label id="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation_label_en-US" xlink:label="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Required for Board Representation</link:label>
    <link:label id="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation_documentation_en-US" xlink:label="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Required for Board Representation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:href="icui-20220630.xsd#icui_SmithsGroupOwnershipRequiredForBoardRepresentation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:to="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_1235a9df-296b-4993-84cc-c01e1cc9a09b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring accrual</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_40a04636-a4e5-4711-adf6-d96c3076e69a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ff92de69-6810-4682-824d-4d885d38b00c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_1a11cd2b-bfbd-4444-bc38-f377babdaf59_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, at cost (12,684 and 119 shares, respectively)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyLineItems_2c8b0435-d6dd-4766-87f5-bca429f56e50_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems" xlink:to="lab_us-gaap_ProductLiabilityContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5cc84491-77a2-445c-b320-16db832a80bb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WEIGHTED AVERAGE NUMBER OF SHARES</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_38a0c892-e0dc-4971-82b8-21508131a89a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEFERRED INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_a55141c6-1e7d-485d-8875-b18c61ddc719_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_1f028e9c-f3a8-4dc8-b9f3-c7c0fd86e859_terseLabel_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales taxes</link:label>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Excise Tax Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_aa51c663-1c65-44c7-89ce-52a6f9a3e60e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_b29d03db-cf97-4b51-936f-569b3b405782_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_UnfavorablecontractliabilityST_a159bcb5-6669-48a3-bce8-715e16fea440_terseLabel_en-US" xlink:label="lab_icui_UnfavorablecontractliabilityST" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UnfavorablecontractliabilityST</link:label>
    <link:label id="lab_icui_UnfavorablecontractliabilityST_label_en-US" xlink:label="lab_icui_UnfavorablecontractliabilityST" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UnfavorablecontractliabilityST</link:label>
    <link:label id="lab_icui_UnfavorablecontractliabilityST_documentation_en-US" xlink:label="lab_icui_UnfavorablecontractliabilityST" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UnfavorablecontractliabilityST</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_UnfavorablecontractliabilityST" xlink:href="icui-20220630.xsd#icui_UnfavorablecontractliabilityST"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_UnfavorablecontractliabilityST" xlink:to="lab_icui_UnfavorablecontractliabilityST" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_d25b4777-0b8e-40ba-b9a7-e7f9d9660f2d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanAxis_779664f9-beac-49a0-9659-4ba532a57d55_terseLabel_en-US" xlink:label="lab_icui_TermLoanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Axis]</link:label>
    <link:label id="lab_icui_TermLoanAxis_label_en-US" xlink:label="lab_icui_TermLoanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Axis]</link:label>
    <link:label id="lab_icui_TermLoanAxis_documentation_en-US" xlink:label="lab_icui_TermLoanAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis" xlink:href="icui-20220630.xsd#icui_TermLoanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanAxis" xlink:to="lab_icui_TermLoanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_d53ebbc6-b790-491e-a6cf-97a4494b99fb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_DerivativeVariableRateFloor_28463d7f-92db-46f0-8d1d-3d867bc958ab_terseLabel_en-US" xlink:label="lab_icui_DerivativeVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">derivative variable rate floor</link:label>
    <link:label id="lab_icui_DerivativeVariableRateFloor_label_en-US" xlink:label="lab_icui_DerivativeVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">derivative variable rate floor</link:label>
    <link:label id="lab_icui_DerivativeVariableRateFloor_documentation_en-US" xlink:label="lab_icui_DerivativeVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">derivative variable rate floor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DerivativeVariableRateFloor" xlink:href="icui-20220630.xsd#icui_DerivativeVariableRateFloor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_DerivativeVariableRateFloor" xlink:to="lab_icui_DerivativeVariableRateFloor" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_be596df7-6c31-4e9e-906a-4df124b5bc11_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_36c07b7c-26d8-4bd5-b76b-395d57f32ea0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_4a8df8d1-45e3-4fc3-921e-dbaace32e899_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_36120c80-7182-4679-85ef-e16db2e8141f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Hedge2Member_f852d62f-d75a-482a-9a8f-e11e2ace6c64_terseLabel_en-US" xlink:label="lab_icui_Hedge2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 2 [Member]</link:label>
    <link:label id="lab_icui_Hedge2Member_label_en-US" xlink:label="lab_icui_Hedge2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 2 [Member]</link:label>
    <link:label id="lab_icui_Hedge2Member_documentation_en-US" xlink:label="lab_icui_Hedge2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge2Member" xlink:href="icui-20220630.xsd#icui_Hedge2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Hedge2Member" xlink:to="lab_icui_Hedge2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InstrumentsPlacedwithCustomersMember_c645d8dd-8aa7-4e60-9efe-8a1cbac09db4_terseLabel_en-US" xlink:label="lab_icui_InstrumentsPlacedwithCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments Placed with Customers [Member]</link:label>
    <link:label id="lab_icui_InstrumentsPlacedwithCustomersMember_label_en-US" xlink:label="lab_icui_InstrumentsPlacedwithCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments Placed with Customers [Member]</link:label>
    <link:label id="lab_icui_InstrumentsPlacedwithCustomersMember_documentation_en-US" xlink:label="lab_icui_InstrumentsPlacedwithCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments Placed with Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InstrumentsPlacedwithCustomersMember" xlink:href="icui-20220630.xsd#icui_InstrumentsPlacedwithCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InstrumentsPlacedwithCustomersMember" xlink:to="lab_icui_InstrumentsPlacedwithCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_16dcf9f8-4752-4a7b-ad81-cfd86272c4fa_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_4f68ef46-314c-4af6-aaa9-d448cdfa3242_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivative Liabilities, at Fair Value</link:label>
    <link:label id="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivative Liabilities, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:to="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_ffbff282-7f89-49e9-b4e1-5f48cff644eb_terseLabel_en-US" xlink:label="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessthanorequalto2point5to1butgreaterthan2to1</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_label_en-US" xlink:label="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 2.50 to1.00 but greater than 2.00 to1.00 [Member]</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_documentation_en-US" xlink:label="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 2.50 to1.00 but greater than 2.00 to1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:href="icui-20220630.xsd#icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:to="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CNY_7b1e7957-2370-437d-b011-03700cc0f37c_terseLabel_en-US" xlink:label="lab_currency_CNY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China, Yuan Renminbi</link:label>
    <link:label id="lab_currency_CNY_label_en-US" xlink:label="lab_currency_CNY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China, Yuan Renminbi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CNY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CNY" xlink:to="lab_currency_CNY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4b2ae6e9-f5b3-427a-a9f4-1b596d0b83e0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_4d006b5e-8e2d-4926-9d02-893d0232ccb3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_43928f54-589f-4900-b60e-7f42b1fe4787_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5e472eff-bd03-4a45-9c9f-a7fed499b0c5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ForeignInfusionSystemSupplierMember_2584dcd0-3488-484c-a302-2fb2ff96c478_terseLabel_en-US" xlink:label="lab_icui_ForeignInfusionSystemSupplierMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Infusion System Supplier</link:label>
    <link:label id="lab_icui_ForeignInfusionSystemSupplierMember_label_en-US" xlink:label="lab_icui_ForeignInfusionSystemSupplierMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Infusion System Supplier [Member]</link:label>
    <link:label id="lab_icui_ForeignInfusionSystemSupplierMember_documentation_en-US" xlink:label="lab_icui_ForeignInfusionSystemSupplierMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Infusion System Supplier</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember" xlink:href="icui-20220630.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ForeignInfusionSystemSupplierMember" xlink:to="lab_icui_ForeignInfusionSystemSupplierMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_e8a1bc93-8fff-4c92-a38c-38ec47bdcd95_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_2096fc2e-8098-49d0-82d5-b1b965c140aa_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ac8e8669-4e93-4e95-a98d-b3748eee1ec8_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d35a763a-b8e7-4a74-9494-e89e0c0236f0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_94d8def1-fe1d-4111-9fa4-c225aafc83c8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_804c84c8-77f7-40e3-bf67-fddf464de9a6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_c0e26063-6679-4fbb-b795-d530c4b85291_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_6904b6a6-06be-43d4-9f7f-6d02974a9770_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Current</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_f27ff8a6-602e-4a29-bad0-9927f619630f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_232d5978-1d3b-4973-9288-0f51b1f511ce_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_c2fef3d4-c010-4e80-897c-cf8782ae54a3_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_50d0f18f-07df-46ed-b3e9-33edfb049973_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranties and returns</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:to="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_BusinessCombinationConsiderationTransferredCash_8397719e-8d63-452e-80a8-ee8b0dadcf02_terseLabel_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationTransferredCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Cash</link:label>
    <link:label id="lab_icui_BusinessCombinationConsiderationTransferredCash_label_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationTransferredCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Cash</link:label>
    <link:label id="lab_icui_BusinessCombinationConsiderationTransferredCash_documentation_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationTransferredCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationTransferredCash" xlink:href="icui-20220630.xsd#icui_BusinessCombinationConsiderationTransferredCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_BusinessCombinationConsiderationTransferredCash" xlink:to="lab_icui_BusinessCombinationConsiderationTransferredCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_5faaf596-b85f-46f7-865d-d2bd9496bdef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets additions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_7009eaa2-960f-4412-93a0-2b2b28dcc78f_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, $1.00 par value Authorized-500 shares; Issued and outstanding - none</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:to="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_ee6684d4-ff96-4837-8954-390d75dbf169_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_EquipmentrevenueMember_24dd475c-5c8f-4a66-aa9e-da9b1d793bab_terseLabel_en-US" xlink:label="lab_icui_EquipmentrevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment revenue [Member]</link:label>
    <link:label id="lab_icui_EquipmentrevenueMember_label_en-US" xlink:label="lab_icui_EquipmentrevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment revenue [Member]</link:label>
    <link:label id="lab_icui_EquipmentrevenueMember_documentation_en-US" xlink:label="lab_icui_EquipmentrevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember" xlink:href="icui-20220630.xsd#icui_EquipmentrevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_EquipmentrevenueMember" xlink:to="lab_icui_EquipmentrevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ad6daf81-f704-4bb2-a612-eb0105bfd75f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInDeferredRevenueRollForward_29a4876f-ac14-4527-8c1f-d58c83d6a3c4_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInDeferredRevenueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Deferred Revenue [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInDeferredRevenueRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInDeferredRevenueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Deferred Revenue [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInDeferredRevenueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInDeferredRevenueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInDeferredRevenueRollForward" xlink:to="lab_us-gaap_MovementInDeferredRevenueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_8249d7b9-d84a-4982-a84c-be3f6de31bb2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_d9220e1a-19da-482c-9ef6-f950d2e2b1c1_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_f9fe8bdb-16b6-43b8-a06d-516a2f9c7c0b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c473469f-dd56-4c61-98d8-574d024405c2_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_9faf4c15-6325-48da-8f39-725a45d6803b_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_7050d7cc-d2b4-4e87-8901-64868a19a1c7_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_8a4080ba-b28f-4f6a-a746-dc810a812a19_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_045095b7-dc1e-41ed-8710-312ecea2b116_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_f6b54cb1-dc2e-4480-a360-9db2dd7f5264_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_3873b171-70d0-4147-aa5d-2da4d9011f75_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_7a148ad2-934d-4852-8aec-30961a56068e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment [Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_a2bfcc09-1629-4f61-8917-33345a12fb45_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:to="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_3b675df7-ba3a-42ee-a49c-0ab988a0cdb5_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL OPERATING EXPENSES</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SpareParts_a3ab2278-bf18-4ada-b4bd-ff5d8233a763_terseLabel_en-US" xlink:label="lab_icui_SpareParts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spare parts</link:label>
    <link:label id="lab_icui_SpareParts_label_en-US" xlink:label="lab_icui_SpareParts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spare parts</link:label>
    <link:label id="lab_icui_SpareParts_documentation_en-US" xlink:label="lab_icui_SpareParts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spare parts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SpareParts" xlink:href="icui-20220630.xsd#icui_SpareParts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SpareParts" xlink:to="lab_icui_SpareParts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_32bd4dbb-5d53-47cd-b7a0-015d2a303418_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ComputerEquipmentAndSoftwareMember_d8ebb1bb-867c-4845-a29c-82441cce83a2_terseLabel_en-US" xlink:label="lab_icui_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software [Member]</link:label>
    <link:label id="lab_icui_ComputerEquipmentAndSoftwareMember_label_en-US" xlink:label="lab_icui_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software [Member]</link:label>
    <link:label id="lab_icui_ComputerEquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_icui_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ComputerEquipmentAndSoftwareMember" xlink:href="icui-20220630.xsd#icui_ComputerEquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ComputerEquipmentAndSoftwareMember" xlink:to="lab_icui_ComputerEquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_de4f16f9-c312-4828-a9df-82ff65854ca1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_bb4eb6d0-3b8b-44b1-85e8-73a325b21530_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_e050093e-3126-4345-91fd-93d21837f17e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_68dff195-3189-4038-bcdd-62f14909602a_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_59ea75bf-8179-423c-b8eb-063c6cb8210a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_62673d07-f0f5-44ed-a6a3-82eb6babe77d_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:to="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_979dc2fc-94af-405f-978b-4f0d7bdae0c1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_b5c05204-26ac-47f3-9584-5f50569b12ca_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_1d14288f-7841-4e5f-bf53-9a1ed45b69c4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_f5eaa05e-f4a0-4b20-ba46-c11969e4079a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment, cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_214704fd-3ce1-4666-881a-b6937c224948_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_af2792bb-53a1-43f5-aa7d-fdaf142a08c5_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_a9fafc3f-b51f-4ace-a2bd-bd520ccb60c7_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_923f6fc9-72fd-45fa-b7b2-301a141e83c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_67f79b56-1a8e-4c03-82db-d92237b5c8e6_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock_2751665b-f74f-4cd6-bdd7-a48e0a54594d_terseLabel_en-US" xlink:label="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Leases [Table Text Block]</link:label>
    <link:label id="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock_label_en-US" xlink:label="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Leases [Table Text Block]</link:label>
    <link:label id="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock_documentation_en-US" xlink:label="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Leases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:href="icui-20220630.xsd#icui_AssetsandLiabilitiesLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:to="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ProFormaAdjustmentInventory_7cb6c67d-fdaf-4edc-b347-9528f31ce49f_terseLabel_en-US" xlink:label="lab_icui_ProFormaAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Inventory</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentInventory_label_en-US" xlink:label="lab_icui_ProFormaAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Inventory</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentInventory_documentation_en-US" xlink:label="lab_icui_ProFormaAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentInventory" xlink:href="icui-20220630.xsd#icui_ProFormaAdjustmentInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ProFormaAdjustmentInventory" xlink:to="lab_icui_ProFormaAdjustmentInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_14acc50b-e391-4419-bf2e-eb352c973242_terseLabel_en-US" xlink:label="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">business combination, recognized identifiable asset acquired and liability assumed,</link:label>
    <link:label id="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_label_en-US" xlink:label="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">business combination, recognized identifiable asset acquired and liability assumed,</link:label>
    <link:label id="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_documentation_en-US" xlink:label="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">business combination, recognized identifiable asset acquired and liability assumed,</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:href="icui-20220630.xsd#icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:to="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_7a4b4fac-1186-422d-8141-7954bba74877_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ProvisionForWarrantyAndReturns_775ebe85-6128-4374-9eb2-a60271032abb_terseLabel_en-US" xlink:label="lab_icui_ProvisionForWarrantyAndReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for warranty and returns</link:label>
    <link:label id="lab_icui_ProvisionForWarrantyAndReturns_label_en-US" xlink:label="lab_icui_ProvisionForWarrantyAndReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for warranty and returns</link:label>
    <link:label id="lab_icui_ProvisionForWarrantyAndReturns_documentation_en-US" xlink:label="lab_icui_ProvisionForWarrantyAndReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for warranty and returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProvisionForWarrantyAndReturns" xlink:href="icui-20220630.xsd#icui_ProvisionForWarrantyAndReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ProvisionForWarrantyAndReturns" xlink:to="lab_icui_ProvisionForWarrantyAndReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_19b4de69-32fa-4650-b45c-2314dfe2ec65_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContingentConsiderationGrossLT_fdefc249-369a-4e27-ae0e-087f2a678bea_terseLabel_en-US" xlink:label="lab_icui_ContingentConsiderationGrossLT" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross LT</link:label>
    <link:label id="lab_icui_ContingentConsiderationGrossLT_label_en-US" xlink:label="lab_icui_ContingentConsiderationGrossLT" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross LT</link:label>
    <link:label id="lab_icui_ContingentConsiderationGrossLT_documentation_en-US" xlink:label="lab_icui_ContingentConsiderationGrossLT" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross LT</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContingentConsiderationGrossLT" xlink:to="lab_icui_ContingentConsiderationGrossLT" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_de26105d-5ac9-47a1-9251-68a20de879b7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_4d5963e0-a542-42f8-8010-0ddf606bcdd4_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_d92fd0d2-d206-4e74-98bc-7b3a5ab5f481_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_531942d4-65fc-4728-8a1f-7ba8afe334b1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_31eee31a-7614-45bd-874a-b429da559ad9_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_1ece5471-4160-4f5b-9177-629c5b9abb37_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3114ab02-480f-4473-bbbf-bd95ff085578_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_fc152bda-d88b-42c7-9c67-bd376fde0136_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET (LOSS) INCOME</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_5220cb7d-59cf-4163-8293-081c8ecdb1ad_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (Loss) Income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_eaae491b-8271-4bcd-ac8c-fd4a181a91b3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_3420c4d8-6eb9-419a-9075-5aac69539dc8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_d7a2d548-fd16-406a-801a-bb0d4cc13527_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_a421caf4-4da8-4b1f-af3a-26a406102489_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_c4e23c10-1cf7-4223-84d8-dda42700b31e_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bfbd64fa-8d35-4371-a2f3-bb5856261e6c_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InfusionSystemsMember_501b81c8-e0a8-47cc-84c5-bb559820f828_terseLabel_en-US" xlink:label="lab_icui_InfusionSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Systems [Member]</link:label>
    <link:label id="lab_icui_InfusionSystemsMember_label_en-US" xlink:label="lab_icui_InfusionSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Systems [Member]</link:label>
    <link:label id="lab_icui_InfusionSystemsMember_documentation_en-US" xlink:label="lab_icui_InfusionSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Systems [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember" xlink:href="icui-20220630.xsd#icui_InfusionSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InfusionSystemsMember" xlink:to="lab_icui_InfusionSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Sparepartsusage_0e100b43-12b7-4cdb-b110-1fcbf7937187_terseLabel_en-US" xlink:label="lab_icui_Sparepartsusage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sparepartsusage</link:label>
    <link:label id="lab_icui_Sparepartsusage_label_en-US" xlink:label="lab_icui_Sparepartsusage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sparepartsusage</link:label>
    <link:label id="lab_icui_Sparepartsusage_documentation_en-US" xlink:label="lab_icui_Sparepartsusage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sparepartsusage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sparepartsusage" xlink:href="icui-20220630.xsd#icui_Sparepartsusage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Sparepartsusage" xlink:to="lab_icui_Sparepartsusage" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_8be74e1a-547e-456d-b830-e59daa969fb4_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_00c10fc7-8afe-486f-8c9d-977c1ea95438_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_ced7a372-c602-4127-85e3-753e6ecc738d_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Prepaidinsuranceandpropertytaxes_94a3a896-afa8-41a1-b511-ffd877cc1fdc_terseLabel_en-US" xlink:label="lab_icui_Prepaidinsuranceandpropertytaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid insurance and property taxes</link:label>
    <link:label id="lab_icui_Prepaidinsuranceandpropertytaxes_label_en-US" xlink:label="lab_icui_Prepaidinsuranceandpropertytaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid insurance and property taxes</link:label>
    <link:label id="lab_icui_Prepaidinsuranceandpropertytaxes_documentation_en-US" xlink:label="lab_icui_Prepaidinsuranceandpropertytaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid insurance and property taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidinsuranceandpropertytaxes" xlink:href="icui-20220630.xsd#icui_Prepaidinsuranceandpropertytaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Prepaidinsuranceandpropertytaxes" xlink:to="lab_icui_Prepaidinsuranceandpropertytaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_RevolverSubLimits_b2897f10-5922-4903-a3db-a828f432cccc_terseLabel_en-US" xlink:label="lab_icui_RevolverSubLimits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver Sub limits</link:label>
    <link:label id="lab_icui_RevolverSubLimits_label_en-US" xlink:label="lab_icui_RevolverSubLimits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver Sub limits</link:label>
    <link:label id="lab_icui_RevolverSubLimits_documentation_en-US" xlink:label="lab_icui_RevolverSubLimits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver Sub limits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RevolverSubLimits" xlink:href="icui-20220630.xsd#icui_RevolverSubLimits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_RevolverSubLimits" xlink:to="lab_icui_RevolverSubLimits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_99a6b671-42d2-40d4-9848-8795cc6bbf37_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_3a4b40ba-7478-4f96-b62c-03ac0c4e486c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT ASSETS:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_9c096b50-16ba-40db-bc81-eb810232a120_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_15b5abd3-09c5-4de7-a411-f8c826cdf1b1_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_7cfde873-3e38-41d8-a173-041af4a93162_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_406c5b01-1e12-4d0f-9a56-1d643ede8de5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContingentConsiderationAllAcquisitions_58fd52f4-77a8-454c-98ce-9121c64385b3_negatedTerseLabel_en-US" xlink:label="lab_icui_ContingentConsiderationAllAcquisitions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration all Acquisitions</link:label>
    <link:label id="lab_icui_ContingentConsiderationAllAcquisitions_label_en-US" xlink:label="lab_icui_ContingentConsiderationAllAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration all Acquisitions</link:label>
    <link:label id="lab_icui_ContingentConsiderationAllAcquisitions_documentation_en-US" xlink:label="lab_icui_ContingentConsiderationAllAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration all Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationAllAcquisitions" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationAllAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContingentConsiderationAllAcquisitions" xlink:to="lab_icui_ContingentConsiderationAllAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_ed957237-483d-4476-8dc3-ad61f8dc6c5d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LongTermMember_77b86bec-a8c4-4662-a6f7-90fd41996ff9_terseLabel_en-US" xlink:label="lab_icui_LongTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term</link:label>
    <link:label id="lab_icui_LongTermMember_label_en-US" xlink:label="lab_icui_LongTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term [Member]</link:label>
    <link:label id="lab_icui_LongTermMember_documentation_en-US" xlink:label="lab_icui_LongTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermMember" xlink:href="icui-20220630.xsd#icui_LongTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LongTermMember" xlink:to="lab_icui_LongTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_39d62750-a68b-4501-842c-30f83e0c3a21_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_30464e90-c6b4-4b12-a3e3-eff819a6fe81_terseLabel_en-US" xlink:label="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessthan4to1butgreaterthan3to1</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_label_en-US" xlink:label="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 4.00 to 1.00 but greater than 3.00 to100 [Member]</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_documentation_en-US" xlink:label="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 4.00 to 1.00 but greater than 3.00 to100</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:href="icui-20220630.xsd#icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:to="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermAPrincipalPaymentInYear5_f3bffa08-bf68-4277-b339-b9621be2bfc5_terseLabel_en-US" xlink:label="lab_icui_TermAPrincipalPaymentInYear5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % in Year 5</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentInYear5_label_en-US" xlink:label="lab_icui_TermAPrincipalPaymentInYear5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % in Year 5</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentInYear5_documentation_en-US" xlink:label="lab_icui_TermAPrincipalPaymentInYear5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % in Year 5</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentInYear5" xlink:href="icui-20220630.xsd#icui_TermAPrincipalPaymentInYear5"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermAPrincipalPaymentInYear5" xlink:to="lab_icui_TermAPrincipalPaymentInYear5" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ca1f437d-147c-4ee4-a83d-c4ef4769133d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_429ac248-e522-4539-b3a6-abfff33ab98d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive income (loss), net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_b9ae1d83-1f5c-457d-8496-d9c9242b2d2f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Contractsettlement_a2509ab0-b9e3-478b-a480-7c2de621e47b_terseLabel_en-US" xlink:label="lab_icui_Contractsettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contract settlement</link:label>
    <link:label id="lab_icui_Contractsettlement_label_en-US" xlink:label="lab_icui_Contractsettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contract settlement</link:label>
    <link:label id="lab_icui_Contractsettlement_documentation_en-US" xlink:label="lab_icui_Contractsettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contract settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contractsettlement" xlink:href="icui-20220630.xsd#icui_Contractsettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Contractsettlement" xlink:to="lab_icui_Contractsettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_f3aa0d14-c256-43eb-9ad9-7e9ec1b2f9f3_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL CASH, CASH EQUIVALENTS AND INVESTMENT SECURITIES</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_b15350f6-cb6d-4822-b296-943a0b7350e0_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b02f7e61-def6-486e-a021-8a56c4ef8302_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock_4c13fe84-674c-4879-a670-62c151390919_terseLabel_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock_label_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Table Text Block]</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock_documentation_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:href="icui-20220630.xsd#icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:to="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_f00d8947-01ed-49ed-8df1-f96cf97bc69c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_f9787aea-4b85-443d-83fc-47a0a3245b9b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingRevenueMember_e472ecce-11b7-4f24-bf4b-1dc71ea8b9dd_terseLabel_en-US" xlink:label="lab_us-gaap_TradingRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Revenue</link:label>
    <link:label id="lab_us-gaap_TradingRevenueMember_label_en-US" xlink:label="lab_us-gaap_TradingRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingRevenueMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingRevenueMember" xlink:to="lab_us-gaap_TradingRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_274b395b-7679-44f9-b9fc-f48d68ab0006_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a154d63f-3775-421b-b97d-a21842bc2050_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_34dadcc4-30ce-4960-ac52-0cd488ff6b74_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_PrepaidVendorExpenses_fcd82803-d193-416c-a6d9-8f298cf9b3b3_terseLabel_en-US" xlink:label="lab_icui_PrepaidVendorExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid vendor expenses</link:label>
    <link:label id="lab_icui_PrepaidVendorExpenses_label_en-US" xlink:label="lab_icui_PrepaidVendorExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid vendor expenses</link:label>
    <link:label id="lab_icui_PrepaidVendorExpenses_documentation_en-US" xlink:label="lab_icui_PrepaidVendorExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid vendor expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PrepaidVendorExpenses" xlink:href="icui-20220630.xsd#icui_PrepaidVendorExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_PrepaidVendorExpenses" xlink:to="lab_icui_PrepaidVendorExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e76acbd5-89e9-47f9-bb76-80cd886a4c0f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_99300c24-a13a-46f6-ac25-8bfb5c5c04b9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_44a4f2c7-4d5d-4779-b76b-29703b5fadca_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3031ec86-9d9d-4947-840f-729dc2aabb67_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_46cee80b-3141-499d-b29f-10be534050c4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_c5f11c9c-7fd5-45e9-a838-62d932800bab_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_05ae8953-35a7-4ab4-9a4d-24e80e0ae8a6_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Remaining Minimum Amount Committed</link:label>
    <link:label id="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_label_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Remaining Minimum Amount Committed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:to="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanDomain_0c01a3c3-0909-458b-b875-df316f7255fa_terseLabel_en-US" xlink:label="lab_icui_TermLoanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Domain]</link:label>
    <link:label id="lab_icui_TermLoanDomain_label_en-US" xlink:label="lab_icui_TermLoanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Domain]</link:label>
    <link:label id="lab_icui_TermLoanDomain_documentation_en-US" xlink:label="lab_icui_TermLoanDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain" xlink:href="icui-20220630.xsd#icui_TermLoanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanDomain" xlink:to="lab_icui_TermLoanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_41893144-7ab6-4328-9d95-fadbac41599d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_ba3f20a1-1ab2-4851-94e3-0b96e834d44e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL CURRENT LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_5afe75f7-78a5-456f-ac51-93aca5990bc0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_1bc4c7a8-dbf6-4deb-8a4b-cacb5977b28f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_OwnershipRequirementForEarnoutPayment_6266b452-1301-4793-af54-8e328fd1920e_terseLabel_en-US" xlink:label="lab_icui_OwnershipRequirementForEarnoutPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership requirement for Earnout Payment</link:label>
    <link:label id="lab_icui_OwnershipRequirementForEarnoutPayment_label_en-US" xlink:label="lab_icui_OwnershipRequirementForEarnoutPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership requirement for Earnout Payment</link:label>
    <link:label id="lab_icui_OwnershipRequirementForEarnoutPayment_documentation_en-US" xlink:label="lab_icui_OwnershipRequirementForEarnoutPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership requirement for Earnout Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OwnershipRequirementForEarnoutPayment" xlink:href="icui-20220630.xsd#icui_OwnershipRequirementForEarnoutPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_OwnershipRequirementForEarnoutPayment" xlink:to="lab_icui_OwnershipRequirementForEarnoutPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_cb01f7bb-68a2-4704-bf16-8a71ddfe5636_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f185e295-9d1c-4cc6-8423-5c6652751c70_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_6e3fe30a-f07c-4b80-a3f5-ad6455f72fb8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_4b6ea2ac-1856-4d74-a7b1-db0a88805de2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Accruedlegalfees_38b5dfa3-45e0-45bb-ab99-0ebd98f02504_terseLabel_en-US" xlink:label="lab_icui_Accruedlegalfees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal accrual</link:label>
    <link:label id="lab_icui_Accruedlegalfees_label_en-US" xlink:label="lab_icui_Accruedlegalfees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued legal fees</link:label>
    <link:label id="lab_icui_Accruedlegalfees_documentation_en-US" xlink:label="lab_icui_Accruedlegalfees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued legal fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedlegalfees" xlink:href="icui-20220630.xsd#icui_Accruedlegalfees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Accruedlegalfees" xlink:to="lab_icui_Accruedlegalfees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_b258e954-c87b-4ffc-88ac-a85308f8aa86_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_cf3f4303-82f0-40de-9eaa-37c3e76b1bf3_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_8ab0663b-53d6-4359-aaa2-eca4e162d107_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bead2f1c-86af-4ea9-a67e-25022ce854f6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AccruedSalariesAndBenefits_40ecc844-e8e0-4b4d-a7af-6b815e840c03_terseLabel_en-US" xlink:label="lab_icui_AccruedSalariesAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Salaries and benefits</link:label>
    <link:label id="lab_icui_AccruedSalariesAndBenefits_label_en-US" xlink:label="lab_icui_AccruedSalariesAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued salaries and benefits</link:label>
    <link:label id="lab_icui_AccruedSalariesAndBenefits_documentation_en-US" xlink:label="lab_icui_AccruedSalariesAndBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued salaries and benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedSalariesAndBenefits" xlink:href="icui-20220630.xsd#icui_AccruedSalariesAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AccruedSalariesAndBenefits" xlink:to="lab_icui_AccruedSalariesAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Prepaidothertaxes_22c02ebb-4fc3-464c-b641-4126447b8e9d_terseLabel_en-US" xlink:label="lab_icui_Prepaidothertaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:label id="lab_icui_Prepaidothertaxes_label_en-US" xlink:label="lab_icui_Prepaidothertaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid other taxes</link:label>
    <link:label id="lab_icui_Prepaidothertaxes_documentation_en-US" xlink:label="lab_icui_Prepaidothertaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid other taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidothertaxes" xlink:href="icui-20220630.xsd#icui_Prepaidothertaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Prepaidothertaxes" xlink:to="lab_icui_Prepaidothertaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_b69e25cb-b61b-44b8-8226-d9fa9cbc60dc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:to="lab_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_6bdf5017-4fab-4207-9820-927faadfdd28_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_4e14b63c-3721-4b91-bcd3-bdba5d674387_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_dfc22b04-253c-4aa0-a9ac-adb67621cc21_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityMember_86d3ebbf-3177-49f5-b008-71b916de80ed_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability</link:label>
    <link:label id="lab_us-gaap_LiabilityMember_label_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityMember" xlink:to="lab_us-gaap_LiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_1c690e51-5c18-48f1-ad87-abdc2ceab3a1_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Benefits</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_b1e326e8-9f4c-4583-934f-cabaae8dff94_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_05568a6d-6cdc-4726-8136-d014ffa18373_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_be41e33c-a8ec-4185-a087-eeff2aaa3727_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeForwardExchangeRate1_698482f6-d3a4-41cf-ae3d-c9d362acf5c6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeForwardExchangeRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Forward Exchange Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeForwardExchangeRate1_label_en-US" xlink:label="lab_us-gaap_DerivativeForwardExchangeRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Forward Exchange Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeForwardExchangeRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeForwardExchangeRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeForwardExchangeRate1" xlink:to="lab_us-gaap_DerivativeForwardExchangeRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_38696566-f467-48bf-9cbb-b713b99b6acc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_73692693-4517-474f-9979-cdb9cadd4d0d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_ed81c49c-9b2e-40e5-88d8-4448347b3d62_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesTotalMember_3bc6f14c-b8b1-4386-b0ad-f5bf839d437f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesTotalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Total [Member]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesTotalMember_label_en-US" xlink:label="lab_us-gaap_LiabilitiesTotalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Total [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesTotalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesTotalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesTotalMember" xlink:to="lab_us-gaap_LiabilitiesTotalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermAPrincipalPaymentYear3And4_804adf1f-9b56-4ef2-bacd-6300ae3b3621_terseLabel_en-US" xlink:label="lab_icui_TermAPrincipalPaymentYear3And4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % Year 3 and 4</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentYear3And4_label_en-US" xlink:label="lab_icui_TermAPrincipalPaymentYear3And4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % Year 3 and 4</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentYear3And4_documentation_en-US" xlink:label="lab_icui_TermAPrincipalPaymentYear3And4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % Year 3 and 4</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentYear3And4" xlink:href="icui-20220630.xsd#icui_TermAPrincipalPaymentYear3And4"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermAPrincipalPaymentYear3And4" xlink:to="lab_icui_TermAPrincipalPaymentYear3And4" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_bebc61bb-cff8-409c-baac-4831540de9e7_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_955e11e6-bef3-49e8-a5fa-b76927881a1b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_3a0a9af4-1c12-46cc-ae55-42a44652d0b4_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_81513093-872b-4fcd-9b12-eb196d84aef0_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LeverageRatioLevelAxis_0b6b6e9c-6f56-4218-ac14-a594e2395c32_terseLabel_en-US" xlink:label="lab_icui_LeverageRatioLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level [Axis]</link:label>
    <link:label id="lab_icui_LeverageRatioLevelAxis_label_en-US" xlink:label="lab_icui_LeverageRatioLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level [Axis]</link:label>
    <link:label id="lab_icui_LeverageRatioLevelAxis_documentation_en-US" xlink:label="lab_icui_LeverageRatioLevelAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelAxis" xlink:href="icui-20220630.xsd#icui_LeverageRatioLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LeverageRatioLevelAxis" xlink:to="lab_icui_LeverageRatioLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_DevelopedTechnologyMember_be395186-a27a-4d2d-b779-6252f81998a7_terseLabel_en-US" xlink:label="lab_icui_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">developed technology</link:label>
    <link:label id="lab_icui_DevelopedTechnologyMember_label_en-US" xlink:label="lab_icui_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">developed technology [Member]</link:label>
    <link:label id="lab_icui_DevelopedTechnologyMember_documentation_en-US" xlink:label="lab_icui_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">developed technology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DevelopedTechnologyMember" xlink:href="icui-20220630.xsd#icui_DevelopedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_DevelopedTechnologyMember" xlink:to="lab_icui_DevelopedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_ba19b335-25bf-4d22-bc3f-0f938d03986d_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax liability</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_48ce1ecc-f32f-49bc-a903-c4317c28d114_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContractassetandliabilitybalancesLineItems_6c8367a1-8ff2-489a-a6be-4489b50c0268_terseLabel_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Line Items]</link:label>
    <link:label id="lab_icui_ContractassetandliabilitybalancesLineItems_label_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Line Items]</link:label>
    <link:label id="lab_icui_ContractassetandliabilitybalancesLineItems_documentation_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Contract asset and liability balances [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesLineItems" xlink:href="icui-20220630.xsd#icui_ContractassetandliabilitybalancesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems" xlink:to="lab_icui_ContractassetandliabilitybalancesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_34434b98-d031-4558-9301-c7c27b542159_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_0a6be111-a3f4-43ca-9962-a4923e27fdcd_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_67be868f-fb30-4a08-9995-53049ab8ab15_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_42a6420f-86e1-4556-9fdd-eb0e4fe2f3e1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueAdditions_aa6f960b-4dbd-4545-aaf3-18d0272094fe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueAdditions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Additions</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueAdditions_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueAdditions" xlink:to="lab_us-gaap_DeferredRevenueAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_VascularAccessMember_1dccb2e0-0007-4f07-96db-97f599e7d5ae_terseLabel_en-US" xlink:label="lab_icui_VascularAccessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vascular Access</link:label>
    <link:label id="lab_icui_VascularAccessMember_label_en-US" xlink:label="lab_icui_VascularAccessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vascular Access [Member]</link:label>
    <link:label id="lab_icui_VascularAccessMember_documentation_en-US" xlink:label="lab_icui_VascularAccessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vascular Access</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_VascularAccessMember" xlink:href="icui-20220630.xsd#icui_VascularAccessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_VascularAccessMember" xlink:to="lab_icui_VascularAccessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_956e28f8-25bb-4bfb-8d5d-9d311c4abe13_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7841544c-459c-4786-a4d1-c0ae953b3bf7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_2a45214b-a9a7-43ab-90ff-38f1676a809d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>icui-20220630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b855b77c-6988-4216-8748-36632a973ac3,g:ab2a959a-be44-44c8-8165-c7a4fa090087-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.icumed.com/role/DEIDocument" xlink:type="simple" xlink:href="icui-20220630.xsd#DEIDocument"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DEIDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:href="icui-20220630.xsd#icui_DocumentAndEntityInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_557a6895-94f4-4d2a-b4c1-a67b3ede3161" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_DocumentType_557a6895-94f4-4d2a-b4c1-a67b3ede3161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_8c096118-ee1d-4be3-ad21-08f271ef55ac" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_DocumentQuarterlyReport_8c096118-ee1d-4be3-ad21-08f271ef55ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_dfe0d526-d153-4fb5-88e4-a1301fc78b10" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_DocumentPeriodEndDate_dfe0d526-d153-4fb5-88e4-a1301fc78b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_89d1ab02-dcae-4910-907e-7e54a9cab987" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_DocumentTransitionReport_89d1ab02-dcae-4910-907e-7e54a9cab987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ffe44f3a-660e-4f09-994d-a1eec1818a96" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_EntityFileNumber_ffe44f3a-660e-4f09-994d-a1eec1818a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f7c41d62-5cd1-4106-b57e-0981c9be285d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f7c41d62-5cd1-4106-b57e-0981c9be285d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_406f269e-f1a5-4d83-82d5-67b6d6995d89" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_EntityTaxIdentificationNumber_406f269e-f1a5-4d83-82d5-67b6d6995d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f6647011-ca68-44fd-8b9f-faae1e4820ed" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_EntityAddressAddressLine1_f6647011-ca68-44fd-8b9f-faae1e4820ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_03291644-6a38-4838-83bb-584d5e9280ee" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_EntityAddressCityOrTown_03291644-6a38-4838-83bb-584d5e9280ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b2cc5708-0872-4355-affd-756fa81b1b65" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_EntityAddressStateOrProvince_b2cc5708-0872-4355-affd-756fa81b1b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9f96cb4f-7e9d-41b7-a376-0a8d04037af8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_EntityAddressPostalZipCode_9f96cb4f-7e9d-41b7-a376-0a8d04037af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_96413008-cb46-4f65-ae33-5df86fdeed5a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_CityAreaCode_96413008-cb46-4f65-ae33-5df86fdeed5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_cec29285-a7ee-44c7-9f7e-a1dc668713bf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_LocalPhoneNumber_cec29285-a7ee-44c7-9f7e-a1dc668713bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_dada82f8-9b9b-4d71-a953-c32153d3bb5c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_EntityCurrentReportingStatus_dada82f8-9b9b-4d71-a953-c32153d3bb5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_db7ea8a4-e838-4ec0-98b8-dbc34768330d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_EntityInteractiveDataCurrent_db7ea8a4-e838-4ec0-98b8-dbc34768330d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_1c286413-d4a7-4687-9cac-10fd9c362ba7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_EntityFilerCategory_1c286413-d4a7-4687-9cac-10fd9c362ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6cbe436b-522f-43b4-897f-e31439f86760" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_EntitySmallBusiness_6cbe436b-522f-43b4-897f-e31439f86760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_0d30ad88-78e3-4299-bd10-d3b869c482c7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_EntityEmergingGrowthCompany_0d30ad88-78e3-4299-bd10-d3b869c482c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_856f511d-4108-4b9e-8452-1f08e3125a24" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_EntityShellCompany_856f511d-4108-4b9e-8452-1f08e3125a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b21fd1d4-fe0f-4ee3-84f4-eafc46520488" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_Security12bTitle_b21fd1d4-fe0f-4ee3-84f4-eafc46520488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_68872636-2601-43f1-b8f2-a8547d9af396" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_TradingSymbol_68872636-2601-43f1-b8f2-a8547d9af396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4eed9e1c-57af-499a-b40e-ac58641bee86" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_SecurityExchangeName_4eed9e1c-57af-499a-b40e-ac58641bee86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_7243a756-ce6a-40ad-884f-70ae7ad10437" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_7243a756-ce6a-40ad-884f-70ae7ad10437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_3a8aa5a6-1a01-4eab-996c-b8532b2bc19a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_EntityCentralIndexKey_3a8aa5a6-1a01-4eab-996c-b8532b2bc19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_f7f92bf8-ec70-4d9c-825a-25b2f1aa89dc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_EntityRegistrantName_f7f92bf8-ec70-4d9c-825a-25b2f1aa89dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_33d8c2bc-851e-42cc-92ca-39ef84f5e632" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_AmendmentFlag_33d8c2bc-851e-42cc-92ca-39ef84f5e632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_b188e00c-9dd4-4354-bc45-1187293816aa" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_CurrentFiscalYearEndDate_b188e00c-9dd4-4354-bc45-1187293816aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e654022d-e08c-4c59-8dfc-7b1f69e23344" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_DocumentFiscalYearFocus_e654022d-e08c-4c59-8dfc-7b1f69e23344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_22bb56fc-febe-4c68-9571-f65cc801e78d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_67f4cc62-a553-4abd-9b06-2b72eba8ad03" xlink:to="loc_dei_DocumentFiscalPeriodFocus_22bb56fc-febe-4c68-9571-f65cc801e78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="icui-20220630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_edbef06e-f6df-412a-8d14-80b9ddcfca2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_fcb892ae-6d72-42bd-990e-4a74e8943fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_edbef06e-f6df-412a-8d14-80b9ddcfca2d" xlink:to="loc_us-gaap_StatementTable_fcb892ae-6d72-42bd-990e-4a74e8943fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_248599b4-550f-48f2-bdbe-575b67ad60a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fcb892ae-6d72-42bd-990e-4a74e8943fd5" xlink:to="loc_srt_StatementScenarioAxis_248599b4-550f-48f2-bdbe-575b67ad60a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b104f8c5-9095-4ec3-b235-b70e46901f9e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_248599b4-550f-48f2-bdbe-575b67ad60a4" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b104f8c5-9095-4ec3-b235-b70e46901f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b47d6a4d-667b-4938-afe9-1b946fc50d36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fcb892ae-6d72-42bd-990e-4a74e8943fd5" xlink:to="loc_us-gaap_StatementLineItems_b47d6a4d-667b-4938-afe9-1b946fc50d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b47d6a4d-667b-4938-afe9-1b946fc50d36" xlink:to="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dbe229dc-f1e0-4dc9-a9f8-36f60845ce66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dbe229dc-f1e0-4dc9-a9f8-36f60845ce66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_7ff64042-b935-4bd1-b063-23ad895ae038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_7ff64042-b935-4bd1-b063-23ad895ae038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_505767a9-adf0-42d8-941f-28941ed68cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_505767a9-adf0-42d8-941f-28941ed68cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_c9a465a7-f6e8-4573-a647-746ba5e81017" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_c9a465a7-f6e8-4573-a647-746ba5e81017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8ac34480-0ef1-450b-9f63-bce2087e852a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:to="loc_us-gaap_InventoryNet_8ac34480-0ef1-450b-9f63-bce2087e852a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_a127bf93-e190-4e05-9ca4-1433d09fac43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:to="loc_us-gaap_PrepaidTaxes_a127bf93-e190-4e05-9ca4-1433d09fac43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_dc01b927-4fa0-4d1a-b132-f2520f7f8d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_dc01b927-4fa0-4d1a-b132-f2520f7f8d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_109fd4a8-4f7d-4819-b7dd-590c9dbbd973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_37a7468d-d97a-4293-af78-bf6967ba1e22" xlink:to="loc_us-gaap_AssetsCurrent_109fd4a8-4f7d-4819-b7dd-590c9dbbd973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_017ea2c3-e03a-4eab-a7b2-34fcc5011c59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_017ea2c3-e03a-4eab-a7b2-34fcc5011c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3a14c95e-af1e-449a-ad3e-8176adf5a91d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3a14c95e-af1e-449a-ad3e-8176adf5a91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_2f851da1-bcae-4e54-b74b-11f88514b9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_2f851da1-bcae-4e54-b74b-11f88514b9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c39e9af7-6045-4f7d-b64f-11f297116d78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_Goodwill_c39e9af7-6045-4f7d-b64f-11f297116d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b529e28e-bf8c-4001-b8b2-a4d24fee699f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b529e28e-bf8c-4001-b8b2-a4d24fee699f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_940b6fc0-6770-40c0-a476-0194e5bdf472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_940b6fc0-6770-40c0-a476-0194e5bdf472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c9d18569-1830-4caf-9ff0-e31aae3024e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c9d18569-1830-4caf-9ff0-e31aae3024e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3cd56acf-ed94-4d1a-bb8b-8ac681c155d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19a3a460-b03b-4845-82d3-09a51dd3e365" xlink:to="loc_us-gaap_Assets_3cd56acf-ed94-4d1a-bb8b-8ac681c155d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b47d6a4d-667b-4938-afe9-1b946fc50d36" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_d45bc681-da80-480b-81d2-012d6c5aedc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_d45bc681-da80-480b-81d2-012d6c5aedc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_39a113cd-cf53-4b4d-a808-dcb74dc65e42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d45bc681-da80-480b-81d2-012d6c5aedc5" xlink:to="loc_us-gaap_AccountsPayableCurrent_39a113cd-cf53-4b4d-a808-dcb74dc65e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_d24af433-0db4-4aea-88f0-9415b4278cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d45bc681-da80-480b-81d2-012d6c5aedc5" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_d24af433-0db4-4aea-88f0-9415b4278cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_e38100f5-eb40-4a94-b5b6-719d4e8c3e95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d45bc681-da80-480b-81d2-012d6c5aedc5" xlink:to="loc_us-gaap_LongTermDebtCurrent_e38100f5-eb40-4a94-b5b6-719d4e8c3e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_0972bf76-22f7-4d6e-938e-633dab5cd66d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d45bc681-da80-480b-81d2-012d6c5aedc5" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_0972bf76-22f7-4d6e-938e-633dab5cd66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_aa1fd095-8ef3-4e5f-8b44-628a46cf955c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d45bc681-da80-480b-81d2-012d6c5aedc5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_aa1fd095-8ef3-4e5f-8b44-628a46cf955c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_423f19c9-4f15-41f3-bf63-83a09607615a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d45bc681-da80-480b-81d2-012d6c5aedc5" xlink:to="loc_us-gaap_LiabilitiesCurrent_423f19c9-4f15-41f3-bf63-83a09607615a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_6176f05f-c035-4c02-a2ba-b78d59d30673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_6176f05f-c035-4c02-a2ba-b78d59d30673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_17723f70-513b-470f-833a-f645236a36b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_17723f70-513b-470f-833a-f645236a36b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a45a8b5a-090b-4304-a188-e751099c6a23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a45a8b5a-090b-4304-a188-e751099c6a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_91e37836-7d6c-41c2-9d76-e7392d02295a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_91e37836-7d6c-41c2-9d76-e7392d02295a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_ecd3bbbb-b418-46a4-b329-f95b914a507c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_ecd3bbbb-b418-46a4-b329-f95b914a507c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_eac3a6e3-b66a-439b-8922-1d90e7776233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_CommitmentsAndContingencies_eac3a6e3-b66a-439b-8922-1d90e7776233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_5b112b06-12bc-4726-8d65-5a1e99c0c1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:to="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_5b112b06-12bc-4726-8d65-5a1e99c0c1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_14def67c-c973-4b3c-ba2d-a260014f33d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:to="loc_us-gaap_CommonStockValue_14def67c-c973-4b3c-ba2d-a260014f33d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_05dbfa36-0147-481a-984b-ecec707450a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_05dbfa36-0147-481a-984b-ecec707450a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_dfeaacf2-32a6-4ca8-90db-f46f4d56e526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:to="loc_us-gaap_TreasuryStockValue_dfeaacf2-32a6-4ca8-90db-f46f4d56e526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_993e5183-8b4c-4eeb-b799-7c6118fec20c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_993e5183-8b4c-4eeb-b799-7c6118fec20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a2c661aa-bed2-485f-b09e-4f9b526b39c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a2c661aa-bed2-485f-b09e-4f9b526b39c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1dff8dec-2084-4966-b41b-2d6c0eb0040f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_afd812ba-bf52-4cd7-8a5f-7e3a61eb2a30" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1dff8dec-2084-4966-b41b-2d6c0eb0040f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d571f69d-e03a-476c-b9a3-b6a09d9e5e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aec44b0a-6ff0-4cc3-b235-2b1b7f8289c1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_d571f69d-e03a-476c-b9a3-b6a09d9e5e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="icui-20220630.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e289a032-5e9d-4428-951d-f39cfa570500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_06266fa5-1dbe-4ed7-94ae-a54a6d3fde84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e289a032-5e9d-4428-951d-f39cfa570500" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_06266fa5-1dbe-4ed7-94ae-a54a6d3fde84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_cc93f892-3435-46d1-9ad1-2158b2da7321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e289a032-5e9d-4428-951d-f39cfa570500" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_cc93f892-3435-46d1-9ad1-2158b2da7321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_0a28dab4-85d8-4ccd-981c-9d6cd54c0495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e289a032-5e9d-4428-951d-f39cfa570500" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_0a28dab4-85d8-4ccd-981c-9d6cd54c0495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_ed2ab377-d13a-46fe-8cff-60f50554ac1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e289a032-5e9d-4428-951d-f39cfa570500" xlink:to="loc_us-gaap_PreferredStockSharesIssued_ed2ab377-d13a-46fe-8cff-60f50554ac1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_bce7a5e2-614b-417a-a8c9-c4119be3cbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e289a032-5e9d-4428-951d-f39cfa570500" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_bce7a5e2-614b-417a-a8c9-c4119be3cbc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_773c803a-5887-4acf-961c-73c1dd3da327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e289a032-5e9d-4428-951d-f39cfa570500" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_773c803a-5887-4acf-961c-73c1dd3da327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b04eb52f-5be2-4ff6-8090-7c68003ea9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e289a032-5e9d-4428-951d-f39cfa570500" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b04eb52f-5be2-4ff6-8090-7c68003ea9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_b2c377f7-4fa6-45ba-a44b-696c84a4bca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e289a032-5e9d-4428-951d-f39cfa570500" xlink:to="loc_us-gaap_CommonStockSharesIssued_b2c377f7-4fa6-45ba-a44b-696c84a4bca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3dd0286f-44ce-4017-9857-bde7764125ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e289a032-5e9d-4428-951d-f39cfa570500" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_3dd0286f-44ce-4017-9857-bde7764125ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_79c21bc8-c6e0-4436-8b17-59af68b1b5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e289a032-5e9d-4428-951d-f39cfa570500" xlink:to="loc_us-gaap_TreasuryStockShares_79c21bc8-c6e0-4436-8b17-59af68b1b5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="icui-20220630.xsd#CondensedConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_ec40bd36-b2be-4757-9cca-7baec8c276a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e7fa286e-8eb0-4add-8f65-2e0cb5d0ff5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ec40bd36-b2be-4757-9cca-7baec8c276a3" xlink:to="loc_us-gaap_StatementTable_e7fa286e-8eb0-4add-8f65-2e0cb5d0ff5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ffb8e771-ded6-489e-ad15-a53e512a9fa0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e7fa286e-8eb0-4add-8f65-2e0cb5d0ff5a" xlink:to="loc_srt_ProductOrServiceAxis_ffb8e771-ded6-489e-ad15-a53e512a9fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cbba0a0d-d93a-4236-ae92-aa7547de0ea5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_ffb8e771-ded6-489e-ad15-a53e512a9fa0" xlink:to="loc_srt_ProductsAndServicesDomain_cbba0a0d-d93a-4236-ae92-aa7547de0ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e7fa286e-8eb0-4add-8f65-2e0cb5d0ff5a" xlink:to="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_ad12ed62-5b36-43ca-a147-b6c10810a7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_RevenuesAbstract_ad12ed62-5b36-43ca-a147-b6c10810a7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b726a3be-8274-405b-970b-b45df44875ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_ad12ed62-5b36-43ca-a147-b6c10810a7a6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b726a3be-8274-405b-970b-b45df44875ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_0228241d-d212-4796-b54e-7cb5b4a177ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_ad12ed62-5b36-43ca-a147-b6c10810a7a6" xlink:to="loc_us-gaap_CostOfRevenue_0228241d-d212-4796-b54e-7cb5b4a177ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c0db6e5a-8cca-48cc-aadd-4bef699d1dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_ad12ed62-5b36-43ca-a147-b6c10810a7a6" xlink:to="loc_us-gaap_GrossProfit_c0db6e5a-8cca-48cc-aadd-4bef699d1dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_f9eca9d7-e0fc-4c0c-83af-416ade2d6e49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_OperatingExpensesAbstract_f9eca9d7-e0fc-4c0c-83af-416ade2d6e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_255f406e-7a2f-43ba-b2d4-2ff6deb52528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f9eca9d7-e0fc-4c0c-83af-416ade2d6e49" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_255f406e-7a2f-43ba-b2d4-2ff6deb52528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_7e629245-9174-4978-9437-dd3ddc52c015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f9eca9d7-e0fc-4c0c-83af-416ade2d6e49" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_7e629245-9174-4978-9437-dd3ddc52c015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringandstrategictransaction_7a85c9e0-e314-43af-95c1-1c0fc3cced66" xlink:href="icui-20220630.xsd#icui_Restructuringandstrategictransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f9eca9d7-e0fc-4c0c-83af-416ade2d6e49" xlink:to="loc_icui_Restructuringandstrategictransaction_7a85c9e0-e314-43af-95c1-1c0fc3cced66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_727299d3-2970-4a76-9e1c-8762f6de7810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f9eca9d7-e0fc-4c0c-83af-416ade2d6e49" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_727299d3-2970-4a76-9e1c-8762f6de7810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contractsettlement_34e5af69-13a9-457a-aa87-fafe84752ec6" xlink:href="icui-20220630.xsd#icui_Contractsettlement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f9eca9d7-e0fc-4c0c-83af-416ade2d6e49" xlink:to="loc_icui_Contractsettlement_34e5af69-13a9-457a-aa87-fafe84752ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_942c6756-903a-42e9-b888-381d54b777ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f9eca9d7-e0fc-4c0c-83af-416ade2d6e49" xlink:to="loc_us-gaap_OperatingExpenses_942c6756-903a-42e9-b888-381d54b777ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1b316604-26c9-4afa-baa7-71023e54bb06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_OperatingIncomeLoss_1b316604-26c9-4afa-baa7-71023e54bb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_1fb62884-1b7b-491a-a9c9-bc9e69fd1443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_InterestExpense_1fb62884-1b7b-491a-a9c9-bc9e69fd1443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_129aa3e3-49df-4d5f-8055-a482f2c95650" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_129aa3e3-49df-4d5f-8055-a482f2c95650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bdd7445c-5d82-47b6-9fab-af4af1c4b9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bdd7445c-5d82-47b6-9fab-af4af1c4b9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_594b278a-9e8f-49ac-974e-951fb74cf715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_594b278a-9e8f-49ac-974e-951fb74cf715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_56690e9d-a266-41ae-9254-ffca3aa7b0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_ProfitLoss_56690e9d-a266-41ae-9254-ffca3aa7b0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8cd99568-f1b9-4601-a9cd-fc9e7cc8346f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_EarningsPerShareAbstract_8cd99568-f1b9-4601-a9cd-fc9e7cc8346f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_cf7cac77-43d2-4995-b598-7d3b8c4bf542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8cd99568-f1b9-4601-a9cd-fc9e7cc8346f" xlink:to="loc_us-gaap_EarningsPerShareBasic_cf7cac77-43d2-4995-b598-7d3b8c4bf542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_27318880-c35b-44a6-9221-c97741df3359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8cd99568-f1b9-4601-a9cd-fc9e7cc8346f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_27318880-c35b-44a6-9221-c97741df3359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bf5f4999-0fbe-4464-b434-2b4fe081ef52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_34a88730-726c-49f6-adde-fd3b44a8e8e8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bf5f4999-0fbe-4464-b434-2b4fe081ef52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e80f349c-c8a0-4c92-ad46-8ba06ce83098" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bf5f4999-0fbe-4464-b434-2b4fe081ef52" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e80f349c-c8a0-4c92-ad46-8ba06ce83098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6a70263f-c753-48e4-bf76-b2254459609c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bf5f4999-0fbe-4464-b434-2b4fe081ef52" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6a70263f-c753-48e4-bf76-b2254459609c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="icui-20220630.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_890df1b3-34c1-4c10-90fb-b821d2ffb092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_941dc6e7-a8f9-4718-a3b9-7bdf58698478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_890df1b3-34c1-4c10-90fb-b821d2ffb092" xlink:to="loc_us-gaap_StatementTable_941dc6e7-a8f9-4718-a3b9-7bdf58698478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_0f1eeaaf-dd4f-4a1d-a91b-266288c3877b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_941dc6e7-a8f9-4718-a3b9-7bdf58698478" xlink:to="loc_srt_StatementScenarioAxis_0f1eeaaf-dd4f-4a1d-a91b-266288c3877b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_117d62f2-64c6-4a16-b966-7cfa62235a9b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_0f1eeaaf-dd4f-4a1d-a91b-266288c3877b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_117d62f2-64c6-4a16-b966-7cfa62235a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e24af8b1-fc00-4891-81a1-6653ee46471e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_941dc6e7-a8f9-4718-a3b9-7bdf58698478" xlink:to="loc_us-gaap_StatementLineItems_e24af8b1-fc00-4891-81a1-6653ee46471e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_df0063d8-4988-4ca4-a43b-7578dd5e1e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e24af8b1-fc00-4891-81a1-6653ee46471e" xlink:to="loc_us-gaap_ProfitLoss_df0063d8-4988-4ca4-a43b-7578dd5e1e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e2cdffbd-73b7-4a48-8bed-8029b3217809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e24af8b1-fc00-4891-81a1-6653ee46471e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e2cdffbd-73b7-4a48-8bed-8029b3217809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5e505edb-8695-4516-9d65-39f2ef2c0c15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e2cdffbd-73b7-4a48-8bed-8029b3217809" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5e505edb-8695-4516-9d65-39f2ef2c0c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a8038e84-f611-4347-821d-cdbd3f94d95e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e2cdffbd-73b7-4a48-8bed-8029b3217809" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a8038e84-f611-4347-821d-cdbd3f94d95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4978692d-d14d-4702-a70d-2f3982ea79fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e2cdffbd-73b7-4a48-8bed-8029b3217809" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4978692d-d14d-4702-a70d-2f3982ea79fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8792d343-836d-4d2e-bb08-9de78d15b3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e2cdffbd-73b7-4a48-8bed-8029b3217809" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8792d343-836d-4d2e-bb08-9de78d15b3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e217b3e7-1395-413b-a4d5-35a25c8217b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e24af8b1-fc00-4891-81a1-6653ee46471e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e217b3e7-1395-413b-a4d5-35a25c8217b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical" xlink:type="simple" xlink:href="icui-20220630.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_448c773a-553d-4e4d-ab50-4dfdef18263b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_4cd7c74a-c4b7-402c-b239-cc8b2d5a0e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_448c773a-553d-4e4d-ab50-4dfdef18263b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_4cd7c74a-c4b7-402c-b239-cc8b2d5a0e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_25ff0569-6294-425d-b5ae-718893f72182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_448c773a-553d-4e4d-ab50-4dfdef18263b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_25ff0569-6294-425d-b5ae-718893f72182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_d313b38c-1b77-49f3-bebb-a31ce4c45c35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_448c773a-553d-4e4d-ab50-4dfdef18263b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_d313b38c-1b77-49f3-bebb-a31ce4c45c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement" xlink:type="simple" xlink:href="icui-20220630.xsd#CondensedConsolidatedStatementsofStockholdersEquityStatement"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_5d14ab20-8259-4660-8fa8-0e22f57b45c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7a4f49a1-8a9a-4aa0-8fcc-82a31e0b19fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_5d14ab20-8259-4660-8fa8-0e22f57b45c0" xlink:to="loc_us-gaap_StatementTable_7a4f49a1-8a9a-4aa0-8fcc-82a31e0b19fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_937cb51b-581e-4c48-bdb1-cfb3323e3906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7a4f49a1-8a9a-4aa0-8fcc-82a31e0b19fd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_937cb51b-581e-4c48-bdb1-cfb3323e3906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_130bdc9f-0020-4fe7-90a7-3b26102b92c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_937cb51b-581e-4c48-bdb1-cfb3323e3906" xlink:to="loc_us-gaap_EquityComponentDomain_130bdc9f-0020-4fe7-90a7-3b26102b92c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CommonStockSharesMember_b9f1d928-f080-4b58-b855-4c024c13fddc" xlink:href="icui-20220630.xsd#icui_CommonStockSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_130bdc9f-0020-4fe7-90a7-3b26102b92c9" xlink:to="loc_icui_CommonStockSharesMember_b9f1d928-f080-4b58-b855-4c024c13fddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f0637149-1f75-4ec1-aaef-bc103c6065c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_130bdc9f-0020-4fe7-90a7-3b26102b92c9" xlink:to="loc_us-gaap_CommonStockMember_f0637149-1f75-4ec1-aaef-bc103c6065c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d3fbc4e0-ee25-465b-9cee-249e1d2cd7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_130bdc9f-0020-4fe7-90a7-3b26102b92c9" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d3fbc4e0-ee25-465b-9cee-249e1d2cd7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_375e4e6b-070f-4e94-93af-df6dd430d81d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_130bdc9f-0020-4fe7-90a7-3b26102b92c9" xlink:to="loc_us-gaap_TreasuryStockMember_375e4e6b-070f-4e94-93af-df6dd430d81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_42b2a62e-d02c-4f29-8a6c-1c83371f91d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_130bdc9f-0020-4fe7-90a7-3b26102b92c9" xlink:to="loc_us-gaap_RetainedEarningsMember_42b2a62e-d02c-4f29-8a6c-1c83371f91d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c2c430cd-7d32-42e9-b43b-e169c7f34744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_130bdc9f-0020-4fe7-90a7-3b26102b92c9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c2c430cd-7d32-42e9-b43b-e169c7f34744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9380ff01-7015-4ba2-ab2c-5238e1287fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7a4f49a1-8a9a-4aa0-8fcc-82a31e0b19fd" xlink:to="loc_us-gaap_StatementLineItems_9380ff01-7015-4ba2-ab2c-5238e1287fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9380ff01-7015-4ba2-ab2c-5238e1287fd1" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4e7ee1f4-eabb-42a4-b7fc-05630b2a5635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4e7ee1f4-eabb-42a4-b7fc-05630b2a5635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_97f8edaf-7e7c-4b19-88e1-cf8f8bbdddb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_StockholdersEquity_97f8edaf-7e7c-4b19-88e1-cf8f8bbdddb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e17ab5f4-3e86-475e-9585-d7aaa6ae9b23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e17ab5f4-3e86-475e-9585-d7aaa6ae9b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_778512ea-1c5c-42aa-ae4b-184fb8d4ec0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_778512ea-1c5c-42aa-ae4b-184fb8d4ec0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_2b36e847-6a9b-4740-8600-745c46a9defc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_2b36e847-6a9b-4740-8600-745c46a9defc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_7285c145-f0f1-4c65-92cb-ec2ae0b08e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_7285c145-f0f1-4c65-92cb-ec2ae0b08e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_59792255-898e-429c-adf7-e7e780a40e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_59792255-898e-429c-adf7-e7e780a40e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_89e3ef3b-f002-4a67-a18e-81855c03d1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_89e3ef3b-f002-4a67-a18e-81855c03d1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_031f591d-3e7c-410e-a1d7-a52120ba6c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_031f591d-3e7c-410e-a1d7-a52120ba6c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e61ca260-8bc9-4aeb-8382-94a194046e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e61ca260-8bc9-4aeb-8382-94a194046e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_88d21e57-0230-4a89-8036-66add0212cce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_88d21e57-0230-4a89-8036-66add0212cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_396321ee-b439-441a-b758-54c4060d078d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_NetIncomeLoss_396321ee-b439-441a-b758-54c4060d078d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5c01d486-d119-4a1a-863c-839280220f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_StockholdersEquity_5c01d486-d119-4a1a-863c-839280220f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7089df9f-c281-41cc-910e-fc7f00ecd58f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_7089df9f-c281-41cc-910e-fc7f00ecd58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_aa494eb1-0d0e-461b-86c1-f15fec4886b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_957036ee-ae8d-4005-91c8-0cb074fd2bc3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_aa494eb1-0d0e-461b-86c1-f15fec4886b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="icui-20220630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_11c841cc-66a4-49ae-82b8-7390ec737fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_89554f07-9282-439e-ba0a-f7b1f5d1d8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11c841cc-66a4-49ae-82b8-7390ec737fd6" xlink:to="loc_us-gaap_StatementTable_89554f07-9282-439e-ba0a-f7b1f5d1d8d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_35fddf0b-5dd1-404a-a419-8072f42abbff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_89554f07-9282-439e-ba0a-f7b1f5d1d8d9" xlink:to="loc_srt_StatementScenarioAxis_35fddf0b-5dd1-404a-a419-8072f42abbff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b25b66b6-8c11-4cb4-9191-65e745472c34" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_35fddf0b-5dd1-404a-a419-8072f42abbff" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b25b66b6-8c11-4cb4-9191-65e745472c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_705bbee2-1e9f-42aa-b812-275248b0eb20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_89554f07-9282-439e-ba0a-f7b1f5d1d8d9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_705bbee2-1e9f-42aa-b812-275248b0eb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_258008f4-e75e-4904-a52c-0007ef4a7e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_705bbee2-1e9f-42aa-b812-275248b0eb20" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_258008f4-e75e-4904-a52c-0007ef4a7e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_45fd7634-5e29-4a42-954f-1faa078bd875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_89554f07-9282-439e-ba0a-f7b1f5d1d8d9" xlink:to="loc_us-gaap_StatementLineItems_45fd7634-5e29-4a42-954f-1faa078bd875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_1a6a4fb7-ce78-431c-a29d-3b136a6ff77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_45fd7634-5e29-4a42-954f-1faa078bd875" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_1a6a4fb7-ce78-431c-a29d-3b136a6ff77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_a8c409c1-c114-4848-9949-e30bb5048220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_1a6a4fb7-ce78-431c-a29d-3b136a6ff77f" xlink:to="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_a8c409c1-c114-4848-9949-e30bb5048220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_a8c409c1-c114-4848-9949-e30bb5048220" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_41783692-9060-439a-89a6-8f150b91bb18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_ProfitLoss_41783692-9060-439a-89a6-8f150b91bb18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_520e46bf-fcc9-4b4e-a2d3-698ec362764f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_520e46bf-fcc9-4b4e-a2d3-698ec362764f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AmortizationOfInventoryStepUp_885052bd-be2a-425e-8aa8-1dee111df9b0" xlink:href="icui-20220630.xsd#icui_AmortizationOfInventoryStepUp"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_icui_AmortizationOfInventoryStepUp_885052bd-be2a-425e-8aa8-1dee111df9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_e4e6ddd6-3a6c-444d-8d2c-e6d82187ca1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_e4e6ddd6-3a6c-444d-8d2c-e6d82187ca1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_5b655420-2d10-4475-801f-4a72ab009a00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_5b655420-2d10-4475-801f-4a72ab009a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProvisionForWarrantyAndReturns_697e5cf0-23fd-4500-b9c9-08d79c2c3d58" xlink:href="icui-20220630.xsd#icui_ProvisionForWarrantyAndReturns"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_icui_ProvisionForWarrantyAndReturns_697e5cf0-23fd-4500-b9c9-08d79c2c3d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c34f2493-901a-4ae3-ade6-f2d2915d422c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_ShareBasedCompensation_c34f2493-901a-4ae3-ade6-f2d2915d422c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_3c973b67-21d6-4f5b-86bb-f9d3224c0e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_3c973b67-21d6-4f5b-86bb-f9d3224c0e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_a44bab24-c18e-4e00-a2c6-4e92c55e476e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_a44bab24-c18e-4e00-a2c6-4e92c55e476e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_ebc96f8b-15f2-471e-9bfe-01dd8830a7a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_ebc96f8b-15f2-471e-9bfe-01dd8830a7a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5807f66c-bcb1-4387-a7bb-ee66bbfa5517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5807f66c-bcb1-4387-a7bb-ee66bbfa5517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sparepartsusage_bc40b1a5-8b3f-40e9-940e-767a6652eef4" xlink:href="icui-20220630.xsd#icui_Sparepartsusage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_icui_Sparepartsusage_bc40b1a5-8b3f-40e9-940e-767a6652eef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_521a3e3c-893c-4eea-ad98-875cfa78aae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_521a3e3c-893c-4eea-ad98-875cfa78aae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_417252f5-306a-456d-9b22-f1068756fa55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_417252f5-306a-456d-9b22-f1068756fa55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1e88bd71-6525-411a-bbdf-98d75602a160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1e88bd71-6525-411a-bbdf-98d75602a160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2cf61349-debf-4b4c-9276-dbe62e24dd5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2cf61349-debf-4b4c-9276-dbe62e24dd5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9ccb93aa-9b9f-42a0-adf8-8864f2f2f98e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9ccb93aa-9b9f-42a0-adf8-8864f2f2f98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f016c56f-1297-49cf-97c4-a15283dd1125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f016c56f-1297-49cf-97c4-a15283dd1125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7c222259-5621-4b10-a885-1d33f84ba28f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7c222259-5621-4b10-a885-1d33f84ba28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_0b281f78-c42e-4fa9-b1c9-1e5893ae65d7" xlink:href="icui-20220630.xsd#icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_0b281f78-c42e-4fa9-b1c9-1e5893ae65d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c3aeafa-fa46-45ff-8a5f-91940a9df3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_997021da-e635-4e6e-9b03-2879001daf08" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c3aeafa-fa46-45ff-8a5f-91940a9df3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df72a101-9ea9-41b0-849f-713656b85a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_a8c409c1-c114-4848-9949-e30bb5048220" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df72a101-9ea9-41b0-849f-713656b85a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a7a79476-0bdd-4772-aeac-04d2ce1f9465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df72a101-9ea9-41b0-849f-713656b85a0f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a7a79476-0bdd-4772-aeac-04d2ce1f9465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_66e2144f-1a52-4c2b-b589-6dc6aff69ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df72a101-9ea9-41b0-849f-713656b85a0f" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_66e2144f-1a52-4c2b-b589-6dc6aff69ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_44c8d1dd-09b3-4555-b39f-fec08d5d48ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df72a101-9ea9-41b0-849f-713656b85a0f" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_44c8d1dd-09b3-4555-b39f-fec08d5d48ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_a82aa1cc-d5fd-47e5-99af-f72162368e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df72a101-9ea9-41b0-849f-713656b85a0f" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_a82aa1cc-d5fd-47e5-99af-f72162368e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_6884046e-6ecf-4172-9aa0-742e4c3948fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df72a101-9ea9-41b0-849f-713656b85a0f" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_6884046e-6ecf-4172-9aa0-742e4c3948fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_021c46e8-35c1-4e55-9c89-9dd97d1e5a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df72a101-9ea9-41b0-849f-713656b85a0f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_021c46e8-35c1-4e55-9c89-9dd97d1e5a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_a8c409c1-c114-4848-9949-e30bb5048220" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_7a898c82-2f97-48cd-8c54-c9660829394f" xlink:href="icui-20220630.xsd#icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:to="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_7a898c82-2f97-48cd-8c54-c9660829394f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_f9648fc9-4ba0-4001-87b7-4b7d7befb638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_f9648fc9-4ba0-4001-87b7-4b7d7befb638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_75636ddc-73e0-41ac-a5a3-744cee8746ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_75636ddc-73e0-41ac-a5a3-744cee8746ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_a28b5d61-43fd-402f-a7ab-bafe182bb539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_a28b5d61-43fd-402f-a7ab-bafe182bb539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_c00e223a-03c9-447a-82f4-cef1739caf47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_c00e223a-03c9-447a-82f4-cef1739caf47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0e3d1722-0ad2-47e9-8c98-f5aa100159da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0e3d1722-0ad2-47e9-8c98-f5aa100159da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a6cd387d-ccfa-4425-b2e8-9c040fb5f787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8b83f510-e821-4344-aa9c-837512b3a423" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a6cd387d-ccfa-4425-b2e8-9c040fb5f787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_14a96eb7-ca75-4b4a-9e1a-fa4e859597c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_1a6a4fb7-ce78-431c-a29d-3b136a6ff77f" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_14a96eb7-ca75-4b4a-9e1a-fa4e859597c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_bf2254d8-0032-4c0d-933a-34cb310eb3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_14a96eb7-ca75-4b4a-9e1a-fa4e859597c1" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_bf2254d8-0032-4c0d-933a-34cb310eb3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fd7a0bac-f7f4-4caa-8135-a4aa0d8e2f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_45fd7634-5e29-4a42-954f-1faa078bd875" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fd7a0bac-f7f4-4caa-8135-a4aa0d8e2f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_964fab85-22ca-4d5d-b847-498f9d7b44c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_45fd7634-5e29-4a42-954f-1faa078bd875" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_964fab85-22ca-4d5d-b847-498f9d7b44c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_7cf151ab-1e86-453a-b217-9db05bea8956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_45fd7634-5e29-4a42-954f-1faa078bd875" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_7cf151ab-1e86-453a-b217-9db05bea8956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_13260465-c803-4c3b-8d95-f07875dde7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7cf151ab-1e86-453a-b217-9db05bea8956" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_13260465-c803-4c3b-8d95-f07875dde7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fff0fc93-228f-483a-9b70-9de2f77b260e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_45fd7634-5e29-4a42-954f-1faa078bd875" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fff0fc93-228f-483a-9b70-9de2f77b260e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_1705a17b-8d65-4e53-9ebe-6148e16db0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fff0fc93-228f-483a-9b70-9de2f77b260e" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_1705a17b-8d65-4e53-9ebe-6148e16db0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bb648516-de30-4ac2-8b67-944dd9a1e442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fff0fc93-228f-483a-9b70-9de2f77b260e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bb648516-de30-4ac2-8b67-944dd9a1e442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_334ec3fb-35ca-478a-8ec5-a99dba2f69fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fff0fc93-228f-483a-9b70-9de2f77b260e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_334ec3fb-35ca-478a-8ec5-a99dba2f69fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationAllAcquisitions_45b6ae54-01ba-4e4a-a34f-3007bafad9f8" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationAllAcquisitions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fff0fc93-228f-483a-9b70-9de2f77b260e" xlink:to="loc_icui_ContingentConsiderationAllAcquisitions_45b6ae54-01ba-4e4a-a34f-3007bafad9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GoodwillAcquiredDuringPeriodAllAcquisitions_d891d4ff-5702-4671-9f2b-f6d993ee6d75" xlink:href="icui-20220630.xsd#icui_GoodwillAcquiredDuringPeriodAllAcquisitions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fff0fc93-228f-483a-9b70-9de2f77b260e" xlink:to="loc_icui_GoodwillAcquiredDuringPeriodAllAcquisitions_d891d4ff-5702-4671-9f2b-f6d993ee6d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_ac175cba-38a4-46e9-a44f-6a4c1bb94aec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fff0fc93-228f-483a-9b70-9de2f77b260e" xlink:to="loc_us-gaap_LiabilitiesAssumed1_ac175cba-38a4-46e9-a44f-6a4c1bb94aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BasisofPresentation" xlink:type="simple" xlink:href="icui-20220630.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fef54412-b2c4-4349-87a0-e649a9e3e02e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b26ffd56-7ed2-4142-8371-5c20ba6594ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fef54412-b2c4-4349-87a0-e649a9e3e02e" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b26ffd56-7ed2-4142-8371-5c20ba6594ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="icui-20220630.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_eeda24b2-f898-4417-961d-2aa4df26ef1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_c607dbd7-e62e-4b80-8d80-eeb85b13db2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_eeda24b2-f898-4417-961d-2aa4df26ef1e" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_c607dbd7-e62e-4b80-8d80-eeb85b13db2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_e8090f20-52c0-4153-9b2e-d62c0d4c9588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NewAccountingPronouncementsNewAccountingPronouncementsAdoptedPolicies" xlink:type="simple" xlink:href="icui-20220630.xsd#NewAccountingPronouncementsNewAccountingPronouncementsAdoptedPolicies"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NewAccountingPronouncementsNewAccountingPronouncementsAdoptedPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions" xlink:type="simple" xlink:href="icui-20220630.xsd#BusinessCombinationsandAssetAcquisitions"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c30b4c44-eebe-45ad-a491-0ecdc8ea2d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_550d9ab0-83ef-4ec1-9e27-1e83904676b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c30b4c44-eebe-45ad-a491-0ecdc8ea2d1c" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_550d9ab0-83ef-4ec1-9e27-1e83904676b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables" xlink:type="simple" xlink:href="icui-20220630.xsd#BusinessCombinationsandAssetAcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5fac4121-9ee2-44da-9321-d248294f481e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_a472293a-710d-4d45-a47c-e5c7ce4f3a36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5fac4121-9ee2-44da-9321-d248294f481e" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_a472293a-710d-4d45-a47c-e5c7ce4f3a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_5a02b258-d222-411f-b698-126e2cc3f3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5fac4121-9ee2-44da-9321-d248294f481e" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_5a02b258-d222-411f-b698-126e2cc3f3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_345efb5a-2167-43b4-a5a9-dcb0c48e3b69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_189b68d7-6cd5-40f4-94af-a3dc3011a492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_345efb5a-2167-43b4-a5a9-dcb0c48e3b69" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_189b68d7-6cd5-40f4-94af-a3dc3011a492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_93689f38-b202-4265-bc40-a4dd9505aeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_189b68d7-6cd5-40f4-94af-a3dc3011a492" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_93689f38-b202-4265-bc40-a4dd9505aeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c7d27d74-7f92-44f8-a701-8e907d0c49a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_93689f38-b202-4265-bc40-a4dd9505aeb9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c7d27d74-7f92-44f8-a701-8e907d0c49a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_2724a2c1-1134-4408-8a2a-0b2b72654267" xlink:href="icui-20220630.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c7d27d74-7f92-44f8-a701-8e907d0c49a7" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_2724a2c1-1134-4408-8a2a-0b2b72654267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2a1f681b-7017-4791-bdb1-516112e80390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_189b68d7-6cd5-40f4-94af-a3dc3011a492" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_2a1f681b-7017-4791-bdb1-516112e80390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_8f14e07d-14e5-4472-a757-398cd0bf9a37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a1f681b-7017-4791-bdb1-516112e80390" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_8f14e07d-14e5-4472-a757-398cd0bf9a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_a0abca0a-a9b0-4fc0-aa07-5af8a07c25e6" xlink:href="icui-20220630.xsd#icui_Contingentconsiderationgross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a1f681b-7017-4791-bdb1-516112e80390" xlink:to="loc_icui_Contingentconsiderationgross_a0abca0a-a9b0-4fc0-aa07-5af8a07c25e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_f47e346c-36cc-4092-b3f4-b4d70148166d" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationGrossST"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a1f681b-7017-4791-bdb1-516112e80390" xlink:to="loc_icui_ContingentConsiderationGrossST_f47e346c-36cc-4092-b3f4-b4d70148166d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_83eb5e0e-dd6e-4012-aa11-04fe66f24076" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a1f681b-7017-4791-bdb1-516112e80390" xlink:to="loc_icui_ContingentConsiderationGrossLT_83eb5e0e-dd6e-4012-aa11-04fe66f24076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationHoldbackLiability_fa0328c7-40e1-4ab4-8086-c49c977f6920" xlink:href="icui-20220630.xsd#icui_BusinessCombinationConsiderationHoldbackLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a1f681b-7017-4791-bdb1-516112e80390" xlink:to="loc_icui_BusinessCombinationConsiderationHoldbackLiability_fa0328c7-40e1-4ab4-8086-c49c977f6920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d6c0e35f-e274-4bca-871a-d99056fde187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a1f681b-7017-4791-bdb1-516112e80390" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d6c0e35f-e274-4bca-871a-d99056fde187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#BusinessCombinationsandAssetAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2353ba42-06f8-4848-aaad-167c897d0335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae921024-d9f1-4cb7-b85b-ead083624aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2353ba42-06f8-4848-aaad-167c897d0335" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae921024-d9f1-4cb7-b85b-ead083624aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_639142bb-47fc-4b01-ab2e-c91ef22853bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae921024-d9f1-4cb7-b85b-ead083624aa9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_639142bb-47fc-4b01-ab2e-c91ef22853bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cbd60a2b-9787-49f9-818a-19e094f3555a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_639142bb-47fc-4b01-ab2e-c91ef22853bd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cbd60a2b-9787-49f9-818a-19e094f3555a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_1dc12d88-1aae-4e94-8c57-520d4589fd7c" xlink:href="icui-20220630.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cbd60a2b-9787-49f9-818a-19e094f3555a" xlink:to="loc_icui_SmithsMedicalMember_1dc12d88-1aae-4e94-8c57-520d4589fd7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c813084d-cb83-4f03-9ec2-4d712421815d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae921024-d9f1-4cb7-b85b-ead083624aa9" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_c813084d-cb83-4f03-9ec2-4d712421815d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_fd4113db-b1cd-4b2a-81a0-8e217d2f1ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c813084d-cb83-4f03-9ec2-4d712421815d" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_fd4113db-b1cd-4b2a-81a0-8e217d2f1ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationTransferredCash_21576ea0-d49a-4372-bc94-a6352c4fb2fa" xlink:href="icui-20220630.xsd#icui_BusinessCombinationConsiderationTransferredCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c813084d-cb83-4f03-9ec2-4d712421815d" xlink:to="loc_icui_BusinessCombinationConsiderationTransferredCash_21576ea0-d49a-4372-bc94-a6352c4fb2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_51025daa-cdf3-4329-b3c9-4c572e4a672b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c813084d-cb83-4f03-9ec2-4d712421815d" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_51025daa-cdf3-4329-b3c9-4c572e4a672b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_016243e3-9533-4f76-a2b6-476882828cde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c813084d-cb83-4f03-9ec2-4d712421815d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_016243e3-9533-4f76-a2b6-476882828cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MinimumStockPriceTargetForEarnOutPayment_0981f38f-3e5c-4823-80b3-9075e444a4bd" xlink:href="icui-20220630.xsd#icui_MinimumStockPriceTargetForEarnOutPayment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c813084d-cb83-4f03-9ec2-4d712421815d" xlink:to="loc_icui_MinimumStockPriceTargetForEarnOutPayment_0981f38f-3e5c-4823-80b3-9075e444a4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_b927e3b4-9d21-4fa7-85c0-aee73561565f" xlink:href="icui-20220630.xsd#icui_RequiredShareHoldingOfStockIssuedAtAcquisition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c813084d-cb83-4f03-9ec2-4d712421815d" xlink:to="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_b927e3b4-9d21-4fa7-85c0-aee73561565f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9d5800a8-1f8f-4a2f-bdd9-e4f648c03e83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_652c3d13-f460-4ae6-bfd5-b080c1391262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9d5800a8-1f8f-4a2f-bdd9-e4f648c03e83" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_652c3d13-f460-4ae6-bfd5-b080c1391262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9d272a00-3778-4a4f-b56d-7638bb5a52bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_652c3d13-f460-4ae6-bfd5-b080c1391262" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9d272a00-3778-4a4f-b56d-7638bb5a52bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a810f65-9a91-460e-a932-95ea01db00fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9d272a00-3778-4a4f-b56d-7638bb5a52bb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a810f65-9a91-460e-a932-95ea01db00fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_2e13f578-1f86-4f53-aa14-b771cf6f96bb" xlink:href="icui-20220630.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a810f65-9a91-460e-a932-95ea01db00fd" xlink:to="loc_icui_SmithsMedicalMember_2e13f578-1f86-4f53-aa14-b771cf6f96bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_35404ca2-dfaa-4fc8-9462-39334bc9b81e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_652c3d13-f460-4ae6-bfd5-b080c1391262" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_35404ca2-dfaa-4fc8-9462-39334bc9b81e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_35404ca2-dfaa-4fc8-9462-39334bc9b81e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_0a4c3397-c654-4ad8-aaa9-42ed97cce626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:to="loc_us-gaap_CustomerRelationshipsMember_0a4c3397-c654-4ad8-aaa9-42ed97cce626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DevelopedTechnologyMember_159dff12-4423-40d1-919e-73e3cb283db0" xlink:href="icui-20220630.xsd#icui_DevelopedTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:to="loc_icui_DevelopedTechnologyMember_159dff12-4423-40d1-919e-73e3cb283db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_51239555-d53f-4e90-b889-72275af4a925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_51239555-d53f-4e90-b889-72275af4a925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_fc2eb94b-2003-4ec3-9c5b-d9b7b74d6001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_fc2eb94b-2003-4ec3-9c5b-d9b7b74d6001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_eca4e4ad-746e-4730-b0f1-d30ffc50ae31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_eca4e4ad-746e-4730-b0f1-d30ffc50ae31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_4e909076-8117-4eda-89fb-13e3275eefe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_4e909076-8117-4eda-89fb-13e3275eefe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_0d02bc01-44ed-4a71-b182-930da175fb0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ebbe790a-ef53-4c18-8cf6-372b5fca9a74" xlink:to="loc_us-gaap_TrademarksMember_0d02bc01-44ed-4a71-b182-930da175fb0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_652c3d13-f460-4ae6-bfd5-b080c1391262" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_3544d5cb-8d7c-47f8-9f98-ceaa0a524b55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_3544d5cb-8d7c-47f8-9f98-ceaa0a524b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_67e68a2e-45d8-444c-8086-4cae87049edf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_67e68a2e-45d8-444c-8086-4cae87049edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_eb976a85-3c08-40a4-9cd9-d64f330bbdee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_eb976a85-3c08-40a4-9cd9-d64f330bbdee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_b0cc08f3-4fc2-4138-862b-1fa82261db8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_b0cc08f3-4fc2-4138-862b-1fa82261db8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_8518f7d2-5feb-4f79-8d0a-0f29b4a0dcbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_8518f7d2-5feb-4f79-8d0a-0f29b4a0dcbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2dcdeca1-89b5-4196-b9ea-da03008d37c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2dcdeca1-89b5-4196-b9ea-da03008d37c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a5d9176a-baa1-4e68-becf-caf37cb22e18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a5d9176a-baa1-4e68-becf-caf37cb22e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_e515d6ed-5301-47a6-bab6-6c25b9e02889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_e515d6ed-5301-47a6-bab6-6c25b9e02889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_96ae9486-f708-46bd-a166-3b6661478698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_96ae9486-f708-46bd-a166-3b6661478698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_3b630478-df1c-4d10-bebc-1c5ff3378bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_3b630478-df1c-4d10-bebc-1c5ff3378bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_973c11a6-ebf1-4bda-bf4a-4ef5658251ab" xlink:href="icui-20220630.xsd#icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_973c11a6-ebf1-4bda-bf4a-4ef5658251ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_afe28f6a-ec99-47e5-b93f-a6dfd9f17373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_afe28f6a-ec99-47e5-b93f-a6dfd9f17373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_7d3b95ec-57a4-4355-a7ff-f83ef0affdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_7d3b95ec-57a4-4355-a7ff-f83ef0affdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_4c60ea2c-75d1-4e5a-bcd8-b9d7137d3f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_4c60ea2c-75d1-4e5a-bcd8-b9d7137d3f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_74bb003b-b4c8-4b93-869d-a136c90f1b14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_74bb003b-b4c8-4b93-869d-a136c90f1b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_63e24df1-8840-4920-84d7-4aa8656af46e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_63e24df1-8840-4920-84d7-4aa8656af46e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_a5b8679b-3ba0-4293-a844-6f0a02024f8a" xlink:href="icui-20220630.xsd#icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_a5b8679b-3ba0-4293-a844-6f0a02024f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_ece63125-a3cb-4f09-88a0-fdbab6a8e700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_ece63125-a3cb-4f09-88a0-fdbab6a8e700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_c5543bd1-8e9b-4fcb-b45c-59a48a97d315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_c5543bd1-8e9b-4fcb-b45c-59a48a97d315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ed0b0ea0-3950-4034-a3c3-4f38cdfbece5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ed0b0ea0-3950-4034-a3c3-4f38cdfbece5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationGoodwillNonDeductible_ece1c70c-2fc8-46d9-9b56-32e8fa0610fd" xlink:href="icui-20220630.xsd#icui_BusinessCombinationGoodwillNonDeductible"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_icui_BusinessCombinationGoodwillNonDeductible_ece1c70c-2fc8-46d9-9b56-32e8fa0610fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5ed73875-ed63-4e12-8355-21de1c7f0024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5ed73875-ed63-4e12-8355-21de1c7f0024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e1067a87-8c3f-48f8-95d8-07cd384b48a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fda2576-23a7-4de3-84a4-ce2b19dbe3a5" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e1067a87-8c3f-48f8-95d8-07cd384b48a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ca592884-7516-43ef-96f4-1861a705ace7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_55fac140-d36e-4bc1-94d3-ad7c1fb9af33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ca592884-7516-43ef-96f4-1861a705ace7" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_55fac140-d36e-4bc1-94d3-ad7c1fb9af33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6aa80f80-c79f-496c-b59d-3540da78b013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_55fac140-d36e-4bc1-94d3-ad7c1fb9af33" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6aa80f80-c79f-496c-b59d-3540da78b013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1a6fbcef-e297-445f-94a1-ced977f73499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6aa80f80-c79f-496c-b59d-3540da78b013" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1a6fbcef-e297-445f-94a1-ced977f73499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5eda333b-3328-4f62-81cf-97cd0dcac838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1a6fbcef-e297-445f-94a1-ced977f73499" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5eda333b-3328-4f62-81cf-97cd0dcac838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_908437ec-a481-4293-b7e5-208859ef093d" xlink:href="icui-20220630.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5eda333b-3328-4f62-81cf-97cd0dcac838" xlink:to="loc_icui_SmithsMedicalMember_908437ec-a481-4293-b7e5-208859ef093d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis_d3bf10e3-01e9-49c4-afc5-e19f6b2356c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6aa80f80-c79f-496c-b59d-3540da78b013" xlink:to="loc_us-gaap_NonrecurringAdjustmentAxis_d3bf10e3-01e9-49c4-afc5-e19f6b2356c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_ef7381c5-bc05-47d4-a277-28dba0cd44a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_d3bf10e3-01e9-49c4-afc5-e19f6b2356c1" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_ef7381c5-bc05-47d4-a277-28dba0cd44a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_01783c5c-7764-4d64-8e5e-a10b5dc426a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_ef7381c5-bc05-47d4-a277-28dba0cd44a0" xlink:to="loc_us-gaap_AcquisitionRelatedCostsMember_01783c5c-7764-4d64-8e5e-a10b5dc426a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_26ef5fb1-132b-43a8-97ed-d8ce90ea0205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6aa80f80-c79f-496c-b59d-3540da78b013" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_26ef5fb1-132b-43a8-97ed-d8ce90ea0205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_300e5e5b-2055-4f55-82ef-2748cff84dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_26ef5fb1-132b-43a8-97ed-d8ce90ea0205" xlink:to="loc_us-gaap_Revenues_300e5e5b-2055-4f55-82ef-2748cff84dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_52e7db38-a021-4201-8e73-b22353845a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_26ef5fb1-132b-43a8-97ed-d8ce90ea0205" xlink:to="loc_us-gaap_ProfitLoss_52e7db38-a021-4201-8e73-b22353845a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_628c4841-76f9-40de-b8e5-14942d0ef356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_26ef5fb1-132b-43a8-97ed-d8ce90ea0205" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_628c4841-76f9-40de-b8e5-14942d0ef356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_93bef73d-02e6-4ce2-881c-0f98ec2e9400" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ca592884-7516-43ef-96f4-1861a705ace7" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_93bef73d-02e6-4ce2-881c-0f98ec2e9400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentAmortization_a7103619-9094-49a3-88e1-4b5e295aff00" xlink:href="icui-20220630.xsd#icui_ProFormaAdjustmentAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ca592884-7516-43ef-96f4-1861a705ace7" xlink:to="loc_icui_ProFormaAdjustmentAmortization_a7103619-9094-49a3-88e1-4b5e295aff00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentFinanceCosts_33c30014-569e-45d5-94dd-34c916b472f3" xlink:href="icui-20220630.xsd#icui_ProFormaAdjustmentFinanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ca592884-7516-43ef-96f4-1861a705ace7" xlink:to="loc_icui_ProFormaAdjustmentFinanceCosts_33c30014-569e-45d5-94dd-34c916b472f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentInventory_6eac50c9-ab49-44a8-b63e-7926d74ba1d6" xlink:href="icui-20220630.xsd#icui_ProFormaAdjustmentInventory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ca592884-7516-43ef-96f4-1861a705ace7" xlink:to="loc_icui_ProFormaAdjustmentInventory_6eac50c9-ab49-44a8-b63e-7926d74ba1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentRelatedPartyLoans_9e70f0d7-9a88-4821-ada8-a500b08062c4" xlink:href="icui-20220630.xsd#icui_ProFormaAdjustmentRelatedPartyLoans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ca592884-7516-43ef-96f4-1861a705ace7" xlink:to="loc_icui_ProFormaAdjustmentRelatedPartyLoans_9e70f0d7-9a88-4821-ada8-a500b08062c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_28d5521d-7d98-4f3a-b5fd-d03ddc4bd2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ca592884-7516-43ef-96f4-1861a705ace7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_28d5521d-7d98-4f3a-b5fd-d03ddc4bd2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7000ed9e-d229-4010-826f-16ded94108dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1e983772-9fb0-4074-bac2-5883fb02a244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_530f2a30-9ef7-489f-b949-284360119eb4" xlink:href="icui-20220630.xsd#icui_SmithsMedicalMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2134a37c-5025-4aaf-bd39-331f309cd9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_cb4f6edb-97c0-4b83-a862-d3daea363349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_157d8cb0-6388-42af-bf74-699b577bb77d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes" xlink:type="simple" xlink:href="icui-20220630.xsd#RestructuringStrategicTransactionandIntegrationNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_44d06e35-201f-4139-82fc-81a3651e9b57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_962e5ea2-4590-48ea-a0b3-ee817830fd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_44d06e35-201f-4139-82fc-81a3651e9b57" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_962e5ea2-4590-48ea-a0b3-ee817830fd6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables" xlink:type="simple" xlink:href="icui-20220630.xsd#RestructuringStrategicTransactionandIntegrationTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e01662e0-b89c-4152-99c7-059338c746fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_d2319cf9-9f16-4e32-95c0-69f80d8a3d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e01662e0-b89c-4152-99c7-059338c746fe" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_d2319cf9-9f16-4e32-95c0-69f80d8a3d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#RestructuringStrategicTransactionandIntegrationRestructuringDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_023fdd96-0e67-4d58-a817-2c6b4f03c8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringstrategictransactionandintegration_52e45daf-cf9a-4e4d-a0c2-b74ab46a68a8" xlink:href="icui-20220630.xsd#icui_Restructuringstrategictransactionandintegration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_023fdd96-0e67-4d58-a817-2c6b4f03c8a4" xlink:to="loc_icui_Restructuringstrategictransactionandintegration_52e45daf-cf9a-4e4d-a0c2-b74ab46a68a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_da542824-9a2a-497b-826e-917b13e9cc04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_023fdd96-0e67-4d58-a817-2c6b4f03c8a4" xlink:to="loc_us-gaap_RestructuringCosts_da542824-9a2a-497b-826e-917b13e9cc04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#RestructuringStrategicTransactionandIntegrationLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5f2795f3-85c1-47d2-b618-3d6ee3e84bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2c4b9714-904e-491d-a11d-21ce4c78a06b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5f2795f3-85c1-47d2-b618-3d6ee3e84bf4" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2c4b9714-904e-491d-a11d-21ce4c78a06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_1accaec5-193a-4a4c-b4da-7506d46675b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2c4b9714-904e-491d-a11d-21ce4c78a06b" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_1accaec5-193a-4a4c-b4da-7506d46675b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_d2d59ae3-3ec1-48cd-a617-e329d966d069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1accaec5-193a-4a4c-b4da-7506d46675b5" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_d2d59ae3-3ec1-48cd-a617-e329d966d069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_b0f61a4d-536e-4170-aa1f-a9b220e58385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_d2d59ae3-3ec1-48cd-a617-e329d966d069" xlink:to="loc_us-gaap_EmployeeSeveranceMember_b0f61a4d-536e-4170-aa1f-a9b220e58385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_d10b571e-4adf-4904-a779-bdff03af53d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_d2d59ae3-3ec1-48cd-a617-e329d966d069" xlink:to="loc_us-gaap_FacilityClosingMember_d10b571e-4adf-4904-a779-bdff03af53d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_8c1a84e3-f2df-421d-aa9d-b994d9273a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2c4b9714-904e-491d-a11d-21ce4c78a06b" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_8c1a84e3-f2df-421d-aa9d-b994d9273a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_9a02cbd6-0a74-4ca2-b76c-07901053e4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c1a84e3-f2df-421d-aa9d-b994d9273a45" xlink:to="loc_us-gaap_RestructuringReserve_9a02cbd6-0a74-4ca2-b76c-07901053e4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_25f62d78-8fad-41a5-9a6d-14cdb4f20692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c1a84e3-f2df-421d-aa9d-b994d9273a45" xlink:to="loc_us-gaap_RestructuringCharges_25f62d78-8fad-41a5-9a6d-14cdb4f20692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_911113b6-82a3-48be-92db-f12a654f9f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c1a84e3-f2df-421d-aa9d-b994d9273a45" xlink:to="loc_us-gaap_PaymentsForRestructuring_911113b6-82a3-48be-92db-f12a654f9f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_a0291b0d-16e2-4832-bdd3-e9db8d6f2238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c1a84e3-f2df-421d-aa9d-b994d9273a45" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_a0291b0d-16e2-4832-bdd3-e9db8d6f2238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_1ad903c4-7931-4865-8a6e-981453d0868a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c1a84e3-f2df-421d-aa9d-b994d9273a45" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_1ad903c4-7931-4865-8a6e-981453d0868a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_414f8c54-2fb9-400a-b4fe-5d1d96118498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c1a84e3-f2df-421d-aa9d-b994d9273a45" xlink:to="loc_us-gaap_RestructuringReserve_414f8c54-2fb9-400a-b4fe-5d1d96118498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities_2f8dd12e-8800-45f0-a7d1-66142e912a18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c1a84e3-f2df-421d-aa9d-b994d9273a45" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities_2f8dd12e-8800-45f0-a7d1-66142e912a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/StrategicTransactionandIntegrationDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#StrategicTransactionandIntegrationDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/StrategicTransactionandIntegrationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_193c5dc6-549c-44fb-830b-17971608a85f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_StrategicTransactionandIntegration_0fdae4d4-392d-47d0-96ca-d342c71496a4" xlink:href="icui-20220630.xsd#icui_StrategicTransactionandIntegration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_193c5dc6-549c-44fb-830b-17971608a85f" xlink:to="loc_icui_StrategicTransactionandIntegration_0fdae4d4-392d-47d0-96ca-d342c71496a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueNotes" xlink:type="simple" xlink:href="icui-20220630.xsd#RevenueNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2cb0551c-f124-443b-aadc-119973e3c1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_1661177b-eb0c-4e7b-8b3a-214cee8713e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2cb0551c-f124-443b-aadc-119973e3c1ab" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_1661177b-eb0c-4e7b-8b3a-214cee8713e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueTables" xlink:type="simple" xlink:href="icui-20220630.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_beded2d7-216a-4769-8c6b-07611d79dd16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c549798e-09e3-41b2-9698-8e25145c8865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_beded2d7-216a-4769-8c6b-07611d79dd16" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c549798e-09e3-41b2-9698-8e25145c8865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_58cb1a41-d279-4772-8527-0f3310011cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_beded2d7-216a-4769-8c6b-07611d79dd16" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_58cb1a41-d279-4772-8527-0f3310011cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#RevenueDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5f3f8382-a33c-472f-882e-2ae515bd7b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_12080865-c48c-434a-810c-b94aa39b7f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5f3f8382-a33c-472f-882e-2ae515bd7b9a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_12080865-c48c-434a-810c-b94aa39b7f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8c8bb3e5-10d0-46ff-abb7-5c3e6a1f01b1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_12080865-c48c-434a-810c-b94aa39b7f0a" xlink:to="loc_srt_ProductOrServiceAxis_8c8bb3e5-10d0-46ff-abb7-5c3e6a1f01b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_923fa40c-298d-4ce3-a1db-505eca2fa78b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8c8bb3e5-10d0-46ff-abb7-5c3e6a1f01b1" xlink:to="loc_srt_ProductsAndServicesDomain_923fa40c-298d-4ce3-a1db-505eca2fa78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember_982702b4-b9fd-4e7d-9a14-d22a44b6ed4f" xlink:href="icui-20220630.xsd#icui_InfusionSystemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_923fa40c-298d-4ce3-a1db-505eca2fa78b" xlink:to="loc_icui_InfusionSystemsMember_982702b4-b9fd-4e7d-9a14-d22a44b6ed4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember_5f2dbc1c-d08b-4639-b8c1-1429a2b10945" xlink:href="icui-20220630.xsd#icui_EquipmentrevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_923fa40c-298d-4ce3-a1db-505eca2fa78b" xlink:to="loc_icui_EquipmentrevenueMember_5f2dbc1c-d08b-4639-b8c1-1429a2b10945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember_aeec051b-3c29-4eb8-b217-ccce8c791508" xlink:href="icui-20220630.xsd#icui_SoftwarerevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_923fa40c-298d-4ce3-a1db-505eca2fa78b" xlink:to="loc_icui_SoftwarerevenueMember_aeec051b-3c29-4eb8-b217-ccce8c791508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_b3d755c4-1f7b-4bed-b03a-1c5a165fc5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_12080865-c48c-434a-810c-b94aa39b7f0a" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_b3d755c4-1f7b-4bed-b03a-1c5a165fc5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_14ac58b8-b04a-4e1b-81ca-766f4af2ca89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b3d755c4-1f7b-4bed-b03a-1c5a165fc5cb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_14ac58b8-b04a-4e1b-81ca-766f4af2ca89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#RevenueDisaggregatedRevenuebyGeographyDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_82808de8-03dd-4643-a9f6-90798dab21b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f23d1282-a180-423c-b4e0-3b22f6094837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_82808de8-03dd-4643-a9f6-90798dab21b2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f23d1282-a180-423c-b4e0-3b22f6094837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b7564e77-0de4-4fb6-af02-92268fe90e75" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f23d1282-a180-423c-b4e0-3b22f6094837" xlink:to="loc_srt_StatementGeographicalAxis_b7564e77-0de4-4fb6-af02-92268fe90e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ccbe9a36-fbd3-418c-8c46-909427f61ff6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_b7564e77-0de4-4fb6-af02-92268fe90e75" xlink:to="loc_srt_SegmentGeographicalDomain_ccbe9a36-fbd3-418c-8c46-909427f61ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_ef0b8a67-c827-4e67-b665-f2189e77317f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ccbe9a36-fbd3-418c-8c46-909427f61ff6" xlink:to="loc_us-gaap_EMEAMember_ef0b8a67-c827-4e67-b665-f2189e77317f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherforeigncountriesMember_b2777b78-fc86-4982-9cf0-e8cb73c0524e" xlink:href="icui-20220630.xsd#icui_OtherforeigncountriesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ccbe9a36-fbd3-418c-8c46-909427f61ff6" xlink:to="loc_icui_OtherforeigncountriesMember_b2777b78-fc86-4982-9cf0-e8cb73c0524e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignMember_7d8e3433-288d-487e-aec8-64f48d26beb4" xlink:href="icui-20220630.xsd#icui_ForeignMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ccbe9a36-fbd3-418c-8c46-909427f61ff6" xlink:to="loc_icui_ForeignMember_7d8e3433-288d-487e-aec8-64f48d26beb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_52cc0fe6-ea29-4399-ae61-51f5d9c82f18" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ccbe9a36-fbd3-418c-8c46-909427f61ff6" xlink:to="loc_country_US_52cc0fe6-ea29-4399-ae61-51f5d9c82f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_00f6c491-212c-4b55-8f73-a603056c5c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f23d1282-a180-423c-b4e0-3b22f6094837" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_00f6c491-212c-4b55-8f73-a603056c5c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_74cfd13e-6b56-4a92-9bfa-f4128d4e763c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_00f6c491-212c-4b55-8f73-a603056c5c7e" xlink:to="loc_us-gaap_Revenues_74cfd13e-6b56-4a92-9bfa-f4128d4e763c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#RevenueDisaggregatedRevenuebyProductLineDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6ac14aac-0fa5-44a6-b565-57ee58de78d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_55b5c72f-eed2-4f20-90eb-5e8213ff1048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6ac14aac-0fa5-44a6-b565-57ee58de78d1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_55b5c72f-eed2-4f20-90eb-5e8213ff1048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e8446bc5-cb53-4960-a1e3-347fb03caa9b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_55b5c72f-eed2-4f20-90eb-5e8213ff1048" xlink:to="loc_srt_ProductOrServiceAxis_e8446bc5-cb53-4960-a1e3-347fb03caa9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e8446bc5-cb53-4960-a1e3-347fb03caa9b" xlink:to="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesMember_cfd440a3-98f2-4f0a-8b9a-aed639f2f013" xlink:href="icui-20220630.xsd#icui_InfusionConsumablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:to="loc_icui_InfusionConsumablesMember_cfd440a3-98f2-4f0a-8b9a-aed639f2f013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember_c0d4b13a-04d0-429e-b2fe-32d8c69f7392" xlink:href="icui-20220630.xsd#icui_InfusionSystemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:to="loc_icui_InfusionSystemsMember_c0d4b13a-04d0-429e-b2fe-32d8c69f7392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IVSolutionsMember_3f1c1c4b-84cc-49bb-8ea8-193210b88b3f" xlink:href="icui-20220630.xsd#icui_IVSolutionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:to="loc_icui_IVSolutionsMember_3f1c1c4b-84cc-49bb-8ea8-193210b88b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CriticalCareMember_013877ed-4284-4986-bc67-e7bc4001d2e9" xlink:href="icui-20220630.xsd#icui_CriticalCareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:to="loc_icui_CriticalCareMember_013877ed-4284-4986-bc67-e7bc4001d2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesSmithsMedicalMember_b25a03eb-4ee6-4947-9462-dce8f5561ff5" xlink:href="icui-20220630.xsd#icui_InfusionConsumablesSmithsMedicalMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:to="loc_icui_InfusionConsumablesSmithsMedicalMember_b25a03eb-4ee6-4947-9462-dce8f5561ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_VascularAccessMember_aa524075-1f8d-4327-9269-3563ccc272c3" xlink:href="icui-20220630.xsd#icui_VascularAccessMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:to="loc_icui_VascularAccessMember_aa524075-1f8d-4327-9269-3563ccc272c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_VitalCareMember_fad90faf-45bd-45e8-8258-5cab3b7fd569" xlink:href="icui-20220630.xsd#icui_VitalCareMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0d7c3cf1-a035-4b1b-ba7c-36a3eedb4563" xlink:to="loc_icui_VitalCareMember_fad90faf-45bd-45e8-8258-5cab3b7fd569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_bb9c241f-21d8-4e75-abcb-cb5f36541d25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_55b5c72f-eed2-4f20-90eb-5e8213ff1048" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_bb9c241f-21d8-4e75-abcb-cb5f36541d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_eb40572d-3ebc-4d34-806c-cb790ce942ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bb9c241f-21d8-4e75-abcb-cb5f36541d25" xlink:to="loc_us-gaap_Revenues_eb40572d-3ebc-4d34-806c-cb790ce942ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueContractLiabilitiesDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#RevenueContractLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5d10b048-54e4-44f2-af32-610546a18c44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesTable_ce0c05a2-b94a-413f-90a4-f8380ca24873" xlink:href="icui-20220630.xsd#icui_ContractassetandliabilitybalancesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5d10b048-54e4-44f2-af32-610546a18c44" xlink:to="loc_icui_ContractassetandliabilitybalancesTable_ce0c05a2-b94a-413f-90a4-f8380ca24873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7255e9c1-0d3c-40ee-a815-cf74c7cec691" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_ce0c05a2-b94a-413f-90a4-f8380ca24873" xlink:to="loc_srt_ProductOrServiceAxis_7255e9c1-0d3c-40ee-a815-cf74c7cec691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e0cadbe8-88bb-4b06-90d6-3dfd101e2015" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_7255e9c1-0d3c-40ee-a815-cf74c7cec691" xlink:to="loc_srt_ProductsAndServicesDomain_e0cadbe8-88bb-4b06-90d6-3dfd101e2015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember_18b887fc-b075-40a5-8aa9-9161393e4da5" xlink:href="icui-20220630.xsd#icui_EquipmentrevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e0cadbe8-88bb-4b06-90d6-3dfd101e2015" xlink:to="loc_icui_EquipmentrevenueMember_18b887fc-b075-40a5-8aa9-9161393e4da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember_298a97a4-2b91-45fd-b73f-db1c4bc5607c" xlink:href="icui-20220630.xsd#icui_SoftwarerevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e0cadbe8-88bb-4b06-90d6-3dfd101e2015" xlink:to="loc_icui_SoftwarerevenueMember_298a97a4-2b91-45fd-b73f-db1c4bc5607c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GovernmentGrantRevenueMember_4d4ebd12-9ff5-4cba-a61d-ea41db8942c8" xlink:href="icui-20220630.xsd#icui_GovernmentGrantRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e0cadbe8-88bb-4b06-90d6-3dfd101e2015" xlink:to="loc_icui_GovernmentGrantRevenueMember_4d4ebd12-9ff5-4cba-a61d-ea41db8942c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherDeferredRevenueMember_14221855-7951-48fd-a950-93c1a97f72dd" xlink:href="icui-20220630.xsd#icui_OtherDeferredRevenueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e0cadbe8-88bb-4b06-90d6-3dfd101e2015" xlink:to="loc_icui_OtherDeferredRevenueMember_14221855-7951-48fd-a950-93c1a97f72dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_98a66f02-0063-437b-a695-6fc9f6480530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_ce0c05a2-b94a-413f-90a4-f8380ca24873" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_98a66f02-0063-437b-a695-6fc9f6480530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81ab58ee-434d-41cb-b399-5cc518e6ebf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_98a66f02-0063-437b-a695-6fc9f6480530" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81ab58ee-434d-41cb-b399-5cc518e6ebf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_2ebfd83e-b314-445b-b329-a0dfd41e0d95" xlink:href="icui-20220630.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81ab58ee-434d-41cb-b399-5cc518e6ebf9" xlink:to="loc_icui_SmithsMedicalMember_2ebfd83e-b314-445b-b329-a0dfd41e0d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_1b35f211-ef58-460b-9c5b-c07271e1430a" xlink:href="icui-20220630.xsd#icui_TimingAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_ce0c05a2-b94a-413f-90a4-f8380ca24873" xlink:to="loc_icui_TimingAxis_1b35f211-ef58-460b-9c5b-c07271e1430a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_f4117485-5e2f-4afa-aa3a-c38f44138c28" xlink:href="icui-20220630.xsd#icui_TimingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingAxis_1b35f211-ef58-460b-9c5b-c07271e1430a" xlink:to="loc_icui_TimingDomain_f4117485-5e2f-4afa-aa3a-c38f44138c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermMember_de069813-1018-4899-a504-fd34ee0ae8b3" xlink:href="icui-20220630.xsd#icui_ShortTermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingDomain_f4117485-5e2f-4afa-aa3a-c38f44138c28" xlink:to="loc_icui_ShortTermMember_de069813-1018-4899-a504-fd34ee0ae8b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermMember_3fe2decf-85af-47f7-8f8c-4194109dea6f" xlink:href="icui-20220630.xsd#icui_LongTermMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingDomain_f4117485-5e2f-4afa-aa3a-c38f44138c28" xlink:to="loc_icui_LongTermMember_3fe2decf-85af-47f7-8f8c-4194109dea6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesLineItems_f9137b00-2541-4636-a4c2-4c10ba1091a1" xlink:href="icui-20220630.xsd#icui_ContractassetandliabilitybalancesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_ce0c05a2-b94a-413f-90a4-f8380ca24873" xlink:to="loc_icui_ContractassetandliabilitybalancesLineItems_f9137b00-2541-4636-a4c2-4c10ba1091a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInDeferredRevenueRollForward_e3be2bf7-ab0a-4bf8-ae5b-3139366ef1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInDeferredRevenueRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_f9137b00-2541-4636-a4c2-4c10ba1091a1" xlink:to="loc_us-gaap_MovementInDeferredRevenueRollForward_e3be2bf7-ab0a-4bf8-ae5b-3139366ef1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_7dc18ce7-2f54-4241-978a-f10c3c674d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_f9137b00-2541-4636-a4c2-4c10ba1091a1" xlink:to="loc_us-gaap_ContractWithCustomerLiability_7dc18ce7-2f54-4241-978a-f10c3c674d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_2dc04c48-c5f3-4be2-82c3-2e9203fbc92a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_f9137b00-2541-4636-a4c2-4c10ba1091a1" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_2dc04c48-c5f3-4be2-82c3-2e9203fbc92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueAdditions_38edb890-978f-4792-b98f-82cad2b87a81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueAdditions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_f9137b00-2541-4636-a4c2-4c10ba1091a1" xlink:to="loc_us-gaap_DeferredRevenueAdditions_38edb890-978f-4792-b98f-82cad2b87a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_31283669-c0c5-443d-b1b1-5505b31da2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_f9137b00-2541-4636-a4c2-4c10ba1091a1" xlink:to="loc_us-gaap_ContractWithCustomerLiability_31283669-c0c5-443d-b1b1-5505b31da2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_98213d09-9ef5-4b16-b8a7-94a03d8b57e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_f9137b00-2541-4636-a4c2-4c10ba1091a1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_98213d09-9ef5-4b16-b8a7-94a03d8b57e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesNotes" xlink:type="simple" xlink:href="icui-20220630.xsd#LeasesNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0d9ed3a3-2c06-46a3-866e-ecfa80c96b75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_57efb861-96a3-471b-9c6a-090401158fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0d9ed3a3-2c06-46a3-866e-ecfa80c96b75" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_57efb861-96a3-471b-9c6a-090401158fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesTables" xlink:type="simple" xlink:href="icui-20220630.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0d8eea39-0230-4bce-87e0-2aef919c70f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_50837c16-2ac5-4279-b140-82bcac654e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0d8eea39-0230-4bce-87e0-2aef919c70f1" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_50837c16-2ac5-4279-b140-82bcac654e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_4a4566f7-3019-45f2-99a5-dd1f234fe6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0d8eea39-0230-4bce-87e0-2aef919c70f1" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_4a4566f7-3019-45f2-99a5-dd1f234fe6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AssetsandLiabilitiesLeasesTableTextBlock_d04379f6-b686-46d2-8397-6374fe08a80b" xlink:href="icui-20220630.xsd#icui_AssetsandLiabilitiesLeasesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0d8eea39-0230-4bce-87e0-2aef919c70f1" xlink:to="loc_icui_AssetsandLiabilitiesLeasesTableTextBlock_d04379f6-b686-46d2-8397-6374fe08a80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_d1b3e425-2631-4042-9b25-67aa34fc083d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0d8eea39-0230-4bce-87e0-2aef919c70f1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_d1b3e425-2631-4042-9b25-67aa34fc083d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesTextDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#LeasesTextDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesTextDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_abcd9142-5615-47cf-a72d-178051a08f72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_c00b6d49-90d5-481a-a34c-66a935629937" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_abcd9142-5615-47cf-a72d-178051a08f72" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_c00b6d49-90d5-481a-a34c-66a935629937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e0db06e9-6193-4b5c-8c59-2150cb7cd3b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c00b6d49-90d5-481a-a34c-66a935629937" xlink:to="loc_srt_RangeAxis_e0db06e9-6193-4b5c-8c59-2150cb7cd3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fd72ff22-545c-46dc-9ffe-fde59355351b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e0db06e9-6193-4b5c-8c59-2150cb7cd3b2" xlink:to="loc_srt_RangeMember_fd72ff22-545c-46dc-9ffe-fde59355351b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9fff9dde-5ceb-4fae-8b2b-fd4cc7c15571" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fd72ff22-545c-46dc-9ffe-fde59355351b" xlink:to="loc_srt_MaximumMember_9fff9dde-5ceb-4fae-8b2b-fd4cc7c15571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_74864462-cd7c-4862-ad27-de118e21f863" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fd72ff22-545c-46dc-9ffe-fde59355351b" xlink:to="loc_srt_MinimumMember_74864462-cd7c-4862-ad27-de118e21f863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_7d8dfa0b-e437-41f9-8961-7cbb9dc1b0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c00b6d49-90d5-481a-a34c-66a935629937" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_7d8dfa0b-e437-41f9-8961-7cbb9dc1b0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Optiontoextendinyears_35e9d0d9-e778-402a-9879-625cd0f5477d" xlink:href="icui-20220630.xsd#icui_Optiontoextendinyears"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7d8dfa0b-e437-41f9-8961-7cbb9dc1b0cf" xlink:to="loc_icui_Optiontoextendinyears_35e9d0d9-e778-402a-9879-625cd0f5477d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ed96ca93-9327-4eaa-a7d0-ed60bf520923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7d8dfa0b-e437-41f9-8961-7cbb9dc1b0cf" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ed96ca93-9327-4eaa-a7d0-ed60bf520923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#LeasesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_887b943b-8ad9-422d-a559-20f8562455f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_3b1d6f7c-c456-45be-b408-56264732aa8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_887b943b-8ad9-422d-a559-20f8562455f8" xlink:to="loc_us-gaap_OperatingLeaseCost_3b1d6f7c-c456-45be-b408-56264732aa8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_2dfae482-6fcb-4351-8f5e-02c28fa5a7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_887b943b-8ad9-422d-a559-20f8562455f8" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_2dfae482-6fcb-4351-8f5e-02c28fa5a7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_75f70926-5aa2-4fac-8a7e-940f76fcf469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_887b943b-8ad9-422d-a559-20f8562455f8" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_75f70926-5aa2-4fac-8a7e-940f76fcf469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_2f7c9f3f-72d7-4814-aace-a3f1dce08baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_887b943b-8ad9-422d-a559-20f8562455f8" xlink:to="loc_us-gaap_ShortTermLeaseCost_2f7c9f3f-72d7-4814-aace-a3f1dce08baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_e6c95cb5-5544-42fa-a830-0ec9e0d5a5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_887b943b-8ad9-422d-a559-20f8562455f8" xlink:to="loc_us-gaap_LeaseCost_e6c95cb5-5544-42fa-a830-0ec9e0d5a5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#LeasesCashFlowOperatingActivitiesLesseeDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b80057f4-a48f-435f-90e7-bc76e4625341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_99d04109-bd90-4d9b-912d-0cf932cba114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b80057f4-a48f-435f-90e7-bc76e4625341" xlink:to="loc_us-gaap_OperatingLeasePayments_99d04109-bd90-4d9b-912d-0cf932cba114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_230cc123-5a31-43d8-a0c2-c35014b76575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b80057f4-a48f-435f-90e7-bc76e4625341" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_230cc123-5a31-43d8-a0c2-c35014b76575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_57dfd27d-4587-4310-a258-88113767710e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b80057f4-a48f-435f-90e7-bc76e4625341" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_57dfd27d-4587-4310-a258-88113767710e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_7edc4582-76cd-4813-bc5c-2096df793c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b80057f4-a48f-435f-90e7-bc76e4625341" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_7edc4582-76cd-4813-bc5c-2096df793c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#LeasesAssetsandLiabilitiesLesseeDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b2300069-9e1d-4930-9741-dc035cadde0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_02a8d0a3-dcc8-4b76-a063-eda71b8debde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b2300069-9e1d-4930-9741-dc035cadde0e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_02a8d0a3-dcc8-4b76-a063-eda71b8debde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8c28bbfe-9e96-458b-a53c-5b24c6a6cd47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b2300069-9e1d-4930-9741-dc035cadde0e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8c28bbfe-9e96-458b-a53c-5b24c6a6cd47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f2f3cf7e-851f-4daa-a22b-6a68c37c2c36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b2300069-9e1d-4930-9741-dc035cadde0e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f2f3cf7e-851f-4daa-a22b-6a68c37c2c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_5b61a6be-f993-4d60-95f6-c5059847acbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b2300069-9e1d-4930-9741-dc035cadde0e" xlink:to="loc_us-gaap_OperatingLeaseLiability_5b61a6be-f993-4d60-95f6-c5059847acbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d76e753a-d93c-4768-a9fe-4d303e8511b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b2300069-9e1d-4930-9741-dc035cadde0e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d76e753a-d93c-4768-a9fe-4d303e8511b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_45ebe6c4-d631-489d-9a75-ebc5ed910e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b2300069-9e1d-4930-9741-dc035cadde0e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_45ebe6c4-d631-489d-9a75-ebc5ed910e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_297008ab-0c95-4f22-867e-9af1aa81384a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b2300069-9e1d-4930-9741-dc035cadde0e" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_297008ab-0c95-4f22-867e-9af1aa81384a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_b0a4b666-a5ed-49b5-adf3-f32a8d9f62cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b2300069-9e1d-4930-9741-dc035cadde0e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_b0a4b666-a5ed-49b5-adf3-f32a8d9f62cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c73316c3-c2d4-422b-a11f-813fd1a7f52e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b2300069-9e1d-4930-9741-dc035cadde0e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c73316c3-c2d4-422b-a11f-813fd1a7f52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_ff8757f5-841f-4b19-9703-8b0e47104aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b2300069-9e1d-4930-9741-dc035cadde0e" xlink:to="loc_us-gaap_FinanceLeaseLiability_ff8757f5-841f-4b19-9703-8b0e47104aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_22988686-b649-428d-9e66-8e21eeeab4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b2300069-9e1d-4930-9741-dc035cadde0e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_22988686-b649-428d-9e66-8e21eeeab4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_2b5fe39d-2581-4ae1-9e8b-65a758207257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b2300069-9e1d-4930-9741-dc035cadde0e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_2b5fe39d-2581-4ae1-9e8b-65a758207257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesMaturityDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#LeasesMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_f7530b87-a94b-4731-b142-f79c97cda09d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_f7530b87-a94b-4731-b142-f79c97cda09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_25c1b7af-4578-4532-869c-54d3924b91ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_25c1b7af-4578-4532-869c-54d3924b91ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_4d905f89-cbe8-42c1-802e-0b55ecd57e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_4d905f89-cbe8-42c1-802e-0b55ecd57e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6f7f6d94-88da-490d-9fec-bff62a1ccca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6f7f6d94-88da-490d-9fec-bff62a1ccca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4683385b-603b-4b8c-8829-68ab2450a85c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4683385b-603b-4b8c-8829-68ab2450a85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_907674d9-c751-4f3d-a6ff-d27c1a409038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_907674d9-c751-4f3d-a6ff-d27c1a409038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9d1d5aa0-ad4b-4ea5-86a5-69b6aa941ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9d1d5aa0-ad4b-4ea5-86a5-69b6aa941ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2bdf4bcb-9f3e-436d-a6aa-f148ea3c2e43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2bdf4bcb-9f3e-436d-a6aa-f148ea3c2e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_002db9c8-45c8-4002-8003-e0d4c5047ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_002db9c8-45c8-4002-8003-e0d4c5047ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_91808f9e-dabc-4f0e-9973-8a9e14d8d2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_OperatingLeaseLiability_91808f9e-dabc-4f0e-9973-8a9e14d8d2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_e9f651d5-edcc-42b3-a164-09e4549e7729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_e9f651d5-edcc-42b3-a164-09e4549e7729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2c616d83-6357-46ef-9ff2-2adbcf5057ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2c616d83-6357-46ef-9ff2-2adbcf5057ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3a31084d-9d03-4fa8-8b3b-1a83c228f8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3a31084d-9d03-4fa8-8b3b-1a83c228f8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_7acb84bd-c47a-4007-8d88-797cdcba69e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_7acb84bd-c47a-4007-8d88-797cdcba69e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_d66d6eeb-4c7a-4c91-83a8-6d20d3cbc4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_d66d6eeb-4c7a-4c91-83a8-6d20d3cbc4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_7b41c792-d8c3-4c37-931e-3a7e2664aa5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_7b41c792-d8c3-4c37-931e-3a7e2664aa5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_24c86d73-8035-4603-86a8-3484216caaf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_24c86d73-8035-4603-86a8-3484216caaf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_4e3dd396-5ba1-421a-8bae-40a21e10cf18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_4e3dd396-5ba1-421a-8bae-40a21e10cf18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c0afd460-1a16-4f58-a41c-06eae9fabf7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c0afd460-1a16-4f58-a41c-06eae9fabf7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_2972c71e-3ab7-4680-b90b-c22c84dd9d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7b88960-0585-467c-a405-6573e416f9b7" xlink:to="loc_us-gaap_FinanceLeaseLiability_2972c71e-3ab7-4680-b90b-c22c84dd9d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="icui-20220630.xsd#NetIncomePerShare"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NetIncomePerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_21602504-723f-44ab-bd42-bd060cebbece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_b28e9c33-3ae9-4c58-9f30-4feac525ae4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_21602504-723f-44ab-bd42-bd060cebbece" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_b28e9c33-3ae9-4c58-9f30-4feac525ae4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="icui-20220630.xsd#NetIncomePerShareTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NetIncomePerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3586e46f-8b5b-4195-a93f-24856e44bddd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7dfc8270-6b09-49c2-bf75-457821f81026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3586e46f-8b5b-4195-a93f-24856e44bddd" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7dfc8270-6b09-49c2-bf75-457821f81026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#NetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f135094b-5284-4042-8d67-643b1049680b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2b72e5f7-9f4c-4a3b-a49f-2e2e3279016b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f135094b-5284-4042-8d67-643b1049680b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2b72e5f7-9f4c-4a3b-a49f-2e2e3279016b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ca8b790b-3a4f-4fe9-afe6-2e740b7e71e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2b72e5f7-9f4c-4a3b-a49f-2e2e3279016b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ca8b790b-3a4f-4fe9-afe6-2e740b7e71e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ef38bb0-92e2-4866-8572-fa8969d36982" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ca8b790b-3a4f-4fe9-afe6-2e740b7e71e2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ef38bb0-92e2-4866-8572-fa8969d36982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2b72e5f7-9f4c-4a3b-a49f-2e2e3279016b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_18a4ebfc-bf4c-44b7-b9e8-87ec117ac1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_18a4ebfc-bf4c-44b7-b9e8-87ec117ac1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_16180e04-e080-40b3-9785-9baf0ece21ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:to="loc_us-gaap_ProfitLoss_16180e04-e080-40b3-9785-9baf0ece21ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_667b57fe-9ba6-4f95-9a77-4e64770269cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_667b57fe-9ba6-4f95-9a77-4e64770269cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_493284af-ef4c-4f3a-9308-66e7b453d803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_493284af-ef4c-4f3a-9308-66e7b453d803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f8084b28-407b-485d-9681-34112694d4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f8084b28-407b-485d-9681-34112694d4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_74271e03-16fe-4df6-ae72-67668af04074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:to="loc_us-gaap_EarningsPerShareBasic_74271e03-16fe-4df6-ae72-67668af04074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6da81129-cd4d-487d-862f-5512cc4277a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f91592a0-1b17-47ea-b6d1-d01fa6564c42" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6da81129-cd4d-487d-862f-5512cc4277a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NetIncomePerShareDetails1" xlink:type="simple" xlink:href="icui-20220630.xsd#NetIncomePerShareDetails1"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NetIncomePerShareDetails1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_27ede0ae-7409-4f4f-98de-a6a91c0cb08b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_01c97e0d-1cb6-4193-80b0-bbee88352ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_27ede0ae-7409-4f4f-98de-a6a91c0cb08b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_01c97e0d-1cb6-4193-80b0-bbee88352ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6cfe48b4-544a-4830-820c-891716ec58e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_27ede0ae-7409-4f4f-98de-a6a91c0cb08b" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6cfe48b4-544a-4830-820c-891716ec58e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5b8e685f-a5ed-44a0-94e5-ef7816c88c57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_27ede0ae-7409-4f4f-98de-a6a91c0cb08b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5b8e685f-a5ed-44a0-94e5-ef7816c88c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_59998d94-548e-4356-ac0b-7541b173c6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_27ede0ae-7409-4f4f-98de-a6a91c0cb08b" xlink:to="loc_us-gaap_EarningsPerShareBasic_59998d94-548e-4356-ac0b-7541b173c6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_cea500ee-b5de-441f-8f29-70e5c7081bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_27ede0ae-7409-4f4f-98de-a6a91c0cb08b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_cea500ee-b5de-441f-8f29-70e5c7081bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes" xlink:type="simple" xlink:href="icui-20220630.xsd#DerivativeFinancialInstrumentsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3a8b0a43-1e38-4707-ba96-995abb807515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_40e787f6-2e8b-4858-8309-8daf00f84986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3a8b0a43-1e38-4707-ba96-995abb807515" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_40e787f6-2e8b-4858-8309-8daf00f84986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="icui-20220630.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fd3db4fd-d691-40e3-830e-0a4cf21bf064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_c6604df9-f530-41f6-a4c9-541a0c52b7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fd3db4fd-d691-40e3-830e-0a4cf21bf064" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_c6604df9-f530-41f6-a4c9-541a0c52b7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f96a8fc0-5b11-43df-bd1b-baa328417cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fd3db4fd-d691-40e3-830e-0a4cf21bf064" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f96a8fc0-5b11-43df-bd1b-baa328417cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d97a8738-b846-4d9c-9600-56f1562be01b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_fa0519dc-e4d3-4679-af9e-3a3558cf077e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d97a8738-b846-4d9c-9600-56f1562be01b" xlink:to="loc_us-gaap_DerivativeTable_fa0519dc-e4d3-4679-af9e-3a3558cf077e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_61b78cf2-fda4-402c-8eb5-6bfb5f365a77" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fa0519dc-e4d3-4679-af9e-3a3558cf077e" xlink:to="loc_srt_CurrencyAxis_61b78cf2-fda4-402c-8eb5-6bfb5f365a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_98c5ebb1-1d72-49bd-8942-51a829d2a5ae" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_61b78cf2-fda4-402c-8eb5-6bfb5f365a77" xlink:to="loc_currency_AllCurrenciesDomain_98c5ebb1-1d72-49bd-8942-51a829d2a5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN_e447d763-c700-4698-adf9-faf63952a8b7" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_MXN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_98c5ebb1-1d72-49bd-8942-51a829d2a5ae" xlink:to="loc_currency_MXN_e447d763-c700-4698-adf9-faf63952a8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_e69417a1-cf33-4e3b-a01b-89f61279b665" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_98c5ebb1-1d72-49bd-8942-51a829d2a5ae" xlink:to="loc_currency_EUR_e69417a1-cf33-4e3b-a01b-89f61279b665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CZK_32c4a0eb-e51b-4678-8f14-6c0b37755df7" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CZK"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_98c5ebb1-1d72-49bd-8942-51a829d2a5ae" xlink:to="loc_currency_CZK_32c4a0eb-e51b-4678-8f14-6c0b37755df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_b51ac00d-e956-4a9a-a2cf-cf4c4a4cc945" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_JPY"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_98c5ebb1-1d72-49bd-8942-51a829d2a5ae" xlink:to="loc_currency_JPY_b51ac00d-e956-4a9a-a2cf-cf4c4a4cc945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisAxis_2502d45f-a2a7-426c-8b77-ce72493700fe" xlink:href="icui-20220630.xsd#icui_Srt_MultipleCurrencyAxisAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fa0519dc-e4d3-4679-af9e-3a3558cf077e" xlink:to="loc_icui_Srt_MultipleCurrencyAxisAxis_2502d45f-a2a7-426c-8b77-ce72493700fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisDomain_19e742c0-e427-45a7-9288-8d350788f4ba" xlink:href="icui-20220630.xsd#icui_Srt_MultipleCurrencyAxisDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_Srt_MultipleCurrencyAxisAxis_2502d45f-a2a7-426c-8b77-ce72493700fe" xlink:to="loc_icui_Srt_MultipleCurrencyAxisDomain_19e742c0-e427-45a7-9288-8d350788f4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherCurrenciesMember_5fd08226-5d80-458c-b1aa-2e30ead34f59" xlink:href="icui-20220630.xsd#icui_OtherCurrenciesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_Srt_MultipleCurrencyAxisDomain_19e742c0-e427-45a7-9288-8d350788f4ba" xlink:to="loc_icui_OtherCurrenciesMember_5fd08226-5d80-458c-b1aa-2e30ead34f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e533d961-c90f-4b60-a992-87faaa4a4ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fa0519dc-e4d3-4679-af9e-3a3558cf077e" xlink:to="loc_us-gaap_DerivativeLineItems_e533d961-c90f-4b60-a992-87faaa4a4ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_560190e2-8d47-4736-81dd-5daa92aa28f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e533d961-c90f-4b60-a992-87faaa4a4ab4" xlink:to="loc_us-gaap_DerivativeNotionalAmount_560190e2-8d47-4736-81dd-5daa92aa28f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#DerivativeFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ca545b83-c61f-4e2a-9d45-d6730ebf98ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_11cab3eb-b77c-402d-a1d9-e74f8e0ff427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ca545b83-c61f-4e2a-9d45-d6730ebf98ef" xlink:to="loc_us-gaap_DerivativeTable_11cab3eb-b77c-402d-a1d9-e74f8e0ff427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3bcfa680-b32d-40bc-b19b-5013bcfc3ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_11cab3eb-b77c-402d-a1d9-e74f8e0ff427" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3bcfa680-b32d-40bc-b19b-5013bcfc3ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_156f45c5-7203-4be9-a861-8f1f3d4f3c30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3bcfa680-b32d-40bc-b19b-5013bcfc3ed5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_156f45c5-7203-4be9-a861-8f1f3d4f3c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge2Member_b091dd57-0c99-4dcd-8825-575e1307bddf" xlink:href="icui-20220630.xsd#icui_Hedge2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_156f45c5-7203-4be9-a861-8f1f3d4f3c30" xlink:to="loc_icui_Hedge2Member_b091dd57-0c99-4dcd-8825-575e1307bddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge3MemberMember_2607b3d1-49e1-45f7-9674-abe4a00ef79d" xlink:href="icui-20220630.xsd#icui_Hedge3MemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_156f45c5-7203-4be9-a861-8f1f3d4f3c30" xlink:to="loc_icui_Hedge3MemberMember_2607b3d1-49e1-45f7-9674-abe4a00ef79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_937e2ba4-9650-4e31-a17f-5997500ee231" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_11cab3eb-b77c-402d-a1d9-e74f8e0ff427" xlink:to="loc_srt_CurrencyAxis_937e2ba4-9650-4e31-a17f-5997500ee231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_e4787339-1995-4c28-9d79-c2eb7fbcc94e" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_937e2ba4-9650-4e31-a17f-5997500ee231" xlink:to="loc_currency_AllCurrenciesDomain_e4787339-1995-4c28-9d79-c2eb7fbcc94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN_b0dbc487-d872-416a-9940-c248ee01b56d" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_MXN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_e4787339-1995-4c28-9d79-c2eb7fbcc94e" xlink:to="loc_currency_MXN_b0dbc487-d872-416a-9940-c248ee01b56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY_a09439c1-9dd1-46f5-adc6-09aeed2b4f31" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CNY"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_e4787339-1995-4c28-9d79-c2eb7fbcc94e" xlink:to="loc_currency_CNY_a09439c1-9dd1-46f5-adc6-09aeed2b4f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_64a2d4b2-ad32-45f9-a7f0-fda9db5542b7" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_e4787339-1995-4c28-9d79-c2eb7fbcc94e" xlink:to="loc_currency_USD_64a2d4b2-ad32-45f9-a7f0-fda9db5542b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_98ffcb48-57df-433f-89ed-ec8401967427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_11cab3eb-b77c-402d-a1d9-e74f8e0ff427" xlink:to="loc_us-gaap_DerivativeLineItems_98ffcb48-57df-433f-89ed-ec8401967427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeForwardExchangeRate1_90d88060-e7cd-48cd-a0c9-af0292c34d98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeForwardExchangeRate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_98ffcb48-57df-433f-89ed-ec8401967427" xlink:to="loc_us-gaap_DerivativeForwardExchangeRate1_90d88060-e7cd-48cd-a0c9-af0292c34d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_0f296163-af2d-4caf-ae55-d9086fff35e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_98ffcb48-57df-433f-89ed-ec8401967427" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_0f296163-af2d-4caf-ae55-d9086fff35e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_04d9eff6-2414-405d-80a9-a4328300b39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_98ffcb48-57df-433f-89ed-ec8401967427" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_04d9eff6-2414-405d-80a9-a4328300b39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a1eb5234-67b4-4dfe-a29a-b446ddd0a41c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_98ffcb48-57df-433f-89ed-ec8401967427" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a1eb5234-67b4-4dfe-a29a-b446ddd0a41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#DerivativeFinancialInstrumentsInterestRateSwapsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_dd636a8f-31fb-4b42-9792-afa7134830e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_a3cde0e2-6162-42a1-8124-c3de23707eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_dd636a8f-31fb-4b42-9792-afa7134830e5" xlink:to="loc_us-gaap_DerivativeTable_a3cde0e2-6162-42a1-8124-c3de23707eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f93212f4-7984-4eb5-826b-0447995e8d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_a3cde0e2-6162-42a1-8124-c3de23707eaa" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f93212f4-7984-4eb5-826b-0447995e8d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c25ec7b5-aad8-49f2-ab29-c0ff41f337dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f93212f4-7984-4eb5-826b-0447995e8d2b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c25ec7b5-aad8-49f2-ab29-c0ff41f337dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_77e616f7-f7fb-4d66-8892-c3fb7c39fdfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c25ec7b5-aad8-49f2-ab29-c0ff41f337dd" xlink:to="loc_us-gaap_InterestRateSwapMember_77e616f7-f7fb-4d66-8892-c3fb7c39fdfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_5db057a1-978c-4f01-a9ac-c56fac906135" xlink:href="icui-20220630.xsd#icui_TermLoanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_a3cde0e2-6162-42a1-8124-c3de23707eaa" xlink:to="loc_icui_TermLoanAxis_5db057a1-978c-4f01-a9ac-c56fac906135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_5f408903-6617-46d2-924a-24155bcbc651" xlink:href="icui-20220630.xsd#icui_TermLoanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAxis_5db057a1-978c-4f01-a9ac-c56fac906135" xlink:to="loc_icui_TermLoanDomain_5f408903-6617-46d2-924a-24155bcbc651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_d4b19d3b-b85a-438d-b66b-02a25c459866" xlink:href="icui-20220630.xsd#icui_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_5f408903-6617-46d2-924a-24155bcbc651" xlink:to="loc_icui_TermLoanAMember_d4b19d3b-b85a-438d-b66b-02a25c459866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_352f0e6f-1155-470d-a8c0-93767bcca759" xlink:href="icui-20220630.xsd#icui_TermLoanBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_5f408903-6617-46d2-924a-24155bcbc651" xlink:to="loc_icui_TermLoanBMember_352f0e6f-1155-470d-a8c0-93767bcca759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_7abffde0-fc3b-425d-b29c-2793b26c3e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_a3cde0e2-6162-42a1-8124-c3de23707eaa" xlink:to="loc_us-gaap_DerivativeLineItems_7abffde0-fc3b-425d-b29c-2793b26c3e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_9fd2fa9b-fc86-4ae7-84ad-1623ad949acf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_7abffde0-fc3b-425d-b29c-2793b26c3e16" xlink:to="loc_us-gaap_DerivativeNotionalAmount_9fd2fa9b-fc86-4ae7-84ad-1623ad949acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestRateSwapEndingNotionalValue_53fdcdda-7f04-409b-a5fb-231b0aaa8e53" xlink:href="icui-20220630.xsd#icui_InterestRateSwapEndingNotionalValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_7abffde0-fc3b-425d-b29c-2793b26c3e16" xlink:to="loc_icui_InterestRateSwapEndingNotionalValue_53fdcdda-7f04-409b-a5fb-231b0aaa8e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_dc7f4366-7756-4ee5-9497-0d8a1f017271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_7abffde0-fc3b-425d-b29c-2793b26c3e16" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_dc7f4366-7756-4ee5-9497-0d8a1f017271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DerivativeVariableRateFloor_8fa65635-62ce-449e-838c-01ac0f806051" xlink:href="icui-20220630.xsd#icui_DerivativeVariableRateFloor"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_7abffde0-fc3b-425d-b29c-2793b26c3e16" xlink:to="loc_icui_DerivativeVariableRateFloor_8fa65635-62ce-449e-838c-01ac0f806051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a21760bd-3291-4350-9474-fdaec14befcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d60c7623-0be0-48bd-a514-6d0b32455af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a21760bd-3291-4350-9474-fdaec14befcc" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d60c7623-0be0-48bd-a514-6d0b32455af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b4faad45-3d5f-43ab-b4c4-c62c70e81123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d60c7623-0be0-48bd-a514-6d0b32455af5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b4faad45-3d5f-43ab-b4c4-c62c70e81123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7b7eb75e-3497-4cb4-b523-75d98c00d1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b4faad45-3d5f-43ab-b4c4-c62c70e81123" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7b7eb75e-3497-4cb4-b523-75d98c00d1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_5ae62477-2163-4e06-bb96-54234d111934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7b7eb75e-3497-4cb4-b523-75d98c00d1b9" xlink:to="loc_us-gaap_ForeignExchangeContractMember_5ae62477-2163-4e06-bb96-54234d111934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ab785f80-a106-473a-9dc2-75f5f479a0da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7b7eb75e-3497-4cb4-b523-75d98c00d1b9" xlink:to="loc_us-gaap_InterestRateSwapMember_ab785f80-a106-473a-9dc2-75f5f479a0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7260fdc8-4f97-44cf-bde8-efc45997c05e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d60c7623-0be0-48bd-a514-6d0b32455af5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7260fdc8-4f97-44cf-bde8-efc45997c05e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_19f47772-f426-42b8-802b-4c80df340757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7260fdc8-4f97-44cf-bde8-efc45997c05e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_19f47772-f426-42b8-802b-4c80df340757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_27c7b656-bbcc-4f73-9c3d-3de107ea630f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_19f47772-f426-42b8-802b-4c80df340757" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_27c7b656-bbcc-4f73-9c3d-3de107ea630f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_569386a5-88f3-4258-8017-c5caa560853a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_19f47772-f426-42b8-802b-4c80df340757" xlink:to="loc_us-gaap_OtherAssetsMember_569386a5-88f3-4258-8017-c5caa560853a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_c952109e-369a-4c87-b49a-bec314bb4eef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_19f47772-f426-42b8-802b-4c80df340757" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_c952109e-369a-4c87-b49a-bec314bb4eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_ce740da3-bb38-4d47-b657-3d5a0ca4ac3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_19f47772-f426-42b8-802b-4c80df340757" xlink:to="loc_us-gaap_OtherLiabilitiesMember_ce740da3-bb38-4d47-b657-3d5a0ca4ac3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b7226c09-3305-45e7-b0c5-039dcc027557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d60c7623-0be0-48bd-a514-6d0b32455af5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b7226c09-3305-45e7-b0c5-039dcc027557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2e69f9e1-9aa3-4b69-bd5c-7d2088ec564b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b7226c09-3305-45e7-b0c5-039dcc027557" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2e69f9e1-9aa3-4b69-bd5c-7d2088ec564b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_ef5126b5-d188-4800-a745-ede7b518abe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d60c7623-0be0-48bd-a514-6d0b32455af5" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_ef5126b5-d188-4800-a745-ede7b518abe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_82303b03-5319-4fe7-b4dc-c92f8fb0e38d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ef5126b5-d188-4800-a745-ede7b518abe4" xlink:to="loc_us-gaap_DerivativeAssets_82303b03-5319-4fe7-b4dc-c92f8fb0e38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_d8cce746-5501-42f7-9783-b2300122e226" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ef5126b5-d188-4800-a745-ede7b518abe4" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_d8cce746-5501-42f7-9783-b2300122e226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_fe13be09-fd3a-42ac-8d81-d70e6c9acaee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ef5126b5-d188-4800-a745-ede7b518abe4" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_fe13be09-fd3a-42ac-8d81-d70e6c9acaee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_de89a182-31af-4732-9ce5-16287208ef02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ef5126b5-d188-4800-a745-ede7b518abe4" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_de89a182-31af-4732-9ce5-16287208ef02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_d9b0d769-d70c-4294-b46b-bd3b3c4b6673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ef5126b5-d188-4800-a745-ede7b518abe4" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_d9b0d769-d70c-4294-b46b-bd3b3c4b6673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_4a5bc46c-2645-4051-b6d4-d73700aba068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ef5126b5-d188-4800-a745-ede7b518abe4" xlink:to="loc_us-gaap_DerivativeLiabilities_4a5bc46c-2645-4051-b6d4-d73700aba068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7a6d6dd6-2dac-49e7-8abd-d8028af609c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a0c86202-560d-4069-a341-8474932056d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7a6d6dd6-2dac-49e7-8abd-d8028af609c8" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a0c86202-560d-4069-a341-8474932056d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9a069e93-14ba-4268-8270-a757b874db23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a0c86202-560d-4069-a341-8474932056d8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9a069e93-14ba-4268-8270-a757b874db23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a9e90dfc-994d-487f-9829-50db5a59a104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9a069e93-14ba-4268-8270-a757b874db23" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a9e90dfc-994d-487f-9829-50db5a59a104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_205e240b-efa3-42ee-8404-ea1e433cdbc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a9e90dfc-994d-487f-9829-50db5a59a104" xlink:to="loc_us-gaap_ForeignExchangeContractMember_205e240b-efa3-42ee-8404-ea1e433cdbc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_17ebc37b-54d9-4b94-a64e-32f477a2c17b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a9e90dfc-994d-487f-9829-50db5a59a104" xlink:to="loc_us-gaap_InterestRateSwapMember_17ebc37b-54d9-4b94-a64e-32f477a2c17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_189caa7b-d50d-4a54-bc79-edebbc550d94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a0c86202-560d-4069-a341-8474932056d8" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_189caa7b-d50d-4a54-bc79-edebbc550d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_a42e4e31-cc4b-465d-8073-82cc65dcec63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_189caa7b-d50d-4a54-bc79-edebbc550d94" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_a42e4e31-cc4b-465d-8073-82cc65dcec63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_024f8570-20cd-47b8-ba44-d12968bb7a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ef690c86-1a0f-4bdd-aba3-49e6d19e335d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_024f8570-20cd-47b8-ba44-d12968bb7a53" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ef690c86-1a0f-4bdd-aba3-49e6d19e335d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f8283c17-71bc-49ff-a993-5c010fd2b53f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ef690c86-1a0f-4bdd-aba3-49e6d19e335d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f8283c17-71bc-49ff-a993-5c010fd2b53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4a6fe299-c6f9-453b-a4fb-076035f88570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f8283c17-71bc-49ff-a993-5c010fd2b53f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4a6fe299-c6f9-453b-a4fb-076035f88570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_75b1fe8d-b2b4-4548-a739-b955ef3269ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a6fe299-c6f9-453b-a4fb-076035f88570" xlink:to="loc_us-gaap_ForeignExchangeContractMember_75b1fe8d-b2b4-4548-a739-b955ef3269ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8dea3de1-e74a-4efa-aec6-cd46e05250a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a6fe299-c6f9-453b-a4fb-076035f88570" xlink:to="loc_us-gaap_InterestRateSwapMember_8dea3de1-e74a-4efa-aec6-cd46e05250a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_489a8ad6-b6e9-48ca-b5ab-c563a0b9d35a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ef690c86-1a0f-4bdd-aba3-49e6d19e335d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_489a8ad6-b6e9-48ca-b5ab-c563a0b9d35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f274fc2b-30c6-432b-a052-e74259f69218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_489a8ad6-b6e9-48ca-b5ab-c563a0b9d35a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f274fc2b-30c6-432b-a052-e74259f69218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingRevenueMember_1df77f23-cc05-4988-8f68-4abad68d55b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f274fc2b-30c6-432b-a052-e74259f69218" xlink:to="loc_us-gaap_TradingRevenueMember_1df77f23-cc05-4988-8f68-4abad68d55b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_7867af4d-3099-405c-935a-e4d275895edc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f274fc2b-30c6-432b-a052-e74259f69218" xlink:to="loc_us-gaap_CostOfSalesMember_7867af4d-3099-405c-935a-e4d275895edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_ea400e55-a7ba-49fc-be6c-b149dc9f2975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f274fc2b-30c6-432b-a052-e74259f69218" xlink:to="loc_us-gaap_InterestExpenseMember_ea400e55-a7ba-49fc-be6c-b149dc9f2975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f9618053-0115-4a16-bc65-3551ac42843b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ef690c86-1a0f-4bdd-aba3-49e6d19e335d" xlink:to="loc_us-gaap_HedgingDesignationAxis_f9618053-0115-4a16-bc65-3551ac42843b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_eca8273d-6005-4ed8-a065-b0debcb0f850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_f9618053-0115-4a16-bc65-3551ac42843b" xlink:to="loc_us-gaap_HedgingDesignationDomain_eca8273d-6005-4ed8-a065-b0debcb0f850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3e01483f-6464-417a-bf06-0cc837e67fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ef690c86-1a0f-4bdd-aba3-49e6d19e335d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3e01483f-6464-417a-bf06-0cc837e67fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f346b1bf-4efb-4914-abea-976db1d55415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3e01483f-6464-417a-bf06-0cc837e67fd6" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f346b1bf-4efb-4914-abea-976db1d55415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_9a5af5f9-d124-4188-a761-680a588a5204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f346b1bf-4efb-4914-abea-976db1d55415" xlink:to="loc_us-gaap_CashFlowHedgingMember_9a5af5f9-d124-4188-a761-680a588a5204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a332ffd8-577d-4c4e-a736-5f819e1ce981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ef690c86-1a0f-4bdd-aba3-49e6d19e335d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a332ffd8-577d-4c4e-a736-5f819e1ce981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_f6e7a621-72a6-475f-ae5b-946696ad6592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a332ffd8-577d-4c4e-a736-5f819e1ce981" xlink:to="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_f6e7a621-72a6-475f-ae5b-946696ad6592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_0467de5b-92e6-4edf-9216-b83488bda726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a332ffd8-577d-4c4e-a736-5f819e1ce981" xlink:to="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_0467de5b-92e6-4edf-9216-b83488bda726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_5def0355-2acc-4aa5-bb7d-f9d21addc882" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a332ffd8-577d-4c4e-a736-5f819e1ce981" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_5def0355-2acc-4aa5-bb7d-f9d21addc882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_48886faa-5fda-47aa-8b11-f9870f1f8b78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a332ffd8-577d-4c4e-a736-5f819e1ce981" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_48886faa-5fda-47aa-8b11-f9870f1f8b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_d4901ad2-fae5-4b6c-873c-9f11be89a3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a332ffd8-577d-4c4e-a736-5f819e1ce981" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_d4901ad2-fae5-4b6c-873c-9f11be89a3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes" xlink:type="simple" xlink:href="icui-20220630.xsd#FairValueMeasuresandDisclosuresNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9764b280-b776-4323-8633-2f36fa08d759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_4ee2d9d3-a8c0-470c-96df-e0e80c5a3884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9764b280-b776-4323-8633-2f36fa08d759" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_4ee2d9d3-a8c0-470c-96df-e0e80c5a3884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables" xlink:type="simple" xlink:href="icui-20220630.xsd#FairValueMeasuresandDisclosuresTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ae97780c-c137-4c8c-b526-fe5c62e9f7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_a41f4aa4-b27d-44e2-9b26-80e504d85a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ae97780c-c137-4c8c-b526-fe5c62e9f7e2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_a41f4aa4-b27d-44e2-9b26-80e504d85a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_8530bdd3-2021-4d1f-8d91-9ae330b1590d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ae97780c-c137-4c8c-b526-fe5c62e9f7e2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_8530bdd3-2021-4d1f-8d91-9ae330b1590d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_c870a3a8-4849-4a8a-994a-d608ad32f357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ae97780c-c137-4c8c-b526-fe5c62e9f7e2" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_c870a3a8-4849-4a8a-994a-d608ad32f357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#FairValueMeasuresandDisclosuresDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c4f40b13-b994-498b-a26e-240623497a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_96565c84-62da-4d57-9c78-c8e2b1eb56a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c4f40b13-b994-498b-a26e-240623497a44" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_96565c84-62da-4d57-9c78-c8e2b1eb56a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5cd976f5-cdbd-4575-a6c8-30296b1e4bae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_96565c84-62da-4d57-9c78-c8e2b1eb56a3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5cd976f5-cdbd-4575-a6c8-30296b1e4bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_545bd036-e70e-4cf7-9549-07e8f5168b64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5cd976f5-cdbd-4575-a6c8-30296b1e4bae" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_545bd036-e70e-4cf7-9549-07e8f5168b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_a309dbb2-9009-4ed5-b94e-2d6c8bead724" xlink:href="icui-20220630.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_545bd036-e70e-4cf7-9549-07e8f5168b64" xlink:to="loc_icui_PursuitVascularInc.Member_a309dbb2-9009-4ed5-b94e-2d6c8bead724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_75859d0f-540a-4bf6-8a65-a12282a8d1fb" xlink:href="icui-20220630.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_545bd036-e70e-4cf7-9549-07e8f5168b64" xlink:to="loc_icui_SmithsMedicalMember_75859d0f-540a-4bf6-8a65-a12282a8d1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_6cc6774d-fb97-4653-aec5-dbe675c9ba3c" xlink:href="icui-20220630.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_545bd036-e70e-4cf7-9549-07e8f5168b64" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_6cc6774d-fb97-4653-aec5-dbe675c9ba3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_77734049-f52d-4e5c-b6e5-557f00db9af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_96565c84-62da-4d57-9c78-c8e2b1eb56a3" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_77734049-f52d-4e5c-b6e5-557f00db9af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_7e95b338-7961-45a4-af17-678e9d15ef09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_77734049-f52d-4e5c-b6e5-557f00db9af3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_7e95b338-7961-45a4-af17-678e9d15ef09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_41d5063d-7603-4433-bdc9-0159f168148b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_7e95b338-7961-45a4-af17-678e9d15ef09" xlink:to="loc_us-gaap_LiabilityMember_41d5063d-7603-4433-bdc9-0159f168148b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1748e0e5-788c-4e97-9025-92124a1e52ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_96565c84-62da-4d57-9c78-c8e2b1eb56a3" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1748e0e5-788c-4e97-9025-92124a1e52ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_217f8b9f-2739-4362-94ce-65c064fce2a4" xlink:href="icui-20220630.xsd#icui_Contingentconsiderationgross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1748e0e5-788c-4e97-9025-92124a1e52ae" xlink:to="loc_icui_Contingentconsiderationgross_217f8b9f-2739-4362-94ce-65c064fce2a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f6d54a11-6ccf-42b1-b6b8-0d454657c810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1748e0e5-788c-4e97-9025-92124a1e52ae" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f6d54a11-6ccf-42b1-b6b8-0d454657c810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_c27ceb4d-c302-4082-8644-1d9693ef3896" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationGrossST"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1748e0e5-788c-4e97-9025-92124a1e52ae" xlink:to="loc_icui_ContingentConsiderationGrossST_c27ceb4d-c302-4082-8644-1d9693ef3896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_bc2a4a75-0e12-430b-bc90-f6ef4f66766c" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1748e0e5-788c-4e97-9025-92124a1e52ae" xlink:to="loc_icui_ContingentConsiderationGrossLT_bc2a4a75-0e12-430b-bc90-f6ef4f66766c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_074f98b3-454d-40a4-8983-c20628b6e946" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1748e0e5-788c-4e97-9025-92124a1e52ae" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_074f98b3-454d-40a4-8983-c20628b6e946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OwnershipRequirementForEarnoutPayment_069c030e-f0b3-4acd-970e-dd21515d3a08" xlink:href="icui-20220630.xsd#icui_OwnershipRequirementForEarnoutPayment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1748e0e5-788c-4e97-9025-92124a1e52ae" xlink:to="loc_icui_OwnershipRequirementForEarnoutPayment_069c030e-f0b3-4acd-970e-dd21515d3a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5178875b-aa24-4ab6-bc21-a0875e14d091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_83c2baa4-f7b9-448b-aae1-11e2a3cbfa1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5178875b-aa24-4ab6-bc21-a0875e14d091" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_83c2baa4-f7b9-448b-aae1-11e2a3cbfa1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2e0ff1c1-e292-4816-b84d-9b54d9fbf1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_83c2baa4-f7b9-448b-aae1-11e2a3cbfa1b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2e0ff1c1-e292-4816-b84d-9b54d9fbf1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_811ab4c2-3354-44e2-9d19-332b078cc69a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2e0ff1c1-e292-4816-b84d-9b54d9fbf1cc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_811ab4c2-3354-44e2-9d19-332b078cc69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_24ae3160-f154-4800-887b-e543f08acdb6" xlink:href="icui-20220630.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_811ab4c2-3354-44e2-9d19-332b078cc69a" xlink:to="loc_icui_PursuitVascularInc.Member_24ae3160-f154-4800-887b-e543f08acdb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3ccf157a-293b-416f-aff0-6ddbb8ccc527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_83c2baa4-f7b9-448b-aae1-11e2a3cbfa1b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3ccf157a-293b-416f-aff0-6ddbb8ccc527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ce9b3ca6-e0b6-4584-9784-0e78b003b2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3ccf157a-293b-416f-aff0-6ddbb8ccc527" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ce9b3ca6-e0b6-4584-9784-0e78b003b2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_3ebe37bd-1300-44c1-b71e-bbffeb10b064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3ccf157a-293b-416f-aff0-6ddbb8ccc527" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_3ebe37bd-1300-44c1-b71e-bbffeb10b064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_eb82d2c9-2bd4-4a36-975e-8d37e331c03d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3ccf157a-293b-416f-aff0-6ddbb8ccc527" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_eb82d2c9-2bd4-4a36-975e-8d37e331c03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CurrencyTranslationOnEarnOut_a87b72b9-1a10-46c0-9aab-1c9d630e4f54" xlink:href="icui-20220630.xsd#icui_CurrencyTranslationOnEarnOut"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3ccf157a-293b-416f-aff0-6ddbb8ccc527" xlink:to="loc_icui_CurrencyTranslationOnEarnOut_a87b72b9-1a10-46c0-9aab-1c9d630e4f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a2949776-b2bc-4e36-8733-21d4bf9cee66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_955f9991-3f2a-4a88-97a1-14c32f66a11c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a2949776-b2bc-4e36-8733-21d4bf9cee66" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_955f9991-3f2a-4a88-97a1-14c32f66a11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_619d583e-c44c-4806-b837-c50440facd58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_955f9991-3f2a-4a88-97a1-14c32f66a11c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_619d583e-c44c-4806-b837-c50440facd58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_56bed086-3b90-40d2-a4f2-edd0ec3db41b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_619d583e-c44c-4806-b837-c50440facd58" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_56bed086-3b90-40d2-a4f2-edd0ec3db41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_305fad12-c6fb-4dc1-8eef-688544869864" xlink:href="icui-20220630.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_56bed086-3b90-40d2-a4f2-edd0ec3db41b" xlink:to="loc_icui_PursuitVascularInc.Member_305fad12-c6fb-4dc1-8eef-688544869864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9345f063-ed22-471c-9648-97b78c3598e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_955f9991-3f2a-4a88-97a1-14c32f66a11c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9345f063-ed22-471c-9648-97b78c3598e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4761cbf0-d414-4e4f-8b5e-f9516a6eaa21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9345f063-ed22-471c-9648-97b78c3598e4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4761cbf0-d414-4e4f-8b5e-f9516a6eaa21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_33d64a90-2112-429d-9914-087ce1021205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_955f9991-3f2a-4a88-97a1-14c32f66a11c" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_33d64a90-2112-429d-9914-087ce1021205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7b545858-b516-4da1-80d8-f17bab667bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_33d64a90-2112-429d-9914-087ce1021205" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7b545858-b516-4da1-80d8-f17bab667bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_bb316df4-39dd-420f-918b-59a8c371716f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_955f9991-3f2a-4a88-97a1-14c32f66a11c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_bb316df4-39dd-420f-918b-59a8c371716f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_c086a43e-6601-441e-9721-5983bca46cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_bb316df4-39dd-420f-918b-59a8c371716f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_c086a43e-6601-441e-9721-5983bca46cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_65a8a356-ecbc-43ce-b6f6-f5c14c32115d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_955f9991-3f2a-4a88-97a1-14c32f66a11c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_65a8a356-ecbc-43ce-b6f6-f5c14c32115d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1ed1c0c2-97f1-4a64-b19e-af1a91c04120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_65a8a356-ecbc-43ce-b6f6-f5c14c32115d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1ed1c0c2-97f1-4a64-b19e-af1a91c04120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_bf74a33f-87c8-408f-b372-987757c3ed05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_65a8a356-ecbc-43ce-b6f6-f5c14c32115d" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_bf74a33f-87c8-408f-b372-987757c3ed05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_05137d94-790e-41f6-9f2c-1a6d400255c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_551c84b8-59f7-4880-a516-db60419fc37c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_05137d94-790e-41f6-9f2c-1a6d400255c3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_551c84b8-59f7-4880-a516-db60419fc37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bcda04b8-3e59-4345-8688-4fd1c12bc8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_551c84b8-59f7-4880-a516-db60419fc37c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bcda04b8-3e59-4345-8688-4fd1c12bc8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35e35f5c-3064-4c04-9aee-f4758f5717c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bcda04b8-3e59-4345-8688-4fd1c12bc8dc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35e35f5c-3064-4c04-9aee-f4758f5717c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_c3de3150-bcc7-4413-9abc-a2e2c2dadc4f" xlink:href="icui-20220630.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35e35f5c-3064-4c04-9aee-f4758f5717c3" xlink:to="loc_icui_PursuitVascularInc.Member_c3de3150-bcc7-4413-9abc-a2e2c2dadc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_7c073c6e-fa7b-4a70-9a92-3de5db3a6e51" xlink:href="icui-20220630.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35e35f5c-3064-4c04-9aee-f4758f5717c3" xlink:to="loc_icui_SmithsMedicalMember_7c073c6e-fa7b-4a70-9a92-3de5db3a6e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_b8526eea-bc88-48bc-bdbf-0d33c0cdfa05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_551c84b8-59f7-4880-a516-db60419fc37c" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_b8526eea-bc88-48bc-bdbf-0d33c0cdfa05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_de7bd330-dfc7-4138-8bd1-15222c607cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_b8526eea-bc88-48bc-bdbf-0d33c0cdfa05" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_de7bd330-dfc7-4138-8bd1-15222c607cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MeasurementinputadjustedEBITDAvolatilityDomain_ff5cf105-eb58-4b18-b4a1-37fdce7994c8" xlink:href="icui-20220630.xsd#icui_MeasurementinputadjustedEBITDAvolatilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_de7bd330-dfc7-4138-8bd1-15222c607cfe" xlink:to="loc_icui_MeasurementinputadjustedEBITDAvolatilityDomain_ff5cf105-eb58-4b18-b4a1-37fdce7994c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_d36669e9-1688-48a9-b775-8edda7aed74c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_de7bd330-dfc7-4138-8bd1-15222c607cfe" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_d36669e9-1688-48a9-b775-8edda7aed74c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_bc812f0f-527d-42d0-b5f6-39903aa5f9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_de7bd330-dfc7-4138-8bd1-15222c607cfe" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_bc812f0f-527d-42d0-b5f6-39903aa5f9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MeasurementInputMarketPriceofRiskDomain_3d1cb7ca-5b43-4e4f-b94d-42239c39ac49" xlink:href="icui-20220630.xsd#icui_MeasurementInputMarketPriceofRiskDomain"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_de7bd330-dfc7-4138-8bd1-15222c607cfe" xlink:to="loc_icui_MeasurementInputMarketPriceofRiskDomain_3d1cb7ca-5b43-4e4f-b94d-42239c39ac49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_e361e570-f17d-4ac2-8fc1-fa504075676b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_de7bd330-dfc7-4138-8bd1-15222c607cfe" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_e361e570-f17d-4ac2-8fc1-fa504075676b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_9f527e33-3d92-4bc0-af11-d1a4fcac660a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_551c84b8-59f7-4880-a516-db60419fc37c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_9f527e33-3d92-4bc0-af11-d1a4fcac660a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_a199fc69-a73f-41e2-8caf-abb1d62e2aef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_9f527e33-3d92-4bc0-af11-d1a4fcac660a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_a199fc69-a73f-41e2-8caf-abb1d62e2aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_15fd9837-3fbc-4da6-8762-f20c599f412e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c25ad4bc-35c3-410b-8dc9-6ec52915a70b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_15fd9837-3fbc-4da6-8762-f20c599f412e" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c25ad4bc-35c3-410b-8dc9-6ec52915a70b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a48bb895-1601-45c7-88a7-bc6c7e64edf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c25ad4bc-35c3-410b-8dc9-6ec52915a70b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a48bb895-1601-45c7-88a7-bc6c7e64edf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b0125f42-90f6-4e40-b77b-9067b0ab689a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a48bb895-1601-45c7-88a7-bc6c7e64edf1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b0125f42-90f6-4e40-b77b-9067b0ab689a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_ac1ced5d-afe0-44de-abfb-e97eec555393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b0125f42-90f6-4e40-b77b-9067b0ab689a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_ac1ced5d-afe0-44de-abfb-e97eec555393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1e0daf64-9b3c-466d-a373-3f06cb0a0c79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b0125f42-90f6-4e40-b77b-9067b0ab689a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1e0daf64-9b3c-466d-a373-3f06cb0a0c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_39614a19-8810-45f4-b46d-55dad6559a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b0125f42-90f6-4e40-b77b-9067b0ab689a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_39614a19-8810-45f4-b46d-55dad6559a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_93a2fa6c-481e-4999-8cf7-999a625ccd14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c25ad4bc-35c3-410b-8dc9-6ec52915a70b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_93a2fa6c-481e-4999-8cf7-999a625ccd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_987b1bf2-738d-447d-aae5-52a3bab55819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_93a2fa6c-481e-4999-8cf7-999a625ccd14" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_987b1bf2-738d-447d-aae5-52a3bab55819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_d1460688-c830-4652-b749-9d8e551c2cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_987b1bf2-738d-447d-aae5-52a3bab55819" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_d1460688-c830-4652-b749-9d8e551c2cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_76c87889-c3f0-4a88-a356-f7bf04f88282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_987b1bf2-738d-447d-aae5-52a3bab55819" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_76c87889-c3f0-4a88-a356-f7bf04f88282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_fc932ef1-2346-428a-bed1-2d77c2c96012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_987b1bf2-738d-447d-aae5-52a3bab55819" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_fc932ef1-2346-428a-bed1-2d77c2c96012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_435ee4ba-e559-4b08-a552-670ff4738c17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_987b1bf2-738d-447d-aae5-52a3bab55819" xlink:to="loc_us-gaap_OtherAssetsMember_435ee4ba-e559-4b08-a552-670ff4738c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_5d4e5a08-fc44-40ec-b3cc-eb515a8f48c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_987b1bf2-738d-447d-aae5-52a3bab55819" xlink:to="loc_us-gaap_OtherLiabilitiesMember_5d4e5a08-fc44-40ec-b3cc-eb515a8f48c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_e2cb9a1e-083b-444b-a2ef-1f3083680248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c25ad4bc-35c3-410b-8dc9-6ec52915a70b" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_e2cb9a1e-083b-444b-a2ef-1f3083680248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8650ac03-06b8-4dfc-99a0-d4b648c2a73e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_e2cb9a1e-083b-444b-a2ef-1f3083680248" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8650ac03-06b8-4dfc-99a0-d4b648c2a73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EarnoutliabilityMember_db0fd098-cc0e-4444-aa27-40a26968d5d4" xlink:href="icui-20220630.xsd#icui_EarnoutliabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8650ac03-06b8-4dfc-99a0-d4b648c2a73e" xlink:to="loc_icui_EarnoutliabilityMember_db0fd098-cc0e-4444-aa27-40a26968d5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesTotalMember_7c87ce10-8782-4ef0-835a-ede8a79980cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesTotalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8650ac03-06b8-4dfc-99a0-d4b648c2a73e" xlink:to="loc_us-gaap_LiabilitiesTotalMember_7c87ce10-8782-4ef0-835a-ede8a79980cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EarnOutLiabilityST_f3db2264-17c6-482f-8627-ad7abc1085c8" xlink:href="icui-20220630.xsd#icui_EarnOutLiabilityST"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8650ac03-06b8-4dfc-99a0-d4b648c2a73e" xlink:to="loc_icui_EarnOutLiabilityST_f3db2264-17c6-482f-8627-ad7abc1085c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_STEarnoutLiabilityMember_b19c17bd-52ef-451d-bd19-3bbf438c6ac0" xlink:href="icui-20220630.xsd#icui_STEarnoutLiabilityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8650ac03-06b8-4dfc-99a0-d4b648c2a73e" xlink:to="loc_icui_STEarnoutLiabilityMember_b19c17bd-52ef-451d-bd19-3bbf438c6ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_c01e6a97-17f6-4a3c-ad08-5291aafe78a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c25ad4bc-35c3-410b-8dc9-6ec52915a70b" xlink:to="loc_us-gaap_InvestmentTypeAxis_c01e6a97-17f6-4a3c-ad08-5291aafe78a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_10e668e5-9d7d-44df-b3be-627004f0b331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_c01e6a97-17f6-4a3c-ad08-5291aafe78a7" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_10e668e5-9d7d-44df-b3be-627004f0b331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_68ee3c38-9c3f-4eb5-830a-9538386c32b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_10e668e5-9d7d-44df-b3be-627004f0b331" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_68ee3c38-9c3f-4eb5-830a-9538386c32b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_39eb5b45-7dd0-4fdd-b23d-6a4137a89809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_10e668e5-9d7d-44df-b3be-627004f0b331" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_39eb5b45-7dd0-4fdd-b23d-6a4137a89809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c25ad4bc-35c3-410b-8dc9-6ec52915a70b" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_11c5c56e-4f86-42ae-a441-2a26dec356bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_11c5c56e-4f86-42ae-a441-2a26dec356bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_83fc3ccb-f1aa-45d8-a1a4-8aa6977e70db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeAssetsAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_83fc3ccb-f1aa-45d8-a1a4-8aa6977e70db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_3a1d908b-f320-43d1-a0e0-d4eedba06d30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_3a1d908b-f320-43d1-a0e0-d4eedba06d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_47780d7d-4d89-4842-a50a-ef98d8ae4c84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonfinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_47780d7d-4d89-4842-a50a-ef98d8ae4c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_ff0f4bf6-ded9-46fa-bac9-f00a0116c758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeLiabilitiesAtFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_ff0f4bf6-ded9-46fa-bac9-f00a0116c758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_feb9be3d-ee92-416d-bca6-10f47bd1b16a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_feb9be3d-ee92-416d-bca6-10f47bd1b16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_3168ad4a-1459-4429-97df-74220e09afdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_3168ad4a-1459-4429-97df-74220e09afdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_e1146bd4-5732-4229-8756-17c22b7b17ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_e1146bd4-5732-4229-8756-17c22b7b17ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_a99eb408-81cc-43c4-bb4f-c1ccec85448e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84431ebb-5ca3-4722-9fb1-7a42c0ed4d10" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_a99eb408-81cc-43c4-bb4f-c1ccec85448e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InvestmentSecuritiesNotes" xlink:type="simple" xlink:href="icui-20220630.xsd#InvestmentSecuritiesNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InvestmentSecuritiesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_66db3c8c-cde9-4cf0-9856-0ee57af30d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock_dc9f9e9c-d072-44e5-a27c-c77de17599ef" xlink:href="icui-20220630.xsd#icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_66db3c8c-cde9-4cf0-9856-0ee57af30d4b" xlink:to="loc_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock_dc9f9e9c-d072-44e5-a27c-c77de17599ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InvestmentSecuritiesTables" xlink:type="simple" xlink:href="icui-20220630.xsd#InvestmentSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InvestmentSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1cd132c3-ec7a-41f6-b86c-7b5541428c87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_cc242bc4-1806-4566-948a-e3018eb3b41b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1cd132c3-ec7a-41f6-b86c-7b5541428c87" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_cc242bc4-1806-4566-948a-e3018eb3b41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_f9b1806e-9b65-4033-8460-ac62aa233d09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1cd132c3-ec7a-41f6-b86c-7b5541428c87" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_f9b1806e-9b65-4033-8460-ac62aa233d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InvestmentSecuritiesDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#InvestmentSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InvestmentSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_21515f90-5233-4009-ab3b-b02b3de1899a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_7be9d8d7-afe3-46f4-838e-4040b464aecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_21515f90-5233-4009-ab3b-b02b3de1899a" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_7be9d8d7-afe3-46f4-838e-4040b464aecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_7631f6f5-a635-420f-a7dd-f87add6cb515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_21515f90-5233-4009-ab3b-b02b3de1899a" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_7631f6f5-a635-420f-a7dd-f87add6cb515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InvestmentSecuritiesTableDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#InvestmentSecuritiesTableDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InvestmentSecuritiesTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ec4c47e6-1ee7-4947-a35e-090481b4f9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_89773a6e-f8c2-4580-9dcd-ce351cf7c22a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ec4c47e6-1ee7-4947-a35e-090481b4f9ed" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_89773a6e-f8c2-4580-9dcd-ce351cf7c22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_22830ea2-698c-458e-874a-597aa752e435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_89773a6e-f8c2-4580-9dcd-ce351cf7c22a" xlink:to="loc_us-gaap_InvestmentTypeAxis_22830ea2-698c-458e-874a-597aa752e435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_3be230b6-b72c-4bdb-973f-38fa429149f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_22830ea2-698c-458e-874a-597aa752e435" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_3be230b6-b72c-4bdb-973f-38fa429149f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AvailableforsaleDebtSecurityCurrentMember_1c50d12e-5794-4bc6-af19-ff22602b2813" xlink:href="icui-20220630.xsd#icui_AvailableforsaleDebtSecurityCurrentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3be230b6-b72c-4bdb-973f-38fa429149f6" xlink:to="loc_icui_AvailableforsaleDebtSecurityCurrentMember_1c50d12e-5794-4bc6-af19-ff22602b2813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongtermInvestmentsDomain_94668a46-58eb-4ab5-a0a8-cafda21c73a8" xlink:href="icui-20220630.xsd#icui_LongtermInvestmentsDomain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3be230b6-b72c-4bdb-973f-38fa429149f6" xlink:to="loc_icui_LongtermInvestmentsDomain_94668a46-58eb-4ab5-a0a8-cafda21c73a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_b552b426-da0d-47fd-ab89-76673ee1f657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3be230b6-b72c-4bdb-973f-38fa429149f6" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_b552b426-da0d-47fd-ab89-76673ee1f657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_5911cfe5-fdbb-4458-83b8-b22007f40ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3be230b6-b72c-4bdb-973f-38fa429149f6" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_5911cfe5-fdbb-4458-83b8-b22007f40ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_89773a6e-f8c2-4580-9dcd-ce351cf7c22a" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3b793d8d-972d-4b42-8627-29fc195faa7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3b793d8d-972d-4b42-8627-29fc195faa7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_2e40ff2c-18fd-4207-84ec-b17da5eb8b39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_2e40ff2c-18fd-4207-84ec-b17da5eb8b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_6839ada3-2da9-4b11-aab4-5e54af163805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_6839ada3-2da9-4b11-aab4-5e54af163805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_35a1345e-bfd4-4df7-af50-caa9cfd9d143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_35a1345e-bfd4-4df7-af50-caa9cfd9d143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_652073ad-a24e-4563-88d6-c2a2746f4866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_652073ad-a24e-4563-88d6-c2a2746f4866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_14caf6ea-9698-4fea-b313-a4bb888a21d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_14caf6ea-9698-4fea-b313-a4bb888a21d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_128daf0f-0bf6-4bc9-8d8d-74d366c44314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_128daf0f-0bf6-4bc9-8d8d-74d366c44314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_7fea62c1-f628-47b5-9ea5-281844cbd4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_38ebc446-2398-4b6d-a447-1007a7382cac" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_7fea62c1-f628-47b5-9ea5-281844cbd4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/EquityMethodInvestmentsDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#EquityMethodInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/EquityMethodInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0b0fde5f-9a5f-4c23-b754-ce266f9ffd0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_e6dda250-57ba-4319-b81c-99a3adcb76cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0b0fde5f-9a5f-4c23-b754-ce266f9ffd0b" xlink:to="loc_us-gaap_EquityMethodInvestments_e6dda250-57ba-4319-b81c-99a3adcb76cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_bfe6a336-41cb-44fc-abf6-fd647dbe43e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0b0fde5f-9a5f-4c23-b754-ce266f9ffd0b" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_bfe6a336-41cb-44fc-abf6-fd647dbe43e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_648bfeba-22e3-432e-acbd-ae65d12379dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0b0fde5f-9a5f-4c23-b754-ce266f9ffd0b" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_648bfeba-22e3-432e-acbd-ae65d12379dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes" xlink:type="simple" xlink:href="icui-20220630.xsd#PrepaidsandOtherCurrentAssetsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_98b89fdd-a334-4649-9995-4a6f8e1493c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_2d445457-5ce4-4458-9d92-cf9c4328272d" xlink:href="icui-20220630.xsd#icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_98b89fdd-a334-4649-9995-4a6f8e1493c8" xlink:to="loc_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_2d445457-5ce4-4458-9d92-cf9c4328272d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables" xlink:type="simple" xlink:href="icui-20220630.xsd#PrepaidsandOtherCurrentAssetsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_86c33abe-8863-4c17-bafc-04a97bd3748e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_efb0fa73-9061-4771-9b8d-a05a4c72a717" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_86c33abe-8863-4c17-bafc-04a97bd3748e" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_efb0fa73-9061-4771-9b8d-a05a4c72a717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_824c0c5b-ee82-49da-b787-68c0d2916658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_86c33abe-8863-4c17-bafc-04a97bd3748e" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_824c0c5b-ee82-49da-b787-68c0d2916658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_ecae5e9d-79a2-430c-9642-9bcadc64079e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_a07285e6-5b18-4c6d-b081-eea88825876b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_ecae5e9d-79a2-430c-9642-9bcadc64079e" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_a07285e6-5b18-4c6d-b081-eea88825876b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PrepaidVendorExpenses_9371936e-65ea-48a2-8344-904919c0b202" xlink:href="icui-20220630.xsd#icui_PrepaidVendorExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_ecae5e9d-79a2-430c-9642-9bcadc64079e" xlink:to="loc_icui_PrepaidVendorExpenses_9371936e-65ea-48a2-8344-904919c0b202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsAndOtherAssets_549e06bb-296e-4dde-8095-a687435221d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_ecae5e9d-79a2-430c-9642-9bcadc64079e" xlink:to="loc_us-gaap_DeferredCostsAndOtherAssets_549e06bb-296e-4dde-8095-a687435221d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidinsuranceandpropertytaxes_478551e0-8145-47da-bd50-2dc534fbaaad" xlink:href="icui-20220630.xsd#icui_Prepaidinsuranceandpropertytaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_ecae5e9d-79a2-430c-9642-9bcadc64079e" xlink:to="loc_icui_Prepaidinsuranceandpropertytaxes_478551e0-8145-47da-bd50-2dc534fbaaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidothertaxes_f074be6a-01ee-4a41-86fd-b6d2704397ce" xlink:href="icui-20220630.xsd#icui_Prepaidothertaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_ecae5e9d-79a2-430c-9642-9bcadc64079e" xlink:to="loc_icui_Prepaidothertaxes_f074be6a-01ee-4a41-86fd-b6d2704397ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Deferredtaxcharge_8571fcde-c4bd-45aa-9fdd-6387a13ea9a6" xlink:href="icui-20220630.xsd#icui_Deferredtaxcharge"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_ecae5e9d-79a2-430c-9642-9bcadc64079e" xlink:to="loc_icui_Deferredtaxcharge_8571fcde-c4bd-45aa-9fdd-6387a13ea9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_40f9bc88-1448-4a88-afbb-a2fbdc8db254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_ecae5e9d-79a2-430c-9642-9bcadc64079e" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_40f9bc88-1448-4a88-afbb-a2fbdc8db254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositAssets_be16a83d-189b-4723-80ad-fe964e0822ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_ecae5e9d-79a2-430c-9642-9bcadc64079e" xlink:to="loc_us-gaap_DepositAssets_be16a83d-189b-4723-80ad-fe964e0822ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_4e5e5b1f-9b69-423a-9230-f25c1f680d54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_ecae5e9d-79a2-430c-9642-9bcadc64079e" xlink:to="loc_us-gaap_OtherAssetsCurrent_4e5e5b1f-9b69-423a-9230-f25c1f680d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f2cdc371-c7e9-4755-b27c-cb5fb5392b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_ecae5e9d-79a2-430c-9642-9bcadc64079e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f2cdc371-c7e9-4755-b27c-cb5fb5392b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_48a81fc5-f950-4faf-9657-398e859ba34a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeAssetsAtFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_ecae5e9d-79a2-430c-9642-9bcadc64079e" xlink:to="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_48a81fc5-f950-4faf-9657-398e859ba34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/OtherAssetsNoncurrentDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#OtherAssetsNoncurrentDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/OtherAssetsNoncurrentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9fd7b9c1-5aa3-456c-9430-8837e55e41e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_f04d67cf-5944-4f01-840e-9d54f965bcbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9fd7b9c1-5aa3-456c-9430-8837e55e41e6" xlink:to="loc_us-gaap_DerivativeTable_f04d67cf-5944-4f01-840e-9d54f965bcbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_542b6183-0a83-4571-aab2-e0bc0cea6f50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f04d67cf-5944-4f01-840e-9d54f965bcbf" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_542b6183-0a83-4571-aab2-e0bc0cea6f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ca6b0e85-1bd8-4ef1-8c79-2dafbf549aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_542b6183-0a83-4571-aab2-e0bc0cea6f50" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ca6b0e85-1bd8-4ef1-8c79-2dafbf549aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3e49188c-3ee7-4a4a-93f8-78e4c27ad870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ca6b0e85-1bd8-4ef1-8c79-2dafbf549aad" xlink:to="loc_us-gaap_InterestRateSwapMember_3e49188c-3ee7-4a4a-93f8-78e4c27ad870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_c868cac0-4bd8-46bf-aa48-d4accbc5e153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ca6b0e85-1bd8-4ef1-8c79-2dafbf549aad" xlink:to="loc_us-gaap_ForeignExchangeMember_c868cac0-4bd8-46bf-aa48-d4accbc5e153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_d3b809dc-b6df-42a7-b35b-5869c6d1df31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f04d67cf-5944-4f01-840e-9d54f965bcbf" xlink:to="loc_us-gaap_DerivativeLineItems_d3b809dc-b6df-42a7-b35b-5869c6d1df31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_45c0d15f-04f8-4486-bf91-1bf0799d0780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d3b809dc-b6df-42a7-b35b-5869c6d1df31" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_45c0d15f-04f8-4486-bf91-1bf0799d0780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_e473cde7-e6e4-4c47-a273-f2d25437109b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9fd7b9c1-5aa3-456c-9430-8837e55e41e6" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_e473cde7-e6e4-4c47-a273-f2d25437109b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SpareParts_b1d3c173-90b2-49d0-86b0-91a3ca028ff3" xlink:href="icui-20220630.xsd#icui_SpareParts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9fd7b9c1-5aa3-456c-9430-8837e55e41e6" xlink:to="loc_icui_SpareParts_b1d3c173-90b2-49d0-86b0-91a3ca028ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_355770cf-8022-4df7-81da-46c4cb3c40b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9fd7b9c1-5aa3-456c-9430-8837e55e41e6" xlink:to="loc_us-gaap_EquityMethodInvestments_355770cf-8022-4df7-81da-46c4cb3c40b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_13af81e3-bd85-4ebe-b6ff-7514c79be7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9fd7b9c1-5aa3-456c-9430-8837e55e41e6" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_13af81e3-bd85-4ebe-b6ff-7514c79be7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_8ba59144-0f6a-4534-b612-85fd9237e107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9fd7b9c1-5aa3-456c-9430-8837e55e41e6" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_8ba59144-0f6a-4534-b612-85fd9237e107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_ce624072-e3fc-43fd-9ded-e9f69df2e2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9fd7b9c1-5aa3-456c-9430-8837e55e41e6" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_ce624072-e3fc-43fd-9ded-e9f69df2e2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_97af8101-b111-4b14-a818-06a827c1d239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9fd7b9c1-5aa3-456c-9430-8837e55e41e6" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_97af8101-b111-4b14-a818-06a827c1d239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7cd4fe23-87f1-4fd7-a581-d52d8f801e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9fd7b9c1-5aa3-456c-9430-8837e55e41e6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7cd4fe23-87f1-4fd7-a581-d52d8f801e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/Inventories" xlink:type="simple" xlink:href="icui-20220630.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_45a0a1d8-696b-4715-9dda-25986b96e536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_554c190a-1d0b-4400-a0ef-32f9274b9096" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_45a0a1d8-696b-4715-9dda-25986b96e536" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_554c190a-1d0b-4400-a0ef-32f9274b9096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InventoriesTables" xlink:type="simple" xlink:href="icui-20220630.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_3ddfec62-d170-4c30-a599-ed1a036d3559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1153534c-446d-4165-9a85-3bebcc140a77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_3ddfec62-d170-4c30-a599-ed1a036d3559" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1153534c-446d-4165-9a85-3bebcc140a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InventoriesDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_8b79b440-6993-4721-82ca-461634394a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_9d4075bc-f4d6-4fbc-8758-bccaa5a7357b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8b79b440-6993-4721-82ca-461634394a0a" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_9d4075bc-f4d6-4fbc-8758-bccaa5a7357b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8fd6f8b4-5403-4bb8-a0f1-522b1238ba46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8b79b440-6993-4721-82ca-461634394a0a" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8fd6f8b4-5403-4bb8-a0f1-522b1238ba46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_0da0a693-495e-44de-a8cc-460ba2e5c4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8b79b440-6993-4721-82ca-461634394a0a" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_0da0a693-495e-44de-a8cc-460ba2e5c4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_86b75e07-a2d0-4d82-bc05-9759b555e0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8b79b440-6993-4721-82ca-461634394a0a" xlink:to="loc_us-gaap_InventoryNet_86b75e07-a2d0-4d82-bc05-9759b555e0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="icui-20220630.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_39f65982-acad-4310-97a6-5c6d38202d45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_4bacb565-1b91-4fa7-8fbd-54002c7f058e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_39f65982-acad-4310-97a6-5c6d38202d45" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_4bacb565-1b91-4fa7-8fbd-54002c7f058e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="icui-20220630.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_be3e4c8b-8b60-48e0-bb00-73e9f80ed431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_b1956fbf-0052-4119-a06c-cc5e38f8a323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_be3e4c8b-8b60-48e0-bb00-73e9f80ed431" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_b1956fbf-0052-4119-a06c-cc5e38f8a323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#PropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a1de876f-719e-4400-8573-b8374d5e69cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3eb37b61-9161-4dcc-93be-fa16091ddddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a1de876f-719e-4400-8573-b8374d5e69cd" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3eb37b61-9161-4dcc-93be-fa16091ddddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1887b503-9a82-4017-a1f1-8bccabf2170d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3eb37b61-9161-4dcc-93be-fa16091ddddc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1887b503-9a82-4017-a1f1-8bccabf2170d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_174e3166-23f8-4033-838b-716e8746e0e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1887b503-9a82-4017-a1f1-8bccabf2170d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_174e3166-23f8-4033-838b-716e8746e0e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember_e1b80315-c02d-46f3-a81b-62dad08a72e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_174e3166-23f8-4033-838b-716e8746e0e6" xlink:to="loc_us-gaap_LandBuildingsAndImprovementsMember_e1b80315-c02d-46f3-a81b-62dad08a72e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MoldsMember_3de78c2d-1651-4171-a8ed-563154f3c33d" xlink:href="icui-20220630.xsd#icui_MoldsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_174e3166-23f8-4033-838b-716e8746e0e6" xlink:to="loc_icui_MoldsMember_3de78c2d-1651-4171-a8ed-563154f3c33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ComputerEquipmentAndSoftwareMember_4583ee06-03e8-4945-8e3b-14c7626e02b1" xlink:href="icui-20220630.xsd#icui_ComputerEquipmentAndSoftwareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_174e3166-23f8-4033-838b-716e8746e0e6" xlink:to="loc_icui_ComputerEquipmentAndSoftwareMember_4583ee06-03e8-4945-8e3b-14c7626e02b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InstrumentsPlacedwithCustomersMember_6406db55-56d2-494b-bbed-db9ff3acc6be" xlink:href="icui-20220630.xsd#icui_InstrumentsPlacedwithCustomersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_174e3166-23f8-4033-838b-716e8746e0e6" xlink:to="loc_icui_InstrumentsPlacedwithCustomersMember_6406db55-56d2-494b-bbed-db9ff3acc6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f5fa7841-1227-49b3-b1b6-5c8752f21f46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3eb37b61-9161-4dcc-93be-fa16091ddddc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f5fa7841-1227-49b3-b1b6-5c8752f21f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_427aa31f-c9cf-4010-9d51-e07cecdec5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f5fa7841-1227-49b3-b1b6-5c8752f21f46" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_427aa31f-c9cf-4010-9d51-e07cecdec5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5e687461-b5b6-4c3f-b46a-0ba2a9467633" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f5fa7841-1227-49b3-b1b6-5c8752f21f46" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5e687461-b5b6-4c3f-b46a-0ba2a9467633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a0d2474c-d027-4c0d-b23b-2ba9b2e142ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f5fa7841-1227-49b3-b1b6-5c8752f21f46" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a0d2474c-d027-4c0d-b23b-2ba9b2e142ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_b2a2d5a4-c4a0-4485-8b5a-4ec93e2202d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f5fa7841-1227-49b3-b1b6-5c8752f21f46" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_b2a2d5a4-c4a0-4485-8b5a-4ec93e2202d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_59018c90-aa11-4203-96ae-7d2c44072617" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f5fa7841-1227-49b3-b1b6-5c8752f21f46" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_59018c90-aa11-4203-96ae-7d2c44072617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_dd62c57d-f64b-49c6-9541-8ced2f6f700e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f5fa7841-1227-49b3-b1b6-5c8752f21f46" xlink:to="loc_us-gaap_ConstructionInProgressGross_dd62c57d-f64b-49c6-9541-8ced2f6f700e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipmentTextDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#PropertyandEquipmentTextDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PropertyandEquipmentTextDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2e318e15-a9ae-4c95-8edc-011917e26405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_0e9facb0-23fa-4113-962f-7e77da803af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2e318e15-a9ae-4c95-8edc-011917e26405" xlink:to="loc_us-gaap_Depreciation_0e9facb0-23fa-4113-962f-7e77da803af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes" xlink:type="simple" xlink:href="icui-20220630.xsd#GoodwillandIntangibleAssetsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3fc89cb9-1a1e-49bf-98f3-53c9c5d96d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_40c3dd92-c5b8-4660-82d2-21ac9fc27e95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3fc89cb9-1a1e-49bf-98f3-53c9c5d96d3e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_40c3dd92-c5b8-4660-82d2-21ac9fc27e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="icui-20220630.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0ca1d1c7-81e5-4ebb-82f9-ac23cf3bb659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_64f5a5bf-35f2-4b7f-b5eb-119f594205bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0ca1d1c7-81e5-4ebb-82f9-ac23cf3bb659" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_64f5a5bf-35f2-4b7f-b5eb-119f594205bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_b42c57d2-4bb9-473d-b434-1db4cf1f92c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0ca1d1c7-81e5-4ebb-82f9-ac23cf3bb659" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_b42c57d2-4bb9-473d-b434-1db4cf1f92c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_560674dc-8d60-4122-9f98-81c3ec5d7826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0ca1d1c7-81e5-4ebb-82f9-ac23cf3bb659" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_560674dc-8d60-4122-9f98-81c3ec5d7826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#GoodwillandIntangibleAssetsGoodwillTableDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_de97faac-1a12-43a9-b1ea-21b5748e8ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9ceee916-6899-47d3-a253-ed8ff9047022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_de97faac-1a12-43a9-b1ea-21b5748e8ae8" xlink:to="loc_us-gaap_Goodwill_9ceee916-6899-47d3-a253-ed8ff9047022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_09c9bd1f-baca-43e0-a16d-a6c73c440566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_de97faac-1a12-43a9-b1ea-21b5748e8ae8" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_09c9bd1f-baca-43e0-a16d-a6c73c440566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_e1a5b584-7762-420b-9c7c-199263cd9ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_de97faac-1a12-43a9-b1ea-21b5748e8ae8" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_e1a5b584-7762-420b-9c7c-199263cd9ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_64c27db5-500a-4c4b-a586-3428112a3e10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_de97faac-1a12-43a9-b1ea-21b5748e8ae8" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_64c27db5-500a-4c4b-a586-3428112a3e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#GoodwillandIntangibleAssetsIntangiblesTableDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e6b5e11e-b7d7-4e91-a9ea-1a708f5f9cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7b8a4b3a-e6ab-4fda-a37e-90006829ab7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e6b5e11e-b7d7-4e91-a9ea-1a708f5f9cfb" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7b8a4b3a-e6ab-4fda-a37e-90006829ab7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_542bd84a-cc3b-4f2f-9bc3-cee43779add3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7b8a4b3a-e6ab-4fda-a37e-90006829ab7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_542bd84a-cc3b-4f2f-9bc3-cee43779add3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_542bd84a-cc3b-4f2f-9bc3-cee43779add3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_17df1e57-0ebe-4523-85e0-06eaa1704356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:to="loc_us-gaap_PatentsMember_17df1e57-0ebe-4523-85e0-06eaa1704356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_1791e962-1b52-4fb1-a344-cf6a67a6b76e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:to="loc_us-gaap_CustomerContractsMember_1791e962-1b52-4fb1-a344-cf6a67a6b76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_2b695667-88bb-4f66-8bdd-7f47afd23fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_2b695667-88bb-4f66-8bdd-7f47afd23fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_afba8cc3-98f8-4f9c-858d-9f5f00984c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:to="loc_us-gaap_TrademarksMember_afba8cc3-98f8-4f9c-858d-9f5f00984c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_35a55a2f-8797-4f07-9327-272914131676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:to="loc_us-gaap_TradeNamesMember_35a55a2f-8797-4f07-9327-272914131676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_f7ba6899-0f66-4fff-b2a9-30fdb7044a22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_f7ba6899-0f66-4fff-b2a9-30fdb7044a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_e87d9900-d9e8-4e73-a07b-ba1d2c9ed920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_443a9289-8d85-4732-ac32-9a5a7d60c4fc" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_e87d9900-d9e8-4e73-a07b-ba1d2c9ed920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_63a0b1c0-075a-4f01-be3c-eed20db54492" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7b8a4b3a-e6ab-4fda-a37e-90006829ab7a" xlink:to="loc_srt_ConsolidationItemsAxis_63a0b1c0-075a-4f01-be3c-eed20db54492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a5e51864-fa22-4456-a1f7-e4605d1fa0aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_63a0b1c0-075a-4f01-be3c-eed20db54492" xlink:to="loc_srt_ConsolidationItemsDomain_a5e51864-fa22-4456-a1f7-e4605d1fa0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4f02525e-95d1-45b3-a4af-25cf5f9813f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7b8a4b3a-e6ab-4fda-a37e-90006829ab7a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4f02525e-95d1-45b3-a4af-25cf5f9813f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0fde0e82-e6a5-4dab-a787-a1eb52c1e5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4f02525e-95d1-45b3-a4af-25cf5f9813f8" xlink:to="loc_us-gaap_SegmentDomain_0fde0e82-e6a5-4dab-a787-a1eb52c1e5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ab11aebd-9e5f-434e-98bd-35c41f017103" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7b8a4b3a-e6ab-4fda-a37e-90006829ab7a" xlink:to="loc_srt_RangeAxis_ab11aebd-9e5f-434e-98bd-35c41f017103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7f2f7490-3b8a-4ddd-860e-b69b452ea97e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ab11aebd-9e5f-434e-98bd-35c41f017103" xlink:to="loc_srt_RangeMember_7f2f7490-3b8a-4ddd-860e-b69b452ea97e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7b8a4b3a-e6ab-4fda-a37e-90006829ab7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_570013a9-8ead-4f6a-9a78-901ef661543b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_570013a9-8ead-4f6a-9a78-901ef661543b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_15ff01a2-8716-47b7-b61e-9eee9acf14e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_15ff01a2-8716-47b7-b61e-9eee9acf14e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ea074800-2c4a-4567-81c4-22b15c2146aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ea074800-2c4a-4567-81c4-22b15c2146aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7038a2ab-4de7-4d65-acb0-61eca9693679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7038a2ab-4de7-4d65-acb0-61eca9693679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9eec40c4-84ff-4d5f-b7d1-f3168e9887af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9eec40c4-84ff-4d5f-b7d1-f3168e9887af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_da741338-e516-402c-9839-da6f5ace68df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_da741338-e516-402c-9839-da6f5ace68df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_437dde1e-3967-4209-8180-6a3a5acfc74c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e666c3ed-9459-4367-b32c-42be717f2e89" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_437dde1e-3967-4209-8180-6a3a5acfc74c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#GoodwillandIntangibleAssetsTextDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_071f4014-0147-415f-8027-98d1ef1275f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7b9b64bf-7204-46a1-a071-2212086407dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_071f4014-0147-415f-8027-98d1ef1275f9" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7b9b64bf-7204-46a1-a071-2212086407dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#GoodwillandIntangibleAssets5YearAmortizationDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a8de45e6-7a44-4eb7-b403-920d70381e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_83c47e25-e47c-455e-9d28-ecd8d71e5374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a8de45e6-7a44-4eb7-b403-920d70381e8d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_83c47e25-e47c-455e-9d28-ecd8d71e5374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7ce68ef4-9700-4139-b292-24adc388ff18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a8de45e6-7a44-4eb7-b403-920d70381e8d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7ce68ef4-9700-4139-b292-24adc388ff18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1f40dc2c-0de0-481c-8d3b-bb1d8178d508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a8de45e6-7a44-4eb7-b403-920d70381e8d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1f40dc2c-0de0-481c-8d3b-bb1d8178d508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8a2ee5ab-88ea-4ec8-9670-27bbd73a63b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a8de45e6-7a44-4eb7-b403-920d70381e8d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8a2ee5ab-88ea-4ec8-9670-27bbd73a63b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_49217d37-096e-44dc-8c9a-9cbf6fb05ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a8de45e6-7a44-4eb7-b403-920d70381e8d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_49217d37-096e-44dc-8c9a-9cbf6fb05ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c6b40384-0142-4bd0-bc14-6be7b3e26f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a8de45e6-7a44-4eb7-b403-920d70381e8d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c6b40384-0142-4bd0-bc14-6be7b3e26f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_fa468240-b5e9-4dd0-977c-595a8ea97af1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a8de45e6-7a44-4eb7-b403-920d70381e8d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_fa468240-b5e9-4dd0-977c-595a8ea97af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eab42239-8dfe-4d47-a711-3447300a0a92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a8de45e6-7a44-4eb7-b403-920d70381e8d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eab42239-8dfe-4d47-a711-3447300a0a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesNotes" xlink:type="simple" xlink:href="icui-20220630.xsd#AccruedLiabilitiesNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_53bd2e49-617e-46c0-a76c-b0659a4a70f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_701e3e48-faad-4300-9f9d-548f684e207f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_53bd2e49-617e-46c0-a76c-b0659a4a70f3" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_701e3e48-faad-4300-9f9d-548f684e207f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="icui-20220630.xsd#AccruedLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_26f5fe36-2956-4b60-9c40-09836e28d774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_64fde866-b214-4fc6-85ff-d7611612dc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_26f5fe36-2956-4b60-9c40-09836e28d774" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_64fde866-b214-4fc6-85ff-d7611612dc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#AccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedSalariesAndBenefits_5e34a55c-ba30-4656-9e8a-cb5423d3384d" xlink:href="icui-20220630.xsd#icui_AccruedSalariesAndBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_icui_AccruedSalariesAndBenefits_5e34a55c-ba30-4656-9e8a-cb5423d3384d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrent_39c8f44e-586a-45ca-b5ea-b526cc589c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedBonusesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_us-gaap_AccruedBonusesCurrent_39c8f44e-586a-45ca-b5ea-b526cc589c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c066446e-5fe2-466f-84c9-acc9f9c8abbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c066446e-5fe2-466f-84c9-acc9f9c8abbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_897c2854-012e-4abc-9812-ebbf47c64d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_897c2854-012e-4abc-9812-ebbf47c64d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_9aff7d50-df0b-46ca-93c1-94e798f009c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_us-gaap_RestructuringReserveCurrent_9aff7d50-df0b-46ca-93c1-94e798f009c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_UnfavorablecontractliabilityST_46a856c5-786e-4bd5-8a47-ca7b701a92b2" xlink:href="icui-20220630.xsd#icui_UnfavorablecontractliabilityST"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_icui_UnfavorablecontractliabilityST_46a856c5-786e-4bd5-8a47-ca7b701a92b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedothertaxes_de1f827e-257f-46e2-819b-80bb916a07e5" xlink:href="icui-20220630.xsd#icui_Accruedothertaxes"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_icui_Accruedothertaxes_de1f827e-257f-46e2-819b-80bb916a07e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_135bc826-f8f9-4e64-9dd5-abc6f5d6ac84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_135bc826-f8f9-4e64-9dd5-abc6f5d6ac84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedlegalfees_5c7d2d75-bdc3-4f75-b790-163eeecc768b" xlink:href="icui-20220630.xsd#icui_Accruedlegalfees"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_icui_Accruedlegalfees_5c7d2d75-bdc3-4f75-b790-163eeecc768b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Outsidesalescommissions_10721762-77cc-4e1f-bdf9-5c182b26abc7" xlink:href="icui-20220630.xsd#icui_Outsidesalescommissions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_icui_Outsidesalescommissions_10721762-77cc-4e1f-bdf9-5c182b26abc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_86562c1d-66eb-4655-94cd-65503a319a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_86562c1d-66eb-4655-94cd-65503a319a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_FieldServiceCorrectiveAction_429600f2-4e09-4f41-bb79-999bba53c344" xlink:href="icui-20220630.xsd#icui_FieldServiceCorrectiveAction"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_icui_FieldServiceCorrectiveAction_429600f2-4e09-4f41-bb79-999bba53c344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedfreight_89f0c5eb-2962-4baf-966d-f4f5eed2b925" xlink:href="icui-20220630.xsd#icui_Accruedfreight"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_icui_Accruedfreight_89f0c5eb-2962-4baf-966d-f4f5eed2b925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_fb0cc4de-63fa-44fa-86d8-07e4143a3a23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_fb0cc4de-63fa-44fa-86d8-07e4143a3a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_253a649b-6635-43fe-98ad-d9578540034d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_253a649b-6635-43fe-98ad-d9578540034d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a4307451-bd65-4723-b62d-53ffec37badc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a4307451-bd65-4723-b62d-53ffec37badc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_13fa8f60-45bc-4e72-a7aa-047be6b16420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_13fa8f60-45bc-4e72-a7aa-047be6b16420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedAuditFees_e5b50d67-5f37-4e32-b829-0be3adfe17c4" xlink:href="icui-20220630.xsd#icui_AccruedAuditFees"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_icui_AccruedAuditFees_e5b50d67-5f37-4e32-b829-0be3adfe17c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_dfd1f491-2f67-4460-a22d-cd067d768428" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_us-gaap_DerivativeTable_dfd1f491-2f67-4460-a22d-cd067d768428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b58f128a-6083-482a-b640-77f9b9fbff4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dfd1f491-2f67-4460-a22d-cd067d768428" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b58f128a-6083-482a-b640-77f9b9fbff4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_09b479e3-a0d1-4d44-b6c0-b2dc7ec4058d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b58f128a-6083-482a-b640-77f9b9fbff4e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_09b479e3-a0d1-4d44-b6c0-b2dc7ec4058d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_6d7992bc-fbf5-47ff-aa2d-5055eea0e193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_09b479e3-a0d1-4d44-b6c0-b2dc7ec4058d" xlink:to="loc_us-gaap_ForeignExchangeMember_6d7992bc-fbf5-47ff-aa2d-5055eea0e193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6adc765c-e8bd-4ede-9c52-66b666aa8ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dfd1f491-2f67-4460-a22d-cd067d768428" xlink:to="loc_us-gaap_DerivativeLineItems_6adc765c-e8bd-4ede-9c52-66b666aa8ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_2a01d604-66dd-480f-a681-e3e1fc2eab88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6adc765c-e8bd-4ede-9c52-66b666aa8ef7" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_2a01d604-66dd-480f-a681-e3e1fc2eab88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable_f8a39fc1-ba46-4709-8d27-fd4129221803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_17beddf4-327a-4967-b149-3f84cc10bfb3" xlink:to="loc_us-gaap_ProductLiabilityContingencyTable_f8a39fc1-ba46-4709-8d27-fd4129221803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_0b09f8c4-c89b-4a9f-91b0-7e87a3fbbd16" xlink:href="icui-20220630.xsd#icui_TimingAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_f8a39fc1-ba46-4709-8d27-fd4129221803" xlink:to="loc_icui_TimingAxis_0b09f8c4-c89b-4a9f-91b0-7e87a3fbbd16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_5ba33fb1-07d4-461f-b3b8-2023ef2c09dc" xlink:href="icui-20220630.xsd#icui_TimingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingAxis_0b09f8c4-c89b-4a9f-91b0-7e87a3fbbd16" xlink:to="loc_icui_TimingDomain_5ba33fb1-07d4-461f-b3b8-2023ef2c09dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermMember_0da79ce5-010f-48cb-867d-1503d0e59037" xlink:href="icui-20220630.xsd#icui_ShortTermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingDomain_5ba33fb1-07d4-461f-b3b8-2023ef2c09dc" xlink:to="loc_icui_ShortTermMember_0da79ce5-010f-48cb-867d-1503d0e59037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems_72b87451-f04d-42e4-b31b-c5ef1ff6f6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_f8a39fc1-ba46-4709-8d27-fd4129221803" xlink:to="loc_us-gaap_ProductLiabilityContingencyLineItems_72b87451-f04d-42e4-b31b-c5ef1ff6f6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_1a1b0a5b-d6f6-4d90-9ce2-c548aa928022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_72b87451-f04d-42e4-b31b-c5ef1ff6f6d3" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_1a1b0a5b-d6f6-4d90-9ce2-c548aa928022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#AccruedLiabilitiesLongtermliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_36f5dd91-c1fd-4229-a594-5e29da8d1aac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_71f4ea9d-c71f-479f-8069-4e0ee41ef076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_36f5dd91-c1fd-4229-a594-5e29da8d1aac" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_71f4ea9d-c71f-479f-8069-4e0ee41ef076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_95dd63e3-d5c6-4fa0-95fc-a711b532c236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_36f5dd91-c1fd-4229-a594-5e29da8d1aac" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_95dd63e3-d5c6-4fa0-95fc-a711b532c236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRentCurrentAndNoncurrent_04785726-f357-4c6e-93f2-ec91ba549ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRentCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_36f5dd91-c1fd-4229-a594-5e29da8d1aac" xlink:to="loc_us-gaap_AccruedRentCurrentAndNoncurrent_04785726-f357-4c6e-93f2-ec91ba549ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Liabilitiesforcontracts_ea16bced-5d4a-40df-b570-92466d6bcb72" xlink:href="icui-20220630.xsd#icui_Liabilitiesforcontracts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_36f5dd91-c1fd-4229-a594-5e29da8d1aac" xlink:to="loc_icui_Liabilitiesforcontracts_ea16bced-5d4a-40df-b570-92466d6bcb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_02eb989e-8d82-454f-ba12-19d29799e057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeLiabilitiesAtFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_36f5dd91-c1fd-4229-a594-5e29da8d1aac" xlink:to="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_02eb989e-8d82-454f-ba12-19d29799e057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_06c8fe10-1d71-49d1-8c2a-e99fc5997ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_36f5dd91-c1fd-4229-a594-5e29da8d1aac" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_06c8fe10-1d71-49d1-8c2a-e99fc5997ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_997e1502-6f77-4043-8ebb-2d5560eaa34e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_36f5dd91-c1fd-4229-a594-5e29da8d1aac" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_997e1502-6f77-4043-8ebb-2d5560eaa34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_761d4d05-884e-423f-a45e-6f90d0e91e84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_36f5dd91-c1fd-4229-a594-5e29da8d1aac" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_761d4d05-884e-423f-a45e-6f90d0e91e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_f32380a8-4b78-4e69-b42e-762a95557394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_36f5dd91-c1fd-4229-a594-5e29da8d1aac" xlink:to="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_f32380a8-4b78-4e69-b42e-762a95557394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_cd53bdd7-ed37-4dee-9f50-dc90def9a8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_36f5dd91-c1fd-4229-a594-5e29da8d1aac" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_cd53bdd7-ed37-4dee-9f50-dc90def9a8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable_81861f7b-b91f-4eba-9f3b-8004239ad2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_36f5dd91-c1fd-4229-a594-5e29da8d1aac" xlink:to="loc_us-gaap_ProductLiabilityContingencyTable_81861f7b-b91f-4eba-9f3b-8004239ad2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_c65e4f26-a575-4887-88a6-fc7d42e1a884" xlink:href="icui-20220630.xsd#icui_TimingAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_81861f7b-b91f-4eba-9f3b-8004239ad2d2" xlink:to="loc_icui_TimingAxis_c65e4f26-a575-4887-88a6-fc7d42e1a884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_4bba79a3-1d96-4e4e-85ae-e7e9b5aa6f10" xlink:href="icui-20220630.xsd#icui_TimingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingAxis_c65e4f26-a575-4887-88a6-fc7d42e1a884" xlink:to="loc_icui_TimingDomain_4bba79a3-1d96-4e4e-85ae-e7e9b5aa6f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermMember_c14e0774-adf7-4df0-8141-4666b04130db" xlink:href="icui-20220630.xsd#icui_LongTermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingDomain_4bba79a3-1d96-4e4e-85ae-e7e9b5aa6f10" xlink:to="loc_icui_LongTermMember_c14e0774-adf7-4df0-8141-4666b04130db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems_63368949-4749-4287-841a-8814ae750144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_81861f7b-b91f-4eba-9f3b-8004239ad2d2" xlink:to="loc_us-gaap_ProductLiabilityContingencyLineItems_63368949-4749-4287-841a-8814ae750144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_43008444-cc60-4af1-91f5-69b232cad90d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_63368949-4749-4287-841a-8814ae750144" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_43008444-cc60-4af1-91f5-69b232cad90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_64544f59-a59b-4afe-951f-ea7d676a4495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_63368949-4749-4287-841a-8814ae750144" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_64544f59-a59b-4afe-951f-ea7d676a4495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_61d2451e-4d84-4f11-9c86-ec3a9b55563a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_36f5dd91-c1fd-4229-a594-5e29da8d1aac" xlink:to="loc_us-gaap_DerivativeTable_61d2451e-4d84-4f11-9c86-ec3a9b55563a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5707178a-0365-4db6-942b-dd32b87ca58c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_61d2451e-4d84-4f11-9c86-ec3a9b55563a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5707178a-0365-4db6-942b-dd32b87ca58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ae932aba-8770-4eaa-bee9-07ccb7fa2a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5707178a-0365-4db6-942b-dd32b87ca58c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ae932aba-8770-4eaa-bee9-07ccb7fa2a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_a4529882-a86f-4985-917a-592ac49344dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ae932aba-8770-4eaa-bee9-07ccb7fa2a3d" xlink:to="loc_us-gaap_ForeignExchangeMember_a4529882-a86f-4985-917a-592ac49344dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_396a9b35-5f53-486e-a940-bab872335ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_61d2451e-4d84-4f11-9c86-ec3a9b55563a" xlink:to="loc_us-gaap_DerivativeLineItems_396a9b35-5f53-486e-a940-bab872335ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_92394bcf-555a-4a89-9ed4-94f0058a3202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_396a9b35-5f53-486e-a940-bab872335ae6" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_92394bcf-555a-4a89-9ed4-94f0058a3202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxes" xlink:type="simple" xlink:href="icui-20220630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_df185bdf-bafd-4749-910b-8ec974d01473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_4cb8fe6d-0144-401b-8129-64d72dd75bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_df185bdf-bafd-4749-910b-8ec974d01473" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_4cb8fe6d-0144-401b-8129-64d72dd75bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#IncomeTaxesEffectivetaxrateDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b898bb93-56fa-4e75-b1ce-81a0d7afec4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3c860b12-6363-455a-ba7b-8ba214773d77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b898bb93-56fa-4e75-b1ce-81a0d7afec4c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3c860b12-6363-455a-ba7b-8ba214773d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_5818bdac-1deb-4e6a-be20-7adc9a3c4bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b898bb93-56fa-4e75-b1ce-81a0d7afec4c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_5818bdac-1deb-4e6a-be20-7adc9a3c4bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_418014bb-765b-4cdf-b486-885a7527288f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b898bb93-56fa-4e75-b1ce-81a0d7afec4c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_418014bb-765b-4cdf-b486-885a7527288f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationTaxExpense_eb9cdd2e-5c77-4abe-a2d0-19c2740b3170" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationTaxExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b898bb93-56fa-4e75-b1ce-81a0d7afec4c" xlink:to="loc_icui_ContingentConsiderationTaxExpense_eb9cdd2e-5c77-4abe-a2d0-19c2740b3170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsNotes" xlink:type="simple" xlink:href="icui-20220630.xsd#LongTermObligationsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_LOngTermObligationsDisclosureAbstract_80acc9f8-daa6-41ec-9d2c-612bd5ccf867" xlink:href="icui-20220630.xsd#icui_LOngTermObligationsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_43a66124-c330-470f-bc64-aeda9a4f8f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_80acc9f8-daa6-41ec-9d2c-612bd5ccf867" xlink:to="loc_us-gaap_LongTermDebtTextBlock_43a66124-c330-470f-bc64-aeda9a4f8f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsTables" xlink:type="simple" xlink:href="icui-20220630.xsd#LongTermObligationsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_LOngTermObligationsDisclosureAbstract_9a26071b-a163-45c4-a23c-fcf1fb44c9e3" xlink:href="icui-20220630.xsd#icui_LOngTermObligationsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_6d734aad-e6ea-4e53-bfd0-b09323bc2e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_9a26071b-a163-45c4-a23c-fcf1fb44c9e3" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_6d734aad-e6ea-4e53-bfd0-b09323bc2e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d050711b-842d-4f85-823a-d77565c88055" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_9a26071b-a163-45c4-a23c-fcf1fb44c9e3" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d050711b-842d-4f85-823a-d77565c88055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestExpenseOnLongTermDebtTableTextBlock_8abe669c-08dc-47e0-a978-b25128172bb0" xlink:href="icui-20220630.xsd#icui_InterestExpenseOnLongTermDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_9a26071b-a163-45c4-a23c-fcf1fb44c9e3" xlink:to="loc_icui_InterestExpenseOnLongTermDebtTableTextBlock_8abe669c-08dc-47e0-a978-b25128172bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock_0509cdb5-5b64-40bb-9d6c-8407e1a5b645" xlink:href="icui-20220630.xsd#icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_9a26071b-a163-45c4-a23c-fcf1fb44c9e3" xlink:to="loc_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock_0509cdb5-5b64-40bb-9d6c-8407e1a5b645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#LongTermObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_LOngTermObligationsDisclosureAbstract_26a1d6ab-a8b2-413e-b3a0-8677d26da939" xlink:href="icui-20220630.xsd#icui_LOngTermObligationsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ec7acefc-a391-49fc-8e11-3d7b78276326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_26a1d6ab-a8b2-413e-b3a0-8677d26da939" xlink:to="loc_us-gaap_DebtInstrumentTable_ec7acefc-a391-49fc-8e11-3d7b78276326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5d9b7129-6f6b-45e2-b1f9-35320f0aa36e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ec7acefc-a391-49fc-8e11-3d7b78276326" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5d9b7129-6f6b-45e2-b1f9-35320f0aa36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3b933f46-a2e7-4803-99f2-9d67345dedc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5d9b7129-6f6b-45e2-b1f9-35320f0aa36e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3b933f46-a2e7-4803-99f2-9d67345dedc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e2593a4d-1c00-4dce-af95-5391dd4b9d98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3b933f46-a2e7-4803-99f2-9d67345dedc5" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e2593a4d-1c00-4dce-af95-5391dd4b9d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_ef043979-7abc-4cb4-abc5-28daaf77ea55" xlink:href="icui-20220630.xsd#icui_TermLoanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ec7acefc-a391-49fc-8e11-3d7b78276326" xlink:to="loc_icui_TermLoanAxis_ef043979-7abc-4cb4-abc5-28daaf77ea55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_fa133a2e-2694-4ad3-84f4-57dbdc706132" xlink:href="icui-20220630.xsd#icui_TermLoanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAxis_ef043979-7abc-4cb4-abc5-28daaf77ea55" xlink:to="loc_icui_TermLoanDomain_fa133a2e-2694-4ad3-84f4-57dbdc706132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_a378b002-8dc3-4f42-9178-62d8bc8712b8" xlink:href="icui-20220630.xsd#icui_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_fa133a2e-2694-4ad3-84f4-57dbdc706132" xlink:to="loc_icui_TermLoanAMember_a378b002-8dc3-4f42-9178-62d8bc8712b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_4ff2b76d-0aaa-4abe-8121-83ceb6e027a1" xlink:href="icui-20220630.xsd#icui_TermLoanBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_fa133a2e-2694-4ad3-84f4-57dbdc706132" xlink:to="loc_icui_TermLoanBMember_4ff2b76d-0aaa-4abe-8121-83ceb6e027a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ec7acefc-a391-49fc-8e11-3d7b78276326" xlink:to="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TotalSeniorSecuredCreditFacility_bc483222-d0bd-4985-b21c-5ba2bf944d2b" xlink:href="icui-20220630.xsd#icui_TotalSeniorSecuredCreditFacility"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:to="loc_icui_TotalSeniorSecuredCreditFacility_bc483222-d0bd-4985-b21c-5ba2bf944d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_7288e4b5-ea43-4fa7-99c7-0aeb330050e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_7288e4b5-ea43-4fa7-99c7-0aeb330050e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_28e44ffc-8f4d-4ee2-ba94-697d1f157052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_28e44ffc-8f4d-4ee2-ba94-697d1f157052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RevolverSubLimits_b721067f-6b79-4804-b13c-2edf9d4a45fb" xlink:href="icui-20220630.xsd#icui_RevolverSubLimits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:to="loc_icui_RevolverSubLimits_b721067f-6b79-4804-b13c-2edf9d4a45fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_66a06f56-1a95-4218-8079-2c9ec71e3780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_66a06f56-1a95-4218-8079-2c9ec71e3780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e80269e9-a6db-418c-a88c-e255d2bbbf3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:to="loc_us-gaap_LongTermDebt_e80269e9-a6db-418c-a88c-e255d2bbbf3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_19634170-da21-466e-8b7d-1cd016e4d79c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_19634170-da21-466e-8b7d-1cd016e4d79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount_efbd7af8-727c-40e6-aa9a-1fc00da6dcf7" xlink:href="icui-20220630.xsd#icui_LeverageRatioCalculationCeilingSubtractedAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9b243b28-6c09-4496-ad6d-cbfc17ad78ab" xlink:to="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount_efbd7af8-727c-40e6-aa9a-1fc00da6dcf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#LongTermObligationsInterestRateTermsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cd56a2dc-1266-44e8-b93a-ba34fb25efc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestPercentageAddedToFederalFundsRate_e0fa2b7a-bd21-4484-a625-42400a853505" xlink:href="icui-20220630.xsd#icui_InterestPercentageAddedToFederalFundsRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cd56a2dc-1266-44e8-b93a-ba34fb25efc8" xlink:to="loc_icui_InterestPercentageAddedToFederalFundsRate_e0fa2b7a-bd21-4484-a625-42400a853505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestPercentageAddedToBaseRate_ff2f7e0b-4ce8-43b0-9e2e-75453833d8a4" xlink:href="icui-20220630.xsd#icui_InterestPercentageAddedToBaseRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cd56a2dc-1266-44e8-b93a-ba34fb25efc8" xlink:to="loc_icui_InterestPercentageAddedToBaseRate_ff2f7e0b-4ce8-43b0-9e2e-75453833d8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans_7a23cc61-8bf6-4195-8bde-6ba59dce5d04" xlink:href="icui-20220630.xsd#icui_TerSOFRInterestRateAdjustmentForBaseRateLoans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cd56a2dc-1266-44e8-b93a-ba34fb25efc8" xlink:to="loc_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans_7a23cc61-8bf6-4195-8bde-6ba59dce5d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_fc85aeac-65c1-4c0b-9f29-8e9941d68980" xlink:href="icui-20220630.xsd#icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cd56a2dc-1266-44e8-b93a-ba34fb25efc8" xlink:to="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_fc85aeac-65c1-4c0b-9f29-8e9941d68980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_bfa011c1-738e-4295-bfe5-722d4eed2f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cd56a2dc-1266-44e8-b93a-ba34fb25efc8" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_bfa011c1-738e-4295-bfe5-722d4eed2f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBaseRateLoans_93d469f4-71d7-498d-91b5-3647ee53b349" xlink:href="icui-20220630.xsd#icui_ApplicableMarginBaseRateLoans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cd56a2dc-1266-44e8-b93a-ba34fb25efc8" xlink:to="loc_icui_ApplicableMarginBaseRateLoans_93d469f4-71d7-498d-91b5-3647ee53b349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginTermSOFRLoans_f8f213b6-3e11-4263-9d3c-9bfbad4abaaf" xlink:href="icui-20220630.xsd#icui_ApplicableMarginTermSOFRLoans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cd56a2dc-1266-44e8-b93a-ba34fb25efc8" xlink:to="loc_icui_ApplicableMarginTermSOFRLoans_f8f213b6-3e11-4263-9d3c-9bfbad4abaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_3a511c99-afbc-492e-84b3-e0dacfcfff72" xlink:href="icui-20220630.xsd#icui_ApplicableMarginBasedOnLeverageRatioTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cd56a2dc-1266-44e8-b93a-ba34fb25efc8" xlink:to="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_3a511c99-afbc-492e-84b3-e0dacfcfff72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_c7b317b7-c198-4a5f-8f64-3f5cf37c076e" xlink:href="icui-20220630.xsd#icui_TermLoanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_3a511c99-afbc-492e-84b3-e0dacfcfff72" xlink:to="loc_icui_TermLoanAxis_c7b317b7-c198-4a5f-8f64-3f5cf37c076e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_06ff857c-6fcd-4324-82e4-baa9d4377762" xlink:href="icui-20220630.xsd#icui_TermLoanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAxis_c7b317b7-c198-4a5f-8f64-3f5cf37c076e" xlink:to="loc_icui_TermLoanDomain_06ff857c-6fcd-4324-82e4-baa9d4377762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_c35f511d-93a8-4d8e-a27c-14fb80801eb0" xlink:href="icui-20220630.xsd#icui_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_06ff857c-6fcd-4324-82e4-baa9d4377762" xlink:to="loc_icui_TermLoanAMember_c35f511d-93a8-4d8e-a27c-14fb80801eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_554a1a15-7c81-4495-ba64-0addc3f41ca4" xlink:href="icui-20220630.xsd#icui_TermLoanBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_06ff857c-6fcd-4324-82e4-baa9d4377762" xlink:to="loc_icui_TermLoanBMember_554a1a15-7c81-4495-ba64-0addc3f41ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelAxis_b3468c16-11be-4efa-96a9-83c1f43e9ced" xlink:href="icui-20220630.xsd#icui_LeverageRatioLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_3a511c99-afbc-492e-84b3-e0dacfcfff72" xlink:to="loc_icui_LeverageRatioLevelAxis_b3468c16-11be-4efa-96a9-83c1f43e9ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:href="icui-20220630.xsd#icui_LeverageRatioLevelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelAxis_b3468c16-11be-4efa-96a9-83c1f43e9ced" xlink:to="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Greaterthan400to100Member_6b878b94-b934-41ae-a118-1f82dae9bf3e" xlink:href="icui-20220630.xsd#icui_Greaterthan400to100Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:to="loc_icui_Greaterthan400to100Member_6b878b94-b934-41ae-a118-1f82dae9bf3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_abebcae5-6712-4838-abca-b80f8fed8e32" xlink:href="icui-20220630.xsd#icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:to="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_abebcae5-6712-4838-abca-b80f8fed8e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_8d612a7f-2936-4afa-b6c0-ef526460c75b" xlink:href="icui-20220630.xsd#icui_LessThanOrEqual300To100ButGreaterThan250to100Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:to="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_8d612a7f-2936-4afa-b6c0-ef526460c75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_cf7bcab2-fc39-49db-8b69-4e8d08adefae" xlink:href="icui-20220630.xsd#icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:to="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_cf7bcab2-fc39-49db-8b69-4e8d08adefae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo200To100Member_30ee325c-3f92-4bcc-91af-35a9d0034f1e" xlink:href="icui-20220630.xsd#icui_LessThanOrEqualTo200To100Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:to="loc_icui_LessThanOrEqualTo200To100Member_30ee325c-3f92-4bcc-91af-35a9d0034f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GreaterThan275To100Member_87810cd0-adca-4292-b71b-d63e67caad44" xlink:href="icui-20220630.xsd#icui_GreaterThan275To100Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:to="loc_icui_GreaterThan275To100Member_87810cd0-adca-4292-b71b-d63e67caad44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThan275To100Member_1e3031b5-dd5b-4ebb-9414-eb8d900959b4" xlink:href="icui-20220630.xsd#icui_LessThan275To100Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_065ea96a-e8d1-4ac8-9404-321f805e1d48" xlink:to="loc_icui_LessThan275To100Member_1e3031b5-dd5b-4ebb-9414-eb8d900959b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a312379d-f308-40e3-a9c2-4b7b027edc28" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_3a511c99-afbc-492e-84b3-e0dacfcfff72" xlink:to="loc_srt_RangeAxis_a312379d-f308-40e3-a9c2-4b7b027edc28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2459fd56-8312-4a53-9835-fa8a011a3e68" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a312379d-f308-40e3-a9c2-4b7b027edc28" xlink:to="loc_srt_RangeMember_2459fd56-8312-4a53-9835-fa8a011a3e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2a45be1d-4caa-4eaf-9a35-e25c388a7708" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2459fd56-8312-4a53-9835-fa8a011a3e68" xlink:to="loc_srt_MaximumMember_2a45be1d-4caa-4eaf-9a35-e25c388a7708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_10fcb048-b97a-45ba-8e2f-14265c33f47f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2459fd56-8312-4a53-9835-fa8a011a3e68" xlink:to="loc_srt_MinimumMember_10fcb048-b97a-45ba-8e2f-14265c33f47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_089b5a89-3e90-4a14-b95f-b656ed8621a2" xlink:href="icui-20220630.xsd#icui_ApplicableMarginBasedOnLeverageRatioLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_3a511c99-afbc-492e-84b3-e0dacfcfff72" xlink:to="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_089b5a89-3e90-4a14-b95f-b656ed8621a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBaseRateLoans_21d69751-3fee-4021-916d-7055e654e817" xlink:href="icui-20220630.xsd#icui_ApplicableMarginBaseRateLoans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_089b5a89-3e90-4a14-b95f-b656ed8621a2" xlink:to="loc_icui_ApplicableMarginBaseRateLoans_21d69751-3fee-4021-916d-7055e654e817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginTermSOFRLoans_a532f38b-098a-4739-9d21-6f40104bef5d" xlink:href="icui-20220630.xsd#icui_ApplicableMarginTermSOFRLoans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_089b5a89-3e90-4a14-b95f-b656ed8621a2" xlink:to="loc_icui_ApplicableMarginTermSOFRLoans_a532f38b-098a-4739-9d21-6f40104bef5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_f014bbbf-6cad-44d4-858a-16881b3d3cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_089b5a89-3e90-4a14-b95f-b656ed8621a2" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_f014bbbf-6cad-44d4-858a-16881b3d3cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_4dd40f14-4cab-4511-829c-3b7ad9b7609a" xlink:href="icui-20220630.xsd#icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_089b5a89-3e90-4a14-b95f-b656ed8621a2" xlink:to="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_4dd40f14-4cab-4511-829c-3b7ad9b7609a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#LongTermObligationsTerminatedCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bd8efafb-1b1c-47d1-9a11-0004ee9e87e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_239f9229-3f49-441e-80f1-f3d80c430001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bd8efafb-1b1c-47d1-9a11-0004ee9e87e2" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_239f9229-3f49-441e-80f1-f3d80c430001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationDate1_a61a1d16-5c8c-4ad5-be97-cdd80c13adf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bd8efafb-1b1c-47d1-9a11-0004ee9e87e2" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationDate1_a61a1d16-5c8c-4ad5-be97-cdd80c13adf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_3f870731-6abb-454f-bf00-321f9367cee3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bd8efafb-1b1c-47d1-9a11-0004ee9e87e2" xlink:to="loc_us-gaap_LinesOfCreditCurrent_3f870731-6abb-454f-bf00-321f9367cee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsTableDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#LongTermObligationsTableDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0dcbf1c8-869f-4a9e-bc73-6e386bd2188c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_09f48637-839a-463b-9efc-099b4f3ae756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0dcbf1c8-869f-4a9e-bc73-6e386bd2188c" xlink:to="loc_us-gaap_DebtInstrumentTable_09f48637-839a-463b-9efc-099b4f3ae756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_c2ef0db2-d700-41da-b365-9cfa87c4088c" xlink:href="icui-20220630.xsd#icui_TermLoanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_09f48637-839a-463b-9efc-099b4f3ae756" xlink:to="loc_icui_TermLoanAxis_c2ef0db2-d700-41da-b365-9cfa87c4088c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_1a60919a-7a2b-48e8-b83f-fba9f2f852e0" xlink:href="icui-20220630.xsd#icui_TermLoanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAxis_c2ef0db2-d700-41da-b365-9cfa87c4088c" xlink:to="loc_icui_TermLoanDomain_1a60919a-7a2b-48e8-b83f-fba9f2f852e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_0609ccda-4e53-4c0b-a009-e4085ad95ed7" xlink:href="icui-20220630.xsd#icui_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_1a60919a-7a2b-48e8-b83f-fba9f2f852e0" xlink:to="loc_icui_TermLoanAMember_0609ccda-4e53-4c0b-a009-e4085ad95ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_ffefffa2-19c8-4dd2-9b82-62de36cc9ad2" xlink:href="icui-20220630.xsd#icui_TermLoanBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_1a60919a-7a2b-48e8-b83f-fba9f2f852e0" xlink:to="loc_icui_TermLoanBMember_ffefffa2-19c8-4dd2-9b82-62de36cc9ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c3e1dd4b-ed6d-4c9a-9d54-08d91572d6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_09f48637-839a-463b-9efc-099b4f3ae756" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c3e1dd4b-ed6d-4c9a-9d54-08d91572d6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ecea38ed-1813-4963-8495-c7f30bcb8ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c3e1dd4b-ed6d-4c9a-9d54-08d91572d6b1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ecea38ed-1813-4963-8495-c7f30bcb8ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ea68c47b-d8c8-4a19-9c96-860b613d993b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ecea38ed-1813-4963-8495-c7f30bcb8ec0" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ea68c47b-d8c8-4a19-9c96-860b613d993b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_09f48637-839a-463b-9efc-099b4f3ae756" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_68e52ab5-1582-4c77-b094-733320e3def4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_68e52ab5-1582-4c77-b094-733320e3def4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_03600ef4-b225-43aa-9585-65dd3623a458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_03600ef4-b225-43aa-9585-65dd3623a458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_5f030f65-6a08-4f56-9326-bb32a9109c14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_5f030f65-6a08-4f56-9326-bb32a9109c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_6a332f19-db54-4798-bb68-879f5f137038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_6a332f19-db54-4798-bb68-879f5f137038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_3a87b529-8683-44e6-bc20-a1f2278414ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:to="loc_us-gaap_DebtCurrent_3a87b529-8683-44e6-bc20-a1f2278414ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e5181fc4-abe0-44e0-869c-a5505c2e3786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e5181fc4-abe0-44e0-869c-a5505c2e3786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_0f7fa3e9-cdea-4304-8073-852e42634435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ea326657-4a50-413b-a909-b3b41f12267a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_0f7fa3e9-cdea-4304-8073-852e42634435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#LongTermObligationsScheduleofMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_LOngTermObligationsDisclosureAbstract_802f4d7b-2ad2-4e97-be76-c4d6ed4427be" xlink:href="icui-20220630.xsd#icui_LOngTermObligationsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_a9a4cc8c-7a9a-4523-883b-3c3c3ec73237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_802f4d7b-2ad2-4e97-be76-c4d6ed4427be" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_a9a4cc8c-7a9a-4523-883b-3c3c3ec73237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_a78fc56b-7a12-493b-b807-093ca7097ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_802f4d7b-2ad2-4e97-be76-c4d6ed4427be" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_a78fc56b-7a12-493b-b807-093ca7097ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b25b5c38-734c-4823-9fa5-f7176e08c58d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_802f4d7b-2ad2-4e97-be76-c4d6ed4427be" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b25b5c38-734c-4823-9fa5-f7176e08c58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_fb33bc2e-8853-4393-baad-bf5c4dd45231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_802f4d7b-2ad2-4e97-be76-c4d6ed4427be" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_fb33bc2e-8853-4393-baad-bf5c4dd45231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7bf415ec-ae1f-41a7-9964-6e4f6b07c755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_802f4d7b-2ad2-4e97-be76-c4d6ed4427be" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7bf415ec-ae1f-41a7-9964-6e4f6b07c755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a2157039-72f6-42db-bb21-b44bb9d7135f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_802f4d7b-2ad2-4e97-be76-c4d6ed4427be" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a2157039-72f6-42db-bb21-b44bb9d7135f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_a48b3780-0427-4db4-a3ef-3a39ed6fe797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_802f4d7b-2ad2-4e97-be76-c4d6ed4427be" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_a48b3780-0427-4db4-a3ef-3a39ed6fe797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_2e2290b9-7180-4d39-b9a0-25444e83ed97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_802f4d7b-2ad2-4e97-be76-c4d6ed4427be" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_2e2290b9-7180-4d39-b9a0-25444e83ed97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#LongTermObligationsInterestExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9081e677-3075-4910-bb7f-aa71d04dd70b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_2e3539fd-8c18-4c91-832b-9eb51039ced0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9081e677-3075-4910-bb7f-aa71d04dd70b" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_2e3539fd-8c18-4c91-832b-9eb51039ced0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_77f2db19-58ba-4c5e-ac45-06d01f2b528e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9081e677-3075-4910-bb7f-aa71d04dd70b" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_77f2db19-58ba-4c5e-ac45-06d01f2b528e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_834563db-7574-4832-8d4a-e21fed7ed7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9081e677-3075-4910-bb7f-aa71d04dd70b" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_834563db-7574-4832-8d4a-e21fed7ed7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_c2247aa2-dd81-44c3-aed5-6b33bb0c7462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9081e677-3075-4910-bb7f-aa71d04dd70b" xlink:to="loc_us-gaap_InterestExpenseDebt_c2247aa2-dd81-44c3-aed5-6b33bb0c7462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#LongTermObligationsPrincipalPaymentDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f876b488-f02e-4566-a6cc-023291ed7ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentFirst2Years_8f833663-eac0-4f81-9148-79a544f4699e" xlink:href="icui-20220630.xsd#icui_TermAPrincipalPaymentFirst2Years"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f876b488-f02e-4566-a6cc-023291ed7ee2" xlink:to="loc_icui_TermAPrincipalPaymentFirst2Years_8f833663-eac0-4f81-9148-79a544f4699e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentYear3And4_2cf3d98a-fd1d-4cb0-94d1-fe245b410460" xlink:href="icui-20220630.xsd#icui_TermAPrincipalPaymentYear3And4"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f876b488-f02e-4566-a6cc-023291ed7ee2" xlink:to="loc_icui_TermAPrincipalPaymentYear3And4_2cf3d98a-fd1d-4cb0-94d1-fe245b410460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentInYear5_c91787f8-41f6-420c-8835-a1d82af60093" xlink:href="icui-20220630.xsd#icui_TermAPrincipalPaymentInYear5"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f876b488-f02e-4566-a6cc-023291ed7ee2" xlink:to="loc_icui_TermAPrincipalPaymentInYear5_c91787f8-41f6-420c-8835-a1d82af60093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBPrincipalPayment_0f434bf8-e83a-45e7-88d1-c0da4665192a" xlink:href="icui-20220630.xsd#icui_TermLoanBPrincipalPayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f876b488-f02e-4566-a6cc-023291ed7ee2" xlink:to="loc_icui_TermLoanBPrincipalPayment_0f434bf8-e83a-45e7-88d1-c0da4665192a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_1d2910ff-a1e6-494f-8e79-d2ef06b411a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f876b488-f02e-4566-a6cc-023291ed7ee2" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_1d2910ff-a1e6-494f-8e79-d2ef06b411a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="icui-20220630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7e5da657-b443-4b76-b6e6-eef4b0b3562d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_70c84afa-49d3-4973-8b2b-24f299dd8ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7e5da657-b443-4b76-b6e6-eef4b0b3562d" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_70c84afa-49d3-4973-8b2b-24f299dd8ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#CommitmentsandContingenciesContingencyDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ae4cacad-6988-47e9-80f2-ad10d4d57f73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5c683317-b429-4877-a978-6c820dae2862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ae4cacad-6988-47e9-80f2-ad10d4d57f73" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5c683317-b429-4877-a978-6c820dae2862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1767f18a-1fce-404f-b39b-f50a8e77547a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5c683317-b429-4877-a978-6c820dae2862" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1767f18a-1fce-404f-b39b-f50a8e77547a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e846880-2058-47aa-9ace-cd003bdd6f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1767f18a-1fce-404f-b39b-f50a8e77547a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e846880-2058-47aa-9ace-cd003bdd6f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_d513d125-78b0-496f-a781-e36885e28029" xlink:href="icui-20220630.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e846880-2058-47aa-9ace-cd003bdd6f4a" xlink:to="loc_icui_SmithsMedicalMember_d513d125-78b0-496f-a781-e36885e28029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_412a0fd9-c0f9-4085-b1f7-01257d59d8a2" xlink:href="icui-20220630.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e846880-2058-47aa-9ace-cd003bdd6f4a" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_412a0fd9-c0f9-4085-b1f7-01257d59d8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InternationalDistributorMember_8a4327c1-f80e-4db7-b4d0-9fe865f0cee6" xlink:href="icui-20220630.xsd#icui_InternationalDistributorMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e846880-2058-47aa-9ace-cd003bdd6f4a" xlink:to="loc_icui_InternationalDistributorMember_8a4327c1-f80e-4db7-b4d0-9fe865f0cee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_fe0e420b-0308-41d5-a5d0-afe61bd55de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5c683317-b429-4877-a978-6c820dae2862" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_fe0e420b-0308-41d5-a5d0-afe61bd55de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_a0db8b1a-74ce-483f-82a3-c4b3f9baee48" xlink:href="icui-20220630.xsd#icui_Contingentconsiderationgross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_fe0e420b-0308-41d5-a5d0-afe61bd55de1" xlink:to="loc_icui_Contingentconsiderationgross_a0db8b1a-74ce-483f-82a3-c4b3f9baee48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_efd21afa-bcb1-4855-8397-130124a0e765" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationGrossST"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_fe0e420b-0308-41d5-a5d0-afe61bd55de1" xlink:to="loc_icui_ContingentConsiderationGrossST_efd21afa-bcb1-4855-8397-130124a0e765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_5db7530b-0aa4-4dbb-a50a-202994bbfb88" xlink:href="icui-20220630.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_fe0e420b-0308-41d5-a5d0-afe61bd55de1" xlink:to="loc_icui_ContingentConsiderationGrossLT_5db7530b-0aa4-4dbb-a50a-202994bbfb88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3c1edfd2-3982-4f7b-bc05-ef7ae658a397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_fe0e420b-0308-41d5-a5d0-afe61bd55de1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3c1edfd2-3982-4f7b-bc05-ef7ae658a397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_3a72e079-f4a3-4937-98f5-be26b270bf30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_fe0e420b-0308-41d5-a5d0-afe61bd55de1" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_3a72e079-f4a3-4937-98f5-be26b270bf30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes" xlink:type="simple" xlink:href="icui-20220630.xsd#CollaborativeandOtherArrangementsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_83da84b9-b90c-422f-827e-ebb5e4059d27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_d95ea5dc-aa21-40a4-a681-26eff24dd556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_83da84b9-b90c-422f-827e-ebb5e4059d27" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_d95ea5dc-aa21-40a4-a681-26eff24dd556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsTables" xlink:type="simple" xlink:href="icui-20220630.xsd#CollaborativeandOtherArrangementsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CollaborativeandOtherArrangementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#CollaborativeandOtherArrangementsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ebc3e895-c8e8-499a-9d1c-d8edbef47170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_b1f8ad4e-89da-4516-8911-70ec40e468cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ebc3e895-c8e8-499a-9d1c-d8edbef47170" xlink:to="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_b1f8ad4e-89da-4516-8911-70ec40e468cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/Equity" xlink:type="simple" xlink:href="icui-20220630.xsd#Equity"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/Equity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_601ed0c8-15bf-47f1-9a44-ea99037690bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_d8b6407e-897a-48f6-9359-a0cab35ecf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_601ed0c8-15bf-47f1-9a44-ea99037690bc" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_d8b6407e-897a-48f6-9359-a0cab35ecf1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/EquityTables" xlink:type="simple" xlink:href="icui-20220630.xsd#EquityTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/EquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_23271b08-559b-48ab-aaf9-bc20651aaf21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_28348250-62d4-40d3-8aa9-97dad09b0b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_23271b08-559b-48ab-aaf9-bc20651aaf21" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_28348250-62d4-40d3-8aa9-97dad09b0b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/EquityDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#EquityDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/EquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_cc8cb384-1b36-4903-a7aa-658c10dfeba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TreasuryStockPurchasePlan_ab999b35-c8eb-4060-a407-a0d196f05cfa" xlink:href="icui-20220630.xsd#icui_TreasuryStockPurchasePlan"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cc8cb384-1b36-4903-a7aa-658c10dfeba8" xlink:to="loc_icui_TreasuryStockPurchasePlan_ab999b35-c8eb-4060-a407-a0d196f05cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_11f04b9a-a917-44ca-a554-719b331ecd94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cc8cb384-1b36-4903-a7aa-658c10dfeba8" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_11f04b9a-a917-44ca-a554-719b331ecd94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_b76de93e-e059-4406-b29b-006ca6b8aa38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cc8cb384-1b36-4903-a7aa-658c10dfeba8" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_b76de93e-e059-4406-b29b-006ca6b8aa38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_734b2934-8c95-4334-9109-1b181c56c9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cc8cb384-1b36-4903-a7aa-658c10dfeba8" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_734b2934-8c95-4334-9109-1b181c56c9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsGroupOwnershipAcquisitionSharesIssued_db6fd8ba-54d6-4640-9ac1-c6caf648ff45" xlink:href="icui-20220630.xsd#icui_SmithsGroupOwnershipAcquisitionSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cc8cb384-1b36-4903-a7aa-658c10dfeba8" xlink:to="loc_icui_SmithsGroupOwnershipAcquisitionSharesIssued_db6fd8ba-54d6-4640-9ac1-c6caf648ff45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsGroupOwnershipRequiredForBoardRepresentation_a81e4071-dfa2-41a9-a8b7-98d4a98f0e97" xlink:href="icui-20220630.xsd#icui_SmithsGroupOwnershipRequiredForBoardRepresentation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cc8cb384-1b36-4903-a7aa-658c10dfeba8" xlink:to="loc_icui_SmithsGroupOwnershipRequiredForBoardRepresentation_a81e4071-dfa2-41a9-a8b7-98d4a98f0e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="icui-20220630.xsd#EquityAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_572ff45c-cc12-49c1-ad0e-ad4725c9d8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_eba07e69-aee8-4c26-9239-520a0f75e1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_572ff45c-cc12-49c1-ad0e-ad4725c9d8ff" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_eba07e69-aee8-4c26-9239-520a0f75e1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_20b0a092-0a41-4f61-84ca-14cf91c98062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_eba07e69-aee8-4c26-9239-520a0f75e1ea" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_20b0a092-0a41-4f61-84ca-14cf91c98062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_34143f7c-6cc1-4c39-b549-5e9c3a306a36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_20b0a092-0a41-4f61-84ca-14cf91c98062" xlink:to="loc_us-gaap_EquityComponentDomain_34143f7c-6cc1-4c39-b549-5e9c3a306a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_a2955aaa-5b94-415a-97fa-4a67ed67fbbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_34143f7c-6cc1-4c39-b549-5e9c3a306a36" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_a2955aaa-5b94-415a-97fa-4a67ed67fbbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_67a840e2-22e8-428c-8119-84684d5a22da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_34143f7c-6cc1-4c39-b549-5e9c3a306a36" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_67a840e2-22e8-428c-8119-84684d5a22da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0eed7480-3d8f-43ee-a0d5-13e546d5cda5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_34143f7c-6cc1-4c39-b549-5e9c3a306a36" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0eed7480-3d8f-43ee-a0d5-13e546d5cda5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3d0a043-9696-4b7c-9f52-5911c7c0d9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_eba07e69-aee8-4c26-9239-520a0f75e1ea" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3d0a043-9696-4b7c-9f52-5911c7c0d9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2bc2c8e6-a480-4073-a5bf-24a0f328d627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3d0a043-9696-4b7c-9f52-5911c7c0d9d4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2bc2c8e6-a480-4073-a5bf-24a0f328d627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_bab0e1d5-690a-4c26-a980-7e4a7f1eac70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3d0a043-9696-4b7c-9f52-5911c7c0d9d4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_bab0e1d5-690a-4c26-a980-7e4a7f1eac70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2768a117-8b5e-40dd-9c34-58b20fb7718a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3d0a043-9696-4b7c-9f52-5911c7c0d9d4" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2768a117-8b5e-40dd-9c34-58b20fb7718a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f377260f-12d9-4d3c-aaea-2ed55bdc4411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3d0a043-9696-4b7c-9f52-5911c7c0d9d4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f377260f-12d9-4d3c-aaea-2ed55bdc4411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_623b0306-8a0a-4a70-b5eb-8137b3de49f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3d0a043-9696-4b7c-9f52-5911c7c0d9d4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_623b0306-8a0a-4a70-b5eb-8137b3de49f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615851181040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEI Document - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0022692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">951 Calle Amanecer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Clemente<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">366-2183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.10 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ICUI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,899,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000883984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ICU MEDICAL INC/DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document And Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852484736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">$ 255,698<span></span>
</td>
<td class="nump">$ 552,827<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">13,191<span></span>
</td>
<td class="nump">14,420<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">TOTAL CASH, CASH EQUIVALENTS AND INVESTMENT SECURITIES</a></td>
<td class="nump">268,889<span></span>
</td>
<td class="nump">567,247<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for doubtful accounts</a></td>
<td class="nump">216,124<span></span>
</td>
<td class="nump">105,894<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">583,050<span></span>
</td>
<td class="nump">290,235<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">27,111<span></span>
</td>
<td class="nump">19,586<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">94,663<span></span>
</td>
<td class="nump">46,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">TOTAL CURRENT ASSETS</a></td>
<td class="nump">1,189,837<span></span>
</td>
<td class="nump">1,029,809<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">PROPERTY AND EQUIPMENT, net</a></td>
<td class="nump">667,783<span></span>
</td>
<td class="nump">468,365<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">83,323<span></span>
</td>
<td class="nump">39,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">1,837<span></span>
</td>
<td class="nump">4,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">GOODWILL</a></td>
<td class="nump">1,421,216<span></span>
</td>
<td class="nump">43,439<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">INTANGIBLE ASSETS, net</a></td>
<td class="nump">1,080,329<span></span>
</td>
<td class="nump">188,311<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred Income Tax Assets</a></td>
<td class="nump">43,942<span></span>
</td>
<td class="nump">42,604<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">OTHER ASSETS</a></td>
<td class="nump">101,728<span></span>
</td>
<td class="nump">63,743<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">4,589,995<span></span>
</td>
<td class="nump">1,880,738<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">201,874<span></span>
</td>
<td class="nump">81,128<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">247,656<span></span>
</td>
<td class="nump">118,195<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term Debt, Current Maturities</a></td>
<td class="nump">19,063<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax liability</a></td>
<td class="nump">17,102<span></span>
</td>
<td class="nump">1,454<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Contingent earn-out liability</a></td>
<td class="nump">290<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">TOTAL CURRENT LIABILITIES</a></td>
<td class="nump">485,985<span></span>
</td>
<td class="nump">200,777<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent Earn-Out Liability, Noncurrent</a></td>
<td class="nump">30,119<span></span>
</td>
<td class="nump">2,589<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">1,636,029<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">128,200<span></span>
</td>
<td class="nump">41,830<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">DEFERRED INCOME TAXES</a></td>
<td class="nump">204,992<span></span>
</td>
<td class="nump">1,490<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">INCOME TAX LIABILITY</a></td>
<td class="nump">18,804<span></span>
</td>
<td class="nump">18,021<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>STOCKHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue', window );">Convertible preferred stock, $1.00 par value Authorized-500 shares; Issued and outstanding - none</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.10 par value - Authorized-80,000 shares; Issued 23,899 shares at June 30,2022 and 21,280 shares at December 31, 2021 and outstanding 23,898 shares at June 30, 2022 and 21,280 shares at December 31, 2021</a></td>
<td class="nump">2,390<span></span>
</td>
<td class="nump">2,128<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,309,598<span></span>
</td>
<td class="nump">721,412<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury Stock, at cost (12,684 and 119 shares, respectively)</a></td>
<td class="num">(92)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">866,245<span></span>
</td>
<td class="nump">911,787<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(92,275)<span></span>
</td>
<td class="num">(19,269)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">TOTAL STOCKHOLDERS' EQUITY</a></td>
<td class="nump">2,085,866<span></span>
</td>
<td class="nump">1,616,031<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 4,589,995<span></span>
</td>
<td class="nump">$ 1,880,738<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding nonredeemable convertible preferred stock or outstanding convertible preferred stock that is redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615851024160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="nump">$ 7,557<span></span>
</td>
<td class="nump">$ 7,038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred stock, par value</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock, authorized shares</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible preferred stock, issued shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred stock, outstanding shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">80,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">23,899,000<span></span>
</td>
<td class="nump">21,280,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">23,898,000<span></span>
</td>
<td class="nump">21,280,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">406<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615853603120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Income - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">$ 561,004<span></span>
</td>
<td class="nump">$ 321,677<span></span>
</td>
<td class="nump">$ 1,104,126<span></span>
</td>
<td class="nump">$ 639,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of goods sold</a></td>
<td class="nump">393,411<span></span>
</td>
<td class="nump">198,148<span></span>
</td>
<td class="nump">767,706<span></span>
</td>
<td class="nump">403,514<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">167,593<span></span>
</td>
<td class="nump">123,529<span></span>
</td>
<td class="nump">336,420<span></span>
</td>
<td class="nump">236,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">158,748<span></span>
</td>
<td class="nump">73,921<span></span>
</td>
<td class="nump">311,960<span></span>
</td>
<td class="nump">146,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">22,562<span></span>
</td>
<td class="nump">11,385<span></span>
</td>
<td class="nump">46,433<span></span>
</td>
<td class="nump">22,094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Restructuringandstrategictransaction', window );">Restructuring, strategic transaction and integration</a></td>
<td class="nump">13,525<span></span>
</td>
<td class="nump">3,753<span></span>
</td>
<td class="nump">47,430<span></span>
</td>
<td class="nump">6,636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent earn-out</a></td>
<td class="num">(27,194)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(27,194)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contractsettlement', window );">contract settlement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">TOTAL OPERATING EXPENSES</a></td>
<td class="nump">167,641<span></span>
</td>
<td class="nump">89,059<span></span>
</td>
<td class="nump">378,629<span></span>
</td>
<td class="nump">175,169<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">(LOSS) INCOME FROM OPERATIONS</a></td>
<td class="num">(48)<span></span>
</td>
<td class="nump">34,470<span></span>
</td>
<td class="num">(42,209)<span></span>
</td>
<td class="nump">61,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="num">(16,273)<span></span>
</td>
<td class="num">(163)<span></span>
</td>
<td class="num">(29,917)<span></span>
</td>
<td class="num">(324)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">OTHER (EXPENSE) INCOME, net</a></td>
<td class="num">(533)<span></span>
</td>
<td class="nump">525<span></span>
</td>
<td class="nump">471<span></span>
</td>
<td class="nump">1,208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(Loss) Income from Continuing Operations before Income Taxes, Noncontrolling Interest</a></td>
<td class="num">(16,854)<span></span>
</td>
<td class="nump">34,832<span></span>
</td>
<td class="num">(71,655)<span></span>
</td>
<td class="nump">61,924<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">BENEFIT (PROVISION) FOR INCOME TAXES</a></td>
<td class="nump">9,380<span></span>
</td>
<td class="num">(6,434)<span></span>
</td>
<td class="nump">26,113<span></span>
</td>
<td class="num">(9,795)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET (LOSS) INCOME</a></td>
<td class="num">$ (7,474)<span></span>
</td>
<td class="nump">$ 28,398<span></span>
</td>
<td class="num">$ (45,542)<span></span>
</td>
<td class="nump">$ 52,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>NET INCOME PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="nump">$ 1.34<span></span>
</td>
<td class="num">$ (1.91)<span></span>
</td>
<td class="nump">$ 2.46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="nump">$ 1.31<span></span>
</td>
<td class="num">$ (1.91)<span></span>
</td>
<td class="nump">$ 2.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>WEIGHTED AVERAGE NUMBER OF SHARES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">23,897<span></span>
</td>
<td class="nump">21,200<span></span>
</td>
<td class="nump">23,787<span></span>
</td>
<td class="nump">21,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">23,897<span></span>
</td>
<td class="nump">21,703<span></span>
</td>
<td class="nump">23,787<span></span>
</td>
<td class="nump">21,718<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Contractsettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contract settlement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Contractsettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Restructuringandstrategictransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and strategic transaction expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Restructuringandstrategictransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615937119136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (Loss) Income</a></td>
<td class="num">$ (7,474)<span></span>
</td>
<td class="nump">$ 28,398<span></span>
</td>
<td class="num">$ (45,542)<span></span>
</td>
<td class="nump">$ 52,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</a></td>
<td class="nump">8,144<span></span>
</td>
<td class="num">(352)<span></span>
</td>
<td class="nump">31,716<span></span>
</td>
<td class="num">(1,296)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of taxes of $0 for all periods</a></td>
<td class="num">(99,805)<span></span>
</td>
<td class="nump">1,302<span></span>
</td>
<td class="num">(104,751)<span></span>
</td>
<td class="num">(6,156)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Other Adjustments, after Tax</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="num">(91,647)<span></span>
</td>
<td class="nump">962<span></span>
</td>
<td class="num">(73,006)<span></span>
</td>
<td class="num">(7,429)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Income</a></td>
<td class="num">$ (99,121)<span></span>
</td>
<td class="nump">$ 29,360<span></span>
</td>
<td class="num">$ (118,548)<span></span>
</td>
<td class="nump">$ 44,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852475104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Paranthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</a></td>
<td class="nump">$ 4,370<span></span>
</td>
<td class="num">$ (111)<span></span>
</td>
<td class="nump">$ 11,681<span></span>
</td>
<td class="num">$ (409)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615846895088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock Shares [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,058,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Dec. 31, 2020</a></td>
<td class="nump">$ 1,502,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,106<span></span>
</td>
<td class="nump">$ 693,068<span></span>
</td>
<td class="num">$ (39)<span></span>
</td>
<td class="nump">$ 808,652<span></span>
</td>
<td class="num">$ (1,522)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">4,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Adjustments to Additional Paid in Capital, Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</a></td>
<td class="num">(7,723)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,723)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="nump">6,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other Comprehensive (Loss) Income, Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</a></td>
<td class="num">(8,391)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income Attributable to Parent</a></td>
<td class="nump">23,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Mar. 31, 2021</a></td>
<td class="nump">1,520,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,122<span></span>
</td>
<td class="nump">701,586<span></span>
</td>
<td class="num">(5,410)<span></span>
</td>
<td class="nump">832,383<span></span>
</td>
<td class="num">(9,913)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,219,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="num">(8,391)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,391)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,058,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Dec. 31, 2020</a></td>
<td class="nump">$ 1,502,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,106<span></span>
</td>
<td class="nump">693,068<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="nump">808,652<span></span>
</td>
<td class="num">(1,522)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</a></td>
<td class="num">(37,882)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Jun. 30, 2021</a></td>
<td class="nump">$ 1,557,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,122<span></span>
</td>
<td class="nump">705,582<span></span>
</td>
<td class="num">(2,269)<span></span>
</td>
<td class="nump">860,781<span></span>
</td>
<td class="num">(8,951)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,219,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="num">(7,429)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,219,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Mar. 31, 2021</a></td>
<td class="nump">1,520,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,122<span></span>
</td>
<td class="nump">701,586<span></span>
</td>
<td class="num">(5,410)<span></span>
</td>
<td class="nump">832,383<span></span>
</td>
<td class="num">(9,913)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Adjustments to Additional Paid in Capital, Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,685)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</a></td>
<td class="num">(96)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(96)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="nump">6,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other Comprehensive (Loss) Income, Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</a></td>
<td class="nump">962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income Attributable to Parent</a></td>
<td class="nump">28,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Jun. 30, 2021</a></td>
<td class="nump">1,557,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,122<span></span>
</td>
<td class="nump">705,582<span></span>
</td>
<td class="num">(2,269)<span></span>
</td>
<td class="nump">860,781<span></span>
</td>
<td class="num">(8,951)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,219,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="nump">$ 962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">962<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Dec. 31, 2021</a></td>
<td class="nump">21,280,000<span></span>
</td>
<td class="nump">21,280,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Dec. 31, 2021</a></td>
<td class="nump">$ 1,616,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,128<span></span>
</td>
<td class="nump">721,412<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="nump">911,787<span></span>
</td>
<td class="num">(19,269)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">2,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Adjustments to Additional Paid in Capital, Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,965)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</a></td>
<td class="num">(8,743)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,743)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Stock Issued During Period, Value, Acquisitions</a></td>
<td class="nump">$ 575,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="nump">575,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock Issued During Period, Shares, Acquisitions</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="nump">$ 12,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other Comprehensive (Loss) Income, Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</a></td>
<td class="nump">18,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income Attributable to Parent</a></td>
<td class="num">(38,068)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38,068)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Mar. 31, 2022</a></td>
<td class="nump">2,178,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,390<span></span>
</td>
<td class="nump">1,306,264<span></span>
</td>
<td class="num">(2,843)<span></span>
</td>
<td class="nump">873,719<span></span>
</td>
<td class="num">(628)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,897,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="nump">$ 18,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,641<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Dec. 31, 2021</a></td>
<td class="nump">21,280,000<span></span>
</td>
<td class="nump">21,280,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Dec. 31, 2021</a></td>
<td class="nump">$ 1,616,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,128<span></span>
</td>
<td class="nump">721,412<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="nump">911,787<span></span>
</td>
<td class="num">(19,269)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</a></td>
<td class="num">(44,759)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Jun. 30, 2022</a></td>
<td class="nump">$ 2,085,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,390<span></span>
</td>
<td class="nump">1,309,598<span></span>
</td>
<td class="num">(92)<span></span>
</td>
<td class="nump">866,245<span></span>
</td>
<td class="num">(92,275)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Jun. 30, 2022</a></td>
<td class="nump">23,898,000<span></span>
</td>
<td class="nump">23,899,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="num">$ (73,006)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,897,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Mar. 31, 2022</a></td>
<td class="nump">2,178,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,390<span></span>
</td>
<td class="nump">1,306,264<span></span>
</td>
<td class="num">(2,843)<span></span>
</td>
<td class="nump">873,719<span></span>
</td>
<td class="num">(628)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Adjustments to Additional Paid in Capital, Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,428)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</a></td>
<td class="num">(1,695)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,695)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="nump">7,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other Comprehensive (Loss) Income, Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</a></td>
<td class="num">(91,647)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income Attributable to Parent</a></td>
<td class="num">(7,474)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,474)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Jun. 30, 2022</a></td>
<td class="nump">$ 2,085,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,390<span></span>
</td>
<td class="nump">$ 1,309,598<span></span>
</td>
<td class="num">$ (92)<span></span>
</td>
<td class="nump">$ 866,245<span></span>
</td>
<td class="num">(92,275)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Jun. 30, 2022</a></td>
<td class="nump">23,898,000<span></span>
</td>
<td class="nump">23,899,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="num">$ (91,647)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (91,647)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615846780976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (Loss) Income</a></td>
<td class="num">$ (45,542)<span></span>
</td>
<td class="nump">$ 52,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">119,697<span></span>
</td>
<td class="nump">44,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_AmortizationOfInventoryStepUp', window );">Amortization of Inventory Step-up</a></td>
<td class="nump">22,676<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Noncash lease expense</a></td>
<td class="nump">10,888<span></span>
</td>
<td class="nump">4,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="num">(99)<span></span>
</td>
<td class="nump">342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ProvisionForWarrantyAndReturns', window );">Provision for warranty and returns</a></td>
<td class="nump">1,483<span></span>
</td>
<td class="num">(345)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation</a></td>
<td class="nump">19,854<span></span>
</td>
<td class="nump">12,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="nump">267<span></span>
</td>
<td class="nump">829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeAmortizationOfPremium', window );">Bond premium amortization</a></td>
<td class="nump">211<span></span>
</td>
<td class="nump">364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Debt Issuance Costs amortization</a></td>
<td class="nump">3,495<span></span>
</td>
<td class="nump">144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent earn-out</a></td>
<td class="num">(27,194)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Sparepartsusage', window );">Sparepartsusage</a></td>
<td class="nump">5,229<span></span>
</td>
<td class="nump">5,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other Noncash Income (Expense)</a></td>
<td class="num">(2,807)<span></span>
</td>
<td class="nump">1,574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(1,090)<span></span>
</td>
<td class="nump">2,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(100,024)<span></span>
</td>
<td class="nump">13,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">4,710<span></span>
</td>
<td class="nump">759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Increase (Decrease) in Other Operating Assets</a></td>
<td class="num">(17,323)<span></span>
</td>
<td class="num">(7,632)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">22,149<span></span>
</td>
<td class="num">(1,648)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(33,509)<span></span>
</td>
<td class="num">(17,068)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes', window );">Income taxes, including excess tax benefits and deferred income taxes</a></td>
<td class="num">(45,798)<span></span>
</td>
<td class="num">(5,970)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="num">(62,727)<span></span>
</td>
<td class="nump">106,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(48,039)<span></span>
</td>
<td class="num">(29,693)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of asset</a></td>
<td class="nump">900<span></span>
</td>
<td class="nump">203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Intangible assets additions</a></td>
<td class="num">(4,440)<span></span>
</td>
<td class="num">(4,136)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of investment securities</a></td>
<td class="num">(3,397)<span></span>
</td>
<td class="num">(10,034)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sale of investment securities</a></td>
<td class="nump">26,198<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,872,942)<span></span>
</td>
<td class="num">(36,660)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts', window );">Proceeds from issuance of long-term debt, net of lender debt issuance costs</a></td>
<td class="nump">1,672,631<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of Long-term Debt</a></td>
<td class="nump">18,125<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of Debt Issuance Costs</a></td>
<td class="num">(1,852)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">2,992<span></span>
</td>
<td class="nump">5,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Finance Lease, Principal Payments</a></td>
<td class="num">(321)<span></span>
</td>
<td class="num">(296)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment, Tax Withholding, Share-based Payment Arrangement</a></td>
<td class="nump">10,438<span></span>
</td>
<td class="nump">7,819<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="nump">1,644,887<span></span>
</td>
<td class="num">(2,699)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAbstract', window );"><strong>Effect of Exchange Rate on Cash [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="num">(6,347)<span></span>
</td>
<td class="num">(783)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</a></td>
<td class="num">(297,129)<span></span>
</td>
<td class="nump">65,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">255,698<span></span>
</td>
<td class="nump">462,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital Expenditures Incurred but Not yet Paid</a></td>
<td class="nump">5,539<span></span>
</td>
<td class="nump">1,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>NON-CASH INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair Value of Assets Acquired</a></td>
<td class="nump">1,658,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="num">(1,844,164)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</a></td>
<td class="num">(575,975)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationAllAcquisitions', window );">Contingent consideration all Acquisitions</a></td>
<td class="num">(55,158)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_GoodwillAcquiredDuringPeriodAllAcquisitions', window );">Goodwill, acquired during period</a></td>
<td class="nump">1,437,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Liabilities Assumed</a></td>
<td class="num">$ (621,206)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_AmortizationOfInventoryStepUp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of Inventory Step-up</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_AmortizationOfInventoryStepUp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationAllAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent consideration all Acquisitions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationAllAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_GoodwillAcquiredDuringPeriodAllAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill, acquired during period - All acquisitions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_GoodwillAcquiredDuringPeriodAllAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change during the reporting period in the carrying amount as of the balance sheet date of payments made for taxes. Also includes the net change during the reporting period in the account that represents the temporary difference that results from income (loss) that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of long-term debt, net of lender debt issuance costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ProvisionForWarrantyAndReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision for warranty and returns</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ProvisionForWarrantyAndReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Sparepartsusage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sparepartsusage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Sparepartsusage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeAmortizationOfPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of purchase premium on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeAmortizationOfPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615934882800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation:<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Basis of Presentation [Text Block]</a></td>
<td class="text">Basis of Presentation<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S.") and pursuant to the rules&#160;and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and reflect all adjustments, consisting of only normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of the consolidated results for the interim periods presented. Results for the interim period are not necessarily indicative of results for the full year. Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules&#160;and regulations. The condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report on Form&#160;10-K of ICU Medical,&#160;Inc., ("ICU") a Delaware corporation, filed with the SEC for the year ended December&#160;31, 2021.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are engaged in the development, manufacturing and sale of innovative medical products used in infusion therapy and critical care applications.&#160;We sell the majority of our products through our direct sales force and through independent distributors throughout the U.S. and internationally.&#160;We also sell certain products on an original equipment manufacturer basis to other medical device manufacturers. All subsidiaries are wholly owned and are included in the condensed consolidated financial statements.&#160;All intercompany balances and transactions have been eliminated.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired Smiths Medical 2020 Limited ("Smiths Medical"), see Note 3: Acquisitions. Our condensed consolidated statement of operations includes the results of operations for Smiths Medical from January 7, 2022 through June 25, 2022, which is the current end of their 4-4-5 accounting period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615934763456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements:<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Pronouncements and Changes in Accounting Principles [Text Block]</a></td>
<td class="text">New Accounting Pronouncements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional guidance for a limited period of time to ease the potential burden for reference rate reform on financial reporting. Due to concerns about structural risks of interbank offered rates and, particularly, the risk of cessation of the London Interbank Offered Rate ("LIBOR"), regulators around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction-based and less susceptible to manipulation. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued as a result of reference rate reform. Optional expedients may be applied to contracts that are modified as a result of the reference rate reform. Modifications of contracts within the scope of Topic 470, Debt, should be accounted for by prospectively adjusting the effective interest rate. Modifications of contracts within the scope of ASC 842, Leases, should be accounted for as a continuation of the existing contracts with no reassessments of the lease classification and the discount rate (incremental borrowing rate). Exceptions to Topic 815, Derivatives and Hedging, results in not having a dedesignation of a hedging relationship if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. In November 2021, we entered into two forward-starting swaps whereby the variable leg of the swap referenced LIBOR. These swaps were amended in early 2022 to transition to an alternative reference rate (see Note 8: Derivatives and Hedging Activities). The amendments in this ASU allow for certain expedients that will allow us to assume that our hedged interest payments are probable of occurring regardless of any expected modification in their terms related to reference rate reform and will allow us to continue hedge accounting for a cash flow hedge for which the hedged interest rate risk changes if the hedge is highly effective under ASC 815, Derivatives and Hedging, or the optional expedient under this ASU is elected. The impact of this ASU on our contracts has not been and is not expected to be material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (c)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854634752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination Disclosure</a></td>
<td class="text">Acquisitions<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Acquisition</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired 100.0% of the equity interests in Smiths Medical, the holding company of Smiths Group plc's global medical device business, from Smiths Group International Holdings Limited (&#8220;Smiths&#8221;). The acquisition of Smiths Medical aligns with our strategic growth plans, enabling us to broaden our product offerings to include syringe and ambulatory infusion devices, vascular access, and vital care products and to strengthen and expand our global market reach.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash consideration for the acquisition was $1.9&#160;billion, which was financed with existing cash balances and proceeds from the credit agreement entered into on January 6, 2022 (see Note 17: Long-Term Debt). We also issued share consideration to Smiths of 2.5&#160;million shares of our common stock. The fair value of the common shares issued to Smiths was determined based on the opening market price of our common stock on the acquisition date. Smiths may be entitled to an additional $100.0&#160;million in cash consideration contingent on our common stock achieving certain price targets for certain periods after closing in accordance with the terms of the Share Sale and Purchase Agreement (the "Purchase Agreement"). In the event that (a) on or prior to the third anniversary of closing the 30-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $300.00 per share or (b) on or prior to the fourth anniversary of closing the 45-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $300.00 per share (each a "Price Target"), and provided Smiths beneficially owns at least 50.0% of the shares of common stock issued at closing at the time the Price Target is achieved, then Smiths will be entitled to receive the additional $100.0&#160;million in cash consideration. The fair value of the contingent consideration was determined using an option pricing model, specifically the Monte Carlo Simulation. In the analysis, the determinants of payout are simulated in a risk neutral framework over a large number of simulation paths. The fair value of the contingent consideration is then calculated as the average present value across all simulated paths. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preliminary Purchase Price Allocation</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated purchase price and the preliminary allocation of the purchase price related to the assets acquired and liabilities assumed (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated cash consideration for acquired assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preliminary fair value of contingent consideration payable to Smiths</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of ICU Medical, Inc. common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Price per share (ICU's opening market price on the acquisition date)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of ICU shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated consideration to be paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,552,450&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Preliminary Purchase Price Allocation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105,291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175,099)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - not tax deductible</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444,939&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated Purchase Consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,552,450&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimated identifiable intangible assets include $540.0&#160;million of customer relationships, $400.0&#160;million of developed technology, $30.0&#160;million of internally developed software, and $5.0&#160;million of trade mark. The estimated weighted-average amortization period for the total identifiable intangible assets is approximately <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU2_ddab537f-8bc6-4122-8738-75e9f83ccca8">nine</span> years, and, for each identifiable intangible asset is estimated as follows: <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU3_94ff8303-bbea-4e2c-80a0-75c79ec80ddf">eight</span> years for customer relationships, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU4_39b70a39-6a8c-49b7-a62c-b1011d2a541c">ten</span> years for developed technology, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU5_9bab9dac-782a-4c71-afdc-921a87d1c7b7">five</span> years for internally developed software, and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDYw_9c9b33b6-6b8e-4b28-8e2a-6c3cc63df867">six</span> months for the trade mark. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimated accrued liabilities includes, among other things, accrued warranty reserves, accrued restructuring initiatives, accrued salaries and related benefits, deferred revenue and accrued sales and use taxes.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above purchase price and purchase price allocation are preliminary and subject to future revision as the acquired assets and liabilities assumed are dependent upon the finalization of the related valuations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The identifiable intangible assets and other long-lived assets acquired have been valued as Level 3 assets at fair value. The estimated fair value of identifiable intangible assets were developed using the income approach and are based on critical estimates, judgments and assumptions derived from: analysis of market conditions; discount rate; discounted cash flows; royalty rates; customer retention rates; and/or estimated useful lives. Certain other intangible assets were valued using a cost to replace method, estimating the labor and non-labor costs required to replace the asset under the premise that it was not part of the transaction. Property, plant and equipment was valued with the consideration of remaining economic lives. The raw materials inventory was valued at historical cost and adjusted for any obsolescence which we estimate to approximate replacement cost, the work in process was valued at estimated sales proceeds less costs to complete and costs to sell, and finished goods inventory was valued at estimated sales proceeds less costs to sell. The prepaid expenses and other current assets and assumed liabilities were recorded at their carrying values as of the date of the acquisition, as their carrying values approximated their fair values due to their short-term nature.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Information</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smiths Medical is included in our consolidated results beginning on January 7, 2022. Total revenues and net loss attributable to Smiths Medical for the period from January 7, 2022 to June 30, 2022 were $437.8&#160;million and $65.5&#160;million, respectively, and for the three months ended June 30, 2022 were $222.9&#160;million and $26.0&#160;million. The following unaudited pro forma financial information presents the combined results of operations of ICU and Smiths Medical as if the acquisition had occurred on January 1, 2021. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place on the date indicated or of results that may occur in the future. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.425%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561,004&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625,942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124,823&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,227,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,474)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,425)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results presented above include the impact of the following adjustments: incremental amortization expense on intangible assets acquired of $1.3&#160;million and $55.5&#160;million for the six months ended June 30, 2022 and 2021, respectively, incremental interest expense, including amortization of debt discount and debt issuance costs, on the Credit Facilities of $0.8&#160;million and $25.4&#160;million for the six months ended June 30, 2022 and 2021, respectively; and a $27.4&#160;million expense related to the increase in fair value of inventory for the six months ended June 30, 2021. In addition, there were non-recurring adjustments directly attributable to the business combination, including acquisition-related cost of $13.5&#160;million for the six months ended June 30, 2021 and adjustments related to the extinguishment of related party loans receivable and payable equal to $80.7&#160;million and $45.0&#160;million for the six months ended June 30, 2022 and 2021, respectively. The unaudited pro forma results include IFRS to U.S. GAAP adjustments for Smiths Medical historical results and adjustments for accounting policy alignment, which were materially similar to the Company. Any differences in accounting policies were adjusted to reflect the accounting policies of the Company in the unaudited pro forma results presented. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Acquisition</span></div>During November 2021, we acquired a small foreign infusion systems supplier and paid an initial gross cash payment of approximately $15.4&#160;million. In addition to the initial cash consideration, total consideration for the acquisition includes an additional holdback of $0.5&#160;million, to be paid two years from the completion date of the acquisition, and also a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of June 30, 2022, the total consideration which includes the acquisition date fair value of the contingent consideration was $17.1&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854443904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Strategic Transaction and Integration (Notes)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Related Activities Disclosure</a></td>
<td class="text">Restructuring, Strategic Transaction and Integration<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Restructuring, strategic transaction and integration expenses were $13.5 million and $3.8 million for the three months ended June 30, 2022 and 2021, respectively, and $47.4 million and $6.6 million for six months ended June 30, 2022 and 2021, respectively.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three and six months ended June 30, 2022, restructuring charges were $1.7&#160;million and $4.9&#160;million, respectively,  and were related to severance costs. Restructuring charges during the three and six months ended June 30, 2021 were not material.&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity in our restructuring-related accrual by major type of cost for the period ended June&#160;30, 2022 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.840%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Severance Pay and Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retention and Facility Closure Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired restructuring liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,030)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,030)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,340&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,865&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,205&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,352)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,404&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,559&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,963&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strategic Transaction and Integration Expenses</span></div>&#160;&#160;&#160;&#160;We incurred and expensed $11.8 million and $3.7 million in strategic transaction and integration expenses during the three months ended June 30, 2022 and 2021, respectively, and we incurred and expensed $42.5 million and $6.5 million in strategic transaction and integration expenses during the six months ended June 30, 2022 and 2021, respectively, which are included in restructuring, strategic transaction and integration expenses in our condensed consolidated statements of operations. The strategic transaction and integration expenses during the three and six months ended June 30, 2022 were primarily related to transaction and integration expenses associated with our acquisition of Smiths Medical on January 6, 2022 (see Note 3: Acquisitions) which primarily included legal expenses, bank fees and employee costs. The six months ended June 30, 2022 also included a United Kingdom stamp tax. The strategic transaction and integration expenses for the three and six months ended June 30, 2021 were primarily related to integration costs associated with acquisitions, the Hospira Infusion Systems ("HIS") earn-out dispute with Pfizer and one-time costs incurred to comply with regulatory initiatives.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854386112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Notes)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customer [Text Block]</a></td>
<td class="text">Revenue<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Following our acquisition of Smiths Medical, our primary product lines are Infusion Consumables, Infusion Systems, IV Solutions, Critical Care, Infusion Systems-Smiths Medical, Vascular Access-Smiths Medical and Vital Care-Smiths Medical. The vast majority of our sales of these products are made on a stand-alone basis to hospitals and distributors. Revenue is typically recognized upon transfer of control of the products, which we deem to be at point of shipment. However, for purposes of revenue recognition for our software licenses and renewals, we consider the control of these products to be transferred to a customer at a certain point in time; therefore, we recognize revenue at the start of the applicable license term.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Payment is typically due in full within 30 days of delivery or the start of the contract term.  Revenue is recorded in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We offer certain volume-based rebates to our distribution customers, which we record as variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between the prices we charge our distribution customers and the contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts in order to determine the transaction price, we use information available at the time, including our historical experience.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We also warranty products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available at that time and our historical experience. We also provide for extended service-type warranties, which we consider to be separate performance obligations. We allocate a portion of the transaction price to the extended service-type warranty based on its estimated relative selling price, and recognize revenue over the period the warranty service is provided. Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue disaggregated</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents our revenues disaggregated by product line (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.841%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product line</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Consumables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,456&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,977&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Systems-Smiths Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vascular Access-Smiths Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vital Care-Smiths Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561,004&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,677&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104,126&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639,723&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Infusion Systems-Smiths Medical, Vascular Access-Smiths Medical and Vital Care-Smiths Medical represent our newly integrated product lines following our acquisition of Smiths Medical on January 6, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table represents our revenues disaggregated by geography (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.841%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geography</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,761&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Foreign</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104,126&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639,723&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract balances</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the changes in our contract balances for the six months ended June 30, 2022 and 2021 (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,461)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of acquired deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,067)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,972)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,005)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,066)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,430)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,435)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,968)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of June 30, 2022, revenue from remaining performance obligations is as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.516%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recognition Timing</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&lt; 12 Months</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&gt; 12 Months</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,744)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,647)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,569)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,903)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,278)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,572)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,494)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Other deferred revenue includes pump development programs, purchased training and extended warranty.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854480944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Notes)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Lessee, Operating Leases [Text Block]</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception. Our operating lease assets are separately stated in operating lease right-of-use ("ROU") assets and our financing lease assets are included in other assets on our condensed consolidated balance sheets. Our lease liabilities are included in accrued liabilities and other long-term liabilities on our condensed consolidated balance sheets. We have elected not to recognize an ROU asset and lease liability for leases with terms of twelve months or less.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Lease ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Most of our leases do not provide an implicit rate, therefore we use our incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term based on the information available at commencement date. Our lease ROU assets exclude lease incentives and initial direct costs incurred. Our lease terms include options to extend when it is reasonably certain that we will exercise that option. All of our leases have </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stated lease payments, which may include fixed rental increases. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our leases are for corporate, research and development and sales and support offices, distribution facilities, device service centers and certain equipment. Our leases have original lease terms of one year to fifteen years, some of which include options to extend the leases for up to an additional five years. For all of our leases, we do not include optional periods of extension in our current lease terms for the exercise of options to extend is not reasonably certain.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of our lease cost (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:36.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.266%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.266%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.713%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,657&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; reduction of ROU asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,676&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,026&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,056&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,046&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense on our finance leases is included in other income (expense), net in our condensed consolidated statements of operations. The reduction of the operating and finance ROU assets is included as noncash lease expense in selling, general and administrative expenses in our condensed consolidated statements of operations.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental cash flow information related to our leases (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,323</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,847</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,929</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,009</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,491</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,971</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,420</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,980</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,335</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,652&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,676&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,420&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854489072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share:<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Share [Text Block]</a></td>
<td class="text">Net Income Per Share<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period plus dilutive securities. Dilutive securities include outstanding common stock options and unvested restricted stock units, less the number of shares that could have been purchased with the proceeds from the exercise of the options, using the treasury stock method. Options and restricted stock units that are anti-dilutive are not included in the treasury stock method calculation. Due to the net loss for the three and six months ended June 30 2022, any potentially common shares were not included in the computation of diluted earnings per share as they would have had an anti-dilutive effect, therefore basic and diluted net loss per share are equal for the period. There were 12,107 and 12,080 anti-dilutive securities for the three and six months ended June 30, 2021, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the calculation of net earnings per common share (&#8220;EPS&#8221;) &#8212; basic and diluted (in thousands, except per share data):&#160; </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,474)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,542)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding (basic)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common and common equivalent shares outstanding (diluted)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,897&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,703&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,787&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,718&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.31)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.34&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.91)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.46&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No dilutive effect for the three and six months ended June 30, 2022;  therefore, zero incremental shares included for the period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854395696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments and Hedging Activities Disclosure [Text Block]</a></td>
<td class="text">Derivatives and Hedging Activities<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Accounting and Hedging Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The purposes of our cash flow hedging programs are to manage the foreign currency exchange rate risk on forecasted revenues and expenses denominated in currencies other than the functional currency of the operating unit, and to manage floating interest rate risk associated with future interest payments on the variable-rate term loans issued in January 2022. We do not issue derivatives for trading or speculative purposes.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions. The derivative instruments we utilize, including various foreign exchange contracts and interest rate swaps, are designated and qualify as cash flow hedges. Our derivative instruments are recorded at fair value on the condensed consolidated balance sheets and are classified based on the instrument's maturity date. We record gains or losses from changes in the fair values of the derivative instruments as a component of other comprehensive income (loss) and we reclassify those gains or losses into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. If the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, we reclassify the gain or loss on the related derivative instrument from accumulated other comprehensive loss into earnings immediately.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Rate Risk</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange Forward Contracts</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign exchange forward contracts to hedge a portion of our forecasted foreign currency-denominated revenues and expenses to minimize the effect of foreign exchange rate movements on the related cash flows. These contracts are agreements to buy or sell a quantity of a currency at a predetermined future date and at a predetermined exchange rate. Our foreign exchange forward contracts hedge exposures principally denominated in Mexican Pesos ("MXN"), Euros, Czech Koruna ("CZK"), Japanese Yen ("JPY"), U.S. Dollar ("USD") and Chinese Renminbi ("CNH") and have varying maturities with an average term of approximately twelve months. The total notional amount of these outstanding derivative contracts as of June&#160;30, 2022 was $209.2&#160;million, which included the notional equivalent of $43.1&#160;million in MXN, $39.7&#160;million in Euros, $18.3&#160;million in CZK, $18.8&#160;million in JPY, $19.3&#160;million in CNH, $36.3&#160;million in USD and $33.9&#160;million in other foreign currencies, with terms currently through July 2023. We did not have such derivative contracts as of December 31, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cross-currency Par Forward Contracts</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into cross-currency par forward contracts to hedge a portion of our Mexico forecasted expenses denominated in MXN. These contracts are agreements to exchange cash flows from one currency to another at specified intervals over the contract term with all exchanges occurring at the same predetermined rate. In November 2021, we entered into a one-year cross-currency par forward contract with a term from December 1, 2021 to December 1, 2022. The total notional amount of this outstanding derivative as of June&#160;30, 2022 and December 31, 2021 was approximately 208.2 million MXN and 413.1&#160;million MXN, respectively. The derivative instrument matures in equal monthly amounts at a fixed forward rate of 21.60 MXN/USD. Preceding this contract we had a one-year cross-currency par forward contract with a term from November 3, 2020 to December 1, 2021 that matured in equal monthly amounts at a fixed forward rate of 24.26 MXN/USD.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Floating Interest Rate Risk</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, in anticipation of entering into the new senior secured credit facilities in January 2022, which includes a variable-rate term loan A and a variable-rate term loan B (see Note 17: Long-Term Debt), we entered into two forward-starting interest rate swaps. In February 2022, certain terms under the agreements were amended to reflect the transition from LIBOR to the Secured Overnight Financing Rate ("SOFR"), an alternative reference rate. Under the interest rate swap agreements we exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount. Effective March 30, 2022, the term loan A swap, as amended, has an initial notional amount of $300.0&#160;million, reducing to $150.0&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2027. We will pay a fixed rate of 1.32% and will receive the greater of 3-month USD SOFR or (0.15)%. Effective March 30, 2022, the term loan B swap, as amended, has an initial notional amount of $750.0&#160;million, reducing to $46.9&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2026. We will pay a fixed rate of 1.17% and will receive the greater of 3-month USD SOFR or 0.35%. These swaps effectively convert the relevant portion of the floating-rate term loans to fixed rates.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair values of our derivative instruments included within the Condensed Consolidated Balance Sheets (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:48.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Condensed Consolidated Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Derivatives</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,575&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized the following gains on our derivative instruments designated as cash flow hedges (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.730%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain Recognized in Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,371&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,534&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.894%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Reclassified From Accumulated Other Comprehensive (Loss) Income into Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,524)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,524)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,857&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,136&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,744&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents location of gain reclassified from accumulated other comprehensive income into income as a result that a forecasted transaction is no longer probable of occurring.</span></div>As of June&#160;30, 2022, we expect an estimated $8.5&#160;million in deferred gains on the outstanding foreign exchange contracts and an estimated $15.7&#160;million in deferred gains on the interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854395696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures (Notes)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Disclosures</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. There are three levels of inputs that may be used to measure fair value:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1:  quoted prices in active markets for identical assets or liabilities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2:  inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3:  unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Earn-out Liabilities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired Smiths Medical with a combination of cash consideration and share consideration issued at closing. Total consideration for the acquisition includes a potential earn-out payment of $100.0&#160;million in cash contingent on our common stock achieving certain Price Targets from the closing date to either the third or fourth anniversary of closing (see Note 3: Acquisitions for additional information) and provided Smiths beneficially owns at least 50.0% of the shares of common stock issued at closing at the time the Price Target is achieved. The initial estimated fair value of the earn-out was determined to be $53.5&#160;million. The initial fair value of the earn-out was determined using a Monte Carlo simulation model. The model utilized several assumptions including volatility and the risk-free interest rate. The assumed volatility is based on the average of the historical volatility of our common stock price and the implied volatility of certain at-the-money traded options. The risk-free interest rate is equal to the yield on U.S. Treasury securities at constant maturity for the period commensurate with the term of the earn-out. At each reporting date subsequent to the acquisition, we will remeasure the earn-out liability and recognize any changes in its fair value in our consolidated statements of operations. If the probability of achieving the Price Targets during their respective measurement periods is significantly greater than initially anticipated, the realization of an additional liability and related expense will have a significant impact on our consolidated financial statements in the period recognized. As of June 30, 2022, the estimated fair value of the contingent earn-out is $26.1&#160;million.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of June 30, 2022, the estimated fair value of the total contingent earn-out is $1.7&#160;million. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out payment shall not exceed $6.0&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of both June 30, 2022 and December 31, 2021, the estimated fair value of the contingent earn-out is $2.6&#160;million. The estimated fair value of the contingent earn-out is calculated using a probability-weighted cash flow model based on historical revenue streams and the likelihood that the revenue targets will be met.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the fourth quarter of 2019, we recognized an earn-out liability related to the acquisition of Pursuit Vascular, Inc. ("Pursuit"). Pursuit's former equity holders were entitled up to $50.0 million in additional cash consideration contingent upon the achievement of certain sales and gross profit targets for specific customers. The earn-out was calculated as a percentage of gross profit achieved during the earn-out period against a pre-determined target gross profit, not to exceed $50.0 million. During the earn-out period, we used a Monte Carlo simulation model to determine the fair value of the earn-out liability. The Monte Carlo simulation model utilized multiple input variables to determine the value of the earn-out liability including historical volatility, a risk-free interest rate, counter party credit risk and projected future gross profit (see the simulation input table below related to Pursuit). The historical volatility was based on the median of ICU and a certain peer group. The risk-free interest rate was equal to the yield, as of the valuation date, of the zero-coupon U.S. Treasury bill that was commensurate with the term of the earn-out. The counter party credit risk was based on a synthetic credit rating of B1. As of June 30, 2021, the earn-out measurement period ended. Based on the actual sales and gross profit achieved during the measurement period, we calculated the actual earn-out amount to be $26.3&#160;million. The $26.3&#160;million earn-out calculation was finalized and accepted by Pursuit's former equity holders and was paid out in the fourth quarter of 2021. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contingent earn-out liabilities are separately stated on our condensed consolidated balance sheets.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a reconciliation of the Level 3 earn-out liabilities measured at estimated fair value (in thousands):  </span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition date fair value estimate of earn-out</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of earn-out (included in income from operations as a separate line item)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,409&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;$53.5 million relates to our acquisition of Smiths Medical and $1.6 million relates to our acquisition of a small foreign infusions systems supplier in the fourth quarter of 2021 (see Note 3: Acquisitions).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; Primarily relates to the change in fair value of the Smiths Medical earn-out.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of earn-out (included in income from operations as a separate line item)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of earn-out (included in income from operations as a separate line item)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide quantitative information about Level 3 inputs for fair value measurement of our earn-out liabilities related to Smiths Medical and Pursuit:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smiths Medical Earn-out</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.961%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At Acquisition<br/>January 6, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-Free Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pursuit Earn-out</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue/Gross Profit Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-Free Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Counter Party Risk</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments, Foreign Exchange Contracts and Interest Rate Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our investments consist of corporate bonds and U.S treasury securities. The fair value of our corporate bonds is estimated using observable market-based inputs such as quoted prices, interest rates and yield curves or Level 2 inputs. The fair value of our U.S. treasury securities are based on quoted market prices in active markets and are included in the Level 1 fair value hierarchy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair value of our Level 2 foreign exchange contracts, including forward contracts and cross-currency par forward contracts, is estimated using observable market inputs such as known notional value amounts, spot and forward exchange rates. These inputs relate to liquid, heavily traded currencies with active markets which are available for the full term of the derivative.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our Level 2 interest rate swaps is estimated using a pricing model that reflects the terms of the contracts, including the period to maturity, and relies on observable market inputs such as known notional value amounts and USD interest rate curves.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our assets and liabilities measured at fair value on a recurring basis consisted of the following Level 1, 2 and 3 inputs as defined above (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - ST</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,036&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,409&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency par forward contract:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,069&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854395696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities (Notes)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock', window );">investments in Debt and Marketable Equity Securities and Equity Method Investments [Text Block]</a></td>
<td class="text">Investment Securities<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Available-for-sale Securities</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our available-for-sale investment securities currently consist of short-term and long-term corporate bonds and short-term U.S. treasury securities and are considered &#8220;investment grade&#8221; and are carried at fair value. We assess our investment in available-for-sale debt securities for impairment each reporting period. If an unrealized loss exists, we determine whether any portion of the decline in fair value below the amortized cost basis is credit-related by reviewing several factors, including, but not limited to, the extent of the fair value decline and changes in the financial condition of the issuer. We record an impairment for credit-related losses through an allowance, limited to the amount of the unrealized loss. If we either intend to sell or it is more likely than not we will be required to sell the debt security before its anticipated recovery, any allowance is written off and the amortized cost basis is written down to fair value through a charge against net earnings. Unrealized gains and non-credit-related unrealized losses are recorded, net of tax, in other comprehensive income (loss). We did not have any investments in available-for-sale debt securities in unrealized loss positions as of June 30, 2022 or December 31, 2021.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost of the debt securities are adjusted for the amortization of premiums computed under the effective interest method. Such amortization is included in other income, net in our condensed consolidated statements of operations. Realized gains and losses are accounted for on the specific identification method. There have been no realized gains or losses on the disposal of these investments. The scheduled maturities of the debt securities are between 2022 and 2024. All short-term investment securities are callable within one year.  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.301%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding <br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,028&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,028&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding<br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,040&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,040&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Non-Marketable Equity Securities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, we acquired approximately a 20.0% non-marketable equity interest in a nonpublic company and entered into a three-year distribution agreement where we have the exclusive rights to market, sell and distribute the company's products in exchange for a cash payment of $3.3&#160;million. In addition, we were granted an exclusive license for all of the seller's intellectual property. At the expiration of the distribution agreement we have the right but not the obligation to acquire the remaining interest in the business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the equity method of accounting for investments when we determine we have a significant influence, but not a controlling interest in the investee. We determine whether we have significant influence by considering key factors such as ownership interest, representation on the board of directors, participation in policy making decisions, business relationship and material intra-entity transactions, among other factors. Our equity method investment is reported at cost and adjusted each period for our share of the investee's income or (loss) and dividend paid, if any. We eliminate any intra-entity profits to the extent of our beneficial interest. We record our share of the investee's income or (loss) on a one quarter lag. We report our proportionate share of the investee's income or (loss) resulting from this investment in other income, net in our condensed consolidated statements of operations. The carrying value of our equity method investment is reported in other assets on our </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condensed consolidated balance sheets (see Note 11: Prepaid Expenses and Other Current Assets and Other Assets). We assess our equity method investments for impairment on an annual basis or whenever events or circumstances indicate that the carrying value of the investment may not be recoverable. Our recorded share of the investee's loss was not material for the three and six months ended June 30, 2022. We did not receive any dividend distributions from this investment during the three and six months ended June 30, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-marketable equity method investment consists of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in non-marketable debt securities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter 2022, we received $19.0&#160;million in proceeds from a promissory note related to an acquired investment as part of the Smiths Medical acquisition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>investments in Debt and Marketable Equity Securities and Equity Method Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615855478896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaids and Other Current Assets (Notes)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock', window );">Prepaids, other current assets and other noncurrent assets [Text Block]</a></td>
<td class="text">Prepaid Expenses and Other Current Assets and Other Assets<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses and receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,081&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid vendor expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance and property taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT/GST receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax charge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,663&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,847&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pump lease receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spare parts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,728&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,743&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaids, other current assets and other noncurrent assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854535168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories:<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories [Text Block]</a></td>
<td class="text">Inventories<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Inventories are stated at the lower of cost or net realizable value with cost determined using the first-in, first-out method. Inventory costs include material, labor and overhead related to the manufacturing of our products. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583,050&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, inventories increased significantly due to the acquisition of Smiths Medical. All acquired inventory was recorded at fair value on January 6, 2022 in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (see Note 3: Acquisitions).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854443904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment:<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment [Text Block]</a></td>
<td class="text">Property, Plant and Equipment<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consists of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407,580&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, building and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments placed with customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,592&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,384&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147,292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905,104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(479,509)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(436,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,783&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468,365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Instruments placed with customers consist of drug-delivery and monitoring systems placed with customers under operating leases.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $24.9 million and $46.4&#160;million for the three and six months ended June 30, 2022, respectively. Depreciation expense was $16.3&#160;million and $32.7&#160;million for the three and six months ended June 30, 2021 and 2021, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June 30, 2022, property, plant and equipment and related depreciation expense increased significantly due to the acquisition of Smiths Medical (see Note 3: Acquisitions).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854360352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Notes)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets Disclosure [Text Block]</a></td>
<td class="text">Goodwill and Intangible Assets, Net<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the carrying amount of our goodwill (in thousands):</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,439&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,034)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,421,216&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to Smiths Medical acquired on January 6, 2022.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other reflects measurement period adjustments related to a 2021 acquisition of a small foreign infusion systems supplier.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life&#160;in&#160;Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,603&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">581,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">513,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">584,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">505,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,237,260&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">185,554&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,051,706&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,265,883&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">185,554&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,080,329&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275,835&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,882&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,953&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">301,193&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,882&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with definite lives are amortized on a straight-line basis over their estimated useful lives. During the three months ended June&#160;30, 2022 and 2021, intangible asset amortization expense was $41.6 million and $5.8 million, respectively.  During the six months ended June&#160;30, 2022 and 2021, intangible asset amortization expense was $73.3&#160;million and $11.6&#160;million, respectively. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June 30, 2022, intangible assets and related amortization expense increased significantly due to the acquisition of Smiths Medical (see Note 3: Acquisitions).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022 estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051,706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854395696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Notes)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</a></td>
<td class="text">Accrued Liabilities and Other Long-Term Liabilities&#160;&#160;&#160;&#160;Accrued liabilities consist of the following (in thousands):&#160;<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incentive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-ST</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,929&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties and returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Field service corrective action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued freight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued audit fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,656&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,195&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to field corrective actions associated with certain products in connection with a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities consist of the following (in thousands):&#160;</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-LT</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liability-LT</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Field service corrective action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,830&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854395696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes:<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
<td class="text">Income Taxes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes were accrued at an estimated effective tax rate of 56% and 36% for the three and six months ended June 30, 2022, respectively, as compared to 18% and 16% for the three and six months ended June 30, 2021, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective tax rate for the three and six months ended June 30, 2022 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, section 162(m) excess compensation, foreign-derived intangible income ("FDII") and tax credits and the following discrete items recognized during the interim period:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the three and six months ended June 30, 2022 of $0.0&#160;million and $2.6&#160;million, respectively. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The revaluation of the contingent consideration during the three and six months ended June 30, 2022 resulted in a tax expense of $0.0&#160;million  and $0.0&#160;million, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective tax rate for the three and six months ended June 30, 2021 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, global intangible low taxed income ("GILTI"), FDII and tax credits. The effective tax rate during the three and six months ended June 30, 2021 included a discrete tax benefit of $0.4&#160;million and $2.2 million, respectively, related to excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854478464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations (Notes)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LOngTermObligationsDisclosureAbstract', window );"><strong>LOng-Term Obligations Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-term Debt [Text Block]</a></td>
<td class="text">Long-Term Debt<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Credit Agreement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, in connection with the acquisition of Smiths Medical, we entered into a Credit Agreement (the "Credit Agreement") with Wells Fargo Bank, National Association, Wells Fargo Securities, LLC, Barclays Bank PLC and certain other financial institutions (the &#8220;Lenders&#8221;) for $2.2&#160;billion of senior secured credit facilities. The senior secured credit facilities include (i) a five-year Tranche A term loan of $850.0&#160;million (the "Term Loan A"), (ii) a seven-year Tranche B term loan of $850.0&#160;million (the "Term Loan B") and (iii) a five-year revolving credit facility of $500.0&#160;million (the "Revolving Credit Facility"), with separate sub-limits of $50.0&#160;million for letters of credit and swingline loans (collectively, the "Senior Secured Credit Facilities"). We used the proceeds from borrowings under the Term Loan A and the Term Loan B (collectively, the "Term Loans") to fund a portion of the cash consideration for the purchase of Smiths Medical and the related fees and expenses incurred in connection with the acquisition. We did not incur borrowings under the Revolving Credit Facility on the closing date of the acquisition. The proceeds from any future borrowings under the Revolving Credit Facility may be used for working capital and other general corporate purposes.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with entering into the Credit Agreement, during the period ended March 31, 2022, we incurred $37.8 million in debt discount and issuance costs, which were allocated to the Term Loan A, the Term Loan B and the Revolving Credit Facility based on lender commitment amounts relative to each type of fees paid. The lender and third-party discount and issuance costs allocated to the Term Loan A and the Term Loan B were $15.8 million and $13.4 million, respectively, and are reflected as a direct deduction from the face amount of the corresponding term loans on the condensed consolidated balance sheet. These costs are being amortized to interest expense over the respective terms of the loans using the effective interest method. The issuance costs allocated to the Revolving Credit Facility were $8.7 million, which are capitalized and included in prepaid expenses and other current assets and other assets on our condensed consolidated balance sheets. These costs are being amortized to interest expense over the term of the Revolving Credit Facility using the straight-line method. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net funds received from the Term Loan A and the Term Loan B, after deducting debt issuance costs, were $834.2 million and $836.6 million, respectively.   </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity Dates</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity date for the Term Loan A and the Revolving Credit Facility is January 6, 2027, and the maturity date for the Term Loan B is January 6, 2029. Pursuant to the terms and conditions of the Credit Agreement, the maturity dates of the Term Loans and the Revolving Credit Facility may be extended upon our request, subject to the consent of the Lenders.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Terms</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, the Term Loans and borrowings under the Revolving Credit Facility denominated in U.S. dollars bear interest, at our option, on either: (1) the Base Rate, as defined below, plus the applicable margin, as indicated below ("Base Rate Loans") or (2) the Adjusted Term Secured Overnight Financing Rate ("Adjusted Term SOFR"), as defined below, plus the applicable margin, as indicated below ("Term SOFR Loans"). </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Base Rate is defined as the highest of (a) the Prime Rate, (b) the Federal Funds Rate plus 0.50% and (c) Adjusted Term SOFR (as defined below) for a one-month period plus, in each case, plus 1.00%.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted Term SOFR is the rate per annum equal to (a) Term SOFR plus (b) the Term SOFR Adjustment. Term SOFR is the forward-looking term rate based on SOFR and is calculated separately for Term SOFR Loans and Base Rate Loans, as specified in the Credit Agreement. The Term SOFR Adjustment is a percentage per annum of 0.10% for Base Rate Loans and between 0.10% to 0.25% for Term SOFR Loans based on the applicable interest period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility Commitment Fee</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility has a per annum commitment fee at an initial rate of 0.25% which is applied to the available amount of the Revolving Credit Facility. Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the commitment fee will be determined by reference to the leverage ratio in effect from time to time as set forth in the table below.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Applicable Interest Margins</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan A and borrowings under the Revolving Credit Facility have an initial applicable margin of 0.75% per annum for Base Rate Loans and 1.75% per annum for Term SOFR Loans.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan A and borrowings under the Revolving Credit Facility will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitment Fee Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 4.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 4.00 to 1.0 but greater than 3.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 3.00 to 1.0 but greater than 2.50 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.50 to 1.0 but greater than 2.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15%</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan B has an initial applicable margin of 1.5% per annum for Base Rate Loans and 2.5% per annum for Term SOFR Loans.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan B will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: </span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.368%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.665%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 2.75 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.75 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principal Payments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on the Term Loans are due on the last day of each calendar quarter commencing on June 30, 2022. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan A will amortize in nineteen consecutive quarterly installments in an amount equal to 2.50% of the original principal amount in each of the first two years, 5.00% in each of the third and fourth years and 7.50% in the fifth year, with a final payment of the remaining outstanding principal balance due on the maturity date.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan B matures in twenty-seven consecutive quarterly installments in an amount equal to 0.25% of the original principal amount, with a final payment of the remaining outstanding principal balance due on the maturity date.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may borrow, prepay and re-borrow amounts under the Revolving Credit Facility, in accordance with the terms and conditions of the Credit Agreement, with all outstanding amounts due at maturity. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2022, we prepaid $16.0 million in principal payments on the Term Loan A principal balance. During 2022, we paid $18.1&#160;million in principal payments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Payments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest payments on Base Rate Loans are payable quarterly in arrears on the last business day of each calendar quarter and the applicable maturity date. Interest periods on Term SOFR Loans will be determined, at our option, as either one, three or six months and will be payable on the last day of each interest period and the applicable maturity date. In the case of any interest periods of more than three months' duration, the interest payment will be payable on each day prior to the last day of such interest period that occurs at three-month intervals.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commitment fee on the Revolving Credit Facility is payable quarterly in arrears on the third business day following the last day of each calendar quarter and at the maturity date. The commitment fee is included in interest expense in our condensed consolidated statements of operations.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantors and Collateral</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Credit Agreement are unconditionally guaranteed, on a joint and several basis, by ICU Medical, Inc. and certain of our existing subsidiaries. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Covenants</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains affirmative and negative covenants, including certain financial covenants. The negative covenants include restrictions regarding the incurrence of liens and indebtedness, certain merger and acquisition transactions, asset sales and other dispositions, other investments, dividends, share purchases and payments affecting subsidiaries, changes in nature of business, fiscal year or organizational documents, prepayments and redemptions of subordinated and other junior debt, transactions with affiliates, and other matters.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenants include the Senior Secured Leverage Ratio and the Interest Coverage Ratio, both defined below, and pertain to the Term Loan A and the Revolving Credit Facility.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Secured Leverage Ratio is defined, at any such date, as the ratio of: (a) all Funded Debt, as defined in the Credit Agreement, that is secured by a lien on any asset or property minus the lesser of (i) all unrestricted cash and cash equivalents and (ii) $500.0&#160;million, to (b) Consolidated EBITDA, as defined in the Credit Agreement, for the most recently completed four fiscal quarters, calculated on a pro forma basis. The maximum Senior Secured Leverage Ratio is 4.50 to 1.00 until June 30, 2024. Thereafter, the maximum Senior Secured Leverage Ratio is 4.00 to 1.00, with limited permitted exception.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Interest Coverage ratio is defined, at any such date, as the ratio of Consolidated EBITDA, as defined in the Credit Agreement, to Consolidated Interest Expense, as defined in the Credit Agreement, paid or payable in cash, for the most recently completed four fiscal quarters. The minimum Interest Coverage ratio is 3.00 to 1.00.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were in compliance with all financial covenants as of June 30, 2022.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary events of default, including, among others: non-payments of principal and interest; breach of representations and warranties; covenant defaults; cross-defaults and cross-acceleration to certain other material indebtedness; the existence of bankruptcy or insolvency proceedings; certain events under ERISA; material judgments; and a change of control. If an event of default occurs and is not cured within any applicable grace period or is not waived, the administrative agent and the Lenders are entitled to take various actions, including, without limitation, the acceleration of all amounts due and the termination of commitments under the Senior Secured Credit Facilities.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2017 Credit Facility</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On November 8, 2017, we entered into a five-year senior secured revolving credit facility with various lenders for $150.0 million, with Wells Fargo Bank, National Association as the administrative agent, swingline lender and issuing lender (the "Prior Credit Facility"). The Prior Credit Facility, which was set to mature on November 8, 2022, was terminated in connection with entering into the Credit Agreement on January 6, 2022. There were no borrowings outstanding under the Prior Credit Facility at that date or at December 31, 2021. The remaining unamortized deferred debt issuance costs related to the Prior Credit Facility were not material and were expensed in connection with its termination. See further details of the terms of the Prior Credit Facility in Note 11 in Part II, Item 8, of our 2021 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of our long-term debt consist of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B &#8212; principal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less unamortized debt issuance costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,783)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying value of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,655,092&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636,029&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprised of $14.2 million and $12.6 million relating to the Term Loan A and the Term Loan B, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years is approximately (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,681,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total interest expense related to our long-term debt (in thousands):</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.841%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment fee &#8212; Revolving Credit Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,730&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,742&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LOngTermObligationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>LOng-Term Obligations Disclosure [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LOngTermObligationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854303856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies:<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies [Text Block]</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are involved in various legal proceedings, most of which are routine litigation, in the normal course of business.&#160;Our management does not believe that the resolution of the unsettled legal proceedings that we are involved with will have a material adverse impact on our financial position or results of operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, we have agreed to indemnify our officers and directors to the maximum extent permitted under Delaware law and to indemnify customers as to certain intellectual property matters or other matters related to sales of our products.&#160;There is no maximum limit on the indemnification that may be required under these agreements.&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we can provide no assurances, we have never incurred, nor do we expect to incur, any material liability for indemnification.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired Smiths Medical. Total consideration for the acquisition includes a potential earn-out payment of $100.0&#160;million in cash contingent on our common stock achieving a certain volume-weighted average price from </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the closing date to either the third or fourth anniversary of closing. As of June&#160;30, 2022, the estimated fair value of the contingent earn-out is $26.1&#160;million (see Note 9: Fair Value Measurements).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to being acquired, during 2021, Smiths Medical received a Warning Letter from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility. The Warning Letter cited, among other things, failures to comply with FDA's medical device reporting requirements and failures to comply with applicable portions of the Quality System Regulation. A provision for the estimated costs related to the field service corrective action was recorded on the opening acquired balance sheet of Smiths Medical in the amount of $55.1&#160;million. The initial estimate recorded was based on a probability-weighted estimate of the costs required to settle the obligation. The actual costs to be incurred are dependent upon the scope of the work necessary to achieve regulatory clearance and could differ from the original estimate. The estimated field service corrective action recorded at June 30, 2022 is $53.9&#160;million.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of June&#160;30, 2022, the estimated fair value of the contingent earn-out is $1.7&#160;million (see Note 9: Fair Value Measurements).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out shall not exceed $6.0&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of June&#160;30, 2022, the estimated fair value of the contingent earn-out is $2.6&#160;million (see Note 9: Fair Value Measurements).</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments</span></div>&#160;&#160;&#160;&#160;We have non-cancelable operating lease agreements where we are contractually obligated to pay certain lease payment amounts (see Note 6: Leases).<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854535840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborative and Other Arrangements (Notes)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaborative Arrangement Disclosure [Text Block]</a></td>
<td class="text">Collaborative and Other Arrangements&#160;&#160;&#160;&#160;On February 3, 2017, we entered into two Manufacturing and Supply Agreements ("MSAs") whereby (i) Pfizer will manufacture and supply us with certain agreed upon products for an initial five-year term with a one-time two-year option to extend and (ii) we will manufacture and supply Pfizer certain agreed upon products for a term of five or ten years depending on the product, also with a one-time two-year option to extend. The MSAs provide each party with mutually beneficial interests and both of the MSAs are to be jointly managed by both Pfizer and ICU. The initial supply price, which will be annually updated, is in full consideration for all costs associated with the manufacture, documentation, packaging and certification of the products. On January 1, 2021, we amended our MSA with Pfizer, whereby we manufacture and supply certain agreed upon products to Pfizer. The amendments included a change to the term of the agreement to end on December 31, 2024 with Pfizer's unilateral election to extend through December 31, 2025. Other changes to the terms of the MSA included (i) amendments to our level of supply of products to Pfizer, (ii) certain changes to our manufacturing lines, (iii) updates to our supply price with added volume price tiers for annual periods and (iv) certain minimum purchase requirements for certain products. On February 1, 2022, effective as of January 1, 2022, upon our request, Pfizer executed a Product Addendum (the "Product Addendum") to our MSA, whereby Pfizer manufactures and supplies to us certain agreed upon products. The Product Addendum includes the supply of additional product to us subject to certain time and pricing terms and conditions. The Product Addendum includes a minimum purchase obligation of $29.6&#160;million and expires on November 30, 2022. As of March 31, 2022, we had satisfied the minimum purchase obligations under the Product Addendum.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854386112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure</a></td>
<td class="text">Stockholders' Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shareholders Agreement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the completion of the Smiths Medical acquisition on January 6, 2022, Smiths owns approximately 10.5% of the total outstanding shares of our common stock (see Note 3: Acquisitions). At closing, in connection with the issuance of the share consideration, we entered into a Shareholders Agreement (the &#8220;Shareholders Agreement&#8221;) with Smiths. The Shareholders Agreement imposes certain restrictions on Smiths including prohibiting certain transfers of the shares of our common stock issued (i) for 6 months following the closing of the acquisition transaction and (ii) to certain of our competitors and certain other parties, as well as customary standstill limitations. The Shareholders Agreement also permits Smiths to designate one individual for election to our Board of Directors (the "Board") so long as Smiths beneficially owns at least 5.0% of the total outstanding shares of our common stock. On February 1, 2022, our Board appointed a new director designated by Smiths pursuant to the Shareholders Agreement who was elected to the Board at the 2022 Annual Meeting of Stockholders held in May 2022. This appointment expands the size of our Board from eight to nine members. See our Current Report on Form 8-K filed on February 1, 2022 for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In August 2019, our Board approved a share purchase plan to purchase up to $100.0 million of our common stock. This plan has no expiration date. During the three months ended June&#160;30, 2022, we did not purchase any shares of our common stock under our share purchase plan. As of June&#160;30, 2022, all of the $100.0 million available for purchase was remaining under the plan. We are currently limited on share purchases in accordance with the terms and conditions of our Credit Agreement (see Note 17: Long-Term Debt).  </span></div><div><span><br/></span></div><div><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2022, we withheld 44,759 shares of our common stock from employee vested restricted stock units in consideration for $10.4 million in payments made on the employees' behalf for their minimum statutory income tax withholding obligations. For the three months ended June 30, 2021, we withheld&#160;37,882&#160;shares of our common stock from employee vested restricted stock units in consideration for&#160;$7.8 million&#160;in payments made on the employees' behalf for their minimum statutory income tax withholding obligations. Treasury stock is used to issue shares for stock option exercises and restricted stock grants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive (Loss) Income ("AOCI")</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of AOCI, net of tax, were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Losses) Gains on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,045)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,946)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,946)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,572&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,641&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,991)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(628)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,805)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,245&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89,546)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,805)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,144&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,647)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,796)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,479&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92,275)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,381)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,522)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,752)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,458)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(945)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,391)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,839)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,913)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,649&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(687)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(687)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(352)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,537)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,487&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,951)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854389136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text">The following table summarizes the estimated purchase price and the preliminary allocation of the purchase price related to the assets acquired and liabilities assumed (in thousands):<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated cash consideration for acquired assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preliminary fair value of contingent consideration payable to Smiths</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of ICU Medical, Inc. common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Price per share (ICU's opening market price on the acquisition date)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of ICU shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated consideration to be paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,552,450&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Preliminary Purchase Price Allocation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105,291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175,099)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - not tax deductible</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444,939&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated Purchase Consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,552,450&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimated identifiable intangible assets include $540.0&#160;million of customer relationships, $400.0&#160;million of developed technology, $30.0&#160;million of internally developed software, and $5.0&#160;million of trade mark. The estimated weighted-average amortization period for the total identifiable intangible assets is approximately <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU2_ddab537f-8bc6-4122-8738-75e9f83ccca8">nine</span> years, and, for each identifiable intangible asset is estimated as follows: <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU3_94ff8303-bbea-4e2c-80a0-75c79ec80ddf">eight</span> years for customer relationships, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU4_39b70a39-6a8c-49b7-a62c-b1011d2a541c">ten</span> years for developed technology, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU5_9bab9dac-782a-4c71-afdc-921a87d1c7b7">five</span> years for internally developed software, and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDYw_9c9b33b6-6b8e-4b28-8e2a-6c3cc63df867">six</span> months for the trade mark. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimated accrued liabilities includes, among other things, accrued warranty reserves, accrued restructuring initiatives, accrued salaries and related benefits, deferred revenue and accrued sales and use taxes.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.425%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561,004&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625,942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124,823&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,227,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,474)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,425)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854535168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Strategic Transaction and Integration (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity in our restructuring-related accrual by major type of cost for the period ended June&#160;30, 2022 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.840%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Severance Pay and Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retention and Facility Closure Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired restructuring liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,030)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,030)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,340&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,865&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,205&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,352)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,404&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,559&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,963&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854297440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text">The following table represents our revenues disaggregated by geography (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.841%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geography</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,761&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Foreign</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104,126&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639,723&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract with Customer, Asset and Liability [Table Text Block]</a></td>
<td class="text">The following table presents the changes in our contract balances for the six months ended June 30, 2022 and 2021 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,461)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of acquired deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,067)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,972)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,005)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,066)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,430)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,435)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,968)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854665664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of our lease cost (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:36.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.266%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.266%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.713%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,657&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; reduction of ROU asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,676&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,026&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,056&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,046&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Cash Flow, Supplemental Disclosures [Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental cash flow information related to our leases (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_AssetsandLiabilitiesLeasesTableTextBlock', window );">Assets and Liabilities, Leases [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,323</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,847</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,929</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,009</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,491</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,971</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,420</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,980</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,335</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,652&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,676&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,420&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_AssetsandLiabilitiesLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets and Liabilities, Leases [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_AssetsandLiabilitiesLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854378752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</a></td>
<td class="text">The following table presents the calculation of net earnings per common share (&#8220;EPS&#8221;) &#8212; basic and diluted (in thousands, except per share data):&#160; <div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,474)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,542)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding (basic)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common and common equivalent shares outstanding (diluted)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,897&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,703&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,787&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,718&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.31)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.34&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.91)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.46&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No dilutive effect for the three and six months ended June 30, 2022;  therefore, zero incremental shares included for the period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854370608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</a></td>
<td class="text">The following table presents the fair values of our derivative instruments included within the Condensed Consolidated Balance Sheets (in thousands):<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:48.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Condensed Consolidated Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Derivatives</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,575&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized the following gains on our derivative instruments designated as cash flow hedges (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.730%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain Recognized in Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,371&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,534&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.894%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Reclassified From Accumulated Other Comprehensive (Loss) Income into Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,524)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,524)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,857&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,136&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,744&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents location of gain reclassified from accumulated other comprehensive income into income as a result that a forecasted transaction is no longer probable of occurring.</span></div>As of June&#160;30, 2022, we expect an estimated $8.5&#160;million in deferred gains on the outstanding foreign exchange contracts and an estimated $15.7&#160;million in deferred gains on the interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854616848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a reconciliation of the Level 3 earn-out liabilities measured at estimated fair value (in thousands):  </span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition date fair value estimate of earn-out</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of earn-out (included in income from operations as a separate line item)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,409&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;$53.5 million relates to our acquisition of Smiths Medical and $1.6 million relates to our acquisition of a small foreign infusions systems supplier in the fourth quarter of 2021 (see Note 3: Acquisitions).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; Primarily relates to the change in fair value of the Smiths Medical earn-out.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of earn-out (included in income from operations as a separate line item)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of earn-out (included in income from operations as a separate line item)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide quantitative information about Level 3 inputs for fair value measurement of our earn-out liabilities related to Smiths Medical and Pursuit:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smiths Medical Earn-out</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.961%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At Acquisition<br/>January 6, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-Free Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pursuit Earn-out</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue/Gross Profit Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-Free Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Counter Party Risk</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Fair Value, by Balance Sheet Grouping</a></td>
<td class="text">Our assets and liabilities measured at fair value on a recurring basis consisted of the following Level 1, 2 and 3 inputs as defined above (in thousands):<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - ST</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,036&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,409&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency par forward contract:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,069&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615851412800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.301%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding <br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,028&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,028&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding<br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,040&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,040&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Method Investments [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-marketable equity method investment consists of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in non-marketable debt securities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter 2022, we received $19.0&#160;million in proceeds from a promissory note related to an acquired investment as part of the Smiths Medical acquisition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615853566624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaids and Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Prepaid Expenses and Other Current Assets [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses and receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,081&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid vendor expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance and property taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT/GST receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax charge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,663&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,847&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Schedule of Other Assets, Noncurrent[TableTextBlock]</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pump lease receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spare parts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,728&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,743&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615858820832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory, Current [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583,050&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, inventories increased significantly due to the acquisition of Smiths Medical. All acquired inventory was recorded at fair value on January 6, 2022 in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (see Note 3: Acquisitions).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854606768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consists of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407,580&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, building and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments placed with customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,592&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,384&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147,292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905,104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(479,509)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(436,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,783&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468,365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615846868512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill [Table Text Block]</a></td>
<td class="text">The following table presents the changes in the carrying amount of our goodwill (in thousands):<div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,439&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,034)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,421,216&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to Smiths Medical acquired on January 6, 2022.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other reflects measurement period adjustments related to a 2021 acquisition of a small foreign infusion systems supplier.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text">Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life&#160;in&#160;Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,603&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">581,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">513,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">584,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">505,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,237,260&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">185,554&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,051,706&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,265,883&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">185,554&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,080,329&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275,835&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,882&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,953&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">301,193&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,882&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022 estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051,706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854465072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities [Table Text Block]</a></td>
<td class="text">Accrued liabilities consist of the following (in thousands):&#160;<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incentive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-ST</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,929&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties and returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Field service corrective action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued freight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued audit fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,656&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,195&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to field corrective actions associated with certain products in connection with a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities consist of the following (in thousands):&#160;</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-LT</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liability-LT</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Field service corrective action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,830&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615858234480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LOngTermObligationsDisclosureAbstract', window );"><strong>LOng-Term Obligations Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of our long-term debt consist of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B &#8212; principal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less unamortized debt issuance costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,783)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying value of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,655,092&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636,029&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprised of $14.2 million and $12.6 million relating to the Term Loan A and the Term Loan B, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years is approximately (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,681,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_InterestExpenseOnLongTermDebtTableTextBlock', window );">Interest expense on long term debt</a></td>
<td class="text">The following table presents the total interest expense related to our long-term debt (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.841%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six months ended <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment fee &#8212; Revolving Credit Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,730&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,742&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock', window );">Applicable Margin Based on Leverage Ratio</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan A and borrowings under the Revolving Credit Facility will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitment Fee Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 4.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 4.00 to 1.0 but greater than 3.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 3.00 to 1.0 but greater than 2.50 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.50 to 1.0 but greater than 2.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Applicable Margin Based on Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_InterestExpenseOnLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest expense on long term debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_InterestExpenseOnLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LOngTermObligationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>LOng-Term Obligations Disclosure [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LOngTermObligationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854572000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">The components of AOCI, net of tax, were as follows (in thousands):<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Losses) Gains on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,045)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,946)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,946)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,572&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,641&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,991)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(628)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,805)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,245&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89,546)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,805)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,144&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,647)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,796)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,479&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92,275)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,381)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,522)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,752)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,458)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(945)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,391)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,839)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,913)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,649&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(687)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(687)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(352)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,537)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,487&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,951)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615851154080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,922,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossST', window );">Contingent Consideration, Gross ST</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossLT', window );">Contingent Consideration, Gross LT</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_BusinessCombinationConsiderationHoldbackLiability', window );">Business Combination, Consideration, Holdback liability</a></td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember', window );">Foreign Infusion System Supplier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="nump">15,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossST', window );">Contingent Consideration, Gross ST</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossLT', window );">Contingent Consideration, Gross LT</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_BusinessCombinationConsiderationHoldbackLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration, Holdback liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_BusinessCombinationConsiderationHoldbackLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossLT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross LT</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossLT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossST">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross ST</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossST</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Contingentconsiderationgross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contingent consideration gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Contingentconsiderationgross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615846864432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions (Details) - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent Earn-Out Liability, Noncurrent</a></td>
<td class="nump">$ 30,119,000<span></span>
</td>
<td colspan="2" class="nump">$ 2,589,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_MinimumStockPriceTargetForEarnOutPayment', window );">Minimum Stock Price Target for Earn-out Payment</a></td>
<td class="nump">$ 300.00<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_RequiredShareHoldingOfStockIssuedAtAcquisition', window );">Required Share Holding Of Stock Issued At Acquisition</a></td>
<td class="nump">0.500<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business Acquisition, Percentage of Voting Interests Acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_BusinessCombinationConsiderationTransferredCash', window );">Business Combination, Consideration Transferred, Cash</a></td>
<td class="nump">$ 1,900,000,000<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</a></td>
<td class="nump">2,500<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent Earn-Out Liability, Noncurrent</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_BusinessCombinationConsiderationTransferredCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_BusinessCombinationConsiderationTransferredCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_MinimumStockPriceTargetForEarnOutPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum Stock Price Target for Earn-out Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_MinimumStockPriceTargetForEarnOutPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_RequiredShareHoldingOfStockIssuedAtAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Required Share Holding Of Stock Issued At Acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_RequiredShareHoldingOfStockIssuedAtAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852208544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions Smiths Medical (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,922,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Software Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Business Acquisition, Share Price</a></td>
<td class="nump">$ 230.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</a></td>
<td class="nump">$ 575,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 575,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</a></td>
<td class="nump">78,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</a></td>
<td class="nump">118,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="nump">226,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226,196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</a></td>
<td class="nump">53,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="nump">210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed', window );">business combination, recognized identifiable asset acquired and liability assumed,</a></td>
<td class="nump">55,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">975,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">975,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</a></td>
<td class="nump">9,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="nump">379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</a></td>
<td class="nump">105,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</a></td>
<td class="nump">175,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable', window );">Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable</a></td>
<td class="num">(24,332)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,332)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</a></td>
<td class="num">(85,739)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(85,739)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="num">(228,689)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(228,689)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</a></td>
<td class="nump">1,107,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,107,511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_BusinessCombinationGoodwillNonDeductible', window );">Business combination, goodwill- non deductible</a></td>
<td class="nump">1,444,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,444,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="nump">2,552,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,552,450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">540,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">540,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical | developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical | Trademarks and Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical | Software and Software Development Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_BusinessCombinationGoodwillNonDeductible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination, goodwill- non deductible</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_BusinessCombinationGoodwillNonDeductible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>business combination, recognized identifiable asset acquired and liability assumed,</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=icui_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=icui_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615846935040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Business Acquisition, Pro Forma Revenue</a></td>
<td class="nump">$ 561,004<span></span>
</td>
<td class="nump">$ 625,942<span></span>
</td>
<td class="nump">$ 1,124,823<span></span>
</td>
<td class="nump">$ 1,227,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">561,004<span></span>
</td>
<td class="nump">321,677<span></span>
</td>
<td class="nump">1,104,126<span></span>
</td>
<td class="nump">639,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (Loss) Income</a></td>
<td class="num">(7,474)<span></span>
</td>
<td class="nump">28,398<span></span>
</td>
<td class="num">(45,542)<span></span>
</td>
<td class="nump">52,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Business Acquisition, Pro Forma Net Income (Loss)</a></td>
<td class="num">(7,474)<span></span>
</td>
<td class="nump">34,244<span></span>
</td>
<td class="num">(59,425)<span></span>
</td>
<td class="nump">$ 31,447<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ProFormaAdjustmentAmortization', window );">Pro Forma Adjustment - Amortization</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">55,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ProFormaAdjustmentFinanceCosts', window );">Pro Forma Adjustment - Finance Costs</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">25,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ProFormaAdjustmentInventory', window );">Pro Forma Adjustment - Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ProFormaAdjustmentRelatedPartyLoans', window );">Pro Forma Adjustment - Related Party Loans</a></td>
<td class="nump">80,700<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonrecurringAdjustmentAxis=us-gaap_AcquisitionRelatedCostsMember', window );">Acquisition-related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Business Acquisition, Transaction Costs</a></td>
<td class="nump">13,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">222,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">437,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (Loss) Income</a></td>
<td class="nump">$ 26,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ProFormaAdjustmentAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pro Forma Adjustment - Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ProFormaAdjustmentAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ProFormaAdjustmentFinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pro Forma Adjustment - Finance Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ProFormaAdjustmentFinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ProFormaAdjustmentInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pro Forma Adjustment - Inventory</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ProFormaAdjustmentInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ProFormaAdjustmentRelatedPartyLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pro Forma Adjustment - Related Party Loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ProFormaAdjustmentRelatedPartyLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonrecurringAdjustmentAxis=us-gaap_AcquisitionRelatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonrecurringAdjustmentAxis=us-gaap_AcquisitionRelatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615851149472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Strategic Transaction and Integration Restructuring (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Restructuringstrategictransactionandintegration', window );">Restructuring, strategic transaction and integration</a></td>
<td class="nump">$ 13,500<span></span>
</td>
<td class="nump">$ 3,800<span></span>
</td>
<td class="nump">$ 47,400<span></span>
</td>
<td class="nump">$ 6,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Restructuringstrategictransactionandintegration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring, strategic transaction and integration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Restructuringstrategictransactionandintegration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852125552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Strategic Transaction and Integration Liability (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">$ 9,205<span></span>
</td>
<td class="nump">$ 664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">1,710<span></span>
</td>
<td class="nump">3,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="nump">3,564<span></span>
</td>
<td class="nump">2,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</a></td>
<td class="nump">350<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">6,963<span></span>
</td>
<td class="nump">9,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restructuring Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,536<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Severance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">7,340<span></span>
</td>
<td class="nump">499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">1,710<span></span>
</td>
<td class="nump">3,222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="nump">3,352<span></span>
</td>
<td class="nump">2,030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">5,404<span></span>
</td>
<td class="nump">7,340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restructuring Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember', window );">Facility Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">1,865<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="nump">212<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">$ 1,559<span></span>
</td>
<td class="nump">1,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restructuring Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,740<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents liabilities associated with restructuring or exit activities of the acquiree, existing at the acquisition date (present liabilities of the acquiree).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852439600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Transaction and Integration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_StrategicTransactionandIntegration', window );">Strategic Transaction and Integration</a></td>
<td class="nump">$ 11.8<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
<td class="nump">$ 42.5<span></span>
</td>
<td class="nump">$ 6.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_StrategicTransactionandIntegration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Strategic Transaction and Integration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_StrategicTransactionandIntegration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852131088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Disaggregated Revenue by Geography (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 561,004<span></span>
</td>
<td class="nump">$ 321,677<span></span>
</td>
<td class="nump">$ 1,104,126<span></span>
</td>
<td class="nump">$ 639,723<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">EMEA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">87,415<span></span>
</td>
<td class="nump">37,761<span></span>
</td>
<td class="nump">173,619<span></span>
</td>
<td class="nump">72,560<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=icui_OtherforeigncountriesMember', window );">Other foreign countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">109,723<span></span>
</td>
<td class="nump">59,249<span></span>
</td>
<td class="nump">218,850<span></span>
</td>
<td class="nump">115,145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=icui_ForeignMember', window );">Foreign [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">197,138<span></span>
</td>
<td class="nump">97,010<span></span>
</td>
<td class="nump">392,469<span></span>
</td>
<td class="nump">187,705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 363,866<span></span>
</td>
<td class="nump">$ 224,667<span></span>
</td>
<td class="nump">$ 711,657<span></span>
</td>
<td class="nump">$ 452,018<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=icui_OtherforeigncountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=icui_OtherforeigncountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=icui_ForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=icui_ForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852070000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Disaggregated Revenue by Product Line (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 561,004<span></span>
</td>
<td class="nump">$ 321,677<span></span>
</td>
<td class="nump">$ 1,104,126<span></span>
</td>
<td class="nump">$ 639,723<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_InfusionConsumablesMember', window );">Infusion Consumables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">144,456<span></span>
</td>
<td class="nump">136,200<span></span>
</td>
<td class="nump">284,977<span></span>
</td>
<td class="nump">262,569<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_InfusionSystemsMember', window );">Infusion Systems [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">87,253<span></span>
</td>
<td class="nump">84,661<span></span>
</td>
<td class="nump">174,265<span></span>
</td>
<td class="nump">168,995<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_IVSolutionsMember', window );">IV Solutions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">94,113<span></span>
</td>
<td class="nump">88,421<span></span>
</td>
<td class="nump">182,593<span></span>
</td>
<td class="nump">182,597<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_CriticalCareMember', window );">Critical Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">12,373<span></span>
</td>
<td class="nump">12,395<span></span>
</td>
<td class="nump">24,530<span></span>
</td>
<td class="nump">25,562<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_InfusionConsumablesSmithsMedicalMember', window );">Infusion Consumables-Smiths Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">77,812<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">144,102<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_VascularAccessMember', window );">Vascular Access</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">77,058<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">156,066<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_VitalCareMember', window );">Vital Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 67,939<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 137,593<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_InfusionConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_InfusionConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_InfusionSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_InfusionSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_IVSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_IVSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_CriticalCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_CriticalCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_InfusionConsumablesSmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_InfusionConsumablesSmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_VascularAccessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_VascularAccessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_VitalCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_VitalCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852340048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Contract Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="num">$ (7,461)<span></span>
</td>
<td class="num">$ (6,430)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="num">(53,066)<span></span>
</td>
<td class="num">(4,968)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TimingAxis=icui_ShortTermMember', window );">Short Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">(30,572)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TimingAxis=icui_LongTermMember', window );">Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">(22,494)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,245)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_EquipmentrevenueMember', window );">Equipment revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (Decrease) in Deferred Revenue</a></td>
<td class="nump">14,606<span></span>
</td>
<td class="nump">4,754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Deferred Revenue, Additions</a></td>
<td class="num">(7,349)<span></span>
</td>
<td class="num">(5,435)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_EquipmentrevenueMember', window );">Equipment revenue [Member] | Short Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">(19,744)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_EquipmentrevenueMember', window );">Equipment revenue [Member] | Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_SoftwarerevenueMember', window );">Software revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (Decrease) in Deferred Revenue</a></td>
<td class="nump">8,737<span></span>
</td>
<td class="nump">4,355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Deferred Revenue, Additions</a></td>
<td class="num">(9,067)<span></span>
</td>
<td class="num">$ (2,212)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_SoftwarerevenueMember', window );">Software revenue [Member] | Short Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">(7,750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_SoftwarerevenueMember', window );">Software revenue [Member] | Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">(1,647)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_GovernmentGrantRevenueMember', window );">Government Grant Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (Decrease) in Deferred Revenue</a></td>
<td class="nump">232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Deferred Revenue, Additions</a></td>
<td class="num">(2,972)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_GovernmentGrantRevenueMember', window );">Government Grant Revenue | Short Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">(1,175)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_GovernmentGrantRevenueMember', window );">Government Grant Revenue | Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">(13,569)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_OtherDeferredRevenueMember', window );">Other deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (Decrease) in Deferred Revenue</a></td>
<td class="nump">2,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Deferred Revenue, Additions</a></td>
<td class="num">(1,005)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_OtherDeferredRevenueMember', window );">Other deferred revenue | Short Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">(1,903)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_OtherDeferredRevenueMember', window );">Other deferred revenue | Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">$ (7,278)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInDeferredRevenueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInDeferredRevenueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TimingAxis=icui_ShortTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TimingAxis=icui_ShortTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TimingAxis=icui_LongTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TimingAxis=icui_LongTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_EquipmentrevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_EquipmentrevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_SoftwarerevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_SoftwarerevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_GovernmentGrantRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_GovernmentGrantRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_OtherDeferredRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_OtherDeferredRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615855375632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Text (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Optiontoextendinyears', window );">Lessee, Operating Lease, Option to Extend</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Optiontoextendinyears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Optiontoextendinyears</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Optiontoextendinyears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615844695456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="nump">$ 5,475<span></span>
</td>
<td class="nump">$ 2,822<span></span>
</td>
<td class="nump">$ 10,653<span></span>
</td>
<td class="nump">$ 5,657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Finance Lease, Interest Expense</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance Lease, Right-of-Use Asset, Amortization</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="nump">340<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term Lease, Cost</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease, Cost</a></td>
<td class="nump">$ 5,676<span></span>
</td>
<td class="nump">$ 3,026<span></span>
</td>
<td class="nump">$ 11,056<span></span>
</td>
<td class="nump">$ 6,046<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615846842560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Cash Flow, Operating Activities, Lessee (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="nump">$ 12,887<span></span>
</td>
<td class="nump">$ 5,657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Finance Lease, Interest Payment on Liability</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</a></td>
<td class="nump">3,829<span></span>
</td>
<td class="nump">1,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 332<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852503488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Assets and Liabilities, Lessee (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">$ 83,323<span></span>
</td>
<td class="nump">$ 39,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">19,929<span></span>
</td>
<td class="nump">9,009<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">68,491<span></span>
</td>
<td class="nump">33,971<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">$ 88,420<span></span>
</td>
<td class="nump">$ 42,980<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">4.39%<span></span>
</td>
<td class="nump">4.98%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset</a></td>
<td class="nump">$ 2,335<span></span>
</td>
<td class="nump">$ 2,673<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance Lease, Liability, Current</a></td>
<td class="nump">650<span></span>
</td>
<td class="nump">643<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance Lease, Liability, Noncurrent</a></td>
<td class="nump">1,741<span></span>
</td>
<td class="nump">2,067<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">$ 2,391<span></span>
</td>
<td class="nump">$ 2,710<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">4.27%<span></span>
</td>
<td class="nump">4.28%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852089584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Maturity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year</a></td>
<td class="nump">$ 12,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months</a></td>
<td class="nump">21,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Lessee, Operating Lease, Liability, Payments, Due Year Two</a></td>
<td class="nump">17,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Lessee, Operating Lease, Liability, Payments, Due Year Three</a></td>
<td class="nump">12,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Lessee, Operating Lease, Liability, Payments, Due Year Four</a></td>
<td class="nump">10,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Lessee, Operating Lease, Liability, Payments, Due Year Five</a></td>
<td class="nump">8,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Lessee, Operating Lease, Liability, Payments, Due after Year Five</a></td>
<td class="nump">17,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Lessee, Operating Lease, Liability, Payments, Due</a></td>
<td class="nump">99,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</a></td>
<td class="num">(11,232)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">88,420<span></span>
</td>
<td class="nump">$ 42,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Finance Lease, Liability, Payments, Remainder of Fiscal Year</a></td>
<td class="nump">371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Finance Lease, Liability, Payments, Due Next Twelve Months</a></td>
<td class="nump">742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">Finance Lease, Liability, Payments, Due Year Two</a></td>
<td class="nump">459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">Finance Lease, Liability, Payments, Due Year Three</a></td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">Finance Lease, Liability, Payments, Due Year Four</a></td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">Finance Lease, Liability, Payments, Due Year Five</a></td>
<td class="nump">189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Finance Lease, Liability, Payments, Due after Year Five</a></td>
<td class="nump">426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Finance Lease, Liability, Payment, Due</a></td>
<td class="nump">2,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Finance Lease, Liability, Undiscounted Excess Amount</a></td>
<td class="num">(285)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">$ 2,391<span></span>
</td>
<td class="nump">$ 2,710<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615846901584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">12,107<span></span>
</td>
<td class="nump">12,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (Loss) Income</a></td>
<td class="num">$ (7,474)<span></span>
</td>
<td class="nump">$ 28,398<span></span>
</td>
<td class="num">$ (45,542)<span></span>
</td>
<td class="nump">$ 52,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding (for basic calculation)</a></td>
<td class="nump">23,897,000<span></span>
</td>
<td class="nump">21,200,000<span></span>
</td>
<td class="nump">23,787,000<span></span>
</td>
<td class="nump">21,176,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">503,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">542,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">23,897,000<span></span>
</td>
<td class="nump">21,703,000<span></span>
</td>
<td class="nump">23,787,000<span></span>
</td>
<td class="nump">21,718,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">EPS - basic</a></td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="nump">$ 1.34<span></span>
</td>
<td class="num">$ (1.91)<span></span>
</td>
<td class="nump">$ 2.46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (In dollars per share)</a></td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="nump">$ 1.31<span></span>
</td>
<td class="num">$ (1.91)<span></span>
</td>
<td class="nump">$ 2.40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615855558064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Details 1) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">12,107<span></span>
</td>
<td class="nump">12,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">503,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">542,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">23,897,000<span></span>
</td>
<td class="nump">21,703,000<span></span>
</td>
<td class="nump">23,787,000<span></span>
</td>
<td class="nump">21,718,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="nump">$ 1.34<span></span>
</td>
<td class="num">$ (1.91)<span></span>
</td>
<td class="nump">$ 2.46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="nump">$ 1.31<span></span>
</td>
<td class="num">$ (1.91)<span></span>
</td>
<td class="nump">$ 2.40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615848352912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 209,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Srt_MultipleCurrencyAxisAxis=icui_OtherCurrenciesMember', window );">other currencies</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">33,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_MXN', window );">Mexico, Pesos</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">43,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro Member Countries, Euro</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">39,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CZK', window );">Czech Republic, Koruny</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">18,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">Japan, Yen</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 18,800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Srt_MultipleCurrencyAxisAxis=icui_OtherCurrenciesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Srt_MultipleCurrencyAxisAxis=icui_OtherCurrenciesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_MXN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_MXN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CZK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CZK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615846829296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>MXN ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>MXN ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</a></td>
<td class="nump">$ 8,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">209,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_MXN', window );">Mexico, Pesos</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">43,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CNY', window );">China, Yuan Renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">19,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 36,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge2Member', window );">Hedge 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeForwardExchangeRate1', window );">Derivative, Forward Exchange Rate</a></td>
<td class="nump">21.60<span></span>
</td>
<td class="nump">21.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative Asset, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 208,200,000<span></span>
</td>
<td class="nump">$ 413,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge3MemberMember', window );">Hedge 3 [Member] [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeForwardExchangeRate1', window );">Derivative, Forward Exchange Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.26<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeForwardExchangeRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual rate at which a foreign currency can be purchased or sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeForwardExchangeRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_MXN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_MXN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CNY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CNY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge3MemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge3MemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615848350864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments Interest Rate Swaps (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 209,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_InterestRateSwapEndingNotionalValue', window );">Interest Rate Swap Ending Notional Value</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative, Fixed Interest Rate</a></td>
<td class="nump">1.32%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_DerivativeVariableRateFloor', window );">derivative variable rate floor</a></td>
<td class="num">(0.0015)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Term Loan B</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_InterestRateSwapEndingNotionalValue', window );">Interest Rate Swap Ending Notional Value</a></td>
<td class="nump">$ 46,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative, Fixed Interest Rate</a></td>
<td class="nump">1.17%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_DerivativeVariableRateFloor', window );">derivative variable rate floor</a></td>
<td class="nump">0.0035<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_DerivativeVariableRateFloor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>derivative variable rate floor</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_DerivativeVariableRateFloor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_InterestRateSwapEndingNotionalValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Rate Swap Ending Notional Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_InterestRateSwapEndingNotionalValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852385840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">$ 48,816<span></span>
</td>
<td class="nump">$ 1,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">9,463<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">627<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">24,870<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">23,946<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative Liability, Current</a></td>
<td class="nump">577<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">9,575<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">627<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">9,463<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative Liability, Current</a></td>
<td class="nump">577<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">39,241<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">23,834<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">15,407<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">23,834<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative Liability, Current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,480<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615846829920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other Comprehensive Income (Loss), before Tax</a></td>
<td class="nump">$ 14,371<span></span>
</td>
<td class="nump">$ 441<span></span>
</td>
<td class="nump">$ 47,534<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other Comprehensive Income (Loss), before Tax</a></td>
<td class="nump">5,225<span></span>
</td>
<td class="nump">441<span></span>
</td>
<td class="nump">8,337<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other Comprehensive Income (Loss), before Tax</a></td>
<td class="nump">$ 9,146<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 39,197<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615844434320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</a></td>
<td class="nump">$ 8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</a></td>
<td class="nump">15,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion', window );">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</a></td>
<td class="nump">1,857<span></span>
</td>
<td class="nump">$ 903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,136<span></span>
</td>
<td class="nump">$ 1,744<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Trading Revenue | Cash Flow Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion', window );">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</a></td>
<td class="nump">1,813<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,356<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Cost of Sales [Member] | Cash Flow Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion', window );">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</a></td>
<td class="nump">1,563<span></span>
</td>
<td class="nump">903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,049<span></span>
</td>
<td class="nump">1,744<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Interest Expense | Cash Flow Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion', window );">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Interest Expense | Cash Flow Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion', window );">Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion</a></td>
<td class="num">$ (1,524)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,524)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of gain reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of loss reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_TradingRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_TradingRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615847758352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 06, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="nump">$ 30,409<span></span>
</td>
<td class="nump">$ 30,409<span></span>
</td>
<td class="nump">$ 57,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossST', window );">Contingent Consideration, Gross ST</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossLT', window );">Contingent Consideration, Gross LT</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_OwnershipRequirementForEarnoutPayment', window );">Ownership requirement for Earnout Payment</a></td>
<td class="nump">0.500<span></span>
</td>
<td class="nump">0.500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=us-gaap_LiabilityMember', window );">Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="nump">26,300<span></span>
</td>
<td class="nump">26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">26,100<span></span>
</td>
<td class="nump">26,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember', window );">Foreign Infusion System Supplier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossST', window );">Contingent Consideration, Gross ST</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossLT', window );">Contingent Consideration, Gross LT</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossLT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross LT</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossLT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossST">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross ST</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossST</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Contingentconsiderationgross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contingent consideration gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Contingentconsiderationgross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_OwnershipRequirementForEarnoutPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ownership requirement for Earnout Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_OwnershipRequirementForEarnoutPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852344304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="nump">$ 30,409<span></span>
</td>
<td class="nump">$ 57,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</a></td>
<td class="num">(27,194)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_CurrencyTranslationOnEarnOut', window );">Currency translation on earn-out</a></td>
<td class="num">(98)<span></span>
</td>
<td class="num">$ (46)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_CurrencyTranslationOnEarnOut">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Currency translation on earn-out</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_CurrencyTranslationOnEarnOut</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3) and still held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615846831120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="nump">$ 30,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,701<span></span>
</td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</a></td>
<td class="num">(27,194)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3) and still held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615846682640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures Liability Measurement Inputs (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jan. 06, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member] | MeasurementinputadjustedEBITDAvolatility [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member] | Measurement Input, Discount Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member] | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0009<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member] | Measurement Input, Market Price of Risk [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="nump">0.0297<span></span>
</td>
<td class="nump">0.0131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical | Measurement Input, Price Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="nump">0.4000<span></span>
</td>
<td class="nump">0.3700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=icui_MeasurementinputadjustedEBITDAvolatilityDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=icui_MeasurementinputadjustedEBITDAvolatilityDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=icui_MeasurementInputMarketPriceofRiskDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=icui_MeasurementInputMarketPriceofRiskDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615846110112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">$ 63,844<span></span>
</td>
<td class="nump">$ 20,101<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue', window );">Interest Rate Derivative Liabilities, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">13,191<span></span>
</td>
<td class="nump">14,420<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">1,837<span></span>
</td>
<td class="nump">4,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate Bond Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">11,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember', window );">US Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">1,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=icui_EarnoutliabilityMember', window );">Earn-out liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">30,119<span></span>
</td>
<td class="nump">2,589<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_LiabilitiesTotalMember', window );">Liabilities, Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,069<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liabilities Fair Value Disclosure</a></td>
<td class="nump">31,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=icui_EarnOutLiabilityST', window );">Earn-out liability ST</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">9,463<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">15,407<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue', window );">Interest Rate Derivative Liabilities, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">23,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">1,404<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Corporate Bond Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | US Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">1,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Earn-out liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Liabilities, Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liabilities Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | ST Earnout Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue', window );">Interest Rate Derivative Liabilities, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">62,440<span></span>
</td>
<td class="nump">20,101<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,420<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">1,837<span></span>
</td>
<td class="nump">4,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Corporate Bond Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">11,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | US Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Earn-out liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Liabilities, Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liabilities Fair Value Disclosure</a></td>
<td class="nump">627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | ST Earnout Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">9,463<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">15,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue', window );">Interest Rate Derivative Liabilities, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">23,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Corporate Bond Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | US Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Earn-out liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">30,119<span></span>
</td>
<td class="nump">2,589<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Liabilities, Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,589<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liabilities Fair Value Disclosure</a></td>
<td class="nump">30,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | ST Earnout Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue', window );">Interest Rate Derivative Liabilities, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateDerivativeAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of interest rate derivative assets, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateDerivativeAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of interest rate derivative liabilities, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateDerivativeLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations not classified as financial liabilities. Includes, but is not limited to, accounts payable and accrued liabilities, commitments, obligations, and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonfinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=icui_EarnoutliabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=icui_EarnoutliabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_LiabilitiesTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_LiabilitiesTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=icui_EarnOutLiabilityST">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=icui_EarnOutLiabilityST</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=icui_STEarnoutLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=icui_STEarnoutLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854496384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Gain (Loss) on Sale of Investments</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments', window );">Proceeds from Sale and Maturity of Other Investments</a></td>
<td class="nump">$ 19<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615851429392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities Table (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">$ 13,191<span></span>
</td>
<td class="nump">$ 14,420<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">15,028<span></span>
</td>
<td class="nump">19,040<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent', window );">Debt Securities, Available-for-sale, Amortized Cost, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,420<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">1,837<span></span>
</td>
<td class="nump">4,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">15,028<span></span>
</td>
<td class="nump">19,040<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=icui_AvailableforsaleDebtSecurityCurrentMember', window );">Available-for-sale Debt Security Current [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=icui_LongtermInvestmentsDomain', window );">Long-term Investments [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent', window );">Debt Securities, Available-for-sale, Noncurrent</a></td>
<td class="nump">1,837<span></span>
</td>
<td class="nump">4,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">1,837<span></span>
</td>
<td class="nump">$ 4,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate Bond Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">11,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent', window );">Debt Securities, Available-for-sale, Amortized Cost, Current</a></td>
<td class="nump">11,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember', window );">US Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">1,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent', window );">Debt Securities, Available-for-sale, Amortized Cost, Current</a></td>
<td class="nump">1,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=icui_AvailableforsaleDebtSecurityCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=icui_AvailableforsaleDebtSecurityCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=icui_LongtermInvestmentsDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=icui_LongtermInvestmentsDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615855552528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity Method Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">$ 3,206<span></span>
</td>
<td class="nump">$ 3,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Equity Method Investment, Aggregate Cost</a></td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852344384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaids and Other Current Assets Prepaids and Other Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other Prepaid Expense, Current</a></td>
<td class="nump">$ 27,081<span></span>
</td>
<td class="nump">$ 14,763<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_PrepaidVendorExpenses', window );">Prepaid vendor expenses</a></td>
<td class="nump">5,655<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsAndOtherAssets', window );">Deferred Costs and Other Assets</a></td>
<td class="nump">7,648<span></span>
</td>
<td class="nump">12,746<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Prepaidinsuranceandpropertytaxes', window );">Prepaid insurance and property taxes</a></td>
<td class="nump">16,542<span></span>
</td>
<td class="nump">6,310<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Prepaidothertaxes', window );">Prepaid Taxes</a></td>
<td class="nump">3,446<span></span>
</td>
<td class="nump">4,156<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Deferredtaxcharge', window );">Deferred tax charge</a></td>
<td class="nump">4,308<span></span>
</td>
<td class="nump">4,241<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">9,463<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositAssets', window );">Deposit Assets</a></td>
<td class="nump">1,294<span></span>
</td>
<td class="nump">1,343<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other Assets, Current</a></td>
<td class="nump">3,819<span></span>
</td>
<td class="nump">2,227<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 94,663<span></span>
</td>
<td class="nump">$ 46,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Deferredtaxcharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax charge</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Deferredtaxcharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_PrepaidVendorExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid vendor expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_PrepaidVendorExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Prepaidinsuranceandpropertytaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid insurance and property taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Prepaidinsuranceandpropertytaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Prepaidothertaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid other taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Prepaidothertaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred cost assets and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852100096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets Noncurrent(Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">Lessor, Operating Lease, Payments to be Received</a></td>
<td class="nump">$ 28,436<span></span>
</td>
<td class="nump">$ 25,941<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_SpareParts', window );">Spare parts</a></td>
<td class="nump">34,352<span></span>
</td>
<td class="nump">28,538<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">3,206<span></span>
</td>
<td class="nump">3,238<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Debt Issuance Costs, Noncurrent, Net</a></td>
<td class="nump">6,016<span></span>
</td>
<td class="nump">2,827<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset</a></td>
<td class="nump">2,335<span></span>
</td>
<td class="nump">2,673<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other Assets, Miscellaneous, Noncurrent</a></td>
<td class="nump">3,437<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">OTHER ASSETS</a></td>
<td class="nump">101,728<span></span>
</td>
<td class="nump">63,743<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">23,834<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">23,834<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember', window );">Foreign Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">$ 112<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_SpareParts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Spare parts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_SpareParts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payments to be received by lessor for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615857876144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Inventory, Raw Materials, Net of Reserves</a></td>
<td class="nump">$ 240,804<span></span>
</td>
<td class="nump">$ 135,528<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Inventory, Work in Process, Net of Reserves</a></td>
<td class="nump">71,101<span></span>
</td>
<td class="nump">36,490<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Inventory, Finished Goods, Net of Reserves</a></td>
<td class="nump">271,145<span></span>
</td>
<td class="nump">118,217<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 583,050<span></span>
</td>
<td class="nump">$ 290,235<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615853622992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">$ 1,147,292<span></span>
</td>
<td class="nump">$ 905,104<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(479,509)<span></span>
</td>
<td class="num">(436,739)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net property and equipment</a></td>
<td class="nump">667,783<span></span>
</td>
<td class="nump">468,365<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and Equipment, Gross</a></td>
<td class="nump">407,580<span></span>
</td>
<td class="nump">321,078<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and Fixtures, Gross</a></td>
<td class="nump">29,538<span></span>
</td>
<td class="nump">7,670<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in Progress, Gross</a></td>
<td class="nump">136,723<span></span>
</td>
<td class="nump">72,153<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember', window );">Land, Buildings and Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">271,723<span></span>
</td>
<td class="nump">243,377<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_MoldsMember', window );">Molds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">75,765<span></span>
</td>
<td class="nump">60,463<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_ComputerEquipmentAndSoftwareMember', window );">Computer Equipment and Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">115,371<span></span>
</td>
<td class="nump">102,979<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_InstrumentsPlacedwithCustomersMember', window );">Instruments Placed with Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">$ 110,592<span></span>
</td>
<td class="nump">$ 97,384<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_MoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_MoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_InstrumentsPlacedwithCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_InstrumentsPlacedwithCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615853616256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment Text (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 24,900,000<span></span>
</td>
<td class="nump">$ 16,300,000<span></span>
</td>
<td class="nump">$ 46,400,000<span></span>
</td>
<td class="nump">$ 32,700,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615851275936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets Goodwill Table (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">GOODWILL</a></td>
<td class="nump">$ 1,421,216<span></span>
</td>
<td colspan="2" class="nump">$ 43,439<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">1,444,939<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill, Purchase Accounting Adjustments</a></td>
<td class="num">(7,128)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Goodwill, Foreign Currency Translation Gain (Loss)</a></td>
<td class="num">$ (60,034)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615851205536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets Intangibles Table (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 1,237,260<span></span>
</td>
<td class="nump">$ 275,835<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">185,554<span></span>
</td>
<td class="nump">112,882<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">1,051,706<span></span>
</td>
<td class="nump">162,953<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">28,623<span></span>
</td>
<td class="nump">25,358<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">1,265,883<span></span>
</td>
<td class="nump">301,193<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">INTANGIBLE ASSETS, net</a></td>
<td class="nump">$ 1,080,329<span></span>
</td>
<td class="nump">$ 188,311<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 28,603<span></span>
</td>
<td class="nump">$ 27,429<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">17,669<span></span>
</td>
<td class="nump">16,764<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 10,934<span></span>
</td>
<td class="nump">$ 10,665<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Customer Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 10,140<span></span>
</td>
<td class="nump">$ 10,412<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">6,310<span></span>
</td>
<td class="nump">6,196<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 3,830<span></span>
</td>
<td class="nump">$ 4,216<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-Related Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 581,669<span></span>
</td>
<td class="nump">$ 57,316<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">68,232<span></span>
</td>
<td class="nump">33,004<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 513,437<span></span>
</td>
<td class="nump">$ 24,312<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 5,425<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">5,425<span></span>
</td>
<td class="nump">425<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 18,253<span></span>
</td>
<td class="nump">$ 18,260<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">5,343<span></span>
</td>
<td class="nump">4,731<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 12,910<span></span>
</td>
<td class="nump">$ 13,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed Technology Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 584,070<span></span>
</td>
<td class="nump">$ 152,893<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">78,703<span></span>
</td>
<td class="nump">49,406<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 505,367<span></span>
</td>
<td class="nump">$ 103,487<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 9,100<span></span>
</td>
<td class="nump">$ 9,100<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">3,872<span></span>
</td>
<td class="nump">2,356<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 5,228<span></span>
</td>
<td class="nump">$ 6,744<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854500784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets Text (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 41,600,000<span></span>
</td>
<td class="nump">$ 5,800,000<span></span>
</td>
<td class="nump">$ 73,300,000<span></span>
</td>
<td class="nump">$ 11,600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852561824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets 5-Year Amortization (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</a></td>
<td class="nump">$ 65,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</a></td>
<td class="nump">136,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Two</a></td>
<td class="nump">135,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Four</a></td>
<td class="nump">127,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Five</a></td>
<td class="nump">127,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Five</a></td>
<td class="nump">119,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Finite-Lived Intangible Assets, Amortization Expense, after Year Five</a></td>
<td class="nump">339,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 1,051,706<span></span>
</td>
<td class="nump">$ 162,953<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615846051456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jan. 06, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_AccruedSalariesAndBenefits', window );">Salaries and benefits</a></td>
<td class="nump">$ 56,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,304<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrent', window );">Incentive compensation</a></td>
<td class="nump">16,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,107<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">19,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,009<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent', window );">Sales taxes</a></td>
<td class="nump">7,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,980<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Restructuring accrual</a></td>
<td class="nump">6,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">664<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_UnfavorablecontractliabilityST', window );">UnfavorablecontractliabilityST</a></td>
<td class="nump">35,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,646<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Accruedothertaxes', window );">Accrued other taxes</a></td>
<td class="nump">2,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,337<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Accrued Professional Fees</a></td>
<td class="nump">10,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">773<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Accruedlegalfees', window );">Legal accrual</a></td>
<td class="nump">3,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,897<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Outsidesalescommissions', window );">Distribution Fees</a></td>
<td class="nump">24,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,645<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent', window );">Warranties and returns</a></td>
<td class="nump">546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_FieldServiceCorrectiveAction', window );">Field service corrective action</a></td>
<td class="nump">30,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Accruedfreight', window );">Accrued freight</a></td>
<td class="nump">10,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,194<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">13,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,099<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">247,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,195<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Liability, Defined Benefit Plan, Current</a></td>
<td class="nump">3,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_AccruedAuditFees', window );">Accrued audit fees</a></td>
<td class="nump">4,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,008<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityContingencyLineItems', window );"><strong>Product Liability Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">53,900<span></span>
</td>
<td class="nump">$ 55,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember', window );">Foreign Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative Liability, Current</a></td>
<td class="nump">577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative Liability, Current</a></td>
<td class="nump">$ 577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_AccruedAuditFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued audit fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_AccruedAuditFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_AccruedSalariesAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued salaries and benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_AccruedSalariesAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Accruedfreight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued freight</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Accruedfreight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Accruedlegalfees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued legal fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Accruedlegalfees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Accruedothertaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued other taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Accruedothertaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_FieldServiceCorrectiveAction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Field service corrective action</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_FieldServiceCorrectiveAction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Outsidesalescommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Outside sales commissions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Outsidesalescommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_UnfavorablecontractliabilityST">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>UnfavorablecontractliabilityST</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_UnfavorablecontractliabilityST</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityAccrualComponentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recorded amount of the accrual for a material component of a product liability contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.Y.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityAccrualComponentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12524-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123377177&amp;loc=d3e11281-110244<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615844441520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities Long-term liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jan. 06, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 68,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent', window );">Accrued Employee Benefits</a></td>
<td class="nump">6,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRentCurrentAndNoncurrent', window );">Accrued Rent</a></td>
<td class="nump">1,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Liabilitiesforcontracts', window );">Liabilities for contracts</a></td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue', window );">Interest Rate Derivative Liabilities, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance Lease, Liability, Noncurrent</a></td>
<td class="nump">1,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other Accrued Liabilities, Noncurrent</a></td>
<td class="nump">3,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent', window );">OTHER LONG-TERM LIABILITIES</a></td>
<td class="nump">128,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">53,900<span></span>
</td>
<td class="nump">$ 55,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityContingencyLineItems', window );"><strong>Product Liability Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">53,900<span></span>
</td>
<td class="nump">$ 55,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Contract with Customer, Liability, Noncurrent</a></td>
<td class="nump">23,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TimingAxis=icui_LongTermMember', window );">Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">23,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityContingencyLineItems', window );"><strong>Product Liability Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">23,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember', window );">Foreign Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Liabilitiesforcontracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liabilities for contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Liabilitiesforcontracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRentCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRentCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of interest rate derivative liabilities, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateDerivativeLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityAccrualComponentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recorded amount of the accrual for a material component of a product liability contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.Y.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityAccrualComponentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TimingAxis=icui_LongTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TimingAxis=icui_LongTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852525632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Effective tax rate (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate</a></td>
<td class="nump">56.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Share-based Payment Arrangement, Expense, Tax Benefit</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationTaxExpense', window );">contingent consideration, tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contingent consideration, tax expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615857763216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TotalSeniorSecuredCreditFacility', window );">TotalSeniorSecuredCreditFacility</a></td>
<td class="nump">$ 2,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">1,681,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_RevolverSubLimits', window );">Revolver Sub limits</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs, Gross</a></td>
<td class="nump">37,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LeverageRatioCalculationCeilingSubtractedAmount', window );">Leverage Ratio Calculation Ceiling Subtracted Amount</a></td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from Issuance of Debt</a></td>
<td class="nump">850,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">834,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs, Gross</a></td>
<td class="nump">15,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">$ 834,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Jan.  06,  2027<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanBMember', window );">Term Loan B</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from Issuance of Debt</a></td>
<td class="nump">$ 850,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">847,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs, Gross</a></td>
<td class="nump">13,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">$ 836,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Jan.  06,  2029<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs, Gross</a></td>
<td class="nump">$ 8,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioCalculationCeilingSubtractedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leverage Ratio Calculation Ceiling Subtracted Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioCalculationCeilingSubtractedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_RevolverSubLimits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revolver Sub limits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_RevolverSubLimits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TotalSeniorSecuredCreditFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>TotalSeniorSecuredCreditFacility</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TotalSeniorSecuredCreditFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615847834640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations Interest Rate Terms (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_InterestPercentageAddedToFederalFundsRate', window );">Interest Percentage Added to Federal Funds Rate</a></td>
<td class="nump">0.0050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_InterestPercentageAddedToBaseRate', window );">Interest Percentage Added to Base Rate</a></td>
<td class="nump">0.0100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans', window );">Ter SOFR Interest Rate % Adjustment for Base Rate Loans</a></td>
<td class="nump">0.0010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans', window );">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</a></td>
<td class="nump">0.0025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans', window );">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</a></td>
<td class="nump">0.0025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans', window );">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</a></td>
<td class="nump">0.0010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans', window );">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</a></td>
<td class="nump">0.0010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LeverageRatioLevelAxis=icui_Greaterthan400to100Member', window );">greaterthan 4to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.35%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.35%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member', window );">lessthan4to1butgreaterthan3to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqual300To100ButGreaterThan250to100Member', window );">lessthanorequal3to1butgreaterthan2point5to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member', window );">lessthanorequalto2point5to1butgreaterthan2to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo200To100Member', window );">lessthanorequalto2to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.15%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.15%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A | greaterthan 4to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A | lessthan4to1butgreaterthan3to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A | lessthanorequal3to1butgreaterthan2point5to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A | lessthanorequalto2point5to1butgreaterthan2to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A | lessthanorequalto2to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanBMember', window );">Term Loan B</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanBMember', window );">Term Loan B | greaterthan2point75to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanBMember', window );">Term Loan B | lessthan2point75to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0225<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ApplicableMarginBaseRateLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Applicable Margin Base Rate Loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ApplicableMarginBaseRateLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Applicable Margin Based on Leverage Ratio [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ApplicableMarginBasedOnLeverageRatioLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ApplicableMarginTermSOFRLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Applicable Margin Term SOFR Loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ApplicableMarginTermSOFRLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_InterestPercentageAddedToBaseRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Percentage Added to Base Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_InterestPercentageAddedToBaseRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_InterestPercentageAddedToFederalFundsRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Percentage Added to Federal Funds Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_InterestPercentageAddedToFederalFundsRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ter SOFR Interest Rate % Adjustment for Base Rate Loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TerSOFRInterestRateAdjustmentForBaseRateLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_Greaterthan400to100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_Greaterthan400to100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqual300To100ButGreaterThan250to100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_LessThanOrEqual300To100ButGreaterThan250to100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo200To100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo200To100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_GreaterThan275To100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_GreaterThan275To100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_LessThan275To100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_LessThan275To100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615859055552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations Terminated Credit Agreement (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 150.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Line of Credit Facility, Expiration Date</a></td>
<td class="text">Nov.  08,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of Credit, Current</a></td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615846685936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations Table (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 1,681,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of Credit Facility, Fair Value of Amount Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</a></td>
<td class="num">(26,783,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Debt, Long-term and Short-term, Combined Amount</a></td>
<td class="nump">1,655,092,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="nump">19,063,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">1,636,029,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 834,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</a></td>
<td class="nump">$ 14,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">4.44%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanBMember', window );">Term Loan B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 847,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</a></td>
<td class="nump">$ 12,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">5.11%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615846842400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Obligations Schedule of Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LOngTermObligationsDisclosureAbstract', window );"><strong>LOng-Term Obligations Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">Long-Term Debt, Maturity, Remainder of Fiscal Year</a></td>
<td class="nump">$ 4,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Long-Term Debt, Maturity, Year One</a></td>
<td class="nump">29,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Long-Term Debt, Maturity, Year Two</a></td>
<td class="nump">51,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Long-Term Debt, Maturity, Year Three</a></td>
<td class="nump">51,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">Long-Term Debt, Maturity, Year Four</a></td>
<td class="nump">72,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">Long-Term Debt, Maturity, Year Five</a></td>
<td class="nump">672,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Long-Term Debt, Maturity, after Year Five</a></td>
<td class="nump">801,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 1,681,875<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LOngTermObligationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>LOng-Term Obligations Disclosure [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LOngTermObligationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615853612608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations Interest Expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Interest Expense, Debt, Excluding Amortization</a></td>
<td class="nump">$ 12,622,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 22,639,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of Debt Issuance Costs and Discounts</a></td>
<td class="nump">1,799,000<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="nump">3,442,000<span></span>
</td>
<td class="nump">144,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount', window );">Line of Credit Facility, Commitment Fee Amount</a></td>
<td class="nump">309,000<span></span>
</td>
<td class="nump">57,000<span></span>
</td>
<td class="nump">661,000<span></span>
</td>
<td class="nump">113,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense, Debt</a></td>
<td class="nump">$ 14,730,000<span></span>
</td>
<td class="nump">$ 129,000<span></span>
</td>
<td class="nump">$ 26,742,000<span></span>
</td>
<td class="nump">$ 257,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615844566976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations Principal Payment (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermAPrincipalPaymentFirst2Years', window );">Term A principal payment % First 2 Years</a></td>
<td class="nump">0.0250<span></span>
</td>
<td class="nump">0.0250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermAPrincipalPaymentYear3And4', window );">Term A Principal Payment % Year 3 and 4</a></td>
<td class="nump">0.0500<span></span>
</td>
<td class="nump">0.0500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermAPrincipalPaymentInYear5', window );">Term A Principal Payment % in Year 5</a></td>
<td class="nump">0.0750<span></span>
</td>
<td class="nump">0.0750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanBPrincipalPayment', window );">Term Loan B Principal Payment %</a></td>
<td class="nump">0.0025<span></span>
</td>
<td class="nump">0.0025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt Instrument, Periodic Payment, Principal</a></td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="nump">$ 18,100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermAPrincipalPaymentFirst2Years">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term A principal payment % First 2 Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermAPrincipalPaymentFirst2Years</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermAPrincipalPaymentInYear5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term A Principal Payment % in Year 5</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermAPrincipalPaymentInYear5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermAPrincipalPaymentYear3And4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term A Principal Payment % Year 3 and 4</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermAPrincipalPaymentYear3And4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanBPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Loan B Principal Payment %</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanBPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852389472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies Contingency (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jan. 06, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossST', window );">Contingent Consideration, Gross ST</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossLT', window );">Contingent Consideration, Gross LT</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">53,900<span></span>
</td>
<td class="nump">$ 53,900<span></span>
</td>
<td class="nump">$ 55,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">26,100<span></span>
</td>
<td class="nump">26,100<span></span>
</td>
<td class="nump">$ 53,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember', window );">Foreign Infusion System Supplier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossST', window );">Contingent Consideration, Gross ST</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossLT', window );">Contingent Consideration, Gross LT</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_InternationalDistributorMember', window );">International Distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossLT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross LT</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossLT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossST">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross ST</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossST</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Contingentconsiderationgross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contingent consideration gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Contingentconsiderationgross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionContingentConsiderationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityAccrualComponentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recorded amount of the accrual for a material component of a product liability contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.Y.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityAccrualComponentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_InternationalDistributorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_InternationalDistributorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615854540672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaborative and Other Arrangements (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted', window );">Purchase Commitment, Remaining Minimum Amount Committed</a></td>
<td class="nump">$ 29.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615844609440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TreasuryStockPurchasePlan', window );">Treasury Stock Purchase Plan</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock Repurchase Program, Remaining Authorized Repurchase Amount</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,759<span></span>
</td>
<td class="nump">37,882<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment, Tax Withholding, Share-based Payment Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,438<span></span>
</td>
<td class="nump">$ 7,819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_SmithsGroupOwnershipAcquisitionSharesIssued', window );">Smiths Group Ownership % Acquisition Shares Issued</a></td>
<td class="nump">0.105<span></span>
</td>
<td class="nump">0.105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_SmithsGroupOwnershipRequiredForBoardRepresentation', window );">Smiths Group Ownership % Required for Board Representation</a></td>
<td class="nump">0.050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_SmithsGroupOwnershipAcquisitionSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Smiths Group Ownership % Acquisition Shares Issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_SmithsGroupOwnershipAcquisitionSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_SmithsGroupOwnershipRequiredForBoardRepresentation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Smiths Group Ownership % Required for Board Representation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_SmithsGroupOwnershipRequiredForBoardRepresentation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TreasuryStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock Purchase Plan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TreasuryStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140615852224800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">$ (92,275)<span></span>
</td>
<td class="num">$ (628)<span></span>
</td>
<td class="num">$ (8,951)<span></span>
</td>
<td class="num">$ (9,913)<span></span>
</td>
<td class="num">$ (92,275)<span></span>
</td>
<td class="num">$ (8,951)<span></span>
</td>
<td class="num">$ (19,269)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (1,522)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="num">(89,546)<span></span>
</td>
<td class="nump">20,851<span></span>
</td>
<td class="nump">1,649<span></span>
</td>
<td class="num">(7,752)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="num">(2,101)<span></span>
</td>
<td class="num">(2,210)<span></span>
</td>
<td class="num">(687)<span></span>
</td>
<td class="num">(639)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="num">(91,647)<span></span>
</td>
<td class="nump">18,641<span></span>
</td>
<td class="nump">962<span></span>
</td>
<td class="num">(8,391)<span></span>
</td>
<td class="num">(73,006)<span></span>
</td>
<td class="num">(7,429)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(123,796)<span></span>
</td>
<td class="num">(23,991)<span></span>
</td>
<td class="num">(10,537)<span></span>
</td>
<td class="num">(11,839)<span></span>
</td>
<td class="num">(123,796)<span></span>
</td>
<td class="num">(10,537)<span></span>
</td>
<td class="num">(19,045)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,381)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="num">(99,805)<span></span>
</td>
<td class="num">(4,946)<span></span>
</td>
<td class="nump">1,302<span></span>
</td>
<td class="num">(7,458)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="num">(99,805)<span></span>
</td>
<td class="num">(4,946)<span></span>
</td>
<td class="nump">1,302<span></span>
</td>
<td class="num">(7,458)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="nump">31,479<span></span>
</td>
<td class="nump">23,335<span></span>
</td>
<td class="nump">1,487<span></span>
</td>
<td class="nump">1,839<span></span>
</td>
<td class="nump">31,479<span></span>
</td>
<td class="nump">1,487<span></span>
</td>
<td class="num">(237)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="nump">10,245<span></span>
</td>
<td class="nump">25,782<span></span>
</td>
<td class="nump">335<span></span>
</td>
<td class="num">(306)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="num">(2,101)<span></span>
</td>
<td class="num">(2,210)<span></span>
</td>
<td class="num">(687)<span></span>
</td>
<td class="num">(639)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="nump">8,144<span></span>
</td>
<td class="nump">23,572<span></span>
</td>
<td class="num">(352)<span></span>
</td>
<td class="num">(945)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="10"></td></tr>
<tr><td colspan="10"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>icui-20220630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:currency="http://xbrl.sec.gov/currency/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:icui="http://www.icumed.com/20220630"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="icui-20220630.xsd" xlink:type="simple"/>
    <context id="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iad30622d1b0f462ca40c8e5a1116afb3_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="i4c25d8908c9a44fe915873cf97ad8d51_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i04438ef32e004d068b07cd8363f49820_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2c62d5316ba94e7c8299c081bae93fc3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1020977b89154456bc4bc43c30abde86_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0f541893d2604b1cb5bdb8cdba0b8805_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8c3e5c01706a44a59cb0634c607efb09_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f27b113c4d4421a8448db7016572b2f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifc6f5985837b4f60a2b0978f880b946b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3ba7f4943fe34dcd87c78019ba0eaec5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1ca88d5a959149c5ab0f5a844b420ce3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7ee94c9079b94b2d8fa66b18e8121025_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i94d55d90e0334acf8952a54ea3eb127b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i588327c08f70456fada2d66c38b51e64_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4b031e42e24b410b9c3e6366a1a16a57_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie1f9683afb0c4a3ea5a33c6e397e1533_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i41bb039617594a87acecb9723e17821e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie62f7b97e63d401a8fa9db1823871df6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2f837794d02a4a309041880510914516_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i751dca1c7f254c71bec4904c65af1d0b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7b2480b622124e56a1087548cb6e0cf0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i396ef2387b3b4cfe950c3f23ad00b3cd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0f22c3698eff4a70b949d07786441335_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic71346e40fe54d37ba3383c1be84de74_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i204a869a54cc47739b6dbf488053eeb3_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia068519b02ab427c9665a8614ee0735b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iea288493ae2f462290ba011ea37b3d86_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id920d44e14eb45dd938699e476719d0a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1e061c30f5d84e94bc70f17124d6757b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifb1f82e7e0dc42abae0fc933d35a46e1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0e4fef5bff944c76884d175d38d5163b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ica66dd658337400da4427ae2a417bec7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0b64a06bc2aa421788ade8257344c7c6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idb7bc6143f0a46a8905e6b6f840e73b8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iec8771f969b149858b2fe843e8e5ca57_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4d268c33a3374123930ac2daf085b23a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie1b618394b8c4a9fbd7ef856984c3846_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i87a9b654e9114b85a43f7707ccf4a716_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i270393932a514786a51aea891f82a426_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idf3bdc1709be44ab8f7e21eff6b6f947_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d78058125d8497e8caf757d8e36e07b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i21594db97b18415da81085ad86be9dbe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i370da095060646f9b9a5b42d2b8a471c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3710964cba21471c9be4ef3805401052_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic44bcf27ee524bb48481e9f36804453e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia8313f8bcbe94858a403e65a717841bf_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic01f9f53437648c6a182b99958017af1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4c7325fe79e2481bb7929b1555e5d560_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i341cb29b86794db193ec2722d6ed4c0b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i33f91750301e465f851bd681c449d83b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i87b490ee070e48afb48c060408137232_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i677d5b1f2bf24e7e814304d237496841_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ieddaa7ac708c434c8a3193b3e07498ba_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i02543008f10f4f5e88a7d69f73b7216b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ide0cac148c1a4f83bdc265c0ca6c1a88_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia5a196eec7194c459ffcb870a785ba8d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic868ed7581a2477f82cf3b4625c2c5ae_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i09c6e851dc8544dc80903b26922759ba_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibff8b68601c04517ba11d27b118b9b3b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8235a1a7b2144b4484a52b863d830ae2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3dcbcc32613744fd9211f209efad177d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7094f1ba4fdb4923823c90a6d6847969_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib67e39c6b55d4121bfac0b087eaee089_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia7b9ceb789614f918f4e10ee376eb65a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9e358c7559e544b4bb8922a2a7bde625_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i59f12359cc364997814de3aec371b48f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i072d1cca614444628db770eff0b59d62_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if3e56704a1f44738b385e2b4569e21d0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i55063029c0d44ea78a93faf80c101754_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic338096c01ce4426a46e77906113c1b8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i92956d7d960f45f3bea45f7aa025342c_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id5289794172a4cb198e8aa0169b4c3b2_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9639169305914239b5bd07cfd412c105_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifd1869288e4244bfa1eeb70afaf8d8b1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">icui:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i69cd3733592345e3b3f6a2fba4b5f08d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic884346985a24c95b00b5aacf1b3975a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idd93fce1951b4c91b5dfa5a11db9552d_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4ddbcba35a73453a9962ad5faf060cf7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i497114901c8d417699b72d49f9b47c6f_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i85f9f9c7345841549043760a5ef3a629_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ida3d6c67a93c4582b8cb475e3d531c8c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0c90af4126704fd9b931fd425c90445a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie3f122ddd9b745f8952af44b2b23b0cb_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibe03e5366a5944d9a0a9a40abcb641dc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30121bdcbe2c464c8ed3b44ec7055f4b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iebdd9a3a6a1149b18e00453de01f406d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i77a00ec4d4be4edfb0626ca6dc4a51d8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2f5dcf4e8d7c447c96f6a1391e551243_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4a9ce85809f343a4aa82fc58533ef7f7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia97a17795307447680a6d14b0a583adb_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic6ddb824958a4849b40442c9bad27a5a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6dd4e597d17447488d221348105e1bdd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i512b8be12e094d459307488f3940c386_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i349a5bf778244242883e275326abbbc6_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia3c50f5fe7bb40ffacbf183985941a02_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic4c07ed0518e42d8a531402774100df5_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iefd60bb319394d118b895166607b7b8d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iee3b1a6579e747d2a23f2be0ea003d7c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i10978132bc5f4022a4c6518a79988c69_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2aeab60d1fcb4a7584c05d0319a0b156_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i961a96cb425c440eada93964a19186b9_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibbee468195c04505b91056e9f3302922_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i920322efa6a64088a2f6d5a382fc36ce_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iae1bb5bb3d0f4ae98eaf40951a717632_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i491a4bfbfd2746e19e9d49c2c5681cee_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8821ac00c20b4afc99c120d017a83ecb_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i712c9670278049fc823b141f1937afa2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id35f7bc641e64653a45020c7540094a9_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i22c729de11504d73a6a77ce1d5ccc78f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8bf1efd2f7fc49028373bab90caa5c99_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesSmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4ee76c84d43746a9b29b9dbe3e3cbab5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesSmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8c55a4b3cfe845d386e5ac7d196b83a1_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesSmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i58eace8558db4d639d849abeb781cfeb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesSmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i77b4bc25012a43c1af56c984cacd3be8_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VascularAccessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if311b897ac014b9587d953a2b2922e0b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VascularAccessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id3ea2c1e27c94bdaa8b13528fbdb0dcb_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VascularAccessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if7c8ec6c32704111ac8f0d54f2437ec5_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VascularAccessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i700cf99eae6a4036bea762420b65262e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VitalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8c0e18fb79fa41c49a1d8e3564ebaf32_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VitalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9bedb9e9ac7948fc9e52661e267a3094_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VitalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id3587782975144bb967dd1df75ddee2f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VitalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7b87c8dac7974a8782e310a9135de722_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7260b43edc5c4f09b88e2c68f47f0400_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib727cbf7f11a4c139194b7e121bfd07c_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8e56919e5c00481180fbdf59082fd04d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idbc9ee3ce53e43b9a4de6b99351dbc6c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idd47aba974954e0781a2414535bc312d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2457c39ef148408db901026663d3bfb7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id767533fe49f44c4a9d6dfa028a7691f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3c248127119d40b5845f0892855f08ae_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8b13c4aa80b74968a828e6ba37616e44_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8435bfea45414116839eacf40cc750c4_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8fba10f79d7446689094ad47012f06b7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3de7eb8fd7af48e39044549859b11d7a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4627a160fec94c4fb9bc050310d7da34_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib2150dcd378042cdb345d5d0d362d0ed_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8494e9281e3c4b64a4ce4f950c59f2db_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iad535f7eeb684a27aeb1b18c36ba3197_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i50a1c52d23e24394a0575ed9cb391bf5_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if490f6070f954ef6a7b2580ba7b91d5a_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7b423f9055fe4080a992d69631ef9969_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i288a4309c79045fab93c86aeac495b54_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id013675bfeeb448290d2bae1c0721424_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib78f819fc4074defb921bd3f7e151c87_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id2160e64516a449cbb6842e6568cca20_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibd0f6486a9914867b3cbed5c46e761c4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i96315c122c9e477f909fef66929bc3ef_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i20a968e1b0184b1bb3eccc6e2daa86f6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1deebfa912054645813b6d49cf6b7ae2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i053cf9509eae4840907fad5c27160755_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i36cddf068b6e4a8597c963ee835bdc8e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2d633f7881b646788b8fc5ddcda35b2b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6801313ae892411d80498d2ae6f075f6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9c13faab0ca94890afab0dfa9adc50c3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i097d704989b14390b8eebff2668fa80d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8dc422a484844921bbf2f8fbbb10898d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i553b9c6ad3c74f348590e3901e6e1b17_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idf36e1c35c0a471f9a34f9aed4cbef39_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i028128b1abf446339af1e589f519b8d9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CZK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5248e92406ce4b4b8dd1c3ea4e3ec5e0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6b6271edab564d0d9a598187c3a83a1b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ife89df7388b14e7cb238bfad25c03b9f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i64b799c44978482fb2ff58859d2765f8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:Srt_MultipleCurrencyAxisAxis">icui:OtherCurrenciesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ice7c1260b0af4402ab4a9770171b528b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2c64e77d7d424ea9a38c6d4686e8b917_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8409b01efbb64d52a8e1b1ba086f135b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge3MemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55561adaa418415b8dbb5d994e03b04a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i19fbaecc04d148dd8a7958cc6db4d311_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib22458f807284867a571b93988d38746_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5f054f416194468e9358fe16a192fca7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if944aaea429e473cb610016ebaa83d93_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2e2c0ba582504cc48fcbbe00aa935289_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie49637e4065640909d80091d4f51b5e2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib6c822cbb6204a8fbc869b98546fc0a9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia88b203034af462ba59ce8d2a771f6a4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i30640c390ffe4ca3bbe943506380dba9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3055adfcb5fa4b46a0af772247ae8ab3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia5ed44f463b34b44bccf081e0e44d41f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iac7fe1e5d9204ae3b38fd2c49a0a6e89_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia6f8316a6a9c4c7b91a059642a5d585a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i835758b56b034a758a8a1945eb8fc86a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iea1b1e213c5e4dee964f3d2dcaa7b6c7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1440f9c7c021440dbd8518b33fc69b16_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia03482d0fb2b4cb88ba9ce3d231c7823_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibcc8fe10383a4514ae5fb955ea53cee7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic437309b851c4a58af26fe68c63fb604_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9410778f607e40788f828c216003f59c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i36babf8d7dfd41d181155b5c382f90ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3b64e553997e42bfa00e761e1f1423e1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifa0f2e530a594d488d3ff7ff069e9259_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9a827026c8f345f481b0f331dcd5ab32_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie10e3fd3b1274966991829e8a47fb1c2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic0057918c4754ed39cdcb09ec091a595_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib1083c069125426aaf5b7d941291660b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i33a3cf5799fb4e7697ec6da3105f357e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7eba8aa425b64fd29a1360ccd19218c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2ef45ebfcb134a09b0559c70de16d1c2_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie350394256c849be935f6f7e19ce7ae1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i25a9e2b857e94469b5a51e1bd32d2292_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9ca9c6f83f3d4ea38a171209da718f73_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6be297d6f8ec4c55a99cf8bffc94a709_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id416d1da99e846e3aaa8a4ffd93c3dc0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie64ccbe5cd244a88a92378e31ed3beea_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6ad63d7dee5443088e6be3aff832a962_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0f932f4ad8184e0b96bb58e33032ad67_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:TradingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i51abb32c548d4ae5992b6128d78ae406_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:TradingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1f713455967a47018e27c47844e6c2c8_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:TradingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie5e0141476f94fe0bfee40a9c342136d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:TradingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8e3b921cd5684eac8e40c2c8881181c2_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if4621aecc6f943bcb50bb51cdee5e129_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaa5feb023289462185a42fb720643359_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1beaa72fcf4443b087df773c477cfd11_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iae30f57ba95c4fc1ab17958acaab1941_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0da6f417faba4021a4bd87936cc94e7a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5fc915cd5e904c928ed953fcd58e88e7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i24fdd3c882204e068d38aca3948a28fb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia62f1bfa4e614fbc90c0973fbb269e1b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie258ecbde2a94022ab481b913bd25b59_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib35fc47993e9429b8c5b9c8b0c6f2875_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib8ab8c183e0c4d38ac3476ef91b085a0_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia5fdd88104094d56a78a0e9fabdc14a4_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2bead07f8fe6479b8b72129168423936_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i24098b59b80b4522b8391e7bf6c24095_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i62dc3d65ef234ddea6fa46fa39a08264_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4ac4af49606d42a88d64c2bf0f4d2ffd_I20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-06</instant>
        </period>
    </context>
    <context id="i2f9761d9634c46b781358f8378ab19ae_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2b0af7a88e20446b955b939f110edf80_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i145f9f310696405282fedab047eef187_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5deeb60e9c8249d1b8f46228ce05178b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2e7b46f30d624154ab030a8d61d3e985_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie3c25d168c744771bf633b071b06a295_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if2461c3123264a1587619f55ed019061_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4371c9b4e2d342968b4e3151c7d4db30_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia9c2724891314520aa738b30070bc9b7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7572d325e38d473d9ae705b76dddaf85_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i26d53d1856c64aba9b247414ff1cbf72_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i271412c8b7d54c31bbe00f90c08636d9_I20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-06</instant>
        </period>
    </context>
    <context id="i20fb2b51d6784bdcb7bd9ea46521840f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id2293f058fbe474d887a278af1dc364d_I20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-06</instant>
        </period>
    </context>
    <context id="i629f0cf89dde42a49602d16e5cfd879b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">icui:MeasurementinputadjustedEBITDAvolatilityDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6fa400eb022d4774bc0cd29d07a48121_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i880eec97a0864f7f95ece75713ea01a9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic5e38a3a78e2405384dff3169dad04c7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">icui:MeasurementInputMarketPriceofRiskDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i904e390537e1451b9a0b56b3895e0ad9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i63cb18161ad04f4abb209fda84a747fe_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib00f088272f9420d8932ea1b42312e11_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i88960ec8f42c4c90b987ccc14648a60b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie327d35dcba8456fb9278a53ad44949a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i335c02bca87342c3af0d55271dc60da8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia5c4a92b0ce541338d7536509042ea7b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iaea350bdc70b431c9a82fd66e420fa04_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibc18153c27d94cd6a2c7151fb5dc9bd0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i517040ce9ec34b609db5b705439f553a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6ffcb622eea74c2297c2e694f6d00439_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id1de545bcfec4a5888eea70f8e7b8036_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i82e5e28cacc74c919e50d739b06edf75_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i688065cd861c47e7bd70568dc32ce595_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibc30cc767c204190b9d227e826c7af7a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i957a2bdf19bb4e459e210f02fdc311af_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia097420328df4d0ba8aad76512275995_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie3f7f6920e264be38b38e91385534cf4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnOutLiabilityST</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icb8b9ef489414d54902e74776b3ad3ca_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:STEarnoutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3db367bb1a0046df994e640235391d11_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:STEarnoutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibf917acde63245d09eb8fa04aa6cb67b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:STEarnoutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2bdd238b3bd44e3aa0a5ddeb8d8233cf_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5bf4e764536e4ffa9c77a176f003216e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9baebbfe2a8c434b87c84f5e0ad8cb0a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i632c944bb938432aa0eedc42d20802a7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic60a257dc9bd4e0eb4f59ade43d2cb14_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic149dfd8f6d1483d9ded55c35ef93307_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i44e3a6c8a6664cad9862b4281ded5217_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8db92612840f4756b2e77eb032bb8d41_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i094fd5abbce944aa910cc40d499b5d9f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icfa1710f03974c6d9d1ae45570f5c02d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id3e79b2e14f043c09c7080259bcdd720_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icfeedac3a27d4227a69f70be2d89e06a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ife12602b15f94cd9890c4082d74581b3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic3695974f62448dab66775d219f590d3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3a4009ff512d42959a09607b0d1d2dd5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i377767425d0240109a95844ff08b1b34_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib8df718d5aa84441b74a7a6e2b03f17e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i56f3580c0d3d47f48f3a427759653368_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib739ab062f854a70996bee0b00130a93_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie8cdb41c17a14a2695ba262420cf3df1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4e5fa69d927941dfb31719735e9e8088_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0a78e7cf24d64503b2511a1cdc74b41f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7507e0229527439dafdb4203eddf647e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i711e70f031664741a45a58f17b0b937b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide25da1d24d146b2b6367f763603416f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib56ba1e346ee4357b863011abaca4f3b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia3ad6f6fa60f49b0995c5869f3d2d033_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i130e8f7da5ee4027903cf2856abf00a3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1bd14230b4e94aff9f2dc05493cfc1b1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie611c9fc1bb545cc8ad94fbe19af222c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8debaac8649c406fbca98e4b486e4b1d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i78603e4cb0ca4c0f99214a90dd735480_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iac454971b49349949220dae2173838e4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1c88697ab66446b8a82b091623fd4777_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i81e0ca54acfd4d24a778f4024742013b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib37a7d73ddd44f5598941e2ca4cc04d4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:LongtermInvestmentsDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id9c9a9e9ea2345208d64fa0d5a8fffda_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:AvailableforsaleDebtSecurityCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9bde06c37d8c4dda852f5deb015fa18f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:LongtermInvestmentsDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0a3de3a660434987a7100fcd8c1caebb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie9d9c289f8a048eb84ce2a838b84d175_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1a7c45ae71c244ff8f548dfdd2b6fb8c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i56979378a15940b694ad44f79ca40db8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieb10aa868d234581b425b2f11483e45f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:MoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id13943d7016047a08b86a41eba983610_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:MoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i35c21123a9bc47cd9c241397fb0086b8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i243cc12eefac42478d6f254dfb50666d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4159aa37c1ba4a859994bf41400f8ba2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie9372198522d4b5e97f8e9e8a9b15104_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if7bed48ab3274a438be9d461548445dd_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2d507359794c441296c07ef57b1f0b4b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i89f8e80bcf3e4d15871f08d9315a0795_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie4a59c6b81a24315a01e330cedd0027d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ife9514c78ddc4a699ba11b09beca198e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ief2e729c06b343f28aba776743c330ef_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i513ee50364c14e7d859a7bb7ef23a477_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibbc7d651107948d2916b913aaa7d668f_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i912dc15e8c1a41bc9d8224503705d967_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib169ababb8144e438fd240b38a3232b3_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic03a916b576f45269b9d7cee1deb9752_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i07478469fd9c4f93a9c4a903a48bc4f4_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id253a421eb2943f5b837dd25a641e2ca_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8e4951321f444b24b28bde3fdc96ef0e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id1cd92e8416b47e985b5956012374d3d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1d3d1938206b417f890a9c160ac8e76a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ief440a8c15424f91aa2bf9703a08d2c8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4ef4386b3aad40caa1451437ce839832_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i821291babde14cd093a6b4ddeccede07_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie00a9e8c2c894c7ca4b21d05ef790de9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia4b19c227969431ca7e4a6627d90949e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3927812c539f471a9f7e842582263841_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i66a5adf9d5824096bc840c2ea8b7fbe9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i19657ff16caa42fc8b51e10fb536a6f4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie1713967f58146769aa8e6ad535a9f9c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9cf2d32391d5446c87fb358fa5d38e52_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4895000d5a7b4fe3b49e4d144fa4308c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i91c9f9c254834c91bccad9081f3bec3e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if2172b4c33734723af96689c9f9c83cf_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i820c1b83d10b4a7caf83661d1ff3d33f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia65456c188d34d4daf133f0f0dbc3e2c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie48f38dcedd64e93a8ecf7ac063f60b0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia442a59e504b4b4cbe247d028ddb1705_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7b85afc4ff3d4a5092568e3fb7e051d8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:Greaterthan400to100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0a39638d60794625b2a97bb8ccf76e08_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:Greaterthan400to100Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if4fa2d7effb948959c4419141b81fa27_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo400To100ButGreaterThan300To100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i01fc89ab55b9471e88acff5bc284c6d9_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo400To100ButGreaterThan300To100Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibdfa16b6f741491d8b6775ba1b22da74_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqual300To100ButGreaterThan250to100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i29510191d44e477fa81d72fe9d21c1ec_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqual300To100ButGreaterThan250to100Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3c9d6aabc294426da5585018b63ccb2f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo250To100ButGreaterThan200To100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6e79efd88abe4a75b2c34f56667180b3_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo250To100ButGreaterThan200To100Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1e5ce3e367bf4ebf8d8b4d98965dedbc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo200To100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i62429302fe0f4afea07772eb2f1866ae_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo200To100Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ide283ac530ac4b1781126c399a2552b9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:GreaterThan275To100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibb1d7ec7e4a44aabae7ac85788f5014f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThan275To100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i48afd3427c1e42f6ad2d86e852ef64dd_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i94b17ce1db9045be81548ad59c39078e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic864df7a10e243439b16f94f4d8947a7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i978540de7dd847ba96e233480ca7d760_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia45c28b3f1cc4a4d9f0add866a4154b7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i326812ecd5b9421880949758af6f0760_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if99dcd7880d44918a4d5f088ad265d59_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i58bf8064282948fe8016498a02b9e92e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i29830fec1151487f84613c8fe2e23f62_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4f62f6e8b1f049a2bfc7cd1ba2c8c6b7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id8b148239611411ab103bf9e35a00370_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if9a33f79f91d4f94880ad5f50170dd8b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i02b67f1e6ebf44f4920d2e1c7a980457_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idffc4822f1e84243b7a821f4b832cdb0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7bb27df1c81b4fe5815f7411937625c3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2b7c25e7ac474113b90c767b63e9973b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i26135335385b4c188e9fa42192dd9586_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3003d8cd4355481fbc735d083ddbdec1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i327a4bd08003426f90e1ed91e3bc0365_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6236b35e282a499d9e7335ded3b1511a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i381b31d9849d4793b208bb77bd5696f5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id987a884b9304292b23dd52b1a4a527a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i88f2c0cc386c4a87970c9caa95befd39_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4d062c01630e4345ab1b152378e6a45f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i368b376abe90453ca246cd3e38e97a22_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i49c58f1374874b18a884724db405192e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6b7fcd5651cc4fba8ada251f0eae1319_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i00701bb034dc42d893efa54ca1dd9b8e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i106e9ee178e6436f90b29d6557dfb488_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i71a8aaadf61b4f2d8e906baa19a20857_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6c3789fe01ab44e98e7b6e29e62a089e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i86d81cabd26944f7aa9415595f6e5c33_I20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2022-01-06</instant>
        </period>
    </context>
    <context id="i4b3ce23df5e4479c839dc97cc6e1b807_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i68ee0370a4e34ec2b3cd2a4b34eed398_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="mxn">
        <measure>iso4217:MXN</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80L2ZyYWc6NjA1Mzg3MTEyZjY0NDk5ZThkNWVkZTJhNzEyMTI2ZTQvdGFibGU6YWRkYjRjODNiYTY4NDU3M2E4ZWI0ZGI1MjQwMWYyYzYvdGFibGVyYW5nZTphZGRiNGM4M2JhNjg0NTczYThlYjRkYjUyNDAxZjJjNl8yLTEtMS0xLTg1NDI3_a9ce8c61-8d5a-44b6-a3c1-c1e5af60049e">0000883984</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80L2ZyYWc6NjA1Mzg3MTEyZjY0NDk5ZThkNWVkZTJhNzEyMTI2ZTQvdGFibGU6YWRkYjRjODNiYTY4NDU3M2E4ZWI0ZGI1MjQwMWYyYzYvdGFibGVyYW5nZTphZGRiNGM4M2JhNjg0NTczYThlYjRkYjUyNDAxZjJjNl8zLTEtMS0xLTg1NDI3_25f1cd81-f1cd-4db6-bed5-692dac619088">ICU MEDICAL INC/DE</dei:EntityRegistrantName>
    <dei:AmendmentFlag
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80L2ZyYWc6NjA1Mzg3MTEyZjY0NDk5ZThkNWVkZTJhNzEyMTI2ZTQvdGFibGU6YWRkYjRjODNiYTY4NDU3M2E4ZWI0ZGI1MjQwMWYyYzYvdGFibGVyYW5nZTphZGRiNGM4M2JhNjg0NTczYThlYjRkYjUyNDAxZjJjNl80LTEtMS0xLTg1NDI3_c6f28d5f-2f58-46c0-b56d-889ce0968e7f">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80L2ZyYWc6NjA1Mzg3MTEyZjY0NDk5ZThkNWVkZTJhNzEyMTI2ZTQvdGFibGU6YWRkYjRjODNiYTY4NDU3M2E4ZWI0ZGI1MjQwMWYyYzYvdGFibGVyYW5nZTphZGRiNGM4M2JhNjg0NTczYThlYjRkYjUyNDAxZjJjNl81LTEtMS0xLTg1NDI3_3a4adc2b-d4b3-41b3-bfd5-e8220fb59d63">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80L2ZyYWc6NjA1Mzg3MTEyZjY0NDk5ZThkNWVkZTJhNzEyMTI2ZTQvdGFibGU6YWRkYjRjODNiYTY4NDU3M2E4ZWI0ZGI1MjQwMWYyYzYvdGFibGVyYW5nZTphZGRiNGM4M2JhNjg0NTczYThlYjRkYjUyNDAxZjJjNl82LTEtMS0xLTg1NDI3_584032b8-2b25-4fda-961d-940de8f7a48e">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80L2ZyYWc6NjA1Mzg3MTEyZjY0NDk5ZThkNWVkZTJhNzEyMTI2ZTQvdGFibGU6YWRkYjRjODNiYTY4NDU3M2E4ZWI0ZGI1MjQwMWYyYzYvdGFibGVyYW5nZTphZGRiNGM4M2JhNjg0NTczYThlYjRkYjUyNDAxZjJjNl83LTEtMS0xLTg1NDI3_30a58d44-dee6-40c5-a6c3-7f2e49af24d5">Q2</dei:DocumentFiscalPeriodFocus>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU2_ddab537f-8bc6-4122-8738-75e9f83ccca8">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="idd93fce1951b4c91b5dfa5a11db9552d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU3_94ff8303-bbea-4e2c-80a0-75c79ec80ddf">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i4ddbcba35a73453a9962ad5faf060cf7_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU4_39b70a39-6a8c-49b7-a62c-b1011d2a541c">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i497114901c8d417699b72d49f9b47c6f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU5_9bab9dac-782a-4c71-afdc-921a87d1c7b7">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i85f9f9c7345841549043760a5ef3a629_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDYw_9c9b33b6-6b8e-4b28-8e2a-6c3cc63df867">P6Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <dei:DocumentType
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGV4dHJlZ2lvbjpmYjJiN2QxODI5M2I0ZWU2OTI1NzNhODZhNjhkOTZlNl8xOTgz_9d379cc3-89ae-4985-9ffb-3583157aac63">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6ODI2OGRjMGJiNTI1NDgzZTkxZjEyYTQ1NGQyODQyM2UvdGFibGVyYW5nZTo4MjY4ZGMwYmI1MjU0ODNlOTFmMTJhNDU0ZDI4NDIzZV8wLTAtMS0xLTg1NDI3_b92ed6a9-bdc0-402c-9046-3d040f5e846c">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGV4dHJlZ2lvbjpmYjJiN2QxODI5M2I0ZWU2OTI1NzNhODZhNjhkOTZlNl8xMjQ_17f83e4b-dc42-4715-bb57-67b572c19e41">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6YWI2ZDBmOGI5ZDNiNDkwNGFlOWJjMmZkODYxZWJkNTMvdGFibGVyYW5nZTphYjZkMGY4YjlkM2I0OTA0YWU5YmMyZmQ4NjFlYmQ1M18wLTAtMS0xLTg1NDI3_3f7fe168-36dc-484c-8f57-fa8efb08887d">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGV4dHJlZ2lvbjpmYjJiN2QxODI5M2I0ZWU2OTI1NzNhODZhNjhkOTZlNl8xOTg0_5e306587-fda5-4669-b76f-02cd127349b3">001-34634</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6Mjg3NDNhNGI1NTA1NDQ1Mzg3YTZjYjU5MTcxNWUwZGYvdGFibGVyYW5nZToyODc0M2E0YjU1MDU0NDUzODdhNmNiNTkxNzE1ZTBkZl8wLTAtMS0xLTg1NDI3_ef807712-9bbb-45ac-9d72-98b978043040">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6Mjg3NDNhNGI1NTA1NDQ1Mzg3YTZjYjU5MTcxNWUwZGYvdGFibGVyYW5nZToyODc0M2E0YjU1MDU0NDUzODdhNmNiNTkxNzE1ZTBkZl8wLTItMS0xLTg1NDI3_215c985d-42fd-45c2-8852-1e14a9adf529">33-0022692</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6MTgzZDlhZjJiZDg5NGRiMzhjYWEzYmRhMjFhYjAyZDQvdGFibGVyYW5nZToxODNkOWFmMmJkODk0ZGIzOGNhYTNiZGEyMWFiMDJkNF8wLTAtMS0xLTg1NDI3_c424a0e7-c450-4f22-ad63-5b1b78f85a32">951 Calle Amanecer</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6MTgzZDlhZjJiZDg5NGRiMzhjYWEzYmRhMjFhYjAyZDQvdGFibGVyYW5nZToxODNkOWFmMmJkODk0ZGIzOGNhYTNiZGEyMWFiMDJkNF8wLTItMS0xLTg1NDI3_bb48c1d0-68da-4a4c-a9d0-ff993eb931e3">San Clemente</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6MTgzZDlhZjJiZDg5NGRiMzhjYWEzYmRhMjFhYjAyZDQvdGFibGVyYW5nZToxODNkOWFmMmJkODk0ZGIzOGNhYTNiZGEyMWFiMDJkNF8wLTQtMS0xLTg1NDI3_145ce4f2-6cc9-4b9a-b7ad-1140ccc98644">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6MTgzZDlhZjJiZDg5NGRiMzhjYWEzYmRhMjFhYjAyZDQvdGFibGVyYW5nZToxODNkOWFmMmJkODk0ZGIzOGNhYTNiZGEyMWFiMDJkNF8wLTYtMS0xLTg1NDI3_3d04331c-136e-49c7-83cb-fa96f603de1e">92673</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGV4dHJlZ2lvbjpmYjJiN2QxODI5M2I0ZWU2OTI1NzNhODZhNjhkOTZlNl8xOTg1_8e1c60bf-2c19-4dd0-886b-92804551a189">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGV4dHJlZ2lvbjpmYjJiN2QxODI5M2I0ZWU2OTI1NzNhODZhNjhkOTZlNl8xOTg2_aa5629cf-e9e9-437e-898f-a28d194a9265">366-2183</dei:LocalPhoneNumber>
    <dei:EntityCurrentReportingStatus
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGV4dHJlZ2lvbjpmYjJiN2QxODI5M2I0ZWU2OTI1NzNhODZhNjhkOTZlNl8xOTg3_1e640920-2106-49c5-bbc7-88386647c6b1">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGV4dHJlZ2lvbjpmYjJiN2QxODI5M2I0ZWU2OTI1NzNhODZhNjhkOTZlNl8xOTgx_b5831886-f1c8-4c3e-90f8-48ad00ed406d">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6ZmExZmE2OWFiOWNhNDA4ZDljZWY4ZjBhOWZlMTg3ZTMvdGFibGVyYW5nZTpmYTFmYTY5YWI5Y2E0MDhkOWNlZjhmMGE5ZmUxODdlM18wLTAtMS0xLTg1NDI3_24c3bb12-9b14-4438-a1ce-24cd2ee2a275">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6ZmExZmE2OWFiOWNhNDA4ZDljZWY4ZjBhOWZlMTg3ZTMvdGFibGVyYW5nZTpmYTFmYTY5YWI5Y2E0MDhkOWNlZjhmMGE5ZmUxODdlM18yLTQtMS0xLTg1NDI3_f98b3802-4c1c-4f74-a722-20070a554ab0">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6ZmExZmE2OWFiOWNhNDA4ZDljZWY4ZjBhOWZlMTg3ZTMvdGFibGVyYW5nZTpmYTFmYTY5YWI5Y2E0MDhkOWNlZjhmMGE5ZmUxODdlM180LTQtMS0xLTg1NDI3_2a4136c5-9b15-4400-b676-946dad5baf7a">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGV4dHJlZ2lvbjpmYjJiN2QxODI5M2I0ZWU2OTI1NzNhODZhNjhkOTZlNl8xOTgy_443a2c1e-2011-4ec5-994c-f12961e61207">false</dei:EntityShellCompany>
    <dei:Security12bTitle
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6Y2M2N2E4MmEzZGU4NGY4ZjlkYzI4NmY4M2M1ODdjNDIvdGFibGVyYW5nZTpjYzY3YTgyYTNkZTg0ZjhmOWRjMjg2ZjgzYzU4N2M0Ml8xLTAtMS0xLTg1NDI3_c3f53d99-ce0f-471e-a60a-61c04860cf6e">Common stock, par value $0.10 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6Y2M2N2E4MmEzZGU4NGY4ZjlkYzI4NmY4M2M1ODdjNDIvdGFibGVyYW5nZTpjYzY3YTgyYTNkZTg0ZjhmOWRjMjg2ZjgzYzU4N2M0Ml8xLTEtMS0xLTg1NDI3_c318619e-c39a-4e83-826d-79f1d9e5f262">ICUI</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6Y2M2N2E4MmEzZGU4NGY4ZjlkYzI4NmY4M2M1ODdjNDIvdGFibGVyYW5nZTpjYzY3YTgyYTNkZTg0ZjhmOWRjMjg2ZjgzYzU4N2M0Ml8xLTItMS0xLTg1NDI3_f2b695fc-b6e6-4783-8346-546e642a1044">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="iad30622d1b0f462ca40c8e5a1116afb3_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xL2ZyYWc6ZmIyYjdkMTgyOTNiNGVlNjkyNTczYTg2YTY4ZDk2ZTYvdGFibGU6ZTBjMDg4ODQ5MjFjNGU0ZTgyZjc5ZWVlZmYwZTY1OGIvdGFibGVyYW5nZTplMGMwODg4NDkyMWM0ZTRlODJmNzllZWVmZjBlNjU4Yl8xLTItMS0xLTg1NDI3_705bdd4a-7264-442c-91d0-15b828c39a0f"
      unitRef="shares">23899381</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNC0xLTEtMS04NTQyNw_4fa68340-aa02-4c4e-ac60-f63f23e33810"
      unitRef="usd">255698000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNC0zLTEtMS04NTQyNw_c7816a3a-1526-470e-a0a1-e9473483f3d0"
      unitRef="usd">552827000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNS0xLTEtMS04NTQyNw_a423844e-874f-4bd9-900c-9c0c2eb0b015"
      unitRef="usd">13191000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNS0zLTEtMS04NTQyNw_84e883a6-02b5-4319-8d81-06bce0c327f7"
      unitRef="usd">14420000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNi0xLTEtMS04NTQyNw_8a62a2ee-9111-40d9-a0ca-8fcc176b3f8a"
      unitRef="usd">268889000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNi0zLTEtMS04NTQyNw_8f5791fa-67d3-4c79-9c18-33fd2dc8da71"
      unitRef="usd">567247000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNy0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOmIyMWUxNDE4Y2EyYTQ4MDViMDdlNjc5YmNhZTczZjg4XzY3_3384f385-257e-48ba-8895-ec7fd9572282"
      unitRef="usd">7557000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNy0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOmIyMWUxNDE4Y2EyYTQ4MDViMDdlNjc5YmNhZTczZjg4Xzgw_0d1abd55-ff43-4954-89d5-03d83c32fcc7"
      unitRef="usd">7038000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNy0xLTEtMS04NTQyNw_2eab2d00-5af4-4fd8-a61d-f20c48990821"
      unitRef="usd">216124000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNy0zLTEtMS04NTQyNw_7c780213-5204-477b-b6b3-ae2adcd49fc1"
      unitRef="usd">105894000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfOC0xLTEtMS04NTQyNw_7ffc5f50-6a4d-441d-8348-7fa70abe137e"
      unitRef="usd">583050000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfOC0zLTEtMS04NTQyNw_f9216bd5-da46-48b1-a355-82bc8bd6fed3"
      unitRef="usd">290235000</us-gaap:InventoryNet>
    <us-gaap:PrepaidTaxes
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfOS0xLTEtMS04NTQyNw_9652d15a-8e3c-4021-b7ef-53e6ddc9b4a4"
      unitRef="usd">27111000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfOS0zLTEtMS04NTQyNw_b868de97-3495-4f39-b1bd-267a25b30699"
      unitRef="usd">19586000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTAtMS0xLTEtODU0Mjc_952a149a-b863-42f4-a8af-74813481cd02"
      unitRef="usd">94663000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTAtMy0xLTEtODU0Mjc_f6a76a36-acfc-48aa-82f4-e8c6fa59895b"
      unitRef="usd">46847000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTMtMS0xLTEtODU0Mjc_16374070-b404-4eee-982f-4e786ac0860e"
      unitRef="usd">1189837000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTMtMy0xLTEtODU0Mjc_a200078c-32a4-4024-a320-77430ba61723"
      unitRef="usd">1029809000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTUtMS0xLTEtODU0Mjc_0a4d4978-bbc2-4212-9b86-e950fc74af67"
      unitRef="usd">667783000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTUtMy0xLTEtODU0Mjc_982c10b6-6cc1-42a0-baea-8cfceabaac7b"
      unitRef="usd">468365000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTYtMS0xLTEtODU0Mjc_f5c8f1f0-3f4e-4d94-8df8-b33a7b0ea9df"
      unitRef="usd">83323000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTYtMy0xLTEtODU0Mjc_20a86bd3-d267-4832-a6f6-a0a9852dc66d"
      unitRef="usd">39847000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTgtMS0xLTEtODU0Mjc_10a412ec-1ecf-44f7-935f-014cb3a8be6c"
      unitRef="usd">1837000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTgtMy0xLTEtODU0Mjc_1a86d6ef-f59e-4310-851a-e13ddbfa98e9"
      unitRef="usd">4620000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:Goodwill
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTktMS0xLTEtODU0Mjc_bfda98b9-97b2-4ede-ba9e-6df8da4bf299"
      unitRef="usd">1421216000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTktMy0xLTEtODU0Mjc_1a768a17-8ec1-4d51-80ce-724b75333158"
      unitRef="usd">43439000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjAtMS0xLTEtODU0Mjc_69837df0-9897-405f-88bb-bfed64c9593f"
      unitRef="usd">1080329000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjAtMy0xLTEtODU0Mjc_98804e62-7dcb-45a0-ada1-b1376c0f6a5c"
      unitRef="usd">188311000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjEtMS0xLTEtODU0Mjc_83c9e78d-6d6f-4ce1-91f0-7a2ee002955e"
      unitRef="usd">43942000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjEtMy0xLTEtODU0Mjc_9803d10d-07df-4df2-993b-02223d06956a"
      unitRef="usd">42604000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjItMS0xLTEtODU0Mjc_3073f79a-92ca-4e1e-9ac6-7bd3d204dd1d"
      unitRef="usd">101728000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjItMy0xLTEtODU0Mjc_ab78ba20-06e6-4bf3-9f75-ba44192aa452"
      unitRef="usd">63743000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjMtMS0xLTEtODU0Mjc_fec7af3c-097d-4c0c-883d-2b9c0e50850b"
      unitRef="usd">4589995000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjMtMy0xLTEtODU0Mjc_795ca416-85d4-4924-bccc-6c25a58dc1ff"
      unitRef="usd">1880738000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjctMS0xLTEtODU0Mjc_76e894b1-f405-4b0f-8d09-037d1c90f66d"
      unitRef="usd">201874000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjctMy0xLTEtODU0Mjc_0b66ff3d-bacc-4678-9b15-ad53ab26038d"
      unitRef="usd">81128000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjgtMS0xLTEtODU0Mjc_141b9bba-62eb-435e-881c-5d90b66c2687"
      unitRef="usd">247656000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjgtMy0xLTEtODU0Mjc_8afdd3aa-5a0b-425b-b184-3ffcbe32cf0b"
      unitRef="usd">118195000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjktMS0xLTEtODU0Mjc_8c946fc1-fc5e-4b0f-bd33-64909c52e4ca"
      unitRef="usd">19063000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjktMy0xLTEtODU0Mjc_b2b95ba6-d096-44ae-bc61-ed506e9069df"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzAtMS0xLTEtODU0Mjc_3a164ca1-4d5d-441a-8d54-75e097f6bd40"
      unitRef="usd">17102000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzAtMy0xLTEtODU0Mjc_d52e19a4-0c54-48ba-809b-99370fedffe8"
      unitRef="usd">1454000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzEtMS0xLTEtODU0Mjc_f3e29878-e144-43fc-b119-df4501652277"
      unitRef="usd">290000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzEtMy0xLTEtODU0Mjc_3f41152b-41d0-4340-ae5b-aac764a9b902"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzItMS0xLTEtODU0Mjc_8080a350-826a-41a8-8dc8-1bd56088a3d1"
      unitRef="usd">485985000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzItMy0xLTEtODU0Mjc_bd6f07d7-06ca-4c37-9865-d066a96bbee2"
      unitRef="usd">200777000</us-gaap:LiabilitiesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzQtMS0xLTEtODU0Mjc_3e65fcad-21d2-4984-9e36-1af803575742"
      unitRef="usd">30119000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzQtMy0xLTEtODU0Mjc_d7802ddb-c456-4e56-9062-abf9b7f1b622"
      unitRef="usd">2589000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzUtMS0xLTEtODU0Mjc_32661f70-c2ec-4eb3-a9fd-4ca83d56fe28"
      unitRef="usd">1636029000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzUtMy0xLTEtODU0Mjc_449c7fd2-8a38-4e55-b490-80f37c922e1a"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzYtMS0xLTEtODU0Mjc_711490af-2640-4710-b423-d26afc11d5c4"
      unitRef="usd">128200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzYtMy0xLTEtODU0Mjc_56404a65-c819-4a16-8dc1-c9dbef278f91"
      unitRef="usd">41830000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzctMS0xLTEtODU0Mjc_8f164938-7420-47bf-9d9c-d91e9adcd46a"
      unitRef="usd">204992000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzctMy0xLTEtODU0Mjc_36d5f6c7-aaaa-4da0-9b8c-4dfd3b733fce"
      unitRef="usd">1490000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzgtMS0xLTEtODU0Mjc_d13d73c4-3ad0-4067-84ed-6b0de57635df"
      unitRef="usd">18804000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzgtMy0xLTEtODU0Mjc_17312d52-ce0a-4631-84dd-a18eb2bde954"
      unitRef="usd">18021000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzktMS0xLTEtODU0Mjc_f34703ab-7e8e-4ea6-81b3-38fc8ac00756"
      unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzktMy0xLTEtODU0Mjc_2871088d-bd3c-4197-a27a-5f41e2e83bf3"
      unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjo5OGE1MzMyNTdmNjY0MjMxYjk0NjE3MTJmMDg0MGI4Yl8zMw_74035a30-b6dc-4262-896d-5cdc139e0378"
      unitRef="usdPerShare">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjo5OGE1MzMyNTdmNjY0MjMxYjk0NjE3MTJmMDg0MGI4Yl82MA_927b724a-ff27-40d9-bd4f-4cd35c5433d5"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjo5OGE1MzMyNTdmNjY0MjMxYjk0NjE3MTJmMDg0MGI4Yl85Ng_316e6b71-e146-49c5-80b6-3ef782e2adf4"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjo5OGE1MzMyNTdmNjY0MjMxYjk0NjE3MTJmMDg0MGI4Yl85Ng_3c2e5024-3c66-49e3-bb58-3aa959f5276c"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjo5OGE1MzMyNTdmNjY0MjMxYjk0NjE3MTJmMDg0MGI4Yl85Ng_e83c1ae3-8c57-42ef-98fa-e78c445f3ada"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjo5OGE1MzMyNTdmNjY0MjMxYjk0NjE3MTJmMDg0MGI4Yl85Ng_f6cb30a4-bc6d-40e3-8a0a-1b8d7019edd4"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMS0xLTEtODU0Mjc_3c3c7471-1194-44c9-82f6-25bd2463953c"
      unitRef="usd">0</us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue>
    <us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMy0xLTEtODU0Mjc_8e53ce40-ac43-42cc-a11c-3226d211576c"
      unitRef="usd">0</us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjplYzdiMzA4NGNhMTc0NDMyYjhlYTJjYzFmODc0MzZiY18xOQ_3bab818f-34b9-4218-bf9a-d4c3f9562f5b"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjplYzdiMzA4NGNhMTc0NDMyYjhlYTJjYzFmODc0MzZiY180Ng_9f74d9e9-430b-4ae0-88b1-4f09468f32c0"
      unitRef="shares">80000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjplYzdiMzA4NGNhMTc0NDMyYjhlYTJjYzFmODc0MzZiY182Ng_1f8962a2-fc5f-4f47-a6e5-cac454f90cfb"
      unitRef="shares">23899000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjplYzdiMzA4NGNhMTc0NDMyYjhlYTJjYzFmODc0MzZiY184Ng_04ae5949-a01b-4404-9eee-21a76abeb24a"
      unitRef="shares">21280000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjplYzdiMzA4NGNhMTc0NDMyYjhlYTJjYzFmODc0MzZiY18xMjE_338a098e-e0db-463a-9db4-8f9ff77f4e2a"
      unitRef="shares">23898000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjplYzdiMzA4NGNhMTc0NDMyYjhlYTJjYzFmODc0MzZiY18xNDE_1633790a-7122-4a62-b0bd-c1f9cf6a48ff"
      unitRef="shares">21280000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMS0xLTEtODU0Mjc_dccc1f9c-d69c-47d9-a9fe-2e236a47a472"
      unitRef="usd">2390000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMy0xLTEtODU0Mjc_d8f3800b-263d-4855-b3f8-572c0e60c1b3"
      unitRef="usd">2128000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDMtMS0xLTEtODU0Mjc_e2025a18-cbc9-4a7c-bd5e-6112b3563a66"
      unitRef="usd">1309598000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDMtMy0xLTEtODU0Mjc_8f550f7b-10c4-44a3-b4d6-264c9356e795"
      unitRef="usd">721412000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:TreasuryStockShares
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDQtMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjowY2Q0MzgzMWE0ZmU0Yjc1OTFlNDc4MDRhM2Q4ODE4MV8yOQ_bb2cb424-f902-4510-b5d2-52a65710f4a7"
      unitRef="shares">406</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDQtMC0xLTEtODU0MjcvdGV4dHJlZ2lvbjowY2Q0MzgzMWE0ZmU0Yjc1OTFlNDc4MDRhM2Q4ODE4MV8zNg_4cdac348-18a5-407a-b0ab-02409e012f81"
      unitRef="shares">119</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDQtMS0xLTEtODU0Mjc_1d7d6836-9cda-4f29-bdea-7ba49355d05c"
      unitRef="usd">92000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDQtMy0xLTEtODU0Mjc_a2adcdf4-12bb-4dbf-87f9-67e10866727a"
      unitRef="usd">27000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDUtMS0xLTEtODU0Mjc_58f53d7d-a235-4de2-8902-f87f96ceb36e"
      unitRef="usd">866245000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDUtMy0xLTEtODU0Mjc_9c051bf9-d922-4ab2-a1db-ef3cb50205da"
      unitRef="usd">911787000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDYtMS0xLTEtODU0Mjc_8a7446d6-78a4-49cd-81ff-55738dbb04b5"
      unitRef="usd">-92275000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDYtMy0xLTEtODU0Mjc_a84bb210-1803-4baa-ac5d-57f746b7383b"
      unitRef="usd">-19269000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDctMS0xLTEtODU0Mjc_645d5e3d-7d16-4e4c-be94-45d75c81a207"
      unitRef="usd">2085866000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDctMy0xLTEtODU0Mjc_7df968fa-74a0-4035-acd1-eeb6318c14ec"
      unitRef="usd">1616031000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDgtMS0xLTEtODU0Mjc_07d51782-7658-4192-906f-9d4eb09cc067"
      unitRef="usd">4589995000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDgtMy0xLTEtODU0Mjc_7ecf9fe4-2d46-462b-9cf4-25760587797c"
      unitRef="usd">1880738000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMi0xLTEtMS04NTQyNw_9d92a596-c230-47ed-ba16-163ae57a0d91"
      unitRef="usd">561004000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMi0zLTEtMS04NTQyNw_ec993baf-1bd8-4709-806a-224128593678"
      unitRef="usd">321677000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMi01LTEtMS04NTQyNw_22fdce6e-67ea-44e6-a4e8-d05c3f83a58c"
      unitRef="usd">1104126000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMi03LTEtMS04NTQyNw_6304aa03-fc65-4853-a42b-389267c65cfd"
      unitRef="usd">639723000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMy0xLTEtMS04NTQyNw_8bba90f8-c284-4077-a3bf-7c23e07d4b8e"
      unitRef="usd">393411000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMy0zLTEtMS04NTQyNw_1177eee8-dafa-4a17-8b4f-0e90378ee59b"
      unitRef="usd">198148000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMy01LTEtMS04NTQyNw_d15b451a-99f0-42a4-a733-5e1811eb53f2"
      unitRef="usd">767706000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMy03LTEtMS04NTQyNw_0e097e06-9da8-4629-895c-0e1fafd71158"
      unitRef="usd">403514000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNC0xLTEtMS04NTQyNw_699d7c9f-6a9a-4e0d-a8e3-dd133c4732fd"
      unitRef="usd">167593000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNC0zLTEtMS04NTQyNw_9b703a6d-5d69-4f0a-bb53-b8ed9b557a60"
      unitRef="usd">123529000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNC01LTEtMS04NTQyNw_f52d97e6-3da7-43d2-a0af-4ea6468da1ad"
      unitRef="usd">336420000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNC03LTEtMS04NTQyNw_dc39afa8-ecd7-4832-836d-4cc83eedf7af"
      unitRef="usd">236209000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNi0xLTEtMS04NTQyNw_d693781a-dd83-4b94-9b5b-a5da3afae64d"
      unitRef="usd">158748000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNi0zLTEtMS04NTQyNw_13279944-d529-40dc-92ec-44240c0f0193"
      unitRef="usd">73921000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNi01LTEtMS04NTQyNw_1e8a9fb9-c224-408d-984e-d6e6d719f702"
      unitRef="usd">311960000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNi03LTEtMS04NTQyNw_6472e04e-e4c3-4073-bee9-b814d5964cf0"
      unitRef="usd">146312000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNy0xLTEtMS04NTQyNw_002ad1cf-a83e-4535-b638-8639df2db6c6"
      unitRef="usd">22562000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNy0zLTEtMS04NTQyNw_063a3fe0-7afb-4978-a525-33fa74bc4c8c"
      unitRef="usd">11385000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNy01LTEtMS04NTQyNw_f58862f0-5ef8-46d7-a303-fcddb17eb37a"
      unitRef="usd">46433000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfNy03LTEtMS04NTQyNw_fd3643c1-9bb8-469c-a922-3e1c097c8ef6"
      unitRef="usd">22094000</us-gaap:ResearchAndDevelopmentExpense>
    <icui:Restructuringandstrategictransaction
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfOC0xLTEtMS04NTQyNw_fdcbd047-fb19-4846-ae24-36ce87301509"
      unitRef="usd">13525000</icui:Restructuringandstrategictransaction>
    <icui:Restructuringandstrategictransaction
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfOC0zLTEtMS04NTQyNw_3557c683-9eb5-4beb-8b8f-4cd16c0027f1"
      unitRef="usd">3753000</icui:Restructuringandstrategictransaction>
    <icui:Restructuringandstrategictransaction
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfOC01LTEtMS04NTQyNw_0846fb90-c783-4790-9bee-646198af17ff"
      unitRef="usd">47430000</icui:Restructuringandstrategictransaction>
    <icui:Restructuringandstrategictransaction
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfOC03LTEtMS04NTQyNw_c33420a8-86fc-4ed3-8c03-6e04e49966ad"
      unitRef="usd">6636000</icui:Restructuringandstrategictransaction>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfOS0xLTEtMS04NTQyNw_672efb5d-922c-4ef4-b4c1-a1fe63af3a60"
      unitRef="usd">-27194000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfOS0zLTEtMS04NTQyNw_fd75fd3f-8d8a-4eec-bc0e-7270d9352041"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfOS01LTEtMS04NTQyNw_c050510e-b889-45da-9adb-3934e16fe7ae"
      unitRef="usd">-27194000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfOS03LTEtMS04NTQyNw_a4b85351-f828-41ff-b388-35216febd268"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <icui:Contractsettlement
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTAtMS0xLTEtODU0Mjc_8bdac89f-1ed4-464a-b090-8d57290d5582"
      unitRef="usd">0</icui:Contractsettlement>
    <icui:Contractsettlement
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTAtMy0xLTEtODU0Mjc_2ebb6c23-5e64-4c9a-83e0-dba1f55fe685"
      unitRef="usd">0</icui:Contractsettlement>
    <icui:Contractsettlement
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTAtNS0xLTEtODU0Mjc_7adb4f12-abd2-473d-9295-e4f2c510e408"
      unitRef="usd">0</icui:Contractsettlement>
    <icui:Contractsettlement
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTAtNy0xLTEtODU0Mjc_b1f40a5c-062f-4bc5-849d-d5d6cea317dc"
      unitRef="usd">127000</icui:Contractsettlement>
    <us-gaap:OperatingExpenses
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTEtMS0xLTEtODU0Mjc_8af48f4a-a80a-4b01-8ffa-076673260acc"
      unitRef="usd">167641000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTEtMy0xLTEtODU0Mjc_4eff3a10-0a6e-45e0-994c-ae333814ec65"
      unitRef="usd">89059000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTEtNS0xLTEtODU0Mjc_ba1d3863-787b-419c-bdd0-4741d9fbcd62"
      unitRef="usd">378629000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTEtNy0xLTEtODU0Mjc_0efb0847-71aa-4e0f-af70-c8749bb62adc"
      unitRef="usd">175169000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTItMS0xLTEtODU0Mjc_03e7f2af-97da-4f9a-9e79-84add5f9e377"
      unitRef="usd">-48000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTItMy0xLTEtODU0Mjc_3debc007-53d1-45ea-bc6d-a6391dc3437d"
      unitRef="usd">34470000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTItNS0xLTEtODU0Mjc_35726923-d2a3-49a4-a9ca-e6042a9b9712"
      unitRef="usd">-42209000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTItNy0xLTEtODU0Mjc_dca32c89-17eb-4cd9-a543-e588800d6025"
      unitRef="usd">61040000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTQtMS0xLTEtODU0Mjc_657b3bfd-9ed6-45e5-9f19-6c9db1377290"
      unitRef="usd">16273000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTQtMy0xLTEtODU0Mjc_cade71d0-38ce-464d-b928-c397c2ee5d46"
      unitRef="usd">163000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTQtNS0xLTEtODU0Mjc_806e6073-a537-4cf4-ad09-416362b7f23b"
      unitRef="usd">29917000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTQtNy0xLTEtODU0Mjc_1d28df4c-120f-43a7-87f9-d50871ba6e00"
      unitRef="usd">324000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTUtMS0xLTEtODU0Mjc_e8ad5a13-3321-4b7e-b931-53aca70c9974"
      unitRef="usd">-533000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTUtMy0xLTEtODU0Mjc_6a1007e9-6742-4b08-8849-be04f01545c9"
      unitRef="usd">525000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTUtNS0xLTEtODU0Mjc_d84ea6be-1a69-4ac8-b2ec-8334a0da3fe5"
      unitRef="usd">471000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTUtNy0xLTEtODU0Mjc_867a6f4a-5004-4d3b-94c3-e3e79d21500a"
      unitRef="usd">1208000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTYtMS0xLTEtODU0Mjc_f8a07140-cc8d-4576-b767-f6f776830176"
      unitRef="usd">-16854000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTYtMy0xLTEtODU0Mjc_b9797233-ba10-4b0d-9e97-977e47c6bdba"
      unitRef="usd">34832000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTYtNS0xLTEtODU0Mjc_7b5cec61-ae77-45f8-b3de-cb1beb23b2bc"
      unitRef="usd">-71655000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTYtNy0xLTEtODU0Mjc_dc517544-017d-4479-ba91-e87da52db0ec"
      unitRef="usd">61924000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTctMS0xLTEtODU0Mjc_03818b8f-25ea-4908-8e81-f1719a45ec5a"
      unitRef="usd">-9380000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTctMy0xLTEtODU0Mjc_fd431091-cbb0-4db4-af49-e3f21ae8d465"
      unitRef="usd">6434000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTctNS0xLTEtODU0Mjc_fa38eb8f-f44e-497e-9ea3-8069fa1ff522"
      unitRef="usd">-26113000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTctNy0xLTEtODU0Mjc_46095bf2-cdad-4699-898f-efe4d6d11658"
      unitRef="usd">9795000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTgtMS0xLTEtODU0Mjc_694bca44-5066-43f8-9bac-f2b98991cbce"
      unitRef="usd">-7474000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTgtMy0xLTEtODU0Mjc_b36dbc33-626b-42ba-b91d-3f1dc83e6848"
      unitRef="usd">28398000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTgtNS0xLTEtODU0Mjc_6c777e2a-1ef8-4921-8c5b-39d3d19495c0"
      unitRef="usd">-45542000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMTgtNy0xLTEtODU0Mjc_599a94c8-c215-4a49-a49d-028e60b79c1c"
      unitRef="usd">52129000</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjAtMS0xLTEtODU0Mjc_3ace7090-f853-4c36-8d00-9049bdb1c4d3"
      unitRef="usdPerShare">-0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjAtMy0xLTEtODU0Mjc_1c664d29-e032-4693-b97d-7c427d0411b9"
      unitRef="usdPerShare">1.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjAtNS0xLTEtODU0Mjc_77f3e0b7-4d89-4cf5-9f27-244897cae761"
      unitRef="usdPerShare">-1.91</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjAtNy0xLTEtODU0Mjc_5c287b1a-1dba-45a8-bd9f-ef7ff9e6207a"
      unitRef="usdPerShare">2.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjEtMS0xLTEtODU0Mjc_365d164f-dc78-4ff5-b7a0-d3803f49298f"
      unitRef="usdPerShare">-0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjEtMy0xLTEtODU0Mjc_b21260af-a8f4-4e5b-be2f-e699be8a2997"
      unitRef="usdPerShare">1.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjEtNS0xLTEtODU0Mjc_fbe60e37-3a26-4186-87f4-dba39273db7a"
      unitRef="usdPerShare">-1.91</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjEtNy0xLTEtODU0Mjc_215b8b58-cb37-4332-befa-987b26939378"
      unitRef="usdPerShare">2.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjMtMS0xLTEtODU0Mjc_63f4b6ae-4a4e-4442-aa23-46c76c1d2d81"
      unitRef="shares">23897000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjMtMy0xLTEtODU0Mjc_7dc67316-042c-4395-acf2-f2bbd2ea49e4"
      unitRef="shares">21200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjMtNS0xLTEtODU0Mjc_4726efc8-02c1-4fad-9e8c-8f36a8f9fe10"
      unitRef="shares">23787000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjMtNy0xLTEtODU0Mjc_9dec3e7d-9a88-4f25-9611-6c294d0a54d0"
      unitRef="shares">21176000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjQtMS0xLTEtODU0Mjc_05555fbd-0927-46da-95ca-1d673f569e3e"
      unitRef="shares">23897000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjQtMy0xLTEtODU0Mjc_e5f81b59-f402-41c5-a91a-86766c24f40f"
      unitRef="shares">21703000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjQtNS0xLTEtODU0Mjc_423b2934-6806-468a-b595-f1282e08632b"
      unitRef="shares">23787000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xOS9mcmFnOmI1MTYzYTU1NmRhZjQ0ZWY5ODM0ZGFlZjVmM2M4NTAwL3RhYmxlOjFkZTBkMTNlZTRhMjQ1YjA4YTdmMmM1Y2NhYmNlZGQ5L3RhYmxlcmFuZ2U6MWRlMGQxM2VlNGEyNDViMDhhN2YyYzVjY2FiY2VkZDlfMjQtNy0xLTEtODU0Mjc_8514220d-387d-40dc-9b1e-f76803c62058"
      unitRef="shares">21718000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfMi0xLTEtMS04NTQyNw_256965ba-9715-42a6-bb7c-f6e33bf4a9d8"
      unitRef="usd">-7474000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfMi0zLTEtMS04NTQyNw_57fe10a4-fbab-40e5-a0ca-ea10e49d8498"
      unitRef="usd">28398000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfMi01LTEtMS04NTQyNw_b1817e2d-c3df-4c75-9e35-c71577c303f9"
      unitRef="usd">-45542000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfMi03LTEtMS04NTQyNw_31371ac2-6cd6-4ec2-9eb5-219ec19cabe1"
      unitRef="usd">52129000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNC0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOjRmN2MyZmIwOTIyNzQyY2Q4MzE4YzYxYThiNTc4NGM1XzQ4_00677c72-c65b-4e3a-8b7e-23ab829c6359"
      unitRef="usd">4370000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNC0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOjRmN2MyZmIwOTIyNzQyY2Q4MzE4YzYxYThiNTc4NGM1XzU2_bb027a36-0359-439a-b4c7-eb965113a103"
      unitRef="usd">-111000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNC0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOjRmN2MyZmIwOTIyNzQyY2Q4MzE4YzYxYThiNTc4NGM1XzU0OTc1NTgxNDEwNg_1c4aa0ed-0416-4630-82ea-fc6c22877ce4"
      unitRef="usd">11681000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNC0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOjRmN2MyZmIwOTIyNzQyY2Q4MzE4YzYxYThiNTc4NGM1XzU0OTc1NTgxNDExNQ_420cf454-4352-48db-9e5c-987dd5113c90"
      unitRef="usd">-409000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNC0xLTEtMS04NTQyNw_d71df4c7-53f6-404c-bbf2-233969e705b6"
      unitRef="usd">8144000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNC0zLTEtMS04NTQyNw_04578eef-1cf9-4efe-b955-28d527ca458e"
      unitRef="usd">-352000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNC01LTEtMS04NTQyNw_b50a612a-8662-4f58-90c4-2261fff1807e"
      unitRef="usd">31716000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNC03LTEtMS04NTQyNw_88b4d435-0b7c-49d6-b7a0-329dfe60a031"
      unitRef="usd">-1296000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNS0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOmI3ODIxZjk5ZjBiYzRkYTNhNDFiZWNmNDFhN2IxNTk1XzU5_043ac23e-827d-43d7-bf91-526072eddcf7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNS0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOmI3ODIxZjk5ZjBiYzRkYTNhNDFiZWNmNDFhN2IxNTk1XzU5_aea17f1e-4e0d-47fa-a7bc-dcadb6deb2e7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNS0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOmI3ODIxZjk5ZjBiYzRkYTNhNDFiZWNmNDFhN2IxNTk1XzU5_b032cd2f-19bb-40f8-8010-5919d2b5d165"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNS0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOmI3ODIxZjk5ZjBiYzRkYTNhNDFiZWNmNDFhN2IxNTk1XzU5_edea30a3-bf49-4eb0-8212-50f6a397261c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNS0xLTEtMS04NTQyNw_07596cc4-eaf0-418d-9aae-b7affae6a537"
      unitRef="usd">-99805000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNS0zLTEtMS04NTQyNw_738dbfac-62a4-454a-87c7-402d1fb10354"
      unitRef="usd">1302000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNS01LTEtMS04NTQyNw_a77e918a-ae52-4f5d-84d4-620860ad87b9"
      unitRef="usd">-104751000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNS03LTEtMS04NTQyNw_ead3e02a-6c55-496e-b6ae-c6b3bd11a0bf"
      unitRef="usd">-6156000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNi0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOjE4ZDdkMmU2YjYxNDRiMWQ5YjFiN2ZkMTU4M2YzMWYzXzM3_2e8f43ae-f3b6-4df8-9e9d-48025832f651"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNi0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOjE4ZDdkMmU2YjYxNDRiMWQ5YjFiN2ZkMTU4M2YzMWYzXzM3_3271c95f-27be-4454-8874-1bcfceea725b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNi0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOjE4ZDdkMmU2YjYxNDRiMWQ5YjFiN2ZkMTU4M2YzMWYzXzM3_63b2b573-8bec-4a87-a53a-5855cd1778b5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNi0wLTEtMS04NTQyNy90ZXh0cmVnaW9uOjE4ZDdkMmU2YjYxNDRiMWQ5YjFiN2ZkMTU4M2YzMWYzXzM3_6bcea9a9-db29-4902-9668-61471d6ac734"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNi0xLTEtMS04NTQyNw_4fdf5a28-1362-4201-af43-9b6df5785f19"
      unitRef="usd">-14000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNi0zLTEtMS04NTQyNw_9eb74e42-f5ab-4f0d-bbfb-b03613ca6a00"
      unitRef="usd">-12000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNi01LTEtMS04NTQyNw_6988703a-ecbb-4c42-99a3-48f5a860dff3"
      unitRef="usd">-29000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNi03LTEtMS04NTQyNw_4518b2e8-10f0-4091-9895-152fca3528d8"
      unitRef="usd">-23000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNy0xLTEtMS04NTQyNw_e674835b-4bef-48b3-be9b-688eaaa4ca06"
      unitRef="usd">-91647000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNy0zLTEtMS04NTQyNw_32cf2cb8-c58f-4197-8a2a-aba3fd4f65ce"
      unitRef="usd">962000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNy01LTEtMS04NTQyNw_7f1d897f-f900-4965-8687-71388cda0078"
      unitRef="usd">-73006000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfNy03LTEtMS04NTQyNw_5edfa8b0-91c7-48a5-9c8a-99690db3f4fc"
      unitRef="usd">-7429000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfOC0xLTEtMS04NTQyNw_efcc5cb2-07b4-4981-a974-36a5b86b767f"
      unitRef="usd">-99121000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfOC0zLTEtMS04NTQyNw_6eb567f3-03ee-4ca4-94d5-1f3291f0b185"
      unitRef="usd">29360000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfOC01LTEtMS04NTQyNw_7d5da0a6-4551-4a9b-a5d0-17c01a5be071"
      unitRef="usd">-118548000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yMi9mcmFnOmQ3ZjYzNjY0OTAzNzRmYWZiMDkwN2JkOWM1NzY3NmU1L3RhYmxlOmE2MDgwNzNjNDQ4NTQzNGU5ZmRkMmIzNGFjMDhiOTBlL3RhYmxlcmFuZ2U6YTYwODA3M2M0NDg1NDM0ZTlmZGQyYjM0YWMwOGI5MGVfOC03LTEtMS04NTQyNw_a1a2bb33-9d71-4764-87f2-5c25d6bfc444"
      unitRef="usd">44700000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2c62d5316ba94e7c8299c081bae93fc3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMi0yLTEtMS04NTQyNw_b91e5882-f018-4f5b-b02b-96f17493c61b"
      unitRef="shares">21280000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i1020977b89154456bc4bc43c30abde86_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMi00LTEtMS04NTQyNw_ca774ec3-4f71-418a-850c-bca5b4eb1490"
      unitRef="usd">2128000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0f541893d2604b1cb5bdb8cdba0b8805_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMi02LTEtMS04NTQyNw_6c79bb58-1cc5-410e-a6e5-53648484cb54"
      unitRef="usd">721412000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8c3e5c01706a44a59cb0634c607efb09_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMi04LTEtMS04NTQyNw_a74cc025-05a9-4081-8122-fa7a5f33b95a"
      unitRef="usd">-27000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1f27b113c4d4421a8448db7016572b2f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMi0xMC0xLTEtODU0Mjc_d7d48fb4-1df7-457b-9879-e557489d6cad"
      unitRef="usd">911787000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifc6f5985837b4f60a2b0978f880b946b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMi0xMi0xLTEtODU0Mjc_d755d490-7038-4dab-8ee1-455821b702ab"
      unitRef="usd">-19269000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMi0xNC0xLTEtODU0Mjc_6e2de77d-0d1d-40f6-af66-0d4b853a6821"
      unitRef="usd">1616031000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i3ba7f4943fe34dcd87c78019ba0eaec5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMy0yLTEtMS04NTQyNw_531eb91b-8789-4a6f-80a7-34e0c162d657"
      unitRef="shares">154000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i1ca88d5a959149c5ab0f5a844b420ce3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMy00LTEtMS04NTQyNw_f150a57b-31dc-40e0-8a30-6f00a590b0d5"
      unitRef="usd">12000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i7ee94c9079b94b2d8fa66b18e8121025_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMy02LTEtMS04NTQyNw_2289fefa-1568-4cab-b7f9-93d12bc3b8cc"
      unitRef="usd">-2965000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i94d55d90e0334acf8952a54ea3eb127b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMy04LTEtMS04NTQyNw_fc6b71fe-b41a-465b-9c2c-4f4fc566dd17"
      unitRef="usd">5927000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMy0xNC0xLTEtODU0Mjc_0bf39131-0e6e-4f6e-9814-245b3ceed59b"
      unitRef="usd">2974000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i3ba7f4943fe34dcd87c78019ba0eaec5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNC0yLTEtMS04NTQyNw_79c66fbc-fbf3-4b74-bcd5-c2fce984ea1a"
      unitRef="shares">37000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i94d55d90e0334acf8952a54ea3eb127b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNC04LTEtMS04NTQyNw_0297ae06-c0f4-4cca-ae96-06529e4ca14a"
      unitRef="usd">8743000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNC0xNC0xLTEtODU0Mjc_b8c67f27-8ce3-4dfb-97ce-99c86e1690e0"
      unitRef="usd">8743000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNS0yLTEtMS04NTQyNw_23ecb287-1b31-4cd7-9b99-065d8ddf8e48"
      unitRef="shares">2500000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i1ca88d5a959149c5ab0f5a844b420ce3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNS00LTEtMS04NTQyNw_96d2dcfc-9084-45cb-90fb-8377f5353032"
      unitRef="usd">250000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i7ee94c9079b94b2d8fa66b18e8121025_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNS02LTEtMS04NTQyNw_9394b151-a42e-4aec-b720-b99641ff061d"
      unitRef="usd">575725000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNS0xNC0xLTEtODU0Mjc_8f40112a-570d-44f5-b604-482cacb48456"
      unitRef="usd">575975000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7ee94c9079b94b2d8fa66b18e8121025_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNi02LTEtMS04NTQyNw_e8187b29-158b-4c6c-b20c-af27a1c8e61e"
      unitRef="usd">12092000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNi0xNC0xLTEtODU0Mjc_8ef38533-a514-416b-820e-cc6c27f84954"
      unitRef="usd">12092000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4b031e42e24b410b9c3e6366a1a16a57_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNy0xMi0xLTEtODU0Mjc_ab0a5cb1-8b66-4439-b224-c8f7963029d6"
      unitRef="usd">18641000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfNy0xNC0xLTEtODU0Mjc_76e58e8f-1ee9-455e-ab6b-9a297f091e29"
      unitRef="usd">18641000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="ie1f9683afb0c4a3ea5a33c6e397e1533_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOC0xMC0xLTEtODU0Mjc_c7b398f4-23f5-4f5d-ba11-0095b39ef229"
      unitRef="usd">-38068000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOC0xNC0xLTEtODU0Mjc_ccd656a4-12a4-4bc2-b33f-e136fb7c9393"
      unitRef="usd">-38068000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i41bb039617594a87acecb9723e17821e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOS0yLTEtMS04NTQyNw_80b7e948-fb42-4607-b2fb-a3fbdf728ced"
      unitRef="shares">23897000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie62f7b97e63d401a8fa9db1823871df6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOS00LTEtMS04NTQyNw_6652133c-3006-453d-b715-efc436203343"
      unitRef="usd">2390000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2f837794d02a4a309041880510914516_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOS02LTEtMS04NTQyNw_d29251d8-d018-4403-9e6f-b03294b974e1"
      unitRef="usd">1306264000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i751dca1c7f254c71bec4904c65af1d0b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOS04LTEtMS04NTQyNw_5e9ca1d5-50e9-40ca-93ef-923e2f45ed56"
      unitRef="usd">-2843000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7b2480b622124e56a1087548cb6e0cf0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOS0xMC0xLTEtODU0Mjc_2a4a8f5c-99bc-4db8-87d0-19d88c48f498"
      unitRef="usd">873719000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i396ef2387b3b4cfe950c3f23ad00b3cd_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOS0xMi0xLTEtODU0Mjc_41e7a48d-94f2-43d8-85ef-675952f51f05"
      unitRef="usd">-628000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0f22c3698eff4a70b949d07786441335_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfOS0xNC0xLTEtODU0Mjc_e954fa7d-2ed8-4e42-93c7-98fdeb53149e"
      unitRef="usd">2178902000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ic71346e40fe54d37ba3383c1be84de74_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTAtMi0xLTEtODU0Mjc_d31bba0b-7119-426a-babd-a1df956dd7f3"
      unitRef="shares">10000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i204a869a54cc47739b6dbf488053eeb3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTAtNC0xLTEtODU0Mjc_c82e53c8-f0de-44e5-b470-c6d884935880"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ia068519b02ab427c9665a8614ee0735b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTAtNi0xLTEtODU0Mjc_135f09c9-cc90-4672-ae6c-ae385048f591"
      unitRef="usd">-4428000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="iea288493ae2f462290ba011ea37b3d86_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTAtOC0xLTEtODU0Mjc_ce0cc9a5-40dd-4f64-919b-e9c507adb2b9"
      unitRef="usd">4446000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTAtMTQtMS0xLTg1NDI3_7102f181-e890-41e5-82ec-fd37b9f865d0"
      unitRef="usd">18000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ic71346e40fe54d37ba3383c1be84de74_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTEtMi0xLTEtODU0Mjc_10a1f372-5b08-4f1d-b054-093a7e57f07a"
      unitRef="shares">8000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iea288493ae2f462290ba011ea37b3d86_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTEtOC0xLTEtODU0Mjc_365ac4da-d733-4c8f-8a53-cbdfc8f75ba4"
      unitRef="usd">1695000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTEtMTQtMS0xLTg1NDI3_8bf46baa-42cb-4158-978c-efb3879aa6d9"
      unitRef="usd">1695000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia068519b02ab427c9665a8614ee0735b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTItNi0xLTEtODU0Mjc_96ed0bbc-3a2d-49ca-b7da-0198708e3811"
      unitRef="usd">7762000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTItMTQtMS0xLTg1NDI3_4b59fda3-8736-4ce6-8c3e-47db31863137"
      unitRef="usd">7762000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id920d44e14eb45dd938699e476719d0a_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTMtMTItMS0xLTg1NDI3_cb85b272-b8ce-46ed-b5b8-77ad17c4be45"
      unitRef="usd">-91647000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTMtMTQtMS0xLTg1NDI3_6a5b1bc6-b6f3-4015-ac61-de7b89d51baa"
      unitRef="usd">-91647000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i1e061c30f5d84e94bc70f17124d6757b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTQtMTAtMS0xLTg1NDI3_bcd39850-6289-4181-8830-3be477b6f06c"
      unitRef="usd">-7474000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTQtMTQtMS0xLTg1NDI3_a92a8419-6460-43b6-bc4d-ef49f5bfe7c1"
      unitRef="usd">-7474000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ifb1f82e7e0dc42abae0fc933d35a46e1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTUtMi0xLTEtODU0Mjc_c985159c-1c78-41b8-921d-1f11200fe671"
      unitRef="shares">23899000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i0e4fef5bff944c76884d175d38d5163b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTUtNC0xLTEtODU0Mjc_45c06e33-ba78-4d74-924d-cb9dae0d4e66"
      unitRef="usd">2390000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ica66dd658337400da4427ae2a417bec7_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTUtNi0xLTEtODU0Mjc_615069e6-ee73-4f31-a0f2-1c5f55b07e7f"
      unitRef="usd">1309598000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0b64a06bc2aa421788ade8257344c7c6_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTUtOC0xLTEtODU0Mjc_6513d8eb-c7b3-4a9a-bfb7-5c494e179d6e"
      unitRef="usd">-92000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idb7bc6143f0a46a8905e6b6f840e73b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTUtMTAtMS0xLTg1NDI3_641a8436-725c-4199-9db5-35e2e5716f54"
      unitRef="usd">866245000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iec8771f969b149858b2fe843e8e5ca57_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTUtMTItMS0xLTg1NDI3_db2c5a10-6099-4952-916c-86dd48f30ac4"
      unitRef="usd">-92275000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOmExZDhiZDBlNWZiZTQxZjc5Y2I4NjE0YjQyM2ZmNGRmL3RhYmxlcmFuZ2U6YTFkOGJkMGU1ZmJlNDFmNzljYjg2MTRiNDIzZmY0ZGZfMTUtMTQtMS0xLTg1NDI3_1329beb5-d790-4709-9804-eb810c1aa91c"
      unitRef="usd">2085866000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4d268c33a3374123930ac2daf085b23a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMi0yLTEtMS04NTQyNw_59947b70-de90-4c87-95a2-201db208ceba"
      unitRef="shares">21058000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie1b618394b8c4a9fbd7ef856984c3846_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMi00LTEtMS04NTQyNw_4f470cf7-b96e-4a51-b47b-a27cd60728c6"
      unitRef="usd">2106000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i87a9b654e9114b85a43f7707ccf4a716_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMi02LTEtMS04NTQyNw_25f1b065-e350-4390-8d15-a7f62e865315"
      unitRef="usd">693068000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i270393932a514786a51aea891f82a426_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMi04LTEtMS04NTQyNw_0e02b7a0-1895-41ed-8722-8d906dddfbb9"
      unitRef="usd">-39000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idf3bdc1709be44ab8f7e21eff6b6f947_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMi0xMC0xLTEtODU0Mjc_51b8ea73-af56-4169-8952-e524cd33a497"
      unitRef="usd">808652000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0d78058125d8497e8caf757d8e36e07b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMi0xMi0xLTEtODU0Mjc_6446b380-d908-4e5e-9ebf-48459d5ce45a"
      unitRef="usd">-1522000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i21594db97b18415da81085ad86be9dbe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMi0xNC0xLTEtODU0Mjc_618e7801-db06-4417-b9bf-4d7f4c0213ef"
      unitRef="usd">1502265000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i370da095060646f9b9a5b42d2b8a471c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMy0yLTEtMS04NTQyNw_b8cf68cd-a077-49d9-996d-81c560b7bdb8"
      unitRef="shares">198000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i3710964cba21471c9be4ef3805401052_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMy00LTEtMS04NTQyNw_390ac132-3f54-4a41-9c39-55786b737bdf"
      unitRef="usd">16000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ic44bcf27ee524bb48481e9f36804453e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMy02LTEtMS04NTQyNw_f7b92832-82af-49a4-b80d-9b60266264d0"
      unitRef="usd">2496000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ia8313f8bcbe94858a403e65a717841bf_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMy04LTEtMS04NTQyNw_aabd3450-9377-43af-a819-321ddb2e5eea"
      unitRef="usd">2352000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ic01f9f53437648c6a182b99958017af1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMy0xNC0xLTEtODU0Mjc_5b08a46d-26fe-47d0-b1e3-3cb70da32843"
      unitRef="usd">4864000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i370da095060646f9b9a5b42d2b8a471c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNC0yLTEtMS04NTQyNw_ea78378d-7aea-4006-8915-3036685e2dbe"
      unitRef="shares">37000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia8313f8bcbe94858a403e65a717841bf_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNC04LTEtMS04NTQyNw_48492232-e35c-4f89-9b8d-5276f7f2d86f"
      unitRef="usd">7723000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ic01f9f53437648c6a182b99958017af1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNC0xNC0xLTEtODU0Mjc_e4807da4-d41f-4179-828a-3c13256d92db"
      unitRef="usd">7723000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic44bcf27ee524bb48481e9f36804453e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNS02LTEtMS04NTQyNw_eb9dc013-8e93-4584-b2a2-51e36e8c8f0a"
      unitRef="usd">6022000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic01f9f53437648c6a182b99958017af1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNS0xNC0xLTEtODU0Mjc_f3ce0ad4-3242-4ed9-85bd-2439f2438920"
      unitRef="usd">6022000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4c7325fe79e2481bb7929b1555e5d560_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNi0xMi0xLTEtODU0Mjc_3ef7192f-841a-47c7-b199-d2c218735f32"
      unitRef="usd">-8391000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ic01f9f53437648c6a182b99958017af1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNi0xNC0xLTEtODU0Mjc_2907ca90-c1a0-4368-bc6d-c188fc381f73"
      unitRef="usd">-8391000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i341cb29b86794db193ec2722d6ed4c0b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNy0xMC0xLTEtODU0Mjc_f4f5c34a-6e8f-4984-96a0-ddff5509c019"
      unitRef="usd">23731000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic01f9f53437648c6a182b99958017af1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfNy0xNC0xLTEtODU0Mjc_75db5dda-afb2-4498-b086-8c81c3d8591a"
      unitRef="usd">23731000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i33f91750301e465f851bd681c449d83b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOC0yLTEtMS04NTQyNw_7a82b5d5-035e-4d79-bf70-1f7976981f15"
      unitRef="shares">21219000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i87b490ee070e48afb48c060408137232_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOC00LTEtMS04NTQyNw_11512afa-dcbd-48af-a9c6-48646b7d4213"
      unitRef="usd">2122000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i677d5b1f2bf24e7e814304d237496841_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOC02LTEtMS04NTQyNw_c8183cfc-86d6-439a-9679-22b96c324fef"
      unitRef="usd">701586000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieddaa7ac708c434c8a3193b3e07498ba_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOC04LTEtMS04NTQyNw_24bea448-196f-456a-8e91-bec11e72eb03"
      unitRef="usd">-5410000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i02543008f10f4f5e88a7d69f73b7216b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOC0xMC0xLTEtODU0Mjc_cce09bc1-98bf-494c-8af5-800c8ee7ce30"
      unitRef="usd">832383000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ide0cac148c1a4f83bdc265c0ca6c1a88_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOC0xMi0xLTEtODU0Mjc_bf37efe9-ac95-4356-a9d7-55c5958745be"
      unitRef="usd">-9913000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia5a196eec7194c459ffcb870a785ba8d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOC0xNC0xLTEtODU0Mjc_f1695954-69fc-4924-8b78-7a053ad46ad8"
      unitRef="usd">1520768000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ic868ed7581a2477f82cf3b4625c2c5ae_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOS0yLTEtMS04NTQyNw_3f55f2ba-8c31-4329-bb36-dbada0aa1c41"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i09c6e851dc8544dc80903b26922759ba_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOS00LTEtMS04NTQyNw_e04653b9-1f59-4ae9-9cbc-59323e98fa9f"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ibff8b68601c04517ba11d27b118b9b3b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOS02LTEtMS04NTQyNw_ee2a0b74-8c74-4b42-9f19-7cca4a9049f0"
      unitRef="usd">-2685000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i8235a1a7b2144b4484a52b863d830ae2_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOS04LTEtMS04NTQyNw_e93ac723-6953-4ba5-a416-c9fd309a5abe"
      unitRef="usd">3237000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfOS0xNC0xLTEtODU0Mjc_e2780fa4-4de6-4dc1-9fae-bf21ae277d70"
      unitRef="usd">552000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ic868ed7581a2477f82cf3b4625c2c5ae_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTAtMi0xLTEtODU0Mjc_10422ed2-ee40-41aa-b6b5-616c8fda3a3d"
      unitRef="shares">0</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8235a1a7b2144b4484a52b863d830ae2_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTAtOC0xLTEtODU0Mjc_ab713f28-4e64-46e2-a5b4-601004211249"
      unitRef="usd">96000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTAtMTQtMS0xLTg1NDI3_3da982ab-935f-479c-96c0-5b30fc829d6c"
      unitRef="usd">96000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibff8b68601c04517ba11d27b118b9b3b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTEtNi0xLTEtODU0Mjc_d0d412b0-2811-4a2b-a710-ecd3d8e100f6"
      unitRef="usd">6681000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTEtMTQtMS0xLTg1NDI3_e80b7f94-cd71-4290-b20b-8496df5397bb"
      unitRef="usd">6681000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3dcbcc32613744fd9211f209efad177d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTItMTItMS0xLTg1NDI3_81d1b95e-354f-4d2f-8153-bbdefe88a07e"
      unitRef="usd">962000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTItMTQtMS0xLTg1NDI3_1e37fe52-da21-4050-a1e2-f7dc4224c4fd"
      unitRef="usd">962000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i7094f1ba4fdb4923823c90a6d6847969_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTMtMTAtMS0xLTg1NDI3_14969954-0a9a-4e2d-a4ba-7e600f22970f"
      unitRef="usd">28398000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTMtMTQtMS0xLTg1NDI3_d4deb5e5-076d-415d-89ed-362289376397"
      unitRef="usd">28398000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib67e39c6b55d4121bfac0b087eaee089_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTQtMi0xLTEtODU0Mjc_bac4bafc-0a4a-4857-9364-6ee8790e0e86"
      unitRef="shares">21219000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ia7b9ceb789614f918f4e10ee376eb65a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTQtNC0xLTEtODU0Mjc_ddfec3a9-6b28-42c5-9293-5daad453b44f"
      unitRef="usd">2122000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9e358c7559e544b4bb8922a2a7bde625_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTQtNi0xLTEtODU0Mjc_d3e3e11d-d31f-447a-9b03-3d8a3d450291"
      unitRef="usd">705582000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i59f12359cc364997814de3aec371b48f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTQtOC0xLTEtODU0Mjc_5039ce6c-d6a1-4945-aeb0-f564b774416a"
      unitRef="usd">-2269000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i072d1cca614444628db770eff0b59d62_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTQtMTAtMS0xLTg1NDI3_4ec92277-c69b-44ce-afdf-b48533ac211f"
      unitRef="usd">860781000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if3e56704a1f44738b385e2b4569e21d0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTQtMTItMS0xLTg1NDI3_756e9a43-912a-40d3-833a-51517fd2f0cf"
      unitRef="usd">-8951000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i55063029c0d44ea78a93faf80c101754_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yNS9mcmFnOjFjZTFjMmMzZTE2NjQ2MjdiM2RkYzk4MjA4ZDc0NGVjL3RhYmxlOjEzMTZiYzZiNzI0NTRmMzg5MmQxMDc1ODZjZjIwZGM5L3RhYmxlcmFuZ2U6MTMxNmJjNmI3MjQ1NGYzODkyZDEwNzU4NmNmMjBkYzlfMTQtMTQtMS0xLTg1NDI3_559edb00-010c-4459-bd41-9f6d151fb065"
      unitRef="usd">1557265000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMy0xLTEtMS04NTQyNw_b1817e2d-c3df-4c75-9e35-c71577c303f9"
      unitRef="usd">-45542000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMy0zLTEtMS04NTQyNw_31371ac2-6cd6-4ec2-9eb5-219ec19cabe1"
      unitRef="usd">52129000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNS0xLTEtMS04NTQyNw_41853c54-250c-448d-a74c-2e7af7e2da88"
      unitRef="usd">119697000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNS0zLTEtMS04NTQyNw_0ad647fa-fd68-4cb3-a507-1f79c9489a75"
      unitRef="usd">44319000</us-gaap:DepreciationDepletionAndAmortization>
    <icui:AmortizationOfInventoryStepUp
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNi0xLTEtMS04NTQyNw_2c38c8a4-c58d-4f60-aed6-48e480c8078d"
      unitRef="usd">22676000</icui:AmortizationOfInventoryStepUp>
    <icui:AmortizationOfInventoryStepUp
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNi0zLTEtMS04NTQyNw_399f954c-55c8-419c-a307-7f227ed17493"
      unitRef="usd">0</icui:AmortizationOfInventoryStepUp>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNy0xLTEtMS04NTQyNw_ec6082fd-3ab7-4610-a18a-e5f9612a4192"
      unitRef="usd">10888000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNy0zLTEtMS04NTQyNw_bad274a0-f81b-475d-86d5-ffc1e8dc4fc4"
      unitRef="usd">4780000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfOC0xLTEtMS04NTQyNw_982bb859-b3b1-4e8f-9289-6f245fd42910"
      unitRef="usd">-99000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfOC0zLTEtMS04NTQyNw_6eada802-f180-4216-896f-740cb14fd862"
      unitRef="usd">342000</us-gaap:ProvisionForDoubtfulAccounts>
    <icui:ProvisionForWarrantyAndReturns
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfOS0xLTEtMS04NTQyNw_2fefeda5-32bf-46b8-b07d-e14523427e92"
      unitRef="usd">1483000</icui:ProvisionForWarrantyAndReturns>
    <icui:ProvisionForWarrantyAndReturns
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfOS0zLTEtMS04NTQyNw_c3b55ec5-1100-4301-9842-df88550b672c"
      unitRef="usd">-345000</icui:ProvisionForWarrantyAndReturns>
    <us-gaap:ShareBasedCompensation
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTAtMS0xLTEtODU0Mjc_1215286d-f8b9-4c9e-beaa-dac2d6f009d2"
      unitRef="usd">19854000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTAtMy0xLTEtODU0Mjc_37399e35-ab73-4214-ac6f-1bb6aa55e40f"
      unitRef="usd">12703000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTEtMS0xLTEtODU0Mjc_b63048e3-65a5-48f4-a8c3-086c762f6608"
      unitRef="usd">-267000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTEtMy0xLTEtODU0Mjc_5819f5f6-332e-477c-9323-51097404a8bb"
      unitRef="usd">-829000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:InvestmentIncomeAmortizationOfPremium
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTItMS0xLTEtODU0Mjc_dd943bae-19e2-4136-a94f-a89039c5c885"
      unitRef="usd">211000</us-gaap:InvestmentIncomeAmortizationOfPremium>
    <us-gaap:InvestmentIncomeAmortizationOfPremium
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTItMy0xLTEtODU0Mjc_cb839902-8d1b-45c6-81b8-6e4eeaa5897f"
      unitRef="usd">364000</us-gaap:InvestmentIncomeAmortizationOfPremium>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTMtMS0xLTEtODU0Mjc_bec71de0-6648-4dac-9820-694c1b5cf206"
      unitRef="usd">3495000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTMtMy0xLTEtODU0Mjc_2fa264c4-ab84-403b-a96c-2c40251d4b2c"
      unitRef="usd">144000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTQtMS0xLTEtODU0Mjc_90e7664e-15b4-4b3b-aeb8-b1f12c2a3b7a"
      unitRef="usd">-27194000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTQtMy0xLTEtODU0Mjc_5ae230f5-5a7d-4fef-80da-2147fb6e7d3f"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <icui:Sparepartsusage
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTYtMS0xLTEtODU0Mjc_64ffbb3d-6c13-47c9-9eb7-8f0db07ee80b"
      unitRef="usd">5229000</icui:Sparepartsusage>
    <icui:Sparepartsusage
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTYtMy0xLTEtODU0Mjc_a5360e4d-7044-429b-85ef-fe586bfddd28"
      unitRef="usd">5356000</icui:Sparepartsusage>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTctMS0xLTEtODU0Mjc_f1568d44-8a91-4f60-a4a0-903dc172e28d"
      unitRef="usd">2807000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTctMy0xLTEtODU0Mjc_42719e2e-52e6-4021-a78a-2df53a037206"
      unitRef="usd">-1574000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTktMS0xLTEtODU0Mjc_a2e3e575-fea7-4af6-870f-cfc3e49d6125"
      unitRef="usd">1090000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMTktMy0xLTEtODU0Mjc_fe86b235-bdf7-4e94-876d-ae38b31d080e"
      unitRef="usd">-2078000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjAtMS0xLTEtODU0Mjc_fadff606-1fa5-4c7d-8df8-3468e0868664"
      unitRef="usd">100024000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjAtMy0xLTEtODU0Mjc_a68ef366-98c5-42e4-a7a2-df4986f13b9d"
      unitRef="usd">-13368000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjEtMS0xLTEtODU0Mjc_5dd2ba57-e531-4566-9925-95ff34415152"
      unitRef="usd">-4710000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjEtMy0xLTEtODU0Mjc_743e49ca-b182-49b9-9047-38983e00d63f"
      unitRef="usd">-759000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjItMS0xLTEtODU0Mjc_d824122a-1581-4ee4-b4eb-7a736d43e3b2"
      unitRef="usd">17323000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjItMy0xLTEtODU0Mjc_ae8eaba4-f217-4d60-8b0a-c41a9d0ec246"
      unitRef="usd">7632000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjMtMS0xLTEtODU0Mjc_62116b00-9826-4c7b-af1a-d8d0e4621950"
      unitRef="usd">22149000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjMtMy0xLTEtODU0Mjc_193e6706-3dc5-45d3-afc6-608d4f285ccb"
      unitRef="usd">-1648000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjQtMS0xLTEtODU0Mjc_e6f0f8c4-74ef-4292-8ae1-14299ba9542e"
      unitRef="usd">-33509000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjQtMy0xLTEtODU0Mjc_9146b8c2-29f2-4b3a-bb9d-f39d5e99134a"
      unitRef="usd">-17068000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjUtMS0xLTEtODU0Mjc_ecfb0830-8776-4840-9166-a296d6ed986a"
      unitRef="usd">-45798000</icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes>
    <icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjUtMy0xLTEtODU0Mjc_daac4a9e-0061-48a3-a08d-3953659a00af"
      unitRef="usd">-5970000</icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjYtMS0xLTEtODU0Mjc_6559a07d-7cea-491b-8293-c3e0dff9a642"
      unitRef="usd">-62727000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjYtMy0xLTEtODU0Mjc_d67a6686-eba5-4aa1-a24a-39e8385cfcbc"
      unitRef="usd">106082000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjgtMS0xLTEtODU0Mjc_ba4942ac-5a37-42cb-b646-ae13c6a11315"
      unitRef="usd">48039000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjgtMy0xLTEtODU0Mjc_ccc59ca3-8ddb-4dd9-a7c5-e3a2364441f5"
      unitRef="usd">29693000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjktMS0xLTEtODU0Mjc_a6aebb63-6aa7-45a3-bef3-dc7915108edb"
      unitRef="usd">900000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMjktMy0xLTEtODU0Mjc_57c82258-39ef-4a6d-a91b-dbac8d5a604e"
      unitRef="usd">203000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzAtMS0xLTEtODU0Mjc_cb174e7b-7007-4a78-bb49-429bc9fbe0f1"
      unitRef="usd">1844164000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzAtMy0xLTEtODU0Mjc_3b845a7b-b383-4233-bcee-de4de0e41b1e"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzEtMS0xLTEtODU0Mjc_276fa507-32a7-477f-ba7d-f22b2de9a4bc"
      unitRef="usd">4440000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzEtMy0xLTEtODU0Mjc_aaef188d-8d13-4f12-b139-442cb0f1225b"
      unitRef="usd">4136000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzMtMS0xLTEtODU0Mjc_838cc18c-4776-4306-b092-6f1f7cb2699f"
      unitRef="usd">3397000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzMtMy0xLTEtODU0Mjc_9f99b304-8fce-4a2f-becb-34a97da4aafc"
      unitRef="usd">10034000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzQtMS0xLTEtODU0Mjc_abdb1e9f-cca5-489c-b80f-ecb81e7054c8"
      unitRef="usd">26198000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzQtMy0xLTEtODU0Mjc_250d3237-5191-49ea-9f26-4114eb33d59b"
      unitRef="usd">7000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzUtMS0xLTEtODU0Mjc_09051ae2-5688-41b9-a853-8e121d858f7d"
      unitRef="usd">-1872942000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzUtMy0xLTEtODU0Mjc_e0b92eb3-0cdf-4202-9005-fb27c1eabdd6"
      unitRef="usd">-36660000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzctMS0xLTEtODU0Mjc_44716822-87d7-4ba4-9b6f-304d68fa8cf1"
      unitRef="usd">1672631000</icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts>
    <icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzctMy0xLTEtODU0Mjc_5a78c956-355d-440c-9dcf-c88e0768b5af"
      unitRef="usd">0</icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzgtMS0xLTEtODU0Mjc_fd521466-91ff-476a-8202-fd3ffb932924"
      unitRef="usd">18125000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzgtMy0xLTEtODU0Mjc_baca9f33-17d8-47f7-86af-320288015c2a"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzktMS0xLTEtODU0Mjc_6bc3cba2-1ded-425d-b641-7ed975184b19"
      unitRef="usd">1852000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfMzktMy0xLTEtODU0Mjc_08657fcb-386f-4e46-94af-6535760d1a41"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDAtMS0xLTEtODU0Mjc_99db17a5-d85a-4d62-9348-ec35d67d8886"
      unitRef="usd">2992000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDAtMy0xLTEtODU0Mjc_140b1e9e-8d6e-4158-bb57-92307e9e5b96"
      unitRef="usd">5416000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDEtMS0xLTEtODU0Mjc_8950f142-b180-410d-a448-6e4a3db13d65"
      unitRef="usd">321000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDEtMy0xLTEtODU0Mjc_93f5102a-1cf4-4fcd-ad07-ebc69e7f5baa"
      unitRef="usd">296000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDItMS0xLTEtODU0Mjc_2c5ef343-d9bc-44b0-b68c-31d7416e0431"
      unitRef="usd">10438000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDItMy0xLTEtODU0Mjc_c7f3512a-1ae9-4033-9ea9-3e5a0507565a"
      unitRef="usd">7819000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDMtMS0xLTEtODU0Mjc_272528c5-4a33-4ac1-b48c-6cb46c983fb4"
      unitRef="usd">1644887000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDMtMy0xLTEtODU0Mjc_f5e5bca3-0d0f-4205-8664-4b4e771ad23c"
      unitRef="usd">-2699000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDQtMS0xLTEtODU0Mjc_5734c425-af85-410b-89b2-8e82486e1d6f"
      unitRef="usd">-6347000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDQtMy0xLTEtODU0Mjc_492ce1d0-9db1-4a47-8ebc-504f39c8f940"
      unitRef="usd">-783000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDUtMS0xLTEtODU0Mjc_400ac14b-5d8e-4901-9c77-dd830a414916"
      unitRef="usd">-297129000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDUtMy0xLTEtODU0Mjc_d9d2d6ec-cb98-4aff-aa81-26f2b7174fb3"
      unitRef="usd">65940000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDYtMS0xLTEtODU0Mjc_c7816a3a-1526-470e-a0a1-e9473483f3d0"
      unitRef="usd">552827000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i21594db97b18415da81085ad86be9dbe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDYtMy0xLTEtODU0Mjc_5dfaa4dc-14e7-4163-9111-2ba25febceb1"
      unitRef="usd">396097000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDctMS0xLTEtODU0Mjc_5f037dfc-6ae9-44de-8345-facc456af367"
      unitRef="usd">255698000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i55063029c0d44ea78a93faf80c101754_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDctMy0xLTEtODU0Mjc_10595029-c248-4d77-a2fc-16e0a804277a"
      unitRef="usd">462037000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOmIyZGVkNTM3Y2U2ZjQ1NjZhM2U2ZjMxMjU3OTM3NTQ4L3RhYmxlcmFuZ2U6YjJkZWQ1MzdjZTZmNDU2NmEzZTZmMzEyNTc5Mzc1NDhfNy0xLTEtMS04NTQyNw_68afaf95-6cda-4fa0-becf-917d7dd91e11"
      unitRef="usd">5539000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOmIyZGVkNTM3Y2U2ZjQ1NjZhM2U2ZjMxMjU3OTM3NTQ4L3RhYmxlcmFuZ2U6YjJkZWQ1MzdjZTZmNDU2NmEzZTZmMzEyNTc5Mzc1NDhfNy0zLTEtMS04NTQyNw_48b6fb80-63a5-4f78-85d7-938615ef64dc"
      unitRef="usd">1857000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOmIyZGVkNTM3Y2U2ZjQ1NjZhM2U2ZjMxMjU3OTM3NTQ4L3RhYmxlcmFuZ2U6YjJkZWQ1MzdjZTZmNDU2NmEzZTZmMzEyNTc5Mzc1NDhfMTEtMS0xLTEtODU0Mjc_71bfb15a-da24-49b5-bd08-cce4fb2bc2f0"
      unitRef="usd">1658692000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOmIyZGVkNTM3Y2U2ZjQ1NjZhM2U2ZjMxMjU3OTM3NTQ4L3RhYmxlcmFuZ2U6YjJkZWQ1MzdjZTZmNDU2NmEzZTZmMzEyNTc5Mzc1NDhfMTItMS0xLTEtODU0Mjc_e0e80e0b-5fbe-4de7-9801-2e40f0bccef9"
      unitRef="usd">1844164000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOmIyZGVkNTM3Y2U2ZjQ1NjZhM2U2ZjMxMjU3OTM3NTQ4L3RhYmxlcmFuZ2U6YjJkZWQ1MzdjZTZmNDU2NmEzZTZmMzEyNTc5Mzc1NDhfMTMtMS0xLTEtODU0Mjc_066ffb0b-cb27-43ed-921c-d559fbc8819a"
      unitRef="usd">575975000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <icui:ContingentConsiderationAllAcquisitions
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOmIyZGVkNTM3Y2U2ZjQ1NjZhM2U2ZjMxMjU3OTM3NTQ4L3RhYmxlcmFuZ2U6YjJkZWQ1MzdjZTZmNDU2NmEzZTZmMzEyNTc5Mzc1NDhfMTQtMS0xLTEtODU0Mjc_d9b56323-c3a9-4767-9138-99907df9981c"
      unitRef="usd">55158000</icui:ContingentConsiderationAllAcquisitions>
    <icui:GoodwillAcquiredDuringPeriodAllAcquisitions
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOmIyZGVkNTM3Y2U2ZjQ1NjZhM2U2ZjMxMjU3OTM3NTQ4L3RhYmxlcmFuZ2U6YjJkZWQ1MzdjZTZmNDU2NmEzZTZmMzEyNTc5Mzc1NDhfMTUtMS0xLTEtODU0Mjc_2c587f3e-b772-4b04-9466-ff332064701f"
      unitRef="usd">1437811000</icui:GoodwillAcquiredDuringPeriodAllAcquisitions>
    <us-gaap:LiabilitiesAssumed1
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOmIyZGVkNTM3Y2U2ZjQ1NjZhM2U2ZjMxMjU3OTM3NTQ4L3RhYmxlcmFuZ2U6YjJkZWQ1MzdjZTZmNDU2NmEzZTZmMzEyNTc5Mzc1NDhfMTYtMS0xLTEtODU0Mjc_38277516-99cb-453a-b6d4-0e3749d190bd"
      unitRef="usd">621206000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8zNC9mcmFnOjZiZmVmMWNmYWZlYTRmN2E5Y2I1YWJhMzdlMTMwNzMwL3RleHRyZWdpb246NmJmZWYxY2ZhZmVhNGY3YTljYjVhYmEzN2UxMzA3MzBfMjA0NQ_c0720f89-f72d-4fcf-b34c-6f0d46d4c748">Basis of Presentation&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S.") and pursuant to the rules&#160;and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) and reflect all adjustments, consisting of only normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of the consolidated results for the interim periods presented. Results for the interim period are not necessarily indicative of results for the full year. Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules&#160;and regulations. The condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report on Form&#160;10-K of ICU Medical,&#160;Inc., ("ICU") a Delaware corporation, filed with the SEC for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are engaged in the development, manufacturing and sale of innovative medical products used in infusion therapy and critical care applications.&#160;We sell the majority of our products through our direct sales force and through independent distributors throughout the U.S. and internationally.&#160;We also sell certain products on an original equipment manufacturer basis to other medical device manufacturers. All subsidiaries are wholly owned and are included in the condensed consolidated financial statements.&#160;All intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2022, we acquired Smiths Medical 2020 Limited ("Smiths Medical"), see Note 3: Acquisitions. Our condensed consolidated statement of operations includes the results of operations for Smiths Medical from January 7, 2022 through June 25, 2022, which is the current end of their 4-4-5 accounting period.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8zNy9mcmFnOjYzOTU3Y2JjYTNmYTQzZGZhMTI5ZDk1YjVmNzBiYzUyL3RleHRyZWdpb246NjM5NTdjYmNhM2ZhNDNkZmExMjlkOTViNWY3MGJjNTJfMjU3MQ_4f005a69-8de5-43fc-a1f6-4c05603a939a">New Accounting Pronouncements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the Financial Accounting Standards Board issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional guidance for a limited period of time to ease the potential burden for reference rate reform on financial reporting. Due to concerns about structural risks of interbank offered rates and, particularly, the risk of cessation of the London Interbank Offered Rate ("LIBOR"), regulators around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction-based and less susceptible to manipulation. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued as a result of reference rate reform. Optional expedients may be applied to contracts that are modified as a result of the reference rate reform. Modifications of contracts within the scope of Topic 470, Debt, should be accounted for by prospectively adjusting the effective interest rate. Modifications of contracts within the scope of ASC 842, Leases, should be accounted for as a continuation of the existing contracts with no reassessments of the lease classification and the discount rate (incremental borrowing rate). Exceptions to Topic 815, Derivatives and Hedging, results in not having a dedesignation of a hedging relationship if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. In November 2021, we entered into two forward-starting swaps whereby the variable leg of the swap referenced LIBOR. These swaps were amended in early 2022 to transition to an alternative reference rate (see Note 8: Derivatives and Hedging Activities). The amendments in this ASU allow for certain expedients that will allow us to assume that our hedged interest payments are probable of occurring regardless of any expected modification in their terms related to reference rate reform and will allow us to continue hedge accounting for a cash flow hedge for which the hedged interest rate risk changes if the hedge is highly effective under ASC 815, Derivatives and Hedging, or the optional expedient under this ASU is elected. The impact of this ASU on our contracts has not been and is not expected to be material.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzQ1Mw_d8a231e7-3b88-4483-b041-cd3e8ec698b4">Acquisitions&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2022, we acquired 100.0% of the equity interests in Smiths Medical, the holding company of Smiths Group plc's global medical device business, from Smiths Group International Holdings Limited (&#x201c;Smiths&#x201d;). The acquisition of Smiths Medical aligns with our strategic growth plans, enabling us to broaden our product offerings to include syringe and ambulatory infusion devices, vascular access, and vital care products and to strengthen and expand our global market reach.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash consideration for the acquisition was $1.9&#160;billion, which was financed with existing cash balances and proceeds from the credit agreement entered into on January 6, 2022 (see Note 17: Long-Term Debt). We also issued share consideration to Smiths of 2.5&#160;million shares of our common stock. The fair value of the common shares issued to Smiths was determined based on the opening market price of our common stock on the acquisition date. Smiths may be entitled to an additional $100.0&#160;million in cash consideration contingent on our common stock achieving certain price targets for certain periods after closing in accordance with the terms of the Share Sale and Purchase Agreement (the "Purchase Agreement"). In the event that (a) on or prior to the third anniversary of closing the 30-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $300.00 per share or (b) on or prior to the fourth anniversary of closing the 45-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $300.00 per share (each a "Price Target"), and provided Smiths beneficially owns at least 50.0% of the shares of common stock issued at closing at the time the Price Target is achieved, then Smiths will be entitled to receive the additional $100.0&#160;million in cash consideration. The fair value of the contingent consideration was determined using an option pricing model, specifically the Monte Carlo Simulation. In the analysis, the determinants of payout are simulated in a risk neutral framework over a large number of simulation paths. The fair value of the contingent consideration is then calculated as the average present value across all simulated paths. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Preliminary Purchase Price Allocation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated purchase price and the preliminary allocation of the purchase price related to the assets acquired and liabilities assumed (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated cash consideration for acquired assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,922,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preliminary fair value of contingent consideration payable to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of ICU Medical, Inc. common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares issued to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Price per share (ICU's opening market price on the acquisition date)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of ICU shares issued to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total estimated consideration to be paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,552,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Preliminary Purchase Price Allocation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;975,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175,099)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill - not tax deductible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated Purchase Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,552,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Estimated identifiable intangible assets include $540.0&#160;million of customer relationships, $400.0&#160;million of developed technology, $30.0&#160;million of internally developed software, and $5.0&#160;million of trade mark. The estimated weighted-average amortization period for the total identifiable intangible assets is approximately &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU2_ddab537f-8bc6-4122-8738-75e9f83ccca8"&gt;nine&lt;/span&gt; years, and, for each identifiable intangible asset is estimated as follows: &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU3_94ff8303-bbea-4e2c-80a0-75c79ec80ddf"&gt;eight&lt;/span&gt; years for customer relationships, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU4_39b70a39-6a8c-49b7-a62c-b1011d2a541c"&gt;ten&lt;/span&gt; years for developed technology, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU5_9bab9dac-782a-4c71-afdc-921a87d1c7b7"&gt;five&lt;/span&gt; years for internally developed software, and &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDYw_9c9b33b6-6b8e-4b28-8e2a-6c3cc63df867"&gt;six&lt;/span&gt; months for the trade mark. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Estimated accrued liabilities includes, among other things, accrued warranty reserves, accrued restructuring initiatives, accrued salaries and related benefits, deferred revenue and accrued sales and use taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The above purchase price and purchase price allocation are preliminary and subject to future revision as the acquired assets and liabilities assumed are dependent upon the finalization of the related valuations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The identifiable intangible assets and other long-lived assets acquired have been valued as Level 3 assets at fair value. The estimated fair value of identifiable intangible assets were developed using the income approach and are based on critical estimates, judgments and assumptions derived from: analysis of market conditions; discount rate; discounted cash flows; royalty rates; customer retention rates; and/or estimated useful lives. Certain other intangible assets were valued using a cost to replace method, estimating the labor and non-labor costs required to replace the asset under the premise that it was not part of the transaction. Property, plant and equipment was valued with the consideration of remaining economic lives. The raw materials inventory was valued at historical cost and adjusted for any obsolescence which we estimate to approximate replacement cost, the work in process was valued at estimated sales proceeds less costs to complete and costs to sell, and finished goods inventory was valued at estimated sales proceeds less costs to sell. The prepaid expenses and other current assets and assumed liabilities were recorded at their carrying values as of the date of the acquisition, as their carrying values approximated their fair values due to their short-term nature.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unaudited Pro Forma Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Smiths Medical is included in our consolidated results beginning on January 7, 2022. Total revenues and net loss attributable to Smiths Medical for the period from January 7, 2022 to June 30, 2022 were $437.8&#160;million and $65.5&#160;million, respectively, and for the three months ended June 30, 2022 were $222.9&#160;million and $26.0&#160;million. The following unaudited pro forma financial information presents the combined results of operations of ICU and Smiths Medical as if the acquisition had occurred on January 1, 2021. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place on the date indicated or of results that may occur in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,227,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,474)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,425)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma results presented above include the impact of the following adjustments: incremental amortization expense on intangible assets acquired of $1.3&#160;million and $55.5&#160;million for the six months ended June 30, 2022 and 2021, respectively, incremental interest expense, including amortization of debt discount and debt issuance costs, on the Credit Facilities of $0.8&#160;million and $25.4&#160;million for the six months ended June 30, 2022 and 2021, respectively; and a $27.4&#160;million expense related to the increase in fair value of inventory for the six months ended June 30, 2021. In addition, there were non-recurring adjustments directly attributable to the business combination, including acquisition-related cost of $13.5&#160;million for the six months ended June 30, 2021 and adjustments related to the extinguishment of related party loans receivable and payable equal to $80.7&#160;million and $45.0&#160;million for the six months ended June 30, 2022 and 2021, respectively. The unaudited pro forma results include IFRS to U.S. GAAP adjustments for Smiths Medical historical results and adjustments for accounting policy alignment, which were materially similar to the Company. Any differences in accounting policies were adjusted to reflect the accounting policies of the Company in the unaudited pro forma results presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2021 Acquisition&lt;/span&gt;&lt;/div&gt;During November 2021, we acquired a small foreign infusion systems supplier and paid an initial gross cash payment of approximately $15.4&#160;million. In addition to the initial cash consideration, total consideration for the acquisition includes an additional holdback of $0.5&#160;million, to be paid two years from the completion date of the acquisition, and also a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of June 30, 2022, the total consideration which includes the acquisition date fair value of the contingent consideration was $17.1&#160;million.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzc_934184ec-ec30-4aa4-97e7-61140bb3c45c"
      unitRef="number">1.000</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <icui:BusinessCombinationConsiderationTransferredCash
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTc0_db733cff-35f1-4de7-84f7-2e7bca1335ad"
      unitRef="usd">1900000000</icui:BusinessCombinationConsiderationTransferredCash>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i92956d7d960f45f3bea45f7aa025342c_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzc1_8d71f4a1-d4cf-4d10-afb1-22745d9bcc8b"
      unitRef="shares">2500000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfOTkz_f57f8a4c-49e2-4287-97b2-46056af04838"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <icui:MinimumStockPriceTargetForEarnOutPayment
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfMTQwMg_3661aa80-6586-4ec7-9b3a-3422591a9a57"
      unitRef="usd">300.00</icui:MinimumStockPriceTargetForEarnOutPayment>
    <icui:MinimumStockPriceTargetForEarnOutPayment
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfMTU5MA_c64bc7af-7f91-4850-b979-28097b88d743"
      unitRef="usd">300.00</icui:MinimumStockPriceTargetForEarnOutPayment>
    <icui:RequiredShareHoldingOfStockIssuedAtAcquisition
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfMTY3NQ_14b630b8-99b2-4368-9372-27d94227f83d"
      unitRef="number">0.500</icui:RequiredShareHoldingOfStockIssuedAtAcquisition>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfMTgyMw_f57f8a4c-49e2-4287-97b2-46056af04838"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzQ1NQ_b8bfaf5a-1dcf-4b41-8fcd-99109b9f034c">The following table summarizes the estimated purchase price and the preliminary allocation of the purchase price related to the assets acquired and liabilities assumed (in thousands):&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated cash consideration for acquired assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,922,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preliminary fair value of contingent consideration payable to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of ICU Medical, Inc. common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares issued to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Price per share (ICU's opening market price on the acquisition date)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of ICU shares issued to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total estimated consideration to be paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,552,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Preliminary Purchase Price Allocation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;975,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175,099)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill - not tax deductible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated Purchase Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,552,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Estimated identifiable intangible assets include $540.0&#160;million of customer relationships, $400.0&#160;million of developed technology, $30.0&#160;million of internally developed software, and $5.0&#160;million of trade mark. The estimated weighted-average amortization period for the total identifiable intangible assets is approximately &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU2_ddab537f-8bc6-4122-8738-75e9f83ccca8"&gt;nine&lt;/span&gt; years, and, for each identifiable intangible asset is estimated as follows: &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU3_94ff8303-bbea-4e2c-80a0-75c79ec80ddf"&gt;eight&lt;/span&gt; years for customer relationships, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU4_39b70a39-6a8c-49b7-a62c-b1011d2a541c"&gt;ten&lt;/span&gt; years for developed technology, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDU5_9bab9dac-782a-4c71-afdc-921a87d1c7b7"&gt;five&lt;/span&gt; years for internally developed software, and &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDYw_9c9b33b6-6b8e-4b28-8e2a-6c3cc63df867"&gt;six&lt;/span&gt; months for the trade mark. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Estimated accrued liabilities includes, among other things, accrued warranty reserves, accrued restructuring initiatives, accrued salaries and related benefits, deferred revenue and accrued sales and use taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMC0yLTEtMS05MDQ0Mw_c5fe6cf5-7e5b-4e24-981c-db8f77837f31"
      unitRef="usd">1922955000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i92956d7d960f45f3bea45f7aa025342c_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMS0yLTEtMS04NTQyNw_012f50e6-b562-4b02-a84f-d34c02bc8ee3"
      unitRef="usd">53520000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i92956d7d960f45f3bea45f7aa025342c_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfNC0yLTEtMS04NTQyNw_ddaa7b87-07d9-41a5-859c-65587e926004"
      unitRef="shares">2500000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfNS0yLTEtMS04NTQyNw_cfeef921-0c0d-44f0-91bf-962fd80acad4"
      unitRef="usdPerShare">230.39</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfNi0yLTEtMS04NTQyNw_fddc8a44-ef1b-4381-8f74-fcd722a898c1"
      unitRef="usd">575975000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i92956d7d960f45f3bea45f7aa025342c_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfNy0yLTEtMS04NTQyNw_455ec063-9067-4a5e-be67-39e60cdab5e0"
      unitRef="usd">2552450000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTAtMi0xLTEtODU0Mjc_36874652-4dce-4134-97a1-e08c6669ea12"
      unitRef="usd">78791000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTEtMi0xLTEtODU0Mjc_4a68b5fa-7b04-4d88-8a0f-a0e0a7d298dd"
      unitRef="usd">118277000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTItMi0xLTEtODU0Mjc_3ee275ed-6395-4dd1-8b50-732151a6cb54"
      unitRef="usd">226196000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTMtMi0xLTEtODU0Mjc_a9a79fff-ae61-48ac-9d00-d0b62ee9446a"
      unitRef="usd">53554000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTQtMi0xLTEtODU0Mjc_8d6ab59e-2a80-426f-8a77-ea320bdfa5e5"
      unitRef="usd">210000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <icui:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTUtMi0xLTEtODU0Mjc_a171f4a4-60cc-4a34-9520-a8109d5fab57"
      unitRef="usd">55161000</icui:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTYtMi0xLTEtODU0Mjc_9671343b-79f2-4bd1-90f2-dea5d9cb52c5"
      unitRef="usd">975000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTctMi0xLTEtODU0Mjc_e749a3ce-594f-45ec-92c0-05430a677d8c"
      unitRef="usd">9303000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTgtMi0xLTEtODU0Mjc_facfacc2-8f18-4619-a127-21163c931f08"
      unitRef="usd">379000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMTktMi0xLTEtODU0Mjc_eb5edba7-c002-4e89-8ce9-c772e5216b9f"
      unitRef="usd">105291000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMjAtMi0xLTEtODU0Mjc_59132e6c-d100-4ae8-8131-ecd62f228741"
      unitRef="usd">175099000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <icui:BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMjEtMi0xLTEtODU0Mjc_a402571d-b8c8-402a-8fe8-0ec2ecb1200a"
      unitRef="usd">24332000</icui:BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMjItMi0xLTEtODU0Mjc_10f5743d-10dc-4198-ba8f-ec36c8640e3e"
      unitRef="usd">85739000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMjMtMi0xLTEtODU0Mjc_f7a92814-a6db-4617-a24c-733f07220344"
      unitRef="usd">228689000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMjQtMi0xLTEtODU0Mjc_dc950235-8c7e-4d18-b621-bf25e595e75e"
      unitRef="usd">1107511000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <icui:BusinessCombinationGoodwillNonDeductible
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMjUtMi0xLTEtODU0Mjc_14ee4b98-1a7a-43d1-8bbe-9c545df71023"
      unitRef="usd">1444939000</icui:BusinessCombinationGoodwillNonDeductible>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="id5289794172a4cb198e8aa0169b4c3b2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjVlMWZkNWVmN2IyYzQ0MTM5N2JjYzI1MDdlNDdhYWI5L3RhYmxlcmFuZ2U6NWUxZmQ1ZWY3YjJjNDQxMzk3YmNjMjUwN2U0N2FhYjlfMjYtMi0xLTEtODU0Mjc_29426d06-f383-40c2-831f-0c986468e30d"
      unitRef="usd">2552450000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9639169305914239b5bd07cfd412c105_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfMjU1MA_138b1839-60d8-4ede-86a7-fc8a9e86e4fb"
      unitRef="usd">540000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ifd1869288e4244bfa1eeb70afaf8d8b1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfMjU4MA_dc3a3149-98bb-4e3d-87c2-1342523d734f"
      unitRef="usd">400000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i69cd3733592345e3b3f6a2fba4b5f08d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NDQy_13277da9-4d43-45c4-8277-f157a55cdcb5"
      unitRef="usd">30000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic884346985a24c95b00b5aacf1b3975a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfMjYxMg_b21aac88-eadc-4298-8fe2-0aaf88cce524"
      unitRef="usd">5000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Revenues
      contextRef="i92956d7d960f45f3bea45f7aa025342c_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNDkwOA_43443ed2-0954-4c71-aa82-6a491ff13782"
      unitRef="usd">437800000</us-gaap:Revenues>
    <us-gaap:ProfitLoss
      contextRef="i92956d7d960f45f3bea45f7aa025342c_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNDkxNQ_685de504-79e1-482f-88c0-ed60c7675594"
      unitRef="usd">65500000</us-gaap:ProfitLoss>
    <us-gaap:Revenues
      contextRef="id5289794172a4cb198e8aa0169b4c3b2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NTE0_477e21f3-2ffa-420b-8df1-eaffe68834f4"
      unitRef="usd">222900000</us-gaap:Revenues>
    <us-gaap:ProfitLoss
      contextRef="id5289794172a4cb198e8aa0169b4c3b2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTQ5NzU1ODI0NTMw_2657ec58-1c1d-4225-8f62-8278966191c8"
      unitRef="usd">26000000</us-gaap:ProfitLoss>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzQ1Ng_3476f781-0109-494f-bf08-0df7aff5f24e">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,227,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,474)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,425)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjIxNGNmMWM5NzczMDRiZjM5ZGUwYmIzNjQwMTIxMDljL3RhYmxlcmFuZ2U6MjE0Y2YxYzk3NzMwNGJmMzlkZTBiYjM2NDAxMjEwOWNfMi0xLTEtMS04NTQyNw_e2de4f66-60d6-450b-af1d-c016d4aed633"
      unitRef="usd">561004000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjIxNGNmMWM5NzczMDRiZjM5ZGUwYmIzNjQwMTIxMDljL3RhYmxlcmFuZ2U6MjE0Y2YxYzk3NzMwNGJmMzlkZTBiYjM2NDAxMjEwOWNfMi0zLTEtMS04NTQyNw_236fc798-6fda-45c6-b3f5-f2fc416af965"
      unitRef="usd">625942000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjIxNGNmMWM5NzczMDRiZjM5ZGUwYmIzNjQwMTIxMDljL3RhYmxlcmFuZ2U6MjE0Y2YxYzk3NzMwNGJmMzlkZTBiYjM2NDAxMjEwOWNfMi01LTEtMS05MDU0NA_b15c8ec7-26cc-4d67-991b-820a6069c9f6"
      unitRef="usd">1124823000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjIxNGNmMWM5NzczMDRiZjM5ZGUwYmIzNjQwMTIxMDljL3RhYmxlcmFuZ2U6MjE0Y2YxYzk3NzMwNGJmMzlkZTBiYjM2NDAxMjEwOWNfMi03LTEtMS05MDU0Ng_ad46895c-a99b-4f90-9970-c15e38535c31"
      unitRef="usd">1227502000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjIxNGNmMWM5NzczMDRiZjM5ZGUwYmIzNjQwMTIxMDljL3RhYmxlcmFuZ2U6MjE0Y2YxYzk3NzMwNGJmMzlkZTBiYjM2NDAxMjEwOWNfMy0xLTEtMS04NTQyNw_2bccce42-c4c4-43b3-8c2e-225798ba95d6"
      unitRef="usd">-7474000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjIxNGNmMWM5NzczMDRiZjM5ZGUwYmIzNjQwMTIxMDljL3RhYmxlcmFuZ2U6MjE0Y2YxYzk3NzMwNGJmMzlkZTBiYjM2NDAxMjEwOWNfMy0zLTEtMS04NTQyNw_3bd6c63e-09e1-433c-9b81-822fac70db8a"
      unitRef="usd">34244000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjIxNGNmMWM5NzczMDRiZjM5ZGUwYmIzNjQwMTIxMDljL3RhYmxlcmFuZ2U6MjE0Y2YxYzk3NzMwNGJmMzlkZTBiYjM2NDAxMjEwOWNfMy01LTEtMS05MDU0OA_8731cfa9-154c-4b1a-9d6a-5a8488db923f"
      unitRef="usd">-59425000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RhYmxlOjIxNGNmMWM5NzczMDRiZjM5ZGUwYmIzNjQwMTIxMDljL3RhYmxlcmFuZ2U6MjE0Y2YxYzk3NzMwNGJmMzlkZTBiYjM2NDAxMjEwOWNfMy03LTEtMS05MDU1MA_26c8a63d-0cda-45d9-8a60-8505f8dabd9b"
      unitRef="usd">31447000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <icui:ProFormaAdjustmentAmortization
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTU0NQ_f64ab53a-539c-4f30-a52f-73d4e7392ced"
      unitRef="usd">1300000</icui:ProFormaAdjustmentAmortization>
    <icui:ProFormaAdjustmentAmortization
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTU1Mg_bdf62c6d-abf2-4dd5-b38f-86fbef3c8bcf"
      unitRef="usd">55500000</icui:ProFormaAdjustmentAmortization>
    <icui:ProFormaAdjustmentFinanceCosts
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTc0NA_a99c6f67-e95d-4ab7-bf44-898268e17b22"
      unitRef="usd">800000</icui:ProFormaAdjustmentFinanceCosts>
    <icui:ProFormaAdjustmentFinanceCosts
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTc1MQ_b34d1747-cd9b-4e27-96cc-c641ad7c59e3"
      unitRef="usd">25400000</icui:ProFormaAdjustmentFinanceCosts>
    <icui:ProFormaAdjustmentInventory
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNTgyNg_75ab3608-7bc1-4f95-ab26-de89d9d6a4af"
      unitRef="usd">27400000</icui:ProFormaAdjustmentInventory>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="ida3d6c67a93c4582b8cb475e3d531c8c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNjA3MA_21959d69-dea2-4d90-81d0-865de9c412e8"
      unitRef="usd">13500000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <icui:ProFormaAdjustmentRelatedPartyLoans
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNjIxNg_94c62293-a3b6-4a5a-9ba0-a5e8710320d6"
      unitRef="usd">80700000</icui:ProFormaAdjustmentRelatedPartyLoans>
    <icui:ProFormaAdjustmentRelatedPartyLoans
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNjIyMw_890627a5-5ab2-4f01-8233-24cbaae66daf"
      unitRef="usd">45000000</icui:ProFormaAdjustmentRelatedPartyLoans>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i0c90af4126704fd9b931fd425c90445a_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNjc5Ng_0ce2d870-a597-4a8d-982b-2dccdf5fda04"
      unitRef="usd">15400000</us-gaap:PaymentsToAcquireBusinessesGross>
    <icui:BusinessCombinationConsiderationHoldbackLiability
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNjkyMg_cb9021f9-4889-40d5-9b06-8d6f9759ff98"
      unitRef="usd">500000</icui:BusinessCombinationConsiderationHoldbackLiability>
    <icui:Contingentconsiderationgross
      contextRef="i0c90af4126704fd9b931fd425c90445a_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzAzOQ_3a0ab32a-b455-4197-ba5b-5f3d05891529"
      unitRef="usd">2500000</icui:Contingentconsiderationgross>
    <icui:ContingentConsiderationGrossST
      contextRef="i0c90af4126704fd9b931fd425c90445a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzA3OQ_a21666b2-407f-4c5f-a0eb-e333580d28ee"
      unitRef="usd">1000000</icui:ContingentConsiderationGrossST>
    <icui:ContingentConsiderationGrossLT
      contextRef="i0c90af4126704fd9b931fd425c90445a_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzIyNg_1be40ef8-a912-418d-b046-fee7976ea1dc"
      unitRef="usd">1500000</icui:ContingentConsiderationGrossLT>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ie3f122ddd9b745f8952af44b2b23b0cb_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80MC9mcmFnOmUwM2YzODY3ZmZiNzRmYWI4MTMyN2ZjZTA3YzM5Zjk2L3RleHRyZWdpb246ZTAzZjM4NjdmZmI3NGZhYjgxMzI3ZmNlMDdjMzlmOTZfNzQ0OA_b99b7fc9-7fa7-45d0-b2f4-129032362e60"
      unitRef="usd">17100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfMTUzNg_b88c822f-04cf-4748-b494-2d001244b2f7">Restructuring, Strategic Transaction and Integration&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Restructuring, strategic transaction and integration expenses were $13.5 million and $3.8 million for the three months ended June 30, 2022 and 2021, respectively, and $47.4 million and $6.6 million for six months ended June 30, 2022 and 2021, respectively.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the three and six months ended June 30, 2022, restructuring charges were $1.7&#160;million and $4.9&#160;million, respectively,  and were related to severance costs. Restructuring charges during the three and six months ended June 30, 2021 were not material.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity in our restructuring-related accrual by major type of cost for the period ended June&#160;30, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Severance Pay and Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retention and Facility Closure Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired restructuring liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,352)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Strategic Transaction and Integration Expenses&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;We incurred and expensed $11.8 million and $3.7 million in strategic transaction and integration expenses during the three months ended June 30, 2022 and 2021, respectively, and we incurred and expensed $42.5 million and $6.5 million in strategic transaction and integration expenses during the six months ended June 30, 2022 and 2021, respectively, which are included in restructuring, strategic transaction and integration expenses in our condensed consolidated statements of operations. The strategic transaction and integration expenses during the three and six months ended June 30, 2022 were primarily related to transaction and integration expenses associated with our acquisition of Smiths Medical on January 6, 2022 (see Note 3: Acquisitions) which primarily included legal expenses, bank fees and employee costs. The six months ended June 30, 2022 also included a United Kingdom stamp tax. The strategic transaction and integration expenses for the three and six months ended June 30, 2021 were primarily related to integration costs associated with acquisitions, the Hospira Infusion Systems ("HIS") earn-out dispute with Pfizer and one-time costs incurred to comply with regulatory initiatives.</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <icui:Restructuringstrategictransactionandintegration
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfMTM2_90c2af6d-dd2d-4b3a-9f26-6a779e00aebe"
      unitRef="usd">13500000</icui:Restructuringstrategictransactionandintegration>
    <icui:Restructuringstrategictransactionandintegration
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfMTQz_6bbd13e7-0be9-4bd1-8656-2a2743ece28e"
      unitRef="usd">3800000</icui:Restructuringstrategictransactionandintegration>
    <icui:Restructuringstrategictransactionandintegration
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfNTQ5NzU1ODE1NDQy_b866eed3-dadc-4c6f-9553-09b48bbb2f94"
      unitRef="usd">47400000</icui:Restructuringstrategictransactionandintegration>
    <icui:Restructuringstrategictransactionandintegration
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfNTQ5NzU1ODE1NDU0_eb4501c4-b83f-4c2f-b7a6-59763156b265"
      unitRef="usd">6600000</icui:Restructuringstrategictransactionandintegration>
    <us-gaap:RestructuringCosts
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfMjc5_b890bcb9-751a-405f-98c0-5850f166719f"
      unitRef="usd">1700000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfNTQ5NzU1ODE2MjQ0_74697366-c6f3-4d83-8105-f620256e2ccf"
      unitRef="usd">4900000</us-gaap:RestructuringCosts>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfMTUyOA_8349118c-6628-4983-89f8-422b919d2126">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity in our restructuring-related accrual by major type of cost for the period ended June&#160;30, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Severance Pay and Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retention and Facility Closure Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired restructuring liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,352)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="ibe03e5366a5944d9a0a9a40abcb641dc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMS0yLTEtMS04NzkzNA_192c628b-f89e-4591-b53f-0f16fd1a36f2"
      unitRef="usd">499000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i30121bdcbe2c464c8ed3b44ec7055f4b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMS02LTEtMS04NzkzNA_222edc1a-14b2-4194-9c3a-e2404c2dbdc1"
      unitRef="usd">165000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMS04LTEtMS04Nzk4Nw_10e04f63-2490-4286-91c8-ca28b0d5d859"
      unitRef="usd">664000</us-gaap:RestructuringReserve>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities
      contextRef="iebdd9a3a6a1149b18e00453de01f406d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMi0yLTEtMS04Nzk4OQ_c0803a31-f15d-4272-9d5e-99c1f9f390c0"
      unitRef="usd">5796000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities
      contextRef="i77a00ec4d4be4edfb0626ca6dc4a51d8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMi02LTEtMS04Nzk5OQ_3c613df2-542f-43ae-9988-7522573a7aed"
      unitRef="usd">1740000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities
      contextRef="i0f22c3698eff4a70b949d07786441335_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMi04LTEtMS04ODAwOQ_12004515-fab6-479b-9b11-b97ccae819c1"
      unitRef="usd">7536000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities>
    <us-gaap:RestructuringCharges
      contextRef="i2f5dcf4e8d7c447c96f6a1391e551243_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMi0yLTEtMS04NzkzNA_eb7bb672-bea3-46e6-bcfa-6513a8fd468d"
      unitRef="usd">3222000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4a9ce85809f343a4aa82fc58533ef7f7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMi02LTEtMS04NzkzNA_06f96c12-42c9-4f2e-bd39-a94d006013e1"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMy04LTEtMS04ODAxMQ_6299827a-5f38-48ab-a1d0-07a99dd2cdcb"
      unitRef="usd">3222000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i2f5dcf4e8d7c447c96f6a1391e551243_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMy0yLTEtMS04NzkzNA_a235a4dc-ba90-4121-9c6a-738d741f1bb6"
      unitRef="usd">2030000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i4a9ce85809f343a4aa82fc58533ef7f7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMy02LTEtMS04NzkzNA_aa815724-55e5-4444-abde-c05a73509b88"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNC04LTEtMS04ODAxMw_fd21dedf-5d0f-4fce-9036-312c5535df78"
      unitRef="usd">2030000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i2f5dcf4e8d7c447c96f6a1391e551243_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNC0yLTEtMS04NzkzNA_44cd60d0-5be5-44d8-8e17-df9f980821bd"
      unitRef="usd">147000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i4a9ce85809f343a4aa82fc58533ef7f7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNC02LTEtMS04NzkzNA_ab26bf68-4672-4e19-90f6-858eb9545a31"
      unitRef="usd">40000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNS04LTEtMS04ODAxNQ_ef099a22-354e-49ac-b57f-99fcae35d1e7"
      unitRef="usd">187000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="iebdd9a3a6a1149b18e00453de01f406d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNi0yLTEtMS04Nzk5Nw_56296464-dcc3-4bdf-b137-054b0cbe8bb8"
      unitRef="usd">7340000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i77a00ec4d4be4edfb0626ca6dc4a51d8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNi02LTEtMS04ODAwNw_d58a83b1-146a-4e8e-8a71-f406332ee54e"
      unitRef="usd">1865000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i0f22c3698eff4a70b949d07786441335_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNi04LTEtMS04ODAxNw_6bf5111e-4702-43b5-8575-c72e6f581c88"
      unitRef="usd">9205000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="ia97a17795307447680a6d14b0a583adb_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNi0yLTEtMS04NzkzNA_dd68f9f0-3b4b-4ac9-9ae9-5e3b8517436f"
      unitRef="usd">1710000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic6ddb824958a4849b40442c9bad27a5a_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNi02LTEtMS04NzkzNA_2fe11888-b75a-4256-bab6-591f9d1cdbc6"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNy04LTEtMS04ODAxOQ_b52cd5f6-9057-4072-8f54-4c97a70021bc"
      unitRef="usd">1710000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="ia97a17795307447680a6d14b0a583adb_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNy0yLTEtMS04NzkzNA_66feeafc-f0a6-4c02-8a51-4c0821f87d70"
      unitRef="usd">3352000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ic6ddb824958a4849b40442c9bad27a5a_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfNy02LTEtMS04NzkzNA_339dcf41-3dbe-46de-8be0-18157f48a24c"
      unitRef="usd">212000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfOC04LTEtMS04ODAxOQ_9fa782a0-40be-4cc3-b8dc-85a3c3b2df70"
      unitRef="usd">3564000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="ia97a17795307447680a6d14b0a583adb_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfOC0yLTEtMS04NzkzNA_dad4037a-3ca1-45c6-81ce-6072a73593f4"
      unitRef="usd">256000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="ic6ddb824958a4849b40442c9bad27a5a_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfOC02LTEtMS04NzkzNA_47585e28-74af-4468-8c39-99dc67f43364"
      unitRef="usd">94000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfOS04LTEtMS04ODAxOQ_9bcad69e-62fe-4a37-bfa2-44f9101f402d"
      unitRef="usd">350000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="ia97a17795307447680a6d14b0a583adb_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfOS0yLTEtMS04NzkzNA_999f24ae-8567-421e-99ea-14fce8a6e59e"
      unitRef="usd">-38000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="ic6ddb824958a4849b40442c9bad27a5a_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfOS02LTEtMS04NzkzNA_842872cd-5051-4f88-bdcb-795393a7ce4c"
      unitRef="usd">0</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMTAtOC0xLTEtODgwMTk_d4a8f6a5-0294-4b9c-b10a-079c65a9e939"
      unitRef="usd">-38000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserve
      contextRef="i6dd4e597d17447488d221348105e1bdd_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMTEtMi0xLTEtODgwMTk_4f1880c9-5f6e-43ea-ad9a-07e146cfb007"
      unitRef="usd">5404000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i512b8be12e094d459307488f3940c386_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMTEtNi0xLTEtODgwMTk_c6a66335-3d08-4d45-867f-8421ece4a8ff"
      unitRef="usd">1559000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RhYmxlOmI1ZTQ4YmQ4YmNhOTRmMTM5ZGQxZjJhM2I4MGQ4YTAxL3RhYmxlcmFuZ2U6YjVlNDhiZDhiY2E5NGYxMzlkZDFmMmEzYjgwZDhhMDFfMTEtOC0xLTEtODgwMTk_2d30147f-a43b-4fb4-b6a1-6141f15c64f7"
      unitRef="usd">6963000</us-gaap:RestructuringReserve>
    <icui:StrategicTransactionandIntegration
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfNjI4_560b3241-5732-4418-89ea-dd59fa5adbd8"
      unitRef="usd">11800000</icui:StrategicTransactionandIntegration>
    <icui:StrategicTransactionandIntegration
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfNjM1_7a025fc3-049a-4c85-89e5-6e140cf02f31"
      unitRef="usd">3700000</icui:StrategicTransactionandIntegration>
    <icui:StrategicTransactionandIntegration
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfNTQ5NzU1ODE1NjAw_8678ce6d-dc38-4c04-a166-92a0b897d5ab"
      unitRef="usd">42500000</icui:StrategicTransactionandIntegration>
    <icui:StrategicTransactionandIntegration
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80My9mcmFnOmNjZDk3NWEwZmYxODQ4ODZiZTgyNDU0NTNmZTNmZWViL3RleHRyZWdpb246Y2NkOTc1YTBmZjE4NDg4NmJlODI0NTQ1M2ZlM2ZlZWJfNTQ5NzU1ODE1NjEw_fbb0f1e2-312a-4754-8b25-1ad3250b6bd1"
      unitRef="usd">6500000</icui:StrategicTransactionandIntegration>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RleHRyZWdpb246NzRmOWI5YjEwNTkzNDdjN2JjNzJiNzE5YmViNmYzY2VfMzQxMA_f1c8dabd-856a-467c-ab6a-c03321dab7ba">Revenue&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Following our acquisition of Smiths Medical, our primary product lines are Infusion Consumables, Infusion Systems, IV Solutions, Critical Care, Infusion Systems-Smiths Medical, Vascular Access-Smiths Medical and Vital Care-Smiths Medical. The vast majority of our sales of these products are made on a stand-alone basis to hospitals and distributors. Revenue is typically recognized upon transfer of control of the products, which we deem to be at point of shipment. However, for purposes of revenue recognition for our software licenses and renewals, we consider the control of these products to be transferred to a customer at a certain point in time; therefore, we recognize revenue at the start of the applicable license term.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Payment is typically due in full within 30 days of delivery or the start of the contract term.  Revenue is recorded in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We offer certain volume-based rebates to our distribution customers, which we record as variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between the prices we charge our distribution customers and the contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts in order to determine the transaction price, we use information available at the time, including our historical experience.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;We also warranty products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available at that time and our historical experience. We also provide for extended service-type warranties, which we consider to be separate performance obligations. We allocate a portion of the transaction price to the extended service-type warranty based on its estimated relative selling price, and recognize revenue over the period the warranty service is provided. Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue disaggregated&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents our revenues disaggregated by product line (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Product line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Infusion Consumables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Infusion Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Infusion Systems-Smiths Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vascular Access-Smiths Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vital Care-Smiths Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Infusion Systems-Smiths Medical, Vascular Access-Smiths Medical and Vital Care-Smiths Medical represent our newly integrated product lines following our acquisition of Smiths Medical on January 6, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table represents our revenues disaggregated by geography (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geography&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, the Middle East and Africa&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents the changes in our contract balances for the six months ended June 30, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of acquired deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance, June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,435)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of June 30, 2022, revenue from remaining performance obligations is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Recognition Timing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&amp;lt; 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&amp;gt; 12 Months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,569)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenue*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,903)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,572)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_________________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Other deferred revenue includes pump development programs, purchased training and extended warranty.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:Revenues
      contextRef="i349a5bf778244242883e275326abbbc6_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfMi0xLTEtMS04NTQyNw_b5341d7e-2c3c-4edd-b84f-4ecfdc8e6e8c"
      unitRef="usd">144456000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia3c50f5fe7bb40ffacbf183985941a02_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfMi0zLTEtMS04NTQyNw_51e60317-8f53-4b38-b73b-92cdf7a03ad1"
      unitRef="usd">136200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic4c07ed0518e42d8a531402774100df5_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfMi01LTEtMS05MDU2MA_76efeb1c-65e5-4cde-a2e8-6356c7459a3d"
      unitRef="usd">284977000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iefd60bb319394d118b895166607b7b8d_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfMi03LTEtMS05MDU2NA_14bd50e9-f6ec-4bd9-9671-d25760919604"
      unitRef="usd">262569000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iee3b1a6579e747d2a23f2be0ea003d7c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfMy0xLTEtMS04NTQyNw_bb49e264-f410-4a15-b3fd-43251db7e756"
      unitRef="usd">87253000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i10978132bc5f4022a4c6518a79988c69_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfMy0zLTEtMS04NTQyNw_7c74f916-3cb8-4413-ae12-9fbbe54f8a56"
      unitRef="usd">84661000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2aeab60d1fcb4a7584c05d0319a0b156_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfMy01LTEtMS05MDU2MA_e71a0938-7bf6-4b89-8924-6c2159a0b36e"
      unitRef="usd">174265000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i961a96cb425c440eada93964a19186b9_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfMy03LTEtMS05MDU2NA_1e0738c0-ec18-4a6e-bc10-6841e0518573"
      unitRef="usd">168995000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibbee468195c04505b91056e9f3302922_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNC0xLTEtMS04NTQyNw_61da8917-1251-40ef-bc1f-f4df6f0fe851"
      unitRef="usd">94113000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i920322efa6a64088a2f6d5a382fc36ce_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNC0zLTEtMS04NTQyNw_5c5474b7-a860-40e8-8a3e-4e64c1711daa"
      unitRef="usd">88421000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae1bb5bb3d0f4ae98eaf40951a717632_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNC01LTEtMS05MDU2MA_7ad67ca7-41cd-4fdd-8f81-c0d5d056ae25"
      unitRef="usd">182593000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i491a4bfbfd2746e19e9d49c2c5681cee_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNC03LTEtMS05MDU2NA_9a6b90eb-d4ec-49b3-8581-811d0bf19879"
      unitRef="usd">182597000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8821ac00c20b4afc99c120d017a83ecb_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNS0xLTEtMS04NTQyNw_bedf6f74-be58-483f-8a82-13b034d6fa1d"
      unitRef="usd">12373000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i712c9670278049fc823b141f1937afa2_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNS0zLTEtMS04NTQyNw_586da575-204a-4000-8e06-dcb109f30c5a"
      unitRef="usd">12395000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id35f7bc641e64653a45020c7540094a9_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNS01LTEtMS05MDU2MA_d614ce14-89a9-4e8a-9576-adf932382368"
      unitRef="usd">24530000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i22c729de11504d73a6a77ce1d5ccc78f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNS03LTEtMS05MDU2NA_a907726b-d152-4dc0-9969-f2a640e50425"
      unitRef="usd">25562000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8bf1efd2f7fc49028373bab90caa5c99_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNi0xLTEtMS04NTQyNw_abc9e1b7-2978-4258-b813-0f8157f3d5f9"
      unitRef="usd">77812000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4ee76c84d43746a9b29b9dbe3e3cbab5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNi0zLTEtMS04NTQyNw_19a0aa0a-b3fd-4ed6-9705-db319c561241"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8c55a4b3cfe845d386e5ac7d196b83a1_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNi01LTEtMS05MDU2MA_f957e4b9-28a4-4d7a-82d2-4b1887970e3e"
      unitRef="usd">144102000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i58eace8558db4d639d849abeb781cfeb_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNi03LTEtMS05MDU2NA_b403da4c-3f06-455e-a840-be3d575cfd4f"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i77b4bc25012a43c1af56c984cacd3be8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNy0xLTEtMS04NTQyNw_ca2746f7-5f92-4c00-9a48-b9831ca1865b"
      unitRef="usd">77058000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if311b897ac014b9587d953a2b2922e0b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNy0zLTEtMS04NTQyNw_9c2c50a2-7853-4879-b3bd-82e2264d1f70"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id3ea2c1e27c94bdaa8b13528fbdb0dcb_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNy01LTEtMS05MDU2MA_a82bcea0-c210-4bd6-8155-b1f60b32fec6"
      unitRef="usd">156066000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if7c8ec6c32704111ac8f0d54f2437ec5_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfNy03LTEtMS05MDU2NA_19f2fec9-e743-4e48-b60a-e0d3fd665969"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i700cf99eae6a4036bea762420b65262e_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfOC0xLTEtMS04NTQyNw_82cec0f5-efd0-47cc-bf6f-309584ae1fa1"
      unitRef="usd">67939000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8c0e18fb79fa41c49a1d8e3564ebaf32_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfOC0zLTEtMS04NTQyNw_8f793144-6879-4d74-89de-25572d87159b"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9bedb9e9ac7948fc9e52661e267a3094_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfOC01LTEtMS05MDU2MA_d3138bd6-2844-442c-908c-ee445d3c4157"
      unitRef="usd">137593000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id3587782975144bb967dd1df75ddee2f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfOC03LTEtMS05MDU2NA_cd7ec1ea-084d-42a6-8038-9ce7d07d7e62"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfOS0xLTEtMS04NTQyNw_b5d23ed9-fda5-4c54-a7b1-181e4b49b261"
      unitRef="usd">561004000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfOS0zLTEtMS04NTQyNw_eb78bb66-83d2-4af7-90bb-54c976138192"
      unitRef="usd">321677000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfOS01LTEtMS05MDU2MA_87001daf-08ae-4a15-a19f-1ec6122e3ae3"
      unitRef="usd">1104126000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjhiZGM1MWQ1MDAzNjQ1ZWNiZTZhN2Y2OTE5NGMxZWJhL3RhYmxlcmFuZ2U6OGJkYzUxZDUwMDM2NDVlY2JlNmE3ZjY5MTk0YzFlYmFfOS03LTEtMS05MDU2NA_52df927d-8691-4fce-8f72-7cdfd0c6e058"
      unitRef="usd">639723000</us-gaap:Revenues>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RleHRyZWdpb246NzRmOWI5YjEwNTkzNDdjN2JjNzJiNzE5YmViNmYzY2VfMzQxMg_09a636fc-9b57-4dc6-97ec-6d43dca10202">The following table represents our revenues disaggregated by geography (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geography&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, the Middle East and Africa&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i7b87c8dac7974a8782e310a9135de722_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfMi0xLTEtMS04NTQyNw_03725e4e-cc74-4882-be88-a8c383ccb720"
      unitRef="usd">87415000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7260b43edc5c4f09b88e2c68f47f0400_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfMi0zLTEtMS04NTQyNw_2e6c2548-384f-4cef-94c4-0d092c3e8f79"
      unitRef="usd">37761000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib727cbf7f11a4c139194b7e121bfd07c_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfMi01LTEtMS04NTQyNw_19df7b14-4ec6-4c2c-8567-fe989b3432d2"
      unitRef="usd">173619000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8e56919e5c00481180fbdf59082fd04d_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfMi03LTEtMS04NTQyNw_c9ae281f-42a1-493d-acfc-1c21cf670ae2"
      unitRef="usd">72560000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idbc9ee3ce53e43b9a4de6b99351dbc6c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfNi0xLTEtMS04NTQyNw_29c41541-6ec4-4deb-b8d8-7a661fc4afbe"
      unitRef="usd">109723000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idd47aba974954e0781a2414535bc312d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfNi0zLTEtMS04NTQyNw_44e37ac9-22c0-4ff1-a2f4-628455d29512"
      unitRef="usd">59249000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2457c39ef148408db901026663d3bfb7_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfNi01LTEtMS04NTQyNw_3f866ae7-0deb-42cf-ab40-dbd12d34aea1"
      unitRef="usd">218850000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id767533fe49f44c4a9d6dfa028a7691f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfNi03LTEtMS04NTQyNw_84d19eca-a945-4d99-abae-495c0008aa53"
      unitRef="usd">115145000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3c248127119d40b5845f0892855f08ae_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfNy0xLTEtMS04NTQyNw_c5e417a1-cbca-4739-92de-5fa67b63f50f"
      unitRef="usd">197138000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8b13c4aa80b74968a828e6ba37616e44_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfNy0zLTEtMS04NTQyNw_43a30ba2-b39c-4a9d-aa5d-62f53aa18875"
      unitRef="usd">97010000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8435bfea45414116839eacf40cc750c4_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfNy01LTEtMS04NTQyNw_49914a0d-203e-49ec-b14d-d901205d9893"
      unitRef="usd">392469000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8fba10f79d7446689094ad47012f06b7_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfNy03LTEtMS04NTQyNw_80c338bd-44ff-46cb-8c4a-3edd080005cc"
      unitRef="usd">187705000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3de7eb8fd7af48e39044549859b11d7a_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfOC0xLTEtMS04NTQyNw_79ca8b4c-81c7-4e21-afa0-02760985223b"
      unitRef="usd">363866000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4627a160fec94c4fb9bc050310d7da34_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfOC0zLTEtMS04NTQyNw_5f7eeeb1-8a49-4e73-9cb1-19fd3822dbce"
      unitRef="usd">224667000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib2150dcd378042cdb345d5d0d362d0ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfOC01LTEtMS04NTQyNw_663a7f92-b395-484f-8c14-e15cbc03f37d"
      unitRef="usd">711657000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8494e9281e3c4b64a4ce4f950c59f2db_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfOC03LTEtMS04NTQyNw_22866126-598f-41ce-8bbf-3e654ad97426"
      unitRef="usd">452018000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfOS0xLTEtMS04NTQyNw_3f57d069-f1e9-497e-8d7e-2f58f0320477"
      unitRef="usd">561004000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfOS0zLTEtMS04NTQyNw_494b400a-e851-4d50-b17b-15a1ea7c648f"
      unitRef="usd">321677000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfOS01LTEtMS04NTQyNw_3600bad2-5f9d-4dd1-8bb6-d439c0ff8c35"
      unitRef="usd">1104126000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjBhNzZiMjBhZTgyYzRmOTJhMGE4ZmE4MDhiNjZlYjdjL3RhYmxlcmFuZ2U6MGE3NmIyMGFlODJjNGY5MmEwYThmYTgwOGI2NmViN2NfOS03LTEtMS04NTQyNw_75f27dd9-ff16-4b47-bd0f-f513fe66e4a0"
      unitRef="usd">639723000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RleHRyZWdpb246NzRmOWI5YjEwNTkzNDdjN2JjNzJiNzE5YmViNmYzY2VfMzQwNg_cabcb6e1-8ab5-4914-8aea-89e7fd8b2443">The following table presents the changes in our contract balances for the six months ended June 30, 2022 and 2021 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of acquired deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance, June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,435)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMS0xLTEtMS04NTQyNw_0cbc9d4f-4caa-4d7c-8a70-2315103a6431"
      unitRef="usd">7461000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="iad535f7eeb684a27aeb1b18c36ba3197_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMi0xLTEtMS04NTQyNw_6db06add-5395-4088-8a62-3995f7ca0124"
      unitRef="usd">51245000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i50a1c52d23e24394a0575ed9cb391bf5_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMy0xLTEtMS04NTQyNw_82505e18-15fb-4bef-9ff8-e013e97faaac"
      unitRef="usd">-14606000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="i50a1c52d23e24394a0575ed9cb391bf5_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfNC0xLTEtMS04NTQyNw_4e371b13-eb45-4767-bdba-13ed59ba9b7f"
      unitRef="usd">7349000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="if490f6070f954ef6a7b2580ba7b91d5a_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfNS0xLTEtMS04NTQyNw_54da918e-2de4-4055-933c-8d35975e0ebd"
      unitRef="usd">-8737000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="if490f6070f954ef6a7b2580ba7b91d5a_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfNi0xLTEtMS04NTQyNw_c5f1e648-0c08-4f5d-aee3-d1c6c226cceb"
      unitRef="usd">9067000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:DeferredRevenueAdditions
      contextRef="i7b423f9055fe4080a992d69631ef9969_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfNy0xLTEtMS04NTQyNw_9da301f8-3db1-4779-8aa5-ef7ecdec9fe2"
      unitRef="usd">2972000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i7b423f9055fe4080a992d69631ef9969_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfOC0xLTEtMS04NTQyNw_3f3cc33f-107b-4197-9fe9-f87ebc29bfff"
      unitRef="usd">-232000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="i288a4309c79045fab93c86aeac495b54_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfOS0xLTEtMS04NTQyNw_c9ce5628-f1b5-4ce6-bf63-b8b82005e834"
      unitRef="usd">1005000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i288a4309c79045fab93c86aeac495b54_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMTAtMS0xLTEtODU0Mjc_ac2fa007-56f6-40b1-bc08-dc65324054be"
      unitRef="usd">-2458000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMTEtMS0xLTEtODU0Mjc_1936579b-24fe-4e5b-ad41-a10732235ddd"
      unitRef="usd">53066000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i21594db97b18415da81085ad86be9dbe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMTMtMS0xLTEtODU0Mjc_73ed80ac-b3a6-4441-b769-8199804501dd"
      unitRef="usd">6430000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="id013675bfeeb448290d2bae1c0721424_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMTQtMS0xLTEtODU0Mjc_2aa1abcb-0d0c-4168-b08e-0176c1bb76a5"
      unitRef="usd">-4754000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="id013675bfeeb448290d2bae1c0721424_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMTUtMS0xLTEtODU0Mjc_ad096ea8-de2f-442c-87b1-7061dbf1a1b6"
      unitRef="usd">5435000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ib78f819fc4074defb921bd3f7e151c87_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMTYtMS0xLTEtODU0Mjc_9783ceea-f17b-4ece-8913-fd34b66c8a62"
      unitRef="usd">-4355000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="ib78f819fc4074defb921bd3f7e151c87_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMTctMS0xLTEtODU0Mjc_142833f0-47e7-4df6-b08b-38e24ffa2215"
      unitRef="usd">2212000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i55063029c0d44ea78a93faf80c101754_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOmUyMGI1MjdmZWZlYjQ2MmFiMDFlNDZkYTZiN2MxYTQwL3RhYmxlcmFuZ2U6ZTIwYjUyN2ZlZmViNDYyYWIwMWU0NmRhNmI3YzFhNDBfMTgtMS0xLTEtODU0Mjc_de3de220-ec37-40f6-b658-0851f6225cb4"
      unitRef="usd">4968000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="id2160e64516a449cbb6842e6568cca20_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfMi0xLTEtMS04NTQyNw_f750643a-72c1-4ea9-aa42-cdab82f16233"
      unitRef="usd">19744000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ibd0f6486a9914867b3cbed5c46e761c4_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfMi0zLTEtMS04NTQyNw_7f30f241-e48f-4204-a1f3-8ee3d3e20e04"
      unitRef="usd">0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i96315c122c9e477f909fef66929bc3ef_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfMy0xLTEtMS04NTQyNw_e8e1da84-068a-4453-9852-1c099413d7c5"
      unitRef="usd">7750000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i20a968e1b0184b1bb3eccc6e2daa86f6_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfMy0zLTEtMS04NTQyNw_6c5b45db-c5d7-4361-8e3c-f20083edc7b6"
      unitRef="usd">1647000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i1deebfa912054645813b6d49cf6b7ae2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfNC0xLTEtMS04NTQyNw_c1273107-f120-4c25-afe0-9b5ccc36b6d8"
      unitRef="usd">1175000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i053cf9509eae4840907fad5c27160755_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfNC0zLTEtMS04NTQyNw_0a717d84-5da1-44e9-adfa-f8fd8f4ac90c"
      unitRef="usd">13569000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i36cddf068b6e4a8597c963ee835bdc8e_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfNS0xLTEtMS04NTQyNw_215862bc-95ff-4a64-bac1-b3b28efaea9a"
      unitRef="usd">1903000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i2d633f7881b646788b8fc5ddcda35b2b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfNS0zLTEtMS04NTQyNw_34c32e8a-3506-449a-b686-d16ac82e0d4c"
      unitRef="usd">7278000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i6801313ae892411d80498d2ae6f075f6_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfNi0xLTEtMS04NTQyNw_179acb98-7871-4e9c-b8ad-9d3b99e876de"
      unitRef="usd">30572000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i9c13faab0ca94890afab0dfa9adc50c3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80Ni9mcmFnOjc0ZjliOWIxMDU5MzQ3YzdiYzcyYjcxOWJlYjZmM2NlL3RhYmxlOjRkZGU4ODQxOWM3ODQ0YTNhNGQ3OGU3ODMxNDBkODg3L3RhYmxlcmFuZ2U6NGRkZTg4NDE5Yzc4NDRhM2E0ZDc4ZTc4MzE0MGQ4ODdfNi0zLTEtMS04NTQyNw_a6954749-0ac5-479d-a80e-4ec2c8ef023f"
      unitRef="usd">22494000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RleHRyZWdpb246MGZiYmVkZjQ3NDg2NDIyMGFjMDk5NWZjYzI5NWQ4M2JfMjc3OA_74d263c8-129f-48f9-9bc4-421feeeb6231">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine if an arrangement is a lease at inception. Our operating lease assets are separately stated in operating lease right-of-use ("ROU") assets and our financing lease assets are included in other assets on our condensed consolidated balance sheets. Our lease liabilities are included in accrued liabilities and other long-term liabilities on our condensed consolidated balance sheets. We have elected not to recognize an ROU asset and lease liability for leases with terms of twelve months or less.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Lease ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Most of our leases do not provide an implicit rate, therefore we use our incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term based on the information available at commencement date. Our lease ROU assets exclude lease incentives and initial direct costs incurred. Our lease terms include options to extend when it is reasonably certain that we will exercise that option. All of our leases have &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;stated lease payments, which may include fixed rental increases. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Our leases are for corporate, research and development and sales and support offices, distribution facilities, device service centers and certain equipment. Our leases have original lease terms of one year to fifteen years, some of which include options to extend the leases for up to an additional five years. For all of our leases, we do not include optional periods of extension in our current lease terms for the exercise of options to extend is not reasonably certain.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of our lease cost (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost &#x2014; interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost &#x2014; reduction of ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense on our finance leases is included in other income (expense), net in our condensed consolidated statements of operations. The reduction of the operating and finance ROU assets is included as noncash lease expense in selling, general and administrative expenses in our condensed consolidated statements of operations.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental cash flow information related to our leases (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,323&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,847&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,929&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,009&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,491&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,971&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,420&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,980&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,335&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,710&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 30, 2022, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i097d704989b14390b8eebff2668fa80d_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RleHRyZWdpb246MGZiYmVkZjQ3NDg2NDIyMGFjMDk5NWZjYzI5NWQ4M2JfMTUxNQ_ba85247c-a071-4b60-9579-4527bcc5077b">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i8dc422a484844921bbf2f8fbbb10898d_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RleHRyZWdpb246MGZiYmVkZjQ3NDg2NDIyMGFjMDk5NWZjYzI5NWQ4M2JfMTUyMQ_e27ffa74-91c6-4a79-b0e0-4b0e5667e40b">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <icui:Optiontoextendinyears
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RleHRyZWdpb246MGZiYmVkZjQ3NDg2NDIyMGFjMDk5NWZjYzI5NWQ4M2JfMTYwMA_9ce66b75-ef82-4bd4-8e29-0d8360cf998f">P5Y</icui:Optiontoextendinyears>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RleHRyZWdpb246MGZiYmVkZjQ3NDg2NDIyMGFjMDk5NWZjYzI5NWQ4M2JfMjc4Ng_25e77204-cf47-4d57-a2c1-e88ae1379512">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of our lease cost (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost &#x2014; interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost &#x2014; reduction of ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfMi0xLTEtMS04NTQyNw_ea82e914-8ad9-4c19-91d0-ee42224be911"
      unitRef="usd">5475000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfMi0zLTEtMS04NTQyNw_8b6ad47b-ce59-46c4-89d2-0c3cd1191110"
      unitRef="usd">2822000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfMi01LTEtMS04NTQyNw_040e0059-c428-4b3f-a545-60801951a95c"
      unitRef="usd">10653000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfMi03LTEtMS04NTQyNw_eea0fd3a-2d5b-43f9-89cd-0b6ce7784889"
      unitRef="usd">5657000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfMy0xLTEtMS04NTQyNw_87d28744-65d7-4d3a-bb99-2f644111687b"
      unitRef="usd">28000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfMy0zLTEtMS04NTQyNw_9da48dc9-2234-4de8-bbac-cc8250b113fe"
      unitRef="usd">32000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfMy01LTEtMS04NTQyNw_190292b5-c81d-4f1d-a3c3-a88ef961b394"
      unitRef="usd">57000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfMy03LTEtMS04NTQyNw_49f07759-9244-448a-be58-e705864a3814"
      unitRef="usd">63000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfNC0xLTEtMS04NTQyNw_ac05b617-2ab5-4324-9388-a5ee199b9ce2"
      unitRef="usd">170000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfNC0zLTEtMS04NTQyNw_1471f3a0-9934-4a06-8e1e-04ff48922411"
      unitRef="usd">166000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfNC01LTEtMS04NTQyNw_aab7793d-f4a7-405d-90a3-40ba932e69ab"
      unitRef="usd">340000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfNC03LTEtMS04NTQyNw_f7f4b32e-ee40-4dc3-827c-aa357def078f"
      unitRef="usd">317000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:ShortTermLeaseCost
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfNS0xLTEtMS04NTQyNw_e66ed0a5-ad1a-4758-8ccb-da11f76b780d"
      unitRef="usd">3000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfNS0zLTEtMS04NTQyNw_ea608d7a-68aa-425e-8d85-4793fd45a66d"
      unitRef="usd">6000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfNS01LTEtMS04NTQyNw_97080f39-4736-44bd-b033-7ca27794d8f1"
      unitRef="usd">6000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfNS03LTEtMS04NTQyNw_76ebfff6-2330-4bfe-b8fb-a6fb177e42f7"
      unitRef="usd">9000</us-gaap:ShortTermLeaseCost>
    <us-gaap:LeaseCost
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfOC0xLTEtMS04NTQyNw_ec36d727-8617-428a-b9db-2dd1bb4048bd"
      unitRef="usd">5676000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfOC0zLTEtMS04NTQyNw_f364b914-2eac-4c2d-97b5-9fcc447a5512"
      unitRef="usd">3026000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfOC01LTEtMS04NTQyNw_322fd17d-0c27-47c7-9995-de2a0e6fe916"
      unitRef="usd">11056000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmU0YWYyYTg2NmE1NzRkNWQ4YTM0ZDIzODJmOGM3ODA4L3RhYmxlcmFuZ2U6ZTRhZjJhODY2YTU3NGQ1ZDhhMzRkMjM4MmY4Yzc4MDhfOC03LTEtMS04NTQyNw_c8f10fd8-b4b4-40ee-98e5-cad13c18c7a1"
      unitRef="usd">6046000</us-gaap:LeaseCost>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RleHRyZWdpb246MGZiYmVkZjQ3NDg2NDIyMGFjMDk5NWZjYzI5NWQ4M2JfMjc4MA_762bf5c4-e581-48cd-beb1-f0c7637cea04">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental cash flow information related to our leases (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjFiYTA0ZjE2ZTYzNzQwNTRhODg3NzZiNWU5YjYwMGIwL3RhYmxlcmFuZ2U6MWJhMDRmMTZlNjM3NDA1NGE4ODc3NmI1ZTliNjAwYjBfMy0xLTEtMS04NTQyNw_15df0805-05a9-463e-ae86-6d12160e00ad"
      unitRef="usd">12887000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjFiYTA0ZjE2ZTYzNzQwNTRhODg3NzZiNWU5YjYwMGIwL3RhYmxlcmFuZ2U6MWJhMDRmMTZlNjM3NDA1NGE4ODc3NmI1ZTliNjAwYjBfMy0zLTEtMS04NTQyNw_43b73c79-a80c-4225-94ad-2dbf294f52e6"
      unitRef="usd">5657000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjFiYTA0ZjE2ZTYzNzQwNTRhODg3NzZiNWU5YjYwMGIwL3RhYmxlcmFuZ2U6MWJhMDRmMTZlNjM3NDA1NGE4ODc3NmI1ZTliNjAwYjBfNC0xLTEtMS04NTQyNw_47c78679-ae27-4a83-b313-98d8fe4bea29"
      unitRef="usd">57000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjFiYTA0ZjE2ZTYzNzQwNTRhODg3NzZiNWU5YjYwMGIwL3RhYmxlcmFuZ2U6MWJhMDRmMTZlNjM3NDA1NGE4ODc3NmI1ZTliNjAwYjBfNC0zLTEtMS04NTQyNw_857ec3d8-5c41-430c-a029-6d1638eab3ba"
      unitRef="usd">63000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjFiYTA0ZjE2ZTYzNzQwNTRhODg3NzZiNWU5YjYwMGIwL3RhYmxlcmFuZ2U6MWJhMDRmMTZlNjM3NDA1NGE4ODc3NmI1ZTliNjAwYjBfNy0xLTEtMS04NTQyNw_5d54c48f-d7f5-4c37-a603-8d1dd0925af9"
      unitRef="usd">3829000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjFiYTA0ZjE2ZTYzNzQwNTRhODg3NzZiNWU5YjYwMGIwL3RhYmxlcmFuZ2U6MWJhMDRmMTZlNjM3NDA1NGE4ODc3NmI1ZTliNjAwYjBfNy0zLTEtMS04NTQyNw_d36014e8-01e9-4e3d-ba69-903ee8a1cf3e"
      unitRef="usd">1282000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjFiYTA0ZjE2ZTYzNzQwNTRhODg3NzZiNWU5YjYwMGIwL3RhYmxlcmFuZ2U6MWJhMDRmMTZlNjM3NDA1NGE4ODc3NmI1ZTliNjAwYjBfOC0xLTEtMS04NTQyNw_8251b613-7140-4dbc-976f-a50c2f37ab9d"
      unitRef="usd">38000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjFiYTA0ZjE2ZTYzNzQwNTRhODg3NzZiNWU5YjYwMGIwL3RhYmxlcmFuZ2U6MWJhMDRmMTZlNjM3NDA1NGE4ODc3NmI1ZTliNjAwYjBfOC0zLTEtMS04NTQyNw_660d0504-c740-4fd9-acbc-d5a86fb74d94"
      unitRef="usd">332000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <icui:AssetsandLiabilitiesLeasesTableTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RleHRyZWdpb246MGZiYmVkZjQ3NDg2NDIyMGFjMDk5NWZjYzI5NWQ4M2JfMjc3Ng_46d627f1-27d3-47f9-a970-2d7e573b8105">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,323&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,847&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,929&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,009&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,491&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,971&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,420&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,980&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,335&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,710&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</icui:AssetsandLiabilitiesLeasesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfMy0xLTEtMS04NTQyNw_48877f3f-8254-4bbc-af89-4ea3d7b587d5"
      unitRef="usd">83323000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfMy0zLTEtMS04NTQyNw_4cb1fd0f-216a-405e-8cc8-c90d143a5e7d"
      unitRef="usd">39847000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfNS0xLTEtMS04NTQyNw_f22e9ce9-46dc-4dbf-b725-1c5d01ee7b84"
      unitRef="usd">19929000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfNS0zLTEtMS04NTQyNw_2838fdc6-b29f-4b1f-8c28-0684a5c516aa"
      unitRef="usd">9009000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfNi0xLTEtMS04NTQyNw_a2fe1444-0c3a-4af7-8259-6b99aae61c1a"
      unitRef="usd">68491000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfNi0zLTEtMS04NTQyNw_e4e7765a-2d9c-4a47-a6d5-baa220364143"
      unitRef="usd">33971000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfNy0xLTEtMS04NTQyNw_6d27c046-c264-4395-b4e4-c3e66a78e5e0"
      unitRef="usd">88420000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfNy0zLTEtMS04NTQyNw_10095220-0c91-4f44-b0fe-1df6ece3d10e"
      unitRef="usd">42980000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfMTAtMS0xLTEtODU0Mjc_bbc27a88-b55c-4bb1-976d-9b37839ee0ae">P6Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfMTAtMy0xLTEtODU0Mjc_b34813dd-3a48-484b-8302-823a53022682">P5Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfMTMtMS0xLTEtODU0Mjc_3fedb92b-0708-4fcb-85fb-4e4452719bf2"
      unitRef="number">0.0439</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOjY1ZWM2ODI5NDA1MDRjYzk5MTBmMjFiNWFhYjA1ODExL3RhYmxlcmFuZ2U6NjVlYzY4Mjk0MDUwNGNjOTkxMGYyMWI1YWFiMDU4MTFfMTMtMy0xLTEtODU0Mjc_42d7d1f0-e390-425d-95d3-93cc53a5f7bc"
      unitRef="number">0.0498</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfMy0xLTEtMS04NTQyNw_5c8f88fd-c853-4927-88fb-a0b779133eb2"
      unitRef="usd">2335000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfMy0zLTEtMS04NTQyNw_1135b702-da22-4b5f-9c6f-ec7781fdfcc2"
      unitRef="usd">2673000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfNS0xLTEtMS04NTQyNw_0f1a3807-e8d2-479b-87f3-648b24a34d47"
      unitRef="usd">650000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfNS0zLTEtMS04NTQyNw_e616dc3e-168c-4ba2-9901-fb61734fc9e5"
      unitRef="usd">643000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfNi0xLTEtMS04NTQyNw_39d6a6cd-44ae-4afd-beab-caf472fdd40f"
      unitRef="usd">1741000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfNi0zLTEtMS04NTQyNw_2206edc1-7e6f-47b0-a43a-cdaa6d31e8d3"
      unitRef="usd">2067000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfNy0xLTEtMS04NTQyNw_70c41b7a-3c9c-4e3b-b248-f9569e7c2ac3"
      unitRef="usd">2391000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfNy0zLTEtMS04NTQyNw_d7051fa7-67df-4ddc-a822-f99539a412e8"
      unitRef="usd">2710000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfMTAtMS0xLTEtODU0Mjc_e8a39cdb-2bff-4d9f-b501-88d74384352a">P5Y3M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfMTAtMy0xLTEtODU0Mjc_16ddbc9a-6378-4cf3-8ba8-b7ea86933230">P5Y7M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfMTMtMS0xLTEtODU0Mjc_13f373a4-fea3-4ee9-a8a2-8acde8525704"
      unitRef="number">0.0427</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmNmMjZkZWQ0MmFlMTQwMWFhNzJmOWU1YzMwMWE5NGNjL3RhYmxlcmFuZ2U6Y2YyNmRlZDQyYWUxNDAxYWE3MmY5ZTVjMzAxYTk0Y2NfMTMtMy0xLTEtODU0Mjc_6a1338da-d1bf-45e2-a2fe-a815daf7ff18"
      unitRef="number">0.0428</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RleHRyZWdpb246MGZiYmVkZjQ3NDg2NDIyMGFjMDk5NWZjYzI5NWQ4M2JfMjc3Mg_63c4dcdf-cd7d-4f23-9be7-375d7e1f373a">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 30, 2022, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfMS0xLTEtMS04NTQyNw_6cd9045b-c561-4853-8edb-224121e6f42e"
      unitRef="usd">12546000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfMS0zLTEtMS04NTQyNw_4a935ad6-153f-4402-9466-c081fca7c46e"
      unitRef="usd">371000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfMi0xLTEtMS04NTQyNw_93976c0d-cc2e-497d-b085-3441dfe52bda"
      unitRef="usd">21260000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfMi0zLTEtMS04NTQyNw_53f65113-6928-4480-ba44-e6866c2dfab6"
      unitRef="usd">742000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfMy0xLTEtMS04NTQyNw_2a97fc8a-24ed-4dc4-920c-66effcfdf1cd"
      unitRef="usd">17283000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfMy0zLTEtMS04NTQyNw_648f127c-2969-436f-be08-80deda0ce203"
      unitRef="usd">459000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfNC0xLTEtMS04NTQyNw_b11aee87-32f5-4916-bfa3-d9b483169ea6"
      unitRef="usd">12361000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfNC0zLTEtMS04NTQyNw_cfbd12a5-7d7b-43d7-bcea-e8e0ff55cf1e"
      unitRef="usd">273000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfNS0xLTEtMS04NTQyNw_dc163015-f667-4a22-a134-a440a14de9b8"
      unitRef="usd">10574000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfNS0zLTEtMS04NTQyNw_ec632348-a6b9-4597-8c1e-9f4bfee297bc"
      unitRef="usd">216000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfNi0xLTEtMS04NTQyNw_66e46c0d-78e5-454d-befe-31dc92824a93"
      unitRef="usd">8128000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfNi0zLTEtMS04NTQyNw_49c71eac-7853-482f-9861-9d594c05db63"
      unitRef="usd">189000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfNy0xLTEtMS04NTQyNw_a2dfd849-b9a7-496b-91a6-ffd96699d463"
      unitRef="usd">17500000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfNy0zLTEtMS04NTQyNw_022a8514-1e82-445b-b447-ba80fdb0d7c6"
      unitRef="usd">426000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfOC0xLTEtMS04NTQyNw_5f312b2d-aff1-474b-8559-b4db2adb1e2b"
      unitRef="usd">99652000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfOC0zLTEtMS04NTQyNw_a20a233d-3c86-4c8b-91a2-520c30e0faec"
      unitRef="usd">2676000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfOS0xLTEtMS04NTQyNw_d0ec20f8-6e12-465d-951a-31b72e3bef3b"
      unitRef="usd">11232000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfOS0zLTEtMS04NTQyNw_a97d360b-5bdc-4990-858a-3ca1ef219152"
      unitRef="usd">285000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfMTAtMS0xLTEtODU0Mjc_57ae2c9e-d609-48e9-8e5d-520b4d64e2d0"
      unitRef="usd">88420000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV80OS9mcmFnOjBmYmJlZGY0NzQ4NjQyMjBhYzA5OTVmY2MyOTVkODNiL3RhYmxlOmRlMDBkZDk0NDNiNzQyYWE5YTAwOWJlNjdiYjczNjUzL3RhYmxlcmFuZ2U6ZGUwMGRkOTQ0M2I3NDJhYTlhMDA5YmU2N2JiNzM2NTNfMTAtMy0xLTEtODU0Mjc_2ee64cc3-f125-47e3-aa97-f4268245e8b6"
      unitRef="usd">2391000</us-gaap:FinanceLeaseLiability>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RleHRyZWdpb246OTVkNjkyYTM1ZDA0NDIxYTkwZWJlNzkzYTI5NzViNDlfMTQwOQ_1a066a52-50a4-4d74-a5e2-78411d8ea218">Net Income Per Share&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period plus dilutive securities. Dilutive securities include outstanding common stock options and unvested restricted stock units, less the number of shares that could have been purchased with the proceeds from the exercise of the options, using the treasury stock method. Options and restricted stock units that are anti-dilutive are not included in the treasury stock method calculation. Due to the net loss for the three and six months ended June 30 2022, any potentially common shares were not included in the computation of diluted earnings per share as they would have had an anti-dilutive effect, therefore basic and diluted net loss per share are equal for the period. There were 12,107 and 12,080 anti-dilutive securities for the three and six months ended June 30, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents the calculation of net earnings per common share (&#x201c;EPS&#x201d;) &#x2014; basic and diluted (in thousands, except per share data):&#160; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,474)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares outstanding (basic)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common and common equivalent shares outstanding (diluted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS &#x2014; diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;No dilutive effect for the three and six months ended June 30, 2022;  therefore, zero incremental shares included for the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RleHRyZWdpb246OTVkNjkyYTM1ZDA0NDIxYTkwZWJlNzkzYTI5NzViNDlfOTkw_98497284-c5ed-49bf-927f-607ef3d660d9"
      unitRef="shares">12107</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RleHRyZWdpb246OTVkNjkyYTM1ZDA0NDIxYTkwZWJlNzkzYTI5NzViNDlfOTk3_4bfe432f-7a3c-428c-9bce-ff04d3162a83"
      unitRef="shares">12080</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RleHRyZWdpb246OTVkNjkyYTM1ZDA0NDIxYTkwZWJlNzkzYTI5NzViNDlfMTQwMg_33abbb8f-6155-4a2a-a8e8-a56768877aa6">The following table presents the calculation of net earnings per common share (&#x201c;EPS&#x201d;) &#x2014; basic and diluted (in thousands, except per share data):&#160; &lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,474)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares outstanding (basic)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common and common equivalent shares outstanding (diluted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS &#x2014; diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;No dilutive effect for the three and six months ended June 30, 2022;  therefore, zero incremental shares included for the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfMi0xLTEtMS04NTQyNw_256965ba-9715-42a6-bb7c-f6e33bf4a9d8"
      unitRef="usd">-7474000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfMi0zLTEtMS04NTQyNw_57fe10a4-fbab-40e5-a0ca-ea10e49d8498"
      unitRef="usd">28398000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfMi01LTEtMS04NTQyNw_b1817e2d-c3df-4c75-9e35-c71577c303f9"
      unitRef="usd">-45542000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfMi03LTEtMS04NTQyNw_31371ac2-6cd6-4ec2-9eb5-219ec19cabe1"
      unitRef="usd">52129000</us-gaap:ProfitLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfMy0xLTEtMS04NTQyNw_63f4b6ae-4a4e-4442-aa23-46c76c1d2d81"
      unitRef="shares">23897000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfMy0zLTEtMS04NTQyNw_7dc67316-042c-4395-acf2-f2bbd2ea49e4"
      unitRef="shares">21200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfMy01LTEtMS04NTQyNw_4726efc8-02c1-4fad-9e8c-8f36a8f9fe10"
      unitRef="shares">23787000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfMy03LTEtMS04NTQyNw_9dec3e7d-9a88-4f25-9611-6c294d0a54d0"
      unitRef="shares">21176000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNC0xLTEtMS04NTQyNw_930c83af-e89e-438f-92ad-1b82f8b63f31"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNC0zLTEtMS04NTQyNw_cd9a6fb1-4de4-4c20-b3de-2e610b3c0a2f"
      unitRef="shares">503000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNC01LTEtMS04NTQyNw_b7d842c9-67bc-4257-988f-63d11182f43e"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNC03LTEtMS04NTQyNw_d7b5b2d8-0732-4d09-a788-d5cce1498c52"
      unitRef="shares">542000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNS0xLTEtMS04NTQyNw_9dac36d3-6e97-4c6a-81ba-0f45c4602294"
      unitRef="shares">23897000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNS0zLTEtMS04NTQyNw_41381648-f09c-4241-a5dd-84f93556c66a"
      unitRef="shares">21703000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNS01LTEtMS04NTQyNw_cd305ef7-c73e-462d-a3a8-c8d575a3ab1d"
      unitRef="shares">23787000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNS03LTEtMS04NTQyNw_75ce3419-d5d2-4cb4-83ef-bcfbe31ac138"
      unitRef="shares">21718000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNi0xLTEtMS04NTQyNw_61d955e9-61a4-4ab0-80a8-d63129757838"
      unitRef="usdPerShare">-0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNi0zLTEtMS04NTQyNw_c51ba753-f611-4921-96b0-084768785567"
      unitRef="usdPerShare">1.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNi01LTEtMS04NTQyNw_4117a0bf-fb48-4336-974c-a13222568f08"
      unitRef="usdPerShare">-1.91</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNi03LTEtMS04NTQyNw_bcbafbfc-bf5d-4867-a2b5-433d68795084"
      unitRef="usdPerShare">2.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNy0xLTEtMS04NTQyNw_75a26f61-842b-4541-91bd-48bca22ce41f"
      unitRef="usdPerShare">-0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNy0zLTEtMS04NTQyNw_3f3304c0-dc4a-4881-b79e-a4665b631f1f"
      unitRef="usdPerShare">1.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNy01LTEtMS04NTQyNw_92950e01-8ac7-46ac-ab13-95ff2beb032e"
      unitRef="usdPerShare">-1.91</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81Mi9mcmFnOjk1ZDY5MmEzNWQwNDQyMWE5MGViZTc5M2EyOTc1YjQ5L3RhYmxlOjdmMmY0ZWI2MThiZDQ4YjZiNmNiM2U1ZjEyOWQxNTQ0L3RhYmxlcmFuZ2U6N2YyZjRlYjYxOGJkNDhiNmI2Y2IzZTVmMTI5ZDE1NDRfNy03LTEtMS04NTQyNw_11579d77-4212-4022-a7de-e285e2228a09"
      unitRef="usdPerShare">2.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNTk2Nw_4d959adb-89f6-4d8a-b928-ea553f5d5f88">Derivatives and Hedging Activities&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hedge Accounting and Hedging Program&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The purposes of our cash flow hedging programs are to manage the foreign currency exchange rate risk on forecasted revenues and expenses denominated in currencies other than the functional currency of the operating unit, and to manage floating interest rate risk associated with future interest payments on the variable-rate term loans issued in January 2022. We do not issue derivatives for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions. The derivative instruments we utilize, including various foreign exchange contracts and interest rate swaps, are designated and qualify as cash flow hedges. Our derivative instruments are recorded at fair value on the condensed consolidated balance sheets and are classified based on the instrument's maturity date. We record gains or losses from changes in the fair values of the derivative instruments as a component of other comprehensive income (loss) and we reclassify those gains or losses into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. If the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, we reclassify the gain or loss on the related derivative instrument from accumulated other comprehensive loss into earnings immediately.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Exchange Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Exchange Forward Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into foreign exchange forward contracts to hedge a portion of our forecasted foreign currency-denominated revenues and expenses to minimize the effect of foreign exchange rate movements on the related cash flows. These contracts are agreements to buy or sell a quantity of a currency at a predetermined future date and at a predetermined exchange rate. Our foreign exchange forward contracts hedge exposures principally denominated in Mexican Pesos ("MXN"), Euros, Czech Koruna ("CZK"), Japanese Yen ("JPY"), U.S. Dollar ("USD") and Chinese Renminbi ("CNH") and have varying maturities with an average term of approximately twelve months. The total notional amount of these outstanding derivative contracts as of June&#160;30, 2022 was $209.2&#160;million, which included the notional equivalent of $43.1&#160;million in MXN, $39.7&#160;million in Euros, $18.3&#160;million in CZK, $18.8&#160;million in JPY, $19.3&#160;million in CNH, $36.3&#160;million in USD and $33.9&#160;million in other foreign currencies, with terms currently through July 2023. We did not have such derivative contracts as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cross-currency Par Forward Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into cross-currency par forward contracts to hedge a portion of our Mexico forecasted expenses denominated in MXN. These contracts are agreements to exchange cash flows from one currency to another at specified intervals over the contract term with all exchanges occurring at the same predetermined rate. In November 2021, we entered into a one-year cross-currency par forward contract with a term from December 1, 2021 to December 1, 2022. The total notional amount of this outstanding derivative as of June&#160;30, 2022 and December 31, 2021 was approximately 208.2 million MXN and 413.1&#160;million MXN, respectively. The derivative instrument matures in equal monthly amounts at a fixed forward rate of 21.60 MXN/USD. Preceding this contract we had a one-year cross-currency par forward contract with a term from November 3, 2020 to December 1, 2021 that matured in equal monthly amounts at a fixed forward rate of 24.26 MXN/USD.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Floating Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, in anticipation of entering into the new senior secured credit facilities in January 2022, which includes a variable-rate term loan A and a variable-rate term loan B (see Note 17: Long-Term Debt), we entered into two forward-starting interest rate swaps. In February 2022, certain terms under the agreements were amended to reflect the transition from LIBOR to the Secured Overnight Financing Rate ("SOFR"), an alternative reference rate. Under the interest rate swap agreements we exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount. Effective March 30, 2022, the term loan A swap, as amended, has an initial notional amount of $300.0&#160;million, reducing to $150.0&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2027. We will pay a fixed rate of 1.32% and will receive the greater of 3-month USD SOFR or (0.15)%. Effective March 30, 2022, the term loan B swap, as amended, has an initial notional amount of $750.0&#160;million, reducing to $46.9&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2026. We will pay a fixed rate of 1.17% and will receive the greater of 3-month USD SOFR or 0.35%. These swaps effectively convert the relevant portion of the floating-rate term loans to fixed rates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the fair values of our derivative instruments included within the Condensed Consolidated Balance Sheets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Cash Flow Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Condensed Consolidated Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Exchange Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized the following gains on our derivative instruments designated as cash flow hedges (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Derivatives designated as cash flow hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as cash flow hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Reclassified From Accumulated Other Comprehensive (Loss) Income into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Gain (Loss) Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Derivatives designated as cash flow hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as cash flow hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Represents location of gain reclassified from accumulated other comprehensive income into income as a result that a forecasted transaction is no longer probable of occurring.&lt;/span&gt;&lt;/div&gt;As of June&#160;30, 2022, we expect an estimated $8.5&#160;million in deferred gains on the outstanding foreign exchange contracts and an estimated $15.7&#160;million in deferred gains on the interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMjM3MA_f4ce09dc-b731-4a1a-bb86-5b6abdef84f9"
      unitRef="usd">209200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i553b9c6ad3c74f348590e3901e6e1b17_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMjQxNg_659c3996-98be-4bd4-88e0-f58edfcb2edd"
      unitRef="usd">43100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="idf36e1c35c0a471f9a34f9aed4cbef39_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMjQzNw_1a0333fd-ddfa-41e2-82e6-f3cfa1f7ebfa"
      unitRef="usd">39700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i028128b1abf446339af1e589f519b8d9_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMjQ1MA_7f01ba0f-3578-4d54-ac77-0d3e47bcf501"
      unitRef="usd">18300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5248e92406ce4b4b8dd1c3ea4e3ec5e0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMjQ3MA_fa873337-0a26-4175-9150-91ead0d6ffd1"
      unitRef="usd">18800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6b6271edab564d0d9a598187c3a83a1b_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNTQ5NzU1ODIwMjA5_8bd0103d-bf02-4c3d-8049-18fadc96d052"
      unitRef="usd">19300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ife89df7388b14e7cb238bfad25c03b9f_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNTQ5NzU1ODIwMjI0_22428ba4-d744-4c49-b4e2-cd4122f86d6f"
      unitRef="usd">36300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i64b799c44978482fb2ff58859d2765f8_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMjQ5Mw_70230e9d-0685-49b8-ab47-dcee5f296c0f"
      unitRef="usd">33900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ice7c1260b0af4402ab4a9770171b528b_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMzI0NQ_31297fdb-b44c-4a43-ba1a-81f564191232"
      unitRef="mxn">208200000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i2c64e77d7d424ea9a38c6d4686e8b917_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMzI1Ng_e3e596c1-13ed-44ec-bb32-55c06bd3a94b"
      unitRef="mxn">413100000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeForwardExchangeRate1
      contextRef="ice7c1260b0af4402ab4a9770171b528b_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMzM2NA_50e4c052-c92b-4f1e-a38d-642ea7478be2"
      unitRef="number">21.60</us-gaap:DerivativeForwardExchangeRate1>
    <us-gaap:DerivativeForwardExchangeRate1
      contextRef="i8409b01efbb64d52a8e1b1ba086f135b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfMzU3Mw_eece240f-cfc8-4d49-9d3b-16aa21326e74"
      unitRef="number">24.26</us-gaap:DerivativeForwardExchangeRate1>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i55561adaa418415b8dbb5d994e03b04a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNDM2MQ_81673b57-03cb-4785-97ab-397aaf63fb5d"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <icui:InterestRateSwapEndingNotionalValue
      contextRef="i55561adaa418415b8dbb5d994e03b04a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNDM3Nw_8391bb66-57a1-4873-83f8-b0c0793ce482"
      unitRef="usd">150000000</icui:InterestRateSwapEndingNotionalValue>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i55561adaa418415b8dbb5d994e03b04a_I20220630"
      decimals="6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNDQ4NA_bed24950-dee4-4f99-b890-8bd667ab8c6c"
      unitRef="number">0.0132</us-gaap:DerivativeFixedInterestRate>
    <icui:DerivativeVariableRateFloor
      contextRef="i55561adaa418415b8dbb5d994e03b04a_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNDUzOQ_d1d8730b-30fe-4281-add8-285da5c052a3"
      unitRef="number">-0.0015</icui:DerivativeVariableRateFloor>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i19fbaecc04d148dd8a7958cc6db4d311_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNDYzNw_864e9765-cf63-413d-bfe3-314559e4a732"
      unitRef="usd">750000000</us-gaap:DerivativeNotionalAmount>
    <icui:InterestRateSwapEndingNotionalValue
      contextRef="i19fbaecc04d148dd8a7958cc6db4d311_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNDY1Mw_9b268b46-a76d-4118-b2c2-224b6a50110c"
      unitRef="usd">46900000</icui:InterestRateSwapEndingNotionalValue>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i19fbaecc04d148dd8a7958cc6db4d311_I20220630"
      decimals="6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNDc2MA_fff0aa17-d80d-444a-bfa0-9280c0c6662d"
      unitRef="number">0.0117</us-gaap:DerivativeFixedInterestRate>
    <icui:DerivativeVariableRateFloor
      contextRef="i19fbaecc04d148dd8a7958cc6db4d311_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNDgxNQ_d04f882b-738f-4d19-9ead-8f706c116821"
      unitRef="number">0.0035</icui:DerivativeVariableRateFloor>
    <us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNTk1Mw_7fde67f7-a6d7-4a18-8e68-dd110c8b0edc">The following table presents the fair values of our derivative instruments included within the Condensed Consolidated Balance Sheets (in thousands):&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Cash Flow Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Condensed Consolidated Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Exchange Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized the following gains on our derivative instruments designated as cash flow hedges (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Derivatives designated as cash flow hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as cash flow hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):</us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="ib22458f807284867a571b93988d38746_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNC0yLTEtMS04NTQyNw_f5acea91-536b-4d75-b16a-7ef5aa610271"
      unitRef="usd">9463000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i5f054f416194468e9358fe16a192fca7_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNC00LTEtMS04NTQyNw_e68f4496-be82-4a00-8871-706f4f579788"
      unitRef="usd">15407000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="if944aaea429e473cb610016ebaa83d93_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNC02LTEtMS04NTQyNw_83474f5c-5f24-4b06-a5dc-f551880f4f4e"
      unitRef="usd">24870000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="i2e2c0ba582504cc48fcbbe00aa935289_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNS0yLTEtMS04NTQyNw_363eec8c-0cd9-480f-aad1-c1a327bf586b"
      unitRef="usd">112000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="ie49637e4065640909d80091d4f51b5e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNS00LTEtMS04NTQyNw_844c77cb-f5d1-4b3b-bc00-2288e617a5e8"
      unitRef="usd">23834000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="ib6c822cbb6204a8fbc869b98546fc0a9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNS02LTEtMS04NTQyNw_acd3c730-9dbd-48c3-b97e-c656b9f3a75f"
      unitRef="usd">23946000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssets
      contextRef="ia88b203034af462ba59ce8d2a771f6a4_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNi0yLTEtMS04NTQyNw_6c12d581-8bde-44de-9ef4-6f6fb21b3ab5"
      unitRef="usd">9575000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i30640c390ffe4ca3bbe943506380dba9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNi00LTEtMS04NTQyNw_93af4ac5-7114-4b48-b0f2-ed0f21a5ae6e"
      unitRef="usd">39241000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfNi02LTEtMS04NTQyNw_0909cba1-1580-44b7-81f0-ff4b282d65c3"
      unitRef="usd">48816000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i3055adfcb5fa4b46a0af772247ae8ab3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfOC0yLTEtMS04NTQyNw_17086cfe-b5be-47a9-bdd4-4b4ee7ca9601"
      unitRef="usd">577000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="ia5ed44f463b34b44bccf081e0e44d41f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfOC00LTEtMS04NTQyNw_3eefb8f7-7cec-4ef7-bde3-a791bcd6d74e"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="iac7fe1e5d9204ae3b38fd2c49a0a6e89_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfOC02LTEtMS04NTQyNw_2909b4af-b465-470c-ba12-0e649ad11a7e"
      unitRef="usd">577000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="ia6f8316a6a9c4c7b91a059642a5d585a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfOS0yLTEtMS04NTQyNw_ba060b5b-677a-4dc4-9f63-701b572a15e2"
      unitRef="usd">50000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i835758b56b034a758a8a1945eb8fc86a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfOS00LTEtMS04NTQyNw_a158ff7e-d919-4e86-a234-c5ef095d340a"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="iea1b1e213c5e4dee964f3d2dcaa7b6c7_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfOS02LTEtMS04NTQyNw_10d56fa2-42cd-4855-b428-befca239f131"
      unitRef="usd">50000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilities
      contextRef="ia88b203034af462ba59ce8d2a771f6a4_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTAtMi0xLTEtODU0Mjc_53cf136f-8a6c-4773-95e6-0424323a0ae5"
      unitRef="usd">627000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i30640c390ffe4ca3bbe943506380dba9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTAtNC0xLTEtODU0Mjc_f75cae5e-d314-4aaf-b34f-36f9032a6c49"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTAtNi0xLTEtODU0Mjc_2db4f454-629f-4403-94f7-bf491f8bfaf8"
      unitRef="usd">627000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i1440f9c7c021440dbd8518b33fc69b16_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTMtMi0xLTEtODU0Mjc_0d9d1599-4b9e-4a2d-9f2d-e1644bf80438"
      unitRef="usd">1061000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="ia03482d0fb2b4cb88ba9ce3d231c7823_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTMtNC0xLTEtODU0Mjc_1a21f524-ed72-446e-b428-1f44a4c46511"
      unitRef="usd">0</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="ibcc8fe10383a4514ae5fb955ea53cee7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTMtNi0xLTEtODU0Mjc_5046c209-8498-4dc5-9b58-2c377330dd58"
      unitRef="usd">1061000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="ic437309b851c4a58af26fe68c63fb604_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTQtMi0xLTEtODU0Mjc_a96d4d60-4ce8-4e24-bc0b-c0feb757801d"
      unitRef="usd">0</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="i9410778f607e40788f828c216003f59c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTQtNC0xLTEtODU0Mjc_c0d87923-06a3-4752-b46f-6473c6fc1555"
      unitRef="usd">0</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="i36babf8d7dfd41d181155b5c382f90ce_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTQtNi0xLTEtODU0Mjc_78d353e6-58a7-4a6f-9860-e5388725a250"
      unitRef="usd">0</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssets
      contextRef="i3b64e553997e42bfa00e761e1f1423e1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTUtMi0xLTEtODU0Mjc_67576db6-7b3b-46f9-89ea-aaa0af219188"
      unitRef="usd">1061000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ifa0f2e530a594d488d3ff7ff069e9259_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTUtNC0xLTEtODU0Mjc_a9d3e67c-f7d5-49a1-92c2-995e1f5f7b05"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTUtNi0xLTEtODU0Mjc_bd62533d-7ee8-4b8b-87f0-662fe05b2537"
      unitRef="usd">1061000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i9a827026c8f345f481b0f331dcd5ab32_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTctMi0xLTEtODU0Mjc_47ee5466-4ae5-4392-8fb4-cd823a94f476"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="ie10e3fd3b1274966991829e8a47fb1c2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTctNC0xLTEtODU0Mjc_628835fc-2da1-4bb9-bf58-53fcc1043ebb"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="ic0057918c4754ed39cdcb09ec091a595_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTctNi0xLTEtODU0Mjc_268d8bb1-d16b-4c60-acda-8793c931206c"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="ib1083c069125426aaf5b7d941291660b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTgtMi0xLTEtODU0Mjc_27a2494e-5709-45e4-baf1-b05d8d997577"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i33a3cf5799fb4e7697ec6da3105f357e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTgtNC0xLTEtODU0Mjc_6561d436-d993-4a03-90b0-3a61fbefbea8"
      unitRef="usd">1480000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i7eba8aa425b64fd29a1360ccd19218c4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTgtNi0xLTEtODU0Mjc_ca0c8fc1-6335-4113-920e-45ad6a136c59"
      unitRef="usd">1480000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilities
      contextRef="i3b64e553997e42bfa00e761e1f1423e1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTktMi0xLTEtODU0Mjc_a5d10a39-b063-476c-afc8-07f3bb9816b2"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ifa0f2e530a594d488d3ff7ff069e9259_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTktNC0xLTEtODU0Mjc_9ecfc897-84c4-4633-b645-edd929c1dc24"
      unitRef="usd">1480000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmZmYmQ0OTkzMWI3MTQ5ZWFhOTNmM2M1N2U5NmM5MTZmL3RhYmxlcmFuZ2U6ZmZiZDQ5OTMxYjcxNDllYWE5M2YzYzU3ZTk2YzkxNmZfMTktNi0xLTEtODU0Mjc_3083dd82-a99b-40cc-a615-e2470ba46b7d"
      unitRef="usd">1480000</us-gaap:DerivativeLiabilities>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i2ef45ebfcb134a09b0559c70de16d1c2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNS0yLTEtMS04NTQyNw_3499c9af-307c-4ac8-8e0d-4a3adb6f02fe"
      unitRef="usd">5225000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="ie350394256c849be935f6f7e19ce7ae1_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNS00LTEtMS04NTQyNw_e523c9b2-8349-4c5d-a3b7-11fa2d7d6488"
      unitRef="usd">441000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i25a9e2b857e94469b5a51e1bd32d2292_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNC02LTEtMS05MDU3OA_e240bd99-cb7a-4499-a726-9c1b709a6298"
      unitRef="usd">8337000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i9ca9c6f83f3d4ea38a171209da718f73_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNC04LTEtMS05MDU4MA_35c665da-1b8c-4a66-8d4d-04d369e34c42"
      unitRef="usd">39000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i6be297d6f8ec4c55a99cf8bffc94a709_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNi0yLTEtMS04NTQyNw_11e3be45-c070-4f17-bbe2-169061b08900"
      unitRef="usd">9146000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="id416d1da99e846e3aaa8a4ffd93c3dc0_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNi00LTEtMS04NTQyNw_5c5368f1-181a-4b38-baa0-d2e7b9c6f3ac"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="ie64ccbe5cd244a88a92378e31ed3beea_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNS02LTEtMS05MDU3OA_c36f25ca-3564-4c7e-a8c2-0e7ef0b64508"
      unitRef="usd">39197000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i6ad63d7dee5443088e6be3aff832a962_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNS04LTEtMS05MDU4MA_5cbc35d8-f1ef-42a9-a387-e3d385b4af98"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNy0yLTEtMS04NTQyNw_f0c887f6-b8b4-452a-bdba-93e9c3bef24c"
      unitRef="usd">14371000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNy00LTEtMS04NTQyNw_905bfaf5-9674-4a4c-8be3-c777e7e0d0eb"
      unitRef="usd">441000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNi02LTEtMS05MDU3OA_04255198-b1ed-4e54-ad5c-acc930db6ae0"
      unitRef="usd">47534000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOjZhMzk3Nzk1NGQ3YTQwOWNhMjBkOGVlZjBmZjMwZTg4L3RhYmxlcmFuZ2U6NmEzOTc3OTU0ZDdhNDA5Y2EyMGQ4ZWVmMGZmMzBlODhfNi04LTEtMS05MDU4MA_6fa80a32-0375-4b3e-a67d-fa782dbfea1e"
      unitRef="usd">39000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNTk2Ng_2dbf82ef-c685-49b2-ad28-c23176bc5f49">&lt;div style="margin-top:5pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Reclassified From Accumulated Other Comprehensive (Loss) Income into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Gain (Loss) Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Derivatives designated as cash flow hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as cash flow hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Represents location of gain reclassified from accumulated other comprehensive income into income as a result that a forecasted transaction is no longer probable of occurring.&lt;/span&gt;&lt;/div&gt;As of June&#160;30, 2022, we expect an estimated $8.5&#160;million in deferred gains on the outstanding foreign exchange contracts and an estimated $15.7&#160;million in deferred gains on the interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i0f932f4ad8184e0b96bb58e33032ad67_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNS00LTEtMS04NTQyNw_568ef0e3-0e0c-4766-b4ff-9bcffe05d793"
      unitRef="usd">1813000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i51abb32c548d4ae5992b6128d78ae406_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNS02LTEtMS04NTQyNw_1a1ca0af-cb95-4b20-a2b6-fb455ea0882b"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i1f713455967a47018e27c47844e6c2c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNC04LTEtMS05MDU4Mg_3d30cd76-7844-47f4-a119-5a0c43c66ae1"
      unitRef="usd">4356000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ie5e0141476f94fe0bfee40a9c342136d_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNC0xMC0xLTEtOTA1ODQ_661b1381-39d6-4f9c-8193-2a75e73905c7"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i8e3b921cd5684eac8e40c2c8881181c2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNi00LTEtMS04NTQyNw_ebce3773-d5cf-4eb0-ae5e-fa51eb22dae8"
      unitRef="usd">1563000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="if4621aecc6f943bcb50bb51cdee5e129_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNi02LTEtMS04NTQyNw_3bd3db1a-f017-4fe4-a77e-397563914512"
      unitRef="usd">903000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="iaa5feb023289462185a42fb720643359_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNS04LTEtMS05MDU4Mg_372dc948-c395-4b85-a57b-6affe3f25bae"
      unitRef="usd">1049000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i1beaa72fcf4443b087df773c477cfd11_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNS0xMC0xLTEtOTA1ODQ_3a5e2911-57ec-40ef-9340-beb90da4844e"
      unitRef="usd">1744000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="iae30f57ba95c4fc1ab17958acaab1941_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNy00LTEtMS04NTQyNw_d1a4125e-352b-4674-8d4f-d6da5e7edf16"
      unitRef="usd">5000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i0da6f417faba4021a4bd87936cc94e7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNy02LTEtMS04NTQyNw_394eed89-a054-4eef-ab55-a64252460ce2"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i5fc915cd5e904c928ed953fcd58e88e7_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNi04LTEtMS05MDU4Mg_6dfa835c-29eb-4cbb-ae8a-a716e2fd8dce"
      unitRef="usd">255000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i24fdd3c882204e068d38aca3948a28fb_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNi0xMC0xLTEtOTA1ODQ_37ee2587-02ab-46a3-92fa-0c175caea78c"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="ia62f1bfa4e614fbc90c0973fbb269e1b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNy00LTEtMS05MDU4Ng_def1a483-296b-444e-b36f-a992712d05ad"
      unitRef="usd">1524000</us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="ie258ecbde2a94022ab481b913bd25b59_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNy02LTEtMS05MDU4OA_0f4861f7-d8bc-4cc8-ba39-94b223af6bef"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="ib35fc47993e9429b8c5b9c8b0c6f2875_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNy04LTEtMS05MDU5MA_770b211e-b99d-4a18-b381-f03bf19611e3"
      unitRef="usd">1524000</us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="ib8ab8c183e0c4d38ac3476ef91b085a0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfNy0xMC0xLTEtOTA1OTI_4be7a216-7e32-47c9-8ab9-545df71cd955"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="ia5fdd88104094d56a78a0e9fabdc14a4_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfOS00LTEtMS04NTQyNw_69cce413-7971-49ac-8292-aed8e1908073"
      unitRef="usd">1857000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i2bead07f8fe6479b8b72129168423936_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfOS02LTEtMS04NTQyNw_afe5646c-795c-4b53-9275-ac463aa13f21"
      unitRef="usd">903000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i24098b59b80b4522b8391e7bf6c24095_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfOC04LTEtMS05MDU4Mg_126de7a3-f6da-401f-8f12-87c542626d88"
      unitRef="usd">4136000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i62dc3d65ef234ddea6fa46fa39a08264_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RhYmxlOmI2MzJkYmZjOWJiMjRhZmRhOGNkNjEwMmVhNWM4ZWY4L3RhYmxlcmFuZ2U6YjYzMmRiZmM5YmIyNGFmZGE4Y2Q2MTAyZWE1YzhlZjhfOC0xMC0xLTEtOTA1ODQ_478dfd4f-c42e-4654-ae53-c45bb4336444"
      unitRef="usd">1744000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNTYyOA_78351d08-510a-4303-9279-9dfd8686114e"
      unitRef="usd">8500000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81NS9mcmFnOjI5Y2I3NjJhMTNlZjQzZTg4ZDc1OTlkNzUzNjM4ZGFmL3RleHRyZWdpb246MjljYjc2MmExM2VmNDNlODhkNzU5OWQ3NTM2MzhkYWZfNTcxMg_f7a0cf22-4215-4809-8d02-da3b9d42116e"
      unitRef="usd">15700000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNzQ3NQ_177e5fc9-e725-40cd-852a-5f7bf136cf2d">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. There are three levels of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1:  quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2:  inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3:  unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent Earn-out Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2022, we acquired Smiths Medical with a combination of cash consideration and share consideration issued at closing. Total consideration for the acquisition includes a potential earn-out payment of $100.0&#160;million in cash contingent on our common stock achieving certain Price Targets from the closing date to either the third or fourth anniversary of closing (see Note 3: Acquisitions for additional information) and provided Smiths beneficially owns at least 50.0% of the shares of common stock issued at closing at the time the Price Target is achieved. The initial estimated fair value of the earn-out was determined to be $53.5&#160;million. The initial fair value of the earn-out was determined using a Monte Carlo simulation model. The model utilized several assumptions including volatility and the risk-free interest rate. The assumed volatility is based on the average of the historical volatility of our common stock price and the implied volatility of certain at-the-money traded options. The risk-free interest rate is equal to the yield on U.S. Treasury securities at constant maturity for the period commensurate with the term of the earn-out. At each reporting date subsequent to the acquisition, we will remeasure the earn-out liability and recognize any changes in its fair value in our consolidated statements of operations. If the probability of achieving the Price Targets during their respective measurement periods is significantly greater than initially anticipated, the realization of an additional liability and related expense will have a significant impact on our consolidated financial statements in the period recognized. As of June 30, 2022, the estimated fair value of the contingent earn-out is $26.1&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of June 30, 2022, the estimated fair value of the total contingent earn-out is $1.7&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out payment shall not exceed $6.0&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of both June 30, 2022 and December 31, 2021, the estimated fair value of the contingent earn-out is $2.6&#160;million. The estimated fair value of the contingent earn-out is calculated using a probability-weighted cash flow model based on historical revenue streams and the likelihood that the revenue targets will be met.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the fourth quarter of 2019, we recognized an earn-out liability related to the acquisition of Pursuit Vascular, Inc. ("Pursuit"). Pursuit's former equity holders were entitled up to $50.0 million in additional cash consideration contingent upon the achievement of certain sales and gross profit targets for specific customers. The earn-out was calculated as a percentage of gross profit achieved during the earn-out period against a pre-determined target gross profit, not to exceed $50.0 million. During the earn-out period, we used a Monte Carlo simulation model to determine the fair value of the earn-out liability. The Monte Carlo simulation model utilized multiple input variables to determine the value of the earn-out liability including historical volatility, a risk-free interest rate, counter party credit risk and projected future gross profit (see the simulation input table below related to Pursuit). The historical volatility was based on the median of ICU and a certain peer group. The risk-free interest rate was equal to the yield, as of the valuation date, of the zero-coupon U.S. Treasury bill that was commensurate with the term of the earn-out. The counter party credit risk was based on a synthetic credit rating of B1. As of June 30, 2021, the earn-out measurement period ended. Based on the actual sales and gross profit achieved during the measurement period, we calculated the actual earn-out amount to be $26.3&#160;million. The $26.3&#160;million earn-out calculation was finalized and accepted by Pursuit's former equity holders and was paid out in the fourth quarter of 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our contingent earn-out liabilities are separately stated on our condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide a reconciliation of the Level 3 earn-out liabilities measured at estimated fair value (in thousands):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earn-out Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition date fair value estimate of earn-out&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of earn-out (included in income from operations as a separate line item)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;$53.5 million relates to our acquisition of Smiths Medical and $1.6 million relates to our acquisition of a small foreign infusions systems supplier in the fourth quarter of 2021 (see Note 3: Acquisitions).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160; Primarily relates to the change in fair value of the Smiths Medical earn-out.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earn-out Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of earn-out (included in income from operations as a separate line item)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of earn-out (included in income from operations as a separate line item)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide quantitative information about Level 3 inputs for fair value measurement of our earn-out liabilities related to Smiths Medical and Pursuit:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smiths Medical Earn-out&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Simulation Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At Acquisition&lt;br/&gt;January 6, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-Free Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pursuit Earn-out&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Simulation Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue/Gross Profit Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-Free Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Counter Party Risk&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments, Foreign Exchange Contracts and Interest Rate Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Our investments consist of corporate bonds and U.S treasury securities. The fair value of our corporate bonds is estimated using observable market-based inputs such as quoted prices, interest rates and yield curves or Level 2 inputs. The fair value of our U.S. treasury securities are based on quoted market prices in active markets and are included in the Level 1 fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The fair value of our Level 2 foreign exchange contracts, including forward contracts and cross-currency par forward contracts, is estimated using observable market inputs such as known notional value amounts, spot and forward exchange rates. These inputs relate to liquid, heavily traded currencies with active markets which are available for the full term of the derivative.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our Level 2 interest rate swaps is estimated using a pricing model that reflects the terms of the contracts, including the period to maturity, and relies on observable market inputs such as known notional value amounts and USD interest rate curves.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our assets and liabilities measured at fair value on a recurring basis consisted of the following Level 1, 2 and 3 inputs as defined above (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&#160;measurements&#160;as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&#160;carrying&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&lt;br/&gt;in&#160;active&lt;br/&gt;markets&#160;for&lt;br/&gt;identical&lt;br/&gt;assets&#160;(level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;other&lt;br/&gt;observable&lt;br/&gt;inputs&#160;(level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&#160;(level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out liability - ST&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out liability - LT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&#160;measurements&#160;as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&#160;carrying&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&lt;br/&gt;in&#160;active&lt;br/&gt;markets&#160;for&lt;br/&gt;identical&lt;br/&gt;assets&#160;(level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;other&lt;br/&gt;observable&lt;br/&gt;inputs&#160;(level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&#160;(level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency par forward contract:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out liability - LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward-starting interest rate swaps:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <icui:Contingentconsiderationgross
      contextRef="id5289794172a4cb198e8aa0169b4c3b2_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMTE4MQ_91ab19a1-9ff5-443d-9ad7-06948c11454f"
      unitRef="usd">100000000</icui:Contingentconsiderationgross>
    <icui:OwnershipRequirementForEarnoutPayment
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMTQzMQ_2c10e94b-9546-43f8-8d72-dcf93ba2bc1d"
      unitRef="number">0.500</icui:OwnershipRequirementForEarnoutPayment>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4ac4af49606d42a88d64c2bf0f4d2ffd_I20220106"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMTU5NA_1330b56b-2521-4b73-8575-c6b905d97a58"
      unitRef="usd">53500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNTQ5NzU1ODIxOTIy_f59d24ec-ad59-465c-93e0-1388e5d882c4"
      unitRef="usd">26100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <icui:Contingentconsiderationgross
      contextRef="i0c90af4126704fd9b931fd425c90445a_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMjc2OA_64038993-b9c1-4409-b815-b5c71f4c97de"
      unitRef="usd">2500000</icui:Contingentconsiderationgross>
    <icui:ContingentConsiderationGrossST
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMjgwOA_9c22209f-eeb2-4e49-9efb-953d242d9250"
      unitRef="usd">1000000</icui:ContingentConsiderationGrossST>
    <icui:ContingentConsiderationGrossLT
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMjk1NQ_1a06907f-d7b7-44e1-998c-91186c8e6fbb"
      unitRef="usd">1500000</icui:ContingentConsiderationGrossLT>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2f9761d9634c46b781358f8378ab19ae_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMzEzMQ_e31d472a-8c4f-47bc-a50e-89fc769b6b32"
      unitRef="usd">1700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <icui:Contingentconsiderationgross
      contextRef="i2b0af7a88e20446b955b939f110edf80_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMzQ3Ng_c210bcb3-1869-407a-a970-7c605c4a4114"
      unitRef="usd">6000000</icui:Contingentconsiderationgross>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i145f9f310696405282fedab047eef187_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfMzkwMg_bcd64318-012a-43df-b20e-0d4faea8abe4"
      unitRef="usd">2600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <icui:Contingentconsiderationgross
      contextRef="i5deeb60e9c8249d1b8f46228ce05178b_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNDMwMQ_33f35956-a609-469f-ba96-6d1f41ba7150"
      unitRef="usd">50000000</icui:Contingentconsiderationgross>
    <icui:Contingentconsiderationgross
      contextRef="i5deeb60e9c8249d1b8f46228ce05178b_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNDU5MQ_3c62b2a1-77c8-4b69-abf3-035d8c4a0fe7"
      unitRef="usd">50000000</icui:Contingentconsiderationgross>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i2e7b46f30d624154ab030a8d61d3e985_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNTUzMA_4d5a4def-b930-4b54-9ce0-454ae140202c"
      unitRef="usd">26300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i2e7b46f30d624154ab030a8d61d3e985_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNTUzOA_8265f006-3126-4aeb-a644-9f66431d4896"
      unitRef="usd">26300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNzQ1NA_b2fc117c-8621-4a8e-93a4-6efb8f94f544">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide a reconciliation of the Level 3 earn-out liabilities measured at estimated fair value (in thousands):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earn-out Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition date fair value estimate of earn-out&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of earn-out (included in income from operations as a separate line item)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;$53.5 million relates to our acquisition of Smiths Medical and $1.6 million relates to our acquisition of a small foreign infusions systems supplier in the fourth quarter of 2021 (see Note 3: Acquisitions).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160; Primarily relates to the change in fair value of the Smiths Medical earn-out.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earn-out Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of earn-out (included in income from operations as a separate line item)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of earn-out (included in income from operations as a separate line item)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmEwNmNmZTBiZWI0YTRjMTQ5NjU3ZmIwYjhlOTAxNWM0L3RhYmxlcmFuZ2U6YTA2Y2ZlMGJlYjRhNGMxNDk2NTdmYjBiOGU5MDE1YzRfMS0yLTEtMS04NTQyNw_96e54acd-0072-4aad-857e-96140723a3d4"
      unitRef="usd">2589000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmEwNmNmZTBiZWI0YTRjMTQ5NjU3ZmIwYjhlOTAxNWM0L3RhYmxlcmFuZ2U6YTA2Y2ZlMGJlYjRhNGMxNDk2NTdmYjBiOGU5MDE1YzRfMi0yLTEtMS04NTQyNw_686eda1c-171e-4934-95a1-3353ff8badb8"
      unitRef="usd">55158000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <icui:CurrencyTranslationOnEarnOut
      contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmEwNmNmZTBiZWI0YTRjMTQ5NjU3ZmIwYjhlOTAxNWM0L3RhYmxlcmFuZ2U6YTA2Y2ZlMGJlYjRhNGMxNDk2NTdmYjBiOGU5MDE1YzRfNC0yLTEtMS04NTQyNw_9c894aed-7464-4ca8-add3-fa38c99fe8c6"
      unitRef="usd">46000</icui:CurrencyTranslationOnEarnOut>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i0f22c3698eff4a70b949d07786441335_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmEwNmNmZTBiZWI0YTRjMTQ5NjU3ZmIwYjhlOTAxNWM0L3RhYmxlcmFuZ2U6YTA2Y2ZlMGJlYjRhNGMxNDk2NTdmYjBiOGU5MDE1YzRfNS0yLTEtMS04NTQyNw_977ea1e4-a65e-411d-a8c3-d56467ce072b"
      unitRef="usd">57701000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmEwNmNmZTBiZWI0YTRjMTQ5NjU3ZmIwYjhlOTAxNWM0L3RhYmxlcmFuZ2U6YTA2Y2ZlMGJlYjRhNGMxNDk2NTdmYjBiOGU5MDE1YzRfNi0yLTEtMS04NTQyNw_ec64671b-b901-4913-87e8-079739c1ee6a"
      unitRef="usd">27194000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <icui:CurrencyTranslationOnEarnOut
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmEwNmNmZTBiZWI0YTRjMTQ5NjU3ZmIwYjhlOTAxNWM0L3RhYmxlcmFuZ2U6YTA2Y2ZlMGJlYjRhNGMxNDk2NTdmYjBiOGU5MDE1YzRfNy0yLTEtMS05MDE5MA_1897228a-bf8a-436c-9fe9-052f45d30530"
      unitRef="usd">98000</icui:CurrencyTranslationOnEarnOut>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmEwNmNmZTBiZWI0YTRjMTQ5NjU3ZmIwYjhlOTAxNWM0L3RhYmxlcmFuZ2U6YTA2Y2ZlMGJlYjRhNGMxNDk2NTdmYjBiOGU5MDE1YzRfNy0yLTEtMS04NTQyNw_1e1dc4af-7fc2-4a98-9102-c953e7d033ca"
      unitRef="usd">30409000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ie3c25d168c744771bf633b071b06a295_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRjMzgxYTBmOWVlNDRhZTFhNTFkNjBjNzM4MjE1MWZiL3RhYmxlcmFuZ2U6NGMzODFhMGY5ZWU0NGFlMWE1MWQ2MGM3MzgyMTUxZmJfMS0yLTEtMS04NTQyNw_eed03b4e-b277-4b7f-9bdc-37da10f2d1e7"
      unitRef="usd">26300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="if2461c3123264a1587619f55ed019061_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRjMzgxYTBmOWVlNDRhZTFhNTFkNjBjNzM4MjE1MWZiL3RhYmxlcmFuZ2U6NGMzODFhMGY5ZWU0NGFlMWE1MWQ2MGM3MzgyMTUxZmJfMy0yLTEtMS04NTQyNw_c093a20f-b0a5-41e4-9fbb-e2b50a13d166"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i4371c9b4e2d342968b4e3151c7d4db30_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRjMzgxYTBmOWVlNDRhZTFhNTFkNjBjNzM4MjE1MWZiL3RhYmxlcmFuZ2U6NGMzODFhMGY5ZWU0NGFlMWE1MWQ2MGM3MzgyMTUxZmJfNC0yLTEtMS04NTQyNw_f0cb61d4-a334-43b4-8ae0-9403658cc422"
      unitRef="usd">26300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="ia9c2724891314520aa738b30070bc9b7_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRjMzgxYTBmOWVlNDRhZTFhNTFkNjBjNzM4MjE1MWZiL3RhYmxlcmFuZ2U6NGMzODFhMGY5ZWU0NGFlMWE1MWQ2MGM3MzgyMTUxZmJfNS0yLTEtMS04NTQyNw_ee382de8-821b-4137-b2e4-b53f4f6b2b15"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i7572d325e38d473d9ae705b76dddaf85_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRjMzgxYTBmOWVlNDRhZTFhNTFkNjBjNzM4MjE1MWZiL3RhYmxlcmFuZ2U6NGMzODFhMGY5ZWU0NGFlMWE1MWQ2MGM3MzgyMTUxZmJfNi0yLTEtMS04NTQyNw_f4978435-c28d-4dff-b79a-71d8334f249b"
      unitRef="usd">26300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNzQ3OQ_6f7a7a63-56be-4376-aafb-217c0a61b436">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide quantitative information about Level 3 inputs for fair value measurement of our earn-out liabilities related to Smiths Medical and Pursuit:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smiths Medical Earn-out&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Simulation Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At Acquisition&lt;br/&gt;January 6, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-Free Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pursuit Earn-out&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Simulation Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue/Gross Profit Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-Free Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Counter Party Risk&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i26d53d1856c64aba9b247414ff1cbf72_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjM0OGVjZDdhZGI0MzQwMjJiZDY1Mjk3Njc5OTJjNzM1L3RhYmxlcmFuZ2U6MzQ4ZWNkN2FkYjQzNDAyMmJkNjUyOTc2Nzk5MmM3MzVfMS0yLTEtMS05MDIwMw_333a05ad-11aa-4319-9ae5-186e13833e42"
      unitRef="number">0.4000</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i271412c8b7d54c31bbe00f90c08636d9_I20220106"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjM0OGVjZDdhZGI0MzQwMjJiZDY1Mjk3Njc5OTJjNzM1L3RhYmxlcmFuZ2U6MzQ4ZWNkN2FkYjQzNDAyMmJkNjUyOTc2Nzk5MmM3MzVfMS0yLTEtMS04NTQyNw_318768d0-62e5-4842-94ca-5359337fe501"
      unitRef="number">0.3700</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i20fb2b51d6784bdcb7bd9ea46521840f_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjM0OGVjZDdhZGI0MzQwMjJiZDY1Mjk3Njc5OTJjNzM1L3RhYmxlcmFuZ2U6MzQ4ZWNkN2FkYjQzNDAyMmJkNjUyOTc2Nzk5MmM3MzVfMi0yLTEtMS05MDIwMw_a4d6d9a6-1732-460f-ae2b-68cfcc3e7d59"
      unitRef="number">0.0297</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="id2293f058fbe474d887a278af1dc364d_I20220106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjM0OGVjZDdhZGI0MzQwMjJiZDY1Mjk3Njc5OTJjNzM1L3RhYmxlcmFuZ2U6MzQ4ZWNkN2FkYjQzNDAyMmJkNjUyOTc2Nzk5MmM3MzVfMi0yLTEtMS04NTQyNw_709bbabb-669c-4285-b1f7-ddc405448303"
      unitRef="number">0.0131</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i629f0cf89dde42a49602d16e5cfd879b_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRkMTRjNDhmNDc1NTRjZTk4NjU0NzUwZTUyNjMxYWRmL3RhYmxlcmFuZ2U6NGQxNGM0OGY0NzU1NGNlOTg2NTQ3NTBlNTI2MzFhZGZfMS0yLTEtMS04NTQyNw_ce1c6c3a-3808-43f9-8651-82efe5192447"
      unitRef="number">0.2500</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i6fa400eb022d4774bc0cd29d07a48121_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRkMTRjNDhmNDc1NTRjZTk4NjU0NzUwZTUyNjMxYWRmL3RhYmxlcmFuZ2U6NGQxNGM0OGY0NzU1NGNlOTg2NTQ3NTBlNTI2MzFhZGZfMi0yLTEtMS04NTQyNw_e925a7ed-027c-4c35-8ef8-c21fb35b4918"
      unitRef="number">0.1250</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i880eec97a0864f7f95ece75713ea01a9_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRkMTRjNDhmNDc1NTRjZTk4NjU0NzUwZTUyNjMxYWRmL3RhYmxlcmFuZ2U6NGQxNGM0OGY0NzU1NGNlOTg2NTQ3NTBlNTI2MzFhZGZfMy0yLTEtMS04NTQyNw_2b230b4f-ce3f-4c7b-a03b-5ddf6523ad9a"
      unitRef="number">0.0009</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ic5e38a3a78e2405384dff3169dad04c7_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjRkMTRjNDhmNDc1NTRjZTk4NjU0NzUwZTUyNjMxYWRmL3RhYmxlcmFuZ2U6NGQxNGM0OGY0NzU1NGNlOTg2NTQ3NTBlNTI2MzFhZGZfNC0yLTEtMS04NTQyNw_af6ece08-dfb2-4b60-b42c-01d07787e8da"
      unitRef="number">0.0310</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RleHRyZWdpb246OWRlOWI0YjI3M2EzNGM3Nzk1ZDJkOWJiMWI0YThkZDVfNzQ3MQ_bcca3952-13a9-4e36-a6d7-7560246bf5d4">Our assets and liabilities measured at fair value on a recurring basis consisted of the following Level 1, 2 and 3 inputs as defined above (in thousands):&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&#160;measurements&#160;as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&#160;carrying&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&lt;br/&gt;in&#160;active&lt;br/&gt;markets&#160;for&lt;br/&gt;identical&lt;br/&gt;assets&#160;(level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;other&lt;br/&gt;observable&lt;br/&gt;inputs&#160;(level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&#160;(level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out liability - ST&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out liability - LT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&#160;measurements&#160;as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&#160;carrying&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&lt;br/&gt;in&#160;active&lt;br/&gt;markets&#160;for&lt;br/&gt;identical&lt;br/&gt;assets&#160;(level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;other&lt;br/&gt;observable&lt;br/&gt;inputs&#160;(level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&#160;(level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency par forward contract:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out liability - LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward-starting interest rate swaps:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i904e390537e1451b9a0b56b3895e0ad9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNC0xLTEtMS04NTQyNw_744e591c-2adc-44ad-9b8d-f1aba67b1518"
      unitRef="usd">11787000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i63cb18161ad04f4abb209fda84a747fe_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNC0zLTEtMS04NTQyNw_b140022d-771d-4512-b7b2-73efa1e8a73c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ib00f088272f9420d8932ea1b42312e11_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNC01LTEtMS04NTQyNw_1983cd88-ed22-4e68-be37-dd39ff02da6d"
      unitRef="usd">11787000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i88960ec8f42c4c90b987ccc14648a60b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNC03LTEtMS04NTQyNw_a40b7014-2ab9-4a01-8976-26a096968a6a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ie327d35dcba8456fb9278a53ad44949a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNS0xLTEtMS05MDE5Mg_5211791e-aa33-45c8-9dc0-73237ab36a73"
      unitRef="usd">1404000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i335c02bca87342c3af0d55271dc60da8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNS0zLTEtMS05MDE5Mg_10282ede-19b8-4ecb-b13a-26612eca6544"
      unitRef="usd">1404000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ia5c4a92b0ce541338d7536509042ea7b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNS01LTEtMS05MDE5Mg_085cf875-05ea-493e-a9f7-e956ea79f7ed"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="iaea350bdc70b431c9a82fd66e420fa04_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNS03LTEtMS05MDE5Mg_5d5199b1-555a-47c5-bb82-9e1a9ef76ba6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNS0xLTEtMS04NTQyNw_33537a28-c4b8-493b-b89b-bdf403d77d15"
      unitRef="usd">1837000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="ibc18153c27d94cd6a2c7151fb5dc9bd0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNS0zLTEtMS04NTQyNw_3487c9fc-f812-42a2-8b19-e6291ad28414"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i517040ce9ec34b609db5b705439f553a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNS01LTEtMS04NTQyNw_8a3efa81-3b9e-4c64-bee9-f41a1c96b09a"
      unitRef="usd">1837000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i6ffcb622eea74c2297c2e694f6d00439_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNS03LTEtMS04NTQyNw_a11e008d-e2b7-4775-a436-7aac1057ab82"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="if944aaea429e473cb610016ebaa83d93_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNy0xLTEtMS04NTQyNw_32c88e1f-2a0e-4736-828d-344b88ecff6f"
      unitRef="usd">9463000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="id1de545bcfec4a5888eea70f8e7b8036_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNy0zLTEtMS04NTQyNw_5401c00b-a070-42b3-8717-3294094f1f79"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i82e5e28cacc74c919e50d739b06edf75_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNy01LTEtMS04NTQyNw_2c9dc7f7-253b-4340-82cb-146b24059866"
      unitRef="usd">9463000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i688065cd861c47e7bd70568dc32ce595_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfNy03LTEtMS04NTQyNw_f4f22b2e-046d-4bca-8d93-060233d19b1c"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ib6c822cbb6204a8fbc869b98546fc0a9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfOC0xLTEtMS04NTQyNw_0b1846fa-9637-45d6-97ca-5b90ae680d3a"
      unitRef="usd">112000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ibc30cc767c204190b9d227e826c7af7a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfOC0zLTEtMS04NTQyNw_d1eddfa2-6e23-4c0e-a89f-5763a862527e"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i957a2bdf19bb4e459e210f02fdc311af_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfOC01LTEtMS04NTQyNw_2ef4bd1d-5fd2-4909-9dcd-5d1dda1653b9"
      unitRef="usd">112000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ia097420328df4d0ba8aad76512275995_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfOC03LTEtMS04NTQyNw_90cdb0a5-ebc2-4ac1-b6b6-724e20f29371"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="if944aaea429e473cb610016ebaa83d93_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTQtMS0xLTEtOTAxOTQ_ea3108a9-bdfa-4281-a50a-bcfd924513fb"
      unitRef="usd">15407000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="id1de545bcfec4a5888eea70f8e7b8036_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTQtMy0xLTEtOTAxOTQ_634f701e-15b4-46da-b2d5-25d30277fda0"
      unitRef="usd">0</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="i82e5e28cacc74c919e50d739b06edf75_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTQtNS0xLTEtOTAxOTQ_149ed541-2ca7-4f12-9703-d24122d59f32"
      unitRef="usd">15407000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="i688065cd861c47e7bd70568dc32ce595_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTQtNy0xLTEtOTAxOTQ_dcf0ad4a-e33d-4fa1-9deb-1ffae0889af5"
      unitRef="usd">0</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="ib6c822cbb6204a8fbc869b98546fc0a9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTMtMS0xLTEtODU0Mjc_45c99b22-9b8f-45bd-b7a4-6b1d96dfc621"
      unitRef="usd">23834000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="ibc30cc767c204190b9d227e826c7af7a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTMtMy0xLTEtODU0Mjc_5d02172c-a941-4502-b462-17a5790b9e19"
      unitRef="usd">0</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="i957a2bdf19bb4e459e210f02fdc311af_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTMtNS0xLTEtODU0Mjc_37b9ee94-6203-46aa-be4e-36f53c3321cc"
      unitRef="usd">23834000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="ia097420328df4d0ba8aad76512275995_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTMtNy0xLTEtODU0Mjc_76b409f3-d559-4c06-ad8f-6b655a07d8d0"
      unitRef="usd">0</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTQtMS0xLTEtODU0Mjc_af96e303-24dd-4b9e-b8c0-b951ee0c7479"
      unitRef="usd">63844000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibc18153c27d94cd6a2c7151fb5dc9bd0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTQtMy0xLTEtODU0Mjc_ab86cda5-ca93-4586-89d6-2f690c85bede"
      unitRef="usd">1404000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i517040ce9ec34b609db5b705439f553a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTQtNS0xLTEtODU0Mjc_3d829396-6116-4d3d-b86b-77ab883890be"
      unitRef="usd">62440000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6ffcb622eea74c2297c2e694f6d00439_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTQtNy0xLTEtODU0Mjc_721451b4-8c06-4383-9c40-b77e4212cbd4"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ie3f7f6920e264be38b38e91385534cf4_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTktMS0xLTEtOTA2NzA_84fca8f7-a715-4be5-8fac-384958712c93"
      unitRef="usd">290000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="icb8b9ef489414d54902e74776b3ad3ca_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTktMy0xLTEtOTA2NzI_5cbf0aff-8fc8-4bdc-aa91-4e6849b8ae98"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i3db367bb1a0046df994e640235391d11_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTktNS0xLTEtOTA2NzY_6054b18b-e784-4e5e-acde-f89bf740628c"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ibf917acde63245d09eb8fa04aa6cb67b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTktNy0xLTEtOTA2NzQ_cfd4f268-15e9-450a-99a9-1aefb5a003bb"
      unitRef="usd">290000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i2bdd238b3bd44e3aa0a5ddeb8d8233cf_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTgtMS0xLTEtODU0Mjc_6f6bbfbe-20cf-4fc6-b44d-2c5364129bed"
      unitRef="usd">30119000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i5bf4e764536e4ffa9c77a176f003216e_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTgtMy0xLTEtODU0Mjc_df19c65b-986a-4755-894e-922e6ddbc60c"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i9baebbfe2a8c434b87c84f5e0ad8cb0a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTgtNS0xLTEtODU0Mjc_1cc11fc4-f238-4b5b-9ac7-7ceaa337a65d"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i632c944bb938432aa0eedc42d20802a7_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMTgtNy0xLTEtODU0Mjc_b09c7a45-5a5b-4cfb-810a-1bc74c080878"
      unitRef="usd">30119000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="iac7fe1e5d9204ae3b38fd2c49a0a6e89_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjAtMS0xLTEtODU0Mjc_5fa5ff3e-6da2-42ea-9674-ae9689ebf657"
      unitRef="usd">577000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ic60a257dc9bd4e0eb4f59ade43d2cb14_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjAtMy0xLTEtODU0Mjc_cad1cd17-619d-44c1-992a-fa2ea69cc7fb"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ic149dfd8f6d1483d9ded55c35ef93307_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjAtNS0xLTEtODU0Mjc_54072b99-9746-4caf-9a02-4503e0340bef"
      unitRef="usd">577000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i44e3a6c8a6664cad9862b4281ded5217_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjAtNy0xLTEtODU0Mjc_526f8b44-e52e-4fbc-ab4c-6431e2f44b9d"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i8db92612840f4756b2e77eb032bb8d41_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjEtMS0xLTEtODU0Mjc_1a54d917-4402-4236-bbd8-a4dbb5638226"
      unitRef="usd">50000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i094fd5abbce944aa910cc40d499b5d9f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjEtMy0xLTEtODU0Mjc_9183ff7e-f572-4d23-9aad-83540a80a377"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="icfa1710f03974c6d9d1ae45570f5c02d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjEtNS0xLTEtODU0Mjc_eddda053-1e4a-4e76-95c1-d3bb4f028caa"
      unitRef="usd">50000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="id3e79b2e14f043c09c7080259bcdd720_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjEtNy0xLTEtODU0Mjc_37839e69-a999-4bbd-926b-81d31e8a77ea"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="icfeedac3a27d4227a69f70be2d89e06a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjQtMS0xLTEtODU0Mjc_9ee03151-0996-491e-853f-dcabf347aaf8"
      unitRef="usd">31036000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="ife12602b15f94cd9890c4082d74581b3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjQtMy0xLTEtODU0Mjc_c9d7f2e4-e9c8-487c-82ae-8fc4762853e3"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="ic3695974f62448dab66775d219f590d3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjQtNS0xLTEtODU0Mjc_97122d15-d0cb-4344-9069-94c4df328a29"
      unitRef="usd">627000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i3a4009ff512d42959a09607b0d1d2dd5_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOmQwODIwZGIzZDY3MDQ2OWE4NjYwZDNhZDNjMGI3MWIzL3RhYmxlcmFuZ2U6ZDA4MjBkYjNkNjcwNDY5YTg2NjBkM2FkM2MwYjcxYjNfMjQtNy0xLTEtODU0Mjc_039aa2e6-1950-4623-8ed3-83f0507db77c"
      unitRef="usd">30409000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNC0xLTEtMS04NTQyNw_4476e069-124f-4253-bb6f-d8b08f6514f3"
      unitRef="usd">14420000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i377767425d0240109a95844ff08b1b34_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNC0zLTEtMS04NTQyNw_43f1a3bb-f679-42ff-838d-adaed8d41810"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ib8df718d5aa84441b74a7a6e2b03f17e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNC01LTEtMS04NTQyNw_4a610cc2-e7a4-426c-afc6-cbafa41f8f7e"
      unitRef="usd">14420000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i56f3580c0d3d47f48f3a427759653368_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNC03LTEtMS04NTQyNw_39783a37-dcef-4f35-a63f-9b6558147dc3"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNS0xLTEtMS04NTQyNw_2e7ae138-c0b9-431d-9008-a3ff90270971"
      unitRef="usd">4620000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i377767425d0240109a95844ff08b1b34_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNS0zLTEtMS04NTQyNw_09782be2-2862-4a9c-bc11-aa69ced9d565"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="ib8df718d5aa84441b74a7a6e2b03f17e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNS01LTEtMS04NTQyNw_4168df5e-6215-495b-a80b-4b90b261ab70"
      unitRef="usd">4620000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i56f3580c0d3d47f48f3a427759653368_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNS03LTEtMS04NTQyNw_7088fe5b-c827-43a2-9c9f-36d5c7365d54"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ibcc8fe10383a4514ae5fb955ea53cee7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNy0xLTEtMS04NTQyNw_9c9feaf4-fe1c-421f-98ab-cf31c09f369e"
      unitRef="usd">1061000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ib739ab062f854a70996bee0b00130a93_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNy0zLTEtMS04NTQyNw_a388018b-c345-42f3-be2a-d2feb6b456fa"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ie8cdb41c17a14a2695ba262420cf3df1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNy01LTEtMS04NTQyNw_14cf4abb-b755-4f38-abdb-3efe1d887d57"
      unitRef="usd">1061000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i4e5fa69d927941dfb31719735e9e8088_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfNy03LTEtMS04NTQyNw_32609add-d3d8-4617-80d2-895366391d55"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTAtMS0xLTEtODU0Mjc_fc6f17e5-bbf7-4a0e-8b11-41bf370ff777"
      unitRef="usd">20101000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i377767425d0240109a95844ff08b1b34_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTAtMy0xLTEtODU0Mjc_43f6f094-457c-498c-9eb0-557109864a07"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib8df718d5aa84441b74a7a6e2b03f17e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTAtNS0xLTEtODU0Mjc_b3291514-c60e-4156-a12e-1dec00367c25"
      unitRef="usd">20101000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i56f3580c0d3d47f48f3a427759653368_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTAtNy0xLTEtODU0Mjc_c17ce107-6b1a-47af-9fa7-2dbdfe0f1e57"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i0a78e7cf24d64503b2511a1cdc74b41f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTMtMS0xLTEtODU0Mjc_76d5ff0a-505b-4d3e-894b-45425562c61c"
      unitRef="usd">2589000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i7507e0229527439dafdb4203eddf647e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTMtMy0xLTEtODU0Mjc_61d9f067-08e7-4c55-bb7a-dfb6fc132d81"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i711e70f031664741a45a58f17b0b937b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTMtNS0xLTEtODU0Mjc_51a5f8c5-8054-4567-9bfe-c60903d7dade"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ide25da1d24d146b2b6367f763603416f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTMtNy0xLTEtODU0Mjc_d4bef741-3c31-41fe-bc31-e5fd3259be4e"
      unitRef="usd">2589000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="ib56ba1e346ee4357b863011abaca4f3b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTgtMS0xLTEtOTA2NjE_e7a6f3c0-17a3-4f4c-8c1b-92d6886988c4"
      unitRef="usd">1480000</us-gaap:InterestRateDerivativeLiabilitiesAtFairValue>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="ia3ad6f6fa60f49b0995c5869f3d2d033_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTgtMy0xLTEtOTA2NjM_545040c2-db34-4860-89c9-28ef12e3f794"
      unitRef="usd">0</us-gaap:InterestRateDerivativeLiabilitiesAtFairValue>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="i130e8f7da5ee4027903cf2856abf00a3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTgtNS0xLTEtOTA2NjU_7de8c069-c59f-41c6-8140-2c194408f31e"
      unitRef="usd">1480000</us-gaap:InterestRateDerivativeLiabilitiesAtFairValue>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="i1bd14230b4e94aff9f2dc05493cfc1b1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTgtNy0xLTEtOTA2Njg_72b2cb93-dcb0-4374-ab66-3123d6b377ba"
      unitRef="usd">0</us-gaap:InterestRateDerivativeLiabilitiesAtFairValue>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ie611c9fc1bb545cc8ad94fbe19af222c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTktMS0xLTEtODU0Mjc_30b1494a-ec4c-4eb9-b788-c15e6cde0b78"
      unitRef="usd">4069000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i8debaac8649c406fbca98e4b486e4b1d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTktMy0xLTEtODU0Mjc_38db2cde-34a6-43a8-92a3-6401411ed136"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i78603e4cb0ca4c0f99214a90dd735480_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTktNS0xLTEtODU0Mjc_83eea3b8-85b7-4a15-bb62-1b24f33cb228"
      unitRef="usd">1480000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="iac454971b49349949220dae2173838e4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV81OC9mcmFnOjlkZTliNGIyNzNhMzRjNzc5NWQyZDliYjFiNGE4ZGQ1L3RhYmxlOjZkYWQxOTE3OGQzYTRlN2ZhZDFjNTM2NDczNTM4NGQyL3RhYmxlcmFuZ2U6NmRhZDE5MTc4ZDNhNGU3ZmFkMWM1MzY0NzM1Mzg0ZDJfMTktNy0xLTEtODU0Mjc_4252bb8c-5c26-410f-bd4f-82975fe7023d"
      unitRef="usd">2589000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <icui:InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RleHRyZWdpb246N2I5MDczMDc5YzM0NGQ5ZWJlOTU1Zjk5ZTRjZjhiMGRfNDE1Mw_92300b2b-7477-4cb9-a382-0037a649dc82">Investment Securities&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Available-for-sale Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Our available-for-sale investment securities currently consist of short-term and long-term corporate bonds and short-term U.S. treasury securities and are considered &#x201c;investment grade&#x201d; and are carried at fair value. We assess our investment in available-for-sale debt securities for impairment each reporting period. If an unrealized loss exists, we determine whether any portion of the decline in fair value below the amortized cost basis is credit-related by reviewing several factors, including, but not limited to, the extent of the fair value decline and changes in the financial condition of the issuer. We record an impairment for credit-related losses through an allowance, limited to the amount of the unrealized loss. If we either intend to sell or it is more likely than not we will be required to sell the debt security before its anticipated recovery, any allowance is written off and the amortized cost basis is written down to fair value through a charge against net earnings. Unrealized gains and non-credit-related unrealized losses are recorded, net of tax, in other comprehensive income (loss). We did not have any investments in available-for-sale debt securities in unrealized loss positions as of June 30, 2022 or December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost of the debt securities are adjusted for the amortization of premiums computed under the effective interest method. Such amortization is included in other income, net in our condensed consolidated statements of operations. Realized gains and losses are accounted for on the specific identification method. There have been no realized gains or losses on the disposal of these investments. The scheduled maturities of the debt securities are between 2022 and 2024. All short-term investment securities are callable within one year.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Holding &lt;br/&gt;Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Holding&lt;br/&gt;Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Non-Marketable Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, we acquired approximately a 20.0% non-marketable equity interest in a nonpublic company and entered into a three-year distribution agreement where we have the exclusive rights to market, sell and distribute the company's products in exchange for a cash payment of $3.3&#160;million. In addition, we were granted an exclusive license for all of the seller's intellectual property. At the expiration of the distribution agreement we have the right but not the obligation to acquire the remaining interest in the business.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply the equity method of accounting for investments when we determine we have a significant influence, but not a controlling interest in the investee. We determine whether we have significant influence by considering key factors such as ownership interest, representation on the board of directors, participation in policy making decisions, business relationship and material intra-entity transactions, among other factors. Our equity method investment is reported at cost and adjusted each period for our share of the investee's income or (loss) and dividend paid, if any. We eliminate any intra-entity profits to the extent of our beneficial interest. We record our share of the investee's income or (loss) on a one quarter lag. We report our proportionate share of the investee's income or (loss) resulting from this investment in other income, net in our condensed consolidated statements of operations. The carrying value of our equity method investment is reported in other assets on our &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;condensed consolidated balance sheets (see Note 11: Prepaid Expenses and Other Current Assets and Other Assets). We assess our equity method investments for impairment on an annual basis or whenever events or circumstances indicate that the carrying value of the investment may not be recoverable. Our recorded share of the investee's loss was not material for the three and six months ended June 30, 2022. We did not receive any dividend distributions from this investment during the three and six months ended June 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our non-marketable equity method investment consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in non-marketable debt securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter 2022, we received $19.0&#160;million in proceeds from a promissory note related to an acquired investment as part of the Smiths Medical acquisition.&lt;/span&gt;&lt;/div&gt;</icui:InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RleHRyZWdpb246N2I5MDczMDc5YzM0NGQ5ZWJlOTU1Zjk5ZTRjZjhiMGRfNDE1NQ_d61e5282-1b42-45c2-ade2-b38816f9a51f"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RleHRyZWdpb246N2I5MDczMDc5YzM0NGQ5ZWJlOTU1Zjk5ZTRjZjhiMGRfNDE1Nw_84eafbd8-316c-4210-9e40-4e02d8d114cc">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Holding &lt;br/&gt;Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Holding&lt;br/&gt;Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="i904e390537e1451b9a0b56b3895e0ad9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMi0xLTEtMS04NTQyNw_ee79471c-d2a3-41a9-9ac1-2b6794bfab73"
      unitRef="usd">11787000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="i1c88697ab66446b8a82b091623fd4777_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMi0zLTEtMS04NTQyNw_fa698af7-ea08-462e-9f09-8d0c7429ef04"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i904e390537e1451b9a0b56b3895e0ad9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMi01LTEtMS04NTQyNw_a35b9b61-ee5f-4fd9-a078-62ea2efdadf0"
      unitRef="usd">11787000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="ie327d35dcba8456fb9278a53ad44949a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMy0xLTEtMS04NjkzMA_3d46e442-f0ee-4eed-9c49-753da35f512a"
      unitRef="usd">1404000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="i81e0ca54acfd4d24a778f4024742013b_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMy0zLTEtMS05MDIwNg_f07fd99b-4391-40bf-8f9f-828a459c7cdd"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ie327d35dcba8456fb9278a53ad44949a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMy01LTEtMS05MDIwNg_7aa8ceda-9b0f-4c26-813f-4039890c58b4"
      unitRef="usd">1404000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
      contextRef="ib37a7d73ddd44f5598941e2ca4cc04d4_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMy0xLTEtMS04NTQyNw_b80d2dfb-4360-4cc4-ab6f-7e4284024109"
      unitRef="usd">1837000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib37a7d73ddd44f5598941e2ca4cc04d4_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMy0zLTEtMS04NTQyNw_583ca19d-7e27-4044-b2c1-474fc8b2b80c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="ib37a7d73ddd44f5598941e2ca4cc04d4_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMy01LTEtMS04NTQyNw_b719a151-9e5e-47f8-8e79-3be771d87b32"
      unitRef="usd">1837000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfNC0xLTEtMS04NTQyNw_cd7ce93f-7413-45f6-9064-a96d1e75de7e"
      unitRef="usd">15028000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib37a7d73ddd44f5598941e2ca4cc04d4_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfNC0zLTEtMS04NTQyNw_c8b80f4b-5c78-4278-a67f-0032362165b8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfNC01LTEtMS04NTQyNw_37da64e5-8de1-4656-bd6b-a3af39fd80a9"
      unitRef="usd">15028000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfOC0xLTEtMS04NTQyNw_ed40eaad-4ea3-4eb0-a512-8987fc652692"
      unitRef="usd">14420000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="id9c9a9e9ea2345208d64fa0d5a8fffda_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfOC0zLTEtMS04NTQyNw_80dee62c-2a4b-4a4f-9275-6132bb5e5a5d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfOC01LTEtMS04NTQyNw_6cecdb9c-7799-41e1-b1f5-b2b4ac547a40"
      unitRef="usd">14420000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
      contextRef="i9bde06c37d8c4dda852f5deb015fa18f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfOS0xLTEtMS04NTQyNw_74d97761-3101-46d8-9152-52aaa9fe0e31"
      unitRef="usd">4620000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i9bde06c37d8c4dda852f5deb015fa18f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfOS0zLTEtMS04NTQyNw_f1e4200e-3f5e-4cfc-90a5-d3ebd91c8e77"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i9bde06c37d8c4dda852f5deb015fa18f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfOS01LTEtMS04NTQyNw_4738fe59-4055-47bb-b919-5f28e0d4ef3a"
      unitRef="usd">4620000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMTAtMS0xLTEtODU0Mjc_8f809c8e-4dc9-49d9-9764-16234f5c17cb"
      unitRef="usd">19040000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i9bde06c37d8c4dda852f5deb015fa18f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMTAtMy0xLTEtODU0Mjc_027751a8-de30-4ec6-ac5c-8245bdc2a539"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOjA3NTljMzRmNjhmMTQ0YTI5MDQyYTIxOWI4ZWViN2E5L3RhYmxlcmFuZ2U6MDc1OWMzNGY2OGYxNDRhMjkwNDJhMjE5YjhlZWI3YTlfMTAtNS0xLTEtODU0Mjc_d96e68e2-d038-4c06-a7af-a5973bb871ae"
      unitRef="usd">19040000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RleHRyZWdpb246N2I5MDczMDc5YzM0NGQ5ZWJlOTU1Zjk5ZTRjZjhiMGRfMjA4Mg_cedef215-f3c0-4e21-b547-a8f0dc233b78"
      unitRef="number">0.200</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RleHRyZWdpb246N2I5MDczMDc5YzM0NGQ5ZWJlOTU1Zjk5ZTRjZjhiMGRfMjMxNQ_d82b94dc-63e2-418c-bb23-c8b683d386f0"
      unitRef="usd">3300000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RleHRyZWdpb246N2I5MDczMDc5YzM0NGQ5ZWJlOTU1Zjk5ZTRjZjhiMGRfNDE1MA_433c4e52-7116-429e-98da-6a9659337fa6">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our non-marketable equity method investment consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in non-marketable debt securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter 2022, we received $19.0&#160;million in proceeds from a promissory note related to an acquired investment as part of the Smiths Medical acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOmQyMDNkY2IwNDY1YzQ0Mjg5YTcwNzAxOTA1NTZmYjQyL3RhYmxlcmFuZ2U6ZDIwM2RjYjA0NjVjNDQyODlhNzA3MDE5MDU1NmZiNDJfMi0yLTEtMS04NTQyNw_34071615-abd2-4533-bbcb-f60f0e1465dc"
      unitRef="usd">3206000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RhYmxlOmQyMDNkY2IwNDY1YzQ0Mjg5YTcwNzAxOTA1NTZmYjQyL3RhYmxlcmFuZ2U6ZDIwM2RjYjA0NjVjNDQyODlhNzA3MDE5MDU1NmZiNDJfMi00LTEtMS04NTQyNw_60072c1b-0de3-4cdd-98c2-552f7cbb568c"
      unitRef="usd">3238000</us-gaap:EquityMethodInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82MS9mcmFnOjdiOTA3MzA3OWMzNDRkOWViZTk1NWY5OWU0Y2Y4YjBkL3RleHRyZWdpb246N2I5MDczMDc5YzM0NGQ5ZWJlOTU1Zjk5ZTRjZjhiMGRfNTQ5NzU1ODIwMTE1_13dbfef4-6d46-4853-86d0-cea47ac47c88"
      unitRef="usd">19000000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <icui:PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RleHRyZWdpb246MDA4MjIxYjMwZjQ2NDlkNTgzZDcwZTliMmZhYzIwYzlfMjI2_1d677a44-c489-4003-b26a-f8c26a9b46d6">Prepaid Expenses and Other Current Assets and Other Assets&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consist of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaid expenses and receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid vendor expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance and property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VAT/GST receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pump lease receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spare parts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</icui:PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RleHRyZWdpb246MDA4MjIxYjMwZjQ2NDlkNTgzZDcwZTliMmZhYzIwYzlfMjIx_d8c69ef4-0250-4e17-a1c7-16b79acf66fb">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consist of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaid expenses and receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid vendor expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance and property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VAT/GST receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfMi0yLTEtMS04NTQyNw_c28a4d30-0c00-4e82-a9aa-f30c1e5ff354"
      unitRef="usd">27081000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfMi00LTEtMS04NTQyNw_ef76e607-6a80-46da-b0e8-a8cf3732079d"
      unitRef="usd">14763000</us-gaap:OtherPrepaidExpenseCurrent>
    <icui:PrepaidVendorExpenses
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfMy0yLTEtMS04ODIyMg_27c08220-6386-4a82-b8e0-a8249bb253c7"
      unitRef="usd">5655000</icui:PrepaidVendorExpenses>
    <icui:PrepaidVendorExpenses
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfMy00LTEtMS04ODIxNQ_f0a348e9-a871-4349-8ca1-c1d61058095a"
      unitRef="usd">0</icui:PrepaidVendorExpenses>
    <us-gaap:DeferredCostsAndOtherAssets
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfMy0yLTEtMS04NTQyNw_02579ceb-6650-4817-a7a3-9b4179eb3c18"
      unitRef="usd">7648000</us-gaap:DeferredCostsAndOtherAssets>
    <us-gaap:DeferredCostsAndOtherAssets
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfMy00LTEtMS04NTQyNw_f978f9b4-cc87-4696-9ed5-e74be38693bb"
      unitRef="usd">12746000</us-gaap:DeferredCostsAndOtherAssets>
    <icui:Prepaidinsuranceandpropertytaxes
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfNC0yLTEtMS04NTQyNw_4218a4d2-10e7-462e-bae7-7bbb89f294fd"
      unitRef="usd">16542000</icui:Prepaidinsuranceandpropertytaxes>
    <icui:Prepaidinsuranceandpropertytaxes
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfNC00LTEtMS04NTQyNw_0f3698d0-a97c-499a-8889-124386d189b3"
      unitRef="usd">6310000</icui:Prepaidinsuranceandpropertytaxes>
    <icui:Prepaidothertaxes
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfNS0yLTEtMS04NTQyNw_90e25280-2479-4f22-ba4d-9af47f1ece15"
      unitRef="usd">3446000</icui:Prepaidothertaxes>
    <icui:Prepaidothertaxes
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfNS00LTEtMS04NTQyNw_909ff03d-7d6a-4345-9cfb-3eccdb42ef12"
      unitRef="usd">4156000</icui:Prepaidothertaxes>
    <icui:Deferredtaxcharge
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfNi0yLTEtMS04NTQyNw_1eb1e72e-b9e2-4e68-acf8-70ed5b0678b1"
      unitRef="usd">4308000</icui:Deferredtaxcharge>
    <icui:Deferredtaxcharge
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfNi00LTEtMS04NTQyNw_cd97c9e3-41ae-4315-8dad-be5ce550fe05"
      unitRef="usd">4241000</icui:Deferredtaxcharge>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfNy0yLTEtMS04NTQyNw_c6442f95-a70a-4adf-ac4e-b65508d76e85"
      unitRef="usd">9463000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfNy00LTEtMS04NTQyNw_79a11aa2-cd48-47b1-97b2-b9bbe0e56612"
      unitRef="usd">1061000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="if944aaea429e473cb610016ebaa83d93_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfOC0yLTEtMS04NzY2MQ_41853bf8-8e5f-4fd0-98cb-a6b01cdb6629"
      unitRef="usd">15407000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="ibcc8fe10383a4514ae5fb955ea53cee7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfOC00LTEtMS04NzY2OA_567d34b6-93a8-46c3-bec8-38095a9c5b4e"
      unitRef="usd">0</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:DepositAssets
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfOC0yLTEtMS04NTQyNw_7718df43-25a5-4b82-905c-6fe84b1957de"
      unitRef="usd">1294000</us-gaap:DepositAssets>
    <us-gaap:DepositAssets
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfOC00LTEtMS04NTQyNw_d0575381-5836-4c60-a1f1-5237357d10ae"
      unitRef="usd">1343000</us-gaap:DepositAssets>
    <us-gaap:OtherAssetsCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfOS0yLTEtMS04NTQyNw_6602fbb7-dd00-460f-bb72-ecbc8532c233"
      unitRef="usd">3819000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfOS00LTEtMS04NTQyNw_e45a4c5e-ae86-441e-aea4-fc962cc8ad68"
      unitRef="usd">2227000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfMTAtMi0xLTEtODU0Mjc_fdd74777-1918-4aaa-97cc-dca70631f118"
      unitRef="usd">94663000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjJhMzcxZDFmODdlMzQ2ZDliMGRhYTVhOGI2NDZiNDFhL3RhYmxlcmFuZ2U6MmEzNzFkMWY4N2UzNDZkOWIwZGFhNWE4YjY0NmI0MWFfMTAtNC0xLTEtODU0Mjc_999b050f-f576-4133-80b7-11aa90817021"
      unitRef="usd">46847000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RleHRyZWdpb246MDA4MjIxYjMwZjQ2NDlkNTgzZDcwZTliMmZhYzIwYzlfMjI0_1ec0a082-6129-4ccc-9523-0114c147389d">&lt;div style="margin-top:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pump lease receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spare parts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfMi0yLTEtMS04NTQyNw_ce06f05f-220f-4154-be5b-743317f18413"
      unitRef="usd">28436000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfMi00LTEtMS04NTQyNw_e8a949cf-1b9c-4e93-82b5-cb80693e5cdf"
      unitRef="usd">25941000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <icui:SpareParts
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfMy0yLTEtMS04NTQyNw_9807f877-e93a-4fc1-8c66-f9d89bd942ae"
      unitRef="usd">34352000</icui:SpareParts>
    <icui:SpareParts
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfMy00LTEtMS04NTQyNw_96044906-1f9b-4b7b-b7de-9145665e60c6"
      unitRef="usd">28538000</icui:SpareParts>
    <us-gaap:EquityMethodInvestments
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfNC0yLTEtMS04NTQyNw_33115010-405c-4bab-8c6a-d6a112735718"
      unitRef="usd">3206000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfNC00LTEtMS04NTQyNw_f3e6868d-fcff-49aa-8a52-7f7f4728ad2d"
      unitRef="usd">3238000</us-gaap:EquityMethodInvestments>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfNS0yLTEtMS04NTQyNw_b47cb9ea-b308-4ee2-8ddf-0a66a4b349ad"
      unitRef="usd">6016000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfNS00LTEtMS04NTQyNw_aaee600a-27bb-4e17-abf2-3a854443dfef"
      unitRef="usd">2827000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfNi0yLTEtMS04NTQyNw_2b18ce4c-953c-4f24-ba35-f5bb80f40191"
      unitRef="usd">2335000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfNi00LTEtMS04NTQyNw_a946921f-b9f1-4136-aca6-46c26d9d7ec4"
      unitRef="usd">2673000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="i30640c390ffe4ca3bbe943506380dba9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfNy0yLTEtMS04NTQyNw_e966a309-3da8-4f4d-8c93-6d6fa4138ab0"
      unitRef="usd">23834000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="ifa0f2e530a594d488d3ff7ff069e9259_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfNy00LTEtMS04NTQyNw_5d6814fa-34f8-4356-a3a6-97267394f05e"
      unitRef="usd">0</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="i0a3de3a660434987a7100fcd8c1caebb_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfOC0yLTEtMS04NTQyNw_e7c7a020-d7b8-4c2a-b08f-c90292234390"
      unitRef="usd">112000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="ie9d9c289f8a048eb84ce2a838b84d175_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfOC00LTEtMS04NTQyNw_96d85fca-7719-4fcc-8ba0-b50c1fd061ae"
      unitRef="usd">0</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfOS0yLTEtMS04NTQyNw_d8078314-1d68-41f1-af94-53b8e9d3dc30"
      unitRef="usd">3437000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfOS00LTEtMS04NTQyNw_c89f19c2-3baa-4716-a369-fa348706dd78"
      unitRef="usd">526000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfMTAtMi0xLTEtODU0Mjc_c36bf5a7-638f-4fed-a99a-63a640700268"
      unitRef="usd">101728000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82NC9mcmFnOjAwODIyMWIzMGY0NjQ5ZDU4M2Q3MGU5YjJmYWMyMGM5L3RhYmxlOjRjZWNiZGFiMzFmYTQ2NDRiNTdlYTFkYmZlN2M4MDI3L3RhYmxlcmFuZ2U6NGNlY2JkYWIzMWZhNDY0NGI1N2VhMWRiZmU3YzgwMjdfMTAtNC0xLTEtODU0Mjc_b3de94e8-ecdb-488a-b629-5d45f0ce9282"
      unitRef="usd">63743000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RleHRyZWdpb246Njc4YTIyYWIzMWI2NDM2MWIyMWMzMjE0NTU4MWEyOWRfNTg0_a2943c19-1e53-4e81-aafc-340cca4db0bc">Inventories&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Inventories are stated at the lower of cost or net realizable value with cost determined using the first-in, first-out method. Inventory costs include material, labor and overhead related to the manufacturing of our products. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, inventories increased significantly due to the acquisition of Smiths Medical. All acquired inventory was recorded at fair value on January 6, 2022 in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (see Note 3: Acquisitions).&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RleHRyZWdpb246Njc4YTIyYWIzMWI2NDM2MWIyMWMzMjE0NTU4MWEyOWRfNTk3_5784b8ee-f36a-4cd2-a274-d2b6ee3b3199">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, inventories increased significantly due to the acquisition of Smiths Medical. All acquired inventory was recorded at fair value on January 6, 2022 in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (see Note 3: Acquisitions).&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RhYmxlOmU3N2M4MTcwMzRiZTQzMTc4NGI2M2Y0NjJiYzY0MWZjL3RhYmxlcmFuZ2U6ZTc3YzgxNzAzNGJlNDMxNzg0YjYzZjQ2MmJjNjQxZmNfMi0xLTEtMS04NTQyNw_5f4b027a-6e3c-4a1b-8441-76b852fae2d3"
      unitRef="usd">240804000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RhYmxlOmU3N2M4MTcwMzRiZTQzMTc4NGI2M2Y0NjJiYzY0MWZjL3RhYmxlcmFuZ2U6ZTc3YzgxNzAzNGJlNDMxNzg0YjYzZjQ2MmJjNjQxZmNfMi0zLTEtMS04NTQyNw_abdaee76-1a5f-4818-b556-47d48fb78a06"
      unitRef="usd">135528000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RhYmxlOmU3N2M4MTcwMzRiZTQzMTc4NGI2M2Y0NjJiYzY0MWZjL3RhYmxlcmFuZ2U6ZTc3YzgxNzAzNGJlNDMxNzg0YjYzZjQ2MmJjNjQxZmNfMy0xLTEtMS04NTQyNw_63ac3a49-62f2-4427-9659-da755ef0aa7f"
      unitRef="usd">71101000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RhYmxlOmU3N2M4MTcwMzRiZTQzMTc4NGI2M2Y0NjJiYzY0MWZjL3RhYmxlcmFuZ2U6ZTc3YzgxNzAzNGJlNDMxNzg0YjYzZjQ2MmJjNjQxZmNfMy0zLTEtMS04NTQyNw_136efaaf-b8a4-4f4c-9970-57115aba4784"
      unitRef="usd">36490000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RhYmxlOmU3N2M4MTcwMzRiZTQzMTc4NGI2M2Y0NjJiYzY0MWZjL3RhYmxlcmFuZ2U6ZTc3YzgxNzAzNGJlNDMxNzg0YjYzZjQ2MmJjNjQxZmNfNC0xLTEtMS04NTQyNw_0b6a6fe6-565d-4ca4-aca7-ac048e21d3f1"
      unitRef="usd">271145000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RhYmxlOmU3N2M4MTcwMzRiZTQzMTc4NGI2M2Y0NjJiYzY0MWZjL3RhYmxlcmFuZ2U6ZTc3YzgxNzAzNGJlNDMxNzg0YjYzZjQ2MmJjNjQxZmNfNC0zLTEtMS04NTQyNw_44797281-e350-4e2c-9094-c91dd1f0368c"
      unitRef="usd">118217000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RhYmxlOmU3N2M4MTcwMzRiZTQzMTc4NGI2M2Y0NjJiYzY0MWZjL3RhYmxlcmFuZ2U6ZTc3YzgxNzAzNGJlNDMxNzg0YjYzZjQ2MmJjNjQxZmNfNS0xLTEtMS04NTQyNw_1da3ce35-c7d6-4ba8-832e-fe475b266971"
      unitRef="usd">583050000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV82Ny9mcmFnOjY3OGEyMmFiMzFiNjQzNjFiMjFjMzIxNDU1ODFhMjlkL3RhYmxlOmU3N2M4MTcwMzRiZTQzMTc4NGI2M2Y0NjJiYzY0MWZjL3RhYmxlcmFuZ2U6ZTc3YzgxNzAzNGJlNDMxNzg0YjYzZjQ2MmJjNjQxZmNfNS0zLTEtMS04NTQyNw_8b651dff-3c7b-40da-a603-18057fc18b5f"
      unitRef="usd">290235000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RleHRyZWdpb246ODg1YWIyNjUxMzQ2NDBlNGE4N2RmY2MyMGYzNDllNmFfNjAy_21fdf4ca-1256-4e55-bb63-65b26f219d59">Property, Plant and Equipment&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment consists of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land, building and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments placed with customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,147,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(479,509)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(436,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________________ &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Instruments placed with customers consist of drug-delivery and monitoring systems placed with customers under operating leases.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $24.9 million and $46.4&#160;million for the three and six months ended June 30, 2022, respectively. Depreciation expense was $16.3&#160;million and $32.7&#160;million for the three and six months ended June 30, 2021 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended June 30, 2022, property, plant and equipment and related depreciation expense increased significantly due to the acquisition of Smiths Medical (see Note 3: Acquisitions).&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RleHRyZWdpb246ODg1YWIyNjUxMzQ2NDBlNGE4N2RmY2MyMGYzNDllNmFfNjAw_bb9c0f91-6149-42d7-9800-b4c060c28eb2">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment consists of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land, building and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments placed with customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,147,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(479,509)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(436,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfMi0xLTEtMS04NTQyNw_839ef5d4-c8fd-4170-81de-b32f3c21d8fd"
      unitRef="usd">407580000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfMi0zLTEtMS04NTQyNw_d99e0642-d703-40b9-a35e-b747d40f1f2e"
      unitRef="usd">321078000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1a7c45ae71c244ff8f548dfdd2b6fb8c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfMy0xLTEtMS04NTQyNw_359dcd6b-abd2-45cf-8471-ffa15f0f1662"
      unitRef="usd">271723000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i56979378a15940b694ad44f79ca40db8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfMy0zLTEtMS04NTQyNw_7e930b89-c9e9-489e-89ea-5a45a981c04c"
      unitRef="usd">243377000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ieb10aa868d234581b425b2f11483e45f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfNC0xLTEtMS04NTQyNw_f7198016-384e-4054-9973-a49129b1bba3"
      unitRef="usd">75765000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id13943d7016047a08b86a41eba983610_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfNC0zLTEtMS04NTQyNw_d7080e19-c4d7-44ad-8021-89169438a151"
      unitRef="usd">60463000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i35c21123a9bc47cd9c241397fb0086b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfNS0xLTEtMS04NTQyNw_5faf0136-70cb-421a-8f48-1618b4af0129"
      unitRef="usd">115371000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i243cc12eefac42478d6f254dfb50666d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfNS0zLTEtMS04NTQyNw_f232499b-ca7d-418c-8854-f1410d547183"
      unitRef="usd">102979000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfNi0xLTEtMS04NTQyNw_c84df23a-230f-41f8-adf0-719a70045495"
      unitRef="usd">29538000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfNi0zLTEtMS04NTQyNw_221766c5-68b5-4ceb-b3f3-aa51484cdc08"
      unitRef="usd">7670000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4159aa37c1ba4a859994bf41400f8ba2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfNy0xLTEtMS04NTQyNw_4ec1b1a7-a898-4efc-80b6-bf6227d5487b"
      unitRef="usd">110592000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie9372198522d4b5e97f8e9e8a9b15104_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfNy0zLTEtMS04NTQyNw_3226e13b-6db5-4a96-bcfc-119a0f5fbcb8"
      unitRef="usd">97384000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfOC0xLTEtMS04NTQyNw_b8342d8b-4f41-420a-8ad1-e4c3a6222c12"
      unitRef="usd">136723000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfOC0zLTEtMS04NTQyNw_86c22402-5820-4fcf-8f71-e4dfa22f7821"
      unitRef="usd">72153000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfOS0xLTEtMS04NTQyNw_740f191f-8833-42f8-a55a-3688b6a7186d"
      unitRef="usd">1147292000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfOS0zLTEtMS04NTQyNw_04999323-431b-40fd-9d43-c181cc5f20b1"
      unitRef="usd">905104000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfMTAtMS0xLTEtODU0Mjc_a32b88a8-e6a9-4194-b269-10bd429fb8ff"
      unitRef="usd">479509000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfMTAtMy0xLTEtODU0Mjc_1a205fad-0344-47e6-9973-d75a7f2d76e8"
      unitRef="usd">436739000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfMTEtMS0xLTEtODU0Mjc_d43e9d3f-d200-4874-9f65-cc78469058da"
      unitRef="usd">667783000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RhYmxlOmRjMGFjZjdlZWZmYTQ0MmI5YTJiNTVlZmE5ZmFlNjljL3RhYmxlcmFuZ2U6ZGMwYWNmN2VlZmZhNDQyYjlhMmI1NWVmYTlmYWU2OWNfMTEtMy0xLTEtODU0Mjc_4d10df42-1c3f-4925-a7b6-b266cd3cd2c6"
      unitRef="usd">468365000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RleHRyZWdpb246ODg1YWIyNjUxMzQ2NDBlNGE4N2RmY2MyMGYzNDllNmFfMzEz_34f0a4ae-b9de-416b-b185-723b55a0dbba"
      unitRef="usd">24900000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RleHRyZWdpb246ODg1YWIyNjUxMzQ2NDBlNGE4N2RmY2MyMGYzNDllNmFfMzIw_67d3c059-dec1-4313-8428-34f93effdbb3"
      unitRef="usd">46400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RleHRyZWdpb246ODg1YWIyNjUxMzQ2NDBlNGE4N2RmY2MyMGYzNDllNmFfNTQ5NzU1ODE0NzQ5_62574526-9c90-4691-97a3-49cf71f7f679"
      unitRef="usd">16300000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83MC9mcmFnOjg4NWFiMjY1MTM0NjQwZTRhODdkZmNjMjBmMzQ5ZTZhL3RleHRyZWdpb246ODg1YWIyNjUxMzQ2NDBlNGE4N2RmY2MyMGYzNDllNmFfNTQ5NzU1ODE0NzY0_cc98764d-92ba-4fd9-976d-96549c3a2da2"
      unitRef="usd">32700000</us-gaap:Depreciation>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RleHRyZWdpb246NWY3MDM3NzRmZDJkNGEwNWIzYmJmMDZiYWU0ZGVmM2RfMTQyNQ_e2f9eadd-eb0e-4c0c-95a7-6724eb8a1ee7">Goodwill and Intangible Assets, Net&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the carrying amount of our goodwill (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,421,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Relates to Smiths Medical acquired on January 6, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Other reflects measurement period adjustments related to a 2021 acquisition of a small foreign infusion systems supplier.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets, Net&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Life&#160;in&#160;Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-contractual customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;581,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;513,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;584,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;505,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,237,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;185,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,051,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Internally developed software*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,265,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;185,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,080,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________________ &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Life in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-contractual customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;275,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Internally developed software*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;301,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________________ &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with definite lives are amortized on a straight-line basis over their estimated useful lives. During the three months ended June&#160;30, 2022 and 2021, intangible asset amortization expense was $41.6 million and $5.8 million, respectively.  During the six months ended June&#160;30, 2022 and 2021, intangible asset amortization expense was $73.3&#160;million and $11.6&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended June 30, 2022, intangible assets and related amortization expense increased significantly due to the acquisition of Smiths Medical (see Note 3: Acquisitions).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022 estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,051,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RleHRyZWdpb246NWY3MDM3NzRmZDJkNGEwNWIzYmJmMDZiYWU0ZGVmM2RfMTQyMA_42a796c6-3e9f-47a8-ba55-64f351cfd36f">The following table presents the changes in the carrying amount of our goodwill (in thousands):&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,421,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Relates to Smiths Medical acquired on January 6, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Other reflects measurement period adjustments related to a 2021 acquisition of a small foreign infusion systems supplier.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjRmMjBiNDc1ZjY5YzRmMjBhYmMwNzg4ZDQ2YTU2ZDIyL3RhYmxlcmFuZ2U6NGYyMGI0NzVmNjljNGYyMGFiYzA3ODhkNDZhNTZkMjJfMS0yLTEtMS04NTQyNw_e99293ce-e88e-45e0-bdf1-9f5016caafb5"
      unitRef="usd">43439000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjRmMjBiNDc1ZjY5YzRmMjBhYmMwNzg4ZDQ2YTU2ZDIyL3RhYmxlcmFuZ2U6NGYyMGI0NzVmNjljNGYyMGFiYzA3ODhkNDZhNTZkMjJfMi0yLTEtMS04NTQyNw_d7b7c7ae-3fbd-4410-b797-7e9db31ce39c"
      unitRef="usd">1444939000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjRmMjBiNDc1ZjY5YzRmMjBhYmMwNzg4ZDQ2YTU2ZDIyL3RhYmxlcmFuZ2U6NGYyMGI0NzVmNjljNGYyMGFiYzA3ODhkNDZhNTZkMjJfMy0yLTEtMS04NTQyNw_fdb8bcd3-6c46-47de-84cb-86884de35919"
      unitRef="usd">-7128000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjRmMjBiNDc1ZjY5YzRmMjBhYmMwNzg4ZDQ2YTU2ZDIyL3RhYmxlcmFuZ2U6NGYyMGI0NzVmNjljNGYyMGFiYzA3ODhkNDZhNTZkMjJfNC0yLTEtMS04NTQyNw_0b90a3bb-df8d-48d6-b9f7-665fc0a7ab7a"
      unitRef="usd">-60034000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjRmMjBiNDc1ZjY5YzRmMjBhYmMwNzg4ZDQ2YTU2ZDIyL3RhYmxlcmFuZ2U6NGYyMGI0NzVmNjljNGYyMGFiYzA3ODhkNDZhNTZkMjJfNS0yLTEtMS04NTQyNw_3e449487-73ab-4c1c-b3e4-8ae9fd9a8313"
      unitRef="usd">1421216000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RleHRyZWdpb246NWY3MDM3NzRmZDJkNGEwNWIzYmJmMDZiYWU0ZGVmM2RfMTQyNw_e772a81a-146d-44f6-8df3-6ae0ad80e3fa">Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Life&#160;in&#160;Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-contractual customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;581,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;513,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;584,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;505,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,237,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;185,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,051,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Internally developed software*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,265,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;185,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,080,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________________ &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Life in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-contractual customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;275,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Internally developed software*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;301,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if7bed48ab3274a438be9d461548445dd_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMi0yLTEtMS04NTQyNw_05544c65-bbff-4a62-806f-7aad21f42e22">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2d507359794c441296c07ef57b1f0b4b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMi00LTEtMS04NTQyNw_f01befdf-1491-46c7-85b5-a1ac431715c2"
      unitRef="usd">28603000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2d507359794c441296c07ef57b1f0b4b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMi02LTEtMS04NTQyNw_5e8d5bb8-ea7c-4319-afa1-c59336b41782"
      unitRef="usd">17669000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2d507359794c441296c07ef57b1f0b4b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMi04LTEtMS04NTQyNw_16a1e601-98ae-4d01-8d92-87c57064902e"
      unitRef="usd">10934000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i89f8e80bcf3e4d15871f08d9315a0795_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMy0yLTEtMS04NTQyNw_0d8b3e1f-6efb-4137-90fe-2a807ce81dc6">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie4a59c6b81a24315a01e330cedd0027d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMy00LTEtMS04NTQyNw_ab8f3f1e-9305-4e16-b1c2-a406e039fcbb"
      unitRef="usd">10140000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie4a59c6b81a24315a01e330cedd0027d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMy02LTEtMS04NTQyNw_0d5d8a3e-5a6e-4b26-b8bc-dcac7796c41f"
      unitRef="usd">6310000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie4a59c6b81a24315a01e330cedd0027d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMy04LTEtMS04NTQyNw_3bb0e89d-2e85-43c7-bde2-ec2ccde717db"
      unitRef="usd">3830000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ife9514c78ddc4a699ba11b09beca198e_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNC0yLTEtMS04NTQyNw_f894183f-0f9c-4c6b-a2d5-1048b341cc9c">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ief2e729c06b343f28aba776743c330ef_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNC00LTEtMS04NTQyNw_30a8d1ce-5687-4b62-8068-b0db874facc9"
      unitRef="usd">581669000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ief2e729c06b343f28aba776743c330ef_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNC02LTEtMS04NTQyNw_6377408f-5249-480e-a2eb-05efdbf3834c"
      unitRef="usd">68232000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ief2e729c06b343f28aba776743c330ef_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNC04LTEtMS04NTQyNw_d8789d53-f22f-47a3-add4-bd748dd9d6b1"
      unitRef="usd">513437000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i85f9f9c7345841549043760a5ef3a629_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNS0yLTEtMS04NTQyNw_a1877f3f-b8a3-478e-aec9-39cafe6241d8">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i513ee50364c14e7d859a7bb7ef23a477_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNS00LTEtMS04NTQyNw_e5520563-7283-428a-959f-288f88d364cd"
      unitRef="usd">5425000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i513ee50364c14e7d859a7bb7ef23a477_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNS02LTEtMS04NTQyNw_0d8f42f6-39d9-4e8b-937b-90fc1f45c07e"
      unitRef="usd">5425000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i513ee50364c14e7d859a7bb7ef23a477_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNS04LTEtMS04NTQyNw_a58ef612-9f1a-4ac0-b19b-a0301dba74f8"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ibbc7d651107948d2916b913aaa7d668f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNi0yLTEtMS04NTQyNw_81117b2a-5eca-4463-916c-7dd5c1af724c">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i912dc15e8c1a41bc9d8224503705d967_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNi00LTEtMS04NTQyNw_df59b934-565a-4047-a229-a9da09b8353f"
      unitRef="usd">18253000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i912dc15e8c1a41bc9d8224503705d967_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNi02LTEtMS04NTQyNw_b09b82e6-09d6-4965-90dc-cd38435bedd5"
      unitRef="usd">5343000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i912dc15e8c1a41bc9d8224503705d967_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNi04LTEtMS04NTQyNw_8ab0dcb4-f4d8-495b-ac56-da6ee7c96eb7"
      unitRef="usd">12910000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib169ababb8144e438fd240b38a3232b3_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNy0yLTEtMS04NTQyNw_ecfa6fb7-d2a3-4b5a-8b45-7bf109a8edd1">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic03a916b576f45269b9d7cee1deb9752_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNy00LTEtMS04NTQyNw_6d0de33a-e6fe-43e3-b083-bbfd48942195"
      unitRef="usd">584070000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic03a916b576f45269b9d7cee1deb9752_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNy02LTEtMS04NTQyNw_56fcd544-b22e-4073-87e6-9107189d1a72"
      unitRef="usd">78703000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic03a916b576f45269b9d7cee1deb9752_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfNy04LTEtMS04NTQyNw_f66fa124-4625-43a7-aa32-59e5036fcf49"
      unitRef="usd">505367000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i07478469fd9c4f93a9c4a903a48bc4f4_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfOC0yLTEtMS04NTQyNw_af0347e8-2cb4-47c5-aa43-548da1e22fed">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id253a421eb2943f5b837dd25a641e2ca_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfOC00LTEtMS04NTQyNw_563be082-9e37-48c1-997e-ab0f5b9c8505"
      unitRef="usd">9100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id253a421eb2943f5b837dd25a641e2ca_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfOC02LTEtMS04NTQyNw_b07fc09f-00e3-4326-86d7-104f9dd5fa82"
      unitRef="usd">3872000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id253a421eb2943f5b837dd25a641e2ca_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfOC04LTEtMS04NTQyNw_2414bb25-f440-404e-845e-b82b19210430"
      unitRef="usd">5228000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfOS00LTEtMS04NTQyNw_e3b21718-0988-4974-bc9c-ed870f94c3e3"
      unitRef="usd">1237260000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfOS02LTEtMS04NTQyNw_32318599-3e56-4687-86ed-f55b741c8d5a"
      unitRef="usd">185554000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfOS04LTEtMS04NTQyNw_cde56a6a-e5ba-4bb1-81bb-4ecdfd99e7a5"
      unitRef="usd">1051706000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMTEtNC0xLTEtODU0Mjc_65104b85-f00c-44d7-8b0e-9b94aa883151"
      unitRef="usd">28623000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMTEtOC0xLTEtODU0Mjc_f352d8fa-b3b5-4ede-aa51-0ff21a18d2d7"
      unitRef="usd">28623000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMTMtNC0xLTEtODU0Mjc_e7ae662c-157d-491c-8663-f348ae074f31"
      unitRef="usd">1265883000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMTMtNi0xLTEtODU0Mjc_f150df22-41da-46f3-afc3-15511db0e3be"
      unitRef="usd">185554000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjIzYWZkMzg2YTE1ODQzOGY5MjkxMTQxNDY0ZDZlOWFhL3RhYmxlcmFuZ2U6MjNhZmQzODZhMTU4NDM4ZjkyOTExNDE0NjRkNmU5YWFfMTMtOC0xLTEtODU0Mjc_b2e7da31-1b79-4117-9fb4-16545cb8c204"
      unitRef="usd">1080329000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i8e4951321f444b24b28bde3fdc96ef0e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMi0yLTEtMS04NTQyNw_b53f72b6-9535-4bc3-9d4c-aa921185c921">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id1cd92e8416b47e985b5956012374d3d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMi00LTEtMS04NTQyNw_2dd49742-93d6-4ee6-9f5e-9cad356da4c7"
      unitRef="usd">27429000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id1cd92e8416b47e985b5956012374d3d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMi02LTEtMS04NTQyNw_55e6035c-5f6e-46ee-88c7-b7de217a2531"
      unitRef="usd">16764000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id1cd92e8416b47e985b5956012374d3d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMi04LTEtMS04NTQyNw_7c9399a1-52ad-4172-9ea0-57be8aa9ba20"
      unitRef="usd">10665000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i1d3d1938206b417f890a9c160ac8e76a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMy0yLTEtMS04NTQyNw_55aa7c04-bdb5-43e2-b752-33c42856f82c">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ief440a8c15424f91aa2bf9703a08d2c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMy00LTEtMS04NTQyNw_4a61a7a1-ce2c-4842-8fb3-f7df60566b4c"
      unitRef="usd">10412000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ief440a8c15424f91aa2bf9703a08d2c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMy02LTEtMS04NTQyNw_2a50e096-ff46-4de9-b6cb-77c152804552"
      unitRef="usd">6196000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ief440a8c15424f91aa2bf9703a08d2c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMy04LTEtMS04NTQyNw_25a96122-6af5-4eca-a4a7-7c0f5e7fd9f4"
      unitRef="usd">4216000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4ef4386b3aad40caa1451437ce839832_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNC0yLTEtMS04NTQyNw_f1d0ce9b-85a2-4cf4-91cb-41d700d45403">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i821291babde14cd093a6b4ddeccede07_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNC00LTEtMS04NTQyNw_c74ec8a6-26ae-48c5-a157-3b6a26ae92fb"
      unitRef="usd">57316000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i821291babde14cd093a6b4ddeccede07_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNC02LTEtMS04NTQyNw_c7640979-72cb-440b-aa44-15e39839da9a"
      unitRef="usd">33004000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i821291babde14cd093a6b4ddeccede07_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNC04LTEtMS04NTQyNw_d4688a56-92ed-4e81-bbc0-9bcfc0f3e04c"
      unitRef="usd">24312000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie00a9e8c2c894c7ca4b21d05ef790de9_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNS0yLTEtMS04NTQyNw_64c687be-3b46-441e-9c62-6120c8da0ea1">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia4b19c227969431ca7e4a6627d90949e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNS00LTEtMS04NTQyNw_e6fe2201-341d-416b-be82-3f3e87923dc9"
      unitRef="usd">425000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia4b19c227969431ca7e4a6627d90949e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNS02LTEtMS04NTQyNw_6e2c01d8-cf89-49d4-b170-21835182d796"
      unitRef="usd">425000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia4b19c227969431ca7e4a6627d90949e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNS04LTEtMS04NTQyNw_f9fa2787-6277-433c-9c58-e33821027f11"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i3927812c539f471a9f7e842582263841_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNi0yLTEtMS04NTQyNw_cf8d93bc-e107-40dd-8f22-4b9fa619a805">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i66a5adf9d5824096bc840c2ea8b7fbe9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNi00LTEtMS04NTQyNw_fae9a19e-ac0d-4085-8e91-62dac61b117a"
      unitRef="usd">18260000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i66a5adf9d5824096bc840c2ea8b7fbe9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNi02LTEtMS04NTQyNw_d01befda-73b1-4211-81f4-a92bd8995ff6"
      unitRef="usd">4731000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i66a5adf9d5824096bc840c2ea8b7fbe9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNi04LTEtMS04NTQyNw_4b464d92-a76d-4ebc-908a-74aa607a4d8d"
      unitRef="usd">13529000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i19657ff16caa42fc8b51e10fb536a6f4_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNy0yLTEtMS04NTQyNw_49d271e2-853c-4127-9c1a-51b641c84924">P13Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie1713967f58146769aa8e6ad535a9f9c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNy00LTEtMS04NTQyNw_2d463305-fbb9-4eee-a665-20900ff9c0cb"
      unitRef="usd">152893000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie1713967f58146769aa8e6ad535a9f9c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNy02LTEtMS04NTQyNw_a8ff554a-26f6-4517-b6cf-57d8c20b3802"
      unitRef="usd">49406000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie1713967f58146769aa8e6ad535a9f9c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfNy04LTEtMS04NTQyNw_d6bc4d0d-2a69-443a-8cee-c503c1aa1d98"
      unitRef="usd">103487000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i9cf2d32391d5446c87fb358fa5d38e52_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfOC0yLTEtMS04NTQyNw_d5e2ff6e-ac41-438b-a092-43a02ec847c6">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4895000d5a7b4fe3b49e4d144fa4308c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfOC00LTEtMS04NTQyNw_15b40cfa-1d4b-47e7-bf19-c02084fc42ce"
      unitRef="usd">9100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4895000d5a7b4fe3b49e4d144fa4308c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfOC02LTEtMS04NTQyNw_e6837eab-b53f-4ca8-804f-283918ab09be"
      unitRef="usd">2356000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4895000d5a7b4fe3b49e4d144fa4308c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfOC04LTEtMS04NTQyNw_48542630-14f7-4b87-8ccd-1ebf4e19a351"
      unitRef="usd">6744000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfOS00LTEtMS04NTQyNw_d87df289-2fba-424b-ba2f-0736adfdab0f"
      unitRef="usd">275835000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfOS02LTEtMS04NTQyNw_246a9b47-f312-488b-adf7-8a2455d2beee"
      unitRef="usd">112882000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfOS04LTEtMS04NTQyNw_1454989d-e718-44ae-859e-ddd4e66f0fdf"
      unitRef="usd">162953000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMTEtNC0xLTEtODU0Mjc_3227f07a-87b1-468b-88e8-f4794d244864"
      unitRef="usd">25358000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMTEtOC0xLTEtODU0Mjc_9850df89-b972-4c8d-b61f-8c35c7bccf5b"
      unitRef="usd">25358000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMTMtNC0xLTEtODU0Mjc_8bd2cedb-1ab5-470e-9b2b-7906a8349584"
      unitRef="usd">301193000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMTMtNi0xLTEtODU0Mjc_fa3c3492-e409-4522-bf34-d95276d1bc7d"
      unitRef="usd">112882000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOjg3OWEwMTlmYjAyZjRiZTc5MTE2YWIxMDg1MTYwMDliL3RhYmxlcmFuZ2U6ODc5YTAxOWZiMDJmNGJlNzkxMTZhYjEwODUxNjAwOWJfMTMtOC0xLTEtODU0Mjc_d9589791-c56c-4c6f-a53a-e7f9cca69210"
      unitRef="usd">188311000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RleHRyZWdpb246NWY3MDM3NzRmZDJkNGEwNWIzYmJmMDZiYWU0ZGVmM2RfMTA3MA_1e70af2d-e633-4c78-98b2-4ad9a8c337cb"
      unitRef="usd">41600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RleHRyZWdpb246NWY3MDM3NzRmZDJkNGEwNWIzYmJmMDZiYWU0ZGVmM2RfMTA3Nw_dbb42cc2-0b62-44e3-8a3e-1533ba8d4ac8"
      unitRef="usd">5800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RleHRyZWdpb246NWY3MDM3NzRmZDJkNGEwNWIzYmJmMDZiYWU0ZGVmM2RfNTQ5NzU1ODE1Nzcx_13ae3a95-b59a-4ada-bd39-c4efeb020754"
      unitRef="usd">73300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RleHRyZWdpb246NWY3MDM3NzRmZDJkNGEwNWIzYmJmMDZiYWU0ZGVmM2RfNTQ5NzU1ODE1Nzg2_a1ffdc33-c1c3-4397-866b-a720cb1e0b5b"
      unitRef="usd">11600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RleHRyZWdpb246NWY3MDM3NzRmZDJkNGEwNWIzYmJmMDZiYWU0ZGVmM2RfMTQzMw_2fb1a773-bdf2-4ae0-b848-8d4f9b715a66">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022 estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,051,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOmI5MWMzMGYwYjcwYzQyNDFhOTNkMTY5YmQxMDdlYzE4L3RhYmxlcmFuZ2U6YjkxYzMwZjBiNzBjNDI0MWE5M2QxNjliZDEwN2VjMThfMC0yLTEtMS04NTQyNw_0b96bcab-e71d-4526-9d48-3f10ece8a942"
      unitRef="usd">65893000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOmI5MWMzMGYwYjcwYzQyNDFhOTNkMTY5YmQxMDdlYzE4L3RhYmxlcmFuZ2U6YjkxYzMwZjBiNzBjNDI0MWE5M2QxNjliZDEwN2VjMThfMS0yLTEtMS04NTQyNw_0d21ca9d-813d-404b-9d41-aa35f874b369"
      unitRef="usd">136217000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOmI5MWMzMGYwYjcwYzQyNDFhOTNkMTY5YmQxMDdlYzE4L3RhYmxlcmFuZ2U6YjkxYzMwZjBiNzBjNDI0MWE5M2QxNjliZDEwN2VjMThfMi0yLTEtMS04NTQyNw_b427463c-23c8-400d-8e31-6497ed12d116"
      unitRef="usd">135578000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOmI5MWMzMGYwYjcwYzQyNDFhOTNkMTY5YmQxMDdlYzE4L3RhYmxlcmFuZ2U6YjkxYzMwZjBiNzBjNDI0MWE5M2QxNjliZDEwN2VjMThfMy0yLTEtMS04NTQyNw_d59589bf-ea6c-4fa1-95ac-b37948c33519"
      unitRef="usd">127922000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOmI5MWMzMGYwYjcwYzQyNDFhOTNkMTY5YmQxMDdlYzE4L3RhYmxlcmFuZ2U6YjkxYzMwZjBiNzBjNDI0MWE5M2QxNjliZDEwN2VjMThfNC0yLTEtMS04NTQyNw_3c676f16-bff6-4b4d-9943-a03441cc35af"
      unitRef="usd">127384000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOmI5MWMzMGYwYjcwYzQyNDFhOTNkMTY5YmQxMDdlYzE4L3RhYmxlcmFuZ2U6YjkxYzMwZjBiNzBjNDI0MWE5M2QxNjliZDEwN2VjMThfNS0yLTEtMS04NTQyNw_ce5ade77-40db-48ac-bf10-07307706bc16"
      unitRef="usd">119279000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOmI5MWMzMGYwYjcwYzQyNDFhOTNkMTY5YmQxMDdlYzE4L3RhYmxlcmFuZ2U6YjkxYzMwZjBiNzBjNDI0MWE5M2QxNjliZDEwN2VjMThfNi0yLTEtMS04NTQyNw_ce11b10a-2b56-4346-ac9e-b999aac57ba9"
      unitRef="usd">339433000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83My9mcmFnOjVmNzAzNzc0ZmQyZDRhMDViM2JiZjA2YmFlNGRlZjNkL3RhYmxlOmI5MWMzMGYwYjcwYzQyNDFhOTNkMTY5YmQxMDdlYzE4L3RhYmxlcmFuZ2U6YjkxYzMwZjBiNzBjNDI0MWE5M2QxNjliZDEwN2VjMThfNy0yLTEtMS04NTQyNw_8eebaf67-514a-498e-aa55-ae4a72a48f90"
      unitRef="usd">1051706000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RleHRyZWdpb246NmNiNjY5Y2U1MDJlNDJkNzgyYWE1YjU1M2Y0NmQ4Y2VfOTM5_08d04297-7c0d-42c5-89ce-06b1fe7cf3f2">Accrued Liabilities and Other Long-Term Liabilities&#160;&#160;&#160;&#160;Accrued liabilities consist of the following (in thousands):&#160;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incentive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability-ST&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranties and returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Field service corrective action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued freight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued audit fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined benefit plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;___________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Relates to field corrective actions associated with certain products in connection with a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#x2019;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term liabilities consist of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability-LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward-starting interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liability-LT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Field service corrective action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RleHRyZWdpb246NmNiNjY5Y2U1MDJlNDJkNzgyYWE1YjU1M2Y0NmQ4Y2VfOTM2_03dcc703-6f2f-4279-bbe1-32d528760278">Accrued liabilities consist of the following (in thousands):&#160;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incentive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability-ST&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranties and returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Field service corrective action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued freight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued audit fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined benefit plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;___________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Relates to field corrective actions associated with certain products in connection with a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#x2019;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term liabilities consist of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability-LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward-starting interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liability-LT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Field service corrective action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <icui:AccruedSalariesAndBenefits
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMi0xLTEtMS04NTQyNw_d94b3f4c-056e-43e9-8701-4143bf6cf1b2"
      unitRef="usd">56453000</icui:AccruedSalariesAndBenefits>
    <icui:AccruedSalariesAndBenefits
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMi0zLTEtMS04NTQyNw_4c92fa18-5c06-4608-90d6-393e968d1e3a"
      unitRef="usd">27304000</icui:AccruedSalariesAndBenefits>
    <us-gaap:AccruedBonusesCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMy0xLTEtMS04NTQyNw_868c5d4b-1e9f-4674-8467-733a96dbe535"
      unitRef="usd">16632000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMy0zLTEtMS04NTQyNw_52be2d26-c96d-4d9a-a4c9-605f5aba617c"
      unitRef="usd">33107000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfNS0xLTEtMS04NTQyNw_f545631f-b9aa-4356-be64-ffa7f46a28b8"
      unitRef="usd">19929000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfNS0zLTEtMS04NTQyNw_a6ecfa6e-a0a6-4307-ba15-68f19c313465"
      unitRef="usd">9009000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfOS0xLTEtMS04NTQyNw_ba53d63b-668b-496b-8eaf-9c710d39507e"
      unitRef="usd">7012000</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfOS0zLTEtMS04NTQyNw_92e32b47-5ffc-4342-bead-6e8c67d93cee"
      unitRef="usd">1980000</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTAtMS0xLTEtODU0Mjc_8bd2af25-02e5-4089-8f45-d26f9b618178"
      unitRef="usd">6963000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTAtMy0xLTEtODU0Mjc_53825f10-d99f-4c5f-9fa4-634417b64ed3"
      unitRef="usd">664000</us-gaap:RestructuringReserveCurrent>
    <icui:UnfavorablecontractliabilityST
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTItMS0xLTEtODU0Mjc_75289167-c1a9-4c9e-9734-4da69fc21e7d"
      unitRef="usd">35009000</icui:UnfavorablecontractliabilityST>
    <icui:UnfavorablecontractliabilityST
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTItMy0xLTEtODU0Mjc_ac124ed1-915a-480e-9b3d-8a0f11dcdf32"
      unitRef="usd">12646000</icui:UnfavorablecontractliabilityST>
    <icui:Accruedothertaxes
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTMtMS0xLTEtODU0Mjc_dc054986-acf2-482d-b615-c19fe63f9c11"
      unitRef="usd">2840000</icui:Accruedothertaxes>
    <icui:Accruedothertaxes
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTMtMy0xLTEtODU0Mjc_7fc309cb-1b61-4ad5-8987-ccd36de56277"
      unitRef="usd">4337000</icui:Accruedothertaxes>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTQtMS0xLTEtODU0Mjc_d0ebf7a3-8953-40b2-81cf-12096e306f61"
      unitRef="usd">10271000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTQtMy0xLTEtODU0Mjc_b9ea10f3-8b78-46d2-8e7d-55d2a64c8797"
      unitRef="usd">773000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <icui:Accruedlegalfees
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTUtMS0xLTEtODU0Mjc_9648d2d7-be76-489a-a65e-3883087de61c"
      unitRef="usd">3921000</icui:Accruedlegalfees>
    <icui:Accruedlegalfees
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTUtMy0xLTEtODU0Mjc_10f01306-8381-44dd-9009-6905302ffe02"
      unitRef="usd">3897000</icui:Accruedlegalfees>
    <icui:Outsidesalescommissions
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTctMS0xLTEtODU0Mjc_a207d9cf-6a97-4cf1-89c1-29051227e7b3"
      unitRef="usd">24634000</icui:Outsidesalescommissions>
    <icui:Outsidesalescommissions
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTctMy0xLTEtODU0Mjc_d9ef8980-dfd2-4ccb-aa57-e759253a2acb"
      unitRef="usd">5645000</icui:Outsidesalescommissions>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTgtMS0xLTEtODU0Mjc_04d03e67-af05-4f42-872c-e24462c1634e"
      unitRef="usd">546000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTgtMy0xLTEtODU0Mjc_878619fd-e527-4de6-9128-cac05b3abd4f"
      unitRef="usd">532000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <icui:FieldServiceCorrectiveAction
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTktMS0xLTEtODkzMzQ_8f652722-92d9-4a0c-967c-0b50bf9c1cb7"
      unitRef="usd">30529000</icui:FieldServiceCorrectiveAction>
    <icui:FieldServiceCorrectiveAction
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTktMy0xLTEtODkzNDE_f088af30-f578-46cb-b61d-802d4ddd11a2"
      unitRef="usd">0</icui:FieldServiceCorrectiveAction>
    <icui:Accruedfreight
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTktMS0xLTEtODU0Mjc_46bb5272-38eb-4107-bdbb-a907ff9b0cf6"
      unitRef="usd">10903000</icui:Accruedfreight>
    <icui:Accruedfreight
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMTktMy0xLTEtODU0Mjc_72da726c-6a70-45d5-a62d-164901cae0d5"
      unitRef="usd">9194000</icui:Accruedfreight>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i0a3de3a660434987a7100fcd8c1caebb_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjAtMS0xLTEtODU0Mjc_f4f95ea3-2943-4ad8-8d77-87fb23f97708"
      unitRef="usd">577000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="ie9d9c289f8a048eb84ce2a838b84d175_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjAtMy0xLTEtODU0Mjc_6c2991f5-eceb-454c-8ca1-365f8c7c8a8f"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesCurrent>
    <icui:AccruedAuditFees
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjUtMS0xLTEtODU0Mjc_2c9913a5-49d4-4196-a56a-2f02d5394020"
      unitRef="usd">4741000</icui:AccruedAuditFees>
    <icui:AccruedAuditFees
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjUtMy0xLTEtODU0Mjc_dcdc3c7c-ec8a-4aaf-beb7-0bd411491ed3"
      unitRef="usd">1008000</icui:AccruedAuditFees>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjYtMS0xLTEtODU0Mjc_e1e2992d-931c-4642-ba36-386cca5100ff"
      unitRef="usd">3230000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjYtMy0xLTEtODU0Mjc_5f04ac5f-0228-467e-b3a1-8fef2a2025d4"
      unitRef="usd">0</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjgtMS0xLTEtODU0Mjc_089a8133-7eba-4824-a973-49f99a3d940c"
      unitRef="usd">13466000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjgtMy0xLTEtODU0Mjc_231b9f19-7290-43fe-85c2-81b44add115e"
      unitRef="usd">8099000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjktMS0xLTEtODU0Mjc_f2ce828b-f124-4902-8c4c-fc0cff3596e1"
      unitRef="usd">247656000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOmE2NjQyMzU1NDVjYjRjNzdiYTExMGRlODQwMjdhMTYzL3RhYmxlcmFuZ2U6YTY2NDIzNTU0NWNiNGM3N2JhMTEwZGU4NDAyN2ExNjNfMjktMy0xLTEtODU0Mjc_5dd80f2b-124e-426c-bd75-38abf93be11b"
      unitRef="usd">118195000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMy0xLTEtMS04NTQyNw_ca971f34-7214-420d-9acf-71afec674763"
      unitRef="usd">68491000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMy0zLTEtMS04NTQyNw_baa0e60f-b3b1-4457-8fa9-c7c52dd586b4"
      unitRef="usd">33971000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfNC0xLTEtMS04NTQyNw_d2079ab1-ede6-4af3-aab2-1b99be1d0b0b"
      unitRef="usd">6895000</us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfNC0zLTEtMS04NTQyNw_cd2bbb70-0b03-42cf-84e5-7d01a6c91a53"
      unitRef="usd">1369000</us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent>
    <us-gaap:AccruedRentCurrentAndNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfNS0xLTEtMS04NTQyNw_07d73171-dc97-4582-b883-a981da04bbee"
      unitRef="usd">1146000</us-gaap:AccruedRentCurrentAndNoncurrent>
    <us-gaap:AccruedRentCurrentAndNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfNS0zLTEtMS04NTQyNw_f245c805-6624-4ead-ac50-ff789d46c604"
      unitRef="usd">1262000</us-gaap:AccruedRentCurrentAndNoncurrent>
    <icui:Liabilitiesforcontracts
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfNi0xLTEtMS04NTQyNw_9c603903-b23e-4aaa-a33f-b62c3814594b"
      unitRef="usd">135000</icui:Liabilitiesforcontracts>
    <icui:Liabilitiesforcontracts
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfNi0zLTEtMS04NTQyNw_c1a78960-2d43-4990-a609-4944eecf1a4c"
      unitRef="usd">202000</icui:Liabilitiesforcontracts>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfNy0xLTEtMS04NTQyNw_9bde889c-c6e8-4204-b9b6-199e602ebc6b"
      unitRef="usd">0</us-gaap:InterestRateDerivativeLiabilitiesAtFairValue>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfNy0zLTEtMS04NTQyNw_7a2d7342-eaa1-4a62-94bd-0aa91e2f44af"
      unitRef="usd">1480000</us-gaap:InterestRateDerivativeLiabilitiesAtFairValue>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i0a3de3a660434987a7100fcd8c1caebb_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfOC0xLTEtMS04NTQyNw_9d6f5745-6eb1-4b47-9d66-04ca620e6410"
      unitRef="usd">50000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="ie9d9c289f8a048eb84ce2a838b84d175_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfOC0zLTEtMS04NTQyNw_e4fc7f6b-96bf-46a7-a1c1-b5f9f2139519"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTAtMS0xLTEtODU0Mjc_a664205b-1956-403e-a406-ebc3021ad337"
      unitRef="usd">1741000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTAtMy0xLTEtODU0Mjc_9989cbd6-9475-4d65-874a-537adc857142"
      unitRef="usd">2067000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTEtMS0xLTEtODU0Mjc_529825f5-15db-4010-924e-a7a4a9316193"
      unitRef="usd">23229000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTEtMy0xLTEtODU0Mjc_e73b865c-c9a1-42de-b21c-a42ff67281e1"
      unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ProductLiabilityAccrualComponentAmount
      contextRef="i9c13faab0ca94890afab0dfa9adc50c3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTItMS0xLTEtODU0Mjc_031e48c6-60c6-41db-ac74-bbc4e0ddd707"
      unitRef="usd">23385000</us-gaap:ProductLiabilityAccrualComponentAmount>
    <us-gaap:ProductLiabilityAccrualComponentAmount
      contextRef="i91c9f9c254834c91bccad9081f3bec3e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTItMy0xLTEtODU0Mjc_25fbae9f-465d-41d0-996c-3e47bb0dc160"
      unitRef="usd">0</us-gaap:ProductLiabilityAccrualComponentAmount>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTMtMS0xLTEtODU0Mjc_abe4ed5b-8596-4ca7-af28-e9ed681de079"
      unitRef="usd">3128000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTMtMy0xLTEtODU0Mjc_55b63ad2-ac9d-47e5-9c15-2aee913487ff"
      unitRef="usd">1479000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTQtMS0xLTEtODU0Mjc_a4482248-d083-4556-ba3c-355e939b64c7"
      unitRef="usd">128200000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83Ni9mcmFnOjZjYjY2OWNlNTAyZTQyZDc4MmFhNWI1NTNmNDZkOGNlL3RhYmxlOjg5N2I3MDMyOGE2NTQ5NzE4ODE3MmQ2ODFjNzExOWMwL3RhYmxlcmFuZ2U6ODk3YjcwMzI4YTY1NDk3MTg4MTcyZDY4MWM3MTE5YzBfMTQtMy0xLTEtODU0Mjc_95bfdade-0b69-4b71-abba-44821dd85fb0"
      unitRef="usd">41830000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfMTE1OA_1d228ae2-2366-409e-bdb1-49c1a776ab6e">Income Taxes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes were accrued at an estimated effective tax rate of 56% and 36% for the three and six months ended June 30, 2022, respectively, as compared to 18% and 16% for the three and six months ended June 30, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The effective tax rate for the three and six months ended June 30, 2022 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, section 162(m) excess compensation, foreign-derived intangible income ("FDII") and tax credits and the following discrete items recognized during the interim period:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the three and six months ended June 30, 2022 of $0.0&#160;million and $2.6&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The revaluation of the contingent consideration during the three and six months ended June 30, 2022 resulted in a tax expense of $0.0&#160;million  and $0.0&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The effective tax rate for the three and six months ended June 30, 2021 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, global intangible low taxed income ("GILTI"), FDII and tax credits. The effective tax rate during the three and six months ended June 30, 2021 included a discrete tax benefit of $0.4&#160;million and $2.2 million, respectively, related to excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfOTU_4c3a1811-0c1b-45ae-b0b9-7dde86daa98b"
      unitRef="number">0.56</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNTQ5NzU1ODE1MjEx_a2e65db0-ed70-4822-a338-529d5f3401cb"
      unitRef="number">0.36</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNTQ5NzU1ODE1MjAy_6695ef59-32dc-4517-ad1a-0d3cdea18ff4"
      unitRef="number">0.18</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNTQ5NzU1ODE1MjA3_425e6787-4273-4b8f-86fd-87a9c496f624"
      unitRef="number">0.16</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfMjU1_bfaba7a5-8155-4ffe-846b-4c02d0f3d78c"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNjY2_2baef5d1-57c0-4fa1-a017-28e8fef29075"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNTQ5NzU1ODE1NTky_7b56b771-21f1-4369-8f3f-a1d140d17c70"
      unitRef="usd">2600000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <icui:ContingentConsiderationTaxExpense
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNTQ5NzU1ODE1NjA2_c2ca3e46-53ce-4577-a413-93656158aa92"
      unitRef="usd">0</icui:ContingentConsiderationTaxExpense>
    <icui:ContingentConsiderationTaxExpense
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNTQ5NzU1ODE1NjIw_219b32ca-d504-4da0-884b-34d7731108fd"
      unitRef="usd">0</icui:ContingentConsiderationTaxExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNzU4_b848f603-32bb-442f-b277-f547181fd798"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfMTAyNg_34a30ed3-fb41-4bc6-bae9-6044cccfefca"
      unitRef="usd">400000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV83OS9mcmFnOmViMGI5NWY4MmQxYjRkMTFhMDE5NmZjMTk0YTM3YjVjL3RleHRyZWdpb246ZWIwYjk1ZjgyZDFiNGQxMWEwMTk2ZmMxOTRhMzdiNWNfNTQ5NzU1ODE1NjMz_7428be21-3964-4cd1-85da-64dc2caebf8c"
      unitRef="usd">2.2</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:LongTermDebtTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTEyMTg_c1aeb66d-7be0-4bc1-b0e6-f46a2be82c8e">Long-Term Debt&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2022, in connection with the acquisition of Smiths Medical, we entered into a Credit Agreement (the "Credit Agreement") with Wells Fargo Bank, National Association, Wells Fargo Securities, LLC, Barclays Bank PLC and certain other financial institutions (the &#x201c;Lenders&#x201d;) for $2.2&#160;billion of senior secured credit facilities. The senior secured credit facilities include (i) a five-year Tranche A term loan of $850.0&#160;million (the "Term Loan A"), (ii) a seven-year Tranche B term loan of $850.0&#160;million (the "Term Loan B") and (iii) a five-year revolving credit facility of $500.0&#160;million (the "Revolving Credit Facility"), with separate sub-limits of $50.0&#160;million for letters of credit and swingline loans (collectively, the "Senior Secured Credit Facilities"). We used the proceeds from borrowings under the Term Loan A and the Term Loan B (collectively, the "Term Loans") to fund a portion of the cash consideration for the purchase of Smiths Medical and the related fees and expenses incurred in connection with the acquisition. We did not incur borrowings under the Revolving Credit Facility on the closing date of the acquisition. The proceeds from any future borrowings under the Revolving Credit Facility may be used for working capital and other general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with entering into the Credit Agreement, during the period ended March 31, 2022, we incurred $37.8 million in debt discount and issuance costs, which were allocated to the Term Loan A, the Term Loan B and the Revolving Credit Facility based on lender commitment amounts relative to each type of fees paid. The lender and third-party discount and issuance costs allocated to the Term Loan A and the Term Loan B were $15.8 million and $13.4 million, respectively, and are reflected as a direct deduction from the face amount of the corresponding term loans on the condensed consolidated balance sheet. These costs are being amortized to interest expense over the respective terms of the loans using the effective interest method. The issuance costs allocated to the Revolving Credit Facility were $8.7 million, which are capitalized and included in prepaid expenses and other current assets and other assets on our condensed consolidated balance sheets. These costs are being amortized to interest expense over the term of the Revolving Credit Facility using the straight-line method. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net funds received from the Term Loan A and the Term Loan B, after deducting debt issuance costs, were $834.2 million and $836.6 million, respectively.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity Dates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity date for the Term Loan A and the Revolving Credit Facility is January 6, 2027, and the maturity date for the Term Loan B is January 6, 2029. Pursuant to the terms and conditions of the Credit Agreement, the maturity dates of the Term Loans and the Revolving Credit Facility may be extended upon our request, subject to the consent of the Lenders.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Rate Terms&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In general, the Term Loans and borrowings under the Revolving Credit Facility denominated in U.S. dollars bear interest, at our option, on either: (1) the Base Rate, as defined below, plus the applicable margin, as indicated below ("Base Rate Loans") or (2) the Adjusted Term Secured Overnight Financing Rate ("Adjusted Term SOFR"), as defined below, plus the applicable margin, as indicated below ("Term SOFR Loans"). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Base Rate is defined as the highest of (a) the Prime Rate, (b) the Federal Funds Rate plus 0.50% and (c) Adjusted Term SOFR (as defined below) for a one-month period plus, in each case, plus 1.00%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adjusted Term SOFR is the rate per annum equal to (a) Term SOFR plus (b) the Term SOFR Adjustment. Term SOFR is the forward-looking term rate based on SOFR and is calculated separately for Term SOFR Loans and Base Rate Loans, as specified in the Credit Agreement. The Term SOFR Adjustment is a percentage per annum of 0.10% for Base Rate Loans and between 0.10% to 0.25% for Term SOFR Loans based on the applicable interest period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facility Commitment Fee&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Revolving Credit Facility has a per annum commitment fee at an initial rate of 0.25% which is applied to the available amount of the Revolving Credit Facility. Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the commitment fee will be determined by reference to the leverage ratio in effect from time to time as set forth in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Applicable Interest Margins&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan A and borrowings under the Revolving Credit Facility have an initial applicable margin of 0.75% per annum for Base Rate Loans and 1.75% per annum for Term SOFR Loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan A and borrowings under the Revolving Credit Facility will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Term SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Commitment Fee Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than 4.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 4.00 to 1.0 but greater than 3.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 3.00 to 1.0 but greater than 2.50 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 2.50 to 1.0 but greater than 2.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 2.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan B has an initial applicable margin of 1.5% per annum for Base Rate Loans and 2.5% per annum for Term SOFR Loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan B will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Term SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than 2.75 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.75 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Principal Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Principal payments on the Term Loans are due on the last day of each calendar quarter commencing on June 30, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan A will amortize in nineteen consecutive quarterly installments in an amount equal to 2.50% of the original principal amount in each of the first two years, 5.00% in each of the third and fourth years and 7.50% in the fifth year, with a final payment of the remaining outstanding principal balance due on the maturity date.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan B matures in twenty-seven consecutive quarterly installments in an amount equal to 0.25% of the original principal amount, with a final payment of the remaining outstanding principal balance due on the maturity date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may borrow, prepay and re-borrow amounts under the Revolving Credit Facility, in accordance with the terms and conditions of the Credit Agreement, with all outstanding amounts due at maturity. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During March 2022, we prepaid $16.0 million in principal payments on the Term Loan A principal balance. During 2022, we paid $18.1&#160;million in principal payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest payments on Base Rate Loans are payable quarterly in arrears on the last business day of each calendar quarter and the applicable maturity date. Interest periods on Term SOFR Loans will be determined, at our option, as either one, three or six months and will be payable on the last day of each interest period and the applicable maturity date. In the case of any interest periods of more than three months' duration, the interest payment will be payable on each day prior to the last day of such interest period that occurs at three-month intervals.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The commitment fee on the Revolving Credit Facility is payable quarterly in arrears on the third business day following the last day of each calendar quarter and at the maturity date. The commitment fee is included in interest expense in our condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantors and Collateral&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our obligations under the Credit Agreement are unconditionally guaranteed, on a joint and several basis, by ICU Medical, Inc. and certain of our existing subsidiaries. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Covenants&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement contains affirmative and negative covenants, including certain financial covenants. The negative covenants include restrictions regarding the incurrence of liens and indebtedness, certain merger and acquisition transactions, asset sales and other dispositions, other investments, dividends, share purchases and payments affecting subsidiaries, changes in nature of business, fiscal year or organizational documents, prepayments and redemptions of subordinated and other junior debt, transactions with affiliates, and other matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial covenants include the Senior Secured Leverage Ratio and the Interest Coverage Ratio, both defined below, and pertain to the Term Loan A and the Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Senior Secured Leverage Ratio is defined, at any such date, as the ratio of: (a) all Funded Debt, as defined in the Credit Agreement, that is secured by a lien on any asset or property minus the lesser of (i) all unrestricted cash and cash equivalents and (ii) $500.0&#160;million, to (b) Consolidated EBITDA, as defined in the Credit Agreement, for the most recently completed four fiscal quarters, calculated on a pro forma basis. The maximum Senior Secured Leverage Ratio is 4.50 to 1.00 until June 30, 2024. Thereafter, the maximum Senior Secured Leverage Ratio is 4.00 to 1.00, with limited permitted exception.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Interest Coverage ratio is defined, at any such date, as the ratio of Consolidated EBITDA, as defined in the Credit Agreement, to Consolidated Interest Expense, as defined in the Credit Agreement, paid or payable in cash, for the most recently completed four fiscal quarters. The minimum Interest Coverage ratio is 3.00 to 1.00.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We were in compliance with all financial covenants as of June 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement contains customary events of default, including, among others: non-payments of principal and interest; breach of representations and warranties; covenant defaults; cross-defaults and cross-acceleration to certain other material indebtedness; the existence of bankruptcy or insolvency proceedings; certain events under ERISA; material judgments; and a change of control. If an event of default occurs and is not cured within any applicable grace period or is not waived, the administrative agent and the Lenders are entitled to take various actions, including, without limitation, the acceleration of all amounts due and the termination of commitments under the Senior Secured Credit Facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2017 Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On November 8, 2017, we entered into a five-year senior secured revolving credit facility with various lenders for $150.0 million, with Wells Fargo Bank, National Association as the administrative agent, swingline lender and issuing lender (the "Prior Credit Facility"). The Prior Credit Facility, which was set to mature on November 8, 2022, was terminated in connection with entering into the Credit Agreement on January 6, 2022. There were no borrowings outstanding under the Prior Credit Facility at that date or at December 31, 2021. The remaining unamortized deferred debt issuance costs related to the Prior Credit Facility were not material and were expensed in connection with its termination. See further details of the terms of the Prior Credit Facility in Note 11 in Part II, Item 8, of our 2021 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of our long-term debt consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effective Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan A &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan B &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving Credit Facility &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less unamortized debt issuance costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total carrying value of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,636,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprised of $14.2 million and $12.6 million relating to the Term Loan A and the Term Loan B, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years is approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;672,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;801,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,681,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the total interest expense related to our long-term debt (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitment fee &#x2014; Revolving Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LongTermDebtTextBlock>
    <icui:TotalSeniorSecuredCreditFacility
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMzQy_8150f52e-8608-45d5-9437-4a6a60641d90"
      unitRef="usd">2200000000</icui:TotalSeniorSecuredCreditFacility>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="if2172b4c33734723af96689c9f9c83cf_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNDY2_15b73261-c8b3-4f70-8447-88fe6407e0b0"
      unitRef="usd">850000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i820c1b83d10b4a7caf83661d1ff3d33f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNTMx_9c6b579c-9f57-4828-8d1e-5449a419ab9f"
      unitRef="usd">850000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia65456c188d34d4daf133f0f0dbc3e2c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNjA1_7b10cca1-0b24-44a4-a951-c25062128b5b"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <icui:RevolverSubLimits
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNjcx_49f4bf64-0cf5-469d-9aff-b2d056c008a4"
      unitRef="usd">50000000</icui:RevolverSubLimits>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTQwMA_c54ab961-a40f-4547-ac0e-0f4fed82d4d2"
      unitRef="usd">37800000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="ie48f38dcedd64e93a8ecf7ac063f60b0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTcxMQ_25b4c3c8-2cf1-4862-8733-48114ab073e0"
      unitRef="usd">15800000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="ia442a59e504b4b4cbe247d028ddb1705_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTcxOA_0df23a68-a475-4d34-9c41-3e77faf8d78f"
      unitRef="usd">13400000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="ia65456c188d34d4daf133f0f0dbc3e2c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMjA2OQ_2bfa6b2e-a403-4417-a184-2421796b440a"
      unitRef="usd">8700000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:LongTermDebt
      contextRef="ie48f38dcedd64e93a8ecf7ac063f60b0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMjQ1Ng_89845ddc-8036-4f7a-b359-366ce67174c3"
      unitRef="usd">834200000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia442a59e504b4b4cbe247d028ddb1705_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMjQ2Mw_52d18140-fd01-4edd-b088-afa47c5f1858"
      unitRef="usd">836600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="if2172b4c33734723af96689c9f9c83cf_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMjU3Ng_70b6091b-384f-4b06-88c3-59f9b8d87c57">2027-01-06</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i820c1b83d10b4a7caf83661d1ff3d33f_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMjYyNQ_be6194e0-cb2f-463a-b424-07e46c38532c">2029-01-06</us-gaap:DebtInstrumentMaturityDate>
    <icui:InterestPercentageAddedToFederalFundsRate
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMzM3Mw_a2733144-32b1-43f6-9b9a-670f946745a5"
      unitRef="number">0.0050</icui:InterestPercentageAddedToFederalFundsRate>
    <icui:InterestPercentageAddedToBaseRate
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMzQ3MA_76ce62dd-614a-4b43-ae29-acbb21e90b50"
      unitRef="number">0.0100</icui:InterestPercentageAddedToBaseRate>
    <icui:TerSOFRInterestRateAdjustmentForBaseRateLoans
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMzc5Mw_3d1f16ce-1a3e-43fa-95f9-aeea13c6e0a0"
      unitRef="number">0.0010</icui:TerSOFRInterestRateAdjustmentForBaseRateLoans>
    <icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans
      contextRef="i097d704989b14390b8eebff2668fa80d_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMzgyOA_bbd19091-f886-4120-b64f-cec97041a52e"
      unitRef="number">0.0010</icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans>
    <icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans
      contextRef="i8dc422a484844921bbf2f8fbbb10898d_I20220630"
      decimals="8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMzgzNA_3e2df748-d959-4f9e-b1cc-426b4de948e3"
      unitRef="number">0.0025</icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNDAyNA_94549f73-ce87-41b3-939b-08f4ad834ed5"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="ie48f38dcedd64e93a8ecf7ac063f60b0_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNDUwNA_d14a41c4-d608-4c5f-b5c6-b8842cfa891e"
      unitRef="number">0.0075</icui:ApplicableMarginBaseRateLoans>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="ie48f38dcedd64e93a8ecf7ac063f60b0_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNDU0MQ_760dbe1f-b2a7-4253-bf65-b7c33fb318b7"
      unitRef="number">0.0175</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBasedOnLeverageRatioTableTextBlock
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTEyMTY_fec935eb-c540-40f2-99cf-051ab3a051cc">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan A and borrowings under the Revolving Credit Facility will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Term SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Commitment Fee Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than 4.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 4.00 to 1.0 but greater than 3.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 3.00 to 1.0 but greater than 2.50 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 2.50 to 1.0 but greater than 2.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 2.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</icui:ApplicableMarginBasedOnLeverageRatioTableTextBlock>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="i7b85afc4ff3d4a5092568e3fb7e051d8_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMS0xLTEtMS04NTQyNw_ba6fc87e-960b-498c-9cbb-d8e89be846ec"
      unitRef="number">0.0225</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="i7b85afc4ff3d4a5092568e3fb7e051d8_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMS0yLTEtMS04NTQyNw_eb616616-a237-4f22-b7af-7fc3051347c3"
      unitRef="number">0.0125</icui:ApplicableMarginBaseRateLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i0a39638d60794625b2a97bb8ccf76e08_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMS0zLTEtMS04NTQyNw_bd66293a-e9c6-45a7-96d0-bfb6ad61c2e6"
      unitRef="number">0.0035</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="if4fa2d7effb948959c4419141b81fa27_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMi0xLTEtMS04NTQyNw_818ec3a1-de54-4448-948a-699381786476"
      unitRef="number">0.0200</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="if4fa2d7effb948959c4419141b81fa27_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMi0yLTEtMS04NTQyNw_9fe011d0-7e97-4e31-acc4-5b1c328166ee"
      unitRef="number">0.0100</icui:ApplicableMarginBaseRateLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i01fc89ab55b9471e88acff5bc284c6d9_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMi0zLTEtMS04NTQyNw_3648758b-049c-4e06-9d30-904ca71a2f01"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="ibdfa16b6f741491d8b6775ba1b22da74_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMy0xLTEtMS04NTQyNw_294a234b-8abf-4112-af52-699e564f9551"
      unitRef="number">0.0175</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="ibdfa16b6f741491d8b6775ba1b22da74_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMy0yLTEtMS04NTQyNw_94530512-8286-4378-8272-ce52ae671cc6"
      unitRef="number">0.0075</icui:ApplicableMarginBaseRateLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i29510191d44e477fa81d72fe9d21c1ec_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfMy0zLTEtMS04NTQyNw_17b03dd3-6d91-46a6-9db1-7752d1ef19d9"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="i3c9d6aabc294426da5585018b63ccb2f_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfNC0xLTEtMS04NTQyNw_e94d2214-4780-48cb-88cb-671418e198e8"
      unitRef="number">0.0150</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="i3c9d6aabc294426da5585018b63ccb2f_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfNC0yLTEtMS04NTQyNw_a2c96333-eb6e-4c3a-a2a6-0c010c710bbc"
      unitRef="number">0.0050</icui:ApplicableMarginBaseRateLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i6e79efd88abe4a75b2c34f56667180b3_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfNC0zLTEtMS04NTQyNw_5969109d-f9e2-4160-b5f9-f7461edcbe98"
      unitRef="number">0.0020</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="i1e5ce3e367bf4ebf8d8b4d98965dedbc_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfNS0xLTEtMS04NTQyNw_716e3912-004b-4a73-85c0-a66bd1a4a108"
      unitRef="number">0.0125</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="i1e5ce3e367bf4ebf8d8b4d98965dedbc_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfNS0yLTEtMS04NTQyNw_146af6bc-9740-4799-840f-2c3904eab6f3"
      unitRef="number">0.0025</icui:ApplicableMarginBaseRateLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i62429302fe0f4afea07772eb2f1866ae_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmQ1ODRiOTdjYjJhYzQyMzFiODllNjNmZjU4ZTg5YjMwL3RhYmxlcmFuZ2U6ZDU4NGI5N2NiMmFjNDIzMWI4OWU2M2ZmNThlODliMzBfNS0zLTEtMS04NTQyNw_115e65e5-fe66-4e7d-9a61-0b66087849e0"
      unitRef="number">0.0015</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="ia442a59e504b4b4cbe247d028ddb1705_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNDk3OQ_09e7349c-cb20-4f5d-9bf3-d014319c0c96"
      unitRef="number">0.015</icui:ApplicableMarginBaseRateLoans>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="ia442a59e504b4b4cbe247d028ddb1705_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNTAxNg_22111f49-cc4d-4c11-94f1-97d18c39d4cd"
      unitRef="number">0.025</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="ide283ac530ac4b1781126c399a2552b9_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmZhODU1MTM0NTZkNDRkYjNiNjYzZWU5ZmUzZTA3NTM4L3RhYmxlcmFuZ2U6ZmE4NTUxMzQ1NmQ0NGRiM2I2NjNlZTlmZTNlMDc1MzhfMS0xLTEtMS04NTQyNw_32c670bb-b6ff-4fcb-8a53-174fc02dbbdd"
      unitRef="number">0.0250</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="ide283ac530ac4b1781126c399a2552b9_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmZhODU1MTM0NTZkNDRkYjNiNjYzZWU5ZmUzZTA3NTM4L3RhYmxlcmFuZ2U6ZmE4NTUxMzQ1NmQ0NGRiM2I2NjNlZTlmZTNlMDc1MzhfMS0yLTEtMS04NTQyNw_fd3cabed-08eb-4ab6-9a1c-f557615e8698"
      unitRef="number">0.0150</icui:ApplicableMarginBaseRateLoans>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="ibb1d7ec7e4a44aabae7ac85788f5014f_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmZhODU1MTM0NTZkNDRkYjNiNjYzZWU5ZmUzZTA3NTM4L3RhYmxlcmFuZ2U6ZmE4NTUxMzQ1NmQ0NGRiM2I2NjNlZTlmZTNlMDc1MzhfMi0xLTEtMS04NTQyNw_c4add4ba-f822-4d17-b84e-5cc7659f9680"
      unitRef="number">0.0225</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="ibb1d7ec7e4a44aabae7ac85788f5014f_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmZhODU1MTM0NTZkNDRkYjNiNjYzZWU5ZmUzZTA3NTM4L3RhYmxlcmFuZ2U6ZmE4NTUxMzQ1NmQ0NGRiM2I2NjNlZTlmZTNlMDc1MzhfMi0yLTEtMS04NTQyNw_ba11b3ad-8291-4f36-ac63-ae0d23b21770"
      unitRef="number">0.0125</icui:ApplicableMarginBaseRateLoans>
    <icui:TermAPrincipalPaymentFirst2Years
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNTU4Nw_69b20dcf-18c5-4b50-8503-4a4d2c770dc8"
      unitRef="number">0.0250</icui:TermAPrincipalPaymentFirst2Years>
    <icui:TermAPrincipalPaymentYear3And4
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNTY1NQ_f272e64a-187d-466c-aa7f-1d8e28ac8e82"
      unitRef="number">0.0500</icui:TermAPrincipalPaymentYear3And4>
    <icui:TermAPrincipalPaymentInYear5
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNTcwMA_c5bafebc-4ae0-4191-a9c6-2ccd0d35e466"
      unitRef="number">0.0750</icui:TermAPrincipalPaymentInYear5>
    <icui:TermLoanBPrincipalPayment
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNTkxNg_477bc12a-7130-440a-af2f-40a20754418b"
      unitRef="number">0.0025</icui:TermLoanBPrincipalPayment>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNjI3Ng_b4902df5-2911-42f0-96bc-cdde93acc154"
      unitRef="usd">16000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfNTQ5NzU1ODI1MTky_bb0fad0b-4aac-4eda-8442-3dd7d5f25bfc"
      unitRef="usd">18100000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <icui:LeverageRatioCalculationCeilingSubtractedAmount
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfODQzMQ_3ba9313c-c3f3-4f76-b6d4-62c61378cb6a"
      unitRef="usd">500000000</icui:LeverageRatioCalculationCeilingSubtractedAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTAwMjM_24a5ce42-ecce-44d0-b826-4263dea430b1"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTAyMjE_f3d25aba-e3ae-45b1-aafe-f2a3e2e7b786">2022-11-08</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LinesOfCreditCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTAzMjU_9ffe22f3-1f03-4bfb-92ac-b672002b0df5"
      unitRef="usd">0</us-gaap:LinesOfCreditCurrent>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTEyMTk_b3d28366-a286-4a77-96e2-55c670c21abb">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of our long-term debt consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effective Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan A &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan B &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving Credit Facility &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less unamortized debt issuance costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total carrying value of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,636,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprised of $14.2 million and $12.6 million relating to the Term Loan A and the Term Loan B, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="if2172b4c33734723af96689c9f9c83cf_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfMy0xLTEtMS04NTQyNw_0ff6f663-085a-4a30-aae6-64fcef8b333b"
      unitRef="number">0.0444</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie48f38dcedd64e93a8ecf7ac063f60b0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfMy0zLTEtMS04NTQyNw_a43afa48-0df7-4865-9137-2d2db1236e58"
      unitRef="usd">834000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i820c1b83d10b4a7caf83661d1ff3d33f_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfNC0xLTEtMS04NTQyNw_ff261258-2a79-49e9-9810-829ffc5ffb6c"
      unitRef="number">0.0511</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia442a59e504b4b4cbe247d028ddb1705_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfNC0zLTEtMS04NTQyNw_c1ef7f4c-3258-41f0-b08d-7ef7c3f68532"
      unitRef="usd">847875000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i48afd3427c1e42f6ad2d86e852ef64dd_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfNS0xLTEtMS04NTQyNw_248e22c6-ce2d-4b6d-8306-ed779ad53a56"
      unitRef="number">0</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfNS0zLTEtMS04NTQyNw_a87e90ff-ac56-4d91-9adf-521da5b114af"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfNi0zLTEtMS04NTQyNw_c616994c-ff47-4490-9d2d-af11f614ba40"
      unitRef="usd">-26783000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfNy0zLTEtMS04NTQyNw_940e9ab0-a0e3-40f1-882e-39e383241dc2"
      unitRef="usd">1655092000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtCurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfOC0zLTEtMS04NTQyNw_6cf8bf78-a1dd-46c2-a044-116ff1271564"
      unitRef="usd">19063000</us-gaap:DebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjYxZjJhMmEwMDZjMTQ5M2Y5OTdkMDk4ZmQyMTE0NDZlL3RhYmxlcmFuZ2U6NjFmMmEyYTAwNmMxNDkzZjk5N2QwOThmZDIxMTQ0NmVfOS0zLTEtMS04NTQyNw_3ec42bb6-8661-4b8b-a6a5-55bea01e8161"
      unitRef="usd">1636029000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="ie48f38dcedd64e93a8ecf7ac063f60b0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTA4NTQ_7844b893-e96b-40e4-8d92-c25ef0ab919a"
      unitRef="usd">14200000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="ia442a59e504b4b4cbe247d028ddb1705_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTA4NjE_387bcf2b-8a63-4ffc-afb3-2d805541834d"
      unitRef="usd">12600000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTEyMjA_10e87473-6b16-4517-b3e9-4d02b9aeb552">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years is approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;672,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;801,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,681,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjcxZWU1Y2Q1OGQ3OTRhMjhhMWU3OTA0Y2I1NjBjZDdmL3RhYmxlcmFuZ2U6NzFlZTVjZDU4ZDc5NGEyOGExZTc5MDRjYjU2MGNkN2ZfMC0yLTEtMS04NTQyNw_27e6766d-caab-483e-a98f-8ca2d0c0db59"
      unitRef="usd">4250000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjcxZWU1Y2Q1OGQ3OTRhMjhhMWU3OTA0Y2I1NjBjZDdmL3RhYmxlcmFuZ2U6NzFlZTVjZDU4ZDc5NGEyOGExZTc5MDRjYjU2MGNkN2ZfMS0yLTEtMS04NTQyNw_14124301-0dbe-418d-b5b0-fec236558c62"
      unitRef="usd">29750000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjcxZWU1Y2Q1OGQ3OTRhMjhhMWU3OTA0Y2I1NjBjZDdmL3RhYmxlcmFuZ2U6NzFlZTVjZDU4ZDc5NGEyOGExZTc5MDRjYjU2MGNkN2ZfMi0yLTEtMS04NTQyNw_34bcba54-38c2-4f69-bd38-02bcb208dbbe"
      unitRef="usd">51000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjcxZWU1Y2Q1OGQ3OTRhMjhhMWU3OTA0Y2I1NjBjZDdmL3RhYmxlcmFuZ2U6NzFlZTVjZDU4ZDc5NGEyOGExZTc5MDRjYjU2MGNkN2ZfMy0yLTEtMS04NTQyNw_d39b71ac-f44e-4582-a9f1-284bc79cb4f2"
      unitRef="usd">51000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjcxZWU1Y2Q1OGQ3OTRhMjhhMWU3OTA0Y2I1NjBjZDdmL3RhYmxlcmFuZ2U6NzFlZTVjZDU4ZDc5NGEyOGExZTc5MDRjYjU2MGNkN2ZfNC0yLTEtMS04NTQyNw_7554ab8f-f074-4a5e-9b1e-596d0d772568"
      unitRef="usd">72250000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjcxZWU1Y2Q1OGQ3OTRhMjhhMWU3OTA0Y2I1NjBjZDdmL3RhYmxlcmFuZ2U6NzFlZTVjZDU4ZDc5NGEyOGExZTc5MDRjYjU2MGNkN2ZfNS0yLTEtMS04NTQyNw_3938cff8-c1f7-4b5e-a6d5-9c5d6ea14419"
      unitRef="usd">672500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjcxZWU1Y2Q1OGQ3OTRhMjhhMWU3OTA0Y2I1NjBjZDdmL3RhYmxlcmFuZ2U6NzFlZTVjZDU4ZDc5NGEyOGExZTc5MDRjYjU2MGNkN2ZfNi0yLTEtMS04NTQyNw_8baaa94d-7f90-4c09-88e3-e342b515d333"
      unitRef="usd">801125000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOjcxZWU1Y2Q1OGQ3OTRhMjhhMWU3OTA0Y2I1NjBjZDdmL3RhYmxlcmFuZ2U6NzFlZTVjZDU4ZDc5NGEyOGExZTc5MDRjYjU2MGNkN2ZfNy0yLTEtMS04NTQyNw_4a7e149f-c026-4a8b-841e-cf2ff5505bb1"
      unitRef="usd">1681875000</us-gaap:DebtInstrumentCarryingAmount>
    <icui:InterestExpenseOnLongTermDebtTableTextBlock
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RleHRyZWdpb246NTc5YjkxMjk2ZjhlNDhjM2JiZjA0MGNjMjRkZGQwZDhfMTEyMjE_c1b669e9-7c3a-42a1-8877-f6a44c32d9af">The following table presents the total interest expense related to our long-term debt (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six months ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitment fee &#x2014; Revolving Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</icui:InterestExpenseOnLongTermDebtTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfMi0xLTEtMS04NTQyNw_20a6b7be-fe96-4c1c-b205-f82aabccba04"
      unitRef="usd">12622000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfMi0zLTEtMS04NTQyNw_c2712dbf-8178-45e1-801e-10df7ef2be5c"
      unitRef="usd">0</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfMi01LTEtMS05MDY5OQ_cb015bd2-0424-46c0-b9bf-6310d521c279"
      unitRef="usd">22639000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfMi03LTEtMS05MDcwMQ_36a0823c-ef0e-4db2-9c5a-ebee40e4a323"
      unitRef="usd">0</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfMy0xLTEtMS04NTQyNw_5f3f03ec-0d59-4090-8da9-8772cbf0f64a"
      unitRef="usd">1799000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfMy0zLTEtMS04NTQyNw_4a993c5a-5547-45e0-8737-87a2d2d04fdf"
      unitRef="usd">72000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfMy01LTEtMS05MDY5OQ_75ce2444-d929-4e0d-a3bd-df1ae9eec38d"
      unitRef="usd">3442000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfMy03LTEtMS05MDcwMQ_bc516713-db13-4dd5-9b12-346c4e11c391"
      unitRef="usd">144000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfNC0xLTEtMS04NTQyNw_28d0c906-4a54-4bae-9908-f770a28f2c5e"
      unitRef="usd">309000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfNC0zLTEtMS04NTQyNw_0fe95e2c-ef1e-4adc-8aa2-849142005236"
      unitRef="usd">57000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfNC01LTEtMS05MDY5OQ_52db7c3d-5a22-4321-b290-9697d1f96697"
      unitRef="usd">661000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfNC03LTEtMS05MDcwMQ_19bc84c0-8206-45ae-ada2-7c72c71ab167"
      unitRef="usd">113000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <us-gaap:InterestExpenseDebt
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfNS0xLTEtMS04NTQyNw_b9749117-cd01-465f-8d0c-3a0c52440613"
      unitRef="usd">14730000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfNS0zLTEtMS04NTQyNw_6835b97e-ef73-4c50-bed6-e43355f5fff5"
      unitRef="usd">129000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfNS01LTEtMS05MDY5OQ_6a261ab4-fa4f-4698-b52e-31bba9b93431"
      unitRef="usd">26742000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84Mi9mcmFnOjU3OWI5MTI5NmY4ZTQ4YzNiYmYwNDBjYzI0ZGRkMGQ4L3RhYmxlOmRiNjRjYTBkM2FlZDQ2YzNhNTgzYjI1NGQzZWUzNmJjL3RhYmxlcmFuZ2U6ZGI2NGNhMGQzYWVkNDZjM2E1ODNiMjU0ZDNlZTM2YmNfNS03LTEtMS05MDcwMQ_d4dbac2d-2380-43e9-a6a2-212376d73228"
      unitRef="usd">257000</us-gaap:InterestExpenseDebt>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMjU3MQ_064e5992-7fd8-407a-9c73-7ebe0829ab87">Stockholders' Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shareholders Agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the completion of the Smiths Medical acquisition on January 6, 2022, Smiths owns approximately 10.5% of the total outstanding shares of our common stock (see Note 3: Acquisitions). At closing, in connection with the issuance of the share consideration, we entered into a Shareholders Agreement (the &#x201c;Shareholders Agreement&#x201d;) with Smiths. The Shareholders Agreement imposes certain restrictions on Smiths including prohibiting certain transfers of the shares of our common stock issued (i) for 6 months following the closing of the acquisition transaction and (ii) to certain of our competitors and certain other parties, as well as customary standstill limitations. The Shareholders Agreement also permits Smiths to designate one individual for election to our Board of Directors (the "Board") so long as Smiths beneficially owns at least 5.0% of the total outstanding shares of our common stock. On February 1, 2022, our Board appointed a new director designated by Smiths pursuant to the Shareholders Agreement who was elected to the Board at the 2022 Annual Meeting of Stockholders held in May 2022. This appointment expands the size of our Board from eight to nine members. See our Current Report on Form 8-K filed on February 1, 2022 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In August 2019, our Board approved a share purchase plan to purchase up to $100.0 million of our common stock. This plan has no expiration date. During the three months ended June&#160;30, 2022, we did not purchase any shares of our common stock under our share purchase plan. As of June&#160;30, 2022, all of the $100.0 million available for purchase was remaining under the plan. We are currently limited on share purchases in accordance with the terms and conditions of our Credit Agreement (see Note 17: Long-Term Debt).  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the six months ended June&#160;30, 2022, we withheld 44,759 shares of our common stock from employee vested restricted stock units in consideration for $10.4 million in payments made on the employees' behalf for their minimum statutory income tax withholding obligations. For the three months ended June 30, 2021, we withheld&#160;37,882&#160;shares of our common stock from employee vested restricted stock units in consideration for&#160;$7.8 million&#160;in payments made on the employees' behalf for their minimum statutory income tax withholding obligations. Treasury stock is used to issue shares for stock option exercises and restricted stock grants.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive (Loss) Income ("AOCI")&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of AOCI, net of tax, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized (Losses) Gains on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99,805)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99,805)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91,647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92,275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(945)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(687)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(687)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(352)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <icui:SmithsGroupOwnershipAcquisitionSharesIssued
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMTU5_3ba3451a-9f3f-404b-b5af-83c7cca80753"
      unitRef="number">0.105</icui:SmithsGroupOwnershipAcquisitionSharesIssued>
    <icui:SmithsGroupOwnershipRequiredForBoardRepresentation
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfOTAw_7551cc34-5171-4c69-9711-2e1b0c8a98eb"
      unitRef="number">0.050</icui:SmithsGroupOwnershipRequiredForBoardRepresentation>
    <icui:TreasuryStockPurchasePlan
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMTQzNw_ce51ef44-eb62-4ffd-87d1-e80ab9412700"
      unitRef="usd">100000000</icui:TreasuryStockPurchasePlan>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMTYzMg_aa18a873-382b-42ae-b071-4349dbf815a2"
      unitRef="usd">100000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMTg3OA_16a4b4a3-d9de-4147-b2f8-7e464fe2da4c"
      unitRef="shares">44759</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMTk3Mw_5185850d-62e2-41cb-a415-8b78cc9af5c3"
      unitRef="usd">10400000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMjEzNw_35115d75-393d-41cf-8f4c-13962d970831"
      unitRef="shares">37882</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8c092ee785ac4cb6b497d26bc2664337_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMjIzMg_b37749a9-8a3f-4648-80b3-f9a5b8e1a939"
      unitRef="usd">7800000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RleHRyZWdpb246MjNkODc4MTEyY2U3NDdiOGI3MDY0MDMwMzM1NDc0MjFfMjU3Mw_f9f5dfcf-242b-46d0-b9bd-58d1dfdb92d5">The components of AOCI, net of tax, were as follows (in thousands):&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized (Losses) Gains on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99,805)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99,805)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91,647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92,275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(945)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(687)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(687)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(352)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i94b17ce1db9045be81548ad59c39078e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMS0yLTEtMS04NTQyNw_33e194d9-50aa-4a70-8e82-eeeafdcabaf5"
      unitRef="usd">-19045000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic864df7a10e243439b16f94f4d8947a7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMS00LTEtMS04NTQyNw_040443a9-dbdf-489e-ae83-b03f6b932f64"
      unitRef="usd">-237000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i978540de7dd847ba96e233480ca7d760_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMS02LTEtMS04NTQyNw_25662bbe-9f1d-4a85-8b3b-0665f29add15"
      unitRef="usd">13000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMS04LTEtMS04NTQyNw_5cf4edbc-65fd-4e2d-9c02-cdf30b6e0158"
      unitRef="usd">-19269000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia45c28b3f1cc4a4d9f0add866a4154b7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMi0yLTEtMS04NTQyNw_652ccae8-2e28-459c-ad7f-87e060a67e96"
      unitRef="usd">-4946000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i326812ecd5b9421880949758af6f0760_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMi00LTEtMS04NTQyNw_c4e69c81-489f-4f7a-86dd-4b22b8aacde7"
      unitRef="usd">25782000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if99dcd7880d44918a4d5f088ad265d59_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMi02LTEtMS04NTQyNw_5a767ad2-399e-4139-a97b-528ffad4a7b2"
      unitRef="usd">15000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMi04LTEtMS04NTQyNw_dc5da14a-687e-4f6b-b1a3-7185a383fb2b"
      unitRef="usd">20851000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia45c28b3f1cc4a4d9f0add866a4154b7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMy0yLTEtMS04NTQyNw_2a3e57c5-50a4-4665-badc-93aa3624b64c"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i326812ecd5b9421880949758af6f0760_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMy00LTEtMS04NTQyNw_7612f292-fbbb-4959-8222-8f0b519ee0aa"
      unitRef="usd">-2210000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if99dcd7880d44918a4d5f088ad265d59_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMy02LTEtMS04NTQyNw_9dec038b-7074-4de9-8fbb-7541f823fcd9"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfMy04LTEtMS04NTQyNw_37508c63-fbed-4e0f-bb85-dbcef6a7b817"
      unitRef="usd">-2210000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia45c28b3f1cc4a4d9f0add866a4154b7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNC0yLTEtMS04NTQyNw_5d28e9d0-8969-498a-bec3-db6cca47a5e8"
      unitRef="usd">-4946000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i326812ecd5b9421880949758af6f0760_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNC00LTEtMS04NTQyNw_85fd53bb-8a47-4236-91a1-ee4d242f9a27"
      unitRef="usd">23572000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="if99dcd7880d44918a4d5f088ad265d59_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNC02LTEtMS04NTQyNw_9ee47c82-40f1-42e8-ad4f-5afb6073e569"
      unitRef="usd">15000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i588327c08f70456fada2d66c38b51e64_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNC04LTEtMS04NTQyNw_ae75081d-75ce-465e-92e7-30c37c0183b1"
      unitRef="usd">18641000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i58bf8064282948fe8016498a02b9e92e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNS0yLTEtMS04NTQyNw_d17a7ba6-97b9-464b-9554-6a415a9a99c4"
      unitRef="usd">-23991000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i29830fec1151487f84613c8fe2e23f62_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNS00LTEtMS04NTQyNw_1a5f33d2-4fca-4f1a-8ede-57667ce6b14e"
      unitRef="usd">23335000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4f62f6e8b1f049a2bfc7cd1ba2c8c6b7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNS02LTEtMS04NTQyNw_622ebef8-abc9-4921-b425-77a730c25f2f"
      unitRef="usd">28000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0f22c3698eff4a70b949d07786441335_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNS04LTEtMS04NTQyNw_52698cb0-e0bc-4b2f-afd9-49ae38504887"
      unitRef="usd">-628000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id8b148239611411ab103bf9e35a00370_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNi0yLTEtMS04NTQyNw_6dd00515-5051-4187-886e-aced9276ce8b"
      unitRef="usd">-99805000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if9a33f79f91d4f94880ad5f50170dd8b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNi00LTEtMS04NTQyNw_71ff4f33-f6ce-4753-9a85-7358e52581ff"
      unitRef="usd">10245000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i02b67f1e6ebf44f4920d2e1c7a980457_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNi02LTEtMS04NTQyNw_ffc34b5d-9a3a-4417-90b7-64c8707c6531"
      unitRef="usd">14000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNi04LTEtMS04NTQyNw_03783155-7927-4fff-9be7-8099b5d33940"
      unitRef="usd">-89546000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id8b148239611411ab103bf9e35a00370_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNy0yLTEtMS04NTQyNw_19a6ebe7-b6e3-4132-b55d-b80b80337db7"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if9a33f79f91d4f94880ad5f50170dd8b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNy00LTEtMS04NTQyNw_5fbe8457-9955-48fa-b763-5ff7ce3018f1"
      unitRef="usd">-2101000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i02b67f1e6ebf44f4920d2e1c7a980457_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNy02LTEtMS04NTQyNw_fed5a645-44c3-4b76-8e97-51f5864eb355"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfNy04LTEtMS04NTQyNw_d9a4b104-fa3d-4645-bc6a-6dd5c5c8ddaf"
      unitRef="usd">-2101000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id8b148239611411ab103bf9e35a00370_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfOC0yLTEtMS04NTQyNw_afd36e96-791c-47a9-8ae8-2705f14be4f3"
      unitRef="usd">-99805000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if9a33f79f91d4f94880ad5f50170dd8b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfOC00LTEtMS04NTQyNw_4e8b4374-77eb-4a58-99b7-c60f1ca49158"
      unitRef="usd">8144000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i02b67f1e6ebf44f4920d2e1c7a980457_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfOC02LTEtMS04NTQyNw_a4a7540c-3ed0-4d4c-af49-83e79b4d92b7"
      unitRef="usd">14000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfOC04LTEtMS04NTQyNw_c037c06b-dac1-4813-8377-c405d11e0889"
      unitRef="usd">-91647000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="idffc4822f1e84243b7a821f4b832cdb0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfOS0yLTEtMS04NTQyNw_2e62bc29-abc2-428b-a660-d503b237f673"
      unitRef="usd">-123796000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7bb27df1c81b4fe5815f7411937625c3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfOS00LTEtMS04NTQyNw_00538b09-228f-441d-926a-119061e6b1e0"
      unitRef="usd">31479000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2b7c25e7ac474113b90c767b63e9973b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfOS02LTEtMS04NTQyNw_bce7e787-2960-480e-be66-1dacdbacb2c3"
      unitRef="usd">42000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOjVhNzVmYzRkYjYyYzQyOGQ5NDRjNzI4YTEwZDdkZmNmL3RhYmxlcmFuZ2U6NWE3NWZjNGRiNjJjNDI4ZDk0NGM3MjhhMTBkN2RmY2ZfOS04LTEtMS04NTQyNw_2a46420e-708b-44d1-adc2-8c442e14b7e0"
      unitRef="usd">-92275000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i26135335385b4c188e9fa42192dd9586_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMS0yLTEtMS04NTQyNw_a643e7c6-1623-4c02-b6bf-dbce41c3964e"
      unitRef="usd">-4381000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3003d8cd4355481fbc735d083ddbdec1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMS00LTEtMS04NTQyNw_9a19cf57-ed96-4d24-b0b9-4f386ad64a48"
      unitRef="usd">2784000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i327a4bd08003426f90e1ed91e3bc0365_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMS02LTEtMS04NTQyNw_1964efce-5412-424a-8637-fd4c5a733716"
      unitRef="usd">75000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i21594db97b18415da81085ad86be9dbe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMS04LTEtMS04NTQyNw_33b2aa97-6698-46d0-b222-ae64f48c802e"
      unitRef="usd">-1522000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6236b35e282a499d9e7335ded3b1511a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMi0yLTEtMS04NTQyNw_d5fc80d1-c38f-4fbb-b6cb-bda515a8ec1a"
      unitRef="usd">-7458000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i381b31d9849d4793b208bb77bd5696f5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMi00LTEtMS04NTQyNw_a04f04bc-485c-4285-ac16-79879854d4bb"
      unitRef="usd">-306000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id987a884b9304292b23dd52b1a4a527a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMi02LTEtMS04NTQyNw_35c35f42-1cb4-4775-ab9c-aedbf09f6065"
      unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic01f9f53437648c6a182b99958017af1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMi04LTEtMS04NTQyNw_8f323550-b815-4378-b8fc-59c32a8a7044"
      unitRef="usd">-7752000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6236b35e282a499d9e7335ded3b1511a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMy0yLTEtMS04NTQyNw_bac55f08-cfb1-4d27-9ebe-29cf208c47b9"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i381b31d9849d4793b208bb77bd5696f5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMy00LTEtMS04NTQyNw_679c8393-310c-40d9-9b54-a9de7de7ab35"
      unitRef="usd">-639000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id987a884b9304292b23dd52b1a4a527a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMy02LTEtMS04NTQyNw_6542be94-0c3c-41b8-8e6a-87d63edbee03"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic01f9f53437648c6a182b99958017af1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfMy04LTEtMS04NTQyNw_dba280c1-f8bf-4848-8df0-b24df5aec882"
      unitRef="usd">-639000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6236b35e282a499d9e7335ded3b1511a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNC0yLTEtMS04NTQyNw_177ac799-5e49-4f54-b75b-e250e326b654"
      unitRef="usd">-7458000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i381b31d9849d4793b208bb77bd5696f5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNC00LTEtMS04NTQyNw_ed1297b8-5324-4cf4-a4b1-0ce8a10ac1e7"
      unitRef="usd">-945000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id987a884b9304292b23dd52b1a4a527a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNC02LTEtMS04NTQyNw_777dd57f-7104-4e41-85ce-33040f3ba4bd"
      unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic01f9f53437648c6a182b99958017af1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNC04LTEtMS04NTQyNw_5e25ea97-71d8-4ff7-a2e9-2b79fe716ec6"
      unitRef="usd">-8391000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i88f2c0cc386c4a87970c9caa95befd39_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNS0yLTEtMS04NTQyNw_e5f5da85-2356-467c-904c-04ebe0a614ca"
      unitRef="usd">-11839000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4d062c01630e4345ab1b152378e6a45f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNS00LTEtMS04NTQyNw_83e4d816-15ed-43d7-b958-209a291fe4f9"
      unitRef="usd">1839000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i368b376abe90453ca246cd3e38e97a22_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNS02LTEtMS04NTQyNw_4e27ae33-72c3-4336-a14b-38055d5a2f46"
      unitRef="usd">87000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia5a196eec7194c459ffcb870a785ba8d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNS04LTEtMS04NTQyNw_fb60afbc-c612-4326-b687-d715c2e97460"
      unitRef="usd">-9913000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i49c58f1374874b18a884724db405192e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNi0yLTEtMS04NTQyNw_24033b1c-f34b-4c51-b311-89750c38e2d6"
      unitRef="usd">1302000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6b7fcd5651cc4fba8ada251f0eae1319_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNi00LTEtMS04NTQyNw_9898fb1b-dd5c-413d-9dd5-d8c2e0ce6c6d"
      unitRef="usd">335000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i00701bb034dc42d893efa54ca1dd9b8e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNi02LTEtMS04NTQyNw_5a7a4111-ecaf-4f4e-b4ce-e37b945d38ce"
      unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNi04LTEtMS04NTQyNw_e7413cf8-cc21-4750-a939-a7be35ef2b59"
      unitRef="usd">1649000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i49c58f1374874b18a884724db405192e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNy0yLTEtMS04NTQyNw_47fc4246-dbdb-41a8-8295-ef2a24534ffe"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6b7fcd5651cc4fba8ada251f0eae1319_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNy00LTEtMS04NTQyNw_b7452041-1147-4f0a-bbb0-761f3fbc370e"
      unitRef="usd">-687000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i00701bb034dc42d893efa54ca1dd9b8e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNy02LTEtMS04NTQyNw_41018484-3d31-4a60-a728-583c90ad553a"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfNy04LTEtMS04NTQyNw_1c680565-45b1-47ca-b05f-3660cdcb32e7"
      unitRef="usd">-687000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i49c58f1374874b18a884724db405192e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfOC0yLTEtMS04NTQyNw_ecd03846-863f-40f2-9a24-4ffa5a895a60"
      unitRef="usd">1302000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6b7fcd5651cc4fba8ada251f0eae1319_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfOC00LTEtMS04NTQyNw_8d61207d-ed9a-4270-a759-f7f4153bb3fe"
      unitRef="usd">-352000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i00701bb034dc42d893efa54ca1dd9b8e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfOC02LTEtMS04NTQyNw_8b5d106f-b95f-4454-b345-888544a8fa57"
      unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i04438ef32e004d068b07cd8363f49820_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfOC04LTEtMS04NTQyNw_d7abf986-a38d-4bef-9d58-727619bfe49d"
      unitRef="usd">962000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i106e9ee178e6436f90b29d6557dfb488_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfOS0yLTEtMS04NTQyNw_4cc79863-9c17-455f-a4d6-b9eb3fbc17e2"
      unitRef="usd">-10537000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i71a8aaadf61b4f2d8e906baa19a20857_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfOS00LTEtMS04NTQyNw_a1806930-d7a0-4281-87b8-89baa5ae0768"
      unitRef="usd">1487000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6c3789fe01ab44e98e7b6e29e62a089e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfOS02LTEtMS04NTQyNw_f6c0ea5c-fb6b-44a4-8892-ae3af8c2e866"
      unitRef="usd">99000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i55063029c0d44ea78a93faf80c101754_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84NS9mcmFnOjIzZDg3ODExMmNlNzQ3YjhiNzA2NDAzMDMzNTQ3NDIxL3RhYmxlOmUxODdhYzY5ZmRhNTRhYTFhMjFmMTVhN2Q2YmU4MmVlL3RhYmxlcmFuZ2U6ZTE4N2FjNjlmZGE1NGFhMWEyMWYxNWE3ZDZiZTgyZWVfOS04LTEtMS04NTQyNw_31a989fc-ca9d-46c1-89fa-53dd63768659"
      unitRef="usd">-8951000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMzcyMg_8b890ff8-cf42-4f04-9c42-a160e79cb394">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we are involved in various legal proceedings, most of which are routine litigation, in the normal course of business.&#160;Our management does not believe that the resolution of the unsettled legal proceedings that we are involved with will have a material adverse impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Off-Balance Sheet Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the normal course of business, we have agreed to indemnify our officers and directors to the maximum extent permitted under Delaware law and to indemnify customers as to certain intellectual property matters or other matters related to sales of our products.&#160;There is no maximum limit on the indemnification that may be required under these agreements.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although we can provide no assurances, we have never incurred, nor do we expect to incur, any material liability for indemnification.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2022, we acquired Smiths Medical. Total consideration for the acquisition includes a potential earn-out payment of $100.0&#160;million in cash contingent on our common stock achieving a certain volume-weighted average price from &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the closing date to either the third or fourth anniversary of closing. As of June&#160;30, 2022, the estimated fair value of the contingent earn-out is $26.1&#160;million (see Note 9: Fair Value Measurements).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to being acquired, during 2021, Smiths Medical received a Warning Letter from the FDA following an inspection of Smiths Medical&#x2019;s Oakdale, Minnesota Facility. The Warning Letter cited, among other things, failures to comply with FDA's medical device reporting requirements and failures to comply with applicable portions of the Quality System Regulation. A provision for the estimated costs related to the field service corrective action was recorded on the opening acquired balance sheet of Smiths Medical in the amount of $55.1&#160;million. The initial estimate recorded was based on a probability-weighted estimate of the costs required to settle the obligation. The actual costs to be incurred are dependent upon the scope of the work necessary to achieve regulatory clearance and could differ from the original estimate. The estimated field service corrective action recorded at June 30, 2022 is $53.9&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of June&#160;30, 2022, the estimated fair value of the contingent earn-out is $1.7&#160;million (see Note 9: Fair Value Measurements).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out shall not exceed $6.0&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of June&#160;30, 2022, the estimated fair value of the contingent earn-out is $2.6&#160;million (see Note 9: Fair Value Measurements).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commitments&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;We have non-cancelable operating lease agreements where we are contractually obligated to pay certain lease payment amounts (see Note 6: Leases).</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <icui:Contingentconsiderationgross
      contextRef="id5289794172a4cb198e8aa0169b4c3b2_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMTA3NA_5d874618-c177-409f-b3a7-9e7c511c5ee6"
      unitRef="usd">100000000</icui:Contingentconsiderationgross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic338096c01ce4426a46e77906113c1b8_I20220630"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMTMwNw_af084cc9-4db6-4961-8165-906776438284"
      unitRef="usd">26100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ProductLiabilityAccrualComponentAmount
      contextRef="i86d81cabd26944f7aa9415595f6e5c33_I20220106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMTg4MA_0d523905-8425-4b34-8479-46b12e24a534"
      unitRef="usd">55100000</us-gaap:ProductLiabilityAccrualComponentAmount>
    <us-gaap:ProductLiabilityAccrualComponentAmount
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMjI0Mw_ed1af346-a09f-4783-8f1e-4de9280aceea"
      unitRef="usd">53900000</us-gaap:ProductLiabilityAccrualComponentAmount>
    <icui:Contingentconsiderationgross
      contextRef="i0c90af4126704fd9b931fd425c90445a_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMjQxMg_5a79a3f8-13cb-4654-85e5-c8f2e6855e1a"
      unitRef="usd">2500000</icui:Contingentconsiderationgross>
    <icui:ContingentConsiderationGrossST
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMjQ1Mg_e11c2465-591e-4be3-ba41-0d286e2ad80b"
      unitRef="usd">1000000</icui:ContingentConsiderationGrossST>
    <icui:ContingentConsiderationGrossLT
      contextRef="id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMjU5OQ_2ad7215c-461e-4a00-afc2-fbb04adb836f"
      unitRef="usd">1500000</icui:ContingentConsiderationGrossLT>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2f9761d9634c46b781358f8378ab19ae_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMjc1Nw_0dc0dd9d-ff86-4803-a543-19ada674413d"
      unitRef="usd">1700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <icui:Contingentconsiderationgross
      contextRef="i4b3ce23df5e4479c839dc97cc6e1b807_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMzEzMQ_31d58ff8-ebbc-438d-a2e0-ef0a7b55ad53"
      unitRef="usd">6000000</icui:Contingentconsiderationgross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i68ee0370a4e34ec2b3cd2a4b34eed398_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV84OC9mcmFnOmE0ZTFmYjQzOGM1MjRjMDViNmEyOWQyYzFkZDNmYjhjL3RleHRyZWdpb246YTRlMWZiNDM4YzUyNGMwNWI2YTI5ZDJjMWRkM2ZiOGNfMzUxOA_34ffa419-d8cc-4d5f-b2f8-179bbcc3cbcf"
      unitRef="usd">2600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV85MS9mcmFnOmVkMjBiYTUyOGYwYjQ4NjVhZWEzMGM4Y2ZiYzBhODQ1L3RleHRyZWdpb246ZWQyMGJhNTI4ZjBiNDg2NWFlYTMwYzhjZmJjMGE4NDVfMTk1MA_49cace45-ff53-4a79-bc0d-f08ec014bb98">Collaborative and Other Arrangements&#160;&#160;&#160;&#160;On February 3, 2017, we entered into two Manufacturing and Supply Agreements ("MSAs") whereby (i) Pfizer will manufacture and supply us with certain agreed upon products for an initial five-year term with a one-time two-year option to extend and (ii) we will manufacture and supply Pfizer certain agreed upon products for a term of five or ten years depending on the product, also with a one-time two-year option to extend. The MSAs provide each party with mutually beneficial interests and both of the MSAs are to be jointly managed by both Pfizer and ICU. The initial supply price, which will be annually updated, is in full consideration for all costs associated with the manufacture, documentation, packaging and certification of the products. On January 1, 2021, we amended our MSA with Pfizer, whereby we manufacture and supply certain agreed upon products to Pfizer. The amendments included a change to the term of the agreement to end on December 31, 2024 with Pfizer's unilateral election to extend through December 31, 2025. Other changes to the terms of the MSA included (i) amendments to our level of supply of products to Pfizer, (ii) certain changes to our manufacturing lines, (iii) updates to our supply price with added volume price tiers for annual periods and (iv) certain minimum purchase requirements for certain products. On February 1, 2022, effective as of January 1, 2022, upon our request, Pfizer executed a Product Addendum (the "Product Addendum") to our MSA, whereby Pfizer manufactures and supplies to us certain agreed upon products. The Product Addendum includes the supply of additional product to us subject to certain time and pricing terms and conditions. The Product Addendum includes a minimum purchase obligation of $29.6&#160;million and expires on November 30, 2022. As of March 31, 2022, we had satisfied the minimum purchase obligations under the Product Addendum.</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted
      contextRef="i4c25d8908c9a44fe915873cf97ad8d51_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV85MS9mcmFnOmVkMjBiYTUyOGYwYjQ4NjVhZWEzMGM4Y2ZiYzBhODQ1L3RleHRyZWdpb246ZWQyMGJhNTI4ZjBiNDg2NWFlYTMwYzhjZmJjMGE4NDVfMTgxMA_17adff83-5a9b-47a4-99b2-a8145a52859e"
      unitRef="usd">29600000</us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDYtMy0xLTEtODU0Mjc_a84bb210-1803-4baa-ac5d-57f746b7383b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDYtMy0xLTEtODU0Mjc_a84bb210-1803-4baa-ac5d-57f746b7383b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTAtMy0xLTEtODU0Mjc_f6a76a36-acfc-48aa-82f4-e8c6fa59895b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTAtMy0xLTEtODU0Mjc_f6a76a36-acfc-48aa-82f4-e8c6fa59895b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMy0xLTEtODU0Mjc_8e53ce40-ac43-42cc-a11c-3226d211576c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMy0xLTEtODU0Mjc_8e53ce40-ac43-42cc-a11c-3226d211576c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzgtMy0xLTEtODU0Mjc_17312d52-ce0a-4631-84dd-a18eb2bde954"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzgtMy0xLTEtODU0Mjc_17312d52-ce0a-4631-84dd-a18eb2bde954"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjItMy0xLTEtODU0Mjc_ab78ba20-06e6-4bf3-9f75-ba44192aa452"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjItMy0xLTEtODU0Mjc_ab78ba20-06e6-4bf3-9f75-ba44192aa452"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDctMy0xLTEtODU0Mjc_7df968fa-74a0-4035-acd1-eeb6318c14ec"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDctMy0xLTEtODU0Mjc_7df968fa-74a0-4035-acd1-eeb6318c14ec"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTUtMy0xLTEtODU0Mjc_982c10b6-6cc1-42a0-baea-8cfceabaac7b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTUtMy0xLTEtODU0Mjc_982c10b6-6cc1-42a0-baea-8cfceabaac7b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzctMy0xLTEtODU0Mjc_36d5f6c7-aaaa-4da0-9b8c-4dfd3b733fce"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzctMy0xLTEtODU0Mjc_36d5f6c7-aaaa-4da0-9b8c-4dfd3b733fce"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfOS0zLTEtMS04NTQyNw_b868de97-3495-4f39-b1bd-267a25b30699"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfOS0zLTEtMS04NTQyNw_b868de97-3495-4f39-b1bd-267a25b30699"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMy0xLTEtODU0Mjc_d8f3800b-263d-4855-b3f8-572c0e60c1b3"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMy0xLTEtODU0Mjc_d8f3800b-263d-4855-b3f8-572c0e60c1b3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDYtMS0xLTEtODU0Mjc_c7816a3a-1526-470e-a0a1-e9473483f3d0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDYtMS0xLTEtODU0Mjc_c7816a3a-1526-470e-a0a1-e9473483f3d0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzktMy0xLTEtODU0Mjc_2871088d-bd3c-4197-a27a-5f41e2e83bf3"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzktMy0xLTEtODU0Mjc_2871088d-bd3c-4197-a27a-5f41e2e83bf3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzItMy0xLTEtODU0Mjc_bd6f07d7-06ca-4c37-9865-d066a96bbee2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzItMy0xLTEtODU0Mjc_bd6f07d7-06ca-4c37-9865-d066a96bbee2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDgtMy0xLTEtODU0Mjc_7ecf9fe4-2d46-462b-9cf4-25760587797c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDgtMy0xLTEtODU0Mjc_7ecf9fe4-2d46-462b-9cf4-25760587797c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjAtMy0xLTEtODU0Mjc_98804e62-7dcb-45a0-ada1-b1376c0f6a5c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjAtMy0xLTEtODU0Mjc_98804e62-7dcb-45a0-ada1-b1376c0f6a5c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTYtMy0xLTEtODU0Mjc_20a86bd3-d267-4832-a6f6-a0a9852dc66d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTYtMy0xLTEtODU0Mjc_20a86bd3-d267-4832-a6f6-a0a9852dc66d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDQtMy0xLTEtODU0Mjc_a2adcdf4-12bb-4dbf-87f9-67e10866727a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDQtMy0xLTEtODU0Mjc_a2adcdf4-12bb-4dbf-87f9-67e10866727a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjMtMy0xLTEtODU0Mjc_795ca416-85d4-4924-bccc-6c25a58dc1ff"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjMtMy0xLTEtODU0Mjc_795ca416-85d4-4924-bccc-6c25a58dc1ff"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDMtMy0xLTEtODU0Mjc_8f550f7b-10c4-44a3-b4d6-264c9356e795"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDMtMy0xLTEtODU0Mjc_8f550f7b-10c4-44a3-b4d6-264c9356e795"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDUtMy0xLTEtODU0Mjc_9c051bf9-d922-4ab2-a1db-ef3cb50205da"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDUtMy0xLTEtODU0Mjc_9c051bf9-d922-4ab2-a1db-ef3cb50205da"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjctMy0xLTEtODU0Mjc_0b66ff3d-bacc-4678-9b15-ad53ab26038d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjctMy0xLTEtODU0Mjc_0b66ff3d-bacc-4678-9b15-ad53ab26038d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTktMy0xLTEtODU0Mjc_1a768a17-8ec1-4d51-80ce-724b75333158"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTktMy0xLTEtODU0Mjc_1a768a17-8ec1-4d51-80ce-724b75333158"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzAtMy0xLTEtODU0Mjc_d52e19a4-0c54-48ba-809b-99370fedffe8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzAtMy0xLTEtODU0Mjc_d52e19a4-0c54-48ba-809b-99370fedffe8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNi0zLTEtMS04NTQyNw_8f5791fa-67d3-4c79-9c18-33fd2dc8da71"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNi0zLTEtMS04NTQyNw_8f5791fa-67d3-4c79-9c18-33fd2dc8da71"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNC0zLTEtMS04NTQyNw_c7816a3a-1526-470e-a0a1-e9473483f3d0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNC0zLTEtMS04NTQyNw_c7816a3a-1526-470e-a0a1-e9473483f3d0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjgtMy0xLTEtODU0Mjc_8afdd3aa-5a0b-425b-b184-3ffcbe32cf0b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjgtMy0xLTEtODU0Mjc_8afdd3aa-5a0b-425b-b184-3ffcbe32cf0b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzQtMy0xLTEtODU0Mjc_d7802ddb-c456-4e56-9062-abf9b7f1b622"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzQtMy0xLTEtODU0Mjc_d7802ddb-c456-4e56-9062-abf9b7f1b622"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTMtMy0xLTEtODU0Mjc_a200078c-32a4-4024-a320-77430ba61723"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTMtMy0xLTEtODU0Mjc_a200078c-32a4-4024-a320-77430ba61723"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNS0zLTEtMS04NTQyNw_84e883a6-02b5-4319-8d81-06bce0c327f7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNS0zLTEtMS04NTQyNw_84e883a6-02b5-4319-8d81-06bce0c327f7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfOC0zLTEtMS04NTQyNw_f9216bd5-da46-48b1-a355-82bc8bd6fed3"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfOC0zLTEtMS04NTQyNw_f9216bd5-da46-48b1-a355-82bc8bd6fed3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNy0zLTEtMS04NTQyNw_7c780213-5204-477b-b6b3-ae2adcd49fc1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNy0zLTEtMS04NTQyNw_7c780213-5204-477b-b6b3-ae2adcd49fc1"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDYtMy0xLTEtODU0Mjc_a84bb210-1803-4baa-ac5d-57f746b7383b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTAtMy0xLTEtODU0Mjc_f6a76a36-acfc-48aa-82f4-e8c6fa59895b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDEtMy0xLTEtODU0Mjc_8e53ce40-ac43-42cc-a11c-3226d211576c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzgtMy0xLTEtODU0Mjc_17312d52-ce0a-4631-84dd-a18eb2bde954"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjItMy0xLTEtODU0Mjc_ab78ba20-06e6-4bf3-9f75-ba44192aa452"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDctMy0xLTEtODU0Mjc_7df968fa-74a0-4035-acd1-eeb6318c14ec"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTUtMy0xLTEtODU0Mjc_982c10b6-6cc1-42a0-baea-8cfceabaac7b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzctMy0xLTEtODU0Mjc_36d5f6c7-aaaa-4da0-9b8c-4dfd3b733fce"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfOS0zLTEtMS04NTQyNw_b868de97-3495-4f39-b1bd-267a25b30699"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDItMy0xLTEtODU0Mjc_d8f3800b-263d-4855-b3f8-572c0e60c1b3"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8yOC9mcmFnOmU4M2IxY2Q0YmQxMjQ5YjlhYmE4MjVmMGJhYTI2ZmRhL3RhYmxlOjdlOTMxNGJiNDMwNjQwNGE5MDA4NGY2ZjI0Y2FkYWYxL3RhYmxlcmFuZ2U6N2U5MzE0YmI0MzA2NDA0YTkwMDg0ZjZmMjRjYWRhZjFfNDYtMS0xLTEtODU0Mjc_c7816a3a-1526-470e-a0a1-e9473483f3d0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzktMy0xLTEtODU0Mjc_2871088d-bd3c-4197-a27a-5f41e2e83bf3"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzItMy0xLTEtODU0Mjc_bd6f07d7-06ca-4c37-9865-d066a96bbee2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDgtMy0xLTEtODU0Mjc_7ecf9fe4-2d46-462b-9cf4-25760587797c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjAtMy0xLTEtODU0Mjc_98804e62-7dcb-45a0-ada1-b1376c0f6a5c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTYtMy0xLTEtODU0Mjc_20a86bd3-d267-4832-a6f6-a0a9852dc66d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDQtMy0xLTEtODU0Mjc_a2adcdf4-12bb-4dbf-87f9-67e10866727a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjMtMy0xLTEtODU0Mjc_795ca416-85d4-4924-bccc-6c25a58dc1ff"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDMtMy0xLTEtODU0Mjc_8f550f7b-10c4-44a3-b4d6-264c9356e795"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNDUtMy0xLTEtODU0Mjc_9c051bf9-d922-4ab2-a1db-ef3cb50205da"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjctMy0xLTEtODU0Mjc_0b66ff3d-bacc-4678-9b15-ad53ab26038d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTktMy0xLTEtODU0Mjc_1a768a17-8ec1-4d51-80ce-724b75333158"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzAtMy0xLTEtODU0Mjc_d52e19a4-0c54-48ba-809b-99370fedffe8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNi0zLTEtMS04NTQyNw_8f5791fa-67d3-4c79-9c18-33fd2dc8da71"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNC0zLTEtMS04NTQyNw_c7816a3a-1526-470e-a0a1-e9473483f3d0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMjgtMy0xLTEtODU0Mjc_8afdd3aa-5a0b-425b-b184-3ffcbe32cf0b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMzQtMy0xLTEtODU0Mjc_d7802ddb-c456-4e56-9062-abf9b7f1b622"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfMTMtMy0xLTEtODU0Mjc_a200078c-32a4-4024-a320-77430ba61723"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNS0zLTEtMS04NTQyNw_84e883a6-02b5-4319-8d81-06bce0c327f7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfOC0zLTEtMS04NTQyNw_f9216bd5-da46-48b1-a355-82bc8bd6fed3"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RhYmxlOmJmOGY4MDJlYTE3MDQ2OTc4YWQxOGVlNGI3OTJkOTVjL3RhYmxlcmFuZ2U6YmY4ZjgwMmVhMTcwNDY5NzhhZDE4ZWU0Yjc5MmQ5NWNfNy0zLTEtMS04NTQyNw_7c780213-5204-477b-b6b3-ae2adcd49fc1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjEwYWJiOTQyODlhYTQ2YWI5NGRmYzUwNmRkZWM0OTYxL3NlYzoxMGFiYjk0Mjg5YWE0NmFiOTRkZmM1MDZkZGVjNDk2MV8xNi9mcmFnOjU3MzRmOWQyNzcyNDRjYjM5MjdkM2Q1MTA0MjQwYjNlL3RleHRyZWdpb246NTczNGY5ZDI3NzI0NGNiMzkyN2QzZDUxMDQyNDBiM2VfMzUx_14ee104f-3485-48f1-bc84-b574ed3c46e2"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>108
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M+<R;"=[<0=D ?#^7TCQV[-VP_"\0_@-02P,$%     @ .YP(542*76#T!@
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M@?;*>^Z!65$5ZS#BTT!]ZS2QV8YC$U6RCG,()A5; BG=(+%JW\9RR9LIAIT
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M+W=O<FMS:&5E=',O<VAE970V+GAM;*U6VV[30!#]E9%!J)72^I+$A9)8:N(
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ML4!,=A 3)\0;5C\4+1D!%Z*\;N9BT91 *UG=0-HS@4TT&*/QN =5MR%[L7R
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M>?@O"I-.82*XLR-!^4I%-3WQ;@6>I<D:/TBHHDW@M.5+N8J>3C7IQ>F9"CJ
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M4_),@/.I0P6T"U;0/74O_@902P,$%     @ .YP(5;:70?F3#0  #B0  !D
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M--^K_P+'PGW/&#"9_A\8<$151DB$BX_[E:%R<)S$2G '].41Q7-5X=1,RZ*
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MZ07DX96ED/53Y"@]Q@HZZ.+BF& 7#NBVIY-D/,8J?U)!S)$*X+:4\VDR&T/
M?E6/TO0\.3O'>X\,8 &9LM!\0*7J1XE,^38:SI+I:"2^-R;G_G(B*E.S;FB
MX._LKE$RF4R2"P"U2^H6/==;N.N#[=_/_\?N[P1NZ:L?Q2H.*(?32;^U447@
M^PJXC0L738\KO48?.9P,=U9B>%$%4(6$4MFJ,H59 EY@!]O+M!_>J'%U.YQ9
MU!ODI*<(A]/M+>@^T(VRWG>4+BTCP3F)_4&6QM;ZSU"TF(^V0TW].')[/($8
MKL%1[OD$*(F*@Q/I&-B%VDJ$P.E[AEWG7[D'F,&I-+VA""Y#/H*#8BI,VATP
MVR(#'T2X1.B]HN': B:-]3P:8B5=>/66. Q97 G(;[&W>$I58UD>P6R)'#=A
M\NSVAHV4SHSS,"3/T>#W=;O=1UVS\T-IKP]BM6OFORN,PJB6BP9&4/.[TSSH
MQJZ^TZ2>ZGXD/5<H;10[T:Q#S:?ILXC!#NTV^H#JO<>KM^DOPM[52RX/!;R<
M/\KI%5 &YP(%W$V8G+PG#(MQN[;N==1=M&[WVK_0:*/8Z)@A34OQ0UUBE#+/
MKKR#VB$SL_!>UFM? ,+O3;XLN<?P<O+KVM\%H;BPL3287[9$D10,;1:MSU-?
M]T+DVG%M%G0OTGV--&0!'H55UCS(@A!-9[_HEY":3*:K7_\&NIS2)-%Z"$!<
M-(4@]R-NUV&N](%YPD4A%($P0UM7>^Z.Q@:,E@JT"5P_G!&=6 #CEGU1F>K$
M?Z.MU'%#M'M"6J8F&D#01M97:LH;FC=US02>JOM:VCJ"$86K<C+S5/SYEDO;
M@RGMB+Q-.B 31\(?9(/".U/J++J*@&;E1I ;K:8)30>:\- 7#557VA%Y('RP
MKQ@/^>^(D?*EDF_JYLZ@.&2*1W9_W=,AF6\:NB(9W51ZVNAJ/V7PI,#W!8;N
ML';4Z&+NRU![05306A\*'$-7AP5@X_E2?.I44?A6@1*@W0I2EH9N'IXR^@M/
M([G>E^LO)E1M/NU4?P8GZ)NQN=<!FY'^&<K] T60E:,2%\%"K#5^[K'9)!3+
M?7N[&.1A25=BD-F-"F.&)B*-QNAI3R6I& _$ITHV.=^8 IJ"?Q !??(_"A'@
M=BY'==O1>#CT%P@5<*)S5@#=JBEJ&NB7NF*0]B[Q9OX2+UX]AG;DO4?TJ> Y
MKJZMGC?USJ01%8A]/+9UNDG<D4^[?FPJU?Z>X,-P.!G/!N<MI6".<3;M+@ 3
M4GZM^->DXB$@*[*&E54H(_XW#^I ^=X34AAWL7U">M;1F,'.I-FTOD<(!?L\
M7*9J<G4O"F'B=?':<<[W ]'9=&^X#A7"Q?&&3M^]V4;P'D$+#0V@SAC0>3]:
M(S9M%%/A>06UBSJ& M)[B:7@#&M#&62JPO,"[0NEKD@U<GG7N_<9Q05V8YJB
MWX#C)<Y35M7R,U;YZAW8 N=7.)3,M;ZB^B/Y$+I097?$"S!/6\@-3V/@%EQP
M_YNCF_[,[L%";NU]^ACS )/GV0BCT@2?SE+,H)/4CQ"87<[3,7].4XP3PU3\
MC'QY3_ER*(YFR60VH5EW/$G2">T^FEXDDW3*SVBTF'$0]^$MVMY%SQ._. PP
MV2C7,FO[68=?WS&845S2!LO5GX#6)^"A>@J^)7M$N2*M@O##T6"\G3S37GJV
MN>B>]#6[E#:26W?3N:]?_-$JZI8$<]FHONX\T<SKCO*0='ZBXY4']XTDXNO:
M_Z#Q3F:Q!9!AP]VZDTX'D_^-82]\[X'(64]D]/G.11/[@*@[H+W#0]N>^47:
MC/A2,5Z'<JM'_>,B2%0*'0_E9 <B<"*>UY3_.R6>CHL_]87J)KW<7EBZW#Z)
M5C%U8>",OQ8GHQ[E\=KMN$K=$TW$D2MF-%PEXM4B^!MZ%5A=_V:&1Z-PV<#W
MXR3I\'PXF&V'?M*?:_^KT _^,JEC$M^\^WA+ZGP:W [$]U=7'[8L)R5V.D6/
M'T99N_[R]XN<%12?-2A ]N!_//4_$D3&:%5+2!%[A^&0?M,,;K[VOPH/Q!4(
M9Z[I]U+%OQ>&'XSZTEM"U3)59N>+@N=+KO^/-X2B%<Z)-?V+*N'  Z7W$_F^
MW_1/>W^C@?EFR7^)0C"&)O[/-=JG[1^[7/F_\>B6^[^4^4E:L";BHPML!7*F
M!_ZV+7ZIS9K_XF-N:@Q3_'&E)(8#6H#W"V/J^(4.:/\$Z/5_ %!+ P04
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M0\J[C&4!&)1D+$Y"[)Y]/]F&@_."5]18],F8#1&S,XX=K]T8@0#F#R0L^U/
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M0&O+DBW;:1(@V;WB>KA>%MGM]</A/M 2;1,KB2I)Q<G]^GN&E!3)=HP6A\*
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ME>(!YM:;HV*!+KG_6*!O4!5/:#D08N&,3%BLM:I".ML!A=9Z+COJ#6>7"4?
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M-:3PU'/ROVY!ZGZ'\1GULP8 +)2I-SD2G1H^7^ZY4T&XP$#WW//6S'S8^UP
MMI1\K"\D7.**3LX7OS7H\(AQG8H/A')D=#(X5Q^VI6<-H4C,XT=4B.<8MI#&
M2\9*5CXM7$J*;HSUOIJ;VNY+S5T)2=&\%4J<INOXT.N.ZYPE;_+.?M!,2,Y&
M@.32][14%O?VI!ZA?$NEJ'/TT -.7A?K(7RJ'WS]8LMQI8$*"/9AE]B=("$[
M.(Q! 5:6M:_MBV9%QG_9*Y730[9.=X=7 M^@>)WB;].IW^D-:YVNRM/6==E]
MUWW$=B!J:M^<IL)4IB<'9G%<,QY4U0J%-=5<7R,6-,(?31UWA,,!5XN-D]<&
M.E,WN^?L)LY\X=T[?RX.K5*"+F=$,'HA?C;I[/@335^JB3O:SB:W,J65CA'.
MV8[#)Q]&.#.OU"1K2!VIS%$CZ(&7VU"V00-M5HK0!\]<=.AX.*6+-U[&':IF
M4W((_'Q]_O%6%':\*XSW$1B3TA5:>0\%\=A)AZV[CU>W5,BI[":0(?7A#Q:*
M(J_L03Y7<FVKM2YJ!5CM/8C7]J<0/2TY3!1*.IH*'VWDFNT#?!F6D4RBHO>=
M/#:D9)SU@L3'.<XPFXC3$6^J$^Q[F2%02F#Q\C2C@Y1J\X'(V[R-Y*2F$^+
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M2NSDO'A#DW?NFJK9-419U#5EU&1EW?YI*G,N!_B0QJ/KK,P1,:Q@!P6^M*
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MS(GTHTNDT:+#*[<8G=AR3N2UDF'_:@\+8/ 63Q]\V?"1RP8:(T;]A,:_*YX
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M7Q/5HDU8(AOY'X+@5/!P6\/@D >I-FZ0=F*C7F6\WFGJ[D&FAXD@T75CO.(
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MONW2ER0:;\#W);'L?N,=#!_0U;]02P,$%     @ .YP(52U"[2H+!   = D
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M.D(HL; .@=// [Y!*1T0T?AZP P&E\[PN?R(_M['3K&LN,$W2OXN2ELM@FD
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MDL!G9;ETIZ]GAU%ZC(6(16G.8N<BG+ H3.&J*+JZD]P2HQ*I3@O!O;_S-*<
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MD.Y2[JRFMX+L[.RTJG2/-5P)/A>ML (-O/M-630'QU-+#MRQ:;4!.QO HA?
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M1-IBE.DLB++(*W6I^$R 2P(6I\Z]2]XUU_5[8[GV)(0DP53]0*00S)JOS)B
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M:9^.[RB#MTRVX:3WA>04B3B@<GYIA>^.L/]/N%%D^IJ$J@$+)X<[7UL\SOI
M\>_T?_[_ZO^UU"L*?=#2U*=AL[QO[A^6/U]3=P_ =_G#'G_T8)Y?K=R'E*U7
ML_N+<M#M7<W&#SNM.%XS+\GP\-)3B/_IW8DW=WCL\Y4>C!8UFG48H/R;TRH7
MIXQ>V\]H9W$TN3>/ ]XG9M9"69!8D6LV_)Y&(A.'IB@XW81!9:4=C3UAN:$Y
M$XTWH/U*:[<7?(!^<EW\!5!+ P04    "  [G A5\\)N:801   A-P  &0
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MQP1T<.A1MZ 9>2D*5A2@)"&FC3GX(@J5YB2A6['4/J>\*7 @:E%:JZGPB!U
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M%RS"YX]XX^%,F?SZT0+^3XK'!93J>?CY7L-K7-I VP .N*?[+T>P02 ?M%B
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MX=4P]4"W+T1K6+5K;N6ULG3'-\.2'E74;@'Y-TK9H^$2],_T[#]02P,$%
M  @ .YP(5757^Q]'!   D@H  !D   !X;"]W;W)K<VAE971S+W-H965T,S$N
M>&ULG59;3R,W%/XK1RFJB&21L>>64(@$++O;55$1L.W#J@_.C#-C,6-G;8=
M?WV//<D0EA#:OLSX<L[G[]SL<[+2YM[60CAX;!ME3P>U<XOCT<@6M6BY/=(+
MH7!GKDW+'4Y--;(+(W@9E-IFQ*(H&[5<JL'T)*Q=F^F)7KI&*G%MP"[;EING
M<]'HU>F #C8+-[*JG5\834\6O!*WPGU=7!N<C7J44K9"6:D5&#$_'9S1X_/4
MRP>!/Z18V:TQ>$MF6M_[R:_EZ2#RA$0C"N<1./X>Q(5H&@^$-+ZO,0?]D5YQ
M>[Q!_QAL1UMFW(H+W?PI2U>?#L8#*,6<+QMWHU>?Q=J>0+#0C0U?6'6R63R
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M&E]WIKO&YS27M #GET+HS8 VZ![HTW\!4$L#!!0    ( #N<"%5R H'%C ,
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MRR[#^2MS8W<\QVE$=\*B><)H]OY=.DANKY#-3F2S:^BS)5W!HI((>@T_$^_
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M!8BX!8S('O&ZP\D4%^]SKKA5+H*@NIR-<*-UI>F^>T"&PZX[G)!S>)REX9H
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M93 +H,8='X3]H@Z_X3&?W/%52AC_"X<Q-IL'4 W&JNX()@==*\=__G0\AS>
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MAH<Y]GS3/9JZB=,S_U"YT0Z3VP^G6+>$H0VX/M;:K29D8/UR'?X'4$L#!!0
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MOI5G322M8?N2#%J-#P(WF-1-+Q$!A=0XCFJ.(RO'JI=%Z.=8C,#T/!%S:R0
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ME?* 9YOB%2./&>?9NOBXHF(-D<LOB.N++.,O!S) _5J;V5]02P,$%     @
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M6'7NTL'7)VK7F#VF!0<9>9"FG+-0I@ZK#ZGJ&T'7U2G,/16"YM7EBN"$L%)
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M%A*FNID=%)"N<TBH Y(+[F@BMAQ\3%9D5<^W);V2(WKA>(V,!7]/DTO@.A<
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MWQ*TY111EU//$5_LDBA'7Q8+RJ6!J@F7KC906@!*"Z%HW5RT]1[!5Q($ EH
M@M("4%H(1>NFJ"T B;)Z40I"[=H5!,/V>H(@,>L+@L0$VX[A]%]4*%'="-OZ
MB:CKI^=8U!6%-$;0%V*@M "4%D+1NFEH:SMB74L+0&L]4%H 2@NA:-T4M;4>
M4;_04VJ!/7R'Z/JFW]>"H=E "X8FV'2'3QF4J$.$^LD)BY3FZ^IH"T<+MLO$
MX65ZT]H<G_E2'1KIM=_AVRF6M ?X-CP<CFGQA[,Z#U&^CC..$KHJNC)NW&*T
M^>'XR^%&L&UUOF/.A&!I=;FAT9+FI4'Q^8HQ<;PI.V@.(4W^ U!+ P04
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MBK,PS%GW^5S(A+*?PBQ8JW>";6 65IB%K6(6-HI9IM3:L5"8A:UA%M[GIU%
M@FZ5:RB+> >X!2O*PD8I"VOP:>SX>\:.]G\/QMC%!ZQ5E(5ARCHXUYZ%+%BX
M=['9@"RB((M8A2QB%+),J;5CH2"+G "RB :R@L#KKC2P*<>ZJAB+//,[%5#]
M(&+!NKT3;@.QR,[#/+M/\\P^SK.!6$0A%CD!8A'-+U"N3[O?Z; IQ[JJ,(O
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MG[%!XS[2[W95@?;1"DP2B=>23<Z?NKO;S>0US*:B#OFD8MQ4O#4#=BK SE'
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M7^A.5S2F-YJB3=X1,:=,0H8S3>F=]71^1=%ZBHGB"UN]IUSI7F"'J>[6*$R
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M0G79^':O<SN0;%EL%TZ8E"PK#A= E=GH">K[&6/R9:!W(,L=Y]%W4$L#!!0
M   ( #N<"%7K;KXQ_ ,  'L.   9    >&PO=V]R:W-H965T<R]S:&5E=#4Y
M+GAM;*U778_B-A3]*U:ZJAAIEGQ"8 I(,R2K3K6[0LM.]Z'J@R<8L#:QJ>W
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MWTQ6MI_E0-!<]U=/5,AN3=^N9,>.F J0SQ>4BNU ):C_ T2_ 5!+ P04
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M:=:6E@9CL%^,P4U"07B.R;&KG4$&&Y#!G0^1G'4P;AX--2:XY?2H=2<)&Z+
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MV!T?EI).ILH)]D[KEX-<ECVW(K$HN*[>MYO5IJ^_*+O9@_5+]WSNMJR'YCM
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M2&925AZN*R\$716GQ^ZH$#0M/BX)C@A3 ^3W"TK%TX5R4!]QG/T+4$L#!!0
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MI$=ATON4L76<W%F__URS55['3?]=/++,NMQD6=7]=>04>BS"C6AWO D I!P
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M[$U_'J<_#Z:_GC-!,Y<';E2[;TWLXWH<.SUGY)F RJ!8TF1O<0;UX.@?PDQ
MA4P/^K&%;*/P0PK%QNR)!JHA$E9@:"=RB/10(/+FR_8163TA#['L3H-1$1)+
MFNP;CI#>R CIH2(DEC396QPA/=.I?5X;*%NSQ01->IPF/12:Q,D'@G71'ATF
M(-/GD.F/#)D^*F1B29.]Q2'3AR$3<=/$5],F>(EL :=-?^#.;^]]$%\=>H1U
M&-I+'!=]E"BE;EX1W*KV2#8!B3Z'1'_D0*6/RI!8TF1O<=ST!^8!#LPA\-7\
M"6LTU&+A5[PH_#DX^0AN7GMXF !2GP.I/S*0^JA BB5-]A8'4A\&4J3D([@5
M;9] C"L;RJG4_W.S$?UV-F)KU3!!DP&GR0#>2M9:-7J@-MR<]H_N3<!CP.$Q
M&#E%,4#=Z<:2)GN+@VJ@"(OBH7:@)E98F:'&<F(-8&(]G<J#=E9BRT83Q!EP
MX@S@L.3QM8'":P J2&))DYW 03(8.4<Q0,U1Q)(F>XM#: !#J'9F4M#.1/2I
MZ[9F0OLRX&BB0#A.!DXR'+);"XO4[K!VDJ)\$)!L&6>V &:V 2E*0<<V=/M8
MGXZK@'-].'H%0P."='"B$MRD=D^9(+60DUHX<MPO1$4W+&FRMSBZA?AYAV$[
M>M=U$A#<\E#+.&:%0W>?Z;!D);@][7XWP64AY[)PY(WG$#6FB"5-]A8GO! F
MO$&S!-H<KJTR@6PA1[90$?OK-T,T,Y7@1K4[W@2GA9S30G_D:8(:+<22)GN+
M4V((4^+I&[)AF_):DP:Z1%9<.#=PZ&]+Z F92G"CVGUK8B,ZY-P9COS+DQ 5
M0K&DR:<K<@B-X'#AZ3,!;D#7'5'7#UN._0(UXO08*7:-3[2Q#9(^;1TH:0(C
M(XZ1$0I&]DU7@EO3[E83$!EQB(Q&AL@(%2*QI,G>XA 9F<Y>C-1(">LPU$:.
ME!$*4N*D*\&Z:(\.$Z09<=*,1B;-")4TL:3)WN*D&<&DB;B'$K5YLN/XHHZK
MCA]?%''PC ;N&/?>'HDZ@I$=QQ?!>@SM+^&X:92HI6[B$MRJ]I@V<W:U>'CU
MR*'+O0)(#D,3U_"8<.ZU/3!M<6 BPKX]^%PDA5:#[::"W2A4.CB)2=&^_D Q
M<C"V+9R,;8^,JGL%T#QFY#AM6SA/VX9Q%2F92=&,OE_:#'S\FRRQA1.Q[3\W
M$W+?'GB<DD*IP=TL'*1M#TV'[%A)>D"YHCW]_C9RV+8MG+9MCWW<MHU[WC:6
MN(;'A!.W;44T%0_.]TW!)S I%!ILLG#ZM@WS[>D<OV]!=0J30I.AMHHE5A0U
M5HZO& Z\,B"77#%4<T4LNC)ZU17DLBM&L%4LO**HO**=]D0ZZJZTGJ'@-0U=
M!6)4%%,95"4&N:0*@7(?&Y8)9 <7%QF2\K07"?<#=$U#6X'+%*5*^BPWN@E/
MBC;U^\D(Q8GE4,C(T4."7$+%3 T5L8@*7'=DX/16;T\KVAULF8!?BHHG/2>,
M1JDTY HH6.(:'A)HC8R\ETVP"J7L/6:$^83"*T11>658R33HG,3:,B.U58A0
M7(7 ]4CZSA;=TFJX-570Q#7<)) ;';GF,,&JJ++WF)&(HU"AA2A*M" 4GJ)M
M_.NLL=9Q'5!D32BI0N J)'TGAVXU-MQ**FCB&FX2$)6._-L7 E=ST?>8$5X5
MJK801=D6C,F!"Z0=]5V@.22 IJ+(RZF5V6B;.1W;M=N+@!'N%.JY$+@$2M_%
MHF^FE*(Y_0XV0IU"!1="QZ9.K'HM>X\9H4ZA_@M1%(!!6"6<-H.VB[DI]!AL
MJ4"A<%F4OG,')V]*H8SV.#%2\H4(-5^(,S:<XM:#01/7\)A8*'I@Z9@!6S0=
M96/:$ZQ_(%,H!D,4U6 0=EV<'G%-(]5?B%#^A< 54_JN#KK94XIF]4>U$:H4
M"K\09^PH*%:ME[W'C$1!A=HQ1%$\!CWIH:.63'L^&2%5H9(,&5Q*QL')GL*M
M.8,FKN$P 5W'+CM#<.O.H(F3/294GB&*TC-8V5-P,]I^J<7Y/9[#0NT:HBA>
M@[Z*@+5H]J88H4ZAM@U1%+?16D7Z8#G<GGY?&X%,H:0.<<?.N<2ML(,FKN$Q
M 6CALC2H6.[V(%LC57*(4":'*.KD(!!\W4+WDK:WTPB9;@OG--X2T LNL#+[
M1KY?L?EV.=@UY9 SB]J46+>[N9);SZ5OK+O**275WV?ITHHW=TE1OIB7TR-=
M)'=Q]8+'2/+]',I?=RD^S:O9=Q47\>Q\R;('=LD6B[P4MED5U306WK4R=E]Y
M[LT5F4Q;[Y?&^>4GI0,Z/PNJSX+JLREO9G:^CA_8QSA[2,JIO6#W99/VZ^H<
MIBQY>#R\*-)UZ<>)=9L61;K<_OG(XM()U07EY_=I6NQ?5 T\I]F/K5FS_P-0
M2P,$%     @ .YP(55=$=8!B @  804  !D   !X;"]W;W)K<VAE971S+W-H
M965T-S(N>&ULA53O3]LP$/U73AF:0$(D36FWL302I8PQK5I%Q?9AV@<WN306
MCAWL2PO__6RGS;JME"_QKWOOWEW\G*R5?C E(L%3):09!251?1&&)BNQ8N9,
MU2CM2:%TQ<@N]3(TM4:6>U EPCB*AF'%N S2Q._-=)JHA@27.--@FJIB^GF,
M0JU'02_8;MSQ94EN(TR3FBUQCG1?S[1=A1U+SBN4ABL)&HM1<-F[& ]<O _X
MSG%M=N;@*EDH]> 6M_DHB)P@%)B18V!V6.$5"N&(K(S'#6?0I73 W?F6_9.O
MW=:R8 :OE/C!<RI'P?L <BQ8(^A.K3_CIAXO,%/"^"^LV]A!/X"L,:2J#=@J
MJ+AL1_:TZ<,.((Y? ,0;0.QUMXF\R@DCEB9:K4&[:,OF)KY4C[;BN'0_94[:
MGG*+H_16KM"0[3+!'+-&<^)HX'B"Q+@P)W $7,*4"V%;:)*0;$H'#+,-_;BE
MCU^@'\)422H-7,L<\[_QH97:Z8VW>L?Q0<(OC3R#?G0*<13'<#^?P/'1R0'>
M?M>'ON?MO]H'<PH37! PF</U8\/I>;<S/R\7AK2]2[_V-:/-<;X_A_/7A:E9
MAJ/ &LB@7F&0OGW3&T8?#U1PWE5P?H@]O;$.A..ORMB_9J_[G D$5<!.8?L4
MMYQ#S^D,O$JC)%SMD3'H9 P.RIAIE2'F!@JMJE:%Z^24D6OALY/TC4K4KPD;
M_">L]^$?9>'.M:]0+[VY#62JD=0ZH-OMWH_+UC9_PMO'9\KTDDL# @L+C<[>
MV?2Z-72[(%5[$RT464OZ:6G?0-0NP)X72M%VX1)TKVKZ&U!+ P04    "  [
MG A5E6KT>_L$  !]&P  &0   'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6R]
M65%OZC84_BM6=C7=*[5-;%*@'2"UL&F=VJFZM-M#U0>3&+!N8C/;@=O]^MDA
M) 2,6WK3O4#B^'SG?.?8SA>[M^+BFYP3HL#W-&&R[\V56ESZOHSF),7RC"\(
MTT^F7*18Z5LQ\^5"$!SG1FGBHR!H^RFFS!OT\K9[,>CQ3"64D7L!9):F6+Q<
MDX2O^A[T-@U?Z6RN3(,_Z"WPC(R)>ES<"WWGER@Q30F3E#,@R+3O7<'+$>H:
M@[S'7Y2LY-8U,%0FG'\S-S=QWPM,1"0AD3(06/\MR9 DB4'2<?Q3@'JE3V.X
M?;U!_RTGK\E,L"1#GOQ-8S7O>UT/Q&2*LT1]Y:O?24'HW.!%/)'Y+U@5?0,/
M1)E4/"V,=00I9>M__+U(Q):!QK$;H,( [1JT#QBT"H/6KD'K@$%8&(1Y9M94
M\CR,L,*#GN K($QOC68N\F3FUIH^9:;N8R7T4ZKMU."&+8E4NI *C$F4":HH
MD> !3Q("/H^(PC217\ I>!R/P.=/7\ G0!EXF/-,8A;+GJ]T# ;)CPI_UVM_
MZ("_-KCC3,TE^)7%)+;8#]WV$#D ?$V^S #:9. :.1'_R-@9: 4G  4(V0)R
MFX](I,UA;@X=X;3*@K1RO-9!O,EV*4[ U5+7P-3C5,_R4XEU89YNM1&X4225
MS[82K#V$=@]F);F4"QR1OJ>7"DG$DGB#GW^"[> 7&_V&P&K)",MDA"[TP7C.
MA3I51*1ZV)4#59;9L9%?([9S1+/J+0>P!2]T:9;;K"R]PA %]5XC=W1/\-G!
M\;SD>.Y$>4/!=5NJ$T'_)3$8<JELM-=.SK<)G0>HNT/;TNLB""O:-0;MDD&[
M:08G8)@)H8MIH^+T=NSP;>\SKA6ZQKA3,NXX&=]R-CMR6';VX^BV.COEV>\4
MM@_%VBUC[?YH=6SQ=M\TGBR]#H^GBS+B"V?$EA5OF\3+9NR ISN23HBPKH%.
M%\<.HH; :MF 0?6*#C[\E5"X:"@?3:'5$[*E6>"/+SB/3.O@)%]Q;KFT2Q6G
MFZ.3 O<FPX&) %'%%+UQH:F$F@1/(VXDO;W03L"C.36$5J=?:2'X\6((-JJ&
MFD*K)Z320] M.=XT\O_D+#K\=BT\O/(FLO0Z_"J"E=:!#8B=H1;XE&7Z&V-W
M$H-[+JGY7CP!U8< %\!,$R*L;/<53[!+U=6ESK-21- MB=XA$*!%J5CJTMX3
MKHZZ5'H&N@7-D(L%%U@1<,U9O%4A:Z1.K*-G5$-H=>:5.H+=CU]BG KLZ(0T
MA%9/2"6^H%M]O>>;JX"LC5W8Z>X-WH_04:C24<@I2QK_3BG<O<;:'=5[65=B
M"?T_8@FYY$W!M"$]56=:B27D%DN/8_"@:<A,O+RR@KF!CIVP3:'5:5<B"7V\
M2$*-BJ2FT.H)J402:G[7"%E441B$NP/<Z?B]Q"KUA!K?*G(O8);M( MI9U#O
M)5U)*=3 [M);UJ]]Y;2W?C6T\U1G:D18O:42)\B]=_,$GT<DRC<YUGXV&\U@
M@A/,(B+!B@@"8B+H4G.?"IX"G,54Z9N(,\D3&F-S,Z5,]Z<X 5+IAOP[\LP6
MM;]UEI 2,<O/9*0&RYA:;VJ6K>6YSU5^VK'3/H27(VAK1Y<C6_\KU-$/.M8G
MW<W1DE^%M#Z8NL-B1ID$"9GJ\(*SCAZL8GW6L[Y1?)&??DRX4CS-+^<$ZX29
M#OKYE'.UN3$.RA.WP7]02P,$%     @ .YP(5?HW]1]V @  W08  !D   !X
M;"]W;W)K<VAE971S+W-H965T-S0N>&ULK55A;YLP$/TK%JNF5NH"@33K.H+4
M)JO62=6B9MT^3/O@P 6L@DWM([3_?K:AB'8DVJI] 9]][]U[!QQA+>2=R@"0
M/!0Y5S,G0RS/7%?%&114C40)7)]LA"PHZE"FKBHET,2"BMSU/6_J%I1Q)PKM
MWE)&H:@P9QR6DJBJ**A\O(!<U#-G[#QMW+ T0[/A1F%)4U@!WI9+J2.W8TE8
M 5PQP8F$S<PY'Y_-3TR^3?C.H%:]-3%.UD+<F> JF3F>$00YQ&@8J+YM80YY
M;HBTC/N6T^E*&F!__<1^:;UK+VNJ8"[R'RS!;.:<.B2!#:URO!'U9VC]6(&Q
MR)6]DKK)G>J*<:50%"U8QP7CS9T^M'WH <:3'0"_!?A_"PA:0&"--LJLK05%
M&H52U$2:;,UF%K8W%JW=,&Z>X@JE/F4:A]&G^XKA([D&S$1"KO@6%.J'A(H<
M+@ IR]41>4=N5PMR>'!$#@CCY%LF*D5YHD(7M0+#X\9MM8NFFK^CVI>*CTC@
M'1/?\_T!^'P_? &QAH\M?/P<[FK?G7F_,^];OF '7\_N,5G &HFV1=J6K""N
M)$,&BOP\7RN4^HW[-62YJ3$9KF&^PC-5TAAFCO[,%,@M.-';-^.I]W&H ?^)
M[%D[@JX=P3[VW>_"D.N&:FJIS*C81H'O34-WVW<SE!2<=DG/5$XZE9-7J3PF
MYVDJ(:4(9"X4#HF>_*DG\+P7HO>6?^4C..G,G;S2W->:@U09*\D29*RW](P=
MLMCP?^A9]$;^"X=[-?RK0[<W?,S@OZ8R95R1'#::WAN]U]5D,TR; $5IY]%:
MH)YN=IGI_P](DZ#/-T+@4V!&7/='BWX#4$L#!!0    ( #N<"%4;D:*RW ,
M *X,   9    >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;*V77V_;-A# OPJA
M%44+=)&HOW9J&TCM#=N 84'3K@]%'VCI'!.51)6D[/3;[RC)BFW1BA_VDHCD
MW?%W1Q[O/-L+^5UM 31Y*O)2S9VMUM6MZZIT"P53-Z*"$E<V0A9,XU ^NJJ2
MP+)&J<A=W_-BMV"\=!:S9NY>+F:BUCDOX5X251<%DS\_0"[V<X<ZAXF/_'&K
MS82[F%7L$1Y ?Z[N)8[<WDK&"R@5%R61L)D[=_1V14.CT$C\RV&OCKZ)<64M
MQ'<S^#.;.YXA@AQ2;4PP_+>#)>2YL80</SJC3K^G43S^/EC_O7$>G5DS!4N1
M?^&9WLZ=B4,RV+ ZUQ_%_@_H'(J,O53DJOE+]IVLYY"T5EH4G3(2%+QL_[.G
M+A!'"NBH7<'O%/QK%8).(3A7""XHA)U"$VJW=:6)PXIIMIA)L2?22*,U\]$$
ML]%&]WEISOU!2USEJ*<7]Q(JQC-%6)F1?_06)%G64D*IR9U2H!6Q2'0K;U:@
M&<_56_(K^?RP(F]>O26O""_)IZVH%8JKF:N1T>SDIAW/AY;'O\#S5UW>D,![
M1WS/]RWJRW'U%:2H3AMU>JKN8F3Z\/A]>/S&7C >'O+;$R::@F$,OMZME99X
M>[_9?&V-AW;C)J5O5<52F#N8LPKD#IS%ZU]H[+VW>?X_&3N)0]#'(1BSOFA]
M/HO&N\-5L;G>VHL;>^;QV2W\Q)O@F>R.?1I*T3")@U[J!#;L8<-1V /F#LI,
M2 (MK?4RMH:BH_VC.(K.((="GATPZ@&C4< 5;  #EY&E4'J86#;0:,"0Q.'D
M#'0H1/TDC.VP<0\;7Q5-7JI:LC)MDZ"26'JD_DDT>[*'-A["Q%'HGR$/I>*
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MTF"]*9M3_(4 91/P^UA*L^S8 9J?DL$_4$L#!!0    ( #N<"%6#6GQDN@0
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MU3]YJ1VQHX#] PINK>#^7P6O5O#V%;P#"GZMX)>>J4PI_3 EBHQ'@J^1T-*
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MD?/>(3DLZ*K4EV+S&=IX3HU>)DIE_\FFP48(SE9*BZHEXPDJQILGO6OSL$-
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M"]( \/U""+W=& ?=^$Y^ U!+ P04    "  [G A5CG%NG7<#   L"@  &0
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MN'D*N?_)K=]1[ZC:,*$)AS5*]ZZ'^)&H^FU23XS<5=UZ)0WV_FJXQ><<*.N
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MQGP-XLQ:H&4?\F+FWB)]/\KN^U,:B[.^\$NO/G(^7?M! +QH"NZBU(OF_DO
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M/D.%ZJIF4K<B0O9J$I'Z [=K;^A(4=&U0(-:2T!EAJFN!4RD4B#F-7G,7EG
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MY6'^<<$\4;#,0)R?<9YNOV07V.V.O_H74$L#!!0    ( #N<"%6OLM@!E (
M /('   9    >&PO=V]R:W-H965T<R]S:&5E=#@R+GAM;*U5;6_3,!#^*U9
M:)-@>6TWE312VY0QI$G3QN #XH.;7!MKCEULIQG\>FPG#=V:5=-8/B3V^9[G
M\9V=N[CFXDX6  K=EY3)L5,HM1ZYKLP**+$\X6M@>F7)18F5GHJ5*]<"<&Y!
M)74#SQNZ)2;,26)KNQ))S"M%"8,K@615EEC\G@+E]=CQG:WAFJP*90QN$J_Q
M"FY W:ZOA)ZY'4M.2F"2<(8$+,?.Q!_-(^-O';X1J.7.&)E(%IS?F<E%/G8\
MLR&@D"G#@/5G S.@U!#I;?QJ.9U.T@!WQUOV3S9V'<L"2YAQ^IWDJA@[9P[*
M88DKJJYY_1G:> :&+^-4VC>J&]_!T$%9)14O6[#>04E8\\7W;1YV )JG'Q"T
M@. Q('H"$+: \+D*40N(GJLP: $V=+>)W28NQ0HGL> U$L9;LYF!S;Y%ZWP1
M9N[)C1)ZE6B<2LXYSVM"*<(L1Q=,8;8B"PIH(B4HB;["O4)'*2A,J#Q&']#M
M38J.WA['KM+BAL+-6J%I(Q0\(12B2\Y4(=&<Y9#WX-/#^.$!O*N#[B(/MI%/
M@X.$7RIV@D+O/0J\(.C9S^SY<+\OG/]3G[]8_4$RPNX:A)8O?-DU2(G,*)>5
M /1CLI!*Z/_[9]\=:%2B?A53\T9RC3,8.[JH21 ;<))W;_RA]['O %Z3+'U-
MLODKD3TXJJ@[JN@0>S(IN5#D#[9UEB_W3ZOO7!K*H:4TK6.31'H[YHG=S6[.
M]QT'9SU^Z;[?:1CV.,[W'?W'RDT:W)TB5H)8V>XA4<8KIIJ+W%F[!C6Q=?F1
M?>J/9GZ//=4-K>D__^B;;GB)Q8HPB2@LM91W<JIKK&@Z3#-1?&U+Z((K79#M
ML-!-&81QT.M+SM5V8@2Z-I_\!5!+ P04    "  [G A52H.L7PT#   =#
M&0   'AL+W=O<FMS:&5E=',O<VAE970X,RYX;6S%EVMOFS 4AO^*Q:JIE=IR
M"R1T"5*:K%NGM:IZV31-^^"0D\2JP9GMA&R_?C90F@M%$UNV+\$&O^>\SP',
M23=E_%', "1:Q301/6,FY?S,-$4T@QB+4S:'1%V9,!YCJ:9\:HHY!SS.1#$U
M'<ORS1B3Q B[V;D;'G;90E*2P U'8A''F/\X!\K2GF$;3R=NR70F]0DS[,[Q
M%.Y /LQON)J9990QB2$1A"6(PZ1G].VS@6UI0;;B$X%4K(V11ADQ]J@GE^.>
M86E'0"&2.@16AR4,@%(=2?GX7@0URIQ:N#Y^BGZ1P2N8$18P8/0S&<M9S^@8
M: P3O*#REJ7OH0#R=+R(49']HK18:QDH6@C)XD*L',0DR8]X511B36"W7A X
MA<#Y78%;"-P,-'>680VQQ&&7LQ1QO5I%TX.L-IE:T9!$W\8[R=55HG0R?,?8
M."64(IR,T64B<3(E(PJH+P1(@;R3+X YZL>,2_(39Y4_'(+$A(HC=((>[H;H
M\. ('2"2H/L96P@51W1-J:SI!&94V#C/;3@OV/BP2$Z1:QTCQW*<"OF@7CZ$
M2,GM3&YORDU5D+(J3ED5)XOG-JO*D(B(,K'@@+[V1T)R]3!^JX+.L[2JL^@W
M]$S,<00]0[V" O@2C/#U*]NWWE25X"\%VRB(6Q;$K8L>7I"$2#CYJ%ZYBH(<
M;SX@;U=JDQ%PC*YA)=%]"G0)Z(HE<E;Y9.29_2RSWG66H>]U K=K+M?I:_TU
MI&^5]*W_1I]G]M;H;==W[/86?JW!AOA>B>_M 3_;..Y35@7M54![7KNS!5UK
MJR&T7T+[^X*^8 M>1>WO4COM0.]W&]2UOAI2MTOJ]MZHE::*NEU%[79:6]2U
MOAI2=TKJSK^F[NQ2VX&ZVUO4M;X:4@<E=; ':CR1P.O9@QUVUPU:[O:.7NNN
M(;MM/?<]UA_17X.L;&.LG:^5;7EVV_*WZ*H6^D[@/5<A-VZN]6ZZ<;["?$H2
M@2A,E- Z;:LZ\KP7S2>2S;-V;L2D:@ZSX4SU[\#U G5]PIA\FN@.L?Q'$/X"
M4$L#!!0    ( #N<"%7E/'["" 8  .T>   9    >&PO=V]R:W-H965T<R]S
M:&5E=#@T+GAM;+59;6_;-A#^*X17#"W012+U9F6.@=1*L P9&C3M^J'H!UJF
M;:&2Z%%TG/[['25;LB6*B0?M2V))O'OTG(['Y\C)CHL?Q9HQB9ZS-"^N1FLI
M-Y>65<1KEM'B@F]8#D^67&14PJ586<5&,+HHC;+4(K;M6QE-\M%T4MY[$-,)
MW\HTR=F#0,4VRZCX^8&E?'<UPJ/#C4_):BW5#6LZV= 5>V3RR^9!P)55>UDD
M&<N+A.=(L.75Z!I?WI"Q,BA'_)VP77'T&RDJ<\Y_J(N[Q=7(5F_$4A9+Y8+"
MOR<V8VFJ/,%[_+-W.JHQE>'Q[X/WVY(\D)G3@LUX^C59R/75:#Q""[:DVU1^
MXKL_V)Z0I_S%/"W*OVBW'VN/4+PM),_VQO &69)7_^GS/A!'!MCM,2![ _):
M V=OX+S6P-T;N&T#I\? VQN4U*V*>QFXB$HZG0B^0T*-!F_J1QG]TAKBE>0J
M41ZE@*<)V,GI=1R++5N@^X3.DS21"2O0VXA)FJ3%._0;^O(8H;=OWJ$W*,G1
MYS7?%C1?%!-+ K;R8,5[G \5#NG!^7.;7R#'?H^(38C&?/:".05SV^\UC\SF
M$8L!'9?F^-3<@H#542-UU$CISSDC:M^NYX44D/C?==&I_+EZ?ZH:7!8;&K.K
M$4SW@HDG-IK^^@OV[=]UL1K26320LY,X.G4<'9/WZ2--J5#!@Z1"<Y:S92*U
MR56Y\4LWJO8]33W?]9R)]70<%R/8N7'I0I+ L=T:\H2P6Q-VC83O\ICEJC2B
MF&=0[ NJRJ6.<>7'.X+'ON^0%F,CVKF,NY".@^U S]BK&7M&QA\W3 #)?(7N
M&13T]_6<^?D>S;9"0#AT]+TN_3 D88N^$?I<^EW(T+9#/7N_9N^_E."0W9(^
M,VU:^QW(P,;M;VQ$.)=D%Q&'8UM/,JA)!D:2GQ@4OFTLMT)]9JIJ(TUU=(,.
MN!_Z[4ELQ#J7K@;1[YG"XYKMV,CV2[ZD3US0.6@=GI<5/SVD].-G'>UQ=UYY
MQYE5\3:BGLN["XF)[_IZYF'-/#0R/ZQZ7*Z9Z$_JL(--QJ[=8FM$.I=M%]%U
MG)ZZA>U&&=FOHOL@^)(52AG3%-TR/>F]KY.(VR3 +=IFR'-Y:T"#P.GA?:0(
ML9'W/5L!4<,TWMN?)'1(.E2-*&=3U6".P[YOW.@X;)0WTRB!TI7,MV73TOMM
M23>C7=]QVX0'E64:4"5Y>@@W@@N;%==7*@3-Y4%S"095.]>S=KHO<%1!]IP'
ME5PZR"/)<TJYD5S8K+EN$Y8ND )/8J6[0'.4W6G9I.K%%]9((=OKR \S\-GL
MNZ ]"S-NQ!<VJZ]##5N*LF/6<M5(+3NTV\NR&>ALKAJQA<.>E1DW:@N;Y=9'
MM3)I26ITC^/ZG70>5&MI0,=VV*,H<:.VL%EN';YIVC2?6LI=[4/<P/<ZG <5
M7!I4C,<X]$Y1;U[@^ U_-[27N-%JV"S6CIJ-")K+',+VH6HST4-*<V,+@C6Z
MC3AM(6-^@;/#U\7LJP&-:L.ODVUTNP#:R[Y%3B.B K>SJ ^JVS28V+;'>L*D
M$6[$-N[.@&!;0#O2=)IH!D(=>A.6QS_1MWL8CNXDRPK]3LV0$FTVJ+=H*&^G
M@6V4(3$KPVY@KRN5"/.(9QN>PTQ"UQG?ZB<4Z6HXSX$>NY5C^V$GFST>;@^+
MS._Z7V-QM -H5HZW7"VI.;IYCM<44DM+>-A=OV&W_?Z/?3_2Z%#B#+V#.J34
MG WJ+1K*VVDP&X5+S HW8B)YHJ6F?=WN&NE*32\(VO-P4'6K@>Q9V4BC;HEG
M3*(CWB]6]2'EZVQ0;]%0WDZCV(AF8A;-YV>/WRW0W>P95$IK(/NR1^GHTSN-
M6B1FM0BJ,V(QR^9,5*]R.#)"<PIJ,88:M6."H86*6-E5\:R257 1\[S@:;*@
MZ@*D)HQ/:(H*"3<RB&1QH?M:UM'17<;$JCPS+< 9K*'5.4I]MSJ7C?#E37E\
MV;I_38++&R"O>S(^'.5:#41U$/P7%:LD+U#*E@!G7P20BJ(Z6ZTN)-^4AX=S
M+B7/RI]K1B$ :@ \7W(N#Q<*H#[AGOX+4$L#!!0    ( #N<"%5JK=HL#04
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MBI$95@S-%'8F0"^BI]<^R5A./^^BA+S*-;QE<<9=1<;II0\T+@&PD3'!1DR
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M@ ])2,+=>%<E6V2,-AG?(*O@7VER"9I> R /H8I\1O;P,0E4.#3AT)).L^C
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MKF=L/KF\FH;X&/!=X-8=K"$H61GS'(R[:L;20 @EECX@</IM\!JE#$!$X_>
MR?8E0^+A>H=^&[63EA5W>&WD#U'Y9L8^,:APS3OI'\WV*PYZS@->::2+7]@.
ML2F#LG/>J"&9&"BA^S]_&<[A("'+7DG(AH0L\NX+198WW/,BMV8+-D036EA$
MJ3&;R D=+F7I+>T*RO,%J9%\92P/AP-<5_#@&[0PMY;K&NGXO8/3&_1<2'<&
M)R TW LIZ41=GGAB$'"2<JAVU5?+7JGVK=-CF*8CR-(L@Z?E#9R>G/T/DY"
MO8ILKR*+N--7<!]LS;7XR\-%C^":N!DI*M[?.VE:6'2DI'>8-=P*S74IN(0E
M.0>5/^<KYRVUR:]CPGH"'XX3"*-SZ5I>XHRUH9;=("O>OYM<I%_>D#?=RYN^
MA5XL.ELVU'JD3"GA ]T1/&*8.:%KN@\M5*=@KDRG_1#DL3HFHR\T26.E,+&;
M(OL\OLB3S2&_Y*"APFS><UL+[4#BFM+2\<=S!K;O]][PIHT]MC*>.C8N&WHB
MT(8 VE\;XW=&:-O]HU/\ U!+ P04    "  [G A5UDJJZHP#  "K#   &0
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MC=I"R[Z=EV^RHON0N7]$*_1,V6HQ9G?O)W9MM+?^<!<GS6T_8JO&(DWB=@W
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M580 &J-R.T@YG2M)*PV-1SVPM#,FQ!T\Q#^R'>Y5MK5SU;[)=F@%U4-'XR;
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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MY&5;0&]+O:V WI9Z6P&]+?6V GI;ZFT%]+;4VPKH;:FW%=#;4F\KH+>CWDY
M;T>]G8#>CGH[ ;W=Y&.)@-Z.>CL!O1WU=@)Z.^KM!/1VU-L)Z.VHMQ/0VU%O
M)Z"WI]Y>0&]/O;V WIYZ>P&]/?7V GK[R<=N ;T]]?8">GOJ[07T]M3;"^CM
MJ;<7T-M3;R^@=Z#>04#O0+V#@-Z!>@<!O0/U#@)Z!^H=!/0.DY^5 GH'ZAT$
M] [4.PCH':AW$- [4.\@H'>DWE% [TB]HX#>D7I' ;TC]8X">D?J'07TCM0[
M"N@=)YM-!/2.U#L*Z!VI=Q30.U+O**!WHMY)0.]$O9. WHEZ)P&]$_5. GHG
MZIT$]$[4.PGHG:AW$M [338+"NB=J'<2T#M1[R2@=Z;>64#O3+VS@-Z9>F<!
MO3/US@)Z9^J=!?3.U#L+Z)VI=Q;0.U/O+*!WGFSV%M [4^\LH'>AWD5 [T*]
MBX#>A7H7 ;T+]2X">A?J703T+M2[".A=J'<1T+M0[_*=>@_CYZ$.MYZO-9__
MG52/EWOK[?'7Y=?)"3M7G-O[BN'I+U!+ P04    "  [G A5C,4FGTX"   G
M-P  $P   %M#;VYT96YT7U1Y<&5S72YX;6S-VTUNVS 0AN&K&-H&EB*2HJ@B
MSJ;MMLVB%U E.A:L/Y!,ZMR^M)P$:)$:#5R@[\:"37*^$0=X=K[Y]C1;OSH,
M_>@WR2Z$^4.6^69GA]JGTVS'N+*=W%"'^-7=9W/=[.M[FXGK:YTUTQCL&-;A
M6".YO?EDM_5#'U:?#_%GWTWC)G&V]\GJXVGC,6N3U//<=TT=XGKV.+:_I:R?
M$])X<MGC=]WLK^*&)'LSX;CRYX#G<U\?K7-=:U=WM0M?ZB'NR@Y]YL-3;WUZ
MOL0;/4[;;=?8=FH>AG@D];.S=>MWUH:A3T]%K\XGAWC#]O297YR_E#D7&'?>
MN6GV<6+.OC_N923'T^LY%K(N=.=?\34QEK[X_>QQVJUM_S([7N^/R>V7>?AL
M>5Q^Q[_.^+7^._L0D#XDI \%Z:. ]*$A?920/@RDCPK21WY-:80B:DXA-:>8
MFE-0S2FJYA16<XJK.076G"*KH,@J*+(*BJR"(JN@R"HHL@J*K((BJZ#(*BBR
M2HJLDB*KI,@J*;)*BJR2(JNDR"HILDJ*K)(BJZ+(JBBR*HJLBB*KHLBJ*+(J
MBJR*(JNBR*HHLA8460N*K 5%UH(B:T&1M:#(6E!D+2BR%A19"XJLFB*KILBJ
M*;)JBJR:(JNFR*HILFJ*K)HBJZ;(6E)D+2FREA192XJL)476DB)K29&UI,A:
M4F0M*;(:BJR&(JNAR&HHLAJ*K(8BJZ'(:BBR&HJLAB)K19&UHLA:462M*+)6
M%%DKBJP51=;J?\KZ?9KV_SA^>:9#W8TO^=GR_[C;GU!+ 0(4 Q0    ( #N<
M"%4'04UB@0   +$    0              "  0    !D;V-0<F]P<R]A<' N
M>&UL4$L! A0#%     @ .YP(522*NCWM    *P(  !$              ( !
MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ .YP(59E<G",0!@
MG"<  !,              ( !RP$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    "  [G A5.,)&Z=P%  #I'@  &               @($,"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ .YP(56]4^& +"0
MKR<  !@              ("!'@X  'AL+W=O<FMS:&5E=',O<VAE970R+GAM
M;%!+ 0(4 Q0    ( #N<"%4@!FGN9P,  !<,   8              " @5\7
M  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    "  [G A51(I=
M8/0&  !R'@  &               @('\&@  >&PO=V]R:W-H965T<R]S:&5E
M=#0N>&UL4$L! A0#%     @ .YP(51V3@9;6 P  5@T  !@
M ("!)B(  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( #N<
M"%6Q=4@"/ ,  (8*   8              " @3(F  !X;"]W;W)K<VAE971S
M+W-H965T-BYX;6Q02P$"% ,4    "  [G A5R<#E2)T/  !\NP  &
M        @(&D*0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%
M  @ .YP(53=7O@'O"0  JRH  !@              ("!=SD  'AL+W=O<FMS
M:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( #N<"%6LNJI8? 4  -T,   8
M              " @9Q#  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"
M% ,4    "  [G A5P<G[3"T&  #V#@  &0              @(%.20  >&PO
M=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( #N<"%6VET'YDPT
M  XD   9              " @;)/  !X;"]W;W)K<VAE971S+W-H965T,3$N
M>&UL4$L! A0#%     @ .YP(56?X9(\/!   "@H  !D              ("!
M?%T  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    "  [G A5
M!0(:I80)  #H&   &0              @('"80  >&PO=V]R:W-H965T<R]S
M:&5E=#$S+GAM;%!+ 0(4 Q0    ( #N<"%7_-B($)P@  +X5   9
M      " @7UK  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%
M  @ .YP(54XL />A!   [PL  !D              ("!VW,  'AL+W=O<FMS
M:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    "  [G A55?(,I>D+  !;(@
M&0              @(&S>   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+
M 0(4 Q0    ( #N<"%466%ZPR X  *0M   9              " @=.$  !X
M;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ .YP(50COQH\S
M"0  B!@  !D              ("!TI,  'AL+W=O<FMS:&5E=',O<VAE970Q
M."YX;6Q02P$"% ,4    "  [G A5#MY$:\@#  "R"   &0
M@($\G0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( #N<
M"%4>:M*HA ,  $P'   9              " @3NA  !X;"]W;W)K<VAE971S
M+W-H965T,C N>&UL4$L! A0#%     @ .YP(52U"[2H+!   = D  !D
M         ("!]J0  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
M    "  [G A5C]CY#WL&  !S$   &0              @($XJ0  >&PO=V]R
M:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( #N<"%7VDD#%] 0  .L*
M   9              " @>JO  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL
M4$L! A0#%     @ .YP(57+]H3/= P  Q0H  !D              ("!%;4
M 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    "  [G A5\\)N
M:801   A-P  &0              @($IN0  >&PO=V]R:W-H965T<R]S:&5E
M=#(U+GAM;%!+ 0(4 Q0    ( #N<"%6_E)<'Q0<  # 3   9
M  " @>3*  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @
M.YP(5:KAHJ8X!0  J0P  !D              ("!X-(  'AL+W=O<FMS:&5E
M=',O<VAE970R-RYX;6Q02P$"% ,4    "  [G A5#RNVE+4'   9%   &0
M            @(%/V   >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4
M Q0    ( #N<"%5-Q;!B[04  (0-   9              " @3O@  !X;"]W
M;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ .YP(5=M>:^.' P
ML@<  !D              ("!7^8  'AL+W=O<FMS:&5E=',O<VAE970S,"YX
M;6Q02P$"% ,4    "  [G A5=5?['T<$  "2"@  &0              @($=
MZ@  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( #N<"%7M
MFI&WG 4  *P/   9              " @9ON  !X;"]W;W)K<VAE971S+W-H
M965T,S(N>&UL4$L! A0#%     @ .YP(57("@<6, P  V@<  !D
M     ("!;O0  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #N<"%6 \+$T+@,  '\&   9              "
M@:8, 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ .YP(
M52;#T0)& P  $@<  !D              ("!"Q ! 'AL+W=O<FMS:&5E=',O
M<VAE970S.2YX;6Q02P$"% ,4    "  [G A5W=5G9P(&  #%#@  &0
M        @(&($P$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0
M   ( #N<"%4WA8VCW 0  *H*   9              " @<$9 0!X;"]W;W)K
M<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ .YP(55+;;#S:!0  ]@X
M !D              ("!U!X! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q0
M2P$"% ,4    "  [G A5D&])C @$  !""@  &0              @('E) $
M>&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( #N<"%48^=T4
MB@,  "D/   9              " @20I 0!X;"]W;W)K<VAE971S+W-H965T
M-#0N>&UL4$L! A0#%     @ .YP(5;TU P!4!   J0\  !D
M ("!Y2P! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    "  [
MG A5-P1C!?4(  #B1@  &0              @(%P,0$ >&PO=V]R:W-H965T
M<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( #N<"%4G8ISH^@0  #8<   9
M          " @9PZ 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#
M%     @ .YP(53X^1O/2 @  6PD  !D              ("!S3\! 'AL+W=O
M<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    "  [G A5#!RUJA %  !_
M&0  &0              @('60@$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM
M;%!+ 0(4 Q0    ( #N<"%44.N\'G@(  /0'   9              " @1U(
M 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ .YP(505C
MQF(Z!   -Q@  !D              ("!\DH! 'AL+W=O<FMS:&5E=',O<VAE
M970U,2YX;6Q02P$"% ,4    "  [G A5)HB\CC4%  "0)   &0
M    @(%C3P$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    (
M #N<"%5C2,8&: 8  #0U   9              " @<]4 0!X;"]W;W)K<VAE
M971S+W-H965T-3,N>&UL4$L! A0#%     @ .YP(5<?G<XZ* @  M@@  !D
M             ("!;EL! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"
M% ,4    "  [G A5;##/038#  !;"P  &0              @($O7@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( #N<"%4_Y$[.XP(
M  L(   9              " @9QA 0!X;"]W;W)K<VAE971S+W-H965T-38N
M>&UL4$L! A0#%     @ .YP(5;/8W[L?!   ( \  !D              ("!
MMF0! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    "  [G A5
M%SZ342H$  !]%@  &0              @($,:0$ >&PO=V]R:W-H965T<R]S
M:&5E=#4X+GAM;%!+ 0(4 Q0    ( #N<"%7K;KXQ_ ,  'L.   9
M      " @6UM 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%
M  @ .YP(56"ZTL)0 P  #PP  !D              ("!H'$! 'AL+W=O<FMS
M:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    "  [G A5*TL:8RH#  !J#0
M&0              @($G=0$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+
M 0(4 Q0    ( #N<"%7*[%NR2 0  . :   9              " @8AX 0!X
M;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ .YP(56N8[_H*
M P  4PL  !D              ("!!WT! 'AL+W=O<FMS:&5E=',O<VAE970V
M,RYX;6Q02P$"% ,4    "  [G A5C :56D(&  #,+@  &0
M@(%(@ $ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( #N<
M"%4599+\LP,  "D1   9              " @<&& 0!X;"]W;W)K<VAE971S
M+W-H965T-C4N>&UL4$L! A0#%     @ .YP(51#>1#VS!0  [B@  !D
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M=#<P+GAM;%!+ 0(4 Q0    ( #N<"%60+LNSK T  +*6   9
M  " @=&D 0!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @
M.YP(55=$=8!B @  804  !D              ("!M+(! 'AL+W=O<FMS:&5E
M=',O<VAE970W,BYX;6Q02P$"% ,4    "  [G A5E6KT>_L$  !]&P  &0
M            @(%-M0$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4
M Q0    ( #N<"%7Z-_4?=@(  -T&   9              " @7^Z 0!X;"]W
M;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ .YP(51N1HK+< P
MK@P  !D              ("!++T! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX
M;6Q02P$"% ,4    "  [G A5LC4%QUT$   /$0  &0              @($_
MP0$ >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( #N<"%7R
M([1O%@,  * (   9              " @=/% 0!X;"]W;W)K<VAE971S+W-H
M965T-S<N>&UL4$L! A0#%     @ .YP(58-:?&2Z!   &A4  !D
M     ("!(,D! 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #N<"%5*@ZQ?#0,  !T,   9              "
M@>?> 0!X;"]W;W)K<VAE971S+W-H965T.#,N>&UL4$L! A0#%     @ .YP(
M5>4\?L((!@  [1X  !D              ("!*^(! 'AL+W=O<FMS:&5E=',O
M<VAE970X-"YX;6Q02P$"% ,4    "  [G A5:JW:+ T%   Q'0  &0
M        @(%JZ $ >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0
M   ( #N<"%4:**(P0@,  *,+   9              " @:[M 0!X;"]W;W)K
M<VAE971S+W-H965T.#8N>&UL4$L! A0#%     @ .YP(5?.Y7=T6!   ,Q$
M !D              ("!)_$! 'AL+W=O<FMS:&5E=',O<VAE970X-RYX;6Q0
M2P$"% ,4    "  [G A5:'?];" (  !Z1P  &0              @(%T]0$
M>&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    ( #N<"%783$XB
MCP(   8&   9              " @<O] 0!X;"]W;W)K<VAE971S+W-H965T
M.#DN>&UL4$L! A0#%     @ .YP(56T]X^V'!   %1<  !D
M ("!D0 " 'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6Q02P$"% ,4    "  [
MG A5T38TQKX"   R"   &0              @(%/!0( >&PO=V]R:W-H965T
M<R]S:&5E=#DQ+GAM;%!+ 0(4 Q0    ( #N<"%7F+#ZC1P,  /$*   9
M          " @40( @!X;"]W;W)K<VAE971S+W-H965T.3(N>&UL4$L! A0#
M%     @ .YP(5;]?1"7@ @  R @  !D              ("!P@L" 'AL+W=O
M<FMS:&5E=',O<VAE970Y,RYX;6Q02P$"% ,4    "  [G A5*LN-MEX$   K
M&@  &0              @('9#@( >&PO=V]R:W-H965T<R]S:&5E=#DT+GAM
M;%!+ 0(4 Q0    ( #N<"%6C%#-[1 (  ( $   9              " @6X3
M @!X;"]W;W)K<VAE971S+W-H965T.34N>&UL4$L! A0#%     @ .YP(5=9*
MJNJ, P  JPP  !D              ("!Z14" 'AL+W=O<FMS:&5E=',O<VAE
M970Y-BYX;6Q02P$"% ,4    "  [G A5,])=.!T(  ")0@  &0
M    @(&L&0( >&PO=V]R:W-H965T<R]S:&5E=#DW+GAM;%!+ 0(4 Q0    (
M #N<"%6(8DI:1 ,  + 4   -              "  0 B @!X;"]S='EL97,N
M>&UL4$L! A0#%     @ .YP(59>*NQS     $P(   L              ( !
M;R4" %]R96QS+RYR96QS4$L! A0#%     @ .YP(55]ECC'.!@  N3\   \
M             ( !6"8" 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( #N<
M"%6T*7[,P@(   HY   :              "  5,M @!X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( #N<"%6,Q2:?3@(  "<W   3
M          "  4TP @!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !I &D
*UAP  ,PR @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>395</ContextCount>
  <ElementCount>451</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>100</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - DEI Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DEIDocument</Role>
      <ShortName>DEI Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome</Role>
      <ShortName>Condensed Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Comprehensive Income (Paranthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Paranthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Stockholders' Equity Statement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity Statement</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - New Accounting Pronouncements:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2104103 - Disclosure - Business Combinations and Asset Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions</Role>
      <ShortName>Business Combinations and Asset Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2110104 - Disclosure - Restructuring, Strategic Transaction and Integration (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes</Role>
      <ShortName>Restructuring, Strategic Transaction and Integration (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2115105 - Disclosure - Revenue (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/RevenueNotes</Role>
      <ShortName>Revenue (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2121106 - Disclosure - Leases (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/LeasesNotes</Role>
      <ShortName>Leases (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2128107 - Disclosure - Net Income Per Share:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/NetIncomePerShare</Role>
      <ShortName>Net Income Per Share:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2132108 - Disclosure - Derivative Financial Instruments (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes</Role>
      <ShortName>Derivative Financial Instruments (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2140109 - Disclosure - Fair Value Measures and Disclosures (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes</Role>
      <ShortName>Fair Value Measures and Disclosures (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2147110 - Disclosure - Investment Securities (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/InvestmentSecuritiesNotes</Role>
      <ShortName>Investment Securities (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2152111 - Disclosure - Prepaids and Other Current Assets (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes</Role>
      <ShortName>Prepaids and Other Current Assets (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2156112 - Disclosure - Inventories:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/Inventories</Role>
      <ShortName>Inventories:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2159113 - Disclosure - Property and Equipment:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2163114 - Disclosure - Goodwill and Intangible Assets (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes</Role>
      <ShortName>Goodwill and Intangible Assets (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2169115 - Disclosure - Accrued Liabilities (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/AccruedLiabilitiesNotes</Role>
      <ShortName>Accrued Liabilities (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2173116 - Disclosure - Income Taxes:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2175117 - Disclosure - Long-Term Obligations (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsNotes</Role>
      <ShortName>Long-Term Obligations (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2184118 - Disclosure - Commitments and Contingencies:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2186119 - Disclosure - Collaborative and Other Arrangements (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes</Role>
      <ShortName>Collaborative and Other Arrangements (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2189120 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Business Combinations and Asset Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables</Role>
      <ShortName>Business Combinations and Asset Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - Restructuring, Strategic Transaction and Integration (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables</Role>
      <ShortName>Restructuring, Strategic Transaction and Integration (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2316303 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/RevenueNotes</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2322304 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/LeasesNotes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2329305 - Disclosure - Net Income Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/NetIncomePerShareTables</Role>
      <ShortName>Net Income Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/NetIncomePerShare</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2333306 - Disclosure - Derivative Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsTables</Role>
      <ShortName>Derivative Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2341307 - Disclosure - Fair Value Measures and Disclosures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables</Role>
      <ShortName>Fair Value Measures and Disclosures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2348308 - Disclosure - Investment Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/InvestmentSecuritiesTables</Role>
      <ShortName>Investment Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/InvestmentSecuritiesNotes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2353309 - Disclosure - Prepaids and Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables</Role>
      <ShortName>Prepaids and Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2357310 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/Inventories</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2360311 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/PropertyandEquipment</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2364312 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2370313 - Disclosure - Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AccruedLiabilitiesTables</Role>
      <ShortName>Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/AccruedLiabilitiesNotes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2376314 - Disclosure - Long-Term Obligations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsTables</Role>
      <ShortName>Long-Term Obligations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/LongTermObligationsNotes</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2390316 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/EquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/Equity</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2406401 - Disclosure - Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails</Role>
      <ShortName>Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Business Combinations and Asset Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails</Role>
      <ShortName>Business Combinations and Asset Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails</Role>
      <ShortName>Business Combinations and Asset Acquisitions Smiths Medical (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails</Role>
      <ShortName>Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Restructuring, Strategic Transaction and Integration Restructuring (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails</Role>
      <ShortName>Restructuring, Strategic Transaction and Integration Restructuring (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - Restructuring, Strategic Transaction and Integration Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails</Role>
      <ShortName>Restructuring, Strategic Transaction and Integration Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - Strategic Transaction and Integration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/StrategicTransactionandIntegrationDetails</Role>
      <ShortName>Strategic Transaction and Integration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2418409 - Disclosure - Revenue Disaggregated Revenue by Geography (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails</Role>
      <ShortName>Revenue Disaggregated Revenue by Geography (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2419410 - Disclosure - Revenue Disaggregated Revenue by Product Line (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails</Role>
      <ShortName>Revenue Disaggregated Revenue by Product Line (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2420411 - Disclosure - Revenue Contract Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RevenueContractLiabilitiesDetails</Role>
      <ShortName>Revenue Contract Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2423412 - Disclosure - Leases Text (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesTextDetails</Role>
      <ShortName>Leases Text (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2424413 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/LeasesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2425414 - Disclosure - Leases Cash Flow, Operating Activities, Lessee (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails</Role>
      <ShortName>Leases Cash Flow, Operating Activities, Lessee (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2426415 - Disclosure - Leases Assets and Liabilities, Lessee (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails</Role>
      <ShortName>Leases Assets and Liabilities, Lessee (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2427416 - Disclosure - Leases Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesMaturityDetails</Role>
      <ShortName>Leases Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2430417 - Disclosure - Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/NetIncomePerShareDetails</Role>
      <ShortName>Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/NetIncomePerShareTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2431418 - Disclosure - Net Income Per Share (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/NetIncomePerShareDetails1</Role>
      <ShortName>Net Income Per Share (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/NetIncomePerShareTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2434419 - Disclosure - Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails</Role>
      <ShortName>Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2435420 - Disclosure - Derivative Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails</Role>
      <ShortName>Derivative Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/DerivativeFinancialInstrumentsTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2436421 - Disclosure - Derivative Financial Instruments Interest Rate Swaps (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails</Role>
      <ShortName>Derivative Financial Instruments Interest Rate Swaps (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2437422 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails</Role>
      <ShortName>Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2438423 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2439424 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails</Role>
      <ShortName>Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2442425 - Disclosure - Fair Value Measures and Disclosures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails</Role>
      <ShortName>Fair Value Measures and Disclosures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2443426 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails</Role>
      <ShortName>Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2444427 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails</Role>
      <ShortName>Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2445428 - Disclosure - Fair Value Measures and Disclosures Liability Measurement Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails</Role>
      <ShortName>Fair Value Measures and Disclosures Liability Measurement Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2446429 - Disclosure - Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails</Role>
      <ShortName>Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2449430 - Disclosure - Investment Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/InvestmentSecuritiesDetails</Role>
      <ShortName>Investment Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/InvestmentSecuritiesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2450431 - Disclosure - Investment Securities Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/InvestmentSecuritiesTableDetails</Role>
      <ShortName>Investment Securities Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2451432 - Disclosure - Equity Method Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/EquityMethodInvestmentsDetails</Role>
      <ShortName>Equity Method Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2454433 - Disclosure - Prepaids and Other Current Assets Prepaids and Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails</Role>
      <ShortName>Prepaids and Other Current Assets Prepaids and Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2455434 - Disclosure - Other Assets Noncurrent(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/OtherAssetsNoncurrentDetails</Role>
      <ShortName>Other Assets Noncurrent(Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2458435 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/InventoriesTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2461436 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/PropertyandEquipmentTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2462437 - Disclosure - Property and Equipment Text (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PropertyandEquipmentTextDetails</Role>
      <ShortName>Property and Equipment Text (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/PropertyandEquipmentTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2465438 - Disclosure - Goodwill and Intangible Assets Goodwill Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails</Role>
      <ShortName>Goodwill and Intangible Assets Goodwill Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2466439 - Disclosure - Goodwill and Intangible Assets Intangibles Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails</Role>
      <ShortName>Goodwill and Intangible Assets Intangibles Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2467440 - Disclosure - Goodwill and Intangible Assets Text (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails</Role>
      <ShortName>Goodwill and Intangible Assets Text (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2468441 - Disclosure - Goodwill and Intangible Assets 5-Year Amortization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails</Role>
      <ShortName>Goodwill and Intangible Assets 5-Year Amortization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2471442 - Disclosure - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AccruedLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/AccruedLiabilitiesTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2472443 - Disclosure - Accrued Liabilities Long-term liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails</Role>
      <ShortName>Accrued Liabilities Long-term liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2474444 - Disclosure - Income Taxes Effective tax rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails</Role>
      <ShortName>Income Taxes Effective tax rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>2477445 - Disclosure - Long-Term Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsDetails</Role>
      <ShortName>Long-Term Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/LongTermObligationsTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>2478446 - Disclosure - Long-Term Obligations Interest Rate Terms (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails</Role>
      <ShortName>Long-Term Obligations Interest Rate Terms (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>2479447 - Disclosure - Long-Term Obligations Terminated Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails</Role>
      <ShortName>Long-Term Obligations Terminated Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>2480448 - Disclosure - Long-Term Obligations Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsTableDetails</Role>
      <ShortName>Long-Term Obligations Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>2481449 - Disclosure - Long-Term Obligations Schedule of Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails</Role>
      <ShortName>Long-Term Obligations Schedule of Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>2482450 - Disclosure - Long-Term Obligations Interest Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails</Role>
      <ShortName>Long-Term Obligations Interest Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>2483451 - Disclosure - Long-Term Obligations Principal Payment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails</Role>
      <ShortName>Long-Term Obligations Principal Payment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>2485452 - Disclosure - Commitments and Contingencies Contingency (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails</Role>
      <ShortName>Commitments and Contingencies Contingency (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>2488453 - Disclosure - Collaborative and Other Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails</Role>
      <ShortName>Collaborative and Other Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>2491454 - Disclosure - Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/EquityDetails</Role>
      <ShortName>Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/EquityTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="icui-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>2492455 - Disclosure - Equity Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Equity Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="icui-20220630.htm">icui-20220630.htm</File>
    <File>icui-20220630.xsd</File>
    <File>icui-20220630_cal.xml</File>
    <File>icui-20220630_def.xml</File>
    <File>icui-20220630_lab.xml</File>
    <File>icui-20220630_pre.xml</File>
    <File>icui-ex31163022.htm</File>
    <File>icui-ex31263022.htm</File>
    <File>icui-ex32163022.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1234">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>114
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "icui-20220630.htm": {
   "axisCustom": 4,
   "axisStandard": 20,
   "contextCount": 395,
   "dts": {
    "calculationLink": {
     "local": [
      "icui-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "icui-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "icui-20220630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "icui-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "icui-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "icui-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 700,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 5,
    "http://xbrl.sec.gov/dei/2021q4": 6,
    "total": 11
   },
   "keyCustom": 66,
   "keyStandard": 385,
   "memberCustom": 43,
   "memberStandard": 57,
   "nsprefix": "icui",
   "nsuri": "http://www.icumed.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - DEI Document",
     "role": "http://www.icumed.com/role/DEIDocument",
     "shortName": "DEI Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - New Accounting Pronouncements:",
     "role": "http://www.icumed.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104103 - Disclosure - Business Combinations and Asset Acquisitions",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions",
     "shortName": "Business Combinations and Asset Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110104 - Disclosure - Restructuring, Strategic Transaction and Integration (Notes)",
     "role": "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes",
     "shortName": "Restructuring, Strategic Transaction and Integration (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115105 - Disclosure - Revenue (Notes)",
     "role": "http://www.icumed.com/role/RevenueNotes",
     "shortName": "Revenue (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121106 - Disclosure - Leases (Notes)",
     "role": "http://www.icumed.com/role/LeasesNotes",
     "shortName": "Leases (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128107 - Disclosure - Net Income Per Share:",
     "role": "http://www.icumed.com/role/NetIncomePerShare",
     "shortName": "Net Income Per Share:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132108 - Disclosure - Derivative Financial Instruments (Notes)",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes",
     "shortName": "Derivative Financial Instruments (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140109 - Disclosure - Fair Value Measures and Disclosures (Notes)",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes",
     "shortName": "Fair Value Measures and Disclosures (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147110 - Disclosure - Investment Securities (Notes)",
     "role": "http://www.icumed.com/role/InvestmentSecuritiesNotes",
     "shortName": "Investment Securities (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152111 - Disclosure - Prepaids and Other Current Assets (Notes)",
     "role": "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes",
     "shortName": "Prepaids and Other Current Assets (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2156112 - Disclosure - Inventories:",
     "role": "http://www.icumed.com/role/Inventories",
     "shortName": "Inventories:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2159113 - Disclosure - Property and Equipment:",
     "role": "http://www.icumed.com/role/PropertyandEquipment",
     "shortName": "Property and Equipment:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2163114 - Disclosure - Goodwill and Intangible Assets (Notes)",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes",
     "shortName": "Goodwill and Intangible Assets (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2169115 - Disclosure - Accrued Liabilities (Notes)",
     "role": "http://www.icumed.com/role/AccruedLiabilitiesNotes",
     "shortName": "Accrued Liabilities (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2173116 - Disclosure - Income Taxes:",
     "role": "http://www.icumed.com/role/IncomeTaxes",
     "shortName": "Income Taxes:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2175117 - Disclosure - Long-Term Obligations (Notes)",
     "role": "http://www.icumed.com/role/LongTermObligationsNotes",
     "shortName": "Long-Term Obligations (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2184118 - Disclosure - Commitments and Contingencies:",
     "role": "http://www.icumed.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2186119 - Disclosure - Collaborative and Other Arrangements (Notes)",
     "role": "http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes",
     "shortName": "Collaborative and Other Arrangements (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2189120 - Disclosure - Equity",
     "role": "http://www.icumed.com/role/Equity",
     "shortName": "Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Business Combinations and Asset Acquisitions (Tables)",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables",
     "shortName": "Business Combinations and Asset Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - Restructuring, Strategic Transaction and Integration (Tables)",
     "role": "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables",
     "shortName": "Restructuring, Strategic Transaction and Integration (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316303 - Disclosure - Revenue (Tables)",
     "role": "http://www.icumed.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322304 - Disclosure - Leases (Tables)",
     "role": "http://www.icumed.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329305 - Disclosure - Net Income Per Share (Tables)",
     "role": "http://www.icumed.com/role/NetIncomePerShareTables",
     "shortName": "Net Income Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333306 - Disclosure - Derivative Financial Instruments (Tables)",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsTables",
     "shortName": "Derivative Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341307 - Disclosure - Fair Value Measures and Disclosures (Tables)",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables",
     "shortName": "Fair Value Measures and Disclosures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348308 - Disclosure - Investment Securities (Tables)",
     "role": "http://www.icumed.com/role/InvestmentSecuritiesTables",
     "shortName": "Investment Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353309 - Disclosure - Prepaids and Other Current Assets (Tables)",
     "role": "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables",
     "shortName": "Prepaids and Other Current Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2357310 - Disclosure - Inventories (Tables)",
     "role": "http://www.icumed.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2360311 - Disclosure - Property and Equipment (Tables)",
     "role": "http://www.icumed.com/role/PropertyandEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Income",
     "role": "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
     "shortName": "Condensed Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2364312 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2370313 - Disclosure - Accrued Liabilities (Tables)",
     "role": "http://www.icumed.com/role/AccruedLiabilitiesTables",
     "shortName": "Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2376314 - Disclosure - Long-Term Obligations (Tables)",
     "role": "http://www.icumed.com/role/LongTermObligationsTables",
     "shortName": "Long-Term Obligations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2390316 - Disclosure - Equity (Tables)",
     "role": "http://www.icumed.com/role/EquityTables",
     "shortName": "Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406401 - Disclosure - Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
     "shortName": "Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "icui:BusinessCombinationConsiderationHoldbackLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407402 - Disclosure - Business Combinations and Asset Acquisitions (Details)",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
     "shortName": "Business Combinations and Asset Acquisitions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "icui:MinimumStockPriceTargetForEarnOutPayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical (Details)",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
     "shortName": "Business Combinations and Asset Acquisitions Smiths Medical (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i92956d7d960f45f3bea45f7aa025342c_D20220101-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details)",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
     "shortName": "Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:Restructuringstrategictransactionandintegration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Restructuring, Strategic Transaction and Integration Restructuring (Details)",
     "role": "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails",
     "shortName": "Restructuring, Strategic Transaction and Integration Restructuring (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:Restructuringstrategictransactionandintegration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i0f22c3698eff4a70b949d07786441335_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - Restructuring, Strategic Transaction and Integration Liability (Details)",
     "role": "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails",
     "shortName": "Restructuring, Strategic Transaction and Integration Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income",
     "role": "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "icui:StrategicTransactionandIntegration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - Strategic Transaction and Integration (Details)",
     "role": "http://www.icumed.com/role/StrategicTransactionandIntegrationDetails",
     "shortName": "Strategic Transaction and Integration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "icui:StrategicTransactionandIntegration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418409 - Disclosure - Revenue Disaggregated Revenue by Geography (Details)",
     "role": "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails",
     "shortName": "Revenue Disaggregated Revenue by Geography (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i7b87c8dac7974a8782e310a9135de722_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419410 - Disclosure - Revenue Disaggregated Revenue by Product Line (Details)",
     "role": "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails",
     "shortName": "Revenue Disaggregated Revenue by Product Line (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i349a5bf778244242883e275326abbbc6_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420411 - Disclosure - Revenue Contract Liabilities (Details)",
     "role": "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
     "shortName": "Revenue Contract Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i9bf0c921a82d4e7c91e5ec8cd112d1fd_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:Optiontoextendinyears",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423412 - Disclosure - Leases Text (Details)",
     "role": "http://www.icumed.com/role/LeasesTextDetails",
     "shortName": "Leases Text (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:Optiontoextendinyears",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424413 - Disclosure - Leases (Details)",
     "role": "http://www.icumed.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425414 - Disclosure - Leases Cash Flow, Operating Activities, Lessee (Details)",
     "role": "http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails",
     "shortName": "Leases Cash Flow, Operating Activities, Lessee (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:AssetsandLiabilitiesLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426415 - Disclosure - Leases Assets and Liabilities, Lessee (Details)",
     "role": "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails",
     "shortName": "Leases Assets and Liabilities, Lessee (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:AssetsandLiabilitiesLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427416 - Disclosure - Leases Maturity (Details)",
     "role": "http://www.icumed.com/role/LeasesMaturityDetails",
     "shortName": "Leases Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430417 - Disclosure - Net Income Per Share (Details)",
     "role": "http://www.icumed.com/role/NetIncomePerShareDetails",
     "shortName": "Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Comprehensive Income (Paranthetical)",
     "role": "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Paranthetical)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431418 - Disclosure - Net Income Per Share (Details 1)",
     "role": "http://www.icumed.com/role/NetIncomePerShareDetails1",
     "shortName": "Net Income Per Share (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434419 - Disclosure - Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails",
     "shortName": "Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i64b799c44978482fb2ff58859d2765f8_I20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435420 - Disclosure - Derivative Financial Instruments (Details)",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
     "shortName": "Derivative Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i6b6271edab564d0d9a598187c3a83a1b_I20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436421 - Disclosure - Derivative Financial Instruments Interest Rate Swaps (Details)",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
     "shortName": "Derivative Financial Instruments Interest Rate Swaps (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i55561adaa418415b8dbb5d994e03b04a_I20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437422 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details)",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
     "shortName": "Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438423 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439424 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
     "shortName": "Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ia5fdd88104094d56a78a0e9fabdc14a4_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442425 - Disclosure - Fair Value Measures and Disclosures (Details)",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
     "shortName": "Fair Value Measures and Disclosures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i2b0af7a88e20446b955b939f110edf80_D20220101-20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "icui:Contingentconsiderationgross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443426 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details)",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails",
     "shortName": "Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "icui:CurrencyTranslationOnEarnOut",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444427 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details)",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
     "shortName": "Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4d268c33a3374123930ac2daf085b23a_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Stockholders' Equity Statement",
     "role": "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity Statement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i370da095060646f9b9a5b42d2b8a471c_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i629f0cf89dde42a49602d16e5cfd879b_I20210630",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445428 - Disclosure - Fair Value Measures and Disclosures Liability Measurement Inputs (Details)",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails",
     "shortName": "Fair Value Measures and Disclosures Liability Measurement Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i629f0cf89dde42a49602d16e5cfd879b_I20210630",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446429 - Disclosure - Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details)",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
     "shortName": "Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnSaleOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449430 - Disclosure - Investment Securities (Details)",
     "role": "http://www.icumed.com/role/InvestmentSecuritiesDetails",
     "shortName": "Investment Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnSaleOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450431 - Disclosure - Investment Securities Table (Details)",
     "role": "http://www.icumed.com/role/InvestmentSecuritiesTableDetails",
     "shortName": "Investment Securities Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451432 - Disclosure - Equity Method Investments (Details)",
     "role": "http://www.icumed.com/role/EquityMethodInvestmentsDetails",
     "shortName": "Equity Method Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentAggregateCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherPrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454433 - Disclosure - Prepaids and Other Current Assets Prepaids and Other Assets (Details)",
     "role": "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails",
     "shortName": "Prepaids and Other Current Assets Prepaids and Other Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherPrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455434 - Disclosure - Other Assets Noncurrent(Details)",
     "role": "http://www.icumed.com/role/OtherAssetsNoncurrentDetails",
     "shortName": "Other Assets Noncurrent(Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458435 - Disclosure - Inventories (Details)",
     "role": "http://www.icumed.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461436 - Disclosure - Property and Equipment (Details)",
     "role": "http://www.icumed.com/role/PropertyandEquipmentDetails",
     "shortName": "Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462437 - Disclosure - Property and Equipment Text (Details)",
     "role": "http://www.icumed.com/role/PropertyandEquipmentTextDetails",
     "shortName": "Property and Equipment Text (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465438 - Disclosure - Goodwill and Intangible Assets Goodwill Table (Details)",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails",
     "shortName": "Goodwill and Intangible Assets Goodwill Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466439 - Disclosure - Goodwill and Intangible Assets Intangibles Table (Details)",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails",
     "shortName": "Goodwill and Intangible Assets Intangibles Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467440 - Disclosure - Goodwill and Intangible Assets Text (Details)",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails",
     "shortName": "Goodwill and Intangible Assets Text (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468441 - Disclosure - Goodwill and Intangible Assets 5-Year Amortization (Details)",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails",
     "shortName": "Goodwill and Intangible Assets 5-Year Amortization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:AccruedSalariesAndBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471442 - Disclosure - Accrued Liabilities (Details)",
     "role": "http://www.icumed.com/role/AccruedLiabilitiesDetails",
     "shortName": "Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:AccruedSalariesAndBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:AssetsandLiabilitiesLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiabilityNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2472443 - Disclosure - Accrued Liabilities Long-term liabilities (Details)",
     "role": "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
     "shortName": "Accrued Liabilities Long-term liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2474444 - Disclosure - Income Taxes Effective tax rate (Details)",
     "role": "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails",
     "shortName": "Income Taxes Effective tax rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "icui:TotalSeniorSecuredCreditFacility",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2477445 - Disclosure - Long-Term Obligations (Details)",
     "role": "http://www.icumed.com/role/LongTermObligationsDetails",
     "shortName": "Long-Term Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "icui:TotalSeniorSecuredCreditFacility",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "icui:InterestPercentageAddedToFederalFundsRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2478446 - Disclosure - Long-Term Obligations Interest Rate Terms (Details)",
     "role": "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails",
     "shortName": "Long-Term Obligations Interest Rate Terms (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "icui:InterestPercentageAddedToFederalFundsRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2479447 - Disclosure - Long-Term Obligations Terminated Credit Agreement (Details)",
     "role": "http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails",
     "shortName": "Long-Term Obligations Terminated Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation:",
     "role": "http://www.icumed.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "ief33feecdaf64ed2b539fd7d0e02b7c8_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2480448 - Disclosure - Long-Term Obligations Table (Details)",
     "role": "http://www.icumed.com/role/LongTermObligationsTableDetails",
     "shortName": "Long-Term Obligations Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2481449 - Disclosure - Long-Term Obligations Schedule of Maturities (Details)",
     "role": "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails",
     "shortName": "Long-Term Obligations Schedule of Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2482450 - Disclosure - Long-Term Obligations Interest Expense (Details)",
     "role": "http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails",
     "shortName": "Long-Term Obligations Interest Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "icui:TermAPrincipalPaymentFirst2Years",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2483451 - Disclosure - Long-Term Obligations Principal Payment (Details)",
     "role": "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails",
     "shortName": "Long-Term Obligations Principal Payment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentPeriodicPaymentPrincipal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "icui:ContingentConsiderationGrossST",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2485452 - Disclosure - Commitments and Contingencies Contingency (Details)",
     "role": "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
     "shortName": "Commitments and Contingencies Contingency (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4b3ce23df5e4479c839dc97cc6e1b807_D20220101-20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "icui:Contingentconsiderationgross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2488453 - Disclosure - Collaborative and Other Arrangements (Details)",
     "role": "http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails",
     "shortName": "Collaborative and Other Arrangements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "icui:TreasuryStockPurchasePlan",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2491454 - Disclosure - Equity (Details)",
     "role": "http://www.icumed.com/role/EquityDetails",
     "shortName": "Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "id9110fa7f5854d8ab13b0b9fff641ae2_D20220401-20220630",
      "decimals": "2",
      "lang": "en-US",
      "name": "icui:SmithsGroupOwnershipRequiredForBoardRepresentation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i4c25d8908c9a44fe915873cf97ad8d51_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2492455 - Disclosure - Equity Accumulated Other Comprehensive Income (Loss) (Details)",
     "role": "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Equity Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220630.htm",
      "contextRef": "i0f22c3698eff4a70b949d07786441335_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 100,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CNY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "China, Yuan Renminbi",
        "terseLabel": "China, Yuan Renminbi"
       }
      }
     },
     "localname": "CNY",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CZK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Czech Republic, Koruny",
        "terseLabel": "Czech Republic, Koruny"
       }
      }
     },
     "localname": "CZK",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro Member Countries, Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_JPY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Japan, Yen",
        "terseLabel": "Japan, Yen"
       }
      }
     },
     "localname": "JPY",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_MXN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mexico, Pesos",
        "terseLabel": "Mexico, Pesos"
       }
      }
     },
     "localname": "MXN",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "United States of America, Dollars"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "verboseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "icui_AccruedAuditFees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued audit fees",
        "label": "Accrued audit fees",
        "terseLabel": "Accrued audit fees"
       }
      }
     },
     "localname": "AccruedAuditFees",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_AccruedSalariesAndBenefits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued salaries and benefits",
        "label": "Accrued salaries and benefits",
        "terseLabel": "Salaries and benefits"
       }
      }
     },
     "localname": "AccruedSalariesAndBenefits",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Accruedfreight": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued freight",
        "label": "Accrued freight",
        "terseLabel": "Accrued freight"
       }
      }
     },
     "localname": "Accruedfreight",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Accruedlegalfees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued legal fees",
        "label": "Accrued legal fees",
        "terseLabel": "Legal accrual"
       }
      }
     },
     "localname": "Accruedlegalfees",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Accruedothertaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued other taxes",
        "label": "Accrued other taxes",
        "terseLabel": "Accrued other taxes"
       }
      }
     },
     "localname": "Accruedothertaxes",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_AmortizationOfInventoryStepUp": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of Inventory Step-up",
        "label": "Amortization of Inventory Step-up",
        "terseLabel": "Amortization of Inventory Step-up"
       }
      }
     },
     "localname": "AmortizationOfInventoryStepUp",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ApplicableMarginBaseRateLoans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Applicable Margin Base Rate Loans",
        "label": "Applicable Margin Base Rate Loans",
        "terseLabel": "Applicable Margin Base Rate Loans"
       }
      }
     },
     "localname": "ApplicableMarginBaseRateLoans",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_ApplicableMarginBasedOnLeverageRatioLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Applicable Margin Based on Leverage Ratio [Line Items]",
        "label": "Applicable Margin Based on Leverage Ratio [Line Items]",
        "terseLabel": "Applicable Margin Based on Leverage Ratio [Line Items]"
       }
      }
     },
     "localname": "ApplicableMarginBasedOnLeverageRatioLineItems",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_ApplicableMarginBasedOnLeverageRatioTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Applicable Margin Based on Leverage Ratio [Table]",
        "label": "Applicable Margin Based on Leverage Ratio [Table]",
        "terseLabel": "Applicable Margin Based on Leverage Ratio [Table]"
       }
      }
     },
     "localname": "ApplicableMarginBasedOnLeverageRatioTable",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Applicable Margin Based on Leverage Ratio",
        "label": "Applicable Margin Based on Leverage Ratio [Table Text Block]",
        "terseLabel": "Applicable Margin Based on Leverage Ratio"
       }
      }
     },
     "localname": "ApplicableMarginBasedOnLeverageRatioTableTextBlock",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_ApplicableMarginTermSOFRLoans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Applicable Margin Term SOFR Loans",
        "label": "Applicable Margin Term SOFR Loans",
        "terseLabel": "Applicable Margin Term SOFR Loans"
       }
      }
     },
     "localname": "ApplicableMarginTermSOFRLoans",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_AssetsandLiabilitiesLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets and Liabilities, Leases [Table Text Block]",
        "label": "Assets and Liabilities, Leases [Table Text Block]",
        "terseLabel": "Assets and Liabilities, Leases [Table Text Block]"
       }
      }
     },
     "localname": "AssetsandLiabilitiesLeasesTableTextBlock",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_AvailableforsaleDebtSecurityCurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available-for-sale Debt Security Current [Member]",
        "label": "Available-for-sale Debt Security Current [Member]",
        "terseLabel": "Available-for-sale Debt Security Current [Member]"
       }
      }
     },
     "localname": "AvailableforsaleDebtSecurityCurrentMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_BusinessCombinationConsiderationHoldbackLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration, Holdback liability",
        "label": "Business Combination, Consideration, Holdback liability",
        "terseLabel": "Business Combination, Consideration, Holdback liability"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationHoldbackLiability",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_BusinessCombinationConsiderationTransferredCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Cash",
        "label": "Business Combination, Consideration Transferred, Cash",
        "terseLabel": "Business Combination, Consideration Transferred, Cash"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredCash",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_BusinessCombinationGoodwillNonDeductible": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination, goodwill- non deductible",
        "label": "Business combination, goodwill- non deductible",
        "terseLabel": "Business combination, goodwill- non deductible"
       }
      }
     },
     "localname": "BusinessCombinationGoodwillNonDeductible",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "business combination, recognized identifiable asset acquired and liability assumed,",
        "label": "business combination, recognized identifiable asset acquired and liability assumed,",
        "terseLabel": "business combination, recognized identifiable asset acquired and liability assumed,"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable",
        "label": "Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable",
        "negatedTerseLabel": "Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable"
       }
      }
     },
     "localname": "BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_CommonStockSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Shares [Member]",
        "label": "Common Stock Shares [Member]",
        "terseLabel": "Common Stock Shares [Member]"
       }
      }
     },
     "localname": "CommonStockSharesMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ComputerEquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer Equipment and Software [Member]",
        "label": "Computer Equipment and Software [Member]",
        "terseLabel": "Computer Equipment and Software [Member]"
       }
      }
     },
     "localname": "ComputerEquipmentAndSoftwareMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ContingentConsiderationAllAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent consideration all Acquisitions",
        "label": "Contingent consideration all Acquisitions",
        "negatedTerseLabel": "Contingent consideration all Acquisitions"
       }
      }
     },
     "localname": "ContingentConsiderationAllAcquisitions",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ContingentConsiderationGrossLT": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Gross LT",
        "label": "Contingent Consideration, Gross LT",
        "terseLabel": "Contingent Consideration, Gross LT"
       }
      }
     },
     "localname": "ContingentConsiderationGrossLT",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ContingentConsiderationGrossST": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Gross ST",
        "label": "Contingent Consideration, Gross ST",
        "terseLabel": "Contingent Consideration, Gross ST"
       }
      }
     },
     "localname": "ContingentConsiderationGrossST",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ContingentConsiderationTaxExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "contingent consideration, tax expense",
        "label": "contingent consideration, tax expense",
        "terseLabel": "contingent consideration, tax expense"
       }
      }
     },
     "localname": "ContingentConsiderationTaxExpense",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Contingentconsiderationgross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "contingent consideration gross",
        "label": "contingent consideration gross",
        "terseLabel": "contingent consideration gross"
       }
      }
     },
     "localname": "Contingentconsiderationgross",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ContractassetandliabilitybalancesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Contract asset and liability balances [Table]",
        "label": "Contract asset and liability balances [Line Items]",
        "terseLabel": "Contract asset and liability balances [Line Items]"
       }
      }
     },
     "localname": "ContractassetandliabilitybalancesLineItems",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_ContractassetandliabilitybalancesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract asset and liability balances [Table]",
        "label": "Contract asset and liability balances [Table]",
        "terseLabel": "Contract asset and liability balances [Table]"
       }
      }
     },
     "localname": "ContractassetandliabilitybalancesTable",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_Contractsettlement": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "contract settlement",
        "label": "contract settlement",
        "terseLabel": "contract settlement"
       }
      }
     },
     "localname": "Contractsettlement",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_CriticalCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Critical Care [Member]",
        "label": "Critical Care [Member]",
        "terseLabel": "Critical Care [Member]"
       }
      }
     },
     "localname": "CriticalCareMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_CurrencyTranslationOnEarnOut": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency translation on earn-out",
        "label": "Currency translation on earn-out",
        "negatedTerseLabel": "Currency translation on earn-out"
       }
      }
     },
     "localname": "CurrencyTranslationOnEarnOut",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Deferredtaxcharge": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax charge",
        "label": "Deferred tax charge",
        "terseLabel": "Deferred tax charge"
       }
      }
     },
     "localname": "Deferredtaxcharge",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_DerivativeVariableRateFloor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "derivative variable rate floor",
        "label": "derivative variable rate floor",
        "terseLabel": "derivative variable rate floor"
       }
      }
     },
     "localname": "DerivativeVariableRateFloor",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_DevelopedTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "developed technology",
        "label": "developed technology [Member]",
        "terseLabel": "developed technology"
       }
      }
     },
     "localname": "DevelopedTechnologyMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Document And Entity Information [Abstract]",
        "label": "Document And Entity Information [Abstract]",
        "terseLabel": "Document And Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.icumed.com/20220630",
     "xbrltype": "stringItemType"
    },
    "icui_EarnOutLiabilityST": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earn-out liability ST",
        "label": "Earn-out liability ST",
        "terseLabel": "Earn-out liability ST"
       }
      }
     },
     "localname": "EarnOutLiabilityST",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_EarnoutliabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earn-out liability [Member]",
        "label": "Earn-out liability [Member]",
        "terseLabel": "Earn-out liability [Member]"
       }
      }
     },
     "localname": "EarnoutliabilityMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_EquipmentrevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment revenue [Member]",
        "label": "Equipment revenue [Member]",
        "terseLabel": "Equipment revenue [Member]"
       }
      }
     },
     "localname": "EquipmentrevenueMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_FieldServiceCorrectiveAction": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Field service corrective action",
        "label": "Field service corrective action",
        "terseLabel": "Field service corrective action"
       }
      }
     },
     "localname": "FieldServiceCorrectiveAction",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ForeignInfusionSystemSupplierMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Infusion System Supplier",
        "label": "Foreign Infusion System Supplier [Member]",
        "terseLabel": "Foreign Infusion System Supplier"
       }
      }
     },
     "localname": "ForeignInfusionSystemSupplierMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ForeignMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign [Member]",
        "label": "Foreign [Member]",
        "terseLabel": "Foreign [Member]"
       }
      }
     },
     "localname": "ForeignMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_GoodwillAcquiredDuringPeriodAllAcquisitions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill, acquired during period - All acquisitions",
        "label": "Goodwill, acquired during period - All acquisitions",
        "terseLabel": "Goodwill, acquired during period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriodAllAcquisitions",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_GovernmentGrantRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Grant Revenue",
        "label": "Government Grant Revenue [Member]",
        "terseLabel": "Government Grant Revenue"
       }
      }
     },
     "localname": "GovernmentGrantRevenueMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_GreaterThan275To100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "greater than 2.75 to1.00",
        "label": "greater than 2.75 to1.00 [Member]",
        "terseLabel": "greaterthan2point75to1"
       }
      }
     },
     "localname": "GreaterThan275To100Member",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Greaterthan400to100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "greaterthan4.00to1.00",
        "label": "greaterthan4.00to1.00 [Member]",
        "terseLabel": "greaterthan 4to1"
       }
      }
     },
     "localname": "Greaterthan400to100Member",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Hedge2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge 2 [Member]",
        "label": "Hedge 2 [Member]",
        "terseLabel": "Hedge 2 [Member]"
       }
      }
     },
     "localname": "Hedge2Member",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Hedge3MemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge 3 [Member]",
        "label": "Hedge 3 [Member] [Member]",
        "terseLabel": "Hedge 3 [Member] [Member]"
       }
      }
     },
     "localname": "Hedge3MemberMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_IVSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IV Solutions [Member]",
        "label": "IV Solutions [Member]",
        "terseLabel": "IV Solutions [Member]"
       }
      }
     },
     "localname": "IVSolutionsMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change during the reporting period in the carrying amount as of the balance sheet date of payments made for taxes. Also includes the net change during the reporting period in the account that represents the temporary difference that results from income (loss) that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase Decrease in income taxes, including excess tax benefits and deferred income taxes",
        "terseLabel": "Income taxes, including excess tax benefits and deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_InfusionConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infusion Consumables [Member]",
        "label": "Infusion Consumables [Member]",
        "terseLabel": "Infusion Consumables [Member]"
       }
      }
     },
     "localname": "InfusionConsumablesMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InfusionConsumablesSmithsMedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infusion Consumables-Smiths Medical",
        "label": "Infusion Consumables-Smiths Medical [Member]",
        "terseLabel": "Infusion Consumables-Smiths Medical"
       }
      }
     },
     "localname": "InfusionConsumablesSmithsMedicalMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InfusionSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infusion Systems [Member]",
        "label": "Infusion Systems [Member]",
        "terseLabel": "Infusion Systems [Member]"
       }
      }
     },
     "localname": "InfusionSystemsMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/RevenueDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InstrumentsPlacedwithCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instruments Placed with Customers [Member]",
        "label": "Instruments Placed with Customers [Member]",
        "terseLabel": "Instruments Placed with Customers [Member]"
       }
      }
     },
     "localname": "InstrumentsPlacedwithCustomersMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InterestExpenseOnLongTermDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest expense on long term debt",
        "label": "Interest expense on long term debt [Table Text Block]",
        "terseLabel": "Interest expense on long term debt"
       }
      }
     },
     "localname": "InterestExpenseOnLongTermDebtTableTextBlock",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_InterestPercentageAddedToBaseRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Percentage Added to Base Rate",
        "label": "Interest Percentage Added to Base Rate",
        "terseLabel": "Interest Percentage Added to Base Rate"
       }
      }
     },
     "localname": "InterestPercentageAddedToBaseRate",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_InterestPercentageAddedToFederalFundsRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Percentage Added to Federal Funds Rate",
        "label": "Interest Percentage Added to Federal Funds Rate",
        "terseLabel": "Interest Percentage Added to Federal Funds Rate"
       }
      }
     },
     "localname": "InterestPercentageAddedToFederalFundsRate",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_InterestRateSwapEndingNotionalValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Ending Notional Value",
        "label": "Interest Rate Swap Ending Notional Value",
        "terseLabel": "Interest Rate Swap Ending Notional Value"
       }
      }
     },
     "localname": "InterestRateSwapEndingNotionalValue",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_InternationalDistributorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Distributor",
        "label": "International Distributor [Member]",
        "terseLabel": "International Distributor"
       }
      }
     },
     "localname": "InternationalDistributorMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "investments in Debt and Marketable Equity Securities and Equity Method Investments",
        "label": "investments in Debt and Marketable Equity Securities and Equity Method Investments [Text Block]",
        "terseLabel": "investments in Debt and Marketable Equity Securities and Equity Method Investments [Text Block]"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_LOngTermObligationsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LOng-Term Obligations Disclosure [Abstract]",
        "label": "LOng-Term Obligations Disclosure [Abstract]",
        "terseLabel": "LOng-Term Obligations Disclosure [Abstract]"
       }
      }
     },
     "localname": "LOngTermObligationsDisclosureAbstract",
     "nsuri": "http://www.icumed.com/20220630",
     "xbrltype": "stringItemType"
    },
    "icui_LessThan275To100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "less than 2.75:1.00",
        "label": "less than 2.75 to1.00 [Member]",
        "terseLabel": "lessthan2point75to1"
       }
      }
     },
     "localname": "LessThan275To100Member",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LessThanOrEqual300To100ButGreaterThan250to100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "less than or equal 3.00 to 1.00 but greater than 2.50to1.00",
        "label": "less than or equal 3.00 to 1.00 but greater than 2.50to1.00 [Member]",
        "terseLabel": "lessthanorequal3to1butgreaterthan2point5to1"
       }
      }
     },
     "localname": "LessThanOrEqual300To100ButGreaterThan250to100Member",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LessThanOrEqualTo200To100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "less than or equal to 2.00 to 1.00",
        "label": "less than or equal to 2.00 to 1.00 [Member]",
        "terseLabel": "lessthanorequalto2to1"
       }
      }
     },
     "localname": "LessThanOrEqualTo200To100Member",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "less than or equal to 2.50 to1.00 but greater than 2.00 to1.00",
        "label": "less than or equal to 2.50 to1.00 but greater than 2.00 to1.00 [Member]",
        "terseLabel": "lessthanorequalto2point5to1butgreaterthan2to1"
       }
      }
     },
     "localname": "LessThanOrEqualTo250To100ButGreaterThan200To100Member",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "less than or equal to 4.00 to 1.00 but greater than 3.00 to100",
        "label": "less than or equal to 4.00 to 1.00 but greater than 3.00 to100 [Member]",
        "terseLabel": "lessthan4to1butgreaterthan3to1"
       }
      }
     },
     "localname": "LessThanOrEqualTo400To100ButGreaterThan300To100Member",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LeverageRatioCalculationCeilingSubtractedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Calculation Ceiling Subtracted Amount",
        "label": "Leverage Ratio Calculation Ceiling Subtracted Amount",
        "terseLabel": "Leverage Ratio Calculation Ceiling Subtracted Amount"
       }
      }
     },
     "localname": "LeverageRatioCalculationCeilingSubtractedAmount",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_LeverageRatioLevelAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Level",
        "label": "Leverage Ratio Level [Axis]",
        "terseLabel": "Leverage Ratio Level [Axis]"
       }
      }
     },
     "localname": "LeverageRatioLevelAxis",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_LeverageRatioLevelDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Level [Domain]",
        "label": "Leverage Ratio Level [Domain]",
        "terseLabel": "Leverage Ratio Level [Domain]"
       }
      }
     },
     "localname": "LeverageRatioLevelDomain",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Liabilitiesforcontracts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liabilities for contracts",
        "label": "Liabilities for contracts",
        "terseLabel": "Liabilities for contracts"
       }
      }
     },
     "localname": "Liabilitiesforcontracts",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_LongTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term",
        "label": "Long Term [Member]",
        "terseLabel": "Long Term"
       }
      }
     },
     "localname": "LongTermMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LongtermInvestmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Investments [Domain]",
        "label": "Long-term Investments [Domain]",
        "terseLabel": "Long-term Investments [Domain]"
       }
      }
     },
     "localname": "LongtermInvestmentsDomain",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_MeasurementInputMarketPriceofRiskDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Market Price of Risk [Domain]",
        "label": "Measurement Input, Market Price of Risk [Domain]",
        "terseLabel": "Measurement Input, Market Price of Risk [Domain]"
       }
      }
     },
     "localname": "MeasurementInputMarketPriceofRiskDomain",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_MeasurementinputadjustedEBITDAvolatilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MeasurementinputadjustedEBITDAvolatility [Domain]",
        "label": "MeasurementinputadjustedEBITDAvolatility [Domain]",
        "terseLabel": "MeasurementinputadjustedEBITDAvolatility [Domain]"
       }
      }
     },
     "localname": "MeasurementinputadjustedEBITDAvolatilityDomain",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_MinimumStockPriceTargetForEarnOutPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum Stock Price Target for Earn-out Payment",
        "label": "Minimum Stock Price Target for Earn-out Payment",
        "terseLabel": "Minimum Stock Price Target for Earn-out Payment"
       }
      }
     },
     "localname": "MinimumStockPriceTargetForEarnOutPayment",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_MoldsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molds [Member]",
        "label": "Molds [Member]",
        "terseLabel": "Molds [Member]"
       }
      }
     },
     "localname": "MoldsMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Optiontoextendinyears": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Optiontoextendinyears",
        "label": "Optiontoextendinyears",
        "terseLabel": "Lessee, Operating Lease, Option to Extend"
       }
      }
     },
     "localname": "Optiontoextendinyears",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LeasesTextDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "icui_OtherCurrenciesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "other currencies",
        "label": "other currencies [Member]",
        "terseLabel": "other currencies"
       }
      }
     },
     "localname": "OtherCurrenciesMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_OtherDeferredRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other deferred revenue",
        "label": "Other deferred revenue [Member]",
        "terseLabel": "Other deferred revenue"
       }
      }
     },
     "localname": "OtherDeferredRevenueMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_OtherforeigncountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other foreign countries [Member]",
        "label": "Other foreign countries [Member]",
        "terseLabel": "Other foreign countries [Member]"
       }
      }
     },
     "localname": "OtherforeigncountriesMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Outsidesalescommissions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outside sales commissions",
        "label": "Outside sales commissions",
        "terseLabel": "Distribution Fees"
       }
      }
     },
     "localname": "Outsidesalescommissions",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_OwnershipRequirementForEarnoutPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership requirement for Earnout Payment",
        "label": "Ownership requirement for Earnout Payment",
        "terseLabel": "Ownership requirement for Earnout Payment"
       }
      }
     },
     "localname": "OwnershipRequirementForEarnoutPayment",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_PrepaidVendorExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid vendor expenses",
        "label": "Prepaid vendor expenses",
        "terseLabel": "Prepaid vendor expenses"
       }
      }
     },
     "localname": "PrepaidVendorExpenses",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Prepaidinsuranceandpropertytaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid insurance and property taxes",
        "label": "Prepaid insurance and property taxes",
        "terseLabel": "Prepaid insurance and property taxes"
       }
      }
     },
     "localname": "Prepaidinsuranceandpropertytaxes",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Prepaidothertaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid other taxes",
        "label": "Prepaid other taxes",
        "terseLabel": "Prepaid Taxes"
       }
      }
     },
     "localname": "Prepaidothertaxes",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaids, other current assets and other noncurrent assets",
        "label": "Prepaids, other current assets and other noncurrent assets [Text Block]",
        "terseLabel": "Prepaids, other current assets and other noncurrent assets [Text Block]"
       }
      }
     },
     "localname": "PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_ProFormaAdjustmentAmortization": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pro Forma Adjustment - Amortization",
        "label": "Pro Forma Adjustment - Amortization",
        "terseLabel": "Pro Forma Adjustment - Amortization"
       }
      }
     },
     "localname": "ProFormaAdjustmentAmortization",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ProFormaAdjustmentFinanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pro Forma Adjustment - Finance Costs",
        "label": "Pro Forma Adjustment - Finance Costs",
        "terseLabel": "Pro Forma Adjustment - Finance Costs"
       }
      }
     },
     "localname": "ProFormaAdjustmentFinanceCosts",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ProFormaAdjustmentInventory": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pro Forma Adjustment - Inventory",
        "label": "Pro Forma Adjustment - Inventory",
        "terseLabel": "Pro Forma Adjustment - Inventory"
       }
      }
     },
     "localname": "ProFormaAdjustmentInventory",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ProFormaAdjustmentRelatedPartyLoans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pro Forma Adjustment - Related Party Loans",
        "label": "Pro Forma Adjustment - Related Party Loans",
        "terseLabel": "Pro Forma Adjustment - Related Party Loans"
       }
      }
     },
     "localname": "ProFormaAdjustmentRelatedPartyLoans",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of long-term debt, net of lender debt issuance costs",
        "label": "Proceeds from issuance of long-term debt, net of lender debt issuance costs",
        "terseLabel": "Proceeds from issuance of long-term debt, net of lender debt issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ProvisionForWarrantyAndReturns": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for warranty and returns",
        "label": "Provision for warranty and returns",
        "terseLabel": "Provision for warranty and returns"
       }
      }
     },
     "localname": "ProvisionForWarrantyAndReturns",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_PursuitVascularInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pursuit Vascular, Inc. [Member] [Member]",
        "label": "Pursuit Vascular, Inc. [Member]",
        "terseLabel": "Pursuit Vascular, Inc. [Member]"
       }
      }
     },
     "localname": "PursuitVascularInc.Member",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_RequiredShareHoldingOfStockIssuedAtAcquisition": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Required Share Holding Of Stock Issued At Acquisition",
        "label": "Required Share Holding Of Stock Issued At Acquisition",
        "terseLabel": "Required Share Holding Of Stock Issued At Acquisition"
       }
      }
     },
     "localname": "RequiredShareHoldingOfStockIssuedAtAcquisition",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_Restructuringandstrategictransaction": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and strategic transaction expenses",
        "label": "Restructuring and strategic transaction",
        "terseLabel": "Restructuring, strategic transaction and integration"
       }
      }
     },
     "localname": "Restructuringandstrategictransaction",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Restructuringstrategictransactionandintegration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring, strategic transaction and integration",
        "label": "Restructuring, strategic transaction and integration",
        "terseLabel": "Restructuring, strategic transaction and integration"
       }
      }
     },
     "localname": "Restructuringstrategictransactionandintegration",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_RevolverSubLimits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolver Sub limits",
        "label": "Revolver Sub limits",
        "terseLabel": "Revolver Sub limits"
       }
      }
     },
     "localname": "RevolverSubLimits",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_STEarnoutLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ST Earnout Liability",
        "label": "ST Earnout Liability [Member]",
        "terseLabel": "ST Earnout Liability"
       }
      }
     },
     "localname": "STEarnoutLiabilityMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ShortTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short Term",
        "label": "Short Term [Member]",
        "terseLabel": "Short Term"
       }
      }
     },
     "localname": "ShortTermMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_SmithsGroupOwnershipAcquisitionSharesIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Smiths Group Ownership % Acquisition Shares Issued",
        "label": "Smiths Group Ownership % Acquisition Shares Issued",
        "terseLabel": "Smiths Group Ownership % Acquisition Shares Issued"
       }
      }
     },
     "localname": "SmithsGroupOwnershipAcquisitionSharesIssued",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_SmithsGroupOwnershipRequiredForBoardRepresentation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Smiths Group Ownership % Required for Board Representation",
        "label": "Smiths Group Ownership % Required for Board Representation",
        "terseLabel": "Smiths Group Ownership % Required for Board Representation"
       }
      }
     },
     "localname": "SmithsGroupOwnershipRequiredForBoardRepresentation",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_SmithsMedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SmithsMedical",
        "label": "SmithsMedical [Member]",
        "terseLabel": "SmithsMedical"
       }
      }
     },
     "localname": "SmithsMedicalMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_SoftwarerevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Software revenue [Member]",
        "label": "Software revenue [Member]",
        "terseLabel": "Software revenue [Member]"
       }
      }
     },
     "localname": "SoftwarerevenueMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_SpareParts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Spare parts",
        "label": "Spare parts",
        "terseLabel": "Spare parts"
       }
      }
     },
     "localname": "SpareParts",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Sparepartsusage": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sparepartsusage",
        "label": "Sparepartsusage",
        "terseLabel": "Sparepartsusage"
       }
      }
     },
     "localname": "Sparepartsusage",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Srt_MultipleCurrencyAxisAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "srt_MultipleCurrencyAxis",
        "label": "srt_MultipleCurrencyAxis [Axis]",
        "terseLabel": "srt_MultipleCurrencyAxis [Axis]"
       }
      }
     },
     "localname": "Srt_MultipleCurrencyAxisAxis",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_Srt_MultipleCurrencyAxisDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "srt_MultipleCurrencyAxis [Domain]",
        "label": "srt_MultipleCurrencyAxis [Domain]",
        "terseLabel": "srt_MultipleCurrencyAxis [Domain]"
       }
      }
     },
     "localname": "Srt_MultipleCurrencyAxisDomain",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_StrategicTransactionandIntegration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Transaction and Integration",
        "label": "Strategic Transaction and Integration",
        "terseLabel": "Strategic Transaction and Integration"
       }
      }
     },
     "localname": "StrategicTransactionandIntegration",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/StrategicTransactionandIntegrationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_TerSOFRInterestRateAdjustmentForBaseRateLoans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ter SOFR Interest Rate % Adjustment for Base Rate Loans",
        "label": "Ter SOFR Interest Rate % Adjustment for Base Rate Loans",
        "terseLabel": "Ter SOFR Interest Rate % Adjustment for Base Rate Loans"
       }
      }
     },
     "localname": "TerSOFRInterestRateAdjustmentForBaseRateLoans",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TermAPrincipalPaymentFirst2Years": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term A principal payment % First 2 Years",
        "label": "Term A principal payment % First 2 Years",
        "terseLabel": "Term A principal payment % First 2 Years"
       }
      }
     },
     "localname": "TermAPrincipalPaymentFirst2Years",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TermAPrincipalPaymentInYear5": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term A Principal Payment % in Year 5",
        "label": "Term A Principal Payment % in Year 5",
        "terseLabel": "Term A Principal Payment % in Year 5"
       }
      }
     },
     "localname": "TermAPrincipalPaymentInYear5",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TermAPrincipalPaymentYear3And4": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term A Principal Payment % Year 3 and 4",
        "label": "Term A Principal Payment % Year 3 and 4",
        "terseLabel": "Term A Principal Payment % Year 3 and 4"
       }
      }
     },
     "localname": "TermAPrincipalPaymentYear3And4",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TermLoanAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan A",
        "label": "Term Loan A [Member]",
        "terseLabel": "Term Loan A"
       }
      }
     },
     "localname": "TermLoanAMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_TermLoanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan",
        "label": "Term Loan [Axis]",
        "terseLabel": "Term Loan [Axis]"
       }
      }
     },
     "localname": "TermLoanAxis",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_TermLoanBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B",
        "label": "Term Loan B [Member]",
        "terseLabel": "Term Loan B"
       }
      }
     },
     "localname": "TermLoanBMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_TermLoanBPrincipalPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B Principal Payment %",
        "label": "Term Loan B Principal Payment %",
        "terseLabel": "Term Loan B Principal Payment %"
       }
      }
     },
     "localname": "TermLoanBPrincipalPayment",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TermLoanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan [Domain]",
        "label": "Term Loan [Domain]",
        "terseLabel": "Term Loan [Domain]"
       }
      }
     },
     "localname": "TermLoanDomain",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans",
        "label": "Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans",
        "terseLabel": "Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans"
       }
      }
     },
     "localname": "TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TimingAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing",
        "label": "Timing [Axis]",
        "terseLabel": "Timing [Axis]"
       }
      }
     },
     "localname": "TimingAxis",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_TimingDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing [Domain]",
        "label": "Timing [Domain]",
        "terseLabel": "Timing [Domain]"
       }
      }
     },
     "localname": "TimingDomain",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_TotalSeniorSecuredCreditFacility": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TotalSeniorSecuredCreditFacility",
        "label": "TotalSeniorSecuredCreditFacility",
        "terseLabel": "TotalSeniorSecuredCreditFacility"
       }
      }
     },
     "localname": "TotalSeniorSecuredCreditFacility",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_TreasuryStockPurchasePlan": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock Purchase Plan",
        "label": "Treasury Stock Purchase Plan",
        "terseLabel": "Treasury Stock Purchase Plan"
       }
      }
     },
     "localname": "TreasuryStockPurchasePlan",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_UnfavorablecontractliabilityST": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UnfavorablecontractliabilityST",
        "label": "UnfavorablecontractliabilityST",
        "terseLabel": "UnfavorablecontractliabilityST"
       }
      }
     },
     "localname": "UnfavorablecontractliabilityST",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_VascularAccessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vascular Access",
        "label": "Vascular Access [Member]",
        "terseLabel": "Vascular Access"
       }
      }
     },
     "localname": "VascularAccessMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_VitalCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vital Care",
        "label": "Vital Care [Member]",
        "terseLabel": "Vital Care"
       }
      }
     },
     "localname": "VitalCareMember",
     "nsuri": "http://www.icumed.com/20220630",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r131",
      "r171",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r191",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r301",
      "r302",
      "r304",
      "r306",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r131",
      "r171",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r191",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r301",
      "r302",
      "r304",
      "r306",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r312",
      "r338",
      "r399",
      "r402",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r634",
      "r637",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesTextDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r312",
      "r338",
      "r399",
      "r402",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r634",
      "r637",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesTextDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r192",
      "r371",
      "r374",
      "r585",
      "r633",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r192",
      "r371",
      "r374",
      "r585",
      "r633",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r312",
      "r338",
      "r389",
      "r399",
      "r402",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r634",
      "r637",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails",
      "http://www.icumed.com/role/LeasesTextDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r312",
      "r338",
      "r389",
      "r399",
      "r402",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r634",
      "r637",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails",
      "http://www.icumed.com/role/LeasesTextDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r144",
      "r149",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r193",
      "r194",
      "r371",
      "r375",
      "r636",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r193",
      "r194",
      "r371",
      "r375",
      "r636",
      "r661",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r144",
      "r149",
      "r281",
      "r400",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r47",
      "r572"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r7",
      "r27",
      "r196",
      "r197"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, net of allowance for doubtful accounts"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedBonusesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r51"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Bonuses, Current",
        "terseLabel": "Incentive compensation"
       }
      }
     },
     "localname": "AccruedBonusesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent": {
     "auth_ref": [
      "r601",
      "r626"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them.",
        "label": "Accrued Employee Benefits",
        "terseLabel": "Accrued Employee Benefits"
       }
      }
     },
     "localname": "AccruedEmployeeBenefitsCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r21",
      "r595",
      "r618"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income tax liability"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r23",
      "r595",
      "r618"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "INCOME TAX LIABILITY"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities [Abstract]",
        "terseLabel": "Accrued Liabilities [Abstract]"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued Liabilities [Member]"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "auth_ref": [
      "r601",
      "r626"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.",
        "label": "Accrued Professional Fees",
        "terseLabel": "Accrued Professional Fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRentCurrentAndNoncurrent": {
     "auth_ref": [
      "r21",
      "r23",
      "r596",
      "r617"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements.",
        "label": "Accrued Rent",
        "terseLabel": "Accrued Rent"
       }
      }
     },
     "localname": "AccruedRentCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r71",
      "r77",
      "r84",
      "r85",
      "r86",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r45",
      "r255"
     ],
     "calculation": {
      "http://www.icumed.com/role/PropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r70",
      "r77",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r30",
      "r74",
      "r76",
      "r77",
      "r621",
      "r642",
      "r645"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r84",
      "r85",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r73",
      "r77",
      "r84",
      "r85",
      "r86",
      "r132",
      "r133",
      "r134",
      "r475",
      "r638",
      "r639",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "AOCI Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r68",
      "r77",
      "r84",
      "r85",
      "r86",
      "r475",
      "r536",
      "r537",
      "r538",
      "r539",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AcquisitionRelatedCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of acquisition-related costs allocated to (included in) reported pro forma earnings (supplemental pro forma information).",
        "label": "Acquisition-related Costs [Member]",
        "terseLabel": "Acquisition-related Costs"
       }
      }
     },
     "localname": "AcquisitionRelatedCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r407",
      "r408",
      "r409",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedLabel": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Adjustments to Additional Paid in Capital, Other"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r403",
      "r404",
      "r412",
      "r413"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r198",
      "r222",
      "r223",
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r96",
      "r117",
      "r325",
      "r546"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Debt Issuance Costs amortization"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r117",
      "r325",
      "r333",
      "r334",
      "r546"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of Debt Issuance Costs and Discounts"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r117",
      "r241",
      "r248"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareDetails",
      "http://www.icumed.com/role/NetIncomePerShareDetails1"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r127",
      "r179",
      "r184",
      "r190",
      "r217",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r470",
      "r476",
      "r526",
      "r570",
      "r572",
      "r593",
      "r616"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r12",
      "r63",
      "r127",
      "r217",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r470",
      "r476",
      "r526",
      "r570",
      "r572"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "TOTAL CURRENT ASSETS"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "CURRENT ASSETS:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r515"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets, Fair Value Disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r205",
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "terseLabel": "Debt Securities, Available-for-sale, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss": {
     "auth_ref": [
      "r207"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss",
        "terseLabel": "Debt Securities, Available-for-sale, Unrealized Loss"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesGrossUnrealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r202",
      "r206",
      "r226",
      "r600"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Debt Securities, Available-for-sale"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r204",
      "r226"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Short-term investment securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r204",
      "r226"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-sale, Noncurrent",
        "terseLabel": "Long-term investment securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r490",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r398",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r398",
      "r401",
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionContingentConsiderationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition, Contingent Consideration [Line Items]",
        "terseLabel": "Business Acquisition, Contingent Consideration [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Business Acquisition, Transaction Costs"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "auth_ref": [
      "r459"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Business Acquisition, Percentage of Voting Interests Acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r437",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Business Acquisition, Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Business Acquisition, Share Price"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r437",
      "r438"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Business Acquisition, Pro Forma Net Income (Loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r437",
      "r438"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Business Acquisition, Pro Forma Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r452",
      "r453",
      "r456"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business Combination, Consideration Transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r452",
      "r453"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "negatedTerseLabel": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r450",
      "r452",
      "r453",
      "r458"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Business Combination, Consideration Transferred, Liabilities Incurred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r116",
      "r462"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in fair value of contingent earn-out"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r451",
      "r454",
      "r460"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Business Combination, Contingent Consideration, Liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r451",
      "r455"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Contingent earn-out liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Measurement Input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r451",
      "r455"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Contingent Earn-Out Liability, Noncurrent"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combination Disclosure"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r442",
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r442",
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r442",
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r442",
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities": {
     "auth_ref": [
      "r442",
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents liabilities associated with restructuring or exit activities of the acquiree, existing at the acquisition date (present liabilities of the acquiree).",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restructuring Liabilities",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restructuring Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r120",
      "r121",
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Capital Expenditures Incurred but Not yet Paid"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]",
        "terseLabel": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-term Investments",
        "totalLabel": "TOTAL CASH, CASH EQUIVALENTS AND INVESTMENT SECURITIES"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r114",
      "r119",
      "r123"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r114",
      "r533"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging [Member]"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "Cash Flow, Supplemental Disclosures [Text Block]"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]",
        "terseLabel": "Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]"
       }
      }
     },
     "localname": "CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r464",
      "r465",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Collaborative Arrangement Disclosure [Text Block]"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r57",
      "r280",
      "r602",
      "r625"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r289",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies [Text Block]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r132",
      "r133",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r26",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common stock, shares outstanding",
        "periodStartLabel": "Common stock, shares outstanding",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r26",
      "r572"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.10 par value - Authorized-80,000 shares; Issued 23,899 shares at June 30,2022 and 21,280 shares at December 31, 2021 and outstanding 23,898 shares at June 30, 2022 and 21,280 shares at December 31, 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r80",
      "r82",
      "r83",
      "r93",
      "r606",
      "r629"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction in Progress, Gross"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract with Customer, Asset and Liability [Table Text Block]"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r359",
      "r360",
      "r372"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "negatedPeriodEndLabel": "Contract with Customer, Liability",
        "negatedPeriodStartLabel": "Contract with Customer, Liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r359",
      "r360",
      "r372"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Contract with Customer, Liability, Noncurrent"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue": {
     "auth_ref": [
      "r25",
      "r351"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding nonredeemable convertible preferred stock or outstanding convertible preferred stock that is redeemable solely at the option of the issuer.",
        "label": "Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value",
        "verboseLabel": "Convertible preferred stock, $1.00 par value Authorized-500 shares; Issued and outstanding - none"
       }
      }
     },
     "localname": "ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate Bond Securities"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r98",
      "r127",
      "r217",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r526"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerContractsMember": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's established relationships with its customers through contracts.",
        "label": "Customer Contracts [Member]",
        "terseLabel": "Customer Contracts [Member]"
       }
      }
     },
     "localname": "CustomerContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.",
        "label": "Customer-Related Intangible Assets [Member]",
        "terseLabel": "Customer-Related Intangible Assets [Member]"
       }
      }
     },
     "localname": "CustomerRelatedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "terseLabel": "Debt, Current"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r22",
      "r327",
      "r597",
      "r615"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term Debt, Gross"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r53",
      "r322",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Debt Instrument, Interest Rate During Period"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r54",
      "r312",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Debt Instrument, Maturity Date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r55"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Debt Instrument, Periodic Payment, Principal"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r55",
      "r126",
      "r131",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r331",
      "r332",
      "r333",
      "r334",
      "r351",
      "r352",
      "r353",
      "r354",
      "r544",
      "r545",
      "r547",
      "r548",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r316",
      "r328",
      "r331",
      "r332",
      "r546"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "terseLabel": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-term and Short-term, Combined Amount",
        "terseLabel": "Debt, Long-term and Short-term, Combined Amount"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent": {
     "auth_ref": [
      "r205",
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Amortized Cost, Current",
        "terseLabel": "Debt Securities, Available-for-sale, Amortized Cost, Current"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent": {
     "auth_ref": [
      "r205",
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-sale, Amortized Cost, Noncurrent",
        "terseLabel": "Debt Securities, Available-for-sale, Noncurrent"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r211",
      "r227",
      "r228"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsAndOtherAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred cost assets and assets classified as other.",
        "label": "Deferred Costs and Other Assets",
        "terseLabel": "Deferred Costs and Other Assets"
       }
      }
     },
     "localname": "DeferredCostsAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "terseLabel": "Prepaid Expenses and Other Current Assets [Table Text Block]"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt Issuance Costs, Gross"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r46",
      "r546"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "terseLabel": "Debt Issuance Costs, Noncurrent, Net"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred Income Tax Assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "DEFERRED INCOME TAXES"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueAdditions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.",
        "label": "Deferred Revenue, Additions",
        "negatedTerseLabel": "Deferred Revenue, Additions"
       }
      }
     },
     "localname": "DeferredRevenueAdditions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositAssets": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.",
        "label": "Deposit Assets",
        "terseLabel": "Deposit Assets"
       }
      }
     },
     "localname": "DepositAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r117",
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r117",
      "r174"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r483",
      "r484",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Derivative Asset, Notional Amount"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r64",
      "r65",
      "r66",
      "r523"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative Asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsCurrent": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Current",
        "terseLabel": "Derivative Asset, Current"
       }
      }
     },
     "localname": "DerivativeAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsNoncurrent": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Noncurrent",
        "terseLabel": "Derivative Asset, Noncurrent"
       }
      }
     },
     "localname": "DerivativeAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Derivative, Fixed Interest Rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeForwardExchangeRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual rate at which a foreign currency can be purchased or sold.",
        "label": "Derivative, Forward Exchange Rate",
        "terseLabel": "Derivative, Forward Exchange Rate"
       }
      }
     },
     "localname": "DerivativeForwardExchangeRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r66",
      "r491",
      "r492",
      "r497",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r509",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Text Block]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r488",
      "r491",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r488",
      "r491",
      "r497",
      "r501",
      "r502",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r496",
      "r500"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "terseLabel": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion": {
     "auth_ref": [
      "r496"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of gain reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion",
        "terseLabel": "Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion": {
     "auth_ref": [
      "r496"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of loss reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion",
        "negatedTerseLabel": "Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion"
       }
      }
     },
     "localname": "DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r64",
      "r65",
      "r66",
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative Liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Current",
        "terseLabel": "Derivative Liability, Current"
       }
      }
     },
     "localname": "DerivativeLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Noncurrent",
        "terseLabel": "Derivative Liability, Noncurrent"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r484",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r482",
      "r485",
      "r486",
      "r488",
      "r489",
      "r494",
      "r497",
      "r504",
      "r505",
      "r507",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed Technology Rights [Member]"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r371",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA [Member]"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "NET INCOME PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r94",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r152",
      "r154",
      "r159",
      "r160",
      "r161",
      "r165",
      "r166",
      "r512",
      "r513",
      "r607",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "EPS - basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/NetIncomePerShareDetails",
      "http://www.icumed.com/role/NetIncomePerShareDetails1"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r94",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r154",
      "r159",
      "r160",
      "r161",
      "r165",
      "r166",
      "r512",
      "r513",
      "r607",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted (In dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/NetIncomePerShareDetails",
      "http://www.icumed.com/role/NetIncomePerShareDetails1"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income Per Share [Text Block]"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of Exchange Rate on Cash [Abstract]",
        "terseLabel": "Effect of Exchange Rate on Cash [Abstract]"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r533"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective Income Tax Rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r128",
      "r418",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Share-based Payment Arrangement, Expense, Tax Benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Severance [Member]"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r84",
      "r85",
      "r86",
      "r132",
      "r133",
      "r134",
      "r138",
      "r146",
      "r148",
      "r168",
      "r219",
      "r350",
      "r355",
      "r407",
      "r408",
      "r409",
      "r422",
      "r423",
      "r511",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r542",
      "r638",
      "r639",
      "r640",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement",
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentAggregateCost": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Aggregate Cost",
        "terseLabel": "Equity Method Investment, Aggregate Cost"
       }
      }
     },
     "localname": "EquityMethodInvestmentAggregateCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityMethodInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity Method Investment, Ownership Percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityMethodInvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r43",
      "r180",
      "r214"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityMethodInvestmentsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Equity Method Investments [Table Text Block]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FacilityClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Facility Closing [Member]",
        "terseLabel": "Facility Closing [Member]"
       }
      }
     },
     "localname": "FacilityClosingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r515",
      "r524",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r515",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r318",
      "r331",
      "r332",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r516",
      "r574",
      "r575",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Disclosures"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r318",
      "r390",
      "r391",
      "r396",
      "r397",
      "r516",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r318",
      "r331",
      "r332",
      "r390",
      "r391",
      "r396",
      "r397",
      "r516",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r318",
      "r331",
      "r332",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r516",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": {
     "auth_ref": [
      "r520"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3) and still held.",
        "label": "Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)",
        "negatedTerseLabel": "Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r519",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r519",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r519"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "terseLabel": "CONTINGENT EARN-OUT LIABILITY"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r318",
      "r331",
      "r332",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r574",
      "r575",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r120",
      "r121",
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Fair Value of Assets Acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r490",
      "r494",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r551",
      "r557",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Finance Lease, Interest Expense"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r553",
      "r560"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Finance Lease, Interest Payment on Liability"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r550",
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance Lease, Liability"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails",
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r550"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance Lease, Liability, Current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r550"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "terseLabel": "Finance Lease, Liability, Payment, Due"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Finance Lease, Liability, Payments, Due after Year Five"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "Finance Lease, Liability, Payments, Due Next Twelve Months"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Finance Lease, Liability, Payments, Due Year Five"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Finance Lease, Liability, Payments, Due Year Four"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Finance Lease, Liability, Payments, Due Year Three"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Finance Lease, Liability, Payments, Due Year Two"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Finance Lease, Liability, Payments, Remainder of Fiscal Year"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Finance Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r552",
      "r560"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Finance Lease, Principal Payments"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r549"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r551",
      "r557",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r563",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r562",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "terseLabel": "Financial Liabilities Fair Value Disclosure"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-Lived Intangible Asset, Useful Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r247"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, after Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Four"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Two"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r242",
      "r244",
      "r247",
      "r251",
      "r586",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r247",
      "r590"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Finite-Lived Intangible Assets, Gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r242",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r247",
      "r586"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-Lived Intangible Assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails",
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": {
     "auth_ref": [
      "r508"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months",
        "terseLabel": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Foreign Currency Contract, Asset, Fair Value Disclosure"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Foreign Currency Contracts, Liability, Fair Value Disclosure"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r66",
      "r390",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeMember": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading of derivative or nonderivative instruments whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange [Member]",
        "terseLabel": "Foreign Exchange"
       }
      }
     },
     "localname": "ForeignExchangeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and Fixtures, Gross"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfInvestments": {
     "auth_ref": [
      "r117"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.",
        "label": "Gain (Loss) on Sale of Investments",
        "terseLabel": "Gain (Loss) on Sale of Investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Loss on disposal of property and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r233",
      "r234",
      "r572",
      "r592"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "GOODWILL"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r235"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, Acquired During Period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r236"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Goodwill, Foreign Currency Translation Gain (Loss)"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r237",
      "r435"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Goodwill, Purchase Accounting Adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r97",
      "r127",
      "r179",
      "r183",
      "r186",
      "r189",
      "r191",
      "r217",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r526"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross Profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r488",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r90",
      "r179",
      "r183",
      "r186",
      "r189",
      "r191",
      "r591",
      "r603",
      "r609",
      "r631"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "(Loss) Income from Continuing Operations before Income Taxes, Noncontrolling Interest"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r257",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r128",
      "r419",
      "r420",
      "r421",
      "r427",
      "r430",
      "r432",
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax Disclosure [Text Block]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r129",
      "r147",
      "r148",
      "r177",
      "r417",
      "r428",
      "r431",
      "r632"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "BENEFIT (PROVISION) FOR INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "negatedTerseLabel": "Increase (Decrease) in Deferred Revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Increase (Decrease) in Other Operating Assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r155",
      "r156",
      "r157",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive securities"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareDetails",
      "http://www.icumed.com/role/NetIncomePerShareDetails1"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r250"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Intangible Assets, Gross (Excluding Goodwill)"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r240",
      "r245"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "INTANGIBLE ASSETS, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r88",
      "r173",
      "r543",
      "r546",
      "r608"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r101",
      "r323",
      "r330",
      "r333",
      "r334"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest Expense, Debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r102",
      "r324",
      "r333",
      "r334"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Interest Expense, Debt, Excluding Amortization"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r508"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateDerivativeAssetsAtFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of interest rate derivative assets, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as assets.",
        "label": "Interest Rate Derivative Assets, at Fair Value",
        "terseLabel": "Interest Rate Derivative Assets, at Fair Value"
       }
      }
     },
     "localname": "InterestRateDerivativeAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateDerivativeLiabilitiesAtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of interest rate derivative liabilities, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as liabilities.",
        "label": "Interest Rate Derivative Liabilities, at Fair Value",
        "terseLabel": "Interest Rate Derivative Liabilities, at Fair Value"
       }
      }
     },
     "localname": "InterestRateDerivativeLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories [Text Block]"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r34",
      "r229"
     ],
     "calculation": {
      "http://www.icumed.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Inventory, Finished Goods, Net of Reserves"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r6",
      "r60",
      "r572"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.icumed.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r36",
      "r229"
     ],
     "calculation": {
      "http://www.icumed.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Inventory, Raw Materials, Net of Reserves"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r35",
      "r229"
     ],
     "calculation": {
      "http://www.icumed.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Inventory, Work in Process, Net of Reserves"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeAmortizationOfPremium": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization of purchase premium on nonoperating securities.",
        "label": "Investment Income, Amortization of Premium",
        "terseLabel": "Bond premium amortization"
       }
      }
     },
     "localname": "InvestmentIncomeAmortizationOfPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LandBuildingsAndImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate held and additions or improvements to real estate held and structures used in the conduct of business.",
        "label": "Land, Buildings and Improvements [Member]",
        "terseLabel": "Land, Buildings and Improvements [Member]"
       }
      }
     },
     "localname": "LandBuildingsAndImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r564",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost [Table Text Block]"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due after Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Four"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Three"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Two"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesTextDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Lessee, Operating Leases [Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceived": {
     "auth_ref": [
      "r568"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payments to be received by lessor for operating lease.",
        "label": "Lessor, Operating Lease, Payments to be Received",
        "terseLabel": "Lessor, Operating Lease, Payments to be Received"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r33",
      "r127",
      "r217",
      "r526",
      "r572",
      "r599",
      "r623"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r120",
      "r121",
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "negatedTerseLabel": "Liabilities Assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r52",
      "r127",
      "r217",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r471",
      "r476",
      "r477",
      "r526",
      "r570",
      "r571",
      "r572"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "TOTAL CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "CURRENT LIABILITIES:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.",
        "label": "Liabilities, Other than Long-term Debt, Noncurrent",
        "terseLabel": "OTHER LONG-TERM LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesOtherThanLongtermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesTotalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of total liabilities, when it serves as a benchmark in a concentration of risk calculation. Sum of all reported liabilities as of the balance sheet date.",
        "label": "Liabilities, Total [Member]",
        "terseLabel": "Liabilities, Total [Member]"
       }
      }
     },
     "localname": "LiabilitiesTotalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liability [Member]",
        "terseLabel": "Liability"
       }
      }
     },
     "localname": "LiabilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Commitment Fee Amount",
        "terseLabel": "Line of Credit Facility, Commitment Fee Amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Line of Credit Facility, Commitment Fee Percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityExpirationDate1": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.",
        "label": "Line of Credit Facility, Expiration Date",
        "terseLabel": "Line of Credit Facility, Expiration Date"
       }
      }
     },
     "localname": "LineOfCreditFacilityExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the amount outstanding under the credit facility.",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "terseLabel": "Line of Credit Facility, Fair Value of Amount Outstanding"
       }
      }
     },
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LinesOfCreditCurrent": {
     "auth_ref": [
      "r20",
      "r594"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line of Credit, Current",
        "terseLabel": "Line of Credit, Current"
       }
      }
     },
     "localname": "LinesOfCreditCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r22",
      "r317",
      "r329",
      "r331",
      "r332",
      "r597",
      "r619"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Long-term Debt, Current Maturities"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r131",
      "r292",
      "r321"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Long-Term Debt, Maturity, after Year Five"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r131",
      "r292",
      "r321"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "Long-Term Debt, Maturity, Year One"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r131",
      "r292",
      "r321"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "Long-Term Debt, Maturity, Year Five"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r131",
      "r292",
      "r321"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "Long-Term Debt, Maturity, Year Four"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r131",
      "r292",
      "r321"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "Long-Term Debt, Maturity, Year Three"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r131",
      "r292",
      "r321"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "Long-Term Debt, Maturity, Year Two"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r131"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "Long-Term Debt, Maturity, Remainder of Fiscal Year"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term Debt, Excluding Current Maturities"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Long-term Debt [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r55",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r13",
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Machinery and Equipment, Gross"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]",
        "terseLabel": "Measurement Input, Price Volatility"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Measurement Input, Risk Free Interest Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInDeferredRevenueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Deferred Revenue [Roll Forward]",
        "terseLabel": "Movement in Deferred Revenue [Roll Forward]"
       }
      }
     },
     "localname": "MovementInDeferredRevenueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r114",
      "r115",
      "r118"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r4",
      "r78",
      "r81",
      "r86",
      "r91",
      "r118",
      "r127",
      "r137",
      "r141",
      "r142",
      "r143",
      "r144",
      "r147",
      "r148",
      "r158",
      "r179",
      "r183",
      "r186",
      "r189",
      "r191",
      "r217",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r513",
      "r526",
      "r604",
      "r627"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net Income Attributable to Parent"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r2",
      "r135",
      "r136",
      "r139",
      "r140",
      "r149",
      "r150",
      "r151",
      "r200",
      "r201",
      "r220",
      "r221",
      "r381",
      "r382",
      "r383",
      "r384",
      "r410",
      "r424",
      "r425",
      "r426",
      "r510",
      "r527",
      "r528",
      "r529",
      "r569",
      "r587",
      "r588",
      "r589",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Text Block]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "NON-CASH INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Noncompete Agreements [Member]"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonfinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of obligations not classified as financial liabilities. Includes, but is not limited to, accounts payable and accrued liabilities, commitments, obligations, and other liabilities.",
        "label": "Nonfinancial Liabilities Fair Value Disclosure",
        "terseLabel": "Nonfinancial Liabilities Fair Value Disclosure"
       }
      }
     },
     "localname": "NonfinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "OTHER (EXPENSE) INCOME, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonrecurringAdjustmentAxis": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about material and nonrecurring adjustment directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).",
        "label": "Nonrecurring Adjustment [Axis]",
        "terseLabel": "Nonrecurring Adjustment [Axis]"
       }
      }
     },
     "localname": "NonrecurringAdjustmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonrecurringAdjustmentDomain": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material, nonrecurring adjustment(s) allocated (included) to (in) reported pro forma revenue and earnings (supplemental pro forma information).",
        "label": "Nonrecurring Adjustment [Domain]",
        "terseLabel": "Nonrecurring Adjustment [Domain]"
       }
      }
     },
     "localname": "NonrecurringAdjustmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "TOTAL OPERATING EXPENSES"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "OPERATING EXPENSES:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r179",
      "r183",
      "r186",
      "r189",
      "r191"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "(LOSS) INCOME FROM OPERATIONS"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r558",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r550"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating Lease, Liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails",
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r550"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r550"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r554",
      "r560"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r549"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Noncash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r563",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r562",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r5",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Basis of Presentation [Text Block]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r51"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r56"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Other Accrued Liabilities, Noncurrent"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r61",
      "r572"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other Assets, Current"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r490",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets [Member]"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "terseLabel": "Other Assets, Miscellaneous, Noncurrent"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "OTHER ASSETS"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r72",
      "r74",
      "r469",
      "r474"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r69",
      "r74",
      "r530",
      "r531",
      "r534"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Other Comprehensive (Loss) Income, Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Axis]",
        "terseLabel": "Other Comprehensive Income Location [Axis]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Domain]",
        "terseLabel": "Other Comprehensive Income Location [Domain]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r77",
      "r84",
      "r85",
      "r87",
      "r535",
      "r537",
      "r542"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r84",
      "r85",
      "r92",
      "r215",
      "r535",
      "r540",
      "r542",
      "r605",
      "r628"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r70",
      "r74"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment, net of taxes of $0 for all periods"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r67",
      "r75",
      "r532",
      "r541"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r79",
      "r82",
      "r84",
      "r85",
      "r87",
      "r92",
      "r350",
      "r535",
      "r540",
      "r542",
      "r605",
      "r628"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other Comprehensive income (loss), net of Tax",
        "totalLabel": "Other comprehensive income (loss), net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement",
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "verboseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r72",
      "r74"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Other Comprehensive Income (Loss), Other Adjustments, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r72",
      "r75",
      "r469"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r490",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other Noncash Income (Expense)"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "auth_ref": [
      "r8",
      "r11",
      "r232"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Other Prepaid Expense, Current"
       }
      }
     },
     "localname": "OtherPrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r112",
      "r263"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "terseLabel": "Payments for Restructuring"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payments of Debt Issuance Costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "terseLabel": "Payment, Tax Withholding, Share-based Payment Arrangement"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r105",
      "r457"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to Acquire Businesses, Gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Intangible assets additions"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r203"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedTerseLabel": "Purchases of investment securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r21",
      "r386",
      "r387",
      "r388",
      "r397"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "terseLabel": "Liability, Defined Benefit Plan, Current"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Convertible preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Convertible preferred stock, authorized shares"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r25",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Convertible preferred stock, issued shares"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Convertible preferred stock, outstanding shares"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets [Abstract]"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r10",
      "r40",
      "r41"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets [Member]"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r9",
      "r11",
      "r231",
      "r232"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from Issuance of Debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sale of investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.",
        "label": "Proceeds from Sale and Maturity of Other Investments",
        "terseLabel": "Proceeds from Sale and Maturity of Other Investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of asset"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r107",
      "r406"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductLiabilityAccrualComponentAmount": {
     "auth_ref": [
      "r287"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recorded amount of the accrual for a material component of a product liability contingency.",
        "label": "Product Liability Accrual, Component Amount",
        "terseLabel": "Product Liability Accrual, Component Amount"
       }
      }
     },
     "localname": "ProductLiabilityAccrualComponentAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductLiabilityContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Liability Contingency [Line Items]",
        "terseLabel": "Product Liability Contingency [Line Items]"
       }
      }
     },
     "localname": "ProductLiabilityContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductLiabilityContingencyTable": {
     "auth_ref": [
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from product liability related to an individual product.",
        "label": "Product Liability Contingency [Table]",
        "terseLabel": "Product Liability Contingency [Table]"
       }
      }
     },
     "localname": "ProductLiabilityContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductWarrantyAccrualClassifiedCurrent": {
     "auth_ref": [
      "r51",
      "r290",
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Product Warranty Accrual, Current",
        "terseLabel": "Warranties and returns"
       }
      }
     },
     "localname": "ProductWarrantyAccrualClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r4",
      "r78",
      "r81",
      "r86",
      "r113",
      "r127",
      "r137",
      "r147",
      "r148",
      "r179",
      "r183",
      "r186",
      "r189",
      "r191",
      "r217",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r469",
      "r472",
      "r473",
      "r479",
      "r480",
      "r513",
      "r526",
      "r609"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net (Loss) Income",
        "totalLabel": "NET (LOSS) INCOME"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r45",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r259",
      "r663",
      "r664",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment [Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r44",
      "r254"
     ],
     "calculation": {
      "http://www.icumed.com/role/PropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total property and equipment, cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r18",
      "r19",
      "r256",
      "r572",
      "r613",
      "r624"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.icumed.com/role/PropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "PROPERTY AND EQUIPMENT, net",
        "totalLabel": "Net property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r18",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment [Table Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r18",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r95",
      "r224"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted": {
     "auth_ref": [
      "r24",
      "r598",
      "r620"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations.",
        "label": "Purchase Commitment, Remaining Minimum Amount Committed",
        "terseLabel": "Purchase Commitment, Remaining Minimum Amount Committed"
       }
      }
     },
     "localname": "PurchaseCommitmentRemainingMinimumAmountCommitted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r77",
      "r84",
      "r85",
      "r87",
      "r535",
      "r539",
      "r542"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "terseLabel": "Repayments of Long-term Debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r414",
      "r584",
      "r677"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r261",
      "r263",
      "r266",
      "r275",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Related Activities Disclosure"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r117",
      "r260",
      "r269",
      "r272"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r262",
      "r263",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r117"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "terseLabel": "Restructuring Costs"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r263",
      "r270"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Restructuring Reserve",
        "periodStartLabel": "Restructuring Reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAccrualAdjustment1": {
     "auth_ref": [
      "r263",
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.",
        "label": "Restructuring Reserve, Accrual Adjustment",
        "terseLabel": "Restructuring Reserve, Accrual Adjustment"
       }
      }
     },
     "localname": "RestructuringReserveAccrualAdjustment1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveCurrent": {
     "auth_ref": [
      "r21",
      "r263",
      "r273"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Current",
        "terseLabel": "Restructuring accrual"
       }
      }
     },
     "localname": "RestructuringReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAdjustment": {
     "auth_ref": [
      "r263",
      "r273"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.",
        "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r29",
      "r355",
      "r411",
      "r572",
      "r622",
      "r641",
      "r645"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r132",
      "r133",
      "r134",
      "r138",
      "r146",
      "r148",
      "r219",
      "r407",
      "r408",
      "r409",
      "r422",
      "r423",
      "r511",
      "r638",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r170",
      "r171",
      "r182",
      "r187",
      "r188",
      "r192",
      "r193",
      "r195",
      "r370",
      "r371",
      "r585"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue from Contract with Customer, Excluding Assessed Tax"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r368",
      "r369",
      "r373",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer [Text Block]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "negatedTerseLabel": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, Remaining Performance Obligation, Amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r89",
      "r127",
      "r170",
      "r171",
      "r182",
      "r187",
      "r188",
      "r192",
      "r193",
      "r195",
      "r217",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r526",
      "r609"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "REVENUES:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r561",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r561",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r601",
      "r626"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.",
        "label": "Sales and Excise Tax Payable",
        "terseLabel": "Sales taxes"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r77",
      "r540",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r611",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r55",
      "r131",
      "r331",
      "r333",
      "r351",
      "r352",
      "r353",
      "r354",
      "r544",
      "r545",
      "r548",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r242",
      "r246",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r238",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets and Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r17",
      "r37",
      "r38",
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory, Current [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Schedule of Other Assets, Noncurrent[TableTextBlock]"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r45",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r262",
      "r263",
      "r264",
      "r265",
      "r272",
      "r273",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r267",
      "r268",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r195",
      "r265",
      "r274",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedLabel": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "terseLabel": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement",
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r559",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short-term Lease, Cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Software and Software Development Costs"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "terseLabel": "Software Development"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r3",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r195",
      "r238",
      "r258",
      "r265",
      "r274",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r59",
      "r84",
      "r85",
      "r86",
      "r132",
      "r133",
      "r134",
      "r138",
      "r146",
      "r148",
      "r168",
      "r219",
      "r350",
      "r355",
      "r407",
      "r408",
      "r409",
      "r422",
      "r423",
      "r511",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r542",
      "r638",
      "r639",
      "r640",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement",
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r168",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r25",
      "r26",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Stock Issued During Period, Shares, Acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r25",
      "r26",
      "r350",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r59",
      "r350",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Stock Issued During Period, Value, Acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r25",
      "r26",
      "r350",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Stock Issued During Period, Value, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock Repurchase Program, Remaining Authorized Repurchase Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r26",
      "r31",
      "r32",
      "r127",
      "r199",
      "r217",
      "r526",
      "r572"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Stockholders' Equity Attributable to Parent",
        "periodStartLabel": "Stockholders' Equity Attributable to Parent"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r85",
      "r127",
      "r132",
      "r133",
      "r134",
      "r138",
      "r146",
      "r217",
      "r219",
      "r355",
      "r407",
      "r408",
      "r409",
      "r422",
      "r423",
      "r467",
      "r468",
      "r478",
      "r511",
      "r526",
      "r535",
      "r536",
      "r542",
      "r639",
      "r640",
      "r684"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "TOTAL STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "STOCKHOLDERS' EQUITY:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r125",
      "r337",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r355",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity Note Disclosure"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/Equity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names [Member]"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and Trade Names"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks [Member]"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingRevenueMember": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which reported facts about trading revenue have been included.",
        "label": "Trading Revenue [Member]",
        "terseLabel": "Trading Revenue"
       }
      }
     },
     "localname": "TradingRevenueMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r58",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r58",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury Stock, Shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r58",
      "r356",
      "r357"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury Stock, at cost (12,684 and 119 shares, respectively)"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r262",
      "r263",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r130",
      "r390",
      "r397",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "US Treasury Securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r153",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/NetIncomePerShareDetails",
      "http://www.icumed.com/role/NetIncomePerShareDetails1"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "WEIGHTED AVERAGE NUMBER OF SHARES"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r152",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding (for basic calculation)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27340-111563"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB TOPIC 5.Y.Q2)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123377177&loc=d3e11281-110244"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12524-110249"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "c",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(17))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8,17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r678": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r679": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r680": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r681": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r682": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r683": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>115
<FILENAME>0000883984-22-000041-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000883984-22-000041-xbrl.zip
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MQ6Y=Q.XOU/C\!YC^!8YN&7/?TUA"L5 X("GYZ,Z2P!D6OSV8KH4.;A[0)%*
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M/L@V)0'.,4M-(5MTD%++CILGB"ZPXX"R@8[1(Z>VGV8IZ^]F;0I'R?UX>@X
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MSGK(U@31Y&($B^=#,M-K*9\ISZ%,8IV8HD0UE.Y:<VZ^@&&?1S!B9S@&=RT
M>>@MDUM*ZA[!@5,!BDO!NXA$Q&.8NKF8+[_[:3ZK"M+#^6,%9LKR0?GKLNYU
M9W:R.#U&.MK.8<?H.9C6VT^2AK?6D*GU<2(Y%+!HQG#4?'! ;N2$*@.;)-4$
MVW<-UHS!6S N);#&U!9&4)<>') ;*4-+J]$0]2YK&OMZ/X]<@HTQFD2)<OVT
M3>@-D'_((O]$9]!5 2F>+,:0BB1(U:'SS9$806-\3;P],?+=VM!6QD=K^F%8
M[XA#4W?:SU]$=;&82LF91]'.85 @;B0V.A2D:*IM3( I9(V5H1IUL6C(AK@]
ML7%MEKC^N%BBQ1(50!<80+UH18V0$= 6FR.5[8F+:[/$]<=$(A&(V9;0VY:9
M0,6:$/M8CWX:UXWA)-N70/SU\>SH]'SC\#;&P^*,=TX:1HR@4D778@WH^TJ&
MCSR&YI"# 7 CL1#%$@7-+ZII@%*RH!(;S3#Z[)7HW1;$PG5:X";V<%L$:M2J
M2Q#%%BD52F_-VJ<.R)6Y2#< #BP&YNPLLC'LC++1QJ6P=:;V*3G9"X]AO? +
M -Z93Y?]%-8=G&_EPF"RCDM,QJ5LH#3.3C-]L,T6G[#A%A1-UXC@1J)@]:$E
MX@A6(L3@4<FH,YP"&%, QW!"8C@(;B0,.L?)E2K6!@,U]2V'*;'8&I@YY2L3
MY&X0'%P<I&9%64Q+C:$8EWWRA%0,(P:-BN./@[]3Z-[Z#B<@DB)GJ."5GF+I
M$\_Z5&$OGA7=,/[8N&%4-].1G$/0K,-SDPRA^APE(*=J2Z3LT8X_7F[>5M<?
M0X,F_WU':LB5H$9?^@QWI-Y)URK25R82WJ ZAKB:$@&Q"\8Z!,\66XBLXF;D
MZDGR^./JK[C@TR.<WV:6Q5:669NWEG))R,8"E9!3+9JE..I%<C%C&.\Q) PW
ME&,*.K;B$A>@BIC)^N!RHTJFCN*DZ) PW$B$;(FS<&3OD@%K+7)NI@9H3NFM
M<!A_A%RW'6X@'AK#K11!B7W,?"3!%!TX0S&XZ&0+XF'O-+^MQ=;,1JPZS50:
M@F4EJ+9F\2&"$#:_!<76=<&WD2A82"H5*9HM%LB-BZC118V*,:$W!;8@"J[/
M^C;0;,8K]TS9E13Z+#(J,=5J:TNA5A&W!676-5K?!F(?964PM1M? LP*I'AK
ML"@1K9)&L]_F_7R">S)[-L>7SWON_LE1I]V[M[<Q_"47#8&7RH&AF4(YB^.8
M&Z2FN)F1A+]A(+B9V6%),T!JJ6GZ -P/\FLZF.1\BEAO_CV2"#@,!#?33T]"
M5-0DL#&0K<U&<_@6BLE.$82Q',D8!H(;B8.5E'B*9PE>P%-!J!*I%!^L7HIC
M.8OQ&03/N<SY5)[VKG$7STY/EO/I=AY;K!42$BJI*0'$I/-9Y1:"#\3>NC&,
M4QTJGILYH0$AL2_2+&0P63-&]:::)T9?/6GN/_X8N4G[W$#:F&(*WC>!T@ 8
ML-18&QJ7,6DH'4O:.$0\-Q(_/3LE/BY96RH8"AGZG(GB<NA_XUAJJ%_"\Z+G
MY39&S+[XQ+WEE"$-FC%C=EDI$/H4;12 +8F8ZT%P,WMP0-E-ZT/<E.E8&U6N
M@MS ,*=@>"R5U&$@N)D\LA%:TU*I"2#&7/I>8V6RQKIFX@7+&7]47)L-;B .
M5DE"N=6$#;+X\V[>T+NED+7ZX/CCX#L:<_;=+X^W*_Y!= EM-$VX*"%M5(A-
M,-Z:FBKZ+8A_:T!N,_539X.I?>!9-N"XDH=00S751U>-C&$@T>:1VTR\@P*B
M28(5I9X4 8$%6E&R$DIS=2S[2S=N<^N/<UA#/R$E0C$#JN<4LF0S^YXQV)*&
M/])\*-.A5SBSW*#EX*KSXL K<S0A!:F%R1=+V]#AJT^?/Q_*-)=7<G*ZE1LJ
M&A33HDFF]<IUBYC(!4W*]>]BZ_NFLB-&\7+(UA:#F B<;Z4/G1 PV6 IKL82
MO9562MR"XZ/W9J]D?G(>].;JKQYM+Y8N9P1O"B=-YD)#*IYS1$&&$BB,I:SR
M&2S/J]0[TF0^E[K%2%9C?4R]1B8$D%TQU1&*99.<!0<CH9O#"9";:1&5<LNV
M- :3H(HFZGWDCU<R:H/E/)8BV6 "Y&;V6S@;C40(-B* 4M2>1SB)(69F=&:X
M#;Q7:X%??+OSF^Y/C_LDQ \TY/ELOMR7^?&UIB:K:P=.53DM:-0LQ>I?B3R3
MU, 0)47+< /W9^%^,#MY-B*T.\\-;)WC(I"2\N#2-).)Q15B+VVT:/\YQ_R5
MV+;3["9FL61L!K)$7I@YBNLG&F,;\"R&(: ],M.V5;ESPV*=":#A.UM/L;>7
M:Y$2BALMV/]1/ON56+@)GGM5OA^1[-OOBDD--7J[I"0NA7 #^O89NH]<:S,Q
M4Q3 '$J?,^A%L@]4.<MP,?]K-O=756H]M93K">0U>DVC<[84(>K?E!N'6KFB
M@NYH;)#_08O[BA&/V5AO/4HN#JRMO5MEK@XE-O7K0Z9NVQ%8"UO?$,DP%LC%
M8-.?J](KK!P,^[')?V0QSI144U?Y0A9\,90[N6TNQMPPFP$/^NLNZ1&>/+OP
M0_W7W>G)]/AT+*+/E:$/2\GZ+_0"+C77<B,B:[+ZH'&)'M^,2/0A>"H<L7I.
MT#PHMS-]HZ*5J$F\3<,6_9U3#;,G?':QO>;BM^]V_V=O\(*OS:N$V0<V",FV
M@A[T#ZG ),V740K^[B^/!B]XX[)UF2Q2 U".6[!9";FT8 OE.D[!WWGZWX,7
M?'"01:FEB2Q H+*NJO^"(%XXR,!7>?Z-X/_YT\'@!1\INF2E(H4(U=2"H62;
M$WOLW5@'G,I]3N/WAB_XIJE4;<EK\FQ!$I/SF1I6ITY?P^[ ES[^C>!_>;PS
M>,%'H%0**YE,RBE=(]=:R,IMJDLQM#Q<P;_+7.?+?^V>'BVG+X_D0Q0^K3-<
M7+N64Z37@@NK$=C>HD:36P#CD !+2L8F2T&#\G!QN=PHO*-?]A4NIZ_D_DF?
MV=U?_FBZ>/$!-/\E]9FXX2)R>C)]!\?QFY/W8CX67)S.Y?OI8@;.IM\H]&^7
M+G_OK__]DB%']7*:15=P(*B,-G.L$'.43.4BE[#6>7N#[N?0M1/K)MZNP-[Z
M\@QI+J>IM$;^X+"OS%I"DV.S/M#V(.+?W6(DN(00HL6*"#:##4J%B4(M!41Y
M@0$<NQ^\?-9]_<YS62P?X5(>O\:7JUE,D_GQ@QE^>$#C_4/#];H?+YR71BC,
M!JH%S8/ZA."06;TE0?76WN#_G^'_PTCP)^<@Y)9-<KGO@,.@!*@H1KGZG&#
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M7,=YA#2&!M;_"7C[<ZQRC/,78\&)B%.-P5HE-I"K*S92L1X1]>&8V[;[U7/
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M. Q%@@'2?YG$0:K&Y5K))C/@4;\;<&?7@D"B'+ Q]$ "&$QQ(6;QC9*88.N
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MS>N \J"8FI4HU  :%&>J$\L)2S80TE;KP(;9\ :6]EIC]>M. <_@P%/"W+M
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M+I WPH97M:)FU2DCUA;[BIJ:I_*H2(BVH#,YI&W$:Q".^5K0C*QI3&EB+!*
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M6!WOY/R)DM9L^ OHAG<>Q:\!JR[ A5,#X'I+R4T/5RG!&OV"N!?$40UBJA)
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MS+T!FCD62#T.<4(9R&GXG6*%8$SWT0JV4T,-K?J_;#<2>U97@Z]NE+U_O_F
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M0I67AT;IROI>;^ .V\.1&\3-]:KCBH#C29JC76=.!^U1VXV7&O>&Q4G3$Z]
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MPAN#.-/$"[6RCIFH""'G9';=#3G/[$A*5/"<3IE$!8NG@AG-XW,ND5> <4L
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M' (33W2F3A.@I(]I]I0@-F?>X6*YGA%6@8\_.RFMBY46Q8L(X;T-Q6G-Z^$
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MC^2\6+#(V.QWN^U1-S#1<*-GOX=]F6#NI'79N;#2;&(T3RB'1&G G7" .L6
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M(V\8^WTXET%7:[S[]; KQMCP1^F2J'J^X8;K&U\DYIICJH#WF ,*K0SJC'I
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M;JD6+EBPDE0H>O2^V90MJ+P8GKNO*F%X41B>]D(AQ+EST<Q2/EA="G$@-/4
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MDF=&6<>1A8 (X^+^,0NTQ (8(KD)RCNWE$60)H2^4(3./4PDS;$+A.^T<T5
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MJQ6[J=_#?ZY2JE*J4KJ[35(:([CVU"1-0:J$ 7E0R@OC)(L*ZB;9^DUR)CI
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M(?0*9!7(6@=D<^ 839Q[H:R)*0%JZBS80+4V"H )(2M1; >V36<(Y0T'$NI
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MB-V>*9F'ZB81I=(4D*5LX0KCA)&1.Y#*1LX"K52W==@]=:)+2Q4M@B"6<21
M@R F8S:13#*= D_4%^SN6CF+W)7K5N2LR'DMKBME 45N/0T $;5!*Q(F0SVC
M3$NH7+<M>#F52E;\\,%12BBC/G-=:8D+4'J:J9 A,SFJY,HJZTJINUS-]NNM
M;'=Q"7"A-SHZP),RO_'[,%^OK%?.?V5=?O7*NOSJE8_SRKK\ZI5U^=4K'^>5
M=?G5*^][^?TTQFQHY]^A]\_J+_G'V3M.S7K@DT-=1X-14Q+Z:=.[N_=/_/EC
M+XS?GWFESKWQU(JG7]^"+MOLQ^/+WW+.8O>Q/X[#1?O6&/TW[P4O8U)?'!?-
M;)S_64;;>+,81><L<&,106%^&)*75(40/5C%_N)FY>Q-[X=G=W"$[R)QPXA_
M$TSY!I_BP4<\&:W\],T\'/;Z9&K>IZ?LTHE)Z=8F9N)1R?<W&#;%L)X>]T,<
MEJORF+ U8^F\'Q:_YW_^742Z]*8O_J5!ZJP7EVE_//KE)UR]2/QWN4SMO[F
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MJ^[.H[O3#,,+)V7TDK L< (B"\<:X"0D8Z2D3FGN"\.8+79[+V<O'I=CHBD
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M&I;RN'P>[>(C7Z52BY@L&JEFRR%RK1+*S#\$+WX0K1-QI=%UXMSQ$"U"2>*
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MOS^^"[]=FQNQ272>BU+Y;H%5-&B[%1ABUTVOO<&QZ;4OI]O));BG?9">_WL
MX-\;Y3_WXA\3M/\P!?OM]M!U^DGKV(<^_=[IN\\_UR"[;$T,LM/#]F$7#*]/
MK>[!I\/.P?X_W19]*P[H#H'WGX#AU-G=WSUO7>Z>@W'5"?_]Y^+PDS^SE,M6
M]UWW\-,!&'.')]#&2>O/ W:PWSD]./TW&727+?KQZ^[E%MN]_#WNGF[AUOLC
MAPN*H](H%M0C'EU$EG&'9,2>@V'E"JY*([K=2UOQR:QEIA!1D8(4UG++A4FK
M1UF@@6)=B+#1"&#EGB7^'(S#QNO?S; ]3#)Y=EDFMEE%'G/,"M>J=^:;RZ6Y
M\[UKG@^N@@HF?P!2W%.'&D_0.RM0@W;W(1I3X\1\"0T;0J]Q-@B@>$W.(3@P
MX.#NT#@'Q3__/<X[EG!;&QHYZ\"(CD,O@+[6N4C7PUG9A6P]?.SE#F5FS62S
ME2G$-'[9^+CY87/CUVPTG(T'PW$Z%EW9'(,QM%JN0KH\",?C3J:=8:4--CX$
M-QY4KD*X8U+[IO&FW^VVA]E@^.7_^W\4H,UO']Z^R9_(;^7+!B%V4EW:9&7,
MF";-<O][.*KJ?_1[,)Q>\OYTX)%T5BU=N/; ^4G;G22EM3D9;O^LW:L,&5A?
M4([2G2G(TX7AT PNR@#01DQ' :9S/QG3M34"[AIW8%G2 ^GB9$E+FVJ8%BFQ
M7_";C7]NO34KU:!>3SL!E BW)/,MZ;OIY?/OBF.8FHM@!IN--V"NFG8VP[(C
M+ TN36+L]T=)9V_X*?@.J]G*S6>;LJ2@'O!]YQX$>!O9W4!@-U/B%15?T3Z,
MJ@\&:GIHEM"&8UB\Y92VV=@_>9#-T1B>],<=#V^'9DP>!CQS.NZ5GLP\CH5E
MOK&AU)/2((+[!P'Z.CNAJ8VM<E+_"6?]9"'U&G_ U)?#(!C]W[2H68DMK?1)
M@K>>VVP"X\&5Q'>-;3!YSLM8NL%9E0FO"3WJP'NFO07NF=)%(HDJ?=(V$%/7
MAD'9,B/-;,S?D4'RYV/FTT#V3R$S;>@= X),U]R'+Z'3/RL1!=XQCL:-R@WH
M1#!#4Z8B;/=Z_2\E:W<K)\W9H._'#@AK/"R;FSI5$GV9LXO<@$MXFFYWV0Q/
M7A97L4(Y;="M80!D2)WIFM,^W'^1D7(\N'K%Z&30'Q^?Y"]]>Y" -O4L@XL+
M^4636])$I_/ "0(!1D:#MAV/^H-I&_WQJ)0A("CR@QG8RIC#A 57W3*=8;_L
MFZOP:MJ?C%<  >UCX+3.5<Z-F1D,@X;-6@TP6C_-R'3B8,K;+ER[%7!A"]XS
M'-MAV[<!32NWQ?E)/\%3_[Q7.<+2E_-L^Q /1I5,!-Z5AUW)>>AI)\%B"1*C
M%&Q9NL-GH2]TVMT4FPG"X:&D?A\;[><SR%ZO\0[6) E4F9&'@C .5W$9MSDI
M?]FX?G7CUR:03FADPXN]:LP&$&PV]H",EZS:-?F=LKM4&DI[XE#-FDPE6J_?
MD@!UKH]QT.].!U64@YIR2LY31\5TJ%GO:)=OR*?HH1-5,1#X"G0+CC@2UT1D
MU@7F?:9SFOGW$,@]K?%B8\&G\%,L;/IJ-F7/[,]'MG1A$%O39?E[T._!1U>R
M?*J>G;78X4YO]IZ)<K,VUNW%Q+H]N-S;_\@.Z+O3@WVP</??7Q[^>7BRN[\C
M#K<_$[!4NZW+W]OPSHL%Z_9T5[3V_>E!MW6R"Q9N:[L%[WK[=?>T\WEO_]]V
MZQ.,Z,]WIZW]=S%M0>Z^/^(18V&D1LH'@3B+#AD2)>(."XF9T4R;>>M6,XZ#
M<,$J$[A5UC+&C2,,R-'"OP7K-I'8U=0WKJ_/[5;NK3ZR&TW@.SOWN$R26WR5
MTG*TW3TP]Y^0O'(@XLHX_MEI NNNY\W #Q\P(VLTLJ5(\$-\<#?W::?7V#4#
M0/DDNYH9Z*>>KQNGOO%['WZ!4"@7Y\-'$&B;^6F$>1,LA0B61+*G4GG8]"<8
M#(U?]L%@=0W%5<J&_(=Q*?S!3+;BTDO+0K)9?MW<1+(]IATK[1'H5VD\ ?#U
M?&G29 4()-;X+ G/I)Y]:?MD+Y?*7.-XW"[-O=) [E3"NC)A4V=@=I."EDK>
MYIZ=]5/&[?16.QZ E,I/#J9]'*37#*9]O%*Q!E=]W![G)H$S06T$L6QL4CE!
M$1TG72_=VQY^'I9*-:A@UO0^PQ_I#3ZWGY6P9MZE:CNP&P>=BW*ITG/Y5&<R
MN&>G\R]0)>"OG6ES>U5S>4I_V?AKY_>]?Y)&4AFB21LV><LP/W[>'X"!F16]
MG+%\9#[#P&\>=+L'.DRV [)BVTZ"O!U!U>]42O27,/=DTB?,*"NNW3[\Z%L@
MWB]EBO/!K*Z)0%V>I*^ $8(R/$Q&>3O=":\"XF^?56;T7820S(R+TM=2KL0H
MA7<,FXV3X(\3@9?[<J TG;3/X.OTSE)'OZ;[YHY?C29/8^JTZ94WSTU1^'H6
M7+4-;4L?QD1L- S,>*6VE;Z1&R87],()X::F?#L/K6LN4FO9<BK;GHYG=F9]
M.[87WU,JBS>^:S<_XJX<8%?-)C.]LBU@"&?9 "QYFA< &]O!@JUXY9>H%,)0
M'D2V%XD/AVDJ@!B2;R4[M]*LIP9#9OU$)NWJ"%?NUH/[L_7A#2 ,J*U_)=X=
M+N]/GI%K8K*:E_"U<LM=?U&CUT^>EG16=U@25W5_)X.$Z\"E:4<KR[-:;'AI
M.<>_M%,Y[?1T I+^8- _SU0'UW[=3&[%<%916+^:6$5$FMA!^TO%7*GA_Y;4
MVISJ^S )R><&K)KM<[ DP2)H'_>FXS(W4GBC':<F;++'X36F))LP6LI*">RS
MOV"Z8'DVP7),+%^%4Z9WEA*%T&9I$4VLBXDOIU&Y<>@F !2(CR_EM\FQD\VK
MO"E7>I?[C=%Y/[WF'(0.R%N3$;4Q/#=GL#;):07$E6;["UC(&4$ZX7BR/.FN
M*UKW);?FT0W#I(DPJ(9:&L\A86ME$_5+UB\C1E(<2>\63&O\,K7MU*MERP8"
M%;[+,_7K[;/<Z?3/\^Q.%FF&_3.+I\CTZK9Q)IHRD+6\F'PB:=4G'OK$4F?5
M ?2\@L".=E)2HN\F/F>0!3#+&6D3X?0NKO"K.\.*E9,!K#]HNGLMU.9F"9%F
M8*&_$R L.SIK0I:2.2<JB.G^\H;T;6F/IJ6='UWYNB0-2__\,!'X],9DPIZ
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M-WTY CNIE('Q6@+I,IZHO*=\L*+'*]I+?.-#\@:V4U12N6O3GT2JAEYBH$K
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M:C* X;/E,&,X[,,K?^_TW>>7QMN7[TGK^(CQ JQ 11"H5QKQ5*W 1JP0]J"
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M/3*!/5+#WKK!WN4<[%$FHRNT0C)ZDTZ42F19%"C2Z#B1)FHI-EY+*IJ:+Q8
MJ&&OAKV7 'N >"R&X+P!]2YX:@73T1<>!TQMX=2#0QAJV/NQL$<JV!.[VQ]Q
M:^O($N%4< 6BTCG$O2R0UL0B$&%&8JF=CC)G+:6\J>AW%W&N@:\&OO49]0.
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MMM$((.#/DD]E, X;KZL56'"^W)^R;[3T[^[&]6XKKZT-/MECECOF#"U $2N
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M#2$X696$%CQHZPASV)F4P+TGF<9CX,_S*_[\KS*5KT9#LYO_/-*2[^C_CTJ
MX-U/NV>[.^#S'VR0UL\/W[*?O[O3Q'OKFS^WUO\ZV/HSIRNO\LD2(!_V][[^
MM;^UODMW=SZRUI_OR=[Z_GX3[M'\VN3-@UV>TY6;Z_O3N%JCU30:PI&VP2#N
MB4&&!(QBY)12[N S4A?0G$+>,6<2PWGE'S\U96L!NY<*=IASIF-B-&+,0V89
MP,KG(#-+W&B*AP7M^,P%[0K8/2C8C9_!T$[:P)5#/@H .^D!]DR@"'OF R$
M=03G2G::3IYC*V!7P.Y5@=V==FH*V#T9V)%Q)B<.,X4!YSRG&G''$K*""R2Q
MQL0(8HW(3$ZX(<4D@TI!N]=^ O=YG[&]!<YICPV-46EA/?=..FY4H-)Y*B5G
M[/95B@O./2C.L7$/-EJ< K.(!N$09\F 4><#PD[ZJ)3F6IOLP4HQ28A;:/B?
M1CS?UN>)XN4]_&&EA*J=P\%Q,O;XPGFQGC+D-IR-&JXVA\._,<B/+N!T&W":
MI-[7H$JTXAS)FJT[PY1SQB *<\7!W90Z9Y[22=:K6R)3X;%;7'F=>]2HR.O<
MY'4\0F2"Y3IX$%#*.,AKU""OUB/O-178$0(N\=(*NW=XJ,CKXLKKW ,?15[G
M)J_C00YB,#4P0\AK$A!/\,,RSY#5@+A&$L<,!^/_WI9_D=?%E=>Y._!%7N<F
MK^/..C<)*R4,,A2,8LXUV,-1:!05%EIRRS0!>97W#D@6*MAY^>.]&$X&(MA-
M%ZP"KZRPS:)XYQ]RF[;2QWY<S;.P>M"%,?HY).\KR#0S,DVI8F,]%DX2A:@%
M<X(SRI%A6B,K8B3&..,C75HA:K)$WMV"B NT'5*$]U%<]2*\<Q/><;>=<$42
MLQ@9D]UVBR72D42$>4I<&YH)J$%XI2S"^W*%]T']]B*\<Q/><1_>6J>480$E
M;A7B6 1DL&7PRED#4"R-=4LKC!?-^X*%]T&=^"*\<Q/><8<^J<0="&E.&,>(
M!\^0IIEIQ3*A0@1O/W,O,#*OO?>RPSYCH?M]6.-#,LQKS_.4&.*#>>WU^&<N
MGTM)0 5I9D>:R8)P4<H8L!7(!F(15T(C[;U#P1*2E'1*XP!(LT"1PQ+I7W3W
MO$CI?:5TW!./5F(=E$526Y!2*B+20=<%+U@*7%@I04KO[8<7*5U<*9V['UZD
M]+Y2.NYR&X4U3LR 6+)<C]$%Y#!C2'E+P1<'"RB1(J4O6DKG[G 7*;VOE([[
MUDIF3M@D$64L$URFB)Q.#EF9'%$J<IK4TLID&?:%W2L?T:9!8^.O!;M\\^HW
MR\ ^S<"^B.R.NM#OY=R.4O2WU*M\'F&T<H1N[H;&UF3N2_1,!D45TCD!AM.<
ME6>"0S0$XAS'7+M0'Z%3\]I +T5^"V@6T'R@J&8!S8< S?%(9V*2N\R<1:/U
MB'L:D%%.().\YUQ9D9FW5U@#TP*:!30+:"YXD+F YD. YGC@F5&: E$!80_F
M)E=>(6.,@.&E%D>9HB%R:860!A8%-0MJ%M1<\*!_0<V'0,WQC0"O$\$I:.2X
MXXCC&)'142!O V&>:*]LWJYK8/X20+,.R?Z[KJFR<JGLZ^42ZPM>_VCQZNN,
MCK&>U[T<5L5.EP_^U24O)^MYPSNY7-IOPTM_;U2'\?B\UM7TLMIUE<Z#\W(]
M T8L^,)RE2O]7#E3F*O[7-0DSS471XVZ5,/X<L-L+I)UZ&U_?QC3'O4)FM2/
M'>C\ET;U)1[F0LOU_6S(%3YS[<Y<"'CT]?Y=NW#+FIK3*GD_;(&L-1B:MYWN
MZ?;)T5%G6+9ZO=WWG6[_!!;!:ZZ8U5S]K"1U27B.HM $<>T#<M$1E+!7DBD?
M+>8OH6)6_]+L5[6T)/CRE7+B=6WL09WR2V6WGVTU+3"'EO' )+IM.2TIEZEY
M@'):?%DS\1 5JM@#%'W*C2U%GTIAHU**9I'&[/65HLGV2W5D8<9RU51[ -TY
MOFJ89OUV -H*S)FZ\#<8: -3L-.V;EC6^\TL:^U>3,:SK,,[GPA\D$;.Z>13
M[=:I9246?"%=U#0ZMW_Z5>IU#RXY' .CYS[)<B\M<C:MBR\F O; K/9_V[/:
M97P%X;"O\)R=5;SW=8/N[>S^A.M.6SL?]K?6O[#6S[UVZ]-'L?MU][3YY^;I
M>#BL^>FO_>;ZAX/FSEZG];4)GMLJ:?VYP;?6/6L=;)*]G4Z[]77U=/?K']-(
M58D("6LL$!8VE_%@$=FH)9*!4'#$(\8V+*T0VM#Z!1*_%6AZH=#TP$3T!9H>
M )K&DT(X<XIY99#5V"-.J4"&VX!H<(D:G@2-<DYD](M'<??\S<*KX?#[<!.\
M-.2=UL47@[R/PO@[Q-^MPW=#'_6L@.TMP'8*95].']$R@VW,R216,^088<CH
MH%/D+EIJYD'^NWB\006)7B@2/0J7<4&B^R+11&%)H:)G02/A.4&<@>UG,379
M(Y5,1^N8L_.@-9X_"=+H6:,%*VJ<F?=IZ^=^C]<0=:])TE WH9-^'*5==-VQ
MA2_6,??XP^_;PR^Q#LH/HNU=!\T>9$7<*]J^* 'U$C._[!R5R/BK"C_-W0D:
M8UW<&F+)YN'&$$G>=GM70U27[)$2HYJ3L3(9/A=!<,]U0D$E@;AG"EF)&=*!
MA #FI[#)Y(-+FBX2M42)GA?X>E3/J<#78L#7N*\5F,2$1XTPB0;QR )R5AID
M,(M16^(3BTLKI$'U(E5I>V4A]K<ED/X:PU=/8D->#G&5B-9=4'8*)8BF@CA)
M&%*DYO5V'ADE$[(">YJ8LLYDMMU[%ZXML?4"3B_90BS@- =P&C<!I<0!"\R1
M5QF<4C#(>D"H(*R6R2D><M5/=O\RO?..MS_K4XVYN5F@VH<G=<QWEE-1TPZ_
M7;IJV J>S=FC;K^=;_NF/I74_AXO3O7\Z^H)K.&9('QQB77];N?D^/I+IAU.
M>HJ1)G)L3"_]W#_?C#FR7R)RO6B_(9N@L6]LY]2>]9?^??7\5?MP='/!X>F+
MT_>)LPR#,ZAK'ZOFQOKFVNJ[1K796ENN5EOKU?;'/[8WUS=7/VQN;/_Z%.T"
M=*&UM;.Q7>UL56M;K?6-UO;&>GZUO?5N<WUU!_YXN]E:;:UMKKZKMG?@C>9&
M:V>[^FUM(#0Q_#YM\L>D:J 0+,[9"])$YSG7,FC+(Q<*0$X&DB0=J+;ZIJLY
MS."MHM3#%2QH^!XU4D2"'=4.\V2%7WJH,Z=M?])^4ZN_?%SPW<7QBUKC]7<R
MWKWB Z>L]>4SET%2E6#L5&"(JP3:RBB,:%!1*.8TP>+%'3AUME,' /K[L3XL
M?NVAT_&3&%>/GS;RMF,$E3O8<*SKV>0CW:'=]_E84 77QG)&M9Q1?05G5,U,
M)P97,UW!:SV).ML0C<[K5N5$ZJW';CWZ>.!BKV*D'K^7?#IU^@C<E"!1CIG.
M*V5F09;!3'DR56\R?>H5ILZ<S_8MZZNHVT=5%CS:R#T501NLO;&<9V)#H17S
MR2@;=!#D\^9=SI>.A1Q?PT;S+H%GTZUU:,_Z*MS[ _A8WT1SYX^#YM>W[=:G
MM_N[7U?)UOK&C_$H8^OK/]#67=[,[5R'?OS9^KJU\PW:OGO6_+1)=C^];</[
MO+GS=MHQ4ZZU4HDEI*G@B#OGD4TZ;SE;%I2#Z0QB:46S!J.3B;UWT@JSY:Z\
M3)AXV6A@7,+>4&(U#3PJ;T@4T6L?"*&!I%"C ;QFI*#!8J#!Q,E.[V"><$*4
M2)NKE,=<?E0C;W @G%D15=X0-0W-)P\<33.2[Y=Y_QPRIQ<H^WJAX7'5^]Y)
M#)?):XKI6$S'.9N.Y[O/:R>]7CPLVF)NVF)*L>I$:30^YR?*X'/Z3$).48&(
M%P&3&)73?&F%F(:9DF3]@+9C 9#7 " /8VT6 'E  !DW-ZEF.@4OD:,F@?-)
MP WU5",L-;?""S!"[=**:6!\ WZ\K)#L-;&XFJ>ZTSW\@NH=PE\84G<=@A%(
MO*02P ]L9[2ZA[X@Q9R1HCUA:EB:(N&<(^P9.*8VJ1RP,D@Z8ZR-DGB2SY[K
M!C=D/J;& _A\+U7$'E@3%Q%[$!$;5\81IDY)81$-!JQYR_.)R2"0LQ;PD4E.
M.,OYI@VC;A"Q5W:8?%!Y>"S%YSYQCIGV(E^)#S/S6+P\!^>!+9<"IG,#T\EM
M-1FH\IA+Y*GDB#,#.,HC1YY%*:W2H"#QTHH&>X7BA0B-%,PIF//PIES!G#EB
MSK@!!Y-M!"@$\)$,03R!M^1PBHB$)*./+! <EU8X;1A] ^8LVN;=)8$<J]*V
MH"EDL[;R96W\34\E_%3_$0-:A5;9+['Z$ ]L^S!;RC4X5#NQ=_ 0*F\A[C%/
M2@1"E^FB.T/S3!S]Q2I?6"4[]>C1;2SY7^G1D2@-)>E<D.H/LQB1*PH6NN+?
MA)/>6;2]HE)OSH?96<WJM#;EM]8_0K_\9^<\559KY(3P.3V.9(: @(QC2C,3
M([:@4^4R&S_G6N5!G\OJGU?D\5E+T&WLTB)!3RI!9V,2Q+@F+ 3$+->(:^Z0
M9I@B39D5\()*39=6Q+*908(*G>NKI7.=T;9<'QV9_&"/XZ*@[Z+F"[X\H_*6
M23%38UD+JQ@GXS>')_F4VES"QOQ6>G,D9EG*_HX]7^_-#:,WB!9-.8.F;$[8
MFBS%X QU""L,FC)YT)0B.<0CYX(J C80:$J^S!:$L?0I1.%?#QHH*/!QUPAP
M@8_'AX\Q0YO3H&"",(K,8,1!"2 C D.&>2_ UD[*^0P?YMYT=B\%/J:P52TX
M.]6K(4RY6J/LA=.E&+.L!;LC6PHS\D$(2(1Y +84IN_&P7)38^5L)"R%+:6P
MI12VE,*6,N\PU*^)P.^XAURX4A9U$<S !E^84LIIM0=)YKQ,M?SZF!$.6N!&
MP_T^O<?-@[>=YL[[TR:XU*V??QUL??I(=G\VX>\-D5WG<?=ZE^Z>0=L[>^OO
MSW8_??P![OD/:"MK'NR*O9U_OC9_PM\[W_ N;4WC21%>)ZT3+%HPU1$W5"'X
MTR&+G5*&,!8=75JA#<;$0N1S%O!X0> QKZS, AZ/ QX3F9F$":<P1<%2BK@3
M"1DO$XI>*0WSE[ROP4.J&SB6%BTQ<Z'O\1J,SL*J4C3%0YN9DY0(11O,K VF
MT*;@1"S36*&H V@#91S2*C$DN7:46\8#5TLK4BS&P: "#R\('A["D"SP<#]X
MF#B'+8D,GD5$I,XIQY8B8S!!R4FB&$_>1 'PP&<S%5](W+50HCP7(^%5L34\
M%DI,$J(P$Z25/B#.;<R$* &Y:!WR-G%%4P@<IUP@5O'"A_*BM&R1KP>1KPEJ
M,L"_&#Q!*LH$1KK#R')FD0_6RL (V.XLAVRPG(T(]W61H5Q)WRE4*(668)$M
MEH*C<\/1R7TSA3TG3EG$?&:5BLPA1[E&R0AI0#=2ZVL<9?/B;2L\* 5P%MR$
M*X S1\ 9-]R"PH(DJY!4 0RW$#R"2:0 .$8PT!Z$1IT!1Y%"@K(8K7Q9^W2%
M!*60H,PO'_3%$#C<G0+EL@I]I?0-CY6Y,H4 )6K+C \.49>R.C4).8$)TCHH
MSC1G@MI,WU (4!:5 *7(SZ/*S]BI3")#<(!Y2#*E$?>)(>VL1DY%JZ5AC +B
M@?S(0G^RD#;'@M@9A?[D%=.?S&A.%O:"N9&?_$)GOESN@D?3DI/4)X0EIICE
M*$7+$(_1(*LM1=KZ$+6@0F&>N0OHY&;;*^4N*-0G"TM]4L#C@<%CS,26EC"F
M@T6!.'!11:0HEPL"!"$BV*12(KH&CT)\<CWQR9CWL7A$*#,3I"Q6LZ\V+X]R
MAISVX8D=[#A<XB49WH]G<_2HVV_G+[RI>5':W^.0*F0(:Y>N&A*-X(M+K.MW
M.R?'UU\RC?'D*<:,J+'1N?1S_]S-/0+<1*X7[3=D$S3VC>V<VK/^TK^ODKJT
M#T<W%QR>OCA]GW#=ZKYOKGVLFAOKFVNK[QK59FMMN5IMK5?;'__8WES?7/VP
MN;']:^:?!>A":VMG8[O:V:K6MEKK&ZWMC?7\:GOKW>;ZZ@[\\7:SM=I:VUQ]
M5VWOP!O-C=;.=O7;VF#YQ_#[M,D?DX^!0O164>HME2QH+A0U4D2"'=4.\V2%
M_W7D+";&4HP>5('D,5 GF$E!!1PQ=<KKS^NU2T P0=>%H-_%?C_&:VI:-.WQ
M20]^[V0XW8''_M'I^F_/4Y=WXG\_G.U]"D>.<MG\<Z^]>_#/M[VO[UEK_0MM
MK6^>01N^-M>_B=:GO:^[/Z&]G][S)OTK@1YFS2^?)?,\^)"0AP%&/%&&C(L*
M,26"BJ0V\I>J"!;/45[(O9,X13J?GM2J)LRIKG#"-&HRJX/!7+=C_85,5'51
M]BM34%V;]Y:CJE6T?C]?E^]T"#V%KW^/@SA?97NQLD='O>X/,"N/8^?L*N?5
M<Z*S M!=Q@/@O0.?%37J02BBV-V8IW[]F6"S$4_=NK%Z'GQ6CQ)T?6**HADC
MI1<,PN_NOB?[:D=O%("<,G8O*\P^W7D:;),!:&;PGD80-A?"I&><5#B__B^V
M%_T$&<N_-#W_MF>96+-_OD"WTMMV#B?MUANV+S_+\$.GN?['M[WU;[@%[\-U
M9_ \L;NS>KKUZ:].ZVN =OB?K:\??XX'G?;^_'C:_//#-^@7;M)-,'#_@KYU
M]IOKJV+WX"-MT;_@?DW:VFFEYN09;NF#P5PXY(4DB&=.(!USE@3EA)(H$Z=@
MVA+:$%S>-^IT6R&Z0TAJGMM[!0P+&#[F\8T;0+#@W&UP;CR;FEO#A T2$<$2
MXAQ39+B4R&--DK?*<PDXQZ94!%]0D'M9R<;3)1.$B94L@86PS-9/8@N>O',:
M.]]C$YJQWR]VV=SP:O)8O&%&28]A17L:$3<J((>U0(QS$E(4U 4+ D(:5$X>
M_WB2W<"RF[_(0OY+BV.J<!?YO8W\CML;8&5(00A#TE -]H;&R,$$HBBUE)Z&
M9)U<6E&<+I#POH80&$@+OY-),:6O!6WN:U)DSV;GM%LLB;DAT>3!=6J-2EY;
M1'D,B ?/D:'8(REA/?L4$O$AIS TJ)YDXKJ;\[- 09PBVX]M29S+=!';VXCM
MN $AN4Z$*H^HD09Q)A-R$6ND<8C!8A\I9DLK7-R[AN(<9?:5Q"1$B4DLE &Q
MWXNQF!#SPJ+6VH0)X0BQ,6J%&$T"<4,D<LDR%(SCFA%IHI7U)A&3]XZ?EF#$
MRY?NF4R(@507P;V-X(X;$3ZY0*@52 7EP(@("CD?+8HZXI2$\(E$4&E3JC64
M*,0#&Q&R1"$6R8AXVSTIB2;S@Z+)1)/@"4P8$2A)J1#/]6,L81S!#&-+>(C&
M:; A<$,HOD N30E#+*APSV)##(2ZR.UMY':"Q=]+1AG7R$IG$!=&(>U)1"9Q
MEV*DIJ[&3LF\LL-*'&)F$T*5.,1"F1#M[R4,,3\HFLR)D#+R.B="Z2@ BG@N
M%9 B8B1X0S7-.5Y+*[I!%N6 =(E"++)LSV1!U#)=Q/8V8CN1>FF\(M%Z$-M<
M<5;3A(R6!)D@#/=8!"=!;(F^]TY&"4+<KL+!?NS%^B1Z"44LBAVQFJ>C&!-S
M1Z7)M A+0PJ:&^2,58@;Z9 A5J*4@I'2F,!K5%(-@>^=8%GB$2]?PF^R)L8D
MNPCO;81WW*2 &;%:$(Y(U!3Q?'[-<:Z0LQJGX'!07BZM</H"@Q+/JW[2@!-^
M) :/4L.C0-1]C9!B=\P+NK8F<RE$8H0Z&I!-B2"NN$-:"#!#>'#4!D<B=4LK
MQC2DF%=N^,(<N)UCB*/ P8-;+ 4&Y@@#XQ:,I=A2Q@)B7DO$O:[=#XH$Q9[A
MB).->5NE(=6];9C'0H'7$#/)*K1J'QR=',=0M3._3>P?O[+PR6^+9KI\/ Q#
M.MH8-GYX^.KJ0?ZK -C< &Q*/@>.GN*DD8P$7# I C*"6,2(4S0R%Q,#.X:0
M!F63=LSO)712I/L&2^1ZJ2Z">QO!G; \C I,8H>$"QYQ8S X(#K7-;4D)DI@
M$BE8'EHLAM2^QK#)'4V[(;?EE'*%KY:J:/X#M-CH_03@?8U15HRON1T.G%+-
M3B@;J3<1!8D-XCH:I".88. ^.AXDCS3@I16M&YS.BQYD?C+TQ&&F@J8%31<6
M35]MG>U'Q-*QLBLT1LF]9R@1*A!7D2$+1C)*G$I-N8@Z4[70!C/S.MSX]% Z
M0^&47Y;XF(&K?3 DKO?OE4G&]WJ=$FR=,YQJ8RV7%EZ&Y 66 18V-Y)\SG[(
MXY5#N:8V1/<X5NK-M551'K9>PX;MY:JF_;]C;WO?]A:E*@-IMD>B_HWLK>^*
MYL'&S]:G]Z>M=1!U$-OFG_^T]W:\:-(-$'5/=K^^%^-5&3($M+Y^.]O=:<(]
M5D'L-W-UI-.]+.X_O_W<W8'V_ORGW5KOI%R%:>O]9V*QE%90)+#EB ?%D<U5
MDI3FA 0=+25Z@,MU88[5#)@"1\F<2LI[PI6R-F*G*0L85A]A+(Y7<6C%XVKS
MT'</8@6C7M7#/BD;EQ?TU%(?-S[VR4O\_+HLR]/7KOC#]D&BXE "*O RJGZ>
MC*K=ARD>AN#=604M;V<\K YAYMJ#F8.W<VV*TU%943LL*SJHEI;9S^%K!S!7
M]1W[5??DN']L#^O;A)->_I6OAV>VNV&Y6F]WZJ<M0&.JH\Y)'QX##<HU-_K1
M#^MX#%MY]<W<A,Y)B%?N.7K:,>!(U3W*:[9?%_TX.?P>^[DC>5,#UGE^.?A6
M-GSZC:J3=S_JHA_G31^V^7C?'L.-3SJAVH?^52[&P^KHI.?WP8X)U6G[>'_0
MB5[7QQCZ5>IU#^IWXH_8\^U^'-43&3:H49WT1ST_[H$U=-([&S;F(![OYUG9
MNM3TZ2T>-*NN2 +RB<Y'+;]SV#T>C4[>R;G^017H4'_2J64;!OD$OM8=5CXY
MKCK=_J D2GUY/K)>-Z??_E$=U#QZ53S,#QB68!E68+&'9]41*!9HE.UTSL;F
M_S1>T[S!0AN #(Q6N'Y5VGJ:SJK3BQG9MP&>.S80,:7HC^N2,+T(W8")JZ4N
M]V%T^_-N7KH]_!__Y\1VSKL^DI0ZIWC0@VN-YT$WQ^SG8 C!R:HDM.!!9Y!T
MV!FPEB0GX.L.E26_HBPO#.D)S;D*_1QU<_M<'C9^#$;T+:R^M8O1W$KCBO8V
M&TCXE2GC+7C_L]'<**HY\B*SBAF7D*$J(8D5V#U!2AQ,30E"\&2ITWI]W6Y]
M8,Z9ACO3B#$/6&J'E0^:29:XT137ZX.,U@<IZ^-)UP?[G ^'<D834I9Y!$:^
M1\;YB%*"Z6-$4JM9O3ZPG@Q0C:'4)7TV.]36U:Y((VN&(\ XN$_G;/FV-L\U
M_LN"569\6!]DV^_'<-*)DT)06VBKAV%H'BU2W;@G\5":7SXS!CZMTX"#1(C,
M<F"1U5&#FR*5U#H[ G+<0XG@!1M+$\&,</ -'(<WE#5!16IE9.,>"NA8D(-.
MIWM:&TAU2;0C6.8Y;6M@)UP8+-E.R K\BHUPV=RH?OM?_X^&B?_/QM_;]2OR
MG]^K_(+0_TPQ!J[4<FN \>;CT?$ERR#88_O[T%NN[N VW3@6OXA"/*?Z<!PO
M"RE+?;CGTUCXD/%GU%@^VVUOV%Y?C-R\F6J[30_%GO?)S-*GQRQ99V;J54V#
M=M7 J6V2D94S0_V_&Q.9GNG0;(];?M</S*M9Y9>V16^QA;#8\SRM4.%=.SQ+
MJ<N7-'!D'OCP0L>F+*JY+*K7D/:?-X5^RT'0WX=!_5(X]:'ZO]@9(;?)CKYG
M2#OGAO2AP_!J/"3S=Z^;VL?O8#T^B\R0NP9C!IDA7\-!\V 7[WW:I,V=_?;>
M^GN^^W6OW3IHM9OT(]G["M=\>O^CM?,>CV>&M.CNV=[7#YW=K[L_MO[\ZUMK
M?1^NVZ2[=//GWLX_!\V=3;&WOD%:ZQ^FU>"B0AHIG$5&$8$XM1(YISQ*,C+F
M$K<FZ*45U>!3&"MOG2N],-ESI2IJ0;K;Y;[=<V]F,@FNX-N#X-M$C3*5(LF9
M-,E9ASB. EGL+8J6X,A-9L?1^21(@YE[$^H5E"LHMX H=QM[[DY[:<6>>SJ\
M(Q-E3#11D<):9B$A[I5 )C*!/)AW2GF&63*YI%)#3"G+6 RZ G7/&NIN@73:
M8T-C5%I8S[V3+M<?IM)Y*B5G3 T-.E(,NJ<%.#8&<(PP1:RG2/H@$8_PRD0G
M$"4F>F*\=9$LK0C:('1>9>,6CU7D&7*Y?[I+:O!O=7;&A%IZK3S1#Y%5.@ED
MHYE:'4Q4JYZGK52G0_6W+F:G3HTJ6#<WK)OD;\W!!2=M1-QR^,$Y1=92AKCT
M2GH2:-" =90UM)E,0"UL\"])RN<>?RI2_E12/AZB4L%+Q8A$F%./.#,"69\H
M2M2Y0*/E)O)<?:9![\_27*1\H:5\#N&7(N6+(>7C@1FNJ(S):X2I)X@G&\!O
MT1[IQ*35R>0P=:W+E2ZZ_&5+^=Q##T7*GTK*QZ,3!L:1106R;;4&*:<"&4D(
MDIX:,-LL>&BXUN5D;IRGSY'6]"G.%]6".N7\\&B\Y]H<N2QF:,]_CKK]=I[Z
M-[V8S[)\C__)02;$EJ><S7"V'_,-EE9^([]?/6;R2F@;GS@NLGGH>S$31]O.
M6AVQ&N#KZO%QK^U.ZA,V.]W1H;$8ABS3J[V>/?Q27S<6&$[M'S&@G['7+:A[
M"]1M3?+-&X:]9C:AJ$T$#TKG@[I@8!&G:=(.?&1&<EIY?>)K@<IE%+;69Q H
MF8?8%_&^C7B/!TA\,%8F!UY3B!QQ3S%R+$1$HR38,8\M34LK K,BVB]:M.<>
M'2D:?5%$?B*-107-J3=(*I>I%81"1N<CYRP00D"K\TPO533Z:Q#[N8=+BD9_
M;/$>#Y,$Y82C02.L& 6UC@VR2FL4!"QJ G::S[R(TU+4GGUMN^>5I#%,S<CT
M&,.7\7].VM]A[1\>3TW8&))HW"MEX]74O7K2?(XAH\U$D+C$A^<&?),594RP
MGLG D(Q&@2LC+=+$6803%YY+F$_#YYS1L3 YNJ4RWJ*&. I"/!U"C <[.&&:
M2*Y1PB9[/IP@*T) FB?#A)!>2EOO(*G[QSL*0KQ0A'BL/)*"$(^ $..Q$1\8
M%C$IY!6+B,M<9Y=9C;P.0@EXZ4B8<R9)08B7AA"/E8-2$.(1$&(\O**$CXP3
M@X((%+P,QY%F,2'GDXN,6 \VQL"&(/<^]/Q8"/$:*'@V_MZ^RDMZCY-*4RJN
MO*Z#C#<-P&*C^2\/;8_(B><;.:+7GMV>2HK\W+F_'Q>D)YEW) E&B&B0)+G0
MBW48:0QF7)",4*.$TAFD\3*;K,ATGW/:-XC%\SFH70#N60/<'?#MGG$O6F#M
M 6!M(EE'$&>58"CEO&=N*$%& K9AS974X&\(J996R#*;Y!.[]^GL@FV+).&O
M%]ON8KS=,V17C+<'1;F)TUR$*(M=0LEQC3AC$AG%/;*$44J%U GKC')3RFD6
MXZT W','N#O@VST#CL5X>PA8&P\<.N]L<LDCET1 7$N%+&BB#' !C#<CP(I;
M6J'+_-Z'UQX-VUY#VM;EN.$P >L^IPA?&OI.Z^)BX^M"1_^&6SH%:V^#M9/D
M/DI8*L%)1II3A[C@X"@3EU'7>4NICYRD>\?_%H\)H #1<P*B!8S2%?BY$_R,
MQ^E88@QSCU'PW +H:(*<,A%9+J5PDI&4X8=,@Y]GST92,.@Y8=!"1],*&MT)
MC<;C:8:";QEA-K3U"G%I/<H&+#(B)>JBPZ!.[AU/*T!4@.B%1;T*_-P)?L;C
M7H0(98("Y*&$(@X: 5D5(HI4BT@IU1:;.NZU2 2,=63KW_5QU97):N]7:SVS
M\W+OCR@T=47WS[_^Y]IJ]<,10AGAWA ]@KUA_7J4WYEWC\2ROI&UB?Z*M8G<
M1-MT;7G[A^"@&J]U.'U^6MU!R#"38L64HC_.F;EUC?7CNBYO/OO9'R]#.ZI
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MU"&H#&B ]>VC@1%QU>UKQA]M#TOF[]CO]JO?EIK_M[7T>Z/:..EU0=^N_8R
MO_^GVSLYM/#AVM[_R1_^96&1Y4'9C8?P[E]_[^9W/RYO+U?KW4[']N#-C]OK
M2P.ELK;?KK_\(1["<UT[WZ?UW^&'^_9[[=O58#W4CMD%K=4&-&O$JU<[?'E
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MJL&Z]5)*&K)A0B:36.]FF#S&"N#%'+EY^K_\:($Y@GG2FCJDF$X(!MD@$VU
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MF'?5R*2?[\A>JK*6R:;KA]=%UGY5Y6SQ5ND$[<SD08G[C,'K&<BK25LYY/U
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MF0]0)@IKZ5-$3N16O\H:Y$*H+)@8E;=&YI:?0I5HP((Z#P-UK(@!S LNF6-
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M.A%$- $+RC&-G+48!1J5RWHHLZNKLE6XNK9<'27WWD7A ^7<:FT-94I'1F(
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M!7$G_M][$);AR%$NFU\[7S]]];1Y^.IGD_YSV-IJ=7:V#O(S8N?C.];::X+
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MFV"RSVSGAST9K/W[?&A;NSL97'#X]?JL??%%Z_;+#XWFJZWMEYMOUQO;K9<
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MMACT)&!($4ZHUTX%P3TCSD6,D\$>:\ED,&,8(E@6&*HI#$UN/!C12NJ D:0
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MXX>3S8>6F_7<A*!&H+F[-;.L$4I=TK]E_J0>QOG>5;K^BY,7HYI<NP<Q#M^
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MA7:\?KOW:SA\_'A=+,6=-(PK!N#E 91CRJJ@6 B 2$D(6,&<1)H3?7C, W\
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MS:A?J72;:Y^A7_ZK3AH;('"(!P_X;X)!1DF.<L)BGH0GRKNE%6*:F"_8*+4
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M94_?=7IYZJJRB>?N;>WX*CQ#'PG9YB,H'5?>F6B18U@C'B-%.H2$L)72<L<
MZT(N1H3)O<E)L8[45Y@77?RT"/-C"/,L3;$V1HFQ150Y!\*<*QF[1!&S6G#.
M64@Q']PT=0FH?&11G,K#J6M2_@;U$QK#FXF?;S&?/ >N,IW&ZECZ4V[*9OH\
MG.3#*\"V,&";=\:ACF@?>?;N9SY7'>/(6290$LYIG#@FAF1@8TS42/\J8EQ3
MEE+$^''$>(Z?&"YA^A)R)I$<A2:1]5;FS)94!A-4]#R+L50EQ=3C"F')O/T$
M<,:PY-@S@U."O<TRYZ+A3  -T3@X:^Y:!^1<X2IHMC TF_<LB49*R[!!+.3L
MO(D'!/R2(1EDL@!NVCH,:,::FMT[U66QG=17C)/%B4;!L!6&!ZYU8"FIE+ T
MT5!A[EH+Y#HQ?G'YM1]-@F?YB A2$YXL8CR!!#,!?(0!'S&* @4Q/&%1\FL_
ME<6D%"=[$C3#EH4(0B Q9]QH917<(OF@/?$V.K<(4E)0Z\:H=46&;5!\E<44
MHZ <H):G%CFL$_(&4T,IX\ HEU9@PZF1#E7$=,%B&DTPGFJ3M,5<1Z>YC]1J
MIN%5($H4TE$7\9UW;@U:)&^14L1DAW2/M+,8.8$]20%+8A='.HH9I&3:KA=P
M/4"F[59GZ&.W:WNQ/R[&CX= L7F_D:"QTHQP1$"'0CP7"K#)<"28T[ WL>!A
M E=8D[,Z'347::[IB<Q-I+D([&T$=JX,.W!% I01,6<MXHID6X<TL((8UPK+
M$)1>6A&T3FY>][5SW"3SSZ/F6;T^SOD5Y46XW]"\&.A\ ")4N,\#A"=>D:?:
M,^F2L I)IG.95=",K3$6WEK)L<*8YL(%!).FHHL*"%B$\#R/O#$%.@MT/CKK
M+-#Y,- YFXC:L1 -CQI%'QSB6EOD)#5(!"Y@4J.AFBZM2-94"RLS]Y3(>8,4
MU/E]7MV=WMA6O?QI\M[K<E!?N&8J53RGYZV*)\)-WPQBM[+RGF?E_9_+J9"G
MPX//+[$.!F,\NOZ2N5R83Y0O.>LL%\?BXM_<W$I0";;.&4ZUL99+"R]#\B+K
M/=%S(\E7J99.+]H;G.=?_1:1&T3['=D$/7QCNT?V>+CTQ^59@BF:MDAP:')]
M!FPN3V@U8!MO/S=:ZVL;;U<_-AL;[;?+C=7V6F/K\U];&VL;JY\VUK>N75QU
MZ4)[<WM]J[&]V7B[V5Y;;V^MK^576YL?-]96M^'-NXWV:OOMQNK'QM8V?-!:
M;V]O-7Y[.Y&S&'Z_:L54?YZD,_U1;!#ZIM%XX%SR.5ZX-^H/CM<Z0]_M#\>#
M6)O\\<>G&]H.VWR_?MPZJ#:G#FQH)^U]>+W_;K]ULO&CO?:9;*Z]VVOM=[_/
MYH]O[WN^L[UQ/-F<<C6%%H5_87-LG;3VX?G;L#%^63_>_/(IM;>_X:^6&LX\
M,0@(!$.P+1%D;?*(<>R]Y<%AYR?<HUHUJYD4.!6X9M(KPC'G@5CE!?%)1RUD
M8-C-YIL_'?-.SD,[B_T7%^',/C"9CE\^[5&6[=6X.[,=/Y8,_:PQ\W\O#'\C
MIT<;CNPHAH8=5>GTN_VC.,BY]7/ <*,_:/3BJ %PW^V<5%GR_[7=<6P<=49[
MDU^$") '< ]W& ]S%OXJ)W]G,,QU YK35_WQ:)H@9;EQ)G&3D.1&I^>[XQ ;
M0#"AG[;;;'0M4)"&[85&'ZC$7K2A46W6\(A1O[H_C,TX 04:#_(3H;']\:!Q
M..B'L1\-EQO73,!35JHXZ_6TN,MV'LS7BS3?V5>A-'<Z1I28M(C[0)&EBB,8
M:!DC<XP8\[-*%34I37%1FFY:F>(:F+B6XCZ?^A1RF1I5*DDP_2B5)%Y;>8A:
M%0J]NF\W+Q3Z,@HLE.(4I3C%W2V<G^S1&>^;\V)>7%+Q%VT!?TU)U1=U0GC&
MQF$!MD[77SN.-M.G"+WX-SZ7Y&%W(^X3F_?!9U;9M+?]4>OD4V=W^Y\3>,W;
M[S=HBV:[^8?.SLD.;GW9W9^U>>]N^VS3_M$^63UIO__0!;(/K[_AG?V=DURF
MKG7P81_:\&/WH)U.CPHO1IDD[C!5%LF8@]<M<4AS3I"23@N:;*0A5Y+@N*GQ
MO0/%2BF)@GK/&_46=;A74.]14>]D-M;?!1NCDHA8D1#71",GA$0\&S234]IB
MN;1"F&B*1?M(E"H2]Q'5+_W!]T:GEPV,/@ZOC[9[];ZO"Z=G>>0W>G]/QKT@
MU<,@U?$</Y/,>F:Y09(FBCBG"ADI# I6"1$3ME:EI15%F@3?N]Q-\66OKSPO
MG'@4>7X4>9YE'H3)F*Q-R&G+<UX.CXQ1& E%B+#.<J7YT@J336YPC>3Y-5C
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M3WA400MCE7,** &S7*FBI==0L&:U]"@$Q4(RI*@&P0+^AHPP"5&MD]8A3VZ
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M&^W5]MN-U8^-K6WXH+7>WMYJ_/9V(ALQ_'[5Y,\(SV2+CT(Y*;0GF##. W?
M0"Q-E G!LA?CTE3&KKR8DD@D@3V(<PW_%4Y%;:3#,J1(K!;YZ"AO"N?R5&U$
M,(A=>SB,;TY?_!DZP\.N/7[3Z55#45WTY]R^,;L)59,U^7JZ)HU9UH+E93D]
M29@^>+IBEZL5.[.O3K[C:IE)>NW7>)G<\3O![G;7GS66P)>B-+8T%AK+;W3;
MJX]W*?O)\6XMO2GGT/)VX;HW.=\:](]F$S?4-/O8U8/QI7H3 UJ%1L'^WKAH
M66ODY&! NAH[T0YN<MSXRQ$CXGD.TUKT\<#%08.19@,4;')I,(J\W%A>;O_3
MV^BC]5Y$;_O#T4W.[&_2X5<U<!<,_Y7B=A&CRH#>84#;<705@+WD]*1_P^KI
MW=%G9H'>3,]Q#=T^;ZF.W C"* %=CSL*_],N1)9"KJB3<*SREI+3O*6$4$9*
MWM)3B_0WMOEE_:BUW3W8V5\]WMW_U-G=]J*UO9[;^*.U]HVTMG>.6FO=SJQ%
M>G/-BYWMU1^;7W8[K;4/!^WW'[KMDVS)WMW;@3YOKGW^T=Y?/=K\\B&UYJN!
M.L&2HDXB(YA W'F&3. >66M@CK3P\,_"ZHO\0J86)D<O[&#LUMU_*>=>@?A@
M:-2<2,=5-%HX883$@!V*!Q:J<Z\IDI3,-S5!F-G,-S2$G.Z&(L-RW<28:S D
M$9'Q-C A@^4^N[NK)K__>=<=-MRGS !9 *\ WF,#WBMVJ'HT")RK12.BQ$QX
M))*,B,L8D=9>(:="I$19*BK/5=E4\M[N5 4""P06""Q9;QX1[F:SWBAOF#&6
M($%M0)RHG+S?8B24BQH42V<ISCIE4TKQ7.#N%60<>3L>PK/CH)+'/!VU"39[
M]K8Q L!%#-,4 Z@1E;3!UGA8Z-;KJ*0MMK&GQ['YVKM"6*L\YLB%'*C-(@7&
M)BABS'.JA4R:^EPHO-3>?41^$'.&>:L]$9SR9(BUU"6C,+-8!^IUL0G54+)F
M;4+<2F(5, 0?J4=<<XIT<@PE%9+$0@)*^HHA<'+OPA\USAI39/G!9;F8.QY>
MNF?-'=0*'+&1*"4N$0_1(">]0TK!3%.-N1!T:44VB5E4QLLBW*]2N(LBOUA!
MGJOJ(ZR1A%(D;<J9BKQ%EEN%@!0G$54*)O&E%=ZDI$Z"_ H<6R9U=R=:^MAV
M&_Y4=9\$K/1[P[W.X9/[O;P8]9T#EC$M';,V<.RM)5P0SI2/FAG-:%'?GQR]
MVO,E>1,)V$?CD!:6(NX31X8 #>$D*(P#%QRSI1532O(^(BG0E%!#G'4A$NX#
M-LR"KA=@O_8Q1*R*]EY#P9K5WKT"*J"M1%3:F$OR"F2)4(@Y:?-'AB:WM")4
MD]V?%Y2RG:]9EHOV_O#2/:N]>R4Y-LH@1?-FR;'+E>PY(B)FLF."-79IA;$F
MQHMR5BC2_2JENZCOBY7D6?4]<*FU%1(9&@.H[YH@YSQ&QOD$&CR+.%O9*8=]
MND[EM5_!4?OVP(9X8 ??RQ'[HG3TB+$U47OJM>%>><L=!050Q*0,#M$4'?WI
M(6IK3D>7W$NM7 3=(1\5<)+]PB5%DE#L=; X6K*TPLL)^R/N_" YQ'A*E9&&
M,^*MBMQ*254PV' 3%Z>CE^W]-K(S5U)8ID@IX!GC)+O928=<U!0QV-FU,I0%
M;T!VZ+U][,HAVVN6U6MU\"*]MY'>635;1NHQ"1KYI WB)G#DB,*($LT$T33
ME!;I+=*[:!T[=7Z ,G@2!_TBP;>3X%GU.IEDJ=(*P80IQ!GSP%V%1I$Q#9H&
M58F0G$DE6U+^K)$4OX+S\4J_KH2DG($O2+]F!M8ZH5XPD[@BUB05-6Q/FE+)
M-"=%OWYZC)I/[P#D(ACF/(H$ T;A$)"N$KL[ "])C-4X%Z 6Y1#\$;=]*:VP
M(9D PL.QD<YKCCV-5CN57#3E$+R&DC6K?2<;C24F(NLQ:-]8"Z2C(4 &@O62
M.$*4S342FE3B&AG7BRP_.UDNA^ /+]VSVGG Q,44+%+,$<1A!I$FB2-KJ O:
M&)%2ULZ;BI$BW$6XRQEX701Y5DGGCDL>#$56R7P&#E388 URS:V56%D>=(!M
MFC7%PK(/E3/P&\GAVEGYB%'T>SUXZ+?C<AJ^J(!S(X5*B4AO+:?):R<(J(#)
M"2:M3+QHZT\/5O,!Y]P$JDBD2 OF$2=4(>.)18(XR0EL/H;FZD"L'(<_9AP;
M4809J9+0A$LEC;4Z2AL$$]8DXXNV7D/)FD]"R"5C6*#DG,E)"$%OEU( ^!F,
M_W_VWK2IC61;&_TK%;QGO]=]0\G.>7"?< 0VN ]]+=$V>#OP%R)'(RPDC@8#
M_O5W997$(#$C0$!U[TV#AJJLS+6>?-;*-2181>Q=]H/1AC;SZAQ;G[B]2F6N
MS?6'5^]I<]WJE(3@%E&9).*"J)QQGI!0(;?4<TQC"N:Z:7"\2)FJM78_.^VN
M[?7Y:O),S+ITG@<<$+42-FK.+-)@5B,O, ,J;$DP.E>&80VNU0*I\BLX5*^2
MSO</XK ^59^7G6Y\HH%19D@0G$NO57),Z&1%8#J*.K/\Z4%J8S:S/(A(4R[E
M:STGB#/MD,6&PF\6TPAVNO)RZ=U\S/3:5W_#'MG:"!A+$%8YGB)SW$0>2&Y6
MR1G6M9F^B(HU;:83X3CVR2(2N$-<1>#QB1CD,<6:)\^ICTOO3 .D8X&<];4J
M/SM5KHWTAU?N:2,]2LU4M [EGD.(>ZN1QCPAJH'^:.NP<:#<M,%$736B5N[:
M1E\819XY4]>"4\DP(CPIQ)U68*/[@$ATB4=B+!,DUW=4?)$*1,SI2+V\MUI6
M8K&-]:W>T'8*6^UM,13M$QTI;*DD"WS4OG#P=N-NN+>>L>N^]UK;G]SZ\1=:
M?FZQ/1J7<.ZY:#4-/"IO2!31:Q]@2PPDU2WO%F^#G,W,#EJ%1+5!-#F+. 5;
MUEF:$%9,VI "<-V46]Z)AF;SRN]<F(9/->+5B+=@B%=;^P^/@3-%X+FTQG&%
M$B,4<9U]Y ',!6TI%R)0%R-8^["N#:WGU>.AQL : Q?GN1<+ VNGR'SQ;MHI
M0KC@1IN HB(:<6XCTL)$% *LJ)0)IY!RCT_:,&)>$8:/U?5N,I")>/,2S9[P
MW+^^QBNYQBO(@UG/\2I=V^D< [1/4F(&O30\M/WX_RZ*F^XAKG'O6,5%6\I;
M,YV:S%Q!9M:[(:;+"<W:D>^,\NS]U>N%PW:G4].;N;4" FK3^H"/,L6!U^&Y
M_ ZC5"6L+-(J9T1+L.>TCAHEK@P/E',M^=([*AI,Z 6*RUP@N*LALX;,&C)?
M,&1N3$&FT0*'7-W1&94;$.F G"0):<^$5\[[)-P"0F9M]-77> E&W[.*U%C8
M^(RG8#%COU:U*F\9+&7HC?+43!:C=I#/:WYJ!C7-H"X(EJAYTP/RIN:,J:E=
MH#X&AXAU G&%(S*..J0,EE8S;H0&4Y-ATB!S2]:?GTH]C[/%&EMK;%V@T\DZ
M0N,Q<+9]'F>391[0E*+(L4%<4(I<8AP%(ZB2@3BOP@.%:-0X6^-LC;./Q&%;
M<5@SV =%UFG/'R"H-LH0Y(7TB'N9D!7,HJB2\=Y*6&2<BT/K!B/W+B"[,,A:
M^FW^/;1PTW?E0V7I;G='Y58.KX3VKW?_#3\FC[)O^S_:W<F(10FO<]50@J]3
M49I5=.?*?XJ3A9B,_VE&>1(*\+@@5MZ[N#)(H<B 4KAX)MWH<#=VB^%N+ [Z
MO;WHAX,B?RY7#^G$(7RP&\IW*U=7^5X_VG"<02F_T>YGAUCL!KC4:!"7+UF"
M=__M^O]^-_/F9')*Z6W#1;K#MTP^F7BM3[OV8+Z&N\7DI*;H "&NYN!T_F"C
ML##.OLW70?F:A;.#]J#H@0:.9R@.A@#6PVJ*TJA376BY6!WU09/+^1WN]F,L
M]F&(NX.BFLZ_1]U8 0S#C0(V%%JN1MY9&C->R,F(2@TNXM%![ Y@N>V@^*];
M[&O!$(*3S669! _:.L(<=@9 2W)B8U7DA&)>%3FA6#)\=H-;;WV<WN'.V@@;
M:7J_N]G>)I_GWM:)__/E^/NW<. HEZUO,.+5)FO]_K+_??7OGZV_U@Y;W]9_
M;^__O0_W:V]_^XKAGOM-^@7VJ1767-DA46&;:$!1,@9;D]+(:$<1M\%8[1E3
MN1(B)\NS2=@%*$<GKW46F-L( .:<Z9@8C1CS@*5V6/F@F62)&TWQN,K-6 !(
M+0 /)@ Y.<DY3KVG"#L)R\XC0]JRB(A@S%D=N/5ZZ9U8GCV2G*Q_ \!Z< "H
M#GC3.5XNSB+.H'WTY'@#DL92C#Y8 )@8J,L]BX(*.&+JE-=CO"&7X T2M;3=
M7]I:6Y]%Z_=7LK&Z1N!>1SN$V<BL$<@)8S/<6.0",\CSF*+#%"O!E]XIMGR9
M2_>NZ*,]-C1&I87UW#OIN%&!2N>IE!SP;JK&5BT.#R\./^B.)2D%V&Z0)Q[V
M(684TE(Z9!7%WI&(70Z.(!?M0^?$81J,;LL&GP>'G.%T60DNQ-IB K.SZ#HH
MO]6/I9OU8JAM=ST0\4$F]V#?M1/8>MUA)OTCN'&OXNS^?T?M0;O\6B\5F_OM
M/(!F#-DN+-X,8'"M'M!:]K98.?WHX(]9$G^'E;FJ ?Q=4/^\8F_ZW1A&G=A+
M5[BJ/XZ&HWX\BP%KU>1M9<-W"\;SOM/S/U^9?C>W/O]N'N[0Y(A5B@&TI\PI
M(T9.<XV 5B3C%!%6 O)% ,&#O/#]45Q:1'5;&631OH"ZG-I<MML=G5;8J+0H
M6Z^]4?\"Q<OO1.MW\V6S$G7A.8L$XE7D*HR# BP[>P"V\E%Y=5"X-^UL/_=&
M\!1A\,?;.:/:V/.274&5VZ5TVIRXF"I'$4QVQQX,XMO)+W^&]N"@8X_?MKOE
ME)5?^G/&BS/M)"J'6+W]YV$[#'>S9W095][1<9C/^,[CMY?+MZ8<7]5[FBY3
MQBY]&R^3.[XGV.4WO>J;5PV6\&7-U(TN^ZSKQUZO5>5B?XG[-HMJ/VM!5J>'
M*(AY[^):"S=M-S]:N>@1G^APY(;/=IO"89Z*H W6WEC.4S1$:,5\,LH&'00I
M3T=FC;E;G4+/;NHG,KL!G"!S]^VR:NZ+/SS97Q?-;\W?S;^V#[?W_.'V[\_'
MK=6/NQM;K9_-K6VQO?_YJ+D:8$QK?/KP!,9WM UDX/O>^W;K]WL8SSIN?EL3
M3?KYJ+77:7]?!1I!_[/7W-I-S=GBNMCE1FO6Y43:D$^E)3(!* 1+!$<?M36<
M+KV38AZ=.A:OO-A"(Q$H&*M[#;T\D&O!_;<.8^=7;);F9(UO<\.WS5E\"Y1X
M:P+2A.7&P=QE?"/(6B:25MPQ:7*3+]F@I.YP\.@ Q^LJ[2\/X#)IVSKLU;@V
M-UQKS^":XU1QR3RBS&O -0P(%QE!DAL50XY@(C+CFF@(=>]TMYJXW1;71$W<
M7BBNY?. &MGFAFRS;5F#R.%\+J%H<S1?L@0983UR3!F>0R8$R8R-JH:A\XJ3
MKAG;C9%-UHSM92+;Q]ZH=K7-#=A:LZXVYJ62B4CD4FZ;Z7A QG"&+&:<$^^9
ML*D"-J9?8"G_10<V55.V%PIL\-D:V.8&;+,^-A^%#5$I,$.#0UQGLI8(S@78
ML5)8.E_:HL0TJ#(U8WM4#=W:C?UHTS#V:][V\N!M)2]LC7%SQ[A9?YN/A#B"
M+:). 'EC7"+K343.&&.M%\I9L$H9,PW.7N!!Z9-7][DIW.7R/D_8.NCY)R#/
M/4SFQ60@/\M-XW44HG^L?6'66ZEC=#9)A03A%G&C([)6"&0CMXI:KI/)N<<-
M+$@#J/ +S3XN(UYG^F_/Y"1?%1-[51QM*9BP^3IG.-6PWW)IX=>0O, R@"1S
M(\F.DDN/F#:L+@QE+F/QB7A;+>OLSZ)XX*#Z%>]!7H:#?^QQ7IN5;H!7^J,8
M/K6M:W?:PW8<K+8'OM,;C/H+$S_?:D^4__O>]MXVW?C6ZK2V5HZ_;V4 \+RY
M_W&W]6V=M+9:^RWX[L9?K<Y,_/Q^J]W: V6G7^'Z?W=:.8;^]X]CN#?9WH/7
MZ#:,X3/?IO])&UM-L8-UP)P:A93' 7'J!=+&1P0&*TE1^<02K0 ;)#B&E0R@
MC#KO9=!,8\E-$,YH@&I-%&= !*6=CK8?3WYQ9O;+M)"-(=AEQ:=>]P?:BOW]
ML^]?VL?^1MG83Q/!_]]3JEY)T_63=7YRL>98"1R- N4VR9E(DD]:)19#\-9.
M6D/._GRD3)6--*M,"Y6'\@1Z1'<P"]XKS)!,-($>*8.<BP0Q&@352F*J]/12
M:Q>455HS$7."H-*P79) J4Z861?297K4.:-'<,5!>S"<)'FD7J?3.\QY6U/9
M'),M]MKMZ;+\C;&H\VS\'/2J#*NW96(7,*[3)(M_G4^N&6_.^/0KUL$^/!I>
M_I4S6["/N0;$$R7D4'-^+L[^W#TI57Q@?X#]VX_V)RH=3&]MY] >#Y;^?7ZC
MAUU^?''!X>Z+\^P7[^#K'[X6S;75]0\KGQK%>NO#<K'26BTVO[[?7%]=7_FR
MOK9Y=7;0 CQ":V-K;;/8VB@^;+16UUJ;:ZOYM\V-3^NK*UOPQ\?UUDKKP_K*
MIV)S"UYHKK6V-HLW'R8*^L=%BW\AP%\+V%-:GZQ7)H"2:Z^YU=AP^!^5\#NE
MCB=]V49R/5J<OX\#BPIV;_B7!RX\ML$Y[[ DL EP*<G2"TG/DG(9^,O#)%*)
MYY3UI>>1]76MD]O,?/0"3TVE^4]3$VT&#O!)>N4Y"_.&$_$<_% W;Q9^F45\
MU7'.XBWFN:3SN3SV34J.OXRY6XT^[CNPNQ@IYX_<1BE>Q&G@INW8_L0&=;$;
M4WNV]OUU#_QJ/=FW?O[:43TVI-M^U'X[MN$F,KC2#>_'$O@\/-1W-*[''NHU
MVMK[?-S\_96T5O\#W_^RU_H=VMM;:S"&+YV-U<^'S;VPV]S:_CWCH=[:IJW5
M]=^MK:^X]0V,\[^:K$7_AL^N'7[_ZRMOK:X<M^C:46NOE3,%CJ;C:0UW+'&/
ML) 1<18-T@H3Q EG+DF?B*-+[X1L\/MW2KVMACQT5>%[9J_72/?JD.Z^58%K
MI'L\I/L]A70<%BY9HA&8_!)QB34R.$C$#(">U(%$9I?>Y?A:/*_XVL?J"?VB
M@V_7N]E6R.5Y<LG:V!V4KI]+C9LZE'9.80-CF'K?ZXX&<?!AU._#,M0(-3>$
M.I[A8EIJ+P)WB$23 *$41QI^(L68-3*X*)C(;>L;DBU2:E,=#+]@+*/6X,?2
MX&F.(:B+-%")/.@KXL%89(%W((E%$M99293/<: -@I]1.8G)608,-EZM](_U
MR=?@C=LXB'V@.MT?12=7 3TYW#Y&FUMW8C]UI/TMV,_)['_*DS^)Z#BN073.
M(-K:G*%!27 A&4G(&6L19T(B%R5'*;<MX-)2[330(-,P]-[Y0G.,I:^39A:4
M!M6J_&BJ/,V'K(P^P0]DL<UY,5@A9XE 4B=B/".,2[!H3 /C1=+DET:'Z@$_
M/N%\AHZV213E !!O4 SM4;R\\?FKM]'GQ3,W\V2O=,/:D6_GLO5'X]#\\>X$
M[[1Z75]O5?/=JC9F6:>S@@7)'))2.\2-=$A'FY#QBN# C, *T$ U,*E];R]8
MK^=%.FN]?B*]GJ:@AD9&'5=(I.1S:C8%:](&)*/V4@7#@#?F%#RC\0+I]6MP
M<'V)@V%_Y(=5.QV;V<<5V=FOWAR>%^,X-^WP1^S_BK4M/.^S@:V5#$+G&A%K
M%ZA-5"!,HT <:X-TX@(%*I-QDFBB]-([V3!RD4I$U&ZM!6485^IQK:JW4]7C
M\ZHJF*8B%ZD*)I_$>P%V0+(<R5R+3[F<*<I 5>4S*L17^U2> A=68XJ@DKG3
MWZ_8'<7:H?*@0>1?N\G^ZO6SH94OGF][<FRZN573F_EAYOH,O5&":D.D0IY8
M YAI(C**<<2#E29Y2J(*2^^8F(>SO_:@+*XBSR5&NE;D1U3D*?)C/:% < @"
M"+:(:PR*[%A VN)$2/ A,9HK$3<DGU?%HMIE<KLCFEY9(.;N1S2OPM":9UI:
M.>'E?-?8,S_L:<Z0B."QX$;G\IFY9S%L(<A)(H!3F!0E2\83LO2.-C2_M[>V
M]I$LKNK.,\^J5MT'4MTIVJ"29]AXAPAH+.(VY()I&LP!'Y@,44BJU-([WF#L
MWJ'/BU<!]UFPAH-^+\7! ";<=HH4Z_".1TNB^N?,S'^,)[D8]2GP Z'3YUEB
M@:-+RC+ ),$0QXXB37Q"A&(C(\,RY<)/!#>H(@MDU-3>B05C%G=2[%IW;Z>[
M4\S"F6@)3J"[3FG$90#=C2H@(0*UDGNM## +I>Y];%I[(VZE=I_B#R 2=>#&
M(_HA.GG*,W6KV<+\$.?K#%LPDNM @T(N*HFXSGF<4D3$M&98JQ ER7F<#4/O
M319J-\3B:NX\W1"UYCZ,YDYQ!> )F "=1YII@C@/ 1F,#9(&"X9I2A'3K+G:
M/",O1!V[\22Q&^W!L-]VHQ(E:G?)@U.<C=%PT ZQ3#_RO?W]=FE7U7@Y1[ST
M,TS'4JR"\0E):Q3B/I'<YH(@"GA)*%51.;;TCO*&9/<.=JO](HNKP7.A.K4&
M/X8&3S&>8&+21F,44J"@P=[E'E,*124,%<Q2Z]W2.]&07"R0 K\&_\@WV^_;
M[DE7GWX<COK=.F#CP0]=_NGWPL@/Q]-_O%(YJ#YT+,!1:L=01\G?!7E^S' '
MS -F42ID$Q:()TZ15M2C2#F7U!.@#& PB/M'B=4^DL55VGD=J-1*^T!*.T47
MM-*2F!10%!0(?X@2&4(U\M9CX7+#')Y :>]?8?(9!VD\1:>\4N\^MF,'IC3V
M?[5]KG<+(N_+TK?5$DSF?JY#D\OB!F.[H+59+FN,V/(%;8R<'<1\@:5W;\AT
MOZC:\GH(WTDI.)N5W'PX$9N5\N:U^34_//UYA@3]_-W\_7E')PE 2BDR-!C$
M+?;(2.41=@*['*_JG5IZQW!#W+]:7>U 65PUGHL#Y>9JG-I',:#?L=^K-?BV
M&GQ\JL&MU;6=A+6VB6&41!E>XEV..0](8UC)$& !+<VMQ#0E],\%4N'7X$*9
MA*ZF?OEJ[3MYC""3\637O.%A>$-EAW'I7"8.B.GH$">Y-&9P#EF#54K&89]D
M&9!J<%T.Y 4K[CQC3&K%?5"Z,,YSH<$J*CV25F'$11#(2AH0D=Q@XFW$H:QI
M2\PSJ@[R(@(V/O:R_'>+>.1W;?='+":IXW7DQJ7P@RT+D5DI,6?<:&457"+Y
MH'T69>=N>N:R"B/]5?J%)@6VVV=:CM20<W/(V9NM')9X,B):AJCA+*?6::2#
M4DBKY"@#CJ>P7GHGU"+U%*D=#'/6U&B"\52;I"WFP!DU]Y%:S33\%H@2EQ %
M>3M-K7T,\]'@*=(@/36&)(&BSVQ?<(^TMP0Q*9+VRFNKTS/T,3R[P-1ZP/6
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ME<E=A0F]=Q?TV@&SN-K\P*WS:FU^(&V>;A0BG&0V4# *#/ )%04"ZT\@:B,
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M!.95XKF<K^1VJ8A@N!UD+>J/8!.O9KV :<\5*,^M\!2Z7]C=]=K;/4W8(;W
M_;V@;8''"S#,"U Q4CLN. X4%(83!\!!2Z8")MR8QL"'JU);P!XN=2& P>X
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M-@T63.?4HU,*5\5EBS&9G9(P($E+?RP#NR]&@UBY;@[&NTEU..-Z_7X9.S<
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MXO7[?-A<V?&" \,#P\%RG,!6!9O!>AP13K 4(5<B"G3I'5/+LYDH$_]YQI(
M!*H\K\N,J52R]IB PV+#0H!X[+9!7*KTQTZGYR<N]BD<;<R Z 34+M?Y7+"B
M=,9W2L=)#IP>5TLH;$GA!L6D,$'IU+<PD.'Q00E&)40>V':H8&A\A>J>[7Y
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M, U8LOHX[,40YD_G8+51=./"LN,;;NSC?#[8YXK0&^7LP')SOP=?7KA%NW7
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M&6&VZR>AQY/(B3&XQH\Z<;PIN.8!@5*]8!NTO"?!&;1\:*I[@S)^ZD<12;!
M($7W1TAB.W92W\X2&J2Q<&GB)T<OHFZ\$2P597P_Q)Q:D!KKOS6NE>U/.@(:
M:0%?HZXHAY)4Q1=1L1PU!E0*5D@?-$88^YY:U8X9&_?'J@'R6^F.0 :H1 ]X
M(/\LK&>_EG7]@_5&+>^SH^.W)V^.?MC/N;91SWGHR!'6$WQ<B+?9W$;+?5[8
M9K6]N-6MZE;^*/$DUW]G21;P#$Y1CZ#U(N2RFCVW@YB[/.-IXO&56 Q&7"]F
M5/!04 +G,&4>B>$0XXD;PT]G7;-R= N6 PE\</ B9W6L@1A)>QC]@G);)="_
MIMR1]0Y;D1]>4_' -!4W3<47MGUM"-8M0JK6WO=-]E^D(-7T&T-,@W6M+;][
M2_$DZ49.=*>.XDDW<!^F];>_^P;57C>)[M;^W SV"0W6[[K>[6AV=XVF[W#I
M?K3M!NT9_ASH* 4V 34+GE8H<#SF'\>UC(/8W%#A -;H]P$(%07Z$95")4"E
M>DUS%=9V0NN>]0HD/.O?@E^)@UXHI8(:JID5,#FXMM(_TT+Z8ZF*&="QTCJL
MZ39]R4V;0M.F<-W$GVUA@DY(ZD9,N*#L.Z 1B-@-2$QYD# _<:)8R/@2U_5\
M=\'RC%0(\X3?5@IMW\[\<BY&;[-+^F4_DI'O:)]1^88?/_3.OWZ <;S_].?'
M/R=_?H4QOOXM.#]]__'\ZQORY^7+Z[]..;SWO+^<;WC^QTO__(^_/L(\\O./
MO\!XWI"_3C\YYZ_/_+./O=[9Y<^?SCV8H_=7=G;A3)9J&/B^<!/"$SMP*+4)
MC1P[%K%G"R%HQAE-J:QAD'1@ZU>,US\\&/OL:Z-" X-/%@99'!*>1=1UA$=\
MXB>I&V8)R0B/$Q+1Z.%AT"#=-DCG+%<')EA4AR8V3WEFDS@1-A6Q;Z>.GX5I
MXGM92(Y>>/YJ9K6!.0-S>PUSVPA[41P0AXN(\YA$*4U"X?D^B1U&(QZ%SF:4
M,^#V'<'-6VY<$(2AEZ;"3C*7@Q@78Z26G]I.& :9EP"INBC&[:K\J@$X W!M
MFOA6ZFR:.2SQ7!I[G(B():X(!(L9!U3C;L:-.KM'.$B6&[>RC B>,AM@#W!0
M>-Q.F./9C&>^DX;"<8-8JK->N!HBW3XY[Q#Z3RLS-UN,M"IDI)4.9$L%<(R0
M\5258 6MZSR#T<M(MCL900^[R=XV8$E)P#R0)#*7,4()3S(')AR'(0:#DS1:
M#KOR;XV:-T'ESW+#WR_OM4'0G2-HOF(0# ./,5",;4]XL4V"A-F41YD=1\()
M'1I&(@F/7I!.0L)[ *CIK-E>%=#WPMCU!.,!5AUSX]A)2!(%,<W"S$$5\-L\
M;UB]C:R^;!%C1(0)BUTTAF4VR2)JQR$'L2GUO#2FE'$18:W!3K0Q5\(P_!-@
M^"Q)..,1,#HG)'%C..>#S(ECRKTPX$'R?1G>\/0V/+UL" IH%$:P<;:?))@C
MZB<V3:+4#KPXRR@G-$HQVWS5EV?X^<GP<Q#'OA<Q)\XBAP1AAIV8>!@R/TX#
M5X3$'.![RNS+U@[. DY=0NT0I',XP,/43EWJVY$;!]2/_2SU4CC G4X<W+MM
MGFFFO16[JLHH6)VC80RA"UQA;LM#A&Z9+H([-%HLXM\RNKV"?;R%U5?7*GL'
M$R[Y>D#,\B^"VU]%51HLW 8+)RMV"X_Z(HA8@(%,Q"9A&-@I=@!.?$K]T"-I
MB,4Q=%/[%G4A--R_:YOE#NP7&VR6#X<#1C"Z%Q@L6S:BT/4R+_'L+$U3FR1!
M8L>>Y]EQYH (G CA4 J"4<=S5VMN;>T%,BC00AE@YS8-(P.TC^V7C1\);* #
M6JX=.1'( %P VP,"V%% W"SV_(SQQ,@ ^\K]V\@ .S"!&!E@O\!@V3CB1X$3
ML] '&4!@*(B3V6D:!S9/F<A"&J6Q&[5*!C#!'L GCQW/<;^(P/T&S<<)]C!@
MN&LP/#]9L8X$W(M%PAT[3L($%**8VJE@/H!AR!@E$0U$O+.HCM9$!QM<V+MX
M$(,&#X &R^:1.,AXX(-B!&IQ9!//#^W$I:XM!.$>\;*$>B@:^9T@VG$'6H,)
M3P,3OEO(R*G(8)S\9]E/:83-->I918P&+-Z5%0[X>#2J\G0L*S]=EN\H*EP&
M*K:#BA63"F!"Q&+/)D[F E2(V*:<9'9 LS1T(E\$8;+#>!(#$T\*)KYK)(H1
M'1X #Y:M*E2@6<7E=A0P89,P$';BB<CV'>;#1KNQG[J !W$G)+L*.6E?ELT>
MQJ,L5A(ZHQ7K67X;"PD==-KE4\VY#.(TBYV0>+&7D#@3L>.&:(1PO#01@!^Z
M1=7M#4HFY_*QCH35$D+<C6B44M AHS3!XO>IG00!L:79D"8T29@LK-%)DM4C
M87<YEVWRQ!GT>^KHMP7X>4GL.YE@KANX)(ZRF(2NSP %/>'Y6>AM!C^#>6W!
MO&4+FDN#S/<Y]J]D%'ZXU(X%%W80A6'$1)BZ1$C,\_U[J\8&^ SPM6?6VS0F
M!7#+0A&G;N:0A'IIQB+&W91Z+&9A&CT8\!ELVP;;EDU^H>>)5&2Q35.&OD+/
MM5/B!78$8AZH^5Z0>1E@VVHO(X-K!M?V%M>V46>=S/.8'R8QS!Y+IJ8)2;@3
M17%(B LG_L.KLP;AMD&XE2I!'NP=2QU;."G#=/?,IAE'K*/"CP.'Q'%T]")<
M W$M4U=-R-BL/I#5NMI <WOOPP;S<HQ];&YW*NPW0'*0^4CL^4GHNL1U:>HZ
M?IHEP@^HX_A1$S)"-O7X-66#V@VI:\H&<>XX@8OI=X%K$S>.[#@.A4V9X(D7
MA0S4@*,72=*)G?O4$=^.L_;32?P$L&*K2!+J^UF49(G+29; T>M0'F2!XT8.
M!QRY!508A&@C0JSDY+D@+&>^;V<A>HZCP+<3K%,;^4$L B^(X7OL*-[QUG0:
MN+?GV,#$?L.$XZ5AE+DB%&E&2$82S^&><%E$D]@A0?1]8<(@P39(L&Q@RC+F
MDS3@P/\^M4%ECNS$22,[)"R.G(B% ?9H=XE!@8- @:T4B\1UG8Q&61 'A,>@
M6/BIDR:P*"%QJ?",8K'O8+%LJP%U,?;= .0$4"-L CMM)ZD [<))$L 0WT^(
M<_0B3CK!CE-7'@(K#B'2S%0^>CPI:0=V%U/UH-T(N5KYR$TH2,4 B6DH?"SY
MZ-EI -)5&COPG^]'/(U,U8-]Y?YMI*,=V%),U8/] H-E*TN0I2(&?=A.$I"9
M2)Q1.XU"WPZR+&+"=]PX<['J@>OL(!;3H$ +98"=6TJ,#- ^ME\QJ0@>T)
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MR$T((T&292R-(X=&<9#2F!MM=H_@;]FTF:6A0[.4V2S$0F6^%]II&$<VC]R
M>7!RD1";8742UV^[,GNH46 +97FLUI7DF=OTY>YG>^@1VD813E@09ZX?D3@B
MJ1NC0SCR"$^)$[B))[1#B#0.H6\V8#6)P&W T-4:/1Z!PR]UF9WY(#@2%KAV
MZKNN'2=1X#"0_ST>HG;L.P_@.[Z)I_;3<WQ8*!&F4<9X$ 8N8R0#>8IRZ@5N
MY@@J7-]-OB]*&"#8!@A6*EO'29RE;FISCD5]7)_;"?QJ\QA$*8>)D(7\Z(7O
MW[OLJX&!IP8#CA,Y;IHZ/N&,>#Q.?)'1@##J<IZD\7<6%@P,; ,#RR:E@$:4
MN"  "$:Q9A\1=DJ8L(4?I0D)N!\S\3"!9 8%]AP%" %Q,?/AM'#0CQ:G3L1X
M[(=^1I+8<XS*L*<0L6QV$1%(!RR+;<8\UR:@)]@T\1.;1JGP Y%Y:2 =:B&Y
MMT/M^Z#$(025F=I"3\B88LH.M TE5VL+$5"-B4="FZ<\!7V*QG;L)8$-^$@]
M$O@DRX0I.["OW+]5@NW]K22F[$#K^'W9?I)&)/ <XMJN2R)0G!QJIZ 3VU'H
M9GZ6,C]R@-_#-<YX4UNHM6S^F$80<\BWC^E7 G!<QXU)3&R?^Z *T1!4H<B+
M[2#V6>)0'@0^-8?\OG+_-H?\#JP?YI!O';\OFSY<%L8.2'(V";!@:,3@D'>"
MS/;#T&&<I;#]48L.^0./*E$EAEH40_(D\HK;&D5B;+^[!L"WJQ6%!...'Y,0
M.X)F-G$RSTXH%AC)0-BE<1)0#+E[H' 14VJ@I9#0#FN(R3C8/?^O)%/QT/6<
MB&/_<VH3+T*%)TCL+,J(&_AIZJ-5T]]%UPC#^.UG_+8&B1AVOQN[+]LWXC3@
ML!499DS"<4^P@*!/ CN.XX 0&L,.1J:LD&'Y%D2$&):_&\NOE$^.:)HE<6A3
M/^8V245F)SR([<B+0C=),T$2?O0B"?>&YP\ANF.Q9- OXX&P?.?1*P:I)5D)
MV3$9F/==FG:?$-MH@P#Z(A'"Q0(;Q ^SQ$F]A(=!$/$L)7&L\S-OKP2:_,S'
M.DI6JPT1QB(X27P[86YDDP!$2$IX",*D2-$E[D;" ^G1Z03^#@SFN^"L_<A=
M-[AZD+BZ!:Q&+HTII3P+W91DH&V+Q E32MV$>DX<1)MAU:!I6]!TI>NZ&SMA
MXCLV2.@.=EUW[1@+?,<);&Q A1.%,9K>R:[K?1A$-8AZ\(@:,C^*DTPX+DT)
M$4DLHC047B)"CSIQ(AX,40UH;@.:RP;,+&2.H &SLS1,;4(HL>,X\6PJ?)IA
M9FL<AD<ODAU7?C.(:1#S:2+F-KI]$" <>@ES." FC6*:^!EPG<-<QXT"8G3[
M/0+693.Q[]($SD-F,YIPFX0,2X9DU Y\SD,?1-$0DP#C3A+<IZQ\"V#U&^9C
MGM?#@DYP?N)F)#97WO5*LP6/?J79@D>_TFS!HU\IM^#'$86C!_[E^><7\FQ#
MJ2<?C&5T_KI/X,+FJ7-G#Q,@*U5:CGOQK[3Z\<7T7)2/EC^^LY#GH9"WI/LT
M@U%RDNO0-$V(%R>4DI#"KSQC(.EQ$*Q($KI_Q_'1=YQ!M'8&Y^5(6&[RW+*T
MO'H^[L.3V** *C+?SX1@G&8A$=Q+ S_)>,0=X7AIQ&(9G^ U78\\):DNBJ0@
M@O;S41^VLCX>\!.Y[5=BP')1G^8U*\IZ7(E+>.//1<D^/;*H^?9$BYK]E\Y?
MEZ_Z?W[\[>O;UW#=Q_<?STX_Y.?]EY.W?_PV^?/KJT]_G9[#][V/(#86XM_O
M00SDP]0CX9^7[XNS/_[*ST_/"(QI<O[Z[/K\CS?>GY=O@K].?_EX]L?[3V?>
M7_G;U^?9V5<V.;OZ.T[CQ,FP7D1&/,R,)';"X#<*5":BA*5^0I3J "PC^#$*
M[#2.O,@+:.P&A,2<)"P*72\B7D@]Q_'9D25 ?A\B1U5CX,^Y?;#H@%L+.]$(
MH)H(-K'9.AY<XF6U?]\>W.)D0IIY1 !542*(SQ/J^)&7D4 (3J+8RXX>EE/D
M$Y_G(X ==@ON_U5<T<)Z5Y4@>Z/T7&^Q7,M(EP\X;,ES/Y0FAL? ,LR6LD;P
M1&M4RG\[UK6P:(5)(I_+XK/@\(OUF59Y.:ZM0LY].)M[Q^J7]0B#*JY[.>O)
M&T%#@<T55I&/\BM)%AU\!FBDU@ 5S@*V?US5 N]*QS5<6M==A:EOQY4%4Z)7
M DD5M!B8Z* <6:DH<O$9QMBC(_F@2H :,Y8D!T_!3\:#6HQ&!8QW99#JMN5I
M7>>C'OPH"JM'X=$47@SG30ZW4@X:#XPO[P]!([/P'3"N+!]08!=\=%GGZM45
M#F1<C&1823D4E2JST]UVU[_W\;8ER;_-,KL)H;GH"3&RCJN*#M0NK=+_HY'X
M^L-NPW']F++#ZL\WWV 0R9:*4*\JH&MD5US:_B#/)I(^RRS+&="MQ'>>5X*-
M2O@+V1H>W*=?\OZX;\&6(&<!J<)Y,(+GC.$AE74J"GJ-[ '_R <L/)Z-:]#X
MY;/E ^$U(PHLG8.P4!3PHK%B.'CJ:()\-,)K@3M*F7S6?% ):9O")]2T$(II
M8.1P)Q^S40,"EW /,!]R_G3810[#14[$N30#TPF?BKW[= (P >_X[QCFWLP+
M+J_UDDE:[;:*&(Z+4:\<7_5P;QF\'A;B<\Z1"F"A03)"AIO;^0% 8(7)>YBZ
MRCM(+ "1^+7X,H1=4)L&WW9@"R<S/"MRFN: QA,T^"VOWBI6[04D+0DP>WP"
MOQU8OU"0GZJ)%<J01$\=P4P3\@50?J^VSN L8[3H6I?E2"+$H 9240>.W%?D
M#'F3/IR $HHQAW%2.+"0Z9$4!*T&-IS/UI!.Y!$++/B/;9H?!Z#81 EQ(X\2
MEKI)+&)*'3=,4L+\U-,J 5E0">:,UT&C(.1LG#^?;N)H83I755G7M[-.AX>F
M,EP>^^?'?P<\CDCH@LK@1I%-G"2S4Y]&=B(B%K@N ]$9JU([3M?9X+D#0BX4
ME0#RU#TMD5])DE#R#@.5H41N ,4,"*L' AA< -34H#_(4: P:.(&0@6(JD!R
M Q2#<TC53EODO1LU?\T3) "F:02LY_+$R#^+GZYS/NHU7NFYN[3)VYG=0E,I
M&6Z^99.)X7OSO1\NK<[<SU[5C&8(*VJGE:"?;)K!8)_3XII.ZJ,?%^;4SP?-
MPP,";V_/W->+9&].?K?.7IZ^.3G^M6.].3_I6L?GI];%[S]?O#E]<_S^S<N+
MFU&[!5,X?WOY\L*Z?&N=O#T_?7E^\?(4?[MX^^N;T^-+^./5F_/C\Y,WQ[]:
M%Y?PP=G+\\L+Z]E)H_C^L&[SUVK3W]2.E[1I)\&:*RSQ7!$2FG'JQBGQ?#_&
MX@NI2!Y8F[Z1YO&,0J,/ @D'\00E%I%+(1&_&O7RBJ/<F $ @79&!X,<53$\
M&^&@TG<"L4S#^!68Z5A^.#CQ*:(&/58*FAG-*]!=B[%HM,0YF)L>A2!I;G,$
M,EA*)PF9XS)!T*9!0A%%B1.ZKL_<5(5DKYY\9-DT]K.6[$_*?@JJ);YV=AZ>
MS)^'OS;RFSD3UY^)\-WUWS1S@.Q98A.>AC::6NW8#0,;=B:*0N+'7DR.7GAA
M=]7ANG@D/JN%L*2%-'ENO4(2^B!)Z$Q0M%9*/>*'7:GX+1-&WU4YBI(EJ%+R
ML-=":,?BXPH_P(B$SI)(BC5318XF%6K] 4R%U_TJ4.530@#RW:O38Z#=HBBO
MY6-1[JA19=$&G,4'RGI0T4^U]99^XD#2'>LL'P"K@. +^\$D*X <#(]=>AW+
M1SA6"G++E=8] 5*DF0J@H(#-4^IKV1\6$V4 @H']L[;Z>B8<9!R&2N2PK) 3
M&W5R9CC=]!PZ'(+B@IX/2]X+_-M@SF^@':/R=3&I1Z)OO1=7&*.!JI=UK%2^
M>EZ&G\$7*^O1@M:,7V>Y*+@%VRM'RLH*%7TLZJ*1ZYK*(K;H\^>-P@R*^6!^
M.ZU4&W-J:<Q9V8#&7$=E4=QM=80XY+$+2\&],"$DBR@%?2$(DB +10#HJ0'2
M=<+UJD$#D.^466"*?L>,5;"4&-52#F!#5,E>@XGK,?&*G!W_[8"^YB=.8,?$
M"VR2^@1^BP BP]3UA$=HX ,F!L&W,%%Q6PY[+I5(3:$S.D.B2VFM*(XB4:=Z
MTV;JP?2NZ5&LJ%N3)!J%I %746Q::-NQ>C55-B9UCX2GJ1U$6G6Y !)'\+3&
M0TWT-0.R;UYV75:?K '@5"V%"7B"TFAP#I(=2_B4%2 3J#S! 7+?N$!#6I;-
M UE9Y5=P6L\608UO3N;X!G].UXR.%A(1O6WE$,(\4 ,3)V8)!383B1O$D<^R
M)*(\YH&[00XQ;+9+-OOXQCF[_EMPEV8^"6V*FCA(Y;X=9ZX 240D7NQ0)@0%
M-O.[F^)H&S;;:T/6J1(1SLO/HI\"SRA98=Z41:T:J*5 4H(;40C(QO+LJ^71
M6%OU&(]143V E6L\1*[?AL$<+%&9$=<+(X=D/$D3W\TX "E\3DA C:WKH9GK
MMR]G5]AQ):%^%MN@7J5P<@5PA@4BL%F<>2*,@T"XP%Q>=U/C)<U;'45,M13K
M@!Z>Y3^@+0MM7W>UA2:NZV0TRH(X(#RFJ>NG3IID6182EXIOVD+##?2QH/N]
M1OJXN#04LH%"7* 0X;H,[@SL($'0385OIY2XML.].!0>'(=.>O3"_:8M=-$&
MJI!&"@D-=326SPH^&X!&.*+5E0"!9 I,@X'TA,F:HA8()$AKIR!U2#ST77W0
M@W31 0EA",+&2!23#M#BHQ/C)K!:)<9?#3%N(,;?@[>__0WD%GDNMH@+D1BI
MX]@T8YZ=I:E#*$]C/\R0&+\!5TO$V%">=I7:C5(X+[UBE/:TTP](T'@#ZGH3
MZXQ.+$\YE\@C6\\\D$]#ER>A3QAH(5'L^D&<Q7Z$))M0<5NIU5C/=D:VS#V_
M!DV1.9PGW,ZR.+1)[/@V#8AOPYYP&D8$&QXBV6[*G;VG\6P/Y=SC\=6X'LVD
M7.F,D.%2J%T.9D$'RD $NE03[X!A$Y6B6;0Y@4Q2Y>E81FM<8^P#<*P,:9C[
M!A18U$8Q%@JM3@+65SYU7*.M!N3J(9 Q,+\%3ZYRB0=X*%%X$(S"G@"[-L>2
M"H;"N"<XH/#N"S$<325VHO19>$Q_:L":S41+VWA6K8$"?72I)ZR[H.ZA](^3
M$%\P.&L[?3?UF?!\G@6"D"AAL9]PED2,A<)-8R=:&XUJQ/$=1JN^_'KVV]^^
MRP&P01P7:0J''!;!HIYP;)$Y-$J#@/+ /WH1?DO8ZNB 04F(J9 T(@V3VHBT
M2=0J,00&R/I:%)^%W8==[%G]&;8T1,X%4G!S_B$1]X"#X6R3KB6I"@@VEG:9
M_XYI)<.3T.&-\22H'S1O*1=8IX91*/U!B8<+KJP59D$CDH[HX;/(Q7FFSB7W
M2C-R+NU.DJ=SG.;4_E7/(IEFSW[D0SR,A7#\"#V2/A', \[D'D7S(C"UGVQR
M@9E#_.%X\_<O;X__QJ99H/@DV)08>),'F9UZJ#E'"3 K _V99:@JAVWR@+4G
MHFP:(G^+L)6]F-+Z@()O!@@L!11XPG6 LWD01A&!(YA2+XR!T[,X#EE&Q>:@
MUG79/VJI'D-N6[\:WY[='TWX93FP&<)T(=U\.MP;X+\ MI@/,E527!-PCJ^L
ME/^BF#3 KAP>(#!-#SKUD$;[I[H=Y8P3P^?6KWB)9+SE9;6V%*AOEZF4N"W)
M5/*<YYM([#MD,!6PWV4EX]#FPMY;E[X4G#69\OT/G\X^_IS_>?G[Y.WK/Z_A
M\"'G'S_T_OH#!+C7<)C H?'GUY][;T]_<Y</G;_@4#I[_4OO_/(-^0N><7YZ
MY9W_\:KX\_+L^L^OO8]_]>'@>?V2G)]^R,XN/[EGQW^3A%$F2 ":8^#;A$:)
MG8(N:6=.+)CC$J"Q>!E2(JR#GL1<."0E@1_'#O&C1 1I$@(P9=EJ^M+<)DC!
M2K4U64Q#N',6TZ/%0ZV'I&^NSD; ?3NP7HFTDL'$/@J$;K2JFX)4:YW1P3A#
M4*I4/ :W+M#U,K&.9RCV[.CLXK@^^F&JE*+)_%T&TZN4V-Z?/D3M2:T> 3JI
ME&,;9-,)"](QVX3Z*^UT,'4I9["O2M1&N5V'5*#.;*O<I$80+X<JXK]4B0Q<
MOE>:3Z_%C8/2X_[VF-0 0%;&(6$L&KS&PG?7VLD\)__K.SL6R+?E[0>M%&1<
MW&G$OZ ,3;^8/B$?TQ_K\R(5 P%Z?2Z#,G 3:QV(DI9H5% BO7P4GC7*,_ZQ
MA$N+B<ZDDAJ0O%JO =[]YN3W19^^7B89N[NLFRFS-N[L$#4=WM&*2S8NUKGH
M:-$XZFE=ES#T49-MI1)1IOO3L7C)QDAL.DML2-DG>M50Y()!LYGJ-%?$FHN;
M5X9U[6SL8R  EX866!?U8C7SSI22K\4F.KF10&!YU9-T4 *^2O&*-HR@BY/U
M$)*:<)V&FA950R2%@=1SE[T#9'[ _T3E+T=+;X5>S4('3,VH?]2K9/[(\E."
MK@9(-9AZ?C3U'-7,QBW=8;/YP/6X@ 5HWP5>KU<'?EM=#.V_:%9N[I6E2N>;
M0QJ$P%K> '<H<II>.4^"FIDX#DW%F>O/1SFJZ@H]YIPMM0:"S[-Q@/8O4X>&
MXPJ&5(O%6"Y\PI)17='4%#_=1J$66=:$<"BE>X'JX )))#@#? ,P:*?A-/$%
MC0R2*G24A74,4QIP&-8SW(*CY8\!;?5JP.[,Z%4_;XYFZQG1YFH) 79O(EY%
MLBO#F/K/9<C,=)>Q,(RV3^H'Z%?4X_2C3C5JWB;!3AD[<FD]452F8F@&ZCG?
M?#U=W:^9#61;9]C.0F/T4&:JX7O1ARG#),_4:%5PC/H>-GHOK!./("A>?0%!
MT875S[+8MP.:I#:)*+&3)/5L&KLDH($7!PF(>E[R3?,$4I;X,LR1"^#/:<!)
M8P-KK&-G%+9OZG;5>73 -$!3=99+HYRXB>SF36_+E/O]E#"RJH1]PT]R>*DT
MT?=+I=DXPRQ[L!FJDEP<(P<EJ3V7=(E7P9AH:\9B]2J$W__Y-E%'1R\NE1$E
MDZ4HE/Y&7ZS;QD<R/=RTYF\PCAM@!M4H7:M@&K..=H%Q73<X=0Q'Z*3.)1Z]
MFE80.&G.17G-^UD-@;?3&@(MT5!;E2^]2>U%T6*679 /U"$L PM[TF\J$\,I
M5]Z6P<?Q0,?*-TH)RBEB4,N8^X$LD*=C>9L-JT%%F<L"H R=-G0PP?<-2A1B
M9<@\[/,K>+?E.O9O'107KP4H0U1)5W3,\]&M7]%$>*BG-Q%&68XRA-1'+:7G
M+(O^[DRFSY54>JP$Y?<RJ0$/S&:(_]GDAV_+OK9\>'_T!(BAM5IIN?DJ<:0S
MIVLA+GC.3]>B(W]S?VH^&=?33W"[]:>P7\VG@*5"IN+(9$F5F-&QW@Q8UWIV
M!)^!JH WHK<0A'+0P7-:Y:)>V?YM:'L\*$1=-\)THS'5*I?F.J]%6ZH%W&@S
M;MR*UMO/&(8OKELRZ(W>F_73>"]0J (&!QV\'*XOM;)/<3.KA0YDW0OT?HN1
MEL;G0[M7TY+@'L?Z%4N!H,7B:/';HQ\4W_7*0MKH-$+//>9U58Z'UK!@_ZRM
MJZ),X8E+B5_3<D36A0#M_'@VFOH(BQ"5U\KT,-..N0 =&%/@KF@E7[L\BU$%
M2Z;4F.Y*FE4-('XE;70ZXXK/-KNS:J*B2F*J)VA+49_1?MH$ $ZCZ=5DZH[U
MF8(L4L!1 >>5K"&#=WS.960]F@NGMIP&Q'IE/<2O.Q8 0H75-28=^%#K][30
M<4N?A;H?$W8PO:YK8>&FF_<.4X3J$4:\7N5,(=> 5=*CI<HKE2 VJ6FBEFSE
M<^D!B#YT.-&;ABEWRCXIIH6A=#Q33T91Z.H%0S'*Y5BG]9HHVAD*$ 2D!1M3
M YMZ,F,8VJ2[Y3FT'VRG@K&F 1:X-7BB2)O_XA:EE:J655X)E3MY7<JP&32+
M2BZ5IMIJ,C4)X6$'<E=>JG1(V,V1B@V;;S8O/30R] TSJ>0;QJ.\@!E,J7YE
MHUGC. 7E&G1M25[BBP[>7WG[S(KTYH/5U 4#:L>_^A1DGN&X/]1.B:$T#<Y*
MC"F^RL1H G=F(UD#:218;P"[<P7$S^7:2!O>@$L7\.P3?+[0XMI "%Z(K!)R
MW -=? G&!,JQ<O;V1#$$O!$CB\$FJ=-<OQD?@!EJ&0+,54D+X*@W@RG,=%;L
MU6/0U.40ACT*HBZ;X%APV;$X-*Y1DU"CBIPUCYZ?&#HOX0'-A1*F4.#0X"%Q
M#G9Q2*<>(LK15E*/Y"9:/?H5$ ^+PL&K>36^TO#"$ <IL_KE .,0YP<C;:Y5
M+FM) TTARPZ!)F5=)IWE=Q."I%4)G#O0MOU5*AA-"6$30DHZZ$B3\; G;>JX
M;!2H#@/ .E96C'-,9L3(L2LMA0,@5NKN*:S60+T,XSGQBG<?3G#Q6$^4L"D3
M:S1.\9KY'.29"?9I)HV_FJI>R,Q+NS:WIW.E!:7321K[12UDQ)=2;Z9/:K97
M.@QDC*MFAIEKX@KI?N&ZY\ U&DE4LG5M+XZF8WUHCL1C>23:RZ.%'?T@#\@3
M&*B]7'M)2@7:% @2@8:O2AJ%\5"1GA5TCJ&!0+D3BUS51U0TF_?G\'-15I<N
M0)S&4R63MW,K,%=1#O$,O20*]!L)!,N>@20G4.:I)#^ELS1=A,]Z020!EH<U
MMS)5'2"77#K&>I1U<[F68WH";NE-Q1]TONJ2>04PK"W==?++V:.ZUA^-G6!*
MA&OD&Q2' -'F"]KAMO;+2M:M'%B)@SG%@Y'4TK3G#H,O=7YRP;O6$]WYS?89
MX)4Y85H&SJLH=RJ56A#@D#(:Z\=4L:M%XP-"KGN'9_P;..^1Z]R&V3:;/:;/
MN]&,(B6#VYB/Z B4Z0+[*.SM[FT95[@8/7*B'+Y[+23/.'Q1!%ESH"U4Y!R
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M59EH,O^+564]5X5;52['^M[*2#2%15D.?-0XZ#%P;:1@:V\3$;?$I0O=V=:
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MD+D/BVD''8N/96#^[-5L7 /4B,KBHH\OAGLP4OJJ*%-:P.-EY44UB4[S:3G
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M5!C//4R\H>MY$YRN'_@1[,8%L,Q63MZ,LU8E'OM?3M1//">T;D N1D<9CET
MP:KAUR;*^H"B*\U:S5K-6LU:392UB;(V4=8F+''/ &?"$DU88A7"$@T[,^S,
ML#/#SO8/>,<:9;VB_\_<%!_13?'%Q:%?%!L\/@8\-L$[!I4/!)4/GR6;V!W#
M$PQ/6"N@K],]=*9@$/D8$-GH:0:5#P25CX G&T5M;I#U2K'4%0HY7>S\._"(
MT_V(+MV/(%)\DFHF+X\?-7&1^Q0/9=9JUFK6:M9JXB)-7*2)BS2!1'L&.!-(
M9 *)JA!(9-B986>&G1EVMG_ .]JXR*4N+7.O<T3W.MW+>N.PKW4,'A\#'INK
M=H/*!X+*A\^2S4V[X0F&)ZP5?M.ZJ'</FRD81#X&1#9ZFD'E T'E(^#)1E&;
M&Q*Y).IQCV(EYSD$39BD"9-<+4SRKV$0P>E3%&.D5KD+?+8J K]YB[2;K^?7
M]?P4A(S%LR$W&%/"#ZD2LH1%>'-6LT8$?8XAC2Q 5V$UK^I7K^F1UF6]_;J&
M"#L5?2QJ[3W5+3535 Q@67>>5J/>D?-T8<;B/,@&!J(?"B<22&3Y$8:Y_>(@
MI>M)J^;6+ =H*IA,@2X'BKXC9R(DP2HRGL(?(;&?FO4 KPQ"6(Z/9+B4<]5@
MC*''I!P"O081\BS> +$)+*ZJ$W.-ULU, A C&0+W24+D2U@1/)S2-))+Y)C
MP(W"A+Z.ZH5%%, TGPO=OO]M!IC%ZL.XO!PGEK#"-0&@L&@LK E7-P60X\)A
MP?"RY\; MKA@,PT"K'F0].-S*HX.\ _%!)9+H*KQS BL4/2#D9]"EXXC"6'+
M$4*^CT( YW@(W5B<)U-\QO7A=&!+3\P80R(5&BUB#%IT) ,&-F&J'Z!<>;)<
MP) ^+A$/2XT'_!D>=Q!O/0]^UBP/Y _#!P5.Z#I>I&;]"K"#OV&L8#B,1$QK
MCC5DCA!B^6.:(T,0 ?%S7A2++[5\0'C'$R3>QK!(0B$<C"1",D$AN:\2X0Z@
M#$"K67\5/LA&C^!\,YBXOHNR#AF$=8JV8+-Q???7_W8FT^L;^M.^/K,^/@(N
M I"?69+,W5*U9<N:RYXG;78IIE>N8*U0(T6)9;6KU4YD1@4:(YTR<^/$Y&OL
M5YRV6:M9JUFK6:O)US#Y&B9?PP0X[QG@3("S"7"N0H"S86>&G1EV9MC9_@'O
M6/,UE O,I&<<98Q)!TS>PXXQ,8A\#(A\T:I?&3PV>+SO>'S9KE\>-AYG;KXM
MQOR5XG3E#M>VVU64MCN Q&N3JF(XY&;[;MG-0\]?,XA\#(ALM[OUED%D@\A[
MC\C=3A75&J.T;DEI;5613>U<:5U4R?RE QZ7!6%6-3\HC;\4*OXRBUU>%+[/
MNYN74[ LD#^:C>3/<A96SQ;(HL2#H?7JLE7OJ,A1>OT5MC1HJ8_RJ0LR<8#C
M]K7P;1G27HC7UU(*ZI8*5=6F5R'S,%;A37C&2V#I->M5\[)NI^N#>2+'<T)7
M</!]3_ABZ,;\QZM6J][5'QU@"E6?8_'I"6<2 %'^R1_(HRN<UWS T0AS$5.B
M1QN#7J<!;_HM;1  E\6Z8AR6]I:,E&UDKV!ZA)?$\U\I"]G=!0FT.WE8Z/\?
MA]D-^DB<]^"\?YP[0UCL6\=[<)ZBDS?YJ&375X-WVC![<>]S=S@</ML.F:,/
M1#_@%+:W("9$B$_!FIS*K,4"K!W^Y>2_7+OA]'I7[>;EE>.TNP[\.ACV.XWN
M %YK7W7M_UR<_/*=0KN!,M[#A)A:^#]OG%_*CG%G N$5\)[FBN3>N:Q?;D[N
MB[ED?3ZEKY?86I7$DV\B G'1'Q-@/@A@YL&4LBQ5MLDWDF@?5+)));(5JP&Z
M8MI-5?-<RE>_UWDN$BE-FLNQA[>;M9JUFK6:M9HT%Y/F8M)<3%SXG@'.Q(6;
MN/ 7!IY)<S'LS+"S*@'.L#.3YK+VW:WT@)DLEV,,4&DV#[V0JL'C8\!CVZZW
M#1X;/#X /&X>-AX?<;S@U645#W?GX8*&01H&N?*^VUTCZ T>[S\>@^%E&SPV
M>+SW>-RN8@J$45BW9(TTJIA0NG.-U22X_/RZ5>#EFODM<]ME;)#:HK5AT!).
MEC3863\;AK)8_+07!^>=6*^NLA08CC9OVED>2C$I9GXB2Q&.]9E/5*L&H)]Q
M"HQLZSPTCHS0@S>R\'8UJXR*ST:$[U6[!37;- Q^A_7N:]N$;R**PT2V$*E9
M=]@J08S<OO5=ZVR$,+GUX7-.DIAIE[!?6ZYBW';A&*+T&.+",;C:,:1H29UQ
M7MDS^6;MBWH[_63]YC=Y4BRPF5<M+4>$9NMJ.6)K3F87^_CL:>N+W#%BWYUP
M5!DJV4B:EFY(X5O]HH!N]:L-$* 4V>@-FD:3 )$ S<CQ^T)US?FW(!KHQ_CM
MU'FR$G_JN,B_RU;M4%IF/O-0MFB2/=LX/VG1GAM:RB1ND63+.H@^3TR\](%;
M<TEL]U1TMQ;WVV?R6F^GBN[L(N=M-S7.OWT^?U'D\QM/-L/G,5]I36$GM;IU
MMLB *ZI^M#W,B%JH^5H/8[<_UEY.-5E/C.!KM:Z:U7/\']90R(Q*,9EZP9-0
MO.KG-KID>XX7!=FZ'.LWW\7M_1U>'P03F!=452MV'E\(WO8">.M3$&0 WZ(
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MR0J:%/&:(>I!9$C1<.1NO'=<C[MR<Z=N6>DF%/>!=T^6%X\_=/HN]8;%53H
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MW)=0#A64%441+O-%%Q%& #@/MBS>6<EW:O2A'R6@^3X(^!2H;"#^P(E@SHD
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M/P/*0P'#'<G"GR.F(?W;*V+ZY,;]\4;G7]CL1J2T'& 5Q)1W[]Z\>_?N?!M
MVX\-;X,T]E#.W*%5XX0#B^J>65^#(-R]U-DOS"%2V0;(]F.[\PAEIH#D0?@%
M2QUQ,F4YTM)\^\&]@-]5WMP4#@S=V]*BUWTRRN4RUV-0M^ZFHN\.\<#1V?7
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M!&@VWEKOL3!]CUJMW?/+7ZB=X8W>P'$;;0*T+6C-6,[JULUL'V;JF#%V@&?
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MY""91OT@PJ<]+^CK_0>YN2/Y*[CUX)!;#S[QZI8AT-Q- \""A*C,81NK%_A
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M^HF*:AV"Z*0V)BA#73#I!B("(=G#!A-@C*>EQ[.&,+X2PU2CW(E118 )J(L
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M *=BE<R:?SITACFW9P\6KM^PJ&8H0#>9$0XZ7#*K-BH<E/"@L;%-5N#C2S7
M7/IZ$&"W"HN!PMZI;#TP<H\<%[!9^$!A*GTAT2YD>J*M/4F2A=$1OQ .'@",
MWZO- .GMEC3"4J_M1?,EO+8K,VN@NNX.+S,+]Q_M.KE9Y!%R'ZIK=:(!LT7
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M[;?T?'S:[X]/3OSV\=GI:=OKNL?MTQ/OM-T[/NYUP=E)#_B]7Z;G8,Q_],]
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M8Q$T"\G7LU&"U^UX;F'C)8,I8^KDN#82JUL((A@9^&=Y J5[)@)AA7500MU
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M>J5YXA:O.ZUY.6MF#5Q;EO6IR8)20:]>19[VB@=!*D!IWKJQK%>-K*:*@=H
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M"Z(#G!#0%A*<L.%P)E=.G\"K_O[3FD YS9STW&*2S/2&JR1O4L@]UVM?DIO
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MR_^MK9$?5HO\&9R#SS_]!U!+ P04    "  [G A5XI-9ORP9  !:\0  %0
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MA+EL)/HT@D(;.W0]IFTH(A\#12JII1I-7J2<\/;Q%49$1^D#?#F++2TGD+V
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MQD3G$K/!>Z:EL,P[[9FR5DD(3D%2__?97R'27TP %E%KIG7RS MK6'*@"_#
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MS\FEOD<0<=1]=7 Q8V< GP;OY_2)]5"C5>-K^N-L$+7+%G1FUKK(=%">0<'
M1 S:EF1X5O8V6V8K]A68Q8XORT<0;Z3X 4?SV>HK54V"<;'<@O_'=BP+!3U\
M=2]F,Q+1BSB;3R'-!R*  FTYBUS1RKPVS,NL& ]@1,X*E35-5G83Q\U571'O
MQ72UON5;^\#7NMHBO6IY/NE-K O-$?SOOYM,,T[_]CWO1\DO+Z936N E*.7
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M-+"1;^7ZKJ.L"3^!RGE%'AP=RW2P)LE")HL>G0HR<RE#(_OE'F G2I0^U='
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M;,DRJ2.K,[9-?IQ4*JX/.AY1H<=I"-+!ZV+W@\@3H:HIPE)C=$)YYBU9QJ*
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M]4T=D:,TM% R]35BC?1KQX*N/>L3^F),C6#N5GJ[V_.>O98;B+7'WF0=Q'_
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M)!I["YX)72\_";+\LQ:M:DH:K&;?[:^2\Z)6#] +:?>G9R\F]#VM'OYE3L?
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MO,A)<5T6^#HI;NA)<;UH-?K4K'TX\2(GQ3FC&48F@9G@0*42P7NL5ZV"H3-
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M'T$9B:C,0?6L$4NVM'LU.6T>8SG;(,2!8F\0HWJ(Z!TN\Y?9?/*_JX_A9G!
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M:_MEQBT@KW&P$",&$IYE(SOI=^".?S-C2%)TM7CW5,Z8?M&]$&H7B$T3E1U
M'B=?.;B"NQ+H0.T<BTA69<E-O3Y7:W:8E."D"V"YR34XD%D>.4YZY%SF2?"G
MAU(:\.8#3M/;J\EEFDR_U!&G[[]]G\_^6L]UOTZX9!X<DUQ#9+4!F2D2T/$
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M:(_(ZL^"WZM%WQM1%O>-:F^6CZ18S"0E.$0"P83A3"V]> *I3 147R<>1FE
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MW6>#D#A# 0X#B_+SGM4S(J;Q2]"W!H)]"Q4I;6T$&R/!GI5@9^956_N\(M_
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M9JS[:K?W_[,N5G8C?RN;A@\WM"+%0O>!>*OY97&OEY5-?\2F8?RV*-$,R3Q
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MP,)#LYD0 [=V()@'YLG)(&SA%P^$]$B^LD?$[9QH!]@Z'6N;\<9SMAVL/'#
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M>.$V53*3&',1*%<ES[2_DJ60I$3 /$O3.$.89O%P<<*IIKM>B%'9)[.ZS<T
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MZC+J]L<EW;#S>TK24H=Q#T>Z 71T)M)Q&,=-%*(>,R9N'X2H/BR;ON6;E7Q
M:8I0IA9.6*80!9& >9(R*'@H0DQS1+!5&:/SHJ9&<AM-0:TJ:'5U/"W0@;#A
MCH(7W(;>!'"$S#Y>?Q$-OR'V\^+&C8I?-/LHD'WY#L>R:6*N_GK_BU@HBII?
M+_@U?RP6A:XMJ:M;;,X5SM)4,B05J&E*A7*<0@J5*T6A0*%$'!$2(*OS1F9B
MIT8E&ZVOP'VC=YT_1PXTMRQ'9H:^&;7XQW3H\$X+YR][<!XJW9XQ]UCNRPHE
MO]6[S$2/6XS+"HZCVEIV=[M1U"<U!V*U$DUW^KHT=GF]KAZ6J^*?@L]B3!AG
M0G%1ACE$7&20Q#S6E:R3A&0<\8#:4%.WN*E1TNOEXHM8575E@*=6<U!JU:\
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MY$Q(2D022X+LEI:G!4V-$#8KHHVR5TVE$@4I:!6V74Z>P==T(=D?M7&6D Z
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M.&0!S()<0"1D"BD+"8S3 ).<A#B.,Y=RV79J3.VSL"V2O&?&%=@9HNL>-Z:
MK2V@-<:M'K;EO)EY]\//QL"?D&$FPKGLM!N.@U21ME3E18I"N\%UKL:SXVBN
M09GF*.K[!5L^BCORK4GW^BBJF1"<Q4G(H1",0X2B!)*8JN]ND,D(HS1FPC+
M<D[4U&BQU10TJ@*E:Y.(:)D,WP&N:=3"!V2#1R#.H74%E*8^8PB7T/ <#S@K
M;N2U_26SC]?I%^]P6'/_HA;UZNV[>R"+*$ONEF$0M$N/F,@DP3F,XCA5:VQ&
M8?[_<_=NS8WK6+K@7^'#F>A=$48U2((@<.;)>:OR3&8Z.^U=W1W[08&KK=.R
MY)+DW)G]ZP<@)5DWD@ $TNRIJ,CM3)-8:WT@/RX ZU)0""0LE<Z1*"3&SFOL
M1C%C8XF'6M&U5?1Y,9VORV*]2#W6=LV .BR4H\#4,S-L$$HL1$GVU[)(#$!_
MA3!D(=SR]+DO?*. -M!"MPF\2.O93BA:UZ_-=P^W7NVTX&!]VGUUF .U=<B^
MF]&/@^:OUY_8=/D/VU-H(HC."%,8%%3F .DR!U21 A1<0PR1S'3J%.'N*7=L
MI+E5VU8?L#LWAXD>QF-@Z\0JGU3:^[E;KE/AYGOU '#/=!L)6V^_S!.IJ$Z:
MJ^Q!/39/0([=-]_; PLFVG3OF]7J99OV]ZT*)JR&WEN"K@QSY3KG5!KF*FQ=
M,D0 12D"D"E;=%7@0G@QEZO@L5%7I7=2*[[-M*U5OZK?J*O]W1O/I:+S;+B1
M5Q\8]\Q>L>#U+Z3HB57<4HJNPH<MIN@)R4DY1=_[ ZOF;PI03]4V/_&:KZJ"
M.!.M<V,XDD"FA5F2E@("GAMWJRS*7&J9&Z_+JSUFLZBQT=3[W[]___CU/OE\
M<_WNYO/-_<W'N__M6>6^&58W]HD#5L]\LZ?DU>NAX5;1B+6AN]&(6XV^6=RP
MA><[S3ZI,=]]1[2>O-^56#S,;8C*C32"IGIJSRXW/M9F:_UZ+O=4,K\SRWYY
M$'>^]^L)DAH3C#4HA3)N$M44L$)!D):E+"0QG)-YM>080NFQ<=?YIJVO9B?[
M=F^6-;MCL*KJ\IYQR<9X.\!^AL;>)1>W](W_&/D=>([EX1CJ>/2MGXL8C7Q[
MFZB^N_C&5_RM6_CV-A4._7O[DQWH3"_F#[;)G W<^<+6FR#/[^IYT]SE5G\S
M L7TF<UNYK;-RR?S>D]*)4B9%3E C)0 R5( QK$$A$E1VLB:DCKUL;Q(B[%]
MQJJVK%6W1VO&5;(QY->F 9)5V=,C#YH;1V>];\3[]N,O -O?E[\$K+AN?I F
MPZX +@'K9'%PT6#QMTB_JC^KWZPF7!2J$"P%A$@%4$&,XY^1%$BHTC+-,#9_
MB[4_NI,Z-LISV+TSNM<71-P:?9V%R_=%@[!]^TU1!UBC;HF>P#38?NBKY-%L
MAIZ X;,3>GIS0%3.>TN$@LW>LZ7:!$10F#$"BPS0C!3&,2MSP%.) <4(02E0
MP8O<.1SG=/RQ4<]6P\2J&!):<@;"=C:) $S/O-$')AYQ-I=A,U" C2=&?N$U
MS0BTQM6<N6VX@)IFG0\B:5HN"W.S;&E:L]*U__EHUKT_V,PZ=#51WLS%TO8:
M_:#J_^Y.(C*49P7)4\"$C4ZFD .6JQ*D:2%4F6*<^T4GAR@Q.B:TU:+M;E?U
MPYX95QNG(=E:DORVM>4O+F<>\:;-S4WK>S+Z9M^^YL';D;L$R*A^79 B@[IY
MET!U[/5=-%8XB=KZWG<OS\\S57T^9Q^F*S%;K%[,LWVO?J[?&7/_:T*U2+EB
M&N0Y)P A@LS"U3901KR 1'),E?(E3A?!HR1+J_A5LJ]ZLJ=[\H?5/JG4#R!'
MI^EP)\38( ]!@C'P#2(]'["B$YV3\,')S0>2<X3F=7]@A]3-9M[]8G,"LCTW
M439YY597O+I+Z260<&YF(!,I HADV'B &3>\IHM,EY"J+)_,U0-;*WGOT3;5
M0P>GUXW6K]N))OV]>EL3;(N0C:K)JQ555I9-**W>T+!L7J^)<J.XZ+@/5.0M
M)M;^_5<#0(O;C=5'@6%[LP9 <]*I-62,,.J[%N+ER7;W,Q2Q9/-5W>?OM1#;
MMB(ZE!Q!C@!79080ALPVPBI!3BDNL5:BR*"/]^8F=FR^VY[6R4G/I+T:@=?K
M]7+*7]956(AY0;^Q@#HLGC/DQG;Q<>^9Y_J&W)OZ_!",2GJ.H@>E.S\XCHG.
M\^XPBONZF"]M11A[#+)78?+G=#7!4.74UF-)*3:T!B4$#!$,I.(2IH04T.\,
MM5G4V*AL7]/]]^@/JZPG0[4 [,9*<6#KF8D"$?,FF&XPHI)*B[A!B:3;[&/R
M<+@CC#"JS@GO%T_/2_6HYJOI#U57-/ALY\[PTX?%$YO.)R5)408I QK)%*!,
M:L (+@##FG',!"EYYD,>;F+'1B1U#X\#M;<5.;:*)W_4JGO2BN,TN%%,?'![
MIILHN'J3CQ],48G(4?2@I.0'QS%!>=X=V.EXFY=[,W]^6:]LY_99OBU"FA*6
M%QJ!4N:VO1TK >=" I7E J=%1K/"J4"*@ZRQT=)KPOE54FM[E53Z)GG@.JP-
M:#<.B@1?S\1S$7+^O7V[,8G;L+=%WK!=>+L-/VFMZW!+0"C7%\7L;KIUGJJ!
MO[#E?ZGUM^54J(7^/EW]U^9#6T",TIQE &MH2QH7&/"L2$'&(,$"0Z2Q4RU+
M'Z%CHY4]M>N7PP9^6\V32G6[Y6J5]_1XO*:AG6OZ K=GTAD!KAYQ9CW@.U#P
M632<_<+2/ %KC55S'6NX #9/ZPZBVGSO#:T6]<,(6"Q_O1Z>OH8"8.,.%DCF
M &<V,B-'&+ TA2 EDDB-F()^-8K;A(V-S[>Z3B^*NFB%U\TWC 5:SSR]4W,O
MGJ*G< H71"+7=&H1.' AIV[33ZLW.=QSX1)SDR5ZD!VZ(3!Y:S-+-YMQ<[F_
M-_>.K:8K>W_U;;M7XG$^_>>+6GV>SM7-6CVM)K80>BE@":@JL5FG%K;?<JJ
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M Z)3#%2A>9Y1J)GRBKQQ$SLV0FDKTE&K'KWXR?%$N)%-?'A[IIU(R,:J?](
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M\)JNNS":NSUPKXK4>_]H)E[=S'^?+Q6;V;?U;VPZ_[Q8K28YT2DI< EPRCE
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M*F$*<<FP7WQRI\RQ^7<[E:\2JW0RG2<;M7>Q4EO5?0.3N_%WX[_(J/;,=C$
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MX,WZGCN#T];]W'V0T#+ ZMD\+Q]_/JOY2EW/Y5[-JO>;-L"98&F&\AR4&.8
MI2D!G' .$).0,X@%S[RB31QDCHWD-BHGJM:YWM=>5%DZVRIM+*"5N@OZ;F06
M&=.>*6P+YT;="LW#\G?O8S=E]@ H<B7A;KD#EQ1V!N*TMK#[K0'KQ_>+N=T[
M,Z,84U936>VE+>8/2YN_DDNSE,RI (7,,H!RI0"7AI.8+%5J*"GG'JU#VR2-
MC7K$3M?D0-FDTM9C,=4*K\-:,Q9H/7/+,'AYK$)CX3;0<C00/[_UJ0LFK0O5
MU@&&6[&ZV'&P='6Z(5IVYD?ST_K7S=SPE%JM5[8>O)*WRZHN/)^IKR]VZ7RK
MZR2+^K<3EK.,\8*"+!42(*I+0,H2@U+F0D%2\#3WRIF/H];86/E\TF%M6+*U
M+*EU-[.8;&V[2FKK=E4V/#W&2)/LYE0./W4]?QL&F+48.:07@-QW@FF(:F^=
M?7H!G ZIJ9>,'IH;(I9FE.W6P%3MUHH%H65&A>%NC+5QDKGQCS4J05IHF&F(
MF4R=3ELZ)8V-CC>*)K-737VS09HP=:/**$CUS'Y;D/:4[&&AW8E$Y-R/)FD#
MYWUT&'V:\]%U0Q@W?%<_U/Q%V>X_UM5<,K'^]^GZ\?W+:KUX4LN//\7LQ<;Y
MV46[^;^TE75TJK(\SRB016YC1-(4<(0+((A N2X*&R;BPQH!.HR-3S8FU%VM
MMD8D?QHKDJT95\G.D&1KB7]%I)#Y<F.DGF>A9Z[J8P*\J>P""*.27(@>@]+?
M!4 =$^,E0T4\^VT,:$T)3E4A"##^E##+8S-;#)42Z(R510[-GVD1$)7LI833
M>SI\-'+SP62L&&2_J;K@&/A_0,QQ5+3CG (/&F'LI\';GP+[1A2'#7)A)+$1
M.ET]*FE3U(XB656!*<98 (UD"1"!)2"0E" K<L-YG.=Y609%$C?+')M7N!?X
MNE4ZJ;2.%4C< K\;F44&M6<*BX!G>!QQ-T+]Q!&WR'V;..)N(!KCB!UNO;19
MX_4/-IW9C;1/B^4=F^WUK*C;M6=2<Y9K 0S_F,6KR#+ BQ("C,I4("(985Y;
M7LZ2QT9.^ZT$=ZH#O5B"E5%^KRM+9T/W"V?$C:EZP;EGOHH'\05]&AWAZJE1
M8Y?T-^K4Z A*<ZM&UP$"PEJNGY]G4V%'^<*6#].Y68H]W=U^^OYYP>:K2:[R
M$I>D +10'* 28<!RS$ N:$HR;9BM="HZURUJ;(3UJFQ2:YM8=1.K;U(I[!&K
MT8YQ.R/%1:[O/?S!0/.(<(D&WD A+N$@^D6Y..'2&N;2/L)P<2Y.EAP$NKC=
M$>8=UD>NUWQ5;0\Z.AR'-XWHE=Z$'_RQ52VBUW#>YJBNP9&(0;__Y\T[_L@W
M7.7WZ*V6:QN[M5K,IK)BIYNU>EIM^CE*6L(,2V@_VA0@+#C@4D&@2,DQ9;R
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M)?Q\P#@IW^=U<V \2C78%[5^7,BZPG$5^/+:ZZ!D@K(<:H,W-<Z/% J0(BV
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M(3GC!!"&#%<416D<AY0!Q77."268:J^E1X.<L7%$K6;R&D,7&H'8A*L;2T1
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MVF7J1"%XAZEYY,%VESJ-V]]9ZKXXT%NL<N&V(;082E+D3(%"IA0@56+ 2\0
MEZ2$!8)*V4:J[LDE!Z-[O>2#Y8B\__W[]X]?[Y/KN[N/]Y[I:(?@.7I.H9#T
M[>MLFEK$#R$^9W!<=^1 PK .Q#GC3C[Y9R^Z^$3\JUK_C4WG]O#)N@T?U&KZ
M,*^.J9;_]L)F4_W+. [OV>KQTVSQY]^5?+"ME>K3),[,JXPQT#S5 *6" H[-
M"X\U1$P4F>)<!)Z4!RLU-A=@_U#7&)58J[9'N%4]'FM$8JU(:C-.LIB^L:I;
MS!^U?>&GZ^'S['WJ/LCL#7@:W^_$77)2?S'2?9W@AROV5B?[%T/9<N)_^=AA
M-/]9F6^&NGU62V8K"3<6:)E( 07D H,T1]PNR@B@BFN0I8;(49I1@J$/E;L*
M'AM=UWI?)3O-NRH_^=&Q\WRX46X?*/=,JRX OQ9_BL>9OE!%Y45GX8-RGR\D
MQ_SF?7\8AWV8KMC#P]*6&JFVLKZK'VK^HNJ 0%04G.""@)0A"9#,!2 $*B R
MC12AL! <^?!6F["Q<=6AKC9)=J-M6"!F*\YN?!0+O;XWG(*!\Z8=%T2B4DVK
MP$'IQ<7T8TIQNB<\8*'J-F]\L4F:4H8UR@#4-M.>* 8XQ05(,84*YTQRY;5R
MW1]\;#2QU6WJVWCV +%,Y!BG2 &*60&0T 6@""(@I:VE5Y*<B-QG2R\8L2%V
M]*R,"[!R(\M0!'HFQYU:5W;9&S=BX]C<Z+$:.P&#1VD<FW8N/N/DF@M3X6YU
M77ASRF;?%JMI5<)D&V$H<JFDT!DH2TP-PS$.&#=_E7D)42E@)J'7@LY%Z-B8
M;Z>S_<3OM$ZV:@>'=CI-@!L)Q(:U9W*(@&AX*IT#1/UDU+4)?IO$.@<H&O/K
M7.X-(Z:FO)9/BZ6:/LSKDPOQZW[)YJLZX?IZ+JN_S2I_;[M%=KV<KFSOF9>E
MK<U4G5$:UKS5]^SGI"!(X*)40-5M$8H"$)YCH#)<XC)#FC"O"/4!=!X;+9[+
M+=ML;->V7R4;ZY.M^<F>_56#NST$#G;&-S D-0Z;H_S*D[",8<#P8]HAGB@W
MHA[9<](SSW>F'[[)(^+]Z1APTJ)^>8;0>] /UX 3<?S=&U)TOX<TU[9L6]7@
MUQ@Q2756()5R( N2 I07*:"4"Y"JE*58%;Q(O;8P@K08VZ?-^_AF4PNO;GYM
M#.KG..=PYN*>[03/QZ@.>JZ<)Z*WDY^S0+[),="A)J,\$SH+5N@!T?G!PLBT
MKA[R1:T?%_(U)^9ZLZFLWB]6ZXEDDA6P*$$**0$H$PIPF6' J,ZR3*4P@U[5
M@AQDCHTH-Q5P:IV35Z6ODIW:B=7;CP]=P'=CO\B0]LQU%Z/I36H>^$2E,!>Y
M@Q*6!Q#'].1SJQ\9B8U3.?GR'U\GA>!EFDH%I#1X(EPJ0#!50.20LSS-B);*
MA6WV!QT;G7Q1/Z=B87PK,Z;C*=,!1NVD$&IYSV^]F]'.K_8Y*UOR$K:7U^_N
M]F_5>UN]L0?##?)*GC-@^\Z=_5W8%_[=BUF'&<_"K.GX=%ZMT=XOYM;!,&^O
M^6DUE97#L9CO? U;RGT379]#HK D'%"-"X!HG@*&*088PA0I 6F>.57 B:+-
MV%[C5\T3FS &;E_6^^[ZJ^)^;L%E,^;F, PV#SV3RM:.9,^0JV1O8@YLN?*<
M'F\_(PJL43V0RS0:U#>) MZQUQ)GT,"=JL7\X5XMGSXHOFN70%4.=4H9($5!
M >*\K!O%PCQ-2RFTP-BI>G6+C+'1I%41&$%/B55RE^N4?&'K31JMYS;2&5@=
M-XDN ZOO+:!PG/QW>9J1B+N'<T;.L#LTS8:>[+^T7.I' *OEVG:FEB]B?;O<
M%'BNRCP@*A2!4@"D: Y0(11@2!. <4D19RG&;FVBFP2,[=7?Z%@=<&W4]"J]
MT0AD^_L> YZ>7_8 9)Q?\B[SV]YP<^_>VVW^=OQF-PX^R&O=9=KVG>Z\+NR+
M;H9\5LOUKV]F+M?7<VGW1)ZW580^+)[8=#ZA,(<*"@QR+LV2"2,$N-0(*((R
MC0E-/:OU.,@<X6M?J6P6^U;IZB'?J7VU*7%5J^X92^8R 6Z^0&18A_ -ZD[)
M]P=]DKMQ]/8-/)")ZBNXR!W4=_  XMB7\+GUPL*D[WZ]8S/;F.SN4:GUWY:+
MEV>SNJGS4'":IH3G&M JWR?'#'!6_54)B4B9I\RK.+N+T+&1T6N]S2O;4WRC
M=U(IGFPU#\L!<IH#-SJ*C6S/?!0'U/""I@XH]5/8M$WPVQ0X=8"BL="IR[V!
M:8AJ.?W!UE7\T&J]K*KHK+;!09^G<W6S5D^VM&&>ZM(X2X6FAJ!4Q@&A@H*R
M$#3' B*N_1(2G<2.C:)>M4[VU+XZB /\PVJ?5.K[9BJZ384;3\4'N&>FBH:M
M?S*C%U1QTQK=1 ^;X.@%QTFJH]_=H<L[I=5RJ635_/@;6YJUH\T#D!59;HL!
M3LJ"(&*X"0B:$H!L3B3AO "9S! 4,"]@(?U6>"YBQT9:[Q?S'\;%K98BSUL+
MDI4UX2IY9LODA]7>=WGG- &N*[S8L/:^)[1%\:Y&T>ALGM^DUGI3,][HG52*
MQUSP^0 5><WG)'K@99\/'*<K/Z^[PXCJJ_IST_381E<O%W/SHZC2E59FL?G^
MT3Q5:G4SW[]F.A?3Y]E>4P6"*6*89:"$L@1(4-O06*0 8U24BL),""_7*X).
M8Z,X8U+RJF]R:%2UJ[4Q*S&^Q,&%6\N"DR9CS+ ;30X\;SUSZ-XLF-=N+ME2
MKI+?GZ6-*7R=L*;YZB4C,R+ 4;DWAEZ#$G-$((]9.^;0ET1B[_HX;O:R(60E
M@QD#/$^961]+""C7 O#4N)FL5 3R@-CK(RECH]WC?J.!9P7G$74CQ8MQZIGF
M_"$*C)EN@*"'*.EC26\0%]U@[/E(Z*:+ ZM4/"Z6:QM]4*5]5*'_N=(9M\&6
MJ600(&;^((02P C+$$^%RDLO!^U4Q-A>_$K#.@1FD_WDGU1Q!DBW5_XR>'I^
MWSV1\:\:T6A\W!H1IV*&K0C1:.9)_8?F*_M-6_VJ?J[O_U2S'^K+8KY^7$UL
M"1H-.0:"VN);&B/ 4KMCKA@L!8-IF7JY *&*C(TL_)-7K45);5)2V]1/_NK)
M%+H1T! 3TW>8@F<6:Y6_>CM_@_35)A#?)(/U1)E1)K$V01::Q]HX7MQR.E45
M:<?J!=?R_[S4>6V[>B>J3*$J*0<I9,AX820%-.<9P((I)0N&\]0K8+L?-<=&
MSMMR)]M$IF2]5]Z$[=2_2N9U'9,U^ZE6]H?_!1.]6"9L-DN>JZH1GAS=TU/@
MQN#_'W?OUATWCJR)_A4^G%F[:BVAA[B0!.8\J6RYVC,NRV.INJ=//>3"U<[I
M5*8Z+RZ[?_T!F,Q47ID $J2X]TQOERV1B(@/Q(< $(AX_;[MF-]3)[JYW?D2
M^LQHDZ9#>DEB<Z6J@\A;DP9NWU0UB:2%S4)CN1J?N6ST<L7HK[.)$ES^<SL;
MCH0+?R%2 D@- R3/$1"J1("@JF($6F_?S[F/$S^T6>/L;;[=*WP;*[+)Q@R_
M&2*RA]J9OWO<.V;T(4*NFJIK]:]?$?H]/?[S=('W+'D=@NO9S[7AIC24ESBO
M)[3(5GN9J*ZS>#,!7=E*;$#E.JQ@G8VTWI%:_#JW4]U(&D&H+CA0.<6 *,T!
M)]I5&,."$%TJJ(JP&,HSDH8V7;B+>MG[Q6)5QQ[7>MYDM::A 9+GH/5S^Y,
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MNZE&\>%U;KN<-_-LI8GC)R.V(,\D-ZH=S(?'$;2>'9*5!H@6=JV(B@)PCC7
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M3AXK<JQSB8W7ZK)5RM#H8E?#P"3F[6BVTT,RC#HFAC!XO.G R_PV(K -[)"
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M29A;=]+L5E]N_XW^'+B3FNYY;:>?B TFLTO?;ZY:3%WY[AV7NZL'*@F4><Y
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MO)"'KUHO/[B.LO[F+S].IT_[Y<=?M?HRGGYYJQ?C+^M;T>O#=,FAS+6J +;
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M?=KI[W@SP*J]P\R0]^(\TC>SIR?;\-)2^U&UZI&F' K),*#&^J!$,F3)F$J
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MH W*<!6&1L;.@NS%A)ML:P0PLSE8<#>FMX;4 527:QVDZBY?QZ_+3NC<-^P
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M)D'.!:.4YU*)H#74D82A+9P>[Q]O/V1N>7K[^/[CK]G=__ET]_'A[B&0&(Z
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M4'H=/[&#I<X7%6^RK2F9F<VS-W.MQJXF6F@^;<^.\.3%Y/#V18/7(1M.>D%
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M;+&WU_?66%>PLN?J8,+JB7IU'<QYS@*(<AB@!^;2GDJ-3+?#0'C*R .-.VA
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M%(OHQJ S!G'FU?%B#]VZOXHY7'@T@._>VT%6/VPY:+/!6BU6WUZ""X;64E)
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MSH?/4<#AS-R9G_[YM^9?S!^<;=0___;_4$L#!!0    ( #N<"%4,AI[32L\
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M_90#K31RX9Q'")EK"+K6ZHG@2]@HYT0/N(81^NDV/AZBH)/COQVT.1]0M'U
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M$E>KXS7#Y$!3I%3J1;4R>%"Z%B@'9Z&$@DY9+3!M9E3O?O:XI=\-3.B>XNO
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M;]V"^Q>L74"3Z O/7C@HS!$/49-4G-9U?*%0B<N2<WK*67KL 2,WS^^OM_G
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M)83:A>/ *R- >BE53#ZV&E:V!9'/[,QVGYVNE>KZ1N458[^'DXL5C#&B]2P
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M=;#G;S\L*03'BF.0K*?=P9L$4?L,==QX#M9%QML \7E>T3085/:^EVD+O76
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M_'3M4J6#VLS[.#RXT43&#4&+070^$9 U>;T^66#:2^F25:99=<.!C.95W/;
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ML<U8A^,OT-'+QOJY0(=(99P+],=%'C/W_X4Y KX6163FP6/9E-X8B"[4.KG
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M!&%V -17?X3Y1?4>R7K^$"[P[H'B!XR7=[_;%HC,"D8?469 K"VQN,D04S#
M:=<V9AZY:=,+8B"A>\'5?)=P;2G2,T+L7=' 3'+C0E8!N*H9WTIX\#87L$H(
MLG-\*+E-B[WAM.Z%6_MOC=L#!=L!=)]XH;@;\;G+\D'.E8E9@;92U+[&'IS5
MIN9U"!%MY!8;);\>0.U>\'7?)7R;"[<' .]IK0?O,2KFP/&T&8NL($95(-%O
M,3FME&N$V1%]+O]]PK2!"/OL/7H7U+M_=USB04U$G_[8"-U ]Z1TI+:>=ZMM
M+M97B_SC?U_5I,';M6];-AJ3HTPN0<I(]VLJ#+PC]<00M0U%LJQ:O27O2^-1
MB8?WEGF[V"YT/6F@VB'?+'E#Q<]X^6F9[_WCWTDTK^FK_YSEY(M'GR S2PI=
MH88@+#'0VHS<:CI5^PV-')VT7C(W1@7=@YS%::5Y/DIP$RT>30MNO]9(#>ZB
M]?1ZD*?,I4@2,-EP/4X\.I/ 1JT55\(EUSIEM)4>O%GI0_J$^>H"WY>G_;"'
M*<<;T=R=E92$$I',!.Z8 :6- :]< )2,.XPR*M[FKCB6\K-1C$-0^-CL.ZEX
M._!47E3MQ<>Z$P0?C0;%I 2G#(.0C A!2)D;Y<"-<D^?(!.N*1Q'%<_YW+Q'
M3#%X[G.-[MZ6LP4&X$QPS77Q##2)G:# / 32-Q"9B)+,,.<;M9\^W>7[MS!?
MO%NNU^\752._+_=6GMF(/KML:Y==60-*"IQT2(Q0+"JC J;<9/O/$'4V5^80
M[#S646,)I8/;\-?5,B'F]4_$R[J9C6-T69GU]7W9=#EYL#DC29D7\G6,)-TK
M6(%@<X;B;,C9I-KFI GB!I%Y-O?D,1AL)[CSN30WANC(-^>#;[9T73NY0S&I
MI"P:X(@6E%>V-N%#8)XIQZ,J'MM<(GTYL-=Y\LY;*P/9EL4E0:Z,8^!SRI!0
M:IY*#;VT,2CV)O%L[M<AN#K$)1TNL YNVQV%CT(XR3 (,-ZEN@,$9U4 [6T(
M5@M4LLV5>F#-<3-L-1+ZRX7'0R30'89V5J3)B$*R2%ZW%;2CF"/X.B=0NA*4
M\%SY8DZ J;,H/!XD_>&%QT-$,76SC=MS5Y:K=:@6RFURS==M2MA-R6/2+'.!
MH*U7=?REJ>,O/90BA"'C53@N7S*^ABW9$VZ.%_2R.=>GQM*[Y>(C?>KS?8MA
MVW93&>.",D!'+8(*D9P2%ARD4'(0/)%JWZ\+T)-+].+_C8^5<;C:P27V?#U]
MU%I$)0SDP#(H6S+YQ<Z#-<9*1/)D=9N@VO$-#IH5"#6"U?@"Z0!=SU35:\_)
M1$0-)<?:NE([<#(ZB*1=F"V*Y=S&W3VRP4&S,I_&N!I)%!V :A__Y-UM(IXD
M-9P4Z6,AO2.>U?%DBGQ@3EL+5CJ10INJ\$%D3GM3GL;C:R>W#D YM*)#1NME
M=ID.L"!%3CK]NO>?\"5QKPNY/&W2;UL4Z4SZ%'$@9(ZLR!DBOP[@^7 3CS?[
MZO-R=3G_%^8WR_7EO=H-\KD9^30)N"-#0PEFP:G:2I_;'#1&%V6;!(R#R.U?
MAXX#U?:R[!ZPM7)COKA:7JW_OB"KYJ+NM\:!?UVNYU7@7/Q,_\6G]?M5==0V
MC<&D#SE($#G4@2*<0PA1@4:MR'4WTK$VC[OC[F-:SZ<7B#>5?@?8?[S?1]RX
M?\ W?6=G4@<NE4:():O:0K8F/6@&*02?2O:9JS;3MX=2.JV'-9TU,:H$.T#H
M@"OHQF RFJX<&8B)0F%-3I7@7#:01!"V9N<XTR84,IS6:?LH]*)ECY9B!S@]
MH%Z9JQ2*P0#>5(86^BE*+HFK,3KG@N"Y3:>/1H7HS1HH].>;'2C%,\+IC N7
M0V$%6.U?HF+RX*H7:E66QJ1:=-JF6=*^%$[;'*$_3 Z26(=(?+B;OZW(S'YH
M=,\L'2XC$H=B!''11@T>@P;AN%,JQ:RPT>S>H:1.V_F@%^OS6!GVF97Z1+7*
M$3FI+WQQA(S4(32?/A^5U5E;J OX0+^H)"1$JQ4D%,847TIFYUI8_D*)TPQ-
MSD&0^Z5M#$ :VD-T?#.7A6S?%*UI-*#K"8)ZR;D9%3-[UIL-$D8'%^CN;;SZ
M^'&%'\,E5F=J%@N:("69 SS5@&M)$*IU4+)1-D=4$MOX&'L0UTO.S@18.UQ(
MW>+N_9\+6N'3_,NON$I5D!]Q9I2CO=%9$J(61DF!$.B*AX!&9RZD]8TR+_8F
ML9<$GPDP>*S ^K3.?EWAES#/Z[#(FXJH[7/2=;OC@QO^[/'5$:RTH;2/9*EM
ME_WQKR^X6->BLLWBVT;D-_CS+CI?!Y*0HE*@C/)T+7H-*ICBD"LO'P]R'*T,
M\&7JCDI;O>'ZMRR_6>SNM>?ZS^\*TT562BMM02=4U_E,/GL!J?A$I\<)*_)+
MV#J6B&E-MM'!\R#Y]52R.4-==GC?GGT^VUJ;->SDLQ<BZX0N2?\6G#-TT25N
M(0:RNY@*WL8L;:N>A"W5V5VTY1K!U;A<OPE?YI?7#S#;M1\N>M?E[^[H8"%K
M(U@)GAD.REH./CHZODP'E:P(EK=)QCZ6\C/0A4.0]VT8[82"[<#3N'O(O+>O
M.XU_MR\G5&))1T"L4[)]#F0=.PO&)9:%Y\8T:IJ_+X73^KK-@=E$4&=X*3_^
MR^U)//QI^(C56E_A _9ZRIL=4T"-/H/U@1 F60)OE" ]ET).1C'KS_=FWWSR
MX4(W^1*!6>$T&M"1.SJ^M7$_<YP.6G#.">VL:?.(_C1-9W ;#T'+8Z4WDC"F
M+MO<[N ?=$*7J^T^UC,O+??2(!B- 90C[CBI%!D.RG.?6"0T#/%L'W[^#*[#
M0Y Q$C\[L+P>6)H/.333RB,S,8+P=5YBSF0R,%_[##FKI!;-\I:>(6K:=]SF
MJF8L<72B:^8+<DMJLWNR';ZLEE]P=?GU,OQ%QT19IS5'!HXK30Y*M0^S9B!R
MTE*5&$(8]*#VY$K3Y@>?1 .-P^5.(+.L#+JFOC"K(II &@()\$%Q<*;0#6NR
ML$Q);].+=O7N3T^;CGL24!S(QZE1<*, B?+T*:P^XLQIRTLB99=4S*!T"+!Y
M8C;2V< E!A_,7BCXYM/3)KNV1<%Q?.S",'DX*??&XE:LT.:= ZX46=QD9D,H
M="D&46).+D>AVZ2K/D'0M-FI)S!(CA=#%VCZ4BNYMI941&Z"DQFX\[%.TI%D
M284,!8DOR)P0H8T+_8",:7-'3X"<0UG> 5[N,>,6\<0)\O)+[4WN00E)^E-(
M!D7HQ(MQ+#=2/-_2,NT@J].\MQS._ [@\QR+;K941,I)6@[)UH$W5FN(FRDS
M49>HI1>QT93T/8C;[T&/G2W"QI9/!Y#;/:YXR[-[DXJ5"X[L0 W%DR.H2J S
M9;0%Z1TZ[6.0JE5?_;T(W ]ZY_N8W$).?0;0=D8(CPB1/?N]$8)@^]-[TGR\
MDFWTB0,Y;+*6QQ+6"''@G+2H-2J.;8J<3Y/ <G, KGM!%::RL:F ]DH1Z(DJ
MIQB"I^N]$/QCBFU&-C\BY P"6D-P\;13-YSM'5QU=^2_71 WKFJ2\V_S]3\W
M/7^U$M%P)X&1NT%\L9O&' *0Q<02!E-T&[/J.:JFQ=-1XGX2.D?ROBL<W8QM
MKFT2MTU74S"1T4T+/&8'"@LQ*5E?^[V46+3RWP0H1L?1MU3U@J-C9?\DJ(X4
M1 >@NF_???@S?+GILXG*<^<2R,W(A*#(@97%@76HDK A.]M&+>VFIQ<@'2OO
M9XSK YG? 82V,^5_K"_WBX^XW41RQJ606&W22GPQL= !4PZR"BG%I)'K-AV9
M=I(S;6)',P =S_H.\'/'G7>WQ?]91L=\3C7H5T")8"%*'4$[XY/)/!?)&U]G
M[_KH3-O&&CJ,TUV!Y;'K.U,ZL<QU :9(62KE#,3B.9VKPJSWF5G7VI1^3%,O
M]]:!XGXAN'8@[SM T3M<KY>K]U]P1=M9?'R'88V_AJ_7XUV7K_$W3$C;S#-4
M5J9,MS":6JR5ZN@H8244D856TG+FVX3>]J7P##(6CW']FPAJZJ21#Y6YOX95
MC3/R+!/?%+[$3=T!L87, ? \R!28<*7L-[WF[IMGD')X""*.X5P'&N>IWAY2
M:VL97>>.1'K=]M+Q',AJ2RI%F12+;2ZM8QJM3)M_>(P^&4,,':#I)EWJI_FB
M)E)NTF_O;N-?\'+&92B.HP1R 31Y%1'IQB\%K.:*O(N(%EOE';U VADD,Q[W
M6#VF:#K VG8CFZOWM_G'3Y?OR]_7UQ;@S,6@/2<_A!5#AT5+15OA IPNV0MB
M%F=M"G*?(>H,TB2/P==8XN@ 6<_X$PF-4,P*0%D2*%DR.;B8 7TQ/A>!XG$6
M;1^^W+29D^,$V8X21@>PNL>9G^?KA!<788'+J_L[\K:J8))^Y)S7=O@*@N,.
MF E.V,2S:#36XV7:SB#-\AB8C2R<ON!V;Q,V956PIHW:0IL@CD'0CD/6(KOB
M&-W_;7K"[B3G##(P1P+5@2+H,R6I>B@+0M_\L(8Z]__Y" E'3U(S8F?6^OVO
M=QU";M&A=&"!9P?&FYJ/S35=0>2?">W)Z_<&M6PW1OH)HL:8GOWHTW<-*;16
MB7L6@&=6>R\R!H%A 2F*%U9%S_S)-MQ)&YNQ\+%K=/8H<NA>B1S>F^O;CXRK
M4!KVW7H.-C+G@LD(R-PR4(GN&_*@/&#F@4F3I=9M[,"&:N6NY\WM(ML<\0V3
M[Z#-N9;D(I)%KTP&Q0V=F> TR(@Q):Y8L&V<]WTI[%?=#,'-TSV)1I1/]ZKG
MB$3J'5\95_FT;C?_%(I<M#[2E4*7EI>UR(Q#G6H RG CE?2*[K1STSZWG_XM
M_/ES('3-P\7Z%[Q\7WXC.:W^J"U'LF)6QP1%94-V.?WDK'9 H Y!!RNU;==6
M_WG:^M4X0[#RI($SCDPZ\+EO=_2?R]4_WRY^72T3KA]MR95LBJLS#A4CCL7H
MR'(C1U +$;F0+@;5V()^FKCI6\PWQ=E(4ND):#_-%_,U7=Q_6R[SHRVQ3#PQ
ME5M>(UW6&2&X1->V83$(U(EVV19H3Q,W?1_YID ;22H] :U&",EEM1I936')
M9%YF)T@1,S+_K/91:_JKV";[\3X5TV8"-(?.4#X?CI'E9;AHU_7SNG]2N![1
M\*5F,QQB8^_\SBB=.E^B;[3BQ.N%?KT(BYN!%9O5[GPV7XSV).*00JY3=!C)
M.1C0B?PU1]S(JLT [!=).[Y\_XD%=CUHJ1A2U*:FF_OZ*AXLN!)SO8^92+8P
MW:S#^/Y43EW0.":6OBWF;R2M/M\ =FF 8V8$//FU1MJJZ42 EW 64:)*+H*+
MABXHAPQB9 RL1%\<PZP:E4%,I[/NL!^YUZ;$ HQI 8IS3ZZ"29"21NF*"U*T
MJ2!ZF;;>]=,0W.RMGPZ3S/EHI:/:H3_]N49ZJ6VGAY< %GA&9TT!RSU>A\6<
MMA*BDU9EC<:G-N7&S173W?/\TP=A4X@E,4H;#0?/Z\R*3+ZEEQ&A!&Z8YYG^
MUV9$YKX4]JZDAF#HZ2#*B%+JX!G@R=V\_EI+1C>EZ]PY&S63-1I$VI=Q\E]Y
MK1JMC[6Q"&[9B<_>'7'38JX-*O:]'P\44<^HNU>FS*U"R4T=QUTK_)B4X"19
M&)8;.L7*(&O6V.=%XCK5=(<"8F^#[##I= "X=V3)O+XBKLX7'VO?^+>?OZR6
M?^"F%F=;Q(X\.B:YAD3>-"A39,T"C6!$#IFY8$6C I:7:>L4;H?"X7')Y;BR
MF;K8\N?E1;ZA6V:T+A')W&A2^[PV?7&801O:C"HR2;E?%_]['YVZ +<-&(YB
MW=0B?[/\_.6*OG5G<B[RAV6Y_)-8NMV.TDXB,@-,(O'$*PT.981:@64$L40\
MCK \@827UYJZ'K<A0$9F]-2XN6L3M29V)<Q_SB\_O;E:7RX_TP+;#1G%3(Y:
M$_)SK3M6$6*D@Y"C+T6&E$S<;\K#/JM-78W;$#NC,[L#L^9)AKV[[;]1= G6
M*0Y<"$L[BN3O\E@C!\YJ089@:925\C)MT]YDT_INAPFH9\C];;5<KV=*V! D
M+Y!\*M7O8+51$ =D-F'*F#2>^*U@0U>G%O2!*-@79,-%T@' 7J5T]?GJ(EQB
M_@&)B#3?R(E^OL"-P!;YU>?EZG+^K\V?/[GYF<8Z^(N.;-3$2)5D@:CJE)\8
M1/#*6"/;A'/&VD&GEOXXH)U$S,/A[:_AO<"/E=+?VZO1FB846!;*J@295;XF
MEB$*LF%%##X*Y$J$-B_]SU'5J5O16(4.%<=H65N'0^OG0+Q<X.KKMU=!%$%D
M'10D%5CMFD;.4=0!%"8O4=0\DC;-?YZFJ5./8QQ8C22*#F[EGZY6B_EE38I<
MY)_F?]6?UM<;T9YQESR#$&KUO*AOSB8@V"R2JET<#&_4DN4IDJ9N^-,44N,(
MH@-$O5EN'/)4Y;+)W?](.]EN)6<CDK89BB$/7/EDP.LZEI'<=E%,L8RUR1E\
MAJBIV_PT1=58PCB?Y)N:7#1R L[]3[9*#GR*ZI,EX@B4W"'7$#SI%I5\?5_-
MB<X2]]RB,(J=:5;S?3=DQM"7D"*KSXRA9IQ592H*6+0V!\=D*&VV>9^*3E\M
M#L+"CO&'AW&[3Q53"X+^G-?F0ODM?6SQ<1XO;AM;71Z6>_SB-T=0,L/H'DG+
MW"SZZMM%=]6^E^1\BAYXX%COM0+>%0E:)I]T]B;+-L; (#*/U3Y[+78O3Y\E
MF;,7D'2L+?<- R>R ,%#\B4)B[Z-?AI&Y[0:K!W.'FNSAM([.WUW>+'%RQ]M
MJ_$:EEX,@R)+@6>>:D]@W'1LC82/XB$D(5.1,9I&;6).JO+N(G WR]Z=$*.*
M#OK_MO=M/6[D2IKO^U^(Y?WRLH#M;I]MP-WVVIX9S),0)(.VSI0ECZ3JT]Y?
MOT&5ZBZ5,Z6D,M58G .CW+:3<?D8C"#C0EM0F2*9CJZP:# R\BR*"13<FD:3
M[EX@ZI*,61\$'<YU/DTO$[AD>-C[YK',2(QWW#UN@Q/U-MRMW,4ZV%9E%K72
M3.2H4Q$ER.0;0Z\SL>,^$8T!R39ZG!!4EZ4V&=C@NSIFXBFW;Z^W5W\/'L9V
M32Z?\&XLMTY3*.9SK<<24K)0@B?1)X7DS#@OVV1]#,G%N"].YP?WV35_<:[E
MHYU^PNU=WR7:NIT_YVH4)S1C< 4@U7BH3O&&P*) H" E&J<]>L VY^ H<?<L
M)$0,PC+K0STNLF(@C6*8?2F!:T< :LKN);F7?;!Q*%;N)?$)'-!W$DK_?3VG
MY7^Y7LT77S[@:K[,,QY2B%F0-PRU,8Q"SD#8S, FI^KSF[%M#MR7J+HD[W (
M1)VLF0FA[,/U*GV%-;Y*:7F]J+/(7N5_7M^.#T)!09CQFCEG97WKC2PD1\(+
M05J5<B!WI"G<7B3ODARW(7 WG*XF!,#=J->;5K'IQ^<5+-976R7^ ^:+=_5E
MV-;IP#D:9CB'.@,OUH;WEBDMO1 2%(HVZ43=:1PWO>C\4!Q8:Q<7(=S_?MTP
M2#BT2MLXH1-OHX0*:*-!(9!%EQU%OT$P"(1< 8[[8DI(I4U'RI'NJU^(TV]J
M1ESTH*,"AA9B'04"#)1#%CCGULL T;7IM-R=QDL*-_K@Z_#5X:!:F\!)_0(_
MKW_\#O]<KMY<P7J][0=@M(S9:V IJ<J:+"S$I!B%8%HY%R#G-L40/8B<2B^/
M87'R?)Q>$Z5-&X_WC/T!WVY+.75U<:0/S&_G4CI5VQO2+Z$V ,^6)UW:E#GT
M)'1<7#8#3'=@GJR]"8#S VP>-)00+A>!QC%>IZ%J4X=V&>2,6P00CFME&E7%
M/B1CLL Z7>%/ZVN.EOX$H'-;)/YFN=BZ(_=L!(&!8GJ*SV2=84!>B=*:I6+!
M.K#1V499ZOL)&O>Z[YQP&D(C$P+61]S603X3VPU3,MI@K'7,^UB-NK7,QYR9
M*]I!R5(5;),,U(F\<>_ZQ@#=<-J:  0_KR#C-UC]URW]4&(=6Z!J[J,G^D,B
MV^PS"Q1F<1Z\3K[-R?B4DG%O[LX)K)-T,!4,55G<]6XR8 R0\^E=H'"]<,>"
MDHY))X/00@GK&F+H 27C5@*>'4/'ZF "&/H%_\2KY?=:8I^^+I97RR\_ML/F
M;]DI+L+VF9A7BZI+*2Q*"$SQDB-YC!H:O<[_A+!QJP+/B; A-30!P-6YS<MO
MWW&#K[ZL\'&W0>]R")RS'&H+,72* 7>111!9IH YR#;/6H=IZ@0S]W> V4!Z
M&1%AZ]5F6T^[O)KGK8JVY;G;^QFK@$>1*-)UM=2_U)GSJ!)#S)+G:+0.G:P8
M+?$ 5?2[IX@Z3,-4FFXUN60=2/23 \]N7X%!([S5K) M95H;6YOZ.H;:<I-%
M 0Z=7I6.A,^8MZ%#:?9%H!PAY@F<9)](^EL[^?IZ/5_@>OT)OVS-YE8Z) ]I
MI*%]0Z0S;2(930V%29/JPYD7JC2J9GB)K'%O#<[TU#.<8J: LAO:=UN$?#KD
MZ&45"YWPF60#SM<>XQB-3 )-;E1?\)",D1\,AU/O4^ <+>N13ZZ/M(-N^L]#
M% (P9A;0%*:5)D%X^JTR20LRT4[P3N_-G8ZJNV7'O3,Z@W-SG("G@(J=#^^*
M+$X'SA1)@,"<,_.6(XLV1&TD0G"=WDRZXV+,I[835/94Z4?(;P*GQ@L;X=U=
MXR*TUB:%)!=M LG%.A:53$S+B$X0Q^C;/'!TH6[<*\3QDU*.4].DH?=O:RS7
M5^_F!6?&<2YJHJW'.E>S6&"!#E<2FL!BK3!:M4E<[$+=9-,#CL1$9] =J:!)
M@V[73$V80I8>)/-.6*9=)(%90;NTED)!*D)CF[XM/Z-LLLD#K<%VA&*F#;0'
MG94?E@O/$+C3GG,FDR;7P=0W:I$TDS(*DZ30MMOMT9#0.T#K9),*FH-Q".5-
M&YZUH[+CRH.L;DI&1[]8P[;MWVC#)0@VD#3/[O%U;7$]1LI!<]CU5<H$(/;;
M(F,YS-&O?Z6KZSI2[+[<&#%I3GO&ZT+A5Z88++HL6%'">@S>.VC34J@OI9/-
M6A@&ADT5-PE@[O$OGG.5P6FAE&=HJL/!27K!J\ RV&(@H?6Y%1R[T#?9Q(:A
M0#BXDB8(/3+KSWG2RN6,Y-JJ0!+3DE-P)3S9>5! /)7D=)NRBR[433;1H0WL
M3E;0Q17HGMAWN^.7&_>);-R%NV?K*2>*YD+3CM,$%PIDF:^#2H+/ HN0SI2_
M0;/(A]'0\RYP,Q=#M#H6YB37C*(A47.#!,5'0G)O-7>YC5%[F:Y+*K+M@Z-G
MTYR&T\[%633SGPBKAP)H8]X.+M/6UG7C;A3#!SZC-FB9 ZUKSSTZB'6=>B)Y
MKL&L0-]FUN!9#=]+ET7/NP%^Q)HS0&:EOABM$UQ5]<V\2MJA- RU(T?%U+2$
M+,FK3=EG)] HUV:V^0#$7Y()[8/(/I>"+?0\@7"E'\M_D)'Y_"^\^A-_7RXV
M7^E4J?$7%LV"X[75)<5E40;)I(:<E/>EB#:I;:?1?4E=V<X'Z).T>W%8KKOU
M\[^6L^IQY43!(\](3'I1^[:J.G1:9"^<SX9/ <([<B^IK]OYD'N,+B\3L(1
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M9K0OUFN4W+5Q#X\D>-R+_(;8>_88>@:%7HK).WX8Z,%O-3%Z#4=_]D3>-A!
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MEJO;Q@CK&8*P,6%F)FM@FF<*]HVCC2.UM9G^*+INK2<.+'!1_7&. <M@TIV
M1?IM0=_"]>8C;'#OR\^KS5N8K_X=KJYQQB7&X -2#.\ETT83;R D$R'+X$)
M;MJ\V?:A\J(ZY9QBJYJI;@*PW,O/0SMLDR\H.!/9":9#%LPG"0Q#*,F$X #;
M')0_(>RB^NV< KXA%30!O+V=+V"1\&#L0P2C,%PR6QR=^UPKYC%&)K,QEB.
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ML.S+6PA2!1U3820)H,C !Q8P:[+,A7/C09'>)YL^=]9.*KT4WS-'KH\6IEE
M^-N"?JR30?&H^L"'_WR \K^#U Q4W7?W_5_FZW2U7%^O\"[LRD5X$VNR-]2P
MJP;U0?#(/*;@=*9PWK4I$G^!J--SPY]]^C.)\C7]G?^:Z11]09M9O:E@F@OB
M55"P:75V,F='PHCG8OB.JG'MQU#X>)[H/9 >)F]$?JU-S*O!W,!?JVU:^]&U
MQQV^.JS)Z43[&2Q1],''&!0SMHZ[P#H\3B0D5 #/#HA(W2:D:&B)[F1[MT8M
M>KBY6+V>+[[LBE?K8#1%;AZ/0C*K+!W8]62-X&A31)"TR9S*KDV-2G<:IVNE
M^F#GJ95JI*,)>-/[.?M89PTG\NIN-+=YBZ0WN/I$FKRF[_UX])=GQ@L?,R0F
M<AV3AK;&KY(S!SD%4(G\P#:[<@#BQPWMSHO7=EJ= I!W)=6[R6R?OI("7L,:
M<WVWQ,5ZRS/QMBNY?DNZ>/@GO_Y5?\29%IZ<C1B9LX:X3M6KH<B(>6_ &>FD
M]VV&- Y#_[C%S,W@?'[=CIU_=?>PNJ&?ZI34U2V3M]Q@#"EGB<RD6A5$_YZ!
MS)R)D*33/"KANJ7;_72I<8N>AP95 _%.,_:XS4U['Z_F7VZ\DS^6F^-N,PY^
M:X XHQN=)T87-]EZ[Y^MM =4GD-*H7B6 2S3 A,+629FA8S9I%2\[=80L=-R
M)]<][:17BV4>1,X*+-&K65**U]YT9.J2U0PP0P!=?)%M7+*]Y(R8YCF\RI]5
M,)VL@(LQ']OWAZ'LQ^YC;0S(/DK/9T$"2,N=B S$-@9,I'>I$BNIB!*U3@'5
M="S(I_05\_45OB\5PO?/W.M[--OLE ;(#"W6<]8H%@L=AI$')55,$D6;$O&?
MTS9YV]('#$]MR\"JF4"8=L_1[Q1UKFX*/\LC&UJW[CU_F1M>&UXQKV5F9#@-
M\U(!R\X9:Y+WW+3)Q^Q+Z3@W"6<'8@.UC1UKW3:;V;G^[Q<O\.7IWUH;$N,^
M)SK7D3,(SK,HC9!>.!ECMZBKQZ+C!/6-D=54\F,CZM7W[U?S5.G_'59?YHOM
M905QAW]2H/D%/U9)/F&/]@L%G-$P$VU]ZXJ17%";:/]PAP+J?S6=@-5_[7'B
M^W/@J[$>+L9Q/^&M\86OM7'=6[PM]L":M""R!<*:CY)"084L*N"UU;_+TE+T
MIL)T?/?';N%-?A@F!PEKHU 5:GLJ^LFC(/\FN^B\=%;)5IESSXB9O'?>1]W/
M<Z!.$_X$W/&'K59J1NI-6G,.T6WS+(J-9&Y1LBA*8,HHR0L'4+9-M+>/FK'3
MYDY4\9[+HI/D/4',[+*850Q*%6WI:$97QZ<I%D*1]?2D"-60\4YM K7]](R+
MF]/U_!/@'"'T"4#G(_ZYO/ISOOCRAM:>;]Y"VM;U[;+649J@0&<F$N=,YX0,
M2B!/C/99SCJ&'-H,0'R1K&D!Z1B]+ULI8>PPJQ[O[Y:PV.XN+%RKX )S$"D^
M3)&"A)@,DSX#%.<0GEX4'6H_\N"K8V?^#W/ZG":LJ6AY!_T"0BF"/9,V4( &
M65%L5C0S+L><'+="=6OQ_?B[8[8B.5HS^_1[A)BFHN%7M^5+ROG(N60^)XKW
MBY:U?,DS*[./R=,9&GV_K3Q^NYD3M+-W%Q\AJJFH^?6.=EV*C*ZF=P/ 38J%
M%W1 >Y4P6N32@>BEYM<]U-SF)GYH-1\CJ@GX>8\/KG=W%4<A2JVB)'@F'IC6
M@1R83%RE6))PD)V'-H45!P@:-UUNZ.!R"*F/;B.6&[CZA(OY<O4)TS6M_MA+
MG<6DO9)2LLSK^.]:VAJE2,Q$D+$$K;/LUHGL9RM-Z>+A2%TN6PEV B;FPVJ9
M$/.Z)GO^MEY?UP[J-\_DLYK(B3H:AJ#KF0B.@J/DR'9B5(ISP['-3<1AFJ84
M1YP&IH'E/P$D/9;.&UBM?M2^CS==KB1Q0H<O6>%29VUBO;,!.LMM<%D481PW
MK:J)#U,UI6-K&#0-IH.QSZ^;RQ5<?;J.[^;?YIOU+#HIN'6%V4A1G?9<LRA4
M8A)S"5F#-J7;@?7LT^/F90]^0ITFNDD8DIME=_,\WBS7F_4_5LOU>F8M<%N,
M90*"85H*SSPGEF0*Y/ )I"".-[(B!T@:=Y)4&Q,RA/0G *.'.3 S])QB1PP,
M;(Y,"T^1@:=?4!I##EF,1;5/Y!YW\E,+L!PMXPG@X[$\=OEX/WZI-7LB6*6%
MXRR#W'8=1N:CJW?YF0N+.KO0JA'<(9K&G>+4WE<Y6OYC>RJ/DJ#>P%6ZOMJJ
MY0U2/+CX0J?P-D,"\\X+PQ)K295G3KK$-$<2&01@HB3.,VV=5#J6Q?1;>-R1
M3(-[.2W%?C'Y: _'.]8_&CA![>#GVV2L=>-FH/88%9![\IA2-A9D3DQ(:PF/
MZ%D,JO8>4+I$:;"D-F_G^^D9)!_[ ZY25=$7?)5)<)^7NX+UM]>+O-[6J",O
M(*,C-G.UM]IK.L-E]?$TY^"-,KS;FV_G)<>_%3Q1^7OSKX>5]-@GVT&N:OKO
MEIM29''(:Q$XR8H,.6<!ZR@QHXWR2F4/W2;3_'2I\2_^SH*7HR0[-D[(5G]Z
M__;C0_/]*O_S>KVI1_W;Y>J6J?H0MYZYFG*>K""/KM0:40HE?<S(; 03<D*3
M><=I1GV6'?^J;TC\M)/X!+#TK;)VS\Y^)F__W@V')"<#"(E9D\BJ)MHWH<C
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MVG&/6!%D]SSW7&#'UAJ3S?KOI9V7LO[[B&HJ:KY-93=&@P!!84[R]2:Y1CU
M4.>0<U)%B]3Q[G6R6?\GJ_D848VMYD>'5OW-U=:P49QB?1*6"1$IQL4"K$X=
MJ84+HFB%(6'NI.W]WQ]1Z6<XO >0Z?1@<;=)# *1S=!GPC8DSX+F=.))43PW
M*++N5N-U:(4Q6T\,H+>7<7"$$,=&PC]6"/2IS5=8:,XW2\'YSLS9Z)V/0==
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M"F+%F-JYW#&AZ,37P-%9TQ,W^]:9G$]U#N2<+/ I8^?=YYFA,]^H*B( 73V
M2"+B4,$1@HZQ1-_7YNQ;9W(.UCC8Z2GP";E<-[ULX4710=QFSL]4$IAIBS 5
M:F_ZXB)M%&X8%@=HC0?5J)CT"&+'S>HY%S#/I<T) /;#:IFOT^:._E<IK:[A
MBCC^OEP0E[M2#@5.(G>!4>14WV658\&7.K9:VB@=CT6UJ;'I1M^X^4#GAF4#
MG4WU+?V*(+NLLOL389'?;[[BZM5J!239[9O;'\O-L7E#G;X\R.MY?QX&>C9_
MO_H"BUUA8(7A\FJ>;S;%(G]XP,Y=T2!<?:+_<D/6?=6^RN!UK"7U/#$M9?7\
M'3*,T:#F)F39YG@:A/S3LX\>J.^!VO8EK]39F[2)$P,@AC0GAP6L%TQ:+$7J
M3+NZ5>I19R+'C6?/C\CG^4AM]'FA!G1[!=7&@NX^?0X3NH^+.QOZ/QN)[J04
MKH[?/H?P6B9N#;/?,2:%O@XEK.-T==B.NQ2)U6S B$4[X=HXGY,X@3Y<K])7
M6.-]JM%-DV5R+W^G7[]=?[OQ]V[^?(-Y%D7QD#4R'^J8:",L_20$<QR3)K?3
M^I3:..M]2?T[G$9]T/G,DV^JVVF>2;]2D+3Y<8S9W/W+ 8SB/AH&,GDWG[Y#
MA^4",T^>"1,+TZX(%D!KAA "5\X&'MOLQ<=TG)QMNB&'Z.ORBC;D^N;+-6S9
MZS3Y:#5W%:". .I+'1)F @.>("J#J8@VV5&=21S7Z)R CV<IH4V4,F6K<;R[
M^NC?#V9!7G0\![4C4DDG(O?,F!!)@Q I*BEA._7*&D$_RS;O\@/;D;M'\U>)
M)'I]1<?IC4M:;Z]6^!47:_)3?UN0H/'=<GWCVM\#67JEO32<69DUA619,0\0
M6' 9,@^1Q]"FD=N)A$_*YO3!TN$T]/8*G+(E.B'Z>_R!P6Q1RSCN"8#J+)>H
MO&8BJEJ&RA6#FF1EC4^"YX(1VHS,',88W51TKQ#HD/RQ/41O_? /5["800PA
MT*E8'7K:'MQR!G1XTF&91;"%FU0ZUL8?6F)2UJ"/,A_7Q \BP0F\@6T9^(C?
M;UE8+;^LX-M=)/;J>O-UN:IS<N__SDU8)F9"%*XCA7P0A*OMJJ .$=3,">)?
M"4PYM!EN?#S-X^:E# "^,ZMM"@#]2K)=?X!Y?KM<?8:__F.^^5K]?N*2_L/V
M3U\3=[D>P73^WC08C<YF# H9<O+T->U"%B6=]YS;!#;2J=MHKO$QU(Z;\#(D
M*%NK:@)PW+6E6'_$K??W>=F53Z<T\:4T\RD8IA7]5,>&DYR%%\G8%')H LEC
M*1XWW65 6)Y%96/G[MU4!?UCM;S^_OY?"_KFU_GW!SD9-UNS3K7'/,O1EES;
MX!J=29A6\UHB(%BB'5>L]J7H;DF@/18=-TME*+>OE92GB)Z/N*TKJ;;\]1)6
MU9-XH+49>('DUPJ6"\@Z)R@P\+&FV60-P1>.3S/W>H#HY;7'G=7=$DL#RGS*
M%P@=KT].OF?HN<Y@UQ&G\-?FUL(X6>U-8BEMYWB2'8+,D7[13AHZR,@<3?C6
MXO9K?>[=9K3SN$-+>P3KXV22E@6I C.2 R_.H, VKS%]J)S4=4@?E#SKQ-]*
M-1-P^N]>OF_D=9=LNM[6^$L>B>H@&0<MF"Y6,%^C:J%3"2(%SUMUD7F)K'&!
MU0X-SRY"AE+-!'#VA(==1:_20JOB$K.T+4D\=<*3T20>#$F!XA94F]3*O>2,
MW.QE.'4OAY;]! #T8-M]7L%B?76CF/S/Z_4VPV97RPTR& /DI)H8-/F1!EAP
MM?$<6(?9NA)C&V^@&WU3.!-/ L+AHW$HK4P+:W_@YA\DI&K1WY(\?\'U_,MB
M:_M7_^<:KN:ESJM[ ^NO;Z^6__K?F+_@>L>S=> U1\FDK*9?^L2\$('5'@8Z
M&Y R-_?1CJ9^"J\)C7!Z'HU."\6_8)DO,+_&!?VPJ8]YZV=[E"-FISUGBGQA
MIA5B?=@S3"@TVF:3,K09;]V/SBD\*31"YM!:FA8&7W*6W]T5T$65R<_1B@4;
M;&U*FU@H1C(3A$@N\1QRFY?7OI2.:R'/%H0T5>#E )0.C??E,_PUDS')Y-$R
MJ)M0<Z<8U!3/VO"@*.FS;50VUY/0BXB1CT3-<1 ]2H430.A+/+W&LESA1TQ7
ML%[/RSS=#/.Z8S5"Y%B+D&W@<+/S@4)%YE"#*[3M4ZL2F^.)O@C#.@QRSZ7:
M":#X*2/5]>X@ZS?7JZJUF\D9]SO860]"..:CJ:U'<V;D:.DZ %7R$IT3ODUH
M-207XSJR9\7Y:,J? / ['4E%.2<M+TS('.JD^UJ<C, D9F-B3EJ+-F4 @[D2
MS;)E)F.0CU+6A 'X8K1YR^R'.H.:%+VY:9FY3?I??M@J;F:EBIR"6^:AGD#@
M.$6]&)D7RI$24(=R7N?B5([&3>29!-#/"HKV>1R[/ZB_1%CC__H?_P]02P,$
M%     @ .YP(52.=<!Y7"   ?RH  !,   !I8W5I+65X,S$Q-C,P,C(N:'1M
MY5I=<QJY$GV_OT)+ZF;C*CZ&#QL;.ZYR,*EP*VOO.F2S^W1+C'I 9<UH=J0!
ML[_^=DN# 0->O'<K(;8?,#-J24?2Z>XCH;,?+J^[@]]_[K&QC17[^?.[C_TN
M*U5JM2_-;JUV.;AD'P8_?62M:E!G@XPG1EJI$ZYJM=Y5B97&UJ:=6FTZG5:G
MS:K.1K7!38V::M64U@:JPHK2^1F]P4_@XOQ?9S]4*NQ2AWD,B65A!MR"8+F1
MR8A]$6!N6:526'5U.LOD:&Q9(V@TV!>=W<H)]^566@7G\W;.:O[YK.8Z.1MJ
M,3L_$W+"I'A;DNV3YHD(CHY;/#AJ'0^CDY,CX(U6*-H@PJ 5_K>.(&MH[NL8
M.U/PMA3+I#(&ZK_3:E3;AZD]G4IAQYUZ$/R[Y$S/SR*=6.POP_K^JV]FK3$+
M=[;"E1PE'3>DDJ\Z+PZUTEGG5>#^3JFD$O%8JEGGQX&,P; KF+(;'?/DQ[+!
M9:@8R&3D#8W\$Q 3PG./4P^YC>THF<!\"/4&@>[=C>50VM>OZD?!:;->K:_"
M_I: 6QL!>Z1K*+_-['5[-X/^^W[W8M"_OF+7[UGW0[_WGO5^ZW4_#_J_]O 5
MEO9NT)%N/GV^N!JPP37[U.N2>3'E08/J#3[TV*>+FW<75[U/E>O?/O9^9Q?=
M 94T@J#QU4>[5U._&4R_S'Z5$[AE_^$R*;,0,BNC&;-CCF0^/-X&<X-K+G$\
MY4)@W*DHB'#)&PC$L5XF F-*I](\2K\5[>O5.>BOW_OIRK0TCJN'- U]-N83
M8!E,)$PQ8MNQ-.R/G&<6,C7#]ZG.+-,)>Z^SV%.G'E1^83IB_>YG]A,(&7)5
M]B7])*SBLIVL+]O&I:&%6%F:5N!!?==KW-B[-7['#:XLKF$\8[>)GBH0(RC[
MI2X66&B$D&C,W-@#NB+CR8SEB<URP!%@+G=I'1>=LQB?,LD5BWB(KS*F8VF9
MU=YNS2"!$(SAV8Q,8GX+V.]2FP;?"02#72JG"; /,@AEAAH S1*LCD@$9&PZ
MEN&8F9P^%O6GD$'1" T@ED:A6"#=,95VC ,T*80.(+6;(C0M<)@3K";8<+8\
M#2^>N\WOA[O (ID@.XAH"S:4D;AHCL794KE,(HQ>G#0N?@]5+K!-9-S2TI>1
MK9(B7HJ$(:Z3#RBU('/!(_.@:_07X<1SF2QRA0;(8(TT<]T9AR?D9LPBI:=F
M3N\,1M)85-Z6<7KI<2/*\A)+S1S,&MH73]36WA%UL+*JKU\=-^KM4U-0L= U
M%)1T%$E\=.O=9SP#QRQDBAPJ( 8P0#H/E31C,B>S& ,R!65Z%M*$2IL<ZU&H
MSK3R%$LS'8+ UX:]048)0(IZVO3NPC%/1L N, K>Y I,D<:;O%(_? ,'_I$:
MJ1\*_^K M8F]0I9XDE-/C(+F$O<]%PG5T[J,UKN,L$L:^T/?0 O2)YNUX OB
M.S_8([XW6C0/EV!P%XD+[A+R7_.R3%HAY+G9O0HE[2$@LXJ>O S0>88-8(B<
M2.,"+UI!XMJA?<,B9"^'_0P4=U0M=,""9.4B)5"AQ/"-6(Q64K@##),/C122
M9Y(&(+U:<8DHH99R0PK"^;AQ<L.%:6T  5E,"U0I12TMPUQQRBXX+ =BH42P
MAM<URW(,OPV!##$!8'T03PCX]>#X.7K <'\\H%T]:J][P,[1<LT1=H^S._L#
M^M!$"J(Y-SKAE%JX01<A.4W<YYF8\Q ]0_*A5-+.2)ULZI:\TE'6L=$[U(KI
MDAQW&>RN&%":9REZ@W%J*@QU)AP )\Q'D*!(4N@46 (I>1N9X*;#$Q^]4J8N
M=>Q,_37"/@OFA_O#_'GL[TVXREV )%I %*$REA-<4+-!X=YKH1T"OG_<+'H=
MT;$B!FOCI?50YW8[@EU2$K^W!MHW1'^]1V3#^8[$^2[XF4 \CJ?4P>X4^\Z)
M*?:'F/<AV:_Y.G?H/*,0I:YD(T&?$(A):.@PS#-BR%)6W]!JK(W%]R'M*B/$
MAPT5!VSLS98J$5(=0^0#ZP(X[B;!'<70*4V2W^,Z\*C&W-Q+( JNSC5 N*SC
MYJ/("#.FY"VHXESF@7WY_YZBE^<.A\]D3^H.A,7<D<J+@$?Q=YG,B]A'='R"
M_EG3X/?0..IPJS-S+SG<"VPRCJ6U (]DEZ%&44/E0B(^U\@;I#P&<T/) O_3
M;F#NI_!'+A&^\\D\"=U9S<$3MIG/@*][N*>\4*@E4=M*Y"/M_^E,(92 !"JT
MP?W>;@K\EI*]UY8NW3M5[ ZDYZ=O3Z)EL0WS)S(;8B076-' ?8C<2N%"2V,5
MY"%*WK)7' ;EALGC&/>2?X(;3)&:-IY3OKSPN8<;O L4#5&&(:B,Y  7-9%>
M[E>&@H=EGW-E,M%J I1X$SXJ?BS)BD +<:KT#+!T.M8^NO(5EB,K_Q%54GT2
M5ZS;%18&0^0I9!6<;<53 YWYEU/, ZGBLXY,W)RY2J?(X9%,*D-MK8X[=(-B
M0LD$M4IQM<!QRA<7ERM.3JKMH$WW*RRRTXIYQ\75BZJ[>E&S8KVL56T?'6XM
M#:KUK66/MMJJ-CR>?[;9=K7=.-ZIV9J;"#\9.-TFY<G;4K/T8,DZC?2.U>=N
MNG1Q8VW*=?KU'=?=F+E$7UC-G,70GS8JXN;^#.HB'^6H=([+[I+2<QK9ZU<M
MC"KN<^GNQ<H(=Z1F0 ,M[?NL[#@I*Y=BM@^H")0(E%IF[J28S>'MP6AWXT!W
M+"%BO3L(<SHU8==^ [!.@IH+^(_?(Z.] &3?(J,<'S;_3D8Y.:Z>!-N+-P3I
MN4$QB4V?0!\C2#&2QE:.K#C/XW/]X+9BJOUUS8[_36,":_<7%U@<B&!1A0\1
M36ZW5]FTKEM4Y<JGOYKI+HF>_P]02P,$%     @ .YP(5><QO$-P"   H2T
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M(XZ"D 2@/V<O0;_0&1V2#U1/-GU@[Y"YX0K[!]N]/0*\:"H8 IT:E5#,+]2
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M2?/ JECRU\I8=X[,%MY57,9&#-6K"%^&2<3H$]C2!F=_,(T";[=*FP>"XEZ
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M"+8BL[N[K%B,93W7NRU<^_27E]TUZLZ?4$L#!!0    ( #N<"%5E\D< 7 4
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M?\EU\@]02P$"% ,4    "  [G A55NJDEAD. P#2C24 $0
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M+3(P,C(P-C,P7VQA8BYX;6Q02P$"% ,4    "  [G A5#(:>TTK/  "ZB D
M%0              @ '% @4 :6-U:2TR,#(R,#8S,%]P<F4N>&UL4$L! A0#
M%     @ .YP(52.=<!Y7"   ?RH  !,              ( !0M(% &EC=6DM
M97@S,3$V,S R,BYH=&U02P$"% ,4    "  [G A5YS&\0W (  "A+0  $P
M            @ '*V@4 :6-U:2UE>#,Q,C8S,#(R+FAT;5!+ 0(4 Q0    (
M #N<"%5E\D< 7 4  "0F   3              "  6OC!0!I8W5I+65X,S(Q
?-C,P,C(N:'1M4$L%!@     )  D 30(  /CH!0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
